PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lahdaoui, F; Delpu, Y; Vincent, A; Renaud, F; Messager, M; Duchene, B; Leteurtre, E; Mariette, C; Torrisani, J; Jonckheere, N; Van Seuningen, I				Lahdaoui, F.; Delpu, Y.; Vincent, A.; Renaud, F.; Messager, M.; Duchene, B.; Leteurtre, E.; Mariette, C.; Torrisani, J.; Jonckheere, N.; Van Seuningen, I.			miR-219-1-3p is a negative regulator of the mucin MUC4 expression and is a tumor suppressor in pancreatic cancer	ONCOGENE			English	Article							CELL-PROLIFERATION; GENE MUC4; ADENOCARCINOMA; TRANSCRIPTION; PROMOTER; GROWTH; IDENTIFICATION; MICRORNAS; MIRNA	Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal cancers in the world with one of the worst outcome. The oncogenic mucin MUC4 has been identified as an actor of pancreatic carcinogenesis as it is involved in many processes regulating pancreatic cancer cell biology. MUC4 is not expressed in healthy pancreas whereas it is expressed very early in pancreatic carcinogenesis. Targeting MUC4 in these early steps may thus appear as a promising strategy to slow-down pancreatic tumorigenesis. miRNA negative regulation of MUC4 could be one mechanism to efficiently downregulate MUC4 gene expression in early pancreatic neoplastic lesions. Using in silico studies, we found two putative binding sites for miR-219-1-3p in the 3'-UTR of MUC4 and showed that miR-219-1-3p expression is downregulated both in PDAC-derived cell lines and human PDAC tissues compared with their normal counterparts. We then showed that miR-219-1-3p negatively regulates MUC4 mucin expression via its direct binding to MUC4 3'-UTR. MiR-219-1-3p overexpression (transient and stable) in pancreatic cancer cell lines induced a decrease of cell proliferation associated with a decrease of cyclin D1 and a decrease of Akt and Erk pathway activation. MiR-219-1-3p overexpression also decreased cell migration. Furthermore, miR-219-1-3p expression was found to be conversely correlated with Muc4 expression in early pancreatic intraepithelial neoplasia lesions of Pdx1-Cre;LSL-Kras(G12D) mice. Most interestingly, in vivo studies showed that miR-219-1-3p injection in xenografted pancreatic tumors in mice decreased both tumor growth and MUC4 mucin expression. Altogether, these results identify miR-219-1-3p as a new negative regulator of MUC4 oncomucin that possesses tumor-suppressor activity in PDAC.	[Lahdaoui, F.; Vincent, A.; Renaud, F.; Messager, M.; Duchene, B.; Leteurtre, E.; Mariette, C.; Jonckheere, N.; Van Seuningen, I.] INSERM, UMR837, JPARC, Team Mucins 5, F-59045 Lille, France; [Lahdaoui, F.; Vincent, A.; Renaud, F.; Messager, M.; Duchene, B.; Leteurtre, E.; Mariette, C.; Jonckheere, N.; Van Seuningen, I.] Univ Lille Nord France, Lille, France; [Lahdaoui, F.; Vincent, A.; Renaud, F.; Messager, M.; Duchene, B.; Leteurtre, E.; Mariette, C.; Jonckheere, N.; Van Seuningen, I.] CHRU Lille, F-59037 Lille, France; [Delpu, Y.; Torrisani, J.] INSERM, Canc Res Ctr Toulouse, UMR 1037, F-59045 Lille, France; [Delpu, Y.; Torrisani, J.] Univ Toulouse 3, F-31062 Toulouse, France	Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Van Seuningen, I (corresponding author), INSERM, JPARC UMR837, Rue Polonovski, F-59045 Lille, France.	isabelle.vanseuningen@inserm.fr	Renaud, Florence/V-5064-2019; Jonckheere, Nicolas/J-6028-2013; Vincent, Audrey/I-2934-2016; Torrisani, Jérôme/M-6203-2014; VAN SEUNINGEN, Isabelle/N-6176-2016	Jonckheere, Nicolas/0000-0002-0496-0661; Vincent, Audrey/0000-0003-0058-2058; Torrisani, Jérôme/0000-0001-6880-9357; Duchene, Belinda/0000-0002-4810-4680; RENAUD, Florence/0000-0003-3614-1713; VAN SEUNINGEN, Isabelle/0000-0002-3131-2694	PhD fellowship of la Ligue Nationale Contre le Cancer; la Ligue Nationale Contre le Cancer (Equipe Labellisee Ligue IVS); 'Contrat Hospitalier de Recherche Translationnelle' (AVIESAN/CHRT)	PhD fellowship of la Ligue Nationale Contre le Cancer; la Ligue Nationale Contre le Cancer (Equipe Labellisee Ligue IVS); 'Contrat Hospitalier de Recherche Translationnelle' (AVIESAN/CHRT)	We thank D Tuveson (Cambridge Research Institute, England, UK) for the kind gift of LStopL-Kras<SUP>G12D</SUP> mouse model, Dr MS Tsao (University Health Network, Toronto, Canada) for the kind gift of human pancreatic ductal cells, MH Gevaert and R Siminsky (Department of Histology, Faculty of Medicine, University of Lille 2) for their technical help, Dr C Cauffiez (EA4483, University of Lille 2) and Dr M Perrais (Inserm UMR837, team 5, Lille) for the in situ hybridization studies, the technical platforms IFR114/IMPRT for luciferase measurements (A.S Drucbert) and the animal facility (D. Taillieu). FL is a recipient of a PhD fellowship of la Ligue Nationale Contre le Cancer. This work is supported by a grant from la Ligue Nationale Contre le Cancer (Equipe Labellisee Ligue 2013, IVS). IVS is the recipient of a 'Contrat Hospitalier de Recherche Translationnelle' (AVIESAN/CHRT).	Andrianifahanana M, 2005, ONCOGENE, V24, P6143, DOI 10.1038/sj.onc.1208756; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chaturvedi P, 2008, CANCER RES, V68, P2065, DOI 10.1158/0008-5472.CAN-07-6041; Chaturvedi P, 2007, MOL CANCER RES, V5, P309, DOI 10.1158/1541-7786.MCR-06-0353; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; du Rieu MC, 2010, CLIN CHEM, V56, P603, DOI 10.1373/clinchem.2009.137364; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Furukawa T, 1996, AM J PATHOL, V148, P1763; Hruban RH, 2008, INT J CLIN EXP PATHO, V1, P306; Humeau M, 2013, CLIN BIOCHEM, V46, P933, DOI 10.1016/j.clinbiochem.2013.03.019; Jonckheere N, 2004, ONCOGENE, V23, P5729, DOI 10.1038/sj.onc.1207769; Jonckheere N, 2007, J BIOL CHEM, V282, P22638, DOI 10.1074/jbc.M700905200; Jonckheere N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032232; Jonckheere Nicolas, 2010, Cancers (Basel), V2, P1794, DOI 10.3390/cancers2041794; Jonckheere N, 2010, BIOCHIMIE, V92, P1, DOI 10.1016/j.biochi.2009.09.018; Jonckheere Nicolas, 2008, Critical Reviews in Oncogenesis, V14, P177; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Lal A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002363; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Lin MB, 2003, CHINESE MED J-PEKING, V116, P1156; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mahlamaki EH, 2002, GENE CHROMOSOME CANC, V35, P353, DOI 10.1002/gcc.10122; Olive KP, 2006, CLIN CANCER RES, V12, P5277, DOI 10.1158/1078-0432.CCR-06-0436; Perrais M, 2001, J BIOL CHEM, V276, P30923, DOI 10.1074/jbc.M104204200; Piessen G, 2007, BIOCHEM J, V402, P81, DOI 10.1042/BJ20061461; Rachagani S, 2012, CARCINOGENESIS, V33, P1953, DOI 10.1093/carcin/bgs225; Schultz NA, 2012, MODERN PATHOL, V25, P1609, DOI 10.1038/modpathol.2012.122; Singh AP, 2007, ONCOGENE, V26, P30, DOI 10.1038/sj.onc.1209764; Skrypek N, 2013, ONCOGENE, V32, P1714, DOI 10.1038/onc.2012.179; Srivastava SK, 2011, CARCINOGENESIS, V32, P1832, DOI 10.1093/carcin/bgr223; Swartz MJ, 2002, AM J CLIN PATHOL, V117, P791; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Torrisani J, 2001, GASTROENTEROLOGY, V120, P200, DOI 10.1053/gast.2001.21192; Torrisani J, 2009, HUM GENE THER, V20, P831, DOI 10.1089/hum.2008.134; van der Sluis M, 2004, BIOCHEM BIOPH RES CO, V325, P952, DOI 10.1016/j.bbrc.2004.10.108; Van Seuningen I, 2000, BIOCHEM J, V348, P675; Vincent A, 2008, FASEB J, V22, P3035, DOI 10.1096/fj.07-103390; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Yu J, 2012, CLIN CANCER RES, V18, P981, DOI 10.1158/1078-0432.CCR-11-2347; Zhang BZ, 2012, HUM GENE THER, V23, P1071, DOI 10.1089/hum.2012.070; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018	45	52	54	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 5	2015	34	6					780	788		10.1038/onc.2014.11	http://dx.doi.org/10.1038/onc.2014.11			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CA4DG	24608432	Green Published			2022-12-25	WOS:000348853800011
J	Frohlich, LF; Mrakovcic, M; Smole, C; Lahiri, P; Zatloukal, K				Froehlich, Leopold F.; Mrakovcic, Maria; Smole, Claudia; Lahiri, Pooja; Zatloukal, Kurt			Epigenetic Silencing of Apoptosis-Inducing Gene Expression Can Be Efficiently Overcome by Combined SAHA and TRAIL Treatment in Uterine Sarcoma Cells	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; SUBEROYLANILIDE HYDROXAMIC ACID; BREAST-CANCER CELLS; HDAC INHIBITORS; COMMON HALLMARK; OVARIAN-CANCER; CASPASE 8; RESISTANCE; DEATH; APO2L/TRAIL	The lack of knowledge about molecular pathology of uterine sarcomas with a representation of 3-7% of all malignant uterine tumors prevents the establishment of effective therapy protocols. Here, we explored advanced therapeutic options to the previously discovered antitumorigenic effects of the histone deacetylase (HDAC) inhibitor suberoylanilide hydroxamic acid (SAHA) by combined treatment with the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo-2L). In addition, we investigated the uterine sarcoma cell lines, MES-SA and ESS-1, regarding the underlying molecular mechanisms of SAHA and TRAIL-induced apoptosis and their resistance towards TRAIL. Compared to single SAHA or TRAIL treatment, the combination of SAHA with TRAIL led to complete cell death of both tumor cell lines after 24 to 48 hours. In contrast to single SAHA treatment, apoptosis occured faster and was more pronounced in ESS-1 cells than in MES-SA cells. Induction of SAHA-and TRAIL-induced apoptosis was accompanied by upregulation of the intrinsic apoptotic pathway via reduction of mitochondrial membrane potential, caspase-3, -6, and -7 activation, and PARP cleavage, but was also found to be partially caspase-independent. Apoptosis resistance was caused by reduced expression of caspase-8 and DR 4/TRAIL-R1 in ESS-1 and MES-SA cells, respectively, due to epigenetic silencing by DNA hypermethylation of gene promoter sequences. Treatment with the demethylating agent 5-Aza-2'-deoxycytidine or gene transfer therefore restored gene expression and increased the sensitivity of both cell lines against TRAIL-induced apoptosis. Our data provide evidence that deregulation of epigenetic silencing by histone acetylation and DNA hypermethylation might play a fundamental role in the origin of uterine sarcomas. Therefore, tumor growth might be efficiently overcome by a cytotoxic combinatorial treatment of HDAC inhibitors with TRAIL.	[Froehlich, Leopold F.; Smole, Claudia; Lahiri, Pooja; Zatloukal, Kurt] Med Univ Graz, Mol Pathol Lab, Graz, Austria; [Mrakovcic, Maria] Med Univ Graz, Med Res Ctr, Graz, Austria	Medical University of Graz; Medical University of Graz	Frohlich, LF (corresponding author), Med Univ Graz, Mol Pathol Lab, Graz, Austria.	leopold.froehlich@medunigraz.at	Lahiri, Pooja/AAE-6663-2019	Lahiri, Pooja/0000-0002-6305-9451	Lore Saldow Research Fund	Lore Saldow Research Fund	This work was supported by the Lore Saldow Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae SI, 2008, ONCOGENE, V27, P490, DOI 10.1038/sj.onc.1210655; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Butler LM, 2006, INT J CANCER, V119, P944, DOI 10.1002/ijc.21939; Carlisi D, 2009, EUR J CANCER, V45, P2425, DOI 10.1016/j.ejca.2009.06.024; Cichorek M, 2008, DERMATOLOGIA ESTETYC, V10, P1; Cowling V, 2002, CELL DEATH DIFFER, V9, P1046, DOI 10.1038/sj.cdd.4401065; D'Angelo E, 2010, GYNECOL ONCOL, V116, P131, DOI 10.1016/j.ygyno.2009.09.023; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Elias A, 2009, CLIN CANCER RES, V15, P5457, DOI 10.1158/1078-0432.CCR-09-1125; Fandy TE, 2005, NEOPLASIA, V7, P646, DOI 10.1593/neo.04655; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Frew AJ, 2008, P NATL ACAD SCI USA, V105, P11317, DOI 10.1073/pnas.0801868105; Frew AJ, 2009, CANCER LETT, V280, P125, DOI 10.1016/j.canlet.2009.02.042; Frohlich LF, 2007, ENDOCRINOLOGY, V148, P2925, DOI 10.1210/en.2006-1298; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Fulda S, 2001, ONCOGENE, V20, P5865, DOI 10.1038/sj.onc.1204750; Fulda S, 2008, CURR CANCER DRUG TAR, V8, P132, DOI 10.2174/156800908783769355; Gillenwater AM, 2007, MOL CANCER THER, V6, P2967, DOI 10.1158/1535-7163.MCT-04-0344; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gunawan B, 1998, INT J CANCER, V77, P424, DOI 10.1002/(SICI)1097-0215(19980729)77:3<424::AID-IJC19>3.0.CO;2-7; Harada K, 2002, CANCER RES, V62, P5897; HARKER WG, 1983, CANCER RES, V43, P4943; Horak P, 2005, MOL CANCER RES, V3, P335, DOI 10.1158/1541-7786.MCR-04-0136; Hrzenjak A, 2008, J PATHOL, V216, P495, DOI 10.1002/path.2434; Hrzenjak A, 2006, MOL CANCER THER, V5, P2203, DOI 10.1158/1535-7163.MCT-05-0480; Hrzenjak A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-49; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kaminskyy VO, 2011, CARCINOGENESIS, V32, P1450, DOI 10.1093/carcin/bgr135; Krikun G, 2004, ENDOCRINOLOGY, V145, P2291, DOI 10.1210/en.2003-1606; Kubota T, 1997, NAT GENET, V16, P16, DOI 10.1038/ng0597-16; Lakshmikanthan V, 2006, INT J CANCER, V119, P221, DOI 10.1002/ijc.21824; Lawrence D, 2001, NAT MED, V7, P383, DOI 10.1038/86397; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Li H, 2007, P NATL ACAD SCI USA, V104, P20001, DOI 10.1073/pnas.0709986104; Lillehammer T, 2007, J GENE MED, V9, P440, DOI 10.1002/jgm.1036; Lin JQ, 2006, BIOCHEM BIOPH RES CO, V346, P1136, DOI 10.1016/j.bbrc.2006.05.209; Lubieniecka JM, 2008, CANCER RES, V68, P4303, DOI 10.1158/0008-5472.CAN-08-0092; MAJOR FJ, 1993, CANCER-AM CANCER SOC, V71, P1702, DOI 10.1002/cncr.2820710440; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Martinez R, 2007, CARCINOGENESIS, V28, P1264, DOI 10.1093/carcin/bgm014; Mrakovcic M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056791; Nakata S, 2004, ONCOGENE, V23, P6261, DOI 10.1038/sj.onc.1207830; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Reichardt P, 2012, ANN ONCOL, V23, P151, DOI 10.1093/annonc/mds359; Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001; Shivapurkar N, 2002, CANCER BIOL THER, V1, P65, DOI 10.4161/cbt.1.1.45; Sonnemann J, 2007, J CANCER RES CLIN, V133, P847, DOI 10.1007/s00432-007-0227-8; Sung ES, 2010, APOPTOSIS, V15, P1256, DOI 10.1007/s10495-010-0521-9; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tavassoli FA, 2003, WHO CLASSIFICATION P, P233; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Tomek S, 2004, GYNECOL ONCOL, V94, P107, DOI 10.1016/j.ygyno.2004.04.012; VALERIOTE F, 1975, CANCER CHEMOTH REP 1, V59, P895; Wagner JM, 2010, CLIN EPIGENETICS, V1, DOI 10.1007/s13148-010-0012-4; Wiegmans AP, 2011, CANCER RES, V71, P3603, DOI 10.1158/0008-5472.CAN-10-3289; Wu YY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-32; Yang P, 2007, INVEST OPHTH VIS SCI, V48, P3341, DOI 10.1167/iovs.06-1340	57	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91558	10.1371/journal.pone.0091558	http://dx.doi.org/10.1371/journal.pone.0091558			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618889	gold, Green Published, Green Submitted			2022-12-25	WOS:000332842400105
J	Bi, ZL; Yang, XL; Yu, W; Shu, JH; Zhang, YZ				Bi, Zhenle; Yang, Xiaoli; Yu, Wei; Shu, Jianhong; Zhang, Yaozhou			Diapause-Associated Protein3 Functions as Cu/Zn Superoxide Dismutase in the Chinese Oak Silkworm (Antheraea pernyi)	PLOS ONE			English	Article							BOMBYX-MORI; OXIDATIVE STRESS; CAENORHABDITIS-ELEGANS; HYDROGEN-PEROXIDE; INSECT DIAPAUSE; TIMER PROTEIN; PEPTIDE PIN; EGGS; EXPRESSION; METABOLISM	To better understand the molecular mechanism underlying of diapause in Antheraea pernyi (A. pernyi), we cloned a novel diapause-associated protein 3 (DAP3) gene from A. pernyi by reverse transcription-polymerase chain reaction (RT-PCR) and studied the biological functions. Sequence analysis revealed that this gene encodes 171 amino acids and has a conserved domain of Copper/Zinc superoxide dismutase (Cu/Zn-SOD). Western blot and qRT-PCR results showed that DAP3 was mainly expressed in the pupal stage, and gradually decreased as diapause development. DAP3 was also expressed in 1st and 5th instar larvae of A. pernyi. In tissues of 5th instar larvae of A. pernyi, DAP3 was mainly expressed in the epidermis, followed by the head, hemolymph and fat body. To identify the SOD activity of DAP3, we constructed a prokaryotic expression vector by inserting the coding region sequence into plasmid pET-28a (+) and obtained the purified rHIS-DAP3 fusion protein by Ni-NTA affinitive column. Importantly, we found the SOD activity of DAP3 fusion protein was approximately 0.6674 U/mu g. To further confirm the SOD activity of DAP3 in vivo, we induced the oxidative stress model of pupae by UV irradiation. The results showed that both the mRNA and protein level of DAP3 significantly increased by UV irradiation. Furthermore, the SOD activity of the total lysate of pupae increased significantly at 10 min post UV irradiation and transiently returned to normal level afterwards. These results suggested that DAP3 might be a novel protein with SOD activity getting involved in regulation of diapause in A. pernyi.	[Bi, Zhenle; Yang, Xiaoli; Yu, Wei; Shu, Jianhong; Zhang, Yaozhou] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Bi, Zhenle; Yang, Xiaoli; Zhang, Yaozhou] Tianjin Int Joint Acad Biomed, Tianjin, Peoples R China	Zhejiang Sci-Tech University; Tianjin International Joint Academy of Biomedicine	Shu, JH (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.	shujianhong@zstu.edu.cn; yaozhou@chinagene.com			National High-tech R D program [2011AA100603]; Zhejiang Natural Science Foundation [LY13H090015]	National High-tech R D program; Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This work was supported by the National High-tech R & D program (grant No. 2011AA100603) and Zhejiang Natural Science Foundation (Grant No: LY13H090015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Smith A, 2002, PARASITE IMMUNOL, V24, P119, DOI 10.1046/j.1365-3024.2002.00445.x; BUECHTER DD, 1988, PHARM RES-DORDR, V5, P253, DOI 10.1023/A:1015914418014; Coates BS, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.19; CRAPO JD, 1992, P NATL ACAD SCI USA, V89, P10405, DOI 10.1073/pnas.89.21.10405; de Loof A, 1970, J. Insect Physiol., V16, P1455, DOI 10.1016/0022-1910(70)90144-7; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; FONTECAVE M, 1987, J BIOL CHEM, V262, P12332; Foth BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r177; Hahn DA, 2011, ANNU REV ENTOMOL, V56, P103, DOI 10.1146/annurev-ento-112408-085436; Hiraki T, 2008, J MOL BIOL, V377, P630, DOI 10.1016/j.jmb.2008.01.020; Honda Y, 2008, EXP GERONTOL, V43, P520, DOI 10.1016/j.exger.2008.02.009; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Hu Xiao-ke, 2002, Yaoxue Xuebao, V37, P23; Isobe M, 2006, CHEMBIOCHEM, V7, P1590, DOI 10.1002/cbic.200600138; Kai H, 1999, CHRONOBIOL INT, V16, P51, DOI 10.3109/07420529908998711; Krieg RC, 2005, J BIOCHEM BIOPH METH, V65, P13, DOI 10.1016/j.jbbm.2005.08.005; Lewis DK, 2002, J INSECT PHYSIOL, V48, P887, DOI 10.1016/S0022-1910(02)00158-0; Li JM, 2011, ARCH INSECT BIOCHEM, V77, P118, DOI 10.1002/arch.20428; Marikovsky M, 2003, J IMMUNOL, V170, P2993, DOI 10.4049/jimmunol.170.6.2993; McCord JM, 2005, BIOMED PHARMACOTHER, V59, P139, DOI 10.1016/j.biopha.2005.03.005; Pitchayawasin-Thapphasaraphong S, 2009, BIOSCI BIOTECH BIOCH, V73, P1578, DOI 10.1271/bbb.90066; SALAMA MS, 1992, ARCH INSECT BIOCHEM, V21, P1, DOI 10.1002/arch.940210102; TAINER JA, 1982, J MOL BIOL, V160, P181, DOI 10.1016/0022-2836(82)90174-7; Ti XA, 2006, J INSECT PHYSIOL, V52, P461, DOI 10.1016/j.jinsphys.2005.12.005; Ti XN, 2005, J INSECT PHYSIOL, V51, P1025, DOI 10.1016/j.jinsphys.2005.04.019; Zhao LC, 2010, ARCH INSECT BIOCHEM, V74, P127, DOI 10.1002/arch.20367; Zhao LC, 2009, COMP BIOCHEM PHYS B, V152, P339, DOI 10.1016/j.cbpb.2008.12.014	27	9	11	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90435	10.1371/journal.pone.0090435	http://dx.doi.org/10.1371/journal.pone.0090435			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24613963	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300025
J	Gonzalez-Perez, D; Molina-Espeja, P; Garcia-Ruiz, E; Alcalde, M				Gonzalez-Perez, David; Molina-Espeja, Patricia; Garcia-Ruiz, Eva; Alcalde, Miguel			Mutagenic Organized Recombination Process by Homologous In Vivo Grouping (MORPHING) for Directed Enzyme Evolution	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; PEROXIDASE; EXPRESSION; CHALLENGE; STABILITY; LIBRARIES; DRIFT; TOOL	Approaches that depend on directed evolution require reliable methods to generate DNA diversity so that mutant libraries can focus on specific target regions. We took advantage of the high frequency of homologous DNA recombination in Saccharomyces cerevisiae to develop a strategy for domain mutagenesis aimed at introducing and in vivo recombining random mutations in defined segments of DNA. Mutagenic Organized Recombination Process by Homologous IN vivo Grouping (MORPHING) is a one-pot random mutagenic method for short protein regions that harnesses the in vivo recombination apparatus of yeast. Using this approach, libraries can be prepared with different mutational loads in DNA segments of less than 30 amino acids so that they can be assembled into the remaining unaltered DNA regions in vivo with high fidelity. As a proof of concept, we present two eukaryotic-ligninolytic enzyme case studies: i) the enhancement of the oxidative stability of a H2O2-sensitive versatile peroxidase by independent evolution of three distinct protein segments (Leu28-Gly57, Leu149-Ala174 and Ile199-Leu268); and ii) the heterologous functional expression of an unspecific peroxygenase by exclusive evolution of its native 43-residue signal sequence.	[Gonzalez-Perez, David; Molina-Espeja, Patricia; Alcalde, Miguel] CSIC, Inst Catalisis & Petr Quim, Dept Biocatalisis, Madrid, Spain; [Garcia-Ruiz, Eva] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Catalisis y Petroleoquimica (ICP); University of Illinois System; University of Illinois Urbana-Champaign	Alcalde, M (corresponding author), CSIC, Inst Catalisis & Petr Quim, Dept Biocatalisis, Madrid, Spain.	malcalde@icp.csic.es	Garcia-Ruiz, Eva/J-5502-2017; González Pérez, David/M-2210-2016; Gonzalez-Perez, David/ABI-6737-2020	Garcia-Ruiz, Eva/0000-0001-7965-9948; Alcalde, Miguel/0000-0001-6780-7616; Gonzalez-Perez, David/0000-0001-9613-4705; Molina-Espeja, Patricia/0000-0002-2590-0932	European Comission [Peroxicats-FP7-KBBE-2010-4-26537, Indox-FP7-KBBE-2013-7-613549]; National Project (Evofacel) [BIO2010-19697]	European Comission(European CommissionEuropean Commission Joint Research Centre); National Project (Evofacel)	This work was supported by the European Comission Projects Peroxicats-FP7-KBBE-2010-4-26537 and Indox-FP7-KBBE-2013-7-613549 and the National Project (Evofacel) [BIO2010-19697]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcalde M, 2010, METHODS MOL BIOL, V634, P3, DOI 10.1007/978-1-60761-652-8_1; Alcolombri U, 2011, J MOL BIOL, V411, P837, DOI 10.1016/j.jmb.2011.06.037; Bershtein S, 2008, CURR OPIN CHEM BIOL, V12, P151, DOI 10.1016/j.cbpa.2008.01.027; Bloom JD, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-17; Bloom JD, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-29; Bloom JD, 2009, P NATL ACAD SCI USA, V106, P9995, DOI 10.1073/pnas.0901522106; Cherry JR, 1999, NAT BIOTECHNOL, V17, P379, DOI 10.1038/7939; Cobb RE, 2012, CURR OPIN CHEM BIOL, V16, P285, DOI 10.1016/j.cbpa.2012.05.186; Da Silva NA, 2012, FEMS YEAST RES, V12, P197, DOI 10.1111/j.1567-1364.2011.00769.x; Dalby PA, 2011, CURR OPIN STRUC BIOL, V21, P473, DOI 10.1016/j.sbi.2011.05.003; Finney-Manchester SP, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt150; Garcia-Ruiz E, 2012, BIOCHEM J, V441, P487, DOI 10.1042/BJ20111199; Goldsmith M, 2013, METHOD ENZYMOL, V523, P257, DOI 10.1016/B978-0-12-394292-0.00012-6; Gonzalez-Perez D, 2012, BIOENGINEERED, V3, P172, DOI 10.4161/bbug.19544; Gupta RD, 2008, NAT METHODS, V5, P939, DOI 10.1038/nmeth.1262; Herman A, 2007, PROTEIN ENG DES SEL, V20, P219, DOI 10.1093/protein/gzm014; Hidalgo A, 2008, PROTEIN ENG DES SEL, V21, P567, DOI 10.1093/protein/gzn034; Hofrichter M, 2006, APPL MICROBIOL BIOT, V71, P276, DOI 10.1007/s00253-006-0417-3; Hofrichter M, 2010, APPL MICROBIOL BIOT, V87, P871, DOI 10.1007/s00253-010-2633-0; Hong KK, 2012, CELL MOL LIFE SCI, V69, P2671, DOI 10.1007/s00018-012-0945-1; Kitajima S, 2008, BIOCHEM BIOPH RES CO, V372, P918, DOI 10.1016/j.bbrc.2008.05.160; Krivoruchko A, 2011, BIOTECHNOL J, V6, P262, DOI 10.1002/biot.201000308; Lutz S, 2010, CURR OPIN BIOTECH, V21, P734, DOI 10.1016/j.copbio.2010.08.011; Miyazaki-Imamura C, 2003, PROTEIN ENG, V16, P423, DOI 10.1093/protein/gzg054; Nevoigt E, 2008, MICROBIOL MOL BIOL R, V72, P379, DOI 10.1128/MMBR.00025-07; Ostrov Nili, 2013, Methods Mol Biol, V978, P187, DOI 10.1007/978-1-62703-293-3_14; Pecyna MJ, 2009, APPL MICROBIOL BIOT, V84, P885, DOI 10.1007/s00253-009-2000-1; Peisajovich SG, 2007, NAT METHODS, V4, P991, DOI 10.1038/nmeth1207-991; POMPON D, 1989, GENE, V83, P15, DOI 10.1016/0378-1119(89)90399-5; Reetz MT, 2007, NAT PROTOC, V2, P891, DOI 10.1038/nprot.2007.72; Reetz MT, 2005, ANGEW CHEM INT EDIT, V44, P4192, DOI 10.1002/anie.200500767; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Ruiz-Duenas FJ, 2009, J EXP BOT, V60, P441, DOI 10.1093/jxb/ern261; Ryan BJ, 2007, BIOCHIMIE, V89, P1029, DOI 10.1016/j.biochi.2007.03.013; Shao ZY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn991; Shivange AV, 2009, CURR OPIN CHEM BIOL, V13, P19, DOI 10.1016/j.cbpa.2009.01.019; Tracewell CA, 2009, CURR OPIN CHEM BIOL, V13, P3, DOI 10.1016/j.cbpa.2009.01.017; Valderrama B, 2002, CHEM BIOL, V9, P555, DOI 10.1016/S1074-5521(02)00149-7; Voloshchuk N, 2010, MOL BIOSYST, V6, P65, DOI 10.1039/b909200p; Wang TW, 2012, APPL MICROBIOL BIOT, V93, P1853, DOI 10.1007/s00253-012-3920-8; Wingler LM, 2011, P NATL ACAD SCI USA, V108, P15135, DOI 10.1073/pnas.1100507108; Wong TS, 2007, ENVIRON MICROBIOL, V9, P2645, DOI 10.1111/j.1462-2920.2007.01411.x; Wong TS, 2006, COMB CHEM HIGH T SCR, V9, P271, DOI 10.2174/138620706776843192; Zumarraga M, 2008, PROTEINS, V71, P250, DOI 10.1002/prot.21699	44	39	44	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90919	10.1371/journal.pone.0090919	http://dx.doi.org/10.1371/journal.pone.0090919			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614282	Green Published, gold, Green Submitted			2022-12-25	WOS:000332839300054
J	Pan, D; Song, YL; Zeng, ZG; Bravery, BD				Pan, Duo; Song, Yan-Ling; Zeng, Zhi-Gao; Bravery, Benjamin D.			Habitat Selection by Eld's Deer following Relocation to a Patchy Landscape	PLOS ONE			English	Article							SPATIAL SEXUAL SEGREGATION; HUMAN DISTURBANCE; CERVUS-ELDI; HOME-RANGE; BEHAVIORAL-RESPONSES; PREDATION RISK; HAINAN ISLAND; DAMA-DAMA; MULE DEER; REINDEER	An emerging issue in wildlife conservation is the re-establishment of viable populations of endangered species in suitable habitats. Here, we studied habitat selection by a population of Hainan Eld's deer (Cervus eldi) relocated to a patchy landscape of farmland and forest. Hainan Eld's deer were pushed to the brink of extinction in the 1970s, but their population expanded rapidly from 26 to more than 1000 individuals by 2003 through effective reserve protection. As part of a wider relocation and population management strategy, 131 deer were removed from the reserve and reintroduced into a farmland-forest landscape in 2005. Habitat use under a context of human disturbance was surveyed by monitoring 19 radio-collared animals. The majority of deer locations (77%) were within 0.6-2 km of villages. Annual home ranges of these collared deer averaged 725 ha (SD 436), which was 55% of the size of the reserve from which they had originated. The annual home ranges contained 54% shrub-grassland, 26% forest and 15% farmland. The relocated deer population selected landscape comprising slash-and-burn agriculture and forest, and avoided both intensively farmed areas and areas containing only forest. Within the selected landscape, deer preferred swiddens and shrub-grasslands. Forests above 300 m in elevation were avoided, whereas forests below 300 m in elevation were overrepresented during the dry season and randomly used during the wet season. Our findings show that reintroduced deer can utilize disturbed habitats, and further demonstrate that subsistence agroforest ecosystems have the capacity to sustain endangered ungulates.	[Pan, Duo; Song, Yan-Ling; Zeng, Zhi-Gao] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Bravery, Benjamin D.] Kexue Commun, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Zeng, ZG (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	zengzhg@ioz.ac.cn			National Natural Science Foundation of China [30770320, 30470260]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (Grants 30770320 and 30470260) http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apollonio M, 2005, J MAMMAL, V86, P937, DOI 10.1644/1545-1542(2005)86[937:LIOHPO]2.0.CO;2; Arroyo B, 2006, BIOL CONSERV, V128, P276, DOI 10.1016/j.biocon.2005.09.035; Aung M, 2001, J MAMMAL, V82, P836, DOI 10.1644/1545-1542(2001)082<0836:EASOOA>2.0.CO;2; Basille M, 2009, ECOGRAPHY, V32, P683, DOI 10.1111/j.1600-0587.2009.05712.x; Beale CM, 2004, J APPL ECOL, V41, P335, DOI 10.1111/j.0021-8901.2004.00900.x; BERGER J, 1983, BIOL CONSERV, V25, P193, DOI 10.1016/0006-3207(83)90036-8; Blumstein DT, 2005, P ROY SOC B-BIOL SCI, V272, P1663, DOI 10.1098/rspb.2005.3147; Bonenfant M, 1996, BEHAV ECOL, V7, P299, DOI 10.1093/beheco/7.3.299; Boroski BB, 1998, J ARID ENVIRON, V38, P561, DOI 10.1006/jare.1997.0351; Caro TM, 2000, PRIORITIES CONSERVAT, V3, P221; CASSIRER EF, 1992, WILDLIFE SOC B, V20, P375; Ciuti S, 2004, BEHAV ECOL SOCIOBIOL, V56, P552, DOI 10.1007/s00265-004-0819-0; de la Torre S, 2000, BIOL CONSERV, V94, P153, DOI 10.1016/S0006-3207(99)00183-4; DIXON KR, 1980, ECOLOGY, V61, P1040, DOI 10.2307/1936821; Drake D, 2005, J ETENSION, V43, p1RIB5; Dwyer CM, 2004, ANIM WELFARE, V13, P269; Fowler GS, 1999, BIOL CONSERV, V90, P143, DOI 10.1016/S0006-3207(99)00026-9; Frid A, 2002, CONSERV ECOL, V6; Fu M., 2013, CHIN WILDL, V34, P40; GEIST V, 1971, OILWEEK, V22, P12; GRIFFITH B, 1988, WILDLIFE SOC B, V16, P206; Harveson PM, 2007, BIOL CONSERV, V134, P321, DOI 10.1016/j.biocon.2006.07.022; Hewison AJM, 2001, CAN J ZOOL, V79, P679, DOI 10.1139/cjz-79-4-679; Jayakody S, 2008, WILDLIFE BIOL, V14, P81, DOI 10.2981/0909-6396(2008)14[81:RDCEVB]2.0.CO;2; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kerley LL, 2002, CONSERV BIOL, V16, P97, DOI 10.1046/j.1523-1739.2002.99290.x; Kuss FR, 1990, VISITOR IMPACT MANAG; LAGORY KE, 1987, ANIM BEHAV, V35, P20, DOI 10.1016/S0003-3472(87)80206-3; MACARTHUR RA, 1982, J WILDLIFE MANAGE, V46, P351, DOI 10.2307/3808646; MADSEN J, 1994, IBIS, V137, P567; Manly B.F.J., 2002, RESOURCE SELECTION A; McShea WJ, 1999, ANIM CONSERV, V2, P173, DOI 10.1111/j.1469-1795.1999.tb00063.x; McShea WJ, 2005, BIOL CONSERV, V125, P101, DOI 10.1016/j.biocon.2005.03.013; McShea WJ, 2001, J MAMMAL, V82, P848, DOI 10.1644/1545-1542(2001)082&lt;0848:FHUASS&gt;2.0.CO;2; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; Naughton-Treves L, 2003, CONSERV BIOL, V17, P1106, DOI 10.1046/j.1523-1739.2003.02045.x; Nellemann C, 2000, ARCTIC, V53, P9; Pan D, 2011, AMBIO, V40, P60, DOI 10.1007/s13280-010-0108-2; Phillips GE, 2000, J WILDLIFE MANAGE, V64, P521, DOI 10.2307/3803250; Powell RA, 2000, METH C CONS, P65; Sawyer H, 2006, J WILDLIFE MANAGE, V70, P396, DOI 10.2193/0022-541X(2006)70[396:WHSOMD]2.0.CO;2; Schaefer JA, 2007, J WILDLIFE MANAGE, V71, P1753, DOI 10.2193/2005-479; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Song Yan-Ling, 1992, Acta Zoologica Sinica, V38, P165; Song YL, 2003, MAMMALIA, V67, P47, DOI 10.1515/mamm.2003.67.1.47; Stankowich T, 2008, BIOL CONSERV, V141, P2159, DOI 10.1016/j.biocon.2008.06.026; Timmins R., 2008, IUCN 2012 IUCN RED L; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Vistnes I, 2001, J WILDLIFE MANAGE, V65, P915, DOI 10.2307/3803040; Vistnes I, 2008, POLAR BIOL, V31, P399, DOI 10.1007/s00300-007-0377-9; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; [王伯荪 Wang Bosun], 2002, [广西植物, Guihaia], V22, P107; Wang Li-bing, 2010, Sichuan Journal of Zoology, V29, P929; West BC, 2002, WILDLIFE SOC B, V30, P139; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Xu L. H., 1983, BIRDS MAMMALS HAINAN, P398; YUAN XC, 1990, J NORTHEAST FOR UNIV, V0018, P00066; Zeng ZG, 2005, FOLIA ZOOL, V54, P249; Zeng ZG, 2011, MAMMALIA, V75, P143, DOI 10.1515/MAMM.2011.006; Zhang Qiong, 2009, Acta Theriologica Sinica, V20, P365	60	7	7	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91158	10.1371/journal.pone.0091158	http://dx.doi.org/10.1371/journal.pone.0091158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614039	gold, Green Published, Green Submitted			2022-12-25	WOS:000332839300085
J	Quets, JJ; Temmerman, S; El-Bana, MI; Al-Rowaily, SL; Assaeed, AM; Nijs, I				Quets, Jan J.; Temmerman, Stijn; El-Bana, Magdy I.; Al-Rowaily, Saud L.; Assaeed, Abdulaziz M.; Nijs, Ivan			Use of Spatial Analysis to Test Hypotheses on Plant Recruitment in a Hyper-Arid Ecosystem	PLOS ONE			English	Article							ARTEMISIA SPECIES ASTERACEAE; PHYTOGENIC MOUNDS NEBKHAS; POINT PATTERN-ANALYSIS; SAND BURIAL DEPTH; SOIL SEED BANK; SAUDI-ARABIA; SOUTHEASTERN SPAIN; WIND EROSION; DESERT; GERMINATION	Mounds originating from wind-blown sediment accumulation beneath vegetation (nebkhas) often indicate land degradation in dry areas. Thus far, most nebkha research has focused on individual plants. Here, we aimed to explore population-scale processes (up to scales of about 100 m) that might explain an observed nebkha landscape pattern. We mapped the Rhazya stricta Decne. population in a 3 ha study site in a hyper-arid region of Saudi Arabia. We compared the spatial patterns of five different cohorts (age classes) of observed nebkha host plants to those expected under several hypothesized drivers of recruitment and intraspecific interaction. We found that all R. stricta cohorts had a limited fractional vegetation cover and established in large-scale clusters. This clustering weakened with cohort age, possibly indicating merging of neighboring vegetation patches. Different cohort clusters did not spatially overlap in most cases, indicating that recruitment patterns changed position over time. Strong indications were found that the main drivers underlying R. stricta spatial configurations were allogenic (i.e. not driven by vegetation) and dynamic. Most likely these drivers were aeolian-driven sand movement or human disturbance which forced offspring recruitment in spatially dynamic clusters. Competition and facilitation were likely active on the field site too, but apparently had a limited effect on the overall landscape structure.	[Quets, Jan J.; Nijs, Ivan] Univ Antwerp, Dept Biol, Plant & Vegetat Ecol PLECO, Antwerp, Belgium; [Temmerman, Stijn] Univ Antwerp, Dept Biol, Antwerp, Belgium; [El-Bana, Magdy I.] Port Said Univ, Fac Sci, Dept Bot, Port Said, Egypt; [Al-Rowaily, Saud L.; Assaeed, Abdulaziz M.] King Saud Univ, Dept Plant Prod, Coll Agr, Riyadh, Saudi Arabia	University of Antwerp; University of Antwerp; Egyptian Knowledge Bank (EKB); Port Said University; King Saud University	Quets, JJ (corresponding author), Univ Antwerp, Dept Biol, Plant & Vegetat Ecol PLECO, Antwerp, Belgium.	Jan.Quets@uantwerpen.be	Temmerman, Stijn/C-5521-2009; El-Bana, Magdy/AAV-3834-2020	El-Bana, Magdy/0000-0003-0493-0208; Nijs, Ivan/0000-0003-3111-680X; Temmerman, Stijn/0000-0003-3346-9115; Assaeed, Abdulaziz/0000-0002-6639-5178	National Plan for Science and Technology, Saudi Arabia [ENV 1471]	National Plan for Science and Technology, Saudi Arabia	The work was funded by the National Plan for Science and Technology, Saudi Arabia (http://npst.ksu.edu.sa/index.php?page_id=101), through research project No. ENV 1471. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rowaily SL, 2012, CATENA, V97, P41, DOI 10.1016/j.catena.2012.05.004; Alyemeni MN, 2002, KUWAIT J SCI ENG, V29, P111; Assaeed A. M., 1997, Annals of Agricultural Science (Cairo), V42, P159; Assaeed AM, 2002, ARID LAND RES MANAG, V16, P83, DOI 10.1080/153249802753365340; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Bagnold R.A., 2005, PHYS BLOWN SAND DESE, P1; Barbier N, 2010, LANDSCAPE ECOL, V25, P889, DOI 10.1007/s10980-010-9466-1; Barot S, 1999, ECOLOGY, V80, P1987, DOI 10.1890/0012-9658(1999)080[1987:DOASPT]2.0.CO;2; Barth HJ, 1999, J ARID ENVIRON, V43, P399, DOI 10.1006/jare.1999.0564; Batanouny KH, 2001, PLANTS DESERTS MIDDL; Berndtsson R, 1996, J HYDROL, V185, P221, DOI 10.1016/0022-1694(95)02987-7; Callaway RM, 1997, OECOLOGIA, V112, P143, DOI 10.1007/s004420050293; Chen H, 1999, PLANT ECOL, V140, P53, DOI 10.1023/A:1009779613847; Clark CJ, 2007, AM NAT, V170, P128, DOI 10.1086/518565; Cooke R.U., 1993, DESERT GEOMORPHOLOGY; Danin A., 1996, PLANTS DESERT DUNES, DOI [10.1007/978-3-642-60975-6, DOI 10.1007/978-3-642-60975-6]; Deblauwe V, 2008, GLOBAL ECOL BIOGEOGR, V17, P715, DOI 10.1111/j.1466-8238.2008.00413.x; Diggle PJ, 1983, STAT ANAL SPATIAL PO; Du JH, 2010, J GEOGR SCI, V20, P712, DOI 10.1007/s11442-010-0806-5; Duncan RP, 2009, ECOLOGY, V90, P2129, DOI 10.1890/08-1436.1; El-Bana MI, 2003, RESTOR ECOL, V11, P317, DOI 10.1046/j.1526-100X.2003.00222.x; El-Bana MI, 2002, PLANT SOIL, V247, P283, DOI 10.1023/A:1021548711206; ERIKSSON O, 1992, OECOLOGIA, V91, P360, DOI 10.1007/BF00317624; Fedriani JM, 2010, ECOGRAPHY, V33, P545, DOI 10.1111/j.1600-0587.2009.06052.x; Fei P, 2012, ADV MATER RES-SWITZ, V356-360, P2465, DOI 10.4028/www.scientific.net/AMR.356-360.2465; Fenner M., 2000, SEEDS ECOLOGY REGENE; Flores J, 2003, J VEG SCI, V14, P911, DOI 10.1111/j.1654-1103.2003.tb02225.x; FOWLER N, 1986, ANNU REV ECOL SYST, V17, P89, DOI 10.1146/annurev.es.17.110186.000513; FRIEDMAN J, 1971, J ECOL, V59, P775, DOI 10.2307/2258139; FRYREAR DW, 1973, CROP SCI, V13, P622, DOI 10.2135/cropsci1973.0011183X001300060011x; GADZIA JSG, 1983, SOUTHWEST NAT, V28, P89, DOI 10.2307/3670596; GILE LH, 1975, QUATERNARY RES, V5, P321, DOI 10.1016/0033-5894(75)90037-X; Haase P, 1997, J VEG SCI, V8, P627, DOI 10.2307/3237366; Haase P, 1996, J VEG SCI, V7, P527, DOI 10.2307/3236301; He Q, 2013, ECOL LETT, V16, P695, DOI 10.1111/ele.12080; Holmgren M, 2010, J ECOL, V98, P1269, DOI 10.1111/j.1365-2745.2010.01709.x; Holmgren Milena, 1997, Ecology (Washington D C), V78, P1966, DOI 10.1890/0012-9658(1997)078[1966:TIOFAC]2.0.CO;2; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; Kefi S, 2008, AM NAT, V172, pE1, DOI 10.1086/588066; Law R, 2009, J ECOL, V97, P616, DOI 10.1111/j.1365-2745.2009.01510.x; Li XH, 2012, J ARID LAND, V4, P36, DOI 10.3724/SP.J.1227.2012.00036; Liu HL, 2011, PLANT SOIL, V345, P69, DOI 10.1007/s11104-011-0761-7; Loosmore NB, 2006, ECOLOGY, V87, P1925, DOI 10.1890/0012-9658(2006)87[1925:SIUTGO]2.0.CO;2; Maliva R., 2012, ARID LANDS WATER EVA; Marriott FHC., 1979, APPLIED STATISTICS, V28, P75, DOI [DOI 10.2307/2346816, 10.2307/2346816]; MAUN MA, 1994, VEGETATIO, V111, P59; McIntire EJB, 2009, ECOLOGY, V90, P46, DOI 10.1890/07-2096.1; Moustakas A, 2008, ACTA OECOL, V33, P355, DOI 10.1016/j.actao.2008.01.008; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; NICKLING WG, 1994, J ARID ENVIRON, V28, P13, DOI 10.1016/S0140-1963(05)80017-5; Nuske RS, 2009, FOREST ECOL MANAG, V259, P107, DOI 10.1016/j.foreco.2009.09.050; Pillay T, 2012, PLANT ECOL, V213, P1609, DOI 10.1007/s11258-012-0115-4; Poulsen JR, 2007, AM NAT, V170, P167, DOI 10.1086/518945; Quets JJ, 2013, ACTA OECOL, V49, P53, DOI 10.1016/j.actao.2013.03.002; Ren J, 2002, J ARID ENVIRON, V51, P603, DOI 10.1016/S0140-1963(01)90979-6; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; Rietkerk M, 2008, TRENDS ECOL EVOL, V23, P169, DOI 10.1016/j.tree.2007.10.013; Shaltout KH, 1996, BIODIVERS CONSERV, V5, P27, DOI 10.1007/BF00056290; Temmerman S, 2007, GEOLOGY, V35, P631, DOI 10.1130/G23502A.1; TENGBERG A, 1995, J ARID ENVIRON, V30, P265, DOI 10.1016/S0140-1963(05)80002-3; Tilman D, 1997, SPATIAL ECOLOGY ROLE; Tobe K, 2006, SEED SCI RES, V16, P61, DOI 10.1079/SSR2005230; Toft CA, 2003, ECOL MONOGR, V73, P605, DOI 10.1890/02-4080; Vincent P, 2008, SAUDI ARABIA ENV OVE; Wang XP, 2007, HYDROL PROCESS, V21, P72, DOI 10.1002/hyp.6185; Warrag MOA, 1995, J ARID ENVIRON, V31, P415, DOI 10.1016/S0140-1963(05)80124-7; Webb RH, 2002, ARID LAND RES MANAG, V16, P291, DOI 10.1080/153249802760284829; Weiner J, 2009, J ECOL, V97, P1220, DOI 10.1111/j.1365-2745.2009.01559.x; Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x; Wiegand T, 2006, J ECOL, V94, P825, DOI 10.1111/j.1365-2745.2006.01113.x; WIENS JA, 1976, ANNU REV ECOL SYST, V7, P81, DOI 10.1146/annurev.es.07.110176.000501; WOOD DM, 1990, AM J BOT, V77, P1411, DOI 10.2307/2444751; WU B, 2013, PLOS ONE, V8; WU HI, 1985, ECOL MODEL, V29, P215, DOI 10.1016/0304-3800(85)90054-7; Yu FH, 2008, ANN BOT-LONDON, V102, P571, DOI 10.1093/aob/mcn119; Yura H, 2006, PLANT ECOL, V185, P199, DOI 10.1007/s11258-005-9095-y; ZHANG DY, 1990, ECOL MODEL, V51, P265; Zhao WZ, 2007, PLANT SOIL, V295, P95, DOI 10.1007/s11104-007-9265-x; Zheng M, 2012, J ARID ENVIRON, V85, P105, DOI 10.1016/j.jaridenv.2012.05.006; Zheng YR, 2005, ANN BOT-LONDON, V95, P1237, DOI 10.1093/aob/mci138	80	6	6	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91184	10.1371/journal.pone.0091184	http://dx.doi.org/10.1371/journal.pone.0091184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614307	Green Submitted, Green Published, gold			2022-12-25	WOS:000332839300092
J	Tamaki, T; Hirata, M; Soeda, S; Nakajima, N; Saito, K; Nakazato, K; Okada, Y; Hashimoto, H; Uchiyama, Y; Mochida, J				Tamaki, Tetsuro; Hirata, Maki; Soeda, Shuichi; Nakajima, Nobuyuki; Saito, Kosuke; Nakazato, Kenei; Okada, Yoshinori; Hashimoto, Hiroyuki; Uchiyama, Yoshiyasu; Mochida, Joji			Preferential and Comprehensive Reconstitution of Severely Damaged Sciatic Nerve Using Murine Skeletal Muscle-Derived Multipotent Stem Cells	PLOS ONE			English	Article							PERIPHERAL-NERVES; PERINEURIAL CELLS; SCHWANN-CELLS; NEURITE OUTGROWTH; PROGENITOR CELLS; SILICONE TUBES; AXONAL GROWTH; IN-VITRO; REGENERATION; INJURY	Loss of vital functions in the somatic motor and sensory nervous systems can be induced by severe peripheral nerve transection with a long gap following trauma. In such cases, autologous nerve grafts have been used as the gold standard, with the expectation of activation and proliferation of graft-concomitant Schwann cells associated with their paracrine effects. However, there are a limited number of suitable sites available for harvesting of nerve autografts due to the unavoidable sacrifice of other healthy functions. To overcome this problem, the potential of skeletal muscle-derived multipotent stem cells (Sk-MSCs) was examined as a novel alternative cell source for peripheral nerve regeneration. Cultured/expanded Sk-MSCs were injected into severely crushed sciatic nerve corresponding to serious neurotmesis. After 4 weeks, engrafted Sk-MSCs preferentially differentiated into not only Schwann cells, but also perineurial/endoneurial cells, and formed myelin sheath and perineurium/endoneurium, encircling the regenerated axons. Increased vascular formation was also observed, leading to a favorable blood supply and waste product excretion. In addition, engrafted cells expressed key neurotrophic and nerve/vascular growth factor mRNAs; thus, endocrine/paracrine effects for the donor/recipient cells were also expected. Interestingly, skeletal myogenic capacity of expanded Sk-MSCs was clearly diminished in peripheral nerve niche. The same differentiation and tissue reconstitution capacity of Sk-MSCs was sufficiently exerted in the long nerve gap bridging the acellular conduit, which facilitated nerve regeneration/reconnection. These effects represent favorable functional recovery in Sk-MSC-treated mice, as demonstrated by good corduroy walking. We also demonstrated that these differentiation characteristics of the Sk-MSCs were comparable to native peripheral nerve-derived cells, whereas the therapeutic capacities were largely superior in Sk-MSCs. Therefore, Sk-MSCs can be a novel/suitable alternative cell source for healthy nerve autografts.	[Tamaki, Tetsuro; Hirata, Maki; Soeda, Shuichi; Nakajima, Nobuyuki; Saito, Kosuke; Nakazato, Kenei; Okada, Yoshinori; Hashimoto, Hiroyuki; Uchiyama, Yoshiyasu] Tokai Univ, Sch Med, Muscle Physiol & Cell Biol Unit, Hiratsuka, Kanagawa 25912, Japan; [Tamaki, Tetsuro; Hirata, Maki] Tokai Univ, Sch Med, Dept Regenerat Med, Div Basic Clin Sci, Hiratsuka, Kanagawa 25912, Japan; [Soeda, Shuichi; Nakajima, Nobuyuki] Tokai Univ, Sch Med, Dept Urol, Div Surg, Hiratsuka, Kanagawa 25912, Japan; [Saito, Kosuke] Tokai Univ, Sch Med, Dept Otolaryngol, Hiratsuka, Kanagawa 25912, Japan; [Nakazato, Kenei] Tokai Univ, Sch Med, Dept Resp Surg, Hiratsuka, Kanagawa 25912, Japan; [Hirata, Maki; Okada, Yoshinori] Tokai Univ, Sch Med, Teaching & Res Support Ctr, Hiratsuka, Kanagawa 25912, Japan; [Hashimoto, Hiroyuki; Uchiyama, Yoshiyasu; Mochida, Joji] Tokai Univ, Sch Med, Dept Orthoped, Div Surg, Hiratsuka, Kanagawa 25912, Japan	Tokai University; Tokai University; Tokai University; Tokai University; Tokai University; Tokai University; Tokai University	Tamaki, T (corresponding author), Tokai Univ, Sch Med, Muscle Physiol & Cell Biol Unit, Hiratsuka, Kanagawa 25912, Japan.	tamaki@is.icc.u-tokai.ac.jp	Tamaki, Tetsuro/I-2615-2019	Tamaki, Tetsuro/0000-0002-9071-049X; Nakajima, Nobuyuki/0000-0001-6307-032X	Tokai University School of Medicine	Tokai University School of Medicine	This work was supported by the grant 2013 Tokai University School of Medicine, Project Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoh Y, 2005, P NATL ACAD SCI USA, V102, P17734, DOI 10.1073/pnas.0508440102; Amoh Y, 2009, J CELL BIOCHEM, V107, P1016, DOI 10.1002/jcb.22204; Araki T, 1996, NEURON, V17, P353, DOI 10.1016/S0896-6273(00)80166-X; Billings SD, 2004, MODERN PATHOL, V17, P141, DOI 10.1038/modpathol.3800042; Bremer M, 2011, GLIA, V59, P1022, DOI 10.1002/glia.21173; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Campbell WW, 2008, CLIN NEUROPHYSIOL, V119, P1951, DOI 10.1016/j.clinph.2008.03.018; Dezawa M, 2001, EUR J NEUROSCI, V14, P1771, DOI 10.1046/j.0953-816x.2001.01814.x; Dezawa Mari, 2005, Current Neuropharmacology, V3, P257, DOI 10.2174/157015905774322507; Dezawa Mari, 2002, Anatomical Science International, V77, P12, DOI 10.1046/j.0022-7722.2002.00012.x; Dubovy Petr, 2004, Anatomical Science International, V79, P198, DOI 10.1111/j.1447-073x.2004.00090.x; Dubovy P, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-58; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Finzsch M, 2010, J CELL BIOL, V189, P701, DOI 10.1083/jcb.200912142; Gordon T, 2010, J COMMUN DISORD, V43, P265, DOI 10.1016/j.jcomdis.2010.04.003; Horie H, 1999, J NEUROSCI, V19, P9964; Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029; Li LN, 2003, P NATL ACAD SCI USA, V100, P9958, DOI 10.1073/pnas.1733025100; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pfister Bryan J., 2011, Critical Reviews in Biomedical Engineering, V39, P81, DOI 10.1615/CritRevBiomedEng.v39.i2.20; POPOVIC M, 1994, J NEUROPATH EXP NEUR, V53, P590, DOI 10.1097/00005072-199411000-00006; Popovic M, 2000, NEUROPATH APPL NEURO, V26, P221, DOI 10.1046/j.1365-2990.2000.00238.x; Pummi KP, 2006, J HISTOCHEM CYTOCHEM, V54, P53, DOI 10.1369/jhc.5A6671.2005; Radtke C, 2011, CELL TRANSPLANT, V20, P145, DOI 10.3727/096368910X522081; Robinson LR, 2000, MUSCLE NERVE, V23, P863, DOI 10.1002/(SICI)1097-4598(200006)23:6<863::AID-MUS4>3.0.CO;2-0; Robinson PP, 2004, J OROFAC PAIN, V18, P287; SCARAVILLI F, 1984, J ANAT, V139, P411; SCHRODER JM, 1993, CLIN NEUROL NEUROSUR, V95, pS78; Schroder K, 2011, ANTIOXID REDOX SIGN, V15, P915, DOI 10.1089/ars.2010.3533; Seddon HJ, 1943, J PHYSIOL-LONDON, V102, P191, DOI 10.1113/jphysiol.1943.sp004027; SUNDERLAND S, 1990, MUSCLE NERVE, V13, P771, DOI 10.1002/mus.880130903; Tamaki T, 2005, CIRCULATION, V112, P2857, DOI 10.1161/CIRCULATIONAHA.105.554832; Tamaki T, 2003, EXP CELL RES, V291, P83, DOI 10.1016/S0014-4827(03)00376-8; Tamaki T, 2002, J CELL BIOL, V157, P571, DOI 10.1083/jcb.200112106; Tamaki T, 2008, STEM CELLS DEV, V17, P653, DOI 10.1089/scd.2008.0070; Tamaki T, 2007, HISTOCHEM CELL BIOL, V128, P349, DOI 10.1007/s00418-007-0331-5; Tamaki T, 2007, STEM CELLS, V25, P2283, DOI 10.1634/stemcells.2006-0746; Tamaki T, 2010, CURR PHARM DESIGN, V16, P956, DOI 10.2174/138161210790883408; THOMAS PK, 1967, J ANAT, V101, P45; Tosaki T, 2008, EXP NEUROL, V213, P381, DOI 10.1016/j.expneurol.2008.06.017; Uemura T, 2012, BIOCHEM BIOPH RES CO, V419, P130, DOI 10.1016/j.bbrc.2012.01.154; Wang L, 2009, NEUROREPORT, V20, P663, DOI 10.1097/WNR.0b013e32832a09f8; Weerasuriya A, 2011, METHODS MOL BIOL, V686, P149, DOI 10.1007/978-1-60761-938-3_6; WEIS J, 1994, ACTA NEUROPATHOL, V88, P159; Zhang JY, 2000, EUR J NEUROSCI, V12, P4171, DOI 10.1046/j.1460-9568.2000.01312.x	45	31	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91257	10.1371/journal.pone.0091257	http://dx.doi.org/10.1371/journal.pone.0091257			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614849	Green Submitted, Green Published, gold			2022-12-25	WOS:000332839300102
J	Blanc, G; Mozar, M; Agarkova, IV; Gurnon, JR; Yanai-Balser, G; Rowe, JM; Xia, YN; Riethoven, JJ; Dunigan, DD; Van Etten, JL				Blanc, Guillaume; Mozar, Michael; Agarkova, Irina V.; Gurnon, James R.; Yanai-Balser, Giane; Rowe, Janet M.; Xia, Yuannan; Riethoven, Jean-Jack; Dunigan, David D.; Van Etten, James L.			Deep RNA Sequencing Reveals Hidden Features and Dynamics of Early Gene Transcription in Paramecium bursaria Chlorella Virus 1	PLOS ONE			English	Article							VARIABILIS NC64A; VACCINIA VIRUS; PBCV-1 ENCODES; EARLY PHASE; HOST-CELLS; GREEN-ALGA; INFECTION; GENOME; DEPOLARIZATION; SITE	Paramecium bursaria chlorella virus 1 (PBCV-1) is the prototype of the genus Chlorovirus (family Phycodnaviridae) that infects the unicellular, eukaryotic green alga Chlorella variabilis NC64A. The 331-kb PBCV-1 genome contains 416 major open reading frames. A mRNA-seq approach was used to analyze PBCV-1 transcriptomes at 6 progressive times during the first hour of infection. The alignment of 17 million reads to the PBCV-1 genome allowed the construction of single-base transcriptome maps. Significant transcription was detected for a subset of 50 viral genes as soon as 7 min after infection. By 20 min post infection (p.i.), transcripts were detected for most PBCV-1 genes and transcript levels continued to increase globally up to 60 min p.i., at which time 41% or the poly (A+)-containing RNAs in the infected cells mapped to the PBCV-1 genome. For some viral genes, the number of transcripts in the latter time points (20 to 60 min p.i.) was much higher than that of the most highly expressed host genes. RNA-seq data revealed putative polyadenylation signal sequences in PBCV-1 genes that were identical to the polyadenylation signal AAUAAA of green algae. Several transcripts have an RNA fragment excised. However, the frequency of excision and the resulting putative shortened protein products suggest that most of these excision events have no functional role but are probably the result of the activity of misled splicesomes.	[Blanc, Guillaume; Mozar, Michael] Aix Marseille Univ, CNRS, UMR7256, Lab Informat Struct & Genom, Marseille, France; [Agarkova, Irina V.; Gurnon, James R.; Yanai-Balser, Giane; Rowe, Janet M.; Dunigan, David D.; Van Etten, James L.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA; [Agarkova, Irina V.; Rowe, Janet M.; Dunigan, David D.; Van Etten, James L.] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE USA; [Xia, Yuannan; Riethoven, Jean-Jack] Univ Nebraska, Ctr Biotechnol, Lincoln, NE USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Blanc, G (corresponding author), Aix Marseille Univ, CNRS, UMR7256, Lab Informat Struct & Genom, Marseille, France.	guillaume.blanc@igs.cnrs-mrs.fr	Blanc, Guillaume/T-6958-2017; Dunigan, David/AAF-1386-2019	Blanc, Guillaume/0000-0001-5728-1104; Goins, Janet/0000-0003-1139-6058; MOZAR, Michael/0000-0002-9592-4083; Dunigan, David D/0000-0001-9496-5396; Riethoven, Jean-Jack/0000-0002-2709-7880	Stanley Medical Research Institute [11R-0001]; NSF-EPSCoR [EPS-1004094]; National Center for Research Resources [P20-RR15635]; National Institute of Allergy and Infectious Diseases [1T32AIO60547]; French Centre National de la Recherche Scientifique; PACA-Bioinfo platform;  [DOE-DE-EE0003142]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER	Stanley Medical Research Institute; NSF-EPSCoR; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); French Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); PACA-Bioinfo platform; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Academic funding only. This research was partially supported by the Stanley Medical Research Institute 11R-0001, NSF-EPSCoR grant EPS-1004094, DOE-DE-EE0003142 and grant P20-RR15635 from the COBRE program of the National Center for Research Resources. JR was supported by a Ruth L. Kirschstein National Research Service Award 1T32AIO60547 from the National Institute of Allergy and Infectious Diseases. GB and MM were supported by the French Centre National de la Recherche Scientifique and PACA-Bioinfo platform. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarkova I, 2008, J VIROL, V82, P12181, DOI 10.1128/JVI.01687-08; Blanc G, 2010, PLANT CELL, V22, P2943, DOI 10.1105/tpc.110.076406; Broyles SS, 2003, J GEN VIROL, V84, P2293, DOI 10.1099/vir.0.18942-0; Byrne D, 2009, GENOME RES, V19, P1233, DOI 10.1101/gr.091561.109; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dunigan DD, 2012, J VIROL, V86, P8821, DOI 10.1128/JVI.00907-12; Dunigan DD, 2006, VIRUS RES, V117, P119, DOI 10.1016/j.virusres.2006.01.024; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fitzgerald LA, 2008, VIROLOGY, V380, P388, DOI 10.1016/j.virol.2008.07.025; Fitzgerald LA, 2007, VIROLOGY, V362, P350, DOI 10.1016/j.virol.2006.12.028; Fitzgerald LA, 2007, VIROLOGY, V358, P459, DOI 10.1016/j.virol.2006.08.034; Frohns F, 2006, J VIROL, V80, P2437, DOI 10.1128/JVI.80.5.2437-2444.2006; Furuta M, 1997, APPL ENVIRON MICROB, V63, P1551, DOI 10.1128/AEM.63.4.1551-1556.1997; GRABHERR R, 1992, VIROLOGY, V188, P721, DOI 10.1016/0042-6822(92)90527-V; Graves MV, 1999, VIROLOGY, V257, P15, DOI 10.1006/viro.1999.9628; Greiner T, 2009, J GEN VIROL, V90, P2033, DOI 10.1099/vir.0.010629-0; Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; Jeanniard A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-158; Kaiser A, 1999, VIROLOGY, V263, P254, DOI 10.1006/viro.1999.9972; Kawasaki T, 2004, VIROLOGY, V318, P214, DOI 10.1016/j.virol.2003.09.015; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Li Y, 1997, VIROLOGY, V237, P360, DOI 10.1006/viro.1997.8805; MEINTS RH, 1986, VIROLOGY, V154, P240, DOI 10.1016/0042-6822(86)90448-4; MEINTS RH, 1984, VIROLOGY, V138, P341, DOI 10.1016/0042-6822(84)90358-1; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Neupartl M, 2008, VIROLOGY, V372, P340, DOI 10.1016/j.virol.2007.10.024; Onimatsu H, 2006, VIROLOGY, V353, P433, DOI 10.1016/j.virol.2006.06.010; Rowe JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090988; Rowe JM, 2013, VIROLOGY, V442, P101, DOI 10.1016/j.virol.2013.04.018; SCHUSTER AM, 1986, VIROLOGY, V148, P181, DOI 10.1016/0042-6822(86)90413-7; SCHUSTER AM, 1990, VIROLOGY, V176, P515, DOI 10.1016/0042-6822(90)90021-I; STRASSER P, 1991, VIROLOGY, V180, P763, DOI 10.1016/0042-6822(91)90089-T; Sun LW, 1999, VIROLOGY, V263, P376, DOI 10.1006/viro.1999.9958; Thiel G, 2010, PROG BOT, V71, P169, DOI 10.1007/978-3-642-02167-1_7; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; VANETTEN JL, 1983, VIROLOGY, V126, P117, DOI 10.1016/0042-6822(83)90466-X; Wilson WH, 2009, CURR TOP MICROBIOL, V328, P1; Wodniok S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-65; YAMADA T, 1994, NUCLEIC ACIDS RES, V22, P2532, DOI 10.1093/nar/22.13.2532; Yanai-Balser GM, 2010, J VIROL, V84, P532, DOI 10.1128/JVI.01698-09; Yang ZL, 2010, P NATL ACAD SCI USA, V107, P11513, DOI 10.1073/pnas.1006594107; Yutin N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-223; Zhang XZ, 2011, P NATL ACAD SCI USA, V108, P14837, DOI 10.1073/pnas.1107847108	44	28	28	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90989	10.1371/journal.pone.0090989	http://dx.doi.org/10.1371/journal.pone.0090989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608750	Green Published, gold, Green Submitted			2022-12-25	WOS:000332485800075
J	Kong, FF; Ying, HM; Du, CR; Huang, S; Zhou, JJ; Hu, CS				Kong, Fang-fang; Ying, Hongmei; Du, Cheng-run; Huang, Shuang; Zhou, Jun-jun; Hu, Chao-su			Effectiveness and Toxicities of Intensity-Modulated Radiation Therapy for Patients with T4 Nasopharyngeal Carcinoma	PLOS ONE			English	Article							CLINICAL-OUTCOMES; PHASE-II; RADIOTHERAPY; CISPLATIN; EXPERIENCE; DOCETAXEL; PATTERNS; FAILURE; PLANS	Objective: To evaluate the effectiveness and toxicities in T4 nasopharyngeal carcinoma (NPC) using intensity-modulated radiotherapy (IMRT) combined with chemotherapy. Methods: This is a retrospective analysis of 81 patients treated with intensity-modulated radiotherapy (IMRT). All the primary tumors were attributed to T4 stage according to the AJCC2010 staging system. And the distribution of disease by N stage was N0 in 13.6%, N1 in 30.9%, N2 in 37%, and N3 in 18.5%. Cisplatin-based chemotherapy was offered to all patients. Radiotherapy-related toxicities were graded according to the Acute and the Late Radiation Morbidity Scoring Criteria of the Radiation Therapy Oncology Group (RTOG) scoring criteria. Chemotherapy-related toxicities were graded by National Cancer Institute Common Toxicity Criteria (NCI-CTC) version 3.0. Prognostic factors were assessed by univariate analysis. Results: With a median follow-up of 37 months, 12 patients experienced local regional failure and total distant metastasis occurred in 18 patients, representing the major mode of failure. Ten patients died. Among them, 70% died of distant metastasis. The 3-year actuarial rates of local failure-free survival (LFFS), regional failure-free survival (RFFS), distant failure-free survival (DFFS), overall survival (OS), and progression-free survival (PFS) were 83.8%, 97.4%, 81.3%, 90%, and 69.7%, respectively. Acute and late toxicities were mild or moderate. Conclusions: IMRT provides excellent local-regional control for T4 NPC. Distant metastasis remains the major cause of treatment failure. Further explorations of the sequence and regimen of systemic therapy are needed in the future.	[Kong, Fang-fang; Ying, Hongmei; Du, Cheng-run; Huang, Shuang; Zhou, Jun-jun; Hu, Chao-su] Fudan Univ, Dept Radiat Oncol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Kong, Fang-fang; Ying, Hongmei; Du, Cheng-run; Huang, Shuang; Zhou, Jun-jun; Hu, Chao-su] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Ying, HM (corresponding author), Fudan Univ, Dept Radiat Oncol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China.	yinghongmei2013@163.com		Hu, Chaosu/0000-0002-6503-0951; Hu, Chaosu/0000-0001-7697-5224				Anne W, 1998, INT J RADIAT ONCOL, V40, P35; Cao CN, 2013, ORAL ONCOL, V49, P175, DOI 10.1016/j.oraloncology.2012.08.013; Cheng JCH, 2001, INT J CANCER, V96, P126, DOI 10.1002/ijc.1004; Du CR, 2013, INT J CLIN ONCOL, V18, P464, DOI 10.1007/s10147-012-0403-y; Hui EP, 2009, J CLIN ONCOL, V27, P242, DOI 10.1200/JCO.2008.18.1545; Hunt MA, 2001, INT J RADIAT ONCOL, V49, P623, DOI 10.1016/S0360-3016(00)01389-4; Kam MKM, 2003, INT J RADIAT ONCOL, V56, P145, DOI 10.1016/S0360-3016(03)00075-0; Kwong DLW, 2004, CANCER, V101, P1584, DOI 10.1002/cncr.20552; Lee AWM, 2004, CLIN ONCOL-UK, V16, P269, DOI 10.1016/j.clon.2004.01.008; Lee AWM, 2002, INT J RADIAT ONCOL, V53, P75, DOI 10.1016/S0360-3016(02)02711-6; Lu HM, 2008, CANCER TREAT REV, V34, P27, DOI 10.1016/j.ctrv.2007.08.004; Ma BBY, 2012, ANN ONCOL, V23, P1287, DOI 10.1093/annonc/mdr401; Ng WT, 2011, INT J RADIAT ONCOL, V79, P420, DOI 10.1016/j.ijrobp.2009.11.024; Sanguineti G, 1997, INT J RADIAT ONCOL, V37, P985, DOI 10.1016/S0360-3016(97)00104-1; Su SF, 2012, INT J RADIAT ONCOL, V82, P327, DOI 10.1016/j.ijrobp.2010.09.011; Teo P, 1996, INT J RADIAT ONCOL, V36, P291, DOI 10.1016/S0360-3016(96)00323-9; Xia P, 2000, INT J RADIAT ONCOL, V48, P329, DOI 10.1016/S0360-3016(00)00585-X; Xiao WW, 2011, CANCER-AM CANCER SOC, V117, P1874, DOI 10.1002/cncr.25754; Xu TT, 2012, MED ONCOL, V29, P272, DOI 10.1007/s12032-010-9803-x; Yi JL, 2006, INT J RADIAT ONCOL, V65, P161, DOI 10.1016/j.ijrobp.2005.12.003	20	14	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91362	10.1371/journal.pone.0091362	http://dx.doi.org/10.1371/journal.pone.0091362			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608637	Green Published, Green Submitted, gold			2022-12-25	WOS:000332485800130
J	Timpka, T; Spreco, A; Gursky, E; Eriksson, O; Dahlstrom, O; Stromgren, M; Ekberg, J; Pilemalm, S; Karlsson, D; Hinkula, J; Holm, E				Timpka, Toomas; Spreco, Armin; Gursky, Elin; Eriksson, Olle; Dahlstrom, Orjan; Stromgren, Magnus; Ekberg, Joakim; Pilemalm, Sofie; Karlsson, David; Hinkula, Jorma; Holm, Einar			Intentions to Perform Non-Pharmaceutical Protective Behaviors during Influenza Outbreaks in Sweden: A Cross-Sectional Study following a Mass Vaccination Campaign	PLOS ONE			English	Article							RISK PERCEPTIONS; HONG-KONG; INFORMATION; RESPONSES; SARS; EUROPE; MODEL	Failure to incorporate the beliefs and attitudes of the public into theoretical models of preparedness has been identified as a weakness in strategies to mitigate infectious disease outbreaks. We administered a cross-sectional telephone survey to a representative sample (n = 443) of the Swedish adult population to examine whether self-reported intentions to improve personal hygiene and increase social distancing during influenza outbreaks could be explained by trust in official information, self-reported health (SF-8), sociodemographic factors, and determinants postulated in protection motivation theory, namely threat appraisal and coping appraisal. The interviewees were asked to make their appraisals for two scenarios: a) an influenza with low case fatality and mild lifestyle impact; b) severe influenza with high case fatality and serious disturbances of societal functions. Every second respondent (50.0%) reported high trust in official information about influenza. The proportion that reported intentions to take deliberate actions to improve personal hygiene during outbreaks ranged between 45-85%, while less than 25% said that they intended to increase social distancing. Multiple logistic regression models with coping appraisal as the explanatory factor most frequently contributing to the explanation of the variance in intentions showed strong discriminatory performance for staying home while not ill (mild outbreaks: Area under the curve [AUC] 0.85 (95% confidence interval 0.82;0.89), severe outbreaks AUC 0.82 (95% CI 0.77;0.85)) and acceptable performance with regard to avoiding public transportation (AUC 0.78 (0.74;0.82), AUC 0.77 (0.72;0.82)), using handwash products (AUC 0.70 (0.65;0.75), AUC 0.76 (0.71;0.80)), and frequently washing hands (AUC 0.71 (0.66;0.76), AUC 0.75 (0.71;0.80)). We conclude that coping appraisal was the explanatory factor most frequently included in statistical models explaining self-reported intentions to carry out non-pharmaceutical health actions in the Swedish outlined context, and that variations in threat appraisal played a smaller role in these models despite scientific uncertainties surrounding a recent mass vaccination campaign.	[Timpka, Toomas; Spreco, Armin; Ekberg, Joakim] Ostergotland Cty Council, Dept Publ Hlth, Linkoping, Sweden; [Timpka, Toomas; Spreco, Armin; Eriksson, Olle; Ekberg, Joakim; Pilemalm, Sofie; Karlsson, David] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Gursky, Elin] ANSER Analyt Serv Inc, Natl Strategies Support Directorate, Arlington, VA USA; [Dahlstrom, Orjan] Linkoping Univ, Dept Behav Sci, Linnaeus Ctr HEAD, Linkoping, Sweden; [Stromgren, Magnus; Holm, Einar] Umea Univ, Dept Geog & Econ Hist, Umea, Sweden; [Hinkula, Jorma] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden	City Council Ostergotland; Linkoping University; Linkoping University; Umea University; Linkoping University	Timpka, T (corresponding author), Ostergotland Cty Council, Dept Publ Hlth, Linkoping, Sweden.	toomas.timpka@liu.se	Hinkula, Jorma/P-6849-2018; Timpka, Toomas/E-8065-2018	Spreco, Armin/0000-0003-0985-8209; Hinkula, Jorma/0000-0003-1908-5609	Swedish Civil Contingencies Agency [2010-2788]; Swedish Science Council [2008-5252]; Swedish Governmental Agency for Innovations (VINNOVA) [2011-03231]	Swedish Civil Contingencies Agency; Swedish Science Council; Swedish Governmental Agency for Innovations (VINNOVA)(Vinnova)	This study was supported by grants from the Swedish Civil Contingencies Agency [2010-2788]; the Swedish Science Council [2008-5252]; and the Swedish Governmental Agency for Innovations (VINNOVA) [2011-03231]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aro A, 2005, EUR J PUBLIC HEALTH, V15, P70; Attlestam I, 2012, SVENSKA DAGBLADET; Bell MA, 2014, J EMERG NURS, V40, P212, DOI 10.1016/j.jen.2012.05.005; Bhutta ZA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S7; Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826; Brewer NT, 2004, ANN BEHAV MED, V27, P125, DOI 10.1207/s15324796abm2702_7; Busija L, 2011, ARTHRIT CARE RES, V63, pS383, DOI 10.1002/acr.20541; Cameron LD, 2001, J HEALTH PSYCHOL, V6, P47, DOI 10.1177/135910530100600104; Cooke R, 2008, PSYCHOL HEALTH, V23, P745, DOI 10.1080/08870440701544437; Cowling BJ, 2010, J INFECT DIS, V202, P867, DOI 10.1086/655811; Durham DP, 2012, RISK ANAL, V32, P2020, DOI 10.1111/j.1539-6924.2012.01823.x; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Fung ICH, 2006, TROP MED INT HEALTH, V11, P1749, DOI 10.1111/j.1365-3156.2006.01734.x; Hosmer DW, 2000, APPL LOGISTIC REGRES, P228; Lau JTF, 2003, J EPIDEMIOL COMMUN H, V57, P864, DOI 10.1136/jech.57.11.864; Leung GM, 2004, INFECT CONT HOSP EP, V25, P1033, DOI 10.1086/502340; Liao QY, 2013, LANCET INFECT DIS, V13, P567, DOI 10.1016/S1473-3099(13)70096-3; Liao QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013350; Miilunpalo S, 1997, J CLIN EPIDEMIOL, V50, P517, DOI 10.1016/S0895-4356(97)00045-0; Mullet E, 2005, J RISK RES, V8, P19, DOI 10.1080/13669870210158571; Nicoll A, 2012, B WORLD HEALTH ORGAN, V90, P311, DOI 10.2471/BLT.11.097972; Raty R, 2010, ENERG POLICY, V38, P646, DOI 10.1016/j.enpol.2009.08.010; Reuter T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022130; Rhodes RE, 2006, BRIT J HEALTH PSYCH, V11, P119, DOI 10.1348/135910705X52633; Rogers R. W., 1983, SOCIAL PSYCHOPHYSIOL, P153, DOI DOI 10.1002/9780470479216.CORPSY0897; ROGERS RW, 1985, PSYCHOL REP, V56, P179, DOI 10.2466/pr0.1985.56.1.179; Rosenstock IM, 1966, MILBANK MEM FUND Q, V44, P127; Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651; Savage L.J., 1954, FDN STAT; Simonsen KA, 2012, FAM PRACT, V29, P139, DOI 10.1093/fampra/cmr064; Slaughter L, 2005, J BIOMED INFORM, V38, P298, DOI 10.1016/j.jbi.2004.12.006; Statistics Sweden, 2012, WOM MEN SWED FACTS F, P64; Sylvan Staffan, 2012, Lakartidningen, V109, P1156; Tang CSK, 2004, PREV MED, V39, P1187, DOI 10.1016/j.ypmed.2004.04.032; Teasdale E, 2012, BRIT J HEALTH PSYCH, V17, P44, DOI 10.1111/j.2044-8287.2011.02017.x; Vaccine European New Integrated Collaboration Effort (VENICE), 2011, PAND A H1N1 2009 INF; Vartti AM, 2009, INT J BEHAV MED, V16, P41, DOI 10.1007/s12529-008-9004-6; Voeten HACM, 2009, INT J BEHAV MED, V16, P49, DOI 10.1007/s12529-008-9006-4; Vukotich Charles J Jr, 2010, Emerg Infect Dis, V16, pe2; Ware JE Jr, 2001, SCORE INTERPRET SING; Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249; Weinstein ND, 1998, PSYCHOL HEALTH, V13, P479, DOI 10.1080/08870449808407305; Wijnans L, 2013, VACCINE, V31, P1246, DOI 10.1016/j.vaccine.2012.12.015	43	30	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91060	10.1371/journal.pone.0091060	http://dx.doi.org/10.1371/journal.pone.0091060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4IY	24608557	Green Published, Green Submitted, gold			2022-12-25	WOS:000332485800091
J	Tuggle, KL; Birket, SE; Cui, XX; Hong, J; Warren, J; Reid, L; Chambers, A; Ji, D; Gamber, K; Chu, KK; Tearney, G; Tang, LP; Fortenberry, JA; Du, M; Cadillac, JM; Bedwell, DM; Rowe, SM; Sorscher, EJ; Fanucchi, MV				Tuggle, Katherine L.; Birket, Susan E.; Cui, Xiaoxia; Hong, Jeong; Warren, Joe; Reid, Lara; Chambers, Andre; Ji, Diana; Gamber, Kevin; Chu, Kengyeh K.; Tearney, Guillermo; Tang, Li Ping; Fortenberry, James A.; Du, Ming; Cadillac, Joan M.; Bedwell, David M.; Rowe, Steven M.; Sorscher, Eric J.; Fanucchi, Michelle V.			Characterization of Defects in Ion Transport and Tissue Development in Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-Knockout Rats	PLOS ONE			English	Article							SURFACE LIQUID DEPTH; CFTR; NA+; MOUSE; CL; EPITHELIA; MODEL; GENE; HYPERABSORPTION; PHENOTYPE	Animal models for cystic fibrosis (CF) have contributed significantly to our understanding of disease pathogenesis. Here we describe development and characterization of the first cystic fibrosis rat, in which the cystic fibrosis transmembrane conductance regulator gene (CFTR) was knocked out using a pair of zinc finger endonucleases (ZFN). The disrupted Cftr gene carries a 16 base pair deletion in exon 3, resulting in loss of CFTR protein expression. Breeding of heterozygous (CFTR+/-) rats resulted in Mendelian distribution of wild-type, heterozygous, and homozygous (CFTR-/-) pups. Nasal potential difference and transepithelial short circuit current measurements established a robust CF bioelectric phenotype, similar in many respects to that seen in CF patients. Young CFTR-/- rats exhibited histological abnormalities in the ileum and increased intracellular mucus in the proximal nasal septa. By six weeks of age, CFTR-/- males lacked the vas deferens bilaterally. Airway surface liquid and periciliary liquid depth were reduced, and submucosal gland size was abnormal in CFTR-/- animals. Use of ZFN based gene disruption successfully generated a CF animal model that recapitulates many aspects of human disease, and may be useful for modeling other CF genotypes, including CFTR processing defects, premature truncation alleles, and channel gating abnormalities.	[Tuggle, Katherine L.; Birket, Susan E.; Hong, Jeong; Tang, Li Ping; Fortenberry, James A.; Du, Ming; Bedwell, David M.; Rowe, Steven M.; Sorscher, Eric J.; Fanucchi, Michelle V.] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA; [Tuggle, Katherine L.; Fanucchi, Michelle V.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Environm Hlth Sci, Birmingham, AL 35294 USA; [Birket, Susan E.; Rowe, Steven M.; Sorscher, Eric J.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Cui, Xiaoxia; Warren, Joe; Reid, Lara; Chambers, Andre; Ji, Diana; Gamber, Kevin] SAGE Labs Inc, St Louis, MO USA; [Hong, Jeong] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA; [Chu, Kengyeh K.; Tearney, Guillermo] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA USA; [Chu, Kengyeh K.] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Tearney, Guillermo] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Du, Ming; Cadillac, Joan M.] Univ Alabama Birmingham, Anim Resources Program, Off Vice President Res, Birmingham, AL USA; [Bedwell, David M.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Fanucchi, MV (corresponding author), Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA.	fanucchi@uab.edu		Gamber, Kevin/0000-0002-0694-7639; Bedwell, David/0000-0002-6605-818X; Sorscher, Eric J./0000-0001-9341-3354	CF Foundation [R464-CR07]; NIH [P30 DK072482, R01 HL116213]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072482] Funding Source: NIH RePORTER	CF Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by CF Foundation Grant R464-CR07 (www.cff.org) and NIH P30 DK072482 (www.nih.gov) to EJS and R01 HL116213 to SMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; Arquitt CK, 2002, J DENT RES, V81, P492, DOI 10.1177/154405910208100712; Boucher RC, 2007, J INTERN MED, V261, P5, DOI 10.1111/j.1365-2796.2006.01744.x; BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; BOUCHER RC, 1988, J PHYSIOL-LONDON, V405, P77, DOI 10.1113/jphysiol.1988.sp017322; Brand JD, 2012, AM J PHYSIOL-LUNG C, V303, pL1079, DOI 10.1152/ajplung.00185.2012; Carbery ID, 2010, GENETICS, V186, P451, DOI 10.1534/genetics.110.117002; Carvalho-Oliveira I, 2007, EXPERT REV MOL DIAGN, V7, P407, DOI 10.1586/14737159.7.4.407; Chang EH, 2012, LARYNGOSCOPE, V122, P1898, DOI 10.1002/lary.23392; Chang EH, 2011, CELLS TISSUES ORGANS, V194, P249, DOI 10.1159/000324248; Chen EYT, 2010, AM J PHYSIOL-LUNG C, V299, pL542, DOI 10.1152/ajplung.00180.2010; Chen JH, 2010, CELL, V143, P911, DOI 10.1016/j.cell.2010.11.029; CHINET TC, 1994, AM J PHYSIOL, V266, pC1061, DOI 10.1152/ajpcell.1994.266.4.C1061; CLARKE LL, 1992, AM J PHYSIOL, V263, pC348, DOI 10.1152/ajpcell.1992.263.2.C348; Collaco A, 2010, AM J PHYSIOL-CELL PH, V299, pC1450, DOI 10.1152/ajpcell.00029.2010; COTTON CU, 1987, J CLIN INVEST, V79, P80, DOI 10.1172/JCI112812; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; Dabrowska E, 2006, Adv Med Sci, V51 Suppl 1, P100; DAWSON DC, 1977, J MEMBRANE BIOL, V37, P213, DOI 10.1007/BF01940933; Derichs N, 2013, EUR RESPIR REV, V22, P58, DOI 10.1183/09059180.00008412; Fanucchi MV, 2012, AM J RESP CELL MOL, V46, P599, DOI 10.1165/rcmb.2011-0196OC; Fanucchi MV, 1998, TOXICOL APPL PHARM, V152, P1, DOI 10.1006/taap.1998.8484; Ferrazzano G F, 2012, Community Dent Health, V29, P106; Fisher JT, 2013, AM J RESP CELL MOL, V49, P837, DOI 10.1165/rcmb.2012-0433OC; Garcia MAS, 2009, J CLIN INVEST, V119, P2613, DOI 10.1172/JCI38662; Grosse Scott D., 2004, Morbidity and Mortality Weekly Report, V53, P1; GRUBB BR, 1994, AM J PHYSIOL, V266, pC1478, DOI 10.1152/ajpcell.1994.266.5.C1478; Guilbault C, 2007, AM J RESP CELL MOL, V36, P1, DOI 10.1165/rcmb.2006-0184TR; HARKEMA JR, 1988, AM J PATHOL, V130, P605; Houwen RH, 2010, J PEDIATR GASTR NUTR, V50, P38, DOI 10.1097/MPG.0b013e3181a6e01d; Itani OA, 2011, P NATL ACAD SCI USA, V108, P10260, DOI 10.1073/pnas.1106695108; Jacob HJ, 1999, GENOME RES, V9, P1013, DOI 10.1101/gr.9.11.1013; JAGELS AE, 1976, J DENT RES, V55, P991, DOI 10.1177/00220345760550065101; Jarzabek Katarzyna, 2004, Reprod Biol, V4, P119; Jayaraman S, 2001, J CLIN INVEST, V107, P317, DOI 10.1172/JCI11154; Liu L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052287, 10.1371/journal.pone.0061188, 10.1371/journal.pone.0083052]; Livraghi-Butrico A, 2013, AM J PHYSIOL-LUNG C, V304, pL469, DOI 10.1152/ajplung.00150.2012; Mashimo T, 2009, CURR PHARM BIOTECHNO, V10, P214, DOI 10.2174/138920109787315105; Meyerholz DK, 2010, AM J RESP CRIT CARE, V182, P1251, DOI 10.1164/rccm.201004-0643OC; Azevedo TDPL, 2006, J DENT CHILD, V73, P159; Pierucci-Alves F, 2011, BIOL REPROD, V85, P442, DOI 10.1095/biolreprod.111.090860; Pilewski Joseph M., 1999, Physiological Reviews, V79, pS215; PRIMOSCH RE, 1980, ORAL SURG ORAL MED O, V50, P301, DOI 10.1016/0030-4220(80)90411-9; Pyle LC, 2010, AM J RESP CELL MOL, V43, P607, DOI 10.1165/rcmb.2009-0281OC; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; Rosenberg LA, 2006, PEDIATR RES, V59, P191, DOI 10.1203/01.pdr.0000196720.25938.be; RUTLAND J, 1981, THORAX, V36, P654, DOI 10.1136/thx.36.9.654; SMOLICH JJ, 1978, J ANAT, V127, P223; Solomon GM, 2010, CHEST, V138, P919, DOI 10.1378/chest.10-0179; Song YL, 2009, AM J PHYSIOL-LUNG C, V297, pL1131, DOI 10.1152/ajplung.00085.2009; STURGESS J, 1982, AM J PATHOL, V106, P303; Sun XS, 2010, J CLIN INVEST, V120, P3149, DOI 10.1172/JCI43052; Tarran R, 2001, MOL CELL, V8, P149, DOI 10.1016/S1097-2765(01)00286-6; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; van der Doef Hubert P J, 2011, Curr Gastroenterol Rep, V13, P265, DOI 10.1007/s11894-011-0185-9; Wright J T, 1996, Adv Dent Res, V10, P270; Wright JT, 1996, J DENT RES, V75, P966, DOI 10.1177/00220345960750041101; Wright JT, 1996, ADV DENT RES, V10, P275; Young J T, 1981, Fundam Appl Toxicol, V1, P309, DOI 10.1016/S0272-0590(81)80037-1	62	109	110	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91253	10.1371/journal.pone.0091253	http://dx.doi.org/10.1371/journal.pone.0091253			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608905	Green Submitted, Green Published, gold			2022-12-25	WOS:000332485800118
J	Cheng, L; Xia, TS; Wang, YF; Zhou, WB; Liang, XQ; Xue, JQ; Shi, L; Wang, Y; Ding, Q				Cheng, Lin; Xia, Tian-Song; Wang, Yi-Fen; Zhou, Wenbin; Liang, Xiu-Qing; Xue, Jin-Qiu; Shi, Liang; Wang, Ying; Ding, Qiang			The Apoptotic Effect of D Rhamnose beta-Hederin, a Novel Oleanane-Type Triterpenoid Saponin on Breast Cancer Cells	PLOS ONE			English	Article							BCL-2 FAMILY PROTEINS; GINSENOSIDE RH2; ANTICANCER; ACTIVATION; INDUCTION; PATHWAYS; DEATH; ERK; GENERATION; ROOTS	There is growing interest in development of natural products as anti-cancer and chemopreventive agents. Many triterpenoids have been proved as potential agents for chemoprevention and therapy of breast cancer. Ginsenosides from ginseng, which mostly belong to dammarane-type triterpenoids, have gained great attention for their anti-breast cancer activity with diverse mechanisms. However, studies of other kinds of triterpenoid saponins on breast cancer are limited. Previously, we purified and identified a novel oleanane-type triterpene saponin named D Rhamnose beta-hederin (DR beta-H) from Clematis ganpiniana, a Chinese traditional anti-tumor herb. In the present study, DR beta-H showed strong inhibitory activity on the growth of various breast cancer cells and induced apoptosis in these cells. DR beta-H inhibited PI3K/AKT and activated ERK signaling pathway. PI3K inhibitor LY294002 synergistically enhanced DR beta-H-induced apoptosis whereas MEK inhibitor U0126 reduced the apoptosis rate. Moreover, DR beta-H regulated the ratio of pro-apoptotic and anti-apoptotic Bcl-2 family proteins. Furthermore, DR beta-H induced depolarization of mitochondrial membrane potential which released Apaf-1 and Cytochrome C from the inter membrane space into the cytosol, where they promoted caspase-9 and caspase-3 activation. This is the first report on the pro-apoptotic effects of DR beta-H, a novel oleanane-type triterpenoid saponin, on breast cancer cells and its comprehensive apoptosis pathways. It implied that oleanane-type triterpenoid saponin DR beta-H could be a promising candidate for chemotherapy of breast cancer.	[Cheng, Lin; Xia, Tian-Song; Zhou, Wenbin; Liang, Xiu-Qing; Xue, Jin-Qiu; Shi, Liang; Wang, Ying; Ding, Qiang] Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Breast Dis Ctr, Nanjing, Jiangsu, Peoples R China; [Wang, Yi-Fen] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming, Peoples R China	Nanjing Medical University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Ding, Q (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Breast Dis Ctr, Nanjing, Jiangsu, Peoples R China.	dingqiang@njmu.edu.cn			Natural Science Foundation of China [81272916, 81202077]; Natural Science Foundation of Jiangsu Province [BK2011855]; key projects of Jiangsu Provincial Health Office [H201110]; Project of Jiangsu Province Traditional Chinese medicine bureau [LZ11084]; Six Talents Peak projects of Jiangsu province; Priority Academic Program Development of Jiangsu higher Education Institutions (PAPD)	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); key projects of Jiangsu Provincial Health Office; Project of Jiangsu Province Traditional Chinese medicine bureau; Six Talents Peak projects of Jiangsu province; Priority Academic Program Development of Jiangsu higher Education Institutions (PAPD)	This work was financially supported by the Natural Science Foundation of China (81272916 and 81202077), the Natural Science Foundation of Jiangsu Province (BK2011855), the key projects of Jiangsu Provincial Health Office (H201110), the Project of Jiangsu Province Traditional Chinese medicine bureau (LZ11084), the Six Talents Peak projects of Jiangsu province (to QD), and a project Funded by the Priority Academic Program Development of Jiangsu higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attele AS, 1999, BIOCHEM PHARMACOL, V58, P1685, DOI 10.1016/S0006-2952(99)00212-9; Augustin JM, 2011, PHYTOCHEMISTRY, V72, P435, DOI 10.1016/j.phytochem.2011.01.015; Bishayee A, 2011, FRONT BIOSCI-LANDMRK, V16, P980, DOI 10.2741/3730; Boutaghane N, 2013, PHYTOCHEMISTRY, V93, P176, DOI 10.1016/j.phytochem.2013.03.020; Breckenridge DG, 2004, CURR OPIN CELL BIOL, V16, P647, DOI 10.1016/j.ceb.2004.09.009; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Choi S, 2011, J CELL BIOCHEM, V112, P330, DOI 10.1002/jcb.22932; Chun J, 2013, CHEM-BIOL INTERACT, V205, P212, DOI 10.1016/j.cbi.2013.07.002; Chun J, 2013, PLANTA MED, V79, P639, DOI 10.1055/s-0032-1328401; Cragg GM, 2013, BIOCHIM BIOPHYS ACTA, V6, P18; Dinda B, 2010, CHEM BIODIVERS, V7, P2327, DOI 10.1002/cbdv.200800070; Ding Q, 2009, J ETHNOPHARMACOL, V126, P382, DOI 10.1016/j.jep.2009.09.028; Ellington AA, 2006, CARCINOGENESIS, V27, P298, DOI 10.1093/carcin/bgi214; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Huang P, 2011, INT J MOL MED, V28, P579, DOI 10.3892/ijmm.2011.727; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kang JH, 2011, PLANT FOOD HUM NUTR, V66, P298, DOI 10.1007/s11130-011-0242-4; Karikas GA, 2010, J BUON, V15, P627; Lee HJ, 2006, CARCINOGENESIS, V27, P2455, DOI 10.1093/carcin/bgl104; Lee JH, 2009, J ETHNOPHARMACOL, V123, P121, DOI 10.1016/j.jep.2009.02.013; Li Q, 2012, BIOORG MED CHEM LETT, V22, P6120, DOI 10.1016/j.bmcl.2012.08.027; Liu GY, 2007, J NAT PROD, V70, P259, DOI 10.1021/np060313t; Ma GX, 2013, CHEM PHARM BULL, V61, P101, DOI 10.1248/cpb.c12-00713; Mirjolet JF, 2000, BRIT J CANCER, V83, P1380, DOI 10.1054/bjoc.2000.1455; Mo SS, 2013, J PHARMACOL SCI, V122, P163, DOI 10.1254/jphs.12193FP; Nhiem NX, 2012, ARCH PHARM RES, V35, P19, DOI 10.1007/s12272-012-0102-2; Park EK, 2010, BRIT J PHARMACOL, V160, P1212, DOI 10.1111/j.1476-5381.2010.00768.x; Park HM, 2012, FOOD CHEM TOXICOL, V50, P2736, DOI 10.1016/j.fct.2012.05.027; Patlolla JMR, 2012, CURR PHARM BIOTECHNO, V13, P147; Podolak I, 2010, PHYTOCHEM REV, V9, P425, DOI 10.1007/s11101-010-9183-z; Qiu YK, 2009, FITOTERAPIA, V80, P219, DOI 10.1016/j.fitote.2009.01.011; Rabi T, 2013, MOL CARCINOG; Rabi T, 2008, MOL CARCINOGEN, V47, P415, DOI 10.1002/mc.20399; Raisova M, 2001, J INVEST DERMATOL, V117, P333, DOI 10.1046/j.0022-202x.2001.01409.x; Ribeiro JT, 2012, ANN ONCOL, V23, P547, DOI 10.1093/annonc/mdr382; Sebolt-Leopold JS, 2000, ONCOGENE, V19, P6594, DOI 10.1038/sj.onc.1204083; Seddighzadeh M, 1999, CLIN EXP METASTAS, V17, P649, DOI 10.1023/A:1006741228402; Seo Y, 2002, J NAT PROD, V65, P65, DOI 10.1021/np010327t; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Swamy SMK, 2003, MOL CELL BIOCHEM, V245, P127, DOI 10.1023/A:1022807207948; Mai TT, 2012, CANCER LETT, V321, P144, DOI 10.1016/j.canlet.2012.01.045; Vincken JP, 2007, PHYTOCHEMISTRY, V68, P275, DOI 10.1016/j.phytochem.2006.10.008; Wang J, 2009, FOOD CHEM TOXICOL, V47, P1716, DOI 10.1016/j.fct.2009.04.034; Wang QF, 2002, CANCER LETT, V183, P169, DOI 10.1016/S0304-3835(01)00828-X; Wang QZ, 2012, FITOTERAPIA, V83, P742, DOI 10.1016/j.fitote.2012.02.013; Wang TH, 2000, CANCER, V88, P2619, DOI 10.1002/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Xiong J, 2009, ENVIRON TOXICOL PHAR, V27, P264, DOI 10.1016/j.etap.2008.11.008; Yuan, 2009, ONCOL REP; Zhang CL, 2004, BIOL PHARM BULL, V27, P1527, DOI 10.1248/bpb.27.1527; Zhang LH, 2013, BBA-GEN SUBJECTS, V1830, P4148, DOI 10.1016/j.bbagen.2013.04.008; Zhao P, 2011, CHEM BIODIVERS, V8, P1931, DOI 10.1002/cbdv.201000265; Zhou Y, 2013, PLANTA MED, V79, P70, DOI 10.1055/s-0032-1327927	54	25	28	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90848	10.1371/journal.pone.0090848	http://dx.doi.org/10.1371/journal.pone.0090848			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603880	gold, Green Published, Green Submitted			2022-12-25	WOS:000332483600095
J	Ishikawa, N; Shimbo, T; Miyano, S; Sikazwe, I; Mwango, A; Ghidinelli, MN; Syakantu, G				Ishikawa, Naoko; Shimbo, Takuro; Miyano, Shinsuke; Sikazwe, Izukanji; Mwango, Albert; Ghidinelli, Massimo N.; Syakantu, Gardner			Health Outcomes and Cost Impact of the New WHO 2013 Guidelines on Prevention of Mother-to-Child Transmission of HIV in Zambia	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; ANTIRETROVIRAL THERAPY; PREGNANCY	Background: Countries are currently progressing towards the elimination of new paediatric HIV infections by 2015. WHO published new consolidated guidelines in June 2013, which now recommend either 'Antiretroviral drugs (ARVs) for women living with HIV during pregnancy and breastfeeding (Option B)' or 'Lifelong antiretroviral therapy (ART) for all pregnant and breastfeeding women living with HIV (Option B+)', while de facto phasing out Option A. This study examined health outcomes and cost impact of the shift to WHO 2013 recommendations in Zambia. Methods: A decision analytic model was developed based on the national health system perspective. Estimated risk and number of cases of HIV transmission to infants and to serodiscordant partners, and proportions of HIV-infected pregnant women with CD4 count of <= 350 cells/mm(3) to initiate ART were compared between 2010 Option A and the 2013 recommendations. Total costs of prevention of mother-to-child transmission of HIV (PMTCT) services per annual cohort of pregnant women, incremental cost-effectiveness ratio (ICER) per infection averted and quality-adjusted life-year (QALY) gained were examined. Results: Our analysis suggested that the shift from 2010 Option A to the 2013 guidelines would result in a 33% reduction of the risk of HIV transmission among exposed infants. The risk of transmission to serodiscordant partners for a period of 24 months would be reduced by 72% with 'ARVs during pregnancy and breastfeeding' and further reduced by 15% with 'Lifelong ART'. The probability of HIV-infected pregnant women to initiate ART would increase by 80%. It was also suggested that while the shift would generate higher PMTCT costs, it would be cost-saving in the long term as it spares future treatment costs by preventing infections in infants and partners. Conclusion: The shift to the WHO 2013 guidelines in Zambia would positively impact health of family and save future costs related to care and treatment.	[Ishikawa, Naoko; Shimbo, Takuro; Miyano, Shinsuke] Natl Ctr Global Hlth & Med, Tokyo, Japan; [Sikazwe, Izukanji] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Mwango, Albert; Syakantu, Gardner] Minist Hlth, Lusaka, Zambia; [Ghidinelli, Massimo N.] Pan Amer Hlth Org, Washington, DC USA	National Center for Global Health & Medicine - Japan; Pan American Health Organization	Ishikawa, N (corresponding author), Natl Ctr Global Hlth & Med, Tokyo, Japan.	n-ishikawa@it.ncgm.go.jp			Ministry of Health, Labor and Welfare, Japan [H23-4]	Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was funded by Research Grant for International Health, H23-4, by the Ministry of Health, Labor and Welfare, Japan (http://www.ncgm.go.jp/kaihatsu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, HIGH POSS COST COVID; [Anonymous], 2012, BUS CAS IMPR EMTCT P; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Binagwaho A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054180; Carter RJ, 2010, JAIDS-J ACQ IMM DEF, V55, P404, DOI 10.1097/QAI.0b013e3181e73f4b; Central Statistical Office Ministry of Health Tropical Diseases Research Centre Inc University of Zambia Macro International Inc, 2009, ZAMB DEM HLTH SURV 2; Changala M, 2012, 22 27 JUL 2012 19 IN; Ciaranello AL, 2013, CLIN INFECT DIS, V56, P430, DOI 10.1093/cid/cis858; Clinton Foundation, 2009, HIV AIDS DIAGN PRIC; Clinton Health Access Initiative, 2012, ANT ARV CEIL PRIC LI; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Farnham PG, 2013, JAIDS-J ACQ IMM DEF, V64, P183, DOI 10.1097/QAI.0b013e3182973966; Fasawe O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057778; Hallett TB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001123; Ishikawa N, 2011, 17 20 JUL 2011 6 IAS; Ishikawa N, 2012, 22 27 JUL 2012 19 IN; Ishikawa N, 2011, COSTING TOOL ELIMINA; Kuznik A, 2012, B WORLD HEALTH ORGAN, V90, P595, DOI 10.2471/BLT.11.095430; Marazzi MC, 2011, AIDS, V25, P1611, DOI 10.1097/QAD.0b013e3283493ed0; Ministry of Health Zambia, 2012, ZAMB COUNTR REP MON; Mugo NR, 2011, AIDS, V25, P1887, DOI 10.1097/QAD.0b013e32834a9338; Orlando S, 2010, JAIDS-J ACQ IMM DEF, V55, P631, DOI 10.1097/QAI.0b013e3181f9f9f5; Reynolds SJ, 2011, AIDS, V25, P473, DOI 10.1097/QAD.0b013e3283437c2b; Robberstad B, 2010, JAIDS-J ACQ IMM DEF, V55, P397, DOI 10.1097/QAI.0b013e3181eef4d3; Shah M, 2011, AIDS, V25, P1093, DOI 10.1097/QAD.0b013e32834670b9; Soorapanth S, 2006, JAIDS-J ACQ IMM DEF, V42, P213, DOI 10.1097/01.qai.0000214812.72916.bc; The Interagency Task Team, 2013, TOOLK EXP SIMPL TREA; UNAIDS Reference Group on Estimates, 2011, WORK PAP MOTH TO CHI; UNICEF, 2013, RAP ASS 2010 WHO GUI; United Nations, 2010, UN DAT; WHO, 2003, GUID COST EFF EN; World Bank, 2013, GDP PER CAP CURR US; World Health Organisation, 2021, CONSOLIDATED GUIDELI; World Health Organization, 2012, PROGR UPD US ANT DRU; World Health Organization, 2021, ANT DRUGS TREAT PREG; Zulliger R, 2013, COST EFFECTIVENESS P	39	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90991	10.1371/journal.pone.0090991	http://dx.doi.org/10.1371/journal.pone.0090991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24604067	Green Published, Green Submitted, gold			2022-12-25	WOS:000332483600119
J	Chan, SH; Huang, WC; Chang, JW; Chang, KJ; Kuo, WH; Wang, MY; Lin, KY; Uen, YH; Hou, MF; Lin, CM; Jang, TH; Tu, CW; Lee, YR; Lee, YH; Tien, MT; Wang, LH				Chan, S-H; Huang, W-C; Chang, J-W; Chang, K-J; Kuo, W-H; Wang, M-Y; Lin, K-Y; Uen, Y-H; Hou, M-F; Lin, C-M; Jang, T-H; Tu, C-W; Lee, Y-R; Lee, Y-H; Tien, M-T; Wang, L-H			MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis	ONCOGENE			English	Article							EXPRESSION PROFILES; FOCAL ADHESIONS; CELL-MIGRATION; TRAFFICKING; PROGRESSION; PROTEINS; DOMAIN	Metastasis is the predominant cause of death in breast cancer patients. Several lines of evidence have shown that microRNAs (miRs) can have an important role in cancer metastasis. Using isogenic pairs of low and high metastatic lines derived from a human breast cancer line, we have identified miR-149 to be a suppressor of breast cancer cell invasion and metastasis. We also identified GIT1 (G-protein-coupled receptor kinase-interacting protein 1) as a direct target of miR-149. Knockdown of GIT1 reduced migration/invasion and metastasis of highly invasive cells. Re-expression of GIT1 significantly rescued miR-149-mediated inhibition of cell migration/invasion and metastasis. Expression of miR-149 impaired fibronectin-induced focal adhesion formation and reduced phosphorylation of focal adhesion kinase and paxillin, which could be restored by re-expression of GIT1. Inhibition of GIT1 led to enhanced protein degradation of paxillin and alpha 5 beta 1 integrin via proteasome and lysosome pathways, respectively. Moreover, we found that GIT1 depletion in metastatic breast cancer cells greatly reduced alpha 5 beta 1-integrin-mediated cell adhesion to fibronectin and collagen. Low level of miR-149 and high level of GIT1 was significantly associated with advanced stages of breast cancer, as well as with lymph node metastasis. We conclude that miR-149 suppresses breast cancer cell migration/invasion and metastasis by targeting GIT1, suggesting potential applications of the miR-149-GIT1 pathway in clinical diagnosis and therapeutics.	[Chan, S-H; Huang, W-C; Chang, J-W; Lin, C-M; Jang, T-H; Wang, L-H] Natl Hlth Res Inst, Inst Mol & Genom Med, Miaoli, Taiwan; [Huang, W-C; Wang, L-H] Natl Cent Univ, Dept Life Sci, Taoyuan, Taiwan; [Chang, K-J; Kuo, W-H; Wang, M-Y] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Lin, K-Y; Uen, Y-H] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Hou, M-F] Kaohsiung Med Univ, Chung Ho Mem Hosp, Dept Surg, Kaohsiung, Taiwan; [Tu, C-W] Chiayi Christian Hosp, Dept Surg, Chiayi, Taiwan; [Lee, Y-R] Chiayi Christian Hosp, Dept Med Res, Chiayi, Taiwan; [Lee, Y-H] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Pathol, Hsinchu, Taiwan; [Tien, M-T] Ind Technol Res Inst, Biomed Technol & Device Res Labs, Hsinchu, Taiwan; [Wang, L-H] Mt Sinai Sch Med, Dept Microbiol, New York, NY USA	National Health Research Institutes - Taiwan; National Central University; National Taiwan University; National Taiwan University Hospital; Chi Mei Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Chia-Yi Christian Hospital; Chia-Yi Christian Hospital; National Taiwan University; National Taiwan University Hospital; Industrial Technology Research Institute - Taiwan; Icahn School of Medicine at Mount Sinai	Wang, LH (corresponding author), Natl Hlth Res Inst, Inst Mol & Genom Med, 35 Keyan Rd, Zhunan Town 35053, Miaoli, Taiwan.	lu-hai.wang@nhri.org.tw	Chan, Shih-Hsuan/AAW-6857-2020; Chan, Shih-Hsuan/AAD-4317-2021; Wang, Lu-Hai/E-3986-2010	Hou, Ming-Feng/0000-0001-6030-9702; Chan, Shih-Hsuan/0000-0002-8703-5139; Chang, King jen/0000-0001-9811-3422; KUO, WEN-HUNG/0000-0002-9881-4605; Lee, Ying-Ray/0000-0002-0349-0960	National Science Council, Taiwan [01D2-MMNSC16]; Department of Health, Taiwan [DOH100-TD-111-004]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Department of Health, Taiwan	We thank the Pathology Core Laboratory and Microarray Core Laboratory of the National Health Research Institutes for H&E and immunohistochemical staining and miRNA array analysis, respectively. This work was supported by grants from National Science Council, Taiwan (01D2-MMNSC16) and the Department of Health, Taiwan (DOH100-TD-111-004).	Calalb MB, 1996, BIOCHEM BIOPH RES CO, V228, P662, DOI 10.1006/bbrc.1996.1714; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Hunziker W, 1996, BIOESSAYS, V18, P379, DOI 10.1002/bies.950180508; Li D, 2011, OMICS, V15, P673, DOI 10.1089/omi.2011.0064; Lin KT, 2012, CANCER RES, V72, P3000, DOI 10.1158/0008-5472.CAN-11-2502; Liu SC, 2000, J CELL SCI, V113, P3563; Luo M, 2010, CANCER LETT, V289, P127, DOI 10.1016/j.canlet.2009.07.005; Luo ZH, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-3; Manabe R, 2002, J CELL SCI, V115, P1497; Narla RK, 2001, CLIN CANCER RES, V7, P2124; Negrini M, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1867; Packeisen J, 2002, J CLIN PATHOL, V55, P613, DOI 10.1136/jcp.55.8.613; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Ramsay AG, 2007, CANCER METAST REV, V26, P567, DOI 10.1007/s10555-007-9078-7; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Schlenker O, 2009, J MOL BIOL, V386, P280, DOI 10.1016/j.jmb.2008.12.050; Schmalzigaug R, 2007, CELL SIGNAL, V19, P1733, DOI 10.1016/j.cellsig.2007.03.010; Silahtaroglu AN, 2007, NAT PROTOC, V2, P2520, DOI 10.1038/nprot.2007.313; Sreekumar Rahul, 2011, Frontiers in Genetics, V2, P58, DOI 10.3389/fgene.2011.00058; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Thievessen I, 2013, J CELL BIOL, V202, P163, DOI 10.1083/jcb.201303129; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041693; White DE, 2007, J MAMMARY GLAND BIOL, V12, P135, DOI 10.1007/s10911-007-9045-5; Yin GY, 2005, J BIOL CHEM, V280, P27705, DOI 10.1074/jbc.M502271200	28	107	112	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 4	2014	33	36					4496	4507		10.1038/onc.2014.10	http://dx.doi.org/10.1038/onc.2014.10			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AO2MY	24608434	hybrid, Green Published			2022-12-25	WOS:000341158800005
J	Gou, WL; Wang, X; Peng, J; Lu, Q; Wang, Y; Wang, AY; Guo, QY; Gao, XP; Xu, WJ; Lu, SB				Gou, Wenlong; Wang, Xin; Peng, Jiang; Lu, Qiang; Wang, Yu; Wang, Aiyuan; Guo, Quanyi; Gao, Xupeng; Xu, Wenjing; Lu, Shibi			Controlled Delivery of Zoledronate Improved Bone Formation Locally In Vivo	PLOS ONE			English	Article							BISPHOSPHONATE-RELATED OSTEONECROSIS; OSTEOGENIC DIFFERENTIATION; PAMIDRONATE TREATMENT; OSTEOBLAST APOPTOSIS; MINERAL DENSITY; OSTEOCYTE; ALENDRONATE; MECHANISMS; INCREASES; CELLS	Bisphosphonates (BPs) have been widely used in clinical treatment of bone diseases with increased bone resorption because of their strong affinity for bone and their inhibition of bone resorption. Recently, there has been growing interest in their improvement of bone formation. However, the effect of local controlled delivery of BPs is unclear. We used polylactide acid-glycolic acid copolymer (PLGA) as a drug carrier to deliver various doses of the bisphosphonate zoledronate (Zol) into the distal femur of 8-week-old Sprague-Dawley rats. After 6 weeks, samples were harvested and analyzed by micro-CT and histology. The average bone mineral density and mineralized bone volume fraction were higher with medium-and high-dose PLGA-Zol (30 and 300 mu g Zol, respectively) than control and low-dose Zol (3 mu g PLGA-Zol; p<0.05). Local controlled delivery of Zol decreased the numbers of osteoclast and increased the numbers of osteoblast. Moreover, local controlled delivery of medium-and high-dose Zol accelerated the expression of bone-formation markers. PLGA used as a drug carrier for controlled delivery of Zol may promote local bone formation.	[Gou, Wenlong; Wang, Xin; Peng, Jiang; Lu, Qiang; Wang, Yu; Wang, Aiyuan; Guo, Quanyi; Gao, Xupeng; Xu, Wenjing; Lu, Shibi] Chinese Peoples Liberat Army Gen Hosp, Inst Orthopaed, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Peng, J (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Inst Orthopaed, Beijing, Peoples R China.	pengjiang301@126.com			National Technology Research and Development Program of China [2012AA020502, 2012CB518106]; National Science Foundation of China [30930092, 30973047, 31240048];  [BWS11J025]	National Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 	This work was funded by a grant from the National Technology Research and Development Program of China (2012AA020502, 2012CB518106) and the National Science Foundation of China (30930092, 30973047, 31240048), and BWS11J025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aya-Ay J, 2007, J BONE MINER RES, V22, P93, DOI 10.1359/JBMR.060817; Belfrage O, 2011, ACTA ORTHOP, V82, P228, DOI 10.3109/17453674.2011.566138; Bellido T, 2011, BONE, V49, P50, DOI 10.1016/j.bone.2010.08.008; Bembi B, 1997, J PEDIATR-US, V131, P622, DOI 10.1016/S0022-3476(97)70074-X; Cenni E, 2008, BIOMATERIALS, V29, P1400, DOI 10.1016/j.biomaterials.2007.12.022; Dai RC, 2008, J BONE MINER METAB, V26, P342, DOI 10.1007/s00774-007-0830-4; EGGELMEIJER F, 1994, J RHEUMATOL, V21, P2016; Freiberg S, 2004, INT J PHARMACEUT, V282, P1, DOI 10.1016/j.ijpharm.2004.04.013; Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3; Gourion-Arsiquaud S, 2010, BONE, V46, P666, DOI 10.1016/j.bone.2009.11.011; Green JR, 2003, CANCER, V97, P840, DOI 10.1002/cncr.11128; Greiner S, 2007, J BIOMED MATER RES A, V80A, P769, DOI 10.1002/jbm.a.30950; Idris AI, 2008, CALCIFIED TISSUE INT, V82, P191, DOI 10.1007/s00223-008-9104-y; Im GI, 2004, BIOMATERIALS, V25, P4105, DOI 10.1016/j.biomaterials.2003.11.024; Jeong HM, 2013, BIOCHEM BIOPH RES CO, V432, P152, DOI 10.1016/j.bbrc.2013.01.068; Kim HK, 2009, CLIN ORTHOP RELAT R, V467, P3121, DOI 10.1007/s11999-008-0409-y; Koch FP, 2011, J CRANIO MAXILL SURG, V39, P562, DOI 10.1016/j.jcms.2010.10.007; KOST J, 1992, TRENDS BIOTECHNOL, V10, P127, DOI 10.1016/0167-7799(92)90194-Z; Lala R, 2000, ACTA PAEDIATR, V89, P188, DOI 10.1080/080352500750028816; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; Lu JG, 2011, J CANCER RES CLIN, V137, P1613, DOI 10.1007/s00432-011-1024-y; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Paccou J, 2010, JOINT BONE SPINE, V77, pS120, DOI 10.1016/S1297-319X(10)70007-5; Pan BQ, 2004, BONE, V34, P112, DOI 10.1016/j.bone.2003.08.013; Peter B, 2005, BONE, V36, P52, DOI 10.1016/j.bone.2004.10.004; Plotkin LI, 2011, BONE, V49, P122, DOI 10.1016/j.bone.2010.08.011; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; Plotkin LI, 2008, J BONE MINER RES, V23, P1712, DOI 10.1359/JBMR.080617; Ponader S, 2008, COLLOID SURFACE B, V64, P275, DOI 10.1016/j.colsurfb.2008.02.002; Pozzi S, 2009, CLIN CANCER RES, V15, P5829, DOI 10.1158/1078-0432.CCR-09-0426; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Roshan-Ghias A, 2011, CLIN BIOMECH, V26, P1039, DOI 10.1016/j.clinbiomech.2011.06.004; Ruggiero SL, 2009, AUST ENDOD J, V35, P119, DOI 10.1111/j.1747-4477.2009.00213.x; Russell RGG, 2008, OSTEOPOROSIS INT, V19, P733, DOI 10.1007/s00198-007-0540-8; Russell RGG, 2011, BONE, V49, P2, DOI 10.1016/j.bone.2011.04.022; Schindeler A, 2011, J BONE JOINT SURG BR, V93B, P1134, DOI 10.1302/0301-620X.93B8.25940; Sharma D, 2013, VASC CELL, V5, DOI 10.1186/2045-824X-5-1; Sinha VR, 2003, J CONTROL RELEASE, V90, P261, DOI 10.1016/S0168-3659(03)00194-9; TENENBAUM HC, 1992, BONE, V13, P249, DOI 10.1016/8756-3282(92)90205-B; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Wang CZ, 2010, BIOMATERIALS, V31, P8674, DOI 10.1016/j.biomaterials.2010.07.096; Xiong Y, 2009, J INT MED RES, V37, P407, DOI 10.1177/147323000903700216; Xu XL, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-303	44	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91317	10.1371/journal.pone.0091317	http://dx.doi.org/10.1371/journal.pone.0091317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618585	Green Published, gold, Green Submitted			2022-12-25	WOS:000332842400073
J	Ardissone, AN; de la Cruz, DM; Davis-Richardson, AG; Rechcigl, KT; Li, N; Drew, JC; Murgas-Torrazza, R; Sharma, R; Hudak, ML; Triplett, EW; Neu, J				Ardissone, Alexandria N.; de la Cruz, Diomel M.; Davis-Richardson, Austin G.; Rechcigl, Kevin T.; Li, Nan; Drew, Jennifer C.; Murgas-Torrazza, Roberto; Sharma, Renu; Hudak, Mark L.; Triplett, Eric W.; Neu, Josef			Meconium Microbiome Analysis Identifies Bacteria Correlated with Premature Birth	PLOS ONE			English	Article							PRETERM BIRTH; LACTIC-ACID; INFLAMMATION; INFECTION; COLONIZATION; ASSOCIATION; MODE	Background: Preterm birth is the second leading cause of death in children under the age of five years worldwide, but the etiology of many cases remains enigmatic. The dogma that the fetus resides in a sterile environment is being challenged by recent findings and the question has arisen whether microbes that colonize the fetus may be related to preterm birth. It has been posited that meconium reflects the in-utero microbial environment. In this study, correlations between fetal intestinal bacteria from meconium and gestational age were examined in order to suggest underlying mechanisms that may contribute to preterm birth. Methods: Meconium from 52 infants ranging in gestational age from 23 to 41 weeks was collected, the DNA extracted, and 16S rRNA analysis performed. Resulting taxa of microbes were correlated to clinical variables and also compared to previous studies of amniotic fluid and other human microbiome niches. Findings: Increased detection of bacterial 16S rRNA in meconium of infants of,33 weeks gestational age was observed. Approximately 61.1% of reads sequenced were classified to genera that have been reported in amniotic fluid. Gestational age had the largest influence on microbial community structure (R = 0.161; p = 0.029), while mode of delivery (C-section versus vaginal delivery) had an effect as well (R = 0.100; p = 0.044). Enterobacter, Enterococcus, Lactobacillus, Photorhabdus, and Tannerella, were negatively correlated with gestational age and have been reported to incite inflammatory responses, suggesting a causative role in premature birth. Interpretation: This provides the first evidence to support the hypothesis that the fetal intestinal microbiome derived from swallowed amniotic fluid may be involved in the inflammatory response that leads to premature birth.	[Ardissone, Alexandria N.; Davis-Richardson, Austin G.; Rechcigl, Kevin T.; Drew, Jennifer C.; Triplett, Eric W.] Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [de la Cruz, Diomel M.; Li, Nan; Murgas-Torrazza, Roberto; Neu, Josef] Univ Florida, Dept Pediat, Gainesville, FL 32610 USA; [Sharma, Renu; Hudak, Mark L.] Univ Florida, Dept Pediat, Jacksonville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Neu, J (corresponding author), Univ Florida, Dept Pediat, Gainesville, FL 32610 USA.	neuj@peds.ufl.edu	Neu, Josef/AAI-2799-2020	Drew, Jennifer/0000-0002-4037-108X; Ardissone, Alexandria/0000-0003-3608-6486	United States National Institutes of Health [HD059153]	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was funded by United States National Institutes of Health grant #HD059153. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brocklehurst P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000262.pub4; Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382; DiGiulio DB, 2012, SEMIN FETAL NEONAT M, V17, P2, DOI 10.1016/j.siny.2011.10.001; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Funkhouser LJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001631; GILBERT WM, 1993, SEMIN PERINATOL, V17, P150; Goepfert AR, 2004, OBSTET GYNECOL, V104, P777, DOI 10.1097/01.AOG.0000139836.47777.6d; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gosalbes MJ, 2013, CLIN EXP ALLERGY, V43, P198, DOI 10.1111/cea.12063; Jarjoura K, 2005, AM J OBSTET GYNECOL, V192, P513, DOI 10.1016/j.ajog.2004.07.018; Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007; Madan JC, 2012, ARCH DIS CHILD-FETAL, V97, pF456, DOI 10.1136/fetalneonatal-2011-301373; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Menon R, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.11.025; Miettinen M, 1996, INFECT IMMUN, V64, P5403, DOI 10.1128/IAI.64.12.5403-5405.1996; Moles L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066986; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308; Nanthakumar NN, 2000, P NATL ACAD SCI USA, V97, P6043, DOI 10.1073/pnas.97.11.6043; Onderdonk AB, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2007.11.068; Rautava S, 2012, NAT REV GASTRO HEPAT, V9, P565, DOI 10.1038/nrgastro.2012.144; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; SALAFIA CM, 1991, AM J OBSTET GYNECOL, V165, P934, DOI 10.1016/0002-9378(91)90443-U; Skogstrand K, 2008, OBSTET GYNECOL, V111, P1118, DOI 10.1097/AOG.0b013e31817057fb; Srinivasan U, 2009, MED HYPOTHESES, V73, P963, DOI 10.1016/j.mehy.2009.06.017; Stewart CJ, 2012, ACTA PAEDIATR, V101, P1121, DOI 10.1111/j.1651-2227.2012.02801.x; WATTS DH, 1992, OBSTET GYNECOL, V79, P351	28	254	275	5	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90784	10.1371/journal.pone.0090784	http://dx.doi.org/10.1371/journal.pone.0090784			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614698	Green Submitted, Green Published, gold			2022-12-25	WOS:000332839300041
J	Ding, YL; Shih, YH; Tsai, FY; Leong, MK				Ding, Yi-Lung; Shih, Yu-Hsuan; Tsai, Fu-Yuan; Leong, Max K.			In Silico Prediction of Inhibition of Promiscuous Breast Cancer Resistance Protein (BCRP/ABCG2)	PLOS ONE			English	Article							VECTOR MACHINE PHE/SVM; MULTIDRUG-RESISTANCE; EXTERNAL VALIDATION; DRUG TRANSPORTERS; ABC TRANSPORTERS; P-GLYCOPROTEIN; RECEPTOR; PHARMACOKINETICS; SELECTION; METRICS	Background: Breast cancer resistant protein has an essential role in active transport of endogenous substances and xenobiotics across extracellular and intracellular membranes along with P-glycoprotein. It also plays a major role in multiple drug resistance and permeation of blood-brain barrier. Therefore, it is of great importance to derive theoretical models to predict the inhibition of both transporters in the process of drug discovery and development. Hitherto, very limited BCRP inhibition predictive models have been proposed as compared with its P-gp counterpart. Methodology/Principal Findings: An in silico BCRP inhibition model was developed in this study using the pharmacophore ensemble/support vector machine scheme to take into account the promiscuous nature of BCRP. The predictions by the PhE/SVM model were found to be in good agreement with the observed values for those molecules in the training set (n = 22, r(2) = 0.82, q(CV)(2) = 0.73, RMSE = 0.40, s = 0.24), test set (n = 97, q(2) = 0.75-0.89, RMSE = 0.31, s = 0.21), and outlier set (n = 16, q(2) = 0.72-0.91, RMSE = 0.29, s = 0.17). When subjected to a variety of statistical validations, the developed PhE/SVM model consistently met the most stringent criteria. A mock test by HIV protease inhibitors also asserted its predictivity. Conclusions/Significance: It was found that this accurate, fast, and robust PhE/SVM model can be employed to predict the BCRP inhibition of structurally diverse molecules that otherwise cannot be carried out by any other methods in a high-throughput fashion to design therapeutic agents with insignificant drug toxicity and unfavorable drug-drug interactions mediated by BCRP to enhance clinical efficacy and/or circumvent drug resistance.	[Ding, Yi-Lung; Shih, Yu-Hsuan; Leong, Max K.] Natl Dong Hwa Univ, Dept Chem, Shoufeng, Hualien, Taiwan; [Tsai, Fu-Yuan] Chang Gung Univ, Ctr Gen Educ, Taoyuan, Taiwan; [Leong, Max K.] Natl Dong Hwa Univ, Dept Life Sci, Shoufeng, Hualien, Taiwan; [Leong, Max K.] Natl Dong Hwa Univ, Inst Biotechnol, Shoufeng, Hualien, Taiwan; [Leong, Max K.] Mennonite Christian Hosp, Dept Med Res & Teaching, Hualien, Taiwan	National Dong Hwa University; Chang Gung University; National Dong Hwa University; National Dong Hwa University	Leong, MK (corresponding author), Natl Dong Hwa Univ, Dept Chem, Shoufeng, Hualien, Taiwan.	leong@mail.ndhu.edu.tw			National Science Council, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was funded by the National Science Council, Taiwan (http://web1.nsc.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2011, CURR PHARM DESIGN, V17, P2793, DOI 10.2174/138161211797440186; Allikmets R, 1998, CANCER RES, V58, P5337; BREIMAN L, 1992, INT STAT REV, V60, P291, DOI 10.2307/1403680; Casalegno M, 2008, J CHEM INF MODEL, V48, P1592, DOI 10.1021/ci7004065; Chang C, 2006, ADV DRUG DELIVER REV, V58, P1431, DOI 10.1016/j.addr.2006.09.006; Chang G, 2003, FEBS LETT, V555, P102, DOI 10.1016/S0014-5793(03)01085-8; CHANG G, 1989, J AM CHEM SOC, V111, P4379, DOI 10.1021/ja00194a035; Chen CN, 2011, CHEM RES TOXICOL, V24, P1765, DOI 10.1021/tx200310j; Chirico N, 2012, J CHEM INF MODEL, V52, P2044, DOI 10.1021/ci300084j; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Consonni V, 2010, J CHEMOMETR, V24, P194, DOI 10.1002/cem.1290; Cramer J, 2007, CHEMMEDCHEM, V2, P1783, DOI 10.1002/cmdc.200700160; Decleves X, 2011, CURR DRUG METAB, V12, P732, DOI 10.2174/138920011798357024; Ecker GF, 2008, DRUG DISCOV TODAY, V13, P311, DOI 10.1016/j.drudis.2007.12.012; El Kamar FG, 2004, DIGEST LIVER DIS, V36, P355, DOI 10.1016/j.dld.2003.10.019; Elmeliegy MA, 2011, CLIN CANCER RES, V17, P89, DOI 10.1158/1078-0432.CCR-10-1934; Evans DA, 2007, J CHEM INF MODEL, V47, P1248, DOI 10.1021/ci7000082; Gandhi YA, 2009, AAPS J, V11, P541, DOI 10.1208/s12248-009-9132-1; Gerstner ER, 2007, J CLIN ONCOL, V25, P2306, DOI 10.1200/JCO.2006.10.0677; GNANADESIKAN R, 1972, BIOMETRICS, V28, P81, DOI 10.2307/2528963; Golbraikh A, 2003, J COMPUT AID MOL DES, V17, P241, DOI 10.1023/A:1025386326946; Gupta A, 2004, J PHARMACOL EXP THER, V310, P334, DOI 10.1124/jpet.104.065342; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Hou XN, 2011, MOL CANCER THER, V10, P117, DOI 10.1158/1535-7163.MCT-10-0438; Hu M, 2013, EXPERT OPIN DRUG MET, V14, P1283; Hu MA, 2011, EXPERT OPIN DRUG MET, V7, P49, DOI 10.1517/17425255.2011.538383; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Ishikawa T, 2012, MINI-REV MED CHEM, V12, P505, DOI 10.2174/138955712800493825; Juvale K, 2012, BIOORG MED CHEM LETT, V22, P6766, DOI 10.1016/j.bmcl.2012.08.024; Juvale K, 2012, BIOORGAN MED CHEM, V20, P346, DOI 10.1016/j.bmc.2011.10.074; Klaassen CD, 2010, PHARMACOL REV, V62, P1, DOI 10.1124/pr.109.002014; Kolossvary I, 1996, J AM CHEM SOC, V118, P5011, DOI 10.1021/ja952478m; Lagorce D, 2011, ADMET MED CHEMISTS, P29; Leong MK, 2008, MED CHEM, V4, P396, DOI 10.2174/157340608784872226; Leong MK, 2007, CHEM RES TOXICOL, V20, P217, DOI 10.1021/tx060230c; Leong MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033829; Leong MK, 2010, TOXICOL SCI, V116, P498, DOI 10.1093/toxsci/kfq159; Leong MK, 2009, PHARM RES-DORDR, V26, P987, DOI 10.1007/s11095-008-9807-9; Lexa KW, 2012, Q REV BIOPHYS, V45, P301, DOI 10.1017/S0033583512000066; Li H, 2000, IUL BIOTECH, V2, P171; Lin JH, 2003, CLIN PHARMACOKINET, V42, P59, DOI 10.2165/00003088-200342010-00003; Litman T, 2001, CELL MOL LIFE SCI, V58, P931, DOI 10.1007/PL00000912; Mao QC, 2005, AAPS J, V7, pE118, DOI 10.1208/aapsj070112; Matsson P, 2007, J PHARMACOL EXP THER, V323, P19, DOI 10.1124/jpet.107.124768; Muenster U, 2008, PHARM RES-DORDR, V25, P2320, DOI 10.1007/s11095-008-9632-1; Nicolle E, 2009, ADV DRUG DELIVER REV, V61, P34, DOI 10.1016/j.addr.2008.10.004; Oh Y, 2009, CANCER, V115, P2930, DOI 10.1002/cncr.24333; Ojha PK, 2011, CHEMOMETR INTELL LAB, V107, P194, DOI 10.1016/j.chemolab.2011.03.011; Pan YM, 2013, MOL PHARMACEUT, V10, P1236, DOI 10.1021/mp300547h; Pick A, 2008, BIOORGAN MED CHEM, V16, P8224, DOI 10.1016/j.bmc.2008.07.034; Pick A, 2011, BIOORGAN MED CHEM, V19, P2090, DOI 10.1016/j.bmc.2010.12.043; Pick A, 2010, BIOORG MED CHEM LETT, V20, P180, DOI 10.1016/j.bmcl.2009.11.004; Poguntke M, 2010, EXPERT OPIN DRUG MET, V6, P1363, DOI 10.1517/17425255.2010.519700; Polgar O, 2008, EXPERT OPIN DRUG MET, V4, P1, DOI 10.1517/17425255.4.1.1 ; Reyes CL, 2005, SCIENCE, V308, P1028, DOI 10.1126/science.1107733; Reymond JL, 2010, MEDCHEMCOMM, V1, P30, DOI 10.1039/c0md00020e; Roy K, 2012, J CHEM INF MODEL, V52, P396, DOI 10.1021/ci200520g; Schnepf R, 2013, EXPERT OPIN DRUG MET, V9, P287, DOI 10.1517/17425255.2013.742063; Schuurmann G, 2008, J CHEM INF MODEL, V48, P2140, DOI 10.1021/ci800253u; Shi Z, 2011, CANCER RES, V71, P3029, DOI 10.1158/0008-5472.CAN-10-3820; Shukla S, 2008, EXPERT OPIN DRUG MET, V4, P205, DOI 10.1517/17425255.4.2.205; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sim HM, 2011, CHEMMEDCHEM, V6, P713, DOI 10.1002/cmdc.201000520; Sim HM, 2008, EUR J PHARM SCI, V35, P293, DOI 10.1016/j.ejps.2008.07.008; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Szakacs G, 2008, DRUG DISCOV TODAY, V13, P379, DOI 10.1016/j.drudis.2007.12.010; Tan KP, 2010, MOL PHARMACOL, V78, P175, DOI 10.1124/mol.110.065078; Tomlinson B, 2010, CLIN PHARMACOL THER, V87, P558, DOI 10.1038/clpt.2009.232; Vahakangas K, 2009, BRIT J PHARMACOL, V158, P665, DOI 10.1111/j.1476-5381.2009.00336.x; Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762; Wei YX, 2012, MOL CANCER THER, V11, P1693, DOI 10.1158/1535-7163.MCT-12-0215; Weiss J, 2007, J ANTIMICROB CHEMOTH, V59, P238, DOI 10.1093/jac/dkl474	73	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90689	10.1371/journal.pone.0090689	http://dx.doi.org/10.1371/journal.pone.0090689			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614353	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300034
J	Fowler, RC; Hanson, ND				Fowler, Randal C.; Hanson, Nancy D.			Emergence of Carbapenem Resistance Due to the Novel Insertion Sequence ISPa8 in Pseudomonas aeruginosa	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; ANTIMICROBIAL RESISTANCE; OPRD; IMIPENEM; GENE; MECHANISMS; EXPRESSION; STRAINS; IMPACT	Chronic lung infections due to the persistence of Pseudomonas aeruginosa in cystic fibrosis patients are typically associated with the emergence of antibiotic resistance. The purpose of this study was to investigate the mechanisms responsible for the emergence of carbapenem resistance when a clinical isolate of P. aeruginosa collected from a patient with cystic fibrosis was challenged with meropenem. Nine carbapenem-resistant mutants were selected with subinhibitory concentrations of meropenem from a clinical isolate of P. aeruginosa and characterized for carbapenem resistance. Increased carbapenem MICs were associated with the identification of the novel insertion sequence ISPa8 within oprD or its promoter region in all the mutants. The position of ISPa8 was different for each of the mutants evaluated. In addition, Southern blot analyses identified multiple copies of ISPa8 within the genomes of the mutants and their parent isolate. These data demonstrate that transposition of IS elements within the Pseudomonas genome can influence antibiotic susceptibility. Understanding the selective pressures associated with the emergence of antibiotic resistance is critical for the judicious use of antimicrobial chemotherapy and the successful treatment of bacterial infections.	[Fowler, Randal C.; Hanson, Nancy D.] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Ctr Res Antiinfect & Biotechnol, Omaha, NE 68178 USA	Creighton University	Hanson, ND (corresponding author), Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Ctr Res Antiinfect & Biotechnol, Omaha, NE 68178 USA.	ndhanson@creighton.edu		Fowler, Randal/0000-0002-6703-0488	Johnson and Johnson Pharmaceutical Research and Development; Creighton University	Johnson and Johnson Pharmaceutical Research and Development(Johnson & JohnsonJohnson & Johnson USA); Creighton University	This work was supported in part by a research grant from Johnson and Johnson Pharmaceutical Research and Development and by Creighton University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade SS, 2003, J ANTIMICROB CHEMOTH, V52, P140, DOI 10.1093/jac/dkg270; Boutoille D, 2004, FEMS MICROBIOL LETT, V230, P143, DOI 10.1016/S0378-1097(03)00882-6; Cao B, 2004, J HOSP INFECT, V57, P112, DOI 10.1016/j.jhin.2004.03.021; Carmeli Y, 1999, ANTIMICROB AGENTS CH, V43, P1379, DOI 10.1128/AAC.43.6.1379; Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLIN LAB S S; Depardieu F, 2007, CLIN MICROBIOL REV, V20, P79, DOI 10.1128/CMR.00015-06; Diene SM, 2013, INT J ANTIMICROB AG, V42, P268, DOI 10.1016/j.ijantimicag.2013.06.001; Doumith M, 2009, J ANTIMICROB CHEMOTH, V63, P659, DOI 10.1093/jac/dkp029; Evans JC, 2007, ANTIMICROB AGENTS CH, V51, P3776, DOI 10.1128/AAC.00837-07; Freulet-Marriere MA, 2000, RES MICROBIOL, V151, P873, DOI 10.1016/S0923-2508(00)01154-2; Fujimura Shigeru, 2007, Journal of Infection and Chemotherapy, V13, P147, DOI 10.1007/s10156-007-0507-x; George AM, 2009, FEMS MICROBIOL LETT, V300, P153, DOI 10.1111/j.1574-6968.2009.01704.x; Goering RV, 2011, MOLECULAR MICROBIOLOGY: DIAGNOSTIC PRINCIPLES AND PRACTICE, SECOND EDITION, P167; Hsueh PR, 2005, INT J ANTIMICROB AG, V26, P463, DOI 10.1016/j.ijantimicag.2005.08.016; Kohler T, 1999, ANTIMICROB AGENTS CH, V43, P424, DOI 10.1128/AAC.43.2.424; Kresse A, 2006, ARCH MICROBIOL, V185, P245, DOI 10.1007/s00203-006-0089-5; Lepper PM, 2002, ANTIMICROB AGENTS CH, V46, P2920, DOI 10.1128/AAC.46.9.2920-2925.2002; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Livermore DM, 2002, J ANTIMICROB CHEMOTH, V47, P247; Ochs MM, 1999, ANTIMICROB AGENTS CH, V43, P1085, DOI 10.1128/AAC.43.5.1085; Pai H, 2001, ANTIMICROB AGENTS CH, V45, P480, DOI 10.1128/AAC.45.2.480-484.2001; Pirnay JP, 2002, ENVIRON MICROBIOL, V4, P872, DOI 10.1046/j.1462-2920.2002.00281.x; Pluss-Suard C, 2013, ANTIMICROB AGENTS CH, V57, P1709, DOI 10.1128/AAC.01348-12; Rawling EG, 1998, J BACTERIOL, V180, P3556, DOI 10.1128/JB.180.14.3556-3562.1998; Ruiz-Martinez L, 2011, INT MICROBIOL, V14, P51, DOI 10.2436/20.1501.01.135; Sakyo S, 2006, J ANTIBIOT, V59, P220, DOI 10.1038/ja.2006.31; Sambrook J, 2001, MOL CLONING LAB MANU; Schmidtke AJ, 2006, ANTIMICROB AGENTS CH, V50, P2030, DOI 10.1128/AAC.01458-05; Wolter DJ, 2009, J ANTIMICROB CHEMOTH, V64, P294, DOI 10.1093/jac/dkp185; Wolter DJ, 2004, DIAGN MICR INFEC DIS, V50, P43, DOI 10.1016/j.diagmicrobio.2004.05.004; Wolter DJ, 2004, FEMS MICROBIOL LETT, V236, P137, DOI 10.1016/j.femsle.2004.05.039; WOODRUFF WA, 1989, J BACTERIOL, V171, P3304, DOI 10.1128/jb.171.6.3304-3309.1989	32	17	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91299	10.1371/journal.pone.0091299	http://dx.doi.org/10.1371/journal.pone.0091299			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614163	Green Submitted, gold, Green Published			2022-12-25	WOS:000332839300108
J	Iminjan, M; Amat, N; Li, XH; Upur, H; Ahmat, D; He, B				Iminjan, Mubarak; Amat, Nurmuhammat; Li, Xiao-Hui; Upur, Halmurat; Ahmat, Dilnur; He, Bin			Investigation into the Toxicity of Traditional Uyghur Medicine Quercus Infectoria Galls Water Extract	PLOS ONE			English	Article							CAM	Objective: Quercus infectoria galls (QIG) is being widely used in Traditional Uyghur Medicine. To gather preclinical safety information for the aqueous extract of QIG, a toxicity study was performed. Methods: Subject animals were randomized, and devided into exposure and control groups. In the acute toxicity phase, three different doses-5, 7.5, and 10 g/kg, respectively-were administered via enema to imprinting control region (ICR) mice. An experiment using the maximum tolerance dose (MTD) i.e.10 g/kg was also performed. Data were gathered for 14 days, and study parameters were clinical signs, body weight, general behavior, adverse effects and mortality. At the day 14, major organs of the subjects were examined histologically. Chronic toxicity was also evaluated in Wistar rats for over 180 consecutive days. The rats were divided into three groups with different doses of 0.2 g/kg, 0.8 g/kg, and 2 g/kg, QIG. Furthermore, observations were carried out in rabbits to investigate if there were signs of irritation. Results: In comparison to control group, acute, chronic toxicity and mortality were not significantly increased in exposure group. Conclusion: Study result suggests that the aqueous extract of QIG is unlikely to have significant toxicity and that clinical trials may proceed safely.	[Iminjan, Mubarak] Cent S Univ, XiangYa Hosp, Changsha, Hunan, Peoples R China; [Iminjan, Mubarak] Xinjiang Med Univ, Inst Pharmaceut Sci, Urumqi, Xinjiang, Peoples R China; [Amat, Nurmuhammat; Upur, Halmurat] Xinjiang Med Univ, Tradit Uyghur Med Inst, Urumqi, Xinjiang, Peoples R China; [Li, Xiao-Hui] Cent S Univ, Dept Pharm, Changsha, Hunan, Peoples R China; [Ahmat, Dilnur] Xinjiang Uyghur Autonomous Reg Petr Hosp, Dept Pharm, Urumqi, Peoples R China; [He, Bin] Xinjiang Uyghur Autonomous Reg Peoples Hosp, Dept Pharm, Urumqi, Xinjiang, Peoples R China	Central South University; Xinjiang Medical University; Xinjiang Medical University; Central South University	Amat, N (corresponding author), Xinjiang Med Univ, Tradit Uyghur Med Inst, Urumqi, Xinjiang, Peoples R China.	nur818@hotmail.com; halmurat@263.net			National Science and technology support program sub project of China [2006BA106A17-09]	National Science and technology support program sub project of China	This study was supported with funding from the National Science and technology support program sub project of China (2006BA106A17-09). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROCK WJ, 1995, FOOD CHEM TOXICOL, V33, P483, DOI 10.1016/0278-6915(95)00008-P; Chopra R.N., 1956, CSIR, V208, P255; Cooper EL, 2004, EVID-BASED COMPL ALT, V1, P215, DOI 10.1093/ecam/neh032; Cooper EL, 2005, EVID-BASED COMPL ALT, V2, P125, DOI 10.1093/ecam/neh094; DAR MS, 1979, PLANTA MED, V35, P156, DOI 10.1055/s-0028-1097197; DAR MS, 1976, J PHARM SCI, V65, P1791, DOI 10.1002/jps.2600651224; Everest A, 2005, J ETHNOBIOL ETHNOMED, V1, DOI 10.1186/1746-4269-1-6; [勾晓玉 GOU Xiao-Yu], 2009, [第四军医大学学报, Journal of the Fourth Military Medical University], V30, P501; Hamid H, 2005, PHARM BIOL, V43, P317, DOI 10.1080/13880200590951711; He J, 2009, WORLD J GASTROENTERO, V15, P3441; Huang JJ, 2010, WORLD J GASTROENTERO, V16, P350; Hwang JK, 2000, PLANTA MED, V66, P273, DOI 10.1055/s-2000-8569; IKRAM M, 1977, PLANTA MED, V31, P286, DOI 10.1055/s-0028-1097531; Kaur G, 2004, J ETHNOPHARMACOL, V90, P285, DOI 10.1016/j.jep.2003.10.009; Kaur G, 2008, CHEM-BIOL INTERACT, V171, P272, DOI 10.1016/j.cbi.2007.10.002; Mabeku LBK, 2007, J ETHNOPHARMACOL, V111, P598, DOI 10.1016/j.jep.2007.01.010; Mubarak I, 2012, CHINA J HOSP PHARM, V32, P1397; Mubarak I, 2011, SCI TECHNOLOGY REV, V29, P29; Nassirhadjy M, 2007, XINJIANG YIKE DA XUE, V29, P935; National Pharmacopoeia Committee, 2005, PHARM PEOPL REP CH 1; Olson H, 2000, REGUL TOXICOL PHARM, V32, P56, DOI 10.1006/rtph.2000.1399; ONDERDONK AB, 1985, DIGEST DIS SCI, V30, pS40, DOI 10.1007/BF01296973; Qin Y, 2009, J ETHNOPHARMACOL, V126, P543, DOI 10.1016/j.jep.2009.08.047; Tsao JCI, 2005, EVID-BASED COMPL ALT, V2, P149, DOI 10.1093/ecam/neh092; TWAIJ HAA, 1983, J ETHNOPHARMACOL, V9, P299, DOI 10.1016/0378-8741(83)90037-5; Wang J.Y., 2007, SHIZHEN GUOYI GUOYAO, V18, P2570; Wu HL, 2005, XINJIANG YIKEDA XUEB, V28, P35; Yamunarani K., 2005, Acta Phytopathologica et Entomologica Hungarica, V40, P43, DOI 10.1556/APhyt.40.2005.1-2.6; Yuan R., 2005, STUDY CHEM CONSTITUE; Zhu M, 2002, PHYTOTHER RES, V16, P276, DOI 10.1002/ptr.839	30	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90756	10.1371/journal.pone.0090756	http://dx.doi.org/10.1371/journal.pone.0090756			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608135	Green Submitted, gold, Green Published			2022-12-25	WOS:000332485800048
J	Thuss, SJ; Venkiteswaran, JJ; Schiff, SL				Thuss, Simon J.; Venkiteswaran, Jason J.; Schiff, Sherry L.			Proper Interpretation of Dissolved Nitrous Oxide Isotopes, Production Pathways, and Emissions Requires a Modelling Approach	PLOS ONE			English	Article							MASS-SPECTROMETRY; STABLE-ISOTOPE; NORTH PACIFIC; DUAL-ISOTOPE; N2O FLUXES; OXYGEN; DENITRIFICATION; RATIOS; RIVER; NITRIFICATION	Stable isotopes (delta N-15 and delta O-18) of the greenhouse gas N2O provide information about the sources and processes leading to N2O production and emission from aquatic ecosystems to the atmosphere. In turn, this describes the fate of nitrogen in the aquatic environment since N2O is an obligate intermediate of denitrification and can be a by-product of nitrification. However, due to exchange with the atmosphere, the delta values at typical concentrations in aquatic ecosystems differ significantly from both the source of N2O and the N2O emitted to the atmosphere. A dynamic model, SIDNO, was developed to explore the relationship between the isotopic ratios of N2O, N2O source, and the emitted N2O. If the N2O production rate or isotopic ratios vary, then the N2O concentration and isotopic ratios may vary or be constant, not necessarily concomitantly, depending on the synchronicity of production rate and source isotopic ratios. Thus prima facie interpretation of patterns in dissolved N2O concentrations and isotopic ratios is difficult. The dynamic model may be used to correctly interpret diel field data and allows for the estimation of the gas exchange coefficient, N2O production rate, and the production-weighted d values of the N2O source in aquatic ecosystems. Combining field data with these modelling efforts allows this critical piece of nitrogen cycling and N2O flux to the atmosphere to be assessed.	[Thuss, Simon J.; Venkiteswaran, Jason J.; Schiff, Sherry L.] Univ Waterloo, Dept Earth & Environm Sci, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Venkiteswaran, JJ (corresponding author), Univ Waterloo, Dept Earth & Environm Sci, Waterloo, ON N2L 3G1, Canada.	jjvenkit@uwaterloo.ca		Venkiteswaran, Jason J./0000-0002-6574-7071	Natural Sciences and Engineering Research Council (NSERC); BIOCAP [336807-06]; NSERC; Environment Canada's Science Horizons Youth Internship Program	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); BIOCAP; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Environment Canada's Science Horizons Youth Internship Program	Funding was provided by a Natural Sciences and Engineering Research Council (NSERC) and BIOCAP grant 336807-06 (SLS), an NSERC scholarship (SJT), and Environment Canada's Science Horizons Youth Internship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An S, 2001, LIMNOL OCEANOGR, V46, P62, DOI 10.4319/lo.2001.46.1.0062; Aravena R., 2010, ENV ISOTOPES BIODEGR, P203; Baulch HM, 2012, FRESHWATER BIOL, V57, P509, DOI 10.1111/j.1365-2427.2011.02720.x; Baulch HM, 2011, ENVIRON SCI TECHNOL, V45, P4682, DOI 10.1021/es104116a; Beaulieu JJ, 2010, ENVIRON SCI TECHNOL, V44, P7527, DOI 10.1021/es1016735; Beaulieu JJ, 2011, P NATL ACAD SCI USA, V108, P214, DOI 10.1073/pnas.1011464108; Bol R, 2003, RAPID COMMUN MASS SP, V17, P2550, DOI 10.1002/rcm.1223; Boontanon N, 2000, NATURWISSENSCHAFTEN, V87, P188, DOI 10.1007/s001140050701; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Brenninkmeijer CAM, 1999, RAPID COMMUN MASS SP, V13, P2028, DOI 10.1002/(SICI)1097-0231(19991030)13:20<2028::AID-RCM751>3.0.CO;2-J; CHAPRA SC, 1991, J ENVIRON ENG-ASCE, V117, P640, DOI 10.1061/(ASCE)0733-9372(1991)117:5(640); Clough TJ, 2007, GLOBAL CHANGE BIOL, V13, P1016, DOI 10.1111/j.1365-2486.2007.01337.x; Clough TJ, 2006, GLOBAL CHANGE BIOL, V12, P352, DOI 10.1111/j.1365-2486.2005.01089.x; Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Dore JE, 1998, NATURE, V396, P63, DOI 10.1038/23921; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Garnier J, 2007, HYDROBIOLOGIA, V588, P291, DOI 10.1007/s10750-007-0670-1; Harrison JA, 2005, AQUAT SCI, V67, P308, DOI 10.1007/s00027-005-0776-3; Hood JLA, 2014, AQUAT SCI, V76, P243, DOI 10.1007/s00027-013-0333-4; INOUE HY, 1994, CHEM GEOL, V113, P135, DOI 10.1016/0009-2541(94)90009-4; Kaiser J, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003613; KIM KR, 1990, NATURE, V347, P58, DOI 10.1038/347058a0; Kool DM, 2007, RAPID COMMUN MASS SP, V21, P3569, DOI 10.1002/rcm.3249; Kroeze C., 2005, ENVIRON SCI-TOKYO, V2, P159, DOI [10.1080/15693430500384671, DOI 10.1080/15693430500384671]; Laursen AE, 2004, FRESHWATER BIOL, V49, P1448, DOI 10.1111/j.1365-2427.2004.01280.x; Lide D. R., 1995, CRC HDB CHEM PHYS; Lorenzen J, 1998, APPL ENVIRON MICROB, V64, P3264; Mandernack KW, 2000, J GEOPHYS RES-ATMOS, V105, P17709, DOI 10.1029/2000JD900055; McElroy MB, 1996, GLOBAL BIOGEOCHEM CY, V10, P651, DOI 10.1029/96GB02346; Mengis M, 1999, GROUND WATER, V37, P448, DOI 10.1111/j.1745-6584.1999.tb01124.x; Naqvi SWA, 1998, NATURE, V394, P462, DOI 10.1038/28828; Park S, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2009GB003615; Perez T, 2001, J GEOPHYS RES-ATMOS, V106, P9869, DOI 10.1029/2000JD900809; PRINN R, 1990, J GEOPHYS RES-ATMOS, V95, P18369, DOI 10.1029/JD095iD11p18369; Prinn RG, 2000, J GEOPHYS RES-ATMOS, V105, P17751, DOI 10.1029/2000JD900141; Priscu JC, 2008, LIMNOL OCEANOGR, V53, P2439, DOI 10.4319/lo.2008.53.6.2439; Rahn T, 2000, GLOBAL BIOGEOCHEM CY, V14, P537, DOI 10.1029/1999GB900070; Reay DS, 2003, GLOBAL CHANGE BIOL, V9, P195, DOI 10.1046/j.1365-2486.2003.00584.x; Rock L, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008330; Rockmann T, 2003, RAPID COMMUN MASS SP, V17, P1897, DOI 10.1002/rcm.1132; Rosamond MS, 2012, NAT GEOSCI, V5, P715, DOI [10.1038/NGEO1556, 10.1038/ngeo1556]; Rosamond MS, 2011, J ENVIRON QUAL, V40, P256, DOI 10.2134/jeq2010.0009; Snider DM, 2013, GEOCHIM COSMOCHIM AC, V112, P102, DOI 10.1016/j.gca.2013.03.003; Snider DM, 2012, GLOBAL CHANGE BIOL, V18, P356, DOI 10.1111/j.1365-2486.2011.02547.x; Snider DM, 2010, ENVIRON SCI TECHNOL, V44, P5358, DOI 10.1021/es1002567; Snider DM, 2009, GEOCHIM COSMOCHIM AC, V73, P877, DOI 10.1016/j.gca.2008.11.004; Spoelstra J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082706; Stein LY, 2003, ANNU REV EARTH PL SC, V31, P329, DOI 10.1146/annurev.earth.31.110502.080901; Sutka RL, 2006, APPL ENVIRON MICROB, V72, P638, DOI 10.1128/AEM.72.1.638-644.2006; Toyoda S, 1999, ANAL CHEM, V71, P4711, DOI 10.1021/ac9904563; Toyoda S, 2009, RAPID COMMUN MASS SP, V23, P809, DOI 10.1002/rcm.3945; Venkiteswaran JJ, 2007, OECOLOGIA, V153, P385, DOI 10.1007/s00442-007-0744-9; Venkiteswaran JJ, 2014, ENVIRON SCI TECHNOL, V48, P1566, DOI 10.1021/es500069j; Wada E., 1996, Mass spectrometry of soils., P177; WAHLEN M, 1985, NATURE, V313, P780, DOI 10.1038/313780a0; Well R, 2009, RAPID COMMUN MASS SP, V23, P2996, DOI 10.1002/rcm.4216; Well R, 2012, GEOCHIM COSMOCHIM AC, V90, P265, DOI 10.1016/j.gca.2012.04.045; Westley MB, 2006, DEEP-SEA RES PT II, V53, P1802, DOI 10.1016/j.dsr2.2006.03.012; Yoshinari T, 1997, MAR CHEM, V56, P253, DOI 10.1016/S0304-4203(96)00073-4; ZAFIRIOU OC, 1990, NATURE, V347, P15, DOI 10.1038/347015a0	60	5	5	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90641	10.1371/journal.pone.0090641	http://dx.doi.org/10.1371/journal.pone.0090641			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608915	Green Published, gold, Green Submitted			2022-12-25	WOS:000332485800040
J	Torres, JM; Espinosa, JC; Aguilar-Calvo, P; Herva, ME; Relano-Gines, A; Villa-Diaz, A; Morales, M; Parra, B; Alamillo, E; Brun, A; Castilla, J; Molina, S; Hawkins, SAC; Andreoletti, O				Torres, Juan-Maria; Espinosa, Juan-Carlos; Aguilar-Calvo, Patricia; Herva, Maria-Eugenia; Relano-Gines, Aroa; Villa-Diaz, Ana; Morales, Monica; Parra, Beatriz; Alamillo, Elia; Brun, Alejandro; Castilla, Joaquin; Molina, Susana; Hawkins, Steve A. C.; Andreoletti, Olivier			Elements Modulating the Prion Species Barrier and Its Passage Consequences	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT-JAKOB-DISEASE; MONOCLONAL-ANTIBODIES; PRPSC ACCUMULATION; MOUSE SCRAPIE; PROTEIN; MICE; AGENT; BSE; TRANSMISSION	The specific characteristics of Transmissible Spongiform Encephalopathy (TSE) strains may be altered during passage across a species barrier. In this study we investigated the biochemical and biological characteristics of Bovine Spongiform Encephalopathy (BSE) after transmission in both natural host species (cattle, sheep, pigs and mice) and in transgenic mice overexpressing the corresponding cellular prion protein (PrPC) in comparison with other non-BSE related prions from the same species. After these passages, most features of the BSE agent remained unchanged. BSE-derived agents only showed slight modifications in the biochemical properties of the accumulated PrPSc, which were demonstrated to be reversible upon re-inoculation into transgenic mice expressing bovine-PrPC. Transmission experiments in transgenic mice expressing bovine, porcine or human-PrP revealed that all BSE-derived agents were transmitted with no or a weak transmission barrier. In contrast, a high species barrier was observed for the non-BSE related prions that harboured an identical PrP amino acid sequence, supporting the theory that the prion transmission barrier is modulated by strain properties (presumably conformation-dependent) rather than by PrP amino acid sequence differences between host and donor. As identical results were observed with prions propagated either in natural hosts or in transgenic mouse models, we postulate that the species barrier and its passage consequences are uniquely governed by the host PrPC sequence and not influenced by other host genetic factors. The results presented herein reinforce the idea that the BSE agent is highly promiscuous, infecting other species, maintaining its properties in the new species, and even increasing its capabilities to jump to other species including humans. These data are essential for the development of an accurate risk assessment for BSE.	[Torres, Juan-Maria; Espinosa, Juan-Carlos; Aguilar-Calvo, Patricia; Herva, Maria-Eugenia; Relano-Gines, Aroa; Villa-Diaz, Ana; Morales, Monica; Parra, Beatriz; Alamillo, Elia; Brun, Alejandro; Castilla, Joaquin; Molina, Susana] Ctr Invest Sanidad Anim CISA INIA, Madrid, Spain; [Castilla, Joaquin] Basque Fdn Sci, CIC BioGUNE, Derio Bilbao, Bizkaia, Spain; [Castilla, Joaquin] Basque Fdn Sci, IKERBASQUE, Derio Bilbao, Bizkaia, Spain; [Hawkins, Steve A. C.] Anim Hlth & Vet Labs Agcy AHVLA New Haw, Addlestone, Surrey, England; [Andreoletti, Olivier] Ecole Natl Vet Toulouse, INRA, ENVT, UMR Interact Hote Agent Pathogene 1225, Toulouse, France	Basque Foundation for Science; CIC bioGUNE; Basque Foundation for Science; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse	Torres, JM (corresponding author), Ctr Invest Sanidad Anim CISA INIA, Madrid, Spain.	jmtorres@inia.es	Torres, Juan Maria/L-8768-2013; Brun, Alejandro/J-9808-2014; Hawkins, Stephen/F-1136-2011; Castilla, Joaquin/D-5261-2011; Molina, Susana/M-8969-2014; Espinosa, Juan Carlos/G-7783-2015; Camarzana, Monica Morales/E-6725-2015; Castilla, Joaquín/J-8414-2019	Torres, Juan Maria/0000-0003-0443-9232; Brun, Alejandro/0000-0001-7865-538X; Castilla, Joaquin/0000-0002-2216-1361; Molina, Susana/0000-0001-7737-5562; Espinosa, Juan Carlos/0000-0002-6719-9902; Camarzana, Monica Morales/0000-0001-9786-9076; Castilla, Joaquín/0000-0002-2216-1361; Villa Diaz, Ana/0000-0001-5419-3387; RELANO GINES, AROA/0000-0002-3906-6360	Spanish Ministerio de Ciencia e Innovacion [RTA2012-00004, AGL2005-03066]; European Union [CT-2001-01309, CT-2004-023183, CT2004-506579, CT2009-222887]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European Union(European Commission)	This work was supported by grants from the Spanish Ministerio de Ciencia e Innovacion (RTA2012-00004 and AGL2005-03066) and grants from the European Union (CT-2001-01309, CT-2004-023183, CT2004-506579 and CT2009-222887). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoletti O, 2004, NAT MED, V10, P591, DOI 10.1038/nm1055; Andreoletti O, 2002, J GEN VIROL, V83, P2607, DOI 10.1099/0022-1317-83-10-2607; Brown DA, 2003, NEUROPATH APPL NEURO, V29, P262, DOI 10.1046/j.1365-2990.2003.00462.x; Bruce ME, 2003, BRIT MED BULL, V66, P99, DOI 10.1093/bmb/66.1.99; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Castilla J, 2004, J NEUROSCI, V24, P5063, DOI 10.1523/JNEUROSCI.5400-03.2004; Castilla J, 2003, ARCH VIROL, V148, P677, DOI 10.1007/s00705-002-0958-4; Chen SG, 2002, NEURON, V34, P854, DOI 10.1016/S0896-6273(02)00736-5; Eloit M, 2005, VET REC, V156, P523, DOI 10.1136/vr.156.16.523-b; Espinosa JC, 2007, J VIROL, V81, P835, DOI 10.1128/JVI.01356-06; Espinosa JC, 2009, EMERG INFECT DIS, V15, P1214, DOI 10.3201/eid1508.081218; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Hunter N, 2003, BRIT MED BULL, V66, P171, DOI 10.1093/bmb/66.1.171; KIMBERLIN RH, 1987, J GEN VIROL, V68, P1875, DOI 10.1099/0022-1317-68-7-1875; KIMBERLIN RH, 1989, J GEN VIROL, V70, P2017, DOI 10.1099/0022-1317-70-8-2017; Krasemann S, 1996, MOL MED, V2, P725, DOI 10.1007/BF03401656; Kupfer L, 2007, BBA-MOL BASIS DIS, V1772, P704, DOI 10.1016/j.bbadis.2006.10.009; Lasmezas CI, 2005, LANCET, V365, P781, DOI 10.1016/S0140-6736(05)17985-9; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Padilla D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001319; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PATTISON IH, 1965, VET REC, V77, P1388, DOI 10.1136/vr.77.47.1388; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; Plinston C, 2011, J VIROL, V85, P1174, DOI 10.1128/JVI.01578-10; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Race R, 2001, J VIROL, V75, P10106, DOI 10.1128/JVI.75.21.10106-10112.2001; SCOTT M, 1993, CELL, V73, P979, DOI 10.1016/0092-8674(93)90275-U; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; Scott MR, 2005, J VIROL, V79, P5259, DOI 10.1128/JVI.79.9.5259-5271.2005; Sigurdson CJ, 2003, BRIT MED BULL, V66, P199, DOI 10.1093/bmb/66.1.199; Simon S, 2008, EMERG INFECT DIS, V14, P608, DOI 10.3201/eid1404.071134; Torres JM, 2011, EMERG INFECT DIS, V17, P1636, DOI 10.3201/eid1709.101403; Uro-Coste E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000029; Wells GAH, 2003, J GEN VIROL, V84, P1021, DOI 10.1099/vir.0.18788-0; Yull HM, 2006, AM J PATHOL, V168, P151, DOI 10.2353/ajpath.2006.050766	40	36	36	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e89722	10.1371/journal.pone.0089722	http://dx.doi.org/10.1371/journal.pone.0089722			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608126	Green Published, Green Submitted, gold			2022-12-25	WOS:000332485800007
J	Tung, MC; Hsieh, MJ; Wang, SS; Yang, SF; Chen, SS; Wang, SW; Lee, LM; Lee, WJ; Chien, MH				Tung, Min-Che; Hsieh, Ming-Ju; Wang, Shian-Shiang; Yang, Shun-Fa; Chen, Shiou-Sheng; Wang, Shih-Wei; Lee, Liang-Ming; Lee, Wei-Jiunn; Chien, Ming-Hsien			Associations of VEGF-C Genetic Polymorphisms with Urothelial Cell Carcinoma Susceptibility Differ between Smokers and Non-Smokers in Taiwan	PLOS ONE			English	Article							BLADDER-CANCER RISK; GROWTH FACTOR-C; TUMOR-GROWTH; METASTASIS; EXPRESSION; SMOKING; ANGIOGENESIS; DETERMINANTS	Background: Vascular endothelial growth factor (VEGF)-C is associated with lymphangiogenesis, pelvic regional lymph node metastasis, and an antiapoptotic phenotype in urothelial cell carcinoma (UCC). Knowledge of potential roles of VEGF-C genetic polymorphisms in susceptibility to UCC is lacking. This study was designed to examine associations between VEGF-C gene variants and UCC susceptibility and evaluate whether they are modified by smoking. Methodology/Principal Findings: Five single-nucleotide polymorphisms (SNPs) of VEGF-C were analyzed by a TaqMan-based real-time polymerase chain reaction (PCR) in 233 patients with UCC and 520 cancer-free controls. A multivariate logistic regression was applied to model associations between genetic polymorphisms and UCC susceptibility, and to determine if the effect was modified by smoking. We found that after adjusting for other covariates, individuals within the entire population and the 476 non-smokers carrying at least one A allele at VEGF-C rs1485766 respectively had 1.742- and 1.834-fold risks of developing UCC than did wild-type (CC) carriers. Among the 277 smokers, we found that VEGF-C rs7664413 T (CT+TT) and rs2046463 G (AG+GG) allelic carriers were more prevalent in UCC patients than in non-cancer participants. Moreover, UCC patients with the smoking habit who had at least one T allele of VEGF-C rs7664413 were at higher risk of developing larger tumor sizes (p = 0.021), compared to those patients with CC homozygotes. Conclusions: Our results suggest that the involvement of VEGF-C genotypes in UCC risk differs among smokers compared to non-smokers among Taiwanese. The genetic polymorphism of VEGF-C rs7664413 might be a predictive factor for the tumor size of UCC patients who have a smoking habit.	[Tung, Min-Che] Tungs Taichung Metro Harbor Hosp, Dept Surg, Taichung, Taiwan; [Tung, Min-Che; Chien, Ming-Hsien] Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan; [Hsieh, Ming-Ju] Changhua Christian Hosp, Canc Res Ctr, Changhua, Taiwan; [Hsieh, Ming-Ju; Wang, Shian-Shiang; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Wang, Shian-Shiang] Taichung Vet Gen Hosp, Div Urol, Dept Surg, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Chen, Shiou-Sheng] Taipei City Hosp, Renai Branch, Div Urol, Taipei, Taiwan; [Chen, Shiou-Sheng] Natl Yang Ming Univ, Sch Med, Dept Urol, Taipei 112, Taiwan; [Wang, Shih-Wei] Mackay Med Coll, Dept Med, Taipei, Taiwan; [Lee, Liang-Ming; Lee, Wei-Jiunn] Taipei Med Univ, Wan Fang Hosp, Dept Urol, Taipei, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Wan Fang Hosp, Taipei, Taiwan	Taipei Medical University; Changhua Christian Hospital; Chung Shan Medical University; Taichung Veterans General Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Taipei City Hospital; National Yang Ming Chiao Tung University; Mackay Medical College; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital	Chien, MH (corresponding author), Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan.	mhchien1976@gmail.com	Yang, Shun-Fa/AAN-1519-2020; Wang, Shih-Wei/AAH-1967-2020; Hsieh, Ming-Ju/GQB-3025-2022	Yang, Shun-Fa/0000-0002-0365-7927; Wang, Shih-Wei/0000-0001-7522-6352; Hsieh, Ming-Ju/0000-0001-9726-3234	Tungs' Taichung Metro Harbor Hospital [CSMU-TTM-101-01]; Taipei Medical University [TMU101-AE3-Y22]; Chung Shan Medical University	Tungs' Taichung Metro Harbor Hospital; Taipei Medical University; Chung Shan Medical University	This study was supported by grants from Chung Shan Medical University and Tungs' Taichung Metro Harbor Hospital (CSMU-TTM-101-01) and Taipei Medical University (TMU101-AE3-Y22). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bando H, 2006, ONCOL REP, V15, P653; Baris D, 2009, JNCI-J NATL CANCER I, V101, P1553, DOI 10.1093/jnci/djp361; Bid HK, 2006, UROLOGY, V67, P1099, DOI 10.1016/j.urology.2005.11.032; Chen M, 2007, CARCINOGENESIS, V28, P2160, DOI 10.1093/carcin/bgm167; Chien MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060283; Chien MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051051; Costa F, 2009, LIFE SCI, V84, P785, DOI 10.1016/j.lfs.2009.03.002; Fairbrother WG, 2000, MOL CELL BIOL, V20, P6816, DOI 10.1128/MCB.20.18.6816-6825.2000; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Garcia-Closas M, 2007, PLOS GENET, V3, P287, DOI 10.1371/journal.pgen.0030029; Goode EL, 2010, CLIN CANCER RES, V16, P995, DOI 10.1158/1078-0432.CCR-09-2553; He YL, 2004, BBA-REV CANCER, V1654, P3, DOI 10.1016/j.bbcan.2003.07.003; Health Do, 2010, CANC RESG ANN REP; Hong JM, 2010, EXP MOL MED, V42, P376, DOI 10.3858/emm.2010.42.5.039; Hsieh MC, 2014, J CLIN LAB IN PRESS; Inamine M, 2012, INT J CLIN ONCOL, V17, P498, DOI 10.1007/s10147-011-0322-3; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kellen E, 2007, CANCER LETT, V245, P51, DOI 10.1016/j.canlet.2005.12.025; Khromova N, 2012, ONCOGENE, V31, P1389, DOI 10.1038/onc.2011.330; Kim EJ, 2005, UROLOGY, V65, P70, DOI 10.1016/j.urology.2004.08.005; Komiya Y, 2005, CANCER LETT, V221, P55, DOI 10.1016/j.canlet.2004.10.042; Ladomery MR, 2007, CANCER LETT, V249, P133, DOI 10.1016/j.canlet.2006.08.015; Marcus PM, 2000, CANCER EPIDEM BIOMAR, V9, P461; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Tsukada S, 2006, MOL ENDOCRINOL, V20, P1104, DOI 10.1210/me.2005-0311; Ueda M, 2002, INT J CANCER, V98, P335, DOI 10.1002/ijc.10193; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; Wang D, 2011, PHARMACOGENOMICS J, V11, P274, DOI 10.1038/tpj.2010.28; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Wang ZG, 2010, BIOCHEM J, V428, P347, DOI 10.1042/BJ20100379; Zu XB, 2006, BJU INT, V98, P1090, DOI 10.1111/j.1464-410X.2006.06446.x	31	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91147	10.1371/journal.pone.0091147	http://dx.doi.org/10.1371/journal.pone.0091147			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608123	Green Submitted, gold, Green Published			2022-12-25	WOS:000332485800105
J	Le Coz, GM; Anton, F; Hanesch, U				Le Coz, Glenn-Marie; Anton, Fernand; Hanesch, Ulrike			Glucocorticoid-Mediated Enhancement of Glutamatergic Transmission May Outweigh Anti-Inflammatory Effects under Conditions of Neuropathic Pain	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ACTIVATED PROTEIN-KINASE; PERIPHERAL-NERVE INJURY; TNF-ALPHA; SCIATIC-NERVE; SPINAL-CORD; EXPRESSION; RATS; HYPERALGESIA; RECEPTORS	At the clinical level comorbidity between chronic pain and dysfunctional hypothalamus-pituitary-adrenal (HPA) axis is well established. We aimed to identify causal relationships in a model of neuropathic pain (chronic constriction injury, CCI) by studying the effects of glucocorticoid receptor agonist (dexamethasone) and antagonist (RU-486) administration on pain behavior and spinal biochemical mediators. Daily injections were performed in Sprague Dawley rats. Weight, plasma corticosterone levels and mechanical pain thresholds were assessed before and during 21 days post-CCI. At days four and 21 we investigated the mRNA expression of spinal mediators. In the dexamethasone-injected group, we observed a diminution of body weight and plasma corticosterone levels during the 21 days post surgery period and a more pronounced pain sensitivity until day 7 post-CCI. This enhanced pain sensitivity in the early period following nerve injury was accompanied by a transient increase of the glutamate receptors mGluR5 and NMDA at day 4. However, at this time point we did not observe any effect of the agonist/antagonist injections on the mRNA expression of pro-inflammatory cytokines. The RU-486-injected rats showed a slight mechanical hypoalgesia until 7 days post-CCI, but without any significant correlation with the expression of the measured markers. Our results indicate that glucocorticoid-related modulations of neuropathic pain processing may rather depend on a modification of glutamatergic transmission than on a change in pro-inflammatory cytokine expression.	[Le Coz, Glenn-Marie; Anton, Fernand; Hanesch, Ulrike] Univ Luxembourg, Lab Neurophysiol & Psychobiol, Luxembourg, Luxembourg	University of Luxembourg	Hanesch, U (corresponding author), Univ Luxembourg, Lab Neurophysiol & Psychobiol, Luxembourg, Luxembourg.	ulrike.hanesch@uni.lu			University of Luxembourg [F3R-INS-PUL-08MPMG, F3R-INS-PUL-11STPA]	University of Luxembourg	This work was supported by grant from the University of Luxembourg (F3R-INS-PUL-08MPMG and F3R-INS-PUL-11STPA). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Alexander JK, 2009, BRAIN BEHAV IMMUN, V23, P851, DOI 10.1016/j.bbi.2009.04.001; Aloisi AM, 2011, PSYCHONEUROENDOCRINO, V36, P1032, DOI 10.1016/j.psyneuen.2010.12.017; Aschner M, 1998, NEUROTOXICOLOGY, V19, P269; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chrousos George P., 2000, Journal of Allergy and Clinical Immunology, V106, pS275; Clark A, 2000, ARTHRITIS RES, V2, P172, DOI 10.1186/ar83; Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005; Davis MC, 2001, ANN BEHAV MED, V23, P215, DOI 10.1207/S15324796ABM2303_9; DAWSON J, 1993, AGENTS ACTIONS, V38, P255, DOI 10.1007/BF01976218; Gomez-Nicola D, 2008, J NEUROCHEM, V107, P1741, DOI 10.1111/j.1471-4159.2008.05746.x; Ji RR, 2013, PAIN, V154, pS10, DOI 10.1016/j.pain.2013.06.022; Junger H, 2000, PAIN, V85, P145, DOI 10.1016/S0304-3959(99)00262-6; Kalariti N., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P113; Kanczkowski W, 2013, P NATL ACAD SCI USA, V110, P14801, DOI 10.1073/pnas.1313945110; Kingery WS, 2001, ANESTH ANALG, V92, P476, DOI 10.1213/00000539-200102000-00037; Kuehl LK, 2010, PAIN, V149, P539, DOI 10.1016/j.pain.2010.03.026; LEE SW, 1988, P NATL ACAD SCI USA, V85, P1204, DOI 10.1073/pnas.85.4.1204; Leung L, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-27; Li HQ, 2007, ANESTHESIOLOGY, V107, P469, DOI 10.1097/01.anes.0000278907.37774.8d; Liberman AC, 2007, CYTOKINE GROWTH F R, V18, P45, DOI 10.1016/j.cytogfr.2007.01.005; Lu J, 2003, NEUROSCIENCE, V121, P123, DOI 10.1016/S0306-4522(03)00421-4; McEwen BS, 2010, METABOLISM, V59, pS9, DOI 10.1016/j.metabol.2010.07.012; McMahon SB, 2005, EXP NEUROL, V192, P444, DOI 10.1016/j.expneurol.2004.11.001; Michaux GPN, 2012, PAIN, V153, P420, DOI 10.1016/j.pain.2011.10.043; Milligan ED, 2003, J NEUROSCI, V23, P1026; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Newton R, 2000, THORAX, V55, P603, DOI 10.1136/thorax.55.7.603; Opree A, 2000, J NEUROSCI, V20, P6289, DOI 10.1523/JNEUROSCI.20-16-06289.2000; Osikowicz M, 2013, EXP PHYSIOL, V98, P372, DOI 10.1113/expphysiol.2012.069922; Ou Guo-Kun, 2013, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V29, P97; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; SNYDER DS, 1982, J IMMUNOL, V129, P1803; Soro A, 1995, J ENDOCRINOL INVEST, V18, P833, DOI 10.1007/BF03349829; Straub RH, 2013, SEMIN ARTHR IN PRESS, DOI [10.1016/j.semarthrit.2013.04.008, DOI 10.1016/J.SEMAR-THRIT.2013.04.008]; Swantek JL, 1997, MOL CELL BIOL, V17, P6274, DOI 10.1128/MCB.17.11.6274; Takasaki I, 2005, EUR J PHARMACOL, V524, P80, DOI 10.1016/j.ejphar.2005.09.045; Urban MO, 2003, NEUROPHARMACOLOGY, V44, P983, DOI 10.1016/S0028-3908(03)00118-7; Wang SX, 2005, J NEUROSCI, V25, P488, DOI 10.1523/JNEUROSCI.4127-04.2005; Wang SX, 2004, J NEUROSCI, V24, P8595, DOI 10.1523/JNEUROSCI.3058-04.2004; Wen YR, 2007, ANESTHESIOLOGY, V107, P312, DOI 10.1097/01.anes.0000270759.11086.e7; Wen ZH, 2005, NEUROSCIENCE, V133, P807, DOI 10.1016/j.neuroscience.2005.03.015; Yan P, 2003, EXP NEUROL, V183, P286, DOI 10.1016/S0014-4886(03)00135-3	44	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91393	10.1371/journal.pone.0091393	http://dx.doi.org/10.1371/journal.pone.0091393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618816	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400085
J	Li, CL; Li, FN; Zhao, K; Yao, J; Cheng, Y; Zhao, L; Li, ZY; Lu, N; Guo, QL				Li, Chenglin; Li, Fanni; Zhao, Kai; Yao, Jing; Cheng, Yao; Zhao, Li; Li, Zhiyu; Lu, Na; Guo, Qinglong			LFG-500 Inhibits the Invasion of Cancer Cells via Down-Regulation of PI3K/AKT/NF-kappa B Signaling Pathway	PLOS ONE			English	Article							NF-KAPPA-B; EPITHELIAL-MESENCHYMAL TRANSITION; MATRIX METALLOPROTEINASES; MATRIX-METALLOPROTEINASE-9 EXPRESSION; STAT3 ACTIVATION; GENE-EXPRESSION; TUMOR INVASION; METASTASIS; CARCINOMA; ERK1/2	Cancer cell invasion, one of the crucial events in local growth and metastatic spread of tumors, possess a broad spectrum of mechanisms, especially altered expression of matrix metalloproteinases. LFG-500 is a novel synthesized flavonoid with strong anti-cancer activity, whose exact molecular mechanism remains incompletely understood. This current study was designed to examine the effects of LFG-500 on tumor metastasis using in vitro and in vivo assays. LFG-500 could inhibit adhesion, migration and invasion of MDA-MB-231 human breast carcinoma cells. Meanwhile, it reduced the activities and expression of MMP-2 and MMP-9 via suppressing the transcriptional activation of NF-kappa B rather than AP-1 or STAT3. Moreover, LFG-500 repressed TNF-alpha induced cell invasion through inhibiting NF-kappa B and subsequent MMP-9 activity. Further elucidation of the mechanism revealed that PI3K/AKT but not MAPK signaling pathway was involved in the inhibitory effect of LFG-500 on NF-kappa B activation. LFG-500 could also suppress lung metastasis of B16F10 murine melanoma cells in vivo. Taken together, these results demonstrated that LFG-500 could block cancer cell invasion via down-regulation of PI3K/AKT/NF-kappa B signaling pathway, which provides new evidence for the anti-cancer activity of LFG-500.	[Li, Chenglin; Li, Fanni; Zhao, Kai; Yao, Jing; Cheng, Yao; Zhao, Li; Li, Zhiyu; Lu, Na; Guo, Qinglong] China Pharmaceut Univ, Minist Educ, Key Lab Drug Qual Control & Pharmacovigilance, State Key Lab Nat Med,Jiangsu Key Lab Carcinogene, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University	Lu, N (corresponding author), China Pharmaceut Univ, Minist Educ, Key Lab Drug Qual Control & Pharmacovigilance, State Key Lab Nat Med,Jiangsu Key Lab Carcinogene, Nanjing, Jiangsu, Peoples R China.	Luna555@163.com; anticancer_drug@163.com			Natural Science Foundation of China [21072232]; State Key Laboratory of Natural Medicines, China Pharmaceutical University [JKGZ201101, SKLNMZZ201210, SKLNMZZCX201303, SKLNMZZJQ201302]; Natural Science Foundation of Jiangsu province [BK2011620, BK20130220]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1193]; National Science & Technology Major Project [2013ZX0 9103-001-007, 2012ZX09304-001]; China Postdoctoral Science Foundation [2013M 541733]; Jiangsu Planned Projects for Postdoctoral Research Funds [1301015B]; Natural Science Foundation of the Higher Education Institutions of Jiangsu Province [13KJB350007]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Natural Medicines, China Pharmaceutical University; Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Science & Technology Major Project; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jiangsu Planned Projects for Postdoctoral Research Funds; Natural Science Foundation of the Higher Education Institutions of Jiangsu Province	This work was supported by the Natural Science Foundation of China (No. 21072232), the Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University (No. JKGZ201101, SKLNMZZ201210, SKLNMZZCX201303, SKLNMZZJQ201302), the Natural Science Foundation of Jiangsu province (No. BK2011620, BK20130220), the Program for Changjiang Scholars and Innovative Research Team in University (IRT1193), the National Science & Technology Major Project (No. 2013ZX0 9103-001-007, 2012ZX09304-001), the China Postdoctoral Science Foundation funded project (2013M 541733), the Jiangsu Planned Projects for Postdoctoral Research Funds (1301015B), and the Natural Science Foundation of the Higher Education Institutions of Jiangsu Province (13KJB350007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Albini A, 1998, Pathol Oncol Res, V4, P230; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BODE W, 1994, EMBO J, V13, P1263, DOI 10.1002/j.1460-2075.1994.tb06378.x; Campbell KJ, 2001, BIOCHEM SOC T, V29, P688; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Chen P, 2011, TOXICOLOGY, V282, P122, DOI 10.1016/j.tox.2011.01.018; Chen Y, 2009, TOXICOLOGY, V259, P10, DOI 10.1016/j.tox.2009.01.010; Cheng JCH, 2006, ONCOGENE, V25, P7009, DOI 10.1038/sj.onc.1209706; Demchenko YN, 2010, BLOOD, V115, P3541, DOI 10.1182/blood-2009-09-243535; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Dolle L, 2006, CURR CANCER DRUG TAR, V6, P729, DOI 10.2174/156800906779010263; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Ellenrieder V, 1999, ANN ONCOL, V10, P46, DOI 10.1023/A:1008380501633; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hong S, 2005, J BIOL CHEM, V280, P25202, DOI 10.1074/jbc.M413985200; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Ichikawa H, 2006, MOL CANCER THER, V5, P1434, DOI 10.1158/1535-7163.MCT-06-0096; Jemal A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1672; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; Johnson LL, 1998, CURR OPIN CHEM BIOL, V2, P466, DOI 10.1016/S1367-5931(98)80122-1; Jones JL, 2003, J PATHOL, V201, P562, DOI 10.1002/path.1483; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kefaloyianni E, 2006, CELL SIGNAL, V18, P2238, DOI 10.1016/j.cellsig.2006.05.004; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Khasigov PZ, 2003, BIOCHEMISTRY-MOSCOW+, V68, P711, DOI 10.1023/A:1025051214001; Lee YC, EUR J PHARM, V632, P23; Li C, 2011, CATAL TODAY, V175, P1, DOI 10.1016/j.cattod.2011.08.002; Li CH, 2013, J NUTR BIOCHEM, V24, P1766, DOI 10.1016/j.jnutbio.2013.03.006; Li YM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.347; Lin YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071903; Mburu YK, 2012, J BIOL CHEM, V287, P3581, DOI 10.1074/jbc.M111.294876; Moon SK, 2004, J CELL PHYSIOL, V198, P417, DOI 10.1002/jcp.10435; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Ozes ON, 1999, NATURE, V401, P82; Philip S, 2003, J BIOL CHEM, V278, P14487, DOI 10.1074/jbc.M207309200; Qi Q, 2008, BIOCHEM CELL BIOL, V86, P386, DOI [10.1139/O08-104, 10.1139/o08-104]; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Schroer N, 2011, CANCER RES, V71, P87, DOI 10.1158/0008-5472.CAN-10-2193; Shishodia S, 2003, CANCER RES, V63, P4375; Sigala JLD, 2004, SCIENCE, V304, P1963, DOI 10.1126/science.1098387; Tai KY, 2008, ONCOGENE, V27, P4044, DOI 10.1038/onc.2008.57; Tian YP, 2010, BIOCHEM BIOPH RES CO, V397, P420, DOI 10.1016/j.bbrc.2010.05.108; Troussard AA, 2000, ONCOGENE, V19, P5444, DOI 10.1038/sj.onc.1203928; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang L, 2010, CANCER LETT, V297, P42, DOI 10.1016/j.canlet.2010.04.022; Wei DY, 2003, ONCOGENE, V22, P319, DOI 10.1038/sj.onc.1206122; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Wu KJ, 2013, CELL SIGNAL, V25, P2625, DOI 10.1016/j.cellsig.2013.08.028; Wu T., 2011, BIOMED PREV NUTR, V1, P132; Yilmaz M, 2007, TRENDS MOL MED, V13, P535, DOI 10.1016/j.molmed.2007.10.004; Zhao J, 2008, EUR J PHARMACOL, V589, P127, DOI 10.1016/j.ejphar.2008.04.063	57	29	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91332	10.1371/journal.pone.0091332	http://dx.doi.org/10.1371/journal.pone.0091332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618693	gold, Green Submitted, Green Published			2022-12-25	WOS:000332842400079
J	Muthuraman, M; Hellriegel, H; Hoogenboom, N; Anwar, AR; Mideksa, KG; Krause, H; Schnitzler, A; Deuschl, G; Raethjen, J				Muthuraman, Muthuraman; Hellriegel, Helge; Hoogenboom, Nienke; Anwar, Abdul Rauf; Mideksa, Kidist Gebremariam; Krause, Holger; Schnitzler, Alfons; Deuschl, Guenther; Raethjen, Jan			Beamformer Source Analysis and Connectivity on Concurrent EEG and MEG Data during Voluntary Movements	PLOS ONE			English	Article							VOLUME CONDUCTION; GRANGER CAUSALITY; COHERENT SOURCES; COMBINING MEG; MOTOR AREAS; BRAIN-AREAS; MODEL; MAGNETOENCEPHALOGRAPHY; LOCALIZATION; SYSTEMS	Electroencephalography (EEG) and magnetoencephalography (MEG) are the two modalities for measuring neuronal dynamics at a millisecond temporal resolution. Different source analysis methods, to locate the dipoles in the brain from which these dynamics originate, have been readily applied to both modalities alone. However, direct comparisons and possible advantages of combining both modalities have rarely been assessed during voluntary movements using coherent source analysis. In the present study, the cortical and sub-cortical network of coherent sources at the finger tapping task frequency (2-4 Hz) and the modes of interaction within this network were analysed in 15 healthy subjects using a beamformer approach called the dynamic imaging of coherent sources (DICS) with subsequent source signal reconstruction and renormalized partial directed coherence analysis (RPDC). MEG and EEG data were recorded simultaneously allowing the comparison of each of the modalities separately to that of the combined approach. We found the identified network of coherent sources for the finger tapping task as described in earlier studies when using only the MEG or combined MEG+EEG whereas the EEG data alone failed to detect single sub-cortical sources. The signal-to-noise ratio (SNR) level of the coherent rhythmic activity at the tapping frequency in MEG and combined MEG+EEG data was significantly higher than EEG alone. The functional connectivity analysis revealed that the combined approach had more active connections compared to either of the modalities during the finger tapping (FT) task. These results indicate that MEG is superior in the detection of deep coherent sources and that the SNR seems to be more vital than the sensitivity to theoretical dipole orientation and the volume conduction effect in the case of EEG.	[Muthuraman, Muthuraman; Hellriegel, Helge; Anwar, Abdul Rauf; Mideksa, Kidist Gebremariam; Deuschl, Guenther; Raethjen, Jan] Univ Kiel, Dept Neurol, Kiel, Germany; [Anwar, Abdul Rauf; Mideksa, Kidist Gebremariam] Univ Kiel, Inst Circuit & Syst Theory, Kiel, Germany; [Hoogenboom, Nienke; Krause, Holger; Schnitzler, Alfons] Univ Dusseldorf, Dept Neurol, Dusseldorf, Germany	University of Kiel; University of Kiel; Heinrich Heine University Dusseldorf	Muthuraman, M (corresponding author), Univ Kiel, Dept Neurol, Kiel, Germany.	m.muthuraman@neurologie.uni-kiel.de	Muthuraman, Muthuraman/ABD-2021-2020; Schnitzler, Alfons/AAT-1054-2021; Schnitzler, Alfons/K-4625-2014; Schnitzler, Alfons/Q-5520-2019; Deuschl, Gunther/A-7986-2010	Muthuraman, Muthuraman/0000-0001-6158-2663; Schnitzler, Alfons/0000-0002-6414-7939; Schnitzler, Alfons/0000-0002-6414-7939; Deuschl, Gunther/0000-0002-4176-9196	Project D2 [Sonderforschungsbereich (SFB) 855]	Project D2	This work was supported by Sonderforschungsbereich (SFB) 855, Project D2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2006, MAGN RESON IMAGING, V24, P181, DOI 10.1016/j.mri.2005.10.022; Ahlfors SP, 2010, BRAIN TOPOGR, V23, P227, DOI 10.1007/s10548-010-0154-x; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amjad AM, 1997, J NEUROSCI METH, V73, P69, DOI 10.1016/S0165-0270(96)02214-5; Babiloni F, 2004, HUM BRAIN MAPP, V22, P52, DOI 10.1002/hbm.20011; Babiloni F, 2001, HUM BRAIN MAPP, V14, P197, DOI 10.1002/hbm.1052; Baillet S, 1999, IEEE T BIO-MED ENG, V46, P522, DOI 10.1109/10.759053; Ball T, 1999, NEUROIMAGE, V10, P682, DOI 10.1006/nimg.1999.0507; Bouet R, 2012, NEUROIMAGE, V59, P3955, DOI 10.1016/j.neuroimage.2011.10.052; Cheyne D, 1990, ADV BIOMAGNETISM, P177; COHEN D, 1983, ELECTROEN CLIN NEURO, V56, P38, DOI 10.1016/0013-4694(83)90005-6; COHEN D, 1972, SCIENCE, V175, P664, DOI 10.1126/science.175.4022.664; COHEN D, 1987, PHYS MED BIOL, V32, P85, DOI 10.1088/0031-9155/32/1/013; CUFFIN BN, 1979, ELECTROEN CLIN NEURO, V47, P132, DOI 10.1016/0013-4694(79)90215-3; de Jongh A, 2005, J CLIN NEUROPHYSIOL, V22, P153, DOI 10.1097/01.WNP.0000158947.68733.51; Ding MZ, 2000, BIOL CYBERN, V83, P35, DOI 10.1007/s004229900137; Farina D, 2004, J APPL PHYSIOL, V96, P1486, DOI 10.1152/japplphysiol.01070.2003; Feige B, 2000, J NEUROPHYSIOL, V84, P2622, DOI 10.1152/jn.2000.84.5.2622; FERGUSON AS, 1994, IEEE T BIO-MED ENG, V41, P455, DOI 10.1109/10.293220; Fuchs M, 1998, ELECTROEN CLIN NEURO, V107, P93, DOI 10.1016/S0013-4694(98)00046-7; Goldenholz DM, 2009, HUM BRAIN MAPP, V30, P1077, DOI 10.1002/hbm.20571; Gramfort A, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-45; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; HAMALAINEN MS, 1989, IEEE T BIO-MED ENG, V36, P165, DOI 10.1109/10.16463; Haufe S, 2013, NEUROIMAGE, V64, P120, DOI 10.1016/j.neuroimage.2012.09.036; Henson RN, 2009, NEUROIMAGE, V47, P581, DOI 10.1016/j.neuroimage.2009.04.063; Hepp-Reymond MC, 1988, FUNCTIONAL ORG MOTOR; Hillebrand A, 2002, NEUROIMAGE, V16, P638, DOI 10.1006/nimg.2002.1102; Huang MX, 2007, NEUROIMAGE, V37, P731, DOI 10.1016/j.neuroimage.2007.06.002; Jones EG, 2002, PHILOS T R SOC B, V357, P1659, DOI 10.1098/rstb.2002.1168; JOURNEE HL, 1983, IEEE T BIO-MED ENG, V30, P304, DOI 10.1109/TBME.1983.325120; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Kandel E. R., 2013, PRINCIPLES NEURAL SC; Lin FH, 2013, MAGN RESON MED, V70, P595, DOI 10.1002/mrm.24479; Liu AK, 2002, HUM BRAIN MAPP, V16, P47, DOI 10.1002/hbm.10024; Llinas R, 2005, TRENDS NEUROSCI, V28, P325, DOI 10.1016/j.tins.2005.04.006; McClelland VM, 2012, J NEUROSCI METH, V205, P190, DOI 10.1016/j.jneumeth.2011.11.001; MEIJS JWH, 1987, ELECTROEN CLIN NEURO, V66, P286, DOI 10.1016/0013-4694(87)90078-2; MELCHER JR, 1988, ELECTROEN CLIN NEURO, V70, P460, DOI 10.1016/0013-4694(88)90024-7; Michalareas G, 2013, HUM BRAIN MAPP, V34, P890, DOI 10.1002/hbm.21482; Mima T, 1999, CLIN NEUROPHYSIOL, V110, P1892, DOI 10.1016/S1388-2457(99)00238-2; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Molins A, 2008, NEUROIMAGE, V42, P1069, DOI 10.1016/j.neuroimage.2008.05.064; Mosher JC, 1999, IEEE T BIO-MED ENG, V46, P245, DOI 10.1109/10.748978; Muthuraman M, 2012, NEUROIMAGE, V60, P1331, DOI 10.1016/j.neuroimage.2012.01.088; Muthuraman M, 2010, BIOMED SIGNAL PROCES, V5, P205, DOI 10.1016/j.bspc.2010.02.006; Muthuraman M, 2008, IEEE ENG MED BIO, P4716, DOI 10.1109/IEMBS.2008.4650266; Nedelko V, 2010, RESTOR NEUROL NEUROS, V28, P737, DOI 10.3233/RNN-2010-0542; Neumaier A, 2001, ACM T MATH SOFTWARE, V27, P27, DOI 10.1145/382043.382304; PARKER F, 1992, BRAIN RES, V584, P11, DOI 10.1016/0006-8993(92)90872-7; Pollok B, 2004, J PHYSIOL-LONDON, V554, P871, DOI 10.1113/jphysiol.2003.051235; Pollok B, 2006, J PHYSIOL-PARIS, V99, P8, DOI 10.1016/j.jphysparis.2005.06.002; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; ROSENBERG JR, 1989, PROG BIOPHYS MOL BIO, V53, P1, DOI 10.1016/0079-6107(89)90004-7; ROTHWELL JC, 1991, EXP PHYSIOL, V76, P159, DOI 10.1113/expphysiol.1991.sp003485; Salmelin R, 1995, ELECTROEN CLIN NEURO, V95, P444, DOI 10.1016/0013-4694(95)00193-X; Schelter B, 2009, J NEUROSCI METH, V179, P121, DOI 10.1016/j.jneumeth.2009.01.006; Schlee W, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-16; SCHLITT HA, 1995, IEEE T BIO-MED ENG, V42, P52, DOI 10.1109/10.362919; Schnitzler A, 2000, ACTA NEUROBIOL EXP, V60, P271; Schoffelen JM, 2008, NEUROIMAGE, V41, P437, DOI 10.1016/j.neuroimage.2008.01.045; Sharon D, 2007, NEUROIMAGE, V36, P1225, DOI 10.1016/j.neuroimage.2007.03.066; STARR A, 1991, BRAIN RES, V558, P181, DOI 10.1016/0006-8993(91)90767-P; Stegeman DF, 2010, CLIN NEUROPHYSIOL, V121, P1633, DOI 10.1016/j.clinph.2010.03.052; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Tapio S, 2001, ALGORITHM 808 ARFIT, P58; Tarkiainen A, 2003, CLIN NEUROPHYSIOL, V114, P1977, DOI 10.1016/S1388-2457(03)00195-0; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; van den Broek SP, 1998, ELECTROEN CLIN NEURO, V106, P522, DOI 10.1016/S0013-4694(97)00147-8; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Winter WR, 2007, STAT MED, V26, P3946, DOI 10.1002/sim.2978; Wu T, 2005, J PHYSIOL-LONDON, V562, P605, DOI 10.1113/jphysiol.2004.076042; Yanagisawa T, 2009, NEUROIMAGE, V45, P1099, DOI 10.1016/j.neuroimage.2008.12.069	75	31	31	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91441	10.1371/journal.pone.0091441	http://dx.doi.org/10.1371/journal.pone.0091441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618596	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400094
J	Peng, J; Cai, S; Wang, L; Zhao, N; Zhang, TJ; Chen, ZX; Meng, FH				Peng, Jing; Cai, Shuang; Wang, Lin; Zhao, Nan; Zhang, Ting-jian; Chen, Zai-xing; Meng, Fan-hao			A Metabonomic Analysis of Serum from Rats Treated with Ricinine Using Ultra Performance Liquid Chromatography Coupled with Mass Spectrometry	PLOS ONE			English	Article							HEPATIC SECRETION; TOF-MS; PLASMA; LIVER; LYSOPHOSPHATIDYLCHOLINE; COMMUNIS; URINE; ACIDS; CIRRHOSIS; SEVERITY	A metabonomic approach based on ultra performance liquid chromatography coupled with mass spectrometry (UPLC/MS) was used to study the hepatotoxicity of ricinine in rats. Potential biomarkers of ricinine toxicity and toxicological mechanism were analyzed by serum metabonomic method. The significant differences in the metabolic profiling of the control and treated rats were clear by using the principal components analysis (PCA) of the chromatographic data. Significant changes of metabolite biomarkers like phenylalanine, tryptophan, cholic acid, LPC and PC were detected in the serum. These biochemical changes were related to the metabolic disorders in amino acids and phospholipids. This research indicates that UPLC/MS-based metabonomic analysis of serum samples can be used to predict the hepatotoxicity and further understand the toxicological mechanism induced by ricinine. This work shows that metabonomics method is a valuable tool in drug mechanism study.	[Peng, Jing; Cai, Shuang; Wang, Lin; Zhao, Nan; Zhang, Ting-jian; Chen, Zai-xing; Meng, Fan-hao] China Med Univ, Sch Pharm, Shenyang, Liaoning, Peoples R China; [Cai, Shuang] China Med Univ, Affiliated Hosp 1, Dept Pharm, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University	Meng, FH (corresponding author), China Med Univ, Sch Pharm, Shenyang, Liaoning, Peoples R China.	fhmeng@cmu.edu.cn			National Natural Science Foundation of China [81274182]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the foundation from National Natural Science Foundation of China (No. 81274182). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradberry Sally M., 2003, Toxicological Reviews, V22, P65, DOI 10.2165/00139709-200322010-00007; Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802; Brindle JT, 2003, ANALYST, V128, P32, DOI 10.1039/b209155k; BRINDLEY DN, 1993, J NUTR BIOCHEM, V4, P442, DOI 10.1016/0955-2863(93)90061-Z; Dunn WB, 2008, INT J EPIDEMIOL, V37, P23, DOI 10.1093/ije/dym281; Ferraz AC, 1999, PHARMACOL BIOCHEM BE, V63, P367, DOI 10.1016/S0091-3057(99)00007-6; Fuchs B, 2005, CLIN BIOCHEM, V38, P925, DOI 10.1016/j.clinbiochem.2005.06.006; GANDHI VM, 1994, J AM OIL CHEM SOC, V71, P827, DOI 10.1007/BF02540457; Gika HG, 2007, J PROTEOME RES, V6, P3291, DOI 10.1021/pr070183p; GRAHAM A, 1991, BIOCHIM BIOPHYS ACTA, V1081, P151, DOI 10.1016/0005-2760(91)90020-I; Griffin JL, 2004, PHYSIOL GENOMICS, V17, P140, DOI 10.1152/physiolgenomics.00158.2003; Guallar-Hoyas C, 2012, BIOANALYSIS, V4, P2227, DOI [10.4155/BIO.12.193, 10.4155/bio.12.193]; Hasim A, 2012, MOL BIOL REP, V39, P8955, DOI 10.1007/s11033-012-1764-z; Kabarowski JHS, 2001, SCIENCE, V293, P702, DOI 10.1126/science.1061781; KANG SS, 1985, J NAT PROD, V48, P155, DOI 10.1021/np50037a041; Lafaye A, 2003, RAPID COMMUN MASS SP, V17, P2541, DOI 10.1002/rcm.1243; Li HK, 2007, J PROTEOME RES, V6, P1364, DOI 10.1021/pr060513q; LIMBERG B, 1984, GUT, V25, P1291, DOI 10.1136/gut.25.11.1291; Lindon JC, 2005, PHARMACOGENOMICS, V6, P691, DOI 10.2217/14622416.6.7.691; MONTANARI A, 1988, HEPATOLOGY, V8, P1034, DOI 10.1002/hep.1840080509; MORGAN MY, 1982, GUT, V23, P362, DOI 10.1136/gut.23.5.362; National Pharmacopoeia Committee, 2010, RIC COMM 1, P330; Ostrow J. Donald, 1993, P673; Palmeira CM, 2004, TOXICOLOGY, V203, P1, DOI 10.1016/j.tox.2004.06.001; Robinson T, 1987, BIOCHEM, V17, P1903; SEKAS G, 1985, J LAB CLIN MED, V105, P190; Takatera A, 2006, J CHROMATOGR B, V838, P31, DOI 10.1016/j.jchromb.2006.03.006; Wang JS, 2009, METABOLOMICS, V5, P407, DOI 10.1007/s11306-009-0165-3; Worbs S, 2011, TOXINS, V3, P1332, DOI 10.3390/toxins3101332	29	8	9	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90416	10.1371/journal.pone.0090416	http://dx.doi.org/10.1371/journal.pone.0090416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618672	Green Published, gold, Green Submitted			2022-12-25	WOS:000332842400016
J	Zeng, J; Liu, D; Qiu, ZX; Huang, Y; Chen, BJ; Wang, L; Xu, H; Huang, N; Liu, LX; Li, WM				Zeng, Jing; Liu, Dan; Qiu, Zhixin; Huang, Yi; Chen, Bojiang; Wang, Lei; Xu, Huan; Huang, Na; Liu, Lunxu; Li, Weimin			GSK3 beta Overexpression Indicates Poor Prognosis and Its Inhibition Reduces Cell Proliferation and Survival of Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; FACTOR-KAPPA-B; THERAPEUTIC TARGET; GENE-EXPRESSION; PROSTATE-CANCER; GROWTH; CARCINOMA; BETA; GSK3	Background: Glycogen synthase kinase 3 beta (GSK3 beta) is centrally involved in diverse cellular processes, including proliferation and apoptosis. This study aimed to investigate the influence of GSK3 beta expression on the prognosis of human non-small cell lung cancer (NSCLC) and the effects of GSK3 beta inhibition in NSCLC cell lines. Methods: Immunohistochemical and western blot assays were used to evaluate the GSK3 beta expression level in human NSCLC tissues. Lentiviral RNA interference was performed to inhibit the expression of GSK3 beta in the A549, H292, H1299 and SK-MES-1 cell lines. Cell survival, apoptosis and motility were evaluated in vivo and in vitro. Results: The levels of GSK3 beta were greater in NSCLC tissues (n = 211) than in control tissues (n = 194) (P<0.001). The 5-year follow-up analysis showed that positive GSK3 beta expression was indicative of poor prognosis (P = 0.006). Furthermore, knockdown of GSK3 beta in NSCLC cell lines suppressed cell proliferation, arrested tumor cells in G0/G1 phase, induced apoptosis and reduced cell motility. A xenograft model showed that the deregulation of GSK3 beta attenuated tumorigenesis, as confirmed by reduced cell proliferation based on Ki-67 and significantly increased apoptotic cell death. The inhibition of GSK3 beta had inconsistent effects on the expression of beta-catenin, depending on the cell type examined. Conclusion: Aberrant expression of GSK3 beta serves as an independent marker of poor prognosis for NSCLC. The inhibition of GSK3 beta suppressed tumorigenesis by attenuating cell proliferation, increasing apoptosis and restraining cell motility. These results identify GSK3 beta as a tumor promoter and a potential therapeutic target in NSCLC.	[Zeng, Jing; Liu, Dan; Qiu, Zhixin; Chen, Bojiang; Wang, Lei; Huang, Na; Li, Weimin] Sichuan Univ, West China Hosp, Dept Resp Med, Chengdu 610064, Sichuan Provinc, Peoples R China; [Huang, Yi] Sichuan Acad Med Sci, Clin Lab Dept, Chengdu, Sichuan Provinc, Peoples R China; [Huang, Yi] Sichuan Prov Peoples Hosp, Chengdu, Sichuan Provinc, Peoples R China; [Xu, Huan] Sichuan Univ, West China Hosp, Dept Pathol, Chengdu 610064, Sichuan Provinc, Peoples R China; [Liu, Lunxu] Sichuan Univ, West China Hosp, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Sichuan University; Sichuan University	Li, WM (corresponding author), Sichuan Univ, West China Hosp, Dept Resp Med, Chengdu 610064, Sichuan Provinc, Peoples R China.	weimi003@gmail.com	liu, liu/GXF-0906-2022; qiu, zhixin/HHC-0554-2022; liu, li/HGC-0900-2022	qiu, zhixin/0000-0003-0256-4419; 	Nature Science Foundation of China [81201851, 81641028]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Nature Science Foundation of China (81201851 to Dan liu and 81641028 to Weimin Li). The website of the National Nature Science Foundation of China is http://www.nsfc.gov.cn/Portal0/default166.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler JT, 2009, MOL CANCER THER, V8, P914, DOI 10.1158/1535-7163.MCT-08-0712; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Bilim V, 2009, BRIT J CANCER, V101, P2005, DOI 10.1038/sj.bjc.6605437; Cao Q, 2006, CELL RES, V16, P671, DOI 10.1038/sj.cr.7310078; Cho YJ, 2010, APMIS, V118, P782, DOI 10.1111/j.1600-0463.2010.02659.x; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Erdal E, 2005, INT J CANCER, V115, P903, DOI 10.1002/ijc.20972; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kobayashi T, 2006, MOL CELL BIOL, V26, P898, DOI 10.1128/MCB.26.3.898-911.2006; Kotliarova S, 2008, CANCER RES, V68, P6643, DOI 10.1158/0008-5472.CAN-08-0850; Le Floch N, 2004, FASEB J, V18, P144, DOI 10.1096/fj.04-2373fje; Liao XB, 2003, MOL CANCER THER, V2, P1215; Liu D, 2011, J CANCER RES CLIN, V137, P1629, DOI 10.1007/s00432-011-1037-6; Liu D, 2011, CANCER-AM CANCER SOC, V117, P3763, DOI 10.1002/cncr.25959; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma C, 2007, CANCER RES, V67, P7756, DOI 10.1158/0008-5472.CAN-06-4665; Mishra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-144; Naito S, 2010, CLIN CANCER RES, V16, P5124, DOI 10.1158/1078-0432.CCR-10-0275; Nowicki MO, 2008, NEURO-ONCOLOGY, V10, P690, DOI 10.1215/15228517-2008-041; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Peeraer G, 2011, MED TEACH, V33, pE382, DOI 10.3109/0142159X.2011.579199; Qiu ZX, 2012, CANCER SCI, V103, P1774, DOI 10.1111/j.1349-7006.2012.02375.x; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Shakoori A, 2005, BIOCHEM BIOPH RES CO, V334, P1365, DOI 10.1016/j.bbrc.2005.07.041; Shakoori A, 2007, CANCER SCI, V98, P1388, DOI 10.1111/j.1349-7006.2007.00545.x; Soto-Cerrato V, 2007, MOL CANCER THER, V6, P362, DOI 10.1158/1535-7163.MCT-06-0266; Sun AJ, 2007, PROSTATE, V67, P976, DOI 10.1002/pros.20586; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Xiaonong Z, 2007, CHINESE J CANC PREVE, V14, P881; Zheng HC, 2007, ANTICANCER RES, V27, P3561; Zhou Y, 2008, LEUKEMIA LYMPHOMA, V49, P1945, DOI 10.1080/10428190802304966	36	60	65	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91231	10.1371/journal.pone.0091231	http://dx.doi.org/10.1371/journal.pone.0091231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618715	Green Published, gold, Green Submitted			2022-12-25	WOS:000332842400060
J	Piron, R; De Koker, S; De Paepe, A; Goossens, J; Grooten, J; Nauwynck, H; Depicker, A				Piron, Robin; De Koker, Stefaan; De Paepe, Annelies; Goossens, Julie; Grooten, Johan; Nauwynck, Hans; Depicker, Ann			Boosting In Planta Production of Antigens Derived from the Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) and Subsequent Evaluation of Their Immunogenicity	PLOS ONE			English	Article							N-GLYCOSYLATION PATTERN; MYSTERY SWINE DISEASE; LELYSTAD-VIRUS; PROTEIN-PRODUCTION; FUSION PROTEINS; NEUTRALIZING ANTIBODIES; EPIDEMIC ABORTION; ARABIDOPSIS SEEDS; SUBUNIT VACCINE; DENDRITIC CELLS	Porcine reproductive and respiratory syndrome (PRRS) is a disease of swine, caused by an arterivirus, the PRRS virus (PRRSV). This virus infects pigs worldwide and causes huge economic losses. Due to genetic drift, current vaccines are losing their power. Adaptable vaccines could provide a solution to this problem. This study aims at producing in planta a set of antigens derived from the PRRSV glycoproteins (GPs) to be included in a subunit vaccine. We selected the GP3, GP4 and GP5 and optimized these for production in an Arabidopsis seed platform by removing transmembrane domains (Tm) and/or adding stabilizing protein domains, such as the green fluorescent protein (GFP) and immunoglobulin (IgG) 'Fragment crystallizable' (Fc) chains. Accumulation of the GPs with and without Tm was low, reaching no more than 0.10% of total soluble protein (TSP) in homozygous seed. However, addition of stabilizing domains boosted accumulation up to a maximum of 2.74% of TSP when GFP was used, and albeit less effectively, also the Fc chains of the porcine IgG3 and murine IgG2a increased antigen accumulation, to 0.96% and 1.81% of TSP respectively, while the murine IgG3 Fc chain did not. Antigens with Tm were less susceptible to these manipulations to increase yield. All antigens were produced in the endoplasmic reticulum and accordingly, they carried high-mannose N-glycans. The immunogenicity of several of those antigens was assessed and we show that vaccination with purified antigens did elicit the production of antibodies with virus neutralizing activity in mice but not in pigs.	[Piron, Robin; De Paepe, Annelies; Depicker, Ann] VIB, Dept Plant Syst Biol, Ghent, Belgium; [Piron, Robin; De Paepe, Annelies; Depicker, Ann] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium; [De Koker, Stefaan; Grooten, Johan] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Goossens, Julie] VUB, Dept Biosci Engn, Brussels, Belgium; [Nauwynck, Hans] Univ Ghent, Dept Virol Parasitol & Immunol, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Vrije Universiteit Brussel; Ghent University	Depicker, A (corresponding author), VIB, Dept Plant Syst Biol, Ghent, Belgium.	anpic@psb.vib-ugent.be		Piron, Robin/0000-0003-2647-4995; Depicker, Ann/0000-0003-0105-7407; De Paepe, Annelies/0000-0002-0975-0452; Nauwynck, Hans/0000-0001-5470-0713	Agency for Innovation by Science and Technology (IWT); Fonds voor Wetenschappelijk Onderzoek (FWO)	Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Fonds voor Wetenschappelijk Onderzoek (FWO)(FWO)	Robin Piron received a predoctoral scholarship for Strategic Basic Research from the Agency for Innovation by Science and Technology (IWT). Stefaan De Koker received a postdoctoral grant from the Fonds voor Wetenschappelijk Onderzoek (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan HT, 2013, PLANT BIOTECHNOL J, V11, P315, DOI 10.1111/pbi.12015; Chen X, 2011, J VIROL METHODS, V173, P153, DOI 10.1016/j.jviromet.2011.02.001; Chia MY, 2011, VET IMMUNOL IMMUNOP, V140, P215, DOI 10.1016/j.vetimm.2011.01.002; Chia MY, 2010, VET IMMUNOL IMMUNOP, V135, P234, DOI 10.1016/j.vetimm.2009.12.003; COLLINS JE, 1992, J VET DIAGN INVEST, V4, P117, DOI 10.1177/104063879200400201; Costers S, 2010, ARCH VIROL, V155, P371, DOI 10.1007/s00705-009-0582-7; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; Czajkowsky DM, 2012, EMBO MOL MED, V4, P1015, DOI 10.1002/emmm.201201379; De Buck S, 2013, PLANT BIOTECHNOL J, V11, P1006, DOI 10.1111/pbi.12094; De Buck Sylvie, 2012, Methods Mol Biol, V911, P305, DOI 10.1007/978-1-61779-968-6_19; De Jaeger G, 2002, NAT BIOTECHNOL, V20, P1265, DOI 10.1038/nbt755; Diaz I, 2006, VIROLOGY, V351, P249, DOI 10.1016/j.virol.2006.03.046; Duran JP, 1997, VIRUS GENES, V14, P19, DOI 10.1023/A:1007931322271; Engering AJ, 1997, EUR J IMMUNOL, V27, P2417, DOI 10.1002/eji.1830270941; Geldhof MF, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-182; GODING JW, 1978, J IMMUNOL METHODS, V20, P241, DOI 10.1016/0022-1759(78)90259-4; Gomord V, 1997, PLANT J, V11, P313, DOI 10.1046/j.1365-313X.1997.11020313.x; Gomord V, 2010, PLANT BIOTECHNOL J, V8, P564, DOI 10.1111/j.1467-7652.2009.00497.x; Goossens A, 1999, PLANT PHYSIOL, V120, P1095, DOI 10.1104/pp.120.4.1095; He X, 2012, PLANT MOL BIOL, V79, P157, DOI 10.1007/s11103-012-9902-5; Hu JZ, 2012, VACCINE, V30, P2068, DOI 10.1016/j.vaccine.2012.01.059; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Karniychuk UU, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-30; Key KF, 2003, J CLIN MICROBIOL, V41, P2433, DOI 10.1128/JCM.41.6.2433-2439.2003; Kimman TG, 2009, VACCINE, V27, P3704, DOI 10.1016/j.vaccine.2009.04.022; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; KREBBERS E, 1988, PLANT PHYSIOL, V87, P859, DOI 10.1104/pp.87.4.859; Labarque GG, 2000, J GEN VIROL, V81, P1327, DOI 10.1099/0022-1317-81-5-1327; Loos A, 2011, PLANT PHYSIOL, V155, P2036, DOI 10.1104/pp.110.171330; Loos A, 2011, PLANT BIOTECHNOL J, V9, P179, DOI 10.1111/j.1467-7652.2010.00540.x; Lopez OJ, 2004, VET IMMUNOL IMMUNOP, V102, P155, DOI 10.1016/j.vetimm.2004.09.005; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Mardassi H, 1996, VIROLOGY, V221, P98, DOI 10.1006/viro.1996.0356; MEULENBERG JJM, 1995, VIROLOGY, V206, P155, DOI 10.1016/S0042-6822(95)80030-1; MEULENBERG JJM, 1993, VIROLOGY, V192, P62, DOI 10.1006/viro.1993.1008; Meulenberg JJM, 1997, VET MICROBIOL, V55, P197, DOI 10.1016/S0378-1135(96)01335-1; Meulenberg JJM, 1997, J VIROL, V71, P6061, DOI 10.1128/JVI.71.8.6061-6067.1997; Morandini F, 2011, PLANT BIOTECHNOL J, V9, P911, DOI 10.1111/j.1467-7652.2011.00605.x; Nagels B, 2012, CRIT REV PLANT SCI, V31, P148, DOI 10.1080/07352689.2011.616075; Nam HM, 2013, ARCH VIROL, V158, P1275, DOI 10.1007/s00705-013-1612-z; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Nielsen HS, 2001, J GEN VIROL, V82, P1263, DOI 10.1099/0022-1317-82-6-1263; Obregon P, 2006, PLANT BIOTECHNOL J, V4, P195, DOI 10.1111/j.1467-7652.2005.00171.x; Opriessnig T, 2002, J VIROL, V76, P11837, DOI 10.1128/JVI.76.23.11837-11844.2002; Paul M, 2010, EXPERT REV VACCINES, V9, P821, DOI [10.1586/erv.10.88, 10.1586/ERV.10.88]; Pearse BR, 2010, BBA-MOL CELL RES, V1803, P684, DOI 10.1016/j.bbamcr.2009.10.008; Peckham GD, 2006, PROTEIN EXPRES PURIF, V49, P183, DOI 10.1016/j.pep.2006.03.011; PlanaDuran J, 1997, VET MICROBIOL, V55, P361, DOI 10.1016/S0378-1135(96)01317-X; Prieto C, 2011, VET J, V189, P323, DOI 10.1016/j.tvjl.2010.07.010; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Rybicki EP, 2010, PLANT BIOTECHNOL J, V8, P620, DOI 10.1111/j.1467-7652.2010.00507.x; Rybicki ER, 2009, DRUG DISCOV TODAY, V14, P16, DOI 10.1016/j.drudis.2008.10.002; Stadejek T, 2008, ARCH VIROL, V153, P1479, DOI 10.1007/s00705-008-0146-2; Tan MCAA, 1997, EUR J IMMUNOL, V27, P2426, DOI 10.1002/eji.1830270942; TERPSTRA C, 1991, VET QUART, V13, P131, DOI 10.1080/01652176.1991.9694297; Van Breedam W, 2011, VET IMMUNOL IMMUNOP, V141, P246, DOI 10.1016/j.vetimm.2011.03.008; Van Droogenbroeck B, 2007, P NATL ACAD SCI USA, V104, P1430, DOI 10.1073/pnas.0609997104; Vanhee M, 2009, VET RES, V40, DOI 10.1051/vetres/2009046; Vimolmangkang S, 2012, PLANTA, V235, P513, DOI 10.1007/s00425-011-1523-8; Virdi V, 2013, P NATL ACAD SCI USA, V110, P11809, DOI 10.1073/pnas.1301975110; Wang W, 2012, VACCINE, V30, P7072, DOI 10.1016/j.vaccine.2012.09.048; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Wissink EHJ, 2005, J VIROL, V79, P12495, DOI 10.1128/JVI.79.19.12495-12506.2005; Wu WH, 2005, VIRUS RES, V114, P177, DOI 10.1016/j.virusres.2005.06.014; Wu WH, 2001, VIROLOGY, V287, P183, DOI 10.1006/viro.2001.1034; Ye LL, 2011, NAT BIOTECHNOL, V29, P158, DOI 10.1038/nbt.1742; Yusibov V, 2011, HUM VACCINES, V7, P313, DOI 10.4161/hv.7.3.14207; Zhou L, 2010, VIRUS RES, V154, P31, DOI 10.1016/j.virusres.2010.07.016; Zuckermann FA, 2007, VET MICROBIOL, V123, P69, DOI 10.1016/j.vetmic.2007.02.009	69	10	10	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91386	10.1371/journal.pone.0091386	http://dx.doi.org/10.1371/journal.pone.0091386			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614617	Green Submitted, Green Published, gold			2022-12-25	WOS:000332839300118
J	Rawlence, NJ; Till, CE; Scofield, RP; Tennyson, AJD; Collins, CJ; Lalas, C; Loh, G; Matisoo-Smith, E; Waters, JM; Spencer, HG; Kennedy, M				Rawlence, Nicolas J.; Till, Charlotte E.; Scofield, R. Paul; Tennyson, Alan J. D.; Collins, Catherine J.; Lalas, Chris; Loh, Graeme; Matisoo-Smith, Elizabeth; Waters, Jonathan M.; Spencer, Hamish G.; Kennedy, Martyn			Strong Phylogeographic Structure in a Sedentary Seabird, the Stewart Island Shag (Leucocarbo chalconotus)	PLOS ONE			English	Article							CORMORANT PHALACROCORAX-CARBO; POPULATION GENETIC-STRUCTURE; DOUBLE-CRESTED CORMORANTS; NEW-ZEALAND; ANCIENT DNA; AVES PHALACROCORACIDAE; CONCERTED EVOLUTION; CYANORAMPHUS; EXTRACTION; PHYLOGENY	New Zealand's endemic Stewart Island Shag (Leucocarbo chalconotus) comprises two regional groups (Otago and Foveaux Strait) that show consistent differentiation in relative frequencies of pied versus dark-bronze morphotypes, the extent of facial carunculation, body size and breeding time. We used modern and ancient DNA (mitochondrial DNA control region one), and morphometric approaches to investigate the phylogeography and taxonomy of L. chalconotus and its closely related sister species, the endemic Chatham Island Shag (L. onslowi). Our analysis shows Leucocarbo shags in southern New Zealand comprise two well-supported clades, each containing both pied and dark-bronze morphs. However, the combined monophyly of these populations is not supported, with the L. chalconotus Otago lineage sister to L. onslowi. Morphometric analysis indicates that Leucocarbo shags from Otago are larger on average than those from Foveaux Strait. Principal coordinate analysis of morphometric data showed substantial morphological differentiation between the Otago and Foveaux Strait clades, and L. onslowi. The phylogeographic partitioning detected within L. chalconotus is marked, and such strong structure is rare for phalacrocoracid species. Our phylogenetic results, together with consistent differences in relative proportions of plumage morphs and facial carunculation, and concordant differentiation in body size and breeding time, suggest several alternative evolutionary hypotheses that require further investigation to determine the level of taxonomic distinctiveness that best represents the L. chalconotus Otago and Foveaux Strait clades.	[Rawlence, Nicolas J.; Till, Charlotte E.; Collins, Catherine J.; Waters, Jonathan M.; Spencer, Hamish G.; Kennedy, Martyn] Univ Otago, Dept Zool, Allan Wilson Ctr Mol Ecol & Evolut, Dunedin, New Zealand; [Till, Charlotte E.] Arizona State Univ, Lab Mol Anthropol, Sch Human Evolut & Social Change, Tempe, AZ USA; [Scofield, R. Paul] Canterbury Museum, Christchurch, New Zealand; [Tennyson, Alan J. D.] Museum New Zealand Papa Tongarewa, Wellington, New Zealand; [Lalas, Chris] Univ Otago, Dept Marine Sci, Dunedin, New Zealand; [Loh, Graeme] Dept Conservat, Dunedin, New Zealand; [Matisoo-Smith, Elizabeth] Univ Otago, Dept Anat, Allan Wilson Ctr Mol Ecol & Evolut, Dunedin, New Zealand	University of Otago; Arizona State University; Arizona State University-Tempe; University of Otago; University of Otago	Rawlence, NJ (corresponding author), Univ Otago, Dept Zool, Allan Wilson Ctr Mol Ecol & Evolut, POB 56, Dunedin, New Zealand.	nic.rawlence@otago.ac.nz; martyn.kennedy@otago.ac.nz	Spencer, Hamish G/B-9637-2008; Waters, Jon/B-4983-2009; Kennedy, Martyn/A-9551-2008; Scofield, R. Paul/A-4271-2011	Spencer, Hamish G/0000-0001-7531-597X; Waters, Jon/0000-0002-1514-7916; Kennedy, Martyn/0000-0001-9376-6520; Scofield, R. Paul/0000-0002-7510-6980; Matisoo-Smith, Elizabeth/0000-0002-3500-8307	Royal Society of New Zealand Marsden Fund; Department of Zoology (University of Otago); Allan Wilson Centre for Molecular Ecology and Evolution	Royal Society of New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Department of Zoology (University of Otago); Allan Wilson Centre for Molecular Ecology and Evolution	Funding was provided by the Royal Society of New Zealand Marsden Fund, the Department of Zoology (University of Otago) and the Allan Wilson Centre for Molecular Ecology and Evolution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVISE JC, 1989, SCIENCE, V243, P646, DOI 10.1126/science.243.4891.646; Barlow EJ, 2011, IBIS, V153, P768, DOI 10.1111/j.1474-919X.2011.01159.x; BLACKBURN A, 1968, Notornis, V15, P51; Boon WM, 2008, EMU, V108, P251, DOI 10.1071/MU07030; Boon WM, 2000, BIRD CONSERV INT, V10, P211, DOI 10.1017/S0959270900000198; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Buller WL., 1888, HIST BIRDS NZ, V2; Bunce M, 2009, P NATL ACAD SCI USA, V106, P20646, DOI 10.1073/pnas.0906660106; Calderon L, 2014, MOL PHYLOGENET EVOL, V72, P42, DOI 10.1016/j.ympev.2013.12.011; Cooper A, 2000, SCIENCE, V289, P1139; Crossland Andrew C., 2012, Notornis, V59, P71; Driesch A, 1976, PEABODY MUSEUM BULLE, V1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Falla R. A., 1932, Records of the Auckland Institute and Museum, V1, P139; Falla RA, 1978, THE NEW GUIDE TO THE; Gibb GC, 2013, MOL PHYLOGENET EVOL, V68, P229, DOI 10.1016/j.ympev.2013.03.021; Gill BJ, 2010, CHECKLIST OF THE BIR; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Heather BD, 2005, THE FIELDGUIDE TO TH; Holland BR, 2010, SYST BIOL, V59, P433, DOI 10.1093/sysbio/syq023; Joseph L, 2009, EMU, V109, P1, DOI 10.1071/MU08024; Kinsky F.C., 1970, ANNOTATED CHECKLIST; Knapp M, 2012, ANN ANAT, V194, P3, DOI 10.1016/j.aanat.2011.03.008; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lalas C., 1983, THESIS; Lalas Chris, 2009, DOC Research & Development Series, V314, P1; Lambert DM, 2005, J HERED, V96, P279, DOI 10.1093/jhered/esi035; Marchant S., 1990, HANDBOOK OF AUSTRALI, V1; Marion L, 2006, EVOL ECOL, V20, P193, DOI 10.1007/s10682-005-5828-6; Mercer DM, 2013, CONSERV GENET, V14, P823, DOI 10.1007/s10592-013-0477-8; Morris-Pocock JA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-14; Peters JL, 1931, CHECK LIST OF BIRDS, V1; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; R Core Team, 2022, R LANG ENV STAT COMP; Rohland N, 2010, MOL ECOL RESOUR, V10, P677, DOI 10.1111/j.1755-0998.2009.02824.x; Schuckard Rob, 2006, Notornis, V53, P297; Scofield RP, 2013, PHOTOGRAPHIC GUIDE B; SIEGELCAUSEY D, 1988, CONDOR, V90, P885, DOI 10.2307/1368846; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Turbott EG, 1990, CHECKLIST OF THE BIR; Waits JL, 2003, WATERBIRDS, V26, P196, DOI 10.1675/1524-4695(2003)026[0196:LMDVID]2.0.CO;2; Walsh PS, 2013, BIOTECHNIQUES, V54, P134; Watt JPC, 1973, NOTORNIS, V22, P265; Wilmshurst JM, 2008, P NATL ACAD SCI USA, V105, P7676, DOI 10.1073/pnas.0801507105; Winney BJ, 2001, HEREDITY, V86, P45, DOI 10.1046/j.1365-2540.2001.00807.x; Worthy T. H., 1998, Records of the Canterbury Museum, V12, P79; Worthy TH, 1996, NEW ZEAL J ZOOL, V23, P89, DOI 10.1080/03014223.1996.9518069; Worthy TH, 2011, ZOOL J LINN SOC-LOND, V163, P277, DOI 10.1111/j.1096-3642.2011.00693.x	48	12	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90769	10.1371/journal.pone.0090769	http://dx.doi.org/10.1371/journal.pone.0090769			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614677	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300040
J	Zhang, YT; Li, X; Chen, ZM; Bepler, G				Zhang, Yingtao; Li, Xin; Chen, Zhengming; Bepler, Gerold			Ubiquitination and Degradation of Ribonucleotide Reductase M1 by the Polycomb Group Proteins RNF2 and Bmi1 and Cellular Response to Gemcitabine	PLOS ONE			English	Article							MYC TRANSGENIC MICE; LUNG-CANCER; IN-VIVO; PANCREATIC-CANCER; LIGASE ACTIVITY; EXPRESSION; RESISTANCE; CELLS; OVEREXPRESSION; TUMORIGENESIS	Ribonucleotide reductase M1 (RRM1) is required for mammalian deoxyribonucleotide (dNTP) metabolism. It is the primary target of the antimetabolite drug gemcitabine, which is among the most efficacious and most widely used cancer therapeutics. Gemcitabine directly binds to RRM1 and irreversibly inactivates ribonucleotide reductase. Intra-tumoral RRM1 levels are predictive of gemcitabine's therapeutic efficacy. The mechanisms that regulate intracellular RRM1 levels are largely unknown. Here, we identified the E3 ubiquitin-protein ligases RNF2 and Bmi1 to associate with RRM1 with subsequent poly-ubiquitination at either position 48 or 63 of ubiquitin. The lysine residues 224 and 548 of RRM1 were identified as major ubiquitination sites. We show that ubiquitinated RRM1 undergoes proteasome-mediated degradation and that targeted post-transcriptional silencing of RNF2 and Bmi1 results in increased RRM1 levels and resistance to gemcitabine. Immunohistochemical analyses of 187 early-stage lung cancer tumor specimens revealed a statistically significant co-expression of RRM1 and Bmi1. We were unable to identify suitable reagents for in situ quantification of RNF2. Our findings suggest that Bmi1 and possibly RNF2 may be attractive biomarkers of gemcitabine resistance in the context of RRM1 expression. They also provide novel information for the rational design of gemcitabine-proteasome inhibitor combination therapies, which so far have been unsuccessful if given to patients without taking the molecular context into account.	[Zhang, Yingtao; Li, Xin; Chen, Zhengming; Bepler, Gerold] Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute	Bepler, G (corresponding author), Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI 48201 USA.	beplerg@karmanos.org			National Cancer Institute [R01-CA129343]; NATIONAL CANCER INSTITUTE [R01CA129343] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant (R01-CA129343) from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Bentley ML, 2011, EMBO J, V30, P3285, DOI 10.1038/emboj.2011.243; Bepler G, 2006, J CLIN ONCOL, V24, P4731, DOI 10.1200/JCO.2006.06.1101; Bergman AM, 2005, CANCER RES, V65, P9510, DOI 10.1158/0008-5472.CAN-05-0989; Bhattacharyya J, 2012, CANCER SCI, V103, P34, DOI 10.1111/j.1349-7006.2011.02121.x; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Chen ZM, 2011, BIOCHEM BIOPH RES CO, V413, P383, DOI 10.1016/j.bbrc.2011.08.111; Davidson JD, 2004, CANCER RES, V64, P3761, DOI 10.1158/0008-5472.CAN-03-3363; Davies AM, 2009, J THORAC ONCOL, V4, P87, DOI 10.1097/JTO.0b013e3181915052; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Fan HZ, 1997, P NATL ACAD SCI USA, V94, P13181, DOI 10.1073/pnas.94.24.13181; Frezza M, 2011, CURR TOP MED CHEM, V11, P2888, DOI 10.2174/156802611798281311; Gautam A, 2003, ONCOGENE, V22, P2135, DOI 10.1038/sj.onc.1206232; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Mao SS, 1992, BIOCHEMISTRY-US, V31, P7933; Nakahira S, 2007, INT J CANCER, V120, P1355, DOI 10.1002/ijc.22390; Perez MAS, 2010, CURR MED CHEM, V17, P2854, DOI 10.2174/092986710792065054; Reynolds C, 2009, J CLIN ONCOL, V27, P5808, DOI 10.1200/JCO.2009.21.9766; Ryan DP, 2006, CANCER-AM CANCER SOC, V107, P2482, DOI 10.1002/cncr.22264; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Wang EF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017918; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Yin T, 2011, CHEMOTHERAPY, V57, P488, DOI 10.1159/000334103; Zheng Z, 2007, NEW ENGL J MED, V356, P800, DOI 10.1056/NEJMoa065411	32	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91186	10.1371/journal.pone.0091186	http://dx.doi.org/10.1371/journal.pone.0091186			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614341	Green Submitted, Green Published, gold			2022-12-25	WOS:000332839300093
J	Fereshtehnejad, SM; Ghazi, L; Shafieesabet, M; Shahidi, GA; Delbari, A; Lokk, J				Fereshtehnejad, Seyed-Mohammad; Ghazi, Ladan; Shafieesabet, Mahdiyeh; Shahidi, Gholam Ali; Delbari, Ahmad; Lokk, Johan			Motor, Psychiatric and Fatigue Features Associated with Nutritional Status and Its Effects on Quality of Life in Parkinson's Disease Patients	PLOS ONE			English	Article							SUBJECTIVE GLOBAL ASSESSMENT; WEIGHT-LOSS; ELDERLY-PATIENTS; NURSING-HOMES; MALNUTRITION; PREVALENCE; PEOPLE; SCALE; IMPAIRMENT; PREDICTORS	Objectives: Parkinson's disease (PD) patients are more likely to develop impaired nutritional status because of the symptoms, medications and complications of the disease. However, little is known about the determinants and consequences of malnutrition in PD. This study aimed to investigate the association of motor, psychiatric and fatigue features with nutritional status as well as the effects of malnutrition on different aspects of quality of life (QoL) in PD patients. Methods: One hundred and fifty patients with idiopathic PD (IPD) were recruited in this study. A demographic checklist, the Unified Parkinson's Disease Rating Scale (UPDRS), the Hospital Anxiety and Depression Scale (HADS) and the Fatigue Severity Scale (FSS) were completed through face-to-face interviews and clinical examinations. The health-related QoL (HRQoL) was also evaluated by means of the Parkinson's Disease Questionnaire (PDQ-39). For evaluation of nutritional status, the Mini Nutritional Assessment (MNA) questionnaire was applied together with anthropometric measurements. Results: Thirty seven (25.3%) patients were at risk of malnutrition and another 3 (2.1%) were malnourished. The total score of the UPDRS scale (r = -0.613, P<0.001) and PD duration (r = -0.284, P = 0.002) had a significant inverse correlation with the total MNA score. The median score of the Hoehn and Yahr stage was significantly higher in PD patients with abnormal nutritional status [2.5 vs. 2.0; P<0.001]. More severe anxiety [8.8 vs. 5.9; P = 0.002], depression [9.0 vs. 3.6; P<0.001] and fatigue [5.4 vs. 4.2; P<0.001] were observed in PD patients with abnormal nutritional status. Except for stigma, all other domains of the PDQ-39 were significantly correlated with the total score of the MNA. Conclusion: Our study demonstrates that disease duration, severity of motor and psychiatric symptoms (depression, anxiety) and fatigue are associated with nutritional status in PD. Different aspects of the HRQoL were affected by patients' nutritional status especially the emotional well-being and mobility domains.	[Fereshtehnejad, Seyed-Mohammad; Delbari, Ahmad; Lokk, Johan] Karolinska Inst, Dept Neurobiol Care Sci & Soc NVS, Div Clin Geriatr, Stockholm, Sweden; [Fereshtehnejad, Seyed-Mohammad] Iran Univ Med Sci, Firoozgar Hosp, FCRDC, Tehran, Iran; [Ghazi, Ladan] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Shafieesabet, Mahdiyeh] Iran Univ Med Sci, MSRC, Fac Med, Tehran, Iran; [Shahidi, Gholam Ali] Iran Univ Med Sci, Dept Neurol, Movement Disorders Clin, Fac Med, Tehran, Iran; [Delbari, Ahmad] Sabzevar Univ Med Sci, Aging Res Ctr, Sabzevar, Khorasan, Iran; [Lokk, Johan] Karolinska Univ Hosp, Dept Geriatr Med, Stockholm, Sweden	Karolinska Institutet; Iran University of Medical Sciences; Karolinska Institutet; Iran University of Medical Sciences; Iran University of Medical Sciences; Karolinska Institutet; Karolinska University Hospital	Fereshtehnejad, SM (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc NVS, Div Clin Geriatr, Stockholm, Sweden.	sm.fereshtehnejad@ki.se	Delbari, Ahmad/D-8560-2017; Fereshtehnejad, Seyed-Mohammad/ABF-6020-2020	Fereshtehnejad, Seyed-Mohammad/0000-0001-9255-9351; Shahidi, Gholam Ali/0000-0002-3889-4973				Afsar B, 2006, J RENAL NUTR, V16, P277, DOI 10.1053/j.jrn.2006.01.012; Ahmed T, 2010, CLIN INTERV AGING, V5, P207; Amaral TF, 2010, CLIN NUTR, V29, P580, DOI 10.1016/j.clnu.2010.02.004; Amirkalali B, 2010, PUBLIC HEALTH NUTR, V13, P1373, DOI 10.1017/S1368980010000303; Andersson I, 2001, J ADV NURS, V35, P69, DOI 10.1046/j.1365-2648.2001.01823.x; Azimian M., 2009, Research Journal of Biological Sciences, V4, P974; Barichella M, 2003, EUR J CLIN NUTR, V57, P543, DOI 10.1038/sj.ejcn.1601581; Barichella M, 2013, BRIT J NUTR, V110, P347, DOI 10.1017/S0007114512004941; Barichella M, 2009, MOVEMENT DISORD, V24, P1881, DOI 10.1002/mds.22705; Barichella M, 2008, NUTR NEUROSCI, V11, P128, DOI 10.1179/147683008X301441; Bauer JM, 2006, DEUT MED WOCHENSCHR, V131, P223, DOI 10.1055/s-2006-924953; BEYER PL, 1995, J AM DIET ASSOC, V95, P979, DOI 10.1016/S0002-8223(95)00269-3; Bollwein J, 2013, J NUTR HEALTH AGING, V17, P351, DOI [10.1007/s12603-013-0034-7, 10.1007/s12603-013-0009-8]; Cereda E, 2010, NUTRITION, V26, P240, DOI 10.1016/j.nut.2009.06.003; Chapman IM, 2006, MED CLIN N AM, V90, P887, DOI 10.1016/j.mcna.2006.05.010; Crogan NL, 2003, J GERONTOL A-BIOL, V58, P159; Durrieu G, 1992, Clin Auton Res, V2, P153, DOI 10.1007/BF01818955; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Guigoz Y, 1996, NUTR REV, V54, pS59; Guigoz Y, 1994, FACTS RES GERONTOL, V2, P15, DOI DOI 10.1016/S0899-9007(98)00171-3; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jaafar A, 2010, MOVEMENT DISORD, V25, pS424; Jaafar AF, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-124; Kaye J, 2006, MOVEMENT DISORD, V21, P1270, DOI 10.1002/mds.20942; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lefton J., 2009, ADA POCKET GUIDE NUT, P160; Lorefalt B, 2004, ACTA NEUROL SCAND, V110, P180, DOI 10.1111/j.1600-0404.2004.00307.x; MARKUS HS, 1993, J NEURAL TRANSM-PARK, V5, P117, DOI 10.1007/BF02251202; Miller N, 2009, J NEUROL NEUROSUR PS, V80, P1047, DOI 10.1136/jnnp.2008.157701; Montazeri Ali, 2003, Health Qual Life Outcomes, V1, P14, DOI 10.1186/1477-7525-1-14; Neumann SA, 2005, J HUM NUTR DIET, V18, P129, DOI 10.1111/j.1365-277X.2005.00596.x; Nojomi M, 2010, J RES MED SCI, V15, P63; Nozaki S, 1999, Rinsho Shinkeigaku, V39, P1010; Persson MD, 2002, J AM GERIATR SOC, V50, P1996, DOI 10.1046/j.1532-5415.2002.50611.x; Peto V, 1998, J NEUROL, V245, pS10, DOI 10.1007/PL00007730; Ramaker C, 2002, MOVEMENT DISORD, V17, P867, DOI 10.1002/mds.10248; Schwab R.S., 1969, PROJECTION TECHNIQUE; Serrano-Urrea R, 2013, GERONTOLOGY, V59, P490, DOI 10.1159/000351763; Sheard J. M., 2013, e-SPEN Journal, V8, pe187; Sheard JM, 2013, J NUTR HEALTH AGING, V17, P148, DOI 10.1007/s12603-012-0386-4; Sheard JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057986; Sheard JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053290; Sheard JM, 2011, NUTR REV, V69, P520, DOI 10.1111/j.1753-4887.2011.00413.x; Teasdale N, 2007, MOVEMENT DISORD, V22, P436, DOI 10.1002/mds.21203; Tsai AC, 2011, INT J NURS STUD, V48, P1429, DOI 10.1016/j.ijnurstu.2011.05.004; Uc EY, 2006, MOVEMENT DISORD, V21, P930, DOI 10.1002/mds.20837; Visvanathan R, 2003, J AM GERIATR SOC, V51, P1007, DOI 10.1046/j.1365-2389.2003.51317.x; Wang G, 2010, PARKINSONISM RELAT D, V16, P119, DOI 10.1016/j.parkreldis.2009.08.009; YAPA RSS, 1989, J CLIN EXP GERONTOL, V11, P155; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	52	41	47	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91153	10.1371/journal.pone.0091153	http://dx.doi.org/10.1371/journal.pone.0091153			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4IY	24608130	Green Submitted, Green Published, gold			2022-12-25	WOS:000332485800106
J	Janke, H; Pastore, F; Schumacher, D; Herold, T; Hopfner, KP; Schneider, S; Berdel, WE; Buchner, T; Woermann, BJ; Subklewe, M; Bohlander, SK; Hiddemann, W; Spiekermann, K; Polzer, H				Janke, Hanna; Pastore, Friederike; Schumacher, Daniela; Herold, Tobias; Hopfner, Karl-Peter; Schneider, Stephanie; Berdel, Wolfgang E.; Buechner, Thomas; Woermann, Bernhard J.; Subklewe, Marion; Bohlander, Stefan K.; Hiddemann, Wolfgang; Spiekermann, Karsten; Polzer, Harald			Activating FLT3 Mutants Show Distinct Gain-of-Function Phenotypes In Vitro and a Characteristic Signaling Pathway Profile Associated with Prognosis in Acute Myeloid Leukemia	PLOS ONE			English	Article							TYROSINE KINASE DOMAIN; INTERNAL TANDEM DUPLICATION; HIGH-DOSE CYTARABINE; CONSTITUTIVE ACTIVATION; PROLONGED MAINTENANCE; INDUCE TRANSFORMATION; JUXTAMEMBRANE DOMAIN; STAT5 ACTIVATION; NORMAL KARYOTYPE; POINT MUTATIONS	About 30% of patients with acute myeloid leukemia (AML) harbour mutations of the receptor tyrosine kinase FLT3, mostly internal tandem duplications (ITD) and point mutations of the second tyrosine kinase domain (TKD). It was the aim of this study to comprehensively analyze clinical and functional properties of various FLT3 mutants. In 672 normal karyotype AML patients FLT3-ITD, but not FLT3-TKD mutations were associated with a worse relapse free and overall survival in multivariate analysis. In paired diagnosis-relapse samples FLT3-ITD showed higher stability (70%) compared to FLT3-TKD (30%). In vitro, FLT3-ITD induced a strong activating phenotype in Ba/F3 cells. In contrast, FLT3-TKD mutations and other point mutations - including two novel mutations - showed a weaker but clear gain-of-function phenotype with gradual increase in proliferation and protection from apoptosis. The pro-proliferative capacity of the investigated FLT3 mutants was associated with cell surface expression and tyrosine 591 phosphorylation of the FLT3 receptor. Western blot experiments revealed STAT5 activation only in FLT3-ITD positive cell lines, in contrast to FLT3-non-ITD mutants, which displayed an enhanced signal of AKT and MAPK activation. Gene expression analysis revealed distinct difference between FLT3-ITD and FLT3-TKD for STAT5 target gene expression as well as deregulation of SOCS2, ENPP2, PRUNE2 and ART3. FLT3-ITD and FLT3 point mutations show a gain-of-function phenotype with distinct signalling properties in vitro. Although poor prognosis in AML is only associated with FLT3-ITD, all activating FLT3 mutations can contribute to leukemogenesis and are thus potential targets for therapeutic interventions.	[Janke, Hanna; Pastore, Friederike; Schumacher, Daniela; Herold, Tobias; Schneider, Stephanie; Subklewe, Marion; Hiddemann, Wolfgang; Spiekermann, Karsten; Polzer, Harald] Univ Munich, Univ Hosp Munich, Dept Internal Med 3, Munich, Germany; [Janke, Hanna; Pastore, Friederike; Herold, Tobias; Hiddemann, Wolfgang; Spiekermann, Karsten; Polzer, Harald] Helmholtz Ctr Munich, Clin Cooperat Grp Leukemia, Munich, Germany; [Pastore, Friederike; Subklewe, Marion; Hiddemann, Wolfgang; Spiekermann, Karsten; Polzer, Harald] German Canc Consortium DKTK, Heidelberg, Germany; [Pastore, Friederike; Subklewe, Marion; Hiddemann, Wolfgang; Spiekermann, Karsten; Polzer, Harald] German Canc Res Ctr, Heidelberg, Germany; [Hopfner, Karl-Peter] Univ Munich, Gene Ctr, Dept Biochem, Munich, Germany; [Berdel, Wolfgang E.; Buechner, Thomas] Univ Munster, Dept Med Hematol Oncol & Pneumol A, Munster, Germany; [Woermann, Bernhard J.] German Soc Hematol & Oncol, Berlin, Germany; [Subklewe, Marion] Helmholtz Ctr Munich, Clin Cooperat Grp Immunotherapy, Munich, Germany; [Bohlander, Stefan K.] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Munich; University of Munster; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Auckland	Janke, H (corresponding author), Univ Munich, Univ Hosp Munich, Dept Internal Med 3, Munich, Germany.	Hanna.Janke@med.uni-muenchen.de	Herold, Tobias/AAD-1072-2019; Hopfner, Karl-Peter/B-6864-2014; Subklewe, Marion/N-5873-2014	Herold, Tobias/0000-0002-9615-9432; Hopfner, Karl-Peter/0000-0002-4528-8357; Subklewe, Marion/0000-0001-9154-9469; Bohlander, Stefan/0000-0002-2202-9088	Deutsche Forschungsgemeinschaft [SFB 684/A12, SFB 684/A6]; German Ministry for Education and Research, BMBF [NGFN-Plus: 01GS0876]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Ministry for Education and Research, BMBF(Federal Ministry of Education & Research (BMBF))	Deutsche Forschungsgemeinschaft, SFB 684/A12 to K. Spiekermann; Deutsche Forschungsgemeinschaft, SFB 684/A6 to S. K. Bohlander; German Ministry for Education and Research, BMBF, NGFN-Plus: 01GS0876 to S. K. Bohlander. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers C, 2013, LEUKEMIA, V27, P1416, DOI 10.1038/leu.2013.14; Bacher U, 2008, BLOOD, V111, P2527, DOI 10.1182/blood-2007-05-091215; Braess J, 2009, BLOOD, V113, P3903, DOI 10.1182/blood-2008-07-162842; Buchner T, 2006, J CLIN ONCOL, V24, P2480, DOI 10.1200/JCO.2005.04.5013; Buchner T, 2003, J CLIN ONCOL, V21, P4496, DOI 10.1200/JCO.2003.02.133; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Choudhary C, 2005, INT J HEMATOL, V82, P93, DOI 10.1532/IJH97.05090; Choudhary C, 2005, BLOOD, V106, P265, DOI 10.1182/blood-2004-07-2942; Choudhary C, 2007, BLOOD, V110, P370, DOI 10.1182/blood-2006-05-024018; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Fenski R, 2000, BRIT J HAEMATOL, V108, P322; Ferrari F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-446; Frohling S, 2007, CANCER CELL, V12, P501, DOI 10.1016/j.ccr.2007.11.005; Ghosh K, 2012, ANN HEMATOL, V91, P1703, DOI 10.1007/s00277-012-1509-z; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; Grundler R, 2005, BLOOD, V105, P4792, DOI 10.1182/blood-2004-11-4430; Hayakawa F, 2000, ONCOGENE, V19, P624, DOI 10.1038/sj.onc.1203354; Heidel F, 2006, BLOOD, V107, P293, DOI 10.1182/blood-2005-06-2469; Herold T, 2011, LEUKEMIA, V25, P1639, DOI 10.1038/leu.2011.125; Jiang JR, 2004, BLOOD, V104, P1855, DOI 10.1182/blood-2004-02-0712; Kazi JU, 2012, J BIOL CHEM, V287, P36509, DOI 10.1074/jbc.M112.376111; Kelly LM, 2002, BLOOD, V99, P310, DOI 10.1182/blood.V99.1.310; Kindler T, 2005, BLOOD, V105, P335, DOI 10.1182/blood-2004-02-0660; Leischner H, 2012, BLOOD, V119, P4026, DOI 10.1182/blood-2011-07-365726; Li ZJ, 2013, J CLIN ONCOL, V31, P1172, DOI 10.1200/JCO.2012.44.3184; Lin DC, 2012, BLOOD, V120, P3310, DOI 10.1182/blood-2011-10-388611; Mead AJ, 2007, BLOOD, V110, P1262, DOI 10.1182/blood-2006-04-015826; Mills KI, 2005, BRIT J HAEMATOL, V130, P203, DOI 10.1111/j.1365-2141.2005.05589.x; Mizuki M, 2000, BLOOD, V96, P3907, DOI 10.1182/blood.V96.12.3907; Neben K, 2005, ONCOGENE, V24, P1580, DOI 10.1038/sj.onc.1208344; Opatz S, 2013, BLOOD; Orfao A, 2007, BRIT J HAEMATOL, V138, P12, DOI 10.1111/j.1365-2141.2007.06619.x; Ortlepp C, 2013, EXP HEMATOL, V41, P444, DOI 10.1016/j.exphem.2013.01.007; Parcells BW, 2006, STEM CELLS, V24, P1174, DOI 10.1634/stemcells.2005-0519; Polzer H, 2013, EXP HEMATOL, V41, P271, DOI 10.1016/j.exphem.2012.10.016; Reindl C, 2006, BLOOD, V107, P3700, DOI 10.1182/blood-2005-06-2596; Rocnik JL, 2006, BLOOD, V108, P1339, DOI 10.1182/blood-2005-11-011429; Schittenhelm MM, 2006, LEUKEMIA, V20, P2008, DOI 10.1038/sj.leu.2404374; Schmidt-Arras DE, 2005, MOL CELL BIOL, V25, P3690, DOI 10.1128/MCB.25.9.3690-3703.2005; Schneider F, 2012, BLOOD, V119, P4383, DOI 10.1182/blood-2010-12-327072; Schnittger S, 2002, BLOOD, V100, P59, DOI 10.1182/blood.V100.1.59; Shih LY, 2004, CLIN CANCER RES, V10, P1326, DOI 10.1158/1078-0432.CCR-0835-03; Smith ML, 2005, BRIT J HAEMATOL, V128, P318, DOI 10.1111/j.1365-2141.2004.05324.x; Soldaini E, 2000, MOL CELL BIOL, V20, P389, DOI 10.1128/MCB.20.1.389-401.2000; Spiekermann K, 2003, CLIN CANCER RES, V9, P2140; Spiekermann K, 2002, BLOOD, V100, P3423, DOI 10.1182/blood-2002-03-0953; Stirewalt DL, 2004, BRIT J HAEMATOL, V124, P481, DOI 10.1111/j.1365-2141.2004.04808.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Vempati S, 2008, CLIN CANCER RES, V14, P4437, DOI 10.1158/1078-0432.CCR-07-1873; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Yanada M, 2005, LEUKEMIA, V19, P1345, DOI 10.1038/sj.leu.2403838; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Zhou JB, 2009, BLOOD, V113, P4052, DOI 10.1182/blood-2008-05-156422	55	56	56	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e89560	10.1371/journal.pone.0089560	http://dx.doi.org/10.1371/journal.pone.0089560			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608088	gold, Green Submitted, Green Published			2022-12-25	WOS:000332485800004
J	Peluso, MO; Campbell, VT; Harari, JA; Tibbitts, TT; Proctor, JL; Whitebread, N; Conley, JM; White, KF; Kutok, JL; Read, MA; McGovern, K; Faia, KL				Peluso, Marisa O.; Campbell, Veronica T.; Harari, Joseph A.; Tibbitts, Thomas T.; Proctor, Jennifer L.; Whitebread, Nigel; Conley, James M.; White, Kerry F.; Kutok, Jeffery L.; Read, Margaret A.; McGovern, Karen; Faia, Kerrie L.			Impact of the Smoothened Inhibitor, IPI-926, on Smoothened Ciliary Localization and Hedgehog Pathway Activity	PLOS ONE			English	Article							PRIMARY CILIUM; DIFFERENTIATION; TRANSLOCATION; CANCER; CELLS	A requisite step for canonical Hedgehog (Hh) pathway activation by Sonic Hedgehog (Shh) ligand is accumulation of Smoothened (Smo) to the primary cilium (PC). Activation of the Hh pathway has been implicated in a broad range of cancers, and several Smo antagonists are being assessed clinically, one of which is approved for the treatment of advanced basal cell carcinoma. Recent reports demonstrate that various Smo antagonists differentially impact Smo localization to the PC while still exerting inhibitory activity. In contrast to other synthetic small molecule Smo antagonists, the natural product cyclopamine binds to and promotes ciliary accumulation of Smo and "primes'' cells for Hh pathway hyper-responsiveness after compound withdrawal. We compared the properties of IPI-926, a semi-synthetic cyclopamine analog, to cyclopamine with regard to potency, ciliary Smo accumulation, and Hh pathway activity after compound withdrawal. Like cyclopamine, IPI-926 promoted accumulation of Smo to the PC. However, in contrast to cyclopamine, IPI-926 treatment did not prime cells for hyper-responsiveness to Shh stimulation after compound withdrawal, but instead demonstrated continuous inhibition of signaling. By comparing the levels of drug-induced ciliary Smo accumulation with the degree of Hh pathway activity after compound withdrawal, we propose that a critical threshold of ciliary Smo is necessary for "priming'' activity to occur. This "priming'' appears achievable with cyclopamine, but not IPI-926, and is cell-line dependent. Additionally, IPI-926 activity was evaluated in a murine tumor xenograft model and a pharmacokinetic/pharmacodynamic relationship was examined to assess for in vivo evidence of Hh pathway hyper-responsiveness. Plasma concentrations of IPI-926 correlated with the degree and duration of Hh pathway suppression, and pathway activity did not exceed baseline levels out to 96 hours post dose. The overall findings suggest that IPI-926 possesses unique biophysical and pharmacological properties that result in Hh pathway inhibition in a manner that differentiates it from cyclopamine.	[Peluso, Marisa O.; Campbell, Veronica T.; Harari, Joseph A.; Tibbitts, Thomas T.; Proctor, Jennifer L.; Whitebread, Nigel; Conley, James M.; White, Kerry F.; Kutok, Jeffery L.; Read, Margaret A.; McGovern, Karen; Faia, Kerrie L.] Infin Pharmaceut Inc, Cambridge, MA 02139 USA		Faia, KL (corresponding author), Infin Pharmaceut Inc, Cambridge, MA 02139 USA.	Kerrie.Faia@infi.com		Conley, James/0000-0001-8901-4713				Arbiser JL, 1999, AM J PATHOL, V155, P723, DOI 10.1016/S0002-9440(10)65171-1; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen YB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001083; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Milenkovic L, 2009, J CELL BIOL, V187, P365, DOI 10.1083/jcb.200907126; Nakamura T, 1997, BIOCHEM BIOPH RES CO, V237, P465, DOI 10.1006/bbrc.1997.7156; Nozawa YI, 2013, CURR OPIN GENET DEV; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Tremblay MR, 2009, J MED CHEM, V52, P4400, DOI 10.1021/jm900305z; van der Horst G, 2003, BONE, V33, P899, DOI 10.1016/j.bone.2003.07.004; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Wang Y, 2012, CHEM BIOL, V19, P972, DOI 10.1016/j.chembiol.2012.06.012; Wang Y, 2012, ACS CHEM BIOL, V7, P1040, DOI 10.1021/cb300028a; Wang Y, 2009, P NATL ACAD SCI USA, V106, P2623, DOI 10.1073/pnas.0812110106; Wilson CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005182; Wu VM, 2012, P NATL ACAD SCI USA, V109, P13644, DOI 10.1073/pnas.1207170109; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386	20	14	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90534	10.1371/journal.pone.0090534	http://dx.doi.org/10.1371/journal.pone.0090534			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608250	Green Submitted, Green Published, gold			2022-12-25	WOS:000332485800030
J	Shimada, T; Yamazaki, Y; Tanaka, K; Ishihama, A				Shimada, Tomohiro; Yamazaki, Yukiko; Tanaka, Kan; Ishihama, Akira			The Whole Set of Constitutive Promoters Recognized by RNA Polymerase RpoD Holoenzyme of Escherichia coli	PLOS ONE			English	Article							PROKARYOTIC GENOME REGULATION; MIXED TRANSCRIPTION SYSTEM; H-NS; STRUCTURAL BASIS; SIGMA SUBUNITS; ALPHA SUBUNIT; PROTEIN; GENES; ACTIVATION; SEQUENCE	The promoter selectivity of Escherichia coli RNA polymerase is determined by the sigma subunit with promoter recognition activity. The model prokaryote Escherichia coli contains seven species of the sigma subunit, each recognizing a specific set of promoters. The major sigma subunit, sigma-70 encoded by rpoD, plays a major role in transcription of growth-related genes. Concomitant with the increase in detection of promoters functioning in vivo under various stressful conditions, the variation is expanding in the consensus sequence of RpoD promoters. In order to identify the canonical sequence of "constitutive promoters'' that are recognized by the RNA polymerase holoenzyme containing RpoD sigma in the absence of supporting transcription factors, an in vitro mixed transcription assay was carried out using a whole set of variant promoters, each harboring one base replacement, within the model promoter with the conserved -35 and -10 sequences of RpoD promoters. The consensus sequences, TTGACA(-35) and TATAAT(-10), were identified to be ideal for the maximum level of open complex formation and the highest rate of promoter opening, respectively. For identification of the full range of constitutive promoters on the E. coli genome, a total of 2,701 RpoD holoenzyme-binding sites were identified by Genomic SELEX screening, and using the reconfirmed consensus promoter sequence, a total of maximum 669 constitutive promoters were identified, implying that the majority of hitherto identified promoters represents the TF-dependent "inducible promoters''. One unique feature of the constitutive promoters is the high level of promoter sequence conservation, about 85% carrying five-out-of-six agreements with -35 or -10 consensus sequence. The list of constitutive promoters provides the community resource toward estimation of the inducible promoters that operate under various stressful conditions in nature.	[Shimada, Tomohiro; Ishihama, Akira] Hosei Univ, Dept Frontier Biosience, Tokyo, Japan; [Shimada, Tomohiro; Ishihama, Akira] Hosei Univ, Micronano Technol Res Ctr, Tokyo, Japan; [Shimada, Tomohiro; Tanaka, Kan] Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 227, Japan; [Yamazaki, Yukiko] Natl Inst Genet, Genet Strains Res Inst, Shizuoka, Japan	Hosei University; Hosei University; Tokyo Institute of Technology; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Ishihama, A (corresponding author), Hosei Univ, Dept Frontier Biosience, Tokyo, Japan.	aishiham@hosei.ac.jp	Tanaka, Kan/E-3724-2015; Shimada, Tomohiro/E-7660-2014; Albers, Pieter/I-2563-2017	Tanaka, Kan/0000-0001-7560-7884; Shimada, Tomohiro/0000-0002-8361-0730; 	MEXT (Ministry of Education, Culture, Sports, Science and Technology of Japan) [21241047, 18310133, 25430173]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities [S0801037];  [24710214]; Grants-in-Aid for Scientific Research [25430173] Funding Source: KAKEN	MEXT (Ministry of Education, Culture, Sports, Science and Technology of Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research from MEXT (Ministry of Education, Culture, Sports, Science and Technology of Japan): (A) (21241047) to AI, (B) (18310133) to AI, (C) (25430173) to AI, and Young Scientists (B) (24710214) to TS. This study was performed under the MEXT-Supported Program for the Strategic Research Foundation at Private Universities 208-2012 (S0801037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SS, 2013, J BIOL CHEM, V288, P13356, DOI 10.1074/jbc.M113.455378; Almron M, 1992, GENE DEV, V6, P2648; Beak A, 2009, ECOSAL ESCHERICHIA C; Burgess RR, 2001, CURR OPIN MICROBIOL, V4, P126, DOI 10.1016/S1369-5274(00)00177-6; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; BUSBY S, 1994, CELL, V79, P743, DOI 10.1016/0092-8674(94)90063-9; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Cho BK, 2009, NAT BIOTECHNOL, V27, P1043, DOI 10.1038/nbt.1582; COLLADOVIDES J, 1991, MICROBIOL REV, V55, P371, DOI 10.1128/MMBR.55.3.371-394.1991; COTTER PA, 1992, FEMS MICROBIOL LETT, V100, P227, DOI 10.1111/j.1574-6968.1992.tb05708.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dame RT, 2001, BIOCHIMIE, V83, P231; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fujita N, 1996, METHOD ENZYMOL, V273, P121; FUKUDA R, 1983, J BIOL CHEM, V258, P2720; Giannoukos G, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r23; GORANSSON M, 1990, NATURE, V344, P682, DOI 10.1038/344682a0; Gordon BRG, 2011, P NATL ACAD SCI USA, V108, P10690, DOI 10.1073/pnas.1102544108; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; Gourse RL, 2006, J BACTERIOL, V188, P4589, DOI 10.1128/JB.00499-06; Gralla JD, 1996, CURR OPIN GENET DEV, V6, P526, DOI 10.1016/S0959-437X(96)80079-7; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; HARLEY CB, 1987, NUCLEIC ACIDS RES, V15, P2343, DOI 10.1093/nar/15.5.2343; Hengge-Aronis R, 2002, CURR OPIN MICROBIOL, V5, P591, DOI 10.1016/S1369-5274(02)00372-7; Herring CD, 2005, J BACTERIOL, V187, P6166, DOI 10.1128/JB.187.17.6166-6174.2005; Huerta AM, 2003, J MOL BIOL, V333, P261, DOI 10.1016/j.jmb.2003.07.017; IGARASHI K, 1991, CELL, V65, P1015, DOI 10.1016/0092-8674(91)90553-B; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; ISHIHAMA A, 1993, J BACTERIOL, V175, P2483, DOI 10.1128/JB.175.9.2483-2489.1993; ISHIHAMA A, 1992, MOL MICROBIOL, V6, P3283, DOI 10.1111/j.1365-2958.1992.tb02196.x; Ishihama A, 2012, P JPN ACAD B-PHYS, V88, P485, DOI 10.2183/pjab.88.485; Ishihama A, 2010, FEMS MICROBIOL REV, V34, P628, DOI 10.1111/j.1574-6976.2010.00227.x; Jishage M, 1997, J BACTERIOL, V179, P959, DOI 10.1128/jb.179.3.959-963.1997; KAJITANI M, 1983, NUCLEIC ACIDS RES, V11, P3873, DOI 10.1093/nar/11.12.3873; KAJITANI M, 1983, NUCLEIC ACIDS RES, V11, P671, DOI 10.1093/nar/11.3.671; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; KOBAYASHI M, 1990, NUCLEIC ACIDS RES, V18, P7367, DOI 10.1093/nar/18.24.7367; Lim CJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00509; Liu XQ, 2004, J BIOL CHEM, V279, P12588, DOI 10.1074/jbc.M313454200; LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI 10.1128/jb.174.12.3843-3849.1992; Maeda H, 2000, NUCLEIC ACIDS RES, V28, P3497, DOI 10.1093/nar/28.18.3497; Mekler V, 2013, NUCLEIC ACIDS RES, V41, P7276, DOI 10.1093/nar/gkt541; Mitchell JE, 2003, NUCLEIC ACIDS RES, V31, P4689, DOI 10.1093/nar/gkg694; Mooney RA, 2009, MOL CELL, V33, P97, DOI 10.1016/j.molcel.2008.12.021; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Ogasawara H, 2010, MICROBIOL-SGM, V156, P2470, DOI 10.1099/mic.0.039131-0; Oshima T, 2006, DNA RES, V13, P141, DOI 10.1093/dnares/dsl009; Paget MSB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-203; Panyukov VV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062601; PRIBNOW D, 1975, J MOL BIOL, V99, P419, DOI 10.1016/S0022-2836(75)80136-7; Raghavan R, 2011, J BACTERIOL, V193, P2871, DOI 10.1128/JB.00398-11; Ramseier TM, 1996, CURR MICROBIOL, V33, P270, DOI 10.1007/s002849900112; Saecker RM, 2011, J MOL BIOL, V412, P754, DOI 10.1016/j.jmb.2011.01.018; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; Shavkunov KS, 2009, NUCLEIC ACIDS RES, V37, P4919, DOI 10.1093/nar/gkp490; Shimada K, 2013, MICROBIOL-SGM, V159, P2501, DOI 10.1099/mic.0.067538-0; Shimada T, 2005, GENES CELLS, V10, P907, DOI 10.1111/j.1365-2443.2005.00888.x; Shimada T, 2012, PLOS ONE, V6; Shimada T, 2014, GENES CELLS IN PRESS; Shimada T, 2008, NUCLEIC ACIDS RES, V36, P3950, DOI 10.1093/nar/gkn339; Shimada T, 2007, MOL MICROBIOL, V66, P744, DOI 10.1111/j.1365-2958.2007.05954.x; Shimada T, 2011, MOL MICROBIOL, V82, P378, DOI 10.1111/j.1365-2958.2011.07818.x; SIEBENLIST U, 1980, CELL, V20, P269, DOI 10.1016/0092-8674(80)90613-3; Singer BS, 1997, NUCLEIC ACIDS RES, V25, P781, DOI 10.1093/nar/25.4.781; Singh SS, 2011, NUCLEIC ACIDS RES, V39, P5109, DOI 10.1093/nar/gkr080; TANAKA K, 1995, NUCLEIC ACIDS RES, V23, P827, DOI 10.1093/nar/23.5.827; Teramoto J, 2010, NUCLEIC ACIDS RES, V38, P3605, DOI 10.1093/nar/gkq077; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vivero A, 2008, J BACTERIOL, V190, P1152, DOI 10.1128/JB.01206-07; Yamazaki Yukiko, 2008, V416, P385, DOI 10.1007/978-1-59745-321-9_26; Young BA, 2004, SCIENCE, V303, P1382, DOI 10.1126/science.1092462	71	75	79	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90447	10.1371/journal.pone.0090447	http://dx.doi.org/10.1371/journal.pone.0090447			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603758	Green Submitted, gold, Green Published			2022-12-25	WOS:000332483600053
J	Stancu, IC; Ris, L; Vasconcelos, B; Marinangeli, C; Goeminne, L; Laporte, V; Haylani, LE; Couturier, J; Schakman, O; Gailly, P; Pierrot, N; Kienlen-Campard, P; Octave, JN; Dewachter, I				Stancu, Ilie-Cosmin; Ris, Laurence; Vasconcelos, Bruno; Marinangeli, Claudia; Goeminne, Leonie; Laporte, Vincent; Haylani, Laetitia E.; Couturier, Julien; Schakman, Olivier; Gailly, Philippe; Pierrot, Nathalie; Kienlen-Campard, Pascal; Octave, Jean-Noel; Dewachter, Ilse			Tauopathy contributes to synaptic and cognitive deficits in a murine model for Alzheimer's disease	FASEB JOURNAL			English	Article						amyloid plaques; neurofibrillary tangles; GSK3; synaptic transmission; hippocampal atrophy	AMYLOID PRECURSOR PROTEIN; TRANSGENIC MICE; TAU-PATHOLOGY; A-BETA; NEUROFIBRILLARY TANGLES; MOUSE MODEL; HYPOTHETICAL MODEL; PLAQUE-FORMATION; MEMORY DEFICITS; MUTANT-TAU	Tau alterations are now considered an executor of neuronal demise and cognitive dysfunction in Alzheimer's disease (AD). Mouse models combining amyloidosis and tauopathy and their parental counterparts are important tools to further investigate the interplay of abnormal amyloid-beta (A beta) and Tau species in pathogenesis, synaptic and neuronal dysfunction, and cognitive decline. Here, we crossed APP/PS1 mice with 5 early-onset familial AD mutations (5xFAD) and TauP301S (PS19) transgenic mice, denoted F+/T+ mice, and phenotypically compared them to their respective parental strains, denoted F+/T- and F-/T+ respectively, as controls. We found dramatically aggravated tauopathy (similar to 10-fold) in F+/T+ mice compared to the parental F-/T+ mice. In contrast, amyloidosis was unaltered compared to the parental F+/T- mice. Tauopathy was invariably and very robustly aggravated in hippocampal and cortical brain regions. Most important, F+/T+ displayed aggravated cognitive deficits in a hippocampus-dependent spatial navigation task, compared to the parental F+/T- strain, while parental F-/T+ mice did not display cognitive impairment. Basal synaptic transmission was impaired in F+/T+ mice compared to nontransgenic mice and the parental strains (>= 40%). Finally, F+/T+ mice displayed a significant hippocampal atrophy (similar to 20%) compared to nontransgenic mice, in contrast to the parental strains. Our data indicate for the first time that pathological A beta species (or APP/PS1) induced changes in Tau contribute to cognitive deficits correlating with synaptic deficits and hippocampal atrophy in an AD model. Our data lend support to the amyloid cascade hypothesis with a role of pathological A beta species as initiator and pathological Tau species as executor.	[Stancu, Ilie-Cosmin; Vasconcelos, Bruno; Marinangeli, Claudia; Goeminne, Leonie; Laporte, Vincent; Haylani, Laetitia E.; Couturier, Julien; Pierrot, Nathalie; Kienlen-Campard, Pascal; Octave, Jean-Noel; Dewachter, Ilse] Catholic Univ Louvain, Alzheimer Dementia Grp, B-1200 Brussels, Belgium; [Schakman, Olivier; Gailly, Philippe] Catholic Univ Louvain, Inst Neurosci, Dept Cell Physiol, B-1200 Brussels, Belgium; [Ris, Laurence] Univ Mons, Dept Neurosci, Mons, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; University of Mons	Dewachter, I (corresponding author), Catholic Univ Louvain, Inst Neuroscience, B 1-54-10,Av Hippocrate 54, B-1200 Brussels, Belgium.	ilse.dewachter@uclouvain.be	Dewachter, Ilse/AAZ-5661-2020	Dewachter, Ilse/0000-0001-7202-515X; Stancu, Ilie-Cosmin/0000-0003-4271-0193; Kienlen-Campard, Pascal/0000-0003-1086-2942; Goeminne, Leonie/0000-0001-5870-5124	Belgian Fonds National pour la Recherche Scientifique-Fonds de la Recherche Scientifique (FNRS-FRS); Interuniversity Attraction Poles Programme-Belgian State-Belgian Science Policy; Belgian Fonds de la Recherche Scientifique Medicale; Stichting Alzheimer Onderzoek-Fondation pour la Recherche sur la Maladie d'Alzheimer (SAO-FRMA); Programme d'Excellence Marshall Diane convention	Belgian Fonds National pour la Recherche Scientifique-Fonds de la Recherche Scientifique (FNRS-FRS)(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Poles Programme-Belgian State-Belgian Science Policy(Belgian Federal Science Policy Office); Belgian Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Stichting Alzheimer Onderzoek-Fondation pour la Recherche sur la Maladie d'Alzheimer (SAO-FRMA); Programme d'Excellence Marshall Diane convention	This work was supported by the Belgian Fonds National pour la Recherche Scientifique-Fonds de la Recherche Scientifique (FNRS-FRS; Qualified Researcher, Impulse Financing, Research Credits), by Interuniversity Attraction Poles Programme-Belgian State-Belgian Science Policy, The Belgian Fonds de la Recherche Scientifique Medicale, the Stichting Alzheimer Onderzoek-Fondation pour la Recherche sur la Maladie d'Alzheimer (SAO-FRMA), and the Programme d'Excellence Marshall Diane convention.	Allen B, 2002, J NEUROSCI, V22, P9340; Ashe KH, 2001, LEARN MEMORY, V8, P301, DOI 10.1101/lm.43701; Bolmont T, 2007, AM J PATHOL, V171, P2012, DOI 10.2353/ajpath.2007.070403; Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256; Brunden KR, 2009, NAT REV DRUG DISCOV, V8, P783, DOI 10.1038/nrd2959; Citron M, 2004, NAT REV NEUROSCI, V5, P677, DOI 10.1038/nrn1495; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Dewachter I, 2002, LANCET NEUROL, V1, P409, DOI 10.1016/S1474-4422(02)00188-6; Dewachter I, 2002, J NEUROSCI, V22, P3445; Duyckaerts C, 2008, ACTA NEUROPATHOL, V115, P5, DOI 10.1007/s00401-007-0312-8; GALLYAS F, 1971, ACTA MORPHOL HUNG, V19, P1; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heraud C, 2014, NEUROBIOL DIS, V62, P100, DOI 10.1016/j.nbd.2013.09.010; Hurtado DE, 2012, J NEUROSCI, V32, P7392, DOI 10.1523/JNEUROSCI.0889-12.2012; Hurtado DE, 2010, AM J PATHOL, V177, P1977, DOI 10.2353/ajpath.2010.100346; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Leroy K, 2007, AM J PATHOL, V171, P976, DOI 10.2353/ajpath.2007.070345; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Li SM, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00005; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Pigino G, 2001, J NEUROSCI, V21, P834, DOI 10.1523/JNEUROSCI.21-03-00834.2001; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Saul A, 2013, NEUROBIOL AGING, V34, P2564, DOI 10.1016/j.neurobiolaging.2013.05.003; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schindowski K, 2006, AM J PATHOL, V169, P599, DOI 10.2353/ajpath.2006.060002; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; St George-Hyslop PH, 2008, LANCET, V372, P180, DOI 10.1016/S0140-6736(08)61047-8; Takashima A, 1998, P NATL ACAD SCI USA, V95, P9637, DOI 10.1073/pnas.95.16.9637; Terwel D, 2005, J BIOL CHEM, V280, P3963, DOI 10.1074/jbc.M409876200; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; Van der Jeugd A, 2012, ACTA NEUROPATHOL, V123, P787, DOI 10.1007/s00401-012-0987-3; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zahs KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00028	47	34	36	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2014	28	6					2620	2631		10.1096/fj.13-246702	http://dx.doi.org/10.1096/fj.13-246702			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AM5GA	24604080				2022-12-25	WOS:000339883600020
J	Manandhar, SP; Calle, EN; Gharakhanian, E				Manandhar, Surya P.; Calle, Erika N.; Gharakhanian, Editte			Distinct Palmitoylation Events at the Amino-terminal Conserved Cysteines of Env7 Direct Its Stability, Localization, and Vacuolar Fusion Regulation in S. cerevisiae*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Lysosomes; Membrane Fusion; Membrane Proteins; Protein Kinases; Protein Palmitoylation; Protein Sorting; Protein Stability; Env7; Yeast Lysosomal Vacuole; Yeast Vacuolar Fusion	PROTEIN PALMITOYLATION; SNARE YKT6; SERINE/THREONINE KINASE; YEAST VACUOLES; EARLY-STAGE; MEMBRANE; COMPLEX; VAC8; RAB; PHOSPHORYLATION	Background: Env7 is a conserved palmitoylated kinase that regulates vacuolar fusion. Results: Specific Env7 palmitoylated cysteines direct its membrane localization, stability, and function. Conclusion: Distinct palmitoylation events direct Env7 membrane localization as well as its stability and function at the membrane. Significance: This may represent the largest set of functions attributed to palmitoylated cysteines in a single protein. Palmitoylation at cysteine residues is the only known reversible form of lipidation and has been implicated in protein membrane association as well as function. Many palmitoylated proteins have regulatory roles in dynamic cellular processes, including membrane fusion. Recently, we identified Env7 as a conserved and palmitoylated protein kinase involved in negative regulation of membrane fusion at the lysosomal vacuole. Env7 contains a palmitoylation consensus sequence, and substitution of its three consecutive cysteines (Cys(13)-Cys(15)) results in a non-palmitoylated and cytoplasmic Env7. In this study, we further dissect and define the role(s) of individual cysteines of the consensus sequence in various properties of Env7 in vivo. Our results indicate that more than one of the cysteines serve as palmitoylation substrates, and any pairwise combination is essential and sufficient for near wild type levels of Env7 palmitoylation, membrane localization, and phosphorylation. Furthermore, individually, each cysteine can serve as a minimum requirement for distinct aspects of Env7 behavior and function in cells. Cys(13) is sufficient for membrane association, Cys(15) is essential for the fusion regulatory function of membrane-bound Env7, and Cys(14) and Cys(15) are redundantly essential for protection of membrane-bound Env7 from proteasomal degradation. A role for Cys(14) and Cys(15) in correct sorting at the membrane is also discussed. Thus, palmitoylation at the N-terminal cysteines of Env7 directs not only its membrane association but also its stability, phosphorylation, and cellular function.	[Manandhar, Surya P.; Calle, Erika N.; Gharakhanian, Editte] Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA	California State University System; California State University Long Beach	Gharakhanian, E (corresponding author), Calif State Univ Long Beach, Dept Biol Sci, 1250 Bellflower Blvd, Long Beach, CA 90840 USA.	e.ghara@csulb.edu			National Science Foundation (NSF)-RUI Grant [0843569]; NSF-Major Research Instrumentation Grant [DBI0722757]; NSF-RUI Grant [0843569]; NSF-LSAMP undergraduate training grant [HRD-1302873]; Direct For Education and Human Resources [1302873] Funding Source: National Science Foundation	National Science Foundation (NSF)-RUI Grant(National Science Foundation (NSF)); NSF-Major Research Instrumentation Grant; NSF-RUI Grant; NSF-LSAMP undergraduate training grant; Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))	This project was supported by National Science Foundation (NSF)-RUI Grant 0843569 (to E. G.) and NSF-Major Research Instrumentation Grant DBI0722757 for confocal microscopy.; Supported by NSF-RUI Grant 0843569.; Supported in part by an NSF-LSAMP undergraduate training grant (HRD-1302873).	Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; Armstrong J, 2010, TRENDS CELL BIOL, V20, P580, DOI 10.1016/j.tcb.2010.06.010; Babu P, 2004, J BIOL CHEM, V279, P27138, DOI 10.1074/jbc.M403071200; Beck JR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003162; Berson AE, 1999, BIOCHEM BIOPH RES CO, V259, P533, DOI 10.1006/bbrc.1999.0811; Blaskovic S, 2013, FEBS J, V280, P2766, DOI 10.1111/febs.12263; Brett CL, 2008, J CELL BIOL, V182, P1141, DOI 10.1083/jcb.200801001; Cabrera M, 2013, J BIOL CHEM, V288, P5166, DOI 10.1074/jbc.M112.431536; Cabrera M, 2010, J CELL BIOL, V191, P845, DOI 10.1083/jcb.201004092; Cabrera M, 2009, MOL BIOL CELL, V20, P1937, DOI 10.1091/mbc.E08-09-0943; Cebollero E, 2009, BBA-MOL CELL RES, V1793, P1413, DOI 10.1016/j.bbamcr.2009.01.008; Chamberlain LH, 2013, BIOCHEM SOC T, V41, P62, DOI 10.1042/BST20120243; Chen Y, 2005, J MOL BIOL, V350, P92, DOI 10.1016/j.jmb.2005.04.061; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Dietrich LEP, 2005, J BIOL CHEM, V280, P15348, DOI 10.1074/jbc.M410582200; Dietrich LEP, 2005, EMBO REP, V6, P245, DOI 10.1038/sj.embor.7400350; Dietrich LEP, 2004, EMBO J, V23, P45, DOI 10.1038/sj.emboj.7600015; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Eswaran J, 2008, STRUCTURE, V16, P115, DOI 10.1016/j.str.2007.10.026; Flaumenhaft R, 2005, HEMATOLOGY, V10, P511, DOI 10.1080/10245330500141507; Forster A, 2003, TRENDS CELL BIOL, V13, P550, DOI 10.1016/j.tcb.2003.09.001; Gao XD, 2005, FEBS J, V272, P2497, DOI 10.1111/j.1742-4658.2005.04670.x; Guinea B, 2005, EXP CELL RES, V312, P135, DOI 10.1016/j.yexcr.2005.10.010; Hach JC, 2013, J VIROL, V87, P9923, DOI 10.1128/JVI.00621-13; He B, 2011, BIOCHEM J, V437, P399, DOI 10.1042/BJ20101381; Hou HT, 2005, P NATL ACAD SCI USA, V102, P17366, DOI 10.1073/pnas.0508885102; Inoue Y, 2010, SEMIN CELL DEV BIOL, V21, P664, DOI 10.1016/j.semcdb.2010.03.009; Kihara A, 2005, MOL CELL BIOL, V25, P9189, DOI 10.1128/MCB.25.21.9189-9197.2005; LaGrassa TJ, 2005, J CELL BIOL, V168, P401, DOI 10.1083/jcb.200407141; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Ligos JM, 2002, J BIOL CHEM, V277, P6333, DOI 10.1074/jbc.M105766200; Manandhar S. P., 2013, FEMS YEAST RES, DOI [10.1111/1567-1364.12128, DOI 10.1111/1567-1364. 12128]; Manandhar SP, 2013, MOL CELL BIOL, V33, P526, DOI 10.1128/MCB.01303-12; Meiringer CTA, 2008, TRAFFIC, V9, P1510, DOI 10.1111/j.1600-0854.2008.00778.x; Nadolski MJ, 2009, J BIOL CHEM, V284, P17720, DOI 10.1074/jbc.M109.005447; Ostrowicz CW, 2008, AUTOPHAGY, V4, P5, DOI 10.4161/auto.5054; Qanbar R, 2003, PHARMACOL THERAPEUT, V97, P1, DOI 10.1016/S0163-7258(02)00300-5; Quevillon-Cheruel S, 2009, J BIOL CHEM, V284, P3552, DOI 10.1074/jbc.M808334200; Resh Marilyn D, 2006, Sci STKE, V2006, pre14, DOI 10.1126/stke.3592006re14; Richards Andrea, 2010, Fungal Biology Reviews, V24, P93, DOI 10.1016/j.fbr.2010.04.002; Rohde J, 2003, J BIOL CHEM, V278, P1656, DOI 10.1074/jbc.M209522200; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Roth AF, 2011, MOL BIOL CELL, V22, P2702, DOI 10.1091/mbc.E11-02-0115; Sato TK, 1998, MOL CELL BIOL, V18, P5308, DOI 10.1128/MCB.18.9.5308; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Song SP, 2013, BIOCHEM J, V454, P323, DOI 10.1042/BJ20121799; Stairs DB, 2005, TRANSGENIC RES, V14, P919, DOI 10.1007/s11248-005-1806-6; Subramanian K, 2006, J CELL SCI, V119, P2477, DOI 10.1242/jcs.02972; SUDO Y, 1992, EMBO J, V11, P2095, DOI 10.1002/j.1460-2075.1992.tb05268.x; Tanimura N, 2006, BIOCHEM BIOPH RES CO, V341, P1177, DOI 10.1016/j.bbrc.2006.01.076; Thayanidhi N, 2012, BIOL CELL, V104, P397, DOI 10.1111/boc.201100048; Valdez-Taubas J, 2005, EMBO J, V24, P2524, DOI 10.1038/sj.emboj.7600724; Veit M, 2001, EMBO J, V20, P3145, DOI 10.1093/emboj/20.12.3145; Wen WY, 2010, MOL CELL, V37, P383, DOI 10.1016/j.molcel.2010.01.024; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; Young FB, 2012, PROG NEUROBIOL, V97, P220, DOI 10.1016/j.pneurobio.2011.11.002; Yount JS, 2013, CURR OPIN CHEM BIOL, V17, P27, DOI 10.1016/j.cbpa.2012.11.008; Zhang MZM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001597; Zhu YZ, 2012, VIROLOGY, V429, P112, DOI 10.1016/j.virol.2012.03.002	60	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11431	11442		10.1074/jbc.M113.524082	http://dx.doi.org/10.1074/jbc.M113.524082			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24610781	Green Published, hybrid			2022-12-25	WOS:000334638500044
J	Woods, SE; Qi, PM; Rosalia, E; Chavarria, T; Discua, A; Mkandawire, J; Fox, JG; Garcia, A				Woods, Stephanie E.; Qi, Peimin; Rosalia, Elizabeth; Chavarria, Tony; Discua, Allan; Mkandawire, John; Fox, James G.; Garcia, Alexis			Laser-Assisted In Vitro Fertilization Facilitates Fertilization of Vitrified-Warmed C57BL/6 Mouse Oocytes with Fresh and Frozen-Thawed Spermatozoa, Producing Live Pups	PLOS ONE			English	Article							AUTOLOGOUS CUMULUS CELLS; CRYOPRESERVED MOUSE; ZONA-PELLUCIDA; EFFICIENT VITRIFICATION; MICRODISSECTED OOCYTES; EMBRYO-TRANSFER; EXCIMER-LASER; DEGREES-C; SPERM; IMPLANTATION	The utility of cryopreserved mouse gametes for reproduction of transgenic mice depends on development of assisted reproductive technologies, including vitrification of unfertilized mouse oocytes. Due to hardening of the zona pellucida, spermatozoa are often unable to penetrate vitrified-warmed (V-W) oocytes. Laser-assisted in vitro fertilization (LAIVF) facilitates fertilization by allowing easier penetration of spermatozoa through a perforation in the zona. We investigated the efficiency of V-W C57BL/6NTac oocytes drilled by the XYClone laser, compared to fresh oocytes. By using DAP213 for cryoprotection, 83% (1,470/1,762) of vitrified oocytes were recovered after warming and 78% were viable. Four groups were evaluated for two-cell embryo and live offspring efficiency: 1) LAIVF using V-W oocytes, 2) LAIVF using fresh oocytes, 3) conventional IVF using V-W oocytes and 4) conventional IVF using fresh oocytes. First, the groups were tested using fresh C57BL/6NTac spermatozoa (74% motile, 15 million/ml). LAIVF markedly improved the two-cell embryo efficiency using both V-W (76%, 229/298) and fresh oocytes (69%, 135/197), compared to conventional IVF (7%, 12/182; 6%, 14/235, respectively). Then, frozen-thawed C57BL/6NTac spermatozoa (35% motile, 15 million/ml) were used and LAIVF was again found to enhance fertilization efficiency, with two-cell embryo rates of 87% (298/343) using V-W oocytes (P<0.05, compared to fresh spermatozoa), and 73% (195/266) using fresh oocytes. Conventional IVF with frozen-thawed spermatozoa using V-W (6%, 10/168) and fresh (5%, 15/323) oocytes produced few two-cell embryos. Although live offspring efficiency following embryo transfer was greater with conventional IVF (35%, 18/51; LAIVF: 6%, 50/784), advantage was seen with LAIVF in live offspring obtained from total oocytes (5%, 50/1,010; conventional IVF: 2%, 18/908). Our results demonstrated that zona-drilled V-W mouse oocytes can be used for IVF procedures using both fresh and frozen-thawed spermatozoa, producing live pups. The ability to cryopreserve mouse gametes for LAIVF may facilitate management of large-scale transgenic mouse production facilities.	[Woods, Stephanie E.; Qi, Peimin; Rosalia, Elizabeth; Chavarria, Tony; Discua, Allan; Mkandawire, John; Fox, James G.; Garcia, Alexis] MIT, Div Comparat Med, Transgen Core Facil, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Garcia, A (corresponding author), MIT, Div Comparat Med, Transgen Core Facil, Cambridge, MA 02139 USA.	agarcia@mit.edu			National Institutes of Health (NIH) National Research Service Award [T32-RR070036]; NIH National Cancer Institute Program Project [P01CA10451]; NATIONAL CANCER INSTITUTE [P01CA026731, P01CA028842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Cancer Institute Program Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	SEW was supported by a National Institutes of Health (NIH) National Research Service Award (T32-RR070036; http://grants.nih.gov/training/nrsa.htm). PQ, ER, AD, JGF, AG and in part TC were supported by departmental funding. JM and in part TC were supported by a NIH National Cancer Institute Program Project (P01CA10451; http://grants.nih.gov/grants/guide/pa-files/PAR-09-025.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agca Y, 2000, ILAR J, V41, P207; ANTINORI S, 1994, HUM REPROD, V9, P1891, DOI 10.1093/oxfordjournals.humrep.a138354; Anzai M, 2006, J REPROD DEVELOP, V52, P601, DOI 10.1262/jrd.18040; Bath ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009387; Borg CL, 2010, HUM REPROD UPDATE, V16, P205, DOI 10.1093/humupd/dmp032; ELDANASOURI I, 1993, HUM REPROD, V8, P464, DOI 10.1093/oxfordjournals.humrep.a138072; ENGINSU ME, 1995, HUM REPROD, V10, P1761, DOI 10.1093/oxfordjournals.humrep.a136170; Fan ZQ, 2009, LAB ANIM-UK, V43, P72, DOI 10.1258/la.2008.008029; Farouk FNO, 2008, J REPROD DEVELOP, V54, P385, DOI 10.1262/jrd.20018; Farouk FN, 2011, ANIM SCI J, V82, P420, DOI 10.1111/j.1740-0929.2010.00869.x; Germond M, 1996, HUM REPROD, V11, P1043; Jin M, 2011, P NATL ACAD SCI USA, V108, P4892, DOI 10.1073/pnas.1018202108; Kaneko T, 2009, CRYOBIOLOGY, V59, P59, DOI 10.1016/j.cryobiol.2009.04.006; Kohaya N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058063; Kuwayama M, 2007, THERIOGENOLOGY, V67, P73, DOI 10.1016/j.theriogenology.2006.09.014; LAUFER N, 1993, FERTIL STERIL, V59, P889; Li MW, 2013, REPRODUCTION, V145, P245, DOI 10.1530/REP-12-0477; Liow SL, 1996, HUM REPROD, V11, P1273; Liu L, 2009, J AM ASSOC LAB ANIM, V48, P39; Meng QG, 2007, ACTA VET HUNG, V55, P369, DOI 10.1556/AVet.55.2007.3.11; Mochida K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049316; Nakagata N, 2000, MAMM GENOME, V11, P572, DOI 10.1007/s003350010109; Nakagata N, 2013, CRYOBIOLOGY, V67, P188, DOI 10.1016/j.cryobiol.2013.06.011; Nakao K, 1997, EXP ANIM TOKYO, V46, P231, DOI 10.1538/expanim.46.231; Peters DD, 2006, BIOL REPROD, V74, P246, DOI 10.1095/biolreprod.105.045112; Peters DD, 2009, MAMM GENOME, V20, P664, DOI 10.1007/s00335-009-9227-0; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; Sakamoto W, 2005, COMPARATIVE MED, V55, P136; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Shimada M, 2008, DEVELOPMENT, V135, P2001, DOI 10.1242/dev.020461; Sztein JM, 1997, CRYOBIOLOGY, V35, P46, DOI 10.1006/cryo.1997.2024; Tanii I, 2011, REPRODUCTION, V141, P163, DOI 10.1530/REP-10-0201; The Jackson Laboratory, 2005, CRYOPR COURS; Wang YP, 2008, CRYOLETTERS, V29, P111; WHITTINGHAM DG, 1972, SCIENCE, V178, P411, DOI 10.1126/science.178.4059.411	35	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91892	10.1371/journal.pone.0091892	http://dx.doi.org/10.1371/journal.pone.0091892			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618785	Green Published, gold, Green Submitted			2022-12-25	WOS:000332842400140
J	Cardenas, JC; Dreber, A; von Essen, E; Ranehill, E				Cardenas, Juan-Camilo; Dreber, Anna; von Essen, Emma; Ranehill, Eva			Gender and Cooperation in Children: Experiments in Colombia and Sweden	PLOS ONE			English	Article							PUBLIC-GOODS; EVOLUTION; MEN	In this article we compare cooperation among Colombian and Swedish children aged 9-12. We illustrate the dynamics of the prisoner's dilemma in a new task that is easily understood by children and performed during a physical education class. We find no robust evidence of a difference in cooperation between Colombia and Sweden overall. However, Colombian girls cooperate less than Swedish girls. We also find indications that girls in Colombia are less cooperative than boys. Finally, there is also a tendency for children to be more cooperative with boys than with girls on average.	[Cardenas, Juan-Camilo] Univ Los Andes, Dept Econ, Bogota, Colombia; [Cardenas, Juan-Camilo] Univ Los Andes, CEDE, Bogota, Colombia; [Dreber, Anna] Stockholm Sch Econ, Dept Econ, S-11383 Stockholm, Sweden; [von Essen, Emma] Aarhus Univ, Dept Econ & Business, Aarhus, Denmark; [von Essen, Emma] Aarhus Univ, TrygFondens Ctr Child Res, Aarhus, Denmark; [Ranehill, Eva] Univ Zurich, Dept Econ, Zurich, Switzerland	Universidad de los Andes (Colombia); Universidad de los Andes (Colombia); Stockholm School of Economics; Aarhus University; Aarhus University; University of Zurich	von Essen, E (corresponding author), Aarhus Univ, Dept Econ & Business, Aarhus, Denmark.	vonessen@econ.au.dk	cardenas, juan-camilo/B-4658-2009	cardenas, juan-camilo/0000-0003-0005-7595; von Essen, Emma/0000-0002-1421-4582	Jan Wallander and Tom Hedelius Foundation; Carl Silfven Foundation; Swedish Council for Working Life and Social Research (FAS); Department of Economics at the Universidad de Los Andes	Jan Wallander and Tom Hedelius Foundation; Carl Silfven Foundation; Swedish Council for Working Life and Social Research (FAS)(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Department of Economics at the Universidad de Los Andes	Financial support from the Jan Wallander and Tom Hedelius Foundation [http://www.handelsbanken.se/shb/inet/IStartSv.nsf/FrameSetOpenView&id=Forskningsstiftelserna] and the Carl Silfven Foundation [http://www.sasse.se/student/education/news/study-scholarships-fund-carl-silfv-n] (E.Ranehill.), the Swedish Council for Working Life and Social Research (FAS) [http://www.forte.se/en/], and the Department of Economics at the Universidad de Los Andes [http://economia.uniandes.edu.co/en] is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen S, 2008, AM ECON REV, V98, P376, DOI 10.1257/aer.98.2.376; Boschini A, 2011, J SOCIO-ECON, V40, P523, DOI 10.1016/j.socec.2011.04.001; Cardenas JC, 2008, J DEV STUD, V44, P311, DOI 10.1080/00220380701848327; Cardenas JC, 2012, J ECON BEHAV ORGAN, V83, P11, DOI 10.1016/j.jebo.2011.06.008; Charness G, 2011, GAME ECON BEHAV, V72, P77, DOI 10.1016/j.geb.2010.07.006; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; Dreber A, 2009, EXPT EC, V14, P567; FISHBEIN HD, 1985, BRIT J DEV PSYCHOL, V3, P393, DOI 10.1111/j.2044-835X.1985.tb00991.x; Gachter S, 2010, PHILOS T R SOC B, V365, P2651, DOI 10.1098/rstb.2010.0135; Gneezy U, 2004, AM ECON REV, V94, P377, DOI 10.1257/0002828041301821; Greiner B, 2005, J ECON PSYCHOL, V26, P711, DOI 10.1016/j.joep.2004.04.003; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Harbaugh WT, 2000, ECON INQ, V38, P95, DOI 10.1093/ei/38.1.95; Harbaugh WT, 2003, TRUST RECIPROCITY GA; Hausmann R., 2012, GLOBAL GENDER GAP RE; Martinsson P, 2013, J ECON PSYCHOL, V34, P148, DOI 10.1016/j.joep.2012.09.005; Martinsson P, 2011, ECON LETT, V110, P248, DOI 10.1016/j.econlet.2010.11.028; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Olson KR, 2008, COGNITION, V108, P222, DOI 10.1016/j.cognition.2007.12.003; Ostrom E, 2003, TRUST RECIPROCITY GA; Peters HE, 2004, INT ECON REV, V45, P283, DOI 10.1111/j.1468-2354.2004.00126.x; Sally D, 2006, J ECON PSYCHOL, V27, P73, DOI 10.1016/j.joep.2005.06.015; TEDESCHI JT, 1969, CHILD DEV, V40, P517, DOI 10.2307/1127419; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850	25	15	15	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90923	10.1371/journal.pone.0090923	http://dx.doi.org/10.1371/journal.pone.0090923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9FH	24614513	Green Published, gold, Green Submitted			2022-12-25	WOS:000332839300057
J	Jayaraman, C; Moon, Y; Rice, IM; Wecksler, ETH; Beck, CL; Sosnoff, JJ				Jayaraman, Chandrasekaran; Moon, Yaejin; Rice, Ian M.; Wecksler, Elizabeth T. Hsiao; Beck, Carolyn L.; Sosnoff, Jacob J.			Shoulder Pain and Cycle to Cycle Kinematic Spatial Variability during Recovery Phase in Manual Wheelchair Users: A Pilot Investigation	PLOS ONE			English	Article							SPINAL-CORD-INJURY; LEADING JOINT HYPOTHESIS; UPPER EXTREMITY; MOTOR VARIABILITY; LIMB MOVEMENTS; PROPULSION; BIOMECHANICS; TASK; KINETICS; COORDINATION	Wheelchair propulsion plays a significant role in the development of shoulder pain in manual wheelchair users (MWU). However wheelchair propulsion metrics related to shoulder pain are not clearly understood. This investigation examined intra-individual kinematic spatial variability during semi-circular wheelchair propulsion as a function of shoulder pain in MWU. Data from 10 experienced adult MWU with spinal cord injury (5 with shoulder pain; 5 without shoulder pain) were analyzed in this study. Participants propelled their own wheelchairs on a dynamometer at 3 distinct speeds (self-selected, 0.7 m/s, 1.1 m/s) for 3 minutes at each speed. Motion capture data of the upper limbs were recorded. Intra-individual kinematic spatial variability of the steady state wrist motion during the recovery phase was determined using principal component analysis (PCA). The kinematic spatial variability was calculated at every 10% intervals (i.e at 11 interval points, from 0% to 100%) along the wrist recovery path. Results: Overall, spatial variability was found to be highest at the start and end of the recovery phase and lowest during the middle of the recovery path. Individuals with shoulder pain displayed significantly higher kinematic spatial variability than individuals without shoulder pain at the start (at 10% interval) of the recovery phase (p<.004). Conclusions: Analysis of intra-individual kinematic spatial variability during the recovery phase of manual wheelchair propulsion distinguished between those with and without shoulder pain. Variability analysis of wheelchair propulsion may offer a new approach to monitor the development and rehabilitation of shoulder pain.	[Jayaraman, Chandrasekaran; Beck, Carolyn L.] Univ Illinois, Dept Ind & Enterprise Syst Engn, Urbana, IL 61801 USA; [Moon, Yaejin; Sosnoff, Jacob J.] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA; [Rice, Ian M.; Wecksler, Elizabeth T. Hsiao] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Sosnoff, JJ (corresponding author), Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA.	jsosnoff@illinois.edu	Sosnoff, Jacob/P-3397-2019; Hsiao-Wecksler, Elizabeth T/C-1910-2015; Jayaraman, Chandrasekaran/I-1765-2019	Sosnoff, Jacob/0000-0002-0286-9207; Hsiao-Wecksler, Elizabeth T/0000-0002-9373-3611; 	National Institutes of Health [1R21HD066129-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD066129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This project is funded in part by the National Institutes of Health (#1R21HD066129-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	BEDNARCZYK JH, 1994, ARCH PHYS MED REHAB, V75, P1327; Bernstein N.A., 1967, COORDINATION REGULAT; Boninger ML, 2005, J REHABIL RES DEV, V42, P9, DOI 10.1682/JRRD.2004.08.0103; Bregman DJJ, 2009, CLIN BIOMECH, V24, P13, DOI 10.1016/j.clinbiomech.2008.09.003; CAMPBELL WI, 1990, ULSTER MED J, V59, P149; Chow JW, 2011, DISABIL REHABIL-ASSI, V6, P365, DOI 10.3109/17483107.2010.525290; Collinger JL, 2008, ARCH PHYS MED REHAB, V89, P667, DOI 10.1016/j.apmr.2007.09.052; Cowan RE, 2008, ARCH PHYS MED REHAB, V89, P260, DOI 10.1016/j.apmr.2007.08.141; Cowan RE, 2009, ARCH PHYS MED REHAB, V90, P1076, DOI 10.1016/j.apmr.2008.10.034; Curtis KA, 1999, SPINAL CORD, V37, P421, DOI 10.1038/sj.sc.3100860; de Groot S, 2004, AM J PHYS MED REHAB, V83, P640, DOI 10.1097/01.phm.0000133437.58810.c6; de Groot S, 2003, J ELECTROMYOGR KINES, V13, P217, DOI 10.1016/S1050-6411(03)00018-X; DiGiovine CP, 2001, J REHABIL RES DEV, V38, P41; Dounskaia N, 2005, EXP BRAIN RES, V166, P1, DOI 10.1007/s00221-005-2339-1; Dounskaia N, 2010, EXERC SPORT SCI REV, V38, P201, DOI 10.1097/JES.0b013e3181f45194; Finley MA, 2004, J REHABIL RES DEV, V41, P385, DOI 10.1682/JRRD.2004.03.0385; Forner Cordero A, 2005, BIOL CYBERN, V93, P63; GELLMAN H, 1988, CLIN ORTHOP RELAT R, P132; Hosseini SM, 2012, ARCH PHYS MED REHAB, V93, P2237, DOI 10.1016/j.apmr.2012.05.021; Ivanenko YP, 2007, J NEUROSCI, V27, P11149, DOI 10.1523/JNEUROSCI.2644-07.2007; Koontz AM, 2009, ARCH PHYS MED REHAB, V90, P1916, DOI 10.1016/j.apmr.2009.05.022; Koontz AM, 2002, J REHABIL RES DEV, V39, P635; Kwarciak AM, 2012, DISABIL REHABIL-ASSI, V7, P459, DOI 10.3109/17483107.2011.650781; LaPlante MP, 2010, ASSIST TECHNOL, V22, P3, DOI 10.1080/10400430903501413; LaPlante MP, 2003, INT WORKSH CTR INCL; Lomond KV, 2011, CLIN BIOMECH, V26, P123, DOI 10.1016/j.clinbiomech.2010.09.012; Lomond KV, 2010, EXP BRAIN RES, V206, P271, DOI 10.1007/s00221-010-2405-1; Madeleine P, 2008, ERGONOMICS, V51, P1078, DOI 10.1080/00140130801958659; Madeleine P, 2008, EXP BRAIN RES, V185, P689, DOI 10.1007/s00221-007-1199-2; Mason BS, 2012, MED SCI SPORT EXER, V44, P126, DOI 10.1249/MSS.0b013e31822a2df0; Mathiassen SE, 2003, ERGONOMICS, V46, P800, DOI 10.1080/0014013031000090125; Mercer JL, 2006, CLIN BIOMECH, V21, P781, DOI 10.1016/j.clinbiomech.2006.04.010; Moon Y, 2013, CLIN BIOMECHANICS; Morrow MMB, 2009, J REHABIL RES DEV, V46, P939, DOI 10.1682/JRRD.2008.12.0165; NICHOLS PJR, 1979, SCAND J REHABIL MED, V11, P29; PATLA AE, 1985, J MOTOR BEHAV, V17, P443; Price R, 2007, ARCH PHYS MED REHAB, V88, P456, DOI 10.1016/j.apmr.2007.01.016; Ranganathan R, 2010, J MOTOR BEHAV, V42, P307, DOI 10.1080/00222895.2010.510542; Ranganathan R, 2010, NEUROSCI LETT, V469, P416, DOI 10.1016/j.neulet.2009.12.041; Rankin JW, 2012, CLIN BIOMECH, V27, P879, DOI 10.1016/j.clinbiomech.2012.07.002; Rankin JW, 2011, J BIOMECH, V44, P1246, DOI 10.1016/j.jbiomech.2011.02.073; Rice IM, 2013, ARCH PHYS M IN PRESS; Richter WM, 2011, ARCH PHYS MED REHAB, V92, P572, DOI 10.1016/j.apmr.2010.11.001; SANDERSON DJ, 1985, J BIOMECH, V18, P423, DOI 10.1016/0021-9290(85)90277-5; Sawatzky BJ, 2005, J REHABIL RES DEV, V42, P1, DOI 10.1682/JRRD.2004.06.0070; Scholz JP, 2000, EXP BRAIN RES, V135, P382, DOI 10.1007/s002210000540; Shimada SD, 1998, J REHABIL RES DEV, V35, P210; Srinivasan D, 2012, CLIN BIOMECH, V27, P979, DOI 10.1016/j.clinbiomech.2012.08.007; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Stergiou UH, 2004, INNOVATIVE ANAL HUMA, P63; VANLANDEWIJCK YC, 1994, MED SCI SPORT EXER, V26, P1373; VEEGER HEJ, 1991, J ELECTROMYOGR KINES, V1, P270, DOI 10.1016/1050-6411(91)90014-V; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042	53	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e89794	10.1371/journal.pone.0089794	http://dx.doi.org/10.1371/journal.pone.0089794			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614232	Green Published, gold, Green Submitted			2022-12-25	WOS:000332839300013
J	Nie, P; Li, HO; Duan, YH; Wang, XM; Ji, XP; Cheng, ZP; Wang, AB; Chen, JH				Nie, Pei; Li, Haiou; Duan, Yanhua; Wang, Ximing; Ji, Xiaopeng; Cheng, Zhaoping; Wang, Anbiao; Chen, Jiuhong			Impact of Sinogram Affirmed Iterative Reconstruction (SAFIRE) Algorithm on Image Quality with 70 kVp-Tube-Voltage Dual-Source CT Angiography in Children with Congenital Heart Disease	PLOS ONE			English	Article							FILTERED BACK-PROJECTION; RADIATION-DOSE REDUCTION; COMPUTED-TOMOGRAPHY; CARDIAC CT; EXPERIENCE; INFANTS	Purpose: To compare the image quality and diagnostic accuracy between sinogram affirmed iterative reconstruction (SAFIRE) algorithm and filtered back projection (FBP) reconstruction algorithm at 70 kVp-tube-voltage DSCT angiography in children with congenital heart disease (CHD). Materials and Methods: Twenty-eight patients (mean age: 13 months; range: 2-48 months; male: 16; female: 12; mean weight: 8 kg) with CHD underwent 70 kVp DSCT angiography. Imaging data were reconstructed with both FBP and SAFIRE algorithms. Subjective image quality was evaluated on a five-point scale. The parameters of image noise, signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) on the objective image quality were compared for the two reconstruction algorithms. Surgery was performed in 20 patients, whereas conventional cardiac angiography (CCA) was performed in 8 patients. The diagnostic accuracy was evaluated on the surgical and/or CCA findings. The effective radiation doses were calculated. Results: Compared to FBP algorithm, SAFIRE algorithm had significantly higher scores for subjective image quality (P<0.05), and lower image noise (P<0.05) as well as higher SNR & CNR values (P>0.05). There was no significant difference in the diagnostic accuracy between the FBP and SAFIRE algorithm (chi(2) = 1.793, P>0.05). The mean effective dose for 70 kVp DSCT angiography was 0.30+/-0.13 mSv. Conclusions: The SAFIRE algorithm can significantly reduce image noise and improve the image quality at 70 kVp DSCT angiography for the assessment of CHD in children.	[Nie, Pei; Li, Haiou; Duan, Yanhua; Wang, Ximing; Ji, Xiaopeng; Cheng, Zhaoping] Shandong Univ, Shandong Med Imaging Res Inst, Shandong Prov Key Lab Diag & Treatment Cardiocere, Jinan 250100, Shandong, Peoples R China; [Wang, Anbiao] Shandong Prov Hosp, Dept Cardiovasc Surg, Jinan, Shandong, Peoples R China; [Chen, Jiuhong] Siemens Ltd China, CT Res Collaborat, Beijing, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Siemens AG	Wang, XM (corresponding author), Shandong Univ, Shandong Med Imaging Res Inst, Shandong Prov Key Lab Diag & Treatment Cardiocere, Jinan 250100, Shandong, Peoples R China.	Wangximing369@hotmail.com		Cheng, Zhaoping/0000-0001-7217-7284				Alkadhi H, 2011, EUR J RADIOL, V80, P36, DOI 10.1016/j.ejrad.2010.12.099; Alkadhi H, 2011, EUR RADIOL, V21, P505, DOI 10.1007/s00330-010-1984-3; Bahner ML, 2005, INVEST RADIOL, V40, P229, DOI 10.1097/01.rli.0000155281.32319.52; Baumueller S, 2012, EUR RADIOL, V22, P2597, DOI 10.1007/s00330-012-2524-0; Bittencourt MS, 2011, INT J CARDIOVAS IMAG, V27, P1081, DOI 10.1007/s10554-010-9756-3; Cheng ZP, 2010, EUR RADIOL, V20, P2503, DOI 10.1007/s00330-010-1822-7; Ebersberger U, 2013, EUR RADIOL, V23, P125, DOI 10.1007/s00330-012-2580-5; Gnannt R, 2012, AM J NEURORADIOL, V33, P1014, DOI 10.3174/ajnr.A2910; Goo HW, 2011, RADIOL CLIN N AM, V49, P997, DOI 10.1016/j.rcl.2011.06.001; Goo HW, 2010, KOREAN J RADIOL, V11, P4, DOI 10.3348/kjr.2010.11.1.4; Han BK, 2012, J CARDIOVASC COMPUT, V6, P200, DOI 10.1016/j.jcct.2012.04.008; Kalra MK, 2012, J COMPUT ASSIST TOMO, V36, P339, DOI 10.1097/RCT.0b013e31825586c0; Katsura M, 2012, EUR RADIOL, V22, P1613, DOI 10.1007/s00330-012-2452-z; Korn A, 2012, AM J NEURORADIOL, V33, P218, DOI 10.3174/ajnr.A2749; Leschka S, 2008, EUR RADIOL, V18, P1809, DOI 10.1007/s00330-008-0966-1; Mahesh Mahadevappa, 2011, Pediatr Radiol, V41 Suppl 2, P493, DOI 10.1007/s00247-011-2169-1; Marin D, 2010, RADIOLOGY, V254, P145, DOI 10.1148/radiol.09090094; Moscariello A, 2011, EUR RADIOL, V21, P2130, DOI 10.1007/s00330-011-2164-9; Nie P, 2012, EUR RADIOL, V22, P2057, DOI 10.1007/s00330-012-2479-1; Oda S, 2012, AM J ROENTGENOL, V198, P1126, DOI 10.2214/AJR.11.7117; Pache G, 2011, EUR J RADIOL, V80, pE440, DOI 10.1016/j.ejrad.2011.01.032; Park EA, 2012, INT J CARDIOVAS IMAG, V28, P1775, DOI 10.1007/s10554-011-0004-2; Paul JF, 2010, PEDIATR RADIOL, V40, P869, DOI 10.1007/s00247-010-1614-x; Ren QG, 2012, EUR J RADIOL, V81, P2597, DOI 10.1016/j.ejrad.2011.12.041; Singh S, 2012, RADIOLOGY, V263, P537, DOI 10.1148/radiol.12110268; Siripornpitak S, 2013, EUR J RADIOL, V82, P1067, DOI 10.1016/j.ejrad.2011.11.042; Utsunomiya D, 2012, EUR RADIOL, V22, P1287, DOI 10.1007/s00330-011-2361-6; Winklehner A, 2011, EUR RADIOL, V21, P2521, DOI 10.1007/s00330-011-2227-y; Young C, 2011, EUR RADIOL, V21, P518, DOI 10.1007/s00330-010-2036-8	29	26	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91123	10.1371/journal.pone.0091123	http://dx.doi.org/10.1371/journal.pone.0091123			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614683	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300079
J	Shiono, M; Takahashi, S; Kakudo, Y; Takahashi, M; Shimodaira, H; Kato, S; Ishioka, C				Shiono, Masatoshi; Takahashi, Shin; Kakudo, Yuichi; Takahashi, Masanobu; Shimodaira, Hideki; Kato, Shunsuke; Ishioka, Chikashi			Upper Arm Central Venous Port Implantation: A 6-Year Single Institutional Retrospective Analysis and Pictorial Essay of Procedures for Insertion	PLOS ONE			English	Article							INTERNAL JUGULAR-VEIN; PINCH-OFF SIGN; ONCOLOGY PATIENTS; ACCESS DEVICE; CATHETER OCCLUSION; CANCER-PATIENTS; COMPLICATIONS; EXPERIENCE; MALIGNANCIES; PLACEMENT	Background: The requirement of central venous (CV) port implantation is increasing with the increase in the number of cancer patients and advancement in chemotherapy. In our division, medical oncologists have implanted all CV ports to save time and consultation costs to other departments. Recently, upper arm implantation has become the first choice as a safe and comfortable method in our unit. Here we report our experience and discuss the procedure and its potential advantages. Methods: All CV port implantations (n = 599) performed in our unit from January 2006 to December 2011 were analyzed. Procedural success and complication rates between subclavian and upper arm groups were compared. Results: Both groups had similar patient characteristics. Upper arm CV port and subclavian implantations were equivalently successful and safe. Although we only retrospectively analyzed data from a single center, the upper arm group had a significantly lower overall postprocedural complication rate than the subclavian group. No pneumothorax risk, less risk of arterial puncture by ultrasound, feasibility of stopping potential arterial bleeding, and prevention of accidental arterial cannulation by targeting the characteristic solitary basilic vein were the identified advantages of upper arm CV port implantation. In addition to the aforementioned advantages, there is no risk of "pinch-off syndrome," possibly less patient fear of manipulation, no scars on the neck and chest, easier accessibility, and compatibility with the "peripherally inserted central catheter" technique. Conclusions: Upper arm implantation may benefit clinicians and patients with respect to safety and comfort. We also introduce our methods for upper arm CV port implantation with the videos.	[Shiono, Masatoshi; Takahashi, Shin; Kakudo, Yuichi; Takahashi, Masanobu; Shimodaira, Hideki; Kato, Shunsuke; Ishioka, Chikashi] Tohoku Univ, Tohoku Univ Hosp, Dept Clin Oncol, Aoba Ku, Sendai, Miyagi 980, Japan; [Kakudo, Yuichi; Kato, Shunsuke; Ishioka, Chikashi] Tohoku Univ, Dept Clin Oncol, Inst Dev Aging & Canc, Aoba Ku, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University	Ishioka, C (corresponding author), Tohoku Univ, Tohoku Univ Hosp, Dept Clin Oncol, Aoba Ku, Sendai, Miyagi 980, Japan.	chikashi@idac.tohoku.ac.jp	Takahashi, Shin/AAE-5011-2019; Kato, Shunsuke/F-7607-2014	Takahashi, Shin/0000-0001-6695-3099; Ishioka, Chikashi/0000-0002-3023-1227	Japanese Ministry of Health, Labour and Welfare	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study has been funded by a Health Labour Sciences Research Grant from the Japanese Ministry of Health, Labour and Welfare. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study. URL: http://www.mhlw.go.jp/jigyo_shiwake/gyousei_review_sheet/2012/h23_pdf/0240.pdf.	AITKEN DR, 1984, AM J SURG, V148, P633, DOI 10.1016/0002-9610(84)90340-4; Akahane A, 2011, CARDIOVASC INTER RAD, V34, P1222, DOI 10.1007/s00270-010-0051-4; ANDRIS DA, 1994, JPEN-PARENTER ENTER, V18, P531, DOI 10.1177/0148607194018006531; Biffi R, 2000, J Vasc Access, V1, P19; Blaivas M, 2009, J ULTRAS MED, V28, P1239, DOI 10.7863/jum.2009.28.9.1239; Bodner LJ, 2000, CARDIOVASC INTER RAD, V23, P187, DOI 10.1007/s002700010041; Burbridge B, 2000, CAN ASSOC RADIOL J, V51, P163; Cayne NS, 2010, ANN VASC SURG, V24, P44, DOI 10.1016/j.avsg.2009.06.017; Charvat J, 2006, SUPPORT CARE CANCER, V14, P1162, DOI 10.1007/s00520-006-0073-2; Cil Barbaros Erhan, 2006, Diagn Interv Radiol, V12, P93; Deppe G, 1996, GYNECOL ONCOL, V62, P340, DOI 10.1006/gyno.1996.0246; Ezaru CS, 2009, ANESTH ANALG, V109, P130, DOI 10.1213/ane.0b013e31818f87e9; Higgs ZCJ, 2005, LANCET, V366, P1407, DOI 10.1016/S0140-6736(05)66878-X; Hills JR, 1997, J VASC INTERV RADIOL, V8, P983, DOI 10.1016/S1051-0443(97)70698-5; Hostetter R., 2010, J ASS VASC ACCESS, V15, P112, DOI [10.2309/java.15-3-3, DOI 10.2309/JAVA.15-3-3]; Huang CH, 1999, J FORMOS MED ASSOC, V98, P265; Kawamura J, 2008, INT J CLIN ONCOL, V13, P349, DOI 10.1007/s10147-008-0766-2; Klotz HP, 1996, J SURG ONCOL, V62, P222, DOI 10.1002/(SICI)1096-9098(199607)62:3<222::AID-JSO14>3.0.CO;2-8; Kusminsky RE, 2007, J AM COLL SURGEONS, V204, P681, DOI 10.1016/j.jamcollsurg.2007.01.039; Lyon RD, 1999, J VASC INTERV RADIOL, V10, P463, DOI 10.1016/S1051-0443(99)70066-7; MANSFIELD PF, 1994, NEW ENGL J MED, V331, P1735, DOI 10.1056/NEJM199412293312602; Marcy P, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.9158; Marcy PY, 2008, EJSO-EUR J SURG ONC, V34, P1262, DOI 10.1016/j.ejso.2007.09.011; Marcy PY, 2005, BREAST CANCER RES TR, V92, P61, DOI 10.1007/s10549-005-1711-y; McGee DC, 2003, NEW ENGL J MED, V348, P1123, DOI 10.1056/NEJMra011883; MIKAMI K, 2011, JPN J INTERVENT RADI, V26, P169; NIEDERHUBER JE, 1982, SURGERY, V92, P706; Pikwer A, 2009, EUR J VASC ENDOVASC, V38, P707, DOI 10.1016/j.ejvs.2009.08.009; PUNT CJA, 1995, ANTI-CANCER DRUG, V6, P594, DOI 10.1097/00001813-199508000-00013; Ryder M A, 1995, Surg Oncol Clin N Am, V4, P395; SALEM RR, 1993, J CLIN ONCOL, V11, P2181, DOI 10.1200/JCO.1993.11.11.2181; SELDINGER SI, 1953, ACTA RADIOL, V39, P368, DOI 10.3109/00016925309136722; Sonobe M, 2009, INT J CLIN ONCOL, V14, P208, DOI 10.1007/s10147-008-0835-6; Verhey PT, 2008, J ASS VASCULAR ACCES, V13, P32, DOI [10.2309/java.13-1-7, DOI 10.2309/JAVA.13-1-7]; Whigham CJ, 1999, J VASC INTERV RADIOL, V10, P767, DOI 10.1016/S1051-0443(99)70112-0; Wirsing M, 2008, CHEST, V134, P527, DOI 10.1378/chest.07-2687; Yip D, 2002, ACTA RADIOL, V43, P371, DOI 10.1034/j.1600-0455.2002.430405.x	37	20	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91335	10.1371/journal.pone.0091335	http://dx.doi.org/10.1371/journal.pone.0091335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614412	Green Submitted, Green Published, gold			2022-12-25	WOS:000332839300114
J	Silva, AM; Oliveira, MI; Sette, L; Almeida, CR; Oliveira, MJ; Barbosa, MA; Santos, SG				Silva, Andreia M.; Oliveira, Marta I.; Sette, Laura; Almeida, Catarina R.; Oliveira, Maria J.; Barbosa, Mario A.; Santos, Susana G.			Resveratrol as a Natural Anti-Tumor Necrosis Factor-alpha Molecule: Implications to Dendritic Cells and Their Crosstalk with Mesenchymal Stromal Cells	PLOS ONE			English	Article							MIXED LYMPHOCYTE-REACTION; NF-KAPPA-B; STEM-CELLS; COSTIMULATORY MOLECULES; RHEUMATOID-ARTHRITIS; INDUCED ACTIVATION; IN-VITRO; T-CELLS; EXPRESSION; DIFFERENTIATION	Dendritic cells (DC) are promising targets for inducing tolerance in inflammatory conditions. Thus, this study aims to investigate the effects of the natural anti-inflammatory molecule resveratrol on human DC at phenotypic and functional levels, including their capacity to recruit mesenchymal stem/stromal cells (MSC). Primary human monocyte-derived DC and bone marrow MSC were used. DC immunophenotyping revealed that small doses of resveratrol (10 mu M) reduce cell activation in response to tumor necrosis factor (TNF)-alpha, significantly decreasing surface expression of CD83 and CD86. Functionally, IL-12/IL-23 secretion induced by TNF-alpha was significantly reduced by resveratrol, while IL-10 levels increased. Resveratrol also inhibited T cell proliferation, in response to TNF-alpha-stimulated DC. The underlying mechanism was investigated by Western blot and imaging flow cytometry (ImageStream(X)), and likely involves impairment of nuclear translocation of the p65 NF-kappa B subunit. Importantly, results obtained demonstrate that DC are able to recruit MSC through extracellular matrix components, and that TNF-alpha impairs DC-mediated recruitment. Matrix metalloproteinases (MMP) produced by both cell populations were visualized by gelatin zymography. Finally, time-lapse microscopy analysis revealed a significant decrease on DC and MSC motility in co-cultures, indicating cell interaction, and TNF-alpha further decreased MSC motility, while resveratrol recovered it. Thus, the current study points out the potential of resveratrol as a natural anti-TNF-alpha drug, capable of modulating DC phenotype and function, as well as DC-mediated MSC recruitment.	[Silva, Andreia M.; Oliveira, Marta I.; Sette, Laura; Almeida, Catarina R.; Oliveira, Maria J.; Barbosa, Mario A.; Santos, Susana G.] Univ Porto, INEB Inst Engn Biomed, P-4100 Oporto, Portugal; [Silva, Andreia M.] Univ Porto, Fac Engn, P-4100 Oporto, Portugal; [Silva, Andreia M.; Barbosa, Mario A.] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4100 Oporto, Portugal; [Oliveira, Maria J.] Univ Porto, Fac Ciencias, P-4100 Oporto, Portugal; [Oliveira, Maria J.] Univ Porto, Fac Med, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto	Santos, SG (corresponding author), Univ Porto, INEB Inst Engn Biomed, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	susana.santos@ineb.up.pt	Almeida, Catarina R/A-7018-2012; Santos, Susana G/L-9351-2013; Barbosa, Mário A/F-5964-2011; Silva, Andreia M./AAY-1152-2021; Oliveira, Marta I A/M-9386-2013; Oliveira, Maria Jose/K-3275-2013	Almeida, Catarina R/0000-0001-6670-6004; Santos, Susana G/0000-0002-8604-2978; Barbosa, Mário A/0000-0003-3568-7482; Silva, Andreia M./0000-0001-6365-1407; Oliveira, Marta I A/0000-0002-0578-9202; Oliveira, Maria Jose/0000-0002-0724-0272	FEDER funds through Programa Operacional Factores de Competitividade - COMPETE; Portuguese funds through FCT - Fundacao para a Ciencia e a Tecnologia [PEst-C/SAU/LA0002/2013, PTDC/SAU-BEB/099954/2008]; FCT-POPH [SFRH/BPD/37090/2007, SFRH/BPD/48533/2008]; FCT-POPH-FSE; North Region Operational Program [ON.2]	FEDER funds through Programa Operacional Factores de Competitividade - COMPETE; Portuguese funds through FCT - Fundacao para a Ciencia e a Tecnologia; FCT-POPH; FCT-POPH-FSE; North Region Operational Program	This work was financed by FEDER funds through Programa Operacional Factores de Competitividade - COMPETE and by Portuguese funds through FCT - Fundacao para a Ciencia e a Tecnologia in the framework of projects PEst-C/SAU/LA0002/2013 and PTDC/SAU-BEB/099954/2008. MIO is recipient of a post-doctoral fellowship from FCT-POPH (SFRH/BPD/37090/2007). CRA was funded by a post-doctoral fellowship from FCT-POPH (SFRH/BPD/48533/2008), SGS and MJO were funded by FCT-POPH-FSE (Ciencia2007). CRA and SGS were also funded by North Region Operational Program (ON.2), in the framework of the "Project on Biomedical Engineering for Regenerative Therapies and Cancer - NORTE-07-0124-FEDER-000005", through QREN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams MB, 2009, RESTOR NEUROL NEUROS, V27, P307, DOI 10.3233/RNN-2009-0480; Almeida CR, 2012, J R SOC INTERFACE, V9, P261, DOI 10.1098/rsif.2011.0357; Augustin MA, 2013, ANN NY ACAD SCI, V1290, P107, DOI 10.1111/nyas.12130; Bertelli AAE, 2001, THERAPIE, V56, P613; Bi XL, 2005, INT IMMUNOPHARMACOL, V5, P185, DOI 10.1016/j.intimp.2004.08.008; Bocker WG, 2008, J MOL MED, V86, P1183, DOI 10.1007/s00109-008-0378-3; Bouffi C, 2009, RHEUMATOLOGY, V48, P1185, DOI 10.1093/rheumatology/kep162; Chapuis F, 1997, EUR J IMMUNOL, V27, P431, DOI 10.1002/eji.1830270213; Chomarat P, 2003, J IMMUNOL, V171, P2262, DOI 10.4049/jimmunol.171.5.2262; Csiszar A, 2006, AM J PHYSIOL-HEART C, V291, pH1694, DOI 10.1152/ajpheart.00340.2006; Dai Z, 2007, PHYTOMEDICINE, V14, P806, DOI 10.1016/j.phymed.2007.04.003; Deng YH, 2011, PHYTOTHER RES, V25, P451, DOI 10.1002/ptr.3279; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Elmali N, 2007, INFLAMMATION, V30, P1, DOI 10.1007/s10753-006-9012-0; Elmali N, 2005, INFLAMM RES, V54, P158, DOI 10.1007/s00011-004-1341-6; Feldmann M, 2005, J AUTOIMMUN, V25, P26, DOI 10.1016/j.jaut.2005.09.006; Fu XB, 2009, WOUND REPAIR REGEN, V17, P185, DOI 10.1111/j.1524-475X.2009.00454.x; Garbi N, 2010, CURR OPIN IMMUNOL, V22, P601, DOI 10.1016/j.coi.2010.08.007; Ghannam S, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt2; Gu XL, 1999, J AGR FOOD CHEM, V47, P3223, DOI 10.1021/jf981211e; Hacquard-Bouder C, 2004, ARTHRITIS RHEUM-US, V50, P1624, DOI 10.1002/art.20211; Hacquard-Bouder C, 2007, ARTHRITIS RHEUM-US, V56, P1478, DOI 10.1002/art.22572; Jongbloed SL, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1864; Kang OH, 2009, PHARMACOL RES, V59, P330, DOI 10.1016/j.phrs.2009.01.009; Kim GY, 2004, INT IMMUNOPHARMACOL, V4, P245, DOI 10.1016/j.intimp.2003.12.009; Kim YA, 2004, ONCOL REP, V11, P441; Kundu JK, 2004, BIOFACTORS, V21, P33, DOI 10.1002/biof.552210108; Lee B, 2005, J NUTR, V135, P2767, DOI 10.1093/jn/135.12.2767; Leiro JM, 2010, MOL IMMUNOL, V47, P1114, DOI 10.1016/j.molimm.2009.10.030; MANGI RJ, 1975, YALE J BIOL MED, V48, P217; Manna SK, 2000, J IMMUNOL, V164, P6509, DOI 10.4049/jimmunol.164.12.6509; Miwa S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052926; Neves AR, 2012, CURR MED CHEM, V19, P1663; Okada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044338; Oliveira MI, 2012, EUR CELLS MATER, V24, P136, DOI 10.22203/eCM.v024a10; Poulsen MM, 2013, ANN NY ACAD SCI, V1290, P74, DOI 10.1111/nyas.12141; Ryu J, 2011, ANTICANCER RES, V31, P4223; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Santos SG, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2492; Scheinecker C, 1998, J IMMUNOL, V161, P3966; Schildknecht A, 2010, P NATL ACAD SCI USA, V107, P199, DOI 10.1073/pnas.0910620107; Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230; Spaggiari GM, 2013, IMMUNOL CELL BIOL, V91, P27, DOI 10.1038/icb.2012.62; Svajger U, 2010, IMMUNOLOGY, V129, P525, DOI 10.1111/j.1365-2567.2009.03205.x; Tondreau T, 2009, CYTOTHERAPY, V11, P559, DOI 10.1080/14653240903051541; Verhasselt V, 1997, J IMMUNOL, V158, P2919; Woo JH, 2004, ONCOGENE, V23, P1845, DOI 10.1038/sj.onc.1207307; Zhu J, 2008, BIOCHEM BIOPH RES CO, V369, P471, DOI 10.1016/j.bbrc.2008.02.034	48	23	24	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91406	10.1371/journal.pone.0091406	http://dx.doi.org/10.1371/journal.pone.0091406			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614867	Green Submitted, gold, Green Published			2022-12-25	WOS:000332839300122
J	Sunthamala, N; Thierry, F; Teissier, S; Pientong, C; Kongyingyoes, B; Tangsiriwatthana, T; Sangkomkamhang, U; Ekalaksananan, T				Sunthamala, Nuchsupha; Thierry, Francoise; Teissier, Sebastien; Pientong, Chamsai; Kongyingyoes, Bunkerd; Tangsiriwatthana, Thumwadee; Sangkomkamhang, Ussanee; Ekalaksananan, Tipaya			E2 Proteins of High Risk Human Papillomaviruses Down-Modulate STING and IFN-kappa Transcription in Keratinocytes	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; VIRAL TRANSCRIPTION; TUMOR-SUPPRESSOR; HELA-CELLS; HPV16 E2; TYPE-16; PROLIFERATION; ONCOPROTEIN; EXPRESSION; REGULATOR	In the early stages of human papillomavirus (HPV) infection, the viral proteins elicit specific immune responses that can participate to regression of ano-genital lesions. HPV E6 protein for instance can reduce type I interferon (IFN) including IFN-kappa that is involved in immune evasion and HPV persistence. To evaluate the role of E2 protein in innate immunity in HPV16-associated cervical lesions, genome-wide expression profiling of human primary keratinocytes (HPK) transduced by HPV16 E2 was investigated using microarrays and innate immunity associated genes were specifically analyzed. The analyses showed that the expression of 779 genes was modulated by HPV16E2 and 92 of them were genes associated with innate immunity. Notably IFN-kappa and STING were suppressed in HPK expressing the E2 proteins of HPV16 or HPV18 and the transactivation amino-terminal domain of E2 was involved in the suppressive effect. The relationship between STING, IFN-kappa and interferon stimulated genes (ISGs) in HPK was confirmed by gene silencing and real time PCR. The expression of STING and IFN-kappa were further determined in clinical specimens by real time PCR. STING and IFN-kappa were down-modulated in HPV positive low grade squamous intraepithelial lesions compared with HPV negative controls. This study demonstrates that E2 proteins of high risk HPV reduce STING and IFN-kappa transcription and its downstream target genes that might be an immune evasion mechanism involved in HPV persistence and cervical cancer development.	[Sunthamala, Nuchsupha; Pientong, Chamsai; Ekalaksananan, Tipaya] Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand; [Sunthamala, Nuchsupha; Thierry, Francoise; Teissier, Sebastien] ASTAR, Inst Med Biol, Singapore, Singapore; [Kongyingyoes, Bunkerd] Khon Kaen Univ, Fac Med, Dept Pharmacol, Khon Kaen, Thailand; [Tangsiriwatthana, Thumwadee; Sangkomkamhang, Ussanee] Khon Kaen Hosp, Dept Obstet & Gynecol, Khon Kaen, Thailand	Khon Kaen University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Khon Kaen University	Ekalaksananan, T (corresponding author), Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand.	tipeka@kku.ac.th		Sunthamala, Nuchsupha/0000-0003-2213-4037	Faculty of Medicine [I54328]; Khon Kaen University [551602, 564102, 573002]; Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program [PHD/0213/2550]	Faculty of Medicine; Khon Kaen University; Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF))	This work was supported by grants from the Faculty of Medicine (I54328), Khon Kaen University (551602, 564102 and 573002) and the Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program (#PHD/0213/2550) to student's NS and advisor's TE is acknowledged. The funders had no role in study design, data collection, data analysis, preparation of manuscript and decision to publish.	Abbate EA, 2004, GENE DEV, V18, P1981, DOI 10.1101/gad.1220104; Arany I, 1995, ANTICANCER RES, V15, P2865; Ashrafi GH, 2005, INT J CANCER, V113, P276, DOI 10.1002/ijc.20558; AU WC, 1995, P NATL ACAD SCI USA, V92, P11657, DOI 10.1073/pnas.92.25.11657; Bauer M, 2000, IMMUNOL LETT, V71, P55, DOI 10.1016/S0165-2478(99)00170-4; Bellanger S, 2001, J VIROL, V75, P7244, DOI 10.1128/JVI.75.16.7244-7251.2001; Bellanger S, 2011, AM J CANCER RES, V1, P373; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Blachon S, 2005, J BIOL CHEM, V280, P36088, DOI 10.1074/jbc.M505138200; Blakaj DM, 2009, FRONT BIOSCI-LANDMRK, V14, P900, DOI 10.2741/3285; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Davidson EJ, 2003, J GEN VIROL, V84, P2089, DOI 10.1099/vir.0.19095-0; De Maeyer E, 1998, Int Rev Immunol, V17, P53, DOI 10.3109/08830189809084487; DeCarlo CA, 2010, LAB INVEST, V90, P1482, DOI 10.1038/labinvest.2010.95; Demeret C, 2003, ONCOGENE, V22, P168, DOI 10.1038/sj.onc.1206108; Desaintes C, 1997, EMBO J, V16, P504, DOI 10.1093/emboj/16.3.504; DOWHANICK JJ, 1995, J VIROL, V69, P7791, DOI 10.1128/JVI.69.12.7791-7799.1995; Evans M, 2001, J IMMUNOL, V167, P5420, DOI 10.4049/jimmunol.167.9.5420; Hegde RS, 1998, J MOL BIOL, V284, P1479, DOI 10.1006/jmbi.1998.2260; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Kadaja M, 2009, VIROLOGY, V384, P360, DOI 10.1016/j.virol.2008.11.032; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Koutsky Laura, 1997, American Journal of Medicine, V102, P3; LaFleur DW, 2001, J BIOL CHEM, V276, P39765, DOI 10.1074/jbc.M102502200; Li SY, 1999, ONCOGENE, V18, P5727, DOI 10.1038/sj.onc.1202960; McBride AA, 2013, VIROLOGY, V445, P57, DOI 10.1016/j.virol.2013.06.006; Mole S, 2009, J PATHOL, V219, P383, DOI 10.1002/path.2608; Muller Mandy, 2012, Open Virol J, V6, P173, DOI 10.2174/1874357901206010173; Muller M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002761; Oldak M, 2010, J VIROL, V84, P1376, DOI 10.1128/JVI.01220-09; Oliveira JG, 2006, P NATL ACAD SCI USA, V103, P1047, DOI 10.1073/pnas.0507624103; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Park JS, 2000, J BIOL CHEM, V275, P6764, DOI 10.1074/jbc.275.10.6764; Peto J, 2004, BRIT J CANCER, V91, P942, DOI 10.1038/sj.bjc.6602049; Ramirez-Salazar E, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-247; Reiser J, 2011, J VIROL, V85, P11372, DOI 10.1128/JVI.05279-11; Rincon-Orozco B, 2009, CANCER RES, V69, P8718, DOI 10.1158/0008-5472.CAN-09-0550; Schiffman M, 2011, JNCI-J NATL CANCER I, V103, P368, DOI 10.1093/jnci/djq562; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stubenrauch F, 2000, J VIROL, V74, P1178, DOI 10.1128/JVI.74.3.1178-1186.2000; Stubenrauch F, 2007, INT J CANCER, V121, P2284, DOI 10.1002/ijc.22907; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920; Um SJ, 2002, CANCER LETT, V179, P205, DOI 10.1016/S0304-3835(01)00871-0; Woo YL, 2010, INT J CANCER, V126, P133, DOI 10.1002/ijc.24804; Xue Yuezhen, 2012, Open Virol J, V6, P163, DOI 10.2174/1874357901206010163; Yasugi T, 1997, J VIROL, V71, P5942, DOI 10.1128/JVI.71.8.5942-5951.1997; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; zurHausen H, 1996, BBA-REV CANCER, V1288, pF55	54	62	68	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91473	10.1371/journal.pone.0091473	http://dx.doi.org/10.1371/journal.pone.0091473			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614210	gold, Green Published, Green Submitted			2022-12-25	WOS:000332839300130
J	Tang, HJ; Lai, CC; Lin, HL; Chao, CM				Tang, Hung-Jen; Lai, Chih-Cheng; Lin, Hsin-Lan; Chao, Chien-Ming			Clinical Manifestations of Bacteremia Caused by Aeromonas Species in Southern Taiwan	PLOS ONE			English	Article							INFECTION; SOBRIA; HYDROPHILA; EPISODES; PATIENT; COMPLEX; CAVIAE	Aim: This study is conducted to investigate the clinical characteristics of patients with bacteremia caused by Aeromonas species. Materials and Methods: Patients with bacteremia caused by Aeromonas species during the period 2009 to 2013 were identified from a computerized database of a regional hospital in southern Taiwan. The medical records of these patients were retrospectively reviewed. Results: A total of 91 patients with bacteremia due to Aeromonas species were identified. In addition to 16 (17.6%) primary bacteremia, the most common source of secondary infection is peritonitis (n = 27, 29.7%), followed by biliary tract infection (n = 18, 19.8%), and SSTI (n = 12, 13.2%), pneumonia (n = 9, 9.9%), catheter-related bloodstream infection (n = 5, 5.5%), and genitourinary tract infection (n = 4, 4.4%). A. hydrophila (n = 35, 38.5%) was the most common pathogen, followed by A. veronii biovar sobria (n = 31, 34.1%), A. caviae (n = 14, 15.4%), and A. veronii biovar veronii (n = 9, 9.9%). Forty-three (47.3%) patients were classified as healthcare-associated infections (HCAI) causes by Aeromonas species, and patients with HCAI were more likely to have cancer, and receive immunosuppressant than patients with community-acquired bacteremia. The overall outcomes, including rate of ICU admission, acute respiratory failure, and mortality were 33.3%, 28.6%, and 23.1%, respectively. Multivariate analysis showed that the in-hospital day mortality was significantly associated only with underlying cancer (P <.001), and initial shock (P <.001). Conclusions: Aeromonas species should be considered one of the causative pathogens of healthcare-associated bacteremia, especially in immunocompromised patients. In addition, it can be associated with high fatality. Cancer and initial shock were the poor prognostic factors.	[Tang, Hung-Jen] Chi Mei Med Ctr, Dept Med, Tainan, Taiwan; [Tang, Hung-Jen] Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr, Tainan, Taiwan; [Lai, Chih-Cheng; Chao, Chien-Ming] Dept Intens Care Med, Tainan, Taiwan; [Lai, Chih-Cheng; Chao, Chien-Ming] Chi Mei Med Ctr, Tainan, Taiwan; [Lin, Hsin-Lan] Chi Mei Med Ctr, Dept Nursing, Tainan, Taiwan; [Chao, Chien-Ming] Min Hwei Coll Hlth Care Management, Dept Nursing, Tainan, Taiwan	Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Chi Mei Hospital; Chi Mei Hospital	Chao, CM (corresponding author), Dept Intens Care Med, Tainan, Taiwan.	ccm870958@yahoo.com.tw						Chao CM, 2013, EUR J CLIN MICROBIOL, V32, P1069, DOI 10.1007/s10096-013-1852-6; Chao CM, 2013, EUR J CLIN MICROBIOL, V32, P543, DOI 10.1007/s10096-012-1771-y; Chao CM, 2013, EUR J CLIN MICROBIOL, V32, P245, DOI 10.1007/s10096-012-1736-1; Chao CM, 2012, J INFECTION, V65, P573, DOI 10.1016/j.jinf.2012.06.012; Chao CM, 2012, AM J TROP MED HYG, V87, P933, DOI 10.4269/ajtmh.2012.12-0275; Chuang HC, 2011, J KOREAN MED SCI, V26, P1415, DOI 10.3346/jkms.2011.26.11.1415; Clinical and Laboratory Standards Institute, 2010, M45A2 CLSI, V30; Hochedez P, 2010, AM J TROP MED HYG, V83, P1123, DOI 10.4269/ajtmh.2010.10-0063; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Kimura M, 2013, SCAND J INFECT DIS, V45, P304, DOI 10.3109/00365548.2012.737474; Ko WC, 2000, J INFECTION, V40, P267, DOI 10.1053/jinf.2000.0654; KO WC, 1995, CLIN INFECT DIS, V20, P1298, DOI 10.1093/clinids/20.5.1298; Lai CC, 2007, BURNS, V33, P255, DOI 10.1016/j.burns.2006.06.003; Lai CC, 2007, CLIN INFECT DIS, V44, P1523, DOI 10.1086/517850; Lamy B, 2009, J CLIN MICROBIOL, V47, P1234, DOI 10.1128/JCM.00155-09; Lay CJ, 2010, INTERNAL MED, V49, P2415, DOI 10.2169/internalmedicine.49.4117; Lin WT, 2013, INTERNAL MED, V52, P2517, DOI 10.2169/internalmedicine.52.0180; Parker JL, 2011, J INFECTION, V62, P109, DOI 10.1016/j.jinf.2010.12.003; Shizuma T, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/930826; Wang CY, 2009, J MICROBIOL IMMUNOL, V42, P510; Wu CJ, 2012, J MICROBIOL IMMUNOL, V9	22	31	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91642	10.1371/journal.pone.0091642	http://dx.doi.org/10.1371/journal.pone.0091642			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614100	Green Submitted, Green Published, gold			2022-12-25	WOS:000332839300145
J	Coura-Vital, W; Ker, HG; Roatt, BM; Aguiar-Soares, RDO; Leal, GGD; Moreira, ND; Oliveira, LAM; Machado, EMD; Morais, MHF; Correa-Oliveira, R; Carneiro, M; Reis, AB				Coura-Vital, Wendel; Ker, Henrique Gama; Roatt, Bruno Mendes; Oliveira Aguiar-Soares, Rodrigo Dian; de Almeida Leal, Gleisiane Gomes; Moreira, Nadia das Dores; Machado Oliveira, Laser Antonio; de Menezes Machado, Evandro Marques; Franco Morais, Maria Helena; Correa-Oliveira, Rodrigo; Carneiro, Mariangela; Reis, Alexandre Barbosa			Evaluation of Change in Canine Diagnosis Protocol Adopted by the Visceral Leishmaniasis Control Program in Brazil and a New Proposal for Diagnosis	PLOS ONE			English	Article							ENDEMIC AREA; MINAS-GERAIS; DOGS; INFANTUM; TESTS; SERODIAGNOSIS; INFECTIONS; ANTIGENS; HEALTH; COHORT	The techniques used for diagnosis of canine visceral leishmaniasis (CVL) in Brazil ELISA and IFAT have been extensively questioned because of the accuracy of these tests. A recent change in the diagnosis protocol excluded IFAT and included the Dual-Path Platform (DPP). We evaluated the prevalence and incidence rates of Leishmania spp. before and after the change in the protocol. In addition, based on our results, we propose a new alternative that is less expensive for the screening and confirmation of CVL. Plasma samples were obtained from a serobank from dogs evaluated in a cross-sectional study (1,226 dogs) and in a cohort study of susceptible animals (n = 447), followed for 26 months. Serology testing was performed using ELISA, IFAT, and DPP. The incidence and prevalence of CVL were determined by using the protocol of the Visceral Leishmaniasis Control and Surveillance Program until 2012 (ELISA and IFAT using filter paper) and the protocol used after 2012 (DPP and ELISA using plasma). The prevalence was 6.2% and the incidence was 2.8 per 1,000 dog-months for the protocol used until 2012. For the new diagnosis protocol for CVL resulted in an incidence of 5.4 per 1,000 dog-months and a prevalence of 8.1%. Our results showed that the prevalence and incidence of infection were far greater than suggested by the previously used protocol and that the magnitude of infection in endemic areas has been underestimated. As tests are performed sequentially and euthanasia of dogs is carried out when the serological results are positive in both tests, the sequence does not affect the number of animals to be eliminated by the Control Program. Then we suggest to municipalities with a large demand of exams to use ELISA for screening and DPP for confirmation, since this allows easier performance and reduced cost.	[Coura-Vital, Wendel; Ker, Henrique Gama; Roatt, Bruno Mendes; Oliveira Aguiar-Soares, Rodrigo Dian; de Almeida Leal, Gleisiane Gomes; Moreira, Nadia das Dores; Machado Oliveira, Laser Antonio; Reis, Alexandre Barbosa] Univ Fed Ouro Preto, Escola Farm, Lab Pesquisas Clin, Ouro Preto, MG, Brazil; [Coura-Vital, Wendel; Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil; [Ker, Henrique Gama; Roatt, Bruno Mendes; Oliveira Aguiar-Soares, Rodrigo Dian; de Almeida Leal, Gleisiane Gomes; Moreira, Nadia das Dores; de Menezes Machado, Evandro Marques; Reis, Alexandre Barbosa] Univ Fed Ouro Preto, Inst Ciencias Exatas & Biol, Lab Imunopatol, Nucleo Pesquisas Ciencias Biol, Ouro Preto, MG, Brazil; [Franco Morais, Maria Helena] Secretaria Municipal Saude, Belo Horizonte, MG, Brazil; [Correa-Oliveira, Rodrigo] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Imunol Celular & Mol, Belo Horizonte, MG, Brazil; [Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Lab Epidemiol Doencas Infecciosas & Parasitarias, Belo Horizonte, MG, Brazil; [Correa-Oliveira, Rodrigo; Reis, Alexandre Barbosa] INCTDT, Salvador, BA, Brazil	Universidade Federal de Ouro Preto; Universidade Federal de Minas Gerais; Universidade Federal de Ouro Preto; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	Reis, AB (corresponding author), Univ Fed Ouro Preto, Escola Farm, Lab Pesquisas Clin, Ouro Preto, MG, Brazil.	alexreis@nupeb.ufop.br	Reis, Alexandre Barbosa/I-9945-2014; Roatt, Bruno M/R-5502-2016; de Oliveira Aguiar-Soares, Rodrigo Dian/ABB-7973-2020; Coura-Vital, Wendel/AAP-9624-2021	Reis, Alexandre Barbosa/0000-0001-8123-4164; Roatt, Bruno M/0000-0001-5281-3263; de Oliveira Aguiar-Soares, Rodrigo Dian/0000-0001-8705-7357; OLIVEIRA, LASER/0000-0002-9918-932X; Correa-Oliveira, Rodrigo/0000-0001-6419-9459; /0000-0002-1434-7676; Machado, Evandro/0000-0003-2786-7117	Federal University of Ouro Preto; Brazilian Ministry of Health; DECIT/MS/CNPq/BR [576062/2008-1]; FAPEMIG/BR [CBB-APQ-3073-4.01/07]; CNPq/BR [472554/2007-7]; PPSUS/MS/CNPq/FAPEMIG/SES-MG [CBB-APQ-00356-10]; FAPEMIG/PPM; PNPD; CNPq; PNPD/CAPES	Federal University of Ouro Preto; Brazilian Ministry of Health; DECIT/MS/CNPq/BR(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG/BR(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq/BR(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PPSUS/MS/CNPq/FAPEMIG/SES-MG(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FAPEMIG/PPM; PNPD; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PNPD/CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by the following grants: Federal University of Ouro Preto; Brazilian Ministry of Health; DECIT/MS/CNPq/BR/grant: 576062/2008-1; FAPEMIG/BR/grant: CBB-APQ-3073-4.01/07, CNPq/BR/grant: 472554/2007-7; PPSUS/MS/CNPq/FAPEMIG/SES-MG/grant CBB-APQ-00356-10; FAPEMIG/PPM and PNPD/Institutional/2011. The funders had no role in the study design, the data collection and analysis, the decision to publish the manuscript, or the preparation of the manuscript. ABR, MC, and RCO are grateful for CNPq fellowships. WCV is supported by a PNPD/CAPES postdoctoral fellowship.	Alves AS, 2012, RES VET SCI, V93, P1329, DOI 10.1016/j.rvsc.2012.07.006; Barata RA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/405083; Brasil 2011. Ministerio da Sadde, 2011, 012011CGDTCGLABDEVIT; CAMARGO MARIO E., 1966, REV INST MED TROP SAO PAULO, V8, P227; Malaquias LCC, 2007, PARASITOL RES, V100, P233, DOI 10.1007/s00436-006-0259-z; Coura-Vital W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071833; Coura-Vital W, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001291; Courtenay O, 2002, J INFECT DIS, V186, P1314, DOI 10.1086/344312; Da Costa RT, 2003, T ROY SOC TROP MED H, V97, P678; da Silva DA, 2013, VET J, V195, P252, DOI 10.1016/j.tvjl.2012.06.010; da Silva ES, 2006, VET RES COMMUN, V30, P637, DOI 10.1007/s11259-006-3324-2; de Arruda MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069988; do Rosario EY, 2005, MEM I OSWALDO CRUZ, V100, P197, DOI 10.1590/S0074-02762005000200015; Falqueto A, 2009, AM J TROP MED HYG, V80, P559, DOI 10.4269/ajtmh.2009.80.559; Ferreira ED, 2007, VET PARASITOL, V146, P235, DOI 10.1016/j.vetpar.2007.02.015; Figueiredo FB, 2010, REV INST MED TROP SP, V52, P193, DOI 10.1590/S0036-46652010000400005; Fraga DBM, 2012, VET PARASITOL, V190, P591, DOI 10.1016/j.vetpar.2012.06.025; Giunchetti RC, 2006, J COMP PATHOL, V135, P100, DOI 10.1016/j.jcpa.2006.06.005; Grimaldi G, 2012, AM J TROP MED HYG, V86, P966, DOI 10.4269/ajtmh.2012.12-0040; Grimaldi G, 2012, T ROY SOC TROP MED H, V106, P54, DOI 10.1016/j.trstmh.2011.10.001; Lira RA, 2006, VET PARASITOL, V137, P11, DOI 10.1016/j.vetpar.2005.12.020; Maia Z, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001484; Marcondes M, 2013, VET PARASITOL, V197, P649, DOI 10.1016/j.vetpar.2013.07.013; Ministerio da Saude, 2006, MAN VIG CONTR LEISHM; MOLINA R, 1994, T ROY SOC TROP MED H, V88, P491, DOI 10.1016/0035-9203(94)90446-4; Michalsky EM, 2007, VET PARASITOL, V147, P67, DOI 10.1016/j.vetpar.2007.03.004; Costa CHN, 2011, REV SOC BRAS MED TRO, V44, P232, DOI 10.1590/S0037-86822011005000014; Nunes CM, 2008, VET PARASITOL, V153, P19, DOI 10.1016/j.vetpar.2008.01.005; Porrozzi R, 2007, CLIN VACCINE IMMUNOL, V14, P544, DOI 10.1128/CVI.00420-06; Quinnell RJ, 2001, PARASITOLOGY, V122, P253, DOI 10.1017/S0031182001007363; Quinnell RJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001992; Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584; Romero HD, 2009, AM J TROP MED HYG, V81, P27; Scalone A, 2002, VET PARASITOL, V104, P275, DOI 10.1016/S0304-4017(01)00643-4; Silva DA, 2011, VET PARASITOL, V179, P257, DOI 10.1016/j.vetpar.2011.01.048; WHO, 2010, WORKING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: FIRST WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1	36	49	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91009	10.1371/journal.pone.0091009	http://dx.doi.org/10.1371/journal.pone.0091009			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608904	Green Published, Green Submitted, gold			2022-12-25	WOS:000332485800079
J	Johnson, GA; Ellis, EA; Kim, H; Muthukrishnan, N; Snavely, T; Pellois, JP				Johnson, Gregory A.; Ellis, E. Ann; Kim, Hansoo; Muthukrishnan, Nandhini; Snavely, Thomas; Pellois, Jean-Philippe			Photoinduced Membrane Damage of E-coli and S-aureus by the Photosensitizer-Antimicrobial Peptide Conjugate Eosin-(KLAKLAK)(2)	PLOS ONE			English	Article							CARE-ASSOCIATED INFECTIONS; GRAM-NEGATIVE BACTERIA; PHOTODYNAMIC THERAPY; LIPID-COMPOSITION; METHYLENE-BLUE; SINGLET OXYGEN; CELL-MEMBRANES; BASIC PEPTIDES; ACIDIC LIPIDS; CHAIN-LENGTH	Background/Objectives: Upon irradiation with visible light, the photosensitizer-peptide conjugate eosin-(KLAKLAK)(2) kills a broad spectrum of bacteria without damaging human cells. Eosin-(KLAKLAK)(2) therefore represents an interesting lead compound for the treatment of local infection by photodynamic bacterial inactivation. The mechanisms of cellular killing by eosin-(KLAKLAK)(2), however, remain unclear and this lack of knowledge hampers the development of optimized therapeutic agents. Herein, we investigate the localization of eosin-(KLAKLAK)(2) in bacteria prior to light treatment and examine the molecular basis for the photodynamic activity of this conjugate. Methodology/Principal Findings: By employing photooxidation of 3,3-diaminobenzidine (DAB), (scanning) transmission electron microscopy ((S)TEM), and energy dispersive X-ray spectroscopy (EDS) methodologies, eosin-(KLAKLAK)(2) is visualized at the surface of E. coli and S. aureus prior to photodynamic irradiation. Subsequent irradiation leads to severe membrane damage. Consistent with these observations, eosin-(KLAKLAK)(2) binds to liposomes of bacterial lipid composition and causes liposomal leakage upon irradiation. The eosin moiety of the conjugate mediates bacterial killing and lipid bilayer leakage by generating the reactive oxygen species singlet oxygen and superoxide. In contrast, the (KLAKLAK)(2) moiety targets the photosensitizer to bacterial lipid bilayers. In addition, while (KLAKLAK)(2) does not disrupt intact liposomes, the peptide accelerates the leakage of photo-oxidized liposomes. Conclusions/Significance: Together, our results suggest that (KLAKLAK)(2) promotes the binding of eosin Y to bacteria cell walls and lipid bilayers. Subsequent light irradiation results in membrane damage from the production of both Type I & II photodynamic products. Membrane damage by oxidation is then further aggravated by the (KLAKLAK)(2) moiety and membrane lysis is accelerated by the peptide. These results therefore establish how photosensitizer and peptide act in synergy to achieve bacterial photo-inactivation. Learning how to exploit and optimize this synergy should lead to the development of future bacterial photoinactivation agents that are effective at low concentrations and at low light doses.	[Johnson, Gregory A.; Muthukrishnan, Nandhini; Snavely, Thomas; Pellois, Jean-Philippe] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Ellis, E. Ann; Kim, Hansoo] Texas A&M Univ, Microscopy & Imaging Ctr, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Pellois, JP (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	pellois@tamu.edu	Muthukrishnan, Nandhini/P-8906-2018	Pellois, Jean-Philippe/0000-0001-8528-4652	Robert A. Welch Foundation [A-1769]; Norman Hackerman Advanced Research Program [E55F9EE7-E488-6873-7D535561D9B426B8]	Robert A. Welch Foundation(The Welch Foundation); Norman Hackerman Advanced Research Program	This work was supported by the Robert A. Welch Foundation (Grant A-1769) (http://www.welch1.org/) and the Norman Hackerman Advanced Research Program (http://www.thecb.state.tx.us/index.cfm?objectid = E55F9EE7-E488-6873-7D535561D9B426B8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009; Allan David, 1994, Trends in Cell Biology, V4, P350, DOI 10.1016/0962-8924(94)90076-0; Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; Azad MA, 2011, ANTIMICROB AGENTS CH, V55, P2137, DOI 10.1128/AAC.01148-10; Batistela VR, 2011, SPECTROCHIM ACTA A, V79, P889, DOI 10.1016/j.saa.2011.03.027; Bourbigot S, 2009, BIOPOLYMERS, V91, P1, DOI 10.1002/bip.21071; Bourre L, 2010, PHOTOCH PHOTOBIO SCI, V9, P1613, DOI 10.1039/c0pp00146e; Braham P, 2009, J PERIODONTOL, V80, P1790, DOI 10.1902/jop.2009.090214; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Costa DCS, 2012, PHOTOCH PHOTOBIO SCI, V11, P1905, DOI 10.1039/c2pp25113b; Cronan JE, 2003, ANNU REV MICROBIOL, V57, P203, DOI 10.1146/annurev.micro.57.030502.090851; Dai T, 2009, PHOTODIAGN PHOTODYN, V6, P170, DOI 10.1016/j.pdpdt.2009.10.008; DEERINCK TJ, 1994, J CELL BIOL, V126, P901, DOI 10.1083/jcb.126.4.901; Demidova TN, 2004, INT J IMMUNOPATH PH, V17, P245, DOI 10.1177/039463200401700304; Ellis EA, 2006, MICROSCOPY TODAY, V14, P50; EVANS WH, 1985, BIOCHEM J, V232, P33, DOI 10.1042/bj2320033; Fomina AF, 2003, EXP CELL RES, V291, P150, DOI 10.1016/S0014-4827(03)00372-0; Gad F, 2004, PHOTOCH PHOTOBIO SCI, V3, P451, DOI 10.1039/b311901g; Gaietta GM, 2011, COLD SPRING HARBOR P, V2011; Girotti AW, 2001, J PHOTOCH PHOTOBIO B, V63, P103, DOI 10.1016/S1011-1344(01)00207-X; Girotti AW, 1998, J LIPID RES, V39, P1529; Gribble GJ, 2000, ENVIRON SCI POLLUT R, V7, P37, DOI 10.1065/espr199910.002; Hamblin MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI 10.1039/b311900a; Hamblin MR, 2002, J ANTIMICROB CHEMOTH, V49, P941, DOI 10.1093/jac/dkf053; Hashimoto MCE, 2012, PHOTOCHEM PHOTOBIOL, V88, P590, DOI 10.1111/j.1751-1097.2012.01137.x; Hawrani A, 2008, J BIOL CHEM, V283, P18636, DOI 10.1074/jbc.M709154200; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; INGRAHAM LM, 1981, J CELL BIOL, V89, P510, DOI 10.1083/jcb.89.3.510; Javadpour MM, 1996, J MED CHEM, V39, P3107, DOI 10.1021/jm9509410; Johnson GA, 2013, MICROSC MICROANAL, V19, P2026; Johnson GA, 2013, BIOCONJUGATE CHEM, V24, P114, DOI 10.1021/bc3005254; JOYCE GH, 1970, J BACTERIOL, V104, P323, DOI 10.1128/JB.104.1.323-330.1970; Kempf M, 2012, INT J ANTIMICROB AG, V39, P105, DOI 10.1016/j.ijantimicag.2011.10.004; Kharkwal GB, 2011, LASER SURG MED, V43, P755, DOI 10.1002/lsm.21080; Ki V, 2008, CAN J INFECT DIS MED, V19, P173, DOI 10.1155/2008/846453; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; KRALJIC I, 1978, PHOTOCHEM PHOTOBIOL, V28, P577, DOI 10.1111/j.1751-1097.1978.tb06972.x; Lakowicz J, 2006, PRINCIPLES FLUORESCE, DOI [DOI 10.1007/978-0-387-46312-4, 10.1007/978-0-387-46312-4]; Lambrechts SAG, 2005, PHOTOCH PHOTOBIO SCI, V4, P503, DOI 10.1039/b502125a; LAMOLA AA, 1973, SCIENCE, V179, P1131, DOI 10.1126/science.179.4078.1131; Lauro FM, 2002, PHOTOCH PHOTOBIO SCI, V1, P468, DOI 10.1039/b200977c; LEWIS BA, 1983, J MOL BIOL, V166, P211, DOI 10.1016/S0022-2836(83)80007-2; Magill SS, 2012, INFECT CONT HOSP EP, V33, P283, DOI 10.1086/664048; Maisch T, 2004, PHOTOCH PHOTOBIO SCI, V3, P907, DOI 10.1039/b407622b; Maisch T, 2011, J DTSCH DERMATOL GES, V9, P360, DOI 10.1111/j.1610-0387.2010.07577.x; MALIK Z, 1992, J PHOTOCH PHOTOBIO B, V14, P262, DOI 10.1016/1011-1344(92)85104-3; Meerovich I, 2013, BIOCHIM BIOPHYS ACTA, V1840, P507; Mishra NN, 2011, ANTIMICROB AGENTS CH, V55, P526, DOI 10.1128/AAC.00680-10; MOHR H, 1995, IMMUNOL INVEST, V24, P73, DOI 10.3109/08820139509062763; Morein S, 1996, J BIOL CHEM, V271, P6801, DOI 10.1074/jbc.271.12.6801; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Morley S, 2013, BRIT J DERMATOL, V168, P617, DOI 10.1111/bjd.12098; MOSIOR M, 1992, BIOCHEMISTRY-US, V31, P1767, DOI 10.1021/bi00121a026; MOSIOR M, 1992, BIOCHIM BIOPHYS ACTA, V1105, P185, DOI 10.1016/0005-2736(92)90178-O; Muthukrishnan N, 2013, PHOTOCHEM PHOTOBIOL, V89, P625, DOI 10.1111/php.12036; Muthukrishnan N, 2012, BBA-GEN SUBJECTS, V1820, P1734, DOI 10.1016/j.bbagen.2012.06.020; NAHAIE MR, 1984, J GEN MICROBIOL, V130, P2427; Natera JE, 2011, J PHOTOCH PHOTOBIO A, V220, P25, DOI 10.1016/j.jphotochem.2011.03.008; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020; Polo L, 2000, J PHOTOCH PHOTOBIO B, V59, P152, DOI 10.1016/S1011-1344(01)00114-2; POOLER JP, 1989, PHOTOCHEM PHOTOBIOL, V50, P55, DOI 10.1111/j.1751-1097.1989.tb04129.x; Pryor WA, 2006, AM J PHYSIOL-REG I, V291, pR491, DOI 10.1152/ajpregu.00614.2005; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Soukos NS, 1998, ANTIMICROB AGENTS CH, V42, P2595, DOI 10.1128/AAC.42.10.2595; Splith K, 2011, EUROPEAN BIOPHYSICS, P1; Srinivasan D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017732; TAMM LK, 1991, BIOCHIM BIOPHYS ACTA, V1071, P123, DOI 10.1016/0304-4157(91)90021-N; Tanaka M, 2012, PHOTOCHEM PHOTOBIOL, V88, P227, DOI 10.1111/j.1751-1097.2011.01005.x; Tardivo JP, 2005, PHOTODIAGN PHOTODYN, V2, P175, DOI 10.1016/S1572-1000(05)00097-9; Tavares A, 2011, PHOTOCHEMICAL PHOTOB, V10; Tegos GP, 2006, ANTIMICROB AGENTS CH, V50, P1402, DOI 10.1128/AAC.50.4.1402-1410.2006; Teixeira V, 2012, PROG LIPID RES, V51, P149, DOI 10.1016/j.plipres.2011.12.005; VALENZENO DP, 1982, PHOTOCHEM PHOTOBIOL, V35, P343; Vatansever F, 2013, FEMS MICROBIOL REV, V37, P955, DOI 10.1111/1574-6976.12026; Vera DM, 2012, PHOTOCHEM PHOTOBIOL; Virtanen JA, 1998, P NATL ACAD SCI USA, V95, P4964, DOI 10.1073/pnas.95.9.4964; Wainwright M, 2000, INT J ANTIMICROB AG, V16, P381, DOI 10.1016/S0924-8579(00)00207-7; Wainwright M, 1998, J ANTIMICROB CHEMOTH, V42, P13, DOI 10.1093/jac/42.1.13; Wainwright M, 2011, J PHOTOCH PHOTOBIO B, V105, P1, DOI 10.1016/j.jphotobiol.2011.06.002; Ward SK, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00063; WHITE DC, 1968, J BACTERIOL, V95, P2198, DOI 10.1128/JB.95.6.2198-2209.1968; Wimley WC, 2011, J MEMBRANE BIOL, V239, P27, DOI 10.1007/s00232-011-9343-0; Wu JS, 2013, ULTRAMICROSCOPY, V128, P24, DOI 10.1016/j.ultramic.2013.01.004; Yamakoshi Y, 2003, J AM CHEM SOC, V125, P12803, DOI 10.1021/ja0355574	85	34	34	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91220	10.1371/journal.pone.0091220	http://dx.doi.org/10.1371/journal.pone.0091220			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608860	Green Published, Green Submitted, gold			2022-12-25	WOS:000332485800116
J	Labruijere, S; Stolk, L; Verbiest, M; de Vries, R; Garrelds, IM; Eilers, PHC; Danser, AHJ; Uitterlinden, AG; MaassenVanDenBrink, A				Labruijere, Sieneke; Stolk, Lisette; Verbiest, Michael; de Vries, Rene; Garrelds, Ingrid M.; Eilers, Paul H. C.; Danser, A. H. Jan; Uitterlinden, Andre G.; MaassenVanDenBrink, Antoinette			Methylation of Migraine-Related Genes in Different Tissues of the Rat	PLOS ONE			English	Article							SPINAL TRIGEMINAL NUCLEUS; DNA METHYLATION; EPIGENETIC REGULATION; ESTROGEN-RECEPTOR; SEX-HORMONES; CGRP; EXPRESSION; HEADACHE; MODULATION; CELLS	17 beta-Estradiol, an epigenetic modulator, is involved in the increased prevalence of migraine in women. Together with the prophylactic efficacy of valproate, which influences DNA methylation and histone modification, this points to the involvement of epigenetic mechanisms. Epigenetic studies are often performed on leukocytes, but it is unclear to what extent methylation is similar in other tissues. Therefore, we investigated methylation of migraine-related genes that might be epigenetically regulated (CGRP-ergic pathway, estrogen receptors, endothelial NOS, as well as MTHFR) in different migraine-related tissues and compared this to methylation in rat as well as human leukocytes. Further, we studied whether 17 beta-estradiol has a prominent role in methylation of these genes. Female rats (n = 35) were ovariectomized or sham-operated and treated with 17 beta-estradiol or placebo. DNA was isolated and methylation was assessed through bisulphite treatment and mass spectrometry. Human methylation data were obtained using the Illumina 450k genome-wide methylation array in 395 female subjects from a population-based cohort study. We showed that methylation of the Crcp, Calcrl, Esr1 and Nos3 genes is tissue-specific and that methylation in leukocytes was not correlated to that in other tissues. Interestingly, the interindividual variation in methylation differed considerably between genes and tissues. Furthermore we showed that methylation in human leukocytes was similar to that in rat leukocytes in our genes of interest, suggesting that rat may be a good model to study human DNA methylation in tissues that are difficult to obtain. In none of the genes a significant effect of estradiol treatment was observed.	[Labruijere, Sieneke; de Vries, Rene; Garrelds, Ingrid M.; Danser, A. H. Jan; MaassenVanDenBrink, Antoinette] Erasmus MC, Div Pharmacol, Dept Internal Med, Rotterdam, Netherlands; [Stolk, Lisette; Verbiest, Michael; Uitterlinden, Andre G.] Erasmus MC, Genet Lab, Dept Internal Med, Rotterdam, Netherlands; [Eilers, Paul H. C.] Erasmus MC, Dept Biostat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	MaassenVanDenBrink, A (corresponding author), Erasmus MC, Div Pharmacol, Dept Internal Med, Rotterdam, Netherlands.	a.vanharen-maassenvandenbrink@erasmusmc.nl	Danser, Jan/GLR-1479-2022	Maassen van den Brink, Antoinette/0000-0001-7176-126X	Netherlands Organisation of Scientific Research NWO [175.010.2005.011, 911-03-012]; Netherlands Genomics Initiative (NGI)/NWO [050-060-810]; Erasmus Medical Center, Rotterdam; Erasmus University, Rotterdam; Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; Netherlands Organization for Scientific Research (Vidi) [917-11-349]; Netherlands Organisation for the Health Research and development (ZonMw)	Netherlands Organisation of Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative (NGI)/NWO(Netherlands Organization for Scientific Research (NWO)); Erasmus Medical Center, Rotterdam; Erasmus University, Rotterdam; Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Netherlands Organization for Scientific Research (Vidi)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for the Health Research and development (ZonMw)	The generation and management of genomics data for the Rotterdam Study is supported by the Netherlands Organisation of Scientific Research NWO investments (nr. 175.010.2005.011, 911-03-012) and the Netherlands Genomics Initiative (NGI)/NWO project nr. 050-060-810 (Netherlands Consortium for Healthy Aging; NCHA). The Rotterdam Study is funded by the Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organisation for the Health Research and development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII) and the Municipality of Rotterdam. Dr. Antoinette MaassenVanDenBrink was supported by the Netherlands Organization for Scientific Research (Vidi grant 917-11-349). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranyi T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-431; Bailey KA, 2013, J BIOCHEM MOL TOXIC, V27, P106, DOI 10.1002/jbt.21462; Bergman Y, 2013, NAT STRUCT MOL BIOL, V20, P274, DOI 10.1038/nsmb.2518; Bijron Jonathan G, 2012, Expert Opin Med Diagn, V6, P421, DOI 10.1517/17530059.2012.702105; Brailoiu E, 2007, J ENDOCRINOL, V193, P311, DOI 10.1677/JOE-07-0017; Brooks JTS, 2009, J APPL PHYSIOL, V106, P212, DOI 10.1152/japplphysiol.90578.2008; Byun HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039220; CARL GF, 1986, NEUROCHEM RES, V11, P671, DOI 10.1007/BF00965336; Chen CCM, 2009, HUM GENET, V125, P591, DOI 10.1007/s00439-009-0652-7; Crescenti A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065744; Doshi T, 2011, TOXICOLOGY, V289, P74, DOI 10.1016/j.tox.2011.07.011; Dumeaux V, 2006, MOL CANCER THER, V5, P868, DOI 10.1158/1535-7163.MCT-05-0329; Durham P, 2013, HEADACHE, V53, P1262, DOI 10.1111/head.12174; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Edvinsson L, 2011, MOL CELL NEUROSCI, V46, P333, DOI 10.1016/j.mcn.2010.10.005; Eftekhari S, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-112; Eftekhari Sajedeh, 2010, Ther Adv Neurol Disord, V3, P369, DOI 10.1177/1756285610388343; Eising E, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-26; Fehrenbacher JC, 2009, BRAIN RES REV, V60, P114, DOI 10.1016/j.brainresrev.2008.12.019; FINKELSTEIN JD, 1978, ARCH BIOCHEM BIOPHYS, V191, P153, DOI 10.1016/0003-9861(78)90077-2; Gentilini D, 2013, AGE, V35, P1961, DOI 10.1007/s11357-012-9463-1; Goadsby PJ, 2002, NEW ENGL J MED, V346, P257, DOI 10.1056/NEJMra010917; Green CD, 2011, EPIGENOMICS-UK, V3, P59, DOI 10.2217/EPI.10.75; Guo SW, 2012, MOL CELL ENDOCRINOL, V358, P185, DOI 10.1016/j.mce.2011.10.025; Gupta S, 2007, HEADACHE, V47, P225, DOI 10.1111/j.1526-4610.2006.00526.x; Ho TW, 2010, NAT REV NEUROL, V6, P573, DOI 10.1038/nrneurol.2010.127; Hofman A, 2011, EUR J EPIDEMIOL, V26, P657, DOI 10.1007/s10654-011-9610-5; Imamura T, 2011, HORM BEHAV, V59, P345, DOI 10.1016/j.yhbeh.2010.05.018; Jenkins NT, 2011, J APPL PHYSIOL, V111, P929, DOI 10.1152/japplphysiol.00541.2011; Jiao J, 2013, MOL PSYCHIATR, V18, P1273, DOI 10.1038/mp.2012.136; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kolodkin MH, 2011, J NEUROENDOCRINOL, V23, P577, DOI 10.1111/j.1365-2826.2011.02147.x; Kvisvik EV, 2011, J HEADACHE PAIN, V12, P443, DOI 10.1007/s10194-011-0329-1; LAMSON G, 1989, DEV BIOL, V132, P62, DOI 10.1016/0012-1606(89)90204-2; Lenz KM, 2013, J NEUROSCI, V33, P2761, DOI 10.1523/JNEUROSCI.1268-12.2013; Li D, 2008, PEPTIDES, V29, P1781, DOI 10.1016/j.peptides.2008.06.010; Lindsey SH, 2009, ENDOCRINOLOGY, V150, P3753, DOI 10.1210/en.2008-1664; Manev H, 2002, EUR J PHARMACOL, V445, P149, DOI 10.1016/S0014-2999(02)01711-9; Mathers JC, 2006, MECH AGEING DEV, V127, P584, DOI 10.1016/j.mad.2006.01.018; McHale CM, 2009, GENOMICS, V93, P343, DOI 10.1016/j.ygeno.2008.12.006; Momparler RL, 2000, J CELL PHYSIOL, V183, P145, DOI 10.1002/(SICI)1097-4652(200005)183:2<145::AID-JCP1>3.0.CO;2-V; Moussaoui S, 1996, NEUROPEPTIDES, V30, P546, DOI 10.1016/S0143-4179(96)90037-2; Novensa L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025335; Nyholt DR, 2004, GENET EPIDEMIOL, V26, P231, DOI 10.1002/gepi.10311; Oterino A, 2010, HEADACHE, V50, P99, DOI 10.1111/j.1526-4610.2009.01484.x; Pardutz A, 2002, EUR J NEUROSCI, V15, P1803, DOI 10.1046/j.1460-9568.2002.02031.x; Park KY, 2008, J BIOL CHEM, V283, P5441, DOI 10.1074/jbc.M708662200; Park KY, 2011, CEPHALALGIA, V31, P614, DOI 10.1177/0333102410391487; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; RCORE TEAM, 2012, R LANG ENV STAT COMP; Scariano JK, 2008, J RECEPT SIG TRANSD, V28, P285, DOI [10.1080/10799890802084614, 10.1080/10799890802084614 ]; Schurks M, 2010, HEADACHE, V50, P588, DOI 10.1111/j.1526-4610.2009.01570.x; Silberstein S, 1999, NEUROLOGY, V53, pS3; Soubry A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-29; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Stovner LJ, 2010, J HEADACHE PAIN, V11, P289, DOI 10.1007/s10194-010-0217-0; Summers T, 2013, J CANCER, V4, P210, DOI 10.7150/jca.5839; Terry MB, 2011, EPIGENETICS-US, V6, P828, DOI 10.4161/epi.6.7.16500; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wessman M, 2007, LANCET NEUROL, V6, P521, DOI 10.1016/S1474-4422(07)70126-6; Zhang B, 2013, GENOME RES, V23, P1522, DOI 10.1101/gr.156539.113; Zhang Y, 2013, NEUROPSYCHOPHARMACOL, V38, P111, DOI 10.1038/npp.2012.149; Zhao ZR, 2010, P NATL ACAD SCI USA, V107, P5605, DOI 10.1073/pnas.0910578107	63	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e87616	10.1371/journal.pone.0087616	http://dx.doi.org/10.1371/journal.pone.0087616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609082	Green Published, gold, Green Submitted			2022-12-25	WOS:000332485800001
J	Nodale, C; Ceccarelli, S; Giuliano, M; Cammarota, M; D'Amici, S; Vescarelli, E; Maffucci, D; Bellati, F; Panici, PB; Romano, F; Angeloni, A; Marchese, C				Nodale, Cristina; Ceccarelli, Simona; Giuliano, Mariateresa; Cammarota, Marcella; D'Amici, Sirio; Vescarelli, Enrica; Maffucci, Diana; Bellati, Filippo; Panici, Pierluigi Benedetti; Romano, Ferdinando; Angeloni, Antonio; Marchese, Cinzia			Gene Expression Profile of Patients with Mayer-Rokitansky-Kuster-Hauser Syndrome: New Insights into the Potential Role of Developmental Pathways	PLOS ONE			English	Article							BETA-CATENIN; MURCS ASSOCIATION; COLORECTAL-CANCER; ALAGILLE-SYNDROME; HUMAN JAGGED1; MUTATIONS; WNT; APLASIA; VAGINA; NOTCH1	Mayer-Rokitansky-Kuster-Hauser syndrome (MRKHS) is a rare disease characterized by congenital aplasia of uterus and vagina. Although many studies have investigated several candidate genes, up to now none of them seem to be responsible for the aetiology of the syndrome. In our study, we identified differences in gene expression profile of in vitro cultured vaginal tissue of MRHKS patients using whole-genome microarray analysis. A group of eight out of sixteen MRKHS patients that underwent reconstruction of neovagina with an autologous in vitro cultured vaginal tissue were subjected to microarray analysis and compared with five healthy controls. Results obtained by array were confirmed by qRT-PCR and further extended to other eight MRKHS patients. Gene profiling of MRKHS patients delineated 275 differentially expressed genes, of which 133 downregulated and 142 upregulated. We selected six deregulated genes (MUC1, HOXC8, HOXB2, HOXB5, JAG1 and DLL1) on the basis of their fold change, their differential expression in most patients and their relevant role in embryological development. All patients showed upregulation of MUC1, while HOXB2 and HOXB5 were downregulated, as well as Notch ligands JAG1 and DLL1 in the majority of them. Interestingly, HOXC8 was significantly upregulated in 47% of patients, with a differential expression only in MRKHS type I patients. Taken together, our results highlighted the dysregulation of developmental genes, thus suggesting a potential alteration of networks involved in the formation of the female reproductive tract and providing a useful clue for understanding the pathophysiology of MRKHS.	[Nodale, Cristina; Ceccarelli, Simona; D'Amici, Sirio; Vescarelli, Enrica; Marchese, Cinzia] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Giuliano, Mariateresa; Cammarota, Marcella] Univ Naples 2, Biotechnol & Mol Biol Sect, Dept Expt Med, Naples, Italy; [Maffucci, Diana; Bellati, Filippo; Panici, Pierluigi Benedetti] Univ Roma La Sapienza, Dept Gynecol Obstetr & Urol Sci, I-00185 Rome, Italy; [Romano, Ferdinando] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, I-00185 Rome, Italy; [Angeloni, Antonio] Univ Roma La Sapienza, Dept Mol Med, I-00185 Rome, Italy	Sapienza University Rome; Universita della Campania Vanvitelli; Sapienza University Rome; Sapienza University Rome; Sapienza University Rome	Marchese, C (corresponding author), Univ Roma La Sapienza, Dept Expt Med, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	cinzia.marchese@uniroma1.it	Angeloni, Antonio/J-9392-2018; Marchese, Cinzia/J-1323-2018; Ceccarelli, Simona/J-4086-2018	Angeloni, Antonio/0000-0003-4969-9548; Ceccarelli, Simona/0000-0001-8789-7719; BENEDETTI PANICI, PIERLUIGI/0000-0001-6752-2039; Bellati, Filippo/0000-0002-2036-9951; Giuliano, Mariateresa/0000-0002-7338-9200; Cammarota, Marcella/0000-0002-6317-5436				Allard S, 2000, DEVELOPMENT, V127, P3349; BAIRD PA, 1974, AM J OBSTET GYNECOL, V118, P290, DOI 10.1016/0002-9378(74)90565-1; Bernardini L, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-25; Biason-Lauber A, 2007, HUM REPROD, V22, P224, DOI 10.1093/humrep/del360; Bulman MP, 2000, NAT GENET, V24, P438, DOI 10.1038/74307; Burell A, 2006, J NEGAT RESULTS BIOM, V5, DOI 10.1186/1477-5751-5-4; Chang XY, 2012, REPROD BIOMED ONLINE, V24, P630, DOI 10.1016/j.rbmo.2012.03.008; Contakos SP, 2005, DEV BIOL, V288, P294, DOI 10.1016/j.ydbio.2005.09.015; DUNCAN PA, 1979, J PEDIATR-US, V95, P399, DOI 10.1016/S0022-3476(79)80514-4; Duru Ugonna A, 2009, J Pediatr Adolesc Gynecol, V22, pe73, DOI 10.1016/j.jpag.2008.07.012; Gervasini C, 2010, GENET MED, V12, P634, DOI 10.1097/GIM.0b013e3181ed6185; GRIFFIN JE, 1976, ANN INTERN MED, V85, P224, DOI 10.7326/0003-4819-85-2-224; Hofstetter G, 2008, WIEN KLIN WOCHENSCHR, V120, P435, DOI 10.1007/s00508-008-0995-4; Hossain A, 2003, J BIOL CHEM, V278, P26511, DOI 10.1074/jbc.M300804200; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Huang L, 2003, CANCER BIOL THER, V2, P702; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Juan AH, 2006, ANN NY ACAD SCI, V1068, P87, DOI 10.1196/annals.1346.046; Kim HA, 2012, J CLIN INVEST, V122, P3248, DOI 10.1172/JCI61216; Kimberley N, 2012, J PEDIATR ADOL GYNEC, V25, P54, DOI 10.1016/j.jpag.2011.08.003; Kwon YJ, 2005, ANAT REC PART A, V283A, P187, DOI 10.1002/ar.a.20160; Ledig S, 2011, FERTIL STERIL, V95, P1589, DOI 10.1016/j.fertnstert.2010.07.1062; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Masse J, 2009, INT J DEV BIOL, V53, P411, DOI 10.1387/ijdb.082680jm; Morcel K, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-9; Nakamura T, 2007, J GASTROENTEROL, V42, P705, DOI 10.1007/s00535-007-2087-z; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Oppelt P, 2005, HUM REPROD, V20, P149, DOI 10.1093/humrep/deh547; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Rall K, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-32; Ravel C, 2009, FERTIL STERIL, V91, P1604, DOI 10.1016/j.fertnstert.2008.12.006; Rodilla V, 2009, P NATL ACAD SCI USA, V106, P6315, DOI 10.1073/pnas.0813221106; SCHMIDTANNWALD I, 1977, GEBURTSH FRAUENHEILK, V37, P386; Tracy MR, 2004, CLIN ORTHOP RELAT R, P183, DOI 10.1097/01.blo.0000132067.49895.20; Turner KJ, 2003, TOXICOL SCI, V74, P114, DOI 10.1093/toxsci/kfg096	35	18	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91010	10.1371/journal.pone.0091010	http://dx.doi.org/10.1371/journal.pone.0091010			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608967	Green Submitted, Green Published, gold			2022-12-25	WOS:000332485800080
J	Sullivan, PS; Peterson, J; Rosenberg, ES; Kelley, CF; Cooper, H; Vaughan, A; Salazar, LF; Frew, P; Wingood, G; DiClemente, R; del Rio, C; Mulligan, M; Sanchez, TH				Sullivan, Patrick S.; Peterson, John; Rosenberg, Eli S.; Kelley, Colleen F.; Cooper, Hannah; Vaughan, Adam; Salazar, Laura F.; Frew, Paula; Wingood, Gina; DiClemente, Ralph; del Rio, Carlos; Mulligan, Mark; Sanchez, Travis H.			Understanding Racial HIV/STI Disparities in Black and White Men Who Have Sex with Men: A Multilevel Approach	PLOS ONE			English	Article							HIV-INFECTION; RISK; SURVEILLANCE; PARTNERS; MSM	Background: The reasons for black/white disparities in HIV epidemics among men who have sex with men have puzzled researchers for decades. Understanding reasons for these disparities requires looking beyond individual-level behavioral risk to a more comprehensive framework. Methods and Findings: From July 2010-Decemeber 2012, 803 men (454 black, 349 white) were recruited through venue-based and online sampling; consenting men were provided HIV and STI testing, completed a behavioral survey and a sex partner inventory, and provided place of residence for geocoding. HIV prevalence was higher among black (43%) versus white (13% MSM (prevalence ratio (PR) 3.3, 95% confidence interval (CI): 2.5-4.4). Among HIV-positive men, the median CD4 count was significantly lower for black (490 cells/mu L) than white (577 cells/mu L) MSM; there was no difference in the HIV RNA viral load by race. Black men were younger, more likely to be bisexual and unemployed, had less educational attainment, and reported fewer male sex partners, fewer unprotected anal sex partners, and less non-injection drug use. Black MSM were significantly more likely than white MSM to have rectal chlamydia and gonorrhea, were more likely to have racially concordant partnerships, more likely to have casual (one-time) partners, and less likely to discuss serostatus with partners. The census tracts where black MSM lived had higher rates of poverty and unemployment, and lower median income. They also had lower proportions of male-male households, lower male to female sex ratios, and lower HIV diagnosis rates. Conclusions: Among black and white MSM in Atlanta, disparities in HIV and STI prevalence by race are comparable to those observed nationally. We identified differences between black and white MSM at the individual, dyadic/sexual network, and community levels. The reasons for black/white disparities in HIV prevalence in Atlanta are complex, and will likely require a multilevel framework to understand comprehensively.	[Sullivan, Patrick S.; Rosenberg, Eli S.; Vaughan, Adam; Sanchez, Travis H.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Peterson, John] Georgia State Univ, Dept Psychol, Atlanta, GA 30303 USA; [Kelley, Colleen F.; Frew, Paula; Mulligan, Mark] Emory Univ, Sch Med, Dept Infect Dis, Atlanta, GA USA; [Cooper, Hannah; Wingood, Gina; DiClemente, Ralph] Emory Univ, Dept Behav Sci & Hlth Educ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Salazar, Laura F.] Georgia State Univ, Inst Publ Hlth, Atlanta, GA 30303 USA; [del Rio, Carlos] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health; University System of Georgia; Georgia State University; Emory University; Emory University; Rollins School Public Health; University System of Georgia; Georgia State University; Emory University; Rollins School Public Health	Sullivan, PS (corresponding author), Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.	pssulli@emory.edu	Frew, Paula M./B-4774-2012; Kelley, Colleen F/O-4819-2016; del Rio, Carlos/B-3763-2012; Mulligan, Mark/V-9275-2019	Frew, Paula M./0000-0002-3078-9124; Kelley, Colleen F/0000-0001-5611-0119; del Rio, Carlos/0000-0002-0153-3517; sanchez, travis/0000-0003-1133-4762; Sullivan, Patrick Sean/0000-0002-7728-0587	National Institute of Mental Health [R01MH085600]; National Institute of Minority Health and Health Disparities [RC1MD004370]; Eunice Kennedy Shriver National Institute for Child Health and Human Development [R01HD067111]; National Institute of Drug Abuse [R01DA029513]; National Institute of Allergy and Infectious Diseases, Emory Center for AIDS Research [P30AI050409]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000454]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067111] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [RC1MD004370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI108335, P30AI050409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029513] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Eunice Kennedy Shriver National Institute for Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Allergy and Infectious Diseases, Emory Center for AIDS Research; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding was provided by the National Institute of Mental Health (R01MH085600), National Institute of Minority Health and Health Disparities (RC1MD004370), Eunice Kennedy Shriver National Institute for Child Health and Human Development (R01HD067111), National Institute of Drug Abuse (R01DA029513), National Institute of Allergy and Infectious Diseases (P30AI050409)-Emory Center for AIDS Research, and the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR000454. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SEX TRANSM DIS SURV; [Anonymous], 4 CDCP; [Anonymous], 60 ONLINE ADULTS USE; [Anonymous], J ACQUIRED IMMUNE DE; [Anonymous], HIV GAY BIS MEN; [Anonymous], SEX TECH; [Anonymous], HIV TEST ALG STAT RE; [Anonymous], 14 INT AIDS C BARC S; [Anonymous], GEORG HIV SURV DAT D; [Anonymous], UNEQUAL OPPORTUNITY; [Anonymous], J URBAN HLTH; [Anonymous], GEORG STD EP 2012 ST; [Anonymous], AIDS BEHAV; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; BRONFENBRENNER U, 1994, PSYCHOL REV, V101, P568, DOI 10.1037/0033-295X.101.4.568; Caliendo A M, 2005, Infect Dis Obstet Gynecol, V13, P145, DOI 10.1080/10647440500068248; Centers for Disease Control and Prevention, 2011, HIV SURV REP, V23; Chan ISF, 1999, BIOMETRICS, V55, P1202, DOI 10.1111/j.0006-341X.1999.01202.x; Crucitti T, 2011, CLIN VACCINE IMMUNOL, V18, P1480, DOI 10.1128/CVI.05069-11; Goodreau SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050522; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Kelley CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053284; Kennedy BP, 1998, BRIT MED J, V317, P917; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070413; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; MacKellar DA, 2007, PUBLIC HEALTH REP, V122, P39, DOI 10.1177/00333549071220S107; Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b; Millett GA, 2006, AM J PUBLIC HEALTH, V96, P1007, DOI 10.2105/AJPH.2005.066720; Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X; Morris M, 2004, NETWORK EPIDEMIOLOGY; Oster AM, 2011, AIDS, V25, P1103, DOI 10.1097/QAD.0b013e3283471efa; PORTNOY J, 1957, PUBLIC HEALTH REP, V72, P761, DOI 10.2307/4589890; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Purcell David W, 2012, Open AIDS J, V6, P98, DOI 10.2174/1874613601206010098; Raymond HF, 2009, AIDS BEHAV, V13, P630, DOI 10.1007/s10461-009-9574-6; Rosenberg ES, 2012, SEX TRANSM DIS, V39, P741, DOI 10.1097/OLQ.0b013e31825ec09b; Rosenberg ES, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-189; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Sanchez Travis, 2006, Morbidity and Mortality Weekly Report, V55, P1; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; Su JR, 2011, ANN INTERN MED, V155, P145, DOI 10.7326/0003-4819-155-3-201108020-00004; Sullivan PS, 2009, AIDS, V23, P1153, DOI 10.1097/QAD.0b013e32832baa34; van der Pol B, 2001, J CLIN MICROBIOL, V39, P1008, DOI 10.1128/JCM.39.3.1008-1016.2001; Winter AK, 2012, JAIDS-J ACQ IMM DEF, V60, P525, DOI 10.1097/QAI.0b013e318257d0ac	44	152	152	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90514	10.1371/journal.pone.0090514	http://dx.doi.org/10.1371/journal.pone.0090514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4IY	24608176	Green Published, gold, Green Submitted			2022-12-25	WOS:000332485800029
J	Thomson, IR; Darveau, CA; Bertram, SM				Thomson, Ian R.; Darveau, Charles-A.; Bertram, Susan M.			Body Morphology, Energy Stores, and Muscle Enzyme Activity Explain Cricket Acoustic Mate Attraction Signaling Variation	PLOS ONE			English	Article							CONDITION-DEPENDENT TRAITS; FEMALE FIELD CRICKETS; FLIGHT MUSCLES; CALLING SONG; INTRASPECIFIC VARIATION; GRYLLUS-BIMACULATUS; METABOLIC-RATE; INSECT FLIGHT; BOMBUS-IMPATIENS; ACHETA-DOMESTICA	High mating success in animals is often dependent on males signalling attractively with high effort. Since males should be selected to maximize their reproductive success, female preferences for these traits should result in minimal signal variation persisting in the population. However, extensive signal variation persists. The genic capture hypothesis proposes genetic variation persists because fitness-conferring traits depend on an individual's basic processes, including underlying physiological, morphological, and biochemical traits, which are themselves genetically variable. To explore the traits underlying signal variation, we quantified among-male differences in signalling, morphology, energy stores, and the activities of key enzymes associated with signalling muscle metabolism in two species of crickets, Gryllus assimilis (chirper: <20 pulses/chirp) and G. texensis (triller: >20 pulses/chirp). Chirping G. assimilis primarily fuelled signalling with carbohydrate metabolism: smaller individuals and individuals with increased thoracic glycogen stores signalled for mates with greater effort; individuals with greater glycogen phosphorylase activity produced more attractive mating signals. Conversely, the more energetic trilling G. texensis fuelled signalling with both lipid and carbohydrate metabolism: individuals with increased beta-hydroxyacyl-CoA dehydrogenase activity and increased thoracic free carbohydrate content signalled for mates with greater effort; individuals with higher thoracic and abdominal carbohydrate content and higher abdominal lipid stores produced more attractive signals. Our findings suggest variation in male reproductive success may be driven by hidden physiological trade-offs that affect the ability to uptake, retain, and use essential nutrients, although the results remain correlational in nature. Our findings indicate that a physiological perspective may help us to understand some of the causes of variation in behaviour.	[Thomson, Ian R.; Bertram, Susan M.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Darveau, Charles-A.] Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada	Carleton University; University of Ottawa	Bertram, SM (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada.	Sue.Bertram@carleton.ca			Natural Sciences and Engineering Research Council (NSERC) of Canada; Canada Foundation for Innovation; Infrastructure Operating Fund	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Infrastructure Operating Fund	This research was supported by individual Discovery Grants from the Natural Sciences and Engineering Research Council (NSERC) of Canada and equipment grants from Canada Foundation for Innovation and Infrastructure Operating Fund to SMB and CAD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RD, 1962, EVOLUTION, V16, P443, DOI 10.1111/j.1558-5646.1962.tb03236.x; Alexander RD, 1957, ANN ENTOMOL SOC AM, V50, P585; BEENAKKE.AM, 1969, J INSECT PHYSIOL, V15, P353, DOI 10.1016/0022-1910(69)90281-9; BEENAKKERS AMT, 1984, INSECT BIOCHEM, V14, P243, DOI 10.1016/0020-1790(84)90057-X; Benjamini Y, 2001, ANN STAT, V29, P1165; Bertram SM, 2011, ANIM BEHAV, V82, P1255, DOI 10.1016/j.anbehav.2011.08.021; Bertram SM, 2000, ANIM BEHAV, V60, P333, DOI 10.1006/anbe.2000.1473; Bertram SM, 2005, ANIM BEHAV, V70, P477, DOI 10.1016/j.anbehav.2004.09.024; Bertram SM, 2007, EVOL ECOL RES, V9, P975; Bertram SM, 2006, ANIM BEHAV, V72, P899, DOI 10.1016/j.anbehav.2006.02.012; Bertram SM, 2012, ECOL EVOL, V2, P181, DOI 10.1002/ece3.76; CADE W, 1975, SCIENCE, V190, P1312, DOI 10.1126/science.190.4221.1312; Cade W, 1979, SEXUAL SELECTION REP, P343; CADE WH, 1992, ANIM BEHAV, V43, P49, DOI 10.1016/S0003-3472(05)80070-3; CADE WH, 1991, J INSECT BEHAV, V4, P185, DOI 10.1007/BF01054611; CADE WH, 1981, SCIENCE, V212, P563, DOI 10.1126/science.212.4494.563; Candy DJ, 1997, COMP BIOCHEM PHYS B, V117, P497, DOI 10.1016/S0305-0491(97)00212-5; CHUDAKOV.IV, 1968, DOKL AKAD NAUK SSSR+, V179, P489; Crnokrak P, 1995, ANIM BEHAV, V50, P1475, DOI 10.1016/0003-3472(95)80004-2; Darveau C-A, 2013, J EXP BIOL IN PRESS; Fisher R.A., 1930, GENETICAL THEORY NAT; Garcia-Berthou E, 2001, J ANIM ECOL, V70, P708, DOI 10.1046/j.1365-2656.2001.00524.x; GOULD SJ, 1975, CONTRIB PRIMATOL, V5, P244; Harper G, 2000, J ANIM SCI, V13, P318; Harrison S, 2013, ECOL LETT UNPUB; HEDRICK AV, 1988, AM NAT, V132, P267, DOI 10.1086/284849; Hill GE, 2011, ECOL LETT, V14, P625, DOI 10.1111/j.1461-0248.2011.01622.x; Holzer B, 2003, BEHAV ECOL, V14, P353, DOI 10.1093/beheco/14.3.353; HOULE D, 1992, GENETICS, V130, P195; Hunt J, 2004, NATURE, V432, P1024, DOI 10.1038/nature03084; Judge KA, 2008, EVOLUTION, V62, P868, DOI 10.1111/j.1558-5646.2008.00318.x; Kaufmann C, 2008, J INSECT PHYSIOL, V54, P367, DOI 10.1016/j.jinsphys.2007.10.007; Kotiaho JS, 1999, OIKOS, V87, P399, DOI 10.2307/3546755; Lorenz MW, 2003, COMP BIOCHEM PHYS B, V136, P197, DOI 10.1016/S1096-4959(03)00227-6; Maklakov AA, 2008, CURR BIOL, V18, P1062, DOI 10.1016/j.cub.2008.06.059; Martin SD, 2000, CAN J ZOOL, V78, P706, DOI 10.1139/cjz-78-5-706; Miyoshi AR, 2007, IHERINGIA SER ZOOL, V97, P461, DOI 10.1590/S0073-47212007000400016; Norin T, 2012, PHYSIOL BIOCHEM ZOOL, V85, P645, DOI 10.1086/665982; Norin T, 2011, J EXP BIOL, V214, P1668, DOI 10.1242/jeb.054205; O'Brien DM, 2001, J EXP ZOOL, V290, P108, DOI 10.1002/jez.1040; Popov A, 1977, J COMP PHYSIOL A, V126, P111; PRESTWICH KN, 1994, AM ZOOL, V34, P625, DOI 10.1093/icb/34.6.625; Roff DA, 2003, J EVOLUTION BIOL, V16, P55, DOI 10.1046/j.1420-9101.2003.00480.x; Roff DA, 1999, EVOLUTION, V53, P216, DOI 10.1111/j.1558-5646.1999.tb05347.x; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; SHIGA S, 1991, J EXP BIOL, V155, P661; SIMMONS LW, 1988, ANIM BEHAV, V36, P380, DOI 10.1016/S0003-3472(88)80009-5; SIMONEAU JA, 1986, CLIN PHYSIOL, V6, P347, DOI 10.1111/j.1475-097X.1986.tb00240.x; Skandalis DA, 2012, PHYSIOL BIOCHEM ZOOL, V85, P657, DOI 10.1086/665568; Skandalis DA, 2011, J INSECT PHYSIOL, V57, P704, DOI 10.1016/j.jinsphys.2011.02.001; SRIHARI T, 1975, J INSECT PHYSIOL, V21, P1, DOI 10.1016/0022-1910(75)90062-1; Suarez RK, 2005, J EXP BIOL, V208, P3573, DOI 10.1242/jeb.01775; Tomkins JL, 2002, ANIM BEHAV, V63, P1009, DOI 10.1006/anbe.2001.1994; Tomkins JL, 2004, TRENDS ECOL EVOL, V19, P323, DOI 10.1016/j.tree.2004.03.029; Wagner WE, 1996, BEHAV ECOL, V7, P279, DOI 10.1093/beheco/7.3.279; WAGNER WE, 1995, ANIM BEHAV, V49, P1269, DOI 10.1006/anbe.1995.0159; WALKER THOMAS J., 1957, ANN ENT SOC AMER, V50, P626; WALKER TJ, 1962, EVOLUTION, V16, P407, DOI 10.2307/2406176; Whattam EM, 2011, ANIM BEHAV, V81, P135, DOI 10.1016/j.anbehav.2010.09.024; Winchell R, 2000, J INSECT PHYSIOL, V46, P1365, DOI 10.1016/S0022-1910(00)00055-X; Zera AJ, 1999, J INSECT PHYSIOL, V45, P275, DOI 10.1016/S0022-1910(98)00123-1; Zera AJ, 1997, PHYSIOL ZOOL, V70, P519, DOI 10.1086/515865	62	17	17	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90409	10.1371/journal.pone.0090409	http://dx.doi.org/10.1371/journal.pone.0090409			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608102	gold, Green Submitted, Green Published			2022-12-25	WOS:000332485800025
J	Reisinger, KW; Kramer, BW; Van der Zee, DC; Brouwers, HAA; Buurman, WA; van Heurn, E; Derikx, JPM				Reisinger, Kostan W.; Kramer, Boris W.; Van der Zee, David C.; Brouwers, Hens A. A.; Buurman, Wim A.; van Heurn, Ernest; Derikx, Joep P. M.			Non-Invasive Serum Amyloid A (SAA) Measurement and Plasma Platelets for Accurate Prediction of Surgical Intervention in Severe Necrotizing Enterocolitis (NEC)	PLOS ONE			English	Article							ACID-BINDING PROTEIN; EARLY-DIAGNOSIS; CALPROTECTIN; PHLEBOTOMY; DISEASE; MARKER	Objective: To evaluate the value of biomarkers to detect severe NEC. Summary Background Data: The time point of surgery in necrotizing enterocolitis (NEC) is critical. Therefore, there is a need for markers that detect severe NEC, because clinical signs of severe NEC often develop late. This study evaluated the value of biomarkers reflecting intestinal cell damage and inflammation to detect severe NEC. Methods: 29 neonates with NEC were included. Two definitions of moderate versus severe NEC were analyzed: medical NEC (n = 12) versus surgical or fatal NEC (n = 17); and Bell stage II NEC (n = 13) versus stage III NEC (n = 16). Urinary intestinal fatty acid binding protein (I-FABP), serum amyloid A (SAA), C3a and C5a, and fecal calprotectin were measured. C-reactive protein (CRP), white blood cell count (WBC) and platelet count data were measured in blood. Results: In both definitions of moderate versus severe NEC, urinary SAA levels were significantly higher in severe NEC. A cutoff value of 34.4 ng/ml was found in surgical NEC versus medical NEC (sensitivity, 83%; specificity, 83%; LR+, 4.88 (95% CI, 1.37-17.0); LR-, 0.20 (95% CI, 0.07-0.60)) at diagnosis of NEC and at one day prior to surgery in neonates who were operated later on. Combination of urinary SAA and platelet count increased the accuracy, with a sensitivity, 94%; specificity, 83%; LR+, 5.53 (95% CI, 1.57-20.0); and LR-, 0.07 (95% CI, 0.01-0.48). Conclusion: Urinary SAA is an accurate marker in differentiating severe NEC from moderate NEC; particularly if combined with serum platelet count.	[Reisinger, Kostan W.; van Heurn, Ernest; Derikx, Joep P. M.] Maastricht Univ, Med Ctr, Dept Surg, Maastricht, Netherlands; [Reisinger, Kostan W.; van Heurn, Ernest; Derikx, Joep P. M.] Nutr & Toxicol Res Inst NUTRIM, Maastricht, Netherlands; [Kramer, Boris W.] Maastricht Univ, Med Ctr, Dept Pediat, Maastricht, Netherlands; [Kramer, Boris W.] Sch Mental Hlth & Neurosci, Sch Oncol & Dev Biol GROW, Maastricht, Netherlands; [Van der Zee, David C.] Univ Med Ctr, Wilhelmina Childrens Hosp, Dept Surg, Utrecht, Netherlands; [Brouwers, Hens A. A.] Univ Med Ctr, Wilhelmina Childrens Hosp, Dept Neonatol, Utrecht, Netherlands; [Buurman, Wim A.] NUTRIM Inst, Dept Surg, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Maastricht University	Reisinger, KW (corresponding author), Maastricht Univ, Med Ctr, Dept Surg, Maastricht, Netherlands.	k.reisinger@maastrichtuniversity.nl	Kramer, Boris/AAO-3183-2021	derikx, joep/0000-0003-0694-7679	AGIKO-stipendium from The Netherlands Organization for Health Research and Development [920-03-438]; Stichting Sint Annadal, Maastricht, the Netherlands	AGIKO-stipendium from The Netherlands Organization for Health Research and Development; Stichting Sint Annadal, Maastricht, the Netherlands(Netherlands Government)	Supported by AGIKO-stipendium 920-03-438 from The Netherlands Organization for Health Research and Development (to JPMD); and by Stichting Sint Annadal, Maastricht, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydemir C, 2011, EARLY HUM DEV, V87, P659, DOI 10.1016/j.earlhumdev.2011.05.004; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Bisquera JA, 2002, PEDIATRICS, V109, P423, DOI 10.1542/peds.109.3.423; Bossuyt PM, 2003, CLIN CHEM, V49, P7, DOI 10.1373/49.1.7; Carroll D, 2003, LANCET, V361, P310, DOI 10.1016/S0140-6736(03)12333-1; Cetinkaya M, 2011, J PEDIATR SURG, V46, P1482, DOI 10.1016/j.jpedsurg.2011.03.069; Cetinkaya M, 2010, PEDIATR SURG INT, V26, P835, DOI 10.1007/s00383-010-2635-0; Edelson MB, 1999, J PEDIATR SURG, V34, P1453, DOI 10.1016/S0022-3468(99)90102-1; Eras Z, 2011, J CLIN LAB ANAL, V25, P233, DOI 10.1002/jcla.20464; Evennett NJ, 2010, J PEDIATR SURG, V45, P735, DOI 10.1016/j.jpedsurg.2009.09.024; Fagerhol MK, 2000, LANCET, V356, P1783, DOI 10.1016/S0140-6736(00)03224-4; Kenton Alexander B, 2005, J Perinatol, V25, P14, DOI 10.1038/sj.jp.7211180; Khoo AK, 2008, EUR J PEDIATR SURG, V18, P419, DOI 10.1055/s-2008-1038908; Lin JC, 2000, PEDIATRICS, V106, part. no., DOI 10.1542/peds.106.2.e19; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; MALLE E, 1993, ATHEROSCLEROSIS, V102, P131, DOI 10.1016/0021-9150(93)90155-N; MEEK RL, 1989, AM J PATHOL, V135, P411; MORECROFT JA, 1994, J PEDIATR SURG, V29, P798, DOI 10.1016/0022-3468(94)90374-3; Moss RL, 2006, NEW ENGL J MED, V354, P2225, DOI 10.1056/NEJMoa054605; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Ng EWY, 2013, ANN SURG, V258, P1111, DOI 10.1097/SLA.0b013e318288ea96; Ng PC, 2010, J CLIN INVEST, V120, P2989, DOI 10.1172/JCI40196; Schlapbach LJ, 2011, GUT, V60, P1438, DOI 10.1136/gut.2010.226027; SMOLLER BR, 1986, NEW ENGL J MED, V314, P1233, DOI 10.1056/NEJM198605083141906; STRAUSS RG, 1995, IMMUNOL INVEST, V24, P341, DOI 10.3109/08820139509062784; Tayman C, 2011, TOHOKU J EXP MED, V224, P143, DOI 10.1620/tjem.224.143; Thuijls G, 2010, ANN SURG, V251, P1174, DOI 10.1097/SLA.0b013e3181d778c4; Veer GV, 2006, CLIN CHEM LAB MED, V44, P292, DOI 10.1515/CCLM.2006.051; Ververidis M, 2001, J PEDIATR SURG, V36, P799, DOI 10.1053/jpsu.2001.22964; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179, DOI 10.1016/s0031-3955(16)34975-6	30	32	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90834	10.1371/journal.pone.0090834	http://dx.doi.org/10.1371/journal.pone.0090834			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603723	Green Submitted, Green Published, gold			2022-12-25	WOS:000332483600090
J	Martinez, A; Peluffo, G; Petruk, AA; Hugo, M; Pineyro, D; Demicheli, V; Moreno, DM; Lima, A; Batthyany, C; Duran, R; Robello, C; Marti, MA; Larrieux, N; Buschiazzo, A; Trujillo, M; Radi, R; Piacenza, L				Martinez, Alejandra; Peluffo, Gonzalo; Petruk, Ariel A.; Hugo, Martin; Pineyro, Dolores; Demicheli, Veronica; Moreno, Diego M.; Lima, Analia; Batthyany, Carlos; Duran, Rosario; Robello, Carlos; Marti, Marcelo A.; Larrieux, Nicole; Buschiazzo, Alejandro; Trujillo, Madia; Radi, Rafael; Piacenza, Lucia			Structural and Molecular Basis of the Peroxynitrite-mediated Nitration and Inactivation of Trypanosoma cruzi Iron-Superoxide Dismutases ( Fe-SODs) A and B DISPARATE SUSCEPTIBILITIES DUE TO THE REPAIR OF TYR35 RADICAL BY CYS83 IN Fe-SODB THROUGH INTRAMOLECULAR ELECTRON TRANSFER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Free Radicals; Nitric Oxide; Oxidation-Reduction; Superoxide Dismutase (SOD); Trypanosome; Trypanosoma cruzi; Nitration; Peroxynitrite; Superoxide	NITRIC-OXIDE; TYROSINE NITRATION; CYTOCHROME-C; CRYSTAL-STRUCTURE; CARBON-DIOXIDE; TRYPAREDOXIN PEROXIDASES; TRANSFER RATES; PROTEIN; MANGANESE; KINETICS	Background: Superoxide dismutases are inactivated by peroxynitrite. Results:T. cruzi cytosolic Fe-SODB is highly resistant toward peroxynitrite-mediated tyrosine nitration and inactivation as compared with mitochondrial Fe-SODA. Conclusion: Intramolecular electron transfer in Fe-SODB from Cys(83) to critical Tyr(35) prevents enzyme nitration and inactivation. Significance: Disparate susceptibilities of Fe-SODs to peroxynitrite can influence parasite virulence during T. cruzi infection of mammalian cells. Trypanosoma cruzi, the causative agent of Chagas disease, contains exclusively iron-dependent superoxide dismutases (Fe-SODs) located in different subcellular compartments. Peroxynitrite, a key cytotoxic and oxidizing effector biomolecule, reacted with T. cruzi mitochondrial (Fe-SODA) and cytosolic (Fe-SODB) SODs with second order rate constants of 4.6 +/- 0.2 x 10(4) m(-1) s(-1) and 4.3 +/- 0.4 x 10(4) m(-1) s(-1) at pH 7.4 and 37 degrees C, respectively. Both isoforms are dose-dependently nitrated and inactivated by peroxynitrite. Susceptibility of T. cruzi Fe-SODA toward peroxynitrite was similar to that reported previously for Escherichia coli Mn- and Fe-SODs and mammalian Mn-SOD, whereas Fe-SODB was exceptionally resistant to oxidant-mediated inactivation. We report mass spectrometry analysis indicating that peroxynitrite-mediated inactivation of T. cruzi Fe-SODs is due to the site-specific nitration of the critical and universally conserved Tyr(35). Searching for structural differences, the crystal structure of Fe-SODA was solved at 2.2 resolution. Structural analysis comparing both Fe-SOD isoforms reveals differences in key cysteines and tryptophan residues. Thiol alkylation of Fe-SODB cysteines made the enzyme more susceptible to peroxynitrite. In particular, Cys(83) mutation (C83S, absent in Fe-SODA) increased the Fe-SODB sensitivity toward peroxynitrite. Molecular dynamics, electron paramagnetic resonance, and immunospin trapping analysis revealed that Cys(83) present in Fe-SODB acts as an electron donor that repairs Tyr(35) radical via intramolecular electron transfer, preventing peroxynitrite-dependent nitration and consequent inactivation of Fe-SODB. Parasites exposed to exogenous or endogenous sources of peroxynitrite resulted in nitration and inactivation of Fe-SODA but not Fe-SODB, suggesting that these enzymes play distinctive biological roles during parasite infection of mammalian cells.	[Martinez, Alejandra; Peluffo, Gonzalo; Hugo, Martin; Pineyro, Dolores; Demicheli, Veronica; Batthyany, Carlos; Robello, Carlos; Trujillo, Madia; Radi, Rafael; Piacenza, Lucia] Univ Republica, Fac Med, Dept Bioquim, Montevideo 11800, Uruguay; [Martinez, Alejandra; Peluffo, Gonzalo; Hugo, Martin; Pineyro, Dolores; Demicheli, Veronica; Batthyany, Carlos; Robello, Carlos; Trujillo, Madia; Radi, Rafael; Piacenza, Lucia] Univ Republica, Fac Med, Ctr Free Radical & Biomed Res, Montevideo 11800, Uruguay; [Pineyro, Dolores; Robello, Carlos] Inst Pasteur Montevideo IIBCE, Mol Biol Unit, Montevideo 11400, Uruguay; [Larrieux, Nicole; Buschiazzo, Alejandro] Inst Pasteur Montevideo IIBCE, Unit Prot Crystallog, Montevideo 11400, Uruguay; [Lima, Analia; Batthyany, Carlos; Duran, Rosario] Inst Pasteur Montevideo IIBCE, Unit Analyt Biochem & Prote, Montevideo 11400, Uruguay; [Buschiazzo, Alejandro] Inst Pasteur, Dept Struct Biol & Chem, F-75015 Paris, France; [Petruk, Ariel A.; Marti, Marcelo A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, INQUIMAE CONICET, Buenos Aires, DF, Argentina; [Petruk, Ariel A.; Marti, Marcelo A.] Univ Buenos Aires, Dept Quim Biol, INQUIMAE CONICET, Buenos Aires, DF, Argentina; [Petruk, Ariel A.] CONICET UNT, Inst Quim Noroeste Argentino, San Miguel De Tucuman, Argentina; [Moreno, Diego M.] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Inst Quim Rosario IQUIR CONICET, RA-2000 Rosario, Santa Fe, Argentina	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Instituto de Investigaciones Biologicas Clemente Estable Uruguay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Instituto de Investigaciones Biologicas Clemente Estable Uruguay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Instituto de Investigaciones Biologicas Clemente Estable Uruguay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Radi, R (corresponding author), Univ Republica, Fac Med, Dept Bioquim, Montevideo 11800, Uruguay.	rradi@fmed.edu.uy; lpiacenza@fmed.edu.uy	Hugo, Martín/AAW-8351-2020; Lima, Analía/ABD-7806-2022; ROBELLO, CARLOS/M-5609-2019; Durán, Rosario/GQH-8502-2022; Buschiazzo, Alejandro/W-1095-2018	Hugo, Martín/0000-0003-3430-6457; ROBELLO, CARLOS/0000-0001-6985-6171; Buschiazzo, Alejandro/0000-0002-2509-6526; Moreno, Diego/0000-0001-5493-8537; Lima, Analia/0000-0002-1855-2327; Marti, Marcelo/0000-0002-7911-9340; Martinez D'Alto, Alejandra/0000-0002-1850-7446; Duran, Rosario/0000-0002-8575-9651; Batthyany, Carlos/0000-0002-0627-1982; Trujillo, Madia/0000-0003-2087-017X	National Institutes of Health [1R01AI095173]; Universidad de la Republica (CSIC, Uruguay); PEDECIBA (Progama de Desarrollo de Ciencias Basicas, Uruguay); CeBEM (Centro de Biolog a Estructural del Mercosur); Agencia Nacional de Investigacion e Innovacion (ANII, Uruguay); Biriden; ASM; Ridaline through Fundacion Manuel Perez, Facultad de Medicina, Universidad de la Republica; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095173] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Universidad de la Republica (CSIC, Uruguay); PEDECIBA (Progama de Desarrollo de Ciencias Basicas, Uruguay); CeBEM (Centro de Biolog a Estructural del Mercosur); Agencia Nacional de Investigacion e Innovacion (ANII, Uruguay); Biriden; ASM; Ridaline through Fundacion Manuel Perez, Facultad de Medicina, Universidad de la Republica; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01AI095173. This work was also supported by a grant from the Universidad de la Republica (CSIC, Uruguay) (to R. R.) and by PEDECIBA (Progama de Desarrollo de Ciencias Basicas, Uruguay) and CeBEM (Centro de Biolog a Estructural del Mercosur).; Supported by a fellowship from the Agencia Nacional de Investigacion e Innovacion (ANII, Uruguay).; Supported by Biriden, ASM, and Ridaline through Fundacion Manuel Perez, Facultad de Medicina, Universidad de la Republica.	Abriata LA, 2009, J BIOL CHEM, V284, P17, DOI 10.1074/jbc.M807203200; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alvarez B, 1999, J BIOL CHEM, V274, P842, DOI 10.1074/jbc.274.2.842; Alvarez-Paggi D, 2010, J AM CHEM SOC, V132, P5769, DOI 10.1021/ja910707r; Aubert C, 1999, P NATL ACAD SCI USA, V96, P5423, DOI 10.1073/pnas.96.10.5423; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; BERATAN DN, 1992, SCIENCE, V258, P1740, DOI 10.1126/science.1334572; BERATAN DN, 1991, SCIENCE, V252, P1285, DOI 10.1126/science.1656523; Bhattacharjee S, 2007, J AM CHEM SOC, V129, P13493, DOI 10.1021/ja073349w; Boucher IW, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-20; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brito C, 1999, J IMMUNOL, V162, P3356; Carballal S, 2014, BBA-GEN SUBJECTS, V1840, P768, DOI 10.1016/j.bbagen.2013.07.005; Case D, 2006, AMBER 9; Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845, DOI 10.1080/07391102.1999.10508297; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cordes M, 2008, ANGEW CHEM INT EDIT, V47, P3461, DOI 10.1002/anie.200705588; Crow JP, 1997, J NEUROCHEM, V69, P1936; CROW JP, 1995, BIOCHEMISTRY-US, V34, P3544, DOI 10.1021/bi00011a008; Demicheli V, 2007, FREE RADICAL BIO MED, V42, P1359, DOI 10.1016/j.freeradbiomed.2007.01.034; Denicola A, 1996, ARCH BIOCHEM BIOPHYS, V333, P49, DOI 10.1006/abbi.1996.0363; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FASMAN GD, 1976, HDB BIOCH MOL BIOL, V1, P305; Ferrer-Sueta G, 2009, ACS CHEM BIOL, V4, P161, DOI 10.1021/cb800279q; Ford E, 2002, FREE RADICAL BIO MED, V32, P1314, DOI 10.1016/S0891-5849(02)00850-X; FORMAN HJ, 1973, ARCH BIOCHEM BIOPHYS, V158, P396, DOI 10.1016/0003-9861(73)90636-X; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; GATTI RM, 1994, FEBS LETT, V348, P287, DOI 10.1016/0014-5793(94)00625-3; Ghafourifar P, 1999, J BIOL CHEM, V274, P31185, DOI 10.1074/jbc.274.44.31185; Giese B, 2008, CURR OPIN CHEM BIOL, V12, P755, DOI 10.1016/j.cbpa.2008.08.026; GRACEFFA P, 1983, ARCH BIOCHEM BIOPHYS, V225, P802, DOI 10.1016/0003-9861(83)90092-9; Guan Y, 1998, BIOCHEMISTRY-US, V37, P4722, DOI 10.1021/bi972394l; Hellman U, 2000, EXS, V88, P43; HUGHES MN, 1970, BIOCHIM BIOPHYS ACTA, V222, P660, DOI 10.1016/0304-4165(70)90192-3; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P431, DOI 10.1016/0003-9861(92)90431-U; Ismail SO, 1997, MOL BIOCHEM PARASIT, V86, P187, DOI 10.1016/S0166-6851(97)00032-7; KIERSZENBAUM F, 1974, J IMMUNOL, V112, P1839; Koppenol WH, 1998, CHEM RES TOXICOL, V11, P87, DOI 10.1021/tx970200x; KOPPENOL WH, 1992, CHEM RES TOXICOL, V5, P834, DOI 10.1021/tx00030a017; Leach A. R., 2001, MOL MODELLING PRINCI; Lepesheva GI, 2011, ADV PARASIT, V75, P65, DOI 10.1016/B978-0-12-385863-4.00004-6; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Ly HK, 2010, CHEMPHYSCHEM, V11, P1225, DOI 10.1002/cphc.200900966; Lymar SV, 1996, CHEM RES TOXICOL, V9, P845, DOI 10.1021/tx960046z; MacMillanCrow LA, 1996, P NATL ACAD SCI USA, V93, P11853, DOI 10.1073/pnas.93.21.11853; MAPLES KR, 1988, DRUG METAB DISPOS, V16, P799; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Moreno DM, 2011, ARCH BIOCHEM BIOPHYS, V507, P304, DOI 10.1016/j.abb.2010.12.011; MUNOZFERNANDEZ MA, 1992, EUR J IMMUNOL, V22, P301, DOI 10.1002/eji.1830220203; Nicholls SJ, 2005, METHOD ENZYMOL, V396, P245, DOI 10.1016/S0076-6879(05)96022-9; Alvarez MN, 2011, J BIOL CHEM, V286, P6627, DOI 10.1074/jbc.M110.167247; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Peloso EF, 2012, ARCH BIOCHEM BIOPHYS, V520, P117, DOI 10.1016/j.abb.2012.02.020; Peskin AV, 2006, FREE RADICAL BIO MED, V40, P45, DOI 10.1016/j.freeradbiomed.2005.08.019; Petruk AA, 2012, ARCH BIOCHEM BIOPHYS, V525, P82, DOI 10.1016/j.abb.2012.05.012; Piacenza L, 2009, INT J PARASITOL, V39, P1455, DOI 10.1016/j.ijpara.2009.05.010; Piacenza L, 2008, BIOCHEM J, V410, P359, DOI 10.1042/BJ20071138; Piacenza L, 2007, BIOCHEM J, V403, P323, DOI 10.1042/BJ20061281; Pryor WA, 1997, FREE RADICAL BIO MED, V23, P331, DOI 10.1016/S0891-5849(97)00121-4; Quijano C, 2001, J BIOL CHEM, V276, P11631, DOI 10.1074/jbc.M009429200; Quint P, 2006, FREE RADICAL BIO MED, V40, P453, DOI 10.1016/j.freeradbiomed.2005.08.045; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; RADI R, 1994, ARCH BIOCHEM BIOPHYS, V308, P89, DOI 10.1006/abbi.1994.1013; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Radi R, 2013, J BIOL CHEM, V288, P26464, DOI 10.1074/jbc.R113.472936; Radi R, 2013, ACCOUNTS CHEM RES, V46, P550, DOI 10.1021/ar300234c; Reece SY, 2006, PHILOS T R SOC B, V361, P1351, DOI 10.1098/rstb.2006.1874; Reiter CD, 2000, J BIOL CHEM, V275, P32460, DOI 10.1074/jbc.M910433199; Romero N, 2003, J BIOL CHEM, V278, P44049, DOI 10.1074/jbc.M305895200; Bachega JFR, 2009, PROTEINS, V77, P26, DOI 10.1002/prot.22412; Sawa T, 2000, J BIOL CHEM, V275, P32467, DOI 10.1074/jbc.M910169199; Shih C, 2008, SCIENCE, V320, P1760, DOI 10.1126/science.1158241; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; STALLINGS WC, 1984, J BIOL CHEM, V259, P695; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; Surmeli NB, 2010, J AM CHEM SOC, V132, P17174, DOI 10.1021/ja105684w; Taylor MC, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-32; Temperton NJ, 1996, MOL BIOCHEM PARASIT, V76, P339, DOI 10.1016/0166-6851(95)02553-7; Tien M, 1999, P NATL ACAD SCI USA, V96, P7809, DOI 10.1073/pnas.96.14.7809; Trapani S, 2008, ACTA CRYSTALLOGR D, V64, P11, DOI 10.1107/S0907444907044460; Trujillo M, 2004, J BIOL CHEM, V279, P34175, DOI 10.1074/jbc.M404317200; Turko IV, 2005, METHOD ENZYMOL, V396, P266, DOI 10.1016/S0076-6879(05)96023-0; Urbina JA, 2010, ACTA TROP, V115, P55, DOI 10.1016/j.actatropica.2009.10.023; Valez V, 2013, ARCH BIOCHEM BIOPHYS, V529, P45, DOI 10.1016/j.abb.2012.10.012; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wilkinson SR, 2006, FREE RADICAL BIO MED, V40, P198, DOI 10.1016/j.freeradbiomed.2005.06.022; Witting PK, 2001, J BIOL CHEM, V276, P16540, DOI 10.1074/jbc.M011707200; Yamakura F, 1998, J BIOL CHEM, V273, P14085, DOI 10.1074/jbc.273.23.14085; Zou MH, 2000, ARCH BIOCHEM BIOPHYS, V376, P149, DOI 10.1006/abbi.2000.1699	92	43	44	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12760	12778		10.1074/jbc.M113.545590	http://dx.doi.org/10.1074/jbc.M113.545590			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24616096	Green Published, hybrid			2022-12-25	WOS:000335581400046
J	Wu, J; Bowe, DB; Sadlonova, A; Whisenhunt, TR; Hu, Y; Rustgi, AK; Nie, YZ; Paterson, AJ; Yang, XY				Wu, Jing; Bowe, Damon B.; Sadlonova, Andrea; Whisenhunt, Thomas R.; Hu, Yong; Rustgi, Anil K.; Nie, Yongzhan; Paterson, Andrew J.; Yang, Xiaoyong			O-GlcNAc Transferase Is Critical for Transducin-like Enhancer of Split ( TLE)-mediated Repression of CanonicalWntSignaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Silencing; O-GlcNAc; Signal Transduction; Transcription Repressor; Wnt Pathway; Groucho; TLE; OGT	CARBOXYL-TERMINAL DOMAIN; RNA-POLYMERASE-II; TRANSCRIPTIONAL REPRESSION; SUBSTRATE-SPECIFICITY; MEDIATED REPRESSION; ACTIVATION DOMAIN; WRPW MOTIF; IN-VIVO; GROUCHO; PROTEIN	Background: The molecular mechanisms by which Groucho/TLEs repress canonical Wnt signaling are incompletely understood. Results: OGT interacts with TLEs and facilitates TLE-mediated transcriptional repression. Removal of O-GlcNAc is essential for gene activation from Wnt-responsive promoters. Conclusion: OGT plays a vital role in TLE-mediated repression of Wnt signaling. Significance:O-GlcNAc modification has a profound influence on diverse signaling pathways. The Drosophila Groucho protein and its mammalian orthologues the transducin-like enhancers of split (TLEs) are critical transcriptional corepressors that repress Wnt and other signaling pathways. Although it is known that Groucho/TLEs are recruited to target genes by pathway-specific transcription factors, molecular events after the corepressor recruitment are largely unclear. We report that association of TLEs with O-GlcNAc transferase, an enzyme that catalyzes posttranslational modification of proteins by O-linked N-acetylglucosamine, is essential for TLE-mediated transcriptional repression. Removal of O-GlcNAc from Wnt-responsive gene promoters is critical for gene activation from Wnt-responsive promoters. Thus, these studies identify a molecular mechanism by which Groucho/TLEs repress gene transcription and provide a model whereby O-GlcNAc may control distinct intracellular signaling pathways.	[Wu, Jing] Xi An Jiao Tong Univ, Ctr Mitochondrial Biol & Med, Key Lab Biomed Informat Engn, Minist Educ,Sch Life Sci & Technol, Xian 710049, Peoples R China; [Wu, Jing] Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Xian 710049, Peoples R China; [Wu, Jing; Yang, Xiaoyong] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06519 USA; [Wu, Jing; Yang, Xiaoyong] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06519 USA; [Bowe, Damon B.; Whisenhunt, Thomas R.; Hu, Yong; Paterson, Andrew J.] Univ Alabama Birmingham, Div Endocrinol & Metab, Birmingham, AL 35294 USA; [Sadlonova, Andrea] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Nie, Yongzhan] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China; [Nie, Yongzhan] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian 710032, Shaanxi, Peoples R China; [Rustgi, Anil K.] Univ Penn, Dept Med GI & Genet, Abramson Canc Ctr, Philadelphia, PA 19104 USA	Xi'an Jiaotong University; Xi'an Jiaotong University; Yale University; Yale University; University of Alabama System; University of Alabama Birmingham; Emory University; Air Force Military Medical University; Air Force Military Medical University; University of Pennsylvania; Pennsylvania Medicine	Yang, XY (corresponding author), Yale Univ, Sch Med, Comparat Med Sect, 333 Cedar St, New Haven, CT 06519 USA.	xiaoyong.yang@yale.edu			National Institutes of Health Grants [R01 DK089098, P01 DK057751, DK043652]; Ellison Medical Foundation; National Natural Science Foundation of China Grant [81120108005/81225003]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043652, R01DK089098, P01DK057751, P30DK034989] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); National Natural Science Foundation of China Grant(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK089098 and P01 DK057751 (to X. Y.) and DK043652 (to A. J. P.). This work was also supported by a grant from the Ellison Medical Foundation (to X. Y.) and National Natural Science Foundation of China Grant 81120108005/81225003 (to Y. N.).	Arce L, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-159; Bowe DB, 2006, MOL CELL BIOL, V26, P8539, DOI 10.1128/MCB.01053-06; Buscarlet M, 2007, TRENDS CELL BIOL, V17, P353, DOI 10.1016/j.tcb.2007.07.002; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Cinnamon E, 2008, CURR OPIN GENET DEV, V18, P435, DOI 10.1016/j.gde.2008.07.010; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; DEHNI G, 1995, MECH DEVELOP, V53, P369, DOI 10.1016/0925-4773(95)00452-1; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Gasperowicz M, 2005, J CELL BIOCHEM, V95, P670, DOI 10.1002/jcb.20476; Grbavec D, 1998, EUR J BIOCHEM, V258, P339, DOI 10.1046/j.1432-1327.1998.2580339.x; Grbavec D, 1996, BIOCHEM BIOPH RES CO, V223, P701, DOI 10.1006/bbrc.1996.0959; Hanson AJ, 2012, MOL CELL, V45, P619, DOI 10.1016/j.molcel.2011.12.032; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Jennings BH, 2008, EMBO REP, V9, P76, DOI 10.1038/sj.embor.7401122; Jennings BH, 2006, MOL CELL, V22, P645, DOI 10.1016/j.molcel.2006.04.024; Jennings BH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-205; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, MOL CELL BIOL, V18, P1248, DOI 10.1128/MCB.18.3.1248; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Li MD, 2012, J BIOL CHEM, V287, P12904, DOI 10.1074/jbc.M111.303792; Li Steven Shoei-Lung, 2000, Proceedings of the National Science Council Republic of China Part B Life Sciences, V24, P47; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Nuthall HN, 2004, MOL CELL BIOL, V24, P8395, DOI 10.1128/MCB.24.19.8395-8407.2004; Olivier-Van Stichelen S, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.36; Olivier-Van Stichelen Stephanie, 2012, Am J Physiol Endocrinol Metab, V302, pE417, DOI 10.1152/ajpendo.00390.2011; Ozcan S, 2010, BBA-GENE REGUL MECH, V1799, P353, DOI 10.1016/j.bbagrm.2010.02.005; Pinto M, 1996, J BIOL CHEM, V271, P33026, DOI 10.1074/jbc.271.51.33026; Ranuncolo SM, 2012, J BIOL CHEM, V287, P23549, DOI 10.1074/jbc.M111.330910; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Sasaki T, 2003, CANCER RES, V63, P801; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Toleman C, 2004, J BIOL CHEM, V279, P53665, DOI 10.1074/jbc.M410406200; Wong KH, 2011, GENE DEV, V25, P2525, DOI 10.1101/gad.179275.111; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Xu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036717; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yang XY, 2001, P NATL ACAD SCI USA, V98, P6611, DOI 10.1073/pnas.111099998; Yochum GS, 2001, MOL CELL BIOL, V21, P4110, DOI 10.1128/MCB.21.13.4110-4118.2001	44	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					12168	12176		10.1074/jbc.M114.553859	http://dx.doi.org/10.1074/jbc.M114.553859			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24616106	hybrid, Green Published			2022-12-25	WOS:000335010600052
J	Acevedo, KM; Opazo, CM; Norrish, D; Challis, LM; Li, QX; White, AR; Bush, AI; Camakaris, J				Acevedo, Karla M.; Opazo, Carlos M.; Norrish, David; Challis, Leesa M.; Li, Qiao-Xin; White, Anthony R.; Bush, Ashley I.; Camakaris, James			Phosphorylation of Amyloid Precursor Protein at Threonine 668 Is Essential for Its Copper-responsive Trafficking in SH-SY5Y Neuroblastoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid Precursor Protein; Confocal Microscopy; Copper; Glycogen Synthase Kinase 3; Phosphorylation; Trafficking	GLYCOGEN-SYNTHASE KINASE-3; CYCLIN-DEPENDENT KINASE-5; SMALL-MOLECULE INHIBITORS; P-TYPE ATPASE; ALZHEIMERS-DISEASE; HIPPOCAMPAL-NEURONS; CYTOPLASMIC DOMAIN; BETA-PROTEIN; IN-VITRO; A-BETA	Background: The function, localization, and processing of the amyloid precursor protein (APP) is regulated by phosphorylation. Results: Copper promotes APP trafficking by phosphorylation at threonine 668 in SH-SY5Y cells. Conclusion: By promoting APP phosphorylation, copper regulates its intracellular localization. Significance: Understanding the role copper plays in regulating APP function in normal neuronal cells will provide insight into the interplay between copper and APP in normal and pathological conditions. Amyloid precursor protein (APP) undergoes post-translational modification, including O- and N-glycosylation, ubiquitination, and phosphorylation as it traffics through the secretory pathway. We have previously reported that copper promotes a change in the cellular localization of APP. We now report that copper increases the phosphorylation of endogenous APP at threonine 668 (Thr-668) in SH-SY5Y neuronal cells. The level of APPT668-p (detected using a phospho-site-specific antibody) exhibited a copper-dependent increase. Using confocal microscopy imaging we demonstrate that the phospho-deficient mutant, Thr-668 to alanine (T668A), does not exhibit detectable copper-responsive APP trafficking. In contrast, mutating a serine to an alanine at residue 655 does not affect copper-responsive trafficking. We further investigated the importance of the Thr-668 residue in copper-responsive trafficking by treating SH-SY5Y cells with inhibitors for glycogen synthase kinase 3- (GSK3) and cyclin-dependent kinases (Cdk), the main kinases that phosphorylate APP at Thr-668 in neurons. Our results show that the GSK3 kinase inhibitors LiCl, SB 216763, and SB 415286 prevent copper-responsive APP trafficking. In contrast, the Cdk inhibitors Purvalanol A and B had no significant effect on copper-responsive trafficking in SH-SY5Y cells. In cultured primary hippocampal neurons, copper promoted APP re-localization to the axon, and this effect was inhibited by the addition of LiCl, indicating that a lithium-sensitive kinase(s) is involved in copper-responsive trafficking in hippocampal neurons. This is consistent with APP axonal transport to the synapse, where APP is involved in a number of functions. We conclude that copper promotes APP trafficking by promoting a GSK3-dependent phosphorylation in SH-SY5Y cells.	[Acevedo, Karla M.; Norrish, David; Challis, Leesa M.; Camakaris, James] Univ Melbourne, Dept Genet, Melbourne, Vic 3010, Australia; [Opazo, Carlos M.; Bush, Ashley I.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Li, Qiao-Xin; White, Anthony R.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia	University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Camakaris, J (corresponding author), Univ Melbourne, Dept Genet, Melbourne, Vic 3010, Australia.	j.camakaris@unimelb.edu.au	Bush, Ashley I/A-1186-2007; Bush, Ashley/Y-2457-2019; White, Anthony/P-5596-2016	Bush, Ashley I/0000-0001-8259-9069; Bush, Ashley/0000-0001-8259-9069; Challis, Leesa/0000-0003-2113-0667; Acevedo, Karla/0000-0002-7996-3445; White, Anthony/0000-0003-1802-9891; Opazo, Carlos/0000-0003-3473-7548	National Health and Medical Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the National Health and Medical Research Council (to J. C.).	Acevedo KM, 2011, J BIOL CHEM, V286, P8252, DOI 10.1074/jbc.M110.128512; Ando K, 1999, J NEUROSCI, V19, P4421; Aplin AE, 1996, J NEUROCHEM, V67, P699; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Barbagallo APM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018006; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Bell KFS, 2008, NEUROBIOL AGING, V29, P554, DOI 10.1016/j.neurobiolaging.2006.11.004; Brodeur J, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-31; Cater MA, 2008, BIOCHEM J, V412, P141, DOI 10.1042/BJ20080103; Chang KA, 2006, MOL CELL BIOL, V26, P4327, DOI 10.1128/MCB.02393-05; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Crespo-Biel N, 2009, NEUROPHARMACOLOGY, V56, P422, DOI 10.1016/j.neuropharm.2008.09.012; Cross DAE, 2001, J NEUROCHEM, V77, P94, DOI 10.1046/j.1471-4159.2001.00251.x; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; El Ayadi A, 2012, P NATL ACAD SCI USA, V109, P13416, DOI 10.1073/pnas.1206786109; Feyt C, 2007, BIOCHEM BIOPH RES CO, V357, P1004, DOI 10.1016/j.bbrc.2007.04.036; Gray N, 1999, CURR MED CHEM, V6, P859; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Greenough M, 2004, AM J PHYSIOL-CELL PH, V287, pC1463, DOI 10.1152/ajpcell.00179.2004; Groemer TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018754; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hoe HS, 2012, CNS NEUROSCI THER, V18, P47, DOI 10.1111/j.1755-5949.2010.00221.x; HUNG AY, 1994, EMBO J, V13, P534, DOI 10.1002/j.1460-2075.1994.tb06291.x; Hung YH, 2009, J BIOL CHEM, V284, P21899, DOI 10.1074/jbc.M109.019521; Iijima K, 2000, J NEUROCHEM, V75, P1085, DOI 10.1046/j.1471-4159.2000.0751085.x; Inomata H, 2003, J BIOL CHEM, V278, P22946, DOI 10.1074/jbc.M212160200; Jorda EG, 2005, NEUROSCIENCE, V134, P1001, DOI 10.1016/j.neuroscience.2005.04.061; Garrido JJ, 2007, FEBS LETT, V581, P1579, DOI 10.1016/j.febslet.2007.03.018; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kimberly WT, 2005, J NEUROSCI, V25, P5533, DOI 10.1523/JNEUROSCI.4883-04.2005; King TD, 2006, BIOCHEM PHARMACOL, V71, P1637, DOI 10.1016/j.bcp.2006.03.005; Kins S, 2006, NEURODEGENER DIS, V3, P218, DOI 10.1159/000095259; KNOPS J, 1993, BIOCHEM BIOPH RES CO, V197, P380, DOI 10.1006/bbrc.1993.2490; Kremer A, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00017; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Liang MH, 2007, J BIOL CHEM, V282, P3904, DOI 10.1074/jbc.M605178200; Liu F, 2003, FEBS LETT, V547, P193, DOI 10.1016/S0014-5793(03)00714-2; Lucas FR, 1997, DEV BIOL, V192, P31, DOI 10.1006/dbio.1997.8734; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Lyckman AW, 1998, J BIOL CHEM, V273, P11100, DOI 10.1074/jbc.273.18.11100; Matsushima T, 2012, J BIOL CHEM, V287, P19715, DOI 10.1074/jbc.M111.334847; Maynard CJ, 2002, J BIOL CHEM, V277, P44670, DOI 10.1074/jbc.M204379200; Medina Miguel, 2011, Int J Alzheimers Dis, V2011, P479249, DOI 10.4061/2011/479249; Muresan Z, 2005, J CELL BIOL, V171, P615, DOI 10.1083/jcb.200502043; Muresan Z, 2005, J NEUROSCI, V25, P3741, DOI 10.1523/JNEUROSCI.0152-05.2005; Muresan Z, 2004, HUM MOL GENET, V13, P475, DOI 10.1093/hmg/ddh054; Muresan Z, 2007, MOL BIOL CELL, V18, P3835, DOI 10.1091/mbc.E06-07-0625; Musardo S, 2013, EUR J PHARMACOL, V719, P84, DOI 10.1016/j.ejphar.2013.07.019; Nakaya T, 2008, J BIOL CHEM, V283, P19119, DOI 10.1074/jbc.M801827200; Naumann N, 2010, HIPPOCAMPUS, V20, P971, DOI 10.1002/hipo.20693; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Oishi M, 1997, MOL MED, V3, P111, DOI 10.1007/BF03401803; PAHLSSON P, 1992, BIOCHEM BIOPH RES CO, V189, P1667, DOI 10.1016/0006-291X(92)90269-Q; Pahlsson P, 1996, ARCH BIOCHEM BIOPHYS, V331, P177, DOI 10.1006/abbi.1996.0296; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Pase L, 2004, BIOCHEM J, V378, P1031, DOI 10.1042/BJ20031181; Peineau S, 2008, BRIT J PHARMACOL, V153, pS428, DOI 10.1038/bjp.2008.2; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Ramelot TA, 2001, J MOL BIOL, V307, P871, DOI 10.1006/jmbi.2001.4535; Sano Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000051; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295, DOI 10.1074/jbc.271.31.18295; Siemes C, 2006, EXP CELL RES, V312, P1939, DOI 10.1016/j.yexcr.2006.02.025; SIMONS M, 1995, J NEUROSCI RES, V41, P121, DOI 10.1002/jnr.490410114; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Standen CL, 2001, J NEUROCHEM, V76, P316, DOI 10.1046/j.1471-4159.2001.00102.x; Steuble M, 2012, BIOL OPEN, V1, P761, DOI 10.1242/bio.20121578; Stys PK, 2012, J PHYSIOL-LONDON, V590, P1357, DOI 10.1113/jphysiol.2011.225276; SUZUKI T, 1994, EMBO J, V13, P1114, DOI 10.1002/j.1460-2075.1994.tb06360.x; Suzuki T, 1997, BIOCHEMISTRY-US, V36, P4643, DOI 10.1021/bi962618k; Suzuki T, 2008, J BIOL CHEM, V283, P29633, DOI 10.1074/jbc.R800003200; Taru H, 2002, J BIOL CHEM, V277, P20070, DOI 10.1074/jbc.M108372200; Treiber C, 2004, J BIOL CHEM, V279, P51958, DOI 10.1074/jbc.M407410200; Turski ML, 2012, MOL CELL BIOL, V32, P1284, DOI 10.1128/MCB.05722-11; Vagnoni A, 2013, HUM MOL GENET, V22, P4646, DOI 10.1093/hmg/ddt313; Vagnoni A, 2012, HUM MOL GENET, V21, P2845, DOI 10.1093/hmg/dds109; Veldhuis NA, 2009, INT J BIOCHEM CELL B, V41, P2403, DOI 10.1016/j.biocel.2009.06.008; Walter J, 1997, J BIOL CHEM, V272, P1896, DOI 10.1074/jbc.272.3.1896; Watanabe T, 2012, J NEUROSCI, V32, P3352, DOI 10.1523/JNEUROSCI.5659-11.2012; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; YAMAZAKI T, 1995, J CELL BIOL, V129, P431, DOI 10.1083/jcb.129.2.431; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007	85	34	34	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11007	11019		10.1074/jbc.M113.538710	http://dx.doi.org/10.1074/jbc.M113.538710			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24610780	Green Published, hybrid			2022-12-25	WOS:000334638500007
J	Michel, LYM; Verkaart, S; Koopman, WJH; Willems, PHGM; Hoenderop, JGJ; Bindels, RJM				Michel, Lauriane Y. M.; Verkaart, Sjoerd; Koopman, Werner J. H.; Willems, Peter H. G. M.; Hoenderop, Joost G. J.; Bindels, Rene J. M.			Function and Regulation of the Na (+) -Ca2+ Exchanger NCX3 Splice Variants in Brain and Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alternative Splicing; Calcium Transport; Endoplasmic Reticulum (ER); Excitotoxicity; Plasma Membrane; Sodium Calcium Exchange; Forward Mode; Muscle Fatigue; NCX; Reverse Mode	EPITHELIAL CA2+ CHANNEL; CARDIAC NA+-CA2+ EXCHANGER; SODIUM-CALCIUM EXCHANGE; NA+/CA2+ EXCHANGER; SODIUM/CALCIUM EXCHANGER; VENTRICULAR MYOCYTES; CA2+-BINDING DOMAIN; MUTATIONAL ANALYSIS; EXTRACELLULAR CA2+; SMOOTH-MUSCLE	Background: The Na+-Ca2+ exchanger isoform 3 (NCX3) participates in maintaining calcium homeostasis in brain and skeletal muscle. Results: The two splice variants of NCX3 have distinct regulation and capacity of exchange. Conclusion: Distinct calcium uptake capacity of muscle NCX3 suggests a novel function in muscle exercise physiology. Significance: This study brings a new understanding of the role of NCX3 variants in excitable tissues. Isoform 3 of the Na+-Ca2+ exchanger (NCX3) is crucial for maintaining intracellular calcium ([Ca2+](i)) homeostasis in excitable tissues. In this sense NCX3 plays a key role in neuronal excitotoxicity and Ca2+ extrusion during skeletal muscle relaxation. Alternative splicing generates two variants (NCX3-AC and NCX3-B). Here, we demonstrated that NCX3 variants display a tissue-specific distribution in mice, with NCX3-B as mostly expressed in brain and NCX-AC as predominant in skeletal muscle. Using Fura-2-based Ca2+ imaging, we measured the capacity and regulation of the two variants during Ca2+ extrusion and uptake in different conditions. Functional studies revealed that, although both variants are activated by intracellular sodium ([Na+](i)), NCX3-AC has a higher [Na+](i) sensitivity, as Ca2+ influx is observed in the presence of extracellular Na+. This effect could be partially mimicked for NCX3-B by mutating several glutamate residues in its cytoplasmic loop. In addition, NCX3-AC displayed a higher capacity of both Ca2+ extrusion and uptake compared with NCX3-B, together with an increased sensitivity to intracellular Ca2+. Strikingly, substitution of Glu(580) in NCX3-B with its NCX3-AC equivalent Lys(580) recapitulated the functional properties of NCX3-AC regarding Ca2+ sensitivity, Lys(580) presumably acting through a structure stabilization of the Ca2+ binding site. The higher Ca2+ uptake capacity of NCX3-AC compared with NCX3-B is in line with the necessity to restore Ca2+ levels in the sarcoplasmic reticulum during prolonged exercise. The latter result, consistent with the high expression in the slow-twitch muscle, suggests that this variant may contribute to the Ca2+ handling beyond that of extruding Ca2+.	[Michel, Lauriane Y. M.; Verkaart, Sjoerd; Hoenderop, Joost G. J.; Bindels, Rene J. M.] Radboud Univ Nijmegen, Dept Physiol, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Koopman, Werner J. H.; Willems, Peter H. G. M.] Radboud Univ Nijmegen, Dept Biochem, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Michel, Lauriane Y. M.; Koopman, Werner J. H.; Willems, Peter H. G. M.; Bindels, Rene J. M.] Radboud Univ Nijmegen, Ctr Syst Biol & Bioenerget, Med Ctr, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Bindels, RJM (corresponding author), Radboud Univ Nijmegen, Dept Physiol, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.	Rene.Bindels@radboudumc.nl	Hoenderop, Joost G.J./H-8047-2014; Bindels, René JM/B-9824-2013; Willems, P.H.G.M./L-4759-2015; Koopman, Werner J.H./AAC-9668-2020; Koopman, Werner J.H./D-3592-2009	Hoenderop, Joost G.J./0000-0002-1816-8544; Bindels, René JM/0000-0003-1167-1339; Willems, P.H.G.M./0000-0002-0915-1599; Koopman, Werner J.H./0000-0002-5340-6747; Koopman, Werner J.H./0000-0002-5340-6747; Michel, Lauriane Y.M./0000-0001-6733-3510	Netherlands Organization for Scientific Research [911-02-008, CSBR09/013V]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by Equipment Grant 911-02-008 from Netherlands Organization for Scientific Research and the Centre for Systems Biology Research Initiative Grant CSBR09/013V from the Netherlands Organization for Scientific Research.	ARMSTRONG RB, 1984, AM J ANAT, V171, P259, DOI 10.1002/aja.1001710303; BALASUBRAMANYAM M, 1994, J CLIN INVEST, V94, P2002, DOI 10.1172/JCI117553; Besserer GM, 2007, P NATL ACAD SCI USA, V104, P18467, DOI 10.1073/pnas.0707417104; Breukels V, 2012, BIOCHEM SOC T, V40, P409, DOI 10.1042/BST20110742; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Cairns SP, 1998, J APPL PHYSIOL, V84, P1395, DOI 10.1152/jappl.1998.84.4.1395; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; CRESPO LM, 1990, NATURE, V345, P618, DOI 10.1038/345618a0; Dunn J, 2002, J BIOL CHEM, V277, P33957, DOI 10.1074/jbc.M206677200; Dyck C, 1999, J GEN PHYSIOL, V114, P701, DOI 10.1085/jgp.114.5.701; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Germinario E, 2008, EUR J APPL PHYSIOL, V104, P445, DOI 10.1007/s00421-008-0796-5; Gkika D, 2006, AM J PHYSIOL-RENAL, V290, pF1253, DOI 10.1152/ajprenal.00298.2005; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hilge M, 2007, ANN NY ACAD SCI, V1099, P7, DOI 10.1196/annals.1387.030; Hilge M, 2009, P NATL ACAD SCI USA, V106, P14333, DOI 10.1073/pnas.0902171106; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P905, DOI 10.1085/jgp.100.6.905; HILGEMANN DW, 1990, NATURE, V344, P242, DOI 10.1038/344242a0; Hinata M, 2002, J PHYSIOL-LONDON, V545, P453, DOI 10.1113/jphysiol.2002.025866; Hirota S, 2007, AM J PHYSIOL-LUNG C, V292, pL438, DOI 10.1152/ajplung.00222.2006; Hoenderop JGJ, 2000, J AM SOC NEPHROL, V11, P1171, DOI 10.1681/ASN.V1171171; Huang J, 2007, AM J PHYSIOL-CELL PH, V293, pC1906, DOI 10.1152/ajpcell.00241.2007; HUERTA M, 1991, JPN J PHYSIOL, V41, P933, DOI 10.2170/jjphysiol.41.933; Hurtado C, 2006, AM J PHYSIOL-HEART C, V290, pH2155, DOI 10.1152/ajpheart.00958.2005; Iwamoto T, 1998, AM J PHYSIOL-CELL PH, V275, pC423, DOI 10.1152/ajpcell.1998.275.2.C423; John SA, 2013, P NATL ACAD SCI USA, V110, P7500, DOI 10.1073/pnas.1218751110; John SA, 2011, P NATL ACAD SCI USA, V108, P1699, DOI 10.1073/pnas.1016114108; Jung SY, 2007, EXP MOL MED, V39, P458, DOI 10.1038/emm.2007.50; Kamsteeg EJ, 1999, EMBO J, V18, P2394, DOI 10.1093/emboj/18.9.2394; KIMURA J, 1986, NATURE, V319, P596, DOI 10.1038/319596a0; Kitao T, 2010, NEUROCHEM INT, V57, P58, DOI 10.1016/j.neuint.2010.04.016; KOFUJI P, 1992, AM J PHYSIOL, V263, pC1241, DOI 10.1152/ajpcell.1992.263.6.C1241; Lambers TT, 2004, J BIOL CHEM, V279, P28855, DOI 10.1074/jbc.M313637200; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Lindgren RM, 2005, GENE, V348, P143, DOI 10.1016/j.gene.2005.01.003; MATSUOKA S, 1995, J GEN PHYSIOL, V105, P403, DOI 10.1085/jgp.105.3.403; Minami A, 2007, J PHYSIOL-LONDON, V585, P413, DOI 10.1113/jphysiol.2007.143032; Nicoll DA, 1996, J BIOL CHEM, V271, P24914, DOI 10.1074/jbc.271.40.24914; Pannaccione A, 2012, J NEUROSCI, V32, P10609, DOI 10.1523/JNEUROSCI.6429-11.2012; Piacentino V, 2002, ANN NY ACAD SCI, V976, P476; Quednau BD, 1997, AM J PHYSIOL-CELL PH, V272, pC1250, DOI 10.1152/ajpcell.1997.272.4.C1250; Rebolledo A, 2006, BIOCHEM BIOPH RES CO, V339, P840, DOI 10.1016/j.bbrc.2005.11.084; Rose CR, 1996, J PHYSIOL-LONDON, V491, P291, DOI 10.1113/jphysiol.1996.sp021216; Secondo A, 2007, CELL CALCIUM, V42, P521, DOI 10.1016/j.ceca.2007.01.006; Sirabella R, 2009, STROKE, V40, P922, DOI 10.1161/STROKEAHA.108.531962; Sokolow S, 2004, J CLIN INVEST, V113, P265, DOI 10.1172/JCI200418688; Szerencsei RT, 2013, CHANNELS, V7, P109, DOI 10.4161/chan.23898; Thurneysen T, 2002, MOL BRAIN RES, V107, P145, DOI 10.1016/S0169-328X(02)00461-8; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; Viatchenko-Karpinski S, 2005, J PHYSIOL-LONDON, V567, P493, DOI 10.1113/jphysiol.2005.091280; Yamamura H, 2013, AM J PHYSIOL-CELL PH, V305, pC299, DOI 10.1152/ajpcell.00065.2013	51	25	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11293	11303		10.1074/jbc.M113.529388	http://dx.doi.org/10.1074/jbc.M113.529388			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24616101	hybrid, Green Published			2022-12-25	WOS:000334638500032
J	Alford, JE; Gumbs, J; Anderson, EC				Alford, Justine E.; Gumbs, Jade; Anderson, Emma C.			A New Role for Clathrin Adaptor Proteins 1 and 3 in Lipoplex Trafficking	PLOS ONE			English	Article							INTRACELLULAR TRAFFICKING; HIV-1 GAG; GENE DELIVERY; PLASMID DNA; TRANSFECTION; COMPLEX; CELLS	Intracellular protein trafficking through secretory and endocytic pathways depends on the function of adaptor proteins that bind motifs on cargo proteins. The adaptor proteins then recruit coat proteins such as clathrin, enabling the formation of a transport vesicle. While studying the role of the clathrin adaptor proteins, AP-1, AP-2 and AP-3 in viral protein trafficking, we discovered that AP-1 and AP-3 potentially have a role in successful transfection of mammalian cells with DNA-liposome complexes (lipoplexes). We showed that AP-1, -2 and -3 are not required for lipoplexes to enter cells, but that lipoplexes and/or released DNA are unable to reach the nucleus in the absence of AP-1 or AP-3, leading to minimal exogenous gene expression. In contrast, gene expression from liposome-delivered mRNA, which does not require nuclear entry, was not impaired by the absence of AP-1 or AP-3. Despite the use of lipoplexes to mediate gene delivery being so widely used in cell biology and, more recently, gene therapy, the mechanism by which lipoplexes or DNA reach the nucleus is poorly characterised. This work sheds light on the components involved in this process, and demonstrates a novel role for AP-1 and AP-3 in trafficking lipoplexes.	[Alford, Justine E.; Gumbs, Jade; Anderson, Emma C.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Anderson, EC (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	e.c.anderson@warwick.ac.uk			UK Medical Research Council [G0701220]; Medical Research Council [G0701220] Funding Source: researchfish; MRC [G0701220] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Medical Research Council (grant number G0701220 to ECA and a PhD studentship to JEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo C, 2009, P NATL ACAD SCI USA, V106, P21161, DOI 10.1073/pnas.0909176106; Batonick M, 2005, VIROLOGY, V342, P190, DOI 10.1016/j.virol.2005.08.001; Camus G, 2007, MOL BIOL CELL, V18, P3193, DOI 10.1091/mbc.E06-12-1147; Cardarelli F, 2012, MOL PHARMACEUT, V9, P334, DOI 10.1021/mp200374e; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; DOWTY ME, 1995, P NATL ACAD SCI USA, V92, P4572, DOI 10.1073/pnas.92.10.4572; Duzgunes N, 2012, METHOD ENZYMOL, V509, P355, DOI 10.1016/B978-0-12-391858-1.00018-6; El Ouahabi A, 1999, J HISTOCHEM CYTOCHEM, V47, P1159; Elouahabi A, 2005, MOL THER, V11, P336, DOI 10.1016/j.ymthe.2004.12.006; Farina F, 2013, NUCLEIC ACIDS RES, V41, P4926, DOI 10.1093/nar/gkt204; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Hirst J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001170; Hoekstra D, 2007, BIOCHEM SOC T, V35, P68, DOI 10.1042/BST0350068; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; Kyere SK, 2012, VIRUS RES, V169, P411, DOI 10.1016/j.virusres.2012.06.007; Lechardeur D, 1999, GENE THER, V6, P482, DOI 10.1038/sj.gt.3300867; Mesika A, 2005, HUM GENE THER, V16, P200, DOI 10.1089/hum.2005.16.200; Miller AM, 2009, ADV DRUG DELIVER REV, V61, P603, DOI 10.1016/j.addr.2009.02.008; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Rehman ZU, 2013, ACS NANO, V7, P3767, DOI 10.1021/nn3049494; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Schmidt MR, 2009, P NATL ACAD SCI USA, V106, P15344, DOI 10.1073/pnas.0904268106; Vaughan EE, 2006, MOL THER, V13, P422, DOI 10.1016/j.ymthe.2005.10.004	23	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91429	10.1371/journal.pone.0091429	http://dx.doi.org/10.1371/journal.pone.0091429			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618578	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400092
J	Brassey, CA; Sellers, WI				Brassey, Charlotte A.; Sellers, William I.			Scaling of Convex Hull Volume to Body Mass in Modern Primates, Non-Primate Mammals and Birds	PLOS ONE			English	Article							EMU DROMAIUS-NOVAEHOLLANDIAE; MITOCHONDRIAL GENOME; MOLECULAR PHYLOGENY; EVOLUTION; LIMB; PROPORTIONS; KINEMATICS; MECHANICS; SKELETON; ANIMALS	The volumetric method of 'convex hulling' has recently been put forward as a mass prediction technique for fossil vertebrates. Convex hulling involves the calculation of minimum convex hull volumes (vol(CH)) from the complete mounted skeletons of modern museum specimens, which are subsequently regressed against body mass (M-b) to derive predictive equations for extinct species. The convex hulling technique has recently been applied to estimate body mass in giant sauropods and fossil ratites, however the biomechanical signal contained within volCH has remained unclear. Specifically, when volCH scaling departs from isometry in a group of vertebrates, how might this be interpreted? Here we derive predictive equations for primates, non-primate mammals and birds and compare the scaling behaviour of Mb to volCH between groups. We find predictive equations to be characterised by extremely high correlation coefficients (r(2) = 0.97-0.99) and low mean percentage prediction error (11-20%). Results suggest non-primate mammals scale body mass to volCH isometrically (b = 0.92, 95%CI = 0.85-1.00, p = 0.08). Birds scale body mass to volCH with negative allometry (b = 0.81, 95%CI = 0.70-0.91, p = 0.011) and apparent density (vol(CH)/M-b) therefore decreases with mass (r(2) = 0.36, p<0.05). In contrast, primates scale body mass to volCH with positive allometry (b = 1.07, 95%CI = 1.01-1.12, p = 0.05) and apparent density therefore increases with size (r(2) = 0.46, p = 0.025). We interpret such departures from isometry in the context of the 'missing mass' of soft tissues that are excluded from the convex hulling process. We conclude that the convex hulling technique can be justifiably applied to the fossil record when a large proportion of the skeleton is preserved. However we emphasise the need for future studies to quantify interspecific variation in the distribution of soft tissues such as muscle, integument and body fat.	[Brassey, Charlotte A.; Sellers, William I.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Brassey, CA (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	charlotte.brassey-2@postgrad.manchester.ac.uk	Brassey, Charlotte A/R-2029-2017; Sellers, William Irvin/Q-3843-2019	Brassey, Charlotte A/0000-0002-6552-541X; Sellers, William Irvin/0000-0002-2913-5406	Natural Environment Research Council [NE/1528134/1]	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Natural Environment Research Council's Doctoral Training Grant (NE/1528134/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1985, ZOOL J LINN SOC-LOND, V83, P1, DOI 10.1111/j.1096-3642.1985.tb00871.x; ALEXANDER RM, 1983, J ZOOL, V200, P215; ALEXANDER RM, 1979, J ZOOL, V187, P169; Allen V, 2009, ANAT REC, V292, P1442, DOI 10.1002/ar.20973; Arnason U, 2000, J MOL EVOL, V50, P569, DOI 10.1007/s002390010060; Auerbach BM, 2004, AM J PHYS ANTHROPOL, V125, P331, DOI 10.1002/ajpa.20032; Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; Bates KT, 2009, PALAEONTOL ELECTRON, V12; Bates KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004532; Brassey CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082668; Brassey CA, 2013, ANAT REC, V296, P395, DOI 10.1002/ar.22658; BROWN F, 1985, NATURE, V316, P788, DOI 10.1038/316788a0; Brown JW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-6; Budgey R., 2000, IBSC25WPIE3; Burbidge ML, 2003, CONSERV GENET, V4, P167, DOI 10.1023/A:1023386506067; Campione NE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-60; Colbert E, 1962, WEIGHTS DINOSAURS; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Crainic TG, 2000, EUR J OPER RES, V122, P272, DOI 10.1016/S0377-2217(99)00233-7; Currey JD, 2003, J BONE MINER RES, V18, P591, DOI 10.1359/jbmr.2003.18.4.591; CURREY JD, 1985, J ZOOL, V206, P453; DAAN S, 1990, AM J PHYSIOL, V259, pR333, DOI 10.1152/ajpregu.1990.259.2.R333; de Berg M., 2008, COMPUTATIONAL GEOMET, V3; De Esteban-Trivigno S, 2011, MAMM BIOL, V76, P755, DOI 10.1016/j.mambio.2011.07.004; Dumont ER, 2010, P ROY SOC B-BIOL SCI, V277, P2193, DOI 10.1098/rspb.2010.0117; Falkingham PL, 2012, PALAEONTOL ELECTRON, V15; Field DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082000; Finstermeier K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069504; FOWLER ME, 1991, J ZOO WILDLIFE MED, V22, P204; Franzen JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005723; Gartner GEA, 2010, PHYSIOL BIOCHEM ZOOL, V83, P43, DOI 10.1086/648509; GILL FB, 2007, ORNITHOLOGY; Grand T.I., 1990, P39; Greenewalt C.H., 1962, SMITHSON MISC COLLNS, V144, P1, DOI DOI 10.1007/S00360-016-1016-Y; Gregory WK, 1905, SCIENCE, V22, P572, DOI 10.1126/science.22.566.572; Guha S, 2007, MOL PHYLOGENET EVOL, V42, P585, DOI 10.1016/j.ympev.2006.06.020; HARTMAN FRANK A., 1961, SMITHSONIAN MISC COLL, V143, P1; Hasegawa M, 2003, GENES GENET SYST, V78, P267, DOI 10.1266/ggs.78.267; Hassanin A, 2003, SYST BIOL, V52, P206, DOI 10.1080/10635150390192726; Henderson DM, 1999, PALEOBIOLOGY, V25, P88; Hill W. C. O., 1953, PRIMATES COMP ANATOM, V1; Holliday CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013120; Hughes S, 2006, MOL PHYLOGENET EVOL, V40, P285, DOI 10.1016/j.ympev.2006.02.004; Hutchinson JR, 2007, J THEOR BIOL, V246, P660, DOI 10.1016/j.jtbi.2007.01.023; Jasinoski SC, 2006, ZOOL J LINN SOC-LOND, V146, P301, DOI 10.1111/j.1096-3642.2006.00200.x; JOHANSON DC, 1979, SCIENCE, V203, P321, DOI 10.1126/science.104384; KAISER A, 1993, J FIELD ORNITHOL, V64, P246; KENDEIGH S C, 1970, Condor, V72, P60, DOI 10.2307/1366475; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; Liu R, 2008, P GRAPH INT 2008 WIN; Maxwell EE, 2007, J MORPHOL, V268, P423, DOI 10.1002/jmor.10527; MCNAB BK, 1994, AM NAT, V144, P628, DOI 10.1086/285697; MORRIS CA, 1995, POULTRY SCI, V74, P1683, DOI 10.3382/ps.0741683; Motani R, 2001, PALEOBIOLOGY, V27, P735, DOI 10.1666/0094-8373(2001)027<0735:EBMFST>2.0.CO;2; Moya-Sola S, 2004, SCIENCE, V306, P1339, DOI 10.1126/science.1103094; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Napier J. R., 1959, Fossil Mammals of Africa, V16, P1; O'Connor PM, 2009, J EXP ZOOL PART A, V311A, P629, DOI 10.1002/jez.548; Packard GC, 2009, J ZOOL, V279, P102, DOI 10.1111/j.1469-7998.2009.00594.x; PATAK A, 1993, J EXP BIOL, V175, P233; Phillips MJ, 2010, SYST BIOL, V59, P90, DOI 10.1093/sysbio/syp079; Polk JD, 2000, J HUM EVOL, V39, P297, DOI 10.1006/jhev.2000.0420; PRANGE HD, 1979, AM NAT, V113, P103, DOI 10.1086/283367; Reid B, 1975, BIOGEOGRAPHY ECOLOGY, P301; Remes Kristian, 2011, P305; Robinson TJ, 2011, SYST BIOL, V60, P439, DOI 10.1093/sysbio/syr045; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Ruff CB, 2003, AM J PHYS ANTHROPOL, V120, P16, DOI 10.1002/ajpa.10118; Sales J, 1999, BRIT POULTRY SCI, V40, P145, DOI 10.1080/00071669987999; Sales J, 1997, BRIT POULTRY SCI, V38, P378, DOI 10.1080/00071669708418006; Schmidt M, 2005, J EXP BIOL, V208, P3367, DOI 10.1242/jeb.01781; Schmidt M, 2008, J EXP BIOL, V211, P3775, DOI 10.1242/jeb.019802; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Scott K.M., 1990, P301; Sellers WI, 2012, BIOL LETTERS, V8, P842, DOI 10.1098/rsbl.2012.0263; Sellers WI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078733; Smith NC, 2006, J ANAT, V209, P765, DOI 10.1111/j.1469-7580.2006.00658.x; Smith RJ, 2009, AM J PHYS ANTHROPOL, V140, P476, DOI 10.1002/ajpa.21090; Smith RJ, 2002, J HUM EVOL, V43, P271, DOI 10.1006/jhev.2002.0573; SMITH RJ, 1993, AM J PHYS ANTHROPOL, V90, P215, DOI 10.1002/ajpa.1330900208; Taylor MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078214; Thomas MG, 2000, P ROY SOC B-BIOL SCI, V267, P2493, DOI 10.1098/rspb.2000.1310; TURCEK FRANTISEK J., 1966, EKOL POLSKA SER A, V14, P617; Videan EN, 2007, ZOO BIOL, V26, P93, DOI 10.1002/zoo.20122; Wedel MJ, 2006, INTEGR ZOOL, V1, P80, DOI 10.1111/j.1749-4877.2006.00019.x; Wirestam R, 2008, AUK, V125, P965, DOI 10.1525/auk.2008.07145	86	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91691	10.1371/journal.pone.0091691	http://dx.doi.org/10.1371/journal.pone.0091691			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618736	gold, Green Published, Green Accepted			2022-12-25	WOS:000332842400119
J	Huntsman, BM; Petty, JT				Huntsman, Brock M.; Petty, J. Todd			Density-Dependent Regulation of Brook Trout Population Dynamics along a Core-Periphery Distribution Gradient in a Central Appalachian Watershed	PLOS ONE			English	Article							RESIDENT BROWN TROUT; BULL TROUT; SALVELINUS-FONTINALIS; SALMO-TRUTTA; VARIABLE ENVIRONMENT; HABITAT SELECTION; MOTTLED SCULPIN; CHINOOK SALMON; STREAM; TEMPERATURE	Spatial population models predict strong density-dependence and relatively stable population dynamics near the core of a species' distribution with increasing variance and importance of density-independent processes operating towards the population periphery. Using a 10-year data set and an information-theoretic approach, we tested a series of candidate models considering density-dependent and density-independent controls on brook trout population dynamics across a core-periphery distribution gradient within a central Appalachian watershed. We sampled seven sub-populations with study sites ranging in drainage area from 1.3-60 km(2) and long-term average densities ranging from 0.335-0.006 trout/m. Modeled response variables included per capita population growth rate of young-of-the-year, adult, and total brook trout. We also quantified a stock-recruitment relationship for the headwater population and coefficients of variability in mean trout density for all sub-populations over time. Density-dependent regulation was prevalent throughout the study area regardless of stream size. However, density-independent temperature models carried substantial weight and likely reflect the effect of year-to-year variability in water temperature on trout dispersal between cold tributaries and warm main stems. Estimated adult carrying capacities decreased exponentially with increasing stream size from 0.24 trout/m in headwaters to 0.005 trout/m in the main stem. Finally, temporal variance in brook trout population size was lowest in the high-density headwater population, tended to peak in mid-sized streams and declined slightly in the largest streams with the lowest densities. Our results provide support for the hypothesis that local density-dependent processes have a strong control on brook trout dynamics across the entire distribution gradient. However, the mechanisms of regulation likely shift from competition for limited food and space in headwater streams to competition for thermal refugia in larger main stems. It also is likely that source-sink dynamics and dispersal from small headwater habitats may partially influence brook trout population dynamics in the main stem.	[Huntsman, Brock M.; Petty, J. Todd] W Virginia Univ, Div Forestry & Nat Resources, Morgantown, WV 26506 USA	West Virginia University	Huntsman, BM (corresponding author), W Virginia Univ, Div Forestry & Nat Resources, Morgantown, WV 26506 USA.	brockhunts@gmail.com		Huntsman, Brock/0000-0003-4090-1949	WV Department of Natural Resources [NRAC 387]; US Fish and Wildlife Service; US Geological Survey	WV Department of Natural Resources; US Fish and Wildlife Service(US Fish & Wildlife Service); US Geological Survey(United States Geological Survey)	This work was funded by WV Department of Natural Resources (NRAC 387), the US Fish and Wildlife Service, and the US Geological Survey. The funders were not involved in any details of this study.	Benda L, 2004, BIOSCIENCE, V54, P413, DOI 10.1641/0006-3568(2004)054[0413:TNDHHC]2.0.CO;2; Breininger DR, 2004, ECOL APPL, V14, P1079, DOI 10.1890/03-5002; Burnham KP, 2002, MULTIMODEL INFERENCE; Cornell KL, 2010, LANDSCAPE ECOL, V25, P109, DOI 10.1007/s10980-009-9405-1; Dunham J, 2003, N AM J FISH MANAGE, V23, P894, DOI 10.1577/M02-028; Dunham JB, 1997, CAN J FISH AQUAT SCI, V54, P1025, DOI 10.1139/cjfas-54-5-1025; Fausch KD, 2002, BIOSCIENCE, V52, P483, DOI 10.1641/0006-3568(2002)052[0483:LTRBTG]2.0.CO;2; FAUSCH KD, 1981, CAN J FISH AQUAT SCI, V38, P1220, DOI 10.1139/f81-164; Flebbe PA, 2006, T AM FISH SOC, V135, P1371, DOI 10.1577/T05-217.1; Goniea TM, 2006, T AM FISH SOC, V135, P408, DOI 10.1577/T04-113.1; Goswami VR, 2011, ECOLOGY, V92, P1680, DOI 10.1890/10-2317.1; Grossman GD, 2012, FRESHWATER BIOL, V57, P1434, DOI 10.1111/j.1365-2427.2012.02806.x; Grossman GD, 2010, FRESHWATER BIOL, V55, P1494, DOI 10.1111/j.1365-2427.2009.02361.x; Grossman GD, 2006, ECOL MONOGR, V76, P217, DOI 10.1890/04-1623; Guo QF, 2005, OIKOS, V108, P47, DOI 10.1111/j.0030-1299.2005.13149.x; Haak AL, 2010, FISHERIES, V35, P530, DOI 10.1577/1548-8446-35.11.530; Hansburger Jeff L., 2008, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V62, P142; Hartman KJ, 2001, PROCEEDINGS OF THE FIFTY-FIFTH ANNUAL CONFERENCE OF THE SOUTHEASTERN ASSOCIATION OF FISH AND WILDLIFE AGENCIES, P38; Hense Z, 2010, N AM J FISH MANAGE, V30, P1041, DOI 10.1577/M09-029.1; Hixon MA, 2002, ECOLOGY, V83, P1490, DOI 10.1890/0012-9658(2002)083[1490:PRHCAC]2.0.CO;2; Hixon MA, 1997, SCIENCE, V277, P946, DOI 10.1126/science.277.5328.946; Hughes NF, 1998, ECOLOGY, V79, P281, DOI 10.1890/0012-9658(1998)079[0281:AMOHSB]2.0.CO;2; Isaak DJ, 2004, T AM FISH SOC, V133, P1254, DOI 10.1577/T03-010.1; Johnston FD, 2007, CAN J FISH AQUAT SCI, V64, P113, DOI 10.1139/F06-172; Johnston FD, 2009, ECOL APPL, V19, P449, DOI 10.1890/07-1507.1; Kanda LL, 2009, ECOLOGY, V90, P1574, DOI 10.1890/08-1263.1; Kendall BE, 2000, AM NAT, V155, P628, DOI 10.1086/303350; Kiffney PM, 2006, CAN J FISH AQUAT SCI, V63, P2518, DOI 10.1139/F06-138; Kim M, 2011, ECOL FRESHW FISH, V20, P144, DOI 10.1111/j.1600-0633.2010.00471.x; Kratzer JF, 2013, N AM J FISH MANAGE, V33, P130, DOI 10.1080/02755947.2012.743934; Krebs CJ, 2002, WILDLIFE RES, V29, P1, DOI 10.1071/WR01074; Kunin WE, 2009, P R SOC B, V276, P1495, DOI 10.1098/rspb.2008.1767; Limm MP, 2009, ENVIRON BIOL FISH, V85, P141, DOI 10.1007/s10641-009-9473-8; Lobon-Cervia J, 2007, CAN J FISH AQUAT SCI, V64, P1429, DOI 10.1139/F07-111; Lobon-Cervia J, 2012, FRESHWATER BIOL, V57, P2181, DOI 10.1111/j.1365-2427.2012.02863.x; Lobon-Cervia J, 2009, FRESHWATER BIOL, V54, P1149, DOI 10.1111/j.1365-2427.2008.02159.x; Martin RW, 2009, J FRESHWATER ECOL, V24, P497, DOI 10.1080/02705060.2009.9664323; McClurg SE, 2007, ECOL APPL, V17, P1087, DOI 10.1890/06-0392; McMahon TE, 2007, T AM FISH SOC, V136, P1313, DOI 10.1577/T06-217.1; MURDOCH WW, 1994, ECOLOGY, V75, P271, DOI 10.2307/1939533; Nicola GG, 2009, OECOLOGIA, V160, P515, DOI 10.1007/s00442-009-1317-x; Nicola GG, 2008, FRESHWATER BIOL, V53, P2364, DOI 10.1111/j.1365-2427.2008.02056.x; Nislow KH, 2006, FRESHWATER BIOL, V51, P388, DOI 10.1111/j.1365-2427.2005.01492.x; PETRANKA JW, 1986, ECOLOGY, V67, P729, DOI 10.2307/1937696; Petty JT, 2007, T AM FISH SOC, V136, P1750, DOI 10.1577/T06-034.1; Petty JT, 2014, HYDROBIOLOGIA, V727, P151, DOI 10.1007/s10750-013-1794-0; Petty JT, 2012, T AM FISH SOC, V141, P1060, DOI 10.1080/00028487.2012.681102; Petty JT, 2010, FRESHWATER BIOL, V55, P780, DOI 10.1111/j.1365-2427.2009.02321.x; Petty JT, 2005, T AM FISH SOC, V134, P572, DOI 10.1577/T03-229.1; Petty JT, 2005, RESTOR ECOL, V13, P348, DOI 10.1111/j.1526-100X.2005.00044.x; Petty JT, 2012, NAT ED, V3, P17; Pope SE, 2000, ECOLOGY, V81, P2498; Poplar-Jeffers IO, 2009, RESTOR ECOL, V17, P404, DOI 10.1111/j.1526-100X.2008.00396.x; Previtali MA, 2009, ECOLOGY, V90, P1996, DOI 10.1890/08-0405.1; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Rieman BE, 2007, T AM FISH SOC, V136, P1552, DOI 10.1577/T07-028.1; Rypel AL, 2012, ECOSYSTEMS, V15, P555, DOI 10.1007/s10021-012-9528-0; Sagarin RD, 2002, ECOL LETT, V5, P137, DOI 10.1046/j.1461-0248.2002.00297.x; SEMLITSCH RD, 1987, ECOLOGY, V68, P1003, DOI 10.2307/1938371; Steiner CF, 2013, OIKOS, V122, P1195, DOI 10.1111/j.1600-0706.2012.20936.x; Stevens MHH, 2009, USE R, P3, DOI 10.1007/978-0-387-89882-7_1; Taniguchi Y, 1998, CAN J FISH AQUAT SCI, V55, P1894, DOI 10.1139/cjfas-55-8-1894; Tincher M, 2013, THESIS W VIRGINIA U; Turchin P, 1999, OIKOS, V84, P153, DOI 10.2307/3546876; Utz RM, 2006, CAN J FISH AQUAT SCI, V63, P2675, DOI 10.1139/F06-152; Utz RM, 2009, CAN J FISH AQUAT SCI, V66, P1072, DOI 10.1139/F09-063; Van Buskirk J, 2005, ECOLOGY, V86, P1936, DOI 10.1890/04-1237; Wagner T, 2013, T AM FISH SOC, V142, P353, DOI 10.1080/00028487.2012.734892; Warren DR, 2012, GLOBAL CHANGE BIOL, V18, P1804, DOI 10.1111/j.1365-2486.2012.02670.x; WATERS TF, 1983, T AM FISH SOC, V112, P137, DOI 10.1577/1548-8659(1983)112<137:ROBTBB>2.0.CO;2; Wenger SJ, 2011, P NATL ACAD SCI USA, V108, P14175, DOI 10.1073/pnas.1103097108; Wenger SJ, 2011, CAN J FISH AQUAT SCI, V68, P988, DOI [10.1139/F2011-034, 10.1139/f2011-034]; Werner EE, 2007, OIKOS, V116, P1713, DOI 10.1111/j.2007.0030-1299.16039.x; Williams CK, 2003, ECOLOGY, V84, P2654, DOI 10.1890/03-0038; Young RG, 2010, T AM FISH SOC, V139, P137, DOI 10.1577/T08-148.1; Zorn TG, 2007, T AM FISH SOC, V136, P691, DOI 10.1577/T06-032.1; Zorn TG, 2007, T AM FISH SOC, V136, P706, DOI 10.1577/T06-275.1	77	35	36	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91673	10.1371/journal.pone.0091673	http://dx.doi.org/10.1371/journal.pone.0091673			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618602	Green Published, gold, Green Submitted			2022-12-25	WOS:000332842400114
J	Screen, M; Raheem, O; Holmlund-Hampf, J; Jonson, PH; Huovinen, S; Hackman, P; Udd, B				Screen, Mark; Raheem, Olayinka; Holmlund-Hampf, Jeanette; Jonson, Per Harald; Huovinen, Sanna; Hackman, Peter; Udd, Bjarne			Gene Expression Profiling in Tibial Muscular Dystrophy Reveals Unfolded Protein Response and Altered Autophagy	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; INCLUSION-BODY MYOSITIS; VALOSIN-CONTAINING PROTEIN; C-TERMINAL TITIN; DISTAL MYOPATHY; ER STRESS; RIMMED VACUOLES; MUSCLE; MUTATIONS; DISEASE	Tibial muscular dystrophy (TMD) is a late onset, autosomal dominant distal myopathy that results from mutations in the two last domains of titin. The cascade of molecular events leading from the causative Titin mutations to the preterm death of muscle cells in TMD is largely unknown. In this study we examined the mRNA and protein changes associated with the myopathology of TMD. To identify these components we performed gene expression profiling using muscle biopsies from TMD patients and healthy controls. The profiling results were confirmed through quantitative real-time PCR and protein level analysis. One of the pathways identified was activation of endoplasmic reticulum (ER) stress response. ER stress activates the unfolded protein response (UPR) pathway. UPR activation was supported by elevation of the marker genes HSPA5, ERN1 and the UPR specific XBP1 splice form. However, UPR activation appears to be insufficient to correct the protein abnormalities causing its activation because degenerative TMD muscle fibres show an increase in ubiquitinated protein inclusions. Abnormalities of VCP-associated degradation pathways are also suggested by the presence of proteolytic VCP fragments in western blotting, and VCP's accumulation within rimmed vacuoles in TMD muscle fibres together with p62 and LC3B positive autophagosomes. Thus, pathways controlling turnover and degradation, including autophagy, are distorted and lead to degeneration and loss of muscle fibres.	[Screen, Mark; Holmlund-Hampf, Jeanette; Jonson, Per Harald; Hackman, Peter; Udd, Bjarne] Univ Helsinki, Folkhalsan Inst Genet, Helsinki, Finland; [Screen, Mark; Holmlund-Hampf, Jeanette; Jonson, Per Harald; Hackman, Peter; Udd, Bjarne] Univ Helsinki, Dept Med Genet, Haartman Inst, Helsinki, Finland; [Raheem, Olayinka; Huovinen, Sanna; Udd, Bjarne] Tampere Univ Hosp, Dept Neurol, Neuromuscular Res Unit, Tampere, Finland; [Raheem, Olayinka; Huovinen, Sanna; Udd, Bjarne] Univ Tampere, FIN-33101 Tampere, Finland; [Huovinen, Sanna] Tampere Univ Hosp, Fimlab Labs, Dept Pathol, Tampere, Finland; [Udd, Bjarne] Vaasa Cent Hosp, Dept Neurol, Vaasa, Finland	University of Helsinki; University of Helsinki; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Vaasa Central Hospital	Screen, M (corresponding author), Univ Helsinki, Folkhalsan Inst Genet, Helsinki, Finland.	mark.screen@helsinki.fi	Jonson, pH/GPX-1306-2022	Huovinen, Sanna/0000-0001-7659-7921; Jonson, Per Harald/0000-0003-2423-359X	Folkhalsan Research Foundation; University of Helsinki; National Doctoral Program of Musculoskeletal Disorders and Biomaterials; Liv och Halsa Foundation; Vaasa Central Hospital District Medical Research funds	Folkhalsan Research Foundation; University of Helsinki; National Doctoral Program of Musculoskeletal Disorders and Biomaterials; Liv och Halsa Foundation; Vaasa Central Hospital District Medical Research funds	The study received funding from the Folkhalsan Research Foundation, the University of Helsinki, the National Doctoral Program of Musculoskeletal Disorders and Biomaterials. Research grants from the Liv och Halsa Foundation and Vaasa Central Hospital District Medical Research funds are also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askanas V, 2008, ACTA NEUROPATHOL, V116, P583, DOI 10.1007/s00401-008-0449-0; Boito CA, 2007, VIRCHOWS ARCH, V451, P1047, DOI 10.1007/s00428-007-0515-3; Carmignac V, 2007, ANN NEUROL, V61, P340, DOI 10.1002/ana.21089; Ceyhan-Birsoy O, 2013, NEUROLOGY, V81, P1205, DOI 10.1212/WNL.0b013e3182a6ca62; Charton K, 2010, HUM MOL GENET, V19, P4608, DOI 10.1093/hmg/ddq388; Chauveau C, 2013, HUM MOL GEN IN PRESS; Chen YN, 2013, TRENDS CELL BIOL, V23, P547, DOI 10.1016/j.tcb.2013.06.005; Ching JK, 2013, HUM MOL GENET, V22, P1167, DOI 10.1093/hmg/dds524; Eisenberg I, 2008, HUM MOL GENET, V17, P3663, DOI 10.1093/hmg/ddn261; Fukuzawa A, 2008, J CELL SCI, V121, P1841, DOI 10.1242/jcs.028019; Gautel M, 1999, REV PHYSIOL BIOCH P, V138, P97, DOI 10.1007/BF02346661; Hackman P, 2002, AM J HUM GENET, V71, P492, DOI 10.1086/342380; Hackman P, 2008, NEUROMUSCULAR DISORD, V18, P922, DOI 10.1016/j.nmd.2008.07.010; Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003; Halawani D, 2010, J NEUROSCI, V30, P6132, DOI 10.1523/JNEUROSCI.5874-09.2010; Haravuori H, 2001, NEUROLOGY, V56, P869, DOI 10.1212/WNL.56.7.869; Ito H, 2005, J CELL BIOCHEM, V95, P932, DOI 10.1002/jcb.20445; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Kolmerer B, 1996, J MOL BIOL, V256, P556, DOI 10.1006/jmbi.1996.0108; Kuga A, 2011, HUM MOL GENET, V20, P2975, DOI 10.1093/hmg/ddr201; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463; Lee HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036221; Liewluck T, 2007, MUSCLE NERVE, V35, P322, DOI 10.1002/mus.20691; LIN HY, 1993, MOL BIOL CELL, V4, P1109, DOI 10.1091/mbc.4.11.1109; Lynch JM, 2012, CELL, V149, P1257, DOI 10.1016/j.cell.2012.03.050; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Nogalska A, 2010, AM J PATHOL, V177, P1377, DOI 10.2353/ajpath.2010.100050; Nogalska A, 2009, ACTA NEUROPATHOL, V118, P407, DOI 10.1007/s00401-009-0564-6; Olive M, 2008, NEUROPATH APPL NEURO, V34, P76, DOI 10.1111/j.1365-2990.2007.00864.x; Palmio J, 2013, J NEUROL NU IN PRESS; Palmio J, 2011, NEUROMUSCULAR DISORD, V21, P551, DOI 10.1016/j.nmd.2011.05.008; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pollazzon M, 2010, J NEUROL, V257, P575, DOI 10.1007/s00415-009-5372-3; Raheem O, 2010, AM J PATHOL, V177, P3025, DOI 10.2353/ajpath.2010.100179; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Tsuruta Y, 2001, ACTA NEUROPATHOL, V101, P579; Udd B, 2005, NEUROLOGY, V64, P636, DOI 10.1212/01.WNL.0000151853.50144.82; UDD B, 1992, J MED GENET, V29, P383, DOI 10.1136/jmg.29.6.383; UDD B, 1993, ARCH NEUROL-CHICAGO, V50, P604, DOI 10.1001/archneur.1993.00540060044015; Udd B, 1998, NEUROMUSCULAR DISORD, V8, P327, DOI 10.1016/S0960-8966(98)00024-8; Van den Bergh PYK, 2003, ANN NEUROL, V54, P248, DOI 10.1002/ana.10647; Vattemi G, 2004, AM J PATHOL, V164, P1, DOI 10.1016/S0002-9440(10)63089-1; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weihl CC, 2010, CURR OPIN NEUROL, V23, P482, DOI 10.1097/WCO.0b013e32833d3897; Yan CZ, 2001, ACTA NEUROPATHOL, V101, P9; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6	50	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90819	10.1371/journal.pone.0090819	http://dx.doi.org/10.1371/journal.pone.0090819			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618559	Green Submitted, Green Published, gold			2022-12-25	WOS:000332842400031
J	Splith, K; Fellmer, P; Matia, I; Varga, M; Oliverius, M; Kuhn, S; Feldbrugge, L; Krenzien, F; Hau, HM; Wiltberger, G; Schmelzle, M; Jonas, S				Splith, Katrin; Fellmer, Peter; Matia, Ivan; Varga, Martin; Oliverius, Martin; Kuhn, Stephanie; Feldbruegge, Linda; Krenzien, Felix; Hau, Hans-Michael; Wiltberger, Georg; Schmelzle, Moritz; Jonas, Sven			Antibody-Mediated Rejection of Arterialised Venous Allografts Is Inhibited by Immunosuppression in Rats	PLOS ONE			English	Article							VEIN ALLOGRAFTS; FRESH; RECONSTRUCTION; CYCLOSPORINE; DOGS; TRANSPLANTATION; SENSITIZATION; CHILDREN; MOFETIL; DISEASE	Objectives and Design: We determined in a rat model (1) the presence and dynamics of alloantibodies recognizing MHC complexes on quiescent Brown-Norway (BN) splenic cells in the sera of Lewis (LEW) recipients of Brown-Norway iliolumbar vein grafts under tacrolimus immunosuppression; and (2) the presence of immunoglobulins in the wall of acute rejected vein allografts. Materials and Methods: Flow cytometry was used for the analysis of day 0, 14 and 30 sera obtained from Lewis recipients of isogeneic iliolumbar vein grafts (group A) or Brown-Norway grafts (group B, C) for the presence of donor specific anti-MHC class I and II antibodies. Tacrolimus 0.2 mg/kg daily was administered from day 1 to day 30 (group C). Histology was performed on day 30. Results: Sera obtained preoperatively and on day 30 were compared in all groups. The statistically significant decrease of anti MHC class I and II antibody binding was observed only in allogenic non-immunosuppressed group B (splenocytes: MHC class I-day 0 (93%+/-67%) vs day 30 (66%+/-67%), p = 0.02, MHC class II-day 0 (105%+/-63%) vs day 30 (83%+/-65%), p = 0.003; B-cells: MHC class I-day 0 (83%+/-65%) vs day 30 (55%+/-66%), p = 0.003, MHC class II-day 0 (101%+/-61%) vs day 30 (79%+/-66%), p = 0.006; T-cells: MHC class I-day 0 (71%+/-67%) vs day 30 (49%+/-65%), p = 0.04). No free clusters of immunoglobulin G deposition were detected in any experimental group. Conclusion: Arterialized venous allografts induce strong donor-specific anti-MHC class I and anti-MHC class II antibody production with subsequent immune-mediated destruction of these allografts with no evidence of immunoglobulin G deposition. Low-dose tacrolimus suppress the donor-specific antibody production.	[Splith, Katrin; Kuhn, Stephanie; Feldbruegge, Linda; Schmelzle, Moritz; Jonas, Sven] Univ Leipzig, Translat Ctr Regenerat Med, D-04109 Leipzig, Germany; [Fellmer, Peter; Matia, Ivan; Feldbruegge, Linda; Krenzien, Felix; Hau, Hans-Michael; Wiltberger, Georg; Schmelzle, Moritz; Jonas, Sven] Univ Leipzig, Dept Visceral Transplantat Thorac & Vasc Surg, D-04109 Leipzig, Germany; [Varga, Martin; Oliverius, Martin] Inst Clin & Expt Med, Transplant Surg Dept, Prague, Czech Republic	Leipzig University; Leipzig University; Institute for Clinical & Experimental Medicine (IKEM)	Matia, I (corresponding author), Univ Leipzig, Dept Visceral Transplantat Thorac & Vasc Surg, D-04109 Leipzig, Germany.	ivan.matia@medizin.uni-leipzig.de	Oliverius, Martin/K-1693-2017; Oliverius, Martin/N-5599-2019; Hau, Hans-Michael/AAJ-1005-2021	Oliverius, Martin/0000-0002-8649-3824; Oliverius, Martin/0000-0002-8649-3824; Splith, Katrin/0000-0002-1841-1495; Krenzien, Felix/0000-0003-0593-9917; , Linda/0000-0002-3372-609X	German Federal Ministry of Education and Research [BMBF 1315883]; German Research Foundation (DFG); Leipzig University	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University	This work was supported by funding from the German Federal Ministry of Education and Research (BMBF 1315883). This work was supported by the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma N, 1999, J VASC SURG, V29, P694, DOI 10.1016/S0741-5214(99)70316-2; Balzer KM, 2004, TISSUE ANTIGENS, V64, P13, DOI 10.1111/j.0001-2815.2004.00236.x; BANDLIEN KO, 1983, ARCH SURG-CHICAGO, V118, P829; Farber A, 2003, J VASC SURG, V38, P15, DOI 10.1016/S0741-5214(03)00330-6; Fellmer PT, 2013, ZENTRALBL CHIR; Freguin-Bouilland C, 2011, TRANSPLANTATION, V91, P35, DOI 10.1097/TP.0b013e3181fe12d6; Hamada N, 2010, ATHEROSCLEROSIS, V208, P97, DOI 10.1016/j.atherosclerosis.2009.07.040; Lopez-Cepero M, 2002, TRANSPLANTATION, V73, P817, DOI 10.1097/00007890-200203150-00029; Madden R, 2002, AM J KIDNEY DIS, V40, P1240, DOI 10.1053/ajkd.2002.36892; Matia I, 2010, EUR J VASC ENDOVASC, V39, P478, DOI 10.1016/j.ejvs.2009.11.016; Matia I, 2007, TRANSPL INT, V20, P371, DOI 10.1111/j.1432-2277.2006.00446.x; MILLER VM, 1993, J VASC SURG, V18, P216, DOI 10.1016/0741-5214(93)90601-H; Mingoli A, 1996, J SURG RES, V62, P95, DOI 10.1006/jsre.1996.0180; Mirelli M, 2005, TRANSPLANT P, V37, P2688, DOI 10.1016/j.transproceed.2005.06.034; O'Connor MJ, 2013, J HEART LUNG TRANSPL, V32, P390, DOI 10.1016/j.healun.2012.12.009; Plissonnier D, 2000, TRANSPLANTATION, V69, P2601, DOI 10.1097/00007890-200006270-00021; Posner MP, 1996, J AM COLL SURGEONS, V183, P208; Randon C, 2010, J VASC SURG, V51, P869, DOI 10.1016/j.jvs.2009.11.062; Shaddy RE, 2004, ANN THORAC SURG, V77, P1734, DOI 10.1016/j.athoracsur.2003.10.047; Shaddy RE, 2001, ANN THORAC SURG, V71, P43, DOI 10.1016/S0003-4975(00)02183-4; Tepperman E, 2010, CAN J SURG, V53, P57; Thaunat O, 2005, P NATL ACAD SCI USA, V102, P14723, DOI 10.1073/pnas.0507223102; Thaunat O, 2006, ARTERIOSCL THROM VAS, V26, P2359, DOI 10.1161/01.ATV.0000241980.09816.ac; Thaunat O, 2012, TRANSPL IMMUNOL, V26, P101, DOI 10.1016/j.trim.2011.11.003; van Herck H, 2000, LAB ANIM, V34, P10, DOI 10.1258/002367700780577993; Varga M, 2012, BRATISL MED J, V113, P5, DOI 10.4149/BLL_2012_001; Vicenti F, 2002, TRANSPLANTATION, V73, P775, DOI 10.1097/00007890-200203150-00021; WAGNER E, 1994, TRANSPLANTATION, V58, P537, DOI 10.1097/00007890-199409150-00002; WAGNER E, 1995, J THORAC CARDIOV SUR, V110, P1732, DOI 10.1016/S0022-5223(95)70037-4	29	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91212	10.1371/journal.pone.0091212	http://dx.doi.org/10.1371/journal.pone.0091212			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618652	Green Submitted, Green Published, gold			2022-12-25	WOS:000332842400056
J	Vasantha, M; Venkatesan, P				Vasantha, Mahalingam; Venkatesan, Perumal			Structural Equation Modeling of Latent Growth Curves of Weight Gain among Treated Tuberculosis Patients	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; MALNUTRITION	Tuberculosis still remains a major public health problem even though it is treatable and curable. Weight gain measurement during anti tuberculosis (TB) treatment period is an important component to assess the progress of TB patients. In this study, Latent Growth Models (LGMs) were implemented in a longitudinal design to predict the change in weight of TB patients who were given three different regimens under randomized controlled clinical trial for anti-TB treatment. Linear and Quadratic LGMs were fitted using Mplus software. The age, sex and treatment response of the TB patients were used as time invariant independent variables of the growth trajectories. The quadratic trend was found to be better in explaining the changes in weight without grouping than the quadratic model for three group comparisons. A significant increase in the change of weight over time was identified while a significant quadratic effect indicated that weights were sustained over time. The growth rate was similar in both the groups. The treament response had significant association with the growth rate of weight scores of the patients.	[Vasantha, Mahalingam; Venkatesan, Perumal] Indian Council Med Res, Natl Inst Res TB, Dept Stat, Madras, Tamil Nadu, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Venkatesan, P (corresponding author), Indian Council Med Res, Natl Inst Res TB, Dept Stat, Madras, Tamil Nadu, India.	venkaticmr@gmail.com		Venkatesan, Perumal/0000-0002-4491-7553				Akaike H, 1973, 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Balasubramanian R, 1991, INDIAN J TUBERC, V38, P51; Baldwin MR, 2004, INT J TUBERC LUNG D, V8, P1484; Bernabe-Ortiz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018474; Biesanz JC, 2004, PSYCHOL METHODS, V9, P30, DOI 10.1037/1082-989X.9.1.30; Bollen KA, 2006, WILEY SER PROBAB ST, P1; Byrne B.M., 2003, UNDERSTANDING STAT, V2, P177, DOI [10.1207/S15328031US0203_02, DOI 10.1207/S15328031US0203_02, 10.1207/s15328031us0203_02]; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; Chaudhuri K., 1993, Indian Journal of Tuberculosis, V40, P83; COCHRAN WG, 1952, ANN MATH STAT, V23, P315, DOI 10.1214/aoms/1177729380; Hoa NB, 2013, INT J TUBERC LUNG D, V17, P61, DOI 10.5588/ijtld.12.0369; Khan A, 2006, AM J RESP CRIT CARE, V174, P344, DOI 10.1164/rccm.200511-1834OC; Krapp F, 2008, INT J TUBERC LUNG D, V12, P1153; Marsh HW, 2009, STRUCT EQU MODELING, V16, P439, DOI 10.1080/10705510903008220; Mathew R, 1997, INT J TUBERC LUNG D, V1, P509; MCARDLE JJ, 1987, CHILD DEV, V58, P110, DOI 10.1111/j.1467-8624.1987.tb03494.x; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; PARAMASIVAN CN, 1993, TUBERCLE LUNG DIS, V74, P23, DOI 10.1016/0962-8479(93)90064-5; Schumacker R. E, 2004, BEGINNERS GUIDE STRU, V2nd, DOI DOI 10.4135/9781412973380.N17; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Schwenk A, 2004, AM J CLIN NUTR, V79, P1006; Stoolmiller M., 1995, ANAL CHANGE, P103; van de Schoot R, 2012, EUR J DEV PSYCHOL, V9, P486, DOI 10.1080/17405629.2012.686740; van Lettow M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-61; Vasantha M, 2008, Indian J Tuberc, V55, P64; Vasantha M, 2009, Indian J Tuberc, V56, P5; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO, 2012, GLOB TUB CONTR; Zudien MV, 2011, PLOS ONE, V6	29	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91152	10.1371/journal.pone.0091152	http://dx.doi.org/10.1371/journal.pone.0091152			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618577	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400052
J	Zhou, ZY; Zheng, J; Dai, YK; Zhou, Z; Chen, S				Zhou, Zhiyong; Zheng, Jian; Dai, Yakang; Zhou, Zhe; Chen, Shi			Robust Non-Rigid Point Set Registration Using Student's-t Mixture Model	PLOS ONE			English	Article								The Student's-t mixture model, which is heavily tailed and more robust than the Gaussian mixture model, has recently received great attention on image processing. In this paper, we propose a robust non-rigid point set registration algorithm using the Student's-t mixture model. Specifically, first, we consider the alignment of two point sets as a probability density estimation problem and treat one point set as Student's-t mixture model centroids. Then, we fit the Student's-t mixture model centroids to the other point set which is treated as data. Finally, we get the closed-form solutions of registration parameters, leading to a computationally efficient registration algorithm. The proposed algorithm is especially effective for addressing the non-rigid point set registration problem when significant amounts of noise and outliers are present. Moreover, less registration parameters have to be set manually for our algorithm compared to the popular coherent points drift (CPD) algorithm. We have compared our algorithm with other state-of-the-art registration algorithms on both 2D and 3D data with noise and outliers, where our non-rigid registration algorithm showed accurate results and outperformed the other algorithms.	[Zhou, Zhiyong; Zheng, Jian; Dai, Yakang; Zhou, Zhe; Chen, Shi] Chinese Acad Sci, Suzhou Inst Biomed Engn & Technol, Suzhou, Peoples R China	Chinese Academy of Sciences; Suzhou Institute of Biomedical Engineering & Technology, CAS	Dai, YK (corresponding author), Chinese Acad Sci, Suzhou Inst Biomed Engn & Technol, Suzhou, Peoples R China.	daiyk@sibet.ac.cn	JIAN, ZHENG/ABC-1339-2021		Hundred Talents Program of CAS; NSFC grants [61301042, 61201117]; NSFJ grant [BK2012189]	Hundred Talents Program of CAS(Chinese Academy of Sciences); NSFC grants(National Natural Science Foundation of China (NSFC)); NSFJ grant	This work was supported in part by the Hundred Talents Program of CAS, NSFC grants (61301042, 61201117) and NSFJ grant (BK2012189). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Hundred Talents Program of CAS: http://www.1000plan.org/qrjh/channel/7, NSFC: http://www.nsfc.gov.cn/Portal0/default152.htm, SFJ: http://www.jstd.gov.cn.	Belongie S, 2002, IEEE T PATTERN ANAL, V24, P509, DOI 10.1109/34.993558; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bing J., 2011, PATTERN ANAL MACHINE, V33, P1633; Chatzis SP, 2009, IEEE T PATTERN ANAL, V31, P1657, DOI 10.1109/TPAMI.2008.215; Chen Z, 2002, NEURAL COMPUT, V14, P2791, DOI 10.1162/089976602760805296; Chui HL, 2003, COMPUT VIS IMAGE UND, V89, P114, DOI 10.1016/S1077-3142(03)00009-2; Chui HL, 2000, IEEE WORKSHOP ON MATHEMATICAL METHODS IN BIOMEDICAL IMAGE ANALYSIS, PROCEEDINGS, P190, DOI 10.1109/MMBIA.2000.852377; Gerogiannis D., 2007, 2007 IEEE 11 INT C C, P1; Gerogiannis D, 2009, IMAGE VISION COMPUT, V27, P1285, DOI 10.1016/j.imavis.2008.11.013; GEWEKE J, 1993, J APPL ECONOM, V8, pS19, DOI 10.1002/jae.3950080504; GIROSI F, 1995, NEURAL COMPUT, V7, P219, DOI 10.1162/neco.1995.7.2.219; Gold S, 1998, PATTERN RECOGN, V31, P1019, DOI 10.1016/S0031-3203(98)80010-1; Li QD, 2011, COMPUT AIDED DESIGN, V43, P394, DOI 10.1016/j.cad.2011.01.007; Li XL, 2012, IEEE T MED IMAGING, V31, P1849, DOI 10.1109/TMI.2012.2203922; Liu JJ, 2007, PR IEEE COMP DESIGN, P17; Madsen RE, 2005, 22 INT C MACH LEARN, P545; Myronenko A, 2010, IEEE T PATTERN ANAL, V32, P2262, DOI 10.1109/TPAMI.2010.46; Peel D, 2000, STAT COMPUT, V10, P339, DOI 10.1023/A:1008981510081; Revow M, 1996, IEEE T PATTERN ANAL, V18, P592, DOI 10.1109/34.506410; Sfikas G, 2008, P IEEE INT C COMP VI, V1, P1, DOI DOI 10.1109/CVPR.2008.4587416; Spiegel M.R., 2013, SCHAUMSOUTLINE PROBA, V4th; Svensen M, 2005, NEUROCOMPUTING, V64, P235, DOI 10.1016/j.neucom.2004.11.018; Tsin Y, 2004, LECT NOTES COMPUT SC, V3023, P558; Wang P, 2011, SCI CHINA INFORM SCI, V54, P2639, DOI 10.1007/s11432-011-4465-7; Yuille A. L., 1988, Second International Conference on Computer Vision (IEEE Cat. No.88CH2664-1), P344, DOI 10.1109/CCV.1988.590011; YUILLE AL, 1989, INT J COMPUT VISION, V3, P155, DOI 10.1007/BF00126430	26	10	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91381	10.1371/journal.pone.0091381	http://dx.doi.org/10.1371/journal.pone.0091381			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618749	gold, Green Published, Green Submitted			2022-12-25	WOS:000332842400083
J	Bruhn, BR; Schroeder, TBH; Li, SY; Billeh, YN; Wang, KW; Mayer, M				Bruhn, Brandon R.; Schroeder, Thomas B. H.; Li, Suyi; Billeh, Yazan N.; Wang, K. W.; Mayer, Michael			Osmosis-Based Pressure Generation: Dynamics and Application	PLOS ONE			English	Article							POWER-GENERATION; POLYETHYLENE GLYCOLS; SAMANEA-SAMAN; MIMOSA-PUDICA; OSMOTIC PUMPS; MAIN PULVINUS; MOTOR CELLS; WATER; DELIVERY; MOVEMENT	This paper describes osmotically-driven pressure generation in a membrane-bound compartment while taking into account volume expansion, solute dilution, surface area to volume ratio, membrane hydraulic permeability, and changes in osmotic gradient, bulk modulus, and degree of membrane fouling. The emphasis lies on the dynamics of pressure generation; these dynamics have not previously been described in detail. Experimental results are compared to and supported by numerical simulations, which we make accessible as an open source tool. This approach reveals unintuitive results about the quantitative dependence of the speed of pressure generation on the relevant and interdependent parameters that will be encountered in most osmotically-driven pressure generators. For instance, restricting the volume expansion of a compartment allows it to generate its first 5 kPa of pressure seven times faster than without a restraint. In addition, this dynamics study shows that plants are near-ideal osmotic pressure generators, as they are composed of many small compartments with large surface area to volume ratios and strong cell wall reinforcements. Finally, we demonstrate two applications of an osmosis-based pressure generator: actuation of a soft robot and continuous volume delivery over long periods of time. Both applications do not need an external power source but rather take advantage of the energy released upon watering the pressure generators.	[Bruhn, Brandon R.; Billeh, Yazan N.; Mayer, Michael] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Schroeder, Thomas B. H.; Mayer, Michael] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Li, Suyi; Wang, K. W.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Mayer, M (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	mimayer@umich.edu	Mayer, Michael/AAS-1777-2020; Mayer, Michael/C-1299-2010	Mayer, Michael/0000-0002-6148-5756; Li, Suyi/0000-0002-0355-1655; Billeh, Yazan/0000-0001-5200-4992; Schroeder, Thomas/0000-0003-2795-1730	Agency: NSF [0937323]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB005582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008353] Funding Source: NIH RePORTER	Agency: NSF; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by: Agency: NSF, Federal Award ID Number: 0937323. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2010, DESALINATION, V261, P205, DOI 10.1016/j.desal.2010.06.017; Achilli A, 2009, J MEMBRANE SCI, V343, P42, DOI 10.1016/j.memsci.2009.07.006; Allen RD, 1967, STUDIES SEISMONASTIC; Benedek GB, 2000, PHYS ILLUSTRATIVE EX; Bessoth FG, 1999, ANAL COMMUN, V36, P213, DOI 10.1039/a902237f; Cath TY, 2006, J MEMBRANE SCI, V281, P70, DOI 10.1016/j.memsci.2006.05.048; Dumais J, 2012, ANNU REV FLUID MECH, V44, P453, DOI 10.1146/annurev-fluid-120710-101200; Eliassi A, 1998, J CHEM ENG DATA, V43, P719, DOI 10.1021/je970228a; Erbacher C, 1999, MIKROCHIM ACTA, V131, P19, DOI 10.1007/s006040050004; FLEURATLESSARD P, 1988, BIOL REV, V63, P1, DOI 10.1111/j.1469-185X.1988.tb00467.x; Gong MM, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.4762851; Good BT, 2007, J COLLOID INTERF SCI, V305, P239, DOI 10.1016/j.jcis.2006.08.067; GORTON HL, 1987, PLANT PHYSIOL, V83, P945, DOI 10.1104/pp.83.4.945; Haynes WM., 2013, CRC HDB CHEM PHYS, V94th; Herz M, 2010, SENSOR ACTUAT A-PHYS, V163, P231, DOI 10.1016/j.sna.2010.05.018; HILL BS, 1981, Q REV BIOPHYS, V14, P173, DOI 10.1017/S0033583500002249; Huang SB, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/4/045008; Ilievski F, 2011, ANGEW CHEM INT EDIT, V50, P1890, DOI 10.1002/anie.201006464; International Energy Agency, 2012, WORLD EN OUTL; Iverson BD, 2008, MICROFLUID NANOFLUID, V5, P145, DOI 10.1007/s10404-008-0266-8; Kagawa H, 2000, JSME INT J C-MECH SY, V43, P923, DOI 10.1299/jsmec.43.923; Kim SJ, 2013, LAB CHIP, V13, P1644, DOI 10.1039/c3lc41415a; Kim Y, 2009, LAB CHIP, V9, P2603, DOI 10.1039/b822423d; Kopp MU, 1998, SCIENCE, V280, P1046, DOI 10.1126/science.280.5366.1046; LAURELL T, 1995, BIOSENS BIOELECTRON, V10, P289, DOI 10.1016/0956-5663(95)96848-S; Leslie DC, 2009, NAT PHYS, V5, P231, DOI 10.1038/NPHYS1196; Liu LX, 2008, EUR J PHARM BIOPHARM, V68, P298, DOI 10.1016/j.ejpb.2007.04.020; Logan BE, 2012, NATURE, V488, P313, DOI 10.1038/nature11477; Martinez RV, 2013, ADV MATER, V25, P205, DOI 10.1002/adma.201203002; Martinez RV, 2012, ADV FUNCT MATER, V22, P1376, DOI 10.1002/adfm.201102978; Mayer M, 1996, ANAL CHIM ACTA, V324, P37, DOI 10.1016/0003-2670(95)00576-5; MAYER WE, 1985, PLANTA, V163, P381, DOI 10.1007/BF00395147; McCutcheon JR, 2006, J MEMBRANE SCI, V284, P237, DOI 10.1016/j.memsci.2006.07.049; McGinnis RL, 2007, J MEMBRANE SCI, V305, P13, DOI 10.1016/j.memsci.2007.08.027; Mescher MJ, 2009, J MICROELECTROMECH S, V18, P501, DOI 10.1109/JMEMS.2009.2015484; MONEY NP, 1989, PLANT PHYSIOL, V91, P766, DOI 10.1104/pp.91.2.766; Moshelion M, 2002, PLANT CELL, V14, P727, DOI 10.1105/tpc.010351; Pinho SP, 2005, J CHEM ENG DATA, V50, P29, DOI 10.1021/je049922y; Rose S, 1955, NATURE, V33, P415; SAMEJIMA M, 1980, PLANT CELL PHYSIOL, V21, P467; Sewell WF, 2009, AUDIOL NEURO-OTOL, V14, P411, DOI 10.1159/000241898; Sharpe PJH, 1987, STOMATAL FUNCTION; Shepherd RF, 2011, P NATL ACAD SCI USA, V108, P20400, DOI 10.1073/pnas.1116564108; Strathmann H, 2000, ULLMANNS ENCY IND CH, DOI DOI 10.1002/14356007.016_; Stroock AD, 2013, ANN REV FLUID MECH; Su YC, 2002, J MICROELECTROMECH S, V11, P736, DOI 10.1109/JMEMS.2002.805045; Swanson D R, 1987, Am J Med, V83, P3, DOI 10.1016/0002-9343(87)90629-2; THEEUWES F, 1976, ANN BIOMED ENG, V4, P343, DOI 10.1007/BF02584524; THEEUWES F, 1975, J PHARM SCI, V64, P1987, DOI 10.1002/jps.2600641218; Walker GM, 2002, LAB CHIP, V2, P131, DOI 10.1039/b204381e; WILL PC, 1980, J PHARM SCI, V69, P747, DOI 10.1002/jps.2600690644; Zimmermann U., 1979, ADV BOT RES, VVolume 6, P45, DOI DOI 10.1016/S0065-2296(08)60329-8	52	21	21	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91350	10.1371/journal.pone.0091350	http://dx.doi.org/10.1371/journal.pone.0091350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614529	Green Published, gold, Green Submitted			2022-12-25	WOS:000332839300115
J	Ebrahimie, M; Esmaeili, F; Cheraghi, S; Houshmand, F; Shabani, L; Ebrahimie, E				Ebrahimie, Marzieh; Esmaeili, Fariba; Cheraghi, Somayeh; Houshmand, Fariba; Shabani, Leila; Ebrahimie, Esmaeil			Efficient and Simple Production of Insulin-Producing Cells from Embryonal Carcinoma Stem Cells Using Mouse Neonate Pancreas Extract, As a Natural Inducer	PLOS ONE			English	Article							VITRO TRANS-DIFFERENTIATION; NUTRITIONAL-STATUS; EXPRESSION; TISSUE; PLURIPOTENCY; REPLICATION; PROGENITOR; IMPROVES; NETWORKS; ISLETS	An attractive approach to replace the destroyed insulin-producing cells (IPCs) is the generation of functional beta cells from stem cells. Embryonal carcinoma (EC) stem cells are pluripotent cells which can differentiate into all cell types. The present study was carried out to establish a simple nonselective inductive culture system for generation of IPCs from P19 EC cells by 1-2 weeks old mouse pancreas extract (MPE). Since, mouse pancreatic islets undergo further remodeling and maturation for 2-3 weeks after birth, we hypothesized that the mouse neonatal MPE contains essential factors to induce in vitro differentiation of pancreatic lineages. Pluripotency of P19 cells were first confirmed by expression analysis of stem cell markers, Oct3/4, Sox-2 and Nanog. In order to induce differentiation, the cells were cultured in a medium supplemented by different concentrations of MPE (50, 100, 200 and 300 mg/ml). The results showed that P19 cells could differentiate into IPCs and form dithizone-positive cell clusters. The generated P19-derived IPCs were immunoreactive to proinsulin, insulin and insulin receptor beta. The expression of pancreatic beta cell genes including, PDX-1, INS1 and INS2 were also confirmed. The peak response at the 100 mg/ml MPE used for investigation of EP300 and CREB1 gene expression. When stimulated with glucose, these cells synthesized and secreted insulin. Network analysis of the key transcription factors (PDX-1, EP300, CREB1) during the generation of IPCs resulted in introduction of novel regulatory candidates such as MIR17, and VEZF1 transcription factors, as well as MORN1, DKFZp761P0212, and WAC proteins. Altogether, we demonstrated the possibility of generating IPCs from undifferentiated EC cells, with the characteristics of pancreatic beta cells. The derivation of pancreatic cells from EC cells which are ES cell siblings would provide a valuable experimental tool in study of pancreatic development and function as well as rapid production of IPCs for transplantation.	[Ebrahimie, Marzieh; Shabani, Leila] Shahrekord Univ, Fac Basic Sci, Dept Biol, Shahrekord, Iran; [Esmaeili, Fariba] Univ Isfahan, Fac Basic Sci, Dept Biol, Esfahan, Iran; [Esmaeili, Fariba; Shabani, Leila] Shahrekord Univ, Biotechnol Res Inst, Shahrekord, Iran; [Cheraghi, Somayeh] Azad Islamic Univ Shahrekord, Fac Basic Sci, Dept Biol, Shahrekord, Iran; [Houshmand, Fariba] Shahrekord Univ Med Sci, Dept Physiol, Fac Med Sci, Shahrekord, Iran; [Ebrahimie, Esmaeil] Shiraz Univ, Inst Biotechnol, Shiraz, Iran; [Ebrahimie, Esmaeil] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	Shahrekord University; University of Isfahan; Shahrekord University; Islamic Azad University; Shahrekord University Medical Sciences; Shiraz University; University of Adelaide	Ebrahimie, E (corresponding author), Shiraz Univ, Inst Biotechnol, Shiraz, Iran.	esmaeili-f@sci.sku.ac.ir	Ebrahimi, Mansour/AAO-9096-2021; Ebrahimie, Esmaeil/AAN-2611-2020; Shabani, Leila/ABA-2527-2021; Houshmand, Fariba/K-2445-2017	Ebrahimi, Mansour/0000-0001-7011-2567; Ebrahimie, Esmaeil/0000-0002-4431-2861; Shabani, Leila/0000-0001-6194-4708; Houshmand, Fariba/0000-0002-2836-9884	Shahrekord University	Shahrekord University	The work carried out in the institute was supported by grant from Shahrekord University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assady S, 2001, DIABETES, V50, P1691, DOI 10.2337/diabetes.50.8.1691; Bai L, 2005, J ENDOCRINOL, V186, P343, DOI 10.1677/joe.1.06078; BANTING FG, 1991, CAN MED ASSOC J, V145, P1281; Blyszczuk P, 2004, INT J DEV BIOL, V48, P1095, DOI 10.1387/ijdb.041904pb; Blyszczuk P, 2003, P NATL ACAD SCI USA, V100, P998, DOI 10.1073/pnas.0237371100; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; Brolen GKC, 2005, DIABETES, V54, P2867, DOI 10.2337/diabetes.54.10.2867; Chambon-Savanovitch C, 2001, J NUTR, V131, P813, DOI 10.1093/jn/131.3.813; Choi KS, 2005, BIOCHEM BIOPH RES CO, V330, P1299, DOI 10.1016/j.bbrc.2005.03.111; Crisera CA, 2000, DIFFERENTIATION, V65, P255, DOI 10.1046/j.1432-0436.2000.6550255.x; Farges MC, 1996, NUTRITION, V12, P189, DOI 10.1016/S0899-9007(96)91124-7; Fujikawa T, 2005, AM J PATHOL, V166, P1781, DOI 10.1016/S0002-9440(10)62488-1; FURUKAWA M, 1995, ENDOCR J, V42, P63, DOI 10.1507/endocrj.42.63; Guo W, 2009, CELL PROLIFERAT, V42, P49, DOI 10.1111/j.1365-2184.2008.00573.x; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; Hardikar AA, 1999, DIABETES RES CLIN PR, V46, P203, DOI 10.1016/S0168-8227(99)00098-4; Hori Y, 2002, P NATL ACAD SCI USA, V99, P16105, DOI 10.1073/pnas.252618999; Hosseinpour B, 2013, GENE, V531, P212, DOI 10.1016/j.gene.2013.09.011; Hu HL, 2012, MOL VIS, V18, P2388; Kahan BW, 2003, DIABETES, V52, P2016, DOI 10.2337/diabetes.52.8.2016; Khoo TS, 2013, DIFFERENTIATION, V85, P110, DOI 10.1016/j.diff.2013.01.004; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim YS, 2003, BIOCHEM BIOPH RES CO, V309, P528, DOI 10.1016/j.bbrc.2003.07.011; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kunisada Y, 2012, STEM CELL RES, V8, P274, DOI 10.1016/j.scr.2011.10.002; Lee J, 2008, BIOCHEM BIOPH RES CO, V375, P547, DOI 10.1016/j.bbrc.2008.08.064; Liu J, 2013, ACTA GEOL SIN-ENGL, V87, P1501, DOI 10.1111/1755-6724.12154; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Miyazaki S, 2004, DIABETES, V53, P1030, DOI 10.2337/diabetes.53.4.1030; Niwa H, 2001, CELL STRUCT FUNCT, V26, P137, DOI 10.1247/csf.26.137; Obayashi T, 2013, NUCLEIC ACIDS RES, V41, pD1014, DOI 10.1093/nar/gks1014; Obayashi T, 2011, NUCLEIC ACIDS RES, V39, pD1016, DOI 10.1093/nar/gkq1147; Obayashi T, 2009, DNA RES, V16, P249, DOI 10.1093/dnares/dsp016; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Pandey S., 2010, INT J PHARM SCI REV, V1, P68; RABINOVITCH A, 1982, DIABETES, V31, P160, DOI 10.2337/diabetes.31.2.160; Reddy S, 2000, PANCREAS, V20, P55, DOI 10.1097/00006676-200001000-00008; Ren JQ, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-1; Shin JS, 2005, BBA-PROTEINS PROTEOM, V1749, P23, DOI 10.1016/j.bbapap.2005.02.003; Shiroi A, 2005, WORLD J GASTROENTERO, V11, P4161; Soria B, 2000, DIABETES, V49, P157, DOI 10.2337/diabetes.49.2.157; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SWENNE I, 1987, DIABETES, V36, P288, DOI 10.2337/diabetes.36.3.288; Trounson A, 2006, ENDOCR REV, V27, P208, DOI 10.1210/er.2005-0016; Xu YX, 2009, TRANSPL P, V41, P1878, DOI 10.1016/j.transproceed.2009.01.087; Yang LJ, 2002, P NATL ACAD SCI USA, V99, P8078, DOI 10.1073/pnas.122210699; Zhang Yanmei, 2012, Sheng Wu Gong Cheng Xue Bao, V28, P214	48	30	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90885	10.1371/journal.pone.0090885	http://dx.doi.org/10.1371/journal.pone.0090885			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614166	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300050
J	Gao, X; Xu, N; Li, SB; Liu, LM				Gao, Xiang; Xu, Nan; Li, Shubo; Liu, Liming			Metabolic Engineering of Candida glabrata for Diacetyl Production	PLOS ONE			English	Article							ALPHA-ACETOLACTATE DECARBOXYLASE; ENHANCED PYRUVATE PRODUCTION; SACCHAROMYCES-CEREVISIAE; TORULOPSIS-GLABRATA; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; LACTOCOCCUS-LACTIS; CARBON FLUX; YEAST; SYNTHASE	In this study, Candida glabrata, an efficient pyruvate-producing strain, was metabolically engineered for the production of the food ingredient diacetyl. A diacetyl biosynthetic pathway was reconstructed based on genetic modifications and medium optimization. The former included (i) channeling carbon flux into the diacetyl biosynthetic pathway by amplification of acetolactate synthase, (ii) elimination of the branched pathway of alpha-acetolactate by deleting the ILV5 gene, and (iii) restriction of diacetyl degradation by deleting the BDH gene. The resultant strain showed an almost 1:1 co-production of alpha-acetolactate and diacetyl (0.95 g L-1). Furthermore, addition of Fe3+ to the medium enhanced the conversion of alpha-acetolactate to diacetyl and resulted in a two-fold increase in diacetyl production (2.1 g L-1). In addition, increased carbon flux was further channeled into diacetyl biosynthetic pathway and a titer of 4.7 g L-1 of diacetyl was achieved by altering the vitamin level in the flask culture. Thus, this study illustrates that C. glabrata could be tailored as an attractive platform for enhanced biosynthesis of beneficial products from pyruvate by metabolic engineering strategies.	[Gao, Xiang; Xu, Nan; Li, Shubo; Liu, Liming] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China; [Gao, Xiang; Xu, Nan; Li, Shubo; Liu, Liming] Jiangnan Univ, Sch Biotechnol, Key Lab Ind Biotechnol, Minist Educ, Wuxi, Jiangsu, Peoples R China; [Gao, Xiang; Xu, Nan; Li, Shubo; Liu, Liming] Jiangnan Univ, Lab Food Microbial Mfg Engn, Wuxi, Jiangsu, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University	Liu, LM (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China.	mingll@jiangnan.edu.cn	Liu, Liming/B-1972-2009	Liu, Liming/0000-0003-3022-936X; Xu, Nan/0000-0002-2510-3394	Supporting Program for Outstanding National Young Talents; Science Foundation for Distinguished Young Scholars of Jiangsu Province [BK2012002]; Program for Innovative Research Team of Ministry of Education of China [IRT1249]; Major State Basic Research Development Program of China (973 Program) [2013CB733600]; National Natural Science Foundation of China [31270079];  [CLE01N1111]	Supporting Program for Outstanding National Young Talents; Science Foundation for Distinguished Young Scholars of Jiangsu Province; Program for Innovative Research Team of Ministry of Education of China; Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 	This work was supported by the Supporting Program for Outstanding National Young Talents, the fund from Wuxi City (CLE01N1111), the Science Foundation for Distinguished Young Scholars of Jiangsu Province (BK2012002), the Program for Innovative Research Team of Ministry of Education of China (IRT1249), the Major State Basic Research Development Program of China (973 Program, 2013CB733600) and National Natural Science Foundation of China (31270079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsumi S, 2009, APPL ENVIRON MICROB, V75, P6306, DOI 10.1128/AEM.01160-09; Bateman JM, 2002, J BIOL CHEM, V277, P47946, DOI 10.1074/jbc.M209071200; Chen DW, 2007, FOOD CHEM, V103, P1343, DOI 10.1016/j.foodchem.2006.10.047; CHUANG LF, 1968, J BACTERIOL, V95, P2083, DOI 10.1128/JB.95.6.2083-2089.1968; Dasari S, 2011, APPL ENVIRON MICROB, V77, P727, DOI 10.1128/AEM.01579-10; Duong CT, 2011, METAB ENG, V13, P638, DOI 10.1016/j.ymben.2011.07.005; Ehsani M, 2009, APPL ENVIRON MICROB, V75, P3196, DOI 10.1128/AEM.02157-08; FALCO SC, 1985, NUCLEIC ACIDS RES, V13, P4011, DOI 10.1093/nar/13.11.4011; GOLLOP N, 1987, ANAL BIOCHEM, V160, P323, DOI 10.1016/0003-2697(87)90054-6; GOLLOP N, 1990, J BACTERIOL, V172, P3444, DOI 10.1128/jb.172.6.3444-3449.1990; Gonzalez E, 2000, J BIOL CHEM, V275, P35876, DOI 10.1074/jbc.M003035200; Gonzalez E, 2010, APPL ENVIRON MICROB, V76, P670, DOI 10.1128/AEM.01521-09; Guo TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036296; HOLTZCLAW WD, 1975, J BACTERIOL, V121, P917, DOI 10.1128/JB.121.3.917-922.1975; Hugenholtz J, 2000, APPL ENVIRON MICROB, V66, P4112, DOI 10.1128/AEM.66.9.4112-4114.2000; Li Y, 2001, APPL MICROBIOL BIOT, V55, P680, DOI 10.1007/s002530100598; Liu LM, 2007, BIOTECHNOL BIOENG, V97, P825, DOI 10.1002/bit.21290; Liu LM, 2007, METAB ENG, V9, P21, DOI 10.1016/j.ymben.2006.07.007; Liu LM, 2006, APPL MICROBIOL BIOT, V72, P377, DOI 10.1007/s00253-005-0284-3; Liu LM, 2004, LETT APPL MICROBIOL, V39, P199, DOI 10.1111/j.1472-765X.2004.01563.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Macierzanka M, 2008, BBA-MOL CELL RES, V1783, P107, DOI 10.1016/j.bbamcr.2007.09.009; MITHIEUX SM, 1995, YEAST, V11, P311, DOI 10.1002/yea.320110403; Mohr B, 1997, INT DAIRY J, V7, P701, DOI 10.1016/S0958-6946(97)00074-5; Monnet C, 2000, APPL ENVIRON MICROB, V66, P5518, DOI 10.1128/AEM.66.12.5518-5520.2000; Monnet C, 2007, FOOD MICROBIOL, V24, P601, DOI 10.1016/j.fm.2007.01.004; Nadal I, 2009, J IND MICROBIOL BIOT, V36, P1233, DOI 10.1007/s10295-009-0617-9; Ng CY, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-68; Omura F, 2008, APPL MICROBIOL BIOT, V78, P503, DOI 10.1007/s00253-007-1333-x; Ott A, 1997, J AGR FOOD CHEM, V45, P850, DOI 10.1021/jf960508e; Park JH, 2007, P NATL ACAD SCI USA, V104, P7797, DOI 10.1073/pnas.0702609104; POULSEN C, 1989, EUR J BIOCHEM, V185, P433, DOI 10.1111/j.1432-1033.1989.tb15133.x; RENNA MC, 1993, J BACTERIOL, V175, P3863, DOI 10.1128/JB.175.12.3863-3875.1993; Shin SH, 2012, J BACTERIOL, V194, P2371, DOI 10.1128/JB.00026-12; Wang YP, 2013, CURR OPIN BIOTECH, V24, P994, DOI 10.1016/j.copbio.2013.03.022; Xu N, 2013, MOL BIOSYST, V9, P205, DOI 10.1039/c2mb25311a; ZELENAYATROITSKAYA O, 1995, EMBO J, V14, P3268, DOI 10.1002/j.1460-2075.1995.tb07330.x; Zhang YJ, 2013, BIORESOURCE TECHNOL, V130, P256, DOI 10.1016/j.biortech.2012.10.036; Zhao L, 2009, WORLD J MICROB BIOT, V25, P57, DOI 10.1007/s11274-008-9862-8; Zhou JW, 2009, J MICROBIOL METH, V76, P70, DOI 10.1016/j.mimet.2008.09.011	40	12	14	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e89854	10.1371/journal.pone.0089854	http://dx.doi.org/10.1371/journal.pone.0089854			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614328	Green Submitted, Green Published, gold			2022-12-25	WOS:000332839300014
J	Guan, XW; Vengoechea, J; Zheng, SY; Sloan, AE; Chen, YW; Brat, DJ; O'Neill, BP; de Groot, J; Yust-Katz, S; Yung, WKA; Cohen, ML; Aldape, KD; Rosenfeld, S; Verhaak, RGW; Barnholtz-Sloan, JS				Guan, Xiaowei; Vengoechea, Jaime; Zheng, Siyuan; Sloan, Andrew E.; Chen, Yanwen; Brat, Daniel J.; O'Neill, Brian Patrick; de Groot, John; Yust-Katz, Shlomit; Yung, Wai-Kwan Alfred; Cohen, Mark L.; Aldape, Kenneth D.; Rosenfeld, Steven; Verhaak, Roeland G. W.; Barnholtz-Sloan, Jill S.			Molecular Subtypes of Glioblastoma Are Relevant to Lower Grade Glioma	PLOS ONE			English	Article							INTEGRATED GENOMIC ANALYSIS; IDH1 MUTATIONS; CLASSIFICATION; TEMOZOLOMIDE; MULTIFORME; SURVIVAL; OLIGODENDROGLIOMAS; DIAGNOSIS; PROFILES; PATHWAYS	Background: Gliomas are the most common primary malignant brain tumors in adults with great heterogeneity in histopathology and clinical course. The intent was to evaluate the relevance of known glioblastoma (GBM) expression and methylation based subtypes to grade II and III gliomas (ie. lower grade gliomas). Methods: Gene expression array, single nucleotide polymorphism (SNP) array and clinical data were obtained for 228 GBMs and 176 grade II/II gliomas (GII/III) from the publically available Rembrandt dataset. Two additional datasets with IDH1 mutation status were utilized as validation datasets (one publicly available dataset and one newly generated dataset from MD Anderson). Unsupervised clustering was performed and compared to gene expression subtypes assigned using the Verhaak et al 840-gene classifier. The glioma-CpG Island Methylator Phenotype (G-CIMP) was assigned using prediction models by Fine et al. Results: Unsupervised clustering by gene expression aligned with the Verhaak 840-gene subtype group assignments. GII/IIIs were preferentially assigned to the proneural subtype with IDH1 mutation and G-CIMP. GBMs were evenly distributed among the four subtypes. Proneural, IDH1 mutant, G-CIMP GII/III s had significantly better survival than other molecular subtypes. Only 6% of GBMs were proneural and had either IDH1 mutation or G-CIMP but these tumors had significantly better survival than other GBMs. Copy number changes in chromosomes 1p and 19q were associated with GII/IIIs, while these changes in CDKN2A, PTEN and EGFR were more commonly associated with GBMs. Conclusions: GBM gene-expression and methylation based subtypes are relevant for GII/III s and associate with overall survival differences. A better understanding of the association between these subtypes and GII/IIIs could further knowledge regarding prognosis and mechanisms of glioma progression.	[Guan, Xiaowei; Vengoechea, Jaime; Sloan, Andrew E.; Chen, Yanwen; Cohen, Mark L.; Barnholtz-Sloan, Jill S.] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH USA; [Vengoechea, Jaime] Univ Hosp Case Med Ctr, Dept Internal Med, Cleveland, OH USA; [Zheng, Siyuan; de Groot, John; Yust-Katz, Shlomit; Yung, Wai-Kwan Alfred; Aldape, Kenneth D.; Verhaak, Roeland G. W.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Sloan, Andrew E.] Univ Hosp Case Med Ctr, Dept Neurol Surg, Cleveland, OH USA; [Brat, Daniel J.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [O'Neill, Brian Patrick] Mayo Clin, Dept Neurol, Rochester, MN USA; [Cohen, Mark L.] Univ Hosp Case Med Ctr, Dept Pathol, Cleveland, OH USA; [Rosenfeld, Steven] Cleveland Clin, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University of Texas System; UTMD Anderson Cancer Center; Case Western Reserve University; Case Western Reserve University Hospital; Emory University; Mayo Clinic; Case Western Reserve University; Case Western Reserve University Hospital; Cleveland Clinic Foundation	Verhaak, RGW (corresponding author), Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.	rverhaak@mdanderson.org; jsb42@case.edu	Barnholtz-Sloan, Jill/A-4817-2011; Zheng, sy/GRS-3136-2022; Sloan, Andrew/AAE-9842-2020; Verhaak, Roel/ABE-7058-2020; Yung, W.K. Alfred/W-5016-2019	Barnholtz-Sloan, Jill/0000-0001-6190-9304; 	NCI [P30 CA043703, HHSN261201000057C, P50 CA108961, FP00073233]; National Cancer Institute [U24CA143883]; NATIONAL CANCER INSTITUTE [P30CA015083, U24CA143883, P30CA043703, P30CA016672, P50CA108961] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	JSB-S, XG, JV, YC, and AES were supported in part by NCI grant P30 CA043703 and NCI contract HHSN261201000057C. SZ and RGWV acknowledge support by National Cancer Institute grant U24CA143883. BPO was supported in part by NCI grant P50 CA108961 and NCI contract FP00073233. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Baysan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047839; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Brennan CW, 2013, SOMATIC GENOMI UNPUB; Cavaliere R, 2005, LANCET NEUROL, V4, P760, DOI 10.1016/S1474-4422(05)70222-2; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Coons SW, 1997, CANCER, V79, P1381, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W; Cooper LAD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012548; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dubbink HJ, 2009, NEUROLOGY, V73, P1792, DOI 10.1212/WNL.0b013e3181c34ace; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Giannini C, 2001, J NEUROPATH EXP NEUR, V60, P248, DOI 10.1093/jnen/60.3.248; Houillier C, 2010, NEUROLOGY, V75, P1560, DOI 10.1212/WNL.0b013e3181f96282; Iwamoto FM, 2008, J NEURO-ONCOL, V88, P293, DOI 10.1007/s11060-008-9563-z; Jiao YC, 2012, ONCOTARGET, V3, P709, DOI 10.18632/oncotarget.588; Lai A, 2011, J CLIN ONCOL, V29, P4482, DOI 10.1200/JCO.2010.33.8715; LANG FF, 1994, J NEUROSURG, V81, P427, DOI 10.3171/jns.1994.81.3.0427; Li A, 2009, CANCER RES, V69, P2091, DOI 10.1158/0008-5472.CAN-08-2100; Lin CL, 2003, SURG NEUROL, V60, P402, DOI 10.1016/S0090-3019(03)00322-7; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Noushmehr H, CANC CELL, V17, P510; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Schomas DA, 2009, NEURO-ONCOLOGY, V11, P437, DOI 10.1215/15228517-2008-102; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; van den Bent MJ, 2010, ACTA NEUROPATHOL, V120, P297, DOI 10.1007/s00401-010-0725-7; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yip S, 2012, J PATHOL, V226, P7, DOI 10.1002/path.2995	34	59	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91216	10.1371/journal.pone.0091216	http://dx.doi.org/10.1371/journal.pone.0091216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614622	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300098
J	Gussgard, AM; Hope, AJ; Jokstad, A; Tenenbaum, H; Wood, R				Gussgard, Anne Margrete; Hope, Andrew J.; Jokstad, Asbjorn; Tenenbaum, Howard; Wood, Robert			Assessment of Cancer Therapy-Induced Oral Mucositis Using a Patient-Reported Oral Mucositis Experience Questionnaire	PLOS ONE			English	Article							NECK-CANCER; RADIATION TREATMENT; SYMPTOM DISTRESS; TREATMENT BREAKS; HEAD; CHEMOTHERAPY; RADIOTHERAPY; VALIDATION; OUTCOMES; GUIDELINES	Objectives: Treatment of oral mucositis (OM) is challenging. In order to develop and test useful treatment approaches, the development of reliable, reproducible and simpler methods than are currently available for assessment of OM is important. A Patient-Reported Oral Mucositis Symptom (PROMS) scale was assessed in patients with head and neck cancer to determine if the patient-reported OM experience, as determined by using the PROMS scale, correlate with OM assessed by clinician-based scoring tools. Materials and Methods: Fifty patients with head and neck cancer and undergoing radiotherapy consented to participate. They were examined before cancer treatment and twice weekly during 6-7 weeks of therapy and once 4-6 weeks after therapy. Signs of OM were evaluated using the 3 clinician-based scoring tools; NCI-CTCAE v.3, the OMAS criteria and the Total VAS-OMAS. The participants' OM experiences were recorded using PROMS-questionnaires consisting of 10 questions on a visual analogue scale. Spearman rank correlation test were applied between the PROMS scale values and the clinician-determined scores. Repeated measures mixed linear models were applied to appraise the strengths of correlation at the different time points throughout the observation period. Results: Thirty-three participants completed all stages of the study. The participant experience of OM using the PROMS scale demonstrates good correlations (Spearman's Rho 0.65-0.78, p<0.001) with the clinician-determined scores on the group level over all time points and poor to good correlations (Spearman's Rho -0.12-0.70, p<0.001) on the group level at different time points during and after therapy. When mouth opening was problematic, i.e. during the 6th and 7th week after commencing cancer treatment, the Spearman's Rho varied between 0.19 and 0.70 (p<0.001). Conclusion: Patient experience of OM, as reported by the PROMS scale may be a feasible substitute for clinical assessment in situations where patients cannot endure oral examinations.	[Gussgard, Anne Margrete; Hope, Andrew J.; Tenenbaum, Howard; Wood, Robert] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; [Jokstad, Asbjorn; Tenenbaum, Howard] Univ Toronto, Fac Dent, Toronto, ON, Canada; [Tenenbaum, Howard] Mt Sinai Hosp, Dept Dent, Toronto, ON M5G 1X5, Canada; [Tenenbaum, Howard] Tel Aviv Univ, Div Periodontol, IL-69978 Tel Aviv, Israel; [Gussgard, Anne Margrete; Jokstad, Asbjorn] UiT Arctic Univ Norway, Fac Hlth Sci, Tromso, Norway	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Tel Aviv University; UiT The Arctic University of Tromso	Gussgard, AM (corresponding author), Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada.	anne.m.gussgard@uit.no	Jokstad, Asbjørn/C-8743-2012	Jokstad, Asbjørn/0000-0002-5902-4520; Gussgard, Anne Margrete/0000-0003-0395-1242				Altman D.G., 1991, PRACTICAL STATISTIC; Clarkson JE, 2010, COCHRANE DB SYST REV, V8; Cleeland CS, 2000, CANCER-AM CANCER SOC, V89, P1634, DOI 10.1002/1097-0142(20001001)89:7<1634::AID-CNCR29>3.0.CO;2-V; DEHAES JCJM, 1990, BRIT J CANCER, V62, P1034, DOI 10.1038/bjc.1990.434; Elting LS, 2008, CANCER-AM CANCER SOC, V113, P2704, DOI 10.1002/cncr.23898; Elting LS, 2007, INT J RADIAT ONCOL, V68, P1110, DOI 10.1016/j.ijrobp.2007.01.053; Epstein JB, 2007, CANCER-AM CANCER SOC, V109, P1914, DOI 10.1002/cncr.22620; Epstein JB, 2012, CA-CANCER J CLIN, V62, P401, DOI 10.3322/caac.21157; Farquhar-Smith P., 2010, ORAL COMPLICATIONS C, P241, DOI [10.1093/med/9780199543588.003.0024, DOI 10.1093/MED/9780199543588.003.0024]; Hammerlid E, 1999, BRIT J CANCER, V80, P766, DOI 10.1038/sj.bjc.6690420; Ho J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-263; Jones HA, 2006, AM J CLIN ONCOL-CANC, V29, P158, DOI 10.1097/01.coc.0000207424.62275.9d; Kushner JA, 2008, J CAN DENT ASSOC, V74, P59; Lalla RV, 2013, SUPPORT CARE CANCER, V21, P301, DOI 10.1007/s00520-012-1660-z; Lambertz CK, 2010, CLIN J ONCOL NURS, V14, P585, DOI 10.1188/10.CJON.585-593; Madsen SM, 2002, J INTERN MED, V251, P156, DOI 10.1046/j.1365-2796.2002.00949.x; Miaskowski C, 2001, J Natl Cancer Inst Monogr, P37; Murphy BA, 2009, J PAIN SYMPTOM MANAG, V38, P522, DOI 10.1016/j.jpainsymman.2008.12.004; Murphy Barbara A, 2007, J Support Oncol, V5, P13; National Cancer Institute, 2010, NAT CANC I COMM TERM; National Cancer Institute, 1982, CANC THER EV PROGR; National Cancer Institute, 1999, NAT CANC I COMM TOX; National Cancer Institute, 2003, NAT CANC I COMM TERM; Quinn B, 2008, EUR J CANCER, V44, P61, DOI 10.1016/j.ejca.2007.09.014; Rosenthal David I, 2007, J Support Oncol, V5, P23; Russo G, 2008, ONCOLOGIST, V13, P886, DOI 10.1634/theoncologist.2008-0024; Sonis ST, 1999, CANCER-AM CANCER SOC, V85, P2103, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2103::AID-CNCR2>3.0.CO;2-0; Trotti A, 2003, RADIOTHER ONCOL, V66, P253, DOI 10.1016/S0167-8140(02)00404-8; Vera-Llonch M, 2006, CANCER-AM CANCER SOC, V106, P329, DOI 10.1002/cncr.21622; Worthington HV, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000978.pub5	30	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91733	10.1371/journal.pone.0091733	http://dx.doi.org/10.1371/journal.pone.0091733			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614512	Green Submitted, Green Published, gold			2022-12-25	WOS:000332839300153
J	Hunter, EJ; Siegmund, T; Chan, RW				Hunter, Eric J.; Siegmund, Thomas; Chan, Roger W.			Strain Modulations as a Mechanism to Reduce Stress Relaxation in Laryngeal Tissues	PLOS ONE			English	Article							TIME-DEPENDENT BEHAVIOR; FUNDAMENTAL-FREQUENCY; MODEL; ELASTOMERS; TEACHERS; VIBRATO	Vocal fold tissues in animal and human species undergo deformation processes at several types of loading rates: a slow strain involved in vocal fold posturing (on the order of 1 Hz or so), cyclic and faster posturing often found in speech tasks or vocal embellishment (1-10 Hz), and shear strain associated with vocal fold vibration during phonation (100 Hz and higher). Relevant to these deformation patterns are the viscous properties of laryngeal tissues, which exhibit non-linear stress relaxation and recovery. In the current study, a large strain time-dependent constitutive model of human vocal fold tissue is used to investigate effects of phonatory posturing cyclic strain in the range of 1 Hz to 10 Hz. Tissue data for two subjects are considered and used to contrast the potential effects of age. Results suggest that modulation frequency and extent (amplitude), as well as the amount of vocal fold overall strain, all affect the change in stress relaxation with modulation added. Generally, the vocal fold cover reduces the rate of relaxation while the opposite is true for the vocal ligament. Further, higher modulation frequencies appear to reduce the rate of relaxation, primarily affecting the ligament. The potential benefits of cyclic strain, often found in vibrato (around 5 Hz modulation) and intonational inflection, are discussed in terms of vocal effort and vocal pitch maintenance. Additionally, elderly tissue appears to not exhibit these benefits to modulation. The exacerbating effect such modulations may have on certain voice disorders, such as muscle tension dysphonia, are explored.	[Hunter, Eric J.] Michigan State Univ, E Lansing, MI 48824 USA; [Hunter, Eric J.] Univ Utah, Natl Ctr Voice & Speech, Salt Lake City, UT USA; [Siegmund, Thomas] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA; [Chan, Roger W.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA	Michigan State University; Utah System of Higher Education; University of Utah; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hunter, EJ (corresponding author), Michigan State Univ, E Lansing, MI 48824 USA.	eric.hunter@ncvs2.org	Chan, Roger W/HII-4167-2022; Siegmund, Thomas/B-6371-2008	Chan, Roger W/0000-0002-7135-9702; Siegmund, Thomas/0000-0001-8162-9609; Hunter, Eric/0000-0001-5571-464X	National Institutes of Health [R01 DC006101, R01 DC008612]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006101, R01DC008612] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding for this work was provided in part by National Institutes of Health grants R01 DC006101 (P.I.: Roger W. Chan) and R01 DC008612 (P.I.: Ingo R. Titze). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIPOURHAGHIGHI F, 1985, J ACOUST SOC AM, V78, P1939, DOI 10.1121/1.392701; Bergstrom JS, 2000, MECH MATER, V32, P627, DOI 10.1016/S0167-6636(00)00028-4; Bergstrom JS, 1998, J MECH PHYS SOLIDS, V46, P931, DOI 10.1016/S0022-5096(97)00075-6; Bretos J, 2003, J VOICE, V17, P343, DOI 10.1067/S0892-1997(03)00006-7; Chan RW, 2009, LOGOP PHONIATR VOCO, P1; Hunter EJ, 2004, J ACOUST SOC AM, V115, P1747, DOI 10.1121/1.1652033; Hunter EJ, 2010, 12 NCVS; Hunter EJ, 2007, J APPL PHYSIOL, V103, P206, DOI 10.1152/japplphysiol.00892.2006; Hunter EJ, 2010, J SPEECH LANG HEAR R, V53, P862, DOI 10.1044/1092-4388(2009/09-0040); MIN YB, 1995, ANN OTO RHINOL LARYN, V104, P563, DOI 10.1177/000348949510400711; OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026; Perlman A. L., 1985, VOCAL FOLD PHYSL BIO, P273; Tembrock G., 1996, AKUSTISCHE KOMMUNIKA; Titze IR, 2007, J ACOUST SOC AM, V121, P469, DOI 10.1121/1.2390676; Titze IR, 2007, J ACOUST SOC AM, V121, P2254, DOI 10.1121/1.2697573; TITZE IR, 1994, J VOICE, V8, P215, DOI 10.1016/S0892-1997(05)80292-9; Yamaguchi C, 2009, AM J PRIMATOL, V71, P617, DOI 10.1002/ajp.20697; Zhang K, 2006, J ACOUST SOC AM, V119, P1050, DOI 10.1121/1.2159433; Zhang K, 2009, J VOICE, V23, P277, DOI 10.1016/j.jvoice.2007.09.010; Zhang K, 2009, J MECH BEHAV BIOMED, V2, P93, DOI 10.1016/j.jmbbm.2008.05.005	20	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90762	10.1371/journal.pone.0090762	http://dx.doi.org/10.1371/journal.pone.0090762			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614616	Green Submitted, gold, Green Published			2022-12-25	WOS:000332839300039
J	Juel, C; Nordsborg, NB; Bangsbo, J				Juel, Carsten; Nordsborg, Nikolai B.; Bangsbo, Jens			Purinergic Effects on Na,K-ATPase Activity Differ in Rat and Human Skeletal Muscle	PLOS ONE			English	Article							EXERCISE; RECEPTOR; ATPASE; PHOSPHORYLATION; PHOSPHOLEMMAN; ACTIVATION; ADENOSINE; AFFINITY; CLONING; FXYD1	Background: P2Y receptor activation may link the effect of purines to increased maximal in vitro activity of the Na, K-ATPase in rat muscle. The hypothesis that a similar mechanism is present in human skeletal muscle was investigated with membranes from rat and human skeletal muscle. Results: Membranes purified from rat and human muscles were used in the Na, K-ATPase assay. Incubation with ADP, the stable ADP analogue MeS-ADP and UDP increased the Na+ dependent Na, K-ATPase activity in rat muscle membranes, whereas similar treatments of human muscle membranes lowered the Na, K-ATPase activity. UTP incubation resulted in unchanged Na, K-ATPase activity in humans, but pre-incubation with the antagonist suramin resulted in inhibition with UTP, suggesting that P2Y receptors are involved. The Na, K-ATPase in membranes from both rat and human could be stimulated by protein kinase A and C activation. Thus, protein kinase A and C activation can increase Na, K-ATPase activity in human muscle but not via P2Y receptor stimulation. Conclusion: The inhibitory effects of most purines (with the exception of UTP) in human muscle membranes are probably due to mass law inhibition of ATP hydrolysis. This inhibition could be blurred in rat due to receptor mediated activation of the Na, K-ATPase. The different effects could be related to a high density of ADP sensitive P2Y1 and P2Y13 receptors in rat, whereas the UTP sensitive P2Y(11) could be more abundant in human. Alternatively, rat could possesses a mechanism for protein-protein interaction between P2Y receptors and the Na, K-ATPase, and this mechanism could be absent in human skeletal muscle (perhaps with the exception of the UTP sensitive P2Y(11) receptor). Perspective: Rat muscle is not a reliable model for purinergic effects on Na, K-ATPase in human skeletal muscle.	[Juel, Carsten] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Nordsborg, Nikolai B.; Bangsbo, Jens] Univ Copenhagen, Dept Nutr Exercise & Sport, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Juel, C (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	cjuel@bio.ku.dk	Juel, Carsten/J-5328-2014; Bangsbo, Jens/A-7192-2015; Nordsborg, Nikolai/O-6173-2014	Juel, Carsten/0000-0002-2373-6358; Bangsbo, Jens/0000-0003-1305-9274; Nordsborg, Nikolai/0000-0001-7077-9265	Lundbeck Foundation [R83-A8169]; Carlsberg Foundation [2010-01-0641]; FNU [11-107221]	Lundbeck Foundation(Lundbeckfonden); Carlsberg Foundation(Carlsberg Foundation); FNU(Danish Natural Science Research Council)	The Lundbeck Foundation (R83-A8169), The Carlsberg Foundation (2010-01-0641), FNU (11-107221). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Bibert S, 2008, J BIOL CHEM, V283, P476, DOI 10.1074/jbc.M705830200; Borno A, 2012, PURINERG SIGNAL, V8, P255, DOI 10.1007/s11302-011-9279-y; Broch-Lips M, 2010, AM J PHYSIOL-CELL PH, V298, pC1438, DOI 10.1152/ajpcell.00361.2009; Buvinic S, 2009, J BIOL CHEM, V284, P34490, DOI 10.1074/jbc.M109.057315; Clausen T, 2003, PHYSIOL REV, V83, P1269, DOI 10.1152/physrev.00011.2003; FORRESTER T, 1969, FED PROC, V28, P1280; Fumagalli M, 2004, BIOCHEM PHARMACOL, V68, P113, DOI 10.1016/j.bcp.2004.02.038; Juel C, 2013, AM J PHYSIOL-REG I, V304, pR1161, DOI 10.1152/ajpregu.00591.2012; Juel C, 2009, AM J PHYSIOL-REG I, V296, pR125, DOI 10.1152/ajpregu.90760.2008; KUGELGEN IV, 2008, BIOTREND REV, V3; Mortensen SP, 2009, AM J PHYSIOL-REG I, V296, pR1140, DOI 10.1152/ajpregu.90822.2008; Tamiya S, 2007, AM J PHYSIOL-CELL PH, V293, pC790, DOI 10.1152/ajpcell.00579.2006; Thomassen M, 2011, AM J PHYSIOL-REG I, V301, pR1808, DOI 10.1152/ajpregu.00066.2011; Walas H, 2012, PFLUG ARCH EUR J PHY, V463, P319, DOI 10.1007/s00424-011-1050-2; Webb TE, 1998, J NEUROCHEM, V71, P1348	16	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91175	10.1371/journal.pone.0091175	http://dx.doi.org/10.1371/journal.pone.0091175			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614174	gold, Green Published			2022-12-25	WOS:000332839300089
J	Lewis, B; Whitney, S; Hudacik, L; Galmin, L; Huaman, MC; Cristillo, AD				Lewis, Brad; Whitney, Stephen; Hudacik, Lauren; Galmin, Lindsey; Huaman, Maria Cecilia; Cristillo, Anthony D.			Nedd4-Mediated Increase in HIV-1 Gag and Env Proteins and Immunity following DNA-Vaccination of BALB/c Mice	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MURINE LEUKEMIA-VIRUS; LATE-BUDDING DOMAINS; ROUS-SARCOMA-VIRUS; LATE ASSEMBLY DOMAIN; E3 UBIQUITIN LIGASE; TSG101 UEV DOMAIN; SIMIAN IMMUNODEFICIENCY; MULTIVESICULAR BODY; PARTICLE RELEASE	The late assembly domain of many viruses is critical for budding. Within these domains, encoded in viral structural proteins, are the conserved motifs PTAP, PPxY and YPxL. These sequences are the key determinants for association of viral proteins with intracellular molecules such as Tsg101, Nedd4 and AIP1/ALIX. While roles for Tsg101 and AIP1/ALIX in HIV-1 budding have been well established, less is known about the role of Nedd4. Recent studies, however, have identified a function for Nedd4-like protein in HIV-1 release. In this study, we investigated post-transcriptional changes of Nedd4 following SHIVSF162P3 infection of rhesus macaques, its role on HIV-1 p24 and gp120 levels in vitro and its potential as an immune modulator in HIV vaccination of BALB/c mice. Increased Nedd4 protein levels were noted in both CD4(+) and CD8(+) T cells following SHIVSF162P3-infection of naive macaques. Transient co-transfection studies in 293 cells with HXB2 and Nedd4 demonstrated a Nedd4-mediated increase in p24 and gp120 levels. This increase was found to be dependent on the Ca2+/calmodulin-regulated phospholipid binding C2 domain and not ubiquitin ligase activity or HIV LTR activity. Co-transfection of Nedd4 with plasmid DNA expressing Gag or Env was further shown to augment both intracellular and extracellular Gag or Env proteins. To assess the potential of Nedd4 as an immune modulator, BALB/c mice were immunized intramuscularly with plasmid DNA encoding HIV gag, env and Nedd4. Nedd4 co-administration was found to increase serum anti-p24 but not anti-gp120 antibodies. Nedd4 co-injection was found to have no affect on Gag-or Env-specific IFN gamma but had a trend of increased Gag-specific IL-6, IL-17A and TNF alpha that was not seen following Env stimulation. Based on our initial findings, Nedd4-mediated changes in HIV protein levels and its potential use in HIV-1 vaccine development warrants further investigation.	[Lewis, Brad; Whitney, Stephen; Hudacik, Lauren; Galmin, Lindsey; Huaman, Maria Cecilia; Cristillo, Anthony D.] Adv BioSci Labs Inc, Rockville, MD 20850 USA		Cristillo, AD (corresponding author), Adv BioSci Labs Inc, Rockville, MD 20850 USA.	anthony.cristillo@ablinc.com						Amit I, 2004, GENE DEV, V18, P1737, DOI 10.1101/gad.294904; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Blot V, 2004, J CELL SCI, V117, P2357, DOI 10.1242/jcs.01095; Calistri A, 2009, J CELL PHYSIOL, V218, P175, DOI 10.1002/jcp.21587; Camus G, 2007, MOL BIOL CELL, V18, P3193, DOI 10.1091/mbc.E06-12-1147; Chung HY, 2008, J VIROL, V82, P4884, DOI 10.1128/JVI.02667-07; Cristillo AD, 2006, VIROLOGY, V346, P151, DOI 10.1016/j.virol.2005.10.038; Cristillo AD, 2008, BIOCHEM BIOPH RES CO, V366, P29, DOI 10.1016/j.bbrc.2007.11.052; Cristillo AD, 2007, VIROLOGY, V366, P197, DOI 10.1016/j.virol.2007.04.012; Demirov DG, 2002, P NATL ACAD SCI USA, V99, P955, DOI 10.1073/pnas.032511899; DIBRINO M, 1994, J IMMUNOL, V152, P620; Dussupt V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000339; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Goila-Gaur R, 2003, J VIROL, V77, P6507, DOI 10.1128/JVI.77.11.6507-6519.2003; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; HUANG MJ, 1995, J VIROL, V69, P6810, DOI 10.1128/JVI.69.11.6810-6818.1995; Humeau LM, 2004, MOL THER, V9, P902, DOI 10.1016/j.ymthe.2004.03.005; Kikonyogo A, 2001, P NATL ACAD SCI USA, V98, P11199, DOI 10.1073/pnas.201268998; Lee EM, 2010, J VIROL METHODS, V163, P287, DOI 10.1016/j.jviromet.2009.10.012; Li F, 2002, J VIROL, V76, P1569, DOI 10.1128/JVI.76.4.1569-1577.2002; Licata JM, 2003, J VIROL, V77, P1812, DOI 10.1128/JVI.77.3.1812-1819.2003; Martin-Serrano J, 2005, J CELL BIOL, V168, P89, DOI 10.1083/jcb.200408155; Martin-Serrano J, 2003, J VIROL, V77, P12373, DOI 10.1128/JVI.77.22.12373-12377.2003; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Martin-Serrano J, 2003, J VIROL, V77, P4794, DOI 10.1128/JVI.77.8.4794-4804.2003; Medina G, 2005, TRAFFIC, V6, P880, DOI 10.1111/j.1600-0854.2005.00323.x; Medina G, 2008, VIROLOGY, V377, P30, DOI 10.1016/j.virol.2008.04.024; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Nydegger S, 2003, TRAFFIC, V4, P902, DOI 10.1046/j.1600-0854.2003.00145.x; Ono A, 2004, J VIROL, V78, P1552, DOI 10.1128/JVI.78.3.1552-1563.2004; Ott DE, 1998, J VIROL, V72, P2962, DOI 10.1128/JVI.72.4.2962-2968.1998; Patnaik A, 2000, P NATL ACAD SCI USA, V97, P13069, DOI 10.1073/pnas.97.24.13069; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Pornillos O, 2002, EMBO J, V21, P2397, DOI 10.1093/emboj/21.10.2397; Pornillos O, 2002, NAT STRUCT BIOL, V9, P812, DOI 10.1038/nsb856; Puffer BA, 1997, J VIROL, V71, P6541, DOI 10.1128/JVI.71.9.6541-6546.1997; Ramon HE, 2012, J IMMUNOL, V188, P4023, DOI 10.4049/jimmunol.1102779; Resh MD, 2005, AIDS REV, V7, P84; Schubert U, 2000, P NATL ACAD SCI USA, V97, P13057, DOI 10.1073/pnas.97.24.13057; Segura-Morales C, 2005, J BIOL CHEM, V280, P27004, DOI 10.1074/jbc.M413735200; Sette P, 2010, J VIROL, V84, P8181, DOI 10.1128/JVI.00634-10; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Thurmond J, 2008, BIOINFORMATICS, V24, P1639, DOI 10.1093/bioinformatics/btn251; Usami Y, 2008, J VIROL, V82, P4898, DOI 10.1128/JVI.02675-07; Vana ML, 2004, J VIROL, V78, P13943, DOI 10.1128/JVI.78.24.13943-13953.2004; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; Weiss ER, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001107; WILLEY RL, 1988, P NATL ACAD SCI USA, V85, P9580, DOI 10.1073/pnas.85.24.9580; Xiang Y, 1996, J VIROL, V70, P5695, DOI 10.1128/JVI.70.8.5695-5700.1996; Yasuda J, 1998, J VIROL, V72, P4095, DOI 10.1128/JVI.72.5.4095-4103.1998; Yasuda J, 2003, J VIROL, V77, P9987, DOI 10.1128/JVI.77.18.9987-9992.2003; Yuan B, 2000, J VIROL, V74, P7250, DOI 10.1128/JVI.74.16.7250-7260.2000	56	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91267	10.1371/journal.pone.0091267	http://dx.doi.org/10.1371/journal.pone.0091267			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614057	Green Published, gold, Green Submitted			2022-12-25	WOS:000332839300105
J	Rowell, EA; Wang, LQ; Chunder, N; Hancock, WW; Wells, AD				Rowell, Emily A.; Wang, Liqing; Chunder, Neelanjana; Hancock, Wayne W.; Wells, Andrew D.			Regulation of T Cell Differentiation and Alloimmunity by the Cyclin-Dependent Kinase Inhibitor p18ink4c	PLOS ONE			English	Article							TRANSPLANTATION TOLERANCE; IN-VIVO; EFFECTOR FUNCTION; CLONAL EXPANSION; P27(KIP1); P18(INK4C); EXPRESSION; CDK6; PROLIFERATION; APOPTOSIS	Cellular proliferation in response to mitogenic stimuli is negatively regulated by the Cip/Kip and the Ink4 families of cyclin-dependent kinase (CDK) inhibitors. Several of these proteins are elevated in anergic T cells, suggesting a potential role in the induction or maintenance of tolerance. Our previous studies showed that p27(kip1) is required for the induction of T cell anergy and transplantation tolerance by costimulatory blockade, but a role for Ink4 proteins in these processes has not been established. Here we show that CD4+ T cells from mice genetically deficient for p18(ink4c) divide more rapidly than wild-type cells in response to antigenic, costimulatory and growth factor signals. However, this gain of proliferative function was accompanied by a moderate increase in the rate of cell death, and was accompanied by an overall defect in the generation of alloreactive IFN gamma-producing effector cells. Consistent with this, p18(ink4c)-deficient T cells were unable to induce graft-vs-host disease in vivo, and p18(ink4c) deficiency cooperated with costimulatory blockade to significantly increase the survival of fully mismatched allografts in a cardiac transplantation model. While both p18(ink4c) and p27(kip1) act to restrict T cell proliferation, p18(ink4c) exerts an opposite effect from p27(kip1) on alloimmunity and organ transplant rejection, most likely by sustaining T cell survival and the development of effector function. Our studies point to additional important links between the cell cycle machinery and the processes of T cell differentiation, survival and tolerance.	[Rowell, Emily A.; Hancock, Wayne W.; Wells, Andrew D.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Wang, Liqing; Chunder, Neelanjana; Hancock, Wayne W.; Wells, Andrew D.] Childrens Hosp Philadelphia, Res Inst, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Wells, AD (corresponding author), Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	adwells@mail.med.upenn.edu			NIH [AI054643]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI054643, R01AI054643] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant AI054643 to ADW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boussiotis VA, 2000, NAT MED, V6, P290, DOI 10.1038/73144; Chunder N, 2012, J IMMUNOL, V189, P5659, DOI 10.4049/jimmunol.1202313; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Dick FA, 2003, MOL CELL, V12, P639, DOI 10.1016/S1097-2765(03)00344-7; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Franklin DS, 1998, GENE DEV, V12, P2899, DOI 10.1101/gad.12.18.2899; Guan KL, 1996, MOL BIOL CELL, V7, P57, DOI 10.1091/mbc.7.1.57; GUAN KL, 1994, GENE DEV, V8, P2939, DOI 10.1101/gad.8.24.2939; Gudmundsdottir H, 1999, J IMMUNOL, V162, P5212; Guo Y, 2002, ONCOGENE, V21, P7545, DOI 10.1038/sj.onc.1205907; HIRAI H, 1995, MOL CELL BIOL, V15, P2672; Kovalev GI, 2001, J IMMUNOL, V167, P3285, DOI 10.4049/jimmunol.167.6.3285; Kozar K, 2005, CELL CYCLE, V4, P388, DOI 10.4161/cc.4.3.1551; Li LQ, 2006, NAT IMMUNOL, V7, P1157, DOI 10.1038/ni1398; Li XC, 2001, IMMUNITY, V14, P407, DOI 10.1016/S1074-7613(01)00121-2; Lissy NA, 2000, NATURE, V407, P642, DOI 10.1038/35036608; Mahony D, 1998, ONCOGENE, V16, P603, DOI 10.1038/sj.onc.1201570; Myers TK, 2004, EXP CELL RES, V300, P365, DOI 10.1016/j.yexcr.2004.07.024; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Noh SJ, 1999, CANCER RES, V59, P558; Rowell EA, 2005, J IMMUNOL, V174, P3359, DOI 10.4049/jimmunol.174.6.3359; Rowell EA, 2006, J IMMUNOL, V177, P5169, DOI 10.4049/jimmunol.177.8.5169; Rowell EA, 2006, CRIT REV IMMUNOL, V26, P189, DOI 10.1615/CritRevImmunol.v26.i3.10; Shen R, 2002, J IMMUNOL, V169, P714, DOI 10.4049/jimmunol.169.2.714; Singh A, 2010, MOL CELL BIOL, V30, P5145, DOI 10.1128/MCB.01045-09; Stiewe T, 2000, NAT GENET, V26, P464, DOI 10.1038/82617; Suchin EJ, 2001, J IMMUNOL, V166, P973, DOI 10.4049/jimmunol.166.2.973; Thullberg M, 2000, FEBS LETT, V470, P161, DOI 10.1016/S0014-5793(00)01307-7; Thullberg M, 2000, ONCOGENE, V19, P2870, DOI 10.1038/sj.onc.1203579; Tourigny MR, 2002, IMMUNITY, V17, P179, DOI 10.1016/S1074-7613(02)00364-3; Tsukiyama T, 2001, J IMMUNOL, V166, P304, DOI 10.4049/jimmunol.166.1.304; Tsutsui T, 1999, MOL CELL BIOL, V19, P7011; Venkataramani R, 1998, NAT STRUCT BIOL, V5, P74, DOI 10.1038/nsb0198-74; Wan YSY, 2003, IMMUNITY, V18, P331, DOI 10.1016/S1074-7613(03)00053-0; Wells AD, 2003, IMMUNOL REV, V196, P25, DOI 10.1046/j.1600-065X.2003.00080.x; Wolfraim LA, 2005, J IMMUNOL, V174, P2481, DOI 10.4049/jimmunol.174.5.2481; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zhang SM, 2000, J IMMUNOL, V165, P6270, DOI 10.4049/jimmunol.165.11.6270; Zindy F, 1997, CELL GROWTH DIFFER, V8, P1139	41	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91587	10.1371/journal.pone.0091587	http://dx.doi.org/10.1371/journal.pone.0091587			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614758	Green Submitted, gold, Green Published			2022-12-25	WOS:000332839300140
J	Sahin, G; Thompson, LH; Lavisse, S; Ozgur, M; Rbah-Vidal, L; Dolle, F; Hantraye, P; Kirik, D				Sahin, Gurdal; Thompson, Lachlan H.; Lavisse, Sonia; Ozgur, Merve; Rbah-Vidal, Latifa; Dolle, Frederic; Hantraye, Philippe; Kirik, Deniz			Differential Dopamine Receptor Occupancy Underlies L-DOPA-Induced Dyskinesia in a Rat Model of Parkinson's Disease	PLOS ONE			English	Article							LEVODOPA-INDUCED DYSKINESIA; IN-VIVO; STRIATAL NEURONS; ULTRASTRUCTURAL-LOCALIZATION; INVOLUNTARY MOVEMENTS; STRIATONIGRAL NEURONS; NONHUMAN-PRIMATES; F-18 FALLYPRIDE; DEFICIENT MICE; BASAL GANGLIA	Dyskinesia is a major side effect of an otherwise effective L-DOPA treatment in Parkinson's patients. The prevailing view for the underlying presynaptic mechanism of L-DOPA-induced dyskinesia (LID) suggests that surges in dopamine (DA) via uncontrolled release from serotonergic terminals results in abnormally high level of extracellular striatal dopamine. Here we used high-sensitivity online microdialysis and PET imaging techniques to directly investigate DA release properties from serotonergic terminals both in the parkinsonian striatum and after neuronal transplantation in 6-OHDA lesioned rats. Although L-DOPA administration resulted in a drift in extracellular DA levels, we found no evidence for abnormally high striatal DA release from serotonin neurons. The extracellular concentration of DA remained at or below levels detected in the intact striatum. Instead, our results showed that an inefficient release pool of DA associated with low D2 receptor binding remained unchanged. Taken together, these findings suggest that differential DA receptor activation rather than excessive release could be the underlying mechanism explaining LID seen in this model. Our data have important implications for development of drugs targeting the serotonergic system to reduce DA release to manage dyskinesia in patients with Parkinson's disease.	[Sahin, Gurdal; Thompson, Lachlan H.; Ozgur, Merve; Kirik, Deniz] Lund Univ, BRAINS Unit, Dept Expt Med Sci, Lund, Sweden; [Thompson, Lachlan H.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3010, Australia; [Lavisse, Sonia; Rbah-Vidal, Latifa; Hantraye, Philippe] CEA, Mol Imaging Res Ctr MIRCen, Inst Imagerie Biomed I2BM, Fontenay Aux Roses, France; [Dolle, Frederic] CEA, Serv Hosp Frederic Joliot, Inst Imagerie Biomed I2BM, F-91406 Orsay, France	Lund University; Florey Institute of Neuroscience & Mental Health; University of Melbourne; CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Sahin, G (corresponding author), Lund Univ, BRAINS Unit, Dept Expt Med Sci, Lund, Sweden.	Gurdal.Sahin@med.lu.se	RBAH-VIDAL, Latifa/M-4118-2015; Sahin, Gurdal/GLT-3712-2022; RBAH-VIDAL, Latifa/D-9150-2014; Dollé, Frédéric/R-5756-2017; Thompson, Lachlan/B-4545-2013	RBAH-VIDAL, Latifa/0000-0002-2273-2443; Sahin, Gurdal/0000-0002-9998-5983; Thompson, Lachlan/0000-0003-2632-0304; Ozgur Erat, Merve/0000-0002-0909-8433	Swedish Research Council [K2009-61P-20945-03-1]; Swedish Parkinson Foundation [334/10]; European Research Council (ERC) [242932]; European Union [LSHB-CT-2005-512146]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Parkinson Foundation; European Research Council (ERC)(European Research Council (ERC)European Commission); European Union(European Commission)	The authors would like to acknowledge the Swedish Research Council (K2009-61P-20945-03-1), Swedish Parkinson Foundation (grant no. 334/10), the European Research Council (ERC) Starting Grant (TreatPD, 242932) and European Union 6th Framework Program project Diagnostic Molecular Imaging (DiMI, LSHB-CT-2005-512146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 1999, NEUROBIOL DIS, V6, P461, DOI 10.1006/nbdi.1999.0259; ARAI R, 1994, BRAIN RES, V667, P295, DOI 10.1016/0006-8993(94)91511-3; Aubert I, 2005, ANN NEUROL, V57, P17, DOI 10.1002/ana.20296; Caille I, 1996, BRAIN RES, V730, P17, DOI 10.1016/0006-8993(96)00424-6; Cao XB, 2010, J NEUROSCI, V30, P7335, DOI 10.1523/JNEUROSCI.0252-10.2010; Carlsson T, 2006, NEUROBIOL DIS, V21, P657, DOI 10.1016/j.nbd.2005.09.008; Carlsson T, 2007, J NEUROSCI, V27, P8011, DOI 10.1523/JNEUROSCI.2079-07.2007; Carlsson T, 2009, BRAIN, V132, P319, DOI 10.1093/brain/awn305; Carta M, 2011, NEUROSCIENCE, V198, P245, DOI 10.1016/j.neuroscience.2011.07.070; Cederfjall E, 2011, NEUROBIOLOGY DIS; CHERGUI K, 1994, NEUROSCIENCE, V62, P641, DOI 10.1016/0306-4522(94)90465-0; Christian BT, 2000, SYNAPSE, V38, P71, DOI 10.1002/1098-2396(200010)38:1<71::AID-SYN8>3.0.CO;2-2; Constantinescu CC, 2011, SYNAPSE, V65, P778, DOI 10.1002/syn.20904; Darmopil S, 2009, BIOL PSYCHIAT, V66, P603, DOI 10.1016/j.biopsych.2009.04.025; DESCARRIES L, 1992, BRAIN RES, V569, P1, DOI 10.1016/0006-8993(92)90363-E; Dumartin B, 2000, P NATL ACAD SCI USA, V97, P1879, DOI 10.1073/pnas.97.4.1879; Dumartin B, 1998, J NEUROSCI, V18, P1650; Eskow KL, 2009, SYNAPSE, V63, P610, DOI 10.1002/syn.20630; Everett GM, 1970, SCIENCE, V168, P847, DOI DOI 10.1126/SCIENCE.168.3933.849; Fahn S, 2003, ANN NY ACAD SCI, V991, P1, DOI 10.1111/j.1749-6632.2003.tb07458.x; FREUND TF, 1984, NEUROSCIENCE, V13, P1189, DOI 10.1016/0306-4522(84)90294-X; Garcia J, 2011, NEUROBIOL DIS, V43, P576, DOI 10.1016/j.nbd.2011.05.004; Gerfen CR, 2002, J NEUROSCI, V22, P5042, DOI 10.1523/JNEUROSCI.22-12-05042.2002; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gonon F, 1997, J NEUROSCI, V17, P5972; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; HERSCH SM, 1995, J NEUROSCI, V15, P5222; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jones SR, 1998, J NEUROSCI, V18, P1979; Kim DS, 2006, NEUROSCIENCE, V137, P1381, DOI 10.1016/j.neuroscience.2005.10.054; Kuhnast B, 2009, J LABELLED COMPD RAD, V52, pS286; Lane EL, 2006, NEUROBIOL DIS, V22, P334, DOI 10.1016/j.nbd.2005.11.011; Laruelle M, 2000, J CEREBR BLOOD F MET, V20, P423, DOI 10.1097/00004647-200003000-00001; Lee CS, 2000, BRAIN, V123, P1365, DOI 10.1093/brain/123.7.1365; LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861, DOI 10.1073/pnas.90.19.8861; Lindgren HS, 2010, J NEUROCHEM, V112, P1465, DOI 10.1111/j.1471-4159.2009.06556.x; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Mela F, 2012, NEUROBIOL DIS, V45, P573, DOI 10.1016/j.nbd.2011.09.015; Moratalla R, 1996, NEURON, V17, P147, DOI 10.1016/S0896-6273(00)80288-3; Moss J, 2008, J NEUROSCI, V28, P11221, DOI 10.1523/JNEUROSCI.2780-08.2008; Mukherjee J, 2005, BRAIN RES, V1032, P77, DOI 10.1016/j.brainres.2004.11.005; MUKHERJEE J, 1995, NUCL MED BIOL, V22, P283, DOI 10.1016/0969-8051(94)00117-3; Munoz A, 2008, BRAIN, V131, P3380, DOI 10.1093/brain/awn235; Muriel MP, 1999, ANN NEUROL, V46, P103, DOI 10.1002/1531-8249(199907)46:1<103::AID-ANA15>3.0.CO;2-Z; Nahimi A, 2012, J NEUROCHEM, V120, P806, DOI 10.1111/j.1471-4159.2011.07598.x; Navailles S, 2011, PSYCHOPHARMACOLOGY, V213, P213, DOI 10.1007/s00213-010-2029-y; Navailles S, 2010, NEUROBIOL DIS, V38, P136, DOI 10.1016/j.nbd.2010.01.012; NG KY, 1970, SCIENCE, V170, P76, DOI 10.1126/science.170.3953.76; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pinheiro J, 2001, MIXED EFFECTS MODELS; R Core Team, 2012, R LANG ENV STAT COMP; Rice ME, 2011, NEUROSCIENCE, V198, P112, DOI 10.1016/j.neuroscience.2011.08.066; SESACK SR, 1994, J NEUROSCI, V14, P88; Slifstein M, 2010, SYNAPSE, V64, P350, DOI 10.1002/syn.20734; St-Hilaire M, 2005, NEUROBIOL DIS, V20, P450, DOI 10.1016/j.nbd.2005.04.001; Stocchi F, 2005, ARCH NEUROL-CHICAGO, V62, P905, DOI 10.1001/archneur.62.6.905; SUAUDCHAGNY MF, 1995, J NEUROCHEM, V65, P2603; Tanaka H, 1999, NEUROREPORT, V10, P631, DOI 10.1097/00001756-199902250-00034; Thorre K, 1997, J CHROMATOGR B, V694, P297, DOI 10.1016/S0378-4347(97)00126-6; Ulusoy A, 2010, P NATL ACAD SCI USA, V107, P13159, DOI 10.1073/pnas.1003432107; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Westin JE, 2007, BIOL PSYCHIAT, V62, P800, DOI 10.1016/j.biopsych.2006.11.032; Winkler C, 2002, NEUROBIOL DIS, V10, P165, DOI 10.1006/nbdi.2002.0499; YUNG KKL, 1995, NEUROSCIENCE, V65, P709, DOI 10.1016/0306-4522(94)00536-E	64	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90759	10.1371/journal.pone.0090759	http://dx.doi.org/10.1371/journal.pone.0090759			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614598	Green Published, gold			2022-12-25	WOS:000332839300038
J	Seidel, UK; Gronewold, J; Volsek, M; Todica, O; Kribben, A; Bruck, H; Hermann, DM				Seidel, Ulla K.; Gronewold, Janine; Volsek, Michaela; Todica, Olga; Kribben, Andreas; Bruck, Heike; Hermann, Dirk M.			Physical, Cognitive and Emotional Factors Contributing to Quality of Life, Functional Health and Participation in Community Dwelling in Chronic Kidney Disease	PLOS ONE			English	Article							DISABILITY INSTRUMENT; DIALYSIS OUTCOMES; PRACTICE PATTERNS; DEPRESSION; MORTALITY; HOSPITALIZATION; ASSOCIATION; PREVALENCE; PREDICTOR; SYMPTOMS	Background: Quality of life (QoL) impairment is a well-known consequence of chronic kidney disease (CKD). The factors influencing QoL and late life functional health are poorly examined. Methods: Using questionnaires combined with neuropsychological examinations, we prospectively evaluated physical, cognitive, and emotional factors influencing QoL, functional health and participation in community dwelling in 119 patients with CKD stages 3-5 including hemodialysis (61.5+/-15.7years; 63% men) and 54 control patients of the same age without CKD but with similar cardiovascular risk profile. Results: Compared with control patients, CKD patients showed impairment of the physical component of QoL and overall function, assessed by the SF-36 and LLFDI, whereas disability, assessed by LLFDI, was selectively impaired in CKD patients on hemodialysis. Multivariable linear regressions (forced entry) confirmed earlier findings that CKD stage (beta = -0.24; p = 0.012) and depression (beta = -0.30; p = 0.009) predicted the QoL physical component. Hitherto unknown, CKD stage (beta = -0.23; p = 0.007), cognition (beta = 0.20; p = 0.018), and depression (beta = -0.51; <0.001) predicted disability assessed by the LLFDI, while age (beta = -0.20; p = 0.023), male gender (B = 5.01; p = 0.004), CKD stage (beta = -0.23; p = 0.005), stroke history (B = -9.00; p = 0.034), and depression (beta = -0.41; p<0.001) predicted overall function. Interestingly, functional health deficits, cognitive disturbances, depression, and anxiety were evident almost only in CKD patients with coronary heart disease (found in 34.2% of CKD patients). The physical component of QoL and functional health decreased with age and depressive symptoms, and increased with cognitive abilities. Conclusions: In CKD, QoL, functional health, and participation in community dwelling are influenced by physical, cognitive, and emotional factors, most prominently in coronary heart disease patients.	[Seidel, Ulla K.; Gronewold, Janine; Todica, Olga; Hermann, Dirk M.] Univ Hosp Essen, Dept Neurol, Essen, Germany; [Volsek, Michaela; Kribben, Andreas; Bruck, Heike] Univ Hosp Essen, Dept Nephrol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Hermann, DM (corresponding author), Univ Hosp Essen, Dept Neurol, Essen, Germany.	dirk.hermann@uk-essen.de	Hermann, Dirk M./AAT-3652-2021; Hermann, Dirk M/AAP-5538-2020; Hermann, Dirk/GZB-9350-2022	Hermann, Dirk M./0000-0003-0198-3152; 	Federal Ministry of Education and Research [BMBF/NGFN 01GR0807]; Heinz Nixdorf Foundation; Dr. Werner Jackstadt Foundation	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Heinz Nixdorf Foundation; Dr. Werner Jackstadt Foundation	This work was supported by the Federal Ministry of Education and Research (BMBF/NGFN 01GR0807), the Heinz Nixdorf Foundation, and Dr. Werner Jackstadt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Kader K, 2009, CLIN J AM SOC NEPHRO, V4, P1057, DOI 10.2215/CJN.00430109; Abdel-Kader K, 2009, CLIN J AM SOC NEPHRO, V4, P711, DOI 10.2215/CJN.05191008; Aschenbrenner S., 2000, REGENSBURGER WORTFLU; Avramovic M, 2012, ARTIF ORGANS, V36, P581, DOI 10.1111/j.1525-1594.2011.01429.x; Baber U, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0386-y; Bullinger M, 1998, SF 36 FRAGEBOGEN ZUM; Buumler G., 1985, FARBE WORT INTERFERE; Chan R, 2009, CLIN J AM SOC NEPHRO, V4, P160, DOI 10.2215/CJN.01520308; Condé Simone Aparecida de Lima, 2010, Braz. J. Nephrol., V32, P242; Cruz MC, 2011, CLINICS, V66, P991, DOI 10.1590/S1807-59322011000600012; DeOreo PB, 1997, AM J KIDNEY DIS, V30, P204, DOI 10.1016/S0272-6386(97)90053-6; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Feng L, 2013, AM J GERIAT PSYCHIAT, V21, P570, DOI 10.1016/j.jagp.2012.12.020; GOKAL R, 1993, KIDNEY INT, V43, pS23; Gyamlani G, 2011, AM J MED SCI, V342, P186, DOI 10.1097/MAJ.0b013e3182113d9e; H?rting, 2000, WECHSLER GEDACHTNIST; Haley SM, 2002, J GERONTOL A-BIOL, V57, pM217, DOI 10.1093/gerona/57.4.M217; Hedayati SS, 2004, AM J KIDNEY DIS, V44, P207, DOI 10.1053/j.ajkd.2004.04.025; Jette AM, 2002, J GERONTOL A-BIOL, V57, pM209, DOI 10.1093/gerona/57.4.M209; Kalantar-Zadeh K, 2001, J AM SOC NEPHROL, V12, P2797, DOI 10.1681/ASN.V12122797; Karnofsky DA, 1949, EVALUATION CHEMOTHER; Karp JF, 2009, J AM GERIATR SOC, V57, P1612, DOI 10.1111/j.1532-5415.2009.02398.x; KIMMEL PL, 1995, J AM SOC NEPHROL, V5, P1826; Lee YJ, 2013, INT J CLIN PRACT, V67, P363, DOI 10.1111/ijcp.12020; Lopes AA, 2003, AM J KIDNEY DIS, V41, P605, DOI 10.1053/ajkd.2003.50122; Lowe SS, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-22; Lowrie EG, 2003, AM J KIDNEY DIS, V41, P1286, DOI 10.1016/S0272-6386(03)00361-5; Mapes DL, 2003, KIDNEY INT, V64, P339, DOI 10.1046/j.1523-1755.2003.00072.x; MCCLELLAN WM, 1991, J CLIN EPIDEMIOL, V44, P83, DOI 10.1016/0895-4356(91)90204-M; Mendelssohn DC, 2009, NEPHROL DIAL TRANSPL, V24, P555, DOI 10.1093/ndt/gfn484; Montinaro V, 2010, CLIN NEPHROL, V73, P36, DOI 10.2379/CNX06364; Mujais SK, 2009, CLIN J AM SOC NEPHRO, V4, P1293, DOI 10.2215/CJN.05541008; Odden MC, 2006, NEPHRON CLIN PRACT, V103, pC1, DOI 10.1159/000090112; Ouellette MM, 2004, STROKE, V35, P1404, DOI 10.1161/01.STR.0000127785.73065.34; Pagels AA, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-71; Perlman RL, 2005, AM J KIDNEY DIS, V45, P658, DOI 10.1053/j.ajkd.2004.12.021; Reitan R, 1992, TRAIL MAKING TEST; Russ M, 2002, REY COMPLEX FIGURE T; Salem S, 2012, AM J NEPHROL, V35, P31, DOI 10.1159/000334742; Seidel UK, 2014, KIDNEY INT, V85, P693, DOI 10.1038/ki.2013.366; U. S. Renal Data System, 2003, AM J KIDNEY DIS S, V41, pS7; U. S. Renal Data System, 2003, AM J KIDNEY DIS S, V41, pv; Watnick S, 2003, AM J KIDNEY DIS, V41, P105, DOI 10.1053/ajkd.2003.50029; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	45	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91176	10.1371/journal.pone.0091176	http://dx.doi.org/10.1371/journal.pone.0091176			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9FH	24614180	Green Submitted, gold, Green Published			2022-12-25	WOS:000332839300090
J	Wang, RP; Sun, PD				Wang, Ruipeng; Sun, Peter D.			Natural Killer Cell-Mediated Shedding of ULBP2	PLOS ONE			English	Article							SOLUBLE UL16-BINDING PROTEIN-2; NKG2D LIGAND EXPRESSION; CLINICAL-SIGNIFICANCE; POOR-PROGNOSIS; CUTTING EDGE; NK CELLS; T-CELLS; RECEPTOR; APOPTOSIS; ACTIVATION	UL16 binding proteins (ULBPs) are a family of cell surface proteins that are present in transformed and stressed cells and ligands for NKG2D. Soluble NKG2D ligands have been found in sera from cancer patients with their protein concentrations correlated with poor cancer prognosis. Here we show, for the first time, that human tumor cells lost their surface expression of ULBP2, but not ULBP1 and ULBP3, during NK cell-mediated cytolysis. In contrast to spontaneous shedding of NKG2D ligands, NK cytolysis-mediated shedding of ULBP2 was linked to target cell apoptosis, although both resulted from metalloproteinase cleavages. Inhibition of ULBP2 shedding by a metalloproteinase inhibitor BB-94 lead to reduced NK cell-mediated cytotoxicity and cytokine production. These results illustrate a regulation of NK cell effector functions through cytolysis-induced NKG2D ligand shedding. Consequently, compounds inhibiting NKG2D ligand shedding may offer therapeutic means to reduce excessive pathogenic NK cell activities.	[Wang, Ruipeng; Sun, Peter D.] NIAID, Struct Immunol Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Sun, PD (corresponding author), NIAID, Struct Immunol Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	psun@nih.gov	Wang, Ruipeng/I-1407-2013	Wang, Ruipeng/0000-0002-1003-1420	National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000853, ZIAAI000697] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The funding is provided by the National Institute of Allergy and Infectious Diseases Intramural research funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Boutet P, 2009, J IMMUNOL, V182, P49, DOI 10.4049/jimmunol.182.1.49; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(09)00098-3; DRANSFIELD I, 1995, BLOOD, V85, P3264, DOI 10.1182/blood.V85.11.3264.bloodjournal85113264; Ferraro C, 2000, CELL DEATH DIFFER, V7, P197, DOI 10.1038/sj.cdd.4400595; Fogel LA, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4232; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Hilpert J, 2012, J IMMUNOL, V189, P1360, DOI 10.4049/jimmunol.1200796; Koolwijk P, 2001, BLOOD, V97, P3123, DOI 10.1182/blood.V97.10.3123; Li K, 2009, CANCER IMMUNOL IMMUN, V58, P641, DOI 10.1007/s00262-008-0585-3; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Madge LA, 1999, J BIOL CHEM, V274, P13643, DOI 10.1074/jbc.274.19.13643; Nuckel H, 2010, LEUKEMIA, V24, P1152, DOI 10.1038/leu.2010.74; Paschen A, 2009, CLIN CANCER RES, V15, P5208, DOI 10.1158/1078-0432.CCR-09-0886; Phenix BN, 2001, BLOOD, V98, P1078, DOI 10.1182/blood.V98.4.1078; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Schleinitz N, 2010, IMMUNOLOGY, V131, P451, DOI 10.1111/j.1365-2567.2010.03360.x; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Tian ZG, 2012, J AUTOIMMUN, V39, P206, DOI 10.1016/j.jaut.2012.05.006; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Waldhauer I, 2006, CANCER RES, V66, P2520, DOI 10.1158/0008-5472.CAN-05-2520; Wang RP, 2012, J LEUKOCYTE BIOL, V91, P299, DOI 10.1189/jlb.0611308; Yamaguchi K, 2012, CANCER SCI, V103, P1405, DOI 10.1111/j.1349-7006.2012.02330.x	29	8	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91133	10.1371/journal.pone.0091133	http://dx.doi.org/10.1371/journal.pone.0091133			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614922	Green Submitted, Green Published, gold			2022-12-25	WOS:000332839300083
J	Zhang, JQ; Chen, LH; Chen, YF; Wang, WW; Cheng, L; Zhou, XD; Wang, J				Zhang, Jiuquan; Chen, Lihua; Chen, Yongfeng; Wang, Wenwei; Cheng, Lin; Zhou, Xiangdong; Wang, Jian			Tumor Vascularity and Glucose Metabolism Correlated in Adenocarcinoma, but Not in Squamous Cell Carcinoma of the Lung	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CONTRAST-ENHANCED MRI; GROUND-GLASS OPACITY; BLOOD-FLOW; FDG UPTAKE; CANCER; CT; ANGIOGENESIS; GROWTH; VOLUME	Background/Objectives: To prospectively examine the relation between tumor vascularity and glucose metabolism in adenocarcinoma (AC) and squamous cell carcinoma(SCC) of the lung by using positron emission tomography/computed tomography (PET/CT) and dynamic contrast enhanced magnetic resonance imaging (DCE-MRI). Materials and Methods: Forty-one consecutive patients with histologically confirmed untreated NSCLC underwent routine diagnostic work-up, including DCE-MRI and PET/CT. PET/CT images were used to derive glucose metabolism (SUVmax and SUVmean), and DCE-MRI images were used to derive tumor vascularity (Ktrans, Kep, Ve and iAUC). Any differences in the DCE-MRI and PET/CT estimations between the NSCLC subtypes were determined by the Wilcoxon rank sum test. Spearman's rank correlation coefficients were calculated between the DCE-MRI parameter values and the SUV. Results: SUVmean and SUVmax in AC were significantly lower than in SCC, but Ktrans and Ve in AC were significantly higher than in SCC. Significant correlations between SUV and DCE-MRI parameters were observed for SUVmax and Ve (rho = -0.357, P = 0.022), SUVmean and Ktrans (rho = -0.341, P = 0.029), and SUVmean and iAUC (rho = -0.374, P = 0.016) in total; for SUVmax and iAUC (rho = -0.420, P = 0.037), SUVmean and Ktrans (rho = -0.411, P = 0.041), SUVmean and Kep (rho = -0.045, P = 0.026), and SUVmean and iAUC (rho = -0.512, P = 0.009) in AC; However, for neither in SCC. Conclusion: AC and SCC showed different patterns in both tumor vascularity and glucose metabolism. Tumor vascularity and glucose metabolism negatively correlated in AC, but not in SCC. These differences may underlie the heterogeneity in clinical aspect of NSCLC subtypes and have implications for their imaging profiling and monitor the treatment response.	[Zhang, Jiuquan; Chen, Lihua; Cheng, Lin; Wang, Jian] Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China; [Chen, Yongfeng; Wang, Wenwei; Zhou, Xiangdong] Third Mil Med Univ, Southwest Hosp, Dept Resp Med, Chongqing, Peoples R China	Army Medical University; Army Medical University	Zhou, XD (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Resp Med, Chongqing, Peoples R China.	zhouxd_sw@163.com; wangjian_811@yahoo.com	ZHANG, JIUQUAN/X-8389-2019	Chen, Lihua/0000-0001-7249-2014; Chen, Lihua/0000-0001-5037-050X; Zhang, Jiuquan/0000-0003-0239-6988				Aronen HJ, 2000, CLIN CANCER RES, V6, P2189; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301; Brown RS, 1999, J NUCL MED, V40, P556; CLAYTON F, 1986, CANCER, V57, P1555, DOI 10.1002/1097-0142(19860415)57:8<1555::AID-CNCR2820570820>3.0.CO;2-N; de Geus-Oei LF, 2007, LUNG CANCER, V55, P79, DOI 10.1016/j.lungcan.2006.08.018; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Garber K, 2004, J NATL CANCER I, V96, P1805, DOI 10.1093/jnci/96.24.1805; George ML, 2001, BRIT J SURG, V88, P1628, DOI 10.1046/j.0007-1323.2001.01947.x; Giaccone G, 2005, J CLIN ONCOL, V23, P3235, DOI 10.1200/JCO.2005.08.409; Hoekstra CJ, 2002, CLIN CANCER RES, V8, P2109; Hunter GJ, 1998, CLIN CANCER RES, V4, P949; Kodama K, 2001, LUNG CANCER-J IASLC, V33, P17, DOI 10.1016/S0169-5002(01)00185-4; Komar G, 2009, CLIN CANCER RES, V15, P5511, DOI 10.1158/1078-0432.CCR-09-0414; Kuriyama K, 1999, AM J ROENTGENOL, V173, P465, DOI 10.2214/ajr.173.2.10430155; Lee KS, 1997, RADIOGRAPHICS, V17, P1345, DOI 10.1148/radiographics.17.6.9397450; Lee Y, 2013, KOREAN J RADIOL, V14, P375, DOI 10.3348/kjr.2013.14.2.375; Mankoff DA, 2002, J NUCL MED, V43, P500; Mankoff DA, 2009, CLIN CANCER RES, V15, P5294, DOI 10.1158/1078-0432.CCR-09-1448; Miles KA, 2008, CANCER IMAGING, V8, P81, DOI 10.1102/1470-7330.2008.0011; Miles KA, 2006, EUR J NUCL MED MOL I, V33, P22, DOI 10.1007/s00259-005-1932-7; NESBITT JC, 1995, ANN THORAC SURG, V60, P466, DOI 10.1016/0003-4975(95)00169-L; Nestle U, 2005, J NUCL MED, V46, P1342; Norris DG, 2001, NMR BIOMED, V14, P77, DOI 10.1002/nbm.682; Noworolski SM, 2008, MAGN RESON IMAGING, V26, P1071, DOI 10.1016/j.mri.2008.01.033; Padhani AR, 2010, RADIOLOGY, V256, P348, DOI 10.1148/radiol.10091760; Sauter AW, 2013, EUR J NUCL MED MOL I, V40, P677, DOI 10.1007/s00259-012-2318-2; Semple S, 2003, P 11 ANN M ISMRM TOR, V11, P1259; Shastry M, 2012, MOL IMAGING, V11, P353, DOI 10.2310/7290.2011.00052; Sobin LH, 2011, TNM CLASSIFICATION M; Tateishi U, 2002, J COMPUT ASSIST TOMO, V26, P185, DOI 10.1097/00004728-200203000-00004; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; van Laarhoven HWM, 2007, NMR BIOMED, V20, P128, DOI 10.1002/nbm.1098; Yu CJ, 2005, LUNG CANCER, V47, P59, DOI 10.1016/j.lungcan.2004.05.018; Zwick S, 2010, EUR RADIOL, V20, P432, DOI 10.1007/s00330-009-1556-6	36	12	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91649	10.1371/journal.pone.0091649	http://dx.doi.org/10.1371/journal.pone.0091649			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614132	Green Submitted, gold, Green Published			2022-12-25	WOS:000332839300146
J	Biller, A; Choli, M; Blaimer, M; Breuer, FA; Jakob, PM; Bartsch, AJ				Biller, Armin; Choli, Morwan; Blaimer, Martin; Breuer, Felix A.; Jakob, Peter M.; Bartsch, Andreas J.			Combined Acquisition Technique (CAT) for Neuroimaging of Multiple Sclerosis at Low Specific Absorption Rates (SAR)	PLOS ONE			English	Article							CLINICALLY ISOLATED SYNDROMES; BRAIN IMAGES; MRI CRITERIA; ROBUST; OPTIMIZATION; REGISTRATION	Purpose: To compare a novel combined acquisition technique (CAT) of turbo-spin-echo (TSE) and echo-planar-imaging (EPI) with conventional TSE. CAT reduces the electromagnetic energy load transmitted for spin excitation. This radiofrequency (RF) burden is limited by the specific absorption rate (SAR) for patient safety. SAR limits restrict high-field MRI applications, in particular. Material and Methods: The study was approved by the local Medical Ethics Committee. Written informed consent was obtained from all participants. T2- and PD-weighted brain images of n = 40 Multiple Sclerosis (MS) patients were acquired by CAT and TSE at 3 Tesla. Lesions were recorded by two blinded, board-certificated neuroradiologists. Diagnostic equivalence of CAT and TSE to detect MS lesions was evaluated along with their SAR, sound pressure level (SPL) and sensations of acoustic noise, heating, vibration and peripheral nerve stimulation. Results: Every MS lesion revealed on TSE was detected by CAT according to both raters (Cohen's kappa of within-rater/across-CAT/TSE lesion detection kappa(CAT) = 1.00, at an inter-rater lesion detection agreement of kappa(LES) = 0.82). CAT reduced the SAR burden significantly compared to TSE (p<0.001). Mean SAR differences between TSE and CAT were 29.0 (+/- 5.7) % for the T2-contrast and 32.7 (+/- 21.9) % for the PD-contrast (expressed as percentages of the effective SAR limit of 3.2 W/kg for head examinations). Average SPL of CAT was no louder than during TSE. Sensations of CAT-vs. TSE-induced heating, noise and scanning vibrations did not differ. Conclusion: T2-/PD-CAT is diagnostically equivalent to TSE for MS lesion detection yet substantially reduces the RF exposure. Such SAR reduction facilitates high-field MRI applications at 3 Tesla or above and corresponding protocol standardizations but CAT can also be used to scan faster, at higher resolution or with more slices. According to our data, CAT is no more uncomfortable than TSE scanning.	[Biller, Armin; Bartsch, Andreas J.] Heidelberg Univ, Dept Neuroradiol, Heidelberg, Germany; [Choli, Morwan; Blaimer, Martin; Breuer, Felix A.; Jakob, Peter M.] Res Ctr Magnet Resonance Bavaria MRB, Wurzburg, Germany; [Jakob, Peter M.] Univ Wurzburg, Dept Expt Phys 5, D-97070 Wurzburg, Germany; [Bartsch, Andreas J.] Univ Oxford, FMRIB Ctr, Oxford, England	Ruprecht Karls University Heidelberg; University of Wurzburg; University of Wurzburg; University of Oxford	Biller, A (corresponding author), Heidelberg Univ, Dept Neuroradiol, Heidelberg, Germany.	armin.biller@med.uni-heidelberg.de		Jakob, Peter/0000-0002-3481-5545; Blaimer, Martin/0000-0002-6360-9871	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by a grant of the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartsch AJ, 2007, NEUROIMAGE, V35, P234, DOI 10.1016/j.neuroimage.2006.11.026; Boss A, 2007, J MAGN RESON IMAGING, V26, P1334, DOI 10.1002/jmri.21156; Choli M, 2013, MAGN RESON MATER PHY, V26, P411, DOI 10.1007/s10334-012-0362-3; Choli M, 2010, J MAGN RESON IMAGING, V32, P997, DOI 10.1002/jmri.22327; Commission IE, 2010, 606012332010 IEC COM; Filippi M, 2011, RADIOLOGY, V259, P659, DOI 10.1148/radiol.11101362; Gallichan D, 2010, HUM BRAIN MAPP, V31, P193, DOI 10.1002/hbm.20856; Haller S, 2009, BRAIN RES, V1282, P74, DOI 10.1016/j.brainres.2009.05.094; HARVEY PR, 1994, MAGNET RESON MED, V32, P236, DOI 10.1002/mrm.1910320213; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Hennig J, 2003, MAGN RESON MED, V49, P527, DOI 10.1002/mrm.10391; Hillenbrand C, 2000, J MAGN RESON IMAGING, V11, P711, DOI 10.1002/1522-2586(200006)11:6<711::AID-JMRI19>3.0.CO;2-9; Jakob PM, 2002, MAGN RESON MED, V47, P425, DOI 10.1002/mrm.10095; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Montalban X, 2010, NEUROLOGY, V74, P427, DOI 10.1212/WNL.0b013e3181cec45c; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Rodegerdts EA, 2006, ACTA RADIOL, V47, P488, DOI 10.1080/02841850600647116; Rovira A, 2009, ARCH NEUROL-CHICAGO, V66, P587, DOI 10.1001/archneurol.2009.49; Shellock FG, 2004, RADIOLOGY, V232, P635, DOI 10.1148/radiol.2323030830; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Swanton JK, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.073247; van den Bergen B, 2007, PHYS MED BIOL, V52, P5429, DOI 10.1088/0031-9155/52/17/022; Wang ZW, 2007, J MAGN RESON IMAGING, V26, P437, DOI 10.1002/jmri.20977	26	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91030	10.1371/journal.pone.0091030	http://dx.doi.org/10.1371/journal.pone.0091030			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608106	Green Published, Green Submitted, gold			2022-12-25	WOS:000332485800084
J	Manjarrez, JR; Sun, L; Prince, T; Matts, RL				Manjarrez, Jacob R.; Sun, Liang; Prince, Thomas; Matts, Robert L.			Hsp90-Dependent Assembly of the DBC2/RhoBTB2-Cullin3 E3-Ligase Complex	PLOS ONE			English	Article							HIGH-AFFINITY BINDING; BREAST-CANCER; DBC2 GENE; UBIQUITIN LIGASES; COLORECTAL-CANCER; SUPPRESSOR GENES; RHOBTB2 DBC2; ALLELIC LOSS; RHO-GTPASES; HSP90	The expression of the wild-type tumor-suppressor gene DBC2 (Deleted-in-Breast Cancer 2, a.k.a RhoBTB2) is suppressed in many cancers, in addition to breast cancer. In a screen for Cdc37-associated proteins, DBC2 was identified to be a potential client protein of the 90 kDa heat shock protein (Hsp90) chaperone machine. Pull down assays of ectopically expressed DBC2 confirmed that DBC2 associated with Hsp90 and its co-chaperone components in reticulocyte lysate and MCF7 cells. Similar to other atypical Rho GTPases, DBC2 was found to have retained the capacity to bind GTP. The ability of DBC2 to bind GTP was modulated by the Hsp90 ATPase cycle, as demonstrated through the use of the Hsp90 chemical inhibitors, geldanamycin and molybdate. The binding of full length DBC2 to GTP was suppressed in the presence of geldanamycin, while it was enhanced in the presence of molybdate. Furthermore, assembly of DBC2-Cullin3-COP9 E3 ligase complexes was Hsp90-dependent. The data suggest a new paradigm for Hsp90-modulated assembly of a Cul3/DBC2 E3 ubiquitin ligase complex that may extend to other E3 ligase complexes.	[Manjarrez, Jacob R.; Sun, Liang; Prince, Thomas; Matts, Robert L.] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Matts, RL (corresponding author), Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA.	robert.matts@okstate.edu		Manjarrez, Jacob/0000-0002-8428-8659	Oklahoma Center for the Advancement of Science and Technology [HR06-070]; N.I.H. [3R01CA125392-03S109]; Sarkeys Foundation; Oklahoma Agricultural Experiment Station [1975]; NATIONAL CANCER INSTITUTE [R01CA125392] Funding Source: NIH RePORTER	Oklahoma Center for the Advancement of Science and Technology; N.I.H.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sarkeys Foundation; Oklahoma Agricultural Experiment Station; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant number HR06-070 from the Oklahoma Center for the Advancement of Science and Technology (RLM), 3R01CA125392-03S109 from N.I.H. (RLM), the Sarkeys Foundation, and the Oklahoma Agricultural Experiment Station (Project 1975). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; American Cancer Society, BREAST CANC FACTS FI; Arlander SJH, 2006, J BIOL CHEM, V281, P2989, DOI 10.1074/jbc.M508687200; Aspenstrom P, 2007, EXP CELL RES, V313, P3673, DOI 10.1016/j.yexcr.2007.07.022; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Berthold J, 2008, ACTA PHARMACOL SIN, V29, P285, DOI 10.1111/j.1745-7254.2008.00773.x; Berthold J, 2008, EXP CELL RES, V314, P3453, DOI 10.1016/j.yexcr.2008.09.005; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Brown MR, 1999, GYNECOL ONCOL, V74, P98, DOI 10.1006/gyno.1999.5439; Cayli S, 2009, J BIOL CHEM, V284, P34944, DOI 10.1074/jbc.M109.037952; Chang FK, 2006, J MOL BIOL, V364, P302, DOI 10.1016/j.jmb.2006.09.026; Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; Cho YG, 2008, ACTA ONCOL, V47, P366, DOI 10.1080/02841860701644094; Collado D, 2007, BIOCHEM BIOPH RES CO, V360, P600, DOI 10.1016/j.bbrc.2007.06.127; CRAIG D, 1992, NUCLEIC ACIDS RES, V20, P4987, DOI 10.1093/nar/20.19.4987; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Dong W, 2012, ASIAN PAC J CANCER P, V13, P2021, DOI 10.7314/APJCP.2012.13.5.2021; Echeverria PC, 2010, BBA-MOL CELL RES, V1803, P641, DOI 10.1016/j.bbamcr.2009.11.012; EMI M, 1992, CANCER RES, V52, P5368; Enchev RI, 2010, STRUCTURE, V18, P518, DOI 10.1016/j.str.2010.02.008; Felts SJ, 2007, CELL STRESS CHAPERON, V12, P353, DOI 10.1379/CSC-299.1; Frederick MJ, 2000, AM J PATHOL, V156, P1937, DOI 10.1016/S0002-9440(10)65067-5; Freeman SN, 2008, J BIOL CHEM, V283, P2353, DOI 10.1074/jbc.M705986200; Freeman SN, 2010, CANCER BIOL THER, V10, P1123, DOI 10.4161/cbt.10.11.13786; FUJIWARA Y, 1993, CANCER RES, V53, P1172; Gano JJ, 2010, MOL CELL PROTEOMICS, V9, P255, DOI 10.1074/mcp.M900261-MCP200; Garritano S, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.15; Hamaguchi M, 2002, P NATL ACAD SCI USA, V99, P13647, DOI 10.1073/pnas.212516099; Han LL, 2013, BIOTECHNOL LETT, V35, P1175, DOI 10.1007/s10529-013-1190-x; Hartson SD, 2000, BIOCHEMISTRY-US, V39, P7631, DOI 10.1021/bi000315r; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hromas R, 1999, BIOCHEM BIOPH RES CO, V255, P703, DOI 10.1006/bbrc.1999.0257; Jones TD, 2005, CANCER-AM CANCER SOC, V104, P1195, DOI 10.1002/cncr.21288; Kato JY, 2009, GENES CELLS, V14, P1209, DOI 10.1111/j.1365-2443.2009.01349.x; Knowles MA, 2005, CANCER LETT, V225, P121, DOI 10.1016/j.canlet.2004.10.047; KNOWLES MA, 1993, ONCOGENE, V8, P1357; Kotiguda GG, 2012, J BIOL CHEM, V287, P42031, DOI 10.1074/jbc.M112.387977; Lerebours F, 1999, INT J CANCER, V81, P854, DOI 10.1002/(SICI)1097-0215(19990611)81:6<854::AID-IJC3>3.0.CO;2-1; Lerebours F, 1999, GENE CHROMOSOME CANC, V25, P147, DOI 10.1002/(SICI)1098-2264(199906)25:2<147::AID-GCC10>3.0.CO;2-Z; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Ling LJ, 2010, CANCER BIOL THER, V10, P1115, DOI 10.4161/cbt.10.11.13431; Matts RL, 2009, CURR TOP MED CHEM, V9, P1462, DOI 10.2174/156802609789895692; McKinnon CM, 2008, ONCOGENE, V27, P6856, DOI 10.1038/onc.2008.317; Mirzaei MH, 2012, CELL J, V14, P19; Paduch M, 2001, ACTA BIOCHIM POL, V48, P829; Perez-Torrado R, 2006, BIOESSAYS, V28, P1194, DOI 10.1002/bies.20500; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Prince T, 2005, BIOCHEMISTRY-US, V44, P15287, DOI 10.1021/bi051423m; Prince T, 2005, BIOCHEM BIOPH RES CO, V331, P1331, DOI 10.1016/j.bbrc.2005.04.047; Prince T, 2004, J BIOL CHEM, V279, P39975, DOI 10.1074/jbc.M406882200; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Schwartz GF, 2008, CANCER, V113, P2627, DOI 10.1002/cncr.23903; Scroggins BT, 2003, BIOCHEMISTRY-US, V42, P12550, DOI 10.1021/bi035001t; Shao J, 2002, BIOCHEMISTRY-US, V41, P6770, DOI 10.1021/bi025737a; Shellenberger TD, 2004, CANCER RES, V64, P8262, DOI 10.1158/0008-5472.CAN-04-2056; Shi Y, 2008, UROL ONCOL-SEMIN ORI, V26, P465, DOI 10.1016/j.urolonc.2007.08.009; Siripurapu V, 2005, J MOL BIOL, V346, P83, DOI 10.1016/j.jmb.2004.11.043; Swalwell JI, 2002, GENE CHROMOSOME CANC, V33, P201, DOI 10.1002/gcc.10015; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; van den Heuvel S, 2004, CURR BIOL, V14, pR59, DOI 10.1016/j.cub.2003.12.044; Vocke CD, 1996, CANCER RES, V56, P2411; Wilkins A, 2004, GENE DEV, V18, P856, DOI 10.1101/gad.1177904; Wilkins A, 2008, METHOD ENZYMOL, V439, P103, DOI 10.1016/S0076-6879(07)00408-9; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Yoshihara T, 2007, BIOCHEM BIOPH RES CO, V358, P1076, DOI 10.1016/j.bbrc.2007.05.037	69	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90054	10.1371/journal.pone.0090054	http://dx.doi.org/10.1371/journal.pone.0090054			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608665	Green Published, gold, Green Submitted			2022-12-25	WOS:000332485800014
J	Meng, H; Zhang, Y; Zhao, LL; Zhao, WJ; He, C; Honaker, CF; Zhai, ZX; Sun, ZK; Siegel, PB				Meng, He; Zhang, Yan; Zhao, Lele; Zhao, Wenjing; He, Chuan; Honaker, Christa F.; Zhai, Zhengxiao; Sun, Zikui; Siegel, Paul B.			Body Weight Selection Affects Quantitative Genetic Correlated Responses in Gut Microbiota	PLOS ONE			English	Article							OBESITY; LINES; MICE	The abundance of gut microbiota can be viewed as a quantitative trait, which is affected by the genetics and environment of the host. To quantify the effects of host genetics, we calculated the heritability of abundance of specific microorganisms and genetic correlations among them in the gut microbiota of two lines of chickens maintained under the same husbandry and dietary regimes. The lines, which originated from a common founder population, had undergone >50 generations of selection for high (HW) or low (LW) 56-day body weight and now differ by more than 10-fold in body weight at selection age. We identified families of Paenibacillaceae, Streptococcaceae, Helicobacteraceae, and Burkholderiaceae that had moderate heritabilities. Although there were no obvious phenotypic correlations among gut microbiota, significant genetic correlations were observed. Moreover, the effects were modified by genetic selection for body weight, which altered the quantitative genetic background of the host. Heritabilities for Bacillaceae, Flavobacteriaceae, Helicobacteraceae, Comamonadaceae, Enterococcaceae, and Streptococcaceae were moderate in LW line and little to zero in the HW line. These results suggest that loci associated with these microbiota families, while exhibiting genetic variation in LW, have been fixed in HW line. Also, long term selection for body weight has altered the genetic correlations among gut microbiota. No microbiota families had significant heritabilities in both the LW and HW lines suggesting that the presence and/or absence of a particular microbiota family either has a strong growth promoting or inhibiting effect, but not both. These results demonstrate that the quantitative genetics of the host have considerable influence on the gut microbiota.	[Meng, He] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai Key Lab Vet Biotechnol, Shanghai 200030, Peoples R China; [Zhang, Yan; Zhao, Lele; Zhao, Wenjing; Zhai, Zhengxiao] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China; [Zhang, Yan] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Honaker, Christa F.; Siegel, Paul B.] Virginia Polytech Inst & State Univ, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA; [He, Chuan; Sun, Zikui] Shanghai Personal Biotechnol Ltd Co, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Meng, H (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai Key Lab Vet Biotechnol, Shanghai 200030, Peoples R China.	menghe@sjtu.edu.cn; yzhang@vbi.vt.edu; pbsiegel@vt.edu	He, Chuan/AAN-4356-2020; zhang, yan/AAG-7349-2019	He, Chuan/0000-0002-8532-2898; zhang, yan/0000-0003-0906-9410	National High Technology Research and Development Program of China [2011AA100901]; National Science Foundation of China [31272430]; Agriculture Development through Science and Technology Key Project of Shanghai [2012 (2-3)]; National Institute of Allergy and Infectious Diseases [HHSN272200900040C]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agriculture Development through Science and Technology Key Project of Shanghai; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National High Technology Research and Development Program of China (grant No. 2011AA100901, http://www.863.gov.cn/), the National Science Foundation of China (grant No. 31272430, http://www.nsfc.gov.cn), and Agriculture Development through Science and Technology Key Project of Shanghai (grant No. 2012 (2-3), http://www.shagri.org/). Yan Zhang's contribution has been funded in part with federal funds from the National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov) under contract no. HHSN272200900040C awarded to B.W. Sobral. No additional funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Dunnington EA, 1996, POULTRY SCI, V75, P1168, DOI 10.3382/ps.0751168; Dunnington EA, 2013, POULTRY SCI; Jacobsson L, 2005, GENET RES, V86, P115, DOI 10.1017/S0016672305007767; Khachatryan ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003064; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Marquez GC, 2010, POULTRY SCI, V89, P2580, DOI 10.3382/ps.2010-01034; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wei S, 2013, POULTRY SCI, V92, P671, DOI 10.3382/ps.2012-02822; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Zhang CH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3163; Zhao LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01163	19	52	65	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e89862	10.1371/journal.pone.0089862	http://dx.doi.org/10.1371/journal.pone.0089862			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608294	gold, Green Published, Green Submitted			2022-12-25	WOS:000332485800010
J	Pang, XD; Zhou, HX				Pang, Xiaodong; Zhou, Huan-Xiang			Design Rules for Selective Binding of Nuclear Localization Signals to Minor Site of Importin alpha	PLOS ONE			English	Article							STRUCTURAL BASIS; CRYSTAL-STRUCTURE; CRYSTALLOGRAPHIC ANALYSIS; SEQUENCE-BINDING; PROTEIN; RECOGNITION; SPECIFICITY; COMPLEX; DOMAIN	Selectivity is a critical issue in molecular recognition. However, design rules that underlie selectivity are often not well understood. Here, we studied five classical nuclear localization signals (NLSs) that contain the motif KRx(W/F/Y)xxAF and selectively bind to the minor site of importin alpha. The selectivity for the minor site is dissected by building structural models for the NLS-importin alpha complexes and analyzing the positive design and negative design in the NLSs. In our models, the KR residues of the motif occupy the P1' and P2' pockets of importin alpha, respectively, forming hydrogen-bonding and cation-pi interactions. The aromatic residue at the P4' position plays dual roles in the selectivity for the minor site: by forming pi-stacking with W357 of importin alpha to reinforce the minor-site binding; and by clashing with the P5 pocket in the major binding site. The F residue at the P8' position occupies a deep pocket, providing additional stabilization. The P7' position sits on a saddle next to the P8' pocket and hence requires a small residue; the A residue fulfills this requirement. The principal ideas behind these blind predictions turn out to be correct in an evaluation against subsequently available X-ray structures for the NLS-importin alpha complexes, but some details are incorrect. These results illustrate that the selectivity for the minor site can be achieved via a variety of design rules.	[Pang, Xiaodong; Zhou, Huan-Xiang] Florida State Univ, Dept Phys, Tallahassee, FL 32306 USA; [Pang, Xiaodong; Zhou, Huan-Xiang] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Zhou, HX (corresponding author), Florida State Univ, Dept Phys, Tallahassee, FL 32306 USA.	hzhou4@fsu.edu	Zhou, Huan-Xiang/AAH-9836-2020; Pang, Xiaodong/N-5853-2016; zhou, huan/GYJ-4398-2022; Zhou, Huan-Xiang/M-5170-2016	Zhou, Huan-Xiang/0000-0001-9020-0302; Pang, Xiaodong/0000-0001-5985-0470; Zhou, Huan-Xiang/0000-0001-9020-0302	NIH [GM058187, GM088187]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088187, R01GM058187] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH Grants GM058187 and GM088187. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRYSON JW, 1995, SCIENCE, V270, P935, DOI 10.1126/science.270.5238.935; Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200; Chang CW, 2013, TRAFFIC, V14, P1144, DOI 10.1111/tra.12098; Chang CW, 2012, PLANT CELL, V24, P5074, DOI 10.1105/tpc.112.104422; Chen MH, 2005, J BIOL CHEM, V280, P10599, DOI 10.1074/jbc.M413194200; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Cutress ML, 2008, J CELL SCI, V121, P957, DOI 10.1242/jcs.022103; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Barros AC, 2012, ACTA CRYSTALLOGR D, V68, P743, DOI 10.1107/S0907444912010281; Dias SMG, 2009, NAT STRUCT MOL BIOL, V16, P930, DOI 10.1038/nsmb.1649; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Giesecke A, 2010, J BIOL CHEM, V285, P17628, DOI 10.1074/jbc.M110.102343; Gilson MK, 2007, ANNU REV BIOPH BIOM, V36, P21, DOI 10.1146/annurev.biophys.36.040306.132550; Gouda H, 2003, BIOPOLYMERS, V68, P16, DOI 10.1002/bip.10270; Hill RB, 2000, ACCOUNTS CHEM RES, V33, P745, DOI 10.1021/ar970004h; Hirano H, 2011, BIOCHEM J, V375, P339; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lott K, 2011, J BIOL CHEM, V286, P28160, DOI 10.1074/jbc.M111.228007; Makkerh JPS, 1996, CURR BIOL, V6, P1025, DOI 10.1016/S0960-9822(02)00648-6; Marfori M, 2012, TRAFFIC, V13, P532, DOI 10.1111/j.1600-0854.2012.01329.x; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Matsuura Y, 2005, EMBO J, V24, P3681, DOI 10.1038/sj.emboj.7600843; Matsuura Y, 2003, EMBO J, V22, P5358, DOI 10.1093/emboj/cdg538; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Meyer EA, 2003, ANGEW CHEM INT EDIT, V42, P1210, DOI 10.1002/anie.200390319; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Moroianu J, 1996, P NATL ACAD SCI USA, V93, P6572, DOI 10.1073/pnas.93.13.6572; Mynott AV, 2011, FEBS J, V278, P1662, DOI 10.1111/j.1742-4658.2011.08086.x; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pumroy RA, 2012, J BIOL CHEM, V287, P2022, DOI 10.1074/jbc.M111.315838; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Takeda AAS, 2011, J MOL BIOL, V412, P226, DOI 10.1016/j.jmb.2011.07.038; Tan C, 2007, J PHYS CHEM B, V111, P12263, DOI 10.1021/jp073399n; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Worch R, 2008, PROTEINS, V71, P2026, DOI 10.1002/prot.21882; Yang SNY, 2010, J BIOL CHEM, V285, P19935, DOI 10.1074/jbc.M109.079574	44	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91025	10.1371/journal.pone.0091025	http://dx.doi.org/10.1371/journal.pone.0091025			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609064	Green Published, Green Submitted, gold			2022-12-25	WOS:000332485800082
J	Teplitsky, C; Tarka, M; Moller, AP; Nakagawa, S; Balbontin, J; Burke, TA; Doutrelant, C; Gregoire, A; Hansson, B; Hasselquist, D; Gustafsson, L; de Lope, F; Marzal, A; Mills, JA; Wheelwright, NT; Yarrall, JW; Charmantier, A				Teplitsky, Celine; Tarka, Maja; Moller, Anders P.; Nakagawa, Shinichi; Balbontin, Javier; Burke, Terry A.; Doutrelant, Claire; Gregoire, Arnaud; Hansson, Bengt; Hasselquist, Dennis; Gustafsson, Lars; de Lope, Florentino; Marzal, Alfonso; Mills, James A.; Wheelwright, Nathaniel T.; Yarrall, John W.; Charmantier, Anne			Assessing Multivariate Constraints to Evolution across Ten Long-Term Avian Studies	PLOS ONE			English	Article							GREAT REED WARBLERS; GENETIC-VARIATION; QUANTITATIVE GENETICS; NATURAL-SELECTION; BODY CONDITION; CLIMATE-CHANGE; DIRECTIONAL SELECTION; VARIANCE; FITNESS; BIRD	Background: In a rapidly changing world, it is of fundamental importance to understand processes constraining or facilitating adaptation through microevolution. As different traits of an organism covary, genetic correlations are expected to affect evolutionary trajectories. However, only limited empirical data are available. Methodology/Principal Findings: We investigate the extent to which multivariate constraints affect the rate of adaptation, focusing on four morphological traits often shown to harbour large amounts of genetic variance and considered to be subject to limited evolutionary constraints. Our data set includes unique long-term data for seven bird species and a total of 10 populations. We estimate population-specific matrices of genetic correlations and multivariate selection coefficients to predict evolutionary responses to selection. Using Bayesian methods that facilitate the propagation of errors in estimates, we compare (1) the rate of adaptation based on predicted response to selection when including genetic correlations with predictions from models where these genetic correlations were set to zero and (2) the multivariate evolvability in the direction of current selection to the average evolvability in random directions of the phenotypic space. We show that genetic correlations on average decrease the predicted rate of adaptation by 28%. Multivariate evolvability in the direction of current selection was systematically lower than average evolvability in random directions of space. These significant reductions in the rate of adaptation and reduced evolvability were due to a general nonalignment of selection and genetic variance, notably orthogonality of directional selection with the size axis along which most (60%) of the genetic variance is found. Conclusions: These results suggest that genetic correlations can impose significant constraints on the evolution of avian morphology in wild populations. This could have important impacts on evolutionary dynamics and hence population persistence in the face of rapid environmental change.	[Teplitsky, Celine] Univ Paris 06, CNRS, Museum Natl Hist Nat, Dept Ecol & Gest Biodiversite,UMR 7204,MNHN, Paris, France; [Tarka, Maja; Hansson, Bengt; Hasselquist, Dennis] Lund Univ, Dept Biol, Lund, Sweden; [Moller, Anders P.] Univ Paris Sud, CNRS, UMR 8079, Lab Ecol Syst & Evolut, Orsay, France; [Nakagawa, Shinichi] Univ Otago, Dept Zool, Dunedin, New Zealand; [Balbontin, Javier] Univ Seville, Dept Zool, Seville, Spain; [Burke, Terry A.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Doutrelant, Claire; Gregoire, Arnaud; Charmantier, Anne] CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, Montpellier, France; [Gustafsson, Lars] Uppsala Univ, Dept Anim Ecol, Evolutionary Biol Ctr, Uppsala, Sweden; [de Lope, Florentino; Marzal, Alfonso] Univ Extremadura, Dept Zool, Badajoz, Spain; [Wheelwright, Nathaniel T.] Bowdoin Coll, Dept Biol, Brunswick, ME 04011 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Lund University; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; University of Otago; University of Sevilla; University of Sheffield; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Uppsala University; Universidad de Extremadura; Bowdoin College	Teplitsky, C (corresponding author), Univ Paris 06, CNRS, Museum Natl Hist Nat, Dept Ecol & Gest Biodiversite,UMR 7204,MNHN, Paris, France.	teplitsky@mnhn.fr	Burke, Terry/B-3196-2011; Teplitsky, Celine/H-3621-2019; Tarka, Maja/L-8065-2013; Hansson, Bengt/L-8874-2013; Gustafsson, Lars/A-7634-2012; Moller, Anders/O-6665-2016; Gustafsson, Lars/O-8056-2019; Gregoire, Arnaud/B-6321-2008; Balbontín, Javier/H-5932-2015; Hasselquist, Dennis/M-5223-2014; Marzal, Alfonso/J-6677-2012; Nakagawa, Shinichi/B-5571-2011	Burke, Terry/0000-0003-3848-1244; Teplitsky, Celine/0000-0001-9458-709X; Tarka, Maja/0000-0001-9651-1101; Hansson, Bengt/0000-0001-6694-8169; Gustafsson, Lars/0000-0001-6566-2863; Moller, Anders/0000-0003-3739-4675; Gustafsson, Lars/0000-0001-6566-2863; Gregoire, Arnaud/0000-0001-6103-355X; Balbontín, Javier/0000-0003-1539-2636; Hasselquist, Dennis/0000-0002-0056-6616; Marzal, Alfonso/0000-0001-5872-1060; Nakagawa, Shinichi/0000-0002-7765-5182	French ANR [ANR-08-JCJC-0041-01, ANR-12-ADAP-0006]; OSU OREME; Swedish RC; Spanish MEC [CGL2009-08976]; NERC [NE/F006071/1, NE/J024597/1] Funding Source: UKRI; Natural Environment Research Council [NE/F006071/1, NE/J024597/1] Funding Source: researchfish; Direct For Biological Sciences [1226941] Funding Source: National Science Foundation	French ANR(French National Research Agency (ANR)); OSU OREME; Swedish RC; Spanish MEC(Spanish Government); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was funded by the French ANR (grant ANR-08-JCJC-0041-01 & ANR-12-ADAP-0006), by the OSU OREME, by grants from the Swedish RC (to BH and DH) and the Spanish MEC (CGL2009-08976) to JB, FdeL and AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AF, 2009, P ROY SOC B-BIOL SCI, V276, P1183, DOI 10.1098/rspb.2008.1671; Akesson M, 2007, J AVIAN BIOL, V38, P58, DOI 10.1111/j.2006.0908-8857.03669.x; ALATALO RV, 1990, AM NAT, V135, P464, DOI 10.1086/285056; Arnold SJ, 2008, EVOLUTION, V62, P2451, DOI 10.1111/j.1558-5646.2008.00472.x; Balbontin J, 2012, BIOL J LINN SOC, V105, P420, DOI 10.1111/j.1095-8312.2011.01800.x; Bjorklund M, 2013, J EVOLUTION BIOL, V26, P1, DOI 10.1111/jeb.12044; Blondel J, 2006, BIOSCIENCE, V56, P661, DOI 10.1641/0006-3568(2006)56[661:ATSOPA]2.0.CO;2; Blows MW, 2007, J EVOLUTION BIOL, V20, P1, DOI 10.1111/j.1420-9101.2006.01164.x; Blows MW, 2004, AM NAT, V163, P329, DOI 10.1086/381941; Charmantier A, 2006, P NATL ACAD SCI USA, V103, P6587, DOI 10.1073/pnas.0511123103; Charmantier A, 2014, QUANTITATIVE GENETICS IN THE WILD, P1; Charmantier A, 2004, J EVOLUTION BIOL, V17, P732, DOI 10.1111/j.1420-9101.2004.00734.x; Chenoweth SF, 2010, AM NAT, V175, P186, DOI 10.1086/649594; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Dingemanse NJ, 2009, P R SOC B, V276, P1285, DOI 10.1098/rspb.2008.1555; Eroukhmanoff F, 2009, EVOL BIOL, V36, P323, DOI 10.1007/s11692-009-9062-y; Etterson JR, 2004, EVOLUTION, V58, P1446, DOI 10.1111/j.0014-3820.2004.tb01726.x; Falconer D. S, 1996, INTRO QUANTITATIVE G; Frentiu FD, 2007, J EVOLUTION BIOL, V20, P639, DOI 10.1111/j.1420-9101.2006.01242.x; Garant D, 2008, MOL ECOL, V17, P179, DOI 10.1111/j.1365-294X.2007.03436.x; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Grant BR, 2003, BIOSCIENCE, V53, P965, DOI 10.1641/0006-3568(2003)053[0965:WDFCTU]2.0.CO;2; GRANT PR, 1995, EVOLUTION, V49, P241, DOI 10.1111/j.1558-5646.1995.tb02236.x; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hall KSS, 2004, J AVIAN BIOL, V35, P7; Hansen TF, 2008, J EVOLUTION BIOL, V21, P1201, DOI 10.1111/j.1420-9101.2008.01573.x; Hansen TF, 2003, J EVOLUTION BIOL, V16, P754, DOI 10.1046/j.1420-9101.2003.00556.x; Hansen TF, 2011, EVOL BIOL, V38, P258, DOI 10.1007/s11692-011-9127-6; Hansen TF, 2011, EVOLUTION, V65, P1821, DOI 10.1111/j.1558-5646.2011.01281.x; Hasselquist D, 1998, ECOLOGY, V79, P2376, DOI 10.2307/176829; Henderson C.R., 1973, J ANIM SCI, V1973, P10, DOI DOI 10.1093/ANSCI/1973.SYMPOSIUM.10; Hendry AP, 2010, EVOLUTION, V64, P1517, DOI 10.1111/j.1558-5646.2010.00947.x; HILL WG, 1992, ANNU REV ECOL SYST, V23, P287, DOI 10.1146/annurev.es.23.110192.001443; Hine E, 2009, PHILOS T R SOC B, V364, P1567, DOI 10.1098/rstb.2008.0313; Kimmel CB, 2012, EVOLUTION, V66, P419, DOI 10.1111/j.1558-5646.2011.01441.x; Kirkpatrick M, 2009, GENETICA, V136, P271, DOI 10.1007/s10709-008-9302-6; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Kruuk LEB, 2000, P NATL ACAD SCI USA, V97, P698, DOI 10.1073/pnas.97.2.698; Kruuk LEB, 2014, QUANTITATIVE GENETICS IN THE WILD, P160; Kruuk LEB, 2008, ANNU REV ECOL EVOL S, V39, P525, DOI 10.1146/annurev.ecolsys.39.110707.173542; LANDE R, 1983, EVOLUTION, V37, P1210, DOI [10.1111/j.1558-5646.1983.tb00236.x, 10.2307/2408842]; Leisler B, 2003, AVIAN MIGRATION, P175; Lynch M., 1998, GENETICS ANAL QUANTI; McCleery RH, 2004, AM NAT, V164, pE62, DOI 10.1086/422660; Merila J, 1999, GENET RES, V73, P165, DOI 10.1017/S0016672398003656; Merila J, 2001, J EVOLUTION BIOL, V14, P918, DOI 10.1046/j.1420-9101.2001.00353.x; Merila J, 2004, PHENOTYPIC INTEGRATION: STUDYING THE ECOLOGY AND EVOLUTION OF COMPLEX PHENOTYPES, P107; Merila J, 2001, GENETICA, V112, P199, DOI 10.1023/A:1013391806317; Merila J, 2012, BIOESSAYS, V34, P811, DOI 10.1002/bies.201200054; Mills JA, 1996, PARTNERSHIPS BIRDS S, P118; MOLLER AP, 1994, EVOLUTION, V48, P1676, DOI 10.1111/j.1558-5646.1994.tb02204.x; Morrissey MB, 2014, QUANTITATIVE GENETICS IN THE WILD, P228; Morrissey MB, 2012, AM NAT, V179, pE97, DOI 10.1086/664686; Morrissey MB, 2012, EVOLUTION, V66, P435, DOI 10.1111/j.1558-5646.2011.01444.x; Morrissey MB, 2010, MOL ECOL RESOUR, V10, P711, DOI 10.1111/j.1755-0998.2009.02817.x; MOUSSEAU TA, 1987, HEREDITY, V59, P181, DOI 10.1038/hdy.1987.113; Nakagawa S, 2008, BIOL LETTERS, V4, P667, DOI 10.1098/rsbl.2008.0349; Podos J, 2001, NATURE, V409, P185, DOI 10.1038/35051570; Roff DA, 1996, EVOLUTION, V50, P1392, DOI [10.2307/2410877, 10.1111/j.1558-5646.1996.tb03913.x]; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; Senar JC, 1997, ARDEA, V85, P269; Siepielski AM, 2009, ECOL LETT, V12, P1261, DOI 10.1111/j.1461-0248.2009.01381.x; Simonsen AK, 2010, INT J PLANT SCI, V171, P972, DOI 10.1086/656512; Stinchcombe JR, 2008, EVOLUTION, V62, P2435, DOI 10.1111/j.1558-5646.2008.00449.x; Teplitsky C, 2011, J EVOLUTION BIOL, V24, P2025, DOI 10.1111/j.1420-9101.2011.02342.x; Teplitsky C, 2014, QUANTITATIVE GENETICS IN THE WILD, P190; Teplitsky C, 2009, EVOLUTION, V63, P716, DOI 10.1111/j.1558-5646.2008.00581.x; Wagner GP, 1996, AM ZOOL, V36, P36; Walsh B, 2009, ANNU REV ECOL EVOL S, V40, P41, DOI 10.1146/annurev.ecolsys.110308.120232; Wheelwright NT, 2006, ANIM BEHAV, V71, P631, DOI 10.1016/j.anbehav.2005.06.012	70	45	45	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90444	10.1371/journal.pone.0090444	http://dx.doi.org/10.1371/journal.pone.0090444			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608111	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000332485800026
J	Yue, YX; Wang, Y; He, Y; Yang, ST; Chen, ZX; Wang, YY; Xing, SS; Shen, CC; Amin, HM; Wu, DP; Song, YH				Yue, Yingxing; Wang, Ying; He, Yang; Yang, Shuting; Chen, Zixing; Wang, Yuanyuan; Xing, Shanshan; Shen, Congcong; Amin, Hesham M.; Wu, Depei; Song, Yao-Hua			Reversal of Bortezomib Resistance in Myelodysplastic Syndrome Cells by MAPK Inhibitors	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; NF-KAPPA-B; MULTIPLE-MYELOMA; MYELOGENOUS LEUKEMIA; IMATINIB RESISTANCE; DRUG-RESISTANCE; IN-VITRO; ERK; ACTIVATION; APOPTOSIS	The myelodysplastic syndromes (MDS) comprise a heterogeneous group of malignant neoplasms with distinctive clinicopathological features. Currently, there is no specific approach for the treatment of MDS. Here, we report that bortezomib (BTZ), a proteasome inhibitor that has been used to treat plasma cell myeloma, induced G2/M phase cycle arrest in the MDS cell line SKM-1 through upregulation of Wee1, a negative regulator of G2/M phase transition. Treatment by BTZ led to reduced SKM-1 cell viability as well as increased apoptosis and autophagy. The BTZ-induced cell death was associated with reduced expression of p-ERK. To elucidate the implications of downregulation of p-ERK, we established the BTZ resistant cell line SKM-1R. Our data show that resistance to BTZ-induced apoptosis could be reversed by the MEK inhibitors U0126 or PD98059. Our results suggest that MAPK pathway may play an important role in mediating BTZ resistance.	[Yue, Yingxing; Yang, Shuting; Xing, Shanshan; Shen, Congcong; Song, Yao-Hua] Soochow Univ, Affiliated Hosp 1, Cyrus Tang Hematol Ctr, Jiangsu Inst Hematol, Suzhou, Peoples R China; [Wang, Ying; He, Yang; Chen, Zixing; Wang, Yuanyuan; Wu, Depei] Soochow Univ, Affiliated Hosp 1, Key Lab Thrombosis & Hemostasis, Jiangsu Inst Hematol,Minist Hlth, Suzhou, Peoples R China; [Amin, Hesham M.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA	Soochow University - China; Soochow University - China; University of Texas System; UTMD Anderson Cancer Center	Wu, DP (corresponding author), Soochow Univ, Affiliated Hosp 1, Key Lab Thrombosis & Hemostasis, Jiangsu Inst Hematol,Minist Hlth, Suzhou, Peoples R China.	wudepei@medmail.com.cn; yaohua_song1@yahoo.com	Lv, Yuanjie/AER-0767-2022		project for the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	project for the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the project for the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams SL, 2010, CELL CYCLE, V9, P1781, DOI 10.4161/cc.9.9.11483; Attar EC, 2013, LEUKEMIA RES, V37, P1016, DOI 10.1016/j.leukres.2013.05.011; Bosman MCJ, 2013, EXP HEMATOL, V41, P530, DOI 10.1016/j.exphem.2013.02.002; Chung E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028350; Fang J, 2012, BLOOD, V120, P858, DOI 10.1182/blood-2012-02-407999; Fenouille N, 2010, CANCER RES, V70, P9659, DOI 10.1158/0008-5472.CAN-10-2034; Hiraoka Y, 2004, P NATL ACAD SCI USA, V101, P6427, DOI 10.1073/pnas.0401631101; Howard D.S., 2013, LEUK RES; Hu JS, 2013, MOL CANCER THER, V12, P1763, DOI 10.1158/1535-7163.MCT-13-0123; Huang J, 2011, INT J HEMATOL, V93, P482, DOI 10.1007/s12185-011-0821-z; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kinkade CW, 2008, J CLIN INVEST, V118, P3051, DOI 10.1172/JCI34764; Kornblau SM, 2006, BLOOD, V108, P2358, DOI 10.1182/blood-2006-02-003475; Lew DJ, 1996, CURR OPIN CELL BIOL, V8, P795, DOI 10.1016/S0955-0674(96)80080-9; Lu SQ, 2011, EXP HEMATOL, V39, P1117, DOI 10.1016/j.exphem.2011.09.003; Manni S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075280; Naci D, 2012, J BIOL CHEM, V287, P17065, DOI 10.1074/jbc.M112.349365; NAKAGAWA T, 1993, BRIT J HAEMATOL, V85, P469; Natarajan-Ame S, 2012, BRIT J HAEMATOL, V158, P232, DOI 10.1111/j.1365-2141.2012.09153.x; Oerlemans R, 2008, BLOOD, V112, P2489, DOI 10.1182/blood-2007-08-104950; Petrucci MT, 2013, BRIT J HAEMATOL, V160, P649, DOI 10.1111/bjh.12198; Ria R, 2013, CLIN CANC RES; Ricciardi MR, 2005, LEUKEMIA, V19, P1543, DOI 10.1038/sj.leu.2403859; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; San-Miguel JF, 2013, J CLIN ONCOL, V31, P3696, DOI 10.1200/JCO.2012.46.7068; Shelton JG, 2005, EXPERT OPIN THER TAR, V9, P1009, DOI 10.1517/14728222.9.5.1009; Shi L, 2010, ONCOTARGET, V1, P22, DOI 10.18632/oncotarget.105; Shringarpure R, 2006, BRIT J HAEMATOL, V134, P145, DOI 10.1111/j.1365-2141.2006.06132.x; Smith AJ, 2011, J BIOL CHEM, V286, P17682, DOI 10.1074/jbc.M110.189092; Staser K, 2013, J CLIN INVEST, V123, P329, DOI 10.1172/JCI66167; Steube KG, 1997, LEUKEMIA LYMPHOMA, V25, P345, DOI 10.3109/10428199709114174; Suzuki M, 2010, EUR J HAEMATOL, V84, P229, DOI 10.1111/j.1600-0609.2009.01387.x; Wang AH, 2011, ANN HEMATOL, V90, P917, DOI 10.1007/s00277-011-1175-6; Yang F, 2012, CANCER BIOL THER, V13, P349, DOI 10.4161/cbt.19239	34	3	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90992	10.1371/journal.pone.0090992	http://dx.doi.org/10.1371/journal.pone.0090992			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608798	Green Published, gold, Green Submitted			2022-12-25	WOS:000332485800076
J	Zhang, Y; Wang, J; Li, ZH; Xiao, J; Zhao, L; Yan, G; Shi, ZJ				Zhang Yang; Wang Jian; Li Zhi-han; Xiao Jun; Zhao Liang; Yan Ge; Shi Zhan-jun			The Geometry of the Bone Structure Associated with Total Hip Arthroplasty	PLOS ONE			English	Article							FEMORAL COMPONENTS; PROXIMAL FEMUR; ANATOMIC BASIS; CT EVALUATION; STEMS; OSTEOTOMIES; MORPHOLOGY; DYSPLASIA; DESIGN; CEMENT	Close adaptation of the prosthesis to the bone is the key to achieving optimal stability and fixation for total hip arthroplasty (THA). However, there have been no adequate studies of bone morphology, especially in different races. The aim of this study was to analyze the geometry of the acetabulum and proximal femur of people from South China, based on three-dimensional reconstruction, and to detect differences between different population subsets. CT scans were performed on 80 healthy volunteers (160 hips) from South China, comprising 40 males (80 hips) and 40 females (80 hips). The images were imported into Mimics 10.01 to perform 3D reconstruction. THA-associated anatomical parameters were measured and compared with other published data. In comparison with published data, it seemed that people from South China have smaller acetabular abduction angle, larger acetabular supro-inferior diameter, larger neck-shaft angle, smaller offset, thinner femoral shaft and more proximal isthmus, which needed to be further confirmed. There were significant differences between the genders in most parameters. As significant differences in canal flare index (CFI) and distal canal flare index (DCFI) were found between genders, it was concluded the most significant differences lay in the isthmus of the femur. Among the femora, according to Noble's classification we identified more normal types and fewer stovepipe and champagne-flute types than expected from the literature, indicating that uncemented prostheses would be suitable for most people from South China. Our findings reveal that simply choosing the smallest of a series of prostheses would not necessarily provide a good fit, due to the different trends from the proximal to the distal part of the femur. Significant variation exists in THA-associated anatomy between genders and population subsets. It is therefore imperative that each patient receives individual consideration rather than assuming all patients have the same anatomy, especially for different races.	[Zhang Yang; Wang Jian; Li Zhi-han; Xiao Jun; Zhao Liang; Yan Ge; Shi Zhan-jun] Southern Med Univ, Nanfang Hosp, Dept Orthopaed Surg, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Shi, ZJ (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Orthopaed Surg, Guangzhou, Guangdong, Peoples R China.	mariaresearcher@hotmail.com	Zhang, Yang/GOP-2217-2022; Zhao, Liang/T-9147-2019					Aydogan M, 2013, EUR J ORTHOP SURG TR, V20; Bargar WL, 1993, J BONE JOINT SURG S3, V75, P255; Blaimont P, 1993, Acta Orthop Belg, V59 Suppl 1, P170; Clark J M, 1987, J Arthroplasty, V2, P99, DOI 10.1016/S0883-5403(87)80016-5; Dai KR, 1985, T ORTHOP RES SOC, V10, P99; Delaunay C, 1998, REV CHIR ORTHOP, V84, P421; Haddad FS, 2000, J BONE JOINT SURG BR, V82B, P526, DOI 10.1302/0301-620X.82B4.10174; HAVELIN LI, 1995, J BONE JOINT SURG BR, V77B, P11, DOI 10.1302/0301-620X.77B1.7822364; Higashi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025403; Hipp JA, 1999, CLIN ORTHOP RELAT R, P134; HUA J, 1994, J BONE JOINT SURG AM, V76A, P95, DOI 10.2106/00004623-199401000-00012; HUISKES R, 1995, CLIN ORTHOP RELAT R, P64; Husmann O, 1997, J ARTHROPLASTY, V12, P444, DOI 10.1016/S0883-5403(97)90201-1; KLAUE K, 1988, CLIN ORTHOP RELAT R, P15; Laine HJ, 2000, J ARTHROPLASTY, V15, P86, DOI 10.1016/S0883-5403(00)91311-1; Lennon AB, 2001, J BIOMECH ENG-T ASME, V123, P623, DOI 10.1115/1.1412452; Lombardi AV, 1995, J BONE JOINT SURG AM, V77A, P1836; Massin P, 2000, J ARTHROPLASTY, V15, P93, DOI 10.1016/S0883-5403(00)91337-8; MURPHY SB, 1990, CLIN ORTHOP RELAT R, P214; NOBLE PC, 1988, CLIN ORTHOP RELAT R, P148; RUBIN PJ, 1992, J BONE JOINT SURG BR, V74, P28, DOI 10.1302/0301-620X.74B1.1732260; Simonet JY, 1993, J BONE JOINT SURG S3, V75, P257; SOTEREANOS NG, 1995, CLIN ORTHOP RELAT R, P146; Tallroth K, 2006, ACTA ORTHOP, V77, P598, DOI 10.1080/17453670610012665; Vandenbussche E, 2008, CLIN ORTHOP RELAT R, V466, P417, DOI 10.1007/s11999-007-0062-x; WALKER PS, 1988, CLIN ORTHOP RELAT R, P25; WHITESIDE LA, 1994, CLIN ORTHOP RELAT R, P184; Xu CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080021	28	6	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91058	10.1371/journal.pone.0091058	http://dx.doi.org/10.1371/journal.pone.0091058			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608343	Green Published, gold, Green Submitted			2022-12-25	WOS:000332485800089
J	Banerjee, T; Mukherjee, S; Ghosh, S; Biswas, M; Dutta, S; Pattari, S; Chatterjee, S; Bandyopadhyay, A				Banerjee, Tanima; Mukherjee, Somaditya; Ghosh, Sudip; Biswas, Monodeep; Dutta, Santanu; Pattari, Sanjib; Chatterjee, Shelly; Bandyopadhyay, Arun			Clinical Significance of Markers of Collagen Metabolism in Rheumatic Mitral Valve Disease	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; CARBOXY-TERMINAL PROPEPTIDE; HEART-DISEASE; MYOCARDIAL FIBROSIS; REGURGITATION; PREVALENCE; PATHOGENESIS; PROCOLLAGEN; PREVENTION; TURNOVER	Background: Rheumatic Heart Disease (RHD), a chronic acquired heart disorder results from Acute Rheumatic Fever. It is a major public health concern in developing countries. In RHD, mostly the valves get affected. The present study investigated whether extracellular matrix remodelling in rheumatic valve leads to altered levels of collagen metabolism markers and if such markers can be clinically used to diagnose or monitor disease progression. Methodology: This is a case control study comprising 118 subjects. It included 77 cases and 41 healthy controls. Cases were classified into two groups-Mitral Stenosis (MS) and Mitral Regurgitation (MR). Carboxy-terminal propeptide of type I procollagen (PICP), amino-terminal propeptide of type III procollagen (PIIINP), total Matrix Metalloproteinase-1(MMP-1) and Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) were assessed. Histopathology studies were performed on excised mitral valve leaflets. A p value <0.05 was considered statistically significant. Results: Plasma PICP and PIIINP concentrations increased significantly (p<0.01) in MS and MR subjects compared to controls but decreased gradually over a one year period post mitral valve replacement (p<0.05). In MS, PICP level and MMP1/TIMP-1 ratio strongly correlated with mitral valve area (r = -0.40; r = 0.49 respectively) and pulmonary artery systolic pressure (r = 0.49; r = -0.49 respectively); while in MR they correlated with left ventricular internal diastolic (r = 0.68; r = -0.48 respectively) and systolic diameters (r = 0.65; r = -0.55 respectively). Receiver operating characteristic curve analysis established PICP as a better marker (AUC = 0.95; 95% CI = 0.91-0.99; p<0.0001). A cut-off >459 ng/mL for PICP provided 91% sensitivity, 90% specificity and a likelihood ratio of 9 in diagnosing RHD. Histopathology analysis revealed inflammation, scarring, neovascularisation and extensive leaflet fibrosis in diseased mitral valve. Conclusions: Levels of collagen metabolism markers correlated with echocardiographic parameters for RHD diagnosis.	[Banerjee, Tanima; Mukherjee, Somaditya; Ghosh, Sudip; Chatterjee, Shelly; Bandyopadhyay, Arun] CSIR Indian Inst Chem Biol, Dept Cell Biol & Physiol, Kolkata, WB, India; [Biswas, Monodeep] Geisinger Community Med Ctr, Dept Cardiol, Scranton, PA USA; [Biswas, Monodeep] Wright Ctr Grad Med Educ, Scranton, PA USA; [Dutta, Santanu] SSKM Hosp, Inst Post Grad Med Educ & Res, Dept Cardiothorac & Vasc Surg, Kolkata, WB, India; [Pattari, Sanjib] Rabindra Nath Tagore Int Inst Cardiac Sci, Dept Pathol, Kolkata, WB, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	Bandyopadhyay, A (corresponding author), CSIR Indian Inst Chem Biol, Dept Cell Biol & Physiol, Kolkata, WB, India.	arunb@iicb.res.in			Council of Scientific and Industrial Research (CSIR), New Delhi, India [NWP 0004, MLP 115]; CSIR, New Delhi	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work is supported by grants from Council of Scientific and Industrial Research (CSIR), New Delhi, India (NWP 0004, MLP 115) to AB. TB and SM are recipients of fellowships from CSIR, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee T, 2012, INT J CARDIOL, V156, P117, DOI 10.1016/j.ijcard.2012.01.026; Boldt A, 2004, HEART, V90, P400, DOI 10.1136/hrt.2003.015347; BRAND A, 1992, AM HEART J, V123, P177, DOI 10.1016/0002-8703(92)90763-L; Carabello BA, 2005, CIRCULATION, V112, P432, DOI 10.1161/CIRCULATIONAHA.104.532498; EISENBERG MJ, 1993, EUR HEART J, V14, P122, DOI 10.1093/eurheartj/14.1.122; Gaasch WH, 2008, CIRCULATION, V118, P2298, DOI 10.1161/CIRCULATIONAHA.107.755942; GANAU A, 1992, J AM COLL CARDIOL, V19, P1550, DOI 10.1016/0735-1097(92)90617-V; Gonzalez A, 2002, J MOL CELL CARDIOL, V34, P1585, DOI 10.1006/jmcc.2002.2081; Guilherme L, 2011, ANN PEDIAT CARDIOL, V4, P13, DOI 10.4103/0974-2069.79617; Hara M, 2005, BIOTECHNIQUES, V39, P373, DOI 10.2144/05393ST05; Kadir IS, 2004, ANN THORAC SURG, V78, P699, DOI 10.1016/S0003-4975(03)01376-6; Khan R, 2006, IMMUNOLOGY, V118, P10, DOI 10.1111/j.1365-2567.2006.02336.x; Lancellotti P, 2010, EUR J ECHOCARDIOGR, V11, P307, DOI 10.1093/ejechocard/jeq031; Leong SW, 2006, CAN J CARDIOL, V22, P1055, DOI 10.1016/S0828-282X(06)70321-X; Lopez B, 2004, J AM COLL CARDIOL, V43, P2028, DOI 10.1016/j.jacc.2003.12.052; Lopez B, 2010, CIRCULATION, V121, P1645, DOI 10.1161/CIRCULATIONAHA.109.912774; Lorell BH, 2000, CIRCULATION, V102, P470; Marciniak A, 2007, EUR HEART J, V28, P2627, DOI 10.1093/eurheartj/ehm072; Marijon E, 2008, B WORLD HEALTH ORGAN, V86, P84, DOI 10.2471/BLT.07.046680; Marijon E, 2007, NEW ENGL J MED, V357, P470, DOI 10.1056/NEJMoa065085; Marijon E, 2012, LANCET, V379, P953, DOI 10.1016/S0140-6736(11)61171-9; Martos R, 2007, CIRCULATION, V115, P888, DOI 10.1161/CIRCULATIONAHA.106.638569; McCarthy KP, 2010, EUR J ECHOCARDIOGR, V11, pI3, DOI 10.1093/ejechocard/jeq153; Narula J, 2001, LANCET, V358, P2000, DOI 10.1016/S0140-6736(01)06993-8; Querejeta R, 2000, CIRCULATION, V101, P1729; Querejeta R, 2004, CIRCULATION, V110, P1263, DOI 10.1161/01.CIR.0000140973.60992.9A; Rabkin E, 2001, CIRCULATION, V104, P2525, DOI 10.1161/hc4601.099489; Remenyi B, 2012, NAT REV CARDIOL, V9, P297, DOI 10.1038/nrcardio.2012.7; Roy SG, 2007, MATRIX BIOL, V26, P269, DOI 10.1016/j.matbio.2006.12.005; Steer AC, 2009, NAT REV CARDIOL, V6, P689, DOI 10.1038/nrcardio.2009.162; Walker GA, 2004, CIRC RES, V95, P253, DOI 10.1161/01.RES.0000136520.07995.aa; World Health Organization, 2008, PROJ MORT BURD DIS 2; World health organization, 2004, 2001 REP WHO EXP CON, P13; Yeghiazarians Y, 2009, MOL THER, V17, P1250, DOI 10.1038/mt.2009.85; Zhang H, 2006, J BIOMED MATER RES A, V76A, P120, DOI 10.1002/jbm.a.30491	35	21	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90527	10.1371/journal.pone.0090527	http://dx.doi.org/10.1371/journal.pone.0090527			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603967	gold, Green Published, Green Submitted			2022-12-25	WOS:000332483600059
J	Chai, YS; Yuan, ZY; Lei, F; Wang, YG; Hu, J; Du, F; Lu, X; Jiang, JF; Xing, DM; Du, LJ				Chai, Yu-Shuang; Yuan, Zhi-Yi; Lei, Fan; Wang, Yu-Gang; Hu, Jun; Du, Feng; Lu, Xi; Jiang, Jing-Fei; Xing, Dong-Ming; Du, Li-Jun			Inhibition of Retinoblastoma mRNA Degradation through Poly (A) Involved in the Neuroprotective Effect of Berberine against Cerebral Ischemia	PLOS ONE			English	Article							OXYGEN-GLUCOSE DEPRIVATION; CELL-CYCLE ARREST; SUBVENTRICULAR ZONE; TUMOR-SUPPRESSOR; PRB PATHWAY; IN-VITRO; APOPTOSIS; GROWTH; RAT; RB	Berberine is one kind of isoquinoline alkaloid with anti-apoptotic effects on the neurons suffering ischemia. To address the explanation for these activities, the berberine-induced cell cycle arrest during neurons suffering ischemia/reperfusion had been studied in the present study. According to the in vitro neurons with oxygen-glucose deprivation and in vivo ICR mice with cerebral ischemia/reperfusion, it was found that berberine could protect the mRNA of retinoblastoma (Rb) from degradation through its function on the poly(A) tail. The prolonged half-life of retinoblastoma 1 (gene of Rb, RB1) mRNA level secures the protein level of retinoblastoma, which facilitates cell cycle arrest of neurons in the process of ischemia/reperfusion and subsequently avoids cells entering in the apoptotic process. The poly(A) tail of RB1 mRNA, as a newly identified target of berberine, could help people focus on the interaction between berberine and mRNA to further understand the biological activities and functions of berberine.	[Chai, Yu-Shuang; Yuan, Zhi-Yi; Lei, Fan; Hu, Jun; Lu, Xi; Jiang, Jing-Fei; Xing, Dong-Ming; Du, Li-Jun] Tsinghua Univ, Sch Life Sci, Lab Mol Pharmacol & Pharmaceut Sci, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China; [Chai, Yu-Shuang; Yuan, Zhi-Yi; Lei, Fan; Hu, Jun; Lu, Xi; Jiang, Jing-Fei; Xing, Dong-Ming; Du, Li-Jun] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Wang, Yu-Gang] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Du, Feng] Tulane Univ, Dept Math, New Orleans, LA 70118 USA	Tsinghua University; Tsinghua University; University of Texas System; UTMD Anderson Cancer Center; Tulane University	Du, LJ (corresponding author), Tsinghua Univ, Sch Life Sci, Lab Mol Pharmacol & Pharmaceut Sci, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China.	lijundu@mail.tsinghua.edu.cn			National Natural Science Foundation of China [30973896, 81374006, 81073092]; National S&T Major Special Project for New Drug R&D Program of China [2012ZX09103-201-041, 2011ZX09101-002-11, 2012ZX09102-201-008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S&T Major Special Project for New Drug R&D Program of China	This work was supported by the National Natural Science Foundation of China (30973896, 81374006 and 81073092) and the National S&T Major Special Project for New Drug R&D Program of China (2012ZX09103-201-041, 2011ZX09101-002-11 and 2012ZX09102-201-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeoye O, 2011, STROKE, V42, P1952, DOI 10.1161/STROKEAHA.110.612358; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Bryant CS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-47; Chai YS, 2013, EUR J PHARMACOL, V708, P44, DOI 10.1016/j.ejphar.2013.02.041; Chen XW, 2012, SCI WORLD J, DOI 10.1100/2012/708292; Choi Byul-Bo Ra, 2011, International Journal of Oral Biology, V36, P129; Choi MS, 2009, INT J ONCOL, V34, P1221, DOI 10.3892/ijo_00000250; Choi MS, 2008, ANTICANCER RES, V28, P3777; Coschi CH, 2010, GENE DEV, V24, P1351, DOI 10.1101/gad.1917610; Della-Morte D, 2011, NEUROSCI LETT, V487, P158, DOI 10.1016/j.neulet.2010.10.013; Di Fiore R, 2013, J CELL PHYSIOL, V228, P1676, DOI 10.1002/jcp.24329; ESUMI M, 1995, GENE, V161, P231, DOI 10.1016/0378-1119(95)00154-X; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Goodrich DW, 2006, ONCOGENE, V25, P5233, DOI 10.1038/sj.onc.1209616; He W, 2012, J PHARMACOL SCI, V119, P341, DOI 10.1254/jphs.12052FP; Hu J, 2012, EUR J PHARMACOL, V674, P132, DOI 10.1016/j.ejphar.2011.11.014; HUANG S, 1992, DNA CELL BIOL, V11, P539, DOI 10.1089/dna.1992.11.539; Islam MM, 2011, MEDCHEMCOMM, V2, P631, DOI 10.1039/c0md00209g; Islam MM, 2009, J PHYS CHEM B, V113, P1210, DOI 10.1021/jp806597w; Jiang Y, 2012, J LEUKEM LYMPH, V21, P342; Katiyar SK, 2009, MOL CARCINOGEN, V48, P24, DOI 10.1002/mc.20453; Lee HG, 2009, NEUROCHEM INT, V54, P84, DOI 10.1016/j.neuint.2008.10.013; Li HY, 2010, EUR J PHARMACOL, V649, P92, DOI 10.1016/j.ejphar.2010.09.023; Li JS, 2013, LAB INVEST, V93, P354, DOI 10.1038/labinvest.2012.172; Li L, 2010, GLIA, V58, P1610, DOI 10.1002/glia.21033; Luo X, 2012, BIOTECHNOL LETT, V34, P627, DOI 10.1007/s10529-011-0813-3; Ma C, 2013, CHEM BIOL DRUG DES, V81, P775, DOI 10.1111/cbdd.12124; Mahata S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-39; Manning AL, 2011, TRENDS CELL BIOL, V21, P433, DOI 10.1016/j.tcb.2011.05.003; Mantena SK, 2006, CARCINOGENESIS, V27, P2018, DOI 10.1093/carcin/bgl043; Manzanero S, 2013, NEUROCHEM INT, V62, P712, DOI 10.1016/j.neuint.2012.11.009; Marti-Fabregas J, 2010, NEUROLOGY, V74, P357, DOI 10.1212/WNL.0b013e3181cbccec; Mazighi M, 2012, STROKE, V43, P1302, DOI 10.1161/STROKEAHA.111.635029; Munro S, 2012, ONCOGENE, V31, P4343, DOI 10.1038/onc.2011.603; NANDI R, 1990, BIOCHIM BIOPHYS ACTA, V1049, P339, DOI 10.1016/0167-4781(90)90107-D; Oshikawa M, 2013, DEVELOPMENT, V140, P2310, DOI 10.1242/dev.095653; Rashidian J, 2007, BBA-MOL BASIS DIS, V1772, P484, DOI 10.1016/j.bbadis.2006.11.009; Refaat A, 2013, ONCOL LETT, V6, P840, DOI 10.3892/ol.2013.1434; Rodrigo R, 2013, CNS NEUROL DISORD-DR, V12, P698; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Sage J, 2010, GENE DEV, V24, P1329, DOI 10.1101/gad.1948010; Serafim TL, 2008, CANCER CHEMOTH PHARM, V61, P1007, DOI 10.1007/s00280-007-0558-9; Sheng R, 2010, AUTOPHAGY, V6, P482, DOI 10.4161/auto.6.4.11737; Sherr Charles J., 1994, Trends in Cell Biology, V4, P15, DOI 10.1016/0962-8924(94)90033-7; Sinha R, 2009, J PHYS CHEM B, V113, P13410, DOI 10.1021/jp9069515; Soriano SG, 2010, ANESTHESIOLOGY, V112, P1155, DOI 10.1097/ALN.0b013e3181d3e0c2; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Stoica BA, 2009, NEUROTOX RES, V16, P221, DOI 10.1007/s12640-009-9050-0; Stone JG, 2011, J NEUROPATH EXP NEUR, V70, P578, DOI 10.1097/NEN.0b013e3182204414; Vuddanda PR, 2010, EXPERT OPIN INV DRUG, V19, P1297, DOI 10.1517/13543784.2010.517745; Wang Y, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023495, DOI 10.1371/J0URNAL.P0NE.0023495]; Wen Y, 2005, FEBS LETT, V579, P4591, DOI 10.1016/j.febslet.2005.07.028; Xie X, 2011, ENDOCR J, V58, P761, DOI 10.1507/endocrj.K11E-024; Yang T, 2014, CELL TRANSPLANT, V23, P221, DOI 10.3727/096368912X661355; Yip NKY, 2013, ONCOL REP, V30, P1107, DOI 10.3892/or.2013.2543; Yu Y, 2012, NEUROCHEM RES, V37, P503, DOI 10.1007/s11064-011-0636-6; Yu Y, 2009, NEUROCHEM RES, V34, P1113, DOI 10.1007/s11064-008-9887-2; Zhang RL, 2006, J CEREBR BLOOD F MET, V26, P857, DOI 10.1038/sj.jcbfm.9600237	59	31	38	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90850	10.1371/journal.pone.0090850	http://dx.doi.org/10.1371/journal.pone.0090850			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603897	Green Submitted, Green Published, gold			2022-12-25	WOS:000332483600097
J	Marcon, E; Scotti, I; Herault, B; Rossi, V; Lang, G				Marcon, Eric; Scotti, Ivan; Herault, Bruno; Rossi, Vivien; Lang, Gabriel			Generalization of the Partitioning of Shannon Diversity	PLOS ONE			English	Article							NONPARAMETRIC-ESTIMATION; ENTROPY; NUMBER; SAMPLE; ALPHA	Traditional measures of diversity, namely the number of species as well as Simpson's and Shannon's indices, are particular cases of Tsallis entropy. Entropy decomposition, i.e. decomposing gamma entropy into alpha and beta components, has been previously derived in the literature. We propose a generalization of the additive decomposition of Shannon entropy applied to Tsallis entropy. We obtain a self-contained definition of beta entropy as the information gain brought by the knowledge of each community composition. We propose a correction of the estimation bias allowing to estimate alpha, beta and gamma entropy from the data and eventually convert them into true diversity. We advocate additive decomposition in complement of multiplicative partitioning to allow robust estimation of biodiversity.	[Marcon, Eric] AgroParisTech, UMR Ecol Forets Guyane, Kourou, France; [Scotti, Ivan] INRA, UMR Ecol Forets Guyane, Kourou, France; [Herault, Bruno; Rossi, Vivien] CIRAD, UMR Ecol Forets Guyane, Kourou, France; [Lang, Gabriel] AgroParisTech, UMR Math Info Appli 518, Paris, France; [Lang, Gabriel] INRA, UMR Math Info Appli 518, Paris, France	AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; INRAE; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Marcon, E (corresponding author), AgroParisTech, UMR Ecol Forets Guyane, Kourou, France.	eric.marcon@ecofog.gf	Marcon, Eric/B-5631-2009; Hérault, Bruno/B-2765-2011; Rossi, Vivien/C-9721-2009	Marcon, Eric/0000-0002-5249-321X; Hérault, Bruno/0000-0002-6950-7286; Rossi, Vivien/0000-0001-5458-1523	Agence Nationale de la Recherche (CEBA) [ANR-10-LABX-25-01]; project Climfor (Fondation pour la Recherche sur la Biodiversite)	Agence Nationale de la Recherche (CEBA)(French National Research Agency (ANR)); project Climfor (Fondation pour la Recherche sur la Biodiversite)	This work has benefited from an "Investissement d'Avenir" grant managed by Agence Nationale de la Recherche (CEBA, ref. ANR-10-LABX-25-01). Funding came from the project Climfor (Fondation pour la Recherche sur la Biodiversite). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonachela JA, 2008, J PHYS A, V41, P1; Borland L, 1998, J MATH PHYS, V39, P6490, DOI 10.1063/1.532660; CHAO A, 1984, SCAND J STAT, V11, P265; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Chao AN, 2013, METHODS ECOL EVOL, V4, P1091, DOI 10.1111/2041-210X.12108; Chao A, 2012, ECOLOGY, V93, P2037, DOI 10.1890/11-1817.1; Dauby G, 2012, ECOGRAPHY, V35, P661, DOI 10.1111/j.1600-0587.2011.06860.x; Ellison AM, 2010, ECOLOGY, V91, P1962, DOI 10.1890/09-1692.1; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Furuichi S, 2004, J MATH PHYS, V45, P4868, DOI 10.1063/1.1805729; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; GRASSBERGER P, 1988, PHYS LETT A, V128, P369, DOI 10.1016/0375-9601(88)90193-4; Harvda J, 1967, KYBERNETIKA, V3, P30; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Holste D, 1998, J PHYS A-MATH GEN, V31, P2551, DOI 10.1088/0305-4470/31/11/007; HORVITZ DG, 1952, J AM STAT ASSOC, V47, P663, DOI 10.2307/2280784; Hou Y, 2012, COMPUTATIONAL INTELL; Hubbell S.P., 2005, BARRO COLORADO FORES; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Jost L, 2010, DIVERS DISTRIB, V16, P65, DOI 10.1111/j.1472-4642.2009.00626.x; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lamberti PW, 2003, PHYSICA A, V329, P81, DOI 10.1016/S0378-4371(03)00566-1; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; Leinster T, 2012, ECOLOGY, V93, P477, DOI 10.1890/10-2402.1; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; MACARTHUR RH, 1965, BIOL REV, V40, P510, DOI 10.1111/j.1469-185X.1965.tb00815.x; Marcon E, 2012, OIKOS, V121, P516, DOI 10.1111/j.1600-0706.2011.19267.x; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Oksanen J., **DATA OBJECT**; PATIL GP, 1982, J AM STAT ASSOC, V77, P548, DOI 10.2307/2287709; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RAO CR, 1985, IEEE T INFORM THEORY, V31, P589, DOI 10.1109/TIT.1985.1057082; ROUTLEDGE RD, 1979, J THEOR BIOL, V76, P503, DOI 10.1016/0022-5193(79)90015-8; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; TSALLIS C, 1988, J STAT PHYS, V52, P479, DOI 10.1007/BF01016429; Tsallis C, 1998, PHYSICA A, V261, P534, DOI 10.1016/S0378-4371(98)00437-3; Tsallis C, 1994, QUIM NOVA, V17, P468; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x	41	47	49	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90289	10.1371/journal.pone.0090289	http://dx.doi.org/10.1371/journal.pone.0090289			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603966	gold, Green Published, Green Submitted			2022-12-25	WOS:000332483600039
J	Chung, L; Onyango, D; Guo, Z; Jia, P; Dai, H; Liu, S; Zhou, M; Lin, W; Pang, I; Li, H; Yuan, YC; Huang, Q; Zheng, L; Lopes, J; Nicolas, A; Chai, W; Raz, D; Reckamp, KL; Shen, B				Chung, L.; Onyango, D.; Guo, Z.; Jia, P.; Dai, H.; Liu, S.; Zhou, M.; Lin, W.; Pang, I.; Li, H.; Yuan, Y-C; Huang, Q.; Zheng, L.; Lopes, J.; Nicolas, A.; Chai, W.; Raz, D.; Reckamp, K. L.; Shen, B.			The FEN1 E359K germline mutation disrupts the FEN1-WRN interaction and FEN1 GEN activity, causing aneuploidy-associated cancers	ONCOGENE			English	Article							OKAZAKI FRAGMENT MATURATION; DNA-DAMAGE RESPONSE; FLAP ENDONUCLEASE-1; REPLICATION FORK; CHROMOSOMAL INSTABILITY; SECONDARY STRUCTURES; TELOMERE STABILITY; TUMOR PROGRESSION; STRUCTURAL BASIS; MUTANT MICE	Polymorphisms and somatic mutations in Flap Endonuclease 1 (FEN1), an essential enzyme involved in DNA replication and repair, can lead to functional deficiencies of the FEN1 protein and a predisposition to cancer. We identified a FEN1 germline mutation that changed residue E359 to K in a patient whose family had a history of breast cancer. We determined that the E359K mutation, which is in the protein-protein domain of FEN1, abolished the interaction of FEN1 with Werner syndrome protein (WRN), an interaction that is critical for resolving stalled DNA replication forks. Furthermore, although the flap endonuclease activity of FEN1 E359K was unaffected, it failed to resolve bubble structures, which require the FEN1 gap-dependent endonuclease activity. To determine the etiological significance of E359K, we established a mouse model containing this mutation. E359K mouse embryonic fibroblasts (MEF) were more sensitive to DNA crosslinking agents that cause replication forks to stall. Cytological analysis suggested that the FEN1-WRN interaction was also required for telomere stability; mutant cell lines had fragile telomeres, increased numbers of spontaneous chromosomal anomalies and higher frequencies of transformation. Moreover, the incidence of cancer was significantly higher in mice homozygous for FEN1 E359K than in wild-type mice, suggesting that the FEN1 E359K mutation is oncogenic.	[Chung, L.; Onyango, D.; Guo, Z.; Dai, H.; Liu, S.; Zhou, M.; Lin, W.; Pang, I.; Zheng, L.; Shen, B.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Radiat Oncol, Duarte, CA 91010 USA; [Guo, Z.] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China; [Jia, P.; Chai, W.] Washington State Univ, Sch Mol Biosci, WWAMI Med Educ Program, Spokane, WA USA; [Liu, S.] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Li, H.; Yuan, Y-C] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA; [Huang, Q.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Pathol, Duarte, CA 91010 USA; [Lopes, J.; Nicolas, A.] CNRS, Inst Curie, Sect Rech Inst, Paris, France; [Lopes, J.] Museum Natl Hist Nat, INSERM U565, USM 503, UMR7196, F-75231 Paris, France; [Raz, D.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Surg, Duarte, CA 91010 USA; [Reckamp, K. L.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; Nanjing Normal University; Washington State University; Zhejiang University; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); Museum National d'Histoire Naturelle (MNHN); City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Reckamp, KL (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Med Oncol & Therapeut Res, 107 East Duarte Rd, Duarte, CA 91010 USA.	kreckamp@coh.org; bshen@coh.org	Li, Hongzhi/E-8530-2012; Brodie, Matthew Andrew/HDN-0096-2022; LIU, SONGBAI/AFL-6448-2022; Chai, Weihang/AAG-5194-2021; Lopes, Judith/K-3788-2017; Brodie, Matthew A D/ABG-1640-2020	Brodie, Matthew Andrew/0000-0002-5711-3458; Lopes, Judith/0000-0003-4907-6797; Brodie, Matthew A D/0000-0002-5711-3458; Shen, Binghui/0000-0002-4408-407X; Reckamp, Karen/0000-0002-9213-0325; liu, songbai/0000-0002-3920-1032	NIH [R01 CA073764]; Ligue Nationale contre le Cancer [EL2007/LNCC, EL2010/LNCC]; NATIONAL CANCER INSTITUTE [R01CA073764, R29CA073764, P30CA033572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112864] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the City of Hope Pathology Core Facility for technical assistance with characterization of mouse cancer specimens (P30CA033572). We thank M Lee and B Armstrong in the City of Hope Microscopy Core Facility for assistance with characterization of chromosomal aberrations and D Stoppa-Lyonnet (Institut Curie) to provide the breast cancer patient DNA. This work was supported by NIH grant R01 CA073764 and Ligue Nationale contre le Cancer (EL2007/LNCC and EL2010/LNCC).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bernstein DA, 2003, EMBO J, V22, P4910, DOI 10.1093/emboj/cdg500; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2011, COLD SPRING HARB SYM, V75, P167; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Gisselsson D, 2000, P NATL ACAD SCI USA, V97, P5357, DOI 10.1073/pnas.090013497; Guo ZG, 2008, J MOL BIOL, V377, P679, DOI 10.1016/j.jmb.2007.10.074; Kitano K, 2010, STRUCTURE, V18, P177, DOI 10.1016/j.str.2009.12.011; Kucherlapati M, 2002, P NATL ACAD SCI USA, V99, P9924, DOI 10.1073/pnas.152321699; Larsen E, 2003, MOL CELL BIOL, V23, P5346, DOI 10.1128/MCB.23.15.5346-5353.2003; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; Liu R, 2006, NUCLEIC ACIDS RES, V34, P1772, DOI 10.1093/nar/gkl106; Lo AWI, 2002, NEOPLASIA, V4, P531, DOI 10.1038/sj.neo.7900267; Lopes J, 2006, MOL CELL BIOL, V26, P6675, DOI 10.1128/MCB.00649-06; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Murnane JP, 2010, CANCER RES, V70, P4255, DOI 10.1158/0008-5472.CAN-09-4357; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Saharia A, 2008, CURR BIOL, V18, P496, DOI 10.1016/j.cub.2008.02.071; Saharia A, 2010, J BIOL CHEM, V285, P27057, DOI 10.1074/jbc.M110.112276; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Sampathi S, 2009, J BIOL CHEM, V284, P3682, DOI 10.1074/jbc.M805362200; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; Singh P, 2007, J BIOL CHEM, V282, P3465, DOI 10.1074/jbc.M606582200; Spiro C, 1999, MOL CELL, V4, P1079, DOI 10.1016/S1097-2765(00)80236-1; Sweasy JB, 2005, P NATL ACAD SCI USA, V102, P14350, DOI 10.1073/pnas.0505166102; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; Wang YX, 2005, NAT GENET, V37, P750, DOI 10.1038/ng1587; Wu ZX, 2012, MUTAT RES-FUND MOL M, V731, P85, DOI 10.1016/j.mrfmmm.2011.11.009; Xu H, ONCOGENE, V30, P1072; Zheng L, 2005, EMBO REP, V6, P83, DOI 10.1038/sj.embor.7400313; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599; Zheng L, 2007, MOL CELL BIOL, V27, P3176, DOI 10.1128/MCB.01652-06; Zheng L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1825; Zheng L, 2011, CELL RES, V21, P1052, DOI 10.1038/cr.2011.35; Zheng L, 2011, NUCLEIC ACIDS RES, V39, P781, DOI 10.1093/nar/gkq884; Zheng L, 2011, J MOL CELL BIOL, V3, P23, DOI 10.1093/jmcb/mjq048	49	23	24	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 12	2015	34	7					902	911		10.1038/onc.2014.19	http://dx.doi.org/10.1038/onc.2014.19			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CB2QF	24608430	Green Accepted			2022-12-25	WOS:000349472000010
J	Liu, L; Zhang, X; Yan, B; Gu, QH; Zhang, XD; Jiao, JP; Sun, DZ; Wang, N; Yue, XQ				Liu, Long; Zhang, Xi; Yan, Bing; Gu, Qunhao; Zhang, Xiaodong; Jiao, Jianpeng; Sun, Dazhi; Wang, Ning; Yue, Xiaoqiang			Elevated Plasma D-Dimer Levels Correlate with Long Term Survival of Gastric Cancer Patients	PLOS ONE			English	Article							HEMOSTATIC PARAMETERS; POOR-PROGNOSIS; UP-REGULATION; COAGULATION; PROGRESSION; METASTASIS; CARCINOMA; STAGE; SERUM	Background: Increasing evidence indicated plasma D-dimer could be regarded as a marker in cancers, however, its role in gastric cancer is still largely unknown. Methods: Plasma D-dimer levels were measured by enzyme linked fluorescent immunoassays and evaluated by receiver operating characteristic (ROC) curves for peritoneal dissemination in gastric cancer and healthy subjects. The overall survival (OS) characteristics were determined using Kaplan-Meier and Cox regression analyses. Results: The average of the plasma D-dimer levels for gastric cancer patients was significantly higher than the healthy subjects. A Spearman correlation analysis showed that plasma D-dimer levels correlated with the depth of invasion, lymph node metastasis, peritoneal dissemination, distant metastasis, tumor size and TNM stage. The mean plasma D-dimer level was 2.20 +/- 1.51 mu g/mL in peritoneal dissemination patients and 1.01 +/- 0.79 mu g/mL in non-peritoneal dissemination patients (P<0.001). Additionally, the mean plasma D-dimer concentration in patients alive at the final follow-up evaluation was 0.79 +/- 0.72 mu g/mL, which was significantly lower than the amounts determined for the deceased patients (1.36 +/- 1.13 mu g/mL) (P<0.001). The AUC of D-dimer was 0.833 (95% CI: 0.780-0.885). At a cut-off value of 1.465 mu g/mL, the D-dimer measurement had a sensitivity of 78.00%, a specificity of 83.76% and an accuracy of 82.59%. The median OS was 48.10 months (95% CI: 43.88-52.31) in patients with plasma D-dimer levels less than 1.465 mu g/mL and 22.39 months (95% CI: 16.95-27.82) in patients with plasma D-dimer levels exceeding 1.465 mu g/mL (log-rank test, P<0.001). Importantly, plasma D-dimer levels exceeding 1.465 mu g/mL were significantly associated with poor OS, as determined using a multivariate Cox regression analysis (hazard ratio [HR], 2.28; 95% CI: 1.36-3.81; P = 0.002). Conclusions: Plasma D-dimer levels are increased in gastric cancer patients and may be a valuable biomarker for peritoneal dissemination, with high D-dimer levels predicting poor outcomes for gastric cancer patients.	[Liu, Long; Yue, Xiaoqiang] Second Mil Med Univ, Changhai Hosp, Dept Tradit Chinese Med, Shanghai, Peoples R China; [Zhang, Xi] Second Mil Med Univ, Dept Anat, Shanghai, Peoples R China; [Yan, Bing; Jiao, Jianpeng; Sun, Dazhi] Second Mil Med Univ, Changzheng Hosp, Dept Tradit Chinese Med, Shanghai, Peoples R China; [Gu, Qunhao; Zhang, Xiaodong] Shanghai Univ Tradit Chinese Med, Yueyang Hosp, Dept Gen Surg, Shanghai, Peoples R China; [Wang, Ning] Second Mil Med Univ, Changhai Hosp, Dept Oncol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Shanghai University of Traditional Chinese Medicine; Naval Medical University	Yue, XQ (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Tradit Chinese Med, Shanghai, Peoples R China.	xiaoqiangyue888@163.com		Yue, Xiaoqiang/0000-0001-6872-9664	National Natural Science Foundation of China [81102693, 81102565]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grants 81102693 and 81102565). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HS, 2012, BRIT J CANCER, V106, P733, DOI 10.1038/bjc.2011.592; Altiay G, 2007, CLIN ONCOL-UK, V19, P494, DOI 10.1016/j.clon.2007.04.002; Ay C, 2012, HAEMATOL-HEMATOL J, V97, P1158, DOI 10.3324/haematol.2011.054718; BICK RL, 1992, SEMIN THROMB HEMOST, V18, P353, DOI 10.1055/s-2007-1002575; Blackwell K, 2004, CANCER-AM CANCER SOC, V101, P77, DOI 10.1002/cncr.20336; Buccheri GR, 2003, CANCER, V97, P3044, DOI 10.1002/cncr.11432; Buller HR, 2007, J THROMB HAEMOST, V5, P246, DOI 10.1111/j.1538-7836.2007.02497.x; CORREA P, 1992, CANCER RES, V52, P6735; Dupuy E, 2003, J HEPATOL, V38, P793, DOI 10.1016/S0168-8278(03)00086-2; Fidan E, 2012, TUMOR BIOL, V33, P1519, DOI 10.1007/s13277-012-0403-6; Gadducci A, 2009, CRIT REV ONCOL HEMAT, V69, P12, DOI 10.1016/j.critrevonc.2008.05.001; Hajjari M, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0670-0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Ke B, 2013, TUMOR BIOL, V34, P3137, DOI 10.1007/s13277-013-0882-0; Kwon HC, 2009, JPN J CLIN ONCOL, V27, P4124; Kwon HC, 2008, JPN J CLIN ONCOL, V38, P2, DOI 10.1093/jjco/hym157; Liu Y, 2012, J BIOMED RES, V26, P315, DOI 10.7555/JBR.26.20110087; LUZZATTO G, 1990, SEMIN ONCOL, V17, P147; Mei DY, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0709-2; SEITZ R, 1993, BLOOD COAGUL FIBRIN, V4, P249, DOI 10.1097/00001721-199304000-00006; Sun Da-zhi, 2010, Zhong Xi Yi Jie He Xue Bao, V8, P332, DOI 10.3736/jcim20100406; Tas Faruk, 2013, J Gastrointest Cancer, V44, P285, DOI 10.1007/s12029-013-9490-x; TATSUTA M, 1993, INT J CANCER, V53, P70, DOI 10.1002/ijc.2910530114; Trotti A, 2009, AJCC CANC STAGING MA, P117; Unsal E, 2004, RESP MED, V98, P93, DOI 10.1016/j.rmed.2003.07.001; Wagner AD, 2006, J CLIN ONCOL, V24, P2903, DOI 10.1200/JCO.2005.05.0245; Wang Yu, 2009, Zhong Xi Yi Jie He Xue Bao, V7, P514, DOI 10.3736/jcim20090604; Xu G, 2005, PRAC J MED PHARM, V22, P977; Yamashita H, 2005, JPN J CLIN ONCOL, V35, P595, DOI 10.1093/jjco/hyi150; Yigit E, 2008, EUR J INTERN MED, V19, P602, DOI 10.1016/j.ejim.2007.06.036; Yonemura Y, 2006, EJSO-EUR J SURG ONC, V32, P602, DOI 10.1016/j.ejso.2006.03.003	32	51	60	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90547	10.1371/journal.pone.0090547	http://dx.doi.org/10.1371/journal.pone.0090547			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618826	gold, Green Submitted, Green Published			2022-12-25	WOS:000332842400022
J	Mazars, C; Briere, C; Grat, S; Pichereaux, C; Rossignol, M; Pereda-Loth, V; Eche, B; Boucheron-Dubuisson, E; Le Disquet, I; Medina, FJ; Graziana, A; Carnero-Diaz, E				Mazars, Christian; Briere, Christian; Grat, Sabine; Pichereaux, Carole; Rossignol, Michel; Pereda-Loth, Veronica; Eche, Brigitte; Boucheron-Dubuisson, Elodie; Le Disquet, Isabel; Javier Medina, Francisco; Graziana, Annick; Carnero-Diaz, Eugenie			Microgravity Induces Changes in Microsome-Associated Proteins of Arabidopsis Seedlings Grown on Board the International Space Station	PLOS ONE			English	Article							POLAR AUXIN TRANSPORT; SHOOT GRAVITROPISM; ROOT GRAVITROPISM; PLANT-CELLS; GLUCOSINOLATE BIOSYNTHESIS; PLASMA-MEMBRANE; JASMONIC ACID; LENTIL ROOT; GENE FAMILY; THALIANA	The "GENARA A'' experiment was designed to monitor global changes in the proteome of membranes of Arabidopsis thaliana seedlings subjected to microgravity on board the International Space Station (ISS). For this purpose, 12-day-old seedlings were grown either in space, in the European Modular Cultivation System (EMCS) under microgravity or on a 1 g centrifuge, or on the ground. Proteins associated to membranes were selectively extracted from microsomes and identified and quantified through LC-MS-MS using a label-free method. Among the 1484 proteins identified and quantified in the 3 conditions mentioned above, 80 membrane-associated proteins were significantly more abundant in seedlings grown under microgravity in space than under 1 g (space and ground) and 69 were less abundant. Clustering of these proteins according to their predicted function indicates that proteins associated to auxin metabolism and trafficking were depleted in the microsomal fraction in mu g space conditions, whereas proteins associated to stress responses, defence and metabolism were more abundant in mu g than in 1 g indicating that microgravity is perceived by plants as a stressful environment. These results clearly indicate that a global membrane proteomics approach gives a snapshot of the cell status and its signaling activity in response to microgravity and highlight the major processes affected.	[Mazars, Christian; Briere, Christian; Grat, Sabine; Graziana, Annick] Univ Toulouse UPS, Lab Rech Sci Vegetales, CNRS, UMR5546, Castanet Tolosan, France; [Pichereaux, Carole; Rossignol, Michel] CNRS, IPBS, Federat Rech Agrobiosci Interact & Biodivers Plat, Toulouse, France; [Pereda-Loth, Veronica; Eche, Brigitte] Univ Toulouse, GSBMS, Toulouse, France; [Boucheron-Dubuisson, Elodie; Le Disquet, Isabel; Carnero-Diaz, Eugenie] Sorbonne Univ, Univ Paris 06, CNRS, UR5,PCMP,EAC 7180, Paris, France; [Javier Medina, Francisco] CSIC, Ctr Invest Biol, Madrid, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Mazars, C (corresponding author), Univ Toulouse UPS, Lab Rech Sci Vegetales, CNRS, UMR5546, Castanet Tolosan, France.	mazars@lrsv.ups-tlse.fr	Medina, F. Javier/M-2278-2014	Medina, F. Javier/0000-0002-0866-7710; Pichereaux, Carole/0000-0002-7559-5358; Mazars, Christian/0000-0002-0670-6042	CNRS -CNES - Universite Paul Sabatier	CNRS -CNES - Universite Paul Sabatier	Funding was supported by CNRS -CNES - Universite Paul Sabatier. The funders had no role in study design, data collection and anlysis, decision to publish, or preparation of the manuscript.	Aarrouf J, 1999, PHYSIOL PLANTARUM, V105, P708, DOI 10.1034/j.1399-3054.1999.105416.x; Abas L, 2006, NAT CELL BIOL, V8, P249, DOI 10.1038/ncb1369; Azri W, 2009, PHYSIOL PLANTARUM, V136, P193, DOI 10.1111/j.1399-3054.2009.01230.x; Bak S, 2001, PLANT CELL, V13, P101, DOI 10.1105/tpc.13.1.101; Bak S, 2001, PLANT PHYSIOL, V127, P108, DOI 10.1104/pp.127.1.108; Barjaktarovic Z, 2007, J EXP BOT, V58, P4357, DOI 10.1093/jxb/erm302; Barlier I, 2000, P NATL ACAD SCI USA, V97, P14819, DOI 10.1073/pnas.260502697; BELL E, 1995, P NATL ACAD SCI USA, V92, P8675, DOI 10.1073/pnas.92.19.8675; Benjamins R, 2001, DEVELOPMENT, V128, P4057; Benjamins R, 2003, PLANT PHYSIOL, V132, P1623, DOI 10.1104/pp.103.019943; Blancaflor EB, 2013, AM J BOT, V100, P143, DOI 10.3732/ajb.1200283; Boot KJM, 2012, J EXP BOT, V63, P4213, DOI 10.1093/jxb/ers106; Bouyssie D, 2007, MOL CELL PROTEOMICS, V6, P1621, DOI 10.1074/mcp.T600069-MCP200; Brinckmann Enno, 2004, J Gravit Physiol, V11, P67; CASPAR T, 1989, PLANTA, V177, P185, DOI 10.1007/BF00392807; Chen RJ, 1999, PLANT PHYSIOL, V120, P343, DOI 10.1104/pp.120.2.343; Cho D, 2012, PLANT PHYSIOL, V160, P1293, DOI 10.1104/pp.112.201442; CLAASSEN DE, 1994, INT REV CYTOL, V156, P301, DOI 10.1016/S0074-7696(08)62257-3; Correll MJ, 2013, PLANTA, V238, P519, DOI 10.1007/s00425-013-1909-x; Daudi A, 2012, PLANT CELL, V24, P275, DOI 10.1105/tpc.111.093039; Davies E, 1999, J Gravit Physiol, V6, pP21; Dayanandan P, 2011, J BIOSCIENCES, V36, P911, DOI 10.1007/s12038-011-9150-x; Driss-Ecole D, 2000, PLANTA, V211, P396, DOI 10.1007/s004250000298; Driss-Ecole D, 2003, PHYSIOL PLANTARUM, V118, P305, DOI 10.1034/j.1399-3054.2003.00121.x; Fang ZY, 2009, PLANT SCI, V176, P170, DOI 10.1016/j.plantsci.2008.09.007; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Fukaki H, 1998, PLANT J, V14, P425, DOI 10.1046/j.1365-313X.1998.00137.x; Fukaki H, 1996, PLANT PHYSIOL, V110, P945, DOI 10.1104/pp.110.3.945; Galvan-Ampudia CS, 2007, TRENDS PLANT SCI, V12, P541, DOI 10.1016/j.tplants.2007.10.004; Hansen CH, 2001, J BIOL CHEM, V276, P24790, DOI 10.1074/jbc.M102637200; Harada A, 2003, P NATL ACAD SCI USA, V100, P8583, DOI 10.1073/pnas.1336802100; HARDHAM AR, 1978, J CELL BIOL, V77, P14, DOI 10.1083/jcb.77.1.14; Hasenstein KH, 1999, ADV SPACE RES-SERIES, V24, P677, DOI 10.1016/S0273-1177(99)00399-3; Herranz R, 2013, ASTROBIOLOGY, V13, P1, DOI 10.1089/ast.2012.0876; Hoson T, 2000, Biol Sci Space, V14, P75, DOI 10.2187/bss.14.75; Hoson T, 2003, INT REV CYTOL, V229, P209, DOI 10.1016/S0074-7696(03)29005-7; Hoson T, 2003, PLANT SOIL, V255, P19, DOI 10.1023/A:1026105431505; Hoson T, 1999, Biol Sci Space, V13, P264; Jambunathan N, 2001, PLANT CELL, V13, P2225, DOI 10.1105/tpc.13.10.2225; Kamada Motoshi, 2004, Biol Sci Space, V18, P156; KISS JZ, 1989, PLANTA, V177, P198, DOI 10.1007/BF00392808; Kittang AI, 2014, PLANT BIOLOGY, V16, P528, DOI 10.1111/plb.12132; Li JJ, 2011, PLANT CELL, V23, P4411, DOI 10.1105/tpc.111.092684; Loth-Pereda V, 2011, PLANT PHYSIOL, V156, P2141, DOI 10.1104/pp.111.180646; Marquardt J, 1997, Biol Sci Space, V11, P244; Martzivanou M, 2003, PHYSIOL PLANTARUM, V118, P221, DOI 10.1034/j.1399-3054.2003.00092.x; MASSON PH, 1995, BIOESSAYS, V17, P119, DOI 10.1002/bies.950170207; Mei Y, 2012, CELL RES, V22, P581, DOI 10.1038/cr.2011.150; MELAN MA, 1993, PLANT PHYSIOL, V101, P441, DOI 10.1104/pp.101.2.441; Mongrand S, 2010, TRENDS PLANT SCI, V15, P656, DOI 10.1016/j.tplants.2010.09.003; Mukherjee AK, 2010, J PROTEOMICS, V73, P709, DOI 10.1016/j.jprot.2009.10.005; Nagasaki N, 2008, FEBS J, V275, P2267, DOI 10.1111/j.1742-4658.2008.06379.x; Nechitailo GS, 2005, ADV SPACE RES-SERIES, V36, P1329, DOI 10.1016/j.asr.2005.06.043; Normanly J, 1999, CURR OPIN PLANT BIOL, V2, P207, DOI 10.1016/S1369-5266(99)80037-5; Oka M, 1995, Biol Sci Space, V9, P331, DOI 10.2187/bss.9.331; Paul AL, 2013, AM J BOT, V100, P226, DOI 10.3732/ajb.1200338; Paul AL, 2012, ASTROBIOLOGY, V12, P40, DOI 10.1089/ast.2011.0696; PERBAL G, 1993, ACTA BOT GALLICA, V140, P615, DOI 10.1080/12538078.1993.10515642; PERBAL G, 1986, NATURWISSENSCHAFTEN, V73, P444, DOI 10.1007/BF00367293; Perbal G, 2003, TRENDS PLANT SCI, V8, P498, DOI 10.1016/j.tplants.2003.09.005; Perbal G, 2002, PHYSIOL PLANTARUM, V114, P336, DOI 10.1034/j.1399-3054.2002.1140302.x; Plaxton WC, 2011, PLANT PHYSIOL, V156, P1006, DOI 10.1104/pp.111.175281; Pollard SK, 2008, MULTTEST RESAMPLING; R Core Team, 2022, R LANG ENV STAT COMP; Rautengarten C, 2011, PLANT CELL, V23, P1373, DOI 10.1105/tpc.111.083931; SALISBURY FB, 1988, PLANT PHYSIOL, V88, P1186, DOI 10.1104/pp.88.4.1186; Salmi ML, 2011, PLANTA, V233, P911, DOI 10.1007/s00425-010-1343-2; Schenck CA, 2013, AM J BOT, V100, P194, DOI 10.3732/ajb.1200339; Schneider K, 2005, J BIOL CHEM, V280, P13962, DOI 10.1074/jbc.M413578200; Silady RA, 2004, PLANT PHYSIOL, V136, P3095, DOI 10.1104/pp.104.050583; Sobol M A, 2007, J Gravit Physiol, V14, pP109; Staswick PE, 2009, PLANT PHYSIOL, V150, P1310, DOI 10.1104/pp.109.138529; Stenzel I, 2003, PLANT MOL BIOL, V51, P895, DOI 10.1023/A:1023049319723; Strohm AK, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00274; Stutte GW, 2006, PLANTA, V224, P1038, DOI 10.1007/s00425-006-0290-4; Sun JQ, 2011, NEW PHYTOL, V191, P360, DOI 10.1111/j.1469-8137.2011.03713.x; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Titapiwatanakun B, 2009, PLANT J, V57, P27, DOI 10.1111/j.1365-313X.2008.03668.x; Tran HT, 2010, PLANT CELL ENVIRON, V33, P1789, DOI 10.1111/j.1365-3040.2010.02184.x; Tripathy BC, 1996, PLANT PHYSIOL, V110, P801, DOI 10.1104/pp.110.3.801; Ueda J, 1999, J PLANT RES, V112, P487, DOI 10.1007/PL00013904; Vellosillo T, 2007, PLANT CELL, V19, P831, DOI 10.1105/tpc.106.046052; Wakabayashi Kazuyuki, 2003, Biol Sci Space, V17, P228; Wakabayashi K, 2009, J PLANT PHYSIOL, V166, P947, DOI 10.1016/j.jplph.2008.12.006; Wang H, 2006, J EXP BOT, V57, P827, DOI 10.1093/jxb/erj066; Wang LS, 2011, PLANT PHYSIOL, V157, P1283, DOI 10.1104/pp.111.183723; Wee CW, 2010, BIOTECHNOL LETT, V32, P1361, DOI 10.1007/s10529-010-0307-8; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Yamauchi Y, 1997, PLANT CELL PHYSIOL, V38, P530, DOI 10.1093/oxfordjournals.pcp.a029201; Yang SH, 2006, PLANT J, V45, P166, DOI 10.1111/j.1365-313X.2005.02585.x; Yano D, 2003, P NATL ACAD SCI USA, V100, P8589, DOI 10.1073/pnas.1430749100; Yee TW, 2012, VGAM VECTOR GEN LINE; Young LS, 2006, PLANT PHYSIOL, V142, P564, DOI 10.1104/pp.106.084798	93	33	33	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91814	10.1371/journal.pone.0091814	http://dx.doi.org/10.1371/journal.pone.0091814			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618597	Green Published, gold			2022-12-25	WOS:000332842400134
J	Zhuang, L; Zhang, ZY; An, XP; Fan, H; Ma, MJ; Anderson, BD; Jiang, JF; Liu, W; Cao, WC; Tong, YG				Zhuang, Lu; Zhang, Zhiyi; An, Xiaoping; Fan, Hang; Ma, Maijuan; Anderson, Benjamin D.; Jiang, Jiafu; Liu, Wei; Cao, Wuchun; Tong, Yigang			An Efficient Strategy of Screening for Pathogens in Wild-Caught Ticks and Mosquitoes by Reusing Small RNA Deep Sequencing Data	PLOS ONE			English	Article							SMALL SILENCING RNAS; SPOTTED-FEVER; DERMACENTOR-SILVARUM; METAGENOMIC ANALYSIS; VIRAL GENOME; RICKETTSIA; VIRUS; DISCOVERY; CHINA	This paper explored our hypothesis that sRNA (18 similar to 30 bp) deep sequencing technique can be used as an efficient strategy to identify microorganisms other than viruses, such as prokaryotic and eukaryotic pathogens. In the study, the clean reads derived from the sRNA deep sequencing data of wild-caught ticks and mosquitoes were compared against the NCBI nucleotide collection (non-redundant nt database) using Blastn. The blast results were then analyzed with in-house Python scripts. An empirical formula was proposed to identify the putative pathogens. Results showed that not only viruses but also prokaryotic and eukaryotic species of interest can be screened out and were subsequently confirmed with experiments. Specially, a novel Rickettsia spp. was indicated to exist in Haemaphysalis longicornis ticks collected in Beijing. Our study demonstrated the reuse of sRNA deep sequencing data would have the potential to trace the origin of pathogens or discover novel agents of emerging/re-emerging infectious diseases.	[Zhuang, Lu; Zhang, Zhiyi; An, Xiaoping; Fan, Hang; Ma, Maijuan; Jiang, Jiafu; Liu, Wei; Cao, Wuchun; Tong, Yigang] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Anderson, Benjamin D.] Univ Florida, Coll Publ Hlth & Hlth Profess, Emerging Pathogens Inst, Gainesville, FL USA	Beijing Institute of Microbiology & Epidemiology; State University System of Florida; University of Florida	Cao, WC (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	caowc@nic.bmi.ac.cn; tong.yigang@gmail.com	Fan, Hang/AAA-8489-2022	Fan, Hang/0000-0002-7927-1684; Ma, Mai-Juan/0000-0002-8105-462X; Tong, Yigang/0000-0002-8503-8045	Natural Science Foundation of China [81222037, 81290344, 81130086, 81072250]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of China (81222037, 81290344, 81130086, 81072250). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliyari R, 2009, IMMUNOL REV, V227, P176, DOI 10.1111/j.1600-065X.2008.00722.x; Cao WC, 2008, J MED ENTOMOL, V45, P741, DOI 10.1603/0022-2585(2008)45[741:MDOSFG]2.0.CO;2; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chen Z., 1999, CHINESE J VECTOR BIO, V5, P18; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Culley AI, 2006, SCIENCE, V312, P1795, DOI 10.1126/science.1127404; Dantas-Torres F, 2007, LANCET INFECT DIS, V7, P724, DOI 10.1016/S1473-3099(07)70261-X; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Galkiewicz JP, 2008, APPL ENVIRON MICROB, V74, P7828, DOI 10.1128/AEM.01303-08; Garcia ME, 2002, J CLIN MICROBIOL, V40, P1567, DOI 10.1128/JCM.40.4.1567-1568.2002; Giampetruzzi A, 2012, VIRUS RES, V163, P262, DOI 10.1016/j.virusres.2011.10.010; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Huang Y, 2012, J GEN VIROL; Huang Y, 2013, J GEN VIROL, V94, P663, DOI 10.1099/vir.0.048231-0; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lin Y., 1999, CHINESE J ZOONOSES, V2, P5; Ma MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024758; Mlotshwa S, 2008, TRENDS PLANT SCI, V13, P375, DOI 10.1016/j.tplants.2008.04.009; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Nga PT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002215; Raoult D, 1996, LANCET, V348, P412, DOI 10.1016/S0140-6736(05)65037-4; Reeves WK, 2005, ANN NY ACAD SCI, V1063, P343, DOI 10.1196/annals.1355.055; Tian ZC, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-19; van Mierlo JT, 2010, CELL HOST MICROBE, V7, P87, DOI 10.1016/j.chom.2010.02.001; Walker DH, 2008, MED CLIN N AM, V92, P1345, DOI 10.1016/j.mcna.2008.06.002; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Zhang JZ, 2000, J CLIN MICROBIOL, V38, P3498, DOI 10.1128/JCM.38.9.3498-3501.2000; Zhang JZ, 2000, EMERG INFECT DIS, V6, P432, DOI 10.3201/eid0604.000426; Zhang LJ, 2006, J CLIN MICROBIOL, V44, P2465, DOI 10.1128/JCM.02272-05	30	9	11	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90831	10.1371/journal.pone.0090831	http://dx.doi.org/10.1371/journal.pone.0090831			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618575	gold, Green Submitted, Green Published			2022-12-25	WOS:000332842400032
J	Fujioka, M; Okamoto, Y; Shinden, S; Okano, HJ; Okano, H; Ogawa, K; Matsunaga, T				Fujioka, Masato; Okamoto, Yasuhide; Shinden, Seiichi; Okano, Hirotaka James; Okano, Hideyuki; Ogawa, Kaoru; Matsunaga, Tatsuo			Pharmacological Inhibition of Cochlear Mitochondrial Respiratory Chain Induces Secondary Inflammation in the Lateral Wall: A Potential Therapeutic Target for Sensorineural Hearing Loss	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SUCCINATE-DEHYDROGENASE; SUDDEN DEAFNESS; ACOUSTIC TRAUMA; MOUSE COCHLEA; INNER-EAR; DYSFUNCTION; 3-NITROPROPIONATE; FIBROCYTES	Cochlear lateral wall has recently been reported as a common site of inflammation, yet precise molecular mechanisms of the inflammatory responses remain elucidated. The present study examined the inflammatory responses in the lateral wall following acute mitochondrial dysfunction induced by a mitochondrial toxin, 3-nitropropionic acid (3-NP). Reverse-transcription (RT)-PCR revealed increases in the expression of the proinflammatory cytokines interleukin (IL)-1 beta and IL-6. Immunohistochemistry showed an increase in the number of activated cochlear macrophages in the lateral wall, which were in close proximity to IL-6-expressing cells. A genome-wide DNA microarray analysis of the lateral wall revealed that 35% and 60% of the genes showing >2-fold upregulation at 1 d and 3 d post-3-NP administration, respectively, were inflammatory genes, including CC-and CXC-type chemokine genes. High expression of CCL-1, 2, and 3 at 1 d, and of CCL-1, 2, 3, 4, and 5, CCR-2 and 5, and CX3CR1 at 3 d post-3-NP administration, coupled with no change in the level of CX3CL1 expression suggested that macrophages and monocytes may be involved in the inflammatory response to 3-NP-mediated injury. Quantitative (q)RT-PCR showed a transient induction of IL-1 beta and IL-6 expression within 24 h of 3-NP-mediated injury, followed by sustained expression of the chemoattractants, CCL-2, 4 and 5, up until 7 d after injury. The expression of CCL-2 and IL-6 was higher in animals showing permanent hearing impairment than in those showing temporary hearing impairment, suggesting that these inflammatory responses may be detrimental to hearing recovery. The present findings suggest that acute mitochondrial dysfunction induces secondary inflammatory responses in the lateral wall of the cochlear and that the IL-6/CCL-2 inflammatory pathway is involved in monocyte activation. Therefore, these secondary inflammatory responses may be a potential post-insult therapeutic target for treatments aimed at preventing the damage caused by acute mitochondrial dysfunction in the cochlear lateral wall.	[Fujioka, Masato; Ogawa, Kaoru] Keio Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Shinjuku Ku, Tokyo, Japan; [Fujioka, Masato; Okano, Hirotaka James; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 160, Japan; [Okamoto, Yasuhide] Inagi Municipal Hosp, Dept Otorhinolaryngol, Tokyo, Japan; [Shinden, Seiichi] Saiseikai Utsunomiya Hosp, Dept Otolaryngol, Utsunomiya, Tochigi, Japan; [Okano, Hirotaka James] Jikei Univ, Sch Med, Div Regenerat Med, Tokyo, Japan; [Okamoto, Yasuhide; Shinden, Seiichi; Matsunaga, Tatsuo] Natl Tokyo Med Ctr, Natl Inst Sensory Organs, Lab Auditory Disorders, Meguro Ku, Tokyo, Japan; [Okamoto, Yasuhide; Shinden, Seiichi; Matsunaga, Tatsuo] Natl Tokyo Med Ctr, Natl Inst Sensory Organs, Div Hearing & Balance Res, Meguro Ku, Tokyo, Japan	Keio University; Keio University; Jikei University	Matsunaga, T (corresponding author), Natl Tokyo Med Ctr, Natl Inst Sensory Organs, Lab Auditory Disorders, Meguro Ku, Tokyo, Japan.	matsunagatatsuo@kankakuki.go.jp	Okano, Hideyuki/I-7584-2019	Fujioka, Masato/0000-0002-5317-0885; Okano, Hirotaka James/0000-0003-4611-7098; matsunaga, tatsuo/0000-0001-9647-1496	MEXT/JSPS KAKENHI [24592560, 24390390]; Ministry of Health Labour and Welfare	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for Scientific Research (C) from MEXT/JSPS KAKENHI grant number 24592560 to M. F. by a Grant-in-Aid for Scientific Research (B) from MEXT/JSPS KAKENHI grant number 24390390 to K.O. and by a Health Labour Sciences Research Grant from the Ministry of Health Labour and Welfare to T. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSTON TA, 1977, P NATL ACAD SCI USA, V74, P3767, DOI 10.1073/pnas.74.9.3767; Belema-Bedada F, 2008, CELL STEM CELL, V2, P566, DOI 10.1016/j.stem.2008.03.003; COLES CJ, 1979, J BIOL CHEM, V254, P5161; Dwyer RM, 2007, CLIN CANCER RES, V13, P5020, DOI 10.1158/1078-0432.CCR-07-0731; Fischel-Ghodsian N, 2003, NEW ENGL J MED, V349, P1293; Fujioka M, 2006, J NEUROSCI RES, V83, P575, DOI 10.1002/jnr.20764; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Haberkamp TJ, 1999, AM J OTOL, V20, P587; Hirose K, 2005, J COMP NEUROL, V489, P180, DOI 10.1002/cne.20619; Hoya N, 2004, NEUROREPORT, V15, P1597, DOI 10.1097/01.wnr.0000133226.94662.80; Hsu CH, 2005, ANN NY ACAD SCI, V1042, P36, DOI 10.1196/annals.1338.004; Lang HN, 2006, J COMP NEUROL, V496, P187, DOI 10.1002/cne.20929; Lee HY, 2004, J NEUROL SCI, V222, P105, DOI 10.1016/j.jns.2004.04.005; Mizutari K, 2008, J NEUROSCI RES, V86, P215, DOI 10.1002/jnr.21470; Mort DJ, 2006, CURR OPIN NEUROL, V19, P1, DOI 10.1097/01.wco.0000196155.92856.a1; Okamoto Y, 2005, AUDIOL NEURO-OTOL, V10, P220, DOI 10.1159/000084843; Okano T, 2008, J NEUROSCI RES, V86, P1758, DOI 10.1002/jnr.21625; Pickles JO, 2004, AUDIOL NEURO-OTOL, V9, P23, DOI 10.1159/000074184; Sun GW, 2012, J NEUROSCI RES, V90, P1713, DOI 10.1002/jnr.23067; Wang Y, 2002, JARO, V3, P248, DOI 10.1007/s101620020028; Yamane H, 1995, EUR ARCH OTO-RHINO-L, V252, P504, DOI 10.1007/BF02114761; YAMANE H, 1995, ACTA OTO-LARYNGOL, P87; Yamasoba T, 2001, J NEUROL SCI, V187, P69, DOI 10.1016/S0022-510X(01)00525-1	23	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90089	10.1371/journal.pone.0090089	http://dx.doi.org/10.1371/journal.pone.0090089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614528	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300017
J	Lu, ZL; Kong, XX; Lu, ZM; Xiao, MX; Chen, MY; Zhu, L; Shen, YM; Hu, XY; Song, SY				Lu, Zhonglei; Kong, Xiangxiang; Lu, Zhaoming; Xiao, Meixiang; Chen, Meiyuan; Zhu, Liang; Shen, Yuemao; Hu, Xiangyang; Song, Siyang			Para-Aminobenzoic Acid (PABA) Synthase Enhances Thermotolerance of Mushroom Agaricus bisporus	PLOS ONE			English	Article							PRECURSOR P-AMINOBENZOATE; SALICYLIC-ACID; TEMPERATURE STRESS; OXIDATIVE STRESS; GENE-EXPRESSION; PROTECTIVE ROLE; ABIOTIC STRESS; GLUCOSE ESTER; ABSCISIC-ACID; SALT STRESS	Most mushrooms are thermo-sensitive to temperatures over 23 degrees C, which greatly restricts their agricultural cultivation. Understanding mushroom's innate heat-tolerance mechanisms may facilitate genetic improvements of their thermotolerance. Agaricus bisporus strain 02 is a relatively thermotolerant mushroom strain, while strain 8213 is quite thermosensitive. Here, we compared their responses at proteomic level to heat treatment at 33 degrees C. We identified 73 proteins that are differentially expressed between 02 and 8213 or induced upon heat stress in strain 02 itself, 48 of which with a known identity. Among them, 4 proteins are constitutively more highly expressed in 02 than 8213; and they can be further upregulated in response to heat stress in 02, but not in 8213. One protein is encoded by the para-aminobenzoic acid (PABA) synthase gene Pabs, which has been shown to scavenge the reactive oxygen species in vitro. Pabs mRNA and its chemical product PABA show similar heat stress induction pattern as PABA synthase protein and are more abundant in 02, indicating transcriptional level upregulation of Pabs upon heat stress. A specific inhibitor of PABA synthesis impaired thermotolerance of 02, while exogenous PABA or transgenic overexpression of 02 derived PABA synthase enhanced thermotolerance of 8213. Furthermore, compared to 8213, 02 accumulated less H2O2 but more defense-related proteins (e. g., HSPs and Chitinase) under heat stress. Together, these results demonstrate a role of PABA in enhancing mushroom thermotolerance by removing H2O2 and elevating defense-related proteins.	[Lu, Zhonglei; Lu, Zhaoming; Xiao, Meixiang; Shen, Yuemao; Song, Siyang] Xiamen Univ, Sch Life Sci, State Key Lab Stress Cell Biol, Xiamen, Fujian, Peoples R China; [Kong, Xiangxiang; Hu, Xiangyang] Chinese Acad Sci, Inst Tibet Plateau Res Kunming, Key Lab Biodivers & Biogeog, Kunming Inst Bot, Kunming, Yunnan, Peoples R China; [Chen, Meiyuan] Fujian Acad Agr Sci, Edible Fungi Inst, Fuzhou, Fujian, Peoples R China; [Zhu, Liang] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA; [Zhu, Liang] Albert Einstein Coll Med, Bronx, NY 10467 USA	Xiamen University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Fujian Academy of Agricultural Sciences; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Hu, XY (corresponding author), Chinese Acad Sci, Inst Tibet Plateau Res Kunming, Key Lab Biodivers & Biogeog, Kunming Inst Bot, Kunming, Yunnan, Peoples R China.	huxiangyang@mail.kib.ac.cn; sysong@xmu.edu.cn	Hu, Xiangyang/AAQ-3313-2021	Shen, Yuemao/0000-0002-3881-0135; Lu, Zhonglei/0000-0002-8915-4828	100 Talents Program of the Chinese Academy of Sciences; National Science Foundation of China [30571295, 30871704, 30971452, 31170256]; Major Science and Technology Program [10201101003-TS-03]	100 Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science and Technology Program	This work was supported by the 100 Talents Program of the Chinese Academy of Sciences, the National Science Foundation of China (grant No. 30571295, 30871704, 30971452, and 31170256), the Major Science and Technology Program (grant No.10201101003-TS-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeselmani M, 2006, PLANT SCI, V171, P382, DOI 10.1016/j.plantsci.2006.04.009; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Asami DK, 2003, J AGR FOOD CHEM, V51, P1237, DOI 10.1021/jf020635c; Bai XG, 2011, J PROTEOME RES, V10, P4349, DOI 10.1021/pr200333f; Basset GJC, 2005, CROP SCI, V45, P449, DOI 10.2135/cropsci2005.0449; Basset GJC, 2004, P NATL ACAD SCI USA, V101, P1496, DOI 10.1073/pnas.0308331100; Camara D, 2012, J BIOL CHEM, V287, P22367, DOI 10.1074/jbc.M112.365833; Chen R, 2003, FOOD TECHNOL BIOTECH, V41, P339; Chen X, 2000, APPL ENVIRON MICROB, V66, P4510, DOI 10.1128/AEM.66.10.4510-4513.2000; Davidson JF, 1996, P NATL ACAD SCI USA, V93, P5116, DOI 10.1073/pnas.93.10.5116; Dana MD, 2006, PLANT PHYSIOL, V142, P722, DOI 10.1104/pp.106.086140; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; Eudes A, 2008, J BIOL CHEM, V283, P15451, DOI 10.1074/jbc.M709591200; Fang WG, 2008, FEMS MICROBIOL LETT, V279, P146, DOI 10.1111/j.1574-6968.2007.00978.x; Gammulla CG, 2010, PROTEOMICS, V10, P3001, DOI 10.1002/pmic.201000054; Gong ZZ, 2005, PLANT CELL, V17, P256, DOI 10.1105/tpc.104.027557; Hanson AD, 2002, CURR OPIN PLANT BIOL, V5, P244, DOI 10.1016/S1369-5266(02)00249-2; Horvath E, 2007, J PLANT GROWTH REGUL, V26, P290, DOI 10.1007/s00344-007-9017-4; HU ML, 1995, J NUTR BIOCHEM, V6, P504, DOI 10.1016/0955-2863(95)00082-B; Hu XY, 2004, CELL RES, V14, P234, DOI 10.1038/sj.cr.7290224; KERRIGAN RW, 1995, CAN J BOT, V73, pS973, DOI 10.1139/b95-347; Larkindale J, 2002, PLANT PHYSIOL, V128, P682, DOI 10.1104/pp.010320; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Lu ZL, 2011, AM J BOT, V98, pE239, DOI 10.3732/ajb.1100067; Neilson KA, 2010, PROTEOMICS, V10, P828, DOI 10.1002/pmic.200900538; Ospina-Giraldo MD, 2000, FUNGAL GENET BIOL, V29, P81, DOI 10.1006/fgbi.2000.1189; Owttrim GW, 2006, NUCLEIC ACIDS RES, V34, P3220, DOI 10.1093/nar/gkl408; Quinlivan EP, 2003, J BIOL CHEM, V278, P20731, DOI 10.1074/jbc.M302894200; Romaine C. Peter, 2006, V344, P453; RUSSO VM, 1993, ANTON LEEUW INT J G, V63, P23, DOI 10.1007/BF00871727; Scott J, 2000, J SCI FOOD AGR, V80, P795, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt;795::AID-JSFA599&gt;3.0.CO;2-K, 10.1002/(SICI)1097-0010(20000515)80:7<795::AID-JSFA599>3.0.CO;2-K]; Senaratna T, 2000, PLANT GROWTH REGUL, V30, P157, DOI 10.1023/A:1006386800974; Suzuki N, 2006, PHYSIOL PLANTARUM, V126, P45, DOI 10.1111/j.0031-9317.2005.00582.x; Tang L, 2006, PLANT CELL REP, V25, P1380, DOI 10.1007/s00299-006-0199-1; Weinstein SJ, 2003, CANCER EPIDEM BIOMAR, V12, P1271; Xiong LM, 1999, PLANT PHYSIOL, V119, P205, DOI 10.1104/pp.119.1.205; Xu CP, 2008, J EXP BOT, V59, P4183, DOI 10.1093/jxb/ern258; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Zhang SQ, 1997, PLANT CELL, V9, P809, DOI 10.1105/tpc.9.5.809	40	26	31	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91298	10.1371/journal.pone.0091298	http://dx.doi.org/10.1371/journal.pone.0091298			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614118	Green Submitted, Green Published, gold			2022-12-25	WOS:000332839300107
J	Rodriguez-Martinez, S; Carrete, M; Roques, S; Rebolo-Ifran, N; Tella, JL				Rodriguez-Martinez, Sol; Carrete, Martina; Roques, Severine; Rebolo-Ifran, Natalia; Tella, Jose L.			High Urban Breeding Densities Do Not Disrupt Genetic Monogamy in a Bird Species	PLOS ONE			English	Article							EXTRA-PAIR PATERNITY; INTRASPECIFIC BROOD PARASITISM; BURROWING OWLS; NATAL DISPERSAL; INDIVIDUAL CONSISTENCY; COMPUTER-PROGRAM; SEXUAL SELECTION; NEST PARASITISM; FERTILIZATION; BIODIVERSITY	Urbanization causes widespread endangerment of biodiversity worldwide. However, some species successfully colonize cities reaching higher densities than in their rural habitats. In these cases, although urban city dwellers may apparently be taking advantage of these new environments, they also face new ecological conditions that may induce behavioural changes. For example, the frequency of alternative reproductive behaviours such as extra-pair paternity and intraspecific brood parasitism might increase with breeding densities. Here, using a panel of 17 microsatellites, we tested whether increments in breeding densities such as those associated with urban invasion processes alter genetic monogamy in the burrowing owl Athene cunicularia. Our results show low rates of extra-pair paternity (1.47%), but relatively high levels of intraspecific brood parasitism (8.82%). However, we were not able to detect differences in the frequency at which either alternative reproductive behaviour occurs along a strong breeding density gradient. Further research is needed to properly ascertain the role of other social and ecological factors in the frequency at which this species presents alternative reproductive strategies. Meanwhile, our results suggest that genetic monogamy is maintained despite the increment in conspecific density associated with a recent urban invasion process.	[Rodriguez-Martinez, Sol] Univ Nacl Sur, Dept Biol Biochem & Pharm, RA-8000 Bahia Blanca, Buenos Aires, Argentina; [Rodriguez-Martinez, Sol; Carrete, Martina; Roques, Severine; Tella, Jose L.] CSIC, Estn Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain; [Carrete, Martina] Univ Pablo de Olavide, Dept Phys Chem & Nat Syst, Seville, Spain; [Rebolo-Ifran, Natalia] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ecol Genet & Evolut, IEGEBA CONICET, Buenos Aires, DF, Argentina	National University of the South; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidad Pablo de Olavide; University of Buenos Aires	Rodriguez-Martinez, S (corresponding author), Univ Nacl Sur, Dept Biol Biochem & Pharm, RA-8000 Bahia Blanca, Buenos Aires, Argentina.	solrodriguez@criba.edu.ar	Rebolo-Ifrán, Natalia/K-1329-2014; Carrete, Martina/A-6376-2009; Tella, José L/I-3707-2015; Carrete, Martina/D-2618-2017	Carrete, Martina/0000-0002-0491-2950; Tella, José L/0000-0002-3038-7424; Rodriguez-Martinez, Sol/0000-0002-7537-6753; Roques, Severine/0000-0002-9029-7789	Canal Sur TV; Fundacion Repsol; MEC (Spain) [CGL2012-31888]; CONICET (Argentina); Ramon y Cajal contract [RYC-2009-04860]	Canal Sur TV; Fundacion Repsol; MEC (Spain)(Spanish Government); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Ramon y Cajal contract(Spanish Government)	Funding was provided by Canal Sur TV, Fundacion Repsol and Project CGL2012-31888 from MEC (Spain). N.R. and S. R. M. are supported by CONICET (Argentina) and M. C. by a Ramon y Cajal contract (RYC-2009-04860). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2001, AM NAT, V158, P599, DOI 10.1086/324113; Aparicio JM, 2006, MOL ECOL, V15, P4659, DOI 10.1111/j.1365-294X.2006.03111.x; Arsenault DP, 2002, CONDOR, V104, P197, DOI 10.1650/0010-5422(2002)104[0197:NEPFIF]2.0.CO;2; Belkhir K, 1996, 5000 CNRS UMR LAB GE; BELTHOFF JR, 1989, CONDOR, V91, P254, DOI 10.2307/1368302; Birkhead TR, 1992, SPERM COMPETITION BI; Bolger Douglas T., 2001, P155; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cardador L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033375; Carrete M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03524; Carrete M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018859; Carrete M, 2010, BIOL LETTERS, V6, P167, DOI 10.1098/rsbl.2009.0739; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Clayton KM, 1999, BIRD CONSERV INT, V9, P163, DOI 10.1017/S0959270900002288; Faeth SH, 2005, BIOSCIENCE, V55, P399, DOI 10.1641/0006-3568(2005)055[0399:TDIUC]2.0.CO;2; Faircloth BC, 2010, CONSERV GENET RESOUR, V2, P167, DOI 10.1007/s12686-010-9214-5; GOWATY PA, 1989, ANIM BEHAV, V38, P272, DOI 10.1016/S0003-3472(89)80089-2; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Griffith SC, 2000, BEHAV ECOL, V11, P265, DOI 10.1093/beheco/11.3.265; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Han JI, 2009, AUK, V126, P779, DOI 10.1525/auk.2009.08203; Hsu YC, 2006, J AVIAN BIOL, V37, P36, DOI 10.1111/j.2006.0908-8857.03687.x; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Martinez JJ, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-68; Kahn NW, 1998, AUK, V115, P1074; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Korfanta NM, 2002, MOL ECOL NOTES, V2, P584, DOI 10.1046/j.1471-8286.2002.00326.x; Korpimaki E, 1996, ANIM BEHAV, V51, P945, DOI 10.1006/anbe.1996.0098; KORPIMAKI E, 1988, J ANIM ECOL, V57, P433, DOI 10.2307/4915; Lack D., 1968, pvii; Lahaye WS, 2001, CONDOR, V103, P691, DOI 10.1650/0010-5422(2001)103[0691:NDOTSO]2.0.CO;2; LANK DB, 1990, EVOLUTION, V44, P1436, DOI 10.1111/j.1558-5646.1990.tb03837.x; Lawless SG, 1997, CONDOR, V99, P213, DOI 10.2307/1370242; Lyon BE, 2008, ANNU REV ECOL EVOL S, V39, P343, DOI 10.1146/annurev.ecolsys.39.110707.173354; Machicote M, 2004, OIKOS, V106, P527, DOI 10.1111/j.0030-1299.2004.13139.x; Macias-Duarte A, 2010, CONSERV GENET RESOUR, V2, P67, DOI 10.1007/s12686-009-9150-4; Marks JS, 1999, CONDOR, V101, P854, DOI 10.2307/1370075; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Marzluff JM., 2001, AVIAN CONSERV ECOL, P1, DOI [DOI 10.1007/978-1-4615-1531-9, 10.1007/978-1-4615-1531-9_1]; Mayer C, 2013, ECOL EVOL, V3, P694, DOI 10.1002/ece3.489; Mcdonald RI, 2008, BIOL CONSERV, V141, P1695, DOI 10.1016/j.biocon.2008.04.025; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Moller AP, 2009, OECOLOGIA, V159, P849, DOI 10.1007/s00442-008-1259-8; Moller AP, 1998, BEHAV ECOL SOCIOBIOL, V43, P345, DOI 10.1007/s002650050501; Moore JA, 2012, IBIS, V154, P354, DOI 10.1111/j.1474-919X.2011.01203.x; MULDER RA, 1994, P ROY SOC B-BIOL SCI, V255, P223, DOI 10.1098/rspb.1994.0032; Muller W, 2001, J ORNITHOL, V142, P195, DOI 10.1007/BF01651787; Negro JJ, 1996, ANIM BEHAV, V51, P935, DOI 10.1006/anbe.1996.0097; PETRIE M, 1991, TRENDS ECOL EVOL, V6, P315, DOI 10.1016/0169-5347(91)90038-Y; Richardson DS, 2001, ANIM BEHAV, V62, P519, DOI 10.1006/anbe.2001.1778; Rodewald AD, 2008, ECOLOGY, V89, P515, DOI 10.1890/07-0358.1; Rodewald AD, 2008, J ANIM ECOL, V77, P83, DOI 10.1111/j.1365-2656.2007.01313.x; Rodewald AD, 2011, ECOLOGY, V92, P1781, DOI 10.1890/11-0022.1; Rodewald AD, 2011, ECOL APPL, V21, P936, DOI 10.1890/10-0863.1; Roulin A, 2004, J AVIAN BIOL, V35, P492, DOI 10.1111/j.0908-8857.2004.03294.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ryder TB, 2012, ECOL EVOL, V2, P976, DOI 10.1002/ece3.254; Saladin V, 2007, J ORNITHOL, V148, P113, DOI 10.1007/s10336-006-0109-x; Serrano D, 2008, BASIC APPL ECOL, V9, P771, DOI 10.1016/j.baae.2007.08.013; Sih A, 2011, EVOL APPL, V4, P367, DOI 10.1111/j.1752-4571.2010.00166.x; STUTCHBURY BJ, 1995, BEHAVIOUR, V132, P675, DOI 10.1163/156853995X00081; Thusius KJ, 2001, BEHAV ECOL, V12, P633, DOI 10.1093/beheco/12.5.633; Tuomainen U, 2011, BIOL REV, V86, P640, DOI 10.1111/j.1469-185X.2010.00164.x; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Waldeck P, 2004, BEHAVIOUR, V141, P725, DOI 10.1163/1568539042245132; Westneat D.F., 1990, Current Ornithology, V7, P331; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Westneat DF, 1997, BEHAV ECOL SOCIOBIOL, V41, P205, DOI 10.1007/s002650050381; WREGE PH, 1987, BEHAV ECOL SOCIOBIOL, V20, P153, DOI 10.1007/BF00299728; Yom-Tov Y, 2001, IBIS, V143, P133, DOI 10.1111/j.1474-919X.2001.tb04177.x	71	20	20	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91314	10.1371/journal.pone.0091314	http://dx.doi.org/10.1371/journal.pone.0091314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614308	Green Submitted, Green Published, gold			2022-12-25	WOS:000332839300112
J	Forkpah, C; Dixon, LR; Fahrbach, SE; Rueppell, O				Forkpah, Cordelia; Dixon, Luke R.; Fahrbach, Susan E.; Rueppell, Olav			Xenobiotic Effects on Intestinal Stem Cell Proliferation in Adult Honey Bee (Apis mellifera L) Workers	PLOS ONE			English	Article							COLONY COLLAPSE DISORDER; PESTICIDE-RESIDUES; HYMENOPTERA; EXPOSURE; MIDGUT; TOXICITY; MICROSPORIDIA; SENSITIVITY; MICROFLORA; ACARICIDES	The causes of the current global decline in honey bee health are unknown. One major group of hypotheses invokes the pesticides and other xenobiotics to which this important pollinator species is often exposed. Most studies have focused on mortality or behavioral deficiencies in exposed honey bees while neglecting other biological functions and target organs. The midgut epithelium of honey bees presents an important interface between the insect and its environment. It is maintained by proliferation of intestinal stem cells throughout the adult life of honey bees. We used caged honey bees to test multiple xenobiotics for effects on the replicative activity of the intestinal stem cells under laboratory conditions. Most of the tested compounds did not alter the replicative activity of intestinal stem cells. However, colchicine, methoxyfenozide, tetracycline, and a combination of coumaphos and tau-fluvalinate significantly affected proliferation rate. All substances except methoxyfenozide decreased proliferation rate. Thus, the results indicate that some xenobiotics frequently used in apiculture and known to accumulate in honey bee hives may have hitherto unknown physiological effects. The nutritional status and the susceptibility to pathogens of honey bees could be compromised by the impacts of xenobiotics on the maintenance of the midgut epithelium. This study contributes to a growing body of evidence that more comprehensive testing of xenobiotics may be required before novel or existing compounds can be considered safe for honey bees and other non-target species.	[Forkpah, Cordelia; Dixon, Luke R.; Rueppell, Olav] Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA; [Fahrbach, Susan E.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA	University of North Carolina; University of North Carolina Greensboro; Wake Forest University	Rueppell, O (corresponding author), Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA.	olav_rueppell@uncg.edu	Rueppell, Olav/G-2679-2010	Rueppell, Olav/0000-0001-5370-4229	North Carolina Biotechnology Center; USDA National Institute of Food and Agriculture [2010-65104-20533]; Division Of Integrative Organismal Systems [1256878] Funding Source: National Science Foundation	North Carolina Biotechnology Center; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was supported by the North Carolina Biotechnology Center and the Agriculture and Food Research Initiative Competitive Grant no. 2010-65104-20533 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; Bendahou N, 1999, ECOTOX ENVIRON SAFE, V44, P147, DOI 10.1006/eesa.1999.1812; Berry JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076536; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Boncristiani H, 2012, J INSECT PHYSIOL, V58, P613, DOI 10.1016/j.jinsphys.2011.12.011; Bryden J, 2013, ECOL LETT, V16, P1463, DOI 10.1111/ele.12188; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Carlson GR, 2001, PEST MANAG SCI, V57, P115, DOI 10.1002/1526-4998(200102)57:2<115::AID-PS245>3.0.CO;2-A; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Decourtye A, 2013, NATURE, V497, P188, DOI 10.1038/497188a; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Ellis JD, 2010, J APICULT RES, V49, P134, DOI 10.3896/IBRA.1.49.1.30; Fernandes KM, 2010, SOCIOBIOLOGY, V56, P489; FEYEREISEN R, 1976, GEN COMP ENDOCR, V29, P319, DOI 10.1016/0016-6480(76)90044-7; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; Gregorc A, 2011, PESTIC BIOCHEM PHYS, V99, P200, DOI 10.1016/j.pestbp.2010.12.005; Hakim RS, 2010, ANNU REV ENTOMOL, V55, P593, DOI 10.1146/annurev-ento-112408-085450; Han P, 2012, ECOTOXICOLOGY, V21, P2214, DOI 10.1007/s10646-012-0976-2; Hawthorne DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026796; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Heylen K, 2011, APIDOLOGIE, V42, P103, DOI 10.1051/apido/2010043; Higes M, 2013, ENV MICROBIOL REP, V5, P17, DOI 10.1111/1758-2229.12024; James RR, 2012, J INVERTEBR PATHOL, V109, P175, DOI 10.1016/j.jip.2011.12.005; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054092; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Kakmand F. A., 2008, J DOHUK U, V11, P144; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Mao WF, 2011, P NATL ACAD SCI USA, V108, P12657, DOI 10.1073/pnas.1109535108; Martel AC, 2006, FOOD ADDIT CONTAM A, V23, P265, DOI 10.1080/02652030500469048; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; Mattila HR, 2006, J ECON ENTOMOL, V99, P604, DOI 10.1603/0022-0493-99.3.604; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Ninov N, 2009, PLOS BIOL, V7, P892, DOI 10.1371/journal.pbio.1000079; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Palmer MJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2648; Pettis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070182; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Rada V, 1997, APIDOLOGIE, V28, P357, DOI 10.1051/apido:19970603; Rharrabe K, 2009, PESTIC BIOCHEM PHYS, V93, P112, DOI 10.1016/j.pestbp.2008.12.002; Rinderer TE, 2012, J APICULT RES, V51, P218, DOI 10.3896/IBRA.1.51.2.13; Smagghe G, 2005, ANN NY ACAD SCI, V1040, P472, DOI 10.1196/annals.1327.094; SMIRLE MJ, 1984, J ECON ENTOMOL, V77, P63, DOI 10.1093/jee/77.1.63; Snodgrass R.E., 1956, ANATOMY HONEY BEE; Sullivan JT, 2005, J INVERTEBR PATHOL, V90, P32, DOI 10.1016/j.jip.2005.04.005; Thompson HM, 2005, FOOD ADDIT CONTAM, V22, P573, DOI 10.1080/02652030500089986; Vachon V, 2012, J INVERTEBR PATHOL, V111, P1, DOI 10.1016/j.jip.2012.05.001; vanEngelsdorp D, 2010, J ECON ENTOMOL, V103, P1517, DOI 10.1603/EC09429; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; WAHL O, 1983, OECOLOGIA, V59, P106, DOI 10.1007/BF00388082; Ward KN, 2008, EXP GERONTOL, V43, P530, DOI 10.1016/j.exger.2008.03.012; Willard LE, 2011, APIDOLOGIE, V42, P508, DOI 10.1007/s13592-011-0006-z; Williams GR, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.04; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931; Wu JY, 2012, J INVERTEBR PATHOL, V109, P326, DOI 10.1016/j.jip.2012.01.005; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743; Yang EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049472	68	21	22	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91180	10.1371/journal.pone.0091180	http://dx.doi.org/10.1371/journal.pone.0091180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608542	Green Submitted, Green Published, gold			2022-12-25	WOS:000332485800111
J	Tong, ZC; Huang, LJ; Ling, JQ; Mao, XL; Ning, Y; Deng, DM				Tong, Zhongchun; Huang, Lijia; Ling, Junqi; Mao, Xueli; Ning, Yang; Deng, Dongmei			Effects of Intracanal Irrigant MTAD Combined with Nisin at Sub-Minimum Inhibitory Concentration Levels on Enterococcus faecalis Growth and the Expression of Pathogenic Genes	PLOS ONE			English	Article							IN-VITRO EVALUATION; ANTIBIOTIC CONCENTRATIONS; ESCHERICHIA-COLI; LIPID-II; CIPROFLOXACIN; COMBINATION; RESISTANCE; DISEASE; HEALTH	Exposure to antibiotics is considered to be the major driver in the selection of antibiotic-resistant bacteria and may induce diverse biological responses in bacteria. MTAD is a common intracanal irrigant, but its bactericidal activity remains to be improved. Previous studies have indicated that the antimicrobial peptide nisin can significantly improve the bactericidal activity of MTAD against Enterococcus faecalis. However, the effects of MTAD and its modification at sub-minimum inhibitory concentration (sub-MIC) levels on Enterococcus faecalis growth and the expression of pathogenic genes still need to be explored. In this study, the results of post-antibiotic effects (PAE) and post-antibiotic sub-MIC effects (PASME) showed that MTADN (nisin in combination with MTAD) had the best post-antibiotic effect. E. faecalis after challenge with MTAD was less sensitive to alkaline solutions compared with MTAN (nisin in place of doxycycline in MTAD) and MTADN. E. faecalis induced with sub-MIC of MTAD generated resistance to the higher concentration, but induction of E. faecalis with MTAN did not cause resistance to higher concentrations. Furthermore, real-time polymerase chain reaction (RT-PCR) showed that the stress caused by sub-MIC exposure to MTAD, MTAN, or MTADN resulted in up-or down-regulation of nine stress genes and four virulence-associated genes in E. faecalis and resulted in different stress states. These findings suggested that nisin improved the post-antibacterial effect of MTAD at sub-MIC levels and has considerable potential for use as a modification of MTAD.	[Tong, Zhongchun; Huang, Lijia; Ling, Junqi; Mao, Xueli; Deng, Dongmei] Sun Yat Sen Univ, Dept Operat Dent & Endodont, Guanghua Sch Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Tong, Zhongchun; Ling, Junqi] Sun Yat Sen Univ, Guangdong Prov Key Lab Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Ning, Yang] Sun Yat Sen Univ, Guanghua Sch Stomatol, Dept Periodontol, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Dongmei] Univ Amsterdam, Dept Cariol Endodontol Pedodontol, Acad Ctr Dent Amsterdam, Amsterdam, Netherlands; [Deng, Dongmei] Vrije Univ Amsterdam, Amsterdam, Netherlands	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Ling, JQ (corresponding author), Sun Yat Sen Univ, Dept Operat Dent & Endodont, Guanghua Sch Stomatol, Guangzhou 510275, Guangdong, Peoples R China.	Junqi_Ling@hotmail.com	Deng, Dongmei/V-9230-2017		Fundamental Research Funds for the Central Universities, China [12ykpy64]; Bairenjihua Research Fund by Sun Yat-Sen University [985[2012]245]	Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities); Bairenjihua Research Fund by Sun Yat-Sen University	This research is supported by the Fundamental Research Funds for the Central Universities, China (No 12ykpy64) and Bairenjihua Research Fund by Sun Yat-Sen University (No 985[2012]245). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa TM, 2000, DRUG RESIST UPDATE, V3, P303, DOI 10.1054/drup.2000.0167; Bernier SP, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00020; Breukink E, 2003, J BIOL CHEM, V278, P19898, DOI 10.1074/jbc.M301463200; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; Craig W, 1996, ANTIBIOTICS LAB MED, P296; Dong LP, 2012, INT J ANTIMICROB AG, V39, P390, DOI 10.1016/j.ijantimicag.2012.01.009; Harada K, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-16; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hughes D, 2012, CURR OPIN MICROBIOL, V15, P555, DOI 10.1016/j.mib.2012.07.005; Kayaoglu G, 2004, CRIT REV ORAL BIOL M, V15, P308, DOI 10.1177/154411130401500506; Lenz CA, 2010, FOOD MICROBIOL, V27, P317, DOI 10.1016/j.fm.2009.11.008; Licata L, 1997, ANTIMICROB AGENTS CH, V41, P950, DOI 10.1128/AAC.41.5.950; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Mohammadi Z, 2012, Chonnam Med J, V48, P133, DOI 10.4068/cmj.2012.48.3.133; Mortensen NP, 2011, INT J ANTIMICROB AG, V38, P27, DOI 10.1016/j.ijantimicag.2011.03.011; MURRAY BE, 1990, CLIN MICROBIOL REV, V3, P46, DOI 10.1128/CMR.3.1.46-65.1990; Odenholt I, 2001, INT J ANTIMICROB AG, V17, P1, DOI 10.1016/S0924-8579(00)00243-0; ODENHOLTTORNQVIST I, 1991, ANTIMICROB AGENTS CH, V35, P1834, DOI 10.1128/AAC.35.9.1834; Pankuch GA, 2009, ANTIMICROB AGENTS CH, V53, P4537, DOI 10.1128/AAC.00785-09; Pinheiro ET, 2006, ORAL MICROBIOL IMMUN, V21, P137, DOI 10.1111/j.1399-302X.2006.00285.x; Reeks BY, 2005, CAN J VET RES, V69, P1; Severina E, 1998, J ANTIMICROB CHEMOTH, V41, P341, DOI 10.1093/jac/41.3.341; Singla MG, 2011, ORAL SURG ORAL MED O, V112, pE70, DOI 10.1016/j.tripleo.2011.02.015; Stuart CH, 2006, J ENDODONT, V32, P93, DOI 10.1016/j.joen.2005.10.049; Tong ZC, 2012, J ENDODONT, V38, P490, DOI 10.1016/j.joen.2011.11.015; Tong ZC, 2011, J ENDODONT, V37, P1116, DOI 10.1016/j.joen.2011.03.020; Torabinejad M, 2003, J ENDODONT, V29, P400, DOI 10.1097/00004770-200306000-00005	27	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90235	10.1371/journal.pone.0090235	http://dx.doi.org/10.1371/journal.pone.0090235			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603760	Green Published, Green Submitted, gold			2022-12-25	WOS:000332483600033
J	Wang, ZQ; Liang, PP; Zhao, ZL; Han, Y; Song, HQ; Xu, JY; Lu, J; Li, KC				Wang, Zhiqun; Liang, Peipeng; Zhao, Zhilian; Han, Ying; Song, Haiqing; Xu, Jianyang; Lu, Jie; Li, Kuncheng			Acupuncture Modulates Resting State Hippocampal Functional Connectivity in Alzheimer Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; APOLIPOPROTEIN-E GENOTYPE; BRAIN NETWORKS; DEFAULT-MODE; EARLY-DIAGNOSIS; FMRI; MRI; ASYMMETRY; CORTEX; DEMENTIA	Our objective is to clarify the effects of acupuncture on hippocampal connectivity in patients with Alzheimer disease (AD) using functional magnetic resonance imaging (fMRI). Twenty-eight right-handed subjects (14 AD patients and 14 healthy elders) participated in this study. Clinical and neuropsychological examinations were performed on all subjects. MRI was performed using a SIEMENS verio 3-Tesla scanner. The fMRI study used a single block experimental design. We first acquired baseline resting state data during the initial 3 minutes and then performed acupuncture stimulation on the Tai chong and He gu acupoints for 3 minutes. Last, we acquired fMRI data for another 10 minutes after the needle was withdrawn. The preprocessing and data analysis were performed using statistical parametric mapping (SPM5) software. Two-sample t-tests were performed using data from the two groups in different states. We found that during the resting state, several frontal and temporal regions showed decreased hippocampal connectivity in AD patients relative to control subjects. During the resting state following acupuncture, AD patients showed increased connectivity in most of these hippocampus related regions compared to the first resting state. In conclusion, we investigated the effect of acupuncture on AD patients by combing fMRI and traditional acupuncture. Our fMRI study confirmed that acupuncture at Tai chong and He gu can enhance the hippocampal connectivity in AD patients.	[Wang, Zhiqun; Liang, Peipeng; Zhao, Zhilian; Lu, Jie; Li, Kuncheng] Capital Med Univ, Dept Radiol, Xuanwu Hosp, Beijing, Peoples R China; [Han, Ying; Song, Haiqing] Capital Med Univ, Dept Neurol, Xuanwu Hosp, Beijing, Peoples R China; [Xu, Jianyang] Chinese Peoples Armed Police Forces, Gen Hosp, Beijing, Peoples R China; [Li, Kuncheng] Minist Educ, Key Lab Neurodegenerat Dis, Beijing, Peoples R China; [Liang, Peipeng; Li, Kuncheng] Beijing Key Lab Magnet Resonance Imaging & Brain, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Lu, J (corresponding author), Capital Med Univ, Dept Radiol, Xuanwu Hosp, Beijing, Peoples R China.	lujie@xwh.ccmu.edu.cn; likuncheng@xwh.ccmu.edu.cn	Han, Ying/H-7111-2017; Lu, Jie/GNW-3367-2022		Scientific Research Foundation for the Returned Overseas Chinese Scholars; Natural Science Foundation of China [81000606, 81370037, 61105118, 81141018, 81030028, 81225012]; China Postdoctoral Science Foundation [201003142];  [Z101107052210002];  [Z111107067311036]	Scientific Research Foundation for the Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); ; 	This work was supported by the Project Sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, the Natural Science Foundation of China (Grant No. 81000606, 81370037, 61105118, 81141018, 81030028, and 81225012), China Postdoctoral Science Foundation funded project (No. 201003142), and Key Work of Special Project supported by the city government (Z101107052210002 and Z111107067311036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G, 2007, ARCH NEUROL-CHICAGO, V64, P1482, DOI 10.1001/archneur.64.10.1482; American Psychiatric Association DSM-IV, 1994, DSM 4 DIAGN STAT MAN; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Backman L, 1999, NEUROLOGY, V52, P1861, DOI 10.1212/WNL.52.9.1861; Bai F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029288; Bai F, 2009, BIOL PSYCHIAT, V65, P951, DOI 10.1016/j.biopsych.2008.10.017; Bai LJ, 2009, BRAIN RES, V1279, P37, DOI 10.1016/j.brainres.2009.04.056; Bigler ED, 2002, J INT NEUROPSYCH SOC, V8, P925, DOI 10.1017/S1355617702870072; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Chetelat G, 2003, NEUROIMAGE, V18, P525, DOI 10.1016/S1053-8119(02)00026-5; Desikan RS, 2009, BRAIN; Dhond RP, 2008, PAIN, V136, P407, DOI 10.1016/j.pain.2008.01.011; Fang JL, 2009, HUM BRAIN MAPP, V30, P1196, DOI 10.1002/hbm.20583; Feng YY, 2012, MAGN RESON IMAGING, V30, P672, DOI 10.1016/j.mri.2012.01.003; Feng YY, 2011, MAGN RESON IMAGING, V29, P958, DOI 10.1016/j.mri.2011.04.009; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Geroldi C, 2000, J NEUROL NEUROSUR PS, V68, P93, DOI 10.1136/jnnp.68.1.93; Goveas JS, 2011, J MAGN RESON IMAGING, V34, P764, DOI 10.1002/jmri.22662; Grady CL, 2003, J NEUROSCI, V23, P986, DOI 10.1523/jneurosci.23-03-00986.2003; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Li SJ, 2002, RADIOLOGY, V225, P253, DOI 10.1148/radiol.2251011301; Liang PP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022153; Liu ZY, 2012, PSYCHIAT RES-NEUROIM, V202, P118, DOI 10.1016/j.pscychresns.2012.03.002; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Pedraza O, 2004, J INT NEUROPSYCH SOC, V10, P664, DOI 10.1017/S1355617704105080; Pennanen C, 2004, NEUROBIOL AGING, V25, P303, DOI 10.1016/S0197-4580(03)00084-8; Petrella JR, 2003, RADIOLOGY, V226, P315, DOI 10.1148/radiol.2262011600; Qin W, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-55; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Szabo CA, 2001, AM J NEURORADIOL, V22, P1342; Tregellas JR, 2007, SCHIZOPHR RES, V92, P262, DOI 10.1016/j.schres.2006.12.033; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wang ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042730; Wang ZQ, 2011, J NEUROL SCI, V309, P79, DOI 10.1016/j.jns.2011.07.017; Wang ZQ, 2009, ACTA RADIOL, V50, P312, DOI 10.1080/02841850802709219; Zhou YL, 2008, ACUPUNCTURE ELECTRO, V33, P9, DOI 10.3727/036012908803861186	43	130	138	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91160	10.1371/journal.pone.0091160	http://dx.doi.org/10.1371/journal.pone.0091160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603951	Green Submitted, Green Published, gold			2022-12-25	WOS:000332483600137
J	Wu, XY; Cai, H; Kallianpur, A; Li, HL; Yang, G; Gao, J; Xiang, YB; Ji, BT; Yu-Tang; Zheng, W; Shu, XO				Wu, Xiaoyan; Cai, Hui; Kallianpur, Asha; Li, Honglan; Yang, Gong; Gao, Jing; Xiang, Yong-Bing; Ji, Bu-Tian; Yu-Tang; Zheng, Wei; Shu, Xiao-Ou			Impact of Premature Ovarian Failure on Mortality and Morbidity among Chinese Women	PLOS ONE			English	Article							ISCHEMIC-HEART-DISEASE; NATURAL MENOPAUSE; BREAST-CANCER; AGE; HEALTH; ESTRONE; RISK; ANDROSTENEDIONE; REPRODUCIBILITY; QUESTIONNAIRE	Objective: To evaluate associations of premature ovarian failure (POF) with mortality and morbidity in Asian populations. Methods: We identified 1,003 cases of POF among 36,402 postmenopausal women who participated in the Shanghai Women's Health Study, a population-based cohort study. Cox regression and logistic regression models were applied in data analysis. Results: After adjustment for potential confounding factors, we found that POF increased the risk of total and cancer-specific mortality (HR (95% CIs): 1.29 (1.08-1.54) and 1.38 (1.05-1.81), respectively). POF was also associated with high prevalence of autoimmune disease (OR (95% CI): 1.56 (1.04-2.35)) but decreased incidence of breast cancer (OR (95% CI): 0.59 (0.38-0.91)). Similar results were observed when hormone replacement therapy users were excluded from the analysis. POF is associated with high waist-to-hip ratio. Conclusions: Our results suggest that women with POF experience increased mortality and that these women may benefit from heightened surveillance and appropriate interventions.	[Wu, Xiaoyan; Cai, Hui; Kallianpur, Asha; Yang, Gong; Zheng, Wei; Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Dept Med, Div Epidemiol, Nashville, TN 37212 USA; [Wu, Xiaoyan; Cai, Hui; Kallianpur, Asha; Yang, Gong; Zheng, Wei; Shu, Xiao-Ou] Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Kallianpur, Asha] Vanderbilt Univ, Sch Med, Div Gen Internal Med & Publ Hlth, Dept Med, Nashville, TN 37212 USA; [Li, Honglan; Gao, Jing; Xiang, Yong-Bing; Yu-Tang] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Ji, Bu-Tian] NCI, Occupat Epidemiol Branch, NIH, Bethesda, MD 20892 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Shanghai Jiao Tong University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Shu, XO (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Epidemiol, Nashville, TN 37212 USA.	Xiao-ou.shu@vanderbilt.edu	Zheng, Wei/O-3351-2013; zhang, weihua/GXV-1334-2022	Zheng, Wei/0000-0003-1226-070X; 	US National Institutes of Health (NHI) [R37 CA 070867, R01 HL079123]; NATIONAL CANCER INSTITUTE [R37CA070867, UM1CA182910] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079123] Funding Source: NIH RePORTER	US National Institutes of Health (NHI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding support for this work was provided by US National Institutes of Health (NHI) grants R37 CA 070867 (PI: W Zheng) and R01 HL079123 (PI: XO Shu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anasti JN, 1998, FERTIL STERIL, V70, P1, DOI 10.1016/S0015-0282(98)00099-5; Atay V, 2007, J INT MED RES, V35, P416, DOI 10.1177/147323000703500317; BEAVIS E L G, 1969, Journal of Obstetrics and Gynaecology of the British Commonwealth, V76, P969; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Betterle C, 1997, J CLIN ENDOCR METAB, V82, P932, DOI 10.1210/jc.82.3.932; BETTERLE C, 1993, CLIN ENDOCRINOL, V39, P35, DOI 10.1111/j.1365-2265.1993.tb01748.x; Cooper GS, 1998, ANN EPIDEMIOL, V8, P229, DOI 10.1016/S1047-2797(97)00207-X; COULAM CB, 1986, OBSTET GYNECOL, V67, P604; FORNEY JP, 1981, J CLIN ENDOCR METAB, V53, P192, DOI 10.1210/jcem-53-1-192; GORDON T, 1978, ANN INTERN MED, V89, P157, DOI 10.7326/0003-4819-89-2-157; Goswami D, 2005, HUM REPROD UPDATE, V11, P391, DOI 10.1093/humupd/dmi012; GRODIN JM, 1973, J CLIN ENDOCR METAB, V36, P207, DOI 10.1210/jcem-36-2-207; Hoek A, 1997, ENDOCR REV, V18, P107, DOI 10.1210/er.18.1.107; Hu FB, 1999, ARCH INTERN MED, V159, P1061, DOI 10.1001/archinte.159.10.1061; Jacobsen BK, 1999, J CLIN EPIDEMIOL, V52, P303, DOI 10.1016/S0895-4356(98)00170-X; JUDD HL, 1974, J CLIN ENDOCR METAB, V39, P1020, DOI 10.1210/jcem-39-6-1020; Jurj AL, 2007, AM J EPIDEMIOL, V165, P1124, DOI 10.1093/aje/kwk119; Kim TJ, 1997, OBSTET GYNECOL, V89, P777, DOI 10.1016/S0029-7844(97)00077-X; LABARBERA AR, 1988, AM J REPROD IMMUNOL, V16, P115; Lokkegaard E, 2006, MATURITAS, V53, P226, DOI 10.1016/j.maturitas.2005.04.009; Luborsky JL, 2003, HUM REPROD, V18, P199, DOI 10.1093/humrep/deg005; LUOTO R, 1994, AM J EPIDEMIOL, V139, P64, DOI 10.1093/oxfordjournals.aje.a116936; MACDONALD PC, 1978, AM J OBSTET GYNECOL, V130, P448, DOI 10.1016/0002-9378(78)90287-9; MACDONALD PC, 1967, J CLIN ENDOCR METAB, V27, P1103, DOI 10.1210/jcem-27-8-1103; Maclaran Kate, 2010, Menopause Int, V16, P38, DOI 10.1258/mi.2010.010014; Monninkhof EM, 1999, BREAST CANCER RES TR, V55, P285, DOI 10.1023/A:1006277207963; Ossewaarde ME, 2005, EPIDEMIOLOGY, V16, P556, DOI 10.1097/01.ede.0000165392.35273.d4; POEHLMAN ET, 1995, ANN INTERN MED, V123, P673, DOI 10.7326/0003-4819-123-9-199511010-00005; Rivera CM, 2009, MENOPAUSE, V16, P15, DOI 10.1097/gme.0b013e31818888f7; Rocca WA, 2006, LANCET ONCOL, V7, P821, DOI 10.1016/S1470-2045(06)70869-5; Schmidt PJ, 2006, JAMA-J AM MED ASSOC, V295, P1374, DOI 10.1001/jama.295.12.1374; Shu XO, 2004, EUR J CLIN NUTR, V58, P17, DOI 10.1038/sj.ejcn.1601738; Shuster LT, 2010, MATURITAS, V65, P161, DOI 10.1016/j.maturitas.2009.08.003; SNOWDON DA, 1989, AM J PUBLIC HEALTH, V79, P709, DOI 10.2105/AJPH.79.6.709; Utian W H, 1999, Climacteric, V2, P284, DOI 10.3109/13697139909038088; Uygur Dilek, 2005, Archives of Gynecology and Obstetrics, V273, P17, DOI 10.1007/s00404-005-0029-7; van der Voort DJM, 2003, OSTEOPOROSIS INT, V14, P525, DOI 10.1007/s00198-003-1408-1; Vujovic Svetlana, 2009, Menopause Int, V15, P72, DOI 10.1258/mi.2009.009020; World Health Organisation, 1977, INT CLASS DIS 9 REV; Zheng W, 2005, AM J EPIDEMIOL, V162, P1123, DOI 10.1093/aje/kwi322	40	53	66	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89597	10.1371/journal.pone.0089597	http://dx.doi.org/10.1371/journal.pone.0089597			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603759	Green Published, gold, Green Submitted			2022-12-25	WOS:000332483600014
J	Manhas, R; Tripathi, P; Khan, S; Lakshmi, BS; Lal, SK; Gowri, VS; Sharma, A; Madhubala, R				Manhas, Reetika; Tripathi, Pankaj; Khan, Sameena; Lakshmi, Bhavana Sethu; Lal, Shambhu Krishan; Gowri, Venkatraman Subramanian; Sharma, Amit; Madhubala, Rentala			Identification and Functional Characterization of a Novel Bacterial Type Asparagine Synthetase A A tRNA SYNTHETASE PARALOG FROM LEISHMANIA DONOVANI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aminoacyl-tRNA Synthetase; Drug Design; Drug Development; Drug Discovery; Drug Resistance; Leishmania; Parasite; Leishmania; Drug Target	RAY-DIFFRACTION DATA; NUCLEOTIDE-SEQUENCE; CRYSTAL-STRUCTURE; TRANSITION; EXPRESSION; ORTHOLOG; CLONING; SYSTEM	Background: Asparagine synthetase A catalyzes the synthesis of asparagine from aspartate in the presence of ammonia as a nitrogen donor. Results:L. donovani ASNA enzyme is of bacterial origin and is both ammonia- and glutamine-dependent. Conclusion:LdASNA is essential for survival of the Leishmania parasite. Significance: The absence of LdASNA homologs from humans validates Leishmania ASNA as a novel drug target. Asparagine is formed by two structurally distinct asparagine synthetases in prokaryotes. One is the ammonia-utilizing asparagine synthetase A (AsnA), and the other is asparagine synthetase B (AsnB) that uses glutamine or ammonia as a nitrogen source. In a previous investigation using sequence-based analysis, we had shown that Leishmania spp. possess asparagine-tRNA synthetase paralog asparagine synthetase A (LdASNA) that is ammonia-dependent. Here, we report the cloning, expression, and kinetic analysis of ASNA from Leishmania donovani. Interestingly, LdASNA was both ammonia- and glutamine-dependent. To study the physiological role of ASNA in Leishmania, gene deletion mutations were attempted via targeted gene replacement. Gene deletion of LdASNA showed a growth delay in mutants. However, chromosomal null mutants of LdASNA could not be obtained as the double transfectant mutants showed aneuploidy. These data suggest that LdASNA is essential for survival of the Leishmania parasite. LdASNA enzyme was recalcitrant toward crystallization so we instead crystallized and solved the atomic structure of its close homolog from Trypanosoma brucei (TbASNA) at 2.2 . A very significant conservation in active site residues is observed between TbASNA and Escherichia coli AsnA. It is evident that the absence of an LdASNA homolog from humans and its essentiality for the parasites make LdASNA a novel drug target.	[Gowri, Venkatraman Subramanian; Madhubala, Rentala] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Khan, Sameena; Sharma, Amit] Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Madhubala, R (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	rentala@outlook.com		madhubala, rentala/0000-0002-0034-399X; Manhas, Reetika/0000-0002-0220-2330; V Subramanian, Gowri/0000-0002-4404-6401	Department of Biotechnology, Government of India; Department of Science and Technology Promotion of University Research and Scientific Excellence grant; University Grants Commission, India; Council of Scientific and Industrial Research, India; Outstanding Scientist Research Programme in Biotechnology grant from the Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology Promotion of University Research and Scientific Excellence grant; University Grants Commission, India(University Grants Commission, India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Outstanding Scientist Research Programme in Biotechnology grant from the Department of Biotechnology, Government of India	This work was supported by a grant from the Department of Biotechnology, Government of India and a Department of Science and Technology Promotion of University Research and Scientific Excellence grant (to R. M.).; Recipient of funding from the University Grants Commission, India.; Recipients of funding from the Council of Scientific and Industrial Research, India.; Supported by an Outstanding Scientist Research Programme in Biotechnology grant from the Department of Biotechnology, Government of India and a J. C. Bose National Fellow.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ambrogelly A, 2010, FEBS LETT, V584, P3055, DOI 10.1016/j.febslet.2010.05.036; Aurrecoechea C, 2010, NUCLEIC ACIDS RES, V38, pD415, DOI 10.1093/nar/gkp941; Blaise M, 2011, J MOL BIOL, V412, P437, DOI 10.1016/j.jmb.2011.07.050; Boehlein SK, 2001, BIOCHEMISTRY-US, V40, P11168, DOI 10.1021/bi0155551; BURCHALL JJ, 1964, J BIOL CHEM, V239, P1794; Charron C, 2004, ACTA CRYSTALLOGR D, V60, P767, DOI 10.1107/S0907444904003117; Chauhan SC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006805; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Darveau A., 1995, METH NEUROSCI, V26, P77, DOI DOI 10.1016/S1043-9471(06)80084-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Francklyn C, 2003, P NATL ACAD SCI USA, V100, P9650, DOI 10.1073/pnas.1934245100; Freitas-Junior LH, 2012, INT J PARASITOL-DRUG, V2, P11, DOI 10.1016/j.ijpddr.2012.01.003; Garcia-Hernandez R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001974; Gilreath MS, 2011, FEBS LETT, V585, P3284, DOI 10.1016/j.febslet.2011.09.008; Gowri VS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-621; Heinz E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002979; Hughes CA, 1997, PLANT MOL BIOL, V33, P301, DOI 10.1023/A:1005784202450; HUMBERT R, 1980, J BACTERIOL, V142, P212, DOI 10.1128/JB.142.1.212-220.1980; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; Koizumi M, 1999, J AM CHEM SOC, V121, P5799, DOI 10.1021/ja990851a; Loureiro I, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002578; Maltezou HC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/617521; NAKAMURA M, 1981, NUCLEIC ACIDS RES, V9, P4669, DOI 10.1093/nar/9.18.4669; Nakatsu T, 1998, NAT STRUCT BIOL, V5, P15, DOI 10.1038/nsb0198-15; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEREZGONZALEZ JA, 1990, GENE, V86, P129, DOI 10.1016/0378-1119(90)90125-B; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pieters R, 2011, CANCER-AM CANCER SOC, V117, P238, DOI 10.1002/cncr.25489; REITZER LJ, 1982, J BACTERIOL, V151, P1299, DOI 10.1128/JB.151.3.1299-1313.1982; Richards NGJ, 2006, ANNU REV BIOCHEM, V75, P629, DOI 10.1146/annurev.biochem.75.103004.142520; Roy H, 2003, P NATL ACAD SCI USA, V100, P9837, DOI 10.1073/pnas.1632156100; Roy H, 2011, NAT CHEM BIOL, V7, P667, DOI [10.1038/NCHEMBIO.632, 10.1038/nchembio.632]; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCOFIELD MA, 1990, J BIOL CHEM, V265, P12895; Sissler M, 1999, P NATL ACAD SCI USA, V96, P8985, DOI 10.1073/pnas.96.16.8985; SUGIYAMA A, 1992, BIOSCI BIOTECH BIOCH, V56, P376, DOI 10.1271/bbb.56.376; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANHEEKE G, 1989, J BIOL CHEM, V264, P5503; Yanagisawa T, 2010, NAT STRUCT MOL BIOL, V17, P1136, DOI 10.1038/nsmb.1889; Yoshida KI, 1999, J BACTERIOL, V181, P6081, DOI 10.1128/JB.181.19.6081-6091.1999	41	9	13	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					12096	12108		10.1074/jbc.M114.554642	http://dx.doi.org/10.1074/jbc.M114.554642			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24610810	Green Published, hybrid			2022-12-25	WOS:000335010600047
J	Hayashida, C; Ito, J; Nakayachi, M; Okayasu, M; Ohyama, Y; Hakeda, Y; Sato, T				Hayashida, Chiyomi; Ito, Junta; Nakayachi, Mai; Okayasu, Mari; Ohyama, Yoko; Hakeda, Yoshiyuki; Sato, Takuya			Osteocytes Produce Interferon-beta as a Negative Regulator of Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone; Cytokines; Interferon; Osteoclast; Osteocyte; Osteoporosis; Osteoclastogenesis	NF-KAPPA-B; BONE-MARROW; C-FOS; IN-VITRO; CELLS; DIFFERENTIATION; MICE; OSTEOPOROSIS; EXPRESSION; RESORPTION	Background: Global interferon- deficiency causes osteoporosis. Lack of interferon- production by osteoclast precursors is considered to induce excess osteoclastogenesis. Results: Isolated osteocytes express higher amount of interferon- mRNA than osteoclast precursors and inhibit osteoclastogenesis partially in interferon--dependent manner. Conclusion: Osteocytes produce interferon- as an inhibitor of osteoclastogenesis. Significance: Osteocytic interferon- might be involved in the regulation of bone homeostasis. Osteoclastogenesis is controlled by osteocytes; osteocytic osteoclastogenesis regulatory molecules are largely unknown. We searched for such factors using newly developed culture methods. Our culture system mimics the three-dimensional cellular structure of bone, consisting of collagen gel-embedded osteocytic MLO-Y4 cells, stromal ST2 cells on the gel as bone lining cells, and bone marrow cells. The gel-embedded MLO-Y4 cells inhibited the osteoclastogenesis induced by 1,25(OH)(2)D-3 without modulating receptor activator of NF-B ligand (RANKL) and osteoprotegerin (OPG) production by ST2 cells, despite MLO-Y4 cells supported osteoclastogenesis in the absence of ST2 cells. In the bone marrow cell culture, the conditioned medium from MLO-Y4 cells decreased the capability of osteoclastic differentiation from the cells induced by macrophage colony-stimulating factor. This decreased capability was concomitant with an increase in protein kinase R mRNA expression and an inhibition of c-Fos translation. These changes were partially normalized by the simultaneous addition of an anti-interferon (IFN)- neutralizing antibody to MLO-Y4 cell conditioned medium. To study primary osteocytes, we prepared non-osteocytic cell-free osteocyte-enriched bone fragments (OEBFs). When osteoclast precursors were induced by macrophage colony-stimulating factor in the presence of OEBFs, the generated cells exhibited a diminished capacity for osteoclastogenesis. OEBFs prepared from OPG-knock-out mice exhibited a similar effect, indicating OPG-independent inhibition. The addition of anti-IFN- neutralizing antibody during the co-culture with OEBFs partially recovered the osteoclastogenic potential of the generated cells. The MLO-Y4 cells and OEBFs expressed IFN- mRNA. Although osteocytic RANKL is known to be important for osteoclastogenesis, our data suggest that osteocytes also produce IFN- as an inhibitor of osteoclastogenesis.	[Hayashida, Chiyomi; Ito, Junta; Hakeda, Yoshiyuki; Sato, Takuya] Meikai Univ, Sch Dent, Div Oral Anat, Sakado, Saitama 3500283, Japan; [Nakayachi, Mai; Okayasu, Mari] Meikai Univ, Sch Dent, Div Orthodont, Dept Human Dev & Fostering, Sakado, Saitama 3500283, Japan; [Ohyama, Yoko] Meikai Univ, Sch Dent, Div Oral & Maxillofacial Surg, Dept Diagnost & Therapeut Sci, Sakado, Saitama 3500283, Japan	Meikai University; Meikai University; Meikai University	Sato, T (corresponding author), Meikai Univ, Sch Dent, Div Oral Anat, Dept Human Dev & Fostering, Sakado, Saitama 3500283, Japan.	satotaku@dent.meikai.ac.jp			Meikai University School of Dentistry; Onuki Foundation; Japan Society for Promotion of Science [25293376]	Meikai University School of Dentistry; Onuki Foundation; Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Miyata Research Grant A from the Meikai University School of Dentistry (to T. S.), the Onuki Foundation (to Y. H.), Grant-in-Aid for Scientific Research (KAKENHI) 25293376 from the Japan Society for Promotion of Science (to Y. H.).	Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chambers TJ, 2011, ANN NY ACAD SCI, V1240, P1, DOI 10.1111/j.1749-6632.2011.06249.x; CHAMBERS TJ, 1985, J CELL SCI, V76, P155; Fulzele K, 2013, BLOOD, V121, P930, DOI 10.1182/blood-2012-06-437160; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Gu GL, 2006, CELL TISSUE RES, V323, P263, DOI 10.1007/s00441-005-0066-3; Hayashi T, 2002, J BIOL CHEM, V277, P27880, DOI 10.1074/jbc.M203836200; Heino TJ, 2002, J CELL BIOCHEM, V85, P185, DOI 10.1002/jcb.10109; Kamioka H, 2001, BONE, V28, P145, DOI 10.1016/S8756-3282(00)00421-X; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Kurata K, 2006, J BONE MINER RES, V21, P616, DOI 10.1359/JBMR.060106; LUBEN RA, 1976, ENDOCRINOLOGY, V99, P526, DOI 10.1210/endo-99-2-526; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Matsuo K, 2000, NAT GENET, V24, P184, DOI 10.1038/72855; Mizuno A, 1998, BIOCHEM BIOPH RES CO, V247, P610, DOI 10.1006/bbrc.1998.8697; Moester MJC, 2010, CALCIFIED TISSUE INT, V87, P99, DOI 10.1007/s00223-010-9372-1; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Okayasu M, 2012, J BIOL CHEM, V287, P19229, DOI 10.1074/jbc.M111.323600; Paic F, 2009, BONE, V45, P682, DOI 10.1016/j.bone.2009.06.010; Sato T, 2007, J BONE MINER METAB, V25, P19, DOI 10.1007/s00774-006-0723-y; Stern AR, 2012, BIOTECHNIQUES, V52, P361, DOI 10.2144/0000113876; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260; VANDERPLAS A, 1992, J BONE MINER RES, V7, P389; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Zhao S, 2002, J BONE MINER RES, V17, P2068, DOI 10.1359/jbmr.2002.17.11.2068; Zheng H, 2006, J BIOL CHEM, V281, P15809, DOI 10.1074/jbc.M513225200	35	25	31	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11545	11555		10.1074/jbc.M113.523811	http://dx.doi.org/10.1074/jbc.M113.523811			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24610813	Green Published, hybrid			2022-12-25	WOS:000334638500054
J	Oh, J; Goo, E; Hwang, I; Rhee, S				Oh, Juntaek; Goo, Eunhye; Hwang, Ingyu; Rhee, Sangkee			Structural Basis for Bacterial Quorum Sensing-mediated Oxalogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acetyl Coenzyme A; Bacterial Pathogenesis; Enzyme Catalysis; Protein Structure; X-ray Crystallography; Burkholderia glumae; ObcA; Oxalate Biosynthetic Component; Oxalate	ACETYLTRANSFERASES; MECHANISM; OXALATE; SYNTHASE	Background: Oxalogenesis in the Burkholderia species is an indispensable event for their survival in the stationary phase. Results: Structural and functional analyses of ObcA, the first enzyme in oxalogenesis, unravel an unprecedented reaction mechanism. Conclusion: ObcA produces a tetrahedral CoA adduct. Significance: This study provides a structural basis for understanding the first step in oxalogenesis. The Burkholderia species utilize acetyl-CoA and oxaloacetate, substrates for citrate synthase in the TCA cycle, to produce oxalic acid in response to bacterial cell to cell communication, called quorum sensing. Quorum sensing-mediated oxalogenesis via a sequential reaction by ObcA and ObcB counteracts the population-collapsing alkaline pH of the stationary growth phase. Thus, the oxalic acid produced plays an essential role as an excreted public good for survival of the group. Here, we report structural and functional analyses of ObcA, revealing mechanistic features distinct from those of citrate synthase. ObcA exhibits a unique fold, in which a (/)(8)-barrel fold is located in the C-domain with the N-domain inserted into a loop following 1 in the barrel fold. Structural analyses of the complexes with oxaloacetate and with a bisubstrate adduct indicate that each of the oxaloacetate and acetyl-CoA substrates is bound to an independent site near the metal coordination shell in the barrel fold. In catalysis, oxaloacetate serves as a nucleophile by forming an enolate intermediate mediated by Tyr(322) as a general base, which then attacks the thioester carbonyl carbon of acetyl-CoA to yield a tetrahedral adduct between the two substrates. Therefore, ObcA catalyzes its reaction by combining the enolase and acetyltransferase superfamilies, but the presence of the metal coordination shell and the absence of general acid(s) produces an unusual tetrahedral CoA adduct as a stable product. These results provide the structural basis for understanding the first step in oxalogenesis and constitute an example of the functional diversity of an enzyme for survival and adaptation in the environment.	[Oh, Juntaek; Goo, Eunhye; Hwang, Ingyu; Rhee, Sangkee] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea; [Rhee, Sangkee] Seoul Natl Univ, Ctr Fungal Pathogenesis, Seoul 151921, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Rhee, S (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea.	srheesnu@snu.ac.kr	Goo, Eunhye/ERO-2624-2022; Oh, Juntaek/AFM-0371-2022	Oh, Juntaek/0000-0002-7625-2779	Next Generation BioGreen 21 Program of Rural Development Administration Plant Molecular Breeding Center [PJ008059]; National Research Foundation of Korea [2008-0061897, 2010-0018280]	Next Generation BioGreen 21 Program of Rural Development Administration Plant Molecular Breeding Center; National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by Next Generation BioGreen 21 Program of Rural Development Administration Plant Molecular Breeding Center PJ008059 (to S. R.), by National Research Foundation of Korea Grant 2008-0061897 (to S. R.), and by Creative Research Initiatives Program of the National Research Foundation of Korea Grant 2010-0018280 (to I. H.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Dandekar AA, 2012, SCIENCE, V338, P264, DOI 10.1126/science.1227289; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Dutton MV, 1996, CAN J MICROBIOL, V42, P881, DOI 10.1139/m96-114; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Gerlt JA, 2005, ARCH BIOCHEM BIOPHYS, V433, P59, DOI 10.1016/j.abb.2004.07.034; Goo E, 2012, P NATL ACAD SCI USA, V109, P19775, DOI 10.1073/pnas.1218092109; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Govindasamy L, 2004, J STRUCT BIOL, V148, P226, DOI 10.1016/j.jsb.2004.06.005; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hoppe B, 2012, NAT REV NEPHROL, V8, P467, DOI 10.1038/nrneph.2012.113; Jogl G, 2003, CELL, V112, P113, DOI 10.1016/S0092-8674(02)01228-X; Li HQ, 1999, J BIOCHEM, V126, P243, DOI 10.1093/oxfordjournals.jbchem.a022429; Murray IA, 1997, ANTIMICROB AGENTS CH, V41, P1; Nakata PA, 2011, MICROBIOL RES, V166, P531, DOI 10.1016/j.micres.2010.11.002; Nakata PA, 2010, FEMS MICROBIOL LETT, V304, P177, DOI 10.1111/j.1574-6968.2010.01895.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pai A, 2012, P NATL ACAD SCI USA, V109, P19810, DOI 10.1073/pnas.1211072109; Raychaudhuri A, 2005, BIOCHEMISTRY-US, V44, P2974, DOI 10.1021/bi048005m; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1872, DOI 10.1107/S090744499901029X; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; WIEGAND G, 1986, ANNU REV BIOPHYS BIO, V15, P97; Yuan H, 2013, BIOPOLYMERS, V99, P98, DOI 10.1002/bip.22128	29	9	9	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11465	11475		10.1074/jbc.M113.543462	http://dx.doi.org/10.1074/jbc.M113.543462			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24616091	Green Published, hybrid			2022-12-25	WOS:000334638500047
J	Slavoff, SA; Heo, JH; Budnik, BA; Hanakahi, LA; Saghatelian, A				Slavoff, Sarah A.; Heo, Jinho; Budnik, Bogdan A.; Hanakahi, Leslyn A.; Saghatelian, Alan			A Human Short Open Reading Frame ( sORF)-encoded Polypeptide That Stimulates DNA End Joining	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Repair; Peptide Interactions; Peptides; Protein-Protein Interactions; Proteomics; Short ORF	STRAND BREAK REPAIR; DEPENDENT PROTEIN-KINASE; RETROVIRAL INFECTION; HUMAN-CELLS; PEPTIDES; DISCOVERY; PATHWAY; KU; BINDING; LOCALIZATION	Background: Large numbers of peptides encoded in human short open reading frames have been recently identified but not yet functionally characterized. Results: A peptide interacts with the Ku heterodimer and stimulates nonhomologous end-joining DNA repair. Conclusion: Newly discovered cellular peptides can be functionally characterized by identifying their interaction partners. Significance: Short ORF-encoded polypeptides participate in essential cellular processes. The recent discovery of numerous human short open reading frame (sORF)-encoded polypeptides (SEPs) has raised important questions about the functional roles of these molecules in cells. Here, we show that a 69-amino acid SEP, MRI-2, physically interacts with the Ku heterodimer to stimulate DNA double-strand break ligation via nonhomologous end joining. The characterization of MRI-2 suggests that this SEP may participate in DNA repair and underscores the potential of SEPs to serve important biological functions in mammalian cells.	[Slavoff, Sarah A.; Saghatelian, Alan] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Budnik, Bogdan A.] Harvard Univ, FAS, Ctr Syst Biol, Cambridge, MA 02138 USA; [Heo, Jinho; Hanakahi, Leslyn A.] Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Chicago, IL 60612 USA	Harvard University; Harvard University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Hanakahi, LA (corresponding author), Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Chicago, IL 60612 USA.	hanakahi@uic.edu; saghatelian@chemistry.harvard.edu	Budnik, Bogdan/AAH-9987-2019; slavoff, sarah/HIK-2036-2022; Budnik, Bogdan/AGG-8824-2022	Budnik, Bogdan/0000-0003-3622-2003; Slavoff, Sarah/0000-0002-4443-2070	National Research Service Award postdoctoral fellowship [1F32GM099408]; National Institutes of Health Grant through the NIGMS [R01GM102491]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM099408, R01GM102491] Funding Source: NIH RePORTER	National Research Service Award postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Grant through the NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Research Service Award postdoctoral fellowship (1F32GM099408) (to S. A. S.) and National Institutes of Health Grant (R01GM102491) through the NIGMS (to A. S.).	Agarwal S, 2006, P NATL ACAD SCI USA, V103, P15933, DOI 10.1073/pnas.0602674103; Andrews SJ, 2014, NAT REV GENET, V15, P193, DOI 10.1038/nrg3520; Baumann P, 1998, P NATL ACAD SCI USA, V95, P14066, DOI 10.1073/pnas.95.24.14066; Bertinato J, 2001, J CELL SCI, V114, P89; Casson SA, 2002, PLANT CELL, V14, P1705, DOI 10.1105/tpc.002618; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Cheung JCY, 2008, NUCLEIC ACIDS RES, V36, P5713, DOI 10.1093/nar/gkn572; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Daniel R, 2004, J VIROL, V78, P8573, DOI 10.1128/JVI.78.16.8573-8581.2004; De Coninck B, 2013, J EXP BOT, V64, P5297, DOI 10.1093/jxb/ert295; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Galindo MI, 2007, PLOS BIOL, V5, P1052, DOI 10.1371/journal.pbio.0050106; Gibson TJ, 2013, NAT METHODS, V10, P715, DOI 10.1038/nmeth.2534; Gross GG, 2013, NEURON, V78, P971, DOI 10.1016/j.neuron.2013.04.017; Hanakahi LA, 2000, CELL, V102, P721, DOI 10.1016/S0092-8674(00)00061-1; Hanakahi L, 2011, MOL CANCER RES, V9, P1366, DOI 10.1158/1541-7786.MCR-11-0230; Hanakahi LA, 2007, PROTEIN EXPRES PURIF, V52, P139, DOI 10.1016/j.pep.2006.10.002; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; Hashimoto Y, 2001, BIOCHEM BIOPH RES CO, V283, P460, DOI 10.1006/bbrc.2001.4765; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Jeanson L, 2002, VIROLOGY, V300, P100, DOI 10.1006/viro.2002.1515; Kastenmayer JP, 2006, GENOME RES, V16, P365, DOI 10.1101/gr.4355406; Kondo T, 2007, NAT CELL BIOL, V9, P660, DOI 10.1038/ncb1595; Lee SH, 2005, P NATL ACAD SCI USA, V102, P18075, DOI 10.1073/pnas.0503676102; Li L, 2001, EMBO J, V20, P3272, DOI 10.1093/emboj/20.12.3272; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Ma J, 2014, J PROTEOME RES, V13, P1757, DOI 10.1021/pr401280w; Magny EG, 2013, SCIENCE, V341, P1116, DOI 10.1126/science.1238802; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Menschaert G, 2013, MOL CELL PROTEOMICS, V12, P1780, DOI 10.1074/mcp.M113.027540; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Rohrig H, 2002, P NATL ACAD SCI USA, V99, P1915, DOI 10.1073/pnas.022664799; Schwaid AG, 2013, J AM CHEM SOC, V135, P16750, DOI 10.1021/ja406606j; Slavoff SA, 2013, NAT CHEM BIOL, V9, P59, DOI [10.1038/NCHEMBIO.1120, 10.1038/nchembio.1120]; Smeaton MB, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm974; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Vanderperre B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070698; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000	41	94	96	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					10950	10957		10.1074/jbc.C113.533968	http://dx.doi.org/10.1074/jbc.C113.533968			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24610814	Green Published, hybrid			2022-12-25	WOS:000334638500001
J	Ghrenassia, E; Roulin, L; Aline-Fardin, A; Marzac, C; Feger, F; Gay, J; Pacanowski, J; Hertig, A; Coppo, P				Ghrenassia, Etienne; Roulin, Louise; Aline-Fardin, Aude; Marzac, Christophe; Feger, Frederic; Gay, Julie; Pacanowski, Jerome; Hertig, Alexandre; Coppo, Paul			The Spectrum of Chronic CD8(+) T-Cell Expansions: Clinical Features in 14 Patients	PLOS ONE			English	Article							REPLICATIVE SENESCENCE; LYMPHOCYTOSIS SYNDROME; SICCA SYNDROME; HIV-INFECTION; NEUTROPENIA; DISEASE; MUTATIONS; HEALTH	Chronic CD8(+) T-cell expansions can result in parotid gland swelling and other organ infiltration in HIV-infected patients, or in persistent cytopenias. We report 14 patients with a CD8(+) T-cell expansion to better characterize the clinical spectrum of this ill-defined entity. Patients (9 women/5 men) were 65 year-old (range, 25-74). Six patients had >= 1 symptomatic organ infiltration, and 9 had >= 1 cytopenia with a CD8(+) (. 50% of total lymphocyte count) and/or a CD8(+)/CD57(+) (. 30% of total lymphocyte count) T-cell expansion for at least 3 months. One patient had both manifestations. A STAT3 mutation, consistent with the diagnosis of large granular lymphocyte leukemia, was found in 2 patients with cytopenia. Organ infiltration involved lymph nodes, the liver, the colon, the kidneys, the skin and the central nervous system. Three patients had a HIV infection for 8 years (range, 0.5-20 years). Two non-HIV patients with hypogammaglobulinemia had been treated with a B-cell depleting monoclonal antibody (rituximab) for a lymphoma. One patient had a myelodysplastic syndrome with colon infiltration and agranulocytosis. The outcome was favorable with efficient antiretroviral therapy and steroids in HIV-infected patients and intravenous immunoglobulins in 2/3 non-HIV patients. Six patients had an agranulocytosis of favorable outcome with granulocyte-colony stimulating factor only (3 cases), cyclophosphamide, methotrexate and cyclosporine A, or no treatment (1 case each). Three patients had a pure red cell aplasia, of favorable outcome in 2 cases with methotrexate and cyclosporine A; one patient was unresponsive. Chronic CD8(+) T-cell expansions with organ infiltration in immunocompromised patients may involve other organs than parotid glands; they are non clonal and of favorable outcome after correction of the immune deficiency and/or steroids. In patients with bone marrow infiltration and unexplained cytopenia, CD8(+) T-cell expansions can be clonal or not; their identification suggests that cytopenias are immune-mediated. Our results extend the clinical spectrum of chronic CD8(+) T-cell expansions.	[Ghrenassia, Etienne; Roulin, Louise; Gay, Julie; Coppo, Paul] Hop Univ Est Parisien, AP HP, Serv Hematol, Paris, France; [Aline-Fardin, Aude] Hop Univ Est Parisien, AP HP, Serv Anat Pathol, Paris, France; [Marzac, Christophe; Feger, Frederic] Hop Univ Est Parisien, AP HP, Lab Immunohematol, Paris, France; [Pacanowski, Jerome] Hop Univ Est Parisien, AP HP, Serv Malad Infect & Trop, Paris, France; [Hertig, Alexandre] Hop Univ Est Parisien, AP HP, Paris, France; [Aline-Fardin, Aude; Gay, Julie; Hertig, Alexandre; Coppo, Paul] Univ Paris 06, Paris, France; [Coppo, Paul] Inst Gustave Roussy, INSERM, U1009, F-94805 Villejuif, France; [Coppo, Paul] Ctr Reference Microangiopathies Thrombot, Paris, France	Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Coppo, P (corresponding author), Hop Univ Est Parisien, AP HP, Serv Hematol, Paris, France.	paul.coppo@sat.aphp.fr						Akhtari M, 2009, AUTOIMMUN REV, V9, P62, DOI 10.1016/j.autrev.2009.03.006; Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Basu D, 2006, ARTHRIT RHEUM-ARTHR, V55, P466, DOI 10.1002/art.21980; Batliwalla F, 1996, HUM IMMUNOL, V48, P68, DOI 10.1016/0198-8859(96)00077-8; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Capsoni F, 2005, ARTHRITIS RES THER, V7, P208, DOI 10.1186/ar1803; Chou JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064702; Coppo P, 2003, ANN RHEUM DIS, V62, P476, DOI 10.1136/ard.62.5.476; Coppo Paul, 2004, Eur J Intern Med, V15, P451, DOI 10.1016/j.ejim.2004.08.009; DANGEAC AD, 1994, EUR J IMMUNOL, V24, P1503, DOI 10.1002/eji.1830240707; Dock JN, 2011, AGING DIS, V2, P382; DWYER E, 1993, J CLIN INVEST, V92, P495, DOI 10.1172/JCI116593; FERRERO D, 1993, HAEMATOLOGICA, V78, P49; Focosi D, 2010, J LEUKOCYTE BIOL, V87, P107, DOI 10.1189/jlb.0809566; GRILLOTCOURVALIN C, 1987, BLOOD, V69, P1204; ITESCU S, 1993, J CLIN INVEST, V91, P2216, DOI 10.1172/JCI116448; ITESCU S, 1989, LANCET, V2, P466; ITESCU S, 1990, ANN INTERN MED, V112, P3, DOI 10.7326/0003-4819-112-1-3; Jerez A, 2012, BLOOD, V120, P3048, DOI 10.1182/blood-2012-06-435297; Kaplan RC, 2011, J INFECT DIS, V203, P452, DOI 10.1093/infdis/jiq071; Koskela HLM, 2012, NEW ENGL J MED, V366, P1905, DOI 10.1056/NEJMoa1114885; LABALETTE M, 1994, CLIN EXP IMMUNOL, V95, P465; Lamy T, 2011, BLOOD, V117, P2764, DOI 10.1182/blood-2010-07-296962; Lassoued K, 1998, AM J HEMATOL, V57, P241, DOI 10.1002/(SICI)1096-8652(199803)57:3<241::AID-AJH12>3.0.CO;2-D; Liote H, 2010, EUR RESPIR J, V35, P681, DOI 10.1183/09031936.00080209; Loschi M, 2011, ACTA HAEMATOL-BASEL, V126, P211, DOI 10.1159/000330515; Mohty M, 2002, LEUKEMIA, V16, P2129, DOI 10.1038/sj.leu.2402645; Nitta H, 2012, BRIT J HAEMATOL, V157, P641, DOI 10.1111/j.1365-2141.2012.09057.x; OKSENHENDLER E, 1992, LANCET, V340, P207, DOI 10.1016/0140-6736(92)90471-E; Rajala HLM, 2013, BLOOD, V121, P4541, DOI 10.1182/blood-2012-12-474577; Ramadan KMA, 2005, J CLIN PATHOL, V58, P1118, DOI 10.1136/jcp.2004.020875; Roden AC, 2008, ARCH PATHOL LAB MED, V132, P1774, DOI 10.1043/1543-2165-132.11.1774; Sato K, 2012, ACTA HAEMATOL-BASEL, V128, P107, DOI 10.1159/000338259; Smith PR, 2000, J CLIN PATHOL, V53, P177, DOI 10.1136/jcp.53.3.177; Stemberger C, 2009, SEMIN IMMUNOL, V21, P62, DOI 10.1016/j.smim.2009.02.004; Strioga M, 2011, IMMUNOLOGY, V134, P17, DOI 10.1111/j.1365-2567.2011.03470.x; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; VINCI G, 1987, EXP HEMATOL, V15, P54; WANG ECY, 1995, J IMMUNOL, V155, P5046; YAMASHITA N, 1993, NAT IMMUN, V12, P79; Zafrani L, 2007, KIDNEY INT, V72, P219, DOI 10.1038/sj.ki.5002207	42	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91505	10.1371/journal.pone.0091505	http://dx.doi.org/10.1371/journal.pone.0091505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618699	gold, Green Published, Green Submitted			2022-12-25	WOS:000332842400098
J	Good, SP; Mallia, DV; Lin, JC; Bowen, GJ				Good, Stephen P.; Mallia, Derek V.; Lin, John C.; Bowen, Gabriel J.			Stable Isotope Analysis of Precipitation Samples Obtained via Crowdsourcing Reveals the Spatiotemporal Evolution of Superstorm Sandy	PLOS ONE			English	Article							WATER; FRACTIONATION; RATIOS; VAPOR; RAIN	Extra-tropical cyclones, such as 2012 Superstorm Sandy, pose a significant climatic threat to the northeastern United Sates, yet prediction of hydrologic and thermodynamic processes within such systems is complicated by their interaction with mid-latitude water patterns as they move poleward. Fortunately, the evolution of these systems is also recorded in the stable isotope ratios of storm-associated precipitation and water vapor, and isotopic analysis provides constraints on difficult-to-observe cyclone dynamics. During Superstorm Sandy, a unique crowdsourced approach enabled 685 precipitation samples to be obtained for oxygen and hydrogen isotopic analysis, constituting the largest isotopic sampling of a synoptic-scale system to date. isotopically, these waters span an enormous range of values (>21 parts per thousand for delta O-18, >160 parts per thousand for delta H-2) and exhibit strong spatiotemporal structure. Low isotope ratios occurred predominantly in the west and south quadrants of the storm, indicating robust isotopic distillation that tracked the intensity of the storm's warm core. Elevated values of deuterium-excess (>25 parts per thousand) were found primarily in the New England region after Sandy made landfall. Isotope mass balance calculations and Lagrangian back-trajectory analysis suggest that these samples reflect the moistening of dry continental air entrained from a mid-latitude trough. These results demonstrate the power of rapid-response isotope monitoring to elucidate the structure and dynamics of water cycling within synoptic-scale systems and improve our understanding of storm evolution, hydroclimatological impacts, and paleo-storm proxies.	[Good, Stephen P.; Bowen, Gabriel J.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; [Mallia, Derek V.; Lin, John C.] Univ Utah, Dept Atmospher Sci, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Good, SP (corresponding author), Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA.	s.good@utah.edu	Good, Stephen/H-4432-2013	Good, Stephen/0000-0003-4363-1577	National Science Foundation, NSF [EF-01241286]	National Science Foundation, NSF(National Science Foundation (NSF))	This project was funded by the National Science Foundation, NSF Grant EF-01241286. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes EA, 2013, P NATL ACAD SCI USA, V110, P15211, DOI 10.1073/pnas.1308732110; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; Brown D, 2013, J GEOPHYS RES-ATMOS, V118, P54, DOI 10.1029/2012JD018507; Coplen TB, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035481; DANSGAARD W, 1964, TELLUS, V16, P436; Emanuel K, 2003, ANNU REV EARTH PL SC, V31, P75, DOI 10.1146/annurev.earth.31.100901.141259; Frappier AB, 2007, GEOLOGY, V35, P111, DOI 10.1130/G23145A.1; Fudeyasu H, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009313; Gedzelman S, 2003, MON WEATHER REV, V131, P1112, DOI 10.1175/1520-0493(2003)131<1112:PHWSIO>2.0.CO;2; GEDZELMAN SD, 1990, MON WEATHER REV, V118, P495, DOI 10.1175/1520-0493(1990)118<0495:TICOPF>2.0.CO;2; GEDZELMAN SD, 1982, J APPL METEOROL, V21, P1385, DOI 10.1175/1520-0450(1982)021<1385:TICOCP>2.0.CO;2; Gupta P, 2009, RAPID COMMUN MASS SP, V23, P2534, DOI 10.1002/rcm.4100; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Janjic ZI, 2003, METEOROL ATMOS PHYS, V82, P271, DOI 10.1007/s00703-001-0587-6; Kim SY, 2013, ENVIRON SCI TECHNOL, V47, P8316, DOI 10.1021/es4009486; Lambert WJ, 2008, J PALEOLIMNOL, V39, P117, DOI 10.1007/s10933-007-9101-6; Lawrence JR, 1996, GEOPHYS RES LETT, V23, P527, DOI 10.1029/96GL00425; Lawrence JR, 1998, J GEOPHYS RES-ATMOS, V103, P11381, DOI 10.1029/97JD03627; Lawrence JR, 2002, J ATMOS CHEM, V41, P67, DOI 10.1023/A:1013808530364; Lin J, 2013, AGU GEOPHYS MONOGRAP; Lin JC, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003161; Lin Y., 2005, 19 INT C HYDR SAN DI, V1, P2, DOI DOI 10.1002/2014WR015442; MAJOUBE M, 1971, J CHIM PHYS PCB, V68, P1423, DOI 10.1051/jcp/1971681423; MERLIVAT L, 1979, J GEOPHYS RES-OCEANS, V84, P5029, DOI 10.1029/JC084iC08p05029; Miller DL, 2006, P NATL ACAD SCI USA, V103, P14294, DOI 10.1073/pnas.0606549103; Rabenhorst T., 2013, WEATHERWISE, V66, P14, DOI [10.1080/00431672.2013.762838, DOI 10.1080/00431672.2013.762838]; Risi C, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035920; Soderberg K, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00160.1; STEWART MK, 1975, J GEOPHYS RES, V80, P1133, DOI 10.1029/JC080i009p01133; Trenberth KE, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008303; Uemura R, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010209; van Geldern R, 2012, LIMNOL OCEANOGR-METH, V10, P1024, DOI 10.4319/lom.2012.10.1024; Wen DY, 2012, ATMOS ENVIRON, V54, P373, DOI 10.1016/j.atmosenv.2012.02.042; Zhang R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026267; Zhu T, 2013, GEOPHYS RES LETT, V40, P3325, DOI 10.1002/grl.50626	35	83	87	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91117	10.1371/journal.pone.0091117	http://dx.doi.org/10.1371/journal.pone.0091117			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618882	Green Published, gold, Green Submitted			2022-12-25	WOS:000332842400048
J	Song, JJ; Zhou, Y; Li, S; Wang, BJ; Zheng, X; Wu, J; Gibbert, K; Dittmer, U; Lu, MJ; Yang, DL				Song, Jingjiao; Zhou, Yun; Li, Sheng; Wang, Baoju; Zheng, Xin; Wu, Jun; Gibbert, Kathrin; Dittmer, Ulf; Lu, Mengji; Yang, Dongliang			Susceptibility of Different Hepatitis B Virus Isolates to Interferon-Alpha in a Mouse Model Based on Hydrodynamic Injection	PLOS ONE			English	Article							CORE PROMOTER; IN-VITRO; GENE-EXPRESSION; HBV REPLICATION; GENOTYPES; PROTEIN; EPIDEMIOLOGY; INHIBITION; ENTECAVIR; INFECTION	Interferon alpha (IFN-alpha) is commonly used for the treatment of chronic hepatitis B (CHB) patients. Many factors including viral genetics may determine the outcome of IFN-alpha therapy. In this study, we tested whether the expression of IFN-alpha directly in the liver inhibits HBV gene expression and replication using a HBV hydrodynamic injection (HI) mouse model. Two replication-competent clones from different HBV isolates that belonging to HBV genotype A and B based on a pAAV vector (pAAV-HBV-A and pAAV-HBV-B) were compared for their susceptibility to IFN-alpha. HBV clones were injected into mice either alone or in combination with a murine (m) IFN-alpha expression plasmid (pmIFN-alpha). HBsAg and HBeAg concentrations and HBV DNA levels in mice differed after injection of these two HBV clones. Co-application of pmIFN-alpha together with the two distinct isolates resulted in markedly different kinetics of decline of HBsAg, HBeAg, and HBV DNA levels in the mice. Immunohistochemical staining of liver sections with anti-HBc showed that mIFN-alpha application completely inhibited the expression of HBcAg in mice inoculated with pAAV-HBV-B, whereas the expression of HBcAg was only reduced in mice with pAAV-HBV-A. Consistently, mice injected with pAAV-HBV-B and pmIFN-alpha showed higher expression levels of the IFN-stimulated genes (ISGs) ISG15, OAS, PKR as well as proinflammatory cytokine IL-6 in the liver. In addition, expression levels of anti-inflammatory cytokine IL-10 was down-regulated significantly in liver of the mice injected with pAAV-HBV-B and pmIFN-alpha. Our data demonstrate that IFN-alpha exerts antiviral activity in HBV mouse model, but different HBV isolates may have diverse susceptibility to IFN-alpha.	[Song, Jingjiao] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Div Clin Immunol, Wuhan 430074, Peoples R China; [Song, Jingjiao] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Ctr Med Expt, Wuhan 430074, Peoples R China; [Zhou, Yun; Li, Sheng; Wang, Baoju; Zheng, Xin; Wu, Jun; Yang, Dongliang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Infect Dis, Wuhan 430074, Peoples R China; [Gibbert, Kathrin; Dittmer, Ulf; Lu, Mengji] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of Duisburg Essen	Lu, MJ (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany.	mengji.lu@uni-due.de; dlyang@hust.edu.cn	Sutter, Kathrin/AAE-9019-2020; Lu, Mengji/ABF-9410-2020; Sutter, Kathrin/AAY-9167-2020	Sutter, Kathrin/0000-0001-6397-6551; 	National Major Science and Technology Project for Infectious Diseases of China [2012ZX10004503]; State Major Basic Research Program of China [2005CB522901, 2007CB512804, 2009CB522500]; National Natural Science Foundation of China [30271170, 81201289]; International Science & Technology Cooperation Program of China [2011DFA31030]; Deutsche Forschungsgemeinschaft [Transregio TRR60, GK1045/2]	National Major Science and Technology Project for Infectious Diseases of China; State Major Basic Research Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from National Major Science and Technology Project for Infectious Diseases of China (2012ZX10004503), State Major Basic Research Program of China (2005CB522901, 2007CB512804 and 2009CB522500), National Natural Science Foundation of China (30271170, 81201289) and International Science & Technology Cooperation Program of China (2011DFA31030) to D. Yang and grants of Deutsche Forschungsgemeinschaft (Transregio TRR60 and GK1045/2) to M. Lu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J HEPATOL, V42, pS84; Boglione L, 2013, J VIRAL HEPATITIS, V20, pe11, DOI 10.1111/jvh.12018; Buckwold VE, 1996, J VIROL, V70, P5845, DOI 10.1128/JVI.70.9.5845-5851.1996; CHEN HS, 1993, J VIROL, V67, P1218, DOI 10.1128/JVI.67.3.1218-1226.1993; Chen JL, 2013, HEPATOLOGY, V57, P470, DOI 10.1002/hep.26064; Chevaliez Stephane, 2009, V189, P203, DOI 10.1007/978-3-540-79086-0_8; Cull VS, 2002, IMMUNOLOGY, V106, P428, DOI 10.1046/j.1365-2567.2002.01423.x; Erhardt A, 2000, HEPATOLOGY, V31, P716, DOI 10.1002/hep.510310323; Ferir G, 2008, REV MED VIROL, V18, P19, DOI 10.1002/rmv.554; Flink HJ, 2006, AM J GASTROENTEROL, V101, P297, DOI 10.1111/j.1572-0241.2006.00418.x; Foster GR, 1998, J VIRAL HEPATITIS, V5, P143, DOI 10.1046/j.1365-2893.1998.00103.x; Guidotti LG, 1996, J VIROL, V70, P7056, DOI 10.1128/JVI.70.10.7056-7061.1996; Hoofnagle JH, 1997, NEW ENGL J MED, V336, P347, DOI 10.1056/NEJM199701303360507; Hou J, 2007, J MED VIROL, V79, P1055, DOI 10.1002/jmv.20935; Huang LR, 2006, P NATL ACAD SCI USA, V103, P17862, DOI 10.1073/pnas.0608578103; Isogawa M, 2005, J VIROL, V79, P7269, DOI 10.1128/JVI.79.11.7269-7272.2005; Kao JH, 2000, J HEPATOL, V33, P998, DOI 10.1016/S0168-8278(00)80135-X; Kao JH, 2007, HEPATOL RES, V37, pS47, DOI 10.1111/j.1872-034X.2007.00105.x; Kao Jia-Horng, 2011, Korean Journal of Internal Medicine, V26, P255, DOI 10.3904/kjim.2011.26.3.255; KELLEY KA, 1985, NUCLEIC ACIDS RES, V13, P825, DOI 10.1093/nar/13.3.825; Lavanchy D, 2005, J CLIN VIROL, V34, pS1, DOI 10.1016/S1386-6532(05)00384-7; Li J, 1999, J VIROL, V73, P1239, DOI 10.1128/JVI.73.2.1239-1244.1999; Liaw YF, 2011, HEPATOLOGY, V53, P62, DOI 10.1002/hep.23952; Lu M, 2005, J VIROL, V79, P6368, DOI 10.1128/JVI.79.10.6368-6376.2005; Lurie Y, 2005, J HEPATOL, V42, P184; Marcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; McMahon BJ, 2005, SEMIN LIVER DIS, V25, P3, DOI 10.1055/s-2005-915644; Mendy ME, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-23; Meng ZJ, 2008, J VIROL METHODS, V150, P27, DOI 10.1016/j.jviromet.2008.02.008; Moucari R, 2009, ANTIVIR THER, V14, P1183, DOI 10.3851/IMP1458; Niederau C, 1996, NEW ENGL J MED, V334, P1422, DOI 10.1056/NEJM199605303342202; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sanchez-Tapias JM, 2002, GASTROENTEROLOGY, V123, P1848, DOI 10.1053/gast.2002.37041; Scaglioni PP, 1997, J VIROL, V71, P345, DOI 10.1128/JVI.71.1.345-353.1997; Shim JH, 2010, J HEPATOL, V52, P176, DOI 10.1016/j.jhep.2009.11.007; Thomas H, 2003, J HEPATOL, V39, pS93, DOI 10.1016/S0168-8278(03)00207-1; Tian YJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002159; Tseng TC, 2008, GASTROENTEROLOGY, V134, P1272, DOI 10.1053/j.gastro.2007.12.046; von Freyend MJ, 2011, J VIRAL HEPATITIS, V18, P216, DOI 10.1111/j.1365-2893.2010.01302.x; Wang Y, 2007, ANTIVIR RES, V75, P139, DOI 10.1016/j.antiviral.2007.02.001; Westland C, 2003, GASTROENTEROLOGY, V125, P107, DOI 10.1016/S0016-5085(03)00700-5; Wiegand J, 2008, ANTIVIR THER, V13, P211; Wieland SF, 2005, P NATL ACAD SCI USA, V102, P9913, DOI 10.1073/pnas.0504273102; Wieland SF, 2000, J VIROL, V74, P4165, DOI 10.1128/JVI.74.9.4165-4173.2000; Wieland SF, 2003, J VIROL, V77, P1227, DOI 10.1128/JVI.77.2.1227-1236.2003; Wieland SF, 2004, P NATL ACAD SCI USA, V101, P2129, DOI 10.1073/pnas.0308478100; WONG DKH, 1993, ANN INTERN MED, V119, P312, DOI 10.7326/0003-4819-119-4-199308150-00011; Wu J, 2007, HEPATOLOGY, V46, P1769, DOI 10.1002/hep.21897; Lei YC, 2006, WORLD J GASTROENTERO, V12, P4492, DOI 10.3748/wjg.v12.i28.4492; Yu XM, 1996, J VIROL, V70, P8719, DOI 10.1128/JVI.70.12.8719-8726.1996; Zhang XY, 2011, HEPATOLOGY, V53, P1476, DOI 10.1002/hep.24195; Zhang YH, 2013, VIRUS RES, V171, P65, DOI 10.1016/j.virusres.2012.10.027; ZOULIM F, 1994, J VIROL, V68, P2026, DOI 10.1128/JVI.68.3.2026-2030.1994; ZWARTHOFF EC, 1985, NUCLEIC ACIDS RES, V13, P791, DOI 10.1093/nar/13.3.791	57	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90977	10.1371/journal.pone.0090977	http://dx.doi.org/10.1371/journal.pone.0090977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618716	Green Published, gold, Green Submitted			2022-12-25	WOS:000332842400041
J	Fransolet, M; Labied, S; Henry, L; Masereel, MC; Rozet, E; Kirschvink, N; Nisolle, M; Munaut, C				Fransolet, Maite; Labied, Soraya; Henry, Laurie; Masereel, Marie-Caroline; Rozet, Eric; Kirschvink, Nathalie; Nisolle, Michelle; Munaut, Carine			Strategies for Using the Sheep Ovarian Cortex as a Model in Reproductive Medicine	PLOS ONE			English	Article							TISSUE CRYOPRESERVATION; FERTILITY PRESERVATION; PRIMORDIAL FOLLICLES; FOLLICULAR VIABILITY; TRANSPLANTATION; RESERVE; DENSITY; BIOPSY; RESTORATION; PRIMATE	Objective: To evaluate and compare the distribution and density of primordial follicles within a whole sheep ovary and to gain insight into how to overcome the impact of natural follicular heterogeneity on the experimental results. Design: Histological study. Setting: Academic research center. Animals: Five-to nine-month-old ewes. Interventions: Freshly sampled whole sheep ovaries were collected and prepared for histological analysis. Main Outcome Measure(s): The follicular densities and distributions were determined for hematoxylin and eosin sections. A mathematical model was derived based on the follicle counts and Monte-Carlo simulations. Results: Heterogeneous distributions and densities of primordial follicles were identified 1) for distinct areas of the same ovarian cortex, 2) between the ovaries of the same animal and 3) across different ewes. A mathematical model based on the analysis of 37,153 primordial follicles from 8 different ovaries facilitated the estimation of the number of cortical biopsies and sections that had to be analyzed to overcome such heterogeneity. Conclusion: The influence of physiological follicular heterogeneity on experimental and clinical results can be overcome when a definite number of cortical pieces and sections are taken into consideration.	[Fransolet, Maite; Labied, Soraya; Henry, Laurie; Masereel, Marie-Caroline; Nisolle, Michelle; Munaut, Carine] Univ Liege, Lab Tumor & Dev Biol, GIGA R, Tour Pathol B23, Liege, Belgium; [Rozet, Eric] Univ Liege, Analyt Chem Lab, CIRM, Inst Pharm, Liege, Belgium; [Rozet, Eric] Arlenda SA, Liege, Belgium; [Kirschvink, Nathalie] Univ Namur UNamur, Vet Integrated Res Unit, Fac Sci, Namur Res Inst Life Sci NARILIS, Namur, Belgium; [Nisolle, Michelle] Univ Liege, Dept Obstet & Gynecol, Hop Citadelle, Liege, Belgium	University of Liege; University of Liege; University of Liege	Munaut, C (corresponding author), Univ Liege, Lab Tumor & Dev Biol, GIGA R, Tour Pathol B23, Liege, Belgium.	c.munaut@ulg.ac.be	Munaut, Carine/K-8138-2019	Kirschvink, Nathalie/0000-0003-1788-4212	"Fonds de la Recherche Scientifique" (F.R.S.-FNRS, Belgium); Interuniversity Attraction Poles program of the Belgian Science Policy (Brussels, Belgium); "Fonds Speciaux de la Recherche" (University of Liege, Belgium); "Fonds Leon Fredericq" (University of Liege, Belgium)	"Fonds de la Recherche Scientifique" (F.R.S.-FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Poles program of the Belgian Science Policy (Brussels, Belgium); "Fonds Speciaux de la Recherche" (University of Liege, Belgium); "Fonds Leon Fredericq" (University of Liege, Belgium)	This study was supported by grants from the "Fonds de la Recherche Scientifique" (F.R.S.-FNRS, Belgium), the Interuniversity Attraction Poles program of the Belgian Science Policy (Brussels, Belgium), the "Fonds Speciaux de la Recherche" (University of Liege, Belgium) and the "Fonds Leon Fredericq" (University of Liege, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer DF, 2004, ILAR J, V45, P212, DOI 10.1093/ilar.45.2.212; Aubard Y, 2001, FERTIL STERIL, V76, P414, DOI 10.1016/S0015-0282(01)01905-7; Baird DT, 1999, ENDOCRINOLOGY, V140, P462, DOI 10.1210/en.140.1.462; Bedaiwy MA, 2008, FERTIL STERIL, V90, P2031, DOI 10.1016/j.fertnstert.2008.08.009; Campos JR, 2011, CLINICS, V66, P2093, DOI 10.1590/S1807-59322011001200015; Chambers EL, 2010, HUM REPROD, V25, P2559, DOI 10.1093/humrep/deq192; Cortvrindt RG, 2001, FERTIL STERIL, V75; Courbiere B, 2005, FERTIL STERIL, V84, P1065, DOI 10.1016/j.fertnstert.2005.03.079; David A, 2011, FERTIL STERIL, V95, P1241, DOI 10.1016/j.fertnstert.2010.06.007; Demeestere I, 2012, OBSTET GYNECOL INT, V2012, DOI 10.1155/2012/961232; Dolmans MM, 2013, J ASSIST REPROD GEN, V30, P305, DOI 10.1007/s10815-013-9952-x; Donnez J, 2013, FERTIL STERIL, V99, P1503, DOI 10.1016/j.fertnstert.2013.03.030; Donnez J, 2010, BEST PRACT RES CL OB, V24, P87, DOI 10.1016/j.bpobgyn.2009.09.003; Gerritse R, 2008, HUM REPROD, V23, P329, DOI 10.1093/humrep/dem384; GOSDEN RG, 1994, HUM REPROD, V9, P597, DOI 10.1093/oxfordjournals.humrep.a138556; Kim SS, 2006, FERTIL STERIL, V85, P1, DOI 10.1016/j.fertnstert.2005.04.071; Lambalk CB, 2004, HUM REPROD, V19, P1055, DOI 10.1093/humrep/deh216; Lass A, 2004, HUM REPROD, V19, P467, DOI 10.1093/humrep/deh118; Lass A, 1997, HUM REPROD, V12, P1028; Lornage J, 2006, Gynecol Obstet Fertil, V34, P746, DOI 10.1016/j.gyobfe.2006.07.024; Lundy T, 1999, J REPROD FERTIL, V115, P251, DOI 10.1530/jrf.0.1150251; MUNN CS, 1986, RADIOLOGY, V159, P731, DOI 10.1148/radiology.159.3.3517957; Nisolle M, 2000, FERTIL STERIL, V74, P122, DOI 10.1016/S0015-0282(00)00548-3; Oktay K, 2000, MOL CELL ENDOCRINOL, V169, P105, DOI 10.1016/S0303-7207(00)00361-0; Poirot C, 2002, HUM REPROD, V17, P1447, DOI 10.1093/humrep/17.6.1447; Qu JP, 2000, HUM REPROD, V15, P302, DOI 10.1093/humrep/15.2.302; Sauvat F, 2013, FASEB J, V27, P1511, DOI 10.1096/fj.12-218297; Schmidt KLT, 2003, HUM REPROD, V18, P1158, DOI 10.1093/humrep/deg246; Sharara FI, 2004, HUM REPROD, V19, P470, DOI 10.1093/humrep/deh110; Soleimani R, 2006, HUM REPROD, V21, P1720, DOI 10.1093/humrep/del057; Tilly Jonathan L, 2003, Reprod Biol Endocrinol, V1, P11, DOI 10.1186/1477-7827-1-11; VandeBerg JL, 2004, GYNECOL OBSTET INVES, V57, P6	32	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91073	10.1371/journal.pone.0091073	http://dx.doi.org/10.1371/journal.pone.0091073			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614306	gold, Green Published, Green Submitted			2022-12-25	WOS:000332839300072
J	Zhao, YL; Yan, H; Yang, RH; Li, Q; Dang, SN; Wang, YY				Zhao, Yaling; Yan, Hong; Yang, Ruihai; Li, Qiang; Dang, Shaonong; Wang, Yuying			Prevalence and Determinants of Metabolic Syndrome among Adults in a Rural Area of Northwest China	PLOS ONE			English	Article							INTERNATIONAL-DIABETES-FEDERATION; 3RD NATIONAL-HEALTH; CARDIOVASCULAR-DISEASE; RISK-FACTORS; US ADULTS; PHYSICAL-ACTIVITY; NUTRITION; TRENDS; DEFINITIONS; POPULATION	Objectives: To evaluate the prevalence and determinants of metabolic syndrome (MetS) among adults in a rural area of Northwest China. Methods: A population-based cross-sectional study was conducted in 2010 among adults aged 18 to 80 years in rural areas of Hanzhong, in Northwest China. Interview, physical and clinical examinations, and fasting blood glucose and lipid measurements were completed for 2990 adults. The definitions of MetS proposed by the Third Report of the National Cholesterol Education Program Expert Panel (Adults Treatment Panel III, ATP III) and the International Diabetes Federation (IDF), and the modified ATP III definition for Asian population were used and compared. Proportions were adjusted for age and sex. Results: The prevalence of MetS was 7.9%, 10.8% and 15.1% according to ATP III, IDF and modified ATP III criteria, respectively. Agreement between ATP III and IDF criteria and that between ATP III and modified ATP III criteria were moderate (Kappa = 0.52 and 0.64, respectively), whereas agreement between IDF and modified ATP III criteria was good (Kappa = 0.83). The prevalence of MetS increased with age, and was higher in women than in men (10.4% versus 5.4%, 13.6% versus 8.1% and 17.4% versus 12.8%, according to ATP III, IDF and modified ATP III criteria, respectively). The most common MetS component was high blood pressure. Having family history of hypertension, lack of physical activity, high economical level, overweight and obesity were positively associated with MetS. Conclusions: MetS is prevalent among rural adults in Northwest China and high blood pressure is the most common MetS component. Prevention and treatment of hypertension and MetS should be a public health priority to reduce cardiovascular diseases in rural areas of Northwest China. More attention should be given to the elderly, women, people with family history of hypertension and obese people who are at high risk of MetS.	[Zhao, Yaling; Yan, Hong; Li, Qiang; Dang, Shaonong] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Xian 710049, Shaanxi, Peoples R China; [Yang, Ruihai] Hanzhong Peoples Hosp, Dept Cardiovasc Dis, Hanzhong, Shaanxi, Peoples R China; [Wang, Yuying] Xi An Jiao Tong Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Yan, H (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Xian 710049, Shaanxi, Peoples R China.	yanhonge@mail.xjtu.edu.cn	Shaonong, Dang/J-7421-2019	Shaonong, Dang/0000-0002-6980-8169	China Medical Board [08-925]; Science and Technology Research and Development Program of Shaanxi Province, China [2013K14-02-15]	China Medical Board; Science and Technology Research and Development Program of Shaanxi Province, China	This work was supported by the China Medical Board (Grant No. 08-925, http://www.chinamedicalboard.org/) and the Science and Technology Research and Development Program of Shaanxi Province, China (Grant No. 2013K14-02-15, http://www.sninfo.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Anjana RM, 2009, METABOLISM, V58, P344, DOI 10.1016/j.metabol.2008.10.006; Bee Ying Tan Jr, 2008, Malays J Nutr, V14, P65; Bener A, 2009, METAB SYNDR RELAT D, V7, P221, DOI 10.1089/met.2008.0077; Cai H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036936; Chen XR, 2009, NUTR METAB CARDIOVAS, V19, P27, DOI 10.1016/j.numecd.2008.01.010; *CHIN NUTR SOC, 2010, DIET GUID CHIN 2011; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cortez-Dias N, 2011, REV PORT CARDIOL, V30, P139; Du SF, 2002, PUBLIC HEALTH NUTR, V5, P169, DOI 10.1079/PHN2001290; Ervin R Bethene, 2009, Natl Health Stat Report, P1; Feng Y, 2006, OBESITY, V14, P2089, DOI 10.1038/oby.2006.244; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Ford ES, 2004, ATHEROSCLEROSIS, V173, P309, DOI 10.1016/j.atherosclerosis.2003.12.022; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Ford ES, 2005, DIABETES CARE, V28, P2745, DOI 10.2337/diacare.28.11.2745; Freiberg MS, 2004, DIABETES CARE, V27, P2954, DOI 10.2337/diacare.27.12.2954; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Guo FJ, 2012, J AM COLL CARDIOL, V60, P599, DOI 10.1016/j.jacc.2012.04.026; He Y, 2006, J AM COLL CARDIOL, V47, P1588, DOI 10.1016/j.jacc.2005.11.074; He Y, 2013, NUTR METAB CARDIOVAS, V23, P920, DOI 10.1016/j.numecd.2012.09.001; Hu SS, 2012, BIOMED ENVIRON SCI, V25, P251, DOI 10.3967/0895-3988.2012.03.001; Ibrahim MM, 2012, LANCET, V380, P611, DOI 10.1016/S0140-6736(12)60861-7; Imperatore G, 2004, AM J EPIDEMIOL, V160, P531, DOI 10.1093/aje/kwh232; International Diabetes Federation, 2013, IDF CONS WORLDW DEF; Kaykhaei MA, 2012, IRAN J PUBLIC HEALTH, V41, P70; Koutsovasilis A, 2009, INTERNAL MED, V48, P179, DOI 10.2169/internalmedicine.48.1654; Krauss RM, 2000, CIRCULATION, V102, P2284; Lao XQ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-64; Lee WY, 2005, DIABETES RES CLIN PR, V67, P70, DOI 10.1016/j.diabres.2004.05.006; Li G, 2010, ASIA PAC J CLIN NUTR, V19, P98; Li JB, 2010, J INT MED RES, V38, P1142, DOI 10.1177/147323001003800343; Mason C, 2009, OBESITY, V17, P1789, DOI 10.1038/oby.2009.87; Mattsson N, 2008, ANN MED, V40, P542, DOI 10.1080/07853890802307709; McAlister FA, 2011, CAN MED ASSOC J, V183, P1007, DOI 10.1503/cmaj.101767; Nestel P, 2007, ASIA PAC J CLIN NUTR, V16, P362; Ng SW, 2009, SOC SCI MED, V68, P1305, DOI 10.1016/j.socscimed.2009.01.035; Nilsson PM, 2007, DIABETIC MED, V24, P464, DOI 10.1111/j.1464-5491.2007.02142.x; Paek KW, 2006, J KOREAN MED SCI, V21, P701, DOI 10.3346/jkms.2006.21.4.701; Park HS, 2007, DIABETES OBES METAB, V9, P50, DOI 10.1111/j.1463-1326.2005.00569.x; Park J, 2008, ASIA PAC J CLIN NUTR, V17, P471; Patry-Parisien J, 2012, HEALTH REP, V23, P53; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Riediger ND, 2011, CAN MED ASSOC J, V183, pE1127, DOI 10.1503/cmaj.110070; Sanisoglu SY, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-92; Sung KC, 2009, AM J CARDIOL, V103, P1732, DOI 10.1016/j.amjcard.2009.02.027; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; Trivedi T, 2013, J RURAL HEALTH, V29, P188, DOI 10.1111/j.1748-0361.2012.00422.x; Villegas R, 2009, METAB SYNDR RELAT D, V7, P37, DOI 10.1089/met.2008.0042; Wang Hui-Jun, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P318; Wang J, 2003, AM J CLIN NUTR, V77, P379, DOI 10.1093/ajcn/77.2.379; WANG L, 2005, REPORT CHINA HLTH NU; Wang W, 2010, J INT MED RES, V38, P150, DOI 10.1177/147323001003800117; Wang ZH, 2008, ASIA PAC J CLIN NUTR, V17, P123; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Xu H, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-683; Xu WH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-246; Zhang Bing, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P330; Zhao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061779; Zhao Y, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-140; Zuo H, 2009, METABOLISM, V58, P1102, DOI 10.1016/j.metabol.2009.04.008	68	54	57	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91578	10.1371/journal.pone.0091578	http://dx.doi.org/10.1371/journal.pone.0091578			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9FH	24614618	gold, Green Submitted, Green Published			2022-12-25	WOS:000332839300138
J	Brown, GT; Cash, BG; Blihoghe, D; Johansson, P; Alnabulsi, A; Murray, GI				Brown, Gordon T.; Cash, Beatriz Gimenez; Blihoghe, Daniela; Johansson, Petronella; Alnabulsi, Ayham; Murray, Graeme I.			The Expression and Prognostic Significance of Retinoic Acid Metabolising Enzymes in Colorectal Cancer	PLOS ONE			English	Article							TUMOR-SPECIFIC EXPRESSION; HUMAN BREAST-CANCER; HUMAN CYTOCHROME-P450; PROSTATE-CANCER; ACYLTRANSFERASE EXPRESSION; MICROSATELLITE INSTABILITY; CYP26 INHIBITORS; REDUCED LECITHIN; COLON-CANCER; VITAMIN-A	Colorectal cancer is one of the most common types of cancer with over fifty percent of patients presenting at an advanced stage. Retinoic acid is a metabolite of vitamin A and is essential for normal cell growth and aberrant retinoic acid metabolism is implicated in tumourigenesis. This study has profiled the expression of retinoic acid metabolising enzymes using a well characterised colorectal cancer tissue microarray containing 650 primary colorectal cancers, 285 lymph node metastasis and 50 normal colonic mucosal samples. Immunohistochemistry was performed on the tissue microarray using monoclonal antibodies which we have developed to the retinoic acid metabolising enzymes CYP26A1, CYP26B1, CYP26C1 and lecithin retinol acyl transferase (LRAT) using a semi-quantitative scoring scheme to assess expression. Moderate or strong expression of CYP26A1 was observed in 32.5% of cancers compared to 10% of normal colonic epithelium samples (p<0.001). CYP26B1 was moderately or strongly expressed in 25.2% of tumours and was significantly less expressed in normal colonic epithelium (p<0.001). CYP26C1 was not expressed in any sample. LRAT also showed significantly increased expression in primary colorectal cancers compared with normal colonic epithelium (p<0.001). Strong CYP26B1 expression was significantly associated with poor prognosis (HR =1.239, 95%CI =1.104-1.390, chi(2) = 15.063, p =0.002). Strong LRAT was also associated with poorer outcome (HR= 1.321, 95%CI = 1.034-1.688, chi(2) = 5.039, p =0.025). In mismatch repair proficient tumours strong CYP26B1 (HR 1.330, 95%CI =1.173-1.509, chi(2) 21.493, p<0.001) and strong LRAT (HR =1.464, 950/0CI=1.110-1.930, chi(2) = 7.425, p= 0.006) were also associated with poorer prognosis. This study has shown that the retinoic acid metabolising enzymes CYP26A1, CYP26B1 and LRAT are significantly overexpressed in colorectal cancer and that CYP26B1 and LRAT are significantly associated with prognosis both in the total cohort and in those tumours which are mismatch repair proficient. CYP26B1 was independently prognostic in a multivariate model both in the whole patient cohort (HR =1.177, 95%CI =1.020-1.216, p=0.026) and in mismatch repair proficient tumours (HR = 1.255, 950/0CI = 1.073 - 1.467, p =0.004).	[Brown, Gordon T.; Murray, Graeme I.] Univ Aberdeen, Sch Med & Dent, Div Appl Med, Aberdeen, Scotland; [Cash, Beatriz Gimenez; Alnabulsi, Ayham] Vertebrate Antibodies, Aberdeen, Scotland; [Blihoghe, Daniela] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel; [Johansson, Petronella] Univ Aberdeen, Sch Biol Sci, Scottish Fish Immunol Res Ctr, Aberdeen, Scotland	University of Aberdeen; Tel Aviv University; University of Aberdeen	Murray, GI (corresponding author), Univ Aberdeen, Sch Med & Dent, Div Appl Med, Aberdeen, Scotland.	g.i.murray@abdn.ac.uk			University of Aberdeen Development Trust; Encompass	University of Aberdeen Development Trust; Encompass	The study was funded by University of Aberdeen Development Trust (http://www.abdn.ac.uk/giving/) and Encompass (http://www.encompassscotland.co.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar M, 2005, DRUG METAB REV, V37, P379, DOI 10.1081/DMR-200046136; Amengual J, 2012, J BIOL CHEM, V287, P24216, DOI 10.1074/jbc.M112.353979; Arnold C, 2010, PHARMACOL REP, V62, P536, DOI 10.1016/S1734-1140(10)70311-X; Ben-Amotz O, 2010, EXPERT REV ANTICANC, V10, P1559, DOI [10.1586/era.10.139, 10.1586/ERA.10.139]; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Bohanes P, 2011, SEMIN ONCOL, V38, P576, DOI 10.1053/j.seminoncol.2011.05.012; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Boorjian S, 2004, CLIN CANCER RES, V10, P3429, DOI 10.1158/1078-0432.CCR-03-0756; Brueggemeier RW, 2005, ENDOCR REV, V26, P331, DOI 10.1210/er.2004-0015; Chen C, 2013, CURR TOP MED CHEM, V13, P1454; Chen Q, 2011, CURR DRUG METAB, V12, P436, DOI 10.2174/138920011795495259; Clarke SJ, 2013, CRIT REV ONCOL HEMAT, V85, P121, DOI 10.1016/j.critrevonc.2012.06.001; Coghlin C, 2013, PROTEOMICS, V13, P2227, DOI 10.1002/pmic.201300245; Coghlin C, 2010, J PATHOL, V222, P1, DOI 10.1002/path.2727; Correia MA, 2011, DRUG METAB REV, V43, P1, DOI 10.3109/03602532.2010.515222; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Fleming I, 2011, CURR OPIN LIPIDOL, V22, P403, DOI 10.1097/MOL.0b013e32834a9790; Geiersbach KB, 2011, ARCH PATHOL LAB MED, V135, P1269, DOI 10.5858/arpa.2011-0035-RA; Gelboin HV, 2006, J CLIN PHARMACOL, V46, P353, DOI 10.1177/0091270005285200; George B, 2011, CURR ONCOL REP, V13, P206, DOI 10.1007/s11912-011-0162-3; Goel A, 2012, GASTROENTEROLOGY, V143, P1442, DOI 10.1053/j.gastro.2012.09.032; Gomaa MS, 2012, BIOORGAN MED CHEM, V20, P6080, DOI 10.1016/j.bmc.2012.08.044; Gomaa MS, 2012, BIOORGAN MED CHEM, V20, P4201, DOI 10.1016/j.bmc.2012.05.076; Gomaa MS, 2008, BIOORGAN MED CHEM, V16, P8301, DOI 10.1016/j.bmc.2007.06.048; Guengerich FP, 2011, PHARMACOL REV, V63, P684, DOI 10.1124/pr.110.003525; Guo XJ, 2002, CANCER RES, V62, P1654; Helvig C, 2011, J PHARMACOL TOX MET, V64, P258, DOI 10.1016/j.vascn.2011.08.005; Hope NR, 2011, HUM PATHOL, V42, P393, DOI 10.1016/j.humpath.2010.08.006; Hrycay EG, 2012, ARCH BIOCHEM BIOPHYS, V522, P71, DOI 10.1016/j.abb.2012.01.003; Huttunen KM, 2008, CURR MED CHEM, V15, P2346, DOI 10.2174/092986708785909120; Kabat GC, 2012, EUR J CLIN NUTR, V66, P549, DOI 10.1038/ejcn.2011.207; Karlgren M, 2007, EXPERT OPIN THER TAR, V11, P61, DOI 10.1517/14728222.11.1.61; Kelley RK, 2011, J NATL COMPR CANC NE, V9, P1293, DOI 10.6004/jnccn.2011.0105; Kumarakulasingham M, 2005, CLIN CANCER RES, V11, P3758, DOI 10.1158/1078-0432.CCR-04-1848; Leroux F, 2005, CURR MED CHEM, V12, P1623, DOI 10.2174/0929867054367185; Lutz JD, 2009, BIOCHEM PHARMACOL, V77, P258, DOI 10.1016/j.bcp.2008.10.012; Lyall MS, 2006, CLIN CANCER RES, V12, P1184, DOI 10.1158/1078-0432.CCR-05-1864; Malesci A, 2012, DIGEST DIS, V30, P296, DOI 10.1159/000336996; Murray GI, 1998, GUT, V43, P791, DOI 10.1136/gut.43.6.791; MURRAY GI, 1993, CANCER-AM CANCER SOC, V71, P36, DOI 10.1002/1097-0142(19930101)71:1<36::AID-CNCR2820710107>3.0.CO;2-J; Murray GI, 1997, CANCER RES, V57, P3026; MURRAY GI, 1991, BRIT J CANCER, V63, P1021, DOI 10.1038/bjc.1991.222; Murray GI, 2001, ANNU REV PHARMACOL, V41, P297, DOI 10.1146/annurev.pharmtox.41.1.297; Murray GI, 1999, BRIT J CANCER, V79, P1836, DOI 10.1038/sj.bjc.6690292; Murray GI, 2010, HISTOPATHOLOGY, V57, P202, DOI 10.1111/j.1365-2559.2010.03606.x; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Niwa T, 2011, CURR DRUG METAB, V12, P549; Njar VCO, 2002, MINI-REV MED CHEM, V2, P261, DOI 10.2174/1389557023406223; O'Dwyer D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027718; Omura T, 2010, J BIOCHEM, V147, P297, DOI 10.1093/jb/mvq001; Osanai M, 2005, MOL PHARMACOL, V67, P1808, DOI 10.1124/mol.104.005769; Panigrahy D, 2010, CANCER METAST REV, V29, P723, DOI 10.1007/s10555-010-9264-x; Park EY, 2012, NUTR CANCER, V64, P732, DOI 10.1080/01635581.2012.687425; Patterson LH, 2002, CURR PHARM DESIGN, V8, P1335, DOI 10.2174/1381612023394502; Pautus S, 2009, J ENZYM INHIB MED CH, V24, P487, DOI [10.1080/14756360802218334, 10.1080/14756360802218334 ]; Pritchard CC, 2011, GUT, V60, P116, DOI 10.1136/gut.2009.206250; Ralton LD, 2010, CURR PROTEOMICS, V7, P212; Rawson JB, 2012, EXPERT REV MOL DIAGN, V12, P499, DOI [10.1586/erm.12.39, 10.1586/ERM.12.39]; Rodriguez-Antona C, 2010, HUM GENET, V127, P1, DOI 10.1007/s00439-009-0748-0; Ross AC, 2011, ANNU REV NUTR, V31, P65, DOI 10.1146/annurev-nutr-072610-145127; Ruiz A, 2010, EXP EYE RES, V90, P186, DOI 10.1016/j.exer.2009.07.002; Sheren-Manoff M, 2006, INT J ONCOL, V29, P1193; Shou M, 2009, DRUG METAB DISPOS, V37, P925, DOI 10.1124/dmd.108.025718; Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200; Stein MN, 2012, CLIN CANCER RES, V18, P1848, DOI 10.1158/1078-0432.CCR-11-1805; Stenstedt K, 2012, ANTICANCER RES, V32, P3869; Sutherland M, 2013, MOL CANCER THER, V12, P27, DOI 10.1158/1535-7163.MCT-12-0405; Thatcher JE, 2009, EXPERT OPIN DRUG MET, V5, P875, DOI 10.1517/17425250903032681; Topletz AR, 2012, BIOCHEM PHARMACOL, V83, P149, DOI 10.1016/j.bcp.2011.10.007; Travica S, 2013, CLIN CANCER RES, V19, P2952, DOI 10.1158/1078-0432.CCR-13-0238; Williams GT, 2007, DATASET COLORECTAL C, P1; Xu DH, 2012, BIOCHEM BIOPH RES CO, V428, P518, DOI 10.1016/j.bbrc.2012.10.071; Yu W, 2012, TOXICOL APPL PHARM, V264, P73, DOI 10.1016/j.taap.2012.07.019	74	35	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90776	10.1371/journal.pone.0090776	http://dx.doi.org/10.1371/journal.pone.0090776			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608339	Green Published, gold, Green Submitted			2022-12-25	WOS:000332485800050
J	Hartwig, SM; Holman, KM; Varga, SM				Hartwig, Stacey M.; Holman, Kaitlyn M.; Varga, Steven M.			Depletion of Alveolar Macrophages Ameliorates Virus-Induced Disease following a Pulmonary Coronavirus Infection	PLOS ONE			English	Article							ACUTE-RESPIRATORY-SYNDROME; REGULATORY T-CELLS; SARS-ASSOCIATED CORONAVIRUS; GENOME SEQUENCE; SYNCYTIAL VIRUS; MICE; IDENTIFICATION; RESISTANT; RESPONSES; OUTBREAK	Coronavlruses cause respiratory disease humans that can range from mild to severe. However, the pathogenesis of pulmonary coronavirus infections poorly understood Mouse hepatitis virus type 1 (MHV-1) is a group 2 coronavirus capable of causing severe morbidity and mortality in highly CD4 and CD8 T cells play a critical role in mediating macrophages (AM) in modulating h Id range adaptive immune response and subsequen hepatitis type susceptible C3H/He mice. MHV-1-induced disease. Here e. However, he pathogenesis of MHV-1) a group 2 coronavirus e have previously shown that both we evaluated the role of alveolar disease. Depletion of AM using clodronate liposornes administered prior to MHV-1 infection was associated h a sign induced morbidity and mortality. A depletion resulted in a decreased number of virus airways. In addition, a significant increase in the frequency and total number of T e as observed following MHV-1 infection in mice depleted of A Our results Modulating MHV-1-induced morbidity and mortality.	[Hartwig, Stacey M.; Holman, Kaitlyn M.; Varga, Steven M.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Varga, Steven M.] Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA USA; [Varga, Steven M.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Varga, SM (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	steven-varga@uiowa.edu	Varga, Steven/C-2009-2009	Varga, Steven/0000-0001-7332-4290	National Institutes of Health [R21 A1083482, R56 A1106776]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083482, R56AI106776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants R21 A1083482 and R56 A1106776 to SMV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida J D, 1967, J Gen Virol, V1, P175, DOI 10.1099/0022-1317-1-2-175; Betts RJ, 2012, J VIROL, V86, P2817, DOI 10.1128/JVI.05685-11; Castilow EM, 2008, J VIROL, V82, P2196, DOI 10.1128/JVI.01949-07; De Albuquerque N, 2006, J VIROL, V80, P10382, DOI 10.1128/JVI.00747-06; Fouchier RAM, 2003, NATURE, V423, P240, DOI 10.1038/423240a; Fulton RB, 2010, J IMMUNOL, V185, P2382, DOI 10.4049/jimmunol.1000423; HAMRE D, 1966, P SOC EXP BIOL MED, V121, P190, DOI 10.3181/00379727-121-30734; Holmes KV, 2003, NEW ENGL J MED, V348, P1948, DOI 10.1056/NEJMp030078; HOLT PG, 1993, J EXP MED, V177, P397, DOI 10.1084/jem.177.2.397; Khanolkar A, 2010, J IMMUNOL, V185, P1132, DOI 10.4049/jimmunol.0902749; Khanolkar A, 2009, J VIROL, V83, P9258, DOI 10.1128/JVI.00355-09; Khanolkar A, 2009, J VIROL, V83, P8946, DOI 10.1128/JVI.01857-08; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Masopust D, 2007, J VIROL, V81, P2002, DOI 10.1128/JVI.01459-06; McDermott DS, 2011, J IMMUNOL, V187, P5568, DOI 10.4049/jimmunol.1102104; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Pribul PK, 2008, J VIROL, V82, P4441, DOI 10.1128/JVI.02541-07; Rai D, 2009, J IMMUNOL, V183, P7672, DOI 10.4049/jimmunol.0902874; Rivera R, 2007, VIROLOGY, V363, P48, DOI 10.1016/j.virol.2007.01.033; Savage NDL, 2008, J IMMUNOL, V181, P2220, DOI 10.4049/jimmunol.181.3.2220; Soroosh P, 2013, J EXP MED, V210, P775, DOI 10.1084/jem.20121849; STRICKLAND DH, 1993, IMMUNOLOGY, V80, P266; TAGUCHI F, 1981, INFECT IMMUN, V34, P1059, DOI 10.1128/IAI.34.3.1059-1061.1981; TYRRELL DAJ, 1965, BMJ-BRIT MED J, V1, P1467, DOI 10.1136/bmj.1.5448.1467; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; VOGEL SN, 1979, J IMMUNOL, V122, P619; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Zhao JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000636; Zhao Z, 2003, J MED MICROBIOL, V52, P715, DOI 10.1099/jmm.0.05320-0; Zhong NS, 2003, LANCET, V362, P1353, DOI 10.1016/S0140-6736(03)14630-2	34	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90720	10.1371/journal.pone.0090720	http://dx.doi.org/10.1371/journal.pone.0090720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608125	Green Published, gold, Green Submitted			2022-12-25	WOS:000332485800047
J	Nome, T; Hoff, AM; Bakken, AC; Rognum, TO; Nesbakken, A; Skotheim, RI				Nome, Torfinn; Hoff, Andreas M.; Bakken, Anne Cathrine; Rognum, Torleiv O.; Nesbakken, Arild; Skotheim, Rolf I.			High Frequency of Fusion Transcripts Involving TCF7L2 in Colorectal Cancer: Novel Fusion Partner and Splice Variants	PLOS ONE			English	Article							HUMAN GENOME; HUMAN-CELLS; GENE FUSION; WNT PATHWAY; INSTABILITY	VTI1A-TCF7L2 was reported as a recurrent fusion gene in colorectal cancer (CRC), found to be expressed in three out of 97 primary cancers, and one cell line, NCI-H508, where a genomic deletion joins the two genes [ 1]. To investigate this fusion further, we analyzed high-throughput DNA and RNA sequencing data from seven CRC cell lines, and identified the gene RP11-57H14.3 (ENSG00000225292) as a novel fusion partner for TCF7L2. The fusion was discovered from both genome and transcriptome data in the HCT116 cell line. By triplicate nested RT-PCR, we tested both the novel fusion transcript and VTI1A-TCF7L2 for expression in a series of 106 CRC tissues, 21 CRC cell lines, 14 normal colonic mucosa, and 20 normal tissues from miscellaneous anatomical sites. Altogether, 42% and 45% of the CRC samples expressed VTI1A-TCF7L2 and TCF7L2-RP11-57H14.3 fusion transcripts, respectively. The fusion transcripts were both seen in 29% of the normal colonic mucosa samples, and in 25% and 75% of the tested normal tissues from other organs, revealing that the TCF7L2 fusion transcripts are neither specific to cancer nor to the colon and rectum. Seven different splice variants were detected for the VTI1A-TCF7L2 fusion, of which three are novel. Four different splice variants were detected for the TCF7L2-RP11-57H14.3 fusion. In conclusion, we have identified novel variants of VTI1A-TCF7L2 fusion transcripts, including a novel fusion partner gene, RP11-57H14.3, and demonstrated detectable levels in a large fraction of CRC samples, as well as in normal colonic mucosa and other tissue types. We suggest that the fusion transcripts observed in a high frequency of samples are transcription induced chimeras that are expressed at low levels in most samples. The similar fusion transcripts induced by genomic rearrangements observed in individual cancer cell lines may yet have oncogenic potential as suggested in the original study by Bass et al.	[Nome, Torfinn; Hoff, Andreas M.; Bakken, Anne Cathrine; Skotheim, Rolf I.] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Canc Prevent, Oslo, Norway; [Nome, Torfinn; Hoff, Andreas M.; Bakken, Anne Cathrine; Nesbakken, Arild; Skotheim, Rolf I.] Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway; [Rognum, Torleiv O.] Univ Oslo, Oslo, Norway; [Rognum, Torleiv O.] Norwegian Inst Publ Hlth, Div Forens Med, Dept Forens Pathol & Clin Forens Med, Oslo, Norway; [Nesbakken, Arild] Oslo Univ Hosp Aker, Dept Gastrointestinal Surg, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH); University of Oslo	Skotheim, RI (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Canc Prevent, Oslo, Norway.	rolf.i.skotheim@rr-research.no	Nome, Torfinn/E-5475-2015; Skotheim, Rolf I./H-6192-2017	Nome, Torfinn/0000-0003-1659-132X; Skotheim, Rolf I./0000-0002-5609-4048; Hoff, Andreas Midboe/0000-0002-6955-6678	Norwegian Cancer Society [PR-2007-0166]; NorStore [NS9013K]; Research Council of Norway through its Centres of Excellence funding scheme [179571]	Norwegian Cancer Society(Norwegian Cancer Society); NorStore; Research Council of Norway through its Centres of Excellence funding scheme	The study was funded by grants from the Norwegian Cancer Society (TN and AMH were financed as PhD-students from the PR-2007-0166 grant to RIS), NorStore (for storage of computer files; project NS9013K), and partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 179571. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.35; Akiva P, 2006, GENOME RES, V16, P30, DOI 10.1101/gr.4137606; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Berg M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013978; Diep CB, 2003, J CLIN ONCOL, V21, P820, DOI 10.1200/JCO.2003.05.190; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Kim RN, 2012, FUNCT INTEGR GENOMIC, V12, P45, DOI 10.1007/s10142-011-0260-1; Li H, 2008, SCIENCE, V321, P1357, DOI 10.1126/science.1156725; Li H, 2009, CELL CYCLE, V8, P218, DOI 10.4161/cc.8.2.7358; LOTHE RA, 1993, CANCER RES, V53, P5849; McPherson A, 2012, GENOME RES, V22, P2250, DOI 10.1101/gr.136572.111; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; NIGRO JM, 1991, CELL, V64, P607, DOI 10.1016/0092-8674(91)90244-S; Nome T, 2013, TRANSL ONCOL, V6, P546, DOI 10.1593/tlo.13457; ODELBERG SJ, 1995, NUCLEIC ACIDS RES, V23, P2049, DOI 10.1093/nar/23.11.2049; Parra G, 2006, GENOME RES, V16, P37, DOI 10.1101/gr.4145906; Prakash T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013284; Rozen S, 2000, Methods Mol Biol, V132, P365; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Thorstensen L, 2005, NEOPLASIA, V7, P99, DOI 10.1593/neo.04448; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679	26	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91264	10.1371/journal.pone.0091264	http://dx.doi.org/10.1371/journal.pone.0091264			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608966	gold, Green Submitted, Green Published			2022-12-25	WOS:000332485800119
J	Ong, J; Salomon, J; te Morsche, RHM; Roelofs, HMJ; Witteman, BJM; Dura, P; Lacko, M; Peters, WHM				Ong, Jennie; Salomon, Jody; te Morsche, Rene H. M.; Roelofs, Hennie M. J.; Witteman, Ben J. M.; Dura, Polat; Lacko, Martin; Peters, Wilbert H. M.			Polymorphisms in the Insulin-Like Growth Factor Axis Are Associated with Gastrointestinal Cancer	PLOS ONE			English	Article							CIRCULATING LEVELS; FACTOR-I; IGF-I; BINDING PROTEIN-3; BREAST-CANCER; FACTOR SYSTEM; RISK; IGFBP-3; OBESITY; GENES	Introduction: Numerous factors influence the development of gastrointestinal (GI) cancer. The insulin-like growth factor (IGF) axis plays a role in embryonic and postnatal growth and tissue repair. Elevated levels of IGFs, low levels of IGF binding proteins (IGFBPs) and over-expression of IGF receptor (IGFR-I) were associated with several stages of cancer. Here, the prevalence of the single nucleotide polymorphisms (SNPs) rs6214 in the IGF type I (IGF-I) gene and rs6898743 in the growth hormone receptor (GHR) gene in patients with GI cancer and controls was studied. Materials & Methods: In this Dutch case-control study, DNA isolated from blood of 1,457 GI cancer patients; 438 patients with head and neck cancer (HNC), 475 with esophageal cancer (EC) and 544 with colorectal cancer (CRC) and 1,457 matched controls, was used to determine the rs6214 and rs6898743 genotypes by polymerase chain reaction. The association between these SNPs and GI cancer, HNC, esophageal adenocarcinoma (EAC), esophageal squamous-cell carcinoma (ESCC) and proximal or distal CRC was studied. Odds ratios (ORs) with 95% confidence interval (95% CI) were calculated via unconditional logistic regression. Results: Overall for GI cancer, the ORs for SNPs rs6214 and rs6898743 were approximately 1.0 (p-value>0.05), using the most common genotypes GG as reference. An OR of 1.54 (95% CI, 1.05-2.27) was found for EC for genotype AA of rs6214. The ORs for EAC were 1.45 (95% CI, 1.04-2.01) and 1.71 (95% CI, 1.10-2.68), for genotypes GA and AA, respectively. Genotype GC of rs6898743 showed an OR of 0.47 (95% CI, 0.26-0.86) for ESCC. Conclusion: The A allele of SNP rs6214 in the IGF-I gene was associated with EAC, and with HNC in women. The GC genotype of rs6898743 in the GHR gene was negatively associated with ESCC.	[Ong, Jennie; Salomon, Jody; te Morsche, Rene H. M.; Roelofs, Hennie M. J.; Dura, Polat; Peters, Wilbert H. M.] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol, NL-6525 ED Nijmegen, Netherlands; [Witteman, Ben J. M.] Hosp Gelderse Vallei, Dept Gastroenterol, Ede, Netherlands; [Lacko, Martin] Maastricht Univ, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Maastricht, Netherlands	Radboud University Nijmegen; Gelderse Vallei Hospital; Maastricht University	Peters, WHM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol, NL-6525 ED Nijmegen, Netherlands.	w.peters@mdl.umcn.nl	te Morsche, R/P-9143-2015; Peters, W.H.M./L-4572-2015					Al-Zahrani A, 2006, HUM MOL GENET, V15, P1, DOI 10.1093/hmg/ddi398; [Anonymous], 2013, CURR PROB SURG, V50, P192, DOI 10.1067/j.cpsurg.2013.01.004; Boeing H, 2013, BEST PRACT RES CL EN, V27, P219, DOI 10.1016/j.beem.2013.04.005; Bonapace G, 2003, J MED GENET, V40, P913, DOI 10.1136/jmg.40.12.913; Canzian F, 2006, BRIT J CANCER, V94, P299, DOI 10.1038/sj.bjc.6602936; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Chhabra Y, 2011, EXPERT REV ENDOCRINO, V6, P71, DOI [10.1586/eem.10.73, 10.1586/EEM.10.73]; D'Aloisio AA, 2009, CANCER EPIDEM BIOMAR, V18, P954, DOI 10.1158/1055-9965.EPI-08-0856; Denley A, 2005, CYTOKINE GROWTH F R, V16, P421, DOI 10.1016/j.cytogfr.2005.04.004; Estivariz CF, 1997, ENDOCRINE, V7, P65, DOI 10.1007/BF02778066; Feik E, 2010, CANCER CAUSE CONTROL, V21, P91, DOI 10.1007/s10552-009-9438-4; Gallagher EJ, 2011, ENDOCRINOLOGY, V152, P2546, DOI 10.1210/en.2011-0231; Giovannucci E, 2000, CANCER EPIDEM BIOMAR, V9, P345; Haggar Fatima A, 2009, Clin Colon Rectal Surg, V22, P191, DOI 10.1055/s-0029-1242458; Hernandez W, 2007, CARCINOGENESIS, V28, P2154, DOI 10.1093/carcin/bgm190; Ho SMY, 2003, CANCER EPIDEM BIOMAR, V12, P426; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; IARC, GLOBOCAN 2008; Ionescu M, 2006, J CLIN ENDOCR METAB, V91, P4792, DOI 10.1210/jc.2006-1702; Kaskel F, 2003, KIDNEY INT, V64, P1141, DOI 10.1046/j.1523-1755.2003.00194.x; Kelemen LE, 2008, NAT REV CANCER, V8, P812, DOI 10.1038/nrc2466; Kim HJ, 2012, EXP THER MED, V3, P93, DOI 10.3892/etm.2011.372; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Ma J, 2000, GROWTH HORM IGF RES, V10, pS28, DOI 10.1016/S1096-6374(00)90013-3; MACAULAY VM, 1992, BRIT J CANCER, V65, P311, DOI 10.1038/bjc.1992.65; McElholm AR, 2010, GASTROENTEROLOGY, V139, P204, DOI 10.1053/j.gastro.2010.04.014; Nakao M, 2011, INT J MOL EPIDEMIOL, V2, P354; NCBI, RS6214 NCBI; NCBI, RS6898743 NCIBI; Renehan AG, 2006, TRENDS ENDOCRIN MET, V17, P328, DOI 10.1016/j.tem.2006.08.006; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472; Zhao J, 2007, HUM REPROD, V22, P1789, DOI 10.1093/humrep/dem052; Zhivotovskiy AS, 2012, ASIAN PAC J CANCER P, V13, P5183, DOI 10.7314/APJCP.2012.13.10.5183	34	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90916	10.1371/journal.pone.0090916	http://dx.doi.org/10.1371/journal.pone.0090916			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608110	Green Published, Green Submitted, gold			2022-12-25	WOS:000332485800065
J	Cadelis, G; Tourres, R; Molinie, J				Cadelis, Gilbert; Tourres, Rachel; Molinie, Jack			Short-Term Effects of the Particulate Pollutants Contained in Saharan Dust on the Visits of Children to the Emergency Department due to Asthmatic Conditions in Guadeloupe (French Archipelago of the Caribbean)	PLOS ONE			English	Article							CASE-CROSSOVER; AIR-POLLUTION; AFRICAN DUST; HOSPITAL ADMISSIONS; DESERT DUST; MATTER; EXACERBATIONS; PARTICLES; SYMPTOMS; EXPOSURE	Background: The prevalence of asthma in children is a significant phenomenon in the Caribbean. Among the etiologic factors aggravating asthma in children, environmental pollution is one of the main causes. In Guadeloupe, pollution is primarily transported by Saharan dust including inhalable particles. Methods: This study assesses, over one year (2011), the short-term effects of pollutants referred to as PM10 (PM10: particulate matter < 10 mu m) and PM2.5-10 (PM2.5-10: particulate matter > 2.5 mu m and < 10 mu m) contained in Saharan dust, on the visits of children aged between 5 and 15 years for asthma in the health emergency department of the main medical facility of the archipelago of Guadeloupe. A time-stratified case-crossover model was applied and the data were analysed by a conditional logistic regression for all of the children but also for sub-groups corresponding to different age classes and genders. Results: The visits for asthma concerned 836 children including 514 boys and 322 girls. The Saharan dust has affected 15% of the days of the study (337 days) and involved an increase in the average daily concentrations of PM10 (49.7 mu g/m(3) vs. 19.2 mu g/m(3)) and PM 2.5-10 (36.2 mu g/m(3) vs. 10.3 mu g/m(3)) compared to days without dust. The excess risk percentages (IR%) for visits related to asthma in children aged between 5 and 15 years on days with dust compared to days without dust were, for PM10, ((IR %: 9.1% (CI95%, 7.1%-11.1%) versus 1.1%(CI95%, -5.9%-4.6%)) and for PM2.5-10 (IR%: 4.5%(CI95%, 2.5%-6.5%) versus 1.6% (CI95%, -1.1%-3.4%). There was no statistical difference in the IR% for periods with Saharan dust among different age group of children and between boys and girls for PM10 and PM2.5-10. Conclusion: The PM10 and PM2.5-10 pollutants contained in the Saharan dust increased the risk of visiting the health emergency department for children with asthma in Guadeloupe during the study period.	[Cadelis, Gilbert; Tourres, Rachel] Univ Hosp Pointe A Pitre, Dept Pulm Med, Pointe A Pitre, Guadeloupe, France; [Molinie, Jack] Univ Antilles Guyane, Lab Res Geosci & Energy, Pointe A Pitre, Guadeloupe, France	CHU Guadeloupe; Universite des Antilles	Cadelis, G (corresponding author), Univ Hosp Pointe A Pitre, Dept Pulm Med, Pointe A Pitre, Guadeloupe, France.	gilbert.cadelis@chu-guadeloupe.fr		Cadelis, Gilbert/0000-0003-3739-6929				Alessandrini ER, 2013, OCCUP ENVIRON MED, V70, P432, DOI 10.1136/oemed-2012-101182; Arcus-Arth A, 2007, RISK ANAL, V27, P97, DOI 10.1111/j.1539-6924.2006.00862.x; Bateson TF, 1999, EPIDEMIOLOGY, V10, P539, DOI 10.1097/00001648-199909000-00013; Bateson TF, 2007, J TOXICOL ENV HEAL A, V71, P3; Bennett WD, 2003, J APPL PHYSIOL, V95, P497, DOI 10.1152/japplphysiol.00718.2002; Brunekreef B, 2005, EUR RESPIR J, V26, P309, DOI 10.1183/09031936.05.00001805; Cadelis G, 2013, REV MAL RESPIR, V30, P203, DOI 10.1016/j.rmr.2012.11.002; Coz E, 2009, ATMOS ENVIRON, V43, P1850, DOI 10.1016/j.atmosenv.2008.12.045; D'Amato G, 2013, MULTIDISCIP RESP MED, V8, DOI 10.1186/2049-6958-8-12; Dougherty RH, 2009, CLIN EXP ALLERGY, V39, P193, DOI 10.1111/j.1365-2222.2008.03157.x; Gordian ME, 1996, ENVIRON HEALTH PERSP, V104, P290, DOI 10.2307/3432887; Griffin DW, 2007, CLIN MICROBIOL REV, V20, P459, DOI 10.1128/CMR.00039-06; Gyan K, 2005, INT J BIOMETEOROL, V49, P371, DOI 10.1007/s00484-005-0257-3; Hashizume Masahiro, 2010, Nihon Eiseigaku Zasshi, V65, P413; Hong YC, 2010, SCI TOTAL ENVIRON, V408, P754, DOI 10.1016/j.scitotenv.2009.11.015; Howitt M. E., 2000, Postgraduate Doctor - Caribbean, V16, P86; Ichinose T, 2008, INHAL TOXICOL, V20, P685, DOI [10.1080/08958370801935133, 10.1080/08958370801935133 ]; Jaakkola JJK, 2003, EUR RESPIR J, V21, p81S, DOI 10.1183/09031936.03.00402703; Janes H, 2005, EPIDEMIOLOGY, V16, P717, DOI 10.1097/01.ede.0000181315.18836.9d; Kanatani KT, 2010, AM J RESP CRIT CARE, V182, P1475, DOI 10.1164/rccm.201002-0296OC; Lin M, 2002, ENVIRON HEALTH PERSP, V110, P575, DOI 10.1289/ehp.02110575; Maclure M, 2000, ANNU REV PUBL HEALTH, V21, P193, DOI 10.1146/annurev.publhealth.21.1.193; MANCINO D, 1984, INT ARCH ALLER A IMM, V73, P10, DOI 10.1159/000233429; Middleton N, 2008, ENV HLTH, V1, P7, DOI DOI 10.1186/1476-069X-7-39; Middleton NJ, 2001, T I BRIT GEOGR, V26, P165, DOI 10.1111/1475-5661.00013; Monteil MA, 2005, BMC PUBLIC HEALTH, V14, P5; Mortimer KM, 2002, EUR RESPIR J, V19, P699, DOI 10.1183/09031936.02.00247102; Mounouchy MA, 2009, REV MAL RESPIR, V26, P944, DOI 10.1016/S0761-8425(09)73329-7; Park JW, 2005, RESPIROLOGY, V10, P470, DOI 10.1111/j.1440-1843.2005.00728.x; Prospero JM, 2008, INT J BIOMETEOROL, V52, P823, DOI 10.1007/s00484-008-0176-1; Rutherford S, 1999, INT J BIOMETEOROL, V42, P217, DOI 10.1007/s004840050108; Samoli E, 2011, ENVIRON RES, V3, P418; Schwartz J, 1996, EPIDEMIOLOGY, V7, P20, DOI 10.1097/00001648-199601000-00005; Taylor DA, 2002, ENVIRON HEALTH PERSP, V110, pA80, DOI 10.1289/ehp.110-a80; Tecer LH, 2008, J TOXICOL ENV HEAL A, V71, P512, DOI 10.1080/15287390801907459; Tobias A, 2011, SCI TOTAL ENVIRON, V412, P386, DOI 10.1016/j.scitotenv.2011.10.027; Vedal S, 1998, AM J RESP CRIT CARE, V157, P1034, DOI 10.1164/ajrccm.157.4.9609008; Venkataraman C, 1999, INHAL TOXICOL, V11, P151, DOI 10.1080/089583799197221; Yang CY, 2005, INHAL TOXICOL, V17, P817, DOI 10.1080/08958370500241254	39	88	90	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91136	10.1371/journal.pone.0091136	http://dx.doi.org/10.1371/journal.pone.0091136			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603899	Green Published, gold, Green Submitted			2022-12-25	WOS:000332483600136
J	Ramineni, R; Sadumpati, V; Khareedu, VR; Vudem, DR				Ramineni, Ramadevi; Sadumpati, Vijayakumar; Khareedu, Venkateswara Rao; Vudem, Dashavantha Reddy			Transgenic Pearl Millet Male Fertility Restorer Line (ICMP451) and Hybrid (ICMH451) Expressing Brassica juncea Nonexpressor of Pathogenesis Related Genes 1 (BjNPR1) Exhibit Resistance to Downy Mildew Disease	PLOS ONE			English	Article							SALICYLIC-ACID GLUCOSYLTRANSFERASE; SELECTABLE MARKER GENE; ENHANCED RESISTANCE; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; DEFENSE RESPONSES; PLANTS RESISTANT; NPR1; OVEREXPRESSION; ACTIVATION	Brassica juncea Nonexpressor of pathogenesis-related genes 1 (BjNPR1) has been introduced into pearl millet male fertility restorer line ICMP451 by Agrobacterium tumefaciens-mediated genetic transformation. Transgenic pearl millet plants were regenerated from the phosphinothricin-resistant calli obtained after co-cultivation with A. tumefaciens strain LBA4404 harbouring Ti plasmid pSB111-bar-BjNPR1. Molecular analyses confirmed the stable integration and expression of BjNPR1 in transgenic pearl millet lines. Transgenes BjNPR1 and bar were stably inherited and disclosed co-segregation in subsequent generations in a Mendelian fashion. Transgenic pearl millet hybrid ICMH451-BjNPR1 was developed by crossing male-sterile line 81A X homozygous transgenic line ICMP451-BjNPR1. T-3 and T-4 homozygous lines of ICMP451-BjNPR1 and hybrid ICMH451-BjNPR1 exhibited resistance to three strains of downy mildew pathogen, while the untransformed ICMP451 and the isogenic hybrid ICMH451 plants were found susceptible. Following infection with S. graminicola, differential expression of systemic acquired resistance pathway genes, UDP-glucose salicylic acid glucosyl transferase and pathogenesis related gene 1 was observed in transgenic ICMP451-BjNPR1 and untransformed plants indicating the activation of systemic acquired resistance pathway contributing to the transgene-mediated resistance against downy mildew. The transgenic pearl millet expressing BjNPR1 showed resistance to multiple strains of S. graminicola and, as such, seems promising for the development of durable downy mildew resistant hybrids.	[Ramineni, Ramadevi; Sadumpati, Vijayakumar; Khareedu, Venkateswara Rao; Vudem, Dashavantha Reddy] Osmania Univ, Ctr Plant Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Osmania University	Vudem, DR (corresponding author), Osmania Univ, Ctr Plant Mol Biol, Hyderabad 500007, Andhra Pradesh, India.	vdreddycpmb@yahoo.com			Department of Biotechnology, Government of India, New Delhi; Council of Scientific and Industrial Research	Department of Biotechnology, Government of India, New Delhi(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	The authors acknowledge the financial support from Department of Biotechnology, Government of India, New Delhi. RR and VS acknowledge the Council of Scientific and Industrial Research for awarding the research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldemita RR, 1996, PLANTA, V199, P612, DOI 10.1007/BF00195194; Bai W, 2011, PLANT BIOTECHNOL J, V9, P205, DOI 10.1111/j.1467-7652.2010.00544.x; BALL SL, 1984, ANN APPL BIOL, V104, P41, DOI 10.1111/j.1744-7348.1984.tb05585.x; Cao H, 1998, P NATL ACAD SCI USA, V95, P6531, DOI 10.1073/pnas.95.11.6531; Chern MS, 2001, PLANT J, V27, P101, DOI 10.1046/j.1365-313x.2001.01070.x; Collins VP, 1997, POULTRY SCI, V76, P326, DOI 10.1093/ps/76.2.326; Crampton BG, 2009, MOL PLANT PATHOL, V10, P291, DOI 10.1111/j.1364-3703.2008.00532.x; Davis AJ, 2003, J APPL POULTRY RES, V12, P137, DOI 10.1093/japr/12.2.137; DEKEYSER RA, 1990, PLANT CELL, V2, P591, DOI 10.1105/tpc.2.7.591; Deshaprabhu SB, 1991, RAW MAT, VVII, P292; EJETA G, 1987, P NATL ACAD SCI USA, V84, P6016, DOI 10.1073/pnas.84.17.6016; Fan WH, 2002, PLANT CELL, V14, P1377, DOI 10.1105/tpc.001628; FINNEGAN J, 1994, BIO-TECHNOL, V12, P883, DOI 10.1038/nbt0994-883; Fitzgerald HA, 2004, MOL PLANT MICROBE IN, V17, P140, DOI 10.1094/MPMI.2004.17.2.140; Friedrich L, 2001, MOL PLANT MICROBE IN, V14, P1114, DOI 10.1094/MPMI.2001.14.9.1114; Hash CT, 2003, WORLD AGR S, P27, DOI 10.1002/9780470384923.ch4; HILL GM, 1990, J ANIM SCI, V68, P2061; Hoseney RC, 1987, ASA MONOGR, V28, P397; Kesarwani M, 2007, PLANT PHYSIOL, V144, P336, DOI 10.1104/pp.106.095299; Khairwal IS, 2008, PEARL MILLET COORDIN, P1; Kim HS, 2002, PLANT J, V32, P151, DOI 10.1046/j.1365-313X.2001.01411.x; Kinkema M, 2000, PLANT CELL, V12, P2339, DOI 10.1105/tpc.12.12.2339; Kumar V, 2013, TRANSGENIC RES, V22, P359, DOI 10.1007/s11248-012-9652-9; Latha AM, 2006, PLANT CELL REP, V25, P927, DOI 10.1007/s00299-006-0141-6; Latha AM, 2005, PLANT SCI, V169, P657, DOI 10.1016/j.plantsci.2005.05.009; Lin WC, 2004, TRANSGENIC RES, V13, P567, DOI 10.1007/s11248-004-2375-9; Makandar R, 2006, MOL PLANT MICROBE IN, V19, P123, DOI 10.1094/MPMI-19-0123; Malnoy M, 2007, MOL PLANT MICROBE IN, V20, P1568, DOI 10.1094/MPMI-20-12-1568; Meur G, 2006, PHYSIOL MOL PLANT P, V68, P128, DOI 10.1016/j.pmpp.2006.09.003; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; O'Kennedy MM, 2004, PLANT CELL REP, V22, P684, DOI 10.1007/s00299-003-0746-y; Pang SZ, 1996, PLANT PHYSIOL, V112, P893, DOI 10.1104/pp.112.3.893; Parkhi V, 2010, TRANSGENIC RES, V19, P959, DOI 10.1007/s11248-010-9374-9; Potlakayala SD, 2007, PHYSIOL MOL PLANT P, V71, P174, DOI 10.1016/j.pmpp.2008.01.003; Priya D Bhanu, 2011, BMC Res Notes, V4, P231, DOI 10.1186/1756-0500-4-231; Quilis J, 2008, MOL PLANT MICROBE IN, V21, P1215, DOI 10.1094/MPMI-21-9-1215; Ramadevi R, 2014, IN VITRO CELL DEV-PL, V50, P392, DOI 10.1007/s11627-013-9592-y; RATHORE KS, 1993, PLANT MOL BIOL, V21, P871, DOI 10.1007/BF00027118; Sadumpati V, 2013, J BIOTECHNOL, V166, P114, DOI 10.1016/j.jbiotec.2013.04.016; Sastry J. G., 2001, Indian Phytopathology, V54, P323; Sato M, 2007, PLANT J, V49, P565, DOI 10.1111/j.1365-313X.2006.02972.x; SINGH SD, 1985, PLANT DIS, V69, P582; SINGH SD, 1995, PLANT DIS, V79, P545, DOI 10.1094/PD-79-0545; Singh SD, 1997, INFORM B, V48, P36; Song JT, 2008, PHYTOCHEMISTRY, V69, P1128, DOI 10.1016/j.phytochem.2007.12.010; Song JT, 2006, MOL CELLS, V22, P233; Song JT, 2009, MOL CELLS, V28, P105, DOI 10.1007/s10059-009-0108-x; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Thakur R. P., 2008, Journal of SAT Agricultural Research, V6, P1; Thakur R. P., 2008, DIS MANAGEMENT ARID, P21; THAKUR RP, 1993, PLANT PATHOL, V42, P715, DOI 10.1111/j.1365-3059.1993.tb01557.x; Upadhyaya H. D., 2007, Journal of SAT Agricultural Research, V3, P1; Uquillas C, 2004, MOL PLANT MICROBE IN, V17, P34, DOI 10.1094/MPMI.2004.17.1.34; Vijayan S, 2012, TRANSGENIC RES, V21, P193, DOI 10.1007/s11248-011-9521-y; Wally O, 2009, PLANTA, V231, P131, DOI 10.1007/s00425-009-1031-2; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Yuan YX, 2007, PLANT BIOTECHNOL J, V5, P313, DOI 10.1111/j.1467-7652.2007.00243.x; Zhang XD, 2010, EUR J PLANT PATHOL, V128, P91, DOI 10.1007/s10658-010-9633-x; Zhang XD, 2010, J PLANT PHYSIOL, V167, P144, DOI 10.1016/j.jplph.2009.08.002; Zhang YL, 1999, P NATL ACAD SCI USA, V96, P6523, DOI 10.1073/pnas.96.11.6523; Zidani S, 2005, AFR J BIOTECHNOL, V4, P862	62	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90839	10.1371/journal.pone.0090839	http://dx.doi.org/10.1371/journal.pone.0090839			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603762	gold, Green Submitted, Green Published			2022-12-25	WOS:000332483600091
J	Geng, YT; Ju, YF; Ren, FL; Qiu, Y; Tomita, Y; Tomoeda, M; Kishida, M; Wang, YY; Jin, L; Su, FQ; Wei, CH; Jia, BQ; Li, Y; Chang, ZJ				Geng, Yongtao; Ju, Yanfang; Ren, Fangli; Qiu, Ying; Tomita, Yasuhiko; Tomoeda, Miki; Kishida, Mioka; Wang, Yinyin; Jin, Lian; Su, Fuqin; Wei, Chunhong; Jia, Baoqing; Li, Yi; Chang, Zhijie			Insulin Receptor Substrate 1/2 ( IRS1/2) Regulates Wnt/beta-Catenin Signaling through Blocking Autophagic Degradation of Dishevelled2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; -Catenin; Cell Proliferation; EMT; Wnt Signaling; Dishevelled2; IRS	EPITHELIAL-MESENCHYMAL TRANSITION; LYSINE 63-LINKED UBIQUITINATION; CANCER CELLS; BETA-CATENIN; WNT; PATHWAY; PROTEIN; GROWTH; PHOSPHORYLATION; PROLIFERATION	Background: IRS1/2 is a critical component of insulin signaling, but it remains unclear whether IRS1/2 functions on Wnt signaling. Results: IRS1/2 interacts with and stabilizes Dvl2 by suppressing its autophagic degradation, leading to promotion of Wnt-mediated EMT and cell proliferation. Conclusion: IRS1/2 positively regulates Wnt/-catenin signaling through Dvl2. Significance: The IRS1/2-Dvl2 node might be implicated in tumorigenesis and metastasis. Wnt signaling plays a pivotal role in cell proliferation, tissue homeostasis, and tumorigenesis. Dishevelled (Dvl) is a central node of Wnt signaling. Insulin receptor substrates (IRSs), as a critical component of insulin signaling, are involved in cell proliferation, metabolism, and cancer development. In this study, we report that IRS1/2 promotes Wnt/-catenin signaling by stabilizing Dvl2. We found that IRS1/2 interacts with Dvl2. Overexpression of IRS1/2 increased the protein level of Dvl2 and promoted canonical Wnt signaling, as evidenced by the increased T cell-specific factor 4 transcriptional activity and the up-regulation of expression of CYCLIN D1 and c-MYC, two Wnt target genes critical for cell growth, whereas depletion of IRS1/2 reduced the level of Dvl2 and attenuated Wnt/-catenin signaling. Biochemical analyses revealed that IRS1/2 decreased Lys-63-linked ubiquitination of Dvl2 and stabilized Dvl2 protein via suppressing its autophagy-mediated degradation. We further revealed that IRS1/2 blocks autophagy-induced formation of the Dvl2-p62/SQSTM1 complex, resulting in disabled association of Dvl2 to autophagosomes. We demonstrated that IRS1/2 promoted the induction of epithelial-mesenchymal transition (EMT) and cell proliferation in response to Wnt stimulation, whereas depletion of Dvl2 impaired the IRS1/2-mediated EMT and cell growth. Our findings revealed that IRS1/2 promotes EMT and cell proliferation through stabilizing Dvl2.	[Geng, Yongtao; Jin, Lian; Wei, Chunhong; Li, Yi] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Geng, Yongtao; Ren, Fangli; Qiu, Ying; Wang, Yinyin; Su, Fuqin; Chang, Zhijie] Tsinghua Univ, Sch Med, State Key Lab Biomembrane & Membrane Biotechnol, Natl Engn Lab Antitumor Therapeut, Beijing 100084, Peoples R China; [Ju, Yanfang; Jia, Baoqing] Chinese Peoples Liberat Army Gen Hosp, Dept Oncol, Beijing 100853, Peoples R China; [Tomita, Yasuhiko; Tomoeda, Miki; Kishida, Mioka] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Pathol, Osaka 5378511, Japan	Peking University; Tsinghua University; Chinese People's Liberation Army General Hospital; Osaka Medical Center for Cancer & Cardiovascular Diseases	Li, Y (corresponding author), Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China.	liyi@pku.edu.cn; zhijiec@tsinghua.edu.cn	Qiu, Ying/Y-3276-2019; Chang, Zhijie/AAH-8109-2019	Chang, Zhijie/0000-0003-1567-3227	973 Project [2011CB910502, 2011ZX08011-006]; National Natural Science Foundation of China [81372167, 81301700, 30871286, 31071225, 31030040]; Tsinghua Science Foundation [20121080018]; 863 Project, China [2012AA021730, 2012AA021703]	973 Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua Science Foundation; 863 Project, China(National High Technology Research and Development Program of China)	This work was supported by 973 Project Grants 2011CB910502 and 2011ZX08011-006, National Natural Science Foundation of China Grants 81372167, 81301700, 30871286, 31071225, and 31030040, Tsinghua Science Foundation Grant 20121080018, and 863 Project Grants 2012AA021730 and 2012AA021703 in China.	Adhikari A, 2009, DEV CELL, V16, P485, DOI 10.1016/j.devcel.2009.04.001; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Bao XL, 2012, MOL VIS, V18, P1983; Bommer GT, 2010, J BIOL CHEM, V285, P1928, DOI 10.1074/jbc.M109.060319; Carew RM, 2011, FEBS J, V278, P3370, DOI 10.1111/j.1742-4658.2011.08261.x; Chan B, 2008, J MAMMARY GLAND BIOL, V13, P415, DOI 10.1007/s10911-008-9101-9; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dalmizrak O, 2007, CANCER RES, V67, P2124, DOI 10.1158/0008-5472.CAN-06-3954; Dearth RK, 2007, CELL CYCLE, V6, P705, DOI 10.4161/cc.6.6.4035; Dearth RK, 2006, MOL CELL BIOL, V26, P9302, DOI 10.1128/MCB.00260-06; Ding Y, 2013, J BIOL CHEM, V288, P8289, DOI 10.1074/jbc.M112.433185; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Nagle JA, 2004, MOL CELL BIOL, V24, P9726, DOI 10.1128/MCB.24.22.9726-9735.2004; Palsgaard J, 2012, J BIOL CHEM, V287, P12016, DOI 10.1074/jbc.M111.337048; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Rong Y, 2006, CANCER RES, V66, P8049, DOI 10.1158/0008-5472.CAN-06-1172; Sharma J, 2012, J BIOL CHEM, V287, P6830, DOI 10.1074/jbc.M111.315135; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; Shi CS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000751; Sorokin AV, 2013, ONCOGENE, V32, P3130, DOI 10.1038/onc.2012.327; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wei W, 2012, MOL CELL BIOL, V32, P3903, DOI 10.1128/MCB.00251-12; Wu YY, 2010, J BIOL CHEM, V285, P34621, DOI 10.1074/jbc.M110.148791; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zhang YQ, 2011, CELL PHYSIOL BIOCHEM, V27, P503, DOI 10.1159/000329952; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	37	42	42	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11230	11241		10.1074/jbc.M113.544999	http://dx.doi.org/10.1074/jbc.M113.544999			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24616100	hybrid, Green Published			2022-12-25	WOS:000334638500026
J	Berzkalns, A; Bates, J; Ye, W; Mukasa, L; France, AM; Patil, N; Yang, ZH				Berzkalns, Anna; Bates, Joseph; Ye, Wen; Mukasa, Leonard; France, Anne Marie; Patil, Naveen; Yang, Zhenhua			The Road to Tuberculosis (Mycobacterium tuberculosis) Elimination in Arkansas; a Re-Examination of Risk Groups	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGIC ANALYSIS; UNITED-STATES; RURAL-COMMUNITY; SURVEILLANCE; POPULATION; TRENDS	Objectives: This study was conducted to generate knowledge useful for developing public health interventions for more effective tuberculosis control in Arkansas. Methods: The study population included 429 culture-confirmed reported cases (January 1, 2004-December 31, 2010). Mycobacterium tuberculosis genotyping data were used to identify cases likely due to recent transmission (clustered) versus reactivation (non-clustered). Poisson regression models estimated average decline rate in incidence over time and assessed the significance of differences between subpopulations. A multinomial logistic model examined differences between clustered and non-clustered incidence. Results: A significant average annual percent decline was found for the overall incidence of culture-confirmed (9%; 95% CI: 5.5%, 16.9%), clustered (6%; 95% CI: 0.5%, 11.6%), and non-clustered tuberculosis cases (12%; 95% CI: 7.6%, 15.9%). However, declines varied among demographic groups. Significant declines in clustered incidence were only observed in males, non-Hispanic blacks, 65 years and older, and the rural population. Conclusions: These findings suggest that the Arkansas tuberculosis control program must target both traditional and non-traditional risk groups for successful tuberculosis elimination. The present study also demonstrates that a thorough analysis of TB trends in different population subgroups of a given geographic region or state can lead to the identification of non-traditional risk factors for TB transmission. Similar studies in other low incidence populations would provide beneficial data for how to control and eventually eliminate TB in the U.S.	[Berzkalns, Anna; Yang, Zhenhua] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Bates, Joseph; Mukasa, Leonard; Patil, Naveen] Arkansas Dept Hlth, Little Rock, AR 72205 USA; [Bates, Joseph; Mukasa, Leonard] Univ Arkansas Med Sci, Fay W Boozman Coll Publ Hlth, Dept Epidemiol, Little Rock, AR 72205 USA; [Ye, Wen] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [France, Anne Marie] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Patil, Naveen] Univ Arkansas Med Sci, Coll Med, Little Rock, AR 72205 USA	University of Michigan System; University of Michigan; University of Arkansas System; University of Arkansas Medical Sciences; University of Michigan System; University of Michigan; Centers for Disease Control & Prevention - USA; University of Arkansas System; University of Arkansas Medical Sciences	Yang, ZH (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.	zhenhua@umich.edu						Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P1398, DOI 10.1128/JCM.02089-07; Borgdorff MW, 2005, EMERG INFECT DIS, V11, P597, DOI 10.3201/eid1104.041103; Braden CR, 1997, J INFECT DIS, V175, P1446, DOI 10.1086/516478; Buchanan I., 2004, CALCULATING POISSON; Burzynski J, 2008, SEMIN RESP CRIT CARE, V29, P492, DOI 10.1055/s-0028-1085701; Cain KP, 2007, AM J RESP CRIT CARE, V175, P75, DOI 10.1164/rccm.200608-1178OC; Centers for Disease Control and Prevention, 2004, REP TUB US 2003; Centers for Disease Control and Prevention, 2010, REP TUB US 2010; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P181; Centers for Disease Control and Prevention (CDC), 2008, REP TUB US 2008; Centers for Disease Control and Prevention (CDC), 2009, REP TUB US 2009; Christianson S, 2010, TUBERCULOSIS, V90, P31, DOI 10.1016/j.tube.2009.12.003; Dillaha JA, 2002, EMERG INFECT DIS, V8, P1246; Eberhardt MS, 2004, AM J PUBLIC HEALTH, V94, P1682, DOI 10.2105/AJPH.94.10.1682; Ellis BA, 2002, EMERG INFECT DIS, V8, P1197; France AM, 2007, AM J EPIDEMIOL, V166, P662, DOI 10.1093/aje/kwm135; Ghosh S, 2012, INFECT GENET EVOL, V12, P782, DOI 10.1016/j.meegid.2011.10.013; Jasmer RM, 1999, ANN INTERN MED, V130, P971, DOI 10.7326/0003-4819-130-12-199906150-00004; Kempf MC, 2005, J CLIN MICROBIOL, V43, P870, DOI 10.1128/JCM.43.2.870-878.2005; National Center for Health Statistics, 2020, DIFF CHAR AD DAY SER; National TB Controllers Association/Center for Disease Control and Prevention Advisory Group on Tubercolosis Genotyping, 2004, GUID APPL GEN TUB PR; Nguyen LN, 2004, RESPIROLOGY, V9, P313, DOI 10.1111/j.1440-1843.2004.00603.x; O'Donnell MR, 2010, INT J TUBERC LUNG D, V14, P733; Oren E, 2011, AM J PUBLIC HEALTH, V101, P1256, DOI 10.2105/AJPH.2010.300030; Orszag P., 2009, OMB B, V10, P1; Pratt RH, 2011, J AM GERIATR SOC, V59, P851, DOI 10.1111/j.1532-5415.2011.03369.x; SAS Institute Inc, 2008, SAS VERS 9 2; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Talarico S, 2011, TUBERCULOSIS, V91, P244, DOI 10.1016/j.tube.2011.01.007; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; U.S. Census Bureau, 2010, 2010 CENS INT POP SE; *US CENS BUR, 2004, AM COMM SURV	32	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90664	10.1371/journal.pone.0090664	http://dx.doi.org/10.1371/journal.pone.0090664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618839	Green Submitted, Green Published, gold			2022-12-25	WOS:000332842400024
J	Gil-Ibanez, P; Bernal, J; Morte, B				Gil-Ibanez, Pilar; Bernal, Juan; Morte, Beatriz			Thyroid Hormone Regulation of Gene Expression in Primary Cerebrocortical Cells: Role of Thyroid Hormone Receptor Subtypes and Interactions with Retinoic Acid and Glucocorticoids	PLOS ONE			English	Article							MOUSE CEREBRAL-CORTEX; TRANSCRIPTIONAL REGULATION; GANGLIONIC EMINENCE; RESPONSE ELEMENT; BRAIN; RAT; DEXAMETHASONE; DEFICIENCY; MIGRATION; STRIATUM	The effects of thyroid hormone on brain development and function are largely mediated by the binding of 3,5,3'-triiodo-L-thyronine (T3) to its nuclear receptors (TR) to regulate positively or negatively gene expression. We have analyzed by quantitative polymerase chain reaction the effect of T3 on primary cultured cells from the embryonic mouse cerebral cortex, on the expression of Hr, Klf9, Shh, Dio3, Aldh1a1, and Aldh1a3. In particular we focused on T3 receptor specificity, and on the crosstalk between T3, retinoic acid and dexamethasone. To check for receptor subtype specificity we used cerebrocortical cells derived from wild type mice and from mice deficient in thyroid hormone receptor subtypes. Receptor subtype specificity was found for Dio3 and Aldh1a1, which were induced by T3 only in cells expressing the T3 receptor alpha 1 subtype. Interactions of T3 with retinoic acid signaling through the control of retinoic acid metabolism are likely to be important during development. T3 had opposing influences on retinoic acid synthesizing enzymes, increasing the expression of Aldh1a1, and decreasing Aldh1a3, while increasing the retinoic acid degrading enzyme Cyp26b1. Dexamethasone increased Klf9 and Aldh1a1 expression. The effects of T3 and dexamethasone on Aldh1a1 were highly synergistic, with mRNA increments of up to 20 fold. The results provide new data on thyroid hormone regulation of gene expression and underscore the importance of thyroid hormone interactions with retinoic acid and glucocorticoids during neural development.	[Gil-Ibanez, Pilar; Bernal, Juan; Morte, Beatriz] CSIC, Inst Invest Biomed, Madrid, Spain; [Gil-Ibanez, Pilar; Bernal, Juan; Morte, Beatriz] Univ Autonoma Madrid UAM, Madrid, Spain; [Gil-Ibanez, Pilar; Bernal, Juan; Morte, Beatriz] Inst Salud Carlos III, Ctr Biomed Res Rare Dis Ciberer, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III	Bernal, J (corresponding author), CSIC, Inst Invest Biomed, Madrid, Spain.	jbernal@iib.uam.es; bmorte@iib.uam.es	Gil-Ibanez, Pilar/AAW-2415-2021; Bernal, Juan/J-6086-2014	Bernal, Juan/0000-0002-5867-4951; Morte, Beatriz/0000-0003-0702-7815	Plan Nacional de I+D [SAF2011-25608]; Ramon Areces Foundation; Center for Biomedical Research on Rare Diseases (CIBERER), Instituto Carlos III, Spain; unta de Ampliacion de Estudios (JAE) from the Consejo Superior de Investigaciones Cientificas (CSIC)	Plan Nacional de I+D; Ramon Areces Foundation; Center for Biomedical Research on Rare Diseases (CIBERER), Instituto Carlos III, Spain; unta de Ampliacion de Estudios (JAE) from the Consejo Superior de Investigaciones Cientificas (CSIC)	Supported with grants from Plan Nacional de I+D SAF2011-25608, the Ramon Areces Foundation, and the Center for Biomedical Research on Rare Diseases (CIBERER), Instituto Carlos III, Spain. PG-I is recipient of a Junta de Ampliacion de Estudios (JAE) predoctoral contract from the Consejo Superior de Investigaciones Cientificas (CSIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DW, 2011, BRAIN RES, V1408, P81, DOI 10.1016/j.brainres.2011.06.051; Attia RR, 2010, J BIOL CHEM, V285, P2375, DOI 10.1074/jbc.M109.039081; Barca-Mayo O, 2011, MOL ENDOCRINOL, V25, P575, DOI 10.1210/me.2010-0213; BARINAGA M, 1983, NATURE, V306, P84, DOI 10.1038/306084a0; BEDO G, 1989, NATURE, V339, P231, DOI 10.1038/339231a0; Bernal J, 2007, NAT CLIN PRACT ENDOC, V3, P249, DOI 10.1038/ncpendmet0424; Bonett RM, 2009, ENDOCRINOLOGY, V150, P1757, DOI 10.1210/en.2008-1441; Castillo AI, 2004, MOL CELL BIOL, V24, P502, DOI 10.1128/MCB.24.2.502-513.2004; Chatonnet F, 2013, P NATL ACAD SCI USA, V110, pE766, DOI 10.1073/pnas.1210626110; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Crandall JE, 2011, J NEUROCHEM, V119, P723, DOI 10.1111/j.1471-4159.2011.07471.x; Cuevas E, 2005, EUR J NEUROSCI, V22, P541, DOI 10.1111/j.1460-9568.2005.04243.x; Dentice M, 2007, P NATL ACAD SCI USA, V104, P14466, DOI 10.1073/pnas.0706754104; Denver RJ, 2009, ENDOCRINOLOGY, V150, P3935, DOI 10.1210/en.2009-0050; Desouza LA, 2011, ENDOCRINOLOGY, V152, P1989, DOI 10.1210/en.2010-1396; DIAMOND DJ, 1985, J MOL BIOL, V181, P41, DOI 10.1016/0022-2836(85)90323-7; Diez D, 2008, ENDOCRINOLOGY, V149, P3989, DOI 10.1210/en.2008-0350; EVANS RM, 1982, P NATL ACAD SCI-BIOL, V79, P7659, DOI 10.1073/pnas.79.24.7659; Flamant F, 2013, BBA-GEN SUBJECTS, V1830, P3900, DOI 10.1016/j.bbagen.2012.06.003; Furlow JD, 2002, ENDOCRINOLOGY, V143, P3295, DOI 10.1210/en.2002-220126; Galton VA, 2007, ENDOCRINOLOGY, V148, P3080, DOI 10.1210/en.2006-1727; Gil-Ibanez P, 2012, 94 ANN M END SOC HOU; Gil-Ibanez P, 2013, ENDOCRINOLOGY, V154, P1940, DOI 10.1210/en.2012-2189; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Hernandez A, 2012, ENDOCRINOLOGY, V153, P2919, DOI 10.1210/en.2011-1905; Jacobs FMJ, 2007, DEVELOPMENT, V134, P2673, DOI 10.1242/dev.02865; Kumar S, 2012, BBA-MOL CELL BIOL L, V1821, P198, DOI 10.1016/j.bbalip.2011.04.004; Liao XH, 2011, ENDOCRINOLOGY, V152, P1180, DOI 10.1210/en.2010-0900; Lin JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052407; Liu YY, 2002, MOL ENDOCRINOL, V16, P2439, DOI 10.1210/me.2001-0324; Lu Z, 2001, BBA-MOL CELL BIOL L, V1532, P213, DOI 10.1016/S1388-1981(01)00135-4; Mayerl S, 2012, ENDOCRINOLOGY, V153, P1528, DOI 10.1210/en.2011-1633; Morte B, 2010, ENDOCRINOLOGY, V151, P2381, DOI 10.1210/en.2009-0944; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Pandak WM, 1997, J LIPID RES, V38, P2483; Ruiz F, 2000, EUR J PHARMACOL, V404, P29, DOI 10.1016/S0014-2999(00)00584-7; Samarut E, 2012, MOL CELL ENDOCRINOL, V348, P348, DOI 10.1016/j.mce.2011.03.025; Smith D, 2001, CEREB CORTEX, V11, P894, DOI 10.1093/cercor/11.10.894; Steineger HH, 1997, BIOCHIMIE, V79, P107, DOI 10.1016/S0300-9084(97)81499-X; Thompson CC, 1996, J NEUROSCI, V16, P7832; YAFFE BM, 1984, J BIOL CHEM, V259, P6284	41	49	49	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91692	10.1371/journal.pone.0091692	http://dx.doi.org/10.1371/journal.pone.0091692			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618783	gold, Green Submitted, Green Published			2022-12-25	WOS:000332842400120
J	Mogk, S; Meiwes, A; Shtopel, S; Schraermeyer, U; Lazarus, M; Kubata, B; Wolburg, H; Duszenko, M				Mogk, Stefan; Meiwes, Andreas; Shtopel, Swetlana; Schraermeyer, Ulrich; Lazarus, Michael; Kubata, Bruno; Wolburg, Hartwig; Duszenko, Michael			Cyclical Appearance of African Trypanosomes in the Cerebrospinal Fluid: New Insights in How Trypanosomes Enter the CNS	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; BRUCEI-BRUCEI; NERVOUS-SYSTEM; LONG SLENDER; BRAIN; MODEL; MICE; DIFFERENTIATION; INFECTION; PATHOGENESIS	It is textbook knowledge that human infective forms of Trypanosoma brucei, the causative agent of sleeping sickness, enter the brain across the blood-brain barrier after an initial phase of weeks (rhodesiense) or months (gambiense) in blood. Based on our results using an animal model, both statements seem questionable. As we and others have shown, the first infection relevant crossing of the blood brain border occurs via the choroid plexus, i.e. via the blood-CSF barrier. In addition, counting trypanosomes in blood-free CSF obtained by an atlanto-occipital access revealed a cyclical infection in CSF that was directly correlated to the trypanosome density in blood infection. We also obtained conclusive evidence of organ infiltration, since parasites were detected in tissues outside the blood vessels in heart, spleen, liver, eye, testis, epididymis, and especially between the cell layers of the pia mater including the Virchow-Robin space. Interestingly, in all organs except pia mater, heart and testis, trypanosomes showed either a more or less degraded appearance of cell integrity by loss of the surface coat (VSG), loss of the microtubular cytoskeleton and loss of the intracellular content, or where taken up by phagocytes and degraded intracellularly within lysosomes. This is also true for trypanosomes placed intrathecally into the brain parenchyma using a stereotactic device. We propose a different model of brain infection that is in accordance with our observations and with well-established facts about the development of sleeping sickness.	[Mogk, Stefan; Meiwes, Andreas; Shtopel, Swetlana; Duszenko, Michael] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany; [Schraermeyer, Ulrich] Univ Tubingen, Inst Ophthalmol, Tubingen, Germany; [Lazarus, Michael] Univ Tsukuba, Int Inst Integrat Sleep Med, Tsukuba, Ibaraki, Japan; [Kubata, Bruno] AU NEPAD Agcy Reg Off, Nairobi, Kenya; [Wolburg, Hartwig] Univ Tubingen, Inst Pathol & Neuropathol, Tubingen, Germany; [Duszenko, Michael] Tongji Univ, Fac Med & Life Sci, Shanghai 200092, Peoples R China	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; University of Tsukuba; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Tongji University	Duszenko, M (corresponding author), Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany.	michael.duszenko@uni-tuebingen.de	Lazarus, Michael/G-3130-2010	Lazarus, Michael/0000-0003-3863-4474	German research foundation [DU 136/15-1]; IZKF, University of Tubingen	German research foundation(German Research Foundation (DFG)); IZKF, University of Tubingen	This work was supported by the German research foundation, grant DU 136/15-1; A.M. received a personal fellowship from IZKF, University of Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottan S, 2012, IEEE T BIO-MED ENG, V59, P1532, DOI 10.1109/TBME.2012.2187448; Bruce SirD., 1914, Transactions of the Royal Society of Tropical Medicine and Hygiene London, V8, DOI 10.1016/S0035-9203(14)90016-5; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Chappuis F, 2005, CLIN MICROBIOL REV, V18, P133, DOI 10.1128/CMR.18.1.133-146.2005; Claes F, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000486; Darsaud A, 2004, SLEEP, V27, P42, DOI 10.1093/sleep/27.1.42; Delgado M, 2009, CELL DEATH DIFFER, V16, P406, DOI 10.1038/cdd.2008.161; Denninger V, 2008, METHOD ENZYMOL, V451, P373, DOI 10.1016/S0076-6879(08)03225-4; Duszenko M, 2006, TRENDS PARASITOL, V22, P536, DOI 10.1016/j.pt.2006.08.010; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Figarella K, 2006, CELL DEATH DIFFER, V13, P1802, DOI 10.1038/sj.cdd.4401862; Figarella K, 2005, CELL DEATH DIFFER, V12, P335, DOI 10.1038/sj.cdd.4401564; Frankmann S, 1987, NEW APPROACH REPEATE; Frevert U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043913; Gonzalez-Rey E, 2006, ANN NY ACAD SCI, V1070, P303, DOI 10.1196/annals.1317.032; Grab DJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000479; Grab DJ, 2008, J NEUROVIROL, V14, P344, DOI 10.1080/13550280802282934; Grandgenett PM, 2007, PLOS PATHOG, V3, P1432, DOI 10.1371/journal.ppat.0030150; GRASSIZUCCONI G, 1995, BRAIN RES BULL, V37, P123, DOI 10.1016/0361-9230(94)00265-3; GREENWOOD BM, 1980, T ROY SOC TROP MED H, V74, P716, DOI 10.1016/0035-9203(80)90184-4; Gruszynski AE, 2003, J BIOL CHEM, V278, P24665, DOI 10.1074/jbc.M301497200; HAMM B, 1990, MOL BIOCHEM PARASIT, V40, P13, DOI 10.1016/0166-6851(90)90075-W; HESSE F, 1995, MOL BIOCHEM PARASIT, V70, P157, DOI 10.1016/0166-6851(95)00027-X; Huang YL, 1995, J NEUROSCI METH, V63, P13, DOI 10.1016/0165-0270(95)00080-1; Jennings F W, 1983, Contrib Microbiol Immunol, V7, P147; JENNINGS FW, 1979, INT J PARASITOL, V9, P381, DOI 10.1016/0020-7519(79)90089-4; Koopmann R, 2012, NAT METHODS, V9, P259, DOI [10.1038/NMETH.1859, 10.1038/nmeth.1859]; Kreier J, 1977, PARASITIC PROTOZOA, V1, P205; Kubata BK, 2000, J EXP MED, V192, P1327, DOI 10.1084/jem.192.9.1327; Kubata BK, 2007, TRENDS PARASITOL, V23, P325, DOI 10.1016/j.pt.2007.05.005; LAI YL, 1983, J APPL PHYSIOL, V54, P1754, DOI 10.1152/jappl.1983.54.6.1754; LAMBERT PH, 1981, J CLIN INVEST, V67, P77, DOI 10.1172/JCI110035; Leggat PA, 2001, TRAVEL MED INFECT DI, V1, P137; Lentner C, 1981, GEIGY SCI TABLES, P1; Masocha W, 2012, VIRULENCE, V3, P202, DOI 10.4161/viru.19178; Mogk S, 2012, NEUROLOGY PSYCHAIT B, V18, P49; Mulenga C, 2001, NEUROPATH APPL NEURO, V27, P77, DOI 10.1046/j.0305-1846.2001.00306.x; Myburgh E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002384; ORMEROD WE, 1986, T ROY SOC TROP MED H, V80, P626, DOI 10.1016/0035-9203(86)90161-6; Osterauer R, 2010, EVOL DEV, V12, P474, DOI 10.1111/j.1525-142X.2010.00433.x; Paxinos Ge WC, 1998, RAT BRAIN STEREOTAXI; PENTREATH VW, 1995, T ROY SOC TROP MED H, V89, P9, DOI 10.1016/0035-9203(95)90637-1; PENTREATH VW, 1992, ANN TROP MED PARASIT, V86, P29, DOI 10.1080/00034983.1992.11812627; POLTERA AA, 1980, CLIN EXP IMMUNOL, V40, P496; Radwanska M, 2002, AM J TROP MED HYG, V67, P684, DOI 10.4269/ajtmh.2002.67.684; RASEROKA B H, 1986, Parasitology Today, V2, P147, DOI 10.1016/0169-4758(86)90182-1; Redecke L, 2013, SCIENCE, V339, P227, DOI 10.1126/science.1229663; Reuner B, 1997, MOL BIOCHEM PARASIT, V90, P269, DOI 10.1016/S0166-6851(97)00160-6; Schlitzer Martin, 2009, Pharm Unserer Zeit, V38, P552, DOI 10.1002/pauz.200900344; SCHMIDT H, 1983, VIRCHOWS ARCH A, V399, P333, DOI 10.1007/BF00612951; SCHULTZBERG M, 1988, J NEUROSCI RES, V21, P56, DOI 10.1002/jnr.490210109; Seed JR, 1997, J PARASITOL, V83, P656, DOI 10.2307/3284243; STEVENS DR, 1977, ACTA NEUROPATHOL, V38, P173, DOI 10.1007/BF00688062; VANMARCK EAE, 1981, ANN SOC BELG MED TR, V61, P57; VICKERMAN K, 1965, NATURE, V208, P762, DOI 10.1038/208762a0; Wewer C, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-51; Wheeler RJ, 2010, TRENDS PARASITOL, V26, P457, DOI 10.1016/j.pt.2010.05.005; WHO, 2013, AFR TRYP SLEEP SICKN; Wilkinson SR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001252; Wolburg H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034304	60	37	37	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91372	10.1371/journal.pone.0091372	http://dx.doi.org/10.1371/journal.pone.0091372			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618708	Green Published, gold, Green Submitted			2022-12-25	WOS:000332842400081
J	Shi, XZ; Wang, L; Xu, S; Zhang, XW; Zhao, XF; Vasta, GR; Wang, JX				Shi, Xiu-Zhen; Wang, Lei; Xu, Sen; Zhang, Xiao-Wen; Zhao, Xiao-Fan; Vasta, Gerardo Raul; Wang, Jin-Xing			A Galectin from the Kuruma Shrimp (Marsupenaeus japonicus) Functions as an Opsonin and Promotes Bacterial Clearance from Hemolymph	PLOS ONE			English	Article							OYSTER CRASSOSTREA-VIRGINICA; C-TYPE LECTINS; RECOGNITION RECEPTORS; FENNEROPENAEUS-CHINENSIS; ADAPTIVE IMMUNITY; CHINESE SHRIMP; INNATE; PHOSPHATIDYLSERINE; HEMOCYTES; DIVERSITY	Galectins are a lectin family characterized by a conserved sequence motif in the carbohydrate recognition domain, which preferential binds to galactosyl moieties. However, few studies about the biological roles of galectins in invertebrates have been reported except for the galectin (CvGal1) from the eastern oyster Crassostrea virginica. Furthermore, galectins have been described in only a few crustacean species, and no functional studies have been reported so far. In this study, we identified and functionally characterized a galectin from the kuruma shrimp Marsupenaeus japonicus, which we designated MjGal. Upon Vibrio anguillarum challenge, expression of MjGal was up-regulated mostly in hemocytes and hepatopancreas, and the protein bound to both Gram-positive and Gram-negative bacteria through the recognition of lipoteichoic acid (LTA) or lipopolysaccharide (LPS), respectively. By also binding to the shrimp hemocyte surface, MjGal functions as an opsonin for microbial pathogens, promoting their phagocytosis. Further, as shown by RNA interference, MjGal participates in clearance of bacteria from circulation, and thereby contributes to the shrimp's immune defense against infectious challenge. Elucidation of functional and mechanistic aspects of shrimp immunity will enable the development of novel strategies for intervention in infectious diseases currently affecting the shrimp farming industry worldwide.	[Shi, Xiu-Zhen; Wang, Lei; Xu, Sen; Zhang, Xiao-Wen; Zhao, Xiao-Fan; Wang, Jin-Xing] Shandong Univ, MOE Key Lab Plant Cell Engn & Germplasm Innovat, Shandong Prov Key Lab Anim Cells & Dev Biol, Sch Life Sci, Jinan 250100, Shandong, Peoples R China; [Vasta, Gerardo Raul] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Vasta, Gerardo Raul] Inst Marine & Environm Technol, Baltimore, MD USA	Shandong University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology	Wang, JX (corresponding author), Shandong Univ, MOE Key Lab Plant Cell Engn & Germplasm Innovat, Shandong Prov Key Lab Anim Cells & Dev Biol, Sch Life Sci, Jinan 250100, Shandong, Peoples R China.	jxwang@sdu.edu.cn	Wang, Jin-Xing/AAU-1514-2021; Zhao, Xiao-Fan/AGW-9886-2022	Zhao, Xiao-Fan/0000-0003-1809-4730; Wang, Jin-Xing/0000-0003-0283-3930	National Natural Science Foundation of China [31130056]; Special Fund for the Major State Basic Research Project [2012CB114405]; Ph.D. Programs Foundation of the Ministry of Education of China [20110131130003]; Provincial Natural Science Foundation of Shandong, China [ZR2011CM014]; National Science Foundation [IOS 1050518, IOB-0618409, IOS-0822257]; National Institutes of Health [5R01GM070589-06]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070589] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for the Major State Basic Research Project; Ph.D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China); Provincial Natural Science Foundation of Shandong, China; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was financially supported by grants from the National Natural Science Foundation of China (No. 31130056), the Special Fund for the Major State Basic Research Project (No. 2012CB114405), the Ph.D. Programs Foundation of the Ministry of Education of China (No. 20110131130003), Provincial Natural Science Foundation of Shandong, China (No. ZR2011CM014) to JXW, and grants IOS 1050518, IOB-0618409, IOS-0822257 from the National Science Foundation, and 5R01GM070589-06 from the National Institutes of Health to GRV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrionuevo P, 2007, J IMMUNOL, V178, P436, DOI 10.4049/jimmunol.178.1.436; Chen HY, 2006, J IMMUNOL, V177, P4991, DOI 10.4049/jimmunol.177.8.4991; Feng CG, 2013, J BIOL CHEM, V288, P24394, DOI 10.1074/jbc.M113.476531; Gauthier L, 2002, P NATL ACAD SCI USA, V99, P13014, DOI 10.1073/pnas.202323999; Han F, 2010, FISH SHELLFISH IMMUN, V29, P875, DOI 10.1016/j.fsi.2010.07.030; Hernandez JD, 2002, GLYCOBIOLOGY, V12, p127R, DOI 10.1093/glycob/cwf081; Hsu DK, 2006, METHOD ENZYMOL, V417, P256, DOI 10.1016/S0076-6879(06)17018-4; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; JOHANSSON MW, 1988, J CELL BIOL, V106, P1795, DOI 10.1083/jcb.106.5.1795; Kim JY, 2008, DEV COMP IMMUNOL, V32, P1131, DOI 10.1016/j.dci.2008.03.002; Kurz S, 2013, J BIOL CHEM, V288, P24410, DOI 10.1074/jbc.M113.478933; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; McTaggart SJ, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-63; Rabinovich GA, 2002, BBA-GEN SUBJECTS, V1572, P274, DOI 10.1016/S0304-4165(02)00314-8; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Sato S, 2009, IMMUNOL REV, V230, P172, DOI 10.1111/j.1600-065X.2009.00790.x; Shi XZ, 2009, COMP BIOCHEM PHYS B, V153, P54, DOI 10.1016/j.cbpb.2009.01.011; Stowell SR, 2008, J BIOL CHEM, V283, P20547, DOI 10.1074/jbc.M802495200; Stowell SR, 2007, BLOOD, V109, P219, DOI 10.1182/blood-2006-03-007153; Stowell SR, 2009, MOL BIOL CELL, V20, P1408, DOI 10.1091/mbc.E08-07-0786; Sun C, 2011, FISH SHELLFISH IMMUN, V30, P295, DOI 10.1016/j.fsi.2010.10.022; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tasumi S, 2007, J IMMUNOL, V179, P3086, DOI 10.4049/jimmunol.179.5.3086; Vasta GR, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00199; Vasta GR, 2012, ADV EXP MED BIOL, V946, P21, DOI 10.1007/978-1-4614-0106-3_2; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; Vasta GR, 2004, CURR OPIN STRUC BIOL, V14, P617, DOI 10.1016/j.sbi.2004.09.008; Vasta GR, 1999, DEV COMP IMMUNOL, V23, P401, DOI 10.1016/S0145-305X(99)00020-8; Wang XW, 2013, FISH SHELLFISH IMMUN, V34, P981, DOI 10.1016/j.fsi.2012.08.008; Wang XW, 2013, DEV COMP IMMUNOL, V39, P27, DOI 10.1016/j.dci.2012.04.009; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Zhang XW, 2009, MOL IMMUNOL, V46, P1626, DOI 10.1016/j.molimm.2009.02.029	35	45	48	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91794	10.1371/journal.pone.0091794	http://dx.doi.org/10.1371/journal.pone.0091794			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618590	Green Submitted, gold, Green Published			2022-12-25	WOS:000332842400133
J	Zhong, Z; Ramshesh, VK; Rehman, H; Liu, QL; Theruvath, TP; Krishnasamy, Y; Lemasters, JJ				Zhong, Zhi; Ramshesh, Venkat K.; Rehman, Hasibur; Liu, Qinlong; Theruvath, Tom P.; Krishnasamy, Yasodha; Lemasters, John J.			Acute Ethanol Causes Hepatic Mitochondrial Depolarization in Mice: Role of Ethanol Metabolism	PLOS ONE			English	Article							ALCOHOLIC FATTY LIVER; PERMEABILITY TRANSITION INHIBITOR; RAT-LIVER; OXIDATIVE STRESS; REACTIVE OXYGEN; SWIFT INCREASE; N-METHYL-4-ISOLEUCINE CYCLOSPORINE; STIMULATES GLYCOGENOLYSIS; MOLECULAR-MECHANISMS; ADAPTIVE INCREASE	Background/Aims: An increase of ethanol metabolism and hepatic mitochondrial respiration occurs in vivo after a single binge of alcohol. Here, our aim was to determine how ethanol intake affects hepatic mitochondrial polarization status in vivo in relation to ethanol metabolism and steatosis. Methods: Hepatic mitochondrial polarization, permeability transition (MPT), and reduce pyridine nucleotides, and steatosis in mice were monitored by intravital confocal/multiphoton microscopy of the fluorescence of rhodamine 123 (Rh123), calcein, NAD(P) H, and BODIPY493/503, respectively, after gavage with ethanol (1-6 g/kg). Results: Mitochondria depolarized in an all-or-nothing fashion in individual hepatocytes as early as 1 h after alcohol. Depolarization was dose-and time-dependent, peaked after 6 to 12 h and maximally affected 94% of hepatocytes. This mitochondrial depolarization was not due to onset of the MPT. After 24 h, mitochondria of most hepatocytes recovered normal polarization and were indistinguishable from untreated after 7 days. Cell death monitored by propidium iodide staining, histology and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) was low throughout. After alcohol, mitochondrial NAD(P) H autofluorescence increased and decreased, respectively, in hepatocytes with polarized and depolarized mitochondria. Ethanol also caused steatosis mainly in hepatocytes with depolarized mitochondria. Depolarization was linked to ethanol metabolism, since deficiency of alcohol dehydrogenase and cytochrome-P450 2E1 (CYP2E1), the major ethanol-metabolizing enzymes, decreased mitochondrial depolarization by similar to 70% and similar to 20%, respectively. Activation of aldehyde dehydrogenase decreased depolarization, whereas inhibition of aldehyde dehydrogenase enhanced depolarization. Activation of aldehyde dehydrogenase also markedly decreased steatosis. Conclusions: Acute ethanol causes reversible hepatic mitochondrial depolarization in vivo that may contribute to steatosis and increased mitochondrial respiration. Onset of this mitochondrial depolarization is linked, at least in part, to metabolism of ethanol to acetaldehyde.	[Zhong, Zhi; Ramshesh, Venkat K.; Rehman, Hasibur; Liu, Qinlong; Theruvath, Tom P.; Krishnasamy, Yasodha; Lemasters, John J.] Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA; [Lemasters, John J.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Zhong, Zhi; Ramshesh, Venkat K.; Lemasters, John J.] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Zhong, Z (corresponding author), Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA.	zhong@musc.edu	Rehman, Hasibur/K-5224-2019	Rehman, Hasibur/0000-0003-1551-6520	National Institutes of Health (NIH) [R01 AA0177561, R01 DK37034]; Charleston Alcohol Research Center [P50 AA010761]; NIH [1P30 CA138313, C06 RR015455]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037034, R01DK073336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA010761] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charleston Alcohol Research Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in part, by Grants R01 AA0177561 and R01 DK37034 from the National Institutes of Health (NIH) and a grant from Charleston Alcohol Research Center [P50 AA010761]. The Cell & Molecular Imaging Core of the Hollings Cancer Center at the Medical University of South Carolina supported by NIH Grant 1P30 CA138313 provided instrumentation and assistance for confocal/multiphoton microscopy. The animals were housed in the Animal Resources at Medical University of South Carolina supported by NIH Grant C06 RR015455. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2002, FREE RADICAL BIO MED, V32, P487, DOI 10.1016/S0891-5849(02)00740-2; ADACHI Y, 1995, GASTROENTEROLOGY, V108, P218, DOI 10.1016/0016-5085(95)90027-6; Andringa KK, 2010, AM J PHYSIOL-GASTR L, V298, pG732, DOI 10.1152/ajpgi.00332.2009; Arteel GE, 1996, AM J PHYSIOL-GASTR L, V271, pG494, DOI 10.1152/ajpgi.1996.271.3.G494; Bailey SM, 1999, FREE RADICAL BIO MED, V27, P891, DOI 10.1016/S0891-5849(99)00138-0; Bergheim I, 2006, J PHARMACOL EXP THER, V316, P592, DOI 10.1124/jpet.105.095042; Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; Bradford BU, 2005, ALCOHOL, V35, P13, DOI 10.1016/j.alcohol.2004.12.001; Cederbaum AI, 2009, ARCH TOXICOL, V83, P519, DOI 10.1007/s00204-009-0432-0; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Choi S, 2005, CURR OPIN GASTROEN, V21, P702, DOI 10.1097/01.mog.0000182863.96421.47; Crabb DW, 2004, ALCOHOL, V34, P35, DOI 10.1016/j.alcohol.2004.07.005; De Rosa MF, 2008, J BIOL CHEM, V283, P4501, DOI 10.1074/jbc.M705473200; El-Assal O, 2004, CELL MOL IMMUNOL, V1, P205; Enomoto N, 2000, AM J PHYSIOL-GASTR L, V279, pG100, DOI 10.1152/ajpgi.2000.279.1.G100; Femandez-Checa JC, 2005, TOXICOL APPL PHARM, V204, P263, DOI 10.1016/j.taap.2004.10.001; Figueira TR, 2013, ANTIOXID REDOX SIGN, V18, P2029, DOI 10.1089/ars.2012.4729; FRENCH SW, 1984, HEPATOLOGY, V4, P912, DOI 10.1002/hep.1840040521; French SW, 2004, HEPATOL RES, V29, P69, DOI 10.1016/j.hepres.2004.02.006; FROMENTY B, 1995, PHARMACOL THERAPEUT, V67, P101, DOI 10.1016/0163-7258(95)00012-6; GORES GJ, 1988, AM J PHYSIOL, V255, pC315, DOI 10.1152/ajpcell.1988.255.3.C315; Holmuhamedov E, 2009, ARCH BIOCHEM BIOPHYS, V481, P226, DOI 10.1016/j.abb.2008.10.036; Holmuhamedov EL, 2012, J BIOL CHEM, V287, P7692, DOI 10.1074/jbc.M111.293399; Ikejima K, 2007, J GASTROEN HEPATOL, V22, pS87, DOI 10.1111/j.1440-1746.2007.04961.x; ISHAK KG, 1991, ALCOHOL CLIN EXP RES, V15, P45, DOI 10.1111/j.1530-0277.1991.tb00518.x; JI SC, 1982, P NATL ACAD SCI-BIOL, V79, P5415, DOI 10.1073/pnas.79.17.5415; Kao E, 2012, HEPATOLOGY, V56, P594, DOI 10.1002/hep.25702; Kim JS, 2003, BIOCHEM BIOPH RES CO, V304, P463, DOI 10.1016/S0006-291X(03)00618-1; King AL, 2014, AM J PHYSIOL-GASTR L, V306, pG265, DOI 10.1152/ajpgi.00278.2013; KUBOTA M, 1992, P SOC EXP BIOL MED, V201, P114, DOI 10.3181/00379727-201-43488; LEMASTERS JJ, 1981, SCIENCE, V213, P661, DOI 10.1126/science.7256265; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Lemasters JJ, 2013, DRUG-INDUCED LIVER DISEASE, 3RD EDITION, P85, DOI 10.1016/B978-0-12-387817-5.00005-4; Leung TM, 2012, HEPATOLOGY, V55, P1596, DOI 10.1002/hep.25543; Levine JA, 2000, EUR J CLIN INVEST, V30, P779; Lieber CS, 2004, ALCOHOL, V34, P9, DOI 10.1016/j.alcohol.2004.07.008; Liu QL, 2012, FREE RADICAL BIO MED, V53, P250, DOI 10.1016/j.freeradbiomed.2012.05.012; Mandayam S, 2004, SEMIN LIVER DIS, V24, P217, DOI 10.1055/s-2004-832936; Matsuhashi T, 1998, FREE RADICAL BIO MED, V24, P139, DOI 10.1016/S0891-5849(97)00210-4; Mayevsky A, 2007, AM J PHYSIOL-CELL PH, V292, pC615, DOI 10.1152/ajpcell.00249.2006; Micuda S, 2005, BASIC CLIN PHARMACOL, V96, P257, DOI 10.1111/j.1742-7843.2005.pto960322.x; Mokuda O, 2004, ANN NUTR METAB, V48, P276, DOI 10.1159/000080463; Nath B, 2011, HEPATOLOGY, V53, P1526, DOI 10.1002/hep.24256; NIEMINEN AL, 1995, BIOCHEM J, V307, P99, DOI 10.1042/bj3070099; Nieminen AL, 1997, AM J PHYSIOL-CELL PH, V272, pC1286; Pessayre D, 2012, DRUG METAB REV, V44, P34, DOI 10.3109/03602532.2011.604086; Pritchard MT, 2007, GASTROENTEROLOGY, V132, P1117, DOI 10.1053/j.gastro.2007.01.053; Rehman H, 2008, J PHARMACOL EXP THER, V327, P699, DOI 10.1124/jpet.108.143578; Rehman H, 2008, TRANSPLANTATION, V85, P1322, DOI 10.1097/TP.0b013e31816de302; Rehman H, 2011, TRANSPLANTATION, V91, P406, DOI 10.1097/TP.0b013e318204bdb2; Rivera CA, 1998, AM J PHYSIOL-GASTR L, V275, pG1252, DOI 10.1152/ajpgi.1998.275.6.G1252; Rogers CQ, 2008, IUBMB LIFE, V60, P790, DOI 10.1002/iub.124; Ross DD, 2004, BEST PRACT RES CL HA, V17, P641, DOI 10.1016/j.beha.2004.08.014; Saito C, 2010, TOXICOL APPL PHARM, V242, P182, DOI 10.1016/j.taap.2009.10.006; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Setshedi M, 2010, OXID MED CELL LONGEV, V3, P178, DOI 10.4161/oxim.3.3.12288; SHELMET JJ, 1988, J CLIN INVEST, V81, P1137, DOI 10.1172/JCI113428; Shi YJ, 2012, J HEPATOL, V56, P137, DOI 10.1016/j.jhep.2011.05.025; Shuttleworth CW, 2010, NEUROCHEM INT, V56, P379, DOI 10.1016/j.neuint.2009.12.015; SIES H, 1974, H-S Z PHYSIOL CHEM, V355, P305, DOI 10.1515/bchm2.1974.355.1.305; SUTER PM, 1994, AM J PHYSIOL, V266, pR1204, DOI 10.1152/ajpregu.1994.266.4.R1204; Theruvath TP, 2008, HEPATOLOGY, V47, P236, DOI 10.1002/hep.21912; Thiele GM, 2001, ALCOHOL CLIN EXP RES, V25, p218S, DOI 10.1111/j.1530-0277.2001.tb02399.x; THURMAN RG, 1979, DRUG ALCOHOL DEPEN, V4, P119, DOI 10.1016/0376-8716(79)90052-8; THURMAN RG, 1982, J PHARMACOL EXP THER, V223, P45; THURMAN RG, 1976, MOL PHARMACOL, V12, P156; Thurman RG, 1996, ANN CLIN LAB SCI, V26, P351; Tsukamoto H, 2009, SEMIN LIVER DIS, V29, P178, DOI 10.1055/s-0029-1214373; VIDELA L, 1970, BIOCHEM J, V118, P275, DOI 10.1042/bj1180275; Williams CD, 2014, TOXICOL APPL PHARM, V274, P417, DOI 10.1016/j.taap.2013.12.003; Yin HQ, 2012, J BIOL CHEM, V287, P9817, DOI 10.1074/jbc.M111.333534; You M, 2004, GASTROENTEROLOGY, V127, P1798, DOI 10.1053/j.gastro.2004.09.049; YUKI T, 1980, BIOCHEM J, V186, P119, DOI 10.1042/bj1860119; Zhong Z, 2007, AM J TRANSPLANT, V7, P1103, DOI 10.1111/j.1600-6143.2007.01770.x; Zhong Z, 2008, AM J PHYSIOL-GASTR L, V295, pG823, DOI 10.1152/ajpgi.90287.2008; Zhong Z, 2006, TRANSPLANTATION, V82, P241, DOI 10.1097/01.tp.0000228867.98158.d2; Zhou ZX, 2003, AM J PATHOL, V163, P1137, DOI 10.1016/S0002-9440(10)63473-6	77	56	56	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91308	10.1371/journal.pone.0091308	http://dx.doi.org/10.1371/journal.pone.0091308			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618581	Green Submitted, gold, Green Published			2022-12-25	WOS:000332842400072
J	Liang, PP; Li, ZH; Deshpande, G; Wang, ZQ; Hu, XP; Li, KC				Liang, Peipeng; Li, Zhihao; Deshpande, Gopikrishna; Wang, Zhiqun; Hu, Xiaoping; Li, Kuncheng			Altered Causal Connectivity of Resting State Brain Networks in Amnesic MCI	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ANTERIOR PREFRONTAL CORTEX; ALZHEIMERS-DISEASE; FUNCTIONAL CONNECTIVITY; DEFAULT-MODE; GLOBAL SIGNAL; HIPPOCAMPAL CONNECTIVITY; HEAD MOTION; FMRI; MRI	Most neuroimaging studies of resting state networks in amnesic mild cognitive impairment (aMCI) have concentrated on functional connectivity (FC) based on instantaneous correlation in a single network. The purpose of the current study was to investigate effective connectivity in aMCI patients based on Granger causality of four important networks at resting state derived from functional magnetic resonance imaging data - default mode network (DMN), hippocampal cortical memory network (HCMN), dorsal attention network (DAN) and fronto-parietal control network (FPCN). Structural and functional MRI data were collected from 16 aMCI patients and 16 age, gender-matched healthy controls. Correlation-purged Granger causality analysis was used, taking gray matter atrophy as covariates, to compare the group difference between aMCI patients and healthy controls. We found that the causal connectivity between networks in aMCI patients was significantly altered with both increases and decreases in the aMCI group as compared to healthy controls. Some alterations were significantly correlated with the disease severity as measured by mini-mental state examination (MMSE), and California verbal learning test (CVLT) scores. When the whole-brain signal averaged over the entire brain was used as a nuisance covariate, the within-group maps were significantly altered while the between-group difference maps did not. These results suggest that the alterations in causal influences may be one of the possible underlying substrates of cognitive impairments in aMCI. The present study extends and complements previous FC studies and demonstrates the coexistence of causal disconnection and compensation in aMCI patients, and thus might provide insights into biological mechanism of the disease.	[Liang, Peipeng; Wang, Zhiqun; Li, Kuncheng] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China; [Liang, Peipeng; Wang, Zhiqun; Li, Kuncheng] Beijing Key Lab Magnet Resonance Imaging & Brain, Beijing, Peoples R China; [Liang, Peipeng; Wang, Zhiqun; Li, Kuncheng] Minist Educ, Key Lab Neurodegenerat Dis, Beijing, Peoples R China; [Li, Zhihao; Hu, Xiaoping] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Li, Zhihao; Hu, Xiaoping] Emory Univ, Atlanta, GA 30322 USA; [Deshpande, Gopikrishna] Auburn Univ, MRI Res Ctr, Dept Elect & Comp Engn, Auburn, AL 36849 USA; [Deshpande, Gopikrishna] Auburn Univ, Dept Psychol, Auburn, AL 36849 USA	Capital Medical University; University System of Georgia; Georgia Institute of Technology; Emory University; Auburn University System; Auburn University; Auburn University System; Auburn University	Hu, XP (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	xhu@bme.gatech.edu; lkc1955@gmail.com	Li, Zhihao/R-4741-2019	Li, Zhihao/0000-0002-6009-7903; Deshpande, Gopikrishna/0000-0001-7471-5357; Hu, Xiaoping/0000-0001-7014-5983	Natural Science Foundation of China [61105118, 81000606, 81271556]; Beijing Nova Program [Z12111000250000]; State Key Laboratory of Cognitive Neuroscience and Learning [CNKOPZD1001]; CAS Key Laboratory of Brain Function and Disease	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program(Beijing Municipal Science & Technology Commission); State Key Laboratory of Cognitive Neuroscience and Learning; CAS Key Laboratory of Brain Function and Disease	This work was supported by the Natural Science Foundation of China (Grant Nos. 61105118, 81000606, 81271556), Beijing Nova Program (Z12111000250000), Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning (No. CNKOPZD1001), Open Research Fund of CAS Key Laboratory of Brain Function and Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2012, NEUROBIOL AGING, V33, P1564, DOI 10.1016/j.neurobiolaging.2011.06.007; Allen G, 2007, ARCH NEUROL-CHICAGO, V64, P1482, DOI 10.1001/archneur.64.10.1482; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bai F, 2008, NEUROSCI LETT, V438, P111, DOI 10.1016/j.neulet.2008.04.021; Bai F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024271; Bai F, 2009, BRAIN RES, V1302, P167, DOI 10.1016/j.brainres.2009.09.028; Belleville S, 2008, NEUROPSYCHOLOGIA, V46, P2225, DOI 10.1016/j.neuropsychologia.2008.02.012; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bokde ALW, 2001, ARCH NEUROL-CHICAGO, V58, P480, DOI 10.1001/archneur.58.3.480; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Celone KA, 2006, J NEUROSCI, V26, P10222, DOI 10.1523/JNEUROSCI.2250-06.2006; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Clement F, 2010, BIOL PSYCHIAT, V68, P894, DOI 10.1016/j.biopsych.2010.02.004; Clement F, 2010, CORTEX, V46, P1005, DOI 10.1016/j.cortex.2009.07.003; DELACOSTE MC, 1993, NEUROBIOL AGING, V14, P1, DOI 10.1016/0197-4580(93)90015-4; Delamillieure P, 2010, BRAIN RES BULL, V81, P565, DOI 10.1016/j.brainresbull.2009.11.014; Delbeuck X, 2003, NEUROPSYCHOL REV, V13, P79, DOI 10.1023/A:1023832305702; Derflinger S, 2011, J ALZHEIMERS DIS, V25, P347, DOI 10.3233/JAD-2011-110041; Deshpande G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014277; Deshpande G, 2011, NEUROIMAGE, V54, P1043, DOI 10.1016/j.neuroimage.2010.09.024; Deshpande G, 2010, NEUROIMAGE, V52, P884, DOI 10.1016/j.neuroimage.2009.11.060; Deshpande G, 2010, IEEE T BIO-MED ENG, V57, P1446, DOI 10.1109/TBME.2009.2037808; Deshpande G, 2010, NEUROIMAGE, V49, P1991, DOI 10.1016/j.neuroimage.2009.08.052; Deshpande G, 2009, HUM BRAIN MAPP, V30, P1361, DOI 10.1002/hbm.20606; Ferreira LK, 2011, NEUROBIOL AGING, V32, P1733, DOI 10.1016/j.neurobiolaging.2009.11.008; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Gomez-Isla T, 1997, CONNECTIONS COGNITIO, P149; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hamalainen A, 2007, NEUROBIOL AGING, V28, P1889, DOI 10.1016/j.neurobiolaging.2006.08.008; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Huijbers W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017463; Kircher TT, 2007, J NEUROL NEUROSUR PS, V78, P812, DOI 10.1136/jnnp.2006.104877; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Li R, 2013, AM J NEURORADIOL, V34, P340, DOI 10.3174/ajnr.A3197; Liang PP, 2012, J ALZHEIMERS DIS, V30, P475, DOI 10.3233/JAD-2012-111721; Liang PP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022153; Liao XH, 2013, NEUROIMAGE, V83, P969, DOI 10.1016/j.neuroimage.2013.07.058; Liu ZY, 2012, NMR BIOMED, V25, P1311, DOI 10.1002/nbm.2803; Marshall GA, 2011, ALZHEIMERS DEMENT, V7, P300, DOI 10.1016/j.jalz.2010.04.005; Miao XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025546; Morrison J, 1986, BIOL SUBSTRATES ALZH, P115; Mosconi L, 2005, NEUROLOGY, V64, P1860, DOI 10.1212/01.WNL.0000163856.13524.08; Mosconi L, 2008, NEUROBIOL AGING, V29, P676, DOI 10.1016/j.neurobiolaging.2006.12.008; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nickl-Jockschat T, 2012, BRAIN STRUCT FUNCT, V217, P115, DOI 10.1007/s00429-011-0333-x; Oakes TR, 2007, NEUROIMAGE, V34, P500, DOI 10.1016/j.neuroimage.2006.10.007; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petrella JR, 2007, RADIOLOGY, V245, P224, DOI 10.1148/radiol.2451061847; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Putcha D, 2011, J NEUROSCI, V31, P17680, DOI 10.1523/JNEUROSCI.4740-11.2011; Qi ZG, 2010, NEUROIMAGE, V50, P48, DOI 10.1016/j.neuroimage.2009.12.025; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Rosano C, 2005, BIOL PSYCHIAT, V57, P761, DOI 10.1016/j.biopsych.2004.12.031; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Thomann PA, 2008, BRAIN COGNITION, V67, P88, DOI 10.1016/j.bandc.2007.11.008; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Wang JH, 2013, BIOL PSYCHIAT, V73, P472, DOI 10.1016/j.biopsych.2012.03.026; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wang L, 2010, NEUROIMAGE, V51, P910, DOI 10.1016/j.neuroimage.2010.02.046; Wang ZQ, 2011, J NEUROL SCI, V309, P79, DOI 10.1016/j.jns.2011.07.017; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Wen XT, 2013, J NEUROSCI, V33, P6444, DOI 10.1523/JNEUROSCI.4939-12.2013; Wu X, 2011, HUM BRAIN MAPP, V32, P1868, DOI 10.1002/hbm.21153; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yang J, 2012, J NEUROL SCI, V316, P21, DOI 10.1016/j.jns.2012.02.010; Yang YH, 2009, SCI CHINA SER C, V52, P789, DOI 10.1007/s11427-009-0089-1; Zhang HY, 2009, BEHAV BRAIN RES, V197, P103, DOI 10.1016/j.bbr.2008.08.012; Zhang ZS, 2010, BEHAV BRAIN RES, V208, P619, DOI 10.1016/j.bbr.2010.01.008	88	36	37	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e88476	10.1371/journal.pone.0088476	http://dx.doi.org/10.1371/journal.pone.0088476			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24613934	Green Published, gold, Green Submitted			2022-12-25	WOS:000332839300005
J	Middleton, CP; Senerchia, N; Stein, N; Akhunov, ED; Keller, B; Wicker, T; Kilian, B				Middleton, Christopher P.; Senerchia, Natacha; Stein, Nils; Akhunov, Eduard D.; Keller, Beat; Wicker, Thomas; Kilian, Benjamin			Sequencing of Chloroplast Genomes from Wheat, Barley, Rye and Their Relatives Provides a Detailed Insight into the Evolution of the Triticeae Tribe	PLOS ONE			English	Article							ACETYL-COA CARBOXYLASE; NUCLEAR-DNA AMOUNTS; DIVERGENCE TIMES; 3-PHOSPHOGLYCERATE KINASE; PHYLOGENETIC ANALYSIS; MOLECULAR EVOLUTION; ANCIENT HAPLOTYPES; SORGHUM-BICOLOR; POLYPLOID WHEAT; ABSOLUTE RATES	Using Roche/454 technology, we sequenced the chloroplast genomes of 12 Triticeae species, including bread wheat, barley and rye, as well as the diploid progenitors and relatives of bread wheat Triticum urartu, Aegilops speltoides and Ae. tauschii. Two wild tetraploid taxa, Ae. cylindrica and Ae. geniculata, were also included. Additionally, we incorporated wild Einkorn wheat Triticum boeoticum and its domesticated form T. monococcum and two Hordeum spontaneum (wild barley) genotypes. Chloroplast genomes were used for overall sequence comparison, phylogenetic analysis and dating of divergence times. We estimate that barley diverged from rye and wheat approximately 8-9 million years ago (MYA). The genome donors of hexaploid wheat diverged between 2.1-2.9 MYA, while rye diverged from Triticum aestivum approximately 3-4 MYA, more recently than previously estimated. Interestingly, the A genome taxa T. boeoticum and T. urartu were estimated to have diverged approximately 570,000 years ago. As these two have a reproductive barrier, the divergence time estimate also provides an upper limit for the time required for the formation of a species boundary between the two. Furthermore, we conclusively show that the chloroplast genome of hexaploid wheat was contributed by the B genome donor and that this unknown species diverged from Ae. speltoides about 980,000 years ago. Additionally, sequence alignments identified a translocation of a chloroplast segment to the nuclear genome which is specific to the rye/wheat lineage. We propose the presented phylogeny and divergence time estimates as a reference framework for future studies on Triticeae.	[Middleton, Christopher P.; Keller, Beat; Wicker, Thomas] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Senerchia, Natacha] Univ Neuchatel, Inst Biol, Lab Evolutionary Bot, CH-2000 Neuchatel, Switzerland; [Stein, Nils; Kilian, Benjamin] Leibniz Inst Plant Genet & Crop Plant Res, Gatersleben, Germany; [Akhunov, Eduard D.] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA	University of Zurich; University of Neuchatel; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Kansas State University	Wicker, T (corresponding author), Univ Zurich, Inst Plant Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland.	wicker@botinst.uzh.ch	Stein, Nils/F-7507-2017; Wicker, Thomas/Z-1978-2019; Keller, Beat/K-3093-2019	Stein, Nils/0000-0003-3011-8731; Keller, Beat/0000-0003-2379-9225; , Thomas/0000-0002-6777-7135; Kilian, Benjamin/0000-0002-9145-6980	COST action [FA0604]; Swiss office for Education and research [37150503]	COST action(European Cooperation in Science and Technology (COST)); Swiss office for Education and research	This research was supported by COST action FA0604 and the Swiss office for Education and research grant number 37150503. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov ED, 2003, GENOME RES, V13, P753, DOI 10.1101/gr.808603; Arbogast BS, 2002, ANNU REV ECOL SYST, V33, P707, DOI 10.1146/annurev.ecolsys.33.010802.150500; Bennett MD, 2011, ANN BOT-LONDON, V107, P467, DOI 10.1093/aob/mcq258; BENNETT MD, 1976, PHILOS T R SOC B, V274, P227, DOI 10.1098/rstb.1976.0044; Bordbar F, 2011, PLANT SYST EVOL, V291, P117, DOI 10.1007/s00606-010-0375-1; Bortiri Esteban, 2008, BMC Res Notes, V1, P61, DOI 10.1186/1756-0500-1-61; Bossolini E, 2007, PLANT J, V49, P704, DOI 10.1111/j.1365-313X.2006.02991.x; Caldwell KS, 2004, GENETICS, V167, P941, DOI 10.1534/genetics.103.016303; Chalupska D, 2008, P NATL ACAD SCI USA, V105, P9691, DOI 10.1073/pnas.0803981105; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dvorak J, 2005, GENETICS, V171, P323, DOI 10.1534/genetics.105.041632; Edwards SV, 2000, EVOLUTION, V54, P1839; Eilam T, 2007, GENOME, V50, P1029, DOI 10.1139/G07-083; Escobar JS, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-181; Feldman M., 1995, EVOLUTION CROP PLANT; Gandhi HT, 2005, THEOR APPL GENET, V111, P561, DOI 10.1007/s00122-005-2047-z; Golovnina KA, 2007, PLANT SYST EVOL, V264, P195, DOI 10.1007/s00606-006-0478-x; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hirosawa S, 2004, GENES GENET SYST, V79, P271, DOI 10.1266/ggs.79.271; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Huang SX, 2002, PLANT MOL BIOL, V48, P805, DOI 10.1023/A:1014868320552; Isidore E, 2005, GENOME RES, V15, P526, DOI 10.1101/gr.3131005; Jansen RK, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-32; JOHNSON BL, 1976, AM J BOT, V63, P1088, DOI 10.2307/2441653; Kihara H, 1944, AGR HORTIC, V19, P889; Kilian B, 2007, MOL BIOL EVOL, V24, P2657, DOI 10.1093/molbev/msm192; Kilian B, 2007, MOL BIOL EVOL, V24, P217, DOI 10.1093/molbev/msl151; Kilian B, 2009, PL GENET GENOM CROP, V7; Lloyd AH, 2011, MOL BIOL EVOL, V28, P2019, DOI 10.1093/molbev/msr021; Matsuo M, 2005, PLANT CELL, V17, P665, DOI 10.1105/tpc.104.027706; Nikiforova SV, 2013, MOL BIOL EVOL, V30, P1751, DOI 10.1093/molbev/mst092; Nock CJ, 2010, PLANT BIOTECHNOL J; Ogihara Y, 2002, MOL GENET GENOMICS, V266, P740, DOI 10.1007/s00438-001-0606-9; Ozkan H, 2010, AOB PLANTS, DOI 10.1093/aobpla/plq015; Paterson AH, 2009, PLANT PHYSIOL, V149, P125, DOI 10.1104/pp.108.129262; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Petersen G, 2006, MOL PHYLOGENET EVOL, V39, P70, DOI 10.1016/j.ympev.2006.01.023; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Provan J, 2004, THEOR APPL GENET, V108, P1182, DOI 10.1007/s00122-003-1538-z; REES H, 1965, HEREDITY, V20, P73, DOI 10.1038/hdy.1965.9; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Saski C, 2007, THEOR APPL GENET, V115, P571, DOI [10.1007/s00122-007-0567-4, 10.1007/s00122-007-0595-0]; Schatz MC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-177; Scherrer B, 2005, PLANT CELL, V17, P361, DOI 10.1105/tpc.104.028225; Senerchia N, 2013, GENOME BIOL EVOL, V5, P1010, DOI 10.1093/gbe/evt064; Sheppard AE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000323; Soltis DE, 2004, TRENDS PLANT SCI, V9, P477, DOI 10.1016/j.tplants.2004.08.008; Steiper ME, 2008, EVOL ANTHROPOL, V17, P179, DOI 10.1002/evan.20177; Tamura K, 2011, MOL BIOL EVOL; Tsunewaki K, 1996, GENES GENET SYST, V71, P293, DOI 10.1266/ggs.71.293; TSUNEWAKI K, 1983, GENETICS, V104, P155; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wicker T, 2009, PLANT PHYSIOL, V149, P258, DOI 10.1104/pp.108.129734	56	111	117	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e85761	10.1371/journal.pone.0085761	http://dx.doi.org/10.1371/journal.pone.0085761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614886	Green Accepted, Green Published, gold			2022-12-25	WOS:000332839300003
J	Sandri, S; Borbely, AU; Fernandes, I; de Oliveira, EM; Knebel, FH; Ruano, R; Zugaib, M; Filippin-Monteiro, F; Bevilacqua, E; Campa, A				Sandri, Silvana; Borbely, Alexandre Urban; Fernandes, Isabella; de Oliveira, Edson Mendes; Knebel, Franciele Hinterholz; Ruano, Rodrigo; Zugaib, Marcelo; Filippin-Monteiro, Fabiola; Bevilacqua, Estela; Campa, Ana			Serum Amyloid A in the Placenta and Its Role in Trophoblast Invasion	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CELL-MIGRATION; ADHESION MOLECULES; FETAL MEMBRANES; EXPRESSION; INTERLEUKIN-8; ANGIOGENESIS; ADIPONECTIN; ADIPOCYTE; RELEASE	The serum amyloid A (SAA) protein is known to function in the acute phase response and immunoregulation. Recently, SAA has been shown to be involved in cell proliferation, differentiation and migratory behavior in different cell types. Here, we evaluated whether exogenous SAA could influence trophoblast invasion and differentiation using both the trophoblast-like BeWo cell line and fully differentiated human extravillous trophoblast cells (EVT) isolated from term placentae. SAA stimulated BeWo cell invasion, as measured in Matrigel invasion assays, and induced metalloprotease mRNA expression and activity. Given that BeWo cells express Toll-like receptor 4 (TLR4), a known receptor for SAA, we examined the role of TLR4 in SAA-induced invasion using a TLR4 neutralizing antibody. We also tested whether SAA could affect markers of trophoblast syncytialization in BeWo cells. We observed that SAA decreased beta hCG secretion and did not influence trophoblast syncytialization. Using EVT cells isolated from human term basal plates, we confirmed that SAA at 1 and 10 mu g/mL doubled EVT invasion in a TLR4-dependent manner, but at 20 mu g/mL inhibited EVT cells invasiveness. In addition, we observed that SAA was expressed in both BeWo cells and human term placentae, specifically in the syncytiotrophoblast, decidual cells and EVT. In conclusion, SAA was identified as a molecule that functions in the placental microenvironment to regulate metalloprotease activity and trophoblast invasion, which are key processes in placentation and placental homeostasis.	[Sandri, Silvana; de Oliveira, Edson Mendes; Knebel, Franciele Hinterholz; Campa, Ana] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin Toxicolog, Sao Paulo, Brazil; [Borbely, Alexandre Urban; Bevilacqua, Estela] Univ Sao Paulo, Inst Ciencias Biomed, Dept Biol Celular & Desenvolvimento, BR-05508 Sao Paulo, Brazil; [Fernandes, Isabella] Univ Sao Paulo, Dept Cirurgia, Fac Vet & Zootecnia, Sao Paulo, Brazil; [Ruano, Rodrigo; Zugaib, Marcelo] Univ Sao Paulo, Fac Med, Dept Obstet & Ginecol, Sao Paulo, Brazil; [Filippin-Monteiro, Fabiola] Univ Fed Santa Catarina, Dept Anal Clin, Florianopolis, SC, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Santa Catarina (UFSC)	Sandri, S (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin Toxicolog, Sao Paulo, Brazil.	ssandri@usp.br	Sandri, Silvana/A-1650-2015; Borbely, Alexandre/GRR-8137-2022; Borbely, Alexandre Urban/Q-2884-2019; Bevilacqua, Estela/H-3354-2011; Filippin-Monteiro, Fabiola Branco/D-6509-2018; Borbely, Alexandre/GPW-8010-2022; Zugaib, Marcelo/A-5724-2013; Campa, Ana/D-4669-2012; de Oliveira, Edson M/C-9885-2014	Borbely, Alexandre/0000-0001-6737-0901; Bevilacqua, Estela/0000-0003-4178-4625; Filippin-Monteiro, Fabiola Branco/0000-0003-4313-1783; Borbely, Alexandre/0000-0001-6737-0901; Zugaib, Marcelo/0000-0003-1155-2671; Campa, Ana/0000-0002-6183-3378; de Oliveira, Edson M/0000-0002-7330-7826; Knebel, Franciele/0000-0001-8275-9499	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2009/05354-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by grant from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2009/05354-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasry SM, 2012, J MOL HISTOL, V43, P253, DOI 10.1007/s10735-012-9410-6; Aplin JD, 2009, PLACENTA, V30, P293, DOI 10.1016/j.placenta.2008.12.001; BADOLATO R, 1995, J IMMUNOL, V155, P4004; Bauer S, 2004, J CLIN ENDOCR METAB, V89, P812, DOI 10.1210/jc.2003-031351; Benaitreau D, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-128; Benaitreau D, 2010, J ENDOCRINOL, V207, P45, DOI 10.1677/JOE-10-0170; Borbely AU, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-7; Connolly M, 2011, ANN RHEUM DIS, V70, P1296, DOI 10.1136/ard.2010.142240; Connolly M, 2010, J IMMUNOL, V184, P6427, DOI 10.4049/jimmunol.0902941; de Oliveira EM, 2013, INFLAMMATION, V36, P1107, DOI 10.1007/s10753-013-9644-9; Eklund KK, 2012, CRIT REV IMMUNOL, V32, P335; Filippin-Monteiro FB, 2012, INT J OBESITY, V36, P1032, DOI 10.1038/ijo.2011.193; Furlaneto CJ, 2000, BIOCHEM BIOPH RES CO, V268, P405, DOI 10.1006/bbrc.2000.2143; Gude NM, 2004, THROMB RES, V114, P397, DOI 10.1016/j.thromres.2004.06.038; Gutfeld O, 2006, J HISTOCHEM CYTOCHEM, V54, P63, DOI 10.1369/jhc.5A6645.2005; Harris LK, 2009, PLACENTA, V30, P299, DOI 10.1016/j.placenta.2008.12.003; Hatanaka E, 2011, CLIN EXP IMMUNOL, V163, P362, DOI 10.1111/j.1365-2249.2010.04300.x; Huppertz B, 1998, CELL TISSUE RES, V291, P133; Jovanovic M, 2009, PLACENTA, V30, P320, DOI 10.1016/j.placenta.2009.01.013; Jovanovic M, 2010, REPRODUCTION, V139, P789, DOI 10.1530/REP-09-0341; Knebel FH, 2013, MEDIAT INFLAMM, V2013; Kovacevic A, 2006, FEBS LETT, V580, P161, DOI 10.1016/j.febslet.2005.11.067; Lakota K, 2011, J BIOMED BIOTECHNOL, V90, P2233; Lee HY, 2005, BIOCHEM BIOPH RES CO, V330, P989, DOI 10.1016/j.bbrc.2005.03.069; Lee MS, 2006, J IMMUNOL, V177, P5585, DOI 10.4049/jimmunol.177.8.5585; Leisser C, 2006, MOL HUM REPROD, V12, P601, DOI 10.1093/molehr/gal066; Liao SJ, 2012, BREAST CANCER RES TR, V133, P853, DOI 10.1007/s10549-011-1844-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loregger T, 2003, PLACENTA, V24, pS104, DOI 10.1053/plac.2002.0929; Lunghi L, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-6; Malassine A, 2002, ENDOCRINE, V19, P3, DOI 10.1385/ENDO:19:1:3; Mullan RH, 2006, ARTHRITIS RHEUM-US, V54, P105, DOI 10.1002/art.21518; O'Hara R, 2004, ARTHRITIS RHEUM-US, V50, P1788, DOI 10.1002/art.20301; Osman I, 2003, MOL HUM REPROD, V9, P41, DOI 10.1093/molehr/gag001; Poitou C, 2005, DIABETOLOGIA, V48, P519, DOI 10.1007/s00125-004-1654-6; Poitou C, 2009, J CLIN ENDOCR METAB, V94, P1810, DOI 10.1210/jc.2008-2040; PreciadoPatt L, 1996, J IMMUNOL, V156, P1189; Pringle KG, 2010, HUM REPROD UPDATE, V16, P415, DOI 10.1093/humupd/dmp046; Ribeiro FP, 2003, MEDIAT INFLAMM, V12, P173, DOI 10.1080/0962935031000134897; Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203; Sharma S, 2010, J REPROD IMMUNOL, V85, P112, DOI 10.1016/j.jri.2010.01.002; Sjoholm K, 2005, J CLIN ENDOCR METAB, V90, P2233, DOI 10.1210/jc.2004-1830; Stenqvist AC, 2008, AM J REPROD IMMUNOL, V60, P33, DOI 10.1111/j.1600-0897.2008.00588.x; Trowsdale J, 2006, NAT IMMUNOL, V7, P241, DOI 10.1038/ni1317; Upragarin N, 2005, HISTOL HISTOPATHOL, V20, P1295, DOI 10.14670/HH-20.1295; Urieli-Shoval S, 2000, CURR OPIN HEMATOL, V7, P64, DOI 10.1097/00062752-200001000-00012; Wang FQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062988, 10.1371/journal.pone.0061792, 10.1371/journal.pone.0069284, 10.1371/journal.pone.0064373, 10.1371/journal.pone.0080480, 10.1371/journal.pone.0078025]; Xu B, 2011, PLACENTA, V32, P241, DOI 10.1016/j.placenta.2010.12.005; Xu P, 2002, J CLIN ENDOCR METAB, V87, P1353, DOI 10.1210/jc.87.3.1353; Yamada T, 2000, SCAND J IMMUNOL, V52, P7	50	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90881	10.1371/journal.pone.0090881	http://dx.doi.org/10.1371/journal.pone.0090881			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614130	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300049
J	Stieler, JT; Prange, R				Stieler, Jens T.; Prange, Reinhild			Involvement of ESCRT-II in Hepatitis B Virus Morphogenesis	PLOS ONE			English	Article							UBIQUITIN-INTERACTING ADAPTER; HUMAN-IMMUNODEFICIENCY-VIRUS; LATE-BUDDING DOMAINS; CAPSID PARTICLES; SORTING PATHWAY; GROWTH-FACTOR; PROTEINS; GAMMA-2-ADAPTIN; TRAFFICKING; COMPLEX	The hepatitis B virus (HBV) is an enveloped DNA virus that replicates via reverse transcription of its pregenomic RNA (pgRNA). Budding of HBV is supposed to occur at intracellular membranes and requires scission functions of the endosomal sorting complex required for transport (ESCRT) provided by ESCRT-III and VPS4. Here, we have investigated the impact of the upstream-acting ESCRT-I and ESCRT-II complexes in HBV morphogenesis. RNA interference knockdown of the ESCRT-I subunits TSG101 and VPS28 did not block, but rather stimulate virus release. In contrast, RNAi-mediated depletion of the ESCRT-II components EAP20, EAP30 and EAP45 greatly reduced virus egress. By analyzing different steps of the HBV maturation pathway, we find that the knockdown of ESCRT-II not only inhibited the production and/or release of enveloped virions, but also impaired intracellular nucleocapsid formation. Transcription/translation studies revealed that the depletion of ESCRT-II neither affected the synthesis and nuclear export of HBV-specific RNAs nor the expression of the viral core and envelope proteins. Moreover, the absence of ESCRT-II had no effects on the assembly capability and integrity of HBV core/capsids. However, the level of encapsidated pgRNA was significantly reduced in ESCRT-II-depleted cells, implicating that ESCRT-II directs steps accompanying the formation of replication-competent nucleocapsids, like e. g. assisting in RNA trafficking and encapsidation. In support of this, the capsid protein was found to interact and colocalize with ESCRT-II subunits in virus-producing cells. Together, these results indicate an essential role for ESCRT-II in the HBV life cycle and suggest that ESCRT-II functions prior to the final HBV budding reaction.	[Stieler, Jens T.; Prange, Reinhild] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med Microbiol & Hyg, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz	Prange, R (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med Microbiol & Hyg, D-55122 Mainz, Germany.	prange@uni-mainz.de	Stieler, Jens T/A-5111-2017	Stieler, Jens T/0000-0002-3770-3258; Prange, Reinhild/0000-0001-8312-4970	Deutsche Forschungsgemeinschaft [SFB 490-D1, PR 305/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (SFB 490-D1, PR 305/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardens A, 2011, CELL MICROBIOL, V13, P602, DOI 10.1111/j.1462-5822.2010.01557.x; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Bowers K, 2006, J BIOL CHEM, V281, P5094, DOI 10.1074/jbc.M508632200; Bruss V, 2007, WORLD J GASTROENTERO, V13, P65, DOI 10.3748/wjg.v13.i1.65; Carlson LA, 2012, P NATL ACAD SCI USA, V109, P16928, DOI 10.1073/pnas.1211759109; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Chen BJ, 2008, VIROLOGY, V372, P221, DOI 10.1016/j.virol.2007.11.008; Chua PK, 2006, VIROLOGY, V354, P1, DOI 10.1016/j.virol.2006.07.018; Doring T, 2010, BBA-MOL CELL RES, V1803, P1252, DOI 10.1016/j.bbamcr.2010.08.001; Dussupt V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000339; Garcia ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072845; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Gerelsaikhan T, 1996, J VIROL, V70, P4269, DOI 10.1128/JVI.70.7.4269-4274.1996; Ghoujal B, 2012, BIOL CELL, V104, P706, DOI 10.1111/boc.201200021; Hartmann-Stuhler C, 2001, J VIROL, V75, P5343, DOI 10.1128/JVI.75.11.5343-5351.2001; Hierro A, 2004, NATURE, V431, P221, DOI 10.1038/nature02914; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P1031, DOI 10.1038/nsmb1163; Hoffmann J, 2013, J HEPATOL, V59, P934, DOI 10.1016/j.jhep.2013.06.020; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Im YJ, 2008, DEV CELL, V14, P902, DOI 10.1016/j.devcel.2008.04.004; Irion U, 2007, NATURE, V445, P554, DOI 10.1038/nature05503; Jurgens MC, 2013, NAT CHEM BIOL, V9, P540, DOI [10.1038/NCHEMBIO.1294, 10.1038/nchembio.1294]; Kamura T, 2001, J BIOL CHEM, V276, P16528, DOI 10.1074/jbc.M010142200; Lambert C, 2007, J VIROL, V81, P9050, DOI 10.1128/JVI.00479-07; Langelier C, 2006, J VIROL, V80, P9465, DOI 10.1128/JVI.01049-06; Lentz TB, 2011, J VIROL, V85, P11916, DOI 10.1128/JVI.05373-11; Malerod L, 2007, TRAFFIC, V8, P1617, DOI 10.1111/j.1600-0854.2007.00630.x; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Martin-Serrano J, 2011, NAT REV MICROBIOL, V9, P519, DOI 10.1038/nrmicro2596; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; Medina GN, 2011, J VIROL, V85, P7353, DOI 10.1128/JVI.00141-11; Medina G, 2008, VIROLOGY, V377, P30, DOI 10.1016/j.virol.2008.04.024; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Nassal M, 2008, VIRUS RES, V134, P235, DOI 10.1016/j.virusres.2007.12.024; Patient R, 2009, CELL MICROBIOL, V11, P1561, DOI 10.1111/j.1462-5822.2009.01363.x; Peel S, 2011, TRENDS BIOCHEM SCI, V36, P199, DOI 10.1016/j.tibs.2010.09.004; Pincetic A, 2008, J BIOL CHEM, V283, P29822, DOI 10.1074/jbc.M804157200; Pincetic A, 2009, ADV VIROL, V2009, DOI 10.1155/2009/623969; Plant JJ., 2011, 3462118 HARV U, P136; Prange R, 2012, MED MICROBIOL IMMUN, V201, P449, DOI 10.1007/s00430-012-0267-9; RADZIWILL G, 1990, J VIROL, V64, P613, DOI 10.1128/JVI.64.2.613-620.1990; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Roingeard P, 1998, HEPATOLOGY, V28, P1128, DOI 10.1002/hep.510280431; Rost M, 2008, J BIOL CHEM, V283, P32119, DOI 10.1074/jbc.M802632200; Rost M, 2006, J BIOL CHEM, V281, P29297, DOI 10.1074/jbc.M603517200; Slagsvold T, 2005, J BIOL CHEM, V280, P19600, DOI 10.1074/jbc.M501510200; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Stuffers S, 2009, TRAFFIC, V10, P925, DOI 10.1111/j.1600-0854.2009.00920.x; Votteler J, 2013, CELL HOST MICROBE, V14, P232, DOI 10.1016/j.chom.2013.08.012; Wang SW, 2004, J VIROL, V78, P716, DOI 10.1128/JVI.78.2.716-723.2004; Wang TL, 2006, BIOCHEM BIOPH RES CO, V350, P413, DOI 10.1016/j.bbrc.2006.09.064; Watanabe T, 2007, P NATL ACAD SCI USA, V104, P10205, DOI 10.1073/pnas.0704000104; Whitacre DC, 2009, EXPERT REV VACCINES, V8, P1565, DOI 10.1586/ERV.09.121; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Yorikawa C, 2005, BIOCHEM J, V387, P17, DOI 10.1042/BJ20041227; Zhadina M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001153; ZHOU S, 1992, P NATL ACAD SCI USA, V89, P10046, DOI 10.1073/pnas.89.21.10046	58	37	39	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91279	10.1371/journal.pone.0091279	http://dx.doi.org/10.1371/journal.pone.0091279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614091	Green Submitted, gold, Green Published			2022-12-25	WOS:000332839300106
J	Vandervoort, A; Houttekier, D; Stichele, RV; van der Steen, JT; Van den Block, L				Vandervoort, An; Houttekier, Dirk; Stichele, Robert Vander; van der Steen, Jenny T.; Van den Block, Lieve			Quality of Dying in Nursing Home Residents Dying with Dementia: Does Advanced Care Planning Matter? A Nationwide Postmortem Study	PLOS ONE			English	Article							OF-LIFE CARE; DIRECTIVES; PEOPLE; FAILURE; BELGIUM	Background: Advance care planning is considered a central component of good quality palliative care and especially relevant for people who lose the capacity to make decisions at the end of life, which is the case for many nursing home residents with dementia. We set out to investigate to what extent (1) advance care planning in the form of written advance patient directives and verbal communication with patient and/or relatives about future care and (2) the existence of written advance general practitioner orders are related to the quality of dying of nursing home residents with dementia. Methods: Cross-sectional study of deaths (2010) using random cluster-sampling. Representative sample of nursing homes in Flanders, Belgium. Deaths of residents with dementia in a three-month period were reported; for each the nurse most involved in care, GP and closest relative completed structured questionnaires. Findings: We identified 101 deaths of residents with dementia in 69 nursing homes (58% response rate). A written advance patient directive was present for 17.5%, GP-orders for 56.7%. Controlling for socio-demographic/clinical characteristics in multivariate regression analyses, chances of having a higher mean rating of emotional well-being (less fear and anxiety) on the Comfort Assessment in Dying with Dementia scale were three times higher with a written advance patient directive and more specifically when having a do-not-resuscitate order (AOR 3.45; CI, 1.1-11) than for those without either (AOR 2.99; CI, 1.1-8.3). We found no association between verbal communication or having a GP order and quality of dying. Conclusion: For nursing home residents with dementia there is a strong association between having a written advance directive and quality of dying. Where wishes are written, relatives report lower levels of emotional distress at the end of life. These results underpin the importance of advance care planning for people with dementia and beginning this process as early as possible.	[Vandervoort, An; Houttekier, Dirk; Stichele, Robert Vander; Van den Block, Lieve] Vrije Univ Brussel, End Of Life Care Res Grp, Brussels, Belgium; [Vandervoort, An; Houttekier, Dirk; Stichele, Robert Vander; Van den Block, Lieve] Univ Ghent, Brussels, Belgium; [Stichele, Robert Vander] Univ Ghent, Heymans Inst Pharmacol, B-9000 Ghent, Belgium; [van der Steen, Jenny T.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [van der Steen, Jenny T.] Vrije Univ Amsterdam, Med Ctr, Expertise Ctr Palliat Care, Dept Gen Practice & Elderly Care Med, Amsterdam, Netherlands; [Van den Block, Lieve] Vrije Univ Brussel, Dept Family Med, Brussels, Belgium	Vrije Universiteit Brussel; Ghent University; Ghent University; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Brussel	Van den Block, L (corresponding author), Vrije Univ Brussel, End Of Life Care Res Grp, Brussels, Belgium.	lvdblock@vub.ac.be	Stichele, Robert Vander/K-7203-2015; van der Steen, Jenny T./E-5118-2016; Houttekier, Dirk/F-4073-2011; Van den Block, Lieve/D-1247-2011	Stichele, Robert Vander/0000-0001-9118-9651; van der Steen, Jenny T./0000-0002-9063-7501; Houttekier, Dirk/0000-0003-0837-9898; Van den Block, Lieve/0000-0002-7770-348X	Vrije Universiteit Brussel (GOA HW, VUB); Dying Well; Research Foundation-Flanders (FWO)	Vrije Universiteit Brussel (GOA HW, VUB); Dying Well; Research Foundation-Flanders (FWO)(FWO)	This study is supported by a grant from Vrije Universiteit Brussel (GOA HW, VUB 2007) and is part of the Dying Well with Dementia study. L. Van den Block is a postdoctoral research fellow of the Research Foundation-Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarshi E, 2011, J PALLIAT MED, V14, P323, DOI 10.1089/jpm.2010.0312; Alhzeimer Europe, 2006, ALHZ EUR REP US ADV; Arnaert A, 1999, ACTA HOSP, V4, P19; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; Bellelli G, 1997, ALZ DIS ASSOC DIS, V11, P71, DOI 10.1097/00002093-199706000-00003; Deliens L., 1991, HUISARTS NU, V20, P113; Dening KH, 2011, INT PSYCHOGERIATR, V23, P1535, DOI 10.1017/S1041610211001608; Detering KM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1345; Evans N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057965; Fagerlin A, 2004, HASTINGS CENT REP, V34, P30, DOI 10.2307/3527683; Hertogh CMPM, 2006, AGE AGEING, V35, P553, DOI 10.1093/ageing/afl103; Heyland DK, 2013, JAMA INTERN MED, V173, P778, DOI 10.1001/jamainternmed.2013.180; Meeussen K, 2012, INT PSYCHOGERIATR, V24, P1581, DOI 10.1017/S1041610212000865; Meeussen K, 2011, J PAIN SYMPTOM MANAG, V42, P565, DOI 10.1016/j.jpainsymman.2011.01.011; Mori M, 2013, SUPPORT CARE CANCER, V21, P629, DOI 10.1007/s00520-012-1581-x; Robinson L, 2012, AGE AGEING, V41, P263, DOI 10.1093/ageing/afr148; SCHNEIDERMAN LJ, 1992, ANN INTERN MED, V117, P599, DOI 10.7326/0003-4819-117-7-599; Seymour Jane, 2010, BMC Palliat Care, V9, P4, DOI 10.1186/1472-684X-9-4; TENO JM, 1994, J CLIN ETHIC, V5, P23; Teno JM, 1997, J AM GERIATR SOC, V45, P508, DOI 10.1111/j.1532-5415.1997.tb05179.x; TENO JM, 2003, GERIATRIC PALLIATIVE, P307; Teno JM, 2007, J AM GERIATR SOC, V55, P189, DOI 10.1111/j.1532-5415.2007.01045.x; van Soest-Poortvliet MC, 2013, J AM MED DIR ASSOC, V14, P179, DOI 10.1016/j.jamda.2012.09.019; Vandervoort A, 2013, J PAIN SYMPTOM MANAG; Vandervoort A, 2012, INT PSYCHOGERIATR, P1, DOI DOI 10.1080/13527258.2012.738334; Vandervoort A, 2013, J AM MED DIR ASSOC, V14, P485, DOI 10.1016/j.jamda.2013.01.016; Volicer L, 2001, ALZ DIS ASSOC DIS, V15, P194, DOI 10.1097/00002093-200110000-00005; World Health Organization, 2004, BETTER PALLIATIVE CA; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665	29	70	71	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91130	10.1371/journal.pone.0091130	http://dx.doi.org/10.1371/journal.pone.0091130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9FH	24614884	Green Submitted, gold, Green Published			2022-12-25	WOS:000332839300081
J	Yeh, TT; Cluff, T; Balasubramaniam, R				Yeh, Ting Ting; Cluff, Tyler; Balasubramaniam, Ramesh			Visual Reliance for Balance Control in Older Adults Persists When Visual Information Is Disrupted by Artificial Feedback Delays	PLOS ONE			English	Article							POSTURAL CONTROL; ELDERLY ADULTS; SPATIAL ORIENTATION; COGNITIVE TASKS; DUAL-TASK; ATTENTION; HEALTHY; STANCE; YOUNG; DYNAMICS	Sensory information from our eyes, skin and muscles helps guide and correct balance. Less appreciated, however, is that delays in the transmission of sensory information between our eyes, limbs and central nervous system can exceed several 10s of milliseconds. Investigating how these time-delayed sensory signals influence balance control is central to understanding the postural system. Here, we investigate how delayed visual feedback and cognitive performance influence postural control in healthy young and older adults. The task required that participants position their center of pressure (COP) in a fixed target as accurately as possible without visual feedback about their COP location (eyes-open balance), or with artificial time delays imposed on visual COP feedback. On selected trials, the participants also performed a silent arithmetic task (cognitive dual task). We separated COP time series into distinct frequency components using low and high-pass filtering routines. Visual feedback delays affected low frequency postural corrections in young and older adults, with larger increases in postural sway noted for the group of older adults. In comparison, cognitive performance reduced the variability of rapid center of pressure displacements in young adults, but did not alter postural sway in the group of older adults. Our results demonstrate that older adults prioritize vision to control posture. This visual reliance persists even when feedback about the task is delayed by several hundreds of milliseconds.	[Yeh, Ting Ting; Cluff, Tyler; Balasubramaniam, Ramesh] McMaster Univ, Dept Kinesiol, Sensorimotor Neurosci Lab, Hamilton, ON, Canada; [Cluff, Tyler] Queens Univ, Ctr Neurosci Studies, LIMB, Kingston, ON, Canada; [Balasubramaniam, Ramesh] Univ Calif Merced, Merced, CA USA	McMaster University; Queens University - Canada; University of California System; University of California Merced	Yeh, TT (corresponding author), McMaster Univ, Dept Kinesiol, Sensorimotor Neurosci Lab, Hamilton, ON, Canada.	yeht2@mcmaster.ca	Balasubramaniam, Ramesh/GWC-4248-2022; Yeh, Ting Ting/AAX-8155-2020	Balasubramaniam, Ramesh/0000-0001-7575-3080; YEH, TING-TING/0000-0003-0018-9467				Allison LK, 2006, EXP BRAIN RES, V175, P342, DOI 10.1007/s00221-006-0559-7; Amiridis IG, 2003, NEUROSCI LETT, V350, P137, DOI 10.1016/S0304-3940(03)00878-4; Balasubramaniam R, 2002, TRENDS COGN SCI, V6, P531, DOI 10.1016/S1364-6613(02)02021-1; Berger L, 2011, GAIT POSTURE, V33, P300, DOI 10.1016/j.gaitpost.2010.10.082; BLASZCZYK JW, 1993, PERCEPTION, V22, P1333, DOI 10.1068/p221333; Boulet J, 2010, PHILOS T R SOC A, V368, P423, DOI 10.1098/rsta.2009.0214; Brauer SG, 2002, GAIT POSTURE, V15, P83, DOI 10.1016/S0966-6362(01)00163-1; Cluff T, 2011, EXP BRAIN RES, V213, P15, DOI 10.1007/s00221-011-2768-y; Cluff T, 2010, EXP BRAIN RES, V203, P647, DOI 10.1007/s00221-010-2274-7; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; Dault MC, 2003, COGNITIVE BRAIN RES, V16, P434, DOI 10.1016/S0926-6410(03)00058-2; Dault MC, 2001, GAIT POSTURE, V14, P110, DOI 10.1016/S0966-6362(01)00113-8; Dimitriou M, 2013, J NEUROSCI, V33, P10898, DOI 10.1523/JNEUROSCI.5669-12.2013; Doumas M, 2010, J NEUROPHYSIOL, V104, P1969, DOI 10.1152/jn.00345.2010; Ehrenfried T, 2003, COGNITIVE BRAIN RES, V17, P140, DOI 10.1016/S0926-6410(03)00088-0; Eikema DJA, 2013, NEUROSCIENCE, V234, P22, DOI 10.1016/j.neuroscience.2012.12.053; Franklin DW, 2008, J NEUROSCI, V28, P14165, DOI 10.1523/JNEUROSCI.4406-08.2008; Goble DJ, 2009, NEUROSCI BIOBEHAV R, V33, P271, DOI 10.1016/j.neubiorev.2008.08.012; Gu MJ, 1996, J BIOMECH, V29, P319, DOI 10.1016/0021-9290(95)00052-6; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; HORAK FB, 1989, NEUROBIOL AGING, V10, P727, DOI 10.1016/0197-4580(89)90010-9; JEKA JJ, 1994, EXP BRAIN RES, V100, P495, DOI 10.1007/BF02738408; Jeka JJ, 1997, PHYS THER, V77, P476, DOI 10.1093/ptj/77.5.476; Jeka J, 2006, EXP BRAIN RES, V174, P517, DOI 10.1007/s00221-006-0502-y; Jeka JJ, 2010, J MOTOR BEHAV, V42, P197, DOI 10.1080/00222895.2010.481693; Kang HG, 2010, J NEUROPHYSIOL, V104, P3510, DOI 10.1152/jn.00820.2009; Kiemel T, 2006, J NEUROPHYSIOL, V95, P1410, DOI 10.1152/jn.01144.2004; Kiemel T, 2002, BIOL CYBERN, V87, P262, DOI 10.1007/s00422-002-0333-2; Knill DC, 2011, J NEUROSCI, V31, P1219, DOI 10.1523/JNEUROSCI.3522-09.2011; Lacour M, 2008, NEUROPHYSIOL CLIN, V38, P411, DOI 10.1016/j.neucli.2008.09.005; Lockhart DB, 2007, NAT NEUROSCI, V10, P1329, DOI 10.1038/nn1986; Loeb GE, 1999, EXP BRAIN RES, V126, P1, DOI 10.1007/s002210050712; Mak L, 2011, SCI MOTRICITE, V74, P81; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Maki BE, 2001, NEUROREPORT, V12, P3583, DOI 10.1097/00001756-200111160-00042; McDowd JM, 1997, J GERONTOL B-PSYCHOL, V52, pP265, DOI 10.1093/geronb/52B.6.P265; McNevin NH, 2002, HUM MOVEMENT SCI, V21, P187, DOI 10.1016/S0167-9457(02)00095-7; Milton JG, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/065005; Morasso PG, 1999, NEURAL NETWORKS, V12, P1173, DOI 10.1016/S0893-6080(99)00058-1; Norris JA, 2005, J BIOMECH, V38, P1263, DOI 10.1016/j.jbiomech.2004.06.014; O'Connor KW, 2008, GAIT POSTURE, V28, P385, DOI 10.1016/j.gaitpost.2008.01.010; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Purves D., 2001, NEUROSCIENCE; Rougier P, 2004, GAIT POSTURE, V19, P154, DOI 10.1016/S0966-6362(03)00056-0; Freitas SMSF, 2012, GAIT POSTURE, V35, P83, DOI 10.1016/j.gaitpost.2011.08.011; ShumwayCook A, 1997, J GERONTOL A-BIOL, V52, pM232, DOI 10.1093/gerona/52A.4.M232; Simoneau M, 1999, J AM GERIATR SOC, V47, P235, DOI 10.1111/j.1532-5415.1999.tb04584.x; Stevenson IH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000629; Stoffregen TA, 1999, J EXP PSYCHOL HUMAN, V25, P1641; Sundermier L, 1996, J GERONTOL A-BIOL, V51, pM45, DOI 10.1093/gerona/51A.2.M45; Szczepanska-Gieracha J, 2012, GAIT POSTURE, V35, P312, DOI 10.1016/j.gaitpost.2011.10.001; Teasdale N, 2001, GAIT POSTURE, V14, P203, DOI 10.1016/S0966-6362(01)00134-5; Ting LH, 2007, PROG BRAIN RES, V165, P299, DOI 10.1016/S0079-6123(06)65019-X; van den Heuvel MRC, 2009, NEUROSCI LETT, V452, P37, DOI 10.1016/j.neulet.2009.01.024; van der Kooij H, 2007, J NEUROPHYSIOL, V98, P730, DOI 10.1152/jn.00457.2006; WADE MG, 1995, J GERONTOL B-PSYCHOL, V50, pP51, DOI 10.1093/geronb/50B.1.P51; Wade MG, 1997, PHYS THER, V77, P619, DOI 10.1093/ptj/77.6.619; Weeks DL, 2003, GERONTOLOGY, V49, P225, DOI 10.1159/000070402; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334; WOOLLACOTT MH, 1986, INT J AGING HUM DEV, V23, P97, DOI 10.2190/VXN3-N3RT-54JB-X16X; Yeh TT, 2010, NEUROSCI LETT, V481, P173, DOI 10.1016/j.neulet.2010.06.081	62	55	57	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91554	10.1371/journal.pone.0091554	http://dx.doi.org/10.1371/journal.pone.0091554			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9FH	24614576	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300136
J	Shin, H; Shannon, CP; Fishbane, N; Ruan, J; Zhou, M; Balshaw, R; Wilson-McManus, JE; Ng, RT; McManus, BM; Tebbutt, SJ				Shin, Heesun; Shannon, Casey P.; Fishbane, Nick; Ruan, Jian; Zhou, Mi; Balshaw, Robert; Wilson-McManus, Janet E.; Ng, Raymond T.; McManus, Bruce M.; Tebbutt, Scott J.		PROOF Ctr Excellence Team	Variation in RNA-Seq Transcriptome Profiles of Peripheral Whole Blood from Healthy Individuals with and without Globin Depletion	PLOS ONE			English	Article							ALLOGRAFT-REJECTION; BIOMARKERS	Background: The molecular profile of circulating blood can reflect physiological and pathological events occurring in other tissues and organs of the body and delivers a comprehensive view of the status of the immune system. Blood has been useful in studying the pathobiology of many diseases. It is accessible and easily collected making it ideally suited to the development of diagnostic biomarker tests. The blood transcriptome has a high complement of globin RNA that could potentially saturate next-generation sequencing platforms, masking lower abundance transcripts. Methods to deplete globin mRNA are available, but their effect has not been comprehensively studied in peripheral whole blood RNA-Seq data. In this study we aimed to assess technical variability associated with globin depletion in addition to assessing general technical variability in RNA-Seq from whole blood derived samples. Results: We compared technical and biological replicates having undergone globin depletion or not and found that the experimental globin depletion protocol employed removed approximately 80% of globin transcripts, improved the correlation of technical replicates, allowed for reliable detection of thousands of additional transcripts and generally increased transcript abundance measures. Differential expression analysis revealed thousands of genes significantly up-regulated as a result of globin depletion. In addition, globin depletion resulted in the down-regulation of genes involved in both iron and zinc metal ion bonding. Conclusions: Globin depletion appears to meaningfully improve the quality of peripheral whole blood RNA-Seq data, and may improve our ability to detect true biological variation. Some concerns remain, however. Key amongst them the significant reduction in RNA yields following globin depletion. More generally, our investigation of technical and biological variation with and without globin depletion finds that high-throughput sequencing by RNA-Seq is highly reproducible within a large dynamic range of detection and provides an accurate estimation of RNA concentration in peripheral whole blood. High-throughput sequencing is thus a promising technology for whole blood transcriptomics and biomarker discovery.	[Shin, Heesun; Shannon, Casey P.; Fishbane, Nick; Ruan, Jian; Zhou, Mi; Balshaw, Robert; Wilson-McManus, Janet E.; Ng, Raymond T.; McManus, Bruce M.; Tebbutt, Scott J.] NCE CECR PROOF Ctr Excellence, Vancouver, BC, Canada; [Shin, Heesun; Tebbutt, Scott J.] Univ British Columbia, UBC Dept Med, Div Resp Med, Vancouver, BC V5Z 1M9, Canada; [McManus, Bruce M.] Univ British Columbia, UBC Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Ng, Raymond T.] Univ British Columbia, UBC Dept Comp Sci, Vancouver, BC V5Z 1M9, Canada; [Fishbane, Nick; Balshaw, Robert] Univ British Columbia, UBC Dept Stat, Vancouver, BC V5Z 1M9, Canada; [Shin, Heesun; Ruan, Jian; McManus, Bruce M.; Tebbutt, Scott J.] Univ British Columbia, UBC James Hogg Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Shin, Heesun; Ruan, Jian; McManus, Bruce M.; Tebbutt, Scott J.] Univ British Columbia, Inst HEART LUNG Hlth, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Tebbutt, SJ (corresponding author), NCE CECR PROOF Ctr Excellence, Vancouver, BC, Canada.	Scott.Tebbutt@hli.ubc.ca	Fishbane, Nick/GYE-0318-2022	Fishbane, Nick/0000-0003-4316-1341; Balshaw, Robert/0000-0002-2455-8792; Shannon, Casey/0000-0002-5687-3156; Tebbutt, Scott/0000-0002-7908-1581	MITACS Accelerate program	MITACS Accelerate program	The authors are grateful for funding from the MITACS Accelerate program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboyoun P, GENOMICRANGES REPRES; Auer PL, 2010, GENETICS, V185, P405, DOI 10.1534/genetics.110.114983; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Brouard S, 2007, P NATL ACAD SCI USA, V104, P15448, DOI 10.1073/pnas.0705834104; Devonshire AS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-662; Gunther OP, 2009, TRANSPLANTATION, V88, P942, DOI 10.1097/TP.0b013e3181b7ccc6; Hollander Z, 2010, TRANSPLANTATION, V90, P1388, DOI 10.1097/TP.0b013e3182003df6; Kam SHY, 2012, J ASTHMA, V49, P219, DOI 10.3109/02770903.2011.654300; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2008, PHYSIOL GENOMICS, V32, P190, DOI 10.1152/physiolgenomics.00216.2007; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Lin D, 2009, J HEART LUNG TRANSPL, V28, P927, DOI 10.1016/j.healun.2009.04.025; Liu J, 2006, J MOL DIAGN, V8, P551, DOI 10.2353/jmoldx.2006.060021; Mastrokolias A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-28; Mohr S, 2007, TRENDS MOL MED, V13, P422, DOI 10.1016/j.molmed.2007.08.003; O'Loughlin A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-250; Raghavachari N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006484; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Roberts A, 2011, BIOINFORMATICS; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Team RC, 2012, R LANG ENV STAT COMP; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	24	56	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91041	10.1371/journal.pone.0091041	http://dx.doi.org/10.1371/journal.pone.0091041			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608128	Green Published, gold, Green Submitted			2022-12-25	WOS:000332485800086
J	Suen, SC; Bendavid, E; Goldhaber-Fiebert, JD				Suen, Sze-chuan; Bendavid, Eran; Goldhaber-Fiebert, Jeremy D.			Disease Control Implications of India's Changing Multi-Drug Resistant Tuberculosis Epidemic	PLOS ONE			English	Article							SOUTH-INDIA; DOTS PROGRAM; REINFECTION; PREVALENCE; DIAGNOSIS	Background: Multi-drug resistant tuberculosis (MDR TB) is a major health challenge in India that is gaining increasing public attention, but the implications of India's evolving MDR TB epidemic are poorly understood. As India's MDR TB epidemic is transitioning from a treatment-generated to transmission-generated epidemic, we sought to evaluate the potential effectiveness of the following two disease control strategies on reducing the prevalence of MDR TB: a) improving treatment of non-MDR TB; b) shortening the infectious period between the activation of MDR TB and initiation of effective MDR treatment. Methods and Findings: We developed a dynamic transmission microsimulation model of TB in India. The model followed individuals by age, sex, TB status, drug resistance status, and treatment status and was calibrated to Indian demographic and epidemiologic TB time trends. The main effectiveness measure was reduction in the average prevalence reduction of MDR TB over the ten years after control strategy implementation. We find that improving non-MDR cure rates to avoid generating new MDR cases will provide substantial non-MDR TB benefits but will become less effective in reducing MDR TB prevalence over time because more cases will occur from direct transmission - by 2015, the model estimates 42% of new MDR cases are transmission-generated and this proportion continues to rise over time, assuming equal transmissibility of MDR and drug-susceptible TB. Strategies that disrupt MDR transmission by shortening the time between MDR activation and treatment are projected to provide greater reductions in MDR prevalence compared with improving non-MDR treatment quality: implementing MDR diagnostic improvements in 2017 is expected to reduce MDR prevalence by 39%, compared with 11% reduction from improving non-MDR treatment quality. Conclusions: As transmission-generated MDR TB becomes a larger driver of the MDR TB epidemic in India, rapid and accurate MDR TB diagnosis and treatment will become increasingly effective in reducing MDR TB cases compared to non-MDR TB treatment improvements.	[Suen, Sze-chuan] Stanford Univ, Dept Management Sci & Engn, Stanford, CA 94305 USA; [Bendavid, Eran] Stanford Univ, Dept Med, Div Gen Med Disciplines, Stanford, CA 94305 USA; [Bendavid, Eran; Goldhaber-Fiebert, Jeremy D.] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; [Bendavid, Eran; Goldhaber-Fiebert, Jeremy D.] Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Suen, SC (corresponding author), Stanford Univ, Dept Management Sci & Engn, Stanford, CA 94305 USA.	ssuen@stanford.edu		Goldhaber-Fiebert, Jeremy/0000-0002-4007-5192	NIH NIA [K01 AG037593-01A1]; National Institute of Allergy and Infectious Diseases [K01-AI084582]; Dr. George Rosenkranz Prize for Health Care Research in Developing Countries; NSF GRFP; Stanford's Freeman Spogli Institute for International Studies and its Global Underdevelopment Action Fund; Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI084582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG037593, P30AG017253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA015612, R01DA015612] Funding Source: NIH RePORTER	NIH NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Dr. George Rosenkranz Prize for Health Care Research in Developing Countries; NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); Stanford's Freeman Spogli Institute for International Studies and its Global Underdevelopment Action Fund; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	JGF was supported in part by an NIH NIA Career Development Award (K01 AG037593-01A1). EBD is supported by the National Institute of Allergy and Infectious Diseases (K01-AI084582) and by the Dr. George Rosenkranz Prize for Health Care Research in Developing Countries. SS was supported in part by the NSF GRFP. The work was supported in part by Stanford's Freeman Spogli Institute for International Studies and its Global Underdevelopment Action Fund and by the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JR, 2008, J INFECT DIS, V198, P1582, DOI 10.1086/592991; [Anonymous], 2011, GLOB TUB CONTR 2011; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Balasubramanian R, 2004, INT J TUBERC LUNG D, V8, P323; Central TB Division Directorate General of Health Services and Ministry of Health and Family Welfare, 2011, TB IND 2011 RNTCP AN; Central TB Division Directorate General of Health Services and Ministry of Health and Family Welfare, 2010, RNTCP PERF REP; Chang K, 2012, J INFECTION, V64, P580, DOI 10.1016/j.jinf.2012.02.012; Cohen T, 2004, NAT MED, V10, P1117, DOI 10.1038/nm1110; COHESIVE-India, 2011, BIH EV SOC FRANCH TE; Crofton J, 1997, GUIDELINES MANAGEMEN, P210; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Dye C, 2012, INDIAN J MED RES, V135, P737; Goldhaber-Fiebert JD, 2010, VALUE HEALTH, V13, P667, DOI 10.1111/j.1524-4733.2010.00698.x; Government of India National DOTS-Plus Committee, 2011, 7 NAT DOTS PLUS COMM, V756, P1; HEYM B, 1994, LANCET, V344, P293, DOI 10.1016/S0140-6736(94)91338-2; Horby P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016965; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; Kapoor SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042458; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Malmborg R, 2006, B WORLD HEALTH ORGAN, V84, P752; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Pantoja A, 2009, INT J TUBERC LUNG D, V13, P698; Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat, 2010, WORLD POP PROSP 2010; Rajeswari R, 2002, INT J TUBERC LUNG D, V6, P789; Rosenzweig MR, 1994, AGEING INT, V21, P50; Rowland K, 2012, NATURE, V9797, DOI [10.1038/nature.2012.9797, DOI 10.1038/NATURE.2012.9797, 10.1038/nature. 2012.9797]; Sachdeva KS, 2011, FACING REALITY MULTI; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; Satyanarayana S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024160; Sharma SK, 2011, INDIAN J MED RES, V133, P308; Singla R, 2009, INT J TUBERC LUNG D, V13, P976; Sinha K., 2012, TIMES INDIA; Srikanth Padma, 2009, Indian J Tuberc, V56, P174; Tobgay KJ, 2006, NATL MED J INDIA, V19, P60; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; UPLEKAR MW, 1991, TUBERCLE, V72, P284, DOI 10.1016/0041-3879(91)90055-W; Vandan N, 2009, PUBLIC HEALTH, V123, P484, DOI 10.1016/j.puhe.2009.05.004; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; World Health Organization, 2010, WHO LIF IND; World Health Organization, 2011, IND MULT RES TUB PRO; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789	41	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e89822	10.1371/journal.pone.0089822	http://dx.doi.org/10.1371/journal.pone.0089822			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608234	Green Published, gold, Green Submitted			2022-12-25	WOS:000332485800009
J	Wang, AL; Carroll, RC; Nawy, S				Wang, Ai Ling; Carroll, Reed C.; Nawy, Scott			Down-Regulation of the RNA Editing Enzyme ADAR2 Contributes to RGC Death in a Mouse Model of Glaucoma	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; AMPA RECEPTORS; GLUTAMATE EXCITOTOXICITY; SYNAPTIC PLASTICITY; NEUROPROTECTION; MECHANISM; TRANSPORT; PATHWAYS; NEURONS; GLUR2	Glaucoma is a progressive neurodegenerative disease of retinal ganglion cells (RGCs) associated with characteristic axon degeneration in the optic nerve. Excitotoxic damage due to increased Ca2+ influx, possibly through NMDA-type glutamate receptors, has been proposed to be a cause of RGC dysfunction and death in glaucoma. Recent work has found that expression of another potentially critical receptor, the Ca2+-permeable AMPA receptor (CP-AMPAR), is elevated during various pathological conditions (including ALS and ischemia), resulting in increased neuronal death. Here we test the hypothesis that CP-AMPARs contribute to RGC death due to elevated Ca2+ influx in glaucoma. AMPA receptors are impermeable to Ca2+ if the tetrameric receptor contains a GluA2 subunit that has undergone Q/R RNA editing at a site in the pore region. The activity of ADAR2, the enzyme responsible for this RNA editing, generally ensures that the vast majority of GluA2 proteins are edited. Here, we demonstrate that ADAR2 levels decrease in a mouse model of glaucoma in which IOP is chronically elevated. Furthermore, using an in vitro model of RGCs, we find that knockdown of ADAR2 using siRNA increased the accumulation of Co2+ in response to glutamate, and decreased the rectification index of AMPA currents detected electrophysiologically, indicating an increased Ca2+ permeability through AMPARs. The RGCs in primary culture also exhibited increased excitotoxic cell death following knock down of ADAR2. Furthermore, cell death was reversed by NASPM, a specific blocker for CP-AMPARs. Together, our data suggest that chronically elevated IOP in adult mice reduces expression of the ADAR2 enzyme, and the loss of ADAR2 editing and subsequent disruption of GluA2 RNA editing might potentially play a role in promoting RGC neuronal death as observed in glaucoma.	[Wang, Ai Ling; Carroll, Reed C.; Nawy, Scott] Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Nawy, S (corresponding author), Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10467 USA.	scott.nawy@einstein.yu.edu		Nawy, Scott/0000-0003-4679-6756	NEI [EY017428]; NATIONAL EYE INSTITUTE [R01EY017428] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by NEI grant EY017428 (S.N.) (http://nei.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.54; Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; Bautista RD, 1999, INT OPHTHALMOL CLIN, V39, P57, DOI 10.1097/00004397-199903930-00007; Bertram KM, 2008, EYE, V22, P582, DOI 10.1038/sj.eye.6702993; Casson RJ, 2006, CLIN EXP OPHTHALMOL, V34, P54, DOI 10.1111/j.1442-9071.2006.01146.x; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; Clarke RJ, 2013, J NEUROSCI, V33, P4140, DOI 10.1523/JNEUROSCI.3712-12.2013; Crish SD, 2010, P NATL ACAD SCI USA, V107, P5196, DOI 10.1073/pnas.0913141107; Diederen RMH, 2006, EXP EYE RES, V83, P45, DOI 10.1016/j.exer.2005.10.031; Gregory MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017659; Guo L, 2006, INVEST OPHTH VIS SCI, V47, P626, DOI 10.1167/iovs.05-0754; Hayreh SS, 2001, PROG RETIN EYE RES, V20, P563, DOI 10.1016/S1350-9462(01)00004-0; Herzog KH, 1998, J NEUROSCI, V18, P2891; Hideyama T, 2012, NEUROBIOL DIS, V45, P1121, DOI 10.1016/j.nbd.2011.12.033; Hogg M, 2011, ADV GENET, V73, P87, DOI 10.1016/B978-0-12-380860-8.00003-3; Kalia LV, 2008, LANCET NEUROL, V7, P742, DOI 10.1016/S1474-4422(08)70165-0; Kanamori A, 2010, J NEUROCHEM, V114, P488, DOI 10.1111/j.1471-4159.2010.06781.x; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Lee SC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-54; Lipton SA, 2004, J ALZHEIMERS DIS, V6, pS61; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Liu SJ, 2012, J PHYSIOL-LONDON, V590, P13, DOI 10.1113/jphysiol.2011.213926; Lotery AJ, 2005, EYE, V19, P369, DOI 10.1038/sj.eye.6701623; Ma YT, 1998, J NEUROSCI, V18, P2097; Neufeld AH, 1997, EXP EYE RES, V65, P739, DOI 10.1006/exer.1997.0394; Neufeld AH, 1997, ARCH OPHTHALMOL-CHIC, V115, P497, DOI 10.1001/archopht.1997.01100150499009; Osborne NN, 2006, EYE, V20, P1392, DOI 10.1038/sj.eye.6702234; Osswald IK, 2007, J PHYSIOL-LONDON, V582, P95, DOI 10.1113/jphysiol.2007.127894; Peng PL, 2006, NEURON, V49, P719, DOI 10.1016/j.neuron.2006.01.025; PRUSS RM, 1991, NEURON, V7, P509, DOI 10.1016/0896-6273(91)90302-G; Quigley HA, 2000, INVEST OPHTH VIS SCI, V41, P3460; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Schuettauf F, 2007, GRAEF ARCH CLIN EXP, V245, P1157, DOI 10.1007/s00417-006-0531-z; Seki M, 2008, PROG BRAIN RES, V173, P495, DOI 10.1016/S0079-6123(08)01134-5; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Silberberg G, 2012, HUM MOL GENET, V21, P311, DOI 10.1093/hmg/ddr461; Taschenberger H, 1999, J NEUROSCI, V19, P3353; Wright A, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00034; Xia Y, 2007, J NEUROSCI, V27, P12221, DOI 10.1523/JNEUROSCI.2086-07.2007	39	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91288	10.1371/journal.pone.0091288	http://dx.doi.org/10.1371/journal.pone.0091288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608178	Green Published, gold, Green Submitted			2022-12-25	WOS:000332485800124
J	Brahimi, F; Ko, E; Malakhov, A; Burgess, K; Saragovi, HU				Brahimi, Fouad; Ko, Eunhwa; Malakhov, Andrey; Burgess, Kevin; Saragovi, H. Uri			Combinatorial Assembly of Small Molecules into Bivalent Antagonists of TrkC or TrkA Receptors	PLOS ONE			English	Article							GROWTH; LIGANDS; NEUROTROPHINS; BINDING	A library of peptidomimetics was assembled combinatorially into dimers on a triazine-based core. The pharmacophore corresponds to beta-turns of the neurotrophin polypeptides neurotrophin-3 (NT-3), nerve growth factor (NGF), or brain-derived neurotrophic factor (BDNF). These are the natural ligands for TrkC, TrkA, and TrkB receptors, respectively. The linker length and the side-chain orientation of each monomer within the bivalent mimics were systematically altered, and the impact of these changes on the function of each ligand was evaluated. While the monovalent peptidomimetics had no detectable binding or bioactivity, four bivalent peptidomimetics (2c, 2d, 2e, 3f) are selective TrkC ligands with antagonistic activity, and two bivalent peptidomimetics (1a, 1b) are TrkC and TrkA ligands with antagonistic activity. All these bivalent compounds block ligand-dependent receptor activation and cell survival, without affecting neuritogenic differentiation. This work adds to our understanding of how the neurotrophins function through Trk receptors, and demonstrates that peptidomimetics can be designed to selectively disturb specific biological signals, and may be used as pharmacological probes or as therapeutic leads. The concept of altering side-chain, linker length, and sequence orientation of a subunit within a pharmacophore provides an easy modular approach to generate larger libraries with diversified bioactivity.	[Brahimi, Fouad; Saragovi, H. Uri] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Ko, Eunhwa; Malakhov, Andrey; Burgess, Kevin] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Saragovi, H. Uri] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Saragovi, H. Uri] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Saragovi, H. Uri] McGill Univ, Ctr Canc, Montreal, PQ H3G 1Y6, Canada	Lady Davis Institute; McGill University; Texas A&M University System; Texas A&M University College Station; McGill University; McGill University; McGill University	Saragovi, HU (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada.	uri.saragovi@mcgill.ca	Burgess, Kevin/B-5372-2015	Burgess, Kevin/0000-0001-6597-1842	Canadian Institute of Health Research; National Institutes of Health [MH070040, GM076261]; Robert A. Welch Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE014318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM076261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070040] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was partially supported by grants from the Canadian Institute of Health Research to HUS and by National Institutes of Health (MH070040, GM076261), and the Robert A. Welch Foundation to Kevin Burgess. We thank Dr Amber Schaefer for helpful discussions, and Sakunchai Khumsubdee for collecting data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angell Y, 2008, J AM CHEM SOC, V130, P556, DOI 10.1021/ja074717z; Beglova N, 2000, J MED CHEM, V43, P3530, DOI 10.1021/jm990441x; Brahimi F, 2010, BBA-GEN SUBJECTS, V1800, P1018, DOI 10.1016/j.bbagen.2010.06.007; Brahimi F, 2009, PEPTIDES, V30, P1833, DOI 10.1016/j.peptides.2009.07.015; Chao MV, 2002, NEURON, V33, P9, DOI 10.1016/S0896-6273(01)00573-6; Chen DJ, 2009, ACS CHEM BIOL, V4, P769, DOI 10.1021/cb9001415; Hempstead BL, 2002, CURR OPIN NEUROBIOL, V12, P260, DOI 10.1016/S0959-4388(02)00321-5; Ivanisevic L, 2003, ONCOGENE, V22, P5677, DOI 10.1038/sj.onc.1206864; Ivanisevic L, 2007, J BIOL CHEM, V282, P16754, DOI 10.1074/jbc.M701996200; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Ko E, 2011, CHEM SOC REV, V40, P4411, DOI 10.1039/c0cs00218f; Lee HB, 2004, J ORG CHEM, V69, P701, DOI 10.1021/jo034167x; LeSauteur L, 1996, NAT BIOTECHNOL, V14, P1120, DOI 10.1038/nbt0996-1120; LESAUTEUR L, 1995, J BIOL CHEM, V270, P6564, DOI 10.1074/jbc.270.12.6564; Liu J, 2010, J MED CHEM, V53, P5044, DOI 10.1021/jm100148d; Longo Frank M., 2005, Current Medicinal Chemistry - Central Nervous System Agents, V5, P29; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; Maliartchouk S, 2000, MOL PHARMACOL, V57, P385; Maliartchouk S, 2000, J BIOL CHEM, V275, P9946, DOI 10.1074/jbc.275.14.9946; Maliartchouk S, 1997, J NEUROSCI, V17, P6031; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Pattarawarapan M, 2002, J MED CHEM, V45, P4387, DOI 10.1021/jm0255421; Rubin Joshua B, 2003, Cancer Treat Res, V115, P1; Saragovi HU, 2000, TRENDS PHARMACOL SCI, V21, P93, DOI 10.1016/S0165-6147(99)01444-3; Saragovi HU, 1999, EXPERT OPIN THER PAT, V9, P737, DOI 10.1517/13543776.9.6.737; Saragovi HU, 1998, J BIOL CHEM, V273, P34933, DOI 10.1074/jbc.273.52.34933; Saragovi HU, 2002, CURR PHARM DESIGN, V8, P2201, DOI 10.2174/1381612023393215; Zaccaro MC, 2005, CHEM BIOL, V12, P1015, DOI 10.1016/j.chembiol.2005.06.015; Zaccaro MC, 2001, J BIOL CHEM, V276, P31023, DOI 10.1074/jbc.M104630200; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	30	11	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89617	10.1371/journal.pone.0089617	http://dx.doi.org/10.1371/journal.pone.0089617			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603864	Green Published, gold, Green Submitted			2022-12-25	WOS:000332483600016
J	Kanaan, RA; Chaddock, C; Allin, M; Picchioni, MM; Daly, E; Shergill, SS; McGuire, PK				Kanaan, Richard A.; Chaddock, Christopher; Allin, Matthew; Picchioni, Marco M.; Daly, Eileen; Shergill, Sukhi S.; McGuire, Philip K.			Gender Influence on White Matter Microstructure: A Tract-Based Spatial Statistics Analysis	PLOS ONE			English	Article							HUMAN CORPUS-CALLOSUM; DIFFUSION-TENSOR; HUMAN BRAIN; SEX-DIFFERENCES; CEREBELLAR VOLUME; HEALTHY-INDIVIDUALS; NERVOUS-SYSTEM; TRANSFER TIME; AGE; DTI	Background: Sexual dimorphism in human brain structure is well recognised, but less is known about gender differences in white matter microstructure. We used diffusion tensor imaging to explore gender differences in fractional anisotropy (FA), an index of microstructural integrity. We previously found increased FA in the corpus callosum in women, and increased FA in the cerebellum and left superior longitudinal fasciculus (SLF) in men, using a whole-brain voxel-based analysis. Methods: A whole-brain tract-based spatial statistics analysis of 120 matched subjects from the previous analysis, and 134 new subjects (147 men and 107 women in total) using a 1.5T scanner, with division into tract-based regions of interest. Results: Men had higher FA in the superior cerebellar peduncles and women had higher FA in corpus callosum in both the first and second samples. The higher SLF FA in men was not found in either sample. Discussion: We confirmed our previous, controversial finding of increased FA in the corpus callosum in women, and increased cerebellar FA in men. The corpus callosum FA difference offers some explanation for the otherwise puzzling advantage in inter-callosal transfer time shown in women; the cerebellar FA difference may be associated with the developmental motor advantage shown in men.	[Kanaan, Richard A.] Univ Melbourne, Dept Psychiat, Austin Hlth, Heidelberg, Vic, Australia; [Chaddock, Christopher; Allin, Matthew; Picchioni, Marco M.; Shergill, Sukhi S.; McGuire, Philip K.] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, London WC2R 2LS, England; [Picchioni, Marco M.] Kings Coll London, St Andrews Acad Ctr, Northampton, England; [Daly, Eileen] Kings Coll London, Inst Psychiat, Dept Dev Psychiat, London WC2R 2LS, England	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of London; King's College London; University of London; King's College London; University of London; King's College London	Kanaan, RA (corresponding author), Univ Melbourne, Dept Psychiat, Austin Hlth, Heidelberg, Vic, Australia.	richard.kanaan@unimelb.edu.au	Picchioni, Marco M/E-3300-2010	Picchioni, Marco M/0000-0001-6681-147X; shergill, sukhi/0000-0003-4928-9100; McGuire, Philip/0000-0003-4381-0532; Kanaan, Richard/0000-0003-0992-1917; Daly, Eileen/0000-0003-3625-3467	Wellcome Trust [072555, 064971]; Medical Research Council [G0901868] Funding Source: researchfish; MRC [G0901868] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by fellowships from the Wellcome Trust (072555 to RK, 064971 to MP and SS). http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2002, NEUROBIOL AGING, V23, P433, DOI 10.1016/S0197-4580(01)00318-9; Allen JS, 2002, AM J PHYS ANTHROPOL, V118, P341, DOI 10.1002/ajpa.10092; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bava S, 2010, BRAIN RES; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brun CC, 2009, NEUROREPORT, V20, P930, DOI 10.1097/WNR.0b013e32832c5e65; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Chen XH, 2007, NEUROIMAGE, V36, P691, DOI 10.1016/j.neuroimage.2007.03.063; Chung SC, 2005, BRAIN RES, V1042, P233, DOI 10.1016/j.brainres.2005.02.033; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; De Bondt T, 2013, EUR RADIOL, V23, P57, DOI 10.1007/s00330-012-2572-5; Duarte-Carvajalino JM, 2012, NEUROIMAGE, V59, P3784, DOI 10.1016/j.neuroimage.2011.10.096; ESCALONA PR, 1991, AM J NEURORADIOL, V12, P927; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gur RC, 1999, J NEUROSCI, V19, P4065; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hsu JL, 2008, NEUROIMAGE, V39, P566, DOI 10.1016/j.neuroimage.2007.09.017; Huster RJ, 2009, HUM BRAIN MAPP, V30, P383, DOI 10.1002/hbm.20509; Hutchinson S, 2003, CEREB CORTEX, V13, P943, DOI 10.1093/cercor/13.9.943; Iacoboni M, 2000, BRAIN, V123, P759, DOI 10.1093/brain/123.4.759; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Jones DK, 2002, HUM BRAIN MAPP, V15, P216, DOI 10.1002/hbm.10018; Kanaan RAA, 2005, BIOL PSYCHIAT, V58, P921, DOI 10.1016/j.biopsych.2005.05.015; Kanaan RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038272; Kang XJ, 2011, NEUROIMAGE, V56, P2011, DOI 10.1016/j.neuroimage.2011.03.016; Lee CEC, 2009, NEURORADIOLOGY, V51, P3, DOI 10.1007/s00234-008-0441-3; Lix LM, 2010, PSYCHOL METHODS, V15, P268, DOI 10.1037/a0017737; Menzler K, 2011, NEUROIMAGE, V54, P2557, DOI 10.1016/j.neuroimage.2010.11.029; Moes PE, 2007, NEUROPSYCHOLOGIA, V45, P2626, DOI 10.1016/j.neuropsychologia.2007.03.017; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Nopoulos P, 2000, PSYCHIAT RES-NEUROIM, V98, P1, DOI 10.1016/S0925-4927(99)00044-X; Oh JS, 2007, NEUROIMAGE, V36, P606, DOI 10.1016/j.neuroimage.2007.03.020; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Pal D, 2011, J CLIN NEUROSCI, V18, P193, DOI 10.1016/j.jocn.2010.05.033; Pangelinan MM, 2011, NEUROIMAGE, V54, P3093, DOI 10.1016/j.neuroimage.2010.11.021; Perrin JS, 2008, J NEUROSCI, V28, P9519, DOI 10.1523/JNEUROSCI.1212-08.2008; Powell JL, 2012, NEUROSCIENCE, V207, P227, DOI 10.1016/j.neuroscience.2012.01.016; Schulte T, 2005, CEREB CORTEX, V15, P1384, DOI 10.1093/cercor/bhi020; Schulte T, 2004, NEUROPSYCHOLOGIA, V42, P257, DOI 10.1016/S0028-3932(03)00155-6; Shin YW, 2005, NEUROREPORT, V16, P795, DOI 10.1097/00001756-200505310-00003; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sullivan EV, 2001, NEUROREPORT, V12, P99, DOI 10.1097/00001756-200101220-00027; Szabo CA, 2003, AM J NEURORADIOL, V24, P644; Szeszko PR, 2003, NEUROREPORT, V14, P2469, DOI 10.1097/00001756-200312190-00035; THOMAS JR, 1985, PSYCHOL BULL, V98, P260, DOI 10.1037/0033-2909.98.2.260; Tuch DS, 2005, P NATL ACAD SCI USA, V102, P12212, DOI 10.1073/pnas.0407259102; Westerhausen R, 2004, COGNITIVE BRAIN RES, V21, P418, DOI 10.1016/j.cogbrainres.2004.07.002; Westerhausen R, 2003, NEUROSCI LETT, V351, P99, DOI 10.1016/j.neulet.2003.07.011; Whitford TJ, 2011, NEUROIMAGE, V54, P2318, DOI 10.1016/j.neuroimage.2010.10.048; Wu YC, 2011, NEUROIMAGE, V54, P1840, DOI 10.1016/j.neuroimage.2010.09.067	52	32	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91109	10.1371/journal.pone.0091109	http://dx.doi.org/10.1371/journal.pone.0091109			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603769	gold, Green Published, Green Submitted			2022-12-25	WOS:000332483600130
J	Prakash, S; Sundd, M; Guptasarma, P				Prakash, Satya; Sundd, Monica; Guptasarma, Purnananda			The Key to the Extraordinary Thermal Stability of P. furiosus Holo-Rubredoxin: Iron Binding-Guided Packing of a Core Aromatic Cluster Responsible for High Kinetic Stability of the Native Structure	PLOS ONE			English	Article							PYROCOCCUS-FURIOSUS; CLOSTRIDIUM-PASTEURIANUM; PROTEIN; APORUBREDOXINS; STABILIZATION; RESIDUES	Pyrococcus furiosus rubredoxin (PfRd), a small, monomeric, 53 residues-long, iron-containing, electron-transfer protein of known structure is sometimes referred to as being the most structurally-stable protein known to man. Here, using a combination of mutational and spectroscopic (CD, fluorescence, and NMR) studies of differently made holo-and apo-forms of PfRd, we demonstrate that it is not the presence of iron, or even the folding of the PfRd chain into a compact well-folded structure that causes holo-PfRd to display its extraordinary thermal stability, but rather the correct iron binding-guided packing of certain residues (specifically, Trp3, Phe29, Trp36, and also Tyr10) within a tight aromatic cluster of six residues in PfRd's hydrophobic core. Binding of the iron atom appears to play a remarkable role in determining subtle details of residue packing, forcing the chain to form a hyper-thermally stable native structure which is kinetically stable enough to survive (subsequent) removal of iron. On the other hand, failure to bind iron causes the same chain to adopt an equally well-folded native-like structure which, however, has a differently-packed aromatic cluster in its core, causing it to be only as stable as any other ordinary mesophile-derived rubredoxin. Our studies demonstrate, perhaps for the very first time ever that hyperthermal stability in proteins can owe to subtle differences in residue packing vis a vis mesostable proteins, without there being any underlying differences in either amino acid sequence, or bound ligand status.	[Prakash, Satya; Guptasarma, Purnananda] Indian Inst Sci Educ & Res IISER, Dept Biol Sci, Sas Nagar, Punjab, India; [Prakash, Satya; Guptasarma, Purnananda] Inst Microbial Technol IMTECH, Prot Engn Div, Chandigarh, India; [Sundd, Monica] Natl Inst Immunol NII, NMR Lab, New Delhi, India	Indian Institute of Science Education & Research (IISER) - Mohali; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Guptasarma, P (corresponding author), Indian Inst Sci Educ & Res IISER, Dept Biol Sci, Sas Nagar, Punjab, India.	guptasarma@iisermohali.ac.in	Guptasarma, Purnananda/C-3976-2009	Guptasarma, Purnananda/0000-0002-4801-3180				Bonomi F, 2008, J BIOL INORG CHEM, V13, P981, DOI 10.1007/s00775-008-0385-4; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; CAVAGNERO S, 1995, BIOCHEMISTRY-US, V34, P9865, DOI 10.1021/bi00031a007; Cavagnero S, 1998, BIOCHEMISTRY-US, V37, P3369, DOI 10.1021/bi9721795; DAY MW, 1992, PROTEIN SCI, V1, P1494, DOI 10.1002/pro.5560011111; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Hiller R, 1997, P NATL ACAD SCI USA, V94, P11329, DOI 10.1073/pnas.94.21.11329; KLUMP H, 1992, J BIOL CHEM, V267, P22681; LeMaster DM, 2005, PROTEINS, V61, P608, DOI 10.1002/prot.20594; LOVENBERG W, 1965, P NATL ACAD SCI USA, V54, P193, DOI 10.1073/pnas.54.1.193; Mukaiyama A, 2009, INT J MOL SCI, V10, P1369, DOI 10.3390/ijms10031369; Samanta U, 1999, ACTA CRYSTALLOGR D, V55, P1421, DOI 10.1107/S090744499900726X; Shehi E, 2003, BIOCHEMISTRY-US, V42, P8362, DOI 10.1021/bi034520t; Strop P, 1999, J AM CHEM SOC, V121, P2341, DOI 10.1021/ja9834780; Vondrasek J, 2005, J AM CHEM SOC, V127, P2615, DOI 10.1021/ja044607h; Zartler ER, 2001, BIOCHEMISTRY-US, V40, P7279, DOI 10.1021/bi0026831	16	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89703	10.1371/journal.pone.0089703	http://dx.doi.org/10.1371/journal.pone.0089703			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603898	Green Published, Green Submitted, gold			2022-12-25	WOS:000332483600019
J	Park, MJ; Kim, DI; Lim, SK; Choi, JH; Han, HJ; Yoon, KC; Park, SH				Park, Min-Jung; Kim, Dong-Il; Lim, Seul-Ki; Choi, Joo-Hee; Han, Ho-Jae; Yoon, Kyung-Chul; Park, Soo-Hyun			High Glucose-induced O-GlcNAcylated Carbohydrate Response Element-binding Protein ( ChREBP) Mediates Mesangial Cell Lipogenesis and Fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Fibrosis; Kidney Metabolism; Lipogenesis; O-GlcNAcylation	LINKED N-ACETYLGLUCOSAMINE; ENDOTHELIAL GROWTH-FACTOR; RENAL LIPID-METABOLISM; INSULIN-RESISTANCE; TRANSCRIPTIONAL ACTIVITY; DIABETIC-NEPHROPATHY; HEPATIC STEATOSIS; ENZYME GENES; LIVER; EXPRESSION	Background: Abnormal lipid synthesis and fibrosis can lead to diabetic nephropathy. Results: High glucose-induced O-GlcNAcylated ChREBP increases the expression of lipogenic and fibrotic proteins and induces lipid accumulation and fibrosis. Conclusion:O-GlcNAcylated ChREBP mediates lipogenesis and fibrosis in mesangial cells. Significance: This is the first report that O-glycosylated ChREBP plays a pathophysiological role in lipogenesis and fibrosis in mesangial cells. Carbohydrate response element-binding protein (ChREBP) is a transcription factor responsible for carbohydrate metabolism in the liver. However, the role of ChREBP in diabetic nephropathy has not been elucidated. Thus, we investigated the role of ChREBP in mesangial cells in diabetic nephropathy. Treatment with 25 mm glucose (high glucose; HG) increased cellular O-GlcNAc and O-GlcNAcylated ChREBP in mesangial cells compared with normal 5.5 mm glucose. O-(2-acetamido-2-deoxy-d-glucopyranosylidene) amino N-phenylcarbamate (PUGNAc), a drug that increases O-GlcNAc, augmented the expression of ChREBP targets, whereas DON, a drug that decreases O-GlcNAc and O-GlcNAcase overexpression, mitigated the increase with HG. O-GlcNAc augmented the protein stability, transcriptional activity, and nuclear translocation of ChREBP. HG treatment also stimulated lipid accumulation and the contents of triglyceride and cholesterol in mesangial cells. In addition, HG triggered expression of hypoxia-inducible factor 1-, vascular endothelial growth factor, and extracellular matrix components related to nephrosclerosis. The ChREBP mutant, W130A, did not exhibit HG-induced lipid accumulation and fibrotic proteins, suggesting that the Trp-130 residue in the MCR3 domain is important in the development of glomerulosclerosis. O-GlcNAcylated ChREBP was elevated in mesangium cells of streptozotocin-induced diabetic rats. In conclusion, HG increased the O-GlcNAcylated ChREBP level, which resulted in lipid accumulation and up-regulation of fibrotic proteins in mesangial cells. These effects may lead mesangial cells to an ultimately pathological state.	[Park, Min-Jung; Kim, Dong-Il; Lim, Seul-Ki; Choi, Joo-Hee; Park, Soo-Hyun] Chonnam Natl Univ, Coll Vet Med, Dept Vet Physiol, Kwangju 500757, South Korea; [Han, Ho-Jae] Seoul Natl Univ, Coll Vet Med, Dept Vet Physiol, Seoul 151741, South Korea; [Yoon, Kyung-Chul] Chonnam Natl Univ, Med Sch & Hosp, Dept Ophthalmol, Kwangju 501757, South Korea	Chonnam National University; Seoul National University (SNU); Chonnam National University	Park, SH (corresponding author), Chonnam Natl Univ, Coll Vet Med, Dept Vet Physiol, Kwangju 500757, South Korea.	parksh@chonnam.ac.kr	Han, Ho Jae/M-1476-2016	Han, Ho Jae/0000-0002-0657-1766	Korean Science and Engineering Foundation [2011-0016649]	Korean Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by Korean Science and Engineering Foundation Grant 2011-0016649.	Amann K, 2013, SEMIN NEPHROL, V33, P23, DOI 10.1016/j.semnephrol.2012.12.003; Amemiya T, 1999, KIDNEY INT, V56, P2055, DOI 10.1046/j.1523-1755.1999.00796.x; Anthonisen EH, 2010, J BIOL CHEM, V285, P1607, DOI 10.1074/jbc.M109.082685; Cho KH, 2010, BBA-GEN SUBJECTS, V1800, P6, DOI 10.1016/j.bbagen.2009.10.009; Davies MN, 2008, J BIOL CHEM, V283, P24029, DOI 10.1074/jbc.M801539200; DECAUX JF, 1989, J BIOL CHEM, V264, P11584; Degrell P, 2009, LIFE SCI, V84, P389, DOI 10.1016/j.lfs.2009.01.007; Denechaud PD, 2008, FEBS LETT, V582, P68, DOI 10.1016/j.febslet.2007.07.084; Denechaud PD, 2008, J CLIN INVEST, V118, P956, DOI 10.1172/JCI34314; Dentin R, 2005, BIOCHIMIE, V87, P81, DOI 10.1016/j.biochi.2004.11.008; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Ferre P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x; Fong JJ, 2012, J BIOL CHEM, V287, P12195, DOI 10.1074/jbc.M111.315804; Goldberg H, 2011, AM J PHYSIOL-ENDOC M, V301, pE713, DOI 10.1152/ajpendo.00108.2011; Guinez C, 2011, DIABETES, V60, P1399, DOI 10.2337/db10-0452; Guo K, 2012, ONCOL REP, V28, P494, DOI 10.3892/or.2012.1844; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Ido-Kitamura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047231; Iizuka K, 2008, ENDOCR J, V55, P617, DOI 10.1507/endocrj.K07E-110; Isoe T, 2010, KIDNEY INT, V78, P48, DOI 10.1038/ki.2010.99; Jeong YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022544; Jiang T, 2005, J BIOL CHEM, V280, P32317, DOI 10.1074/jbc.M500801200; Jiang T, 2005, J AM SOC NEPHROL, V16, P2385, DOI 10.1681/ASN.2004080701; Kiss E, 2013, AM J PATHOL, V182, P727, DOI 10.1016/j.ajpath.2012.11.033; KLAHR S, 1989, KIDNEY INT, V36, pS27; Lehir M, 2007, CURR OPIN NEPHROL HY, V16, P184, DOI 10.1097/MNH.0b013e3280c8eed3; Liu E, 2007, J AM SOC NEPHROL, V18, P2094, DOI 10.1681/ASN.2006010075; Oda H, 1997, KIDNEY INT, V52, pS36; Park SY, 2005, EXP MOL MED, V37, P220, DOI 10.1038/emm.2005.30; Parker GJ, 2003, J BIOL CHEM, V278, P10022, DOI 10.1074/jbc.M207787200; Potter KA, 2012, J NEUROSCI METH, V203, P96, DOI 10.1016/j.jneumeth.2011.09.024; Proctor G, 2006, DIABETES, V55, P2502, DOI 10.2337/db05-0603; Sakiyama H, 2010, BIOCHEM BIOPH RES CO, V402, P784, DOI 10.1016/j.bbrc.2010.10.113; Sakiyama H, 2008, J BIOL CHEM, V283, P24899, DOI 10.1074/jbc.M804308200; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Stoeckman AK, 2004, J BIOL CHEM, V279, P15662, DOI 10.1074/jbc.M311301200; Sun LJ, 2002, J BIOL CHEM, V277, P18919, DOI 10.1074/jbc.M110650200; Sun YM, 2013, BIOCHEM BIOPH RES CO, V433, P359, DOI 10.1016/j.bbrc.2013.02.120; Tovar-Palacio C, 2011, AM J PHYSIOL-RENAL, V300, pF263, DOI 10.1152/ajprenal.00171.2010; Towle HC, 1997, ANNU REV NUTR, V17, P405, DOI 10.1146/annurev.nutr.17.1.405; Tsatsos NG, 2006, BIOCHEM BIOPH RES CO, V340, P449, DOI 10.1016/j.bbrc.2005.12.029; Wang ZW, 2005, DIABETES, V54, P2328, DOI 10.2337/diabetes.54.8.2328; Weinberg JM, 2006, KIDNEY INT, V70, P1560, DOI 10.1038/sj.ki.5001834; Whelan SA, 2010, J BIOL CHEM, V285, P5204, DOI 10.1074/jbc.M109.077818; Wu TT, 2013, AM J PHYSIOL-RENAL, V304, pF820, DOI 10.1152/ajprenal.00294.2012; Ziyadeh FN, 2008, CURR DIABETES REV, V4, P39, DOI 10.2174/157339908783502370	48	63	73	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2014	289	19					13519	13530		10.1074/jbc.M113.530139	http://dx.doi.org/10.1074/jbc.M113.530139			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG6IR	24616092	Green Published, hybrid			2022-12-25	WOS:000335522800047
J	Feng, C; Liu, Y; Wang, GQ; Deng, ZQ; Zhang, Q; Wu, W; Tong, YF; Cheng, CM; Chen, ZZ				Feng, Chong; Liu, Yang; Wang, Guoqiang; Deng, Zengqin; Zhang, Qi; Wu, Wei; Tong, Yufeng; Cheng, Changmei; Chen, Zhongzhou			Crystal Structures of the Human RNA Demethylase Alkbh5 Reveal Basis for Substrate Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Drug Design; Enzyme Inhibitors; mRNA; RNA Modification; AlkB; Alkbh5; Substrate Recognition; m(6)A Demethylase	OXIDATIVE DEMETHYLATION; DNA-DAMAGE; MOLECULAR-REPLACEMENT; PROTEIN COMPLEXES; MESSENGER; REPAIR; MOUSE; GENE; N6-METHYLADENOSINE; 3-METHYLTHYMINE	Background: Human AlkB homolog 5 (Alkbh5) is an RNA demethylase that erases m(6)A modification. Results: Crystal structures of an enzymatically active Alkbh5 construct in complex with cofactors or small molecules were determined. Conclusion: Structure and activity analyses showed that Alkbh5 strongly prefers single-stranded oligos and small molecule inhibitors. Significance: The Alkbh5 structure reveals potential for structure-based design of selective inhibitors. N-6-Methylation of adenosine is the most ubiquitous and abundant modification of nucleoside in eukaryotic mRNA and long non-coding RNA. This modification plays an essential role in the regulation of mRNA translation and RNA metabolism. Recently, human AlkB homolog 5 (Alkbh5) and fat mass- and obesity-associated protein (FTO) were shown to erase this methyl modification on mRNA. Here, we report five high resolution crystal structures of the catalytic core of Alkbh5 in complex with different ligands. Compared with other AlkB proteins, Alkbh5 displays several unique structural features on top of the conserved double-stranded -helix fold typical of this protein family. Among the unique features, a distinct lid region of Alkbh5 plays a vital role in substrate recognition and catalysis. An unexpected disulfide bond between Cys-230 and Cys-267 is crucial for the selective binding of Alkbh5 to single-stranded RNA/DNA by bringing a flipping motif toward the central -helix fold. We generated a substrate binding model of Alkbh5 based on a demethylation activity assay of several structure-guided site-directed mutants. Crystallographic and biochemical studies using various analogs of -ketoglutarate revealed that the active site cavity of Alkbh5 is much smaller than that of FTO and preferentially binds small molecule inhibitors. Taken together, our findings provide a structural basis for understanding the substrate recognition specificity of Alkbh5 and offer a foundation for selective drug design against AlkB members.	[Feng, Chong; Liu, Yang; Wang, Guoqiang; Deng, Zengqin; Zhang, Qi; Wu, Wei; Chen, Zhongzhou] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Cheng, Changmei] Tsinghua Univ, Dept Chem, Minist Educ, Key Lab Bioorgan Phosphorus Chem & Chem Biol, Beijing 100084, Peoples R China; [Tong, Yufeng] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Tong, Yufeng] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5G 1L7, Canada	China Agricultural University; Tsinghua University; University of Toronto; Structural Genomics Consortium; University of Toronto	Cheng, CM (corresponding author), Tsinghua Univ, Dept Chem, Minist Educ, Key Lab Bioorgan Phosphorus Chem & Chem Biol, Beijing 100084, Peoples R China.	chengcm@mail.tsinghua.edu.cn; chenzhongzhou@cau.edu.cn	chen, zhong/E-3900-2015; Tong, Yufeng/D-2785-2011; Deng, Zengqin/AAK-5194-2021	chen, zhong/0000-0003-1319-9664; Tong, Yufeng/0000-0001-7740-1812; Liu, Yang/0000-0003-0679-2275; Deng, Zengqin/0000-0002-5658-2068; Zhang, Qi/0000-0003-1121-8817	National Basic Research Program of China (973 Program) [2011CB965304, 2009CB825501]; National Natural Science Foundation of China [31370720, 31222032, 90919043, 31070664]; Specialized Research Fund for the Doctoral Program of Higher Education [20100008110009]; National Laboratory of Medical Molecular Biology (Peking Union Medical College)	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Laboratory of Medical Molecular Biology (Peking Union Medical College)	This work was supported by the National Basic Research Program of China (973 Program Grants 2011CB965304 and 2009CB825501), National Natural Science Foundation of China (Grants 31370720, 31222032, 90919043, and 31070664), Specialized Research Fund for the Doctoral Program of Higher Education (Grant 20100008110009), and National Laboratory of Medical Molecular Biology (Peking Union Medical College) (to Z. C.).	Aik W, 2013, J MED CHEM, V56, P3680, DOI 10.1021/jm400193d; Aik W, 2012, CURR OPIN STRUC BIOL, V22, P691, DOI 10.1016/j.sbi.2012.10.001; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; CANAANI D, 1979, NUCLEIC ACIDS RES, V6, P2879, DOI 10.1093/nar/6.8.2879; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Fu Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2822; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; HARPER JE, 1990, NUCLEIC ACIDS RES, V18, P5735, DOI 10.1093/nar/18.19.5735; Holland PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008680; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Karkhanis V, 2012, J BIOL CHEM, V287, P29801, DOI 10.1074/jbc.M112.378281; Lee DH, 2005, J BIOL CHEM, V280, P39448, DOI 10.1074/jbc.M509881200; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McDonough MA, 2010, CURR OPIN STRUC BIOL, V20, P659, DOI 10.1016/j.sbi.2010.08.006; Meyer KC, 2012, DIFFUSE LUNG DISEASE: A PRACTICAL APPROACH, SECOND EDITION, P3, DOI 10.1007/978-1-4419-9771-5_1; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Niu Yamei, 2013, Genomics Proteomics & Bioinformatics, V11, P8, DOI 10.1016/j.gpb.2012.12.002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan T, 2013, TRENDS BIOCHEM SCI, V38, P204, DOI 10.1016/j.tibs.2012.12.006; Pastore C, 2012, J BIOL CHEM, V287, P2130, DOI 10.1074/jbc.M111.286187; Sundheim O, 2008, DNA REPAIR, V7, P1916, DOI 10.1016/j.dnarep.2008.07.015; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Thalhammer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016210; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Tsujikawa K, 2007, J CELL MOL MED, V11, P1105, DOI 10.1111/j.1582-4934.2007.00094.x; WEI CM, 1975, NATURE, V257, P251, DOI 10.1038/257251a0; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu LJ, 2009, ACTA CRYSTALLOGR D, V65, P1213, DOI 10.1107/S0907444909037044; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561; Zheng GQ, 2013, RNA BIOL, V10, P915, DOI 10.4161/rna.24711; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zody MC, 2006, NATURE, V440, P1045, DOI 10.1038/nature04689	49	112	116	6	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11571	11583		10.1074/jbc.M113.546168	http://dx.doi.org/10.1074/jbc.M113.546168			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24616105	Green Published, hybrid			2022-12-25	WOS:000335010600001
J	Zhang, TH; Muraih, JK; Tishbi, N; Herskowitz, J; Victor, RL; Silverman, J; Uwumarenogie, S; Taylor, SD; Palmer, M; Mintzer, E				Zhang, TianHua; Muraih, Jawad K.; Tishbi, Nasim; Herskowitz, Jennifer; Victor, Rachel L.; Silverman, Jared; Uwumarenogie, Stephanie; Taylor, Scott D.; Palmer, Michael; Mintzer, Evan			Cardiolipin Prevents Membrane Translocation and Permeabilization by Daptomycin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotic Resistance; Antibiotics Action; Cardiolipin; Fluorescence; Isothermal Titration Calorimetry; Liposomes; Phosphatidylglycerol; Langmuir Monolayers; Lipopeptides	RESISTANT STAPHYLOCOCCUS-AUREUS; BACILLUS-SUBTILIS; OLIGOMER FORMATION; SUSCEPTIBILITY; INHIBITION; STRAINS; BINDING	Background: Daptomycin forms oligomeric pores in bacterial cell membranes. Cardiolipin is a membrane lipid associated with bacterial resistance to the antibiotic. Results: Cardiolipin makes liposomes impervious to daptomycin permeabilization, and it confines daptomycin to the outer membrane leaflet. Conclusion: Preventing daptomycin from reaching the inner membrane leaflet inhibits pore formation. Significance: Bacteria may become resistant to daptomycin by changing their membrane lipid composition. Daptomycin is an acidic lipopeptide antibiotic that, in the presence of calcium, forms oligomeric pores on membranes containing phosphatidylglycerol. It is clinically used against various Gram-positive bacteria such as Staphylococcus aureus and Enterococcus species. Genetic studies have indicated that an increased content of cardiolipin in the bacterial membrane may contribute to bacterial resistance against the drug. Here, we used a liposome model to demonstrate that cardiolipin directly inhibits membrane permeabilization by daptomycin. When cardiolipin is added at molar fractions of 10 or 20% to membranes containing phosphatidylglycerol, daptomycin no longer forms pores or translocates to the inner membrane leaflet. Under the same conditions, daptomycin continues to form oligomers; however, these oligomers contain only close to four subunits, which is approximately half as many as observed on membranes without cardiolipin. The collective findings lead us to propose that a daptomycin pore consists of two aligned tetramers in opposite leaflets and that cardiolipin prevents the translocation of tetramers to the inner leaflet, thereby forestalling the formation of complete, octameric pores. Our findings suggest a possible mechanism by which cardiolipin may mediate resistance to daptomycin, and they provide new insights into the action mode of this important antibiotic.	[Zhang, TianHua; Uwumarenogie, Stephanie; Taylor, Scott D.; Palmer, Michael] Univ Waterloo, Dept Chem, Waterloo, ON N2L 3G1, Canada; [Muraih, Jawad K.] Univ Al Muthanna, Dept Chem, Samawah, Al Muthanna, Iraq; [Tishbi, Nasim; Herskowitz, Jennifer; Victor, Rachel L.; Mintzer, Evan] Yeshiva Univ, Stern Coll Women, Dept Chem & Biochem, New York, NY 10033 USA; [Silverman, Jared] Cubist Pharmaceut Inc, Lexington, MA 02421 USA	University of Waterloo; Yeshiva University	Palmer, M (corresponding author), Univ Waterloo, Dept Chem, Waterloo, ON N2L 3G1, Canada.	mpalmer@uwaterloo.ca	Muraih, Jawad K./F-1873-2019; Muraih, Jawad/ABD-1923-2020	Muraih, Jawad K./0000-0003-0720-0876; 	Collaborative Health Research Project (CHRP) grant by the Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health Research (CHIR)	Collaborative Health Research Project (CHRP) grant by the Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CHIR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a Collaborative Health Research Project (CHRP) grant by the Natural Sciences and Engineering Research Council of Canada (NSERC) and Canadian Institutes of Health Research (CHIR) (to S. D. T. and M. P.).	Abraham T, 2005, BIOCHEMISTRY-US, V44, P2103, DOI 10.1021/bi048077d; ALBORN WE, 1991, ANTIMICROB AGENTS CH, V35, P2282, DOI 10.1128/AAC.35.11.2282; Baltz RH, 2009, CURR OPIN CHEM BIOL, V13, P144, DOI 10.1016/j.cbpa.2009.02.031; CLEJAN S, 1986, J BACTERIOL, V168, P334, DOI 10.1128/jb.168.1.334-340.1986; Davlieva M, 2013, ANTIMICROB AGENTS CH, V57, P289, DOI 10.1128/AAC.01743-12; Friedman L, 2006, ANTIMICROB AGENTS CH, V50, P2137, DOI 10.1128/AAC.00039-06; Hachmann AB, 2009, ANTIMICROB AGENTS CH, V53, P1598, DOI 10.1128/AAC.01329-08; Jo G, 2011, J MICROBIOL BIOTECHN, V21, P1097, DOI 10.4014/jmb.1103.03026; Kawai F, 2004, J BACTERIOL, V186, P1475, DOI 10.1128/JB.186.5.1475-1483.2004; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Laganas V, 2003, ANTIMICROB AGENTS CH, V47, P2682, DOI 10.1128/AAC.47.8.2682-2684.2003; LAKEY JH, 1988, BIOCHEMISTRY-US, V27, P4639, DOI 10.1021/bi00413a009; Mascio C., 2009, 49 INT C ANT AG CHEM; Matsuzaki K, 1998, BIOCHEMISTRY-US, V37, P11856, DOI 10.1021/bi980539y; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; MCINTYRE JC, 1991, BIOCHEMISTRY-US, V30, P11819, DOI 10.1021/bi00115a012; Mishra NN, 2013, ANTIMICROB AGENTS CH, V57, P1082, DOI 10.1128/AAC.02182-12; Mishra NN, 2009, ANTIMICROB AGENTS CH, V53, P2312, DOI 10.1128/AAC.01682-08; Muraih JK, 2012, BBA-BIOMEMBRANES, V1818, P1642, DOI 10.1016/j.bbamem.2012.02.019; Muraih JK, 2012, BBA-BIOMEMBRANES, V1818, P673, DOI 10.1016/j.bbamem.2011.10.027; Muraih JK, 2011, BBA-BIOMEMBRANES, V1808, P1154, DOI 10.1016/j.bbamem.2011.01.001; OPDENKAMP JA, 1969, J BACTERIOL, V99, P298, DOI 10.1128/JB.99.1.298-303.1969; Palmer Kelli L, 2011, Antimicrob Agents Chemother, V55, P3345, DOI 10.1128/AAC.00207-11; Pogliano J, 2012, J BACTERIOL, V194, P4494, DOI 10.1128/JB.00011-12; Silverman JA, 2003, ANTIMICROB AGENTS CH, V47, P2538, DOI 10.1128/AAC.47.8.2538-2544.2003; Tran TT, 2013, ANTIMICROB AGENTS CH, V57, P261, DOI 10.1128/AAC.01454-12; Zhang TH, 2013, BBA-BIOMEMBRANES, V1828, P302, DOI 10.1016/j.bbamem.2012.10.008	28	102	103	3	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11584	11591		10.1074/jbc.M114.554444	http://dx.doi.org/10.1074/jbc.M114.554444			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24616102	Green Published, hybrid			2022-12-25	WOS:000335010600002
J	Brannstrom, K; Lindhagen-Persson, M; Gharibyan, AL; Iakovleva, I; Vestling, M; Sellin, ME; Brannstrom, T; Morozova-Roche, L; Forsgren, L; Olofsson, A				Brannstrom, Kristoffer; Lindhagen-Persson, Malin; Gharibyan, Anna L.; Iakovleva, Irina; Vestling, Monika; Sellin, Mikael E.; Brannstrom, Thomas; Morozova-Roche, Ludmilla; Forsgren, Lars; Olofsson, Anders			A Generic Method for Design of Oligomer-Specific Antibodies	PLOS ONE			English	Article							A-BETA OLIGOMERS; ALZHEIMERS-DISEASE; AMYLOID-BETA; MONOCLONAL-ANTIBODIES; PREFIBRILLAR OLIGOMERS; PASSIVE-IMMUNIZATION; PARKINSONS-DISEASE; TAU OLIGOMERS; SOLUTION NMR; IN-VIVO	Antibodies that preferentially and specifically target pathological oligomeric protein and peptide assemblies, as opposed to their monomeric and amyloid counterparts, provide therapeutic and diagnostic opportunities for protein misfolding diseases. Unfortunately, the molecular properties associated with oligomer-specific antibodies are not well understood, and this limits targeted design and development. We present here a generic method that enables the design and optimisation of oligomer-specific antibodies. The method takes a two-step approach where discrimination between oligomers and fibrils is first accomplished through identification of cryptic epitopes exclusively buried within the structure of the fibrillar form. The second step discriminates between monomers and oligomers based on differences in avidity. We show here that a simple divalent mode of interaction, as within e. g. the IgG isotype, can increase the binding strength of the antibody up to 1500 times compared to its monovalent counterpart. We expose how the ability to bind oligomers is affected by the monovalent affinity and the turnover rate of the binding and, importantly, also how oligomer specificity is only valid within a specific concentration range. We provide an example of the method by creating and characterising a spectrum of different monoclonal antibodies against both the A beta peptide and alpha-synuclein that are associated with Alzheimer's and Parkinson's diseases, respectively. The approach is however generic, does not require identification of oligomer-specific architectures, and is, in essence, applicable to all polypeptides that form oligomeric and fibrillar assemblies.	[Brannstrom, Kristoffer; Lindhagen-Persson, Malin; Gharibyan, Anna L.; Iakovleva, Irina; Vestling, Monika; Morozova-Roche, Ludmilla; Olofsson, Anders] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Sellin, Mikael E.] Umea Univ, Dept Mol Biol, Umea, Sweden; [Brannstrom, Thomas] Umea Univ, Dept Med Biosci, Umea, Sweden; [Forsgren, Lars] Umea Univ, Dept Clin Pharmacol & Clin Neurosci, Umea, Sweden	Umea University; Umea University; Umea University; Umea University	Olofsson, A (corresponding author), Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden.	anders.olofsson@medchem.umu.se	Gharibyan, Anna L./B-3401-2010; Morozova-Roche, Ludmilla/AAV-9983-2021; Brännström, Kristoffer/AAC-1204-2020; Morozova-Roche, Ludmilla A./AAU-9044-2021	Gharibyan, Anna L./0000-0001-9070-6215; Morozova-Roche, Ludmilla/0000-0001-5886-2023; Sellin, Mikael/0000-0002-8355-0803	Parkinsonfonden; Insamlingsstiftelsen Umea University; Alzheimerfonden; Swedish Research Council; Magn. Bergvalls stiftelse; O.E. och Edlas stiftelse; FAMY; Torsten Soderbergs stiftelse; Vasterbottens lans lansting (ALF medel); Medical Faculty of Umea University	Parkinsonfonden; Insamlingsstiftelsen Umea University; Alzheimerfonden; Swedish Research Council(Swedish Research CouncilEuropean Commission); Magn. Bergvalls stiftelse; O.E. och Edlas stiftelse; FAMY; Torsten Soderbergs stiftelse; Vasterbottens lans lansting (ALF medel); Medical Faculty of Umea University	This work was supported by Parkinsonfonden, Insamlingsstiftelsen Umea University, Alzheimerfonden, J.C. Kempe, the Swedish Research Council, Magn. Bergvalls stiftelse, O.E. och Edlas stiftelse, FAMY, Torsten Soderbergs stiftelse, Vasterbottens lans lansting (ALF medel) and the Medical Faculty of Umea University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson O, 2012, J NEUROSCI, V32, P9677, DOI 10.1523/JNEUROSCI.4742-11.2012; [Anonymous], 2012, INT J ALZHEIMERS DIS; Arai H, 2012, BBA-GEN SUBJECTS, V1820, P1908, DOI 10.1016/j.bbagen.2012.08.016; Bae EJ, 2012, J NEUROSCI, V32, P13454, DOI 10.1523/JNEUROSCI.1292-12.2012; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bidinosti M, 2012, J BIOL CHEM, V287, P33691, DOI 10.1074/jbc.M112.379792; Boutajangout A, 2011, J NEUROCHEM, V118, P658, DOI 10.1111/j.1471-4159.2011.07337.x; Cappai R, 2005, FASEB J, V19, P1377, DOI 10.1096/fj.04-3437fje; Castillo-Carranza Diana L, 2013, Front Biosci (Schol Ed), V5, P426; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Danzer KM, 2009, J NEUROCHEM, V111, P192, DOI 10.1111/j.1471-4159.2009.06324.x; Delrieu J, 2012, J NEUROCHEM, V120, P186, DOI 10.1111/j.1471-4159.2011.07458.x; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; DOTY P, 1953, DISCUSS FARADAY SOC, P51; Fawzi NL, 2011, NATURE, V480, P268, DOI 10.1038/nature10577; Frost JL, 2012, NEURODEGENER DIS, V10, P265, DOI 10.1159/000335913; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; Haupt C, 2011, J MOL BIOL, V405, P341, DOI 10.1016/j.jmb.2010.10.059; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Kawasaki Y, 2011, DRUG DISCOV TODAY, V16, P985, DOI 10.1016/j.drudis.2011.07.010; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-57; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 2009, CNS NEUROL DISORD-DR, V8, P65, DOI 10.2174/187152709787601876; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Lasagna-Reeves CA, 2011, CURR ALZHEIMER RES, V8, P659; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Lee EB, 2006, J BIOL CHEM, V281, P4292, DOI 10.1074/jbc.M511018200; Leliveld SR, 2007, J NEUROSCI RES, V85, P2285, DOI 10.1002/jnr.21353; Lindhagen-Persson M, 2008, AMYLOID, V15, P240, DOI 10.1080/13506120802524916; Lindhagen-Persson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013928; Ma QL, 2006, J NEUROSCI RES, V83, P374, DOI 10.1002/jnr.20734; Masliah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019338; Meinhardt K, 2012, P NATL ACAD SCI US; Morgado I, 2012, P NATL ACAD SCI USA, V109, P12503, DOI 10.1073/pnas.1206433109; Mougenot A. L., 2011, NEUROBIOL AGING; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Olofsson A, 2006, J BIOL CHEM, V281, P477, DOI 10.1074/jbc.M508962200; Park MJ, 2011, J CLIN NEUROL, V7, P215, DOI 10.3988/jcn.2011.7.4.215; Perchiacca JM, 2012, P NATL ACAD SCI USA, V109, P84, DOI 10.1073/pnas.1111232108; Robert R, 2010, MOL IMMUNOL, V48, P59, DOI 10.1016/j.molimm.2010.09.012; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Sehlin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032014; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Shughrue PJ, 2010, NEUROBIOL AGING, V31, P189, DOI 10.1016/j.neurobiolaging.2008.04.003; Sipe JD, 2012, AMYLOID, V19, P167, DOI 10.3109/13506129.2012.734345; Sousa MM, 2001, AM J PATHOL, V159, P1993; Tayebi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019998; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Valera E, 2013, PHARM THER; Vilches-Moure JG, 2005, J VET DIAGN INVEST, V17, P346, DOI 10.1177/104063870501700407; Walsh DM, 2005, BIOCHEM SOC T, V33, P1087, DOI 10.1042/BST0331087; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wegiel J, 2007, ACTA NEUROPATHOL, V113, P389, DOI 10.1007/s00401-006-0191-4	59	34	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90857	10.1371/journal.pone.0090857	http://dx.doi.org/10.1371/journal.pone.0090857			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618582	Green Submitted, Green Published, gold			2022-12-25	WOS:000332842400033
J	Groesbeck, AS; Rowell, K; Lepofsky, D; Salomon, AK				Groesbeck, Amy S.; Rowell, Kirsten; Lepofsky, Dana; Salomon, Anne K.			Ancient Clam Gardens Increased Shellfish Production: Adaptive Strategies from the Past Can Inform Food Security Today	PLOS ONE			English	Article							HUMAN IMPACTS; RESOURCE-MANAGEMENT; BRITISH-COLUMBIA; NORTHWEST COAST; COMMUNITY; PREDATORS; GROWTH; ISLAND; SUSTAINABILITY; RESILIENCE	Maintaining food production while sustaining productive ecosystems is among the central challenges of our time, yet, it has been for millennia. Ancient clam gardens, intertidal rock-walled terraces constructed by humans during the late Holocene, are thought to have improved the growing conditions for clams. We tested this hypothesis by comparing the beach slope, intertidal height, and biomass and density of bivalves at replicate clam garden and non-walled clam beaches in British Columbia, Canada. We also quantified the variation in growth and survival rates of littleneck clams (Leukoma staminea) we experimentally transplanted across these two beach types. We found that clam gardens had significantly shallower slopes than non-walled beaches and greater densities of L. staminea and Saxidomus giganteus, particularly at smaller size classes. Overall, clam gardens contained 4 times as many butter clams and over twice as many littleneck clams relative to non-walled beaches. As predicted, this relationship varied as a function of intertidal height, whereby clam density and biomass tended to be greater in clam gardens compared to non-walled beaches at relatively higher intertidal heights. Transplanted juvenile L. staminea grew 1.7 times faster and smaller size classes were more likely to survive in clam gardens than non-walled beaches, specifically at the top and bottom of beaches. Consequently, we provide strong evidence that ancient clam gardens likely increased clam productivity by altering the slope of soft-sediment beaches, expanding optimal intertidal clam habitat, thereby enhancing growing conditions for clams. These results reveal how ancient shellfish aquaculture practices may have supported food security strategies in the past and provide insight into tools for the conservation, management, and governance of intertidal seascapes today.	[Groesbeck, Amy S.; Salomon, Anne K.] Simon Fraser Univ, Sch Resource & Environm Management, Burnaby, BC V5A 1S6, Canada; [Rowell, Kirsten] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Lepofsky, Dana] Simon Fraser Univ, Dept Archaeol, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; University of Washington; University of Washington Seattle; Simon Fraser University	Groesbeck, AS (corresponding author), Simon Fraser Univ, Sch Resource & Environm Management, Burnaby, BC V5A 1S6, Canada.	amysue72@gmail.com; anne.salomon@sfu.ca		Rowell, Kirsten/0000-0001-5827-8863	National Geographic Research and Exploration Grant [8636-09]; Natural Sciences and Engineering Research Council of Canada [385921-2009]; Social Sciences and Humanities Research Council [2011-0833]; David and Lucile Packard Foundation [2008-32497]	National Geographic Research and Exploration Grant(National Geographic Society); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This work was funded by a National Geographic Research and Exploration Grant (8636-09) to Dana Lepofsky, a Natural Sciences and Engineering Research Council of Canada Discovery Grant (385921-2009) to Anne K. Salomon, a Social Sciences and Humanities Research Council Insight Grant (2011-0833) to Dana Lepofsky, and a David and Lucile Packard Foundation Grant (2008-32497) to Kirsten Rowell. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Miller KA, 2011, HIDROBIOLOGICA, V21, P365; Bates D, 2012, LME4 LINEAR MIXED EF; Berkes F., 2000, LINKING SOCIAL ECOLO; Braje TJ, 2007, AM ANTIQUITY, V72, P735, DOI 10.2307/25470443; Brown F., 2009, STAYING COURSE STAYI; BUTMAN CA, 1988, NATURE, V333, P771, DOI 10.1038/333771a0; Caldwell ME, 2012, J ISL COAST ARCHAEOL, V7, P219, DOI 10.1080/15564894.2011.586089; Campbell SK, 2010, ECOL SOC, V15; Cannon Aubrey, 2008, BAR International Series, V1865, P7; Cannon A, 2009, J ARCHAEOL SCI, V36, P1050, DOI 10.1016/j.jas.2008.12.007; COSTAPIERCE BA, 1987, BIOSCIENCE, V37, P320, DOI 10.2307/1310688; EPPLEY RW, 1972, FISH B-NOAA, V70, P1063; Erlandson JM, 2008, J ARCHAEOL SCI, V35, P2144, DOI 10.1016/j.jas.2008.01.014; Erlandson JM, 2010, ANNU REV MAR SCI, V2, P231, DOI 10.1146/annurev.marine.010908.163749; Fitch JE, 1953, FISH B CAL DEP FISH, V90; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Folke C, 2006, GLOBAL ENVIRON CHANG, V16, P253, DOI 10.1016/j.gloenvcha.2006.04.002; Food and Agriculture Organization of the United Nations, 2009, STAT FOOD INS WORLD; FRASER C. McLEAN, 1928, TRANS ROY SOC CANADA, V22, P249; Gelcich S, 2010, P NATL ACAD SCI USA, V107, P16794, DOI 10.1073/pnas.1012021107; Gunderson L., 2002, RESILIENCE BEHAV LAR; Haggan N, 2006, YEARS CHANGE LINKING; Harper JR, 2007, CLAM GARDEN FIELD IN; Harper JR, 1995, FINAL REPORT BROUGHT; Horan RD, 2011, P NATL ACAD SCI USA, V108, P7333, DOI 10.1073/pnas.1005431108; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JOHANNES RE, 1978, ANNU REV ECOL SYST, V9, P349, DOI 10.1146/annurev.es.09.110178.002025; Langouet L, 2009, J MARIT ARCHAEOL, V4, P131, DOI 10.1007/s11457-009-9053-2; Lepofsky D, 2005, AM ANTIQUITY, V70, P267, DOI 10.2307/40035704; Lepofsky D, 2008, BOTANY, V86, P129, DOI 10.1139/B07-094; Lepofsky Dana, 2013, Ecological Processes, V2; Menezes F., 2001, Development (London), V44, P29, DOI 10.1057/palgrave.development.1110288; Menge BA, 2008, ECOL LETT, V11, P151, DOI 10.1111/j.1461-0248.2007.01135.x; Moss ML, 2011, ARCHAEOLOGY OF NORTH PACIFIC FISHERIES, P1; Nakaoka M, 2000, ECOLOGY, V81, P1031, DOI 10.2307/177176; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Parks Canada, 2011, GULF ISL NAT PARK RE; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; PETERSON CH, 1989, ECOLOGY, V70, P1390, DOI 10.2307/1938198; PHIBBS F D, 1971, Proceedings National Shellfisheries Association, V61, P12; Pinkerton E, 2011, MAR POLICY, V35, P63, DOI 10.1016/j.marpol.2010.08.002; Quayle DB, 1972, B FISH RES BOARD CAN, V179; Quayle DB, 1943, CAN J FISH AQUAT SCI, V6, P140; R Core Team, 2012, R LANG ENV STAT COMP; Rick TC, 2008, HUMAN IMPACTS ON ANCIENT MARINE ECOSYSTEMS: A GLOBAL PERSPECTIVE, P1; Roegner GC, 2000, J PLANKTON RES, V22, P1779, DOI 10.1093/plankt/22.9.1779; Sarkar D., 2019, NLME LINEAR NONLINEA; Shaw WN, 1986, 821146 US AR CORPS E; SIMENSTAD CA, 1978, SCIENCE, V200, P403, DOI 10.1126/science.200.4340.403; Smee DL, 2006, J CHEM ECOL, V32, P605, DOI 10.1007/s10886-005-9021-8; Starr A., 2003, NEW POLIT SCI, V25, P19, DOI [10.1080/0739314032000071217, DOI 10.1080/0739314032000071217]; Steneck RS, 2012, P NATL ACAD SCI USA, V109, P7953, DOI 10.1073/pnas.1205591109; Stimpson CM, 2012, CONVERSATION BIOL AP; Szimanski A, 2005, ANCIENT SEA GARDENS; TAMBURRI MN, 1992, BIOL BULL, V183, P327, DOI 10.2307/1542218; THOMPSON DS, 1995, ESTUARIES, V18, P91, DOI 10.2307/1352285; Thompson L, 1949, AM ANTHROPOL, V51, P253, DOI 10.1525/aa.1949.51.2.02a00060; Trosper R. L., 2009, RESILIENCE RECIPROCI; Trosper RL, 2002, ECOL ECON, V41, P329, DOI 10.1016/S0921-8009(02)00041-1; Turner N., 2005, EARTHS BLANKET; Turner NJ, 2007, INDIAN J TRADIT KNOW, V6, P57; Turner Nancy J., 2005, KEEPING IT LIVING TR; Wagner E, 2012, MAR ECOL PROG SER, V468, P149, DOI 10.3354/meps09952; White E. A. F., 2006, THESIS S FRASER U BU; Whiteley J, 2007, J APPL ECOL, V44, P495, DOI 10.1111/j.1365-2664.2007.01283.x; Williams J., 2006, CLAM GARDENS ABORIGI; Williams SL, 2007, ANNU REV ECOL EVOL S, V38, P327, DOI 10.1146/annurev.ecolsys.38.091206.095543	67	87	89	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91235	10.1371/journal.pone.0091235	http://dx.doi.org/10.1371/journal.pone.0091235			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9GM	24618748	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400061
J	Park, JS; Hoke, A				Park, Jae-Sung; Hoeke, Ahmet			Treadmill Exercise Induced Functional Recovery after Peripheral Nerve Repair Is Associated with Increased Levels of Neurotrophic Factors	PLOS ONE			English	Article							SPINAL-CORD-INJURY; AXONAL REGENERATION; VOLUNTARY EXERCISE; SKELETAL-MUSCLE; EXPRESSION; GROWTH; RATS; PLASTICITY; NEURONS; CELLS	Benefits of exercise on nerve regeneration and functional recovery have been reported in both central and peripheral nervous system disease models. However, underlying molecular mechanisms of enhanced regeneration and improved functional outcomes are less understood. We used a peripheral nerve regeneration model that has a good correlation between functional outcomes and number of motor axons that regenerate to evaluate the impact of treadmill exercise. In this model, the median nerve was transected and repaired while the ulnar nerve was transected and prevented from regeneration. Daily treadmill exercise resulted in faster recovery of the forelimb grip function as evaluated by grip power and inverted holding test. Daily exercise also resulted in better regeneration as evaluated by recovery of compound motor action potentials, higher number of axons in the median nerve and larger myofiber size in target muscles. Furthermore, these observations correlated with higher levels of neurotrophic factors, glial derived neurotrophic factor (GDNF), brain derived neurotrophic factor (BDNF) and insulin-like growth factor-1 (IGF-1), in serum, nerve and muscle suggesting that increase in muscle derived neurotrophic factors may be responsible for improved regeneration.	[Hoeke, Ahmet] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Hoke, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	ahoke@jhmi.edu			Dr. Miriam and Sheldon Adelson Medical Research Foundation; Ansari Center for Cell Therapy and Regeneration Research	Dr. Miriam and Sheldon Adelson Medical Research Foundation; Ansari Center for Cell Therapy and Regeneration Research	This study was supported by Dr. Miriam and Sheldon Adelson Medical Research Foundation and Ansari Center for Cell Therapy and Regeneration Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armada-da-Silva PAS, 2013, INT REV NEUROBIOL, V109, P125, DOI 10.1016/B978-0-12-420045-6.00006-7; Asensio-Pinilla E, 2009, EXP NEUROL, V219, P258, DOI 10.1016/j.expneurol.2009.05.034; Cheng FC, 2013, J NEUROSURG, V118, P594, DOI 10.3171/2012.8.JNS111580; Doyle LMF, 2006, NEUROSCIENCE, V141, P321, DOI 10.1016/j.neuroscience.2006.03.044; Edgerton VR, 2004, ANNU REV NEUROSCI, V27, P145, DOI 10.1146/annurev.neuro.27.070203.144308; Ghiani CA, 2007, GLIA, V55, P966, DOI 10.1002/glia.20521; Goldshmit Y, 2008, J NEUROTRAUM, V25, P449, DOI 10.1089/neu.2007.0392; Gomez-Pinilla F, 2001, EUR J NEUROSCI, V13, P1078, DOI 10.1046/j.0953-816x.2001.01484.x; Groover AL, 2013, PAIN; Gustafsson T, 1999, AM J PHYSIOL-HEART C, V276, pH679, DOI 10.1152/ajpheart.1999.276.2.H679; Gyorkos AM, 2013, NEUROSCIENCE; Haastert K, 2008, NEUROSCI LETT, V443, P179, DOI 10.1016/j.neulet.2008.07.087; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1161/CIRCULATIONAHA.107.185649; Hoke A, 2003, J NEUROSCI, V23, P561; Houle JD, 2013, ANN NY ACAD SCI, V1279, P154, DOI 10.1111/nyas.12052; Hutchinson KJ, 2004, BRAIN, V127, P1403, DOI 10.1093/brain/awh160; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Liu G, 2010, EXP NEUROL, V226, P200, DOI 10.1016/j.expneurol.2010.08.032; Matsakas A, 2004, INT J SPORTS MED, V25, P502, DOI 10.1055/s-2004-820945; Mattson MP, 2000, BRAIN RES, V886, P47, DOI 10.1016/S0006-8993(00)02790-6; Molteni R, 2004, P NATL ACAD SCI USA, V101, P8473, DOI 10.1073/pnas.0401443101; Pedersen BK, 2013, COMPR PHYSIOL, V3, P1337, DOI 10.1002/cphy.c120033; Sabatier MJ, 2008, EXP NEUROL, V211, P489, DOI 10.1016/j.expneurol.2008.02.013; Scheib J., 2013, NAT REV NEUROL; Skinner RD, 1996, BRAIN RES, V729, P127, DOI 10.1016/0006-8993(96)00556-2; Tillerson JL, 2003, NEUROSCIENCE, V119, P899, DOI 10.1016/S0306-4522(03)00096-4; Wilhelm JC, 2012, J NEUROSCI, V32, P5002, DOI 10.1523/JNEUROSCI.1411-11.2012; Wood K, 2012, DEV NEUROBIOL, V72, P688, DOI 10.1002/dneu.20960	28	48	51	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90245	10.1371/journal.pone.0090245	http://dx.doi.org/10.1371/journal.pone.0090245			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618564	gold, Green Published, Green Submitted			2022-12-25	WOS:000332842400011
J	Weinheimer-Haus, EM; Judex, S; Ennis, WJ; Koh, TJ				Weinheimer-Haus, Eileen M.; Judex, Stefan; Ennis, William J.; Koh, Timothy J.			Low-Intensity Vibration Improves Angiogenesis and Wound Healing in Diabetic Mice	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; SKIN BLOOD-FLOW; GROWTH-FACTOR; MATRIX-METALLOPROTEINASES; LOW-MAGNITUDE; OLDER-ADULTS; EXERCISE; MACROPHAGE; EXPRESSION; MOUSE	Chronic wounds represent a significant health problem, especially in diabetic patients. In the current study, we investigated a novel therapeutic approach to wound healing - whole body low-intensity vibration (LIV). LIV is anabolic for bone, by stimulating the release of growth factors, and modulating stem cell proliferation and differentiation. We hypothesized that LIV improves the delayed wound healing in diabetic mice by promoting a pro-healing wound environment. Diabetic db/db mice received excisional cutaneous wounds and were subjected to LIV (0.4 g at 45 Hz) for 30 min/d or a non-vibrated sham treatment (controls). Wound tissue was collected at 7 and 15 d post-wounding and wound healing, angiogenesis, growth factor levels and wound cell phenotypes were assessed. LIV increased angiogenesis and granulation tissue formation at day 7, and accelerated wound closure and re-epithelialization over days 7 and 15. LIV also reduced neutrophil accumulation and increased macrophage accumulation. In addition, LIV increased expression of pro-healing growth factors and chemokines (insulin-like growth factor-1, vascular endothelial growth factor and monocyte chemotactic protein-1) in wounds. Despite no evidence of a change in the phenotype of CD11b+ macrophages in wounds, LIV resulted in trends towards a less inflammatory phenotype in the CD11b- cells. Our findings indicate that LIV may exert beneficial effects on wound healing by enhancing angiogenesis and granulation tissue formation, and these changes are associated with increases in pro-angiogenic growth factors.	[Weinheimer-Haus, Eileen M.; Koh, Timothy J.] Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL 60680 USA; [Weinheimer-Haus, Eileen M.; Ennis, William J.; Koh, Timothy J.] Univ Illinois, Ctr Tissue Repair & Regenerat, Chicago, IL USA; [Ennis, William J.] Univ Illinois, Dept Surg, Chicago, IL 60680 USA; [Judex, Stefan] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Koh, TJ (corresponding author), Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL 60680 USA.	tjkoh@uic.edu		Weinheimer-Haus, Eileen/0000-0001-5408-0024; Koh, Timothy/0000-0001-6549-7060	National Institutes of Health [R01GM092850, T32DE018381]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE018381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health (R01GM092850 to TJK and T32DE018381 to EMWH; www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JA, 2001, CRIT CARE MED, V29, P1983, DOI 10.1097/00003246-200110000-00022; Adams V, 2004, ARTERIOSCL THROM VAS, V24, P684, DOI 10.1161/01.ATV.0000124104.23702.a0; Armstrong DG, 2002, J AM PODIAT MED ASSN, V92, P12, DOI 10.7547/87507315-92-1-12; Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x; Brkovic A, 2007, J CELL BIOCHEM, V100, P727, DOI 10.1002/jcb.21124; Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001; Emery CF, 2005, J GERONTOL A-BIOL, V60, P1432, DOI 10.1093/gerona/60.11.1432; Ennis WJ, 2008, GYNECOL ONCOL, V111, pS81, DOI 10.1016/j.ygyno.2008.07.054; Gilsanz V, 2006, J BONE MINER RES, V21, P1464, DOI 10.1359/JBMR.060612; Gomez-Cabello A, 2012, SPORTS MED, V42, P301, DOI 10.2165/11597670-000000000-00000; Goren I, 2003, DIABETES, V52, P2821, DOI 10.2337/diabetes.52.11.2821; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; GRANT M, 1987, J CLIN ENDOCR METAB, V65, P370, DOI 10.1210/jcem-65-2-370; GREENHALGH DG, 1990, AM J PATHOL, V136, P1235; Gregor S, 2008, ARCH SURG-CHICAGO, V143, P189, DOI 10.1001/archsurg.2007.54; Hong KH, 2005, BLOOD, V105, P1405, DOI 10.1182/blood-2004-08-3178; Hui W, 2001, ANN RHEUM DIS, V60, P254, DOI 10.1136/ard.60.3.254; Ito WD, 1997, CIRC RES, V80, P829; Jordan MJ, 2005, J STRENGTH COND RES, V19, P459, DOI 10.1519/13293.1; Keylock KT, 2008, AM J PHYSIOL-REG I, V294, pR179, DOI 10.1152/ajpregu.00177.2007; Kiel DP, 2010, CLIN TRIALS, V7, P354, DOI 10.1177/1740774510371014; Lau E, 2011, J ORTHOP RES, V29, P1075, DOI 10.1002/jor.21334; Laufs U, 2004, CIRCULATION, V109, P220, DOI 10.1161/01.CIR.0000109141.48980.37; LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Lobmann R, 2002, DIABETOLOGIA, V45, P1011, DOI 10.1007/s00125-002-0868-8; Lohman EB, 2007, MED SCI MONITOR, V13, pCR71; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Maloney-Hinds C, 2008, MED SCI MONITOR, V14, pCR112; Mast Bruce A., 1996, Wound Repair and Regeneration, V4, P411, DOI 10.1046/j.1524-475X.1996.40404.x; Mirza R, 2011, CYTOKINE, V56, P256, DOI 10.1016/j.cyto.2011.06.016; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Mirza RE, 2013, DIABETES, V62, P2579, DOI 10.2337/db12-1450; Mobius-Winkler S, 2009, J APPL PHYSIOL, V107, P1943, DOI 10.1152/japplphysiol.00532.2009; Pence BD, 2012, MED SCI SPORT EXER, V44, P1846, DOI 10.1249/MSS.0b013e31825a5971; Rehman J, 2004, J AM COLL CARDIOL, V43, P2314, DOI 10.1016/j.jacc.2004.02.049; Rittweger J, 2010, EUR J APPL PHYSIOL, V108, P877, DOI 10.1007/s00421-009-1303-3; Rubin C, 2001, NATURE, V412, P603, DOI 10.1038/35088122; Rubin C, 2004, J BONE MINER RES, V19, P343, DOI 10.1359/JBMR.0301251; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Stewart JM, 2005, AM J PHYSIOL-REG I, V288, pR623, DOI 10.1152/ajpregu.00513.2004; Trengove Naomi J., 1996, Wound Repair and Regeneration, V4, P234, DOI 10.1046/j.1524-475X.1996.40211.x; Trengove NJ, 2000, WOUND REPAIR REGEN, V8, P13, DOI 10.1046/j.1524-475x.2000.00013.x; Trengove NJ, 1999, WOUND REPAIR REGEN, V7, P442, DOI 10.1046/j.1524-475X.1999.00442.x; Tuan TL, 1998, MOL MED TODAY, V4, P19, DOI 10.1016/S1357-4310(97)80541-2; Voigt J, 2011, INT J LOW EXTR WOUND, V10, P190, DOI 10.1177/1534734611424648; Wetzler C, 2000, J INVEST DERMATOL, V115, P245, DOI 10.1046/j.1523-1747.2000.00029.x; White R, 2008, J Wound Care, V17, P428; White R, 2008, J WOUND CARE, V17, P428; Williams DT, 2007, DIABETIC MED, V24, P1105, DOI 10.1111/j.1464-5491.2007.02218.x; Yamamoto T, 2000, J IMMUNOL, V164, P6174, DOI 10.4049/jimmunol.164.12.6174; Yoshida A, 1996, GROWTH FACTORS, V13, P57, DOI 10.3109/08977199609034566	52	53	53	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91355	10.1371/journal.pone.0091355	http://dx.doi.org/10.1371/journal.pone.0091355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618702	Green Submitted, gold, Green Published			2022-12-25	WOS:000332842400080
J	Witney, TH; Fortt, RR; Aboagye, EO				Witney, Timothy H.; Fortt, Robin R.; Aboagye, Eric O.			Preclinical Assessment of Carboplatin Treatment Efficacy in Lung Cancer by F-18-ICMT-11-Positron Emission Tomography	PLOS ONE			English	Article							INDUCED TUMOR APOPTOSIS; TREATMENT RESPONSE; PET TRACER; CELL-DEATH; CHEMOTHERAPY; THERAPY; BIOMARKERS; MARKER; ERCC1; MODEL	Tumour response to therapy is assessed primarily in the clinic by monitoring reductions in tumour size. However, this approach lacks sensitivity since in many cases several weeks may elapse before there is evidence of tumour shrinkage. There is therefore a need to develop non-invasive imaging techniques for monitoring tumour treatment response in the clinic. Here, we assessed the pre-clinical utility of F-18-ICMT-11 positron emission tomography - a method for detecting caspase 3/7 activation - in non-small cell lung cancer (NSCLC). F-18-ICMT-11 uptake was compared to molecular biochemical measures of cell death in PC9 and A549 NSCLC cells following treatment with carboplatin in vitro and in vivo. Carboplatin-induced apoptosis in the ERCC1 low/mutant EGFR PC9 cells was characterised by time and dose-related increased caspase-3/7 activation, poly-ADP-ribose polymerase cleavage and Annexin V staining. F-18-ICMT-11 uptake was consequently increased up to 14-fold at 200 mu M carboplatin compared to vehicle treated cells (P<0.01). In contrast, necrosis was the predominant death mechanism in ERCC1 high/wt EGFR A549 cells and no change in F-18-ICMT-11 uptake was detected. In vivo, histological analysis of PC9 tumour xenografts indicated high pre-therapy necrosis. A 4.6-fold increase in cleaved caspase-3/7 was measured in non-necrotic regions of PC9 tumours at 48h post carboplatin therapy. Average PET-derived tumour F-18-ICMT-11 uptake was insensitive to changes in apoptosis in the presence of substantial pre-existing necrosis. PET-based voxel intensity sorting however, identified intra-tumoural regions of high F-18-ICMT-11 uptake, enabling accurate assessment of apoptosis and therefore therapy response. In A549 tumours that lacked high pre-therapy necrosis, carboplatin induced growth inhibition that was only minimally associated with apoptosis and thus not detectable by F-18-ICMT-11 PET.	[Witney, Timothy H.; Fortt, Robin R.; Aboagye, Eric O.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England	Imperial College London	Aboagye, EO (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England.	eric.aboagye@imperial.ac.uk	Witney, Timothy/R-9440-2017	Witney, Timothy/0000-0002-9475-2873; ABOAGYE, Eric/0000-0003-2276-6771	Innovative Medicines Initiative Joint Undertaking [115151]; European Union; Cancer Research UK [16584, 10337] Funding Source: researchfish	Innovative Medicines Initiative Joint Undertaking; European Union(European Commission); Cancer Research UK(Cancer Research UK)	The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking (www.imi.europa.eu) under grant agreement number 115151, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007/2013) and EFPIA companies' in kind contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam IS, 2010, BIOCONJUGATE CHEM, V21, P884, DOI 10.1021/bc9004415; Ardizzoni A, 2007, J NATL CANCER I, V99, P847, DOI 10.1093/jnci/djk196; Belhocine T, 2002, CLIN CANCER RES, V8, P2766; Brindle K, 2008, NAT REV CANCER, V8, P94, DOI 10.1038/nrc2289; Challapalli A, 2013, J NUCL MED, V54, P1551, DOI 10.2967/jnumed.112.118760; Cohen A, 2009, CELL RES, V19, P625, DOI 10.1038/cr.2009.17; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fortt R, 2012, NUCL MED BIOL, V39, P1000, DOI 10.1016/j.nucmedbio.2012.03.004; Galban S, 2010, CURR PHARM BIOTECHNO, V11, P701, DOI 10.2174/138920110792246627; Gallagher FA, 2009, P NATL ACAD SCI USA, V106, P19801, DOI 10.1073/pnas.0911447106; Girard N, 2009, AM J SURG PATHOL, V33, P1752, DOI 10.1097/PAS.0b013e3181b8cf03; Glaser M, 2011, BIOORG MED CHEM LETT, V21, P6945, DOI 10.1016/j.bmcl.2011.10.001; Goldstraw P, 2011, LANCET, V378, P1727, DOI 10.1016/S0140-6736(10)62101-0; Hoglund J, 2011, J NUCL MED, V52, P720, DOI 10.2967/jnumed.110.081786; Hu S, 2012, MOL IMAGING BIOL, V14, P762, DOI 10.1007/s11307-012-0551-5; Jablonski D, 2001, P NATL ACAD SCI USA, V98, P5393, DOI 10.1073/pnas.101092598; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Micha D, 2008, CLIN CANCER RES, V14, P7304, DOI 10.1158/1078-0432.CCR-08-0111; Nguyen QD, 2009, P NATL ACAD SCI USA, V106, P16375, DOI 10.1073/pnas.0901310106; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Pfaffle HN, 2013, CANC RES; Nguyen QD, 2013, CLIN CANCER RES, V19, P3914, DOI 10.1158/1078-0432.CCR-12-3814; Reed E, 2005, CLIN CANCER RES, V11, P6100, DOI 10.1158/1078-0432.CCR-05-1083; Rosell R, 2013, LANCET, V382, P720, DOI 10.1016/S0140-6736(13)61715-8; Sinkus R, 2012, EUR J CANCER, V48, P425, DOI 10.1016/j.ejca.2011.11.034; SMITH G, 2008, BALLET REV, V36, P7; Strauss LG, 1996, EUR J NUCL MED, V23, P1409, DOI 10.1007/BF01367602; Usmanij EA, 2013, J NUCL MED, V54, P1528, DOI 10.2967/jnumed.112.116921; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wallace-Brodeur RR, 1999, CELL MOL LIFE SCI, V55, P64, DOI 10.1007/s000180050270; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Witney TH, 2010, BRIT J CANCER, V103, P1400, DOI 10.1038/sj.bjc.6605945; Witney TH, 2012, CLIN CANCER RES, V18, P1063, DOI 10.1158/1078-0432.CCR-11-2462; Witney TH, 2009, NEOPLASIA, V11, P574, DOI 10.1593/neo.09254; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Zhao BS, 2009, J NUCL MED, V50, P239, DOI 10.2967/jnumed.108.056655	41	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91694	10.1371/journal.pone.0091694	http://dx.doi.org/10.1371/journal.pone.0091694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618809	Green Published, gold, Green Submitted			2022-12-25	WOS:000332842400121
J	Krondorfer, I; Lipp, K; Brugger, D; Staudigl, P; Sygmund, C; Haltrich, D; Peterbauer, CK				Krondorfer, Iris; Lipp, Katharina; Brugger, Dagmar; Staudigl, Petra; Sygmund, Christoph; Haltrich, Dietmar; Peterbauer, Clemens K.			Engineering of Pyranose Dehydrogenase for Increased Oxygen Reactivity	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; AGARICUS-MELEAGRIS; ALCOHOL OXIDASE; SACCHAROMYCES-CEREVISIAE; SUBSTRATE-BINDING; O-2 REACTIVITY; ACTIVE-SITE; ACTIVATION; IDENTIFICATION; ENZYME	Pyranose dehydrogenase (PDH), a member of the GMC family of flavoproteins, shows a very broad sugar substrate specificity but is limited to a narrow range of electron acceptors and reacts extremely slowly with dioxygen as acceptor. The use of substituted quinones or (organo) metals as electron acceptors is undesirable for many production processes, especially of food ingredients. To improve the oxygen reactivity, site-saturation mutagenesis libraries of twelve amino acids around the active site of Agaricus meleagris PDH were expressed in Saccharomyces cerevisiae. We established high-throughput screening assays for oxygen reactivity and standard dehydrogenase activity using an indirect Amplex Red/horseradish peroxidase and a DCIP/D-glucose based approach. The low number of active clones confirmed the catalytic role of H512 and H556. Only one position was found to display increased oxygen reactivity. Histidine 103, carrying the covalently linked FAD cofactor in the wild-type, was substituted by tyrosine, phenylalanine, tryptophan and methionine. Variant H103Y was produced in Pichia pastoris and characterized and revealed a five-fold increase of the oxygen reactivity.	[Krondorfer, Iris; Lipp, Katharina; Brugger, Dagmar; Staudigl, Petra; Sygmund, Christoph; Haltrich, Dietmar; Peterbauer, Clemens K.] Univ Nat Resources & Life Sci, Dept Food Sci & Technol, Food Biotechnol Lab, Vienna, Austria; [Lipp, Katharina] Univ Appl Sci Wiener Neustadt, Tulln, Austria	University of Natural Resources & Life Sciences, Vienna	Peterbauer, CK (corresponding author), Univ Nat Resources & Life Sci, Dept Food Sci & Technol, Food Biotechnol Lab, Vienna, Austria.	clemens.peterbauer@boku.ac.at	Haltrich, Dietmar/N-2624-2019	Haltrich, Dietmar/0000-0002-8722-8176; Peterbauer, Clemens/0000-0002-8033-198X	Austrian Science Fund (FWF) [P22094, W1224]; Austrian Science Fund (FWF) [P 22094] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was financed by the Austrian Science Fund (FWF; www.fwf.ac.at): Individual Grant P22094 to CKP Doctoral programme BioToP (Biomolecular Technology of Proteins; grant nr. W1224; IK and DB are members). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcalde M, 2010, METHODS MOL BIOL, V634, P3, DOI 10.1007/978-1-60761-652-8_1; Ander P, 1997, J BIOTECHNOL, V53, P115, DOI 10.1016/S0168-1656(97)01680-5; Baron R, 2009, P NATL ACAD SCI USA, V106, P10603, DOI 10.1073/pnas.0903809106; Bowley DR, 2007, PROTEIN ENG DES SEL, V20, P81, DOI 10.1093/protein/gzl057; Chaiyen P, 2012, TRENDS BIOCHEM SCI, V37, P373, DOI 10.1016/j.tibs.2012.06.005; Finnegan S, 2010, BIOCHEMISTRY-US, V49, P2952, DOI 10.1021/bi902048c; Fraaije MW, 1999, J BIOL CHEM, V274, P35514, DOI 10.1074/jbc.274.50.35514; Gadda G, 2006, ARCH BIOCHEM BIOPHYS, V451, P182, DOI 10.1016/j.abb.2006.04.005; Gadda G, 2012, BIOCHEMISTRY-US, V51, P2662, DOI 10.1021/bi300227d; Garcia-Ruiz E, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-17; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Georgescu Radu, 2003, V230, P171; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Giffhorn F, 2000, APPL MICROBIOL BIOT, V54, P727, DOI 10.1007/s002530000446; Gonzalez-Perez D, 2012, BIOENGINEERED, V3, P172, DOI 10.4161/bbug.19544; Graf MMH, 2013, J COMPUT AID MOL DES, V27, P295, DOI 10.1007/s10822-013-9645-7; Hallberg BM, 2004, J MOL BIOL, V341, P781, DOI 10.1016/j.jmb.2004.06.033; Hernandez-Ortega A, 2012, BIOCHEMISTRY-US, V51, P6595, DOI 10.1021/bi300505z; Hernandez-Ortega A, 2011, J BIOL CHEM, V286, P41105, DOI 10.1074/jbc.M111.282467; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; KENNEY WC, 1976, J BIOL CHEM, V251, P5386; Kittl R, 2008, CURR GENET, V53, P117, DOI 10.1007/s00294-007-0171-9; Klinman JP, 2007, ACCOUNTS CHEM RES, V40, P325, DOI 10.1021/ar6000507; Kujawa M, 2007, FEBS J, V274, P879, DOI 10.1111/j.1742-4658.2007.05634.x; Kujawa M, 2006, J BIOL CHEM, V281, P35104, DOI 10.1074/jbc.M604718200; Leferink NGH, 2009, J BIOL CHEM, V284, P4392, DOI 10.1074/jbc.M808202200; Li SL, 1997, BIOTECHNIQUES, V23, P588, DOI 10.2144/97234bm05; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; McDonald CA, 2011, J AM CHEM SOC, V133, P16809, DOI 10.1021/ja2081873; Mohanty JG, 1997, J IMMUNOL METHODS, V202, P133, DOI 10.1016/S0022-1759(96)00244-X; Peterbauer CK, 2010, APPL MICROBIOL BIOT, V85, P837, DOI 10.1007/s00253-009-2226-y; Pisanelli I, 2010, APPL MICROBIOL BIOT, V86, P599, DOI 10.1007/s00253-009-2308-x; Pommie C, 2004, J MOL RECOGNIT, V17, P17, DOI 10.1002/jmr.647; Saam J, 2010, J BIOL CHEM, V285, P24439, DOI 10.1074/jbc.M110.131193; Sedmera P, 2006, J MOL CATAL B-ENZYM, V41, P32, DOI 10.1016/j.molcatb.2006.04.004; Staudigl P, 2013, BIOMOLECULES, V3, P535, DOI 10.3390/biom3030535; Su QJ, 1999, BIOCHEMISTRY-US, V38, P8572, DOI 10.1021/bi990044o; Sucharitakul J, 2008, BIOCHEMISTRY-US, V47, P8485, DOI 10.1021/bi801039d; Sygmund C, 2008, J BIOTECHNOL, V133, P334, DOI 10.1016/j.jbiotec.2007.10.013; Sygmund C, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-38; Sygmund C, 2012, APPL MICROBIOL BIOT, V94, P695, DOI 10.1007/s00253-011-3667-7; Tan TC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053567, 10.1371/journal.pone.0073165]; Tasca F, 2010, BIOSENS BIOELECTRON, V25, P1710, DOI 10.1016/j.bios.2009.12.017; Volc J, 2004, J MOL CATAL B-ENZYM, V30, P177, DOI 10.1016/j.molcatb.2004.05.006; VOLC J, 1985, FOLIA MICROBIOL, V30, P141, DOI 10.1007/BF02922207; Volc J, 1997, ARCH MICROBIOL, V167, P119, DOI 10.1007/s002030050424; Volc J, 2001, ARCH MICROBIOL, V176, P178, DOI 10.1007/s002030100308; Weis R, 2004, FEMS YEAST RES, V5, P179, DOI 10.1016/j.femsyr.2004.06.016; Winkler A, 2007, J BIOL CHEM, V282, P24437, DOI 10.1074/jbc.M703642200; Zhao GH, 2008, BIOCHEMISTRY-US, V47, P9124, DOI 10.1021/bi8008642; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	52	14	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91145	10.1371/journal.pone.0091145	http://dx.doi.org/10.1371/journal.pone.0091145			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614932	gold, Green Published, Green Submitted			2022-12-25	WOS:000332839300084
J	Lehmann, KDS; Goldman, BW; Dworkin, I; Bryson, DM; Wagner, AP				Lehmann, Kenna D. S.; Goldman, Brian W.; Dworkin, Ian; Bryson, David M.; Wagner, Aaron P.			From Cues to Signals: Evolution of Interspecific Communication via Aposematism and Mimicry in a Predator-Prey System	PLOS ONE			English	Article							BATESIAN MIMICRY; MULLERIAN MIMICRY; THEORETICAL INVESTIGATIONS; WARNING SIGNALS; MODEL; FREQUENCY; RECOGNITION; AUTOMIMICRY; DYNAMICS; STRATEGY	Current theory suggests that many signaling systems evolved from preexisting cues. In aposematic systems, prey warning signals benefit both predator and prey. When the signal is highly beneficial, a third species often evolves to mimic the toxic species, exploiting the signaling system for its own protection. We investigated the evolutionary dynamics of predator cue utilization and prey signaling in a digital predator-prey system in which prey could evolve to alter their appearance to mimic poison-free or poisonous prey. In predators, we observed rapid evolution of cue recognition (i.e. active behavioral responses) when presented with sufficiently poisonous prey. In addition, active signaling (i.e. mimicry) evolved in prey under all conditions that led to cue utilization. Thus we show that despite imperfect and dishonest signaling, given a high cost of consuming poisonous prey, complex systems of interspecific communication can evolve via predator cue recognition and prey signal manipulation. This provides evidence supporting hypotheses that cues may serve as steppings-tones in the evolution of more advanced communication and signaling systems that incorporate information about the environment.	[Lehmann, Kenna D. S.; Dworkin, Ian] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Goldman, Brian W.] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA; [Lehmann, Kenna D. S.; Goldman, Brian W.; Dworkin, Ian; Bryson, David M.; Wagner, Aaron P.] Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA; [Lehmann, Kenna D. S.; Dworkin, Ian] Michigan State Univ, Program Ecol Evolutionary Biol & Behav, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University	Lehmann, KDS (corresponding author), Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA.	kdslehmann@gmail.com	Lehmann, Kenna/AAM-3416-2020	Dworkin, Ian/0000-0002-2874-287X	BEACON Center for the Study of Evolution in Action (NSF Cooperative Agreement) [DBI-0939454]; Michigan State University Institute for Cyber Enabled Research	BEACON Center for the Study of Evolution in Action (NSF Cooperative Agreement); Michigan State University Institute for Cyber Enabled Research	This work was supported by the BEACON Center for the Study of Evolution in Action (NSF Cooperative Agreement DBI-0939454) and the Michigan State University Institute for Cyber Enabled Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronsson M, 2008, ANIM BEHAV, V75, P417, DOI 10.1016/j.anbehav.2007.05.006; Auguie B, 2012, GRIDEXTRA FUNCTIONS; AVERY ML, 1985, J WILDLIFE MANAGE, V49, P1116, DOI 10.2307/3801404; Balogh ACV, 2005, P ROY SOC B-BIOL SCI, V272, P2269, DOI 10.1098/rspb.2005.3227; Balogh ACV, 2010, EVOLUTION, V64, P810, DOI 10.1111/j.1558-5646.2009.00852.x; Barnett CA, 2007, BEHAV ECOL, V18, P645, DOI 10.1093/beheco/arm027; Bates HW., 1862, T LINN SOC LOND, V23, P495, DOI [DOI 10.1111/J.1096-3642.1860.TB00146.X, 10.1111/j.1096-3642.1860.tb00146.x]; Bradbury J.W., 2001, PRINCIPLES ANIMAL CO, Vsecond; BROWER JV, 1960, AM NAT, V94, P271, DOI 10.1086/282128; BROWER LP, 1970, P NATL ACAD SCI USA, V66, P1059, DOI 10.1073/pnas.66.4.1059; Bryson DM, 2013, PLOS ONE, DOI [10.1371/journal.pone.0083242, DOI 10.1371/J0URNAL.P0NE.0083242]; Caley MJ, 2003, P ROY SOC B-BIOL SCI, V270, P667, DOI 10.1098/rspb.2002.2263; Canty A, 2013, BOOT BOOTSTRAP R S S; Davison AC, 1997, BOOTSTRAP METHODS TH; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Edmunds M, 2000, BIOL J LINN SOC, V70, P459; EMLEN JM, 1968, AM NAT, V102, P235, DOI 10.1086/282540; ESTABROOK GF, 1974, AM NAT, V108, P443, DOI 10.1086/282925; Fish J, ROLES STANDING GENET, DOI [10.1101/002493, DOI 10.1101/002493]; Fisher R.A., 1930, GENETICAL THEORY NAT; Fortuna MA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002928; Franks DW, 2007, J THEOR BIOL, V244, P631, DOI 10.1016/j.jtbi.2006.09.019; Franks DW, 2009, EVOLUTION, V63, P256, DOI 10.1111/j.1558-5646.2008.00509.x; Gamberale-Stille G, 2012, EVOLUTION, V66, P807, DOI 10.1111/j.1558-5646.2011.01482.x; Gavrilets S, 1998, J THEOR BIOL, V191, P415, DOI 10.1006/jtbi.1997.0615; Harper GR, 2008, NATURE, V451, P1103, DOI 10.1038/nature06532; Harper GR, 2007, P R SOC B, V274, P1955, DOI 10.1098/rspb.2007.0558; HASSON O, 1991, TRENDS ECOL EVOL, V6, P325, DOI 10.1016/0169-5347(91)90040-5; Holen OH, 2004, AM NAT, V164, P598, DOI 10.1086/424972; Holmgren NMA, 1999, BIOL J LINN SOC, V66, P145; Honma A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003411; HUHEEY J E, 1988, American Naturalist, V131, pS22, DOI 10.1086/284765; HUHEEY JE, 1976, EVOLUTION, V30, P86, DOI 10.1111/j.1558-5646.1976.tb00884.x; HUHEEY JE, 1964, ECOLOGY, V45, P185, DOI 10.2307/1937125; Ihalainen E, 2007, J EVOLUTION BIOL, V20, P780, DOI 10.1111/j.1420-9101.2006.01234.x; Iserbyt A, 2011, P ROY SOC B-BIOL SCI, V278, P3116, DOI 10.1098/rspb.2011.0126; Joron M, 1998, TRENDS ECOL EVOL, V13, P461, DOI 10.1016/S0169-5347(98)01483-9; KANNAN D, 1983, B MATH BIOL, V45, P347, DOI 10.1007/BF02459397; Kikuchi DW, 2010, AM NAT, V176, P830, DOI 10.1086/657041; Kikuchi DW, 2010, P ROY SOC B-BIOL SCI, V277, P1041, DOI 10.1098/rspb.2009.2000; Lev-Yadun S, 2009, ISR J PLANT SCI, V57, P107, DOI 10.1560/IJPS.57.1-2.107; Lewontin R. C., 1970, ANNU REV ECOL SYST, V1, P1, DOI [DOI 10.1146/ANNUREV.ES.01.110170.000245, 10.1146/annurev.es.01.110170.000245]; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; Lindstrom L, 1997, P ROY SOC B-BIOL SCI, V264, P149, DOI 10.1098/rspb.1997.0022; Lindstrom L, 2004, EVOLUTION, V58, P1294, DOI 10.1554/03-271; Mappes J, 1997, EVOLUTION, V51, P2050, DOI 10.1111/j.1558-5646.1997.tb05129.x; MATESSI C, 1972, THEOR POPUL BIOL, V3, P41, DOI 10.1016/0040-5809(72)90033-0; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; MULLER F., 1879, T ENTOMOL SOC LOND, V1879, pxx; Ofria C, 2005, ARTIFICIAL LIFE MODELS IN SOFTWARE, P3, DOI 10.1007/1-84628-214-4_1; Penney HD, 2012, NATURE, V483, P461, DOI 10.1038/nature10961; Pfennig DW, 2007, BEHAV ECOL SOCIOBIOL, V61, P505, DOI 10.1007/s00265-006-0278-x; Pfennig DW, 2012, CURR ZOOL, V58, P608, DOI 10.1093/czoolo/58.4.608; POUGH FH, 1973, P NATL ACAD SCI USA, V70, P2261, DOI 10.1073/pnas.70.8.2261; Przeczek K, 2008, INTEGR ZOOL, V3, P149, DOI 10.1111/j.1749-4877.2008.00091.x; R Core Team R, 2022, R LANG ENV STAT COMP; Randall JE, 2005, ZOOL STUD, V44, P299; Ries L, 2008, EVOLUTION, V62, P1798, DOI 10.1111/j.1558-5646.2008.00401.x; Rowland HM, 2010, ECOL LETT, V13, P1494, DOI 10.1111/j.1461-0248.2010.01539.x; Servedio MR, 2000, EVOLUTION, V54, P751; Sherratt TN, 2003, AM NAT, V162, P377, DOI 10.1086/378047; Sherratt TN, 2002, BEHAV ECOL, V13, P821, DOI 10.1093/beheco/13.6.821; SMITH SM, 1975, SCIENCE, V187, P759, DOI 10.1126/science.187.4178.759; Speed MP, 2010, AM NAT, V176, pE1, DOI 10.1086/652990; Tsoularis A, 2005, J BIOL SYST, V13, P273, DOI 10.1142/S0218339005001483; TURNER JRG, 1984, BIOL J LINN SOC, V23, P247, DOI 10.1111/j.1095-8312.1984.tb00143.x; Wagner A. P., 2013, ARXIV13101369; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickler W, 1968, MIMICY PLANTS ANIMAL; Wilson JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061610	70	12	12	2	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91783	10.1371/journal.pone.0091783	http://dx.doi.org/10.1371/journal.pone.0091783			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614755	Green Published, gold, Green Submitted			2022-12-25	WOS:000332839300159
J	Qiu, CP; Lv, QT; Dongol, S; Wang, CG; Jiang, J				Qiu, Chun-Ping; Lv, Qing-Tao; Dongol, Samina; Wang, Chenguang; Jiang, Jie			Single Nucleotide Polymorphism of SREBF-1 Gene Associated with an Increased Risk of Endometrial Cancer in Chinese Women	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; BINDING PROTEINS; BREAST-CANCER; GROWTH; 17-BETA-HYDROXYSTEROID-DEHYDROGENASE; CHOLESTEROL; ACTIVATORS; EXPRESSION; RECEPTOR; SREBPS	Aim: Elevated levels of sterol regulatory element-binding protein-1 (SREBP-1) have been found in endometrial cancer (EC), suggesting that it is essential to the development of EC. Obesity and diabetes have been established as known risk factors of EC, while SREBF-1 gene polymorphisms have also been found to be associated with obesity and type II diabetes. Therefore, we hypothesize that single nucleotide polymorphism (SNP) in SREBF-1 gene may be associated with increased risk of EC. Method: We analyzed the sequence of SREBF-1 in tissue samples from 30 EC cases and 6 benign controls using high throughput method. Based on the primary results, we selected one SNP (rs2297508) as a genetic marker to conduct a hospital-based case-control study with 139 EC cases and 129 benign controls. The samples were examined under the microscope to determine their histopathology prior to the SNP analysis using RT-PCR. Results: Through sequence analysis, we found 10 SNPs of SREBF-1 associated with EC, including 3 new SNPs. Fourteen percent of EC showed the rs2297508 SNP with C allele, while only 7% had the C allele was present in benign controls (p = 0.027, OR = 1.983). Additionally, the C allele was associated with cancer differentiation (p<0.05) and the depth of myometrial invasion (p<0.05). Conclusion: Our study indicates that SNP (rs2297508) of SREBF-1 may serve as a genetic predisposition factor for the development of EC and screening of such genetic marker may be helpful in its early detection.	[Qiu, Chun-Ping; Dongol, Samina; Jiang, Jie] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan, Peoples R China; [Lv, Qing-Tao] Shandong Univ Tradit Chinese Med, Dept Pharmaceut Chem, Jinan, Peoples R China; [Wang, Chenguang] Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Wang, Chenguang] Thomas Jefferson Univ, Dept Stem Cell Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Wang, Chenguang] Thomas Jefferson Univ, Dept Regenerat Med, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Shandong University; Shandong University of Traditional Chinese Medicine; Jefferson University; Jefferson University; Jefferson University	Jiang, J (corresponding author), Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan, Peoples R China.	qljiangjie@sdu.edu.cn			National Natural Science Foundation of China [81072121, 81372808, 81173614]; Science and Technology Development planning of Shandong [2011GSF12122, 2012G0021823]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development planning of Shandong	This study was accomplished in the cardiovascular laboratory of Qi Lu Hospital of Shandong University and was supported by grants from the National Natural Science Foundation of China (81072121, 81372808 [JJ] and 81173614 [QTL]) as well as the Science and Technology Development planning of Shandong (2011GSF12122 [XZ] and 2012G0021823 [JJ]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Campa D, 2009, BREAST CANCER RES TR, V118, P565, DOI 10.1007/s10549-009-0347-8; Eberle D, 2004, DIABETES, V53, P2153, DOI 10.2337/diabetes.53.8.2153; Horton JD, 2002, BIOCHEM SOC T, V30, P1091, DOI 10.1042/bst0301091; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Huang WC, 2012, MOL CANCER RES, V10, P133, DOI 10.1158/1541-7786.MCR-11-0206; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Kaaks R, 2002, CANCER CAUSE CONTROL, V13, P307, DOI 10.1023/A:1015270324325; Krycer JR, 2010, TRENDS ENDOCRIN MET, V21, P268, DOI 10.1016/j.tem.2010.01.001; Li WH, 2012, CELL CYCLE, V11, P2348, DOI 10.4161/cc.20811; Liu JX, 2008, DIABETES RES CLIN PR, V82, P42, DOI 10.1016/j.diabres.2008.06.017; Luu-The V, 2006, MOL ENDOCRINOL, V20, P437, DOI 10.1210/me.2005-0058; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Modesitt SC, 2012, GYNECOL ONCOL, V124, P431, DOI 10.1016/j.ygyno.2011.11.013; Nagasaki S, 2009, MOL CELL ENDOCRINOL, V307, P163, DOI 10.1016/j.mce.2009.04.002; O'Mara TA, 2011, CARCINOGENESIS, V32, P331, DOI 10.1093/carcin/bgq263; Rashid A, 1997, AM J PATHOL, V150, P201; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Shao W, 2012, CELL METAB, V16, P414, DOI 10.1016/j.cmet.2012.09.002; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sorosky JI, 2008, OBSTET GYNECOL, V111, P436, DOI 10.1097/AOG.0b013e318162f690; Su CK, 2011, J SURG ONCOL, V104, P755, DOI 10.1002/jso.22035; Wang PH, 2010, TAIWAN J OBSTET GYNE, V49, P1, DOI 10.1016/S1028-4559(10)60001-0; Wang Q, 2010, ACTA PHARMACOL SIN, V31, P367, DOI 10.1038/aps.2010.5; Weiss JM, 2006, AM J EPIDEMIOL, V164, P56, DOI 10.1093/aje/kwj152; Yang YA, 2003, EXP CELL RES, V282, P132, DOI 10.1016/S0014-4827(02)00023-X	26	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90491	10.1371/journal.pone.0090491	http://dx.doi.org/10.1371/journal.pone.0090491			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614076	gold, Green Published			2022-12-25	WOS:000332839300027
J	Thein, S; Tao-Cheng, JH; Li, Y; Bayer, KU; Reese, TS; Dosemeci, A				Thein, Soe; Tao-Cheng, Jung-Hwa; Li, Yan; Bayer, K. Ulrich; Reese, Thomas S.; Dosemeci, Ayse			CaMKII Mediates Recruitment and Activation of the Deubiquitinase CYLD at the Postsynaptic Density	PLOS ONE			English	Article							PROTEIN-KINASE-II; HIPPOCAMPAL-NEURONS; PHOSPHORYLATION; UBIQUITINATION; DEGRADATION; INHIBITOR; PROTEASOMES; STARGAZIN; MECHANISM; PROMOTES	NMDA treatment of cultured hippocampal neurons causes recruitment of CYLD, as well as CaMKII, to the postsynaptic density (PSD), as shown by immunoelectron microscopy. Recruitment of CYLD, a deubiquitinase specific for K63-linked polyubiquitins, is blocked by pre-treatment with tatCN21, a CaMKII inhibitor, at a concentration that inhibits the translocation of CaMKII to the PSD. Furthermore, CaMKII co-immunoprecipitates with CYLD from solubilized PSD fractions, indicating an association between the proteins. Purified CaMKII phosphorylates CYLD on at least three residues (S-362, S-418, and S-772 on the human CYLD protein Q9NQC7-1) and promotes its deubiquitinase activity. Activation of CaMKII in isolated PSDs promotes phosphorylation of CYLD on the same residues and also enhances endogenous deubiquitinase activity specific for K63-linked polyubiquitins. Since K63-linked polyubiquitin conjugation to proteins inhibits their interaction with proteasomes, CaMKII-mediated recruitment and upregulation of CYLD is expected to remove K63-linked polyubiquitins and facilitate proteasomal degradation at the PSD.	[Thein, Soe; Reese, Thomas S.; Dosemeci, Ayse] NINDS, Neurobiol Lab, NIH, Bethesda, MD 20892 USA; [Tao-Cheng, Jung-Hwa] NINDS, EM Facil, Bethesda, MD 20892 USA; [Li, Yan] NINDS, Prot Peptide Sequencing Facil, Bethesda, MD 20892 USA; [Bayer, K. Ulrich] Univ Colorado Denver, Sch Med, Dept Pharmacol, Aurora, CO USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Thein, S (corresponding author), NINDS, Neurobiol Lab, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	theinsh@mail.nih.gov; dosemeca@mail.nih.gov			Intramural Research Program NINDS, National Institutes of Health (NIH); NIH [R01 NS081248]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003113, R01NS081248] Funding Source: NIH RePORTER	Intramural Research Program NINDS, National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Intramural Research Program NINDS, National Institutes of Health (NIH) and NIH grant R01 NS081248 (to KUB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bhat RV, 2000, P NATL ACAD SCI USA, V97, P11074, DOI 10.1073/pnas.190297597; Bingol B, 2010, CELL, V140, P567, DOI 10.1016/j.cell.2010.01.024; Buard I, 2010, J NEUROSCI, V30, P8214, DOI 10.1523/JNEUROSCI.1469-10.2010; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Coultrap SJ, 2012, TRENDS NEUROSCI, V35, P607, DOI 10.1016/j.tins.2012.05.003; Djakovic SN, 2009, J BIOL CHEM, V284, P26655, DOI 10.1074/jbc.M109.021956; Dosemeci A, 2000, J NEUROSCI, V20, P3076, DOI 10.1523/JNEUROSCI.20-09-03076.2000; Dosemeci A, 2002, J NEUROCYTOL, V31, P605, DOI 10.1023/A:1025735410738; Dosemeci A, 2007, MOL CELL PROTEOMICS, V6, P1749, DOI 10.1074/mcp.M700040-MCP200; Dosemeci A, 2013, BIOCHEM BIOPH RES CO, V430, P245, DOI 10.1016/j.bbrc.2012.10.131; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Hung AY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009842; Hutti JE, 2009, MOL CELL, V34, P461, DOI 10.1016/j.molcel.2009.04.031; Kato A, 2005, P NATL ACAD SCI USA, V102, P5600, DOI 10.1073/pnas.0501769102; Kristensen AS, 2011, NAT NEUROSCI, V14, P727, DOI 10.1038/nn.2804; Lu ZM, 1998, MOL CELL NEUROSCI, V12, P363, DOI 10.1006/mcne.1998.0723; Massoumi R, 2010, TRENDS BIOCHEM SCI, V35, P392, DOI 10.1016/j.tibs.2010.02.007; Nathan JA, 2013, EMBO J, V32, P552, DOI 10.1038/emboj.2012.354; Oh JS, 2004, J BIOL CHEM, V279, P17980, DOI 10.1074/jbc.M314109200; Opazo P, 2010, NEURON, V67, P239, DOI 10.1016/j.neuron.2010.06.007; Reiley W, 2005, MOL CELL BIOL, V25, P3886, DOI 10.1128/MCB.25.10.3886-3895.2005; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Tao-Cheng JH, 2013, NEUROSCIENCE, V244, P188, DOI 10.1016/j.neuroscience.2013.03.063; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Yang Y, 2011, NEUROSCIENCE, V192, P132, DOI 10.1016/j.neuroscience.2011.06.061; Yang YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071795	32	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91312	10.1371/journal.pone.0091312	http://dx.doi.org/10.1371/journal.pone.0091312			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614225	Green Submitted, gold, Green Published			2022-12-25	WOS:000332839300111
J	Chang, LC; Jamain, S; Lin, CW; Rujescu, D; Tseng, GC; Sibille, E				Chang, Lun-Ching; Jamain, Stephane; Lin, Chien-Wei; Rujescu, Dan; Tseng, George C.; Sibille, Etienne			A Conserved BDNF, Glutamate- and GABA-Enriched Gene Module Related to Human Depression Identified by Coexpression Meta-Analysis and DNA Variant Genome-Wide Association Studies	PLOS ONE			English	Article							CONVERGENT FUNCTIONAL GENOMICS; MAJOR DEPRESSION; PREFRONTAL CORTEX; MOOD DISORDERS; DISEASE; EPIDEMIOLOGY; EXPRESSION; MECHANISMS; BIOMARKERS; NETWORKS	Large scale gene expression (transcriptome) analysis and genome-wide association studies (GWAS) for single nucleotide polymorphisms have generated a considerable amount of gene-and disease-related information, but heterogeneity and various sources of noise have limited the discovery of disease mechanisms. As systematic dataset integration is becoming essential, we developed methods and performed meta-clustering of gene coexpression links in 11 transcriptome studies from postmortem brains of human subjects with major depressive disorder (MDD) and non-psychiatric control subjects. We next sought enrichment in the top 50 meta-analyzed coexpression modules for genes otherwise identified by GWAS for various sets of disorders. One coexpression module of 88 genes was consistently and significantly associated with GWAS for MDD, other neuropsychiatric disorders and brain functions, and for medical illnesses with elevated clinical risk of depression, but not for other diseases. In support of the superior discriminative power of this novel approach, we observed no significant enrichment for GWAS-related genes in coexpression modules extracted from single studies or in meta-modules using gene expression data from non-psychiatric control subjects. Genes in the identified module encode proteins implicated in neuronal signaling and structure, including glutamate metabotropic receptors (GRM1, GRM7), GABA receptors (GABRA2, GABRA4), and neurotrophic and development-related proteins [BDNF, reelin (RELN), Ephrin receptors (EPHA3, EPHA5)]. These results are consistent with the current understanding of molecular mechanisms of MDD and provide a set of putative interacting molecular partners, potentially reflecting components of a functional module across cells and biological pathways that are synchronously recruited in MDD, other brain disorders and MDD-related illnesses. Collectively, this study demonstrates the importance of integrating transcriptome data, gene coexpression modules and GWAS results for providing novel and complementary approaches to investigate the molecular pathology of MDD and other complex brain disorders.	[Chang, Lun-Ching; Lin, Chien-Wei; Tseng, George C.] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Jamain, Stephane] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France; [Jamain, Stephane] Univ Paris Est, Creteil, France; [Jamain, Stephane] Fdn FondaMental, Creteil, France; [Rujescu, Dan] Univ Halle, Dept Psychiat, Halle, Germany; [Tseng, George C.] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; [Sibille, Etienne] Univ Pittsburgh, Dept Psychiat, Ctr Neurosci, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Martin Luther University Halle Wittenberg; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Tseng, GC (corresponding author), Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA.	ctseng@pitt.edu; sibilleel@upmc.edu	Lin, Chien-Wei/AAC-1918-2021; Jamain, Stéphane/P-3710-2017; Jamain, Stéphane/L-1822-2019; Rujescu, Dan/GRS-3875-2022	Lin, Chien-Wei/0000-0003-4023-7339; Jamain, Stéphane/0000-0002-4321-4100; 	National Institute of Mental Health (NIMH) [MH084060, MH085111]; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH084060, R21MH085111] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Mental Health (NIMH) MH084060 (ES) and MH085111 (ES). The funding agency had no role in the study design, data collection and analysis, decision to publish and preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIMH or the National Institutes of Health.	Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bolstad B, 2005, BIOINFORMATICS COMPU; Choudary PV, 2005, P NATL ACAD SCI USA, V102, P15653, DOI 10.1073/pnas.0507901102; Cristino A.S., 2013, MOL PSYCHIAT; Dobrin R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r55; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Elo LL, 2007, BIOINFORMATICS, V23, P2096, DOI 10.1093/bioinformatics/btm309; Gaiteri C, 2013, UNPUB; Gaiteri C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009970; Guilloux JP, 2012, MOL PSYCHIATR, V17, P1130, DOI 10.1038/mp.2011.113; Hasin DS, 2005, ARCH GEN PSYCHIAT, V62, P1097, DOI 10.1001/archpsyc.62.10.1097; Hek K, 2013, BIOL PSYCHIAT; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Klempan TA, 2009, MOL PSYCHIATR, V14, P175, DOI 10.1038/sj.mp.4002110; Kupfer DJ, 2011, ANN NY ACAD SCI, V1242, P1, DOI 10.1111/j.1749-6632.2011.06336.x; Le-Niculescu H, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.9; Le-Niculescu H, 2009, MOL PSYCHIATR, V14, P156, DOI 10.1038/mp.2008.11; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lewis CM, 2010, AM J PSYCHIAT, V167, P949, DOI 10.1176/appi.ajp.2010.09091380; Luscher B, 2011, MOL PSYCHIATR, V16, P383, DOI 10.1038/mp.2010.120; MDD GWAS consortium, 2012, MOL PSYCHIAT; Mueller TI, 1999, AM J PSYCHIAT, V156, P1000; Muglia P, 2010, MOL PSYCHIATR, V15, P589, DOI 10.1038/mp.2008.131; Musselman DL, 1998, ARCH GEN PSYCHIAT, V55, P580, DOI 10.1001/archpsyc.55.7.580; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Niculescu AB, 2013, AM J MED GENET B; Pan A, 2012, DIABETES CARE, V35, P1171, DOI 10.2337/dc11-2055; Rajkowska G, 2007, NEUROPSYCHOPHARMACOL, V32, P471, DOI 10.1038/sj.npp.1301234; Rietschel M, 2010, BIOL PSYCHIAT, V68, P578, DOI 10.1016/j.biopsych.2010.05.038; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Sequeira A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006585; Shi J, 2011, MOL PSYCHIATR, V16, P193, DOI 10.1038/mp.2009.124; Shyn SI, 2011, MOL PSYCHIATR, V16, P202, DOI 10.1038/mp.2009.125; Sibille E, 2004, NEUROPSYCHOPHARMACOL, V29, P351, DOI 10.1038/sj.npp.1300335; Sibille E, 2013, INT J NEUROPSYCHOPH, V16, P1893, DOI 10.1017/S1461145713000436; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; STOUFFER S A, 1949, Sci Am, V180, P11; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Thalamuthu A, 2006, BIOINFORMATICS, V22, P2405, DOI 10.1093/bioinformatics/btl406; Tripp A, 2012, AM J PSYCHIAT, V169, P1194, DOI 10.1176/appi.ajp.2012.12020248; Tseng GC, 2007, BIOINFORMATICS, V23, P2247, DOI 10.1093/bioinformatics/btm320; van den Oord EJCG, 2008, ARCH GEN PSYCHIAT, V65, P1062, DOI 10.1001/archpsyc.65.9.1062; Wang XB, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-52; WEISSMAN MM, 1993, J AFFECT DISORDERS, V29, P77, DOI 10.1016/0165-0327(93)90025-F; Wray NR, 2012, MOL PSYCHIATR, V17, P36, DOI 10.1038/mp.2010.109	48	59	62	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90980	10.1371/journal.pone.0090980	http://dx.doi.org/10.1371/journal.pone.0090980			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608543	Green Published, Green Accepted, gold			2022-12-25	WOS:000332485800072
J	Jacobs, GB; Wilkinson, E; Isaacs, S; Spies, G; de Oliveira, T; Seedat, S; Engelbrecht, S				Jacobs, Graeme Brendon; Wilkinson, Eduan; Isaacs, Shahieda; Spies, Georgina; de Oliveira, Tulio; Seedat, Soraya; Engelbrecht, Susan			HIV-1 Subtypes B and C Unique Recombinant Forms (URFs) and Transmitted Drug Resistance Identified in the Western Cape Province, South Africa	PLOS ONE			English	Article							FULL-LENGTH CLONES; PHYLOGENETIC ANALYSIS; MOLECULAR CHARACTERIZATION; MAXIMUM-LIKELIHOOD; SEQUENCE-ANALYSIS; TYPE-1; TOWN; DIVERSITY; RELIABILITY; GENOME	South Africa has the largest worldwide HIV/AIDS population with 5.6 million people infected and at least 2 million people on antiretroviral therapy. The majority of these infections are caused by HIV-1 subtype C. Using genotyping methods we characterized HIV-1 subtypes of the gag p24 and pol PR and RT fragments, from a cohort of female participants in the Western Cape Province, South Africa. These participants were recruited as part of a study to assess the combined brain and behavioural effects of HIV and early childhood trauma. The partial HIV-1 gag and pol fragments of 84 participants were amplified by PCR and sequenced. Different online tools and manual phylogenetic analysis were used for HIV-1 subtyping. Online tools included: REGA HIV Subtyping tool version 3; Recombinant Identification Program (RIP); Context-based Modeling for Expeditious Typing (COMET); jumping profile Hidden Markov Models (jpHMM) webserver; and subtype classification using evolutionary algorithms (SCUEAL). HIV-1 subtype C predominates within the cohort with a prevalence of 93.8%. We also show, for the first time, the presence of circulating BC strains in at least 4.6% of our study cohort. In addition, we detected transmitted resistance associated mutations in 4.6% of analysed sequences. With tourism and migration rates to South Africa currently very high, we are detecting more and more HIV-1 URFs within our study populations. It is stil unclear what role these unique strains will play in terms of long term antiretroviral treatment and what challenges they will pose to vaccine development. Nevertheless, it remains vitally important to monitor the HIV-1 diversity in South Africa and worldwide as the face of the epidemic is continually changing.	[Jacobs, Graeme Brendon; Wilkinson, Eduan; Isaacs, Shahieda; Engelbrecht, Susan] Univ Stellenbosch, Div Med Virol, ZA-7505 Tygerberg, South Africa; [Wilkinson, Eduan; de Oliveira, Tulio] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa; [Spies, Georgina; Seedat, Soraya] Univ Stellenbosch, Dept Psychiat, ZA-7505 Tygerberg, South Africa; [Engelbrecht, Susan] NHLS, Tygerberg Coastal, South Africa	Stellenbosch University; University of Kwazulu Natal; Stellenbosch University	Engelbrecht, S (corresponding author), Univ Stellenbosch, Div Med Virol, ZA-7505 Tygerberg, South Africa.	susanen@sun.ac.za	Engelbrecht, Susan/G-7286-2011	Engelbrecht, Susan/0000-0002-1318-5994; Seedat, Soraya/0000-0002-5118-786X; Jacobs, Graeme/0000-0002-3259-1496	Poliomyelitis Research Foundation (PRF); Medical Research Council (MRC); National Research Foundation (NRF) of South Africa	Poliomyelitis Research Foundation (PRF); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa)	This study was funded by Poliomyelitis Research Foundation (PRF), the Medical Research Council (MRC) and the National Research Foundation (NRF) of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bredell H, 2002, AIDS RES HUM RETROV, V18, P681, DOI 10.1089/088922202760019400; Bulla I, 2012, STAT APPL GENET MOL, V11, DOI 10.2202/1544-6115.1680; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Oliveira T, 2010, NATURE, V464, P673, DOI 10.1038/464673c; ENGELBRECHT S, 1995, AIDS RES HUM RETROV, V11, P1269, DOI 10.1089/aid.1995.11.1269; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Holguin A, 2008, J CLIN MICROBIOL, V46, P3896, DOI 10.1128/JCM.00515-08; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iweriebor BC, 2011, AIDS RES HUM RETROV, V27, P911, DOI [10.1089/aid.2010.0286, 10.1089/AID.2010.0286]; Jacobs GB, 2006, J MED VIROL, V78, P1529, DOI 10.1002/jmv.20735; Jacobs GB, 2009, J MED VIROL, V81, P1852, DOI 10.1002/jmv.21609; Jacobs GB, 2008, AIDS RES HUM RETROV, V24, P1009, DOI 10.1089/aid.2008.0028; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lessells RJ, 2012, CURR OPIN VIROL, V2, P636, DOI 10.1016/j.coviro.2012.08.006; Loxton AG, 2005, AIDS RES HUM RETROV, V21, P410, DOI 10.1089/aid.2005.21.410; National Strategic Plan for HIV and AIDS, 2011, NAT STRAT PLAN HIV A; Novitsky VA, 1999, J VIROL, V73, P4427, DOI 10.1128/JVI.73.5.4427-4432.1999; Ntemgwa M, 2008, AIDS RES HUM RETROV, V24, P995, DOI 10.1089/aid.2008.0064; Papathanasopoulos MA, 2002, AIDS RES HUM RETROV, V18, P879, DOI 10.1089/08892220260190362; Papathanasopoulos MA, 2002, INFECT GENET EVOL, V18, P879; Pond SLK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000581; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; Rodenburg CM, 2001, AIDS RES HUM RETROV, V17, P161, DOI 10.1089/08892220150217247; Santos AF, 2006, AIDS, V20, P2011; Santos AF, 2010, VIRUSES-BASEL, V2, P503, DOI 10.3390/v2020503; Schultz AK, 2009, NUCLEIC ACIDS RES, V37, pW647, DOI 10.1093/nar/gkp371; South African Department of Health/Directorate Health Systems Research, 2012, 2011 NAT ANT SENT HI; Swanson P, 2003, AIDS RES HUM RETROV, V19, P625, DOI 10.1089/088922203322231003; UNAIDS/WHO working group on global HIV/AIDS & STD surveillance, 2012, AIDS EP UPD; van Harmelen J, 2001, AIDS RES HUM RETROV, V17, P1527, DOI 10.1089/08892220152644232; Van Harmelen JH, 1999, AIDS RES HUM RETROV, V15, P395; vanHarmelen J, 1997, AIDS, V11, P81, DOI 10.1097/00002030-199701000-00012; Wilkinson E, 2009, INFECT GENET EVOL, V9, P840, DOI 10.1016/j.meegid.2009.05.001; WILLIAMSON C, 1995, LANCET, V346, P782, DOI 10.1016/S0140-6736(95)91543-5; Zhang M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-25	38	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90845	10.1371/journal.pone.0090845	http://dx.doi.org/10.1371/journal.pone.0090845			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609015	gold, Green Published, Green Submitted			2022-12-25	WOS:000332485800060
J	Rowe, JM; Jeanniard, A; Gurnon, JR; Xia, YN; Dunigan, DD; Van Etten, JL; Blanc, G				Rowe, Janet M.; Jeanniard, Adrien; Gurnon, James R.; Xia, Yuannan; Dunigan, David D.; Van Etten, James L.; Blanc, Guillaume			Global Analysis of Chlorella variabilis NC64A mRNA Profiles during the Early Phase of Paramecium bursaria Chlorella Virus-1 Infection	PLOS ONE			English	Article							GREEN-ALGA; GENOME; FEATURES; SUBUNIT; REVEALS; PBCV-1; GENES	The PBCV-1/Chlorella variabilis NC64A system is a model for studies on interactions between viruses and algae. Here we present the first global analyses of algal host transcripts during the early stages of infection, prior to virus replication. During the course of the experiment stretching over 1 hour, about a third of the host genes displayed significant changes in normalized mRNA abundance that either increased or decreased compared to uninfected levels. The population of genes with significant transcriptional changes gradually increased until stabilizing at 40 minutes post infection. Functional categories including cytoplasmic ribosomal proteins, jasmonic acid biosynthesis and anaphase promoting complex/cyclosomes had a significant excess in upregulated genes, whereas spliceosomal snRNP complexes and the shikimate pathway had significantly more down-regulated genes, suggesting that these pathways were activated or shut-down in response to the virus infection. Lastly, we examined the expression of C. varibilis RNA polymerase subunits, as PBCV-1 transcription depends on host RNA polymerases. Two subunits were up-regulated, RPB10 and RPC34, suggesting that they may function to support virus transcription. These results highlight genes and pathways, as well as overall trends, for further refinement of our understanding of the changes that take place during the early stages of viral infection.	[Rowe, Janet M.; Gurnon, James R.; Dunigan, David D.; Van Etten, James L.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA; [Rowe, Janet M.; Jeanniard, Adrien; Gurnon, James R.; Dunigan, David D.; Van Etten, James L.] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE USA; [Jeanniard, Adrien; Blanc, Guillaume] Aix Marseille Univ, CNRS, UMR7256, Lab Informat Struct & Genom, Marseille, France; [Xia, Yuannan] Univ Nebraska, Ctr Biotechnol, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of Nebraska System; University of Nebraska Lincoln	Blanc, G (corresponding author), Aix Marseille Univ, CNRS, UMR7256, Lab Informat Struct & Genom, Marseille, France.	guillaume.blanc@igs.cnrs-mrs.fr	Dunigan, David/AAF-1386-2019; Blanc, Guillaume/T-6958-2017	Blanc, Guillaume/0000-0001-5728-1104; Goins, Janet/0000-0003-1139-6058; Dunigan, David D/0000-0001-9496-5396	NSF-EPSCoR [EPS-1004094]; French Ministry of Research; CNRS; PACA-Bioinfo platform; National Center for Research Resources [P20-RR15635]; National Institute of Allergy and Infectious Diseases [1T32AIO60547];  [DOE-DE-EE0003142]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103509] Funding Source: NIH RePORTER	NSF-EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD)); French Ministry of Research(Ministry of Research, FranceEuropean Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); PACA-Bioinfo platform; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by academic funding only. This research was partially supported by NSF-EPSCoR grant EPS-1004094 (JLVE), DOE-DE-EE0003142 (JLVE), French Ministry of Research, CNRS, PACA-Bioinfo platform, and grant P20-RR15635 from the COBRE program of the National Center for Research Resources. JR was supported by a Ruth L. Kirschstein National Research Service Award 1T32AIO60547 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarkova I, 2008, J VIROL, V82, P12181, DOI 10.1128/JVI.01687-08; Agarkova IV, 2006, J VIROL, V80, P8114, DOI 10.1128/JVI.00486-06; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bidle KD, 2007, P NATL ACAD SCI USA, V104, P6049, DOI 10.1073/pnas.0701240104; Blanc G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090989; Blanc G, 2010, PLANT CELL, V22, P2943, DOI 10.1105/tpc.110.076406; Brennan L, 2010, RENEW SUST ENERG REV, V14, P557, DOI 10.1016/j.rser.2009.10.009; Brun I, 1997, EMBO J, V16, P5730, DOI 10.1093/emboj/16.18.5730; Brussaard C.P.D., 2008, PLANT VIRUSES, V2, P1, DOI DOI 10.1016/J.VIROL.2003.10.033; Cerutti H, 2011, EUKARYOT CELL, V10, P1164, DOI 10.1128/EC.05106-11; Christov C, 2001, BIOL PLANTARUM, V44, P367, DOI 10.1023/A:1012490610127; Dillies MA, 2012, BRIEF BIOINFORM; Dunigan DD, 2012, J VIROL, V86, P8821, DOI 10.1128/JVI.00907-12; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gao ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042243; Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; KARAKASHIAN SJ, 1965, EVOLUTION, V19, P368, DOI 10.2307/2406447; Kawasaki T, 2001, Nucleic Acids Res Suppl, P67; Kombrink E, 2012, PLANTA, V236, P1351, DOI 10.1007/s00425-012-1705-z; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Mackinder LCM, 2009, J GEN VIROL, V90, P2306, DOI 10.1099/vir.0.011635-0; Manzur KL, 2003, NAT STRUCT BIOL, V10, P187, DOI 10.1038/nsb898; Mo M, 2012, TRENDS MICROBIOL, V20, P440, DOI 10.1016/j.tim.2012.05.007; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mujtaba S, 2008, NAT CELL BIOL, V10, P1114, DOI 10.1038/ncb1772; Nagasaki K, 2010, MANUAL AQUATIC VIRAL, V10; Nagasaki K, 2008, J MICROBIOL, V46, P235, DOI 10.1007/s12275-008-0098-y; Pagarete A, 2011, FEMS MICROBIOL ECOL, V78, P555, DOI 10.1111/j.1574-6941.2011.01191.x; Piotrowska-Niczyporuk A, 2012, PLANT PHYSIOL BIOCH, V52, P52, DOI 10.1016/j.plaphy.2011.11.009; Rowe JM, 2013, VIROLOGY, V442, P101, DOI 10.1016/j.virol.2013.04.018; SKRDLA MP, 1984, VIROLOGY, V135, P308, DOI 10.1016/0042-6822(84)90188-0; Thiel G, 2010, PROG BOT, V71, P169, DOI 10.1007/978-3-642-02167-1_7; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van Etten JL, 2012, TRENDS PLANT SCI, V17, P1, DOI 10.1016/j.tplants.2011.10.005; VANETTEN JL, 1983, SCIENCE, V219, P994, DOI 10.1126/science.219.4587.994; Wilson WH, 2009, CURR TOP MICROBIOL, V328, P1; Wilson WH, 2005, SCIENCE, V309, P1090, DOI 10.1126/science.1113109; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WOYCHIK NA, 1990, J BIOL CHEM, V265, P17816; Yamada T, 2006, ADV VIRUS RES, V66, P293, DOI 10.1016/S0065-3527(06)66006-5; Yutin N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-223; Zhang XZ, 2011, P NATL ACAD SCI USA, V108, P14837, DOI 10.1073/pnas.1107847108	44	11	13	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90988	10.1371/journal.pone.0090988	http://dx.doi.org/10.1371/journal.pone.0090988			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608695	Green Published, Green Submitted, gold			2022-12-25	WOS:000332485800074
J	Ning, C; Wen, JM; Zhang, YJ; Dai, YB; Wang, W; Zhang, WR; Qi, L; Grenz, A; Eltzschig, HK; Blackburn, MR; Kellems, RE; Xia, Y				Ning, Chen; Wen, Jiaming; Zhang, Yujin; Dai, Yingbo; Wang, Wei; Zhang, Weiru; Qi, Lin; Grenz, Almut; Eltzschig, Holger K.; Blackburn, Michael R.; Kellems, Rodney E.; Xia, Yang			Excess adenosine A2B receptor signaling contributes to priapism through HIF-1 alpha mediated reduction of PDE5 gene expression	FASEB JOURNAL			English	Article						hypoxia-inducible factor; sickle cell disease; phosphodiesterase-5	SICKLE-CELL-DISEASE; DEAMINASE-DEFICIENT MICE; ENDOTHELIAL GROWTH-FACTOR; INDUCIBLE FACTOR-I; PULMONARY INFLAMMATION; HYPOXIA; MANAGEMENT; COMPLICATIONS; CONSEQUENCES; ASSOCIATION	Priapism is featured with prolonged and painful penile erection and is prevalent among males with sickle cell disease (SCD). The disorder is a dangerous urological and hematological emergency since it is associated with ischemic tissue damage and erectile disability. Here we report that phosphodiesterase-5 (PDE5) gene expression and PDE activity is significantly reduced in penile tissues of two independent priapic models: SCD mice and adenosine deaminase (ADA)-deficient mice. Moreover, using ADA enzyme therapy to reduce adenosine or a specific antagonist to block A(2B) adenosine receptor (ADORA2B) signaling, we successfully attenuated priapism in both ADA(-/-) and SCD mice by restoring penile PDE5 gene expression to normal levels. This finding led us to further discover that excess adenosine signaling via ADORA2B activation directly reduces PDE5 gene expression in a hypoxia-inducible factor-1 alpha (HIF-1 alpha)-dependent manner. Overall, we reveal that excess adenosine-mediated ADORA2B signaling underlies reduced penile PDE activity by decreasing PDE5 gene expression in a HIF-1 alpha-dependent manner and provide new insight for the pathogenesis of priapism and novel therapies for the disease.	[Ning, Chen; Wen, Jiaming; Zhang, Yujin; Dai, Yingbo; Wang, Wei; Zhang, Weiru; Blackburn, Michael R.; Kellems, Rodney E.; Xia, Yang] Univ Texas Houston, Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Ning, Chen; Dai, Yingbo; Qi, Lin] Cent S Univ, Xiangya Hosp, Dept Urol, Changsha, Hunan, Peoples R China; [Wang, Wei; Zhang, Weiru] Cent S Univ, Xiangya Hosp, Dept Nephrol, Changsha, Hunan, Peoples R China; [Ning, Chen] Capital Med Univ, Beijing Friendship Hosp, Dept Urol, Beijing, Peoples R China; [Wen, Jiaming; Xia, Yang] Zhejiang Univ, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Grenz, Almut; Eltzschig, Holger K.] Univ Colorado, Sch Med, Dept Anesthesiol, Denver, CO USA; [Blackburn, Michael R.; Kellems, Rodney E.; Xia, Yang] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; Central South University; Central South University; Capital Medical University; Zhejiang University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Texas System; University of Texas Health Science Center Houston	Xia, Y (corresponding author), Univ Texas Houston, Med Sch Houston, Dept Biochem & Mol Biol, 6431 Fannin St,MSB 6-200, Houston, TX 77030 USA.	yang.xia@uth.tmc.edu		Blackburn, Michael/0000-0002-1394-9966	U.S. National Institutes of Health [DK083559, HL119549, HL114457, HL070952, HL092188]; China Scholarship Council [2009637520]; Beijing Natural Science Foundation [7144203]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092188, R01HL113574, R01HL070952, P01HL114457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083559] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); Beijing Natural Science Foundation(Beijing Natural Science Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health grants DK083559 (to Y.X.), HL119549 (to Y.X.), HL114457 (M.R.B., Y.X. and H.K.E.) HL070952 (to M.R.B.), and HL092188 (to H.K.E.), China Scholarship Council grant 2009637520 (to W.R.Z.), and Beijing Natural Science Foundation grant 7144203 (to C.N.). The authors declare no conflicts of interest.	Adeyoju AB, 2002, BJU INT, V90, P898, DOI 10.1046/j.1464-410X.2002.03022.x; Bennett N, 2008, J SEX MED, V5, P1244, DOI 10.1111/j.1743-6109.2008.00770.x; Bivalacqua TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068028; Bivalacqua TJ, 2009, J SEX MED, V6, P2494, DOI 10.1111/j.1743-6109.2009.01359.x; Blackburn MR, 2000, J BIOL CHEM, V275, P32114, DOI 10.1074/jbc.M005153200; Blackburn MR, 2005, ADV IMMUNOL, V86, P1, DOI 10.1016/S0065-2776(04)86001-2; Blackburn MR, 1996, J BIOL CHEM, V271, P15203, DOI 10.1074/jbc.271.25.15203; Blackburn MR, 1998, J BIOL CHEM, V273, P5093, DOI 10.1074/jbc.273.9.5093; Boolell M, 1996, Int J Impot Res, V8, P47; Broderick GA, 2010, J SEX MED, V7, P476, DOI 10.1111/j.1743-6109.2009.01625.x; Bruno D, 2001, J UROLOGY, V166, P803, DOI 10.1016/S0022-5347(05)65841-7; Bucci M, 2010, ARTERIOSCL THROM VAS, V30, P1998, DOI 10.1161/ATVBAHA.110.209783; Burnett AL, 2011, UROL CLIN N AM, V38, P185, DOI 10.1016/j.ucl.2011.02.005; Champion HC, 2005, P NATL ACAD SCI USA, V102, P1661, DOI 10.1073/pnas.0407183102; Chunn JL, 2006, AM J PHYSIOL-LUNG C, V290, pL579, DOI 10.1152/ajplung.00258.2005; Chunn JL, 2005, J IMMUNOL, V175, P1937, DOI 10.4049/jimmunol.175.3.1937; Chunn JL, 2001, J IMMUNOL, V167, P4676, DOI 10.4049/jimmunol.167.8.4676; Colgan SP, 2012, ANNU REV PHYSIOL, V74, P153, DOI 10.1146/annurev-physiol-020911-153230; Eland IA, 2001, UROLOGY, V57, P970, DOI 10.1016/S0090-4295(01)00941-4; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Faria M, 2006, J PHARMACOL EXP THER, V319, P405, DOI 10.1124/jpet.106.107821; Field JJ, 2013, BLOOD, V121, P3329, DOI 10.1182/blood-2012-11-465963; FOWLER JE, 1991, J UROLOGY, V145, P65, DOI 10.1016/S0022-5347(17)38248-4; Hellwig-Burgel T, 2005, J INTERF CYTOK RES, V25, P297, DOI 10.1089/jir.2005.25.297; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Lin CS, 2002, INT J IMPOT RES, V14, P15, DOI 10.1038/sj.ijir.3900802; Merighi S, 2007, MOL PHARMACOL, V72, P395, DOI 10.1124/mol.106.032920; Merighi S, 2006, BIOCHEM PHARMACOL, V72, P19, DOI 10.1016/j.bcp.2006.03.020; Mi T, 2008, J CLIN INVEST, V118, P1491, DOI 10.1172/JCI33467; Montague DK, 2003, J UROLOGY, V170, P1318, DOI 10.1097/01.ju.0000087608.07371.ca; Morrison BF, 2011, NAT REV UROL, V8, P223, DOI 10.1038/nrurol.2011.28; Ning C, 2012, J SEX MED, V9, P2552, DOI 10.1111/j.1743-6109.2012.02896.x; Olujohungbe A, 2013, BRIT J HAEMATOL, V160, P754, DOI 10.1111/bjh.12199; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Paszty C, 1997, Curr Opin Hematol, V4, P88; Pryor J, 2004, J SEX MED, V1, P116, DOI 10.1111/j.1743-6109.2004.10117.x; SERJEANT GR, 1985, LANCET, V2, P1274; Wallace KL, 2010, BLOOD, V116, P5010, DOI 10.1182/blood-2010-06-290643; Wen JM, 2011, FASEB J, V25, P2823, DOI 10.1096/fj.11-181057; Zhang YJ, 2011, NAT MED, V17, P79, DOI 10.1038/nm.2280	41	28	29	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2014	28	6					2725	2735		10.1096/fj.13-247833	http://dx.doi.org/10.1096/fj.13-247833			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AM5GA	24614760	Green Published			2022-12-25	WOS:000339883600030
J	Ali, MP; Huang, DC; Nachman, G; Ahmed, N; Begum, MA; Rabbi, MF				Ali, M. P.; Huang, Dingcheng; Nachman, G.; Ahmed, Nur; Begum, Mahfuz Ara; Rabbi, M. F.			Will Climate Change Affect Outbreak Patterns of Planthoppers in Bangladesh?	PLOS ONE			English	Article							BROWN PLANTHOPPER; INSECTICIDE APPLICATIONS; POPULATION-DYNAMICS; FOREST; TEMPERATURE; RESISTANCE; HOMOPTERA; IMPACTS	Recently, planthoppers outbreaks have intensified across Asia resulting in heavy rice yield losses. The problem has been widely reported as being induced by insecticides while other factors such as global warming that could be potential drivers have been neglected. Here, we speculate that global warming may increase outbreak risk of brown planthopper (Nilaparvata lugens Stal.). We present data that demonstrate the relationship between climate variables (air temperature and precipitation) and the abundance of brown planthopper (BPH) during 1998-2007. Data show that BPH has become significantly more abundant in April over the 10-year period, but our data do not indicate that this is due to a change in climate, as no significant time trends in temperature and precipitation could be demonstrated. The abundance of BPH varied considerably between months within a year which is attributed to seasonal factors, including the availability of suitable host plants. On the other hand, the variation within months is attributed to fluctuations in monthly temperature and precipitation among years. The effects of these weather variables on BPH abundance were analyzed statistically by a general linear model. The statistical model shows that the expected effect of increasing temperatures is ambiguous and interacts with the amount of rainfall. According to the model, months or areas characterized by a climate that is either cold and dry or hot and wet are likely to experience higher levels of BPH due to climate change, whereas other combinations of temperature and rainfall may reduce the abundance of BPH. The analysis indicates that global warming may have contributed to the recent outbreaks of BPH in some rice growing areas of Asia, and that the severity of such outbreaks is likely to increase if climate change exaggerates. Our study highlights the need to consider climate change when designing strategies to manage planthoppers outbreaks.	[Ali, M. P.; Ahmed, Nur; Begum, Mahfuz Ara; Rabbi, M. F.] Bangladesh Rice Res Inst, Div Entomol, Gazipur, Bangladesh; [Huang, Dingcheng] Univ Chinese Acad Sci, Int Affairs Off, Beijing, Peoples R China; [Nachman, G.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Bangladesh Rice Research Institute (BRRI); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Copenhagen	Ali, MP (corresponding author), Bangladesh Rice Res Inst, Div Entomol, Gazipur, Bangladesh.	panna_ali@yahoo.com; huangdc@ucas.ac.cn	ALI, PANNA/P-1625-2017; Ahmed, Nur/D-5917-2019	ALI, PANNA/0000-0001-8197-7064; Ahmed, Nur/0000-0002-6915-3983	Bangladesh Rice Research Institute (BRRI)	Bangladesh Rice Research Institute (BRRI)	This research was supported by Bangladesh Rice Research Institute (BRRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MP, 2012, CEREAL RES COMMUN, V40, P502, DOI 10.1556/CRC.40.2012.0001; [Anonymous], 1988, METEOROL RES REPT; [Anonymous], INSECTICIDE ABUSE RI; Anyamba A, 2001, Cad Saude Publica, V17 Suppl, P133, DOI 10.1590/S0102-311X2001000700022; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Bottrell DG, 2012, J ASIA-PAC ENTOMOL, V15, P122, DOI 10.1016/j.aspen.2011.09.004; BRRI, 2012, BANGL RIC RES I ANN; Cannon RJC, 1998, GLOBAL CHANGE BIOL, V4, P785, DOI 10.1046/j.1365-2486.1998.00190.x; Chien HV, 2009, FARMS APPL INSECTICI; Coley PD, 1998, CLIMATIC CHANGE, V39, P455, DOI 10.1023/A:1005307620024; Dai AG, 2013, NAT CLIM CHANGE, V3, P52, DOI [10.1038/nclimate1633, 10.1038/NCLIMATE1633]; Esbjerg P., 2011, IOBC/WPRS Bulletin, V65, P43; Escalada MM, 2010, THAILAND INSECT INFL; Estay SA, 2009, J APPL ENTOMOL, V133, P491, DOI 10.1111/j.1439-0418.2008.01380.x; FLEMING RA, 1995, WATER AIR SOIL POLL, V82, P445, DOI 10.1007/BF01182854; Hart AJ, 1997, ANN APPL BIOL, V130, P427, DOI 10.1111/j.1744-7348.1997.tb07672.x; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; HEINRICHS EA, 1982, ENVIRON ENTOMOL, V11, P78, DOI 10.1093/ee/11.1.78; Heong K. L., 1998, ECOTOXICOLOGY PESTIC, P381, DOI DOI 10.1007/978-1-4615-5791-3; Heong KL, 2009, PLANTHOPPER OUTBREAK; Heong KL, 2010, ASSESSING BPH OUTBRE; Hibino H, 1996, ANNU REV PHYTOPATHOL, V34, P249, DOI 10.1146/annurev.phyto.34.1.249; Hibino H., 1989, Advances in Disease Vector Research, V6, P209; Hu G, 2011, B ENTOMOL RES, V101, P187, DOI 10.1017/S0007485310000313; IPCC, 2007, CLIMATE CHANGE 2007; IRIN, 2012, HUM NEWS AN; Ishiguro K., 1991, Rice blast modeling and forecasting. Selected papers from the International Rice Research Conference, 27-31 August 1990, Seoul, Korea Republic., P39; Islam Z, 2009, RICE PLANTHOPPER OUT; Jaramillo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006487; Karuppaiah V., 2012, World Journal of Agricultural Sciences, V8, P240; Kiritani K, 2006, POPUL ECOL, V48, P5, DOI 10.1007/s10144-005-0225-0; Kiritani K, 2001, INSECTS CLIMATE; Kontodimas DC, 2004, ENVIRON ENTOMOL, V33, P1, DOI 10.1603/0046-225X-33.1.1; Kulshreshtha J. P., 1974, Indian Farming, V24, P5; Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397; Logan JA, 2003, FRONT ECOL ENVIRON, V1, P130, DOI 10.2307/3867985; Luecha M, 2010, FARMERS INSECTICIDE; Matsumura M, 2010, JARQ-JPN AGR RES Q, V44, P225, DOI 10.6090/jarq.44.225; Matteson PC, 2000, ANNU REV ENTOMOL, V45, P549, DOI 10.1146/annurev.ento.45.1.549; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Moni, 2011, BPH CONTINUES THREAT; Moni, 2012, PLANTHOPPER PROBLEMS; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Petzoldt C, 2008, CLIMATE CHANGE AGR P; Pham Van Du, 2007, Omonrice, P94; Rahman MK, 2009, J ENV PROTECT, V1, P40; SAS, 2008, SAS ENT GUID 4 3; Schiller J.M., 2006, RICE LAOS; Shepard B.M., 1991, CRC HDB PEST MANAGEM, VIII, P255; Singh UP, 2002, BOR RIC E IND RIC WH; Soitong K, 2012, WILL PLANTHOPPERS CO; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; Upmanu L, 1994, WATER RESOUR RES, V31, P2383; Williams DW, 1995, J BIOGEOGR, V22, P665, DOI 10.2307/2845968; Win S. S., 2011, Journal of Entomology, V8, P183, DOI 10.3923/je.2011.183.190; Woiwod IP, 1997, J INSECT CONSERV, V1, P149, DOI 10.1023/A:1018451613970; Yin JL, 2008, ENVIRON ENTOMOL, V37, P206, DOI 10.1603/0046-225X(2008)37[206:CAIAAT]2.0.CO;2	57	30	36	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91678	10.1371/journal.pone.0091678	http://dx.doi.org/10.1371/journal.pone.0091678			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618677	Green Submitted, Green Published, gold			2022-12-25	WOS:000332842400116
J	Jia, FJ; Song, N; Zhao, CY; Xie, JX; Jiang, H				Jia, Fengju; Song, Ning; Zhao, Chenyang; Xie, Junxia; Jiang, Hong			Unexpected Improvements of Spatial Learning and Memory Abilities in Chronic Rotenone Intoxicated Mice	PLOS ONE			English	Article							PARKINSONS-DISEASE; MECHANISMS; EXPOSURE; NEUROGENESIS; MULTICENTER; PROGRESSION; DEMENTIA; FEATURES; CELLS	The liposoluble insecticide rotenone is commonly used as a mitochondrial complex I inhibitor to replicate Parkinson's disease (PD) pathological features. However, there was no assessment of the spatial learning and memory abilities in chronic rotenone-induced PD models. In the present study, by rotarod test and Thioflavine T staining, we first noted the impairment of motor coordination in rotenone-treated group for 3 months, as well as alpha-synuclein inclusions in the nigral dopaminergic neurons in C57BL/6 mice with intragastrical delivery of rotenone (5 mg/Kg) for 3 months rather than 1 month. We then evaluated spatial learning and memory abilities by Morris water maze task in this model. The results showed escape latency reduced in rotenone-intoxicated mice for 3 months, indicating an improvement of learning ability. However, it was delayed slightly but not significantly in rotenone-intoxicated mice for 1 month. Similarly, we demonstrated that spatial memory ability was enhanced in 3-month-treatment group, but impaired in 1-month-treatment group. There were no proliferating cell nuclear antigen and doublecortin positive cells in the hippocampus by double immunofluorescent staining, indicating the absence of hippocampal neurogenesis in rotenone-intoxicated mice. These results suggest that spatial learning and memory abilities are disturbed in chronic rotenone-intoxicated PD model.	[Jiang, Hong] Qingdao Univ, Dept Physiol, Shandong Prov Key Lab Pathogenesis & Prevent Neur, Qingdao 266071, Peoples R China; Qingdao Univ, Coll Med, State Key Disciplines Physiol, Qingdao 266071, Peoples R China	Qingdao University; Qingdao University	Jiang, H (corresponding author), Qingdao Univ, Dept Physiol, Shandong Prov Key Lab Pathogenesis & Prevent Neur, Qingdao 266071, Peoples R China.	jhkyk@163.com			973 Program [2012CB526703, 2011CB504102]; National Natural Science Foundation of China [81171207]; Ministry of Education of China [20103706110002]; Municipal Science and Technology Bureau of Qingdao [12-1-4-2-(19)-jch]; Taishan Scholars Construction Project	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Municipal Science and Technology Bureau of Qingdao; Taishan Scholars Construction Project	This study was funded by grants from the 973 Program (2012CB526703, 2011CB504102 http://www.most.gov.cn/), National Natural Science Foundation of China (81171207 http://www.nsfc.gov.cn/Portal0/default152.htm), Ministry of Education of China (20103706110002http://www.moe.gov.cn/), the Municipal Science and Technology Bureau of Qingdao (12-1-4-2-(19)-jch http://www.qdstc.gov.cn/) and Taishan Scholars Construction Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2010, NEUROLOGY, V75, P1062, DOI 10.1212/WNL.0b013e3181f39d0e; Annerino DM, 2012, ACTA NEUROPATHOL, V124, P665, DOI 10.1007/s00401-012-1040-2; Aulic Suzana, 2013, Int J Cell Biol, V2013, P150952, DOI 10.1155/2013/150952; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Blesa J, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/845618; Braak H, 2007, ACTA NEUROPATHOL, V113, P421, DOI 10.1007/s00401-007-0193-x; Cannon JR, 2009, NEUROBIOL DIS, V34, P279, DOI 10.1016/j.nbd.2009.01.016; Chinta SJ, 2013, J INTERN MED, V273, P429, DOI 10.1111/joim.12029; Codolo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055375; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Drolet RE, 2009, NEUROBIOL DIS, V36, P96, DOI 10.1016/j.nbd.2009.06.017; Ferrer I, 2012, NEUROBIOL DIS, V46, P508, DOI 10.1016/j.nbd.2011.10.019; Golts N, 2002, J BIOL CHEM, V277, P16116, DOI 10.1074/jbc.M107866200; Greene JG, 2009, EXP NEUROL, V218, P154, DOI 10.1016/j.expneurol.2009.04.023; Hanna-Pladdy B, 2013, DEMENT GER COGN D EX, V3, P168, DOI 10.1159/000351421; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; Levy G, 2002, NEUROLOGY, V59, P1708, DOI 10.1212/01.WNL.0000036610.36834.E0; Lim SY, 2010, MOVEMENT DISORD, V25, pS123, DOI 10.1002/mds.22786; Marrinan S, 2013, MOV DISORD; Martin SJ, 2007, CELL MOL LIFE SCI, V64, P401, DOI 10.1007/s00018-007-6336-3; McDowell K, 2012, NEUROBIOL DIS, V46, P597, DOI 10.1016/j.nbd.2011.12.040; Moreira CG, 2012, NEUROTOX RES, V21, P291, DOI 10.1007/s12640-011-9278-3; Morgenstern NA, 2008, J PHYSIOL-LONDON, V586, P3751, DOI 10.1113/jphysiol.2008.154807; Nielsen SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067713; Olanow CW, 2009, NEUROLOGY, V72, pS1, DOI 10.1212/WNL.0b013e3181a1d44c; Pan-Montojo F, 2012, SCI REP-UK, V2, DOI 10.1038/srep00898; Pan-Montojo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008762; Paz GJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003098; Pfeiffer RF, 2011, PARKINSONISM RELAT D, V17, P10, DOI 10.1016/j.parkreldis.2010.08.003; Postuma R, 2010, BRAIN, V133, DOI 10.1093/brain/awq225; Ryan L, 2010, HIPPOCAMPUS, V20, P11, DOI 10.1002/hipo.20607; Savica R, 2009, NEUROLOGY, V73, P1752, DOI 10.1212/WNL.0b013e3181c34af5; Shimizu S, 2013, AGING DIS, V4, P1; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Spivey A, 2011, ENVIRON HEALTH PERSP, V119, pA259, DOI 10.1289/ehp.119-a259a; Stranahan AM, 2008, NAT NEUROSCI, V11, P309, DOI 10.1038/nn2055; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Tieu K, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a009316; Tolleson CM, 2013, DISCOV MED, V15, P61; Van Den Eeden SK, 2003, AM J EPIDEMIOL, V157, P1015, DOI 10.1093/aje/kwg068; Varcin M, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/624925; Wang A, 2011, EUR J EPIDEMIOL, V26, P547, DOI 10.1007/s10654-011-9574-5; Xiong N, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-13; Xiong N, 2012, CRIT REV TOXICOL, V42, P613, DOI 10.3109/10408444.2012.680431; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao Z, 2014, NEUROSCIENCE, V257, P175, DOI 10.1016/j.neuroscience.2013.10.063	47	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91641	10.1371/journal.pone.0091641	http://dx.doi.org/10.1371/journal.pone.0091641			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618574	Green Published, gold, Green Submitted			2022-12-25	WOS:000332842400111
J	Karthik, L; Kumar, G; Keswani, T; Bhattacharyya, A; Chandar, SS; Rao, KVB				Karthik, L.; Kumar, Gaurav; Keswani, Tarun; Bhattacharyya, Arindam; Chandar, S. Sarath; Rao, K. V. Bhaskara			Protease Inhibitors from Marine Actinobacteria as a Potential Source for Antimalarial Compound	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MEROZOITES; ELASTASE INHIBITOR; CYSTEINE PROTEASES; MALARIA; SURFACE; PRECURSOR; RELEASE; COMPLEX; ELASNIN; EGRESS	The study was planned to screen the marine actinobacterial extract for the protease inhibitor activity and its anti-Pf activity under in vitro and in vivo conditions. Out of 100 isolates, only 3 isolates exhibited moderate to high protease inhibitor activities on trypsin, chymotrypsin and proteinase K. Based on protease inhibitor activity 3 isolates were chosen for further studies. The potential isolate was characterized by polyphasic approach and identified as Streptomyces sp LK3 (JF710608). The lead compound was identified as peptide from Streptomyces sp LK3. The double-reciprocal plot displayed inhibition mode is non-competitive and it confirms the irreversible nature of protease inhibitor. The peptide from Streptomyces sp LK3 extract showed significant anti plasmodial activity (IC50: 25.78 mu g/ml). In in vivo model, the highest level of parasitemia suppression (approximate to 45%) was observed in 600 mg/ kg of the peptide. These analyses revealed no significant changes were observed in the spleen and liver tissue during 8 dpi. The results confirmed up-regulation of TGF-beta and down regulation of TNF-alpha in tissue and serum level in PbA infected peptide treated mice compared to PbA infection. The results obtained infer that the peptide possesses anti-Pf activity activity. It suggests that the extracts have novel metabolites and could be considered as a potential source for drug development.	[Karthik, L.; Kumar, Gaurav; Rao, K. V. Bhaskara] VIT Univ, Sch Bio Sci & Technol, Environm Biotechnol Div, Vellore, Tamil Nadu, India; [Keswani, Tarun; Bhattacharyya, Arindam] Univ Calcutta, Dept Zool, Immunol Lab, Kolkata, W Bengal, India; [Chandar, S. Sarath] VIT Univ, Sch Bio Sci & Technol, Div Genet, Vellore, Tamil Nadu, India	Vellore Institute of Technology; University of Calcutta; Vellore Institute of Technology	Rao, KVB (corresponding author), VIT Univ, Sch Bio Sci & Technol, Environm Biotechnol Div, Vellore, Tamil Nadu, India.	kokatibhaskar@yahoo.co.in	LOGANATHAN, KARTHIK/AAE-9188-2021; Bhaskar, Kokati/AAB-3993-2019; Loganathan, KarthiK/P-1658-2016; Kumar, Gaurav/HHZ-2076-2022; Keswani, Tarun/AAQ-5012-2020; Rao, K.V.Bhaskara/C-1797-2019	LOGANATHAN, KARTHIK/0000-0002-2557-2086; Bhaskar, Kokati/0000-0002-6327-1452; Loganathan, KarthiK/0000-0002-2557-2086; Kumar, Gaurav/0000-0002-9464-7811; Keswani, Tarun/0000-0002-0307-692X; Rao, K.V.Bhaskara/0000-0002-6327-1452				Aly ASI, 2005, J EXP MED, V202, P225, DOI 10.1084/jem.20050545; [Anonymous], 1991, MALARIA OBSTACLES OP; Blackman Michael J., 2000, Current Drug Targets, V1, P59, DOI 10.2174/1389450003349461; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Demuth H U, 1990, J Enzyme Inhib, V3, P249, DOI 10.3109/14756369009030375; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; Ersmark K, 2006, MED RES REV, V26, P626, DOI 10.1002/med.20082; Fidock DA, 2004, NAT REV DRUG DISCOV, V3, P509, DOI 10.1038/nrd1416; Gelhaus C, 2005, BIOL CHEM, V386, P499, DOI 10.1515/BC.2005.059; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; HOLDER AA, 1985, NATURE, V317, P270, DOI 10.1038/317270a0; Karthik L, 2013, NANOMED-NANOTECHNOL, V9, P951, DOI 10.1016/j.nano.2013.02.002; Karthik L, 2010, INT J PHARM PHARM SC, V1, P199; Karthik L, 2013, ASIAN PAC J TROP MED, V6, P325, DOI 10.1016/S1995-7645(13)60065-6; Kauth CW, 2006, J BIOL CHEM, V281, P31517, DOI 10.1074/jbc.M604641200; Lee M, 2004, CHEM SOC REV, V33, P401, DOI 10.1039/b209224g; Li XR, 2004, J BIOL CHEM, V279, P5765, DOI 10.1074/jbc.M308716200; Macherla VR, 2005, J MED CHEM, V48, P3684, DOI 10.1021/jm048995+; Maskey RP, 2004, J ANTIBIOT, V57, P771, DOI 10.7164/antibiotics.57.771; McCoubrie JE, 2007, INFECT IMMUN, V75, P5565, DOI 10.1128/IAI.00405-07; MCKERROW JH, 1993, ANNU REV MICROBIOL, V47, P821, DOI 10.1146/annurev.mi.47.100193.004133; NAKAGAWA A, 1980, J ORG CHEM, V45, P3268, DOI 10.1021/jo01304a025; OHNO H, 1978, J ANTIBIOT, V31, P1116, DOI 10.7164/antibiotics.31.1116; Olliaro P, 1996, JAMA-J AM MED ASSOC, V275, P230, DOI 10.1001/jama.275.3.230; Olson JE, 1999, BIOORGAN MED CHEM, V7, P633, DOI 10.1016/S0968-0896(99)00004-8; Pachebat JA, 2001, MOL BIOCHEM PARASIT, V117, P83, DOI 10.1016/S0166-6851(01)00336-X; Pachebat JA, 2007, MOL BIOCHEM PARASIT, V151, P59, DOI 10.1016/j.molbiopara.2006.10.006; Peraud O., 2006, ISOLATION CHARACTERI; Peter I.T., 1998, CURRENT GLOBAL MALAR, P11; Prudhomme J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002335; Putrianti ED, 2010, CELL MICROBIOL, V12, P725, DOI 10.1111/j.1462-5822.2009.01419.x; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; Rosenthal PJ, 2004, INT J PARASITOL, V34, P1489, DOI 10.1016/j.ijpara.2004.10.003; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; Senior K, 2005, DRUG DISCOV TODAY, V10, P1210, DOI 10.1016/S1359-6446(05)03601-9; Serkedjieva, 2005, BIOTECHNOL BIOTECHNO, V19, P126, DOI [10.1080/13102818.2005.10817203, DOI 10.1080/13102818.2005.10817203]; Stafford WHL, 1996, MOL BIOCHEM PARASIT, V80, P159, DOI 10.1016/0166-6851(96)02696-5; SUDA H, 1972, J ANTIBIOT, V25, P263, DOI 10.7164/antibiotics.25.263; TAGUCHI S, 1993, APPL ENVIRON MICROB, V59, P4338, DOI 10.1128/AEM.59.12.4338-4341.1993; UMEZAWA H, 1982, ANNU REV MICROBIOL, V36, P75, DOI 10.1146/annurev.mi.36.100182.000451; UMEZAWA H, 1970, J ANTIBIOT, V23, P259, DOI 10.7164/antibiotics.23.259; Umezawa H, 1972, ENZYME INHIBITOR MIC; UMEZAWA S, 1972, J ANTIBIOT, V25, P267, DOI 10.7164/antibiotics.25.267; Vekemans J, 2008, EXPERT REV VACCINES, V7, P223, DOI 10.1586/14760584.7.2.223; WHO, 1980, WHO TECHN REP SER, V2; WHO, 2010, WORLD MALARIA REPORT; Withers-Martinez C, 2012, INT J PARASITOL, V42, P597, DOI 10.1016/j.ijpara.2012.04.005; WMR, 2011, WORLD MALARIA REPORT; [WMR WHO], 2011, WORLD MAL REP 2011; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049; Yin HQ, 2008, SYST APPL MICROBIOL, V31, P302, DOI 10.1016/j.syapm.2008.05.003	52	112	114	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90972	10.1371/journal.pone.0090972	http://dx.doi.org/10.1371/journal.pone.0090972			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618707	Green Submitted, Green Published, gold			2022-12-25	WOS:000332842400040
J	Schoner, TA; Fuchs, SW; Reinhold-Hurek, B; Bode, HB				Schoener, Tim A.; Fuchs, Sebastian W.; Reinhold-Hurek, Barbara; Bode, Helge B.			Identification and Biosynthesis of a Novel Xanthomonadin-Dialkylresorcinol-Hybrid from Azoarcus sp BH72	PLOS ONE			English	Article							DIFFUSIBLE FACTOR; 3-HYDROXYBENZOIC ACID; PIGMENTS; MICROORGANISMS; FLEXIRUBIN; METABOLITES; UBIQUINONE; FRAGMENTATION; SUBSTANCES; DB-2073	A novel xanthomonadin-dialkylresorcinol hybrid named arcuflavin was identified in Azoarcus sp. BH72 by a combination of feeding experiments, HPLC-MS and MALDI-MS and gene clusters encoding the biosynthesis of this non-isoprenoid aryl-polyene containing pigment are reported. A chorismate-utilizing enzyme from the XanB2-type producing 3-and 4-hydroxybenzoic acid and an AMP-ligase encoded by these gene clusters were characterized, that might perform the first two steps of the polyene biosynthesis. Furthermore, a detailed analysis of the already known or novel biosynthesis gene clusters involved in the biosynthesis of polyene containing pigments like arcuflavin, flexirubin and xanthomonadin revealed the presence of similar gene clusters in a wide range of bacterial taxa, suggesting that polyene and polyene-dialkylresorcinol pigments are more widespread than previously realized.	[Schoener, Tim A.; Fuchs, Sebastian W.; Bode, Helge B.] Goethe Univ Frankfurt, Merck Stiftungsprof Mol Biotechnol, Fachbereich Biowissensch, D-60054 Frankfurt, Germany; [Reinhold-Hurek, Barbara] Univ Bremen, Lab Gen Microbiol, D-28359 Bremen, Germany	Goethe University Frankfurt; University of Bremen	Bode, HB (corresponding author), Goethe Univ Frankfurt, Merck Stiftungsprof Mol Biotechnol, Fachbereich Biowissensch, D-60054 Frankfurt, Germany.	h.bode@bio.uni-frankfurt.de	Bode, Helge B/F-7022-2014	Bode, Helge B/0000-0001-6048-5909	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Work in the Bode lab was funded by the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHENBACH H, 1976, CHEM BER-RECL, V109, P2490, DOI 10.1002/cber.19761090717; ACHENBACH H, 1979, CHEM BER-RECL, V112, P209, DOI 10.1002/cber.19791120119; ACHENBACH H, 1979, CHEM BER-RECL, V112, P1999, DOI 10.1002/cber.19791120610; Andexer JN, 2011, P NATL ACAD SCI USA, V108, P4776, DOI 10.1073/pnas.1015773108; Andrewes AG, 1977, TETRAHEDRON LETT, V45, P4023; Bohm M, 2007, MOL PLANT MICROBE IN, V20, P526, DOI 10.1094/MPMI-20-5-0526; DIANESE JC, 1982, PHYTOPATHOLOGY, V72, P1284, DOI 10.1094/Phyto-72-1284; FAUTZ E, 1980, FEMS MICROBIOL LETT, V8, P87, DOI 10.1016/0378-1097(80)90075-0; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fuchs SW, 2013, ANGEW CHEM INT EDIT, V52, P4108, DOI 10.1002/anie.201210116; Fuchs SW, 2012, ANAL CHEM, V84, P6948, DOI 10.1021/ac300372p; Goel AK, 2002, J BACTERIOL, V184, P3539, DOI 10.1128/JB.184.13.3539-3548.2002; Han JI, 2011, J BACTERIOL, V193, P1183, DOI 10.1128/JB.00925-10; He YW, 2011, MOL PLANT MICROBE IN, V24, P948, DOI 10.1094/MPMI-02-11-0031; IMAI S, 1993, J ANTIBIOT, V46, P1319, DOI 10.7164/antibiotics.46.1319; JENKINS CL, 1985, ANN INST PASTEUR MIC, V136B, P257, DOI 10.1016/S0769-2609(85)80071-5; JENKINS CL, 1982, CURR MICROBIOL, V7, P195, DOI 10.1007/BF01568797; JENKINS CL, 1982, CURR MICROBIOL, V7, P323, DOI 10.1007/BF01566872; Joyce SA, 2008, ANGEW CHEM INT EDIT, V47, P1942, DOI 10.1002/anie.200705148; Juneja P, 2014, J MOL BIOL, V426, P105, DOI 10.1016/j.jmb.2013.09.006; KANDA N, 1975, J ANTIBIOT, V28, P935, DOI 10.7164/antibiotics.28.935; KATO S, 1993, J ANTIBIOT, V46, P1024, DOI 10.7164/antibiotics.46.1024; KITAHARA T, 1975, J ANTIBIOT, V28, P943, DOI 10.7164/antibiotics.28.943; Krause A, 2006, NAT BIOTECHNOL, V24, P1385, DOI 10.1038/nbt1243; Krause A, 2011, MOL PLANT MICROBE IN, V24, P1325, DOI 10.1094/MPMI-05-11-0139; Nanda AK, 2010, J INTEGR PLANT BIOL, V52, P195, DOI 10.1111/j.1744-7909.2010.00933.x; Phelan VV, 2009, CHEM BIOL, V16, P473, DOI 10.1016/j.chembiol.2009.04.007; Poplawsky AR, 2000, APPL ENVIRON MICROB, V66, P5123, DOI 10.1128/AEM.66.12.5123-5127.2000; POPLAWSKY AR, 1993, MOL PLANT MICROBE IN, V6, P545, DOI 10.1094/MPMI-6-545; Poplawsky AR, 1997, J BACTERIOL, V179, P439, DOI 10.1128/jb.179.2.439-444.1997; Rajagopal L, 1997, FEBS LETT, V415, P125, DOI 10.1016/S0014-5793(97)01109-5; Reimer D, 2011, NAT CHEM BIOL, V7, P888, DOI [10.1038/NCHEMBIO.688, 10.1038/nchembio.688]; REINHOLD B, 1986, APPL ENVIRON MICROB, V52, P520, DOI 10.1128/AEM.52.3.520-526.1986; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schoner TA, 2014, MICROB BIOTECHNOL, V7, P232, DOI 10.1111/1751-7915.12110; SIEBERT M, 1992, FEBS LETT, V307, P347, DOI 10.1016/0014-5793(92)80710-X; STARR MP, 1977, ARCH MICROBIOL, V113, P1, DOI 10.1007/BF00428572; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066633; Zhou L, 2013, MOL PLANT MICROBE IN, V26, P1239, DOI 10.1094/MPMI-04-13-0112-R; Zhou L, 2013, MOL MICROBIOL, V87, P80, DOI 10.1111/mmi.12084	41	18	18	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90922	10.1371/journal.pone.0090922	http://dx.doi.org/10.1371/journal.pone.0090922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618669	Green Published, gold, Green Submitted			2022-12-25	WOS:000332842400036
J	Karlskas, IL; Maudal, K; Axelsson, L; Rud, I; Eijsink, VGH; Mathiesen, G				Karlskas, Ingrid Lea; Maudal, Kristina; Axelsson, Lars; Rud, Ida; Eijsink, Vincent G. H.; Mathiesen, Geir			Heterologous Protein Secretion in Lactobacilli with Modified pSIP Vectors	PLOS ONE			English	Article							INDUCIBLE GENE-EXPRESSION; COMPLETE GENOME SEQUENCE; LACTIC-ACID BACTERIA; LACTOCOCCUS-LACTIS; PROTECTIVE ANTIGEN; BACILLUS-SUBTILIS; PLANTARUM; SAKEI; TRANSFORMATION; GASSERI	We describe new variants of the modular pSIP-vectors for inducible gene expression and protein secretion in lactobacilli. The basic functionality of the pSIP system was tested in Lactobacillus strains representing 14 species using pSIP411, which harbors the broad-host-range Lactococcus lactis SH71(rep) replicon and a beta-glucuronidase encoding reporter gene. In 10 species, the inducible gene expression system was functional. Based on these results, three pSIP vectors with different signal peptides were modified by replacing their narrow-host-range L. plantarum 256(rep) replicon with SH71(rep) and transformed into strains of five different species of Lactobacillus. All recombinant strains secreted the target protein NucA, albeit with varying production levels and secretion efficiencies. The Lp_3050 derived signal peptide generally resulted in the highest levels of secreted NucA. These modified pSIP vectors are useful tools for engineering a wide variety of Lactobacillus species.	[Karlskas, Ingrid Lea; Maudal, Kristina; Eijsink, Vincent G. H.; Mathiesen, Geir] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Axelsson, Lars; Rud, Ida] Nofima Norwegian Inst Food Fisheries & Aquacultur, As, Norway	Norwegian University of Life Sciences; Nofima	Mathiesen, G (corresponding author), Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway.	geir.mathiesen@umb.no			FUGE programme of the Norwegian Research Council [183637]	FUGE programme of the Norwegian Research Council	This work was funded by the FUGE programme of the Norwegian Research Council, grant number 183637. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRNE S, 1992, CURR MICROBIOL, V24, P199, DOI 10.1007/BF01579282; Anbazhagan K, 2013, J APPL MICROBIOL, V115, P880, DOI 10.1111/jam.12269; Antelmann H, 2003, MOL MICROBIOL, V49, P143, DOI 10.1046/j.1365-2958.2003.03565.x; AUKRUST T, 1992, FOOD RES INT, V25, P253, DOI 10.1016/0963-9969(92)90121-K; Axelsson L, 2003, LETT APPL MICROBIOL, V37, P115, DOI 10.1046/j.1472-765X.2003.01360.x; Azcarate-Peril MA, 2008, APPL ENVIRON MICROB, V74, P4610, DOI 10.1128/AEM.00054-08; Bohmer N, 2012, APPL MICROBIOL BIOT, V96, P903, DOI 10.1007/s00253-012-4212-z; Bolhuis A, 1999, APPL ENVIRON MICROB, V65, P2934; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; Brockmeier U, 2006, J MOL BIOL, V362, P393, DOI 10.1016/j.jmb.2006.07.034; Bron PA, 2012, NAT REV MICROBIOL, V10, P66, DOI 10.1038/nrmicro2690; Chaillou S, 2005, NAT BIOTECHNOL, V23, P1527, DOI 10.1038/nbt1160; De Vuyst L, 2007, J MOL MICROB BIOTECH, V13, P194, DOI 10.1159/000104752; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; DEVOS WM, 1987, FEMS MICROBIOL LETT, V46, P281, DOI 10.1111/j.1574-6968.1987.tb02466.x; Diep DB, 2009, CURR PHARM BIOTECHNO, V10, P62, DOI 10.2174/138920109787048571; Dieye Y, 2001, J BACTERIOL, V183, P4157, DOI 10.1128/JB.183.14.4157-4166.2001; Eijsink VGH, 2002, ANTON LEEUW INT J G, V81, P639, DOI 10.1023/A:1020582211262; Felis Giovanna E, 2007, Curr Issues Intest Microbiol, V8, P44; Fredriksen L, 2012, APPL ENVIRON MICROB, V78, P5864, DOI 10.1128/AEM.01227-12; Fredriksen L, 2010, APPL ENVIRON MICROB, V76, P7359, DOI 10.1128/AEM.01031-10; Halbmayr E, 2008, J AGR FOOD CHEM, V56, P4710, DOI 10.1021/jf073260+; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kleerebezem M, 2010, FEMS MICROBIOL REV, V34, P199, DOI [10.1111/j.1574-6976.2010.00208.x, 10.1111/j.1574-6976.2009.00208.x]; Klingberg TD, 2005, INT J FOOD MICROBIOL, V105, P419, DOI 10.1016/j.ijfoodmicro.2005.03.020; Kolandaswamy A, 2008, CURR MICROBIOL; Kruger C, 2002, NAT BIOTECHNOL, V20, P702, DOI 10.1038/nbt0702-702; Le Loir Y, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacConaill LE, 2003, APPL ENVIRON MICROB, V69, P6994, DOI 10.1128/AEM.69.12.6994-7001.2003; Mathiesen G, 2008, J APPL MICROBIOL, V105, P215, DOI 10.1111/j.1365-2672.2008.03734.x; Mathiesen G, 2004, J APPL MICROBIOL, V96, P819, DOI 10.1111/j.1365-2672.2004.02206.x; Mathiesen G, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-425; Mohamadzadeh M, 2005, P NATL ACAD SCI USA, V102, P2880, DOI 10.1073/pnas.0500098102; Mohamadzadeh M, 2009, P NATL ACAD SCI USA, V106, P4331, DOI 10.1073/pnas.0900029106; Mohamadzadeh M, 2010, FUTURE MICROBIOL, V5, P1289, DOI 10.2217/FMB.10.78; Morais S, 2013, APPL ENVIRON MICROB, V79, P5242, DOI 10.1128/AEM.01211-13; Park DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059470; Pushnova EA, 2000, ANAL BIOCHEM, V284, P70, DOI 10.1006/abio.2000.4668; Risoen PA, 2000, MOL MICROBIOL, V37, P619, DOI 10.1046/j.1365-2958.2000.02029.x; Selle K, 2013, FEMS MICROBIOL REV, V37, P915, DOI 10.1111/1574-6976.12021; Skulj M, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-6; Sorvig E, 2005, MICROBIOL-SGM, V151, P2439, DOI 10.1099/mic.0.28084-0; Sorvig E, 2005, MICROBIOL-SGM, V151, P421, DOI 10.1099/mic.0.27389-0; Sorvig E, 2003, FEMS MICROBIOL LETT, V229, P119, DOI 10.1016/S0378-1097(03)00798-5; Stoeker L, 2011, CLIN VACCINE IMMUNOL, V18, P1834, DOI 10.1128/CVI.05277-11; Nguyen T, 2011, J AGR FOOD CHEM, V59, P5617, DOI 10.1021/jf104755r; Vaidyanathan H, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-37; van Pijkeren JP, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks147; Von Wright A, 2012, LACTIC ACID BACTERIA: MICROBIOLOGICAL AND FUNCTIONAL ASPECTS, 4TH EDITION, P1; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840; Wells JM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S17	54	39	40	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91125	10.1371/journal.pone.0091125	http://dx.doi.org/10.1371/journal.pone.0091125			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614815	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000332839300080
J	Kim, JS; Park, HM; Chae, S; Lee, TH; Hwang, DJ; Oh, SD; Park, JS; Song, DG; Pan, CH; Choi, D; Kim, YH; Nahm, BH; Kim, YK				Kim, Joung Sug; Park, Hyang-Mi; Chae, Songhwa; Lee, Tae-Ho; Hwang, Duk-Ju; Oh, Sung-Dug; Park, Jong-Sug; Song, Dae-Geun; Pan, Cheol-Ho; Choi, Doil; Kim, Yul-Ho; Nahm, Baek Hie; Kim, Yeon-Ki			A Pepper MSRB2 Gene Confers Drought Tolerance in Rice through the Protection of Chloroplast-Targeted Genes	PLOS ONE			English	Article							METHIONINE SULFOXIDE REDUCTASES; ARABIDOPSIS-THALIANA; STRESS RESPONSES; OXIDATIVE STRESS; EXPRESSION; PROTEIN; PLANTS; PATHWAYS; NUCLEUS; OXYGEN	ackground: The perturbation of the steady state of reactive oxygen species (ROS) due to biotic and abiotic stresses in a plant could lead to protein denaturation through the modification of amino acid residues, including the oxidation of methionine residues. Methionine sulfoxide reductases (MSRs) catalyze the reduction of methionine sulfoxide back to the methionine residue. To assess the role of this enzyme, we generated transgenic rice using a pepper CaMSRB2 gene under the control of the rice Rab21 (responsive to ABA protein 21) promoter with/without a selection marker, the bar gene. Results: A drought resistance test on transgenic plants showed that CaMSRB2 confers drought tolerance to rice, as evidenced by less oxidative stress symptoms and a strengthened PSII quantum yield under stress conditions, and increased survival rate and chlorophyll index after the re-watering. The results from immunoblotting using a methionine sulfoxide antibody and nano-LC-MS/MS spectrometry suggest that porphobilinogen deaminase (PBGD), which is involved in chlorophyll synthesis, is a putative target of CaMSRB2. The oxidized methionine content of PBGD expressed in E. coli increased in the presence of H2O2, and the Met-95 and Met-227 residues of PBGD were reduced by CaMSRB2 in the presence of dithiothreitol (DTT). An expression profiling analysis of the overexpression lines also suggested that photosystems are less severely affected by drought stress. Conclusions: Our results indicate that CaMSRB2 might play an important functional role in chloroplasts for conferring drought stress tolerance in rice.	[Kim, Joung Sug; Nahm, Baek Hie] Myong Ji Univ, Div Biosci & Bioinformat, Yongin, Kyonggido, South Korea; [Chae, Songhwa; Lee, Tae-Ho; Nahm, Baek Hie; Kim, Yeon-Ki] GreenGene BioTech Inc, Genom Genet Inst, Yongin, Kyonggido, South Korea; [Park, Hyang-Mi; Kim, Yul-Ho] Natl Inst Crop Sci, Rice Res Div, Suwon, South Korea; [Hwang, Duk-Ju; Oh, Sung-Dug; Park, Jong-Sug] Rural Dev Adm, Natl Acad Agr Sci, Suwon, South Korea; [Choi, Doil] Seoul Natl Univ, Coll Agr & Life Sci, Seoul, South Korea; [Choi, Doil] Seoul Natl Univ, Plant Genom & Breeding Inst, Seoul, South Korea; [Song, Dae-Geun; Pan, Cheol-Ho] Korea Inst Sci & Technol, Funct Food Ctr, Kangnung, Gangwon Do, South Korea	Myongji University; Rural Development Administration (RDA), Republic of Korea; National Institute of Crop Science; Rural Development Administration (RDA), Republic of Korea; Seoul National University (SNU); Seoul National University (SNU); Korea Institute of Science & Technology (KIST)	Nahm, BH (corresponding author), Myong Ji Univ, Div Biosci & Bioinformat, Yongin, Kyonggido, South Korea.	bhnahm@gmail.com; kim750a11@gmail.com	Choi, Doil/F-5002-2011		Next-Generation BioGreen 21 Program [PJ008070, PJ009484, PJ008145]; RDA the Republic of Korea; 21st Century Frontier Program, Korean ministry of Education, Science and Technology [2011-0031518]; Korea Institute of Science and Technology Gangneung Institute [2Z03850]; BK21	Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); RDA the Republic of Korea; 21st Century Frontier Program, Korean ministry of Education, Science and Technology; Korea Institute of Science and Technology Gangneung Institute(Korea Institute of Science & Technology (KIST)); BK21(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by grants from the Next-Generation BioGreen 21 Program (YKK, grant no. PJ008070 and PJ009484; BHN, grant no. PJ008145), RDA the Republic of Korea and 21st Century Frontier Program, Korean ministry of Education, Science and Technology (BHN, grant no. 2011-0031518) and by grants from the Korea Institute of Science and Technology Gangneung Institute intramural research grant 2Z03850 (DGS and CHP). JSK and BHN were supported by BK21. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn IP, 2008, PLANT PHYSIOL, V146, P213, DOI 10.1104/pp.107.105890; Ankele E, 2007, PLANT CELL, V19, P1964, DOI 10.1105/tpc.106.048744; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Arnoys EJ, 2007, ACTA HISTOCHEM, V109, P89, DOI 10.1016/j.acthis.2006.10.002; Balzergue S, 2001, BIOTECHNIQUES, V30, P496, DOI 10.2144/01303bm06; Beck CF, 2005, PLANTA, V222, P743, DOI 10.1007/s00425-005-0021-2; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; BJORKMAN O, 1987, PLANTA, V170, P489, DOI 10.1007/BF00402983; Bonardi V, 2005, NATURE, V437, P1179, DOI 10.1038/nature04016; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Cheng W, 2011, BIOL PLANTARUM, V55, P173, DOI 10.1007/s10535-011-0025-7; Cho HS, 2004, PLANT CELL, V16, P2665, DOI 10.1105/tpc.104.024281; Cho JI, 2009, PLANT PHYSIOL, V149, P745, DOI 10.1104/pp.108.131227; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; de Carvalho MHC, 2008, PLANT SIGNAL BEHAV, V3, P156, DOI 10.4161/psb.3.3.5536; DEBLOCK M, 1987, EMBO J, V6, P2513, DOI 10.1002/j.1460-2075.1987.tb02537.x; Degenkolbe T, 2009, PLANT MOL BIOL, V69, P133, DOI 10.1007/s11103-008-9412-7; Le DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065637; Ebinuma H, 2004, TRANSGENIC PLANTS ME, P237, DOI [10.1385/1-59259-827-7:237, DOI 10.1385/1-59259-827-7:237]; Ezraty B, 2005, BBA-PROTEINS PROTEOM, V1703, P221, DOI 10.1016/j.bbapap.2004.08.017; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fernandez AP, 2008, CURR OPIN PLANT BIOL, V11, P509, DOI 10.1016/j.pbi.2008.06.002; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Guo XL, 2009, PLANTA, V230, P227, DOI 10.1007/s00425-009-0934-2; Gustavsson N, 2002, PLANT J, V29, P545, DOI 10.1046/j.1365-313X.2002.029005545.x; Hadiarto T, 2011, PLANT CELL REP, V30, P297, DOI 10.1007/s00299-010-0956-z; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hirochika H, 1996, P NATL ACAD SCI USA, V93, P7783, DOI 10.1073/pnas.93.15.7783; Huang MS, 2009, MOL PLANT, V2, P773, DOI 10.1093/mp/ssp029; Jang IC, 1999, MOL BREEDING, V5, P453, DOI 10.1023/A:1009665314850; Jang IC, 2003, PLANT PHYSIOL, V131, P516, DOI 10.1104/pp.007237; Jewell MC, 2010, TRANSGENIC CROP PLANTS: VOL 2, P67, DOI 10.1007/978-3-642-04812-8_2; JONES RM, 1994, BIOCHEM J, V299, P895, DOI 10.1042/bj2990895; Jorgensen RB, 1996, TRENDS PLANT SCI, V1, P356; Kim JS, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-19; Kim MJ, 2012, METHODS MOL BIOL, V786, P65, DOI 10.1007/978-1-61779-292-2_4; KROGMANN DW, 1959, PLANT PHYSIOL, V34, P272, DOI 10.1104/pp.34.3.272; Kwon SJ, 2007, PLANT CELL PHYSIOL, V48, P1713, DOI 10.1093/pcp/pcm143; Laugier E, 2010, PLANT J, V61, P271, DOI 10.1111/j.1365-313X.2009.04053.x; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8; Miyao A, 2012, PLANT CELL PHYSIOL, V53, P256, DOI 10.1093/pcp/pcr172; MUNDY J, 1988, EMBO J, V7, P2279, DOI 10.1002/j.1460-2075.1988.tb03070.x; Nakamura K, 2006, J BIOL CHEM, V281, P36758, DOI 10.1074/jbc.M606797200; Oh SK, 2010, PLANT PHYSIOL, V154, P245, DOI 10.1104/pp.110.162339; Oien DB, 2009, ARCH BIOCHEM BIOPHYS, V485, P35, DOI 10.1016/j.abb.2009.01.020; op den Camp RGL, 2003, PLANT CELL, V15, P2320, DOI 10.1105/tpc.014662; Qin F, 2011, PLANT CELL PHYSIOL, V52, P1569, DOI 10.1093/pcp/pcr106; Reddy AR, 2004, J PLANT PHYSIOL, V161, P1189, DOI 10.1016/j.jplph.2004.01.013; Rodermel S, 2003, BIOESSAYS, V25, P631, DOI 10.1002/bies.10308; Rouhier N, 2006, PHOTOSYNTH RES, V89, P247, DOI 10.1007/s11120-006-9097-1; SEKHAR BPS, 1982, THEOR APPL GENET, V62, P35, DOI 10.1007/BF00276278; Sohn SooIn, 2006, Korean Journal of Breeding, V38, P173; Strand A, 2003, NATURE, V421, P79, DOI 10.1038/nature01204; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Phung TH, 2011, PLANT PHYSIOL, V157, P1746, DOI 10.1104/pp.111.188276; Vannini C, 2007, PLANT SCI, V173, P231, DOI 10.1016/j.plantsci.2007.05.007; WALLSGROVE RM, 1983, PLANT CELL ENVIRON, V6, P301; Wang FZ, 2005, J PLANT PHYSIOL, V162, P465, DOI 10.1016/j.jplph.2004.09.009; WORKMAN C, 2002, GENOME BIOL, V0003; Xu FQ, 2008, PLANT SCI, V175, P674, DOI 10.1016/j.plantsci.2008.07.002; Yi N, 2010, PLANTA, V232, P743, DOI 10.1007/s00425-010-1212-z	64	15	15	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90588	10.1371/journal.pone.0090588	http://dx.doi.org/10.1371/journal.pone.0090588			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614245	gold, Green Published, Green Submitted			2022-12-25	WOS:000332839300032
J	Sahadevan, S; Gunawan, A; Tholen, E; Grosse-Brinkhaus, C; Tesfaye, D; Schellander, K; Hofmann-Apitius, M; Cinar, MU; Uddin, MJ				Sahadevan, Sudeep; Gunawan, Asep; Tholen, Ernst; Grosse-Brinkhaus, Christine; Tesfaye, Dawit; Schellander, Karl; Hofmann-Apitius, Martin; Cinar, Mehmet Ulas; Uddin, Muhammad Jasim			Pathway Based Analysis of Genes and Interactions Influencing Porcine Testis Samples from Boars with Divergent Androstenone Content in Back Fat	PLOS ONE			English	Article							REGULATORY PROTEIN EXPRESSION; LEYDIG-CELL STEROIDOGENESIS; GENOME-WIDE ASSOCIATION; QUANTITATIVE TRAIT LOCI; KINASE-C; ADIPOSE-TISSUE; TAINT; PIGS; BIOSYNTHESIS; CERAMIDE	One of the primary factors contributing to boar taint is the level of androstenone in porcine adipose tissues. A majority of the studies performed to identify candidate biomarkers for the synthesis of androstenone in testis tissues follow a reductionist approach, identifying and studying the effect of biomarkers individually. Although these studies provide detailed information on individual biomarkers, a global picture of changes in metabolic pathways that lead to the difference in androstenone synthesis is still missing. The aim of this work was to identify major pathways and interactions influencing steroid hormone synthesis and androstenone biosynthesis using an integrative approach to provide a bird's eye view of the factors causing difference in steroidogenesis and androstenone biosynthesis. For this purpose, we followed an analysis procedure merging together gene expression data from boars with divergent levels of androstenone and pathway mapping and interaction network retrieved from KEGG database. The interaction networks were weighted with Pearson correlation coefficients calculated from gene expression data and significant interactions and enriched pathways were identified based on these networks. The results show that 1,023 interactions were significant for high and low androstenone animals and that a total of 92 pathways were enriched for significant interactions. Although published articles show that a number of these enriched pathways were activated as a result of downstream signaling of steroid hormones, we speculate that the significant interactions in pathways such as glutathione metabolism, sphingolipid metabolism, fatty acid metabolism and significant interactions in cAMP-PKA/PKC signaling might be the key factors determining the difference in steroidogenesis and androstenone biosynthesis between boars with divergent androstenone levels in our study. The results and assumptions presented in this study are from an in-silico analysis done at the gene expression level and further laboratory experiments at genomic, proteomic or metabolomic level are necessary to validate these findings.	[Sahadevan, Sudeep; Gunawan, Asep; Tholen, Ernst; Grosse-Brinkhaus, Christine; Tesfaye, Dawit; Schellander, Karl; Uddin, Muhammad Jasim] Univ Bonn, Inst Anim Sci, Bonn, Germany; [Sahadevan, Sudeep; Hofmann-Apitius, Martin] Fraunhofer Inst Algorithms & Sci Comp SCAI, St Augustin, Germany; [Gunawan, Asep] Bogor Agr Univ, Dept Anim Prod & Technol, Fac Anim Sci, Bogor, Indonesia; [Hofmann-Apitius, Martin] Bonn Aachen Int Ctr Informat Technol B IT, Bonn, Germany; [Cinar, Mehmet Ulas] Erciyes Univ, Dept Anim Sci, Fac Agr, Kayseri, Turkey	University of Bonn; Fraunhofer Gesellschaft; Fraunhofer Institute Center Schloss Birlinghoven; Bogor Agricultural University; Erciyes University	Uddin, MJ (corresponding author), Univ Bonn, Inst Anim Sci, Bonn, Germany.	judd@itw.uni-bonn.de	Uddin, Muhammad Jasim/P-8497-2019; Gunawan, Asep/GON-4264-2022; Große-Brinkhaus, Christine/AAF-6712-2020; Uddin, Muhammad Jasim/N-3866-2013; Hofmann-Apitius, Martin/E-6123-2018	Uddin, Muhammad Jasim/0000-0002-6732-5534; Große-Brinkhaus, Christine/0000-0002-6190-4463; Uddin, Dr. Md. Jashim/0000-0002-3243-3455; Gunawan, Asep/0000-0003-0468-2443; Hofmann-Apitius, Martin/0000-0001-9012-6720	Federal Ministry of Food and Agriculture, Germany (BMEL); Federal Office for Agriculture and Food, Germany (BLE); State of North Rhine Westphalia	Federal Ministry of Food and Agriculture, Germany (BMEL); Federal Office for Agriculture and Food, Germany (BLE); State of North Rhine Westphalia	This work was financially supported by the Federal Ministry of Food and Agriculture, Germany (BMEL), the Federal Office for Agriculture and Food, Germany (BLE) and State of North Rhine Westphalia with the programme USL "Umweltvertragliche und Standortgerechte Landwirtschaft". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson J.N., 1999, SPHINGOLIPID METABOL; Altamirano F, 2009, J ENDOCRINOL, V202, P299, DOI 10.1677/JOE-09-0044; Babraham Bioinformatics, 2013, FASTQC QUAL CONTR TO; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Billen MJ, 2009, J STEROID BIOCHEM, V113, P98, DOI 10.1016/j.jsbmb.2008.11.012; BONNEAU M, 1992, LIVEST PROD SCI, V32, P63, DOI 10.1016/S0301-6226(12)80012-1; Boron WF., 2005, MED PHYSL CELLULAR M, V2nd; Chalfant C., 2010, SPHINGOLIPIDS SIGNAL; Chandra R, 2000, Indian J Clin Biochem, V15, P155, DOI 10.1007/BF02883745; Chauhan B. S., 2008, PRINCIPLES BIOCH BIO; Chen H, 2008, ENDOCRINOLOGY, V149, P2612, DOI 10.1210/en.2007-1245; Cheng L, 2011, ESSENTIALS ANATOMIC, p125p; Chuang HY, 2010, ANNU REV CELL DEV BI, V26, P721, DOI 10.1146/annurev-cellbio-100109-104122; Droste P, 2013, CHEM-ING-TECH, V85, P849, DOI 10.1002/cite.201200234; Duijvesteijn N, 2012, J ANIM SCI, V90, P2465, DOI 10.2527/jas.2011-4625; Duijvesteijn N, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-42; Dunshea FR, 2001, J ANIM SCI, V79, P2524; Fishbein JC, 2011, ADV MOL TOXICOLOGY; Fix C, 2004, P NATL ACAD SCI USA, V101, P10919, DOI 10.1073/pnas.0404278101; Fleury A, 2004, J STEROID BIOCHEM, V91, P259, DOI 10.1016/j.jsbmb.2004.04.010; Frey P. A., 2007, ENZYMATIC REACTION M; Frieden L., 2011, Lohmann Information, V46, P21; Gatti DM, 2009, BIOINFORMATICS, V25, P541, DOI 10.1093/bioinformatics/btn655; Gregersen VR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-22; Grindflek E, 2011, J ANIM SCI, V89, P680, DOI 10.2527/jas.2010-3290; Grindflek E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-362; Gunawan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063259; Hacker BM, 1998, GENOMICS, V50, P97, DOI 10.1006/geno.1998.5293; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Haugen JE, 2012, MEAT SCI, V90, P9, DOI 10.1016/j.meatsci.2011.07.005; Hu J, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-47; James Squires E, 2010, APPL ANIMAL ENDOCRIN, P103; Jo Y, 2005, BIOL REPROD, V73, P244, DOI 10.1095/biolreprod.104.037721; Kumar TR, 2000, ENDOCRINOLOGY, V141, P4270, DOI 10.1210/en.141.11.4270; Kuuranne T, 2003, DRUG METAB DISPOS, V31, P1117, DOI 10.1124/dmd.31.9.1117; Law CW, 2013, VOON PRECISION WEIGH; Lee GJ, 2005, ANIM GENET, V36, P14, DOI 10.1111/j.1365-2052.2004.01214.x; Lennarz WJ, 2013, ENCY BIOL CHEM; Lervik S, 2013, THERIOGENOLOGY, V79, P986, DOI 10.1016/j.theriogenology.2013.01.023; Leung MCK, 2010, ANIM BIOTECHNOL, V21, P77, DOI 10.1080/10495390903500607; Loscalzo J, 2011, WIRES SYST BIOL MED, V3, P619, DOI 10.1002/wsbm.144; Losel RM, 2003, PHYSIOL REV, V83, P965, DOI 10.1152/physrev.00003.2003; Lucki NC, 2010, STEROIDS, V75, P390, DOI 10.1016/j.steroids.2010.01.020; Mander L., 2010, COMPREHENSIVE NATURA; Manna P. R., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P93, DOI 10.2174/1568008053174714; Manna PR, 2007, J ENDOCRINOL, V193, P53, DOI 10.1677/JOE-06-0201; Manna PR, 2009, ENDOCRINOLOGY, V150, P3308, DOI 10.1210/en.2008-1668; McQueen CA, 2010, COMPREHENSIVE TOXICOLOGY, VOL 10: GASTROINTESTINAL TOXICOLOGY, 2ND EDITION, P1; Meroni SB, 2000, J STEROID BIOCHEM, V75, P307, DOI 10.1016/S0960-0760(00)00188-6; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Merrill AJ., 2006, SPHINGOLIPID BIOL; Moe M, 2007, J ANIM SCI, V85, P2924, DOI 10.2527/jas.2007-0283; Moe M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-405; Morlein D, 2012, MEAT SCI, V91, P435, DOI 10.1016/j.meatsci.2012.02.028; Morales V, 2003, ENDOCRINOLOGY, V144, P4763, DOI 10.1210/en.2003-0569; MORI K, 1989, TOXICOL APPL PHARM, V101, P299, DOI 10.1016/0041-008X(89)90278-0; Nasman J, 2002, J NEUROCHEM, V83, P1252, DOI 10.1046/j.1471-4159.2002.01270.x; Payne AH, 2007, LEYDING CELL HLTH DI; PORN MI, 1991, BIOCHIM BIOPHYS ACTA, V1093, P7; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Quintanilla R, 2003, J ANIM SCI, V81, P385; R Development Core Team RDC, 2013, R LANG ENV STAT COMP; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Ray S, 2013, GENE, V526, P46, DOI 10.1016/j.gene.2013.04.018; Ripley B.D., 1987, STOCHASTIC SIMULATIO; Robic A, 2011, ANIM GENET, V42, P662, DOI 10.1111/j.1365-2052.2011.02195.x; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sakata K, 2000, J UROLOGY, V163, P1333, DOI 10.1016/S0022-5347(05)67773-7; SANTANA P, 1995, ENDOCRINOLOGY, V136, P2345, DOI 10.1210/en.136.5.2345; Sanz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066179; Schomburg D., 2003, SPRINGER HDB ENZYMES; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharifi AM, 2012, MED HYPOTHESES, V78, P465, DOI 10.1016/j.mehy.2011.12.021; Sharma R, 2011, PHYTOTHER RES, V25, P563, DOI 10.1002/ptr.3297; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Spoolder H, 2011, 1 PARM; Stocco DM, 2005, MOL ENDOCRINOL, V19, P2647, DOI 10.1210/me.2004-0532; Suomalainen L, 2003, J CLIN ENDOCR METAB, V88, P5572, DOI 10.1210/jc.2003-030776; Tindall D, 2009, ANDROGEN ACTION IN PROSTATE CANCER, P1, DOI 10.1007/978-0-387-69179-4; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Urs AN, 2006, ENDOCRINOLOGY, V147, P5249, DOI 10.1210/en.2006-0355; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Zhang X, 2012, GENETICS, V190, P1511, DOI 10.1534/genetics.111.137737	86	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91077	10.1371/journal.pone.0091077	http://dx.doi.org/10.1371/journal.pone.0091077			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614349	gold, Green Published, Green Submitted			2022-12-25	WOS:000332839300073
J	Sotelo, T; Soengas, P; Velasco, P; Rodriguez, VM; Cartea, ME				Sotelo, Tamara; Soengas, Pilar; Velasco, Pablo; Rodriguez, Victor M.; Elena Cartea, Maria			Identification of Metabolic QTLs and Candidate Genes for Glucosinolate Synthesis in Brassica oleracea Leaves, Seeds and Flower Buds	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ARABIDOPSIS; BIOSYNTHESIS; CYTOCHROME-P450; BIOAVAILABILITY; PHYTOCHEMICALS; ENVIRONMENT; TRYPTOPHAN; RESISTANCE; BROCCOLI	Glucosinolates are major secondary metabolites found in the Brassicaceae family. These compounds play an essential role in plant defense against biotic and abiotic stresses, but more interestingly they have beneficial effects on human health. We performed a genetic analysis in order to identify the genome regions regulating glucosinolates biosynthesis in a DH mapping population of Brassica oleracea. In order to obtain a general overview of regulation in the whole plant, analyses were performed in the three major organs where glucosinolates are synthesized (leaves, seeds and flower buds). Eighty two significant QTLs were detected, which explained a broad range of variability in terms of individual and total glucosinolate (GSL) content. A meta-analysis rendered eighteen consensus QTLs. Thirteen of them regulated more than one glucosinolate and its content. In spite of the considerable variability of glucosinolate content and profiles across the organ, some of these consensus QTLs were identified in more than one tissue. Consensus QTLs control the GSL content by interacting epistatically in complex networks. Based on in silico analysis within the B. oleracea genome along with synteny with Arabidopsis, we propose seven major candidate loci that regulate GSL biosynthesis in the Brassicaceae family. Three of these loci control the content of aliphatic GSL and four of them control the content of indolic glucosinolates. GSL-ALK plays a central role in determining aliphatic GSL variation directly and by interacting epistatically with other loci, thus suggesting its regulatory effect.	[Sotelo, Tamara; Soengas, Pilar; Velasco, Pablo; Rodriguez, Victor M.; Elena Cartea, Maria] Spanish Council Sci Res MBG CSIC, Dept Plant Genet, Grp Genet Breeding & Biochem Brass, Mision Biol Galicia, Pontevedra, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Mision Biologica de Galicia (MBG)	Sotelo, T (corresponding author), Spanish Council Sci Res MBG CSIC, Dept Plant Genet, Grp Genet Breeding & Biochem Brass, Mision Biol Galicia, Pontevedra, Spain.	tsotelo@mbg.csic.es	Rodriguez, Victor M/M-2742-2014; Velasco, Pablo/C-3902-2012	Rodriguez, Victor M/0000-0002-2861-4093; Velasco, Pablo/0000-0003-3046-8918	National Plan for Research and Development [AGL-2009-09922]; Ministry of Economy and Competitiveness	National Plan for Research and Development; Ministry of Economy and Competitiveness	This work was supported by the National Plan for Research and Development (AGL-2009-09922). Tamara Sotelo acknowledges a pre-doctoral research grant (F.P.I) from the Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bak S, 2001, PLANT CELL, V13, P101, DOI 10.1105/tpc.13.1.101; Bjorkman M, 2011, PHYTOCHEMISTRY, V72, P538, DOI 10.1016/j.phytochem.2011.01.014; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Celenza JL, 2005, PLANT PHYSIOL, V137, P253, DOI 10.1104/pp.104.054395; Chen SX, 2003, PLANT J, V33, P923, DOI 10.1046/j.1365-313X.2003.01679.x; Elena Cartea Maria, 2008, Phytochemistry Reviews, V7, P213, DOI 10.1007/s11101-007-9072-2; Fahey JW, 1997, P NATL ACAD SCI USA, V94, P10367, DOI 10.1073/pnas.94.19.10367; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Feng J, 2012, NEW PHYTOL, V193, P96, DOI 10.1111/j.1469-8137.2011.03890.x; Forte A, 2008, ANN ITAL CHIR, V79, P261; Gao MQ, 2007, THEOR APPL GENET, V115, P277, DOI 10.1007/s00122-007-0568-3; Gao MQ, 2006, PLANT CELL REP, V25, P592, DOI 10.1007/s00299-005-0078-1; Goffinet B, 2000, GENETICS, V155, P463; Halkier BA, 1997, TRENDS PLANT SCI, V2, P425, DOI 10.1016/S1360-1385(97)01128-X; Hasan M, 2008, THEOR APPL GENET, V116, P1035, DOI 10.1007/s00122-008-0733-3; Hirai MY, 2007, P NATL ACAD SCI USA, V104, P6478, DOI 10.1073/pnas.0611629104; Hull AK, 2000, P NATL ACAD SCI USA, V97, P2379, DOI 10.1073/pnas.040569997; Kliebenstein DJ, 2009, PHYTOCHEM REV, V8, P243, DOI 10.1007/s11101-008-9102-8; Kliebenstein DJ, 2001, GENETICS, V159, P359; Kliebenstein DJ, 2001, PLANT CELL, V13, P681, DOI 10.1105/tpc.13.3.681; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; Li G, 2003, THEOR APPL GENET, V106, P1116, DOI 10.1007/s00122-002-1161-4; Li G, 2001, J AM SOC HORTIC SCI, V126, P427, DOI 10.21273/JASHS.126.4.427; Li GY, 2002, GENETICS, V162, P1937; Li GY, 2001, ECON BOT, V55, P255, DOI 10.1007/BF02864563; Liu Z, 2012, PLANT MOL BIOL, V79, P179, DOI 10.1007/s11103-012-9905-2; Lowe AJ, 2004, THEOR APPL GENET, V108, P1103, DOI 10.1007/s00122-003-1522-7; Iniguez-Luy FL, 2009, THEOR APPL GENET, V120, P31, DOI 10.1007/s00122-009-1157-4; Mahmood T, 2003, GENOME, V46, P753, DOI 10.1139/G03-051; Mikkelsen MD, 2000, J BIOL CHEM, V275, P33712, DOI 10.1074/jbc.M001667200; Mikkelsen MD, 2002, AMINO ACIDS, V22, P279, DOI 10.1007/s007260200014; Mithen RF, 2001, ADV BOT RES, V35, P213, DOI 10.1016/S0065-2296(01)35008-5; Naur P, 2003, PLANT PHYSIOL, V133, P63, DOI 10.1104/pp.102.019240; Papst C, 2004, THEOR APPL GENET, V108, P1545, DOI 10.1007/s00122-003-1579-3; Petersen BL, 2002, PLANTA, V214, P562, DOI 10.1007/s004250100659; Pfalz M, 2009, PLANT CELL, V21, P985, DOI 10.1105/tpc.108.063115; Ramchiary N, 2007, THEOR APPL GENET, V116, P77, DOI 10.1007/s00122-007-0648-4; Sarikamis G, 2006, MOL BREEDING, V18, P219, DOI 10.1007/s11032-006-9029-y; SAS, 2011, I INC SAS 9 3 SAS EN; SORENSEN H, 1988, ABSTR PAP AM CHEM S, V195, P79; Utz HF, 2000, GENETICS, V154, P1839; UTZ HF, 2003, COMPUTER PROGRAM MAP; Van Horn L, 2008, J AM DIET ASSOC, V108, P287, DOI 10.1016/j.jada.2007.10.050; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; Van Ooijen JW, 1999, HEREDITY, V83, P613, DOI 10.1038/sj.hdy.6886230; Velasco P, 2008, J AM SOC HORTIC SCI, V133, P551, DOI 10.21273/JASHS.133.4.551; Velasco P, 2007, J AGR FOOD CHEM, V55, P955, DOI 10.1021/jf0624897; Verkerk R, 2009, MOL NUTR FOOD RES, V53, pS219, DOI 10.1002/mnfr.200800065; Virgili F, 2008, FREE RADICAL BIO MED, V45, P1205, DOI 10.1016/j.freeradbiomed.2008.08.001; Wang H, 2011, GENE, V487, P135, DOI 10.1016/j.gene.2011.07.021; Wang JS, 2012, FOOD CHEM, V133, P735, DOI 10.1016/j.foodchem.2012.01.085; Wentzell AM, 2008, PLANT PHYSIOL, V147, P415, DOI 10.1104/pp.107.115279; Wentzell AM, 2007, PLOS GENET, V3, P1687, DOI 10.1371/journal.pgen.0030162; Zang YX, 2009, FEBS J, V276, P3559, DOI 10.1111/j.1742-4658.2009.07076.x; ZENG ZB, 1994, GENETICS, V136, P1457; Zukalova H, 2002, ROST VYROBA, V48, P175	57	29	29	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91428	10.1371/journal.pone.0091428	http://dx.doi.org/10.1371/journal.pone.0091428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614913	Green Submitted, Green Published, gold			2022-12-25	WOS:000332839300124
J	Guo, WB; Liu, F; Zhang, J; Zhang, ZK; Yu, LY; Liu, JR; Chen, HF; Xiao, CQ				Guo, Wenbin; Liu, Feng; Zhang, Jian; Zhang, Zhikun; Yu, Liuyu; Liu, Jianrong; Chen, Huafu; Xiao, Changqing			Abnormal Default-Mode Network Homogeneity in First-Episode, Drug-Naive Major Depressive Disorder	PLOS ONE			English	Article							MICROVASCULAR COMPLICATIONS; HBA(1C) VARIABILITY; YOUNG-ADULTS; RISK-FACTORS; TYPE-1; RETINOPATHY; NEPHROPATHY; ADOLESCENTS; CHILDREN; HBA1C	Background: Default mode network (DMN) is one of the most commonly recognized resting-state networks in major depressive disorder (MDD). However, the homogeneity of this network in MDD is poorly understood. As such, this study was conducted to determine whether or not an abnormal network homogeneity (NH) of DMN is observed in patients with first-episode and drug-naive MDD. Methods: Twenty-four first-episode drug-naive patients with MDD and twenty-four healthy control subjects participated in the study. NH and independent component analysis (ICA) methods were used to analyze data. Results: Depressed patients exhibited a significantly increased NH in the left dorsal medial prefrontal cortex (MPFC) and decreased NH in the right inferior temporal gyrus (ITG) compared with the healthy control subjects. Receiver operating characteristic curves (ROC) were analyzed and results revealed that the NH values of MPFC and ITG could be applied as candidate markers with relatively high sensitivity and specificity to distinguish patients from healthy control subjects. No correlation was observed between the NH values of the two regions and clinical variables. Conclusions: Our findings suggested that an abnormal DMN homogeneity could be observed in MDD, which highlight the importance of the DMN in the pathophysiology of MDD.	[Guo, Wenbin; Zhang, Jian; Zhang, Zhikun; Yu, Liuyu; Liu, Jianrong; Xiao, Changqing] Guangxi Med Univ, Affiliated Hosp 1, Mental Hlth Ctr, Nanning, Guangxi, Peoples R China; [Liu, Feng; Chen, Huafu] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Sichuan, Peoples R China	Guangxi Medical University; University of Electronic Science & Technology of China	Guo, WB (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Mental Hlth Ctr, Nanning, Guangxi, Peoples R China.	guowenbin76@163.com	Liu, Feng/W-7572-2019	Liu, Feng/0000-0002-3570-4222	National Natural Science Foundations of China [81260210, 30900483]; Natural Science Foundations of Guangxi [2013GXNSFAA019107]; Ministry of Health of the Peoples' Republic of China [201002003]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundations of Guangxi; Ministry of Health of the Peoples' Republic of China	The study was supported by grants from the National Natural Science Foundations of China (grant no. 81260210, and no. 30900483), the Natural Science Foundations of Guangxi (no. 2013GXNSFAA019107), and the special funding by the Ministry of Health of the Peoples' Republic of China (grant no. 201002003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, OPHTHALMOLOGY, V98, P786; Dawson AJ, 2013, DIABETIC MED, V30, P1172, DOI 10.1111/dme.12160; Gerstl EM, 2008, EUR J PEDIATR, V167, P447, DOI 10.1007/s00431-007-0586-9; Gonen M, 2005, BIOMETRIKA, V92, P965, DOI 10.1093/biomet/92.4.965; Hammes HP, 2011, DIABETOLOGIA, V54, P1977, DOI 10.1007/s00125-011-2198-1; Hammes HP, 2012, DIABETOLOGIE S2, P103; Hietala K, 2013, DIABETOLOGIA, V56, P737, DOI 10.1007/s00125-012-2816-6; Kilpatrick ES, 2012, DIABETOLOGIA, V55, P2089, DOI 10.1007/s00125-012-2610-5; Kilpatrick ES, 2008, DIABETES CARE, V31, P2198, DOI 10.2337/dc08-0864; Kilpatrick ES, 2006, DIABETES CARE, V29, P1486, DOI 10.2337/dc06-0293; Lachin JM, 2008, DIABETES, V57, P995, DOI 10.2337/db07-1618; Liew Gerald, 2009, Int Ophthalmol Clin, V49, P35, DOI 10.1097/IIO.0b013e31819fd5d7; Luk AOY, 2013, DIABETES-METAB RES, V29, P384, DOI 10.1002/dmrr.2404; Mostafa SA, 2012, DIABETES CARE, V35, P1746, DOI 10.2337/dc11-2079; Penno G, 2013, DIABETES CARE, V36, P2301, DOI 10.2337/dc12-2264; Rodriguez-Segade S, 2012, DIABETIC MED, V29, P1562, DOI 10.1111/j.1464-5491.2012.03767.x; Schwab KO, 2006, DIABETES CARE, V29, P218, DOI 10.2337/diacare.29.02.06.dc05-0724	17	59	61	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91102	10.1371/journal.pone.0091102	http://dx.doi.org/10.1371/journal.pone.0091102			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609111	Green Published, gold, Green Submitted			2022-12-25	WOS:000332485800101
J	Perez-Gonzalez, A; Pazo, A; Navajas, R; Ciordia, S; Rodriguez-Frandsen, A; Nieto, A				Perez-Gonzalez, Alicia; Pazo, Alejandra; Navajas, Rosana; Ciordia, Sergio; Rodriguez-Frandsen, Ariel; Nieto, Amelia			hCLE/C14orf166 Associates with DDX1-HSPC117-FAM98B in a Novel Transcription-Dependent Shuttling RNA-Transporting Complex	PLOS ONE			English	Article							INFLUENZA-VIRUS POLYMERASE; MENTAL-RETARDATION PROTEIN; MESSENGER-RNA; RIBOSOME BIOGENESIS; MASS-SPECTROMETRY; MAMMALIAN-CELLS; BINDING PROTEIN; GLOBAL ANALYSIS; LOCALIZATION; INTERACTS	hCLE/C14orf166 is a nuclear and cytoplasmic protein that interacts with the RNAP II, modulates nuclear RNA metabolism and is present in cytoplasmic RNA granules involved in localized translation. Here we have studied whether hCLE shares common interactors in the nucleus and the cytosol, which could shed light on its participation in the sequential phases of RNA metabolism. Nuclear and cytoplasmic purified hCLE-associated factors were identified and proteins involved in mRNA metabolism, motor-related proteins, cytoskeletal and translation-related factors were found. Purified hCLE complexes also contain RNAs and as expected some hCLE-interacting proteins (DDX1, HSPC117, FAM98B) were found both in the nucleus and the cytoplasm. Moreover, endogenous hCLE fractionates in protein complexes together with DDX1, HSPC117 and FAM98B and silencing of hCLE down-regulates their nuclear and cytosolic accumulation levels. Using a photoactivatable hCLE-GFP protein, nuclear import and export of hCLE was observed indicating that hCLE is a shuttling protein. Interestingly, hCLE nuclear import required active transcription, as did the import of DDX1, HSPC117 and FAM98B proteins. The data indicate that hCLE probably as a complex with DDX1, HSPC117 and FAM98B shuttles between the nucleus and the cytoplasm transporting RNAs suggesting that this complex has a prominent role on nuclear and cytoplasmic RNA fate.	[Perez-Gonzalez, Alicia; Pazo, Alejandra; Navajas, Rosana; Ciordia, Sergio; Rodriguez-Frandsen, Ariel; Nieto, Amelia] CSIC, Ctr Nacl Biotecnol, Madrid, Spain; [Perez-Gonzalez, Alicia; Pazo, Alejandra; Rodriguez-Frandsen, Ariel; Nieto, Amelia] Ciber Enfermedades Resp, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Nieto, A (corresponding author), CSIC, Ctr Nacl Biotecnol, Darwin 3, Madrid, Spain.	anieto@cnb.csic.es	Rodriguez, Ariel/B-3908-2013; Rodriguez Frandsen, Ariel/HDM-7270-2022	Rodriguez, Ariel/0000-0001-6850-5003; Rodriguez Frandsen, Ariel/0000-0001-6850-5003; Ciordia, Sergio/0000-0002-5726-853X; Navajas, Rosana/0000-0002-4481-0553	Ministerio de Ciencia e Innovacion, Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica [BFU2008-00448, BFU2011-26175]; Instituto de Salud Carlos III (Programa especial de investigacion sobre la gripe pandemica) [GR09/0023, GR09/0040, GR09/0039]; Spanish National Proteomics Institute (ProteoRed-ISC III) [2005X747_3]; Ciber de Enfermedades Respiratorias	Ministerio de Ciencia e Innovacion, Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica(Ministry of Science and Innovation, Spain (MICINN)); Instituto de Salud Carlos III (Programa especial de investigacion sobre la gripe pandemica); Spanish National Proteomics Institute (ProteoRed-ISC III); Ciber de Enfermedades Respiratorias	This work was supported by the Ministerio de Ciencia e Innovacion, Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (BFU2008-00448 and BFU2011-26175), Instituto de Salud Carlos III (Programa especial de investigacion sobre la gripe pandemica GR09/0023, GR09/0040, GR09/0039), the Spanish National Proteomics Institute (ProteoRed-ISC III) (grant number 2005X747_3) and Ciber de Enfermedades Respiratorias. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina E, 1998, J BIOL CHEM, V273, P13015, DOI 10.1074/jbc.273.21.13015; Amiel J, 2007, AM J HUM GENET, V80, P988, DOI 10.1086/515582; Bardoni B, 2003, HUM MOL GENET, V12, P1689, DOI 10.1093/hmg/ddg181; Bertolotti A, 1996, EMBO J, V15, P5022, DOI 10.1002/j.1460-2075.1996.tb00882.x; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chen HC, 2002, J BIOL CHEM, V277, P40403, DOI 10.1074/jbc.M206981200; Cisterna B, 2010, INT REV CEL MOL BIO, V284, P67, DOI 10.1016/S1937-6448(10)84002-X; Delestienne N, 2010, FEBS J, V277, P2496, DOI 10.1111/j.1742-4658.2010.07664.x; Drewett V, 2001, NUCLEIC ACIDS RES, V29, P479, DOI 10.1093/nar/29.2.479; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; Emmott E, 2013, J VIROL, V87, P9486, DOI 10.1128/JVI.00321-13; Fant X, 2009, J CELL SCI, V122, P1134, DOI 10.1242/jcs.035238; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Fukuda A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072496; Garaigorta U, 2005, J VIROL, V79, P15246, DOI 10.1128/JVI.79.24.15246-15257.2005; Howng SL, 2004, FEBS LETT, V566, P162, DOI 10.1016/j.febslet.2004.04.024; Huarte M, 2001, J VIROL, V75, P8597, DOI 10.1128/JVI.75.18.8597-8604.2001; Iida Y, 2011, J BIOL CHEM, V286, P16929, DOI 10.1074/jbc.M110.215871; Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027; Jorba N, 2008, PROTEOMICS, V8, P2077, DOI 10.1002/pmic.200700508; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kim HK, 2005, BIOCHEM BIOPH RES CO, V328, P895, DOI 10.1016/j.bbrc.2005.01.041; Kruger T, 2007, J CELL BIOL, V177, P573, DOI 10.1083/jcb.200612048; Kula A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-60; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lee JW, 2011, J PROTEOME RES, V10, P4522, DOI 10.1021/pr200338d; Lin YT, 2006, RNA, V12, P1486, DOI 10.1261/rna.42206; Lloris-Garcera P, 2012, J BIOL CHEM, V287, P26052, DOI 10.1074/jbc.M112.357590; Makise M, 2012, J BIOL CHEM, V287, P38515, DOI 10.1074/jbc.M112.378893; Marko M, 2012, GENE, V506, P331, DOI 10.1016/j.gene.2012.06.088; Miller LC, 2009, MOL CELL NEUROSCI, V40, P485, DOI 10.1016/j.mcn.2009.01.007; ORTIN J, 1980, GENE, V11, P319, DOI 10.1016/0378-1119(80)90072-4; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Perez-Gonzalez A, 2006, J MOL BIOL, V362, P887, DOI 10.1016/j.jmb.2006.07.085; Pinol-Roma Serafin, 1993, Trends in Cell Biology, V3, P151, DOI 10.1016/0962-8924(93)90135-N; Popow J, 2011, SCIENCE, V331, P760, DOI 10.1126/science.1197847; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Robertson-Anderson RM, 2011, J MOL BIOL, V410, P959, DOI 10.1016/j.jmb.2011.04.026; Rodriguez A, 2007, J VIROL, V81, P5315, DOI 10.1128/JVI.02129-06; Rodriguez A, 2011, J VIROL, V85, P12062, DOI 10.1128/JVI.00684-11; Shevchenko A, 2001, ELECTROPHORESIS, V22, P1194, DOI 10.1002/1522-2683()22:6<1194::AID-ELPS1194>3.0.CO;2-A; Stefani G, 2004, J NEUROSCI, V24, P7272, DOI 10.1523/JNEUROSCI.2306-04.2004; Switala J, 1999, BIOCHEMISTRY-US, V38, P3895, DOI 10.1021/bi982863z; Tan M, 2004, J VIROL, V78, P6233, DOI 10.1128/JVI.78.12.6233-6242.2004; Tokunaga K, 2006, GENES CELLS, V11, P305, DOI 10.1111/j.1365-2443.2006.00936.x; Villace P, 2004, NUCLEIC ACIDS RES, V32, P2411, DOI 10.1093/nar/gkh552; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; Ruiz-Loredo AY, 2012, INT REV CEL MOL BIO, V293, P85, DOI 10.1016/B978-0-12-394304-0.00008-7	49	34	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90957	10.1371/journal.pone.0090957	http://dx.doi.org/10.1371/journal.pone.0090957			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608264	Green Published, Green Submitted, gold			2022-12-25	WOS:000332485800069
J	Chaar, V; Laurance, S; Lapoumeroulie, C; Cochet, S; De Grandis, M; Colin, Y; Elion, J; Le Van Kim, C; El Nemer, W				Chaar, Vicky; Laurance, Sandrine; Lapoumeroulie, Claudine; Cochet, Sylvie; De Grandis, Maria; Colin, Yves; Elion, Jacques; Le Van Kim, Caroline; El Nemer, Wassim			\Hydroxycarbamide Decreases Sickle Reticulocyte Adhesion to Resting Endothelium by Inhibiting Endothelial Lutheran/Basal Cell Adhesion Molecule ( Lu/BCAM) through Phosphodiesterase 4A Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adhesion; Blood; Cell Signaling; Endothelial Cell; Protein Phosphorylation; Hydroxycarbamide; Lu; BCAM; Sickle Cell Disease	BLOOD-GROUP GLYCOPROTEIN; CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; VASOOCCLUSIVE EVENTS; BINDING DOMAINS; HYDROXYUREA; DISEASE; LAMININ; ERYTHROCYTES; EXPRESSION; EPINEPHRINE	Background: Hydroxycarbamide treatment may inhibit the proadhesive features of vascular endothelium in sickle cell disease. Results: Hydroxycarbamide treatment of endothelial cells inhibits the interaction between erythroid integrin (41) and endothelial Lu/BCAM. Conclusion: Hydroxycarbamide increases the expression of phosphodiesterase 4A, which decreases cAMP levels leading to less Lu/BCAM phosphorylation and less cell adhesion. Significance: This is the first example of a phosphodiesterase being regulated by hydroxycarbamide. Vaso-occlusive crises are the main acute complication in sickle cell disease. They are initiated by abnormal adhesion of circulating blood cells to vascular endothelium of the microcirculation. Several interactions involving an intricate network of adhesion molecules have been described between sickle red blood cells and the endothelial vascular wall. We have shown previously that young sickle reticulocytes adhere to resting endothelial cells through the interaction of (41) integrin with endothelial Lutheran/basal cell adhesion molecule (Lu/BCAM). In the present work, we investigated the functional impact of endothelial exposure to hydroxycarbamide (HC) on this interaction using transformed human bone marrow endothelial cells and primary human pulmonary microvascular endothelial cells. Adhesion of sickle reticulocytes to HC-treated endothelial cells was decreased despite the HC-derived increase of Lu/BCAM expression. This was associated with decreased phosphorylation of Lu/BCAM and up-regulation of the cAMP-specific phosphodiesterase 4A expression. Our study reveals a novel mechanism for HC in endothelial cells where it could modulate the function of membrane proteins through the regulation of phosphodiesterase expression and cAMP-dependent signaling pathways.	[Chaar, Vicky; Laurance, Sandrine; Lapoumeroulie, Claudine; Cochet, Sylvie; De Grandis, Maria; Colin, Yves; Elion, Jacques; Le Van Kim, Caroline; El Nemer, Wassim] INSERM, U1134, F-75739 Paris, France; [Chaar, Vicky; Laurance, Sandrine; Lapoumeroulie, Claudine; Cochet, Sylvie; De Grandis, Maria; Colin, Yves; Elion, Jacques; Le Van Kim, Caroline; El Nemer, Wassim] Univ Paris Diderot, Sorbonne Paris Cite, UMR S 1134, F-75739 Paris, France; [Chaar, Vicky; Cochet, Sylvie; De Grandis, Maria; Colin, Yves; Le Van Kim, Caroline; El Nemer, Wassim] Inst Natl Transfus Sanguine, F-75739 Paris, France; [Chaar, Vicky; Lapoumeroulie, Claudine; Cochet, Sylvie; De Grandis, Maria; Colin, Yves; Elion, Jacques; Le Van Kim, Caroline; El Nemer, Wassim] Lab Excellence GR Ex, F-75238 Paris, France; [Elion, Jacques] Hop Robert Debre, AP HP, Dept Genet, F-75019 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	El Nemer, W (corresponding author), INSERM, UMR S 1134, INTS, 6 Rue Alexandre Cabanel, F-75015 Paris, France.	wassim.el-nemer@inserm.fr	Cochet, sylvie/I-2721-2015; LAURANCE, Sandrine/AAT-9715-2021; Lapoumeroulie, Claudine/P-3515-2018; Elion, Jacques/A-1048-2014; colin, yves/O-1910-2017; Nemer, Wassim El/N-4247-2017; le van kim, caroline/O-7030-2017	Elion, Jacques/0000-0002-8407-1783; colin, yves/0000-0001-5196-4254; Nemer, Wassim El/0000-0001-8184-427X; LAURANCE, Sandrine/0000-0002-2595-7031; LAPOUMEROULIE, Claudine/0000-0001-6665-3598; le van kim, caroline/0000-0002-3251-1310	Institut National de la Transfusion Sanguine, Agence Nationale de la Recherche (SCADHESION) [1134]; Region Ile-de-France (SESAME) [F-08-1104/R]; Laboratory of Excellence GR-Ex [ANR-11-LABX-0051]; program "Investissements d'avenir" of the French National Research Agency [ANR-11-IDEX-0005-02]; French Ministere de l'Enseignement Superieur et de la Recherche at the Ecole Doctorale B3MI	Institut National de la Transfusion Sanguine, Agence Nationale de la Recherche (SCADHESION)(French National Research Agency (ANR)); Region Ile-de-France (SESAME)(Region Ile-de-France); Laboratory of Excellence GR-Ex; program "Investissements d'avenir" of the French National Research Agency(French National Research Agency (ANR)); French Ministere de l'Enseignement Superieur et de la Recherche at the Ecole Doctorale B3MI	This work was supported by institutional funding to the INSERM unit 1134, Institut National de la Transfusion Sanguine, Agence Nationale de la Recherche (SCADHESION 2007) and Region Ile-de-France (SESAME 2007. F-08-1104/R) and by grants from Laboratory of Excellence GR-Ex, reference ANR-11-LABX-0051. The labex GR-Ex is funded by the program "Investissements d'avenir" of the French National Research Agency, reference ANR-11-IDEX-0005-02.; Recipient of a doctoral fellowship from the French Ministere de l'Enseignement Superieur et de la Recherche at the Ecole Doctorale B3MI.	Adderley SP, 2010, PHARMACOL REP, V62, P475, DOI 10.1016/S1734-1140(10)70303-0; Almeida CB, 2012, BLOOD, V120, P2879, DOI 10.1182/blood-2012-02-409524; Baillie GS, 2009, FEBS J, V276, P1790, DOI 10.1111/j.1742-4658.2009.06926.x; Bartolucci P, 2010, BLOOD, V116, P2152, DOI 10.1182/blood-2009-12-257444; Brun M, 2003, PHARMACOGENOMICS J, V3, P215, DOI 10.1038/sj.tpj.6500176; Cartron JP, 2008, TRANSFUS CLIN BIOL, V15, P39, DOI 10.1016/j.tracli.2008.05.001; Chaar V, 2010, HAEMATOL-HEMATOL J, V95, P1841, DOI 10.3324/haematol.2010.026294; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Cokic VP, 2006, BLOOD, V108, P184, DOI 10.1182/blood-2005-11-4454; COLLINS FS, 1982, AM J MED, V73, P814, DOI 10.1016/0002-9343(82)90763-X; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; El Nemer W, 1998, J BIOL CHEM, V273, P16686; El Nemer W, 2001, J BIOL CHEM, V276, P23757, DOI 10.1074/jbc.M102978200; El Nemer W, 2007, BLOOD, V109, P3544, DOI 10.1182/blood-2006-07-035139; El Nemer W, 2012, BLOOD, V120, P2777, DOI 10.1182/blood-2012-08-447102; Embury S. H., 1994, PATHOGENESIS VASOOCC; Francis SH, 2011, PHYSIOL REV, V91, P651, DOI 10.1152/physrev.00030.2010; Gauthier E, 2005, J BIOL CHEM, V280, P30055, DOI 10.1074/jbc.M503293200; GEE BE, 1995, BLOOD, V85, P268, DOI 10.1182/blood.V85.1.268.bloodjournal851268; HEBBEL RP, 1980, J CLIN INVEST, V65, P154, DOI 10.1172/JCI109646; Hermand P, 2004, EUR J BIOCHEM, V271, P3729, DOI 10.1111/j.1432-1033.2004.04313.x; Hillery CA, 2000, BRIT J HAEMATOL, V109, P322, DOI 10.1046/j.1365-2141.2000.02040.x; Hines PC, 2003, BLOOD, V101, P3281, DOI 10.1182/blood-2001-12-0289; HOOVER R, 1979, BLOOD, V54, P872; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; Kaul DK, 2006, AM J PHYSIOL-CELL PH, V291, pC922, DOI 10.1152/ajpcell.00639.2005; Kim SK, 2002, J NUCL MED, V43, P896; King SB, 2004, FREE RADICAL BIO MED, V37, P737, DOI 10.1016/j.freeradbiomed.2004.02.073; Lapoumeroulie C, 2005, HAEMATOLOGICA, V90, P401; Laurance S, 2011, HAEMATOL-HEMATOL J, V96, P534, DOI 10.3324/haematol.2010.026740; Laurance S, 2010, PHARMACOGENET GENOM, V20, P257, DOI 10.1097/FPC.0b013e32833854d6; Lemonne N, 2013, BLOOD, V121, P3054, DOI 10.1182/blood-2013-01-480277; Lonergan GJ, 2001, RADIOGRAPHICS, V21, P971, DOI 10.1148/radiographics.21.4.g01jl23971; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Mankelow TJ, 2004, BLOOD, V103, P1503, DOI 10.1182/blood-2003-08-2792; Netherton SJ, 2005, MOL PHARMACOL, V67, P263, DOI 10.1124/mol.104.004853; Odievre MH, 2008, HAEMATOLOGICA, V93, P502, DOI 10.3324/haematol.12070; PARSONS SF, 1995, P NATL ACAD SCI USA, V92, P5496, DOI 10.1073/pnas.92.12.5496; Rahuel C, 1996, BLOOD, V88, P1865; Smith JA, 1996, HEMATOL ONCOL CLIN N, V10, P1345, DOI 10.1016/S0889-8588(05)70405-6; Stuart MJ, 2004, LANCET, V364, P1343, DOI 10.1016/S0140-6736(04)17192-4; SWERLICK RA, 1993, BLOOD, V82, P1891; Udani M, 1998, J CLIN INVEST, V101, P2550, DOI 10.1172/JCI1204; Zaccolo M, 2006, BIOCHEM SOC T, V34, P495, DOI 10.1042/BST0340495; Zennadi R, 2004, BLOOD, V104, P3774, DOI 10.1182/blood-2004-01-0042; Zennadi R, 2007, BLOOD, V110, P2708, DOI 10.1182/blood-2006-11-056101	46	28	29	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11512	11521		10.1074/jbc.M113.506121	http://dx.doi.org/10.1074/jbc.M113.506121			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24616094	Green Published, hybrid			2022-12-25	WOS:000334638500051
J	Duechs, MJ; Tilp, C; Tomsic, C; Gantner, F; Erb, KJ				Duechs, Matthias J.; Tilp, Cornelia; Tomsic, Christopher; Gantner, Florian; Erb, Klaus J.			Development of a Novel Severe Triple Allergen Asthma Model in Mice Which Is Resistant to Dexamethasone and Partially Resistant to TLR7 and TLR9 Agonist Treatment	PLOS ONE			English	Article							AIRWAY INFLAMMATION; MURINE MODEL; INTERFERON-GAMMA; IMMUNE-RESPONSE; DUST-MITE; T-CELLS; LUNG; HYPERRESPONSIVENESS; HYPERREACTIVITY; PATHOPHYSIOLOGY	Severe asthma is characterised by persistent inflammation, hyperreactivity and remodeling of the airways. No efficient treatment is available, this is particularly the case for steroid resistant phenotypes. Our aim therefore was to develop a preclinical model showing characteristics of severe human asthma including steroid insensitivity. Mice were first sensitized with ovalbumin, extracts of cockroach or house dust mite followed by a challenge period of seven weeks. Further to this, an additional group of mice was sensitized with all three allergens and then challenged with allergen alternating weekly between allergens. All three allergens applied separately to the mice induced comparably strong Th2-type airway inflammation, airway hyperreactivity and airway remodeling, which was characterised by fibrosis and increased smooth muscle thickness. In contrast, application of all three allergens together resulted in a greater Th2 response and increased airway hyperreactivity and a stronger albeit not significant remodeling phenotype compared to using HDM or CRA. In this triple allergen model dexamethasone application, during the last 4 weeks of challenge, showed no suppressive effects on any of these parameters in this model. In contrast, both TLR7 agonist resiquimod and TLR9 agonist CpG-ODN reduced allergen-specific IgE, eosinophils, and collagen I in the lungs. The TLR9 agonist also reduced IL-4 and IL-5 whilst increasing IFN-gamma and strongly IL-10 levels in the lungs, effects not seen with the TLR7 agonist. However, neither TLR agonist had any effect on airway hyperreactivity and airway smooth muscle mass. In conclusion we have developed a severe asthma model, which is steroid resistant and only partially sensitive to TLR7 and TLR9 agonist treatment. This model may be particular useful to test new potential therapeutics aiming at treating steroid resistant asthma in humans and investigating the underlying mechanisms responsible for steroid insensitivity.	[Duechs, Matthias J.; Tilp, Cornelia; Tomsic, Christopher; Gantner, Florian; Erb, Klaus J.] Boehringer Ingelheim Pharma GmbH & Co KG, Resp Dis Res, Biberach, Germany	Boehringer Ingelheim	Erb, KJ (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, Resp Dis Res, Biberach, Germany.	klaus.erb@bc.boehringer-ingelheim.com			Boehringer Ingelheim Pharma GmbH Co. KG	Boehringer Ingelheim Pharma GmbH Co. KG(Boehringer Ingelheim)	The work was funded by Boehringer Ingelheim Pharma GmbH & Co. KG. The authors are all employed by BI Pharma. They pay the authors' salaries and pay for the experiments (Material used). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonicelli L, 2004, EUR RESPIR J, V23, P723, DOI 10.1183/09031936.04.00004904; Arizmendi NG, 2011, J IMMUNOL, V186, P3164, DOI 10.4049/jimmunol.0903812; Blacquiere MJ, 2010, INT ARCH ALLERGY IMM, V153, P173, DOI 10.1159/000312635; Boniface S, 2003, CLIN EXP ALLERGY, V33, P1238, DOI 10.1046/j.1365-2222.2003.01762.x; Boulares AH, 2003, AM J RESP CELL MOL, V28, P322, DOI 10.1165/rcmb.2001-0015OC; BRUSSELLE GG, 1994, CLIN EXP ALLERGY, V24, P73, DOI 10.1111/j.1365-2222.1994.tb00920.x; Camateros P, 2007, AM J RESP CRIT CARE, V175, P1241, DOI 10.1164/rccm.200701-054OC; Cho SH, 2005, AM J RESP CRIT CARE, V171, P224, DOI 10.1164/rccm.200310-1416OC; Christensen U, 2006, EUR J HUM GENET, V14, P227, DOI 10.1038/sj.ejhg.5201541; Chung KF, 1999, EUR RESPIR J, V13, P1198; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Doganci A, 2008, J IMMUNOL, V181, P1917, DOI 10.4049/jimmunol.181.3.1917; Du Q, 2009, CLIN EXP PHARMACOL P, V36, P43, DOI 10.1111/j.1440-1681.2008.05027.x; Duechs MJ, 2011, PULM PHARMACOL THER, V24, P203, DOI 10.1016/j.pupt.2010.12.009; Ekman AK, 2011, EUR J PHARMACOL, V652, P145, DOI 10.1016/j.ejphar.2010.11.009; Fanucchi MV, 2004, AM J RESP CRIT CARE, V170, P1153, DOI 10.1164/rccm.200404-533OC; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Goplen N, 2009, J ALLERGY CLIN IMMUN, V123, P925, DOI 10.1016/j.jaci.2009.02.009; Henderson WR, 2006, AM J RESP CRIT CARE, V173, P718, DOI 10.1164/rccm.200501-088OC; Holgate ST, 2011, J ALLERGY CLIN IMMUN, V128, P495, DOI 10.1016/j.jaci.2011.06.052; Jain VV, 2003, AM J PHYSIOL-LUNG C, V285, pL1137, DOI 10.1152/ajplung.00073.2003; Kaufman EH, 2011, J ALLERGY CLIN IMMUN, V127, P462, DOI 10.1016/j.jaci.2010.10.029; Kim J, 2004, AM J PHYSIOL-LUNG C, V287, pL503, DOI 10.1152/ajplung.00433.2003; Koch M, 2006, AM J RESP CELL MOL, V35, P211, DOI 10.1165/rcmb.2005-0293OC; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Li JJ, 2010, J IMMUNOL, V185, P4401, DOI 10.4049/jimmunol.1001039; Van LP, 2011, EUR J IMMUNOL, V41, P1992, DOI 10.1002/eji.201040914; Liu JY, 2001, AM J RESP CELL MOL, V25, P3, DOI 10.1165/ajrcmb.25.1.4481; Matsuse H, 2013, RESPIRATION, V85, P429, DOI 10.1159/000345861; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Mcmillan SJ, 2004, CLIN EXP ALLERGY, V34, P497, DOI 10.1111/j.1365-2222.2004.01895.x; Narala VR, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-90; Quarcoo D, 2004, CLIN EXP ALLERGY, V34, P1314, DOI 10.1111/j.1365-2222.2004.02023.x; Shannon J, 2008, CHEST, V133, P420, DOI 10.1378/chest.07-1881; Tanaka H, 2001, INFLAMM RES, V50, P616, DOI 10.1007/PL00000243; ten Hacken NHT, 1998, EUR RESPIR J, V11, P312, DOI 10.1183/09031936.98.11020312; Therien AG, 2008, AM J RESP CELL MOL, V39, P26, DOI 10.1165/rcmb.2007-0240OC; Trujillo-Vargas CM, 2007, AM J RESP CRIT CARE, V175, P336, DOI 10.1164/rccm.200601-054OC; Ulrich K, 2008, PULM PHARMACOL THER, V21, P637, DOI 10.1016/j.pupt.2008.02.006; Wegmann M, 2005, CLIN EXP ALLERGY, V35, P1263, DOI 10.1111/j.1365-2222.2005.02306.x; Wegmann M, 2007, AM J RESP CELL MOL, V36, P61, DOI 10.1165/rcmb.2006-0188OC; Wilson RH, 2009, AM J RESP CRIT CARE, V180, P720, DOI 10.1164/rccm.200904-0573OC; Wohlleben G, 2004, INT IMMUNOL, V16, P585, DOI 10.1093/intimm/dxh062; Xirakia C, 2010, AM J RESP CRIT CARE, V181, P1207, DOI 10.1164/rccm.200908-1255OC	45	29	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91223	10.1371/journal.pone.0091223	http://dx.doi.org/10.1371/journal.pone.0091223			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618687	Green Submitted, gold, Green Published			2022-12-25	WOS:000332842400058
J	Huang, JL; Huang, YL; Zhang, ZY				Huang, Jinliang; Huang, Yaling; Zhang, Zhenyu			Coupled Effects of Natural and Anthropogenic Controls on Seasonal and Spatial Variations of River Water Quality during Baseflow in a Coastal Watershed of Southeast China	PLOS ONE			English	Article							LAND-USE CHANGE; SURFACE-WATER; TEMPORAL VARIABILITY; PHOSPHORUS TRANSFERS; NITROGEN-SOURCES; QIANTANG RIVER; NITRATE EXPORT; CATCHMENT; STREAMS; PATTERNS	Surface water samples of baseflow were collected from 20 headwater sub-watersheds which were classified into three types of watersheds (natural, urban and agricultural) in the flood, dry and transition seasons during three consecutive years (2010-2012) within a coastal watershed of Southeast China. Integrating spatial statistics with multivariate statistical techniques, river water quality variations and their interactions with natural and anthropogenic controls were examined to identify the causal factors and underlying mechanisms governing spatiotemporal patterns of water quality. Anthropogenic input related to industrial effluents and domestic wastewater, agricultural activities associated with the precipitation-induced surface runoff, and natural weathering process were identified as the potential important factors to drive the seasonal variations in stream water quality for the transition, flood and dry seasons, respectively. All water quality indicators except SRP had the highest mean concentrations in the dry and transition seasons. Anthropogenic activities and watershed characteristics led to the spatial variations in stream water quality in three types of watersheds. Concentrations of NH4+-N, SRP, K+, CODMn, and Cl- were generally highest in urban watersheds. NO3-N Concentration was generally highest in agricultural watersheds. Mg2+ concentration in natural watersheds was significantly higher than that in agricultural watersheds. Spatial autocorrelations analysis showed similar levels of water pollution between the neighboring sub-watersheds exhibited in the dry and transition seasons while non-point source pollution contributed to the significant variations in water quality between neighboring sub-watersheds. Spatial regression analysis showed anthropogenic controls played critical roles in variations of water quality in the JRW. Management implications were further discussed for water resource management. This research demonstrates that the coupled effects of natural and anthropogenic controls involved in watershed processes, contribute to the seasonal and spatial variation of headwater stream water quality in a coastal watershed with high spatial variability and intensive anthropogenic activities.	[Huang, Jinliang] Xiamen Univ, Coastal & Ocean Management Inst, Xiamen, Peoples R China; [Huang, Jinliang; Huang, Yaling; Zhang, Zhenyu] Xiamen Univ, Fujian Prov Key Lab Coastal Ecol & Environm Studi, Xiamen, Peoples R China	Xiamen University; Xiamen University	Huang, JL (corresponding author), Xiamen Univ, Coastal & Ocean Management Inst, Xiamen, Peoples R China.	jlhuang@xmu.edu.cn	Zhang, Zhenyu/W-3603-2019		Natural National Science Foundation of China [40810069004, 40901100]; Science Foundation of Fujian Province [2010Y0064]	Natural National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province)	This study was supported by the Natural National Science Foundation of China (Grant No. 40810069004, Grant No. 40901100), and the Science Foundation of Fujian Province (2010Y0064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn DS, 2005, J HYDROL, V313, P234, DOI 10.1016/j.jhydrol.2005.02.038; Alexander RB, 2000, NATURE, V403, P758, DOI 10.1038/35001562; ALTMAN SJ, 1995, J ENVIRON QUAL, V24, P707, DOI 10.2134/jeq1995.00472425002400040023x; Baker A, 2003, HYDROL PROCESS, V17, P2499, DOI 10.1002/hyp.5140; Bowes MJ, 2005, SCI TOTAL ENVIRON, V344, P67, DOI 10.1016/j.scitotenv.2005.02.006; Brando PM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0152; Cao WZ, 2006, ENVIRON GEOCHEM HLTH, V28, P45, DOI 10.1007/s10653-005-9010-4; Carey RO, 2011, ECOL INDIC, V11, P1093, DOI 10.1016/j.ecolind.2010.12.009; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Chang H, 2008, WATER RES, V42, P3285, DOI 10.1016/j.watres.2008.04.006; Chang H, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045012; Chen NW, 2008, BIOGEOCHEMISTRY, V87, P169, DOI 10.1007/s10533-007-9175-2; de Souza ALT, 2013, FOREST ECOL MANAG, V298, P12, DOI 10.1016/j.foreco.2013.02.022; Duan SW, 2013, BIOGEOSCIENCES, V10, P1193, DOI 10.5194/bg-10-1193-2013; Duan SW, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001782; Dultz S, 2013, ENVIRON EARTH SCI, V69, P969, DOI 10.1007/s12665-012-1981-8; Edwards AC, 2008, J HYDROL, V350, P144, DOI 10.1016/j.jhydrol.2007.10.053; Fotheringham A.S., 2002, GEOGRAPHICALLY WEIGH; Gardner KK, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007029; Haygarth P, 2004, HYDROL EARTH SYST SC, V8, P88, DOI 10.5194/hess-8-88-2004; Hill AR, 1996, J ENVIRON QUAL, V25, P743, DOI 10.2134/jeq1996.00472425002500040014x; House WA, 2003, APPL GEOCHEM, V18, P739, DOI 10.1016/S0883-2927(02)00158-0; Huang JL, 2013, OCEAN COAST MANAGE, V81, P29, DOI 10.1016/j.ocecoaman.2012.09.016; Huang JL, 2012, J COASTAL RES, V28, P930, DOI 10.2112/JCOASTRES-D-11-00176.1; Huang JL, 2013, ENVIRON MANAGE, V51, P32, DOI 10.1007/s00267-011-9793-2; Huang JL, 2012, APPL GEOGR, V34, P371, DOI 10.1016/j.apgeog.2012.01.001; [黄金良 Huang Jinliang], 2004, [水土保持学报, Journal of Soil and Water Conservation], V18, P75; Ishizawa H, 2007, SOC SCI RES, V36, P1042, DOI 10.1016/j.ssresearch.2006.06.005; Jarvie HP, 2006, SCI TOTAL ENVIRON, V360, P246, DOI 10.1016/j.scitotenv.2005.08.038; Jarvie HP, 2002, REG ENVIRON CHANGE, V3, P36, DOI 10.1007/s10113-001-0036-6; JONES DP, 1993, SOIL SCI SOC AM J, V57, P256, DOI 10.2136/sssaj1993.03615995005700010044x; Jordan P, 2007, HYDROL EARTH SYST SC, V11, P372, DOI 10.5194/hess-11-372-2007; Kannel PR, 2007, ENVIRON MONIT ASSESS, V129, P433, DOI 10.1007/s10661-006-9375-6; Kaushal SS, 2008, ENVIRON SCI TECHNOL, V42, P5872, DOI 10.1021/es800264f; Kney AD, 2007, J ENVIRON MANAGE, V82, P519, DOI 10.1016/j.jenvman.2006.01.014; Ko KS, 2009, GEOSCI J, V13, P191, DOI 10.1007/s12303-009-0019-z; Lee SW, 2009, LANDSCAPE URBAN PLAN, V92, P80, DOI 10.1016/j.landurbplan.2009.02.008; Li SY, 2013, PLOS ONE; Line DE, 2013, ENVIRON MONIT ASSESS, V185, P6277, DOI 10.1007/s10661-012-3024-z; Liu JG, 2005, NATURE, V435, P1179, DOI 10.1038/4351179a; Martin C, 2004, HYDROL PROCESS, V18, P1237, DOI 10.1002/hyp.1395; May L, 2001, SCI TOTAL ENVIRON, V269, P117, DOI 10.1016/S0048-9697(00)00820-2; MEP, 2011, REP STAT ENV CHIN 20; Mitchell, 2001, HYDROLOGICAL PROCESS, V15, P3305; Mouri G, 2011, J ENVIRON MANAGE, V92, P1837, DOI 10.1016/j.jenvman.2011.03.005; Neal EG, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042385; Ouyang Y, 2006, WATER RES, V40, P3800, DOI 10.1016/j.watres.2006.08.030; Paerl HW, 2006, ECOL ENG, V26, P40, DOI 10.1016/j.ecoleng.2005.09.006; Pasieczna A, 2008, GEOCHEM-EXPLOR ENV A, V8, P323, DOI 10.1144/1467-7873/08-180; Pauwels H, 2001, APPL GEOCHEM, V16, P583, DOI 10.1016/S0883-2927(00)00062-7; Peterson BJ, 2001, SCIENCE, V292, P86, DOI 10.1126/science.1056874; Petry J, 2002, SCI TOTAL ENVIRON, V294, P95, DOI 10.1016/S0048-9697(02)00058-X; Porter-Goff ER, 2013, ECOL INDIC, V32, P97, DOI 10.1016/j.ecolind.2013.03.017; Pratt B, 2012, J HAZARD MATER, V209, P48, DOI 10.1016/j.jhazmat.2011.12.068; Randhir TO, 2009, J HYDROL, V364, P182, DOI 10.1016/j.jhydrol.2008.10.017; Redman CL, 1999, ECOSYSTEMS, V2, P296, DOI 10.1007/s100219900079; Rothwell JJ, 2010, SCI TOTAL ENVIRON, V408, P841, DOI 10.1016/j.scitotenv.2009.10.041; Sliva L, 2001, WATER RES, V35, P3462, DOI 10.1016/S0043-1354(01)00062-8; Smith AJ, 2013, ECOL INDIC, V29, P455, DOI 10.1016/j.ecolind.2013.01.021; Somura H, 2012, J HYDROL, V450, P25, DOI 10.1016/j.jhydrol.2012.05.032; St Laurent J, 2014, WATER RES, V48, P170, DOI 10.1016/j.watres.2013.09.031; State Environmental Protection Administrator of China (SEPAC), 2002, METH MON AN WAT WAST; Su SL, 2013, REG ENVIRON CHANGE, V13, P77, DOI 10.1007/s10113-012-0313-6; Su SL, 2013, ECOL INDIC, V24, P375, DOI 10.1016/j.ecolind.2012.07.015; Sun RH, 2013, J AM WATER RESOUR AS, V49, P741, DOI 10.1111/jawr.12033; Swaney DP, 2012, CURR OPIN ENV SUST, V4, P203, DOI 10.1016/j.cosust.2012.03.004; Tu J, 2008, SCI TOTAL ENVIRON, V407, P358, DOI 10.1016/j.scitotenv.2008.09.031; Tu J, 2013, ENVIRON MANAGE, V51, P1, DOI 10.1007/s00267-011-9738-9; UN-WWAP, 2009, 3 UN WWAP; VanLandeghem MM, 2012, WATER RES, V46, P6638, DOI 10.1016/j.watres.2012.05.002; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Weller DE, 2003, ESTUARIES, V26, P244, DOI 10.1007/BF02695965; Willett VB, 2004, J ENVIRON QUAL, V33, P201, DOI 10.2134/jeq2004.0201; Worrall F, 2001, J HYDROL, V243, P228, DOI 10.1016/S0022-1694(00)00411-X; Yang XY, 2010, J ENVIRON MANAGE, V91, P1943, DOI 10.1016/j.jenvman.2010.04.011; Yin XM, 2012, J FOOD AGRIC ENVIRON, V10, P1214; Zhou F, 2007, WATER RES, V41, P3429, DOI 10.1016/j.watres.2007.04.022	77	36	39	6	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91528	10.1371/journal.pone.0091528	http://dx.doi.org/10.1371/journal.pone.0091528			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618771	Green Published, gold, Green Submitted			2022-12-25	WOS:000332842400100
J	Mao, LG; Wang, QX; Yan, DD; Ma, TT; Liu, PF; Shen, J; Li, Y; Ouyang, CB; Guo, MX; Cao, AC				Mao, Liangang; Wang, Qiuxia; Yan, Dongdong; Ma, Taotao; Liu, Pengfei; Shen, Jin; Li, Yuan; Ouyang, Canbin; Guo, Meixia; Cao, Aocheng			Evaluation of Chloropicrin as a Soil Fumigant against Ralstonia solanacarum in Ginger (Zingiber officinale Rosc.) Production in China	PLOS ONE			English	Article							METHYL-BROMIDE ALTERNATIVES; SOILBORNE DISEASE; TOMATO; EFFICACY; PEPPER; COMBINATIONS; MANAGEMENT; NEMATODE; FILMS; WEED	Background: Chloropicrin (Pic) offers a potential alternative to methyl bromide (MB) against Ralstonia solanacarum in ginger (Zingiber officinale Rosc.) production. MB is scheduled to be withdrawn from routine use by 2015 in developing countries. Methods: Pic treatments were evaluated in a laboratory study and in three commercial ginger fields. Results: Laboratory studies showed that the EC50 value and EC80 value of Pic were 2.7 and 3.7 mg a.i. kg(-1) soil, respectively. Field trials in highly infested soil revealed that treatments of Pic at the dose of 50 g m(-2) covered with totally impermeable film (TIF) or polyethylene film (PE) sharply reduced Ralstonia solanacarum and maintained high ginger yields. Both of the Pic treatments provided results similar to, or in some cases slightly lower than, MB with respect to Ralstonia solanacarum control, plant survival, plant growth and yield. All of the fumigant treatments were significantly better than the non-treated control. Conclusions: The present study confirms that the Pic is a promising alternative with good efficacy against Ralstonia solanacarum for ginger production and could be used in integrated pest management programs in China.	[Mao, Liangang; Wang, Qiuxia; Yan, Dongdong; Ma, Taotao; Liu, Pengfei; Shen, Jin; Li, Yuan; Ouyang, Canbin; Guo, Meixia; Cao, Aocheng] Chinese Acad Agr Sci, Minist Agr, Inst Plant Protect, Dept Pesticides, Beijing 100193, Peoples R China; [Wang, Qiuxia; Yan, Dongdong; Li, Yuan; Ouyang, Canbin; Guo, Meixia; Cao, Aocheng] State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Ministry of Agriculture & Rural Affairs	Cao, AC (corresponding author), Chinese Acad Agr Sci, Minist Agr, Inst Plant Protect, Dept Pesticides, Beijing 100193, Peoples R China.	caoac@vip.sina.com	yan, dongdong/M-4629-2017	Yan, Dongdong/0000-0002-8196-4615	Program on Substituted Technology for Methyl Bromide in China (Special Finance of Chinese Ministry of Agriculture) [2110402]; UNDIO Project on Phasing-out of Methyl Bromide in Agriculture Sector in China [TF/CPR-A/08/003]	Program on Substituted Technology for Methyl Bromide in China (Special Finance of Chinese Ministry of Agriculture); UNDIO Project on Phasing-out of Methyl Bromide in Agriculture Sector in China	This research was supported by the Program on Substituted Technology for Methyl Bromide in China (Special Finance of Chinese Ministry of Agriculture, 2110402) and UNDIO Project on Phasing-out of Methyl Bromide in Agriculture Sector in China (TF/CPR-A/08/003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell CH, 2000, CROP PROT, V19, P563, DOI 10.1016/S0261-2194(00)00073-9; Bringhurst RS, 1960, CALIFORNIA STRAWBEER, V7; Cao AC, 2014, PEST MANAG SCI, V70, P219, DOI 10.1002/ps.3535; Csinos AS, 1997, CROP PROT, V16, P585, DOI 10.1016/S0261-2194(97)00025-2; Desaeger JA, 2008, PEST MANAG SCI, V64, P230, DOI 10.1002/ps.1503; Dow AgroSciences, 2014, TEL SOIL FUM GUID AP; Fennimore SA, 2005, P ANN INT RES C METH, P1; Food and Agriculture Organization of the United Nations (FAO), 2013, FAOSTAT AGR; Gilreath JP, 2008, CROP PROT, V27, P648, DOI 10.1016/j.cropro.2007.09.008; Gilreath JP, 2005, CROP PROT, V24, P903, DOI 10.1016/j.cropro.2005.01.016; Gilreath JP, 2005, CROP PROT, V24, P285, DOI 10.1016/j.cropro.2004.08.008; Gilreath JP, 2004, CROP PROT, V23, P1193, DOI 10.1016/j.cropro.2004.03.020; Gullino ML, 2002, CROP PROT, V21, P741, DOI 10.1016/S0261-2194(02)00031-5; Hutchinson CM, 2000, PEST MANAG SCI, V56, P413, DOI 10.1002/(SICI)1526-4998(200005)56:5<413::AID-PS140>3.0.CO;2-J; KELMAN A, 1954, PHYTOPATHOLOGY, V44, P693; Klose S, 2006, SOIL BIOL BIOCHEM, V38, P1243, DOI 10.1016/j.soilbio.2005.09.025; Lombardo S, 2012, CROP PROT, V37, P59, DOI 10.1016/j.cropro.2012.02.010; Mao LG, 2012, PEST MANAG SCI, V68, P602, DOI 10.1002/ps.2303; Margesin R., 2005, MANUAL SOIL ANAL MON, P47; McKinney HH, 1923, J AGRIC RES, V26, P0195; Nelson D. W., 1985, METHODS SOIL ANAL, P539; Ou LT, 2008, J ENVIRON SCI HEAL B, V43, P376, DOI 10.1080/03601230802062018; Santos BM, 2006, CROP PROT, V25, P690, DOI 10.1016/j.cropro.2005.09.015; Schinner F., 1995, METHODS SOIL BIOL, P386; Steel R.G., 1980, PRINCIPLES PROCEDURE, P481; Stewart ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084168; Wang QX, 2010, J ENVIRON QUAL, V39, P917, DOI 10.2134/jeq2009.0342; YABUUCHI E, 1995, MICROBIOL IMMUNOL, V39, P897, DOI 10.1111/j.1348-0421.1995.tb03275.x; Yan DD, 2012, J AGR FOOD CHEM, V60, P5023, DOI 10.1021/jf300532x	29	26	32	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91767	10.1371/journal.pone.0091767	http://dx.doi.org/10.1371/journal.pone.0091767			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618853	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400125
J	Frocklin, S; de la Torre-Castro, M; Hakansson, E; Carlsson, A; Magnusson, M; Jiddawi, NS				Frocklin, Sara; de la Torre-Castro, Maricela; Hakansson, Elin; Carlsson, Anna; Magnusson, Madeleine; Jiddawi, Narriman S.			Towards Improved Management of Tropical Invertebrate Fisheries: Including Time Series and Gender	PLOS ONE			English	Article							CHWAKA-BAY; MARINE INVERTEBRATE; OVER-EXPLOITATION; ZANZIBAR; ABUNDANCE	Invertebrate harvesting is an important livelihood in tropical settings providing income and food for numerous populations throughout the world. However, the lack of research, policy and management directed towards this livelihood hinders the analysis of time trends to evaluate invertebrate resources status. Another missing aspect is the consideration of gender analysis, i.e., the different roles and interests of men and women engaged in this activity. Based on interviews, catch assessments and inventories this multi-disciplinary study from Chwaka Bay (Zanzibar, Tanzania) shows how unregulated harvesting of invertebrates may result in sharp declines in animal abundance over a relatively short period of time (2005 to 2010), threatening the sustainability of the fishery. Specifically, the results show that catches in general, and prime target species of gastropods and bivalves in particular, had been significantly reduced in number and size. Interviews revealed gender disparities; female harvesters experienced less access to good fishing/ collecting grounds and species of high value, which subsequently resulted in lower individual income. This is tightly linked to women's reproductive roles, which not only leads to limited mobility but also lessen their chances to accumulate livelihood assets (natural, physical, financial, social and human capital) thus impacting livelihood strategies. To protect invertebrate resources from overexploitation, and assure a constant flow of income and food for future generations, this case study illustrates the need for formal monitoring to assess changes in invertebrate resources, and possible ecological consequences, over time. Managers and policy-makers must also address gender to evaluate the contribution of all resource users, their capacity to cope with changing conditions, as well as specific interests.	[Frocklin, Sara; Hakansson, Elin; Carlsson, Anna; Magnusson, Madeleine] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [de la Torre-Castro, Maricela] Stockholm Univ, Dept Phys Geog & Quaternary Geol, S-10691 Stockholm, Sweden; [de la Torre-Castro, Maricela] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden; [Jiddawi, Narriman S.] Univ Dar Salaam, Inst Marine Sci, Zanzibar, Tanzania	Stockholm University; Stockholm University; Stockholm University; University of Dar es Salaam	Frocklin, S (corresponding author), Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden.	sara.frocklin@su.se			Swedish International Development Cooperation Agency, Sida; Swedish Research Council (Vetenskapsradet, VR)	Swedish International Development Cooperation Agency, Sida; Swedish Research Council (Vetenskapsradet, VR)(Swedish Research Council)	SF, AK, MM and EH were financed by the Swedish International Development Cooperation Agency, Sida. MTC was funded by The Swedish Research Council (Vetenskapsradet, VR). VR project: Genus, fattigdom och marina resurser. Project nr. ID (Avtals ID): B0544801; project holder MTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal B, 2000, CAMB J ECON, V24, P283, DOI 10.1093/cje/24.3.283; Anderson M., 2005, PERMANOVA PERMUTATIO; Anderson SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024368; Andrew NL, 2002, OCEANOGR MAR BIOL, V40, P343; Bostrom C, 1997, J SEA RES, V37, P153, DOI 10.1016/S1385-1101(96)00007-X; Bryman A., 2008, SOCIAL RES METHODS, V3rd; Castilla JC, 1998, ECOL APPL, V8, pS124, DOI 10.1890/1051-0761(1998)8[S124:SBFICO]2.0.CO;2; Cederlof U, 1995, AMBIO, V24, P458; Colin PL, 1995, TROPICAL PACIFIC INV; Crawford B, 2010, COAST MANAGE, V38, P195, DOI 10.1080/08920753.2010.483174; de la Torre-Castro M, 2004, OCEAN COAST MANAGE, V47, P361, DOI 10.1016/j.ocecoaman.2004.07.005; de la Torre-Castro M, 2012, PEOPLE NATURE RES CH, DOI DOI 10.1007/s10811-012-9842-0; de la Torre-Castro M, 2012, PEOPLE NATURE RES CH, P279; de la Torre-Castro M, 2006, ECOL SOC, V11; Di Ciommo RC, 2012, OCEAN COAST MANAGE, V62, P15, DOI 10.1016/j.ocecoaman.2012.02.010; EDGAR GJ, 1990, J EXP MAR BIOL ECOL, V137, P215, DOI 10.1016/0022-0981(90)90186-G; Ellis Frank, 2000, RURAL LIVELIHOODS DI; Eriksson BH, 2010, AQUAT LIVING RESOUR, V23, P387, DOI 10.1051/alr/2011002; Eriksson H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035504; Fernandez M, 1997, J SHELLFISH RES, V16, P371; Gossling S, 2004, BIODIVERS CONSERV, V13, P2623, DOI 10.1007/s10531-004-2139-0; Gullstrom M, 2006, ESTUAR COAST SHELF S, V67, P399, DOI 10.1016/j.ecss.2005.11.020; Gullstrom M., 2012, PEOPLE NATURE RES PR, P175; Hakansson E., 2012, PEOPLE NATURE RES CH, P235; Hall SJ, 2012, PNAS; Harding Sandra, 1986, SCI QUESTION FEMINIS; Harper S, 2013, MAR POLICY, V39, P56, DOI 10.1016/j.marpol.2012.10.018; Hobday AJ, 2001, REV FISH BIOL FISHER, V10, P493; IMF, 2013, WOR ECON OUTLOOK, P1; Jackson C, 1994, SOCIAL THEORY ENV; JAMIESON GS, 1993, AM ZOOL, V33, P551; Jiddawi N., 2012, PEOPLE NATURE RES CH, P23; Jiddawi N. S., 2012, PEOPLE NATURE RES CH, P193; Jiddawi NS, 2002, AMBIO, V31, P518, DOI 10.1639/0044-7447(2002)031[0518:MFIT]2.0.CO;2; Kvale S, 1994, INTRO QUALITATIVE RE; Leach M, 2007, DEV CHANGE, V38, P67, DOI 10.1111/j.1467-7660.2007.00403.x; Leiva GE, 2002, REV FISH BIOL FISHER, V11, P283; LIESKE E, 2004, CORAL REEF GUIDE RED; Lyimo T, 2012, PEOPLE NATURE RES CH, P17; Matthews E, 2012, GENDER PERSPECTIVE S; Medard M., 2002, GLOB S WOM FISH 6 AS, P155; NEWTON LC, 1993, BIOL CONSERV, V63, P241, DOI 10.1016/0006-3207(93)90719-H; Nordlund L, 2010, AQUAT LIVING RESOUR, V23, P399, DOI 10.1051/alr/2011006; Nordlund LM, 2014, AMBIO, V43, P1006, DOI 10.1007/s13280-013-0465-8; Perry RI, 1999, REV FISH BIOL FISHER, V9, P125, DOI 10.1023/A:1008946522213; PHILLIPS BF, 2007, FISHERIES MANAGEMENT, P231; Pinnegar JK, 2008, REV FISH BIOL FISHER, V18, P1, DOI 10.1007/s11160-007-9058-6; Population Census, 2012, POP HOUS CENS UN REP; Prescott J, 2013, MAR FRESHWATER RES, V64, P599, DOI 10.1071/MF12081; RICHMOND MD, 2002, FIELD GUIDE SEASHORE; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; Siason IM, 2002, GLOB S WOM FISH 6 AS; Sprague J., 2016, FEMINIST METHODOLOGI; Tobisson E, 1998, AMBIO, V27, P677; Uthicke S, 2001, CORAL REEFS, V19, P271; Weeratunge N, 2010, FISH FISH, V11, P405, DOI 10.1111/j.1467-2979.2010.00368.x; Williams MJ, 2002, GLOB S WOM FISH 6 AS; Williams MJ, 2012, SPC WOMEN FISHERIES, V22; Wynter P, 1997, SAGE, V7, P33	59	48	48	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91161	10.1371/journal.pone.0091161	http://dx.doi.org/10.1371/journal.pone.0091161			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614075	gold, Green Published, Green Submitted			2022-12-25	WOS:000332839300086
J	Hayashi, A; Yamauchi, N; Shibahara, J; Kimura, H; Morikawa, T; Ishikawa, S; Nagae, G; Nishi, A; Sakamoto, Y; Kokudo, N; Aburatani, H; Fukayama, M				Hayashi, Akimasa; Yamauchi, Naoko; Shibahara, Junji; Kimura, Hiroshi; Morikawa, Teppei; Ishikawa, Shumpei; Nagae, Genta; Nishi, Akihiro; Sakamoto, Yoshihiro; Kokudo, Norihiro; Aburatani, Hiroyuki; Fukayama, Masashi			Concurrent Activation of Acetylation and Tri-Methylation of H3K27 in a Subset of Hepatocellular Carcinoma with Aggressive Behavior	PLOS ONE			English	Article							HIGH EXPRESSION; HISTONE MODIFICATIONS; POOR-PROGNOSIS; P53; GENE; EZH2; P300; OVEREXPRESSION; ASSOCIATION; PROTEINS	Analysis of acetylation and tri-methylation of the same residue of histone molecules might identify a subset of hepatocellular carcinoma (HCC) with aggressive behavior. In the present study, we examined acetylation and tri-methylation of lysine 27 on histone H3 (H3K27ac and H3K27me3, respectively) because these two modifications are known to exhibit opposite effects (enhancing and silencing) on gene expression. Neoplastic and non-neoplastic tissues from 198 HCC cases were immunostained with specific monoclonal antibodies against H3K27ac and H3K27me3. The stained tissues were evaluated by an image analyzing program to generate histological scores (H-scores, range 0-300), which were determined by multiplying the percentage of positive-stained cells with the classified immunohistochemical marker intensity (0-3). HCC tissues showed significantly higher H3K27ac (156.7 +/- 86.8) and H3K27me3 H-scores (151.8 +/- 78.1) compared with the background liver (40.3 +/- 33.0 and 64.7 +/- 45.6, respectively) (both P<0.001). The cases with H-scores of high-H3K27ac/high-H3K27me3 (n = 54) showed significant correlation with poor differentiation of morphology (P<0.01) and p53-positive staining (P<0.05), and poor prognosis (P<0.01). Confocal microscopy revealed segregated intranuclear localization of both modifications in the individual cancer cells: H3K27ac localization in central euchromatin regions and H3K27me3 in peripheral heterochromatin regions. Concurrent acetylation and methylation at H3K27 occurs in HCC cells in association with p53 abnormalities. These findings demonstrate that image analyzer-assisted H-scores of H3K27ac and H3K27me3 identified an aggressive subgroup of HCC, and could serve as a prognostic marker for HCC.	[Hayashi, Akimasa; Yamauchi, Naoko; Shibahara, Junji; Morikawa, Teppei; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo, Japan; [Hayashi, Akimasa; Nagae, Genta; Aburatani, Hiroyuki] Univ Tokyo, Adv Sci & Technol Res Ctr, Genome Sci Div, Tokyo, Japan; [Kimura, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Biomol Networks Labs Grp, Suita, Osaka, Japan; [Ishikawa, Shumpei] Tokyo Med & Dent Univ, Med Res Inst, Dept Genom Pathol, Tokyo, Japan; [Sakamoto, Yoshihiro; Kokudo, Norihiro] Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo, Japan; [Nishi, Akihiro] Yale Inst Network Sci, New Haven, CT USA	University of Tokyo; University of Tokyo; Osaka University; Tokyo Medical & Dental University (TMDU); University of Tokyo	Fukayama, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo, Japan.	mfukayama-tky@umin.net	Nagae, Genta/AAN-1167-2021; Nagae, Genta/H-6579-2019; Kimura, Hiroshi/B-9524-2015	Nagae, Genta/0000-0002-2929-7990; Kimura, Hiroshi/0000-0003-0854-083X; Nishi, Akihiro/0000-0003-1629-5985	New Energy and Industrial Technology Development Organization (NEDO), Japan [P10005]	New Energy and Industrial Technology Development Organization (NEDO), Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by the grant, Technology development for drug discovery platform based on the epigenetic mechanism (P10005) from New Energy and Industrial Technology Development Organization (NEDO), Japan (http://www.nedo.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai X, 2008, J CANCER RES CLIN, V134, P83, DOI 10.1007/s00432-007-0252-7; Blanche P, 2013, STAT MED, V32, P5381, DOI 10.1002/sim.5958; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Braun M, 2013, HISTOL HISTOPATHOL, V28, P605, DOI 10.14670/HH-28.605; Cai MY, 2011, MOL MED, V17, P12, DOI 10.2119/molmed.2010.00103; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Chervona Y, 2012, AM J CANCER RES, V2, P589; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; He CC, 2012, HUM PATHOL, V43, P1425, DOI 10.1016/j.humpath.2011.11.003; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Ho WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029179; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; HSU HC, 1993, CANCER RES, V53, P4691; Japan LCSGo, 2003, GEN RUL CLIN PATH ST; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Li M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-5; LITTAU VC, 1964, P NATL ACAD SCI USA, V52, P93, DOI 10.1073/pnas.52.1.93; MAKUUCHI M, 1993, SEMIN SURG ONCOL, V9, P298, DOI 10.1002/ssu.2980090404; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Quint K, 2011, VIRCHOWS ARCH, V459, P129, DOI 10.1007/s00428-011-1103-0; Research FfPoC, 2011, CANC STAT JAP 2011; Rikimaru T, 2007, ONCOLOGY-BASEL, V72, P69, DOI 10.1159/000111106; Salichs E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000397; Sasaki M, 2008, LAB INVEST, V88, P873, DOI 10.1038/labinvest.2008.52; Seligson DB, 2009, AM J PATHOL, V174, P1619, DOI 10.2353/ajpath.2009.080874; Selvi BR, 2010, BBA-GENE REGUL MECH, V1799, P810, DOI 10.1016/j.bbagrm.2010.09.005; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Song L, 2013, HISTOPATHOLOGY, V62, P343, DOI 10.1111/j.1365-2559.2012.04362.x; Sudo T, 2005, BRIT J CANCER, V92, P1754, DOI 10.1038/sj.bjc.6602531; Takayasu K, 2006, GASTROENTEROLOGY, V131, P461, DOI 10.1053/j.gastro.2006.05.021; Tamagawa H, 2013, EJSO-EUR J SURG ONC, V39, P655, DOI 10.1016/j.ejso.2013.02.023; Tandon P, 2009, LIVER INT, V29, P502, DOI 10.1111/j.1478-3231.2008.01957.x; Tang XH, 2004, ONCOGENE, V23, P5759, DOI 10.1038/sj.onc.1207706; Torbenson M, 2004, AM J CLIN PATHOL, V122, P377, DOI 10.1309/YH0H3FKYM4RMU1JF; Van Den Broeck A, 2008, CLIN CANCER RES, V14, P7237, DOI 10.1158/1078-0432.CCR-08-0869; Vleugel MM, 2006, HUM PATHOL, V37, P1085, DOI 10.1016/j.humpath.2006.03.015; Yamada A, 2011, INT J ONCOL, V38, P345, DOI 10.3892/ijo.2010.868; Yokomizo C, 2011, CANCER LETT, V310, P140, DOI 10.1016/j.canlet.2011.06.030	45	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91330	10.1371/journal.pone.0091330	http://dx.doi.org/10.1371/journal.pone.0091330			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614346	gold, Green Submitted, Green Published			2022-12-25	WOS:000332839300113
J	Jeffrey, M; Martin, S; Chianini, F; Eaton, S; Dagleish, MP; Gonzalez, L				Jeffrey, Martin; Martin, Stuart; Chianini, Francesca; Eaton, Samantha; Dagleish, Mark P.; Gonzalez, Lorenzo			Incidence of Infection in Prnp ARR/ARR Sheep following Experimental Inoculation with or Natural Exposure to Classical Scrapie	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; DISEASE-ASSOCIATED PRP; PRION PROTEIN; CLINICAL SCRAPIE; SUFFOLK SHEEP; GENOTYPE; ACCUMULATION; BRAIN; AGENT; SUSCEPTIBILITY	The prion protein gene (Prnp) is highly influential in determining risk and susceptibility of sheep exposed to classical scrapie. Sheep homozygous for alanine at codon 136 and arginine at codons 154 and 171 (ARR/ARR) of the Prnp gene are historically considered to be highly resistant to classical scrapie, although they form a significant fraction of cases of atypical scrapie. To date, experimental transmission of prions to ARR/ARR sheep has only been achieved with the BSE agent and mostly by the intracerebral route. We summarise here the results of six separate studies, in which 95 sheep of the ARR/ARR genotype were naturally exposed to (n = 18) or experimentally challenged with (n = 77) natural or experimental sources of classical scrapie by the oral, intra-intestinal, subcutaneous or intracerebral routes and allowed to survive for periods of up to 94 months post-infection. Only the intracerebral route resulted in disease and/or amplification of disease associated PrP (PrP delta), and only in two of 19 sheep that survived for longer than 36 months. Discriminatory immunohistochemistry and Western blot confirmed the scrapie, non-BSE signature of PrP delta in those two sheep. However, the neuropathological phenotype was different from any other scrapie (classical or atypical) or BSE source previously reported in sheep of any Prnp genotype. These studies confirm the widely held view that ARR/ARR sheep are highly resistant to classical scrapie infection, at least within their commercial lifespan. Moreover, within the constraints of the present studies (only two infected sheep), these results do not support the suggestion that atypical scrapie or BSE are generated by adaptation or mutation of classical scrapie in sheep of resistant ARR/ARR genotype.	[Jeffrey, Martin; Martin, Stuart; Gonzalez, Lorenzo] Anim Hlth & Vet Labs Agcy AHVLA Lasswade, Penicuik, Midlothian, Scotland; [Chianini, Francesca; Eaton, Samantha; Dagleish, Mark P.] Moredun Res Inst, Penicuik, Midlothian, Scotland	Moredun Research Institute	Jeffrey, M (corresponding author), Anim Hlth & Vet Labs Agcy AHVLA Lasswade, Pentlands Sci Pk, Penicuik, Midlothian, Scotland.	martin.jeffrey@ahvla.gsi.gov.uk	González, Lorenzo/A-5325-2010; Chianini, Francesca/K-1451-2013; Jeffrey, Martin/D-2251-2009	González, Lorenzo/0000-0003-4199-4526; Chianini, Francesca/0000-0001-9962-446X; 	Defra [SE1851, SE1948, SE1949, SE1951/1955, SE1952, SE1953]	Defra(Department for Environment, Food & Rural Affairs (DEFRA))	The UK government supported these projects through the following Defra approved grants: SE1851, SE1948, SE1949, SE1951/1955, SE1952 and SE1953. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoletti O, 2006, J GEN VIROL, V87, P1043, DOI 10.1099/vir.0.81318-0; Bencsik A, 2007, J INFECT DIS, V195, P989, DOI 10.1086/512087; Benestad SL, 2003, VET REC, V153, P202, DOI 10.1136/vr.153.7.202; Benestad SL, 2008, VET RES, V39, DOI 10.1051/vetres:2007056; Brun A, 2004, NEUROSCI RES, V48, P75, DOI 10.1016/j.neures.2003.09.004; Chianini F, 2013, VET IMMUNOL IMMUNOP, V152, P348, DOI 10.1016/j.vetimm.2013.01.005; Choi JK, 2006, HYBRIDOMA, V25, P271, DOI 10.1089/hyb.2006.25.271; Eaton SL, 2007, J GEN VIROL, V88, P1384, DOI 10.1099/vir.0.82197-0; Elsen JM, 1999, ARCH VIROL, V144, P431, DOI 10.1007/s007050050516; Goldmann W, 2008, VET RES, V39, DOI 10.1051/vetres:2008010; Gonzalez L, 2006, VET REC, V158, P325, DOI 10.1136/vr.158.10.325; Gonzalez L, 2005, J GEN VIROL, V86, P827, DOI 10.1099/vir.0.80299-0; Gonzalez L, 2013, J COMP PATH IN PRESS, DOI DOI 10.1016/J.JCPA.2013.10.00); Gonzalez L, 2013, J COMP PATH IN PRESS, DOI DOI 10.1016/J.JCPA.2013.06.006); Gonzalez L, 2007, J GEN VIROL, V88, P714, DOI 10.1099/vir.0.82426-0; Gonzalez L, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-55; Gonzalez L, 2012, J GEN VIROL, V93, P203, DOI 10.1099/vir.0.034652-0; Groschup MH, 2007, EMERG INFECT DIS, V13, P1201, DOI 10.3201/eid1308.070077; IKEDA T, 1995, J GEN VIROL, V76, P2577, DOI 10.1099/0022-1317-76-10-2577; Jacobs JG, 2011, J VIROL, V85, P12537, DOI 10.1128/JVI.00448-11; Jeffrey M, 2006, J PATHOL, V209, P4, DOI 10.1002/path.1962; Jeffrey M, 2006, J COMP PATHOL, V134, P17, DOI 10.1016/j.jcpa.2005.06.005; Jeffrey M, 2004, CURR TOP MICROBIOL, V284, P65; Jeffrey M, 2002, J COMP PATHOL, V127, P264, DOI 10.1053/jcpa.2002.0592; Jeffrey M, 2001, J COMP PATHOL, V125, P48, DOI 10.1053/jcpa.2001.0476; McIntyre KM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003994; Ryder SJ, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-9; Siso S, 2012, PRION, V6, P174, DOI 10.4161/pri.18990; Spraker TR, 2002, J VET DIAGN INVEST, V14, P3, DOI 10.1177/104063870201400102; Stack M, 2009, J GEN VIROL, V90, P764, DOI 10.1099/vir.0.005983-0; Thuring CMA, 2005, J COMP PATHOL, V132, P59, DOI 10.1016/j.jcpa.2004.06.004; Tongue SC, 2006, VET REC, V158, P43, DOI 10.1136/vr.158.2.43	32	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91026	10.1371/journal.pone.0091026	http://dx.doi.org/10.1371/journal.pone.0091026			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614120	Green Submitted, Green Published, gold			2022-12-25	WOS:000332839300067
J	Lim, JS; Park, YH; Jang, JW; Park, SY; Kim, S				Lim, Jae-Sung; Park, Young Ho; Jang, Jae-Won; Park, So Yong; Kim, SangYun		Alzheimers Dis Neuroimaging	Differential White Matter Connectivity in Early Mild Cognitive Impairment According to CSF Biomarkers	PLOS ONE			English	Article							ALZHEIMERS ASSOCIATION WORKGROUPS; CEREBROSPINAL-FLUID; DIAGNOSTIC GUIDELINES; PHOSPHORYLATED TAU; NATIONAL INSTITUTE; DISEASE; RECOMMENDATIONS; A-BETA(1-42); INTEGRITY; DEMENTIA	Mild cognitive impairment (MCI) is a heterogeneous group and certain MCI subsets eventually convert to dementia. Cerebrospinal fluid (CSF) biomarkers are known to predict this conversion. We sought evidence for the differences in white matter connectivity between early amnestic MCI (EMCI) subgroups according to a CSF phosphorylated tau(181p)/amyloid beta(1-42) ratio of 0.10. From the Alzheimer's Disease Neuroimaging Initiative database, 16 high-ratio, 25 low-ratio EMCI patients, and 20 normal controls with diffusion tensor images and CSF profiles were included. Compared to the high-ratio group, radial diffusivity significantly increased in both sides of the corpus callosum and the superior and inferior longitudinal fasciculus in the low-ratio group. In widespread white matter skeleton regions, the low-ratio group showed significantly increased mean, axial, and radial diffusivity compared to normal controls. However, the high-ratio group showed no differences when compared to the normal group. In conclusion, our study revealed that there were significant differences in white matter connectivity between EMCI subgroups according to CSF phosphorylated tau(181p)/amyloid beta(1-42) ratios.	[Lim, Jae-Sung] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Neurol, Seoul, South Korea; [Park, Young Ho; Jang, Jae-Won; Park, So Yong; Kim, SangYun] Seoul Natl Univ, Bundang Hosp, Clin Neurosci Ctr, Songnam, South Korea; [Lim, Jae-Sung; Park, Young Ho; Jang, Jae-Won; Park, So Yong; Kim, SangYun] Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kim, S (corresponding author), Seoul Natl Univ, Bundang Hosp, Clin Neurosci Ctr, Songnam, South Korea.	neuroksy@snu.ac.kr	Lim, Jae-Sung/D-5555-2012	Lim, Jae-Sung/0000-0001-6157-2908	Alzheimer's Disease Neuroimaging Initiative (ADNI) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; NATIONAL INSTITUTE ON AGING [U01AG024904] Funding Source: NIH RePORTER	Alzheimer's Disease Neuroimaging Initiative (ADNI); DOD ADNI (Department of Defense); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADNI, 2011, ADNI GO PROC MAN, P83; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Albin RL, 2013, J NUCL MED, V54, P887, DOI 10.2967/jnumed.112.112599; Amlien IK, 2013, RADIOLOGY, V266, P295, DOI 10.1148/radiol.12120319; Arenaza-Urquijo EM, 2011, AM J GERIAT PSYCHIAT, V19, P33, DOI 10.1097/JGP.0b013e3181e448e1; Benitez A, 2014, NEUROIMAGE-CLIN, V4, P64, DOI 10.1016/j.nicl.2013.11.001; Bozzali M, 2011, NEUROIMAGE, V54, P2045, DOI 10.1016/j.neuroimage.2010.08.069; Buchhave P, 2012, ARCH GEN PSYCHIAT, V69, P98, DOI 10.1001/archgenpsychiatry.2011.155; Chetelat G, 2013, NAT REV NEUROL, V9, P123, DOI [10.1038/nrneurol.2013.21, 10.1038/nrneurol.2013.21-c2]; Chiang GC, 2012, AM J NEURORADIOL, V33, P1392, DOI 10.3174/ajnr.A2984; Chua TC, 2008, CURR OPIN NEUROL, V21, P83, DOI 10.1097/WCO.0b013e3282f4594b; Clerx L, 2012, J ALZHEIMERS DIS, V29, P405, DOI 10.3233/JAD-2011-110797; Dimitra S, 2013, ACTA NEUROL BELG, V113, P441, DOI 10.1007/s13760-013-0197-3; Esposito R, 2013, PEERJ, V1, DOI 10.7717/peerj.135; Fieremans E, 2013, AM J NEURORADIOL, V34, P2105, DOI 10.3174/ajnr.A3553; Fischer P, 2007, NEUROLOGY, V68, P288, DOI 10.1212/01.wnl.0000252358.03285.9d; Hampel H, 2003, BRAIN RES BULL, V61, P243, DOI 10.1016/S0361-9230(03)00087-X; Jack CR, 2012, ANN NEUROL, V71, P765, DOI 10.1002/ana.22628; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Knopman DS, 2013, ANN NEUROL, V73, P472, DOI 10.1002/ana.23816; Landau SM, 2013, ANN NEUROL, V74, P826, DOI 10.1002/ana.23908; Lehmann M, 2013, BRAIN, V136, P844, DOI 10.1093/brain/aws327; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nir TM, 2013, NEUROIMAGE-CLIN, V3, P180, DOI 10.1016/j.nicl.2013.07.006; O'Dwyer L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021745; Parnetti L, 2012, J ALZHEIMERS DIS, V29, P229, DOI 10.3233/JAD-2011-111349; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Pievani M, 2011, LANCET NEUROL, V10, P829, DOI 10.1016/S1474-4422(11)70158-2; Sexton CE, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.019; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sjogren M, 2001, CLIN CHEM, V47, P1776; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Thillainadesan S, 2012, INT PSYCHOGERIATR, V24, P1483, DOI 10.1017/S1041610212000270; Weiner MW, 2010, ALZHEIMERS DEMENT, V6, P202, DOI 10.1016/j.jalz.2010.03.007; Zhuang L, 2010, NEUROIMAGE, V53, P16, DOI 10.1016/j.neuroimage.2010.05.068	38	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91400	10.1371/journal.pone.0091400	http://dx.doi.org/10.1371/journal.pone.0091400			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614676	Green Submitted, gold, Green Published			2022-12-25	WOS:000332839300119
J	Mocevic, E; Svendsen, SW; Jorgensen, KT; Frost, P; Bonde, JP				Mocevic, Emina; Svendsen, Susanne Wulff; Jorgensen, Kristian Tore; Frost, Poul; Bonde, Jens Peter			Occupational Lifting, Fetal Death and Preterm Birth: Findings from the Danish National Birth Cohort Using a Job Exposure Matrix	PLOS ONE			English	Article							WORKING HOURS; PHYSICAL-ACTIVITIES; RISK; PREGNANCY; PREECLAMPSIA; PREMATURITY; DELIVERY; WEIGHT	Objective: We examined the association between occupational lifting during pregnancy and risk of fetal death and preterm birth using a job exposure matrix (JEM). Methods: For 68,086 occupationally active women in the Danish National Birth Cohort, interview information on occupational lifting was collected around gestational week 16. We established a JEM based on information from women, who were still pregnant when interviewed. The JEM provided mean total loads lifted per day within homogeneous exposure groups as informed by job and industry codes. All women were assigned an exposure estimate from the JEM. We used Cox regression models with gestational age as underlying time variable and adjustment for covariates. Results: We observed 2,717 fetal deaths and 3,128 preterm births within the study cohort. No exposure-response relation was observed for fetal death, but for women with a prior fetal death, we found a hazard ratio (HR) of 2.87 (95% CI 1.37, 6.01) for stillbirth (fetal death >= 22 completed gestational weeks) among those who lifted >200 kg/day. For preterm birth, we found an exposure-response relation for primigravid women, reaching a HR of 1.43 (95% CI 1.13, 1.80) for total loads >200 kg per day. These findings correspond to an excess fraction of 11% for stillbirth and 10% for preterm birth. Conclusion: We found an increased risk of stillbirth among women with a prior fetal death, who lifted >200 kg/day, and an exposure-response relationship between occupational lifting and preterm birth among primigravid women. The study adds to a large body of prospective studies on occupational lifting and adverse pregnancy outcomes by refined exposure assessment.	[Mocevic, Emina; Jorgensen, Kristian Tore; Bonde, Jens Peter] Univ Copenhagen, Bispebjerg Hosp, Dept Occupat & Environm Med, Copenhagen, Denmark; [Svendsen, Susanne Wulff] Herning Reg Hosp, Univ Dept Occupat Med, Danish Ramazzini Ctr, Herning, Denmark; [Frost, Poul] Aarhus Univ Hosp, Danish Ramazzini Ctr, Dept Occupat Med, DK-8000 Aarhus, Denmark	Aarhus University; University of Copenhagen; Bispebjerg Hospital; Aarhus University; Aarhus University	Mocevic, E (corresponding author), Univ Copenhagen, Bispebjerg Hosp, Dept Occupat & Environm Med, Copenhagen, Denmark.	emina.mocevic.01@regionh.dk			Danish Working Environment Research Fund [20080016458]	Danish Working Environment Research Fund	This study is part of the Danish collaborative MINERVA project addressing occupational risk to human reproduction, which is supported by a grant from the Danish Working Environment Research Fund (contract 20080016458). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLBORG G, 1990, INT J EPIDEMIOL, V19, P90, DOI 10.1093/ije/19.1.90; Andersen AMN, 2000, BRIT MED J, V320, P1708, DOI 10.1136/bmj.320.7251.1708; Armstrong BG, 1998, OCCUP ENVIRON MED, V55, P651, DOI 10.1136/oem.55.10.651; Bonde JP, 2013, SCAND J WORK ENV HEA, V39, P325, DOI 10.5271/sjweh.3337; Bonzini M, 2009, OCCUP ENVIRON MED, V66, P685, DOI 10.1136/oem.2008.043935; Bonzini M, 2007, OCCUP ENVIRON MED, V64, P228, DOI 10.1136/oem.2006.026872; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Burdorf A, 2011, OCCUP ENVIRON MED, V68, P197, DOI 10.1136/oem.2009.046516; Fenster L, 1997, EPIDEMIOLOGY, V8, P66, DOI 10.1097/00001648-199701000-00011; FLORACK EIM, 1993, INT J EPIDEMIOL, V22, P878, DOI 10.1093/ije/22.5.878; Henderson JJ, 2012, J MATERN-FETAL NEO M, V25, P642, DOI 10.3109/14767058.2011.597899; Juhl M, 2013, SCAND J WORK ENV HEA, V39, P335, DOI 10.5271/sjweh.3335; Langhoff-Roos J, 2006, BMJ-BRIT MED J, V332, P937, DOI 10.1136/bmj.38751.524132.2F; Lawson CC, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.006; Lohse Sarah Rytter, 2010, Clin Epidemiol, V2, P247, DOI 10.2147/CLEP.S13815; Nugteren JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039263; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Palmer KT, 2013, OCCUP ENVIRON MED, V70, P213, DOI 10.1136/oemed-2012-101032; Runge SB, 2013, OCCUP ENVIRON MED, V70, P782, DOI 10.1136/oemed-2012-101173; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; SAURELCUBIZOLLES MJ, 1991, J EPIDEMIOL COMMUN H, V45, P29, DOI 10.1136/jech.45.1.29; Snijder CA, 2012, OCCUP ENVIRON MED, V69, P543, DOI 10.1136/oemed-2011-100615; Wilcox AJ., 2010, FERTILITY PREGNANCY	23	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90550	10.1371/journal.pone.0090550	http://dx.doi.org/10.1371/journal.pone.0090550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614129	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300029
J	Tseng, HY; Lin, CP; Hsu, JY; Pike, DA; Huang, WS				Tseng, Hui-Yun; Lin, Chung-Ping; Hsu, Jung-Ya; Pike, David A.; Huang, Wen-San			The Functional Significance of Aposematic Signals: Geographic Variation in the Responses of Widespread Lizard Predators to Colourful Invertebrate Prey	PLOS ONE			English	Article							BATESIAN MIMICRY; SEXUAL DICHROMATISM; NATURAL-SELECTION; WARNING SIGNALS; AVIAN PREDATORS; BIRD PREDATORS; AVOIDANCE; PATTERNS; COLORATION; BEETLES	Conspicuous colouration can evolve as a primary defence mechanism that advertises unprofitability and discourages predatory attacks. Geographic overlap is a primary determinant of whether individual predators encounter, and thus learn to avoid, such aposematic prey. We experimentally tested whether the conspicuous colouration displayed by Old World pachyrhynchid weevils (Pachyrhynchus tobafolius and Kashotonus multipunctatus) deters predation by visual predators (Swinhoe's tree lizard; Agamidae, Japalura swinhonis). During staged encounters, sympatric lizards attacked weevils without conspicuous patterns at higher rates than weevils with intact conspicuous patterns, whereas allopatric lizards attacked weevils with intact patterns at higher rates than sympatric lizards. Sympatric lizards also attacked masked weevils at lower rates, suggesting that other attributes of the weevils (size/shape/smell) also facilitate recognition. Allopatric lizards rapidly learned to avoid weevils after only a single encounter, and maintained aversive behaviours for more than three weeks. The imperfect ability of visual predators to recognize potential prey as unpalatable, both in the presence and absence of the aposematic signal, may help explain how diverse forms of mimicry exploit the predator's visual system to deter predation.	[Tseng, Hui-Yun; Lin, Chung-Ping] Tunghai Univ, Dept Life Sci, Taichung, Taiwan; [Tseng, Hui-Yun; Hsu, Jung-Ya; Huang, Wen-San] Natl Museum Nat Sci, Dept Biol, Taichung, Taiwan; [Lin, Chung-Ping] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Pike, David A.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Pike, David A.] James Cook Univ, Ctr Trop Environm & Sustainabil Sci, Townsville, Qld 4811, Australia; [Huang, Wen-San] Natl Chung Hsing Univ, Dept Life Sci, Taichung, Taiwan	Tunghai University; National Taiwan Normal University; James Cook University; James Cook University; National Chung Hsing University	Lin, CP (corresponding author), Tunghai Univ, Dept Life Sci, Taichung, Taiwan.	treehops@thu.edu.tw; wshuang@mail.nmns.edu.tw	Pike, David A/B-2032-2012	Huang, Wen-San/0000-0003-0073-3557	National Science Council of Taiwan, Taiwan [NSC 99-2621-B-178-001-MY3, NSC 100-2311-B-029-004-MY3]	National Science Council of Taiwan, Taiwan(Ministry of Science and Technology, Taiwan)	This paper is supported by the National Science Council of Taiwan (NSC 99-2621-B-178-001-MY3 and NSC 100-2311-B-029-004-MY3), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrou MA, 2011, NATURE, V469, P84, DOI 10.1038/nature09660; Aronsson M, 2012, ANIM BEHAV, V84, P881, DOI 10.1016/j.anbehav.2012.07.011; Borer M, 2010, EVOLUTION, V64, P3629, DOI 10.1111/j.1558-5646.2010.01137.x; Chouteau M, 2011, AM NAT, V178, P810, DOI 10.1086/662667; Cogliati KM, 2010, ETHOLOGY, V116, P416, DOI 10.1111/j.1439-0310.2010.01755.x; COOPER WE, 1989, COPEIA, P472, DOI 10.2307/1445446; COOPER WE, 1994, ETHOLOGY, V97, P317; Dolenska M, 2009, BIOL J LINN SOC, V98, P234, DOI 10.1111/j.1095-8312.2009.01277.x; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; Endler JA, 2009, AM NAT, V173, pE62, DOI 10.1086/596528; Exnerova A, 2007, BEHAV ECOL, V18, P148, DOI 10.1093/beheco/arl061; Finkbeiner SD, 2012, P ROY SOC B-BIOL SCI, V279, P2769, DOI 10.1098/rspb.2012.0203; Gamberale-Stille G, 1999, EVOL ECOL, V13, P579, DOI 10.1023/A:1006741626575; GITTLEMAN JL, 1980, NATURE, V286, P149, DOI 10.1038/286149a0; Ham AD, 2006, BEHAV ECOL SOCIOBIOL, V60, P482, DOI 10.1007/s00265-006-0190-4; HASEGAWA M, 1994, J ETHOL, V12, P9, DOI 10.1007/BF02350074; Heiling AM, 2003, NATURE, V421, P334, DOI 10.1038/421334a; Holloway G.J., 1991, Chemoecology, V2, P7, DOI 10.1007/BF01240660; Huang WS, 2007, ZOOL SCI, V24, P181, DOI 10.2108/zsj.24.181; Hunter JS, 2009, BEHAV ECOL, V20, P1315, DOI 10.1093/beheco/arp144; JEFFORDS MR, 1979, EVOLUTION, V33, P275, DOI 10.1111/j.1558-5646.1979.tb04681.x; KANEHISA K, 1977, Applied Entomology and Zoology, V12, P225; Kapan DD, 2001, NATURE, V409, P338, DOI 10.1038/35053066; Kikuchi DW, 2010, AM NAT, V176, P830, DOI 10.1086/657041; Kodric-Brown A, 1998, AM ZOOL, V38, P70; Kuchta SR, 2008, EVOLUTION, V62, P984, DOI 10.1111/j.1558-5646.2008.00338.x; Langham GM, 2004, EVOLUTION, V58, P2783; Lindstedt C, 2008, ANIM BEHAV, V75, P1703, DOI 10.1016/j.anbehav.2007.10.024; LINSLEY EG, 1959, ANNU REV ENTOMOL, V4, P99, DOI 10.1146/annurev.en.04.010159.000531; Lynn SK, 2005, ANIM BEHAV, V70, P1221, DOI 10.1016/j.anbehav.2005.03.010; Maan ME, 2012, AM NAT, V179, pE1, DOI 10.1086/663197; Mallet J, 1999, ANNU REV ECOL SYST, V30, P201, DOI 10.1146/annurev.ecolsys.30.1.201; Marples NM, 1998, OIKOS, V83, P161, DOI 10.2307/3546557; Merrill RM, 2012, P ROY SOC B-BIOL SCI, V279, P4907, DOI 10.1098/rspb.2012.1968; Noonan BP, 2009, BIOL LETTERS, V5, P51, DOI 10.1098/rsbl.2008.0586; PASTEELS JM, 1983, ANNU REV ENTOMOL, V28, P263, DOI 10.1146/annurev.en.28.010183.001403; Pekar S, 2011, INVERTEBR BIOL, V130, P83, DOI 10.1111/j.1744-7410.2010.00217.x; Pfennig DW, 2001, NATURE, V410, P323, DOI 10.1038/35066628; Prudic KL, 2007, BEHAV ECOL, V18, P41, DOI 10.1093/beheco/arl046; REICHSTE.T, 1968, SCIENCE, V161, P861, DOI 10.1126/science.161.3844.861; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Saporito RA, 2007, COPEIA, P1006, DOI 10.1643/0045-8511(2007)7[1006:EEFAIT]2.0.CO;2; Schultze W., 1923, Philippine Journal of Science, V23, P609; Seago AE, 2009, J R SOC INTERFACE, V6, pS165, DOI 10.1098/rsif.2008.0354.focus; Shen T-J, 2009, ROLES CHEM VISUAL SE; Siddall EC, 2008, BEHAV ECOL, V19, P425, DOI 10.1093/beheco/arm155; SILLENTULLBERG B, 1985, OECOLOGIA, V67, P411, DOI 10.1007/BF00384948; SMITH SM, 1977, NATURE, V265, P535, DOI 10.1038/265535a0; Speed MP, 2000, ANIM BEHAV, V60, P269, DOI 10.1006/anbe.2000.1430; Starr Christopher K., 1992, Journal of Taiwan Museum, V45, P5; Svadova K, 2009, ANIM BEHAV, V77, P327, DOI 10.1016/j.anbehav.2008.09.034; TERRICK TD, 1995, ANIM BEHAV, V49, P857, DOI 10.1006/anbe.1995.0118; Tso IM, 2006, BEHAV ECOL, V17, P606, DOI 10.1093/beheco/ark010; Valkonen JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022272; Vesely P, 2013, ETHOLOGY, V119, P138, DOI 10.1111/eth.12045; Vitt L. J., 2013, HERPETOLOGY INTRO BI; Wallace A. R., 1895, NATURAL SELECTION TR; Wallace AR, 1889, DARWINISM; Welch V, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.041919	59	30	32	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91777	10.1371/journal.pone.0091777	http://dx.doi.org/10.1371/journal.pone.0091777			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614681	gold, Green Published, Green Accepted			2022-12-25	WOS:000332839300158
J	Uzer, G; Pongkitwitoon, S; Ian, C; Thompson, WR; Rubin, J; Chan, ME; Judex, S				Uzer, Gunes; Pongkitwitoon, Suphannee; Ian, Cheng; Thompson, William R.; Rubin, Janet; Chan, Meilin E.; Judex, Stefan			Gap Junctional Communication in Osteocytes Is Amplified by Low Intensity Vibrations In Vitro	PLOS ONE			English	Article							FLUID SHEAR-STRESS; MESENCHYMAL STEM-CELLS; HIGH-FREQUENCY VIBRATION; BONE-CELLS; OSTEOBLASTIC CELLS; MECHANICAL-STRESS; TRABECULAR BONE; LOW-MAGNITUDE; INTERCELLULAR COMMUNICATION; CONNEXIN-43 HEMICHANNELS	The physical mechanism by which cells sense high-frequency mechanical signals of small magnitude is unknown. During exposure to vibrations, cell populations within a bone are subjected not only to acceleratory motions but also to fluid shear as a result of fluid-cell interactions. We explored displacements of the cell nucleus during exposure to vibrations with a finite element (FE) model and tested in vitro whether vibrations can affect osteocyte communication independent of fluid shear. Osteocyte like MLO-Y4 cells were subjected to vibrations at acceleration magnitudes of 0.15 g and 1 g and frequencies of 30 Hz and 100 Hz. Gap junctional intracellular communication (GJIC) in response to these four individual vibration regimes was investigated. The FE model demonstrated that vibration induced dynamic accelerations caused larger relative nuclear displacement than fluid shear. Across the four regimes, vibrations significantly increased GJIC between osteocytes by 25%. Enhanced GJIC was independent of vibration induced fluid shear; there were no differences in GJIC between the four different vibration regimes even though differences in fluid shear generated by the four regimes varied 23-fold. Vibration induced increases in GJIC were not associated with altered connexin 43 (Cx43) mRNA or protein levels, but were dependent on Akt activation. Combined, the in silico and in vitro experiments suggest that externally applied vibrations caused nuclear motions and that large differences in fluid shear did not influence nuclear motion (<1%) or GJIC, perhaps indicating that vibration induced nuclear motions may directly increase GJIC. Whether the increase in GJIC is instrumental in modulating anabolic and anti-catabolic processes associated with the application of vibrations remains to be determined.	[Uzer, Gunes; Pongkitwitoon, Suphannee; Ian, Cheng; Chan, Meilin E.; Judex, Stefan] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA; [Uzer, Gunes; Thompson, William R.; Rubin, Janet] Univ N Carolina, Dept Med, Chapel Hill, NC USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of North Carolina; University of North Carolina Chapel Hill	Judex, S (corresponding author), SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.	stefan.judex@stonybrook.edu	Thompson, William R./B-2658-2009	Thompson, William R./0000-0002-7022-585X; Uzer, Gunes/0000-0002-1178-4942	NIBIB (NIH); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR064133] Funding Source: NIH RePORTER	NIBIB (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was kindly funded by NIBIB (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai ZW, 2000, J CLIN INVEST, V105, P161, DOI 10.1172/JCI7798; Ajubi NE, 1999, AM J PHYSIOL-ENDOC M, V276, pE171, DOI 10.1152/ajpendo.1999.276.1.E171; Alford AI, 2003, BONE, V33, P64, DOI 10.1016/S8756-3282(03)00167-4; Bacabac RG, 2004, BIOCHEM BIOPH RES CO, V315, P823, DOI 10.1016/j.bbrc.2004.01.138; Bacabac RG, 2006, FASEB J, V20, P858, DOI 10.1096/fj.05-4966.com; Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599; Batra N, 2012, BBA-BIOMEMBRANES, V1818, P1909, DOI 10.1016/j.bbamem.2011.09.018; Batra N, 2012, P NATL ACAD SCI USA, V109, P3359, DOI 10.1073/pnas.1115967109; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Case N, 2008, J BIOL CHEM, V283, P29196, DOI 10.1074/jbc.M801907200; Chan ME, 2009, CELL MOL BIOENG, V2, P405, DOI 10.1007/s12195-009-0075-5; Cheng BX, 2001, J BONE MINER RES, V16, P249, DOI 10.1359/jbmr.2001.16.2.249; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; Cherian PP, 2003, J BIOL CHEM, V278, P43146, DOI 10.1074/jbc.M302993200; CIVITELLI R, 1993, J CLIN INVEST, V91, P1888, DOI 10.1172/JCI116406; Coughlin TR, 2012, J BIOMECH, V45, P2222, DOI 10.1016/j.jbiomech.2012.06.020; Darling EM, 2008, J BIOMECH, V41, P454, DOI 10.1016/j.jbiomech.2007.06.019; DICK DAT, 1970, J PHYSIOL-LONDON, V210, P305, DOI 10.1113/jphysiol.1970.sp009212; Dickerson DA, 2008, BIOMECH MODEL MECHAN, V7, P191, DOI 10.1007/s10237-007-0085-y; Garman R, 2007, J ORTHOP RES, V25, P732, DOI 10.1002/jor.20354; Genetos DC, 2007, J CELL PHYSIOL, V212, P207, DOI 10.1002/jcp.21021; Gouw TH, 1966, FETT WISS TECHNOL, V68, P544, DOI [10.1002/lipi.19660680705, DOI 10.1002/LIPI.19660680705]; Grimston SK, 2006, ANN NY ACAD SCI, V1068, P214, DOI 10.1196/annals.1346.023; Guilak F, 2000, BIOCHEM BIOPH RES CO, V269, P781, DOI 10.1006/bbrc.2000.2360; Heinrich V, 1996, ANN BIOMED ENG, V24, P595, DOI 10.1007/BF02684228; Hu SH, 2005, BIOCHEM BIOPH RES CO, V329, P423, DOI 10.1016/j.bbrc.2005.02.026; Ilvesaro J, 2000, J BONE MINER RES, V15, P919, DOI 10.1359/jbmr.2000.15.5.919; Ishihara Y, 2008, J BONE MINER RES, V23, P350, DOI 10.1359/JBMR.071102; Jiang JX, 2007, FRONT BIOSCI-LANDMRK, V12, P1450, DOI 10.2741/2159; JONES SJ, 1993, ANAT EMBRYOL, V187, P343; Judex S, 2007, J BIOMECH, V40, P1333, DOI 10.1016/j.jbiomech.2006.05.014; Kamioka H, 2007, MICROSC MICROANAL, V13, P108, DOI 10.1017/S143192760707016X; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Klein-Nulend Jenneke, 2003, Curr Osteoporos Rep, V1, P5; KLEINNULEND J, 1995, FASEB J, V9, P441, DOI 10.1096/fasebj.9.5.7896017; Lau E, 2010, BONE, V46, P1508, DOI 10.1016/j.bone.2010.02.031; Li Z, 1999, BONE, V25, P661, DOI 10.1016/S8756-3282(99)00227-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloyd SA, 2013, J BONE MINERAL RES; Loiselle AE, 2013, J ORTHOP RES, V31, P147, DOI 10.1002/jor.22178; McGarry JG, 2004, FASEB J, V18, P482, DOI 10.1096/fj.04-2210fje; Nomura S, 2000, MATRIX BIOL, V19, P91, DOI 10.1016/S0945-053X(00)00050-0; Ozcivici E, 2007, J BIOMECH, V40, P3404, DOI 10.1016/j.jbiomech.2007.05.015; Ozcivici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011178; Patel MJ, 2009, J CELL BIOCHEM, V106, P306, DOI 10.1002/jcb.22007; Rangaswami H, 2012, J BIOL CHEM, V287, P21509, DOI 10.1074/jbc.M112.347245; Riddle RC, 2009, J ORTHOP RES, V27, P143, DOI 10.1002/jor.20723; Saunders MM, 2001, AM J PHYSIOL-CELL PH, V281, pC1917, DOI 10.1152/ajpcell.2001.281.6.C1917; Schiller PC, 2001, BONE, V28, P362, DOI 10.1016/S8756-3282(00)00458-0; SCHIRRMACHER K, 1992, CALCIFIED TISSUE INT, V51, P285, DOI 10.1007/BF00334489; Sen B, 2013, J BONE MINERAL RES; Sen B, 2011, STEM CELLS, V29, P1829, DOI 10.1002/stem.732; Sen B, 2011, J BIOMECH, V44, P593, DOI 10.1016/j.jbiomech.2010.11.022; Shafrir Y, 2002, AM J PHYSIOL-CELL PH, V282, pC479, DOI 10.1152/ajpcell.00394.2001; Simon AM, 1997, NATURE, V385, P525, DOI 10.1038/385525a0; Sugawara Y, 2008, BONE, V43, P19, DOI 10.1016/j.bone.2008.02.020; Sugawara Y, 2011, CALCIFIED TISSUE INT, V88, P416, DOI 10.1007/s00223-011-9471-7; Tanaka SM, 2003, J BIOMECH, V36, P73, DOI 10.1016/S0021-9290(02)00245-2; Taylor AF, 2007, AM J PHYSIOL-CELL PH, V292, pC545, DOI 10.1152/ajpcell.00611.2005; Thompson WR, 2013, STEM CELLS, V31, P2528, DOI 10.1002/stem.1476; Tirkkonen L, 2011, J R SOC INTERFACE, V8, P1736, DOI 10.1098/rsif.2011.0211; Turner CH, 2002, CALCIFIED TISSUE INT, V70, P435, DOI 10.1007/s00223-001-1024-z; Uzer G, 2013, J BIOMECH, V46, P2296, DOI 10.1016/j.jbiomech.2013.06.008; Uzer G, 2012, CELL MOL BIOENG, V5, P266, DOI 10.1007/s12195-012-0231-1; Verbruggen SW, 2012, J R SOC INTERFACE, V9, P2735, DOI 10.1098/rsif.2012.0286; Watabe H, 2011, EXP CELL RES, V317, P2642, DOI 10.1016/j.yexcr.2011.07.015; Xia XC, 2010, MOL CELL BIOL, V30, P206, DOI 10.1128/MCB.01844-08; Yellowley CE, 2000, J BONE MINER RES, V15, P209, DOI 10.1359/jbmr.2000.15.2.209; You J, 2000, J BIOMECH ENG-T ASME, V122, P387, DOI 10.1115/1.1287161; Ziambaras K, 1998, J BONE MINER RES, V13, P218, DOI 10.1359/jbmr.1998.13.2.218	71	37	39	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90840	10.1371/journal.pone.0090840	http://dx.doi.org/10.1371/journal.pone.0090840			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614887	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300044
J	Lai, MS; Cheng, YS; Chen, PR; Tsai, SJ; Huang, BM				Lai, Meng-Shao; Cheng, Yu-Sheng; Chen, Pei-Rong; Tsai, Shaw-Jenq; Huang, Bu-Miin			Fibroblast Growth Factor 9 Activates Akt and MAPK Pathways to Stimulate Steroidogenesis in Mouse Leydig Cells	PLOS ONE			English	Article							HUMAN GLIOMA-CELLS; REGULATES STEROIDOGENESIS; FACTOR RECEPTORS; KINASE PATHWAYS; LUNG-CANCER; TUMOR-CELLS; EXPRESSION; BOVINE; DIFFERENTIATION; SB202190	Fibroblast growth factor 9 (FGF9) is a multifunctional polypeptide belonging to the FGF family and has functions related to bone formation, lens-fiber differentiation, nerve development, gap-junction formation and sex determination. In a previous study, we demonstrated that FGF9 stimulates the production of testosterone in mouse Leydig cells. In the present study, we used both primary mouse Leydig cells and MA-10 mouse Leydig tumor cells to further investigate the molecular mechanism of FGF9-stimulated steroidogenesis. Results showed that FGF9 significantly activated steroidogenesis in both mouse primary and tumor Leydig cells (p<0.05). Furthermore, FGF9 significantly induced the expression of phospho-Akt at 0.5 and 24 hr, phospho-JNK at 0.25, 0.5, and 24 hr, phospho-p38 at 0.5 hr, and phospho-ERK1/2 from 0.25 to 24 hr in primary Leydig cells (p<0.05). Also, FGF9 significantly up-regulated the expression of phospho-Akt at 3 hr, phospho-JNK at 0.25 hr, and phospho-ERK1/2 at 1 and 3 hr in MA-10 cells (p<0.05). Using specific inhibitors of Akt, JNK, p38, and ERK1/2, we further demonstrated that the inhibitors of Akt and ERK1/2 significantly suppressed the stimulatory effect of FGF9 on steroidogenesis in mouse Leydig cells. In conclusion, FGF9 specifically activated the Akt and ERK1/2 in normal mouse Leydig cells and the Akt, JNK and ERK1/2 in MA-10 mouse Leydig tumor cells to stimulate steroidogenesis.	[Lai, Meng-Shao; Huang, Bu-Miin] Natl Cheng Kung Univ, Coll Med, Inst Basic Med, Tainan 70101, Taiwan; [Lai, Meng-Shao; Chen, Pei-Rong; Huang, Bu-Miin] Natl Cheng Kung Univ, Coll Med, Dept Cell Biol & Anat, Tainan 70101, Taiwan; [Cheng, Yu-Sheng] Natl Cheng Kung Univ Hosp, Douliou Branch, Dept Urol, Yunlin, Taiwan; [Tsai, Shaw-Jenq] Natl Cheng Kung Univ, Coll Med, Dept Physiol, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Huang, BM (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Basic Med, Tainan 70101, Taiwan.	bumiin@mail.ncku.edu.tw	Tsai, Shaw-Jenq/AAG-6569-2019	TSAI, SHAW-JENQ/0000-0002-3569-5813	National Science Council Grants of Taiwan, Republic of China [NSC101-2320-B-006-005-MY3]; National Cheng Kung University Hospital Grant [NCKUH-10205009]	National Science Council Grants of Taiwan, Republic of China; National Cheng Kung University Hospital Grant	This work was supported by National Science Council Grants of Taiwan, Republic of China (NSC101-2320-B-006-005-MY3) and National Cheng Kung University Hospital Grant (NCKUH-10205009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SW, 2013, J BIOL CHEM, V288, P15937, DOI 10.1074/jbc.M113.451773; ASCOLI M, 1981, ENDOCRINOLOGY, V108, P88, DOI 10.1210/endo-108-1-88; Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; Brion L, 2011, ENDOCRINOLOGY, V152, P2665, DOI 10.1210/en.2011-0021; Chung CL, 2013, FERTIL STER IN PRESS; Coffey E, 2013, J HISTOCHEM CYTOCHEM, V61, P671, DOI 10.1369/0022155413497366; Cohen RI, 2000, J NEUROSCI RES, V61, P273, DOI 10.1002/1097-4547(20000801)61:3<273::AID-JNR5>3.0.CO;2-I; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Falvella FS, 2009, INT J CANCER, V124, P2880, DOI 10.1002/ijc.24302; Guijarro MV, 2012, ONCOGENE, V31, P4447, DOI 10.1038/onc.2011.619; Hirakawa T, 2002, ENDOCRINOLOGY, V143, P1026, DOI 10.1210/en.143.3.1026; Hiramatsu R, 2010, DEVELOPMENT, V137, P303, DOI 10.1242/dev.040519; Hiramatsu R, 2009, DEVELOPMENT, V136, P129, DOI 10.1242/dev.029587; Hirosawa M, 2009, LEUKEMIA RES, V33, P693, DOI 10.1016/j.leukres.2008.09.028; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim JY, 2010, TOXICOL LETT, V193, P200, DOI 10.1016/j.toxlet.2010.01.011; Lin YM, 2010, INT J ANDROL, V33, P545, DOI 10.1111/j.1365-2605.2009.00966.x; Lovicu FJ, 1998, DEVELOPMENT, V125, P3365; Maillard V, 2011, REPRODUCTION, V141, P467, DOI 10.1530/REP-10-0419; Manna Pulak R, 2011, J Signal Transduct, V2011, P821615, DOI 10.1155/2011/821615; Matsui Y, 2007, CANCER RES, V67, P1212, DOI 10.1158/0008-5472.CAN-06-3283; Menon MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023054; MOHAMMADI M, 1991, MOL CELL BIOL, V11, P5068, DOI 10.1128/MCB.11.10.5068; Muniyappa H, 2008, CELL SIGNAL, V20, P675, DOI 10.1016/j.cellsig.2007.12.003; NARUO K, 1993, J BIOL CHEM, V268, P2857; Niederst MJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004652; Norman M, 2012, J CELL SCI, V125, P59, DOI 10.1242/jcs.085803; Pao HY, 2012, J AGR FOOD CHEM, V60, P4905, DOI 10.1021/jf205091b; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Qiao DH, 2013, MOL CELL BIOL, V33, P4408, DOI 10.1128/MCB.00238-13; Reuss B, 2000, GLIA, V30, P231, DOI 10.1002/(SICI)1098-1136(200005)30:3<231::AID-GLIA3>3.3.CO;2-T; Romero I, 2012, ENDOCRINOLOGY, V153, P1593, DOI 10.1210/en.2011-2123; SAEZ JM, 1994, ENDOCR REV, V15, P574, DOI 10.1210/er.15.5.574; Schreiber NB, 2012, J ENDOCRINOL, V215, P167, DOI 10.1530/JOE-12-0293; Schreiber NB, 2012, ENDOCRINOLOGY, V153, P4491, DOI 10.1210/en.2012-1003; Wang Q, 2013, ENDOCRINOLOGY, V154, P956, DOI 10.1210/en.2012-1836; Yao B, 2011, ASIAN J ANDROL, V13, P438, DOI 10.1038/aja.2010.158	40	38	39	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90243	10.1371/journal.pone.0090243	http://dx.doi.org/10.1371/journal.pone.0090243			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603862	Green Published, gold, Green Submitted			2022-12-25	WOS:000332483600035
J	Petri, I; Dumbell, R; Scherbarth, F; Steinlechner, S; Barrett, P				Petri, Ines; Dumbell, Rebecca; Scherbarth, Frank; Steinlechner, Stephan; Barrett, Perry			Effect of Exercise on Photoperiod-Regulated Hypothalamic Gene Expression and Peripheral Hormones in the Seasonal Dwarf Hamster Phodopus sungorus	PLOS ONE			English	Article							MELATONIN-RELATED RECEPTOR; GROWTH-FACTOR 21; BODY-WEIGHT; SIBERIAN HAMSTER; DJUNGARIAN HAMSTER; ARCUATE NUCLEUS; FOOD-INTAKE; SKELETAL-MUSCLE; NEUROPEPTIDE-Y; MESSENGER-RNA	The Siberian hamster (Phodopus sungorus) is a seasonal mammal responding to the annual cycle in photoperiod with anticipatory physiological adaptations. This includes a reduction in food intake and body weight during the autumn in anticipation of seasonally reduced food availability. In the laboratory, short-day induction of body weight loss can be reversed or prevented by voluntary exercise undertaken when a running wheel is introduced into the home cage. The mechanism by which exercise prevents or reverses body weight reduction is unknown, but one hypothesis is a reversal of short-day photoperiod induced gene expression changes in the hypothalamus that underpin body weight regulation. Alternatively, we postulate an exercise-related anabolic effect involving the growth hormone axis. To test these hypotheses we established photoperiod-running wheel experiments of 8 to 16 weeks duration assessing body weight, food intake, organ mass, lean and fat mass by magnetic resonance, circulating hormones FGF21 and insulin and hypothalamic gene expression. In response to running wheel activity, short-day housed hamsters increased body weight. Compared to short-day housed sedentary hamsters the body weight increase was accompanied by higher food intake, maintenance of tissue mass of key organs such as the liver, maintenance of lean and fat mass and hormonal profiles indicative of long day housed hamsters but there was no overall reversal of hypothalamic gene expression regulated by photoperiod. Therefore the mechanism by which activity induces body weight gain is likely to act largely independently of photoperiod regulated gene expression in the hypothalamus.	[Petri, Ines; Scherbarth, Frank; Steinlechner, Stephan] Univ Vet Med, Dept Zool, Hannover, Germany; [Dumbell, Rebecca; Barrett, Perry] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland	University of Veterinary Medicine Hannover, Foundation; University of Aberdeen	Barrett, P (corresponding author), Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland.	P.Barrett@abdn.ac.uk	Steinlechner, Stephan/AAF-5703-2021; Dumbell, Rebecca/AES-7678-2022	Dumbell, Rebecca/0000-0002-8805-3777; Steinlechner, Stephan/0000-0002-9435-3469; Barrett, Perry/0000-0003-3604-2950	Scottish Government; Deutsche Forschunsgemeinschaft (DFG) [Ste 331/8-1]	Scottish Government; Deutsche Forschunsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Scottish Government in the laboratory of PB. Work in the laboratory of SS was supported by a grant from the Deutsche Forschunsgemeinschaft (DFG, Ste 331/8-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam CL, 2000, ENDOCRINOLOGY, V141, P4349, DOI 10.1210/en.141.12.4349; Adams VL, 2006, ENDOCRINOLOGY, V147, P4843, DOI 10.1210/en.2006-0408; Atgie C, 2009, J PHYSIOL BIOCHEM, V65, P377, DOI 10.1007/BF03185933; Barrett P, 2005, ENDOCRINOLOGY, V146, P1930, DOI 10.1210/en.2004-1452; Barrett P, 2009, ENDOCRINOLOGY, V150, P3655, DOI 10.1210/en.2008-1620; Barrett P, 2007, ENDOCRINOLOGY, V148, P3608, DOI 10.1210/en.2007-0316; Barrett P, 2006, J ENDOCRINOL, V191, P687, DOI 10.1677/joe.1.06929; Barrett P, 2012, J PINEAL RES, V52, P376, DOI 10.1111/j.1600-079X.2011.00963.x; Bechtold DA, 2012, CURR BIOL, V22, P70, DOI 10.1016/j.cub.2011.11.043; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bolborea M, 2011, ENDOCRINOLOGY, V152, P3871, DOI 10.1210/en.2011-1039; BORER KT, 1978, AM J PHYSIOL, V234, pE611, DOI 10.1152/ajpendo.1978.234.6.E611; BORER KT, 1986, ENDOCRINOLOGY, V118, P844, DOI 10.1210/endo-118-2-844; BORER KT, 1983, BIOL REPROD, V29, P38, DOI 10.1095/biolreprod29.1.38; Chen W, 2011, J BIOL CHEM, V286, P34559, DOI 10.1074/jbc.M111.285965; Cuevas-Ramos D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038022; Drew JE, 2001, J NEUROENDOCRINOL, V13, P453, DOI 10.1046/j.1365-2826.2001.00651.x; Ebling FJP, 2008, J NEUROENDOCRINOL, V20, P576, DOI 10.1111/j.1365-2826.2008.01702.x; FIGALA J, 1973, OECOLOGIA, V12, P89, DOI 10.1007/BF00345511; Flores MBS, 2006, DIABETES, V55, P2554, DOI 10.2337/db05-1622; Gattermann R, 2004, PHYSIOL BEHAV, V82, P541, DOI 10.1016/j.physbeh.2004.05.006; GIBBS FP, 1986, PHYSIOL BEHAV, V37, P159, DOI 10.1016/0031-9384(86)90399-9; Hand LE, 2013, ENDOCRINOLOGY, V154, P2081, DOI 10.1210/en.2012-2051; Helwig M, 2013, J NEUROENDOCRINOL, V25, P190, DOI 10.1111/j.1365-2826.2012.02384.x; Henningsen J, 2010, MOL CELL PROTEOMICS, V9, P2482, DOI 10.1074/mcp.M110.002113; Herwig A, 2012, J NEUROENDOCRINOL, V24, P991, DOI 10.1111/j.1365-2826.2012.02324.x; Herwig A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062003; Herwig A, 2009, AM J PHYSIOL-REG I, V296, pR1307, DOI 10.1152/ajpregu.90755.2008; HOFFMANN K, 1973, J COMP PHYSIOL, V85, P267, DOI 10.1007/BF00694233; Hojman P, 2009, DIABETES, V58, P2797, DOI 10.2337/db09-0713; Jethwa PH, 2007, ENDOCRINOLOGY, V148, P4044, DOI 10.1210/en.2007-0038; Keppler D., 1984, METHOD ENZYMAT AN, V6, P11; Klosen P, 2013, FASEB J, V27, P2677, DOI 10.1096/fj.13-229559; LERCHL A, 1993, NEUROENDOCRINOLOGY, V57, P359, DOI 10.1159/000126380; Mercer JG, 2003, EUR J PHARMACOL, V480, P43, DOI 10.1016/j.ejphar.2003.08.091; Mercer JG, 2003, REGUL PEPTIDES, V111, P129, DOI 10.1016/S0167-0115(02)00263-X; Mercer JG, 1997, AM J PHYSIOL-REG I, V273, pR768, DOI 10.1152/ajpregu.1997.273.2.R768; Mercer JG, 2000, AM J PHYSIOL-REG I, V278, pR271, DOI 10.1152/ajpregu.2000.278.1.R271; Mercer JG, 2001, ENDOCRINOLOGY, V142, P4173, DOI 10.1210/en.142.10.4173; Morgan PJ, 1996, ENDOCRINOLOGY, V137, P4018, DOI 10.1210/en.137.9.4018; Murata Y, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/981315; Murphy M, 2013, J NEUROENDOCRINOL, V25, P180, DOI 10.1111/j.1365-2826.2012.02383.x; Murphy M, 2012, ENDOCRINOLOGY, V153, P101, DOI 10.1210/en.2011-1249; Nedachi T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1191, DOI 10.1152/ajpendo.90280.2008; Nilaweera KN, 2009, J NEUROENDOCRINOL, V21, P123, DOI 10.1111/j.1365-2826.2008.01810.x; Nilaweera K, 2011, GLIA, V59, P1695, DOI 10.1002/glia.21216; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Reddy AB, 1999, EUR J NEUROSCI, V11, P3255, DOI 10.1046/j.1460-9568.1999.00746.x; Rodriguez EM, 2005, INT REV CYTOL, V247, P89, DOI 10.1016/S0074-7696(05)47003-5; Ropelle ER, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000465; Ross AW, 2009, J NEUROENDOCRINOL, V21, P610, DOI 10.1111/j.1365-2826.2009.01878.x; Ross AW, 2005, ENDOCRINOLOGY, V146, P1940, DOI 10.1210/en.2004-1538; Ross AW, 2004, ENDOCRINOLOGY, V145, P13, DOI 10.1210/en.2003-0838; Scherbarth F, 2008, J COMP PHYSIOL B, V178, P607, DOI 10.1007/s00360-007-0251-7; Scherbarth F, 2007, AM J PHYSIOL-REG I, V293, pR1368, DOI 10.1152/ajpregu.00106.2007; SCHLATT S, 1995, BIOL REPROD, V53, P1169, DOI 10.1095/biolreprod53.5.1169; Siegel S., 1988, NONPARAMETRIC STAT B, P213, DOI DOI 10.1177/014662168901300212; THOMAS EM, 1993, AM J PHYSIOL, V265, pR951, DOI 10.1152/ajpregu.1993.265.4.R951; Tups A, 2006, J NEUROENDOCRINOL, V18, P139, DOI 10.1111/j.1365-2826.2005.01394.x; Watanabe M, 2004, ENDOCRINOLOGY, V145, P1546, DOI 10.1210/en.2003-1593; WEBB SM, 1985, HORM METAB RES, V17, P107, DOI 10.1055/s-2007-1013464	62	13	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90253	10.1371/journal.pone.0090253	http://dx.doi.org/10.1371/journal.pone.0090253			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603871	Green Published, Green Submitted, gold			2022-12-25	WOS:000332483600036
J	Lung, HL; Man, OY; Yeung, MC; Ko, JMY; Cheung, AKL; Law, EWL; Yu, Z; Shuen, WH; Tung, E; Chan, SHK; Bangarusamy, DK; Cheng, Y; Yang, X; Kan, R; Phoon, Y; Chan, KC; Chua, D; Kwong, DL; Lee, AWM; Ji, MF; Lung, ML				Lung, H. L.; Man, O. Y.; Yeung, M. C.; Ko, J. M. Y.; Cheung, A. K. L.; Law, E. W. L.; Yu, Z.; Shuen, W. H.; Tung, E.; Chan, S. H. K.; Bangarusamy, D. K.; Cheng, Y.; Yang, X.; Kan, R.; Phoon, Y.; Chan, K. C.; Chua, D.; Kwong, D. L.; Lee, A. W. M.; Ji, M. F.; Lung, M. L.			SAA1 polymorphisms are associated with variation in antiangiogenic and tumor-suppressive activities in nasopharyngeal carcinoma	ONCOGENE			English	Article							SERUM AMYLOID-A; AORTIC SMOOTH-MUSCLE; EPSTEIN-BARR-VIRUS; ARG-GLY-ASP; ACUTE-PHASE; MONOCHROMOSOME TRANSFER; EXTRACELLULAR-MATRIX; EPITHELIAL-CELLS; EXPRESSION; PROTEIN	Nasopharyngeal carcinoma (NPC) is a cancer that occurs in high frequency in Southern China. A previous functional complementation approach and the subsequent cDNA microarray analysis have identified that serum amyloid A1 (SAA1) is an NPC candidate tumor suppressor gene. SAA1 belongs to a family of acute-phase proteins that are encoded by five polymorphic coding alleles. The SAA1 genotyping results showed that only three SAA1 isoforms (SAA1.1, 1.3 and 1.5) were observed in both Hong Kong NPC patients and healthy individuals. This study aims to determine the functional role of SAA1 polymorphisms in tumor progression and to investigate the relationship between SAA1 polymorphisms and NPC risk. Indeed, we have shown that restoration of SAA1.1 and 1.3 in the SAA1-deficient NPC cell lines could suppress tumor formation and angiogenesis in vitro and in vivo. The secreted SAA1.1 and SAA1.3 proteins can block cell adhesion and induce apoptosis in the vascular endothelial cells. In contrast, the SAA1.5 cannot induce apoptosis or inhibit angiogenesis because of its weaker binding affinity to alpha V beta 3 integrin. This can explain why SAA1.5 has no tumor-suppressive effects. Furthermore, the NPC tumors with this particular SAA1.5/1.5 genotype showed higher levels of SAA1 gene expression, and SAA1.1 and 1.3 alleles were preferentially inactivated in tumor tissues that were examined. These findings further strengthen the conclusion for the defective function of SAA1.5 in suppression of tumor formation and angiogenesis. Interestingly, the frequency of the SAA1.5/1.5 genotype in NPC patients was similar to 2-fold higher than in the healthy individuals (P = 0.00128, odds ratio = 2.28), which indicates that this SAA1 genotype is significantly associated with a higher NPC risk. Collectively, this homozygous SAA1.5/1.5 genotype appears to be a recessive susceptibility gene, which has lost the antiangiogenic function, whereas SAA1.1 and SAA1.3 are the dominant alleles of the tumor suppressor phenotype.	[Lung, H. L.; Man, O. Y.; Yeung, M. C.; Ko, J. M. Y.; Cheung, A. K. L.; Law, E. W. L.; Yu, Z.; Shuen, W. H.; Tung, E.; Chan, S. H. K.; Cheng, Y.; Yang, X.; Kan, R.; Phoon, Y.; Chan, K. C.; Chua, D.; Kwong, D. L.; Lung, M. L.] Univ Hong Kong, Dept Clin Oncol, Pokfulam, Hong Kong, Peoples R China; [Lung, H. L.; Man, O. Y.; Yeung, M. C.; Ko, J. M. Y.; Cheung, A. K. L.; Law, E. W. L.; Yu, Z.; Shuen, W. H.; Tung, E.; Chan, S. H. K.; Cheng, Y.; Yang, X.; Kan, R.; Phoon, Y.; Chan, K. C.; Chua, D.; Kwong, D. L.; Lung, M. L.] Univ Hong Kong, Ctr Canc Res, Pokfulam, Hong Kong, Peoples R China; [Tung, E.; Chua, D.; Kwong, D. L.; Lee, A. W. M.; Lung, M. L.] Univ Hong Kong, Ctr Nasopharyngeal Carcinoma Res, Hong Kong, Hong Kong, Peoples R China; [Bangarusamy, D. K.] Inst Biomed Sci, Genome Inst Singapore, Singapore, Singapore; [Chua, D.] Hong Kong Sanat & Hosp, Comprehens Oncol Ctr, Hong Kong, Hong Kong, Peoples R China; [Lee, A. W. M.] Pamela Youde Nethersole Eastern Hosp, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Lee, A. W. M.] Univ Hong Kong, Shenzhen Hosp, Dept Clin Oncol, Shenzhen, Peoples R China; [Ji, M. F.] Zhongshan City Hosp, Ctr Canc, Zhongshan, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Pamela Youde Nethersole Eastern Hospital; University of Hong Kong	Lung, HL (corresponding author), Univ Hong Kong, Dept Clin Oncol, L6-02,Fac Med Bldg,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	hllung2@hku.hk; mlilung@hku.hk	Ko, Josephine/U-2972-2019; Cheng, Yue/Z-4456-2019; Chan, Ka Chung/HHR-8759-2022; Lung, Maria Li/C-4495-2009	Ko, Josephine/0000-0002-7997-331X; Ji, Mingfang/0000-0003-4727-2858; Lung, Maria Li/0000-0003-2559-3626	Research Grants Council of the Hong Kong Special Administrative Region [HKU772309]	Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council)	We acknowledge the AoE NPC Tissue Bank for providing the NPC specimens and the NPC TMA. We thank the Hong Kong Red Cross for providing us the blood from healthy individuals. We also thank Dr Edison Tak-Bun Liu for their microarray support in the Genome Institute of Singapore (GIS); Dr Sai Wah Tsao for providing us the immortalized cell lines; Dr John M Nicholls for the TMA analysis and Dr Pui Man Chiu for her help in constructing the NPC TMA and SAA immunohistochemistry staining; Dr Didier Trono for the supply of the lentiviral vectors, pWPI, pMD2. G and psPAX2. We thank Dr David Root for the supply of the lentihair pLKO. 1-TRC cloning vector and Dr David Sabatini for the pLKO. 1-scramble shRNA construct. This work was supported by the General Research Fund (HKU772309 to HLL) of the Research Grants Council of the Hong Kong Special Administrative Region.	Adham M, 2012, CHIN J CANCER, V31, P185, DOI 10.5732/cjc.011.10328; Amal Chandra Kataki, 2011, Chinese Journal of Cancer, V30, P106; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; BADOLATO R, 1994, J EXP MED, V180, P203, DOI 10.1084/jem.180.1.203; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; CABANA VG, 1989, J LIPID RES, V30, P39; Chan KC, 2011, INT J CANCER, V129, P1826, DOI 10.1002/ijc.25855; Cheng Y, 2000, GENE CHROMOSOME CANC, V28, P82, DOI 10.1002/(SICI)1098-2264(200005)28:1<82::AID-GCC10>3.0.CO;2-8; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; CHIANG HS, 1995, BRIT J CANCER, V71, P265, DOI 10.1038/bjc.1995.54; Cho WCS, 2004, CLIN CANCER RES, V10, P43, DOI 10.1158/1078-0432.CCR-0413-3; Deng W, 2004, ONCOGENE, V23, P9090, DOI 10.1038/sj.onc.1208119; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; GLASER R, 1989, P NATL ACAD SCI USA, V86, P9524, DOI 10.1073/pnas.86.23.9524; HOFFMAN JS, 1982, J BIOL CHEM, V257, P518; HUANG DP, 1980, INT J CANCER, V26, P127, DOI 10.1002/ijc.2910260202; Huang Z, 2012, ONCOGENE, V31, P3709, DOI 10.1038/onc.2011.529; Iwamoto Y, 1996, BRIT J CANCER, V73, P589, DOI 10.1038/bjc.1996.102; Ko JMY, 2008, MOL CANCER RES, V6, P592, DOI 10.1158/1541-7786.MCR-07-0154; Kumon Y, 2002, SCAND J IMMUNOL, V56, P504, DOI 10.1046/j.1365-3083.2002.01169.x; Li HM, 2006, INT J CANCER, V119, P1567, DOI 10.1002/ijc.22032; LIANG JS, 1995, J LIPID RES, V36, P37; Liang JS, 1996, J LIPID RES, V37, P2109; Liao QL, 2008, CLIN EXP METASTAS, V25, P465, DOI 10.1007/s10585-008-9152-8; Lindhorst E, 1997, BBA-PROTEIN STRUCT M, V1339, P143, DOI 10.1016/S0167-4838(96)00227-0; Liu CB, 2012, PATHOL ONCOL RES, V18, P117, DOI 10.1007/s12253-011-9459-7; Liu Q, 2013, CHIN J CANCER, V32, P325, DOI 10.5732/cjc.012.10189; Lo PHY, 2010, CANCER RES, V70, P5567, DOI 10.1158/0008-5472.CAN-09-4510; Lung HL, 2005, ONCOGENE, V24, P6525, DOI 10.1038/sj.onc.1208812; Lung HL, 2008, INT J CANCER, V123, P401, DOI 10.1002/ijc.23528; Lung HL, 2006, CANCER RES, V66, P9385, DOI 10.1158/0008-5472.CAN-06-0590; Malle E, 2009, CELL MOL LIFE SCI, V66, P9, DOI 10.1007/s00018-008-8321-x; MITCHELL TI, 1991, J CLIN INVEST, V87, P1177, DOI 10.1172/JCI115116; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mould AP, 2011, CURR PROTOC CELL BIO; NICOSIA RF, 1991, AM J PATHOL, V138, P829; Perron-Sierra F, 2002, BIOORG MED CHEM LETT, V12, P3291, DOI 10.1016/S0960-894X(02)00696-0; PRECIADOPATT L, 1994, EUR J BIOCHEM, V223, P35, DOI 10.1111/j.1432-1033.1994.tb18963.x; PreciadoPatt L, 1996, J IMMUNOL, V156, P1189; Protopopov AI, 2002, J GENE MED, V4, P397, DOI 10.1002/jgm.283; Robertson G P, 1999, Mol Cell Biol Res Commun, V2, P1, DOI 10.1006/mcbr.1999.0141; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Strissel KJ, 1997, EXP CELL RES, V237, P275, DOI 10.1006/excr.1997.3783; Sung HJ, 2011, J PROTEOME RES, V10, P1383, DOI 10.1021/pr101154j; Thorn CF, 2002, J IMMUNOL, V169, P399, DOI 10.4049/jimmunol.169.1.399; Treuting P.M., 2012, COMP ANATOMY HISTOLO; Tsang CM, 2010, INT J CANCER, V127, P1570, DOI 10.1002/ijc.25173; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Urieli-Shoval S, 1998, J HISTOCHEM CYTOCHEM, V46, P1377, DOI 10.1177/002215549804601206; Venetsanakos E, 2002, EXP CELL RES, V273, P21, DOI 10.1006/excr.2001.5424; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Wong VCL, 2012, INT J CANCER, V130, P83, DOI 10.1002/ijc.25970; XU LL, 1995, J IMMUNOL, V155, P1184; YAMADA T, 1994, BBA-MOL BASIS DIS, V1226, P323, DOI 10.1016/0925-4439(94)90044-2; Yamada T, 1999, CLIN CHEM LAB MED, V37, P381, DOI 10.1515/CCLM.1999.063; Zhang H, 2006, CANCER GENET CYTOGEN, V165, P25, DOI 10.1016/j.cancergencyto.2005.07.016	56	21	21	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 12	2015	34	7					878	889		10.1038/onc.2014.12	http://dx.doi.org/10.1038/onc.2014.12			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CB2QF	24608426				2022-12-25	WOS:000349472000008
J	Ivanova, AA; East, MP; Yi, SL; Kahn, RA				Ivanova, Anna A.; East, Michael P.; Yi, Slee L.; Kahn, Richard A.			Characterization of Recombinant ELMOD ( Cell Engulfment and Motility Domain) Proteins as GTPase-activating Proteins ( GAPs) for ARF Family GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ARF; Enzyme Kinetics; GTPase; Sigma Receptor; Signal Transduction; ARL2; ELMOD; GTPase-activating Protein (GAP); HEK Cell Expression; Sigma-1 Receptor (S1R)	ADP-RIBOSYLATION FACTOR; ACID PHOSPHOLIPIDS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; THERAPEUTIC DRUGS; RECEPTOR LIGANDS; STRUCTURAL BASIS; RNA-POLYMERASE; CLONED GENES; EXPRESSION; COMPLEX	Background: ELMOD proteins are atypical GAPs for the ARF family with links to deafness. Results: ELMOD proteins have distinct specific activities for ARF proteins and bind the non-opioid sigma-1 receptor. Conclusion: Different specific activities of ELMOD1-3 are predicted to underlie different cellular functions. Significance: Specificities and regulation of ELMODs contribute to understanding their roles in cell signaling and the inner ear. The ARF family of regulatory GTPases, within the RAS superfamily, is composed of approximate to 30 members in mammals, including up to six ARF and at least 18 ARF-like (ARL) proteins. They exhibit significant structural and biochemical conservation and regulate a variety of essential cellular processes, including membrane traffic, cell division, and energy metabolism; each with links to human diseases. We previously identified members of the ELMOD family as GTPase-activating proteins (GAPs) for ARL2 that displayed crossover activity for ARFs as well. To further characterize the GAP activities of the three human ELMODs as GAPs we developed new preparations of each after overexpression in human embryonic kidney (HEK293T) cells. This allowed much higher specific activities and enhanced stability and solubility of the purified proteins. The specificities of ELMOD1-3 as GAPs for six different members of the ARF family were determined and found to display wide variations, which we believe will reveal differences in cellular functions of family members. The non-opioid sigma-1 receptor (S1R) was identified as a novel effector of GAP activity of ELMOD1-3 proteins as its direct binding to either ELMOD1 or ELMOD2 resulted in loss of GAP activity. These findings are critical to understand the roles of ELMOD proteins in cell signaling in general and in the inner ear specifically, and open the door to exploration of the regulation of their GAP activities via agonists or antagonists of the S1R.	[Ivanova, Anna A.; East, Michael P.; Yi, Slee L.; Kahn, Richard A.] Emory Univ, Dept Biochem, Sch Med, Atlanta, GA 30322 USA	Emory University	Kahn, RA (corresponding author), 1510 Clifton Rd,Room G-217, Atlanta, GA 30322 USA.	rkahn@emory.edu	Kahn, Richard/ABD-2666-2020; Ivanova, Anna/GZK-6458-2022	Kahn, Richard/0000-0002-0259-0601; 	National Institutes of Health [GM090158, GM61268]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110663, R01GM090158, R01GM061268] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM090158 and GM61268 (to A. A. I. and R. A. K.).	Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1114, DOI 10.1107/S0907444906029805; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Bichet P, 2000, PROTEIN EXPRES PURIF, V19, P197, DOI 10.1006/prep.2000.1239; Bowzard JB, 2007, J BIOL CHEM, V282, P17568, DOI 10.1074/jbc.M701347200; Brown MT, 1998, MOL CELL BIOL, V18, P7038, DOI 10.1128/MCB.18.12.7038; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Che MM, 2005, CELL SIGNAL, V17, P1276, DOI 10.1016/j.cellsig.2005.01.007; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; Cobos EJ, 2008, CURR NEUROPHARMACOL, V6, P344, DOI 10.2174/157015908787386113; Dammer EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038658; Du XL, 2009, BIOCHEMISTRY-US, V48, P4538, DOI 10.1021/bi802359b; East MP, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.417477; East MP, 2011, SEMIN CELL DEV BIOL, V22, P3, DOI 10.1016/j.semcdb.2010.07.002; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hashimoto K, 2006, CURR PHARM DESIGN, V12, P3857, DOI 10.2174/138161206778559614; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Jaworek TJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003774; Jian XY, 2009, J BIOL CHEM, V284, P1652, DOI 10.1074/jbc.M804218200; Johnson KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036074; KAHN RA, 1986, J BIOL CHEM, V261, P7906; Kahn RA, 1996, J LIPID MEDIAT CELL, V14, P209, DOI 10.1016/0929-7855(96)00527-5; Kam JL, 2000, J BIOL CHEM, V275, P9653, DOI 10.1074/jbc.275.13.9653; Maheshwar MM, 1997, HUM MOL GENET, V6, P1991, DOI 10.1093/hmg/6.11.1991; Mandiyan V, 1999, EMBO J, V18, P6890, DOI 10.1093/emboj/18.24.6890; Maurice T, 2009, PHARMACOL THERAPEUT, V124, P195, DOI 10.1016/j.pharmthera.2009.07.001; McLaughlin SK, 2013, CANCER CELL, V24, P365, DOI 10.1016/j.ccr.2013.08.004; Mori T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076941; Nie ZZ, 2006, CURR BIOL, V16, P130, DOI 10.1016/j.cub.2005.11.069; Nie ZZ, 2002, J BIOL CHEM, V277, P48965, DOI 10.1074/jbc.M202969200; Niitsu T, 2012, CURR PHARM DESIGN, V18, P875, DOI 10.2174/138161212799436476; Phan J, 2002, J BIOL CHEM, V277, P50564, DOI 10.1074/jbc.M207224200; POLAKIS P, 1992, CANCER SURV, V12, P25; RANDAZZO PA, 1994, J BIOL CHEM, V269, P10758; RANDAZZO PA, 1995, METHOD ENZYMOL, V257, P128; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Seyfried NT, 2012, J PROTEOME RES, V11, P2721, DOI 10.1021/pr2010814; Sharer JD, 2002, MOL BIOL CELL, V13, P71, DOI 10.1091/mbc.01-05-0245; Shern JF, 2003, J BIOL CHEM, V278, P40829, DOI 10.1074/jbc.M308678200; Skuza G, 2004, PHARMACOPSYCHIATRY, V37, pS183, DOI 10.1055/s-2004-832676; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TERUI T, 1994, J BIOL CHEM, V269, P28130; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Tsai Shang-Yi, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P184; Van Valkenburgh H, 2001, J BIOL CHEM, V276, P22826, DOI 10.1074/jbc.M102359200; Zheng Y, 1996, J BIOL CHEM, V271, P23815, DOI 10.1074/jbc.271.39.23815	52	28	29	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11111	11121		10.1074/jbc.M114.548529	http://dx.doi.org/10.1074/jbc.M114.548529			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24616099	Green Published, hybrid			2022-12-25	WOS:000334638500015
J	Araujo, CP; Osorio, ALAR; Jorge, KSG; Ramos, CAN; Filho, AFS; Vidal, CES; Roxo, E; Nishibe, C; Almeida, NF; Junior, AAF; Silva, MR; Neto, JDB; Cerqueira, VD; Zumarraga, MJ; Araujo, FR				Araujo, Cristina P.; Osorio, Ana Luiza A. R.; Jorge, Klaudia S. G.; Ramos, Carlos Alberto N.; Filho, Antonio Francisco S.; Vidal, Carlos Eugenio S.; Roxo, Eliana; Nishibe, Christiane; Almeida, Nalvo F.; Junior, Antonio A. F.; Silva, Marcio R.; Neto, Jose Diomedes B.; Cerqueira, Valiria D.; Zumarraga, Martin J.; Araujo, Flabio R.			Detection of Mycobacterium bovis in Bovine and Bubaline Tissues Using Nested-PCR for TbD1	PLOS ONE			English	Article							TUBERCULOSIS COMPLEX; STRAINS; CATTLE; IDENTIFICATION; AFRICANUM	In the present study, a nested-PCR system, targeting the TbD1 region, involving the performance of conventional PCR followed by real-time PCR, was developed to detect Mycobacterium bovis in bovine/bubaline tissue homogenates. The sensitivity and specificity of the reactions were assessed with DNA samples extracted from tuberculous and non-tuberculous mycobacteria, as well as other actinomycetales species and DNA samples extracted directly from bovine and bubaline tissue homogenates. In terms of analytical sensitivity, the DNA of M. bovis AN5 was detected up to 1.56 ng with conventional PCR, 97.6 pg with real-time PCR, and 1.53 pg with nested-PCR in the reaction mixture. The nested-PCR exhibited 100% analytical specificity for M. bovis when tested with the DNA of reference strains of environmental mycobacteria and closely-related Actinomycetales. A clinical sensitivity value of 76.0% was detected with tissue samples from animals that exhibited positive results in the comparative intradermal tuberculin test (CITT), as well as from those with lesions compatible with tuberculosis (LCT) that rendered positive cultures. A clinical specificity value of 100% was detected with tissue samples from animals with CITT-results, with no visible lesions (NVL) and negative cultures. No significant differences were found between the nested-PCR and culture in terms of detecting CITT+ animals with LCT or with NVL. No significant differences were recorded in the detection of CITT- animals with NVL. However, nested-PCR detected a significantly higher number of positive animals than the culture in the group of animals exhibiting LCT with no previous records of CITT. The use of the nested-PCR assay to detect M. bovis in tissue homogenates provided a rapid diagnosis of bovine and bubaline tuberculosis.	[Araujo, Cristina P.; Osorio, Ana Luiza A. R.; Jorge, Klaudia S. G.; Filho, Antonio Francisco S.] Univ Fed Mato Grosso do Sul, Programa Posgrad Ciencia Anim FAMEZ, Campo Grande, MS, Brazil; [Vidal, Carlos Eugenio S.] Univ Fed Santa Maria, PPGMV, Santa Maria, RS, Brazil; [Roxo, Eliana] Inst Biol Sao Paulo, Sao Paulo, Brazil; [Nishibe, Christiane; Almeida, Nalvo F.] Univ Fed Mato Grosso do Sul, Fac Comp, Campo Grande, MS, Brazil; [Junior, Antonio A. F.] Lab Nacl Agr, Pedro Leopoldo, MG, Brazil; [Silva, Marcio R.] Embrapa Gado Leite, Juiz De Fora, MG, Brazil; [Neto, Jose Diomedes B.; Cerqueira, Valiria D.] UFPA, Castanhal, PA, Brazil; [Zumarraga, Martin J.] Inst Nacl Tecnol Agr, Inst Biotecnol, Buenos Aires, DF, Argentina; [Araujo, Flabio R.] Embrapa Gado Corte, Campo Grande, MS, Brazil	Universidade Federal de Mato Grosso do Sul; Universidade Federal de Santa Maria (UFSM); Universidade Federal de Mato Grosso do Sul; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal do Para; Instituto Nacional de Tecnologia Agropecuaria (INTA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Araujo, FR (corresponding author), Embrapa Gado Corte, Campo Grande, MS, Brazil.	flabio.araujo@embrapa.br	Cerqueira, Valíria/AAW-8867-2020; Silva, Marcio Roberto/V-9005-2019; cerqueira, valiria/AAG-7542-2019; de Souza Filho, Antonio Francisco/G-2382-2015; Fonseca, Antônio Augusto/AAW-4082-2020; Almeida, Nalvo/B-5856-2012; Roxo, Eliana/C-3313-2011	de Souza Filho, Antonio Francisco/0000-0003-4728-1228; Fonseca, Antônio Augusto/0000-0002-2962-5616; Roxo, Eliana/0000-0002-1415-6407; Nascimento Ramos, Carlos Albero/0000-0002-3084-172X; Almeida, Nalvo/0000-0001-5615-1746	CNPq [578278/2008, 479394/2011-3, 305857/2013-4, 310165/2010-5]; FUNDECT [23/200.152/2009, 23/200.582/2012, TO-0096/2012]; Embrapa [03.11.22.003.00.00]; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FUNDECT(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); Embrapa(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	CNPq (grants 578278/2008, 479394/2011-3, 305857/2013-4 and 310165/2010-5), FUNDECT (grants 23/200.152/2009, 23/200.582/2012 and TO-0096/2012), Embrapa (grants 03.11.22.003.00.00) and CAPES (PhD fellowship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KA, 2010, EMERG INFECT DIS, V16, P1296, DOI 10.3201/eid1608.100314; ALFREDSEN S, 1992, VET REC, V131, P51, DOI 10.1136/vr.131.3.51; Ameni G, 2011, VET J, V188, P359, DOI 10.1016/j.tvjl.2010.05.005; [Anonymous], 2012, NORM INT DAS; Ansari-Lari M, 2005, VET PARASITOL, V133, P369, DOI 10.1016/j.vetpar.2005.06.005; Aranaz A, 2003, INT J SYST EVOL MICR, V53, P1785, DOI 10.1099/ijs.0.02532-0; Banu S, 2012, INT J TUBERC LUNG D, V16, P319, DOI 10.5588/ijtld.11.0426; Barandiaran S, 2013, REV ARGENT MICROBIOL, V45, P91; Beyene D, 2009, J INFECT DEV COUNTR, V3, P412, DOI 10.3855/jidc.411; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; CASTETS M, 1969, Bulletin de la Societe Medicale d'Afrique Noire de Langue Francaise, V14, P693; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Costa P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081337; Cousins DV, 2003, INT J SYST EVOL MICR, V53, P1305, DOI 10.1099/ijs.0.02401-0; DUFFIELD BJ, 1989, AUST VET J, V66, P307, DOI 10.1111/j.1751-0813.1989.tb13964.x; Flynn O, 2001, VET MICROBIOL, V78, P221, DOI 10.1016/S0378-1135(00)00297-2; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Johansen IS, 2004, J MOL DIAGN, V6, P231, DOI 10.1016/S1525-1578(10)60515-6; Lahlou O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047113; Mbugi Erasto V., 2012, Onderstepoort j. vet. res., V79, P01; Ministerio da Agricultura Pecuaria e Abastecimento, 2006, PROGR NAC CONTR ERR; Mostowy S, 2005, J BACTERIOL, V187, P6386, DOI 10.1128/JB.187.18.6386-6395.2005; Muller B, 2013, EMERG INFECT DIS, V19, P899, DOI 10.3201/eid1906.120543; Niemann S, 2000, J CLIN MICROBIOL, V38, P152; Niobe-Eyangoh SN, 2004, J CLIN MICROBIOL, V42, P5029, DOI 10.1128/JCM.42.11.5029-5035.2004; Parra A, 2008, VET MICROBIOL, V127, P315, DOI 10.1016/j.vetmic.2007.09.001; Petroff SA, 1915, J EXP MED, V21, P38, DOI 10.1084/jem.21.1.38; Rahim Zeaur, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P706; RODRIGUEZ JG, 1995, MICROBIOL-SGM, V141, P2131, DOI 10.1099/13500872-141-9-2131; Romero B, 2011, EMERG INFECT DIS, V17, P2393, DOI 10.3201/eid1712.101476; Sahraoui N, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-4; Schlesselman JJ, 1982, CASE CONTROL STUDIES, P205; Soini H, 2001, CLIN CHEM, V47, P809; Stavrum R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001973; Tanveer M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-171; Taylor G Michael, 2007, BMC Vet Res, V3, P12, DOI 10.1186/1746-6148-3-12; Thacker TC, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-50; Thakur A, 2012, INDIAN J MICROBIOL, V52, P289, DOI 10.1007/s12088-011-0200-8; Thomas SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027584; van der Merwe M, 2009, J S AFR VET ASSOC, V80, P142; van Ingen J, 2012, EMERG INFECT DIS, V18, P653, DOI 10.3201/eid1804.110888; Weber A, 1998, BERL MUNCH TIERARZTL, V111, P6; WELLS A. Q., 1937, LANCET, V232, P1221	43	20	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91023	10.1371/journal.pone.0091023	http://dx.doi.org/10.1371/journal.pone.0091023			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618787	Green Submitted, Green Published, gold			2022-12-25	WOS:000332842400043
J	Arreghini, M; Manzoni, GM; Castelnuovo, G; Santovito, C; Capodaglio, P				Arreghini, Marco; Manzoni, Gian Mauro; Castelnuovo, Gianluca; Santovito, Cristina; Capodaglio, Paolo			Impact of Fibromyalgia on Functioning in Obese Patients Undergoing Comprehensive Rehabilitation	PLOS ONE			English	Article							BODY-MASS INDEX; QUALITY-OF-LIFE; LOW-BACK-PAIN; KNEE OSTEOARTHRITIS; MUSCULOSKELETAL PAIN; GENERAL-POPULATION; RISK-FACTORS; WEIGHT-LOSS; PREVALENCE; GENDER	A possible link between fibromyalgia (FM) and obesity has been recently suggested but very scanty data on the prevalence of FM in obese populations are available. The aims of the present cross-sectional study were: 1) to estimate the prevalence of FM in a population of obese patients undergoing rehabilitation and 2) to investigate the effect of FM on obese patients' functional capacities. One hundred and thirty Italian obese (Body Mass Index, BMI >= 30) patients admitted to hospital for 1-month rehabilitation treatment took part in the study. All participants were interviewed by a rheumatologist according to the 2010 American College of Rheumatology (ACR) diagnostic criteria for FM. At admission and discharge from hospital (on average, after 28 days), the following measures were compared between the group of patients with FM and the other patients: body weight, body mass index, functional independence (FIM), obesity-related disability (TSD-OC), self-reported functioning and the Timed-Up-Go (TUG) test. Thirty seven patients out of 130 fulfilled the diagnostic criteria for FM. The prevalence rate was 27.7% (95% CI: 20 to 35.4). Between-group comparisons showed that FM patients had higher disability level at the first assessment, had lower scores on the FIM at the final assessment, scored lower on self-reported functioning both at the first and the final assessments and had a lower body weight. The prevalence of FM in our study is much higher than the rates reported in the general normal-weight population (on average, 3.5%) and the 5.15% rate previously reported in a bariatric population. Functional data showed that the FM obese group yielded lower performance capacity and higher disability level as compared to the non-FM obese group. However, due to the relatively small sample size and the selected population, such results need to be confirmed in larger obese subpopulations.	[Arreghini, Marco; Santovito, Cristina; Capodaglio, Paolo] Ist Auxol Italiano IRCCS, Rehabil Unit, Oggebbio, VB, Italy; [Manzoni, Gian Mauro; Castelnuovo, Gianluca] Ist Auxol Italiano IRCCS, Psychol Res Lab, Oggebbio, VB, Italy; [Manzoni, Gian Mauro; Castelnuovo, Gianluca] Catholic Univ Milan, Dept Psychol, Milan, Italy	IRCCS Istituto Auxologico Italiano; IRCCS Istituto Auxologico Italiano; Catholic University of the Sacred Heart	Capodaglio, P (corresponding author), Ist Auxol Italiano IRCCS, Rehabil Unit, Oggebbio, VB, Italy.	p.capodaglio@auxologico.it	Manzoni, Gian Mauro/L-3891-2019; Paolo, Capodaglio/AAB-7795-2019	Manzoni, Gian Mauro/0000-0003-3384-0359; Paolo, Capodaglio/0000-0003-3719-8789				[Anonymous], 1996, SPSS US MAN EX TESTS; Arnold LM, 2006, J CLIN PSYCHIAT, V67, P1219, DOI 10.4088/JCP.v67n0807; Arnold LM, 2004, ARTHRITIS RHEUM-US, V50, P944, DOI 10.1002/art.20042; Arranz L, 2012, RHEUMATOL INT, V32, P3605, DOI 10.1007/s00296-011-2250-y; Bazzichi L, 2007, CLIN EXP RHEUMATOL, V25, P225; Becker J, 2002, CLIN NEUROPHYSIOL, V113, P1429, DOI 10.1016/S1388-2457(02)00201-8; Bennett RM, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-27; Bingefors K, 2004, EUR J PAIN, V8, P435, DOI 10.1016/j.ejpain.2004.01.005; Branco JC, 2010, SEMIN ARTHRITIS RHEU, V39, P448, DOI 10.1016/j.semarthrit.2008.12.003; Bureau UC, 2000, US CENS BUR US CENS; Capodaglio P, 2013, EUR J PHYS REHAB MED, V49, P395; Capodaglio P., 2013, DISABLING OBESITY DE, V1st ed.; Capodaglio P, 2013, DISABIL REHABIL, V35, P1199, DOI 10.3109/09638288.2012.726313; Capodaglio P, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-47; CARMAN WJ, 1994, AM J EPIDEMIOL, V139, P119, DOI 10.1093/oxfordjournals.aje.a116974; Carmona L, 2001, ANN RHEUM DIS, V60, P1040, DOI 10.1136/ard.60.11.1040; Castellan NJ, 1988, NONPARAMETRIC STAT B; Christensen R, 2005, OSTEOARTHR CARTILAGE, V13, P20, DOI 10.1016/j.joca.2004.10.008; Cimolin V, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-55; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Donini LM, 2011, DISABIL REHABIL, V33, P2509, DOI 10.3109/09638288.2011.575529; FELSON DT, 1992, ANN INTERN MED, V116, P535, DOI 10.7326/0003-4819-116-7-535; Geoghegan JM, 2004, J HAND SURG-BRIT EUR, V29B, P315, DOI 10.1016/j.jhsb.2004.02.009; Hamilton B. B., 1987, REHABILITATION OUTCO, P137; Han TS, 1997, INT J OBESITY, V21, P600, DOI 10.1038/sj.ijo.0800448; Holmberg S, 2005, SCAND J RHEUMATOL, V34, P59, DOI 10.1080/03009740510017922; Hudson JI, 1996, RHEUM DIS CLIN N AM, V22, P285, DOI 10.1016/S0889-857X(05)70273-8; JACOBSEN S, 1993, SCAND J RHEUMATOL, V22, P69, DOI 10.3109/03009749309095118; Kawasaki Y, 2008, J NEUROSCI, V28, P5189, DOI 10.1523/JNEUROSCI.3338-07.2008; MAKELA M, 1991, BRIT MED J, V303, P216, DOI 10.1136/bmj.303.6796.216; Malatesta D, 2009, MED SCI SPORT EXER, V41, P426, DOI 10.1249/MSS.0b013e31818606e7; Mannerkorpi K, 2006, ARCH PHYS MED REHAB, V87, P259, DOI 10.1016/j.apmr.2005.10.013; Mannerkorpi K, 1999, ARTHRIT CARE RES, V12, P193, DOI 10.1002/1529-0131(199906)12:3<193::AID-ART6>3.0.CO;2-N; MARTINEZ JE, 1995, J RHEUMATOL, V22, P270; MATHIAS S, 1986, ARCH PHYS MED REHAB, V67, P387; McBeth J, 2012, NAT REV RHEUMATOL, V8, P108, DOI 10.1038/nrrheum.2011.216; Menegoni F, 2009, OBESITY, V17, P1951, DOI 10.1038/oby.2009.82; Mork PJ, 2010, ARTHRIT CARE RES, V62, P611, DOI 10.1002/acr.20118; Neumann L, 2008, CLIN RHEUMATOL, V27, P1543, DOI 10.1007/s10067-008-0966-1; Okifuji A, 2010, J PAIN, V11, P1329, DOI 10.1016/j.jpain.2010.03.006; Okifuji A, 2009, CLIN RHEUMATOL, V28, P475, DOI 10.1007/s10067-009-1094-2; Peltonen M, 2003, PAIN, V104, P549, DOI 10.1016/S0304-3959(03)00091-5; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; PRESCOTT E, 1993, SCAND J RHEUMATOL, V22, P233, DOI 10.3109/03009749309095129; Saber AA, 2008, OBES SURG, V18, P652, DOI 10.1007/s11695-008-9505-z; Salaffi F, 2005, CLIN EXP RHEUMATOL, V23, P819; Stallings SP, 1997, J HAND SURG-AM, V22A, P211, DOI 10.1016/S0363-5023(97)80153-0; Ursini F, 2011, RHEUMATOL INT, V31, P1403, DOI 10.1007/s00296-011-1885-z; Vismara L, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-3; Wahner-Roedler DL, 2007, GENDER MED, V4, P329, DOI 10.1016/S1550-8579(07)80062-3; Wang HL, 2008, J RHEUMATOL, V35, P1366; White KP, 1999, J RHEUMATOL, V26, P1570; WOLFE F, 1995, ARTHRITIS RHEUM-US, V38, P19, DOI 10.1002/art.1780380104; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2013, ARTHRIT CARE RES, V65, P777, DOI 10.1002/acr.21931; Wolfe F, 2011, J RHEUMATOL, V38, P1113, DOI 10.3899/jrheum.100594; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Yunus MB, 2002, SCAND J RHEUMATOL, V31, P27, DOI 10.1080/030097402317255336	58	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91392	10.1371/journal.pone.0091392	http://dx.doi.org/10.1371/journal.pone.0091392			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618795	Green Submitted, Green Published, gold			2022-12-25	WOS:000332842400084
J	Bake, S; Selvamani, A; Cherry, J; Sohrabji, F				Bake, Shameena; Selvamani, Amutha; Cherry, Jessica; Sohrabji, Farida			Blood Brain Barrier and Neuroinflammation Are Critical Targets of IGF-1-Mediated Neuroprotection in Stroke for Middle-Aged Female Rats	PLOS ONE			English	Article							GROWTH-FACTOR-I; CEREBRAL-ARTERY OCCLUSION; TRANSIENT FOCAL ISCHEMIA; IGF-I; ENDOTHELIAL-CELLS; SEX-DIFFERENCES; INSULIN; EXPRESSION; ESTROGEN; INJURY	Ischemia-induced cerebral infarction is more severe in older animals as compared to younger animals, and is associated with reduced availability of insulin-like growth factor (IGF)-1. This study determined the effect of post-stroke IGF-1 treatment, and used microRNA profiling to identify mechanisms underlying IGF-1's neuroprotective actions. Post-stroke ICV administration of IGF-1 to middle-aged female rats reduced infarct volume by 39% when measured 24h later. MicroRNA analyses of ischemic tissue collected at the early post-stroke phase (4h) indicated that 8 out of 168 disease-related miRNA were significantly downregulated by IGF-1. KEGG pathway analysis implicated these miRNA in PI3K-Akt signaling, cell adhesion/ECM receptor pathways and T- and B-cell signaling. Specific components of these pathways were subsequently analyzed in vehicle and IGF-1 treated middle-aged females. Phospho-Akt was reduced by ischemia at 4h, but elevated by IGF-1 treatment at 24h. IGF-1 induced Akt activation was preceded by a reduction of blood brain barrier permeability at 4h post-stroke and global suppression of cytokines including IL-6, IL-10 and TNF-alpha. A subset of these cytokines including IL-6 was also suppressed by IGF-1 at 24h post-stroke. These data are the first to show that the temporal and mechanistic components of post-stroke IGF-1 treatment in older animals, and that cellular components of the blood brain barrier may serve as critical targets of IGF-1 in the aging brain.	[Bake, Shameena; Selvamani, Amutha; Cherry, Jessica; Sohrabji, Farida] Texas A&M Univ, Coll Med, Womens Hlth Neurosci Program, Dept Neurosci & Expt Therapeut, Bryan, TX USA	Texas A&M University System; Texas A&M University College Station	Sohrabji, F (corresponding author), Texas A&M Univ, Coll Med, Womens Hlth Neurosci Program, Dept Neurosci & Expt Therapeut, Bryan, TX USA.	sohrabji@medicine.tamhsc.edu		Sohrabji, Farida/0000-0002-6960-3411	NIH [NS074895]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074895] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH NS074895 to FS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg D, 2011, J CLIN ENDOCR METAB, V96, pE1055, DOI 10.1210/jc.2010-2802; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Baeten KM, 2011, DEV NEUROBIOL, V71, P1018, DOI 10.1002/dneu.20954; Bake S, 2004, ENDOCRINOLOGY, V145, P5471, DOI 10.1210/en.2004-0984; Bake S, 2008, ENDOCRINOLOGY, V149, P3881, DOI 10.1210/en.2008-0288; Brywe KG, 2005, ENDOCRINOLOGY, V146, P4665, DOI 10.1210/en.2005-0389; Chi OZ, 2007, EXP NEUROL, V204, P283, DOI 10.1016/j.expneurol.2006.11.001; Chisalita SI, 2004, AM J PHYSIOL-ENDOC M, V286, pE896, DOI 10.1152/ajpendo.00327.2003; Chisalita SI, 2006, GROWTH HORM IGF RES, V16, P258, DOI 10.1016/j.ghir.2006.06.003; Clark D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047792; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Denli AM, 2003, TRENDS BIOCHEM SCI, V28, P196, DOI 10.1016/S0968-0004(03)00058-6; DiNapoli VA, 2008, NEUROBIOL AGING, V29, P753, DOI 10.1016/j.neurobiolaging.2006.12.007; Faber JE, 2011, ARTERIOSCL THROM VAS, V31, P1748, DOI 10.1161/ATVBAHA.111.227314; Fernandez-Lopez D, 2012, J NEUROSCI, V32, P9588, DOI 10.1523/JNEUROSCI.5977-11.2012; Garcia-Galloway E, 2003, MOL CELL NEUROSCI, V24, P1027, DOI 10.1016/j.mcn.2003.08.005; Gidday JM, 2005, AM J PHYSIOL-HEART C, V289, pH558, DOI 10.1152/ajpheart.01275.2004; GLUCKMAN P, 1992, BIOCHEM BIOPH RES CO, V182, P593, DOI 10.1016/0006-291X(92)91774-K; Hatakeyama N, 2008, CELL TISSUE RES, V334, P243, DOI 10.1007/s00441-008-0690-9; Hochdorfer T, 2011, CELL SIGNAL, V23, P866, DOI 10.1016/j.cellsig.2011.01.012; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Israeli D, 2011, INT J BIOL SCI, V7, P1; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Jezierski MK, 2001, NEUROBIOL AGING, V22, P309; Jezierski MK, 2000, MOL BRAIN RES, V85, P77, DOI 10.1016/S0169-328X(00)00244-8; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Johnsen SP, 2005, J CLIN ENDOCR METAB, V90, P5937, DOI 10.1210/jc.2004-2088; JOHNSON SA, 1995, J IMMUNOL, V155, P4596; KIM JS, 1995, J NEUROIMMUNOL, V56, P127, DOI 10.1016/0165-5728(94)00138-E; Kleinschnitz C, 2013, BLOOD, V121, P679, DOI 10.1182/blood-2012-04-426734; Ko JA, 2009, CELL BIOCHEM FUNCT, V27, P388, DOI 10.1002/cbf.1587; Lee M, 2012, J NEUROL SCI, V313, P142, DOI 10.1016/j.jns.2011.08.048; Lee Won Jun, 2011, Immune Netw, V11, P223, DOI 10.4110/in.2011.11.4.223; Leon RL, 2012, ENDOCRINOLOGY, V153, P3386, DOI 10.1210/en.2011-1859; Lewis DK, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.11.007; Lin SY, 2009, EXP NEUROL, V217, P361, DOI 10.1016/j.expneurol.2009.03.021; Liu FD, 2009, J CEREBR BLOOD F MET, V29, P792, DOI 10.1038/jcbfm.2009.5; Manwani B, 2013, EXP NEUROL; Matsuzaki H, 1999, J NEUROCHEM, V73, P2037; McColl BW, 2009, NEUROSCIENCE, V158, P1049, DOI 10.1016/j.neuroscience.2008.08.019; Mitsui R, 2010, ARCH ORAL BIOL, V55, P963, DOI 10.1016/j.archoralbio.2010.07.023; Muller AP, 2012, MOL CELL NEUROSCI, V49, P9, DOI 10.1016/j.mcn.2011.07.008; Nordell VL, 2003, NEUROBIOL AGING, V24, P733, DOI 10.1016/S0197-4580(02)00193-8; PAXINOS G, 1985, J NEUROSCI METH, V13, P139, DOI 10.1016/0165-0270(85)90026-3; Petrea RE, 2009, STROKE, V40, P1032, DOI 10.1161/STROKEAHA.108.542894; Potter KA, 2013, BIOMATERIALS, V34, P7001, DOI 10.1016/j.biomaterials.2013.05.035; Quesada A, 2004, J NEUROSCI RES, V75, P107, DOI 10.1002/jnr.10833; Rizk NN, 2007, ENDOCRINE, V31, P66, DOI 10.1007/s12020-007-0012-0; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rosenberg Gary A, 2007, Neurosurg Focus, V22, pE4; Russo VC, 2005, ENDOCR REV, V26, P916, DOI 10.1210/er.2004-0024; Selvamani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032662; Selvamani A, 2010, J NEUROSCI, V30, P6852, DOI 10.1523/JNEUROSCI.0761-10.2010; Selvamani A, 2010, NEUROBIOL AGING, V31, P1618, DOI 10.1016/j.neurobiolaging.2008.08.014; Siegel C, 2011, P NATL ACAD SCI USA, V108, P11662, DOI 10.1073/pnas.1102635108; Smith PF, 2003, IDRUGS, V6, P1173; Taglauer ES, 2008, BIOL REPROD, V79, P562, DOI 10.1095/biolreprod.107.066324; Towfighi A, 2007, NEUROLOGY, V69, P1898, DOI 10.1212/01.wnl.0000268491.89956.c2; Tureyen K, 2008, J NEUROCHEM, V105, P1313, DOI 10.1111/j.1471-4159.2008.05233.x; Turtzo LC, 2008, CEREBROVASC DIS, V26, P462, DOI 10.1159/000155983; Wang JM, 2000, BRAIN RES, V859, P381, DOI 10.1016/S0006-8993(00)02008-4; Wang Y, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/276540; Wine RN, 2009, NEUROTOX RES, V16, P280, DOI 10.1007/s12640-009-9060-y; Xie R, 2013, J CEREB BLOOD FLOW M; Yoshimoto T, 2001, BRAIN RES, V899, P148, DOI 10.1016/S0006-8993(01)02220-X; Zhuang Z, 2011, ANN CLIN LAB SCI, V41, P364	66	66	71	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91427	10.1371/journal.pone.0091427	http://dx.doi.org/10.1371/journal.pone.0091427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618563	gold, Green Submitted, Green Published			2022-12-25	WOS:000332842400091
J	Chernobrovkin, AL; Zubarev, RA				Chernobrovkin, Alexey L.; Zubarev, Roman A.			Detection of Viral Proteins in Human Cells Lines by Xeno-Proteomics: Elimination of the Last Valid Excuse for Not Testing Every Cellular Proteome Dataset for Viral Proteins	PLOS ONE			English	Article							PEPTIDE IDENTIFICATION; CULTURES; MISIDENTIFICATION; RETROVIRUS; DNA	Cell cultures used routinely in proteomic experiments may contain proteins from other species because of infection, transfection or just contamination. Since infection or contamination may affect the results of a biological experiment, it is important to test the samples for the presence of "alien'' proteins. Usually cells are tested only for the most common infections, and most of the existing tests are targeting specific contaminations. Here we describe a three-step procedure for reliable untargeted detection of viral proteins using proteomics data, and recommend this or similar procedure to be applied to every proteomics dataset submitted for publication.	[Chernobrovkin, Alexey L.; Zubarev, Roman A.] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Zubarev, Roman A.] SciLifeLab, Stockholm, Sweden	Karolinska Institutet; SciLifeLab	Zubarev, RA (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	roman.zubarev@ki.se	Zubarev, Roman A/W-7891-2018; Chernobrovkin, Alexey/ABF-5732-2020	Zubarev, Roman A/0000-0001-9839-2089; 	Knut and Alice Wallenberg Foundation; Swedish Research council	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research council(Swedish Research CouncilEuropean Commission)	This work was supported by the Knut and Alice Wallenberg Foundation as well as the Swedish Research council.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Alves G, 2013, J PROTEOME RES; [Anonymous], 2012, NAT METHODS, V9, P419, DOI 10.1038/nmeth.2011; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bromenshenk JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013181; Brosch M, 2009, J PROTEOME RES, V8, P3176, DOI 10.1021/pr800982s; Capes-Davis A, 2010, INT J CANCER, V127, P1, DOI 10.1002/ijc.25242; Castro F, 2013, INT J CANCER, V132, P308, DOI 10.1002/ijc.27675; Cmarik JL, 2011, VIRUSES-BASEL, V3, P2442, DOI 10.3390/v3122442; Colaert N, 2011, J PROTEOME RES, V10, P5555, DOI 10.1021/pr200913a; Drexler HG, 2002, CYTOTECHNOLOGY, V39, P75, DOI 10.1023/A:1022913015916; Foster LJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006387; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Gholami AM, 2013, CELL REP; Gillet J-P, 2013, J NATL CANC I; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Horie M, 2010, NATURE, V463, P84, DOI 10.1038/nature08695; Hulo C, 2011, NUCLEIC ACIDS RES, V39, pD576, DOI 10.1093/nar/gkq901; Jern P, 2008, ANNU REV GENET, V42, P709, DOI 10.1146/annurev.genet.42.110807.091501; Knudsen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020873; Korch C, 2012, GYNECOL ONCOL, V127, P241, DOI 10.1016/j.ygyno.2012.06.017; Lacroix M, 2008, INT J CANCER, V122, P1, DOI 10.1002/ijc.23233; Lee D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044954; Lokhov P, 2009, RAPID COMMUN MASS SP, V23, P680, DOI 10.1002/rcm.3928; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Lyutvinskiy Y, 2013, MOL CELL PROTEOMICS, V12, P2324, DOI 10.1074/mcp.O112.023804; Mansky LM, 1998, J GEN VIROL, V79, P1337, DOI 10.1099/0022-1317-79-6-1337; Masters JR, 2012, NATURE, V492, P186, DOI 10.1038/492186a; Masters JRW, 2010, NAT REV CANCER, V10, P441, DOI 10.1038/nrc2852; Merten OW, 2002, CYTOTECHNOLOGY, V39, P91, DOI 10.1023/A:1022969101804; Mobley A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063221; Nesvizhskii AI, 2007, METHOD MOL BIOL, V367, P87, DOI DOI 10.1385/1-59745-275-0:87; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schweppe RE, 2013, J CLIN ENDOCR METAB, V98, P956, DOI 10.1210/jc.2012-4182; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025	36	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91433	10.1371/journal.pone.0091433	http://dx.doi.org/10.1371/journal.pone.0091433			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618588	Green Submitted, gold, Green Published			2022-12-25	WOS:000332842400093
J	Joo, S; Han, D; Lee, EJ; Park, S				Joo, Sungbae; Han, Donguk; Lee, Eun Ju; Park, Sangkyu			Use of Length Heterogeneity Polymerase Chain Reaction (LH-PCR) as Non-Invasive Approach for Dietary Analysis of Svalbard Reindeer, Rangifer tarandus platyrhynchus	PLOS ONE			English	Article							PREY DNA; WINTER; AMPLIFICATION; MACROALGAE; PENGUINS; PRIMERS; REGION; FECES; FOOD	To efficiently investigate the forage preference of Svalbard reindeer (Rangifer tarandus platyrhynchus), we applied length-heterogeneity polymerase chain reaction (LH-PCR) based on length differences of internal transcribed spacer (ITS) regions of ribosomal RNA (rRNA) to fecal samples from R. tarandus platyrhynchus. A length-heterogeneity (LH) database was constructed using both collected potential food sources of Svalbard reindeer and fecal samples, followed by PCR, cloning and sequencing. In total, eighteen fecal samples were collected between 2011 and 2012 from 2 geographic regions and 15 samples were successfully amplified by PCR. The LH-PCR analysis detected abundant peaks, 18.6 peaks on an average per sample, ranging from 100 to 500 bp in size and showing distinct patterns associated with both regions and years of sample collection. Principal component analysis (PCA) resulted in clustering of 15 fecal samples into 3 groups by the year of collection and region with a statistically significant difference at 99.9% level. The first 2 principal components (PCs) explained 71.1% of the total variation among the samples. Through comparison with LH database and identification by cloning and sequencing, lichens (Stereocaulon sp. and Ochrolechia sp.) and plant species (Salix polaris and Saxifraga oppositifolia) were detected as the food sources that contributed most to the Svalbard reindeer diet. Our results suggest that the use of LH-PCR analysis would be a non-invasive and efficient monitoring tool for characterizing the foraging strategy of Svalbard reindeer. Additionally, combining sequence information would increase its resolving power in identification of foraged diet components.	[Joo, Sungbae; Park, Sangkyu] Ajou Univ, Dept Biol Sci, Suwon 441749, South Korea; [Han, Donguk; Lee, Eun Ju] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea	Ajou University; Seoul National University (SNU)	Park, S (corresponding author), Ajou Univ, Dept Biol Sci, Suwon 441749, South Korea.	daphnia@ajou.ac.kr		Park, Sangkyu/0000-0003-3049-0728	National Research Foundation of Korea; Korean Government (MEST) [NRF-C1ABA001-2012-0021071]; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2009-0073291]; Ajou University [S2011-G0001-00078]	National Research Foundation of Korea(National Research Foundation of Korea); Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ajou University	This research was supported by the National Research Foundation of Korea Grant funded by the Korean Government (MEST) (NRF-C1ABA001-2012-0021071) and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology(No. 2009-0073291), in addition to the intramural research fund (S2011-G0001-00078) from Ajou University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamot IA, 2011, THESIS NORWEGIAN U S; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; Barrett RT, 2007, ICES J MAR SCI, V64, P1675, DOI 10.1093/icesjms/fsm152; Begerow D, 2010, APPL MICROBIOL BIOT, V87, P99, DOI 10.1007/s00253-010-2585-4; Bjorkvoll E, 2009, ARCT ANTARCT ALP RES, V41, P88, DOI [10.1657/1938-4246(07-100)[BJORKVOLL]2.0.CO;2, 10.1657/1523-0430-41.1.88]; Brusetti L, 2006, FEMS MICROBIOL ECOL, V56, P154, DOI 10.1111/j.1574-6941.2005.00059.x; Carlton JT, 2003, MAR ECOL PROG SER, V256, P271, DOI 10.3354/meps256271; Chandler DP, 1997, MOL ECOL, V6, P475, DOI 10.1046/j.1365-294X.1997.00205.x; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Chun JY, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm051; Colman JE, 2001, WILDLIFE BIOL, V7, P275, DOI 10.2981/wlb.2001.032; DANELL K, 1994, ECOGRAPHY, V17, P153, DOI 10.1111/j.1600-0587.1994.tb00088.x; Deagle BE, 2005, J HERED, V96, P417, DOI 10.1093/jhered/esi036; Deagle BE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000831; Deagle BE, 2007, CONSERV GENET, V8, P743, DOI 10.1007/s10592-006-9197-7; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; Deagle BE, 2009, MOL ECOL, V18, P2022, DOI 10.1111/j.1365-294X.2009.04158.x; Dunshea G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005252; Hansen BB, 2007, POLAR BIOL, V30, P549, DOI 10.1007/s00300-006-0212-8; Hansen BB, 2012, POLAR RES, V31, DOI 10.3402/polar.v31i0.17258; Hansen BB, 2011, ECOLOGY, V92, P1917, DOI 10.1890/11-0095.1; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Joo S, 2010, J MICROBIOL METH, V81, P61, DOI 10.1016/j.mimet.2010.01.025; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; KLEIN D R, 1990, Rangifer, P123; LEWIS AP, 1994, NUCLEIC ACIDS RES, V22, P2859, DOI 10.1093/nar/22.14.2859; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lindner Elke, 2003, Polar Record, V39, P245; Mathiesen Svein D., 2000, Rangifer, V20, P17; Mills DK, 2007, SOIL SCI SOC AM J, V71, P572, DOI 10.2136/sssaj2006.0147; Moreno LI, 2006, J FORENSIC SCI, V51, P1315, DOI 10.1111/j.1556-4029.2006.00264.x; Murray DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025776; Oehm J, 2011, MOL ECOL RESOUR, V11, P620, DOI 10.1111/j.1755-0998.2011.03001.x; REIMERS E, 1982, ARCTIC ALPINE RES, V14, P295, DOI 10.2307/1550792; Ritchie NJ, 2000, APPL ENVIRON MICROB, V66, P1668, DOI 10.1128/AEM.66.4.1668-1675.2000; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; Shehzad W, 2012, MOL ECOL, V21, P1951, DOI 10.1111/j.1365-294X.2011.05424.x; Staaland H., 1993, Rangifer, V13, P15; STAALAND H, 1988, Rangifer, V8, P2; Suzuki M, 1998, APPL ENVIRON MICROB, V64, P4522; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tyler N. J. C., 1986, RANGIFER, V6, P311, DOI DOI 10.7557/2.6.2.664; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Van der Wal R, 2000, OECOLOGIA, V123, P108, DOI 10.1007/s004420050995; van der Wal R, 1998, CAN J ZOOL, V76, P1117, DOI 10.1139/cjz-76-6-1117; Vestheim H, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-12; White T., 1990, PCR PROTOCOLS GUIDE, P315; Wiencke C., 2012, SEAWEED BIOL ECOLOGI, P265, DOI [10.1007/978-3-642-28451-9_13, DOI 10.1007/978-3-642-28451-9_13]; Wlodarska-Kowalczuk M, 2009, POLAR BIOL, V32, P897, DOI 10.1007/s00300-009-0590-9; Wulff A, 2009, BOT MAR, V52, P491, DOI 10.1515/BOT.2009.072	50	6	8	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91552	10.1371/journal.pone.0091552	http://dx.doi.org/10.1371/journal.pone.0091552			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618847	gold, Green Published, Green Submitted			2022-12-25	WOS:000332842400104
J	Kim, H; Cho, J; Kim, YR; Song, Y; Chun, SI; Suh, JY; Kim, JK; Ryu, YH; Choi, SM; Cho, H; Cho, G				Kim, Hyungjun; Cho, Junghun; Kim, Young R.; Song, Youngkyu; Chun, Song-I; Suh, Ji-Yeon; Kim, Jeong Kon; Ryu, Yeon-Hee; Choi, Sun-Mi; Cho, Hyungjoon; Cho, Gyunggoo			Response of the Primary Auditory and Non-Auditory Cortices to Acoustic Stimulation: A Manganese-Enhanced MRI Study	PLOS ONE			English	Article							RESONANCE-IMAGING MEMRI; MEDIAL GENICULATE-BODY; VISUAL-CORTEX; INFERIOR COLLICULUS; FUNCTIONAL-ACTIVITY; SOCIAL STRESS; RAT; PROJECTIONS; PATHWAY; ORGANIZATION	Structural and functional features of various cerebral cortices have been extensively explored in neuroscience research. We used manganese-enhanced MRI, a non-invasive method for examining stimulus-dependent activity in the whole brain, to investigate the activity in the layers of primary cortices and sensory, such as auditory and olfactory, pathways under acoustic stimulation. Male Sprague-Dawley rats, either with or without exposure to auditory stimulation, were scanned before and 24-29 hour after systemic MnCl2 injection. Cortex linearization and layer-dependent signal extraction were subsequently performed for detecting layer-specific cortical activity. We found stimulus-dependent activity in the deep layers of the primary auditory cortex and the auditory pathways. The primary sensory and visual cortices also showed the enhanced activity, whereas the olfactory pathways did not. Further, we performed correlation analysis of the signal intensity ratios among different layers of each cortex, and compared the strength of correlations between with and without the auditory stimulation. In the primary auditory cortex, the correlation strength between left and right hemisphere showed a slight but not significant increase with the acoustic simulation, whereas, in the primary sensory and visual cortex, the correlation coefficients were significantly smaller. These results suggest the possibility that even though the primary auditory, sensory, and visual cortices showed enhanced activity to the auditory stimulation, these cortices had different associations for auditory processing in the brain network.	[Kim, Hyungjun; Song, Youngkyu; Chun, Song-I; Suh, Ji-Yeon; Kim, Jeong Kon; Cho, Gyunggoo] Korea Basic Sci Inst, Div MR, Ochang Eup, Chungbuk, South Korea; [Kim, Hyungjun; Ryu, Yeon-Hee; Choi, Sun-Mi] Korea Inst Oriental Med, Div Med Res, Taejon, South Korea; [Cho, Junghun; Cho, Hyungjoon] UNIST, Sch Nanobiosci & Chem Engn, Ulsan, South Korea; [Kim, Young R.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging,Dept Radi, Charlestown, MA USA; [Kim, Jeong Kon] Univ Ulsan, Dept Radiol, Asan Med Ctr, Seoul, South Korea	Korea Basic Science Institute (KBSI); Korea Institute of Oriental Medicine (KIOM); Ulsan National Institute of Science & Technology (UNIST); Harvard University; Massachusetts General Hospital; University of Ulsan	Cho, H (corresponding author), UNIST, Sch Nanobiosci & Chem Engn, Ulsan, South Korea.	hjcho@unist.ac.kr; gyunggoo@kbsi.re.kr	Cho, HyungJoon/F-1423-2010	Kim, Hyungjun/0000-0001-7997-7663	Korea Basic Science Institute [E33601]; UNIST (Ulsan National Institute of Science and Technology) [1.130030.01]; Korea Institute of Oriental Medicine [K13290]	Korea Basic Science Institute; UNIST (Ulsan National Institute of Science and Technology); Korea Institute of Oriental Medicine	This research was supported by grants from the Korea Basic Science Institute (E33601), from the 2013 Future Challenge Research Fund (Project No. 1.130030.01) of UNIST (Ulsan National Institute of Science and Technology), and from the Korea Institute of Oriental Medicine (K13290). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman BL, 2007, J NEUROPHYSIOL, V98, P545, DOI 10.1152/jn.00173.2007; BARTH DS, 1995, BRAIN RES, V678, P177, DOI 10.1016/0006-8993(95)00182-P; Bissig D, 2009, NEUROIMAGE, V44, P627, DOI 10.1016/j.neuroimage.2008.10.013; Blanchard RJ, 2001, PHYSIOL BEHAV, V73, P261, DOI 10.1016/S0031-9384(01)00449-8; Budinger E, 2008, BRAIN RES, V1220, P2, DOI 10.1016/j.brainres.2007.07.084; Budinger E, 2009, HEARING RES, V258, P16, DOI 10.1016/j.heares.2009.04.021; Campi KL, 2010, CEREB CORTEX, V20, P89, DOI 10.1093/cercor/bhp082; Cheung MM, 2012, NEUROIMAGE, V60, P1205, DOI 10.1016/j.neuroimage.2012.01.087; D'Amato FR, 2001, PHYSIOL BEHAV, V73, P421, DOI 10.1016/S0031-9384(01)00460-7; FISHMAN MC, 1973, VISION RES, V13, P1415, DOI 10.1016/0042-6989(73)90002-3; GAMES KD, 1988, HEARING RES, V34, P1, DOI 10.1016/0378-5955(88)90047-0; Holt AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014260; Huang SN, 2009, NEUROIMAGE, V46, P589, DOI 10.1016/j.neuroimage.2009.02.027; HUFFMAN RF, 1990, BRAIN RES REV, V15, P295, DOI 10.1016/0165-0173(90)90005-9; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jin SU, 2013, MAGN RESON IMAGING, V31, P1143, DOI 10.1016/j.mri.2013.03.003; Kanold PO, 2011, J NEUROPHYSIOL, V105, P1063, DOI 10.1152/jn.00807.2010; KORALEK KA, 1990, J COMP NEUROL, V299, P133, DOI 10.1002/cne.902990202; Koretsky AP, 2004, NMR BIOMED, V17, P527, DOI 10.1002/nbm.940; LEDOUX JE, 1985, J COMP NEUROL, V242, P182, DOI 10.1002/cne.902420204; Lee HJ, 2012, NEUROIMAGE, V60, P1046, DOI 10.1016/j.neuroimage.2012.01.065; Lee JW, 2007, MAGN RESON IMAGING, V25, P652, DOI 10.1016/j.mri.2006.10.003; Llano DA, 2008, J COMP NEUROL, V507, P1209, DOI 10.1002/cne.21602; PETERS A, 1985, J COMP NEUROL, V238, P263, DOI 10.1002/cne.902380303; ROMANSKI LM, 1993, CEREB CORTEX, V3, P515, DOI 10.1093/cercor/3.6.515; Rouiller EM, 2000, BRAIN RES BULL, V53, P727, DOI 10.1016/S0361-9230(00)00364-6; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Silva AC, 2008, J NEUROSCI METH, V167, P246, DOI 10.1016/j.jneumeth.2007.08.020; Slater BJ, 2013, NEUROSCIENCE, V229, P144, DOI 10.1016/j.neuroscience.2012.10.053; Smith PH, 2012, J COMP NEUROL, V520, P34, DOI 10.1002/cne.22682; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tanaka E, 2008, J ANAT, V213, P743, DOI 10.1111/j.1469-7580.2008.00990.x; Watanabe T, 2008, MAGN RESON MED, V60, P210, DOI 10.1002/mrm.21645; Watson C, 2006, RAT BRAIN STEREOTAXI; Winer JA, 1999, HEARING RES, V130, P42, DOI 10.1016/S0378-5955(98)00217-2; Yu X, 2005, NAT NEUROSCI, V8, P961, DOI 10.1038/nn1477; Yu X, 2008, NEUROIMAGE, V39, P223, DOI 10.1016/j.neuroimage.2007.08.029; Zhang JW, 2013, NEUROIMAGE, V65, P119, DOI 10.1016/j.neuroimage.2012.09.069	38	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90427	10.1371/journal.pone.0090427	http://dx.doi.org/10.1371/journal.pone.0090427			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618696	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400018
J	Sarovich, DS; Price, EP; Webb, JR; Ward, LM; Voutsinos, MY; Tuanyok, A; Mayo, M; Kaestli, M; Currie, BJ				Sarovich, Derek S.; Price, Erin P.; Webb, Jessica R.; Ward, Linda M.; Voutsinos, Marcos Y.; Tuanyok, Apichai; Mayo, Mark; Kaestli, Mirjam; Currie, Bart J.			Variable Virulence Factors in Burkholderia pseudomallei (Melioidosis) Associated with Human Disease	PLOS ONE			English	Article							ACTIN-BASED MOTILITY; IDENTIFICATION; AGENT	Burkholderia pseudomallei is a Gram-negative environmental bacterium that causes melioidosis, a potentially life-threatening infectious disease affecting mammals, including humans. Melioidosis symptoms are both protean and diverse, ranging from mild, localized skin infections to more severe and often fatal presentations including pneumonia, septic shock with multiple internal abscesses and occasionally neurological involvement. Several ubiquitous virulence determinants in B. pseudomallei have already been discovered. However, the molecular basis for differential pathogenesis has, until now, remained elusive. Using clinical data from 556 Australian melioidosis cases spanning more than 20 years, we identified a Burkholderia mallei-like actin polymerization bimA(Bm) gene that is strongly associated with neurological disease. We also report that a filamentous hemagglutinin gene, fhaB3, is associated with positive blood cultures but is negatively correlated with localized skin lesions without sepsis. We show, for the first time, that variably present virulence factors play an important role in the pathogenesis of melioidosis. Collectively, our study provides a framework for assessing other non-ubiquitous bacterial virulence factors and their association with disease, such as candidate loci identified from large-scale microbial genome-wide association studies.	[Sarovich, Derek S.; Price, Erin P.; Webb, Jessica R.; Ward, Linda M.; Voutsinos, Marcos Y.; Mayo, Mark; Kaestli, Mirjam; Currie, Bart J.] Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia; [Tuanyok, Apichai] Univ Hawaii, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA; [Currie, Bart J.] Royal Darwin Hosp, Dept Infect Dis, Darwin, NT, Australia	Charles Darwin University; Menzies School of Health Research; University of Hawaii System	Sarovich, DS (corresponding author), Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia.	derek.sarovich@menzies.edu.au	Sarovich, Derek/H-5587-2019; Price, Erin/N-2336-2013	Sarovich, Derek/0000-0002-6944-3980; Price, Erin/0000-0002-1079-4882; , Mirjam/0000-0002-6053-5141	Australian National Health and Medical Research Council [605820, 1046812]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the Australian National Health and Medical Research Council via project grant awards 605820 and 1046812. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Burtnick MN, 2011, INFECT IMMUN, V79, P1512, DOI 10.1128/IAI.01218-10; Butler D, 2012, NATURE, V490, P456, DOI 10.1038/490456a; Cheng AC, 2008, PLOS MED, V5, P1173, DOI 10.1371/journal.pmed.0050175; Chieng S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-328; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; Cruz-Migoni A, 2011, SCIENCE, V334, P821, DOI 10.1126/science.1211915; Currie BJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000900; Currie BJ, 2000, ACTA TROP, V74, P145, DOI 10.1016/S0001-706X(99)00064-9; Dowling AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015693; El Tahir Y, 2001, INT J MED MICROBIOL, V291, P209, DOI 10.1078/1438-4221-00119; Fierer J, 2001, J CLIN INVEST, V107, P775, DOI 10.1172/JCI12561; French CT, 2011, P NATL ACAD SCI USA, V108, P12095, DOI 10.1073/pnas.1107183108; Gibney KB, 2008, CLIN INFECT DIS, V47, P603, DOI 10.1086/590931; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Kaestli M, 2012, J CLIN MICROBIOL, V50, P2059, DOI 10.1128/JCM.06737-11; Kespichayawattana W, 2000, INFECT IMMUN, V68, P5377, DOI 10.1128/IAI.68.9.5377-5384.2000; Limmathurotsakul D, 2007, AM J TROP MED HYG, V77, P118, DOI 10.4269/ajtmh.2007.77.118; Limmathurotsakul D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002105; Limmathurotsakul D, 2010, AM J TROP MED HYG, V82, P1113, DOI 10.4269/ajtmh.2010.10-0038; Lopez J, 2003, MICROBES INFECT, V5, P1125, DOI 10.1016/j.micinf.2003.07.004; Massey S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00174; Mukhopadhyay C, 2011, AM J TROP MED HYG, V85, P121, DOI 10.4269/ajtmh.2011.11-0166; Owen SJ, 2009, J INFECT DIS, V199, P1761, DOI 10.1086/599210; Poolman JT, 2007, EXPERT REV VACCINES, V6, P47, DOI 10.1586/14760584.6.1.47; Reckseidler SL, 2001, INFECT IMMUN, V69, P34, DOI 10.1128/IAI.69.1.34-44.2001; Sim SH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000178; Sitthidet C, 2008, J CLIN MICROBIOL, V46, P2418, DOI 10.1128/JCM.00368-08; Sitthidet C, 2011, J BACTERIOL, V193, P1901, DOI 10.1128/JB.01455-10; Sitthidet C, 2010, J BACTERIOL, V192, P5249, DOI 10.1128/JB.00608-10; Srinivasan A, 2001, NEW ENGL J MED, V345, P256, DOI 10.1056/NEJM200107263450404; Stevens MP, 2005, MOL MICROBIOL, V56, P40, DOI 10.1111/j.1365-2958.2004.04528.x; Tuanyok A, 2007, J BACTERIOL, V189, P9044, DOI 10.1128/JB.01264-07; Tuanyok A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-566; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385	35	74	74	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91682	10.1371/journal.pone.0091682	http://dx.doi.org/10.1371/journal.pone.0091682			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618705	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400118
J	de Jong, TR; Beiderbeck, DI; Neumann, ID				de Jong, Trynke R.; Beiderbeck, Daniela I.; Neumann, Inga D.			Measuring Virgin Female Aggression in the Female Intruder Test (FIT): Effects of Oxytocin, Estrous Cycle, and Anxiety	PLOS ONE			English	Article							C-FOS EXPRESSION; SEX-DIFFERENCES; MATERNAL AGGRESSION; GENDER-DIFFERENCES; CONDUCT DISORDER; HYPOTHALAMIC AGGRESSION; ARGININE-VASOPRESSIN; INTERMALE AGGRESSION; SOCIAL AGGRESSION; SEROTONIN 1A	The costs of violence and aggression in our society have stimulated the scientific search for the predictors and causes of aggression. The majority of studies have focused on males, which are considered to be more aggressive than females in most species. However, rates of offensive behavior in girls and young women are considerable and are currently rising in Western society. The extrapolation of scientific results from males to young, non-maternal females is a priori limited, based on the profound sex differences in brain areas and functioning of neurotransmitters involved in aggression. Therefore, we established a paradigm to assess aggressive behavior in young virgin female rats, i.e. the female intruder test (FIT). We found that approximately 40% of un-manipulated adult (10-11 weeks old) female Wistar rats attack an intruder female during the FIT, independent of their estrous phase or that of their intruder. In addition, adolescent (7-8 weeks old) female rats selected for high anxiety behavior (HABs) displayed significantly more aggression than non-selected (NAB) or low-anxiety (LAB) rats. Intracerebroventricular infusion of oxytocin (OXT, 0.1 mu g/5 mu l) inhibited aggressive behavior in adult NAB and LAB, but not HAB females. Adolescent NAB rats that had been aggressive towards their intruder showed increased pERK immunoreactivity (IR) in the hypothalamic attack area and reduced pERK-IR in OXT neurons in the paraventricular hypothalamic nucleus compared to non-aggressive NAB rats. Taken together, aggressive behavior in young virgin female rats is partly dependent on trait anxiety, and appears to be under considerable OXT control.	[de Jong, Trynke R.; Beiderbeck, Daniela I.; Neumann, Inga D.] Univ Regensburg, Dept Behav & Mol Neurobiol, D-93053 Regensburg, Germany	University of Regensburg	de Jong, TR (corresponding author), Univ Regensburg, Dept Behav & Mol Neurobiol, D-93053 Regensburg, Germany.	trynke.de-jong@ur.de	de Jong, Trynke R./D-8989-2013	de Jong, Trynke R./0000-0001-8361-6895	Alexander von Humboldt Foundation Research Fellowship for Postdoctoral Researchers; Deutsche Forschungsgemeinschaft; European Community [602407]	Alexander von Humboldt Foundation Research Fellowship for Postdoctoral Researchers(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Community(European Commission)	TdJ was funded by an Alexander von Humboldt Foundation Research Fellowship for Postdoctoral Researchers (http://www.humboldt-foundation.de). The research leading to these results has received funding from the Deutsche Forschungsgemeinschaft (www.dfg.de) and the European Community's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement no 602407 (FemNAT-CD) (http://ec.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBONETTI ME, 1993, AGGRESSIVE BEHAV, V19, P369, DOI 10.1002/1098-2337(1993)19:5<369::AID-AB2480190506>3.0.CO;2-W; Archer J, 2009, BEHAV BRAIN SCI, V32, P249, DOI 10.1017/S0140525X09990951; Baranyi J, 2005, PHYSIOL BEHAV, V84, P511, DOI 10.1016/j.physbeh.2005.01.005; Bartz JA, 2010, PSYCHOL SCI, V21, P1426, DOI 10.1177/0956797610383439; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Beiderbeck DI, 2007, EUR J NEUROSCI, V26, P3597, DOI 10.1111/j.1460-9568.2007.05974.x; Beiderbeck DI, 2012, PSYCHONEUROENDOCRINO, V37, P1969, DOI 10.1016/j.psyneuen.2012.04.011; Berkout OV, 2011, AGGRESS VIOLENT BEH, V16, P503, DOI 10.1016/j.avb.2011.06.001; Blumstein D. T., 2007, QUANTIFYING BEHAV JW; Bosch OJ, 2005, J NEUROSCI, V25, P6807, DOI 10.1523/JNEUROSCI.1342-05.2005; Bosch OJ, 2012, HORM BEHAV, V61, P293, DOI 10.1016/j.yhbeh.2011.11.002; Bosch OJ, 2010, EUR J NEUROSCI, V31, P883, DOI 10.1111/j.1460-9568.2010.07115.x; Calcagnoli F, 2014, BEHAV BRAIN RES, V261, P315, DOI 10.1016/j.bbr.2013.12.050; Calcagnoli F, 2013, PSYCHOPHARMACOLOGY, V229, P639, DOI 10.1007/s00213-013-3124-7; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Campbell A, 1999, BEHAV BRAIN SCI, V22, P203, DOI 10.1017/S0140525X99001818; Campbell A, 2013, AGGRESSIVE BEHAV, V39, P316, DOI 10.1002/ab.21478; Collishaw S, 2012, J ABNORM CHILD PSYCH, V40, P119, DOI 10.1007/s10802-011-9543-1; Cordero MI, 2013, PSYCHONEUROENDOCRINO, V38, P2758, DOI 10.1016/j.psyneuen.2013.07.005; Davis ES, 2004, NEUROSCIENCE, V127, P611, DOI 10.1016/j.neuroscience.2004.05.034; de Boer SF, 2003, BEHAV GENET, V33, P485, DOI 10.1023/A:1025766415159; de Vries GJ, 2008, PROG BRAIN RES, V170, P17, DOI 10.1016/S0079-6123(08)00402-0; Fairchild G, 2013, J CHILD PSYCHOL PSYC, V54, P86, DOI 10.1111/j.1469-7610.2012.02617.x; FERRIS CF, 1992, ANN NY ACAD SCI, V652, P456, DOI 10.1111/j.1749-6632.1992.tb34382.x; Ferris CF, 2000, EXP PHYSIOL, V85, p85S, DOI 10.1111/j.1469-445X.2000.tb00011.x; Fontaine N, 2008, ARCH GEN PSYCHIAT, V65, P320, DOI 10.1001/archgenpsychiatry.2007.41; Fuxjager MJ, 2011, ENDOCRINOLOGY, V152, P3422, DOI 10.1210/en.2011-1099; Gammie SC, 2001, BRAIN RES, V898, P232, DOI 10.1016/S0006-8993(01)02189-8; Goodson JL, 2009, BIOL LETTERS, V5, P554, DOI 10.1098/rsbl.2009.0316; Gutzler SJ, 2010, EUR J NEUROSCI, V31, P1655, DOI 10.1111/j.1460-9568.2010.07190.x; Haller J, 2006, NEUROSCI BIOBEHAV R, V30, P292, DOI 10.1016/j.neubiorev.2005.01.005; Haller J, 2006, PHYSIOL BEHAV, V88, P173, DOI 10.1016/j.physbeh.2006.03.030; Harmon AC, 2002, J NEUROENDOCRINOL, V14, P963, DOI 10.1046/j.1365-2826.2002.00863.x; Hasen NS, 2005, PHYSIOL BEHAV, V84, P681, DOI 10.1016/j.physbeh.2005.02.010; Henniger MSH, 2000, BEHAV BRAIN RES, V111, P153, DOI 10.1016/S0166-4328(00)00151-0; Hines M, 2011, ANNU REV NEUROSCI, V34, P69, DOI 10.1146/annurev-neuro-061010-113654; Ho HP, 2001, NEUROPSYCHOPHARMACOL, V24, P502, DOI 10.1016/S0893-133X(00)00219-0; Hodgins S, 2011, J FORENSIC PSYCHI PS, V22, P669, DOI 10.1080/14789949.2011.617539; Hurlemann R, 2010, J NEUROSCI, V30, P4999, DOI 10.1523/JNEUROSCI.5538-09.2010; JOPPA MA, 1995, NEUROSCIENCE, V68, P783, DOI 10.1016/0306-4522(95)00179-M; Joppa MA, 1997, PHARMACOL BIOCHEM BE, V58, P349, DOI 10.1016/S0091-3057(97)00277-3; Jovanovic H, 2008, NEUROIMAGE, V39, P1408, DOI 10.1016/j.neuroimage.2007.10.016; Kalueff AV, 2005, J NEUROSCI METH, V143, P169, DOI 10.1016/j.jneumeth.2004.10.001; Karriker-Jaffe KJ, 2008, J ABNORM CHILD PSYCH, V36, P1227, DOI 10.1007/s10802-008-9245-5; KOLLACKWALKER S, 1995, NEUROSCIENCE, V66, P721, DOI 10.1016/0306-4522(94)00563-K; Koolhaas JM, 2013, JOVE-J VIS EXP, DOI 10.3791/4367; KRUK MR, 1991, NEUROSCI BIOBEHAV R, V15, P527, DOI 10.1016/S0149-7634(05)80144-7; Lanctot N, 2007, CRIMINOLOGY, V45, P131, DOI 10.1111/j.1745-9125.2007.00074.x; Lehto-Salo P, 2009, NORD J PSYCHIAT, V63, P308, DOI 10.1080/08039480902730615; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Lonstein JS, 2002, NEUROSCI BIOBEHAV R, V26, P869, DOI 10.1016/S0149-7634(02)00087-8; Lukas M, 2013, PSYCHONEUROENDOCRINO, V38, P916, DOI 10.1016/j.psyneuen.2012.09.018; Lukas M, 2011, NEUROPSYCHOPHARMACOL, V36, P2159, DOI 10.1038/npp.2011.95; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; McCarthy MM, 2011, NAT NEUROSCI, V14, P677, DOI 10.1038/nn.2834; Miczek KA, 2007, J NEUROSCI, V27, P11803, DOI 10.1523/JNEUROSCI.3500-07.2007; Morcillo C, 2012, J PSYCHIATR RES, V46, P323, DOI 10.1016/j.jpsychires.2011.10.012; Murgatroyd C, 2004, J NEUROSCI, V24, P7762, DOI 10.1523/JNEUROSCI.1614-04.2004; Naslund J, 2013, PSYCHOPHARMACOLOGY, V230, P29, DOI 10.1007/s00213-013-3133-6; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; Nephew BC, 2008, PHARMACOL BIOCHEM BE, V91, P77, DOI 10.1016/j.pbb.2008.06.013; Neumann ID, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00012; Nishizawa S, 1997, P NATL ACAD SCI USA, V94, P5308, DOI 10.1073/pnas.94.10.5308; Odgers CL, 2008, DEV PSYCHOPATHOL, V20, P673, DOI 10.1017/S0954579408000333; Olivier B, 1995, PHARMACOPSYCHIATRY, V28, P80, DOI 10.1055/s-2007-979624; Pajer KA, 1998, AM J PSYCHIAT, V155, P862, DOI 10.1176/ajp.155.7.862; Paxinos G, 1997, RAT BRAIN STEREOTACT; Pedersen CA, 2002, STRESS, V5, P259, DOI 10.1080/1025389021000037586; Polier GG, 2012, EUR CHILD ADOLES PSY, V21, P31, DOI 10.1007/s00787-011-0229-6; Rimmele U, 2009, J NEUROSCI, V29, P38, DOI 10.1523/JNEUROSCI.4260-08.2009; Schwartzer JJ, 2013, AGGRESSIVE BEHAV, V39, P290, DOI 10.1002/ab.21476; Silva AL, 2010, BEHAV BRAIN RES, V208, P528, DOI 10.1016/j.bbr.2009.12.038; Staffend NA, 2012, NEUROSCIENCE, V227, P163, DOI 10.1016/j.neuroscience.2012.09.064; Takahashi A, 2011, PSYCHOPHARMACOLOGY, V213, P183, DOI 10.1007/s00213-010-2000-y; Thornton AJV, 2012, J INTERPERS VIOLENCE, V27, P1399, DOI 10.1177/0886260511425789; Toth M, 2012, BEHAV BRAIN RES, V233, P120, DOI 10.1016/j.bbr.2012.04.025; Toth M, 2010, BEHAV BRAIN RES, V215, P7, DOI 10.1016/j.bbr.2010.05.050; Trainor BC, 2010, NEUROSCIENCE, V165, P325, DOI 10.1016/j.neuroscience.2009.10.050; Trainor BC, 2010, HORM BEHAV, V58, P506, DOI 10.1016/j.yhbeh.2010.04.008; Veenema AH, 2007, BRAIN BEHAV EVOLUT, V70, P274, DOI 10.1159/000105491; Veenema AH, 2007, HORM BEHAV, V51, P11, DOI 10.1016/j.yhbeh.2006.07.004; Veenema AH, 2008, PROG BRAIN RES, V170, P261, DOI 10.1016/S0079-6123(08)00422-6; Veening JG, 2005, EUR J PHARMACOL, V526, P226, DOI 10.1016/j.ejphar.2005.09.041; Wang YF, 2007, J NEUROSCI, V27, P13822, DOI 10.1523/JNEUROSCI.4119-07.2007; Wasserman GA, 2005, AM J PUBLIC HEALTH, V95, P131, DOI 10.2105/AJPH.2003.024737; Yang CF, 2013, CELL, V153, P896, DOI 10.1016/j.cell.2013.04.017; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327	87	34	35	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91701	10.1371/journal.pone.0091701	http://dx.doi.org/10.1371/journal.pone.0091701			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614336	Green Submitted, Green Published, gold			2022-12-25	WOS:000332839300151
J	Walkowski, S; Singh, M; Puertas, J; Pate, M; Goodrum, K; Benencia, F				Walkowski, Stevan; Singh, Manindra; Puertas, Juan; Pate, Michelle; Goodrum, Kenneth; Benencia, Fabian			Osteopathic Manipulative Therapy Induces Early Plasma Cytokine Release and Mobilization of a Population of Blood Dendritic Cells	PLOS ONE			English	Article							ACUTE MENTAL STRESS; NITRIC-OXIDE; MONOCYTES	It has been claimed that osteopathic manipulative treatment (OMT) is able to enhance the immune response of individuals. In particular, it has been reported that OMT has the capability to increase antibody titers, enhance the efficacy of vaccination, and upregulate the numbers of circulating leukocytes. Recently, it has been shown in human patients suffering chronic low back pain, that OMT is able to modify the levels of cytokines such as IL-6 and TNF-alpha in blood upon repeated treatment. Further, experimental animal models show that lymphatic pump techniques can induce a transient increase of cytokines in the lymphatic circulation. Taking into account all these data, we decided to investigate in healthy individuals the capacity of OMT to induce a rapid modification of the levels of cytokines and leukocytes in circulation. Human volunteers were subjected to a mixture of lymphatic and thoracic OMT, and shortly after the levels of several cytokines were evaluated by protein array technology and ELISA multiplex analysis, while the profile and activation status of circulating leukocytes was extensively evaluated by multicolor flow cytometry. In addition, the levels of nitric oxide and C-reactive protein (CRP) in plasma were determined. In this study, our results show that OMT was not able to induce a rapid modification in the levels of plasma nitrites or CRP or in the proportion or activation status of central memory, effector memory or naive CD4 and CD8 T cells. A significant decrease in the proportion of a subpopulation of blood dendritic cells was detected in OMT patients. Significant differences were also detected in the levels of immune molecules such as IL-8, MCP-1, MIP-1 alpha and most notably, G-CSF. Thus, OMT is able to induce a rapid change in the immunological profile of particular circulating cytokines and leukocytes.	[Walkowski, Stevan] Ohio Univ, Heritage Coll Osteopath Med, Osteopath Manipulat Med Dept, Athens, OH 45701 USA; [Singh, Manindra; Benencia, Fabian] Ohio Univ, Mol & Cellular Biol Program, Athens, OH 45701 USA; [Puertas, Juan; Pate, Michelle; Goodrum, Kenneth; Benencia, Fabian] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA; [Benencia, Fabian] Ohio Univ, Biomed Engn Program, Russ Coll Engn & Technol, Athens, OH 45701 USA; [Benencia, Fabian] Ohio Univ, Inst Diabet, Athens, OH 45701 USA	University System of Ohio; Ohio University; University System of Ohio; Ohio University; University System of Ohio; Ohio University; University System of Ohio; Ohio University; University System of Ohio; Ohio University	Benencia, F (corresponding author), Ohio Univ, Mol & Cellular Biol Program, Athens, OH 45701 USA.	benencia@ohio.edu	Benencia, Fabian/AAH-1613-2020	Benencia, Fabian/0000-0003-3049-6150	Research & Scholarly Affairs Committee grant from Heritage College of Osteopathic Medicine, Ohio University; American Osteopathic Association [10-08-606]	Research & Scholarly Affairs Committee grant from Heritage College of Osteopathic Medicine, Ohio University; American Osteopathic Association	This work was funded by a Research & Scholarly Affairs Committee grant from the Heritage College of Osteopathic Medicine, Ohio University (http://www.oucom.ohiou.edu/) and a research grant (10-08-606) from the American Osteopathic Association (www.osteopathic.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bockenhauer Susan E., 2002, Journal of the American Osteopathic Association, V102, P371; Bonasio R, 2006, CURR OPIN IMMUNOL, V18, P503, DOI 10.1016/j.coi.2006.05.011; Breithaupt Thomas, 2001, Journal of the American Osteopathic Association, V101, P21; Calo L, 1998, ANGIOLOGY, V49, P419, DOI 10.1177/000331979804900601; Castlio Y, 1934, COLL J KANSAS CITY, V18, P196; Castlio Y, 1932, COLL J KANSAS CITY, V16, P111; Chikly BJ, 2005, J AM OSTEOPATH ASSOC, V105, P457; Creasy C, 2013, LYMPHAT RES BIOL, V11, P183, DOI 10.1089/lrb.2013.0007; Dugan EP, 2001, J AM OSTEOPATH ASSOC, V101, P472; Guiney PA, 2005, J AM OSTEOPATH ASSOC, V105, P7; Hodge LM, 2012, INT J OSTEOPATH MED, V15, P13, DOI 10.1016/j.ijosm.2011.11.004; Hodge LM, 2010, LYMPHAT RES BIOL, V8, P103, DOI 10.1089/lrb.2009.0011; Hodge Lisa M., 2007, Lymphatic Research and Biology, V5, P127, DOI 10.1089/lrb.2007.1001; Hruby Raymond J, 2007, Osteopath Med Prim Care, V1, P10, DOI 10.1186/1750-4732-1-10; Jackson Kelly M., 1998, Journal of the American Osteopathic Association, V98, P155; Knott EM, 2005, J AM OSTEOPATH ASSOC, V105, P447; Kop WJ, 2008, AM J CARDIOL, V101, P767, DOI 10.1016/j.amjcard.2007.11.006; Lanzavecchia A, 2001, CURR OPIN IMMUNOL, V13, P291, DOI 10.1016/S0952-7915(00)00218-1; Licciardone JC, 2013, J AM OSTEOPATH ASSOC, V113, P468; Licciardone JC, 2012, J AM OSTEOPATH ASSOC, V112, P596, DOI 10.7556/jaoa.2012.112.9.596; MEASEL JW, 1982, J AM OSTEOPATH ASSOC, V82, P59; Mesina Julian, 1998, Journal of the American Osteopathic Association, V98, P91; Noll D, 2005, INT J OSTEOPATH MED, V8, P124; Noll Donald R., 2000, Journal of the American Osteopathic Association, V100, P776; Noll DR, 2008, J AM OSTEOPATH ASSOC, V108, P69; Noll DR, 2013, J AM OSTEOPATH ASSOC, V113, P520, DOI 10.7556/jaoa.2013.003; Noll Donald R., 2004, Journal of the American Osteopathic Association, V104, P107; Noll Donald R., 1999, Journal of the American Osteopathic Association, V99, P143; Noll DR, 2004, ALTERN THER HEALTH M, V10, P74; Palucka K, 2013, IMMUNITY, V39, P38, DOI 10.1016/j.immuni.2013.07.004; Palucka K, 2013, CURR OPIN IMMUNOL, V25, P396, DOI 10.1016/j.coi.2013.05.001; Patterson MM, 2005, J AM OSTEOPATH ASSOC, V105, P498; PAUL RT, 1986, J AM OSTEOPATH ASSOC, V86, P92; Ridgway D, 2003, CANCER INVEST, V21, P873, DOI 10.1081/CNV-120025091; Rivers WE, 2008, J AM OSTEOPATH ASSOC, V108, P646; Salamon E, 2004, INT J MOL MED, V14, P443; Schander A, 2012, EXP BIOL MED, V237, P58, DOI 10.1258/ebm.2011.011220; Skrzeczynska-Moncznik J, 2008, SCAND J IMMUNOL, V67, P152, DOI 10.1111/j.1365-3083.2007.02051.x; Ward RC, 1997, FDN OSTEOPATHIC MED; Weinstein AA, 2010, BIOL PSYCHOL, V84, P228, DOI 10.1016/j.biopsycho.2010.01.016; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510	42	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90132	10.1371/journal.pone.0090132	http://dx.doi.org/10.1371/journal.pone.0090132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614605	gold, Green Published, Green Submitted			2022-12-25	WOS:000332839300019
J	Ward, AC; Connolly, P; Tucker, NP				Ward, Andrew C.; Connolly, Patricia; Tucker, Nicholas P.			Pseudomonas aeruginosa Can Be Detected in a Polymicrobial Competition Model Using Impedance Spectroscopy with a Novel Biosensor	PLOS ONE			English	Article							ELECTRODE-SOLUTION INTERFACE; DOUBLE-LAYER CAPACITANCE; IMPEDIMETRIC APPROACH; BIOFILM; PYOCYANIN; BACTERIA; ADHESION; SENSOR	Electrochemical Impedance Spectroscopy (EIS) is a powerful technique that can be used to elicit information about an electrode interface. In this article, we highlight six principal processes by which the presence of microorganisms can affect impedance and show how one of these - the production of electroactive metabolites - changes the impedance signature of culture media containing Pseudomonas aeruginosa. EIS, was used in conjunction with a low cost screen printed carbon sensor to detect the presence of P. aeruginosa when grown in isolation or as part of a polymicrobial infection with Staphylococcus aureus. By comparing the electrode to a starting measurement, we were able to identify an impedance signature characteristic of P. aeruginosa. Furthermore, we are able to show that one of the changes in the impedance signature is due to pyocyanin and associated phenazine compounds. The findings of this study indicate that it might be possible to develop a low cost sensor for the detection of P. aeruginosa in important point of care diagnostic applications. In particular, we suggest that a development of the device described here could be used in a polymicrobial clinical sample such as sputum from a CF patient to detect P. aeruginosa.	[Ward, Andrew C.; Connolly, Patricia] Univ Strathclyde, Dept Biomed Engn, Glasgow, Lanark, Scotland; [Tucker, Nicholas P.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland	University of Strathclyde; University of Strathclyde	Connolly, P (corresponding author), Univ Strathclyde, Dept Biomed Engn, Glasgow, Lanark, Scotland.	patricia.connolly@strath.ac.uk		Tucker, Nicholas/0000-0002-6331-3704	Engineering and Phyiscal Sciences Research Council [EP/F50036X/1]	Engineering and Phyiscal Sciences Research Council	This work has been funded by the Engineering and Phyiscal Sciences Research Council (www.epsrc.ac.uk, grant number: EP/F50036X/1) as part of an Engineering Doctorate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bard A. J., 2001, ELECTROCHEMICAL METH; Bayoudh S, 2008, COLLOID SURFACE A, V318, P291, DOI 10.1016/j.colsurfa.2008.01.005; Ben-Yoav H, 2011, ELECTROCHIM ACTA, V56, P7780, DOI 10.1016/j.electacta.2010.12.025; Branski LK, 2009, SURG INFECT, V10, P389, DOI 10.1089/sur.2009.024; Cady P, 1975, NEW APPROACHES IDENT, P74; Connolly P., 2010, WO2009136157, Patent No. [2009136157, WO2009136157 (A3)]; Dheilly A, 2008, APPL MICROBIOL BIOT, V79, P157, DOI 10.1007/s00253-008-1404-7; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Farrow MJ, 2012, BIOSENSORS-BASEL, V2, P171, DOI 10.3390/bios2020171; Firstenberg-Eden R., 1984, IMPEDANCE MICROBIOLO; Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0; Hassett DJ, 2009, TRENDS MICROBIOL, V17, P130, DOI 10.1016/j.tim.2008.12.003; Hernandez ME, 2001, CELL MOL LIFE SCI, V58, P1562, DOI 10.1007/PL00000796; Jefferies JMC, 2012, J MED MICROBIOL, V61, P1052, DOI 10.1099/jmm.0.044818-0; K'Owino IO, 2005, ELECTROANAL, V17, P2101, DOI 10.1002/elan.200503371; Kim S, 2012, ELECTROCHIM ACTA, V82, P126, DOI 10.1016/j.electacta.2012.05.131; Kim T, 2011, WATER RES, V45, P4615, DOI 10.1016/j.watres.2011.06.010; Kirchner S, 2012, JOVE-J VIS EXP, DOI 10.3791/3857; KITO N, 1974, CHEM LETT, P353, DOI 10.1246/cl.1974.353; Korgaonkar A, 2013, P NATL ACAD SCI USA, V110, P1059, DOI 10.1073/pnas.1214550110; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Liu GY, 2009, TRENDS MICROBIOL, V17, P406, DOI 10.1016/j.tim.2009.06.006; Marsili E, 2008, APPL ENVIRON MICROB, V74, P7329, DOI 10.1128/AEM.00177-08; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; McColl D., 2009, WOUNDS UK, V5, P94; Moulton SE, 2004, ELECTROCHIM ACTA, V49, P4223, DOI 10.1016/j.electacta.2004.03.034; Munoz-Berbel X, 2008, ELECTROCHIM ACTA, V53, P5739, DOI 10.1016/j.electacta.2008.03.050; Munoz-Berbel X, 2008, BIOSENS BIOELECTRON, V23, P1540, DOI 10.1016/j.bios.2008.01.007; Munoz-Berbel X, 2006, SENSOR ACTUAT B-CHEM, V118, P129, DOI 10.1016/j.snb.2006.04.070; Munoz-Berbel X, 2007, ELECTROCHEM COMMUN, V9, P2654, DOI 10.1016/j.elecom.2007.08.011; Nair D, 2011, J BACTERIOL, V193, P2332, DOI 10.1128/JB.00027-11; Ohfuji K, 2004, BIOSENS BIOELECTRON, V19, P1237, DOI 10.1016/j.bios.2003.11.010; Paredes J, 2013, SENSOR ACTUAT B-CHEM, V178, P663, DOI 10.1016/j.snb.2013.01.027; Paredes J, 2012, BIOSENS BIOELECTRON, V38, P226, DOI 10.1016/j.bios.2012.05.027; Poortinga AT, 2001, BIOPHYS CHEM, V91, P273, DOI 10.1016/S0301-4622(01)00177-6; Price-Whelan A, 2006, NAT CHEM BIOL, V2, P71, DOI 10.1038/nchembio764; Price-Whelan A, 2007, J BACTERIOL, V189, P6372, DOI 10.1128/JB.00505-07; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Stewart L, 2014, PATHOG DIS, V71, P20, DOI 10.1111/2049-632X.12107; Ur A, 1975, NEW APPROACHES IDENT; Wang J, 1996, ANALYST, V121, P345, DOI 10.1039/an9962100345; Wang Y, 2008, ENVIRON SCI TECHNOL, V42, P2380, DOI 10.1021/es702290a; Wang Y, 2010, J BACTERIOL, V192, P365, DOI 10.1128/JB.01188-09; WATSON D, 1986, EUR J BIOCHEM, V159, P309, DOI 10.1111/j.1432-1033.1986.tb09869.x; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Yang LJ, 2004, BIOSENS BIOELECTRON, V19, P1139, DOI 10.1016/j.bios.2003.10.009; Yang LJ, 2003, BIOSENS BIOELECTRON, V19, P495, DOI 10.1016/S0956-5663(03)00229-X	51	36	38	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91732	10.1371/journal.pone.0091732	http://dx.doi.org/10.1371/journal.pone.0091732			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614411	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000332839300152
J	Wuyun, GW; Shu, M; Cao, ZJ; Huang, W; Zou, X; Li, S; Zhang, X; Luo, H; Wu, YH				Wuyun, Gaowa; Shu, Min; Cao, Zhijun; Huang, Wei; Zou, Xin; Li, Sheng; Zhang, Xin; Luo, Huan; Wu, Yanhong			Neural Representations of the Self and the Mother for Chinese Individuals	PLOS ONE			English	Article							ANTERIOR INSULA; LEFT PARIETAL; ACTIVATION; MEMORY; COGNITION; BRAIN; INTENTION; CULTURE; CORTEX; AREAS	An important question in social neuroscience is the similarities and differences in the neural representations between the self and close others. Most studies examining this topic have identified the medial prefrontal cortex (MPFC) region as the primary area involved in this process. However, several studies have reported conflicting data, making further investigation of this topic very important. In this functional magnetic resonance imaging (fMRI) study, we investigated the brain activity in the anterior cingulate cortex (ACC) when Chinese participants passively listened to their self-name (SN), their mother's name (MN), and unknown names (UN). The results showed that compared with UN recognition, SN perception was associated with a robust activation in a widely distributed bilateral network, including the cortical midline structure (the MPFC and ACC), the inferior frontal gyrus, and the middle temporal gyrus. The SN invoked the bilateral superior temporal gyrus in contrast to the MN; the MN recognition provoked a stronger activation in the central and posterior brain regions in contrast to the SN recognition. The SN and MN caused an activation of overlapping areas, namely, the ACC, MPFC, and superior frontal gyrus. These results suggest that Chinese individuals utilize certain common brain region in processing both the SN and the MN. The present findings provide evidence for the neural basis of the self and close others for Chinese individuals.	[Wuyun, Gaowa; Shu, Min; Cao, Zhijun; Huang, Wei; Zou, Xin; Li, Sheng; Zhang, Xin; Wu, Yanhong] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China; [Luo, Huan] Chinese Acad Sci, Beijing, Peoples R China; [Wu, Yanhong] Capital Normal Univ, Learning & Cognit Lab, Beijing, Peoples R China	Peking University; Chinese Academy of Sciences; Capital Normal University	Wu, YH (corresponding author), Peking Univ, Dept Psychol, Beijing 100871, Peoples R China.	wuyh@pku.edu.cn	Li, Sheng/A-2602-2010	Li, Sheng/0000-0002-6258-3147	Natural Science Foundation of China [31070982, 31371054]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Work was funded by Natural Science Foundation of China http://www.nsfc.gov.cn/ (31070982, 31371054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos T, 2012, EUR J SOC PSYCHOL, V42, P770, DOI 10.1002/ejsp.1882; Aron A, 2003, HANDBOOK OF SELF AND IDENTITY, P442; Berscheid E., 1998, HDB SOCIAL PSYCHOL, P193; Buckner RL, 1996, PSYCHON B REV, V3, P149, DOI 10.3758/BF03212413; Cabeza R, 1997, J COGNITIVE NEUROSCI, V9, P1, DOI 10.1162/jocn.1997.9.1.1; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; D'Argembeau A, 2005, NEUROIMAGE, V25, P616, DOI 10.1016/j.neuroimage.2004.11.048; Feinberg T. E., 2009, AXONS IDENTITY NEURO; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; Han SH, 2010, SOC COGN AFFECT NEUR, V5, P332, DOI 10.1093/scan/nsp027; Heine SJ, 2001, J PERS, V69, P881, DOI 10.1111/1467-6494.696168; Hesse MD, 2006, NEUROSCIENCE, V140, P1209, DOI 10.1016/j.neuroscience.2006.03.030; Kampe KKW, 2003, J NEUROSCI, V23, P5258; KAPUR N, 1995, CORTEX, V31, P99, DOI 10.1016/S0010-9452(13)80108-6; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Kiehl KA, 2001, PSYCHOPHYSIOLOGY, V38, P133, DOI 10.1111/1469-8986.3810133; Lundstrom BN, 2003, NEUROIMAGE, V20, P1934, DOI 10.1016/j.neuroimage.2003.07.017; Macrae CN, 2004, CEREB CORTEX, V14, P647, DOI 10.1093/cercor/bhh025; Markus HR, 2003, PSYCHOL INQ, V14, P277, DOI 10.1207/S15327965PLI1403&4_17; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Modinos G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004618; Muller BW, 2002, NEUROIMAGE, V17, P231, DOI 10.1006/nimg.2002.1176; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Northoff G, 2011, CONSCIOUS COGN, V20, P52, DOI 10.1016/j.concog.2010.09.011; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; Opitz B, 1999, CEREB CORTEX, V9, P379, DOI 10.1093/cercor/9.4.379; Perrin F, 2005, NEUROPSYCHOLOGIA, V43, P12, DOI 10.1016/j.neuropsychologia.2004.07.002; Qin PM, 2012, HUM BRAIN MAPP, V33, P154, DOI 10.1002/hbm.21201; Qin PM, 2010, HUM BRAIN MAPP, V31, P1993, DOI 10.1002/hbm.20989; Ray RD, 2010, SOC COGN AFFECT NEUR, V5, P318, DOI 10.1093/scan/nsp039; Rossion B, 2003, NEUROIMAGE, V19, P877, DOI 10.1016/S1053-8119(03)00105-8; Rushworth MFS, 2003, NEUROIMAGE, V20, pS89, DOI 10.1016/j.neuroimage.2003.09.011; Schilbach L, 2008, CONSCIOUS COGN, V17, P457, DOI 10.1016/j.concog.2008.03.013; Seger CA, 2004, NEUROPSYCHOLOGIA, V42, P1168, DOI 10.1016/j.neuropsychologia.2004.02.003; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; Sugiura M, 2008, NEUROIMAGE, V42, P414, DOI 10.1016/j.neuroimage.2008.03.054; Tacikowski P, 2012, HUM BRAIN MAPP, V19, P1; Talairach J., 1988, COPLANAR STEREOTAXIC; Vanderwal T, 2008, NEUROIMAGE, V41, P1437, DOI 10.1016/j.neuroimage.2008.03.058; Wang G, 2012, SOC COGN AFFECT NEUR, V7, P222, DOI 10.1093/scan/nsr002; Wu YH, 2010, SOC COGN AFFECT NEUR, V5, P324, DOI 10.1093/scan/nsq016; Zhu Y, 2007, NEUROIMAGE, V34, P1310, DOI 10.1016/j.neuroimage.2006.08.047	45	11	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91556	10.1371/journal.pone.0091556	http://dx.doi.org/10.1371/journal.pone.0091556			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9FH	24614597	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300137
J	Huang, SB; Cheng, Y; Lang, DP; Chi, RH; Liu, GF				Huang, Shaobin; Cheng, Yuan; Lang, Dapeng; Chi, Ronghua; Liu, Guofeng			A Formal Algorithm for Verifying the Validity of Clustering Results Based on Model Checking	PLOS ONE			English	Article							TEMPORAL LOGIC; VERIFICATION	The limitations in general methods to evaluate clustering will remain difficult to overcome if verifying the clustering validity continues to be based on clustering results and evaluation index values. This study focuses on a clustering process to analyze crisp clustering validity. First, we define the properties that must be satisfied by valid clustering processes and model clustering processes based on program graphs and transition systems. We then recast the analysis of clustering validity as the problem of verifying whether the model of clustering processes satisfies the specified properties with model checking. That is, we try to build a bridge between clustering and model checking. Experiments on several datasets indicate the effectiveness and suitability of our algorithms. Compared with traditional evaluation indices, our formal method can not only indicate whether the clustering results are valid but, in the case the results are invalid, can also detect the objects that have led to the invalidity.	[Huang, Shaobin; Cheng, Yuan; Lang, Dapeng; Chi, Ronghua; Liu, Guofeng] Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Peoples R China	Harbin Engineering University	Cheng, Y (corresponding author), Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Peoples R China.	changuang7@sina.com	Dapeng, Lang/AAA-5429-2022	Dapeng, Lang/0000-0002-7536-9764	National Key Project of Scientific and Technical Supporting Programs [2012BAH08B02]	National Key Project of Scientific and Technical Supporting Programs	Supported by National Key Project of Scientific and Technical Supporting Programs (No. 2012BAH08B02), http://kjzc.jhgl.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtert E, 2012, PROC INT CONF DATA, P1285, DOI 10.1109/ICDE.2012.128; Amigo E, 2009, INFORM RETRIEVAL, V12, P461, DOI 10.1007/s10791-008-9066-8; Ball T, 2003, ACM SIGPLAN NOTICES, V38, P97, DOI 10.1145/640128.604140; Banerjee A, 2004, P 10 ACM SIGKDD INT, P515; Ben-Hur A, 2002, J MACH LEARN RES, V2, P125, DOI 10.1162/15324430260185565; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Cardoso MGMS, 2009, INTELL DATA ANAL, V13, P725, DOI 10.3233/IDA-2009-0390; Clake E, 1994, DECADE CONCURRENCY R, P124; Clarke E, 2001, FORM METHOD SYST DES, V19, P7, DOI 10.1023/A:1011276507260; Clarke E. M., 1981, LECT NOTES COMPUTER, V131, P52, DOI DOI 10.1007/BFB0025774; Clarke EM, 2009, COMMUN ACM, V52, P75, DOI 10.1145/1592761.1592781; Clarke EM, 1999, MODEL CHECKING, P1; CLARKE EM, 1995, FORM METHOD SYST DES, V6, P217, DOI 10.1007/BF01383968; de Souto M. C. P., 2012, 2012 Brazilian Symposium on Neural Networks (SBRN 2012), P49, DOI 10.1109/SBRN.2012.25; EMERSON EA, 1982, SCI COMPUT PROGRAM, V2, P241, DOI 10.1016/0167-6423(83)90017-5; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Halkidi M, 2002, SIGMOD REC, V31, P19, DOI 10.1145/601858.601862; Halkidi M, 2002, SIGMOD RECORD, V31, P40, DOI 10.1145/565117.565124; Halkidi M, 2001, J INTELL INF SYST, V17, P107, DOI 10.1023/A:1012801612483; Halkidi M, 2001, THIRTEENTH INTERNATIONAL CONFERENCE ON SCIENTIFIC AND STATISTICAL DATABASE MANAGEMENT, PROCEEDINGS, P3, DOI 10.1109/SSDM.2001.938534; Han J, 2006, DATA MINING CONCEPTS, DOI 10.1016/C2009-0-61819-5; Huth M, 2007, LOGIC COMPUTER SCI M, P115; Jegatha Deborah L, 2010, INT J COMPUTER SCI E, V1, P85, DOI [10.5121/ijcses.2010.1207, DOI 10.5121/IJCSES.2010.1207]; Kashyap C, 2013, INT J ENG INNOVATIVE, V2, P210; Kohonen T, 2000, IEEE T NEURAL NETWOR, V11, P574, DOI 10.1109/72.846729; Lamirel Jean-Charles, 2012, New Frontiers in Applied Data Mining. PAKDD 2011 International Workshops. Revised Selected Papers, P209, DOI 10.1007/978-3-642-28320-8_18; Liu Y, 2010, IEEE 10 INT C C DAT, P13; [吕宗磊 Lu Zonglei], 2008, [计算机研究与发展, Journal of Computer Research and Development], V45, P1477; MacQueen J, 1967, P 5 BERKELEY S MATH, V1, DOI DOI 10.1007/S11665-016-2173-6; Martin A, 2001, ELECT NOTES THEORETI, V52, P21; Raimi R, 1997, INT TEST CONF P, P964; Reichart R., 2009, P CONLL 2009 P 13 C, P165, DOI DOI 10.3115/1596374.1596401; Shtern M, 2009, PROC IEEE INT CONF S, P297, DOI 10.1109/ICSM.2009.5306306; Theodoridis S., 2008, PATTERN RECOGN, V4th ed.; VARDI MY, 1986, J COMPUT SYST SCI, V32, P183, DOI 10.1016/0022-0000(86)90026-7; Vendramin Lucas, 2010, Statistical Analysis and Data Mining, V3, P209, DOI 10.1002/sam.10080; Zahid N, 1999, PATTERN RECOGN, V32, P1089, DOI 10.1016/S0031-3203(98)00157-5; Zalik KR, 2011, PATTERN RECOGN LETT, V32, P221, DOI 10.1016/j.patrec.2010.08.007; Zhang T., 1996, ACM SIGMOD RECORD, P103, DOI [10.1145/235968.233324, DOI 10.1145/235968.233324]	40	1	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90109	10.1371/journal.pone.0090109	http://dx.doi.org/10.1371/journal.pone.0090109			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608823	Green Published, gold, Green Submitted			2022-12-25	WOS:000332485800017
J	Nouri, E; Breuillin-Sessoms, F; Feller, U; Reinhardt, D				Nouri, Eva; Breuillin-Sessoms, Florence; Feller, Urs; Reinhardt, Didier			Phosphorus and Nitrogen Regulate Arbuscular Mycorrhizal Symbiosis in Petunia hybrida	PLOS ONE			English	Article							MINERAL ACQUISITION; ROOT-SYSTEM; PHYSIOLOGICAL-RESPONSES; PHOSPHATE TRANSPORTERS; FUNGAL DIVERSITY; NITRATE; PLANTS; SOIL; GENE; EXPRESSION	Phosphorus and nitrogen are essential nutrient elements that are needed by plants in large amounts. The arbuscular mycorrhizal symbiosis between plants and soil fungi improves phosphorus and nitrogen acquisition under limiting conditions. On the other hand, these nutrients influence root colonization by mycorrhizal fungi and symbiotic functioning. This represents a feedback mechanism that allows plants to control the fungal symbiont depending on nutrient requirements and supply. Elevated phosphorus supply has previously been shown to exert strong inhibition of arbuscular mycorrhizal development. Here, we address to what extent inhibition by phosphorus is influenced by other nutritional pathways in the interaction between Petunia hybrida and R. irregularis. We show that phosphorus and nitrogen are the major nutritional determinants of the interaction. Interestingly, the symbiosis-promoting effect of nitrogen starvation dominantly overruled the suppressive effect of high phosphorus nutrition onto arbuscular mycorrhiza, suggesting that plants promote the symbiosis as long as they are limited by one of the two major nutrients. Our results also show that in a given pair of symbiotic partners (Petunia hybrida and R. irregularis), the entire range from mutually symbiotic to parasitic can be observed depending on the nutritional conditions. Taken together, these results reveal complex nutritional feedback mechanisms in the control of root colonization by arbuscular mycorrhizal fungi.	[Nouri, Eva; Breuillin-Sessoms, Florence; Reinhardt, Didier] Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland; [Feller, Urs] Univ Bern, Inst Plant Sci, Bern, Switzerland	University of Fribourg; University of Bern	Reinhardt, D (corresponding author), Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland.	didier.reinhardt@unifr.ch	Feller, Urs/A-1807-2008; Reinhardt, Didier/M-8508-2014	Feller, Urs/0000-0001-7858-5721; Reinhardt, Didier/0000-0003-3495-6783	National Centre of Competence in Research (NCCR)	National Centre of Competence in Research (NCCR)(Swiss National Science Foundation (SNSF))	This work was supported by a grant from the National Centre of Competence in Research (NCCR) "Plant Survival". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT LK, 1984, NEW PHYTOL, V97, P437, DOI 10.1111/j.1469-8137.1984.tb03609.x; Alguacil MM, 2008, ECOL APPL, V18, P527, DOI 10.1890/07-0521.1; Allen JW, 2009, PLANT PHYSIOL, V149, P549, DOI 10.1104/pp.108.129866; AMIJEE F, 1989, NEW PHYTOL, V111, P435, DOI 10.1111/j.1469-8137.1989.tb00706.x; AMIJEE F, 1989, PLANT SOIL, V119, P334, DOI 10.1007/BF02370427; Amtmann A, 2009, NEW PHYTOL, V181, P35, DOI 10.1111/j.1469-8137.2008.02666.x; Angelard C, 2010, CURR BIOL, V20, P1216, DOI 10.1016/j.cub.2010.05.031; [Anonymous], ECOLOGY LETT, V10, P1135; Auge RM, 2001, MYCORRHIZA, V11, P3, DOI 10.1007/s005720100097; BAATH E, 1989, CAN J BOT, V67, P3227, DOI 10.1139/b89-402; Bago B, 1998, NEW PHYTOL, V139, P375, DOI 10.1046/j.1469-8137.1998.00199.x; Balzergue C, 2011, J EXP BOT, V62, P1049, DOI 10.1093/jxb/erq335; Blanke V, 2005, NEW PHYTOL, V166, P981, DOI 10.1111/j.1469-8137.2005.01374.x; BOHLEY P, 1967, H-S Z PHYSIOL CHEM, V348, P100, DOI 10.1515/bchm2.1967.348.1.100; Bouguyon E, 2012, SEMIN CELL DEV BIOL, V23, P648, DOI 10.1016/j.semcdb.2012.01.004; Breuillin F, 2010, PLANT J, V64, P1002, DOI 10.1111/j.1365-313X.2010.04385.x; Brundrett MC, 2002, NEW PHYTOL, V154, P275, DOI 10.1046/j.1469-8137.2002.00397.x; Bucher M, 2007, NEW PHYTOL, V173, P11, DOI 10.1111/j.1469-8137.2006.01935.x; Cai HM, 2012, J BIOSCIENCES, V37, P731, DOI 10.1007/s12038-012-9242-2; Charpentier M, 2013, PLANT PHYSIOL, V163, P496, DOI 10.1104/pp.113.220863; Chen AQ, 2007, NEW PHYTOL, V173, P817, DOI 10.1111/j.1469-8137.2006.01962.x; Clark RB, 1996, SOIL BIOL BIOCHEM, V28, P1495, DOI 10.1016/S0038-0717(96)00163-0; Clark RB, 2000, J PLANT NUTR, V23, P867, DOI 10.1080/01904160009382068; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; Dechorgnat J, 2011, J EXP BOT, V62, P1349, DOI 10.1093/jxb/erq409; Douds Jr D. D., 2000, ARBUSCULAR MYCORRHIZ, P107, DOI [10.1007/978-94-017-0776-3_6, DOI 10.1007/978-94-017-0776-3_6]; Egerton-Warburton LM, 2001, P ROY SOC B-BIOL SCI, V268, P2479, DOI 10.1098/rspb.2001.1844; Fellbaum CR, 2012, P NATL ACAD SCI USA, V109, P2666, DOI 10.1073/pnas.1118650109; FRIESE CF, 1991, MYCOLOGIA, V83, P409, DOI 10.2307/3760351; Garcion C, 2006, TRENDS PLANT SCI, V11, P320, DOI 10.1016/j.tplants.2006.05.009; George E., 2000, ARBUSCULAR MYCORRHIZ, P307, DOI DOI 10.1007/978-94-017-0776-3_14; Gojon A, 2011, J EXP BOT, V62, P2299, DOI 10.1093/jxb/erq419; Govindarajulu M, 2005, NATURE, V435, P819, DOI 10.1038/nature03610; Guether M, 2009, PLANT PHYSIOL, V150, P73, DOI 10.1104/pp.109.136390; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Hell R, 2001, CURR OPIN BIOTECH, V12, P161, DOI 10.1016/S0958-1669(00)00193-2; HEPPER CM, 1983, NEW PHYTOL, V93, P389, DOI 10.1111/j.1469-8137.1983.tb03439.x; Hermans C, 2006, TRENDS PLANT SCI, V11, P610, DOI 10.1016/j.tplants.2006.10.007; Hodge A, 2010, P NATL ACAD SCI USA, V107, P13754, DOI 10.1073/pnas.1005874107; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JASPER DA, 1979, SOIL BIOL BIOCHEM, V11, P501, DOI 10.1016/0038-0717(79)90009-9; Javot H, 2007, P NATL ACAD SCI USA, V104, P1720, DOI 10.1073/pnas.0608136104; Javot H, 2007, PLANT CELL ENVIRON, V30, P310, DOI 10.1111/j.1365-3040.2006.01617.x; Johnson NC, 2010, NEW PHYTOL, V185, P631, DOI 10.1111/j.1469-8137.2009.03110.x; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Jung SC, 2012, J CHEM ECOL, V38, P651, DOI 10.1007/s10886-012-0134-6; Karandashov V, 2005, TRENDS PLANT SCI, V10, P22, DOI 10.1016/j.tplants.2004.12.003; Kiba T, 2012, PLANT CELL, V24, P245, DOI 10.1105/tpc.111.092221; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Lin XG, 2012, ENVIRON SCI TECHNOL, V46, P5764, DOI 10.1021/es3001695; Liu YJ, 2012, NEW PHYTOL, V194, P523, DOI 10.1111/j.1469-8137.2012.04050.x; Lopez-Raez JA, 2008, NEW PHYTOL, V178, P863, DOI 10.1111/j.1469-8137.2008.02406.x; Mader P, 2000, NEW PHYTOL, V146, P155, DOI 10.1046/j.1469-8137.2000.00615.x; Maeda D, 2006, PLANT CELL PHYSIOL, V47, P807, DOI 10.1093/pcp/pcj069; MENGE JA, 1978, NEW PHYTOL, V80, P575, DOI 10.1111/j.1469-8137.1978.tb01589.x; Muchhal US, 1999, P NATL ACAD SCI USA, V96, P5868, DOI 10.1073/pnas.96.10.5868; Muchhal US, 1996, P NATL ACAD SCI USA, V93, P10519, DOI 10.1073/pnas.93.19.10519; Muller A, 2013, PLANT SOIL, V364, P341, DOI 10.1007/s11104-012-1372-7; Nacry P, 2005, PLANT PHYSIOL, V138, P2061, DOI 10.1104/pp.105.060061; Nagajyoti PC, 2010, ENVIRON CHEM LETT, V8, P199, DOI 10.1007/s10311-010-0297-8; Nagy R, 2005, PLANT J, V42, P236, DOI 10.1111/j.1365-313X.2005.02364.x; Nuwaysir EF, 2002, GENOME RES, V12, P1749, DOI 10.1101/gr.362402; Olsson PA, 2010, FEMS MICROBIOL ECOL, V72, P123, DOI 10.1111/j.1574-6941.2009.00833.x; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Remans T, 2006, PLANT PHYSIOL, V140, P909, DOI 10.1104/pp.105.075721; Sawers RJH, 2010, THEOR APPL GENET, V120, P1029, DOI 10.1007/s00122-009-1231-y; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seddas P, 2009, SIGNAL COMMUN PLANTS, P45, DOI 10.1007/978-3-540-89230-4_3; Sekhara RDMR, 2007, PLANT J, V51, P739, DOI 10.1111/j.1365-313X.2007.03175.x; Sieh D, 2013, NEW PHYTOL, V197, P606, DOI 10.1111/nph.12034; Smith FA, 2009, NEW PHYTOL, V182, P347, DOI 10.1111/j.1469-8137.2008.02753.x; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Smith SE, 2011, ANNU REV PLANT BIOL, V62, P227, DOI 10.1146/annurev-arplant-042110-103846; Smith SE, 2004, NEW PHYTOL, V162, P511, DOI 10.1111/j.1469-8137.2004.01039.x; Smith SE, 2003, PLANT PHYSIOL, V133, P16, DOI 10.1104/pp.103.024380; STIEGER PA, 1994, PLANT SOIL, V160, P87, DOI 10.1007/BF00150349; Sugiura M, 2007, PLANT CELL PHYSIOL, V48, P1022, DOI 10.1093/pcp/pcm073; Tawaraya K, 2003, SOIL SCI PLANT NUTR, V49, P655, DOI 10.1080/00380768.2003.10410323; THOMSON BD, 1986, NEW PHYTOL, V103, P751, DOI 10.1111/j.1469-8137.1986.tb00850.x; Tian CJ, 2010, PLANT PHYSIOL, V153, P1175, DOI 10.1104/pp.110.156430; Tsay YF, 2007, FEBS LETT, V581, P2290, DOI 10.1016/j.febslet.2007.04.047; van Diepen LTA, 2007, NEW PHYTOL, V176, P175, DOI 10.1111/j.1469-8137.2007.02150.x; VERWOERD TC, 1989, NUCLEIC ACIDS RES, V17, P2362, DOI 10.1093/nar/17.6.2362; Wang RC, 2009, PLANT PHYSIOL, V151, P472, DOI 10.1104/pp.109.140434; Wegmueller S, 2008, PLANT J, V54, P1115, DOI 10.1111/j.1365-313X.2008.03474.x; Yang SY, 2012, PLANT CELL, V24, P4236, DOI 10.1105/tpc.112.104901; Yoneyama K, 2007, PLANTA, V227, P125, DOI 10.1007/s00425-007-0600-5; Yoneyama K, 2007, PLANTA, V225, P1031, DOI 10.1007/s00425-006-0410-1	88	146	156	4	140	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90841	10.1371/journal.pone.0090841	http://dx.doi.org/10.1371/journal.pone.0090841			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608923	Green Published, Green Submitted, gold			2022-12-25	WOS:000332485800059
J	Scharnowski, F; Rosa, MJ; Golestani, N; Hutton, C; Josephs, O; Weiskopf, N; Rees, G				Scharnowski, Frank; Rosa, Maria Joao; Golestani, Narly; Hutton, Chloe; Josephs, Oliver; Weiskopf, Nikolaus; Rees, Geraint			Connectivity Changes Underlying Neurofeedback Training of Visual Cortex Activity	PLOS ONE			English	Article							DYNAMIC CAUSAL-MODELS; NEURAL ACTIVITY; ACTIVITY FLUCTUATIONS; FMRI NEUROFEEDBACK; DIRECTED ATTENTION; SPATIAL ATTENTION; PARIETAL CORTEX; MECHANISMS; PERCEPTION; ACTIVATION	Neurofeedback based on real-time functional magnetic resonance imaging (fMRI) is a new approach that allows training of voluntary control over regionally specific brain activity. However, the neural basis of successful neurofeedback learning remains poorly understood. Here, we assessed changes in effective brain connectivity associated with neurofeedback training of visual cortex activity. Using dynamic causal modeling (DCM), we found that training participants to increase visual cortex activity was associated with increased effective connectivity between the visual cortex and the superior parietal lobe. Specifically, participants who learned to control activity in their visual cortex showed increased top-down control of the superior parietal lobe over the visual cortex, and at the same time reduced bottom-up processing. These results are consistent with efficient employment of top-down visual attention and imagery, which were the cognitive strategies used by participants to increase their visual cortex activity.	[Scharnowski, Frank; Hutton, Chloe; Josephs, Oliver; Weiskopf, Nikolaus; Rees, Geraint] UCL, Wellcome Trust Ctr Neuroimaging, UCL Inst Neurol, London, England; [Scharnowski, Frank; Golestani, Narly; Rees, Geraint] UCL, UCL Inst Cognit Neurosci, London, England; [Scharnowski, Frank] Ecole Polytech Fed Lausanne, Swiss Inst Technol Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Scharnowski, Frank] Univ Geneva, CIBM, Dept Radiol & Med Informat, Geneva, Switzerland; [Rosa, Maria Joao] Kings Coll London, Inst Psychiat, Dept Neurosci, London WC2R 2LS, England; [Golestani, Narly] Univ Geneva, Univ Med Sch, Geneva, Switzerland	University of London; University College London; University of London; University College London; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; University of London; King's College London; University of Geneva	Scharnowski, F (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, UCL Inst Neurol, London, England.	frank.scharnowski@epfl.ch	Weiskopf, Nikolaus/B-9357-2008; Rees, Geraint/C-1493-2008; Rosa, Maria J./K-3185-2015; Golestani, Narly/C-4879-2009	Weiskopf, Nikolaus/0000-0001-5239-1881; Rees, Geraint/0000-0002-9623-7007; Rosa, Maria J./0000-0001-9822-3752; Golestani, Narly/0000-0001-7388-4714; Scharnowski, Frank/0000-0002-9973-2521	Swiss National Science Foundation; European Union; Wellcome Trust [091593/Z10/Z]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Swiss National Science Foundation, the European Union, and the Wellcome Trust (GR). The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust 091593/Z10/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Birbaumer N, 2013, TRENDS COGN SCI, V17, P295, DOI 10.1016/j.tics.2013.04.009; Boly M, 2007, P NATL ACAD SCI USA, V104, P12187, DOI 10.1073/pnas.0611404104; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Chiu YC, 2009, J NEUROSCI, V29, P3930, DOI 10.1523/JNEUROSCI.5737-08.2009; Decharms RC, 2007, TRENDS COGN SCI, V11, P473, DOI 10.1016/j.tics.2007.08.014; Deichmann R, 2004, NEUROIMAGE, V21, P757, DOI 10.1016/j.neuroimage.2003.09.062; Desseilles M, 2011, NEUROIMAGE, V54, P1662, DOI 10.1016/j.neuroimage.2010.08.061; Disner SG, 2011, NAT REV NEUROSCI, V12, P467, DOI 10.1038/nrn3027; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Driver J, 2001, COGNITION, V79, P39, DOI 10.1016/S0010-0277(00)00124-4; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Friston KJ, 2007, NEUROIMAGE, V34, P220, DOI 10.1016/j.neuroimage.2006.08.035; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Greenberg AS, 2010, J NEUROSCI, V30, P14330, DOI 10.1523/JNEUROSCI.4248-09.2010; Hayes JP, 2012, BIOL MOOD ANXIETY DI, V2, DOI 10.1186/2045-5380-2-9; Hesselmann G, 2008, P NATL ACAD SCI USA, V105, P10984, DOI 10.1073/pnas.0712043105; Hesselmann G, 2008, J NEUROSCI, V28, P14481, DOI 10.1523/JNEUROSCI.4398-08.2008; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Hutton C, 2011, NEUROIMAGE, V57, P101, DOI 10.1016/j.neuroimage.2011.04.018; Hutton C, 2002, NEUROIMAGE, V16, P217, DOI 10.1006/nimg.2001.1054; James W., 1890, PRINCIPLES PSYCHOL; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kelley TA, 2008, CEREB CORTEX, V18, P114, DOI 10.1093/cercor/bhm036; Kiebel SJ, 2007, NEUROIMAGE, V34, P1487, DOI 10.1016/j.neuroimage.2006.10.026; Koenigs M, 2009, J NEUROSCI, V29, P14980, DOI 10.1523/JNEUROSCI.3706-09.2009; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; Koush Y, 2013, NEUROIMAGE, V81, P422, DOI 10.1016/j.neuroimage.2013.05.010; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Lee JH, 2012, NEUROSCI RES, V72, P347, DOI 10.1016/j.neures.2012.01.002; Lee S, 2011, NEUROREHAB NEURAL RE, V25, P259, DOI 10.1177/1545968310385128; Li X, 2008, P NATL ACAD SCI USA, V105, P6202, DOI 10.1073/pnas.0801390105; Mechelli A, 2004, CEREB CORTEX, V14, P1256, DOI 10.1093/cercor/bhh087; Patel R, 2012, NEUROSCI BIOBEHAV R, V36, P2130, DOI 10.1016/j.neubiorev.2012.06.003; Penny WD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000709; Rota G, 2011, BRAIN LANG, V117, P123, DOI 10.1016/j.bandl.2010.07.008; Scharnowski F, 2012, J NEUROSCI, V32, P17830, DOI 10.1523/JNEUROSCI.6334-11.2012; Shibata K, 2011, SCIENCE, V334, P1413, DOI 10.1126/science.1212003; Slotnick SD, 2005, CEREB CORTEX, V15, P1570, DOI 10.1093/cercor/bhi035; Stephan KE, 2010, NEUROIMAGE, V49, P3099, DOI 10.1016/j.neuroimage.2009.11.015; Stephan KE, 2007, J BIOSCIENCES, V32, P129, DOI 10.1007/s12038-007-0012-5; Stephan KE, 2008, NEUROIMAGE, V42, P649, DOI 10.1016/j.neuroimage.2008.04.262; Stephan KE, 2009, NEUROIMAGE, V46, P1004, DOI 10.1016/j.neuroimage.2009.03.025; Stokes M, 2009, J NEUROSCI, V29, P1565, DOI 10.1523/JNEUROSCI.4657-08.2009; Sulzer J, 2013, NEUROIMAGE, V76, P386, DOI 10.1016/j.neuroimage.2013.03.033; Vossel S, 2012, J NEUROSCI, V32, P10637, DOI 10.1523/JNEUROSCI.0414-12.2012; Vuilleumier P, 2008, CURR BIOL, V18, P1525, DOI 10.1016/j.cub.2008.08.072; Weiskopf N, 2004, J PHYSIOL-PARIS, V98, P357, DOI 10.1016/j.jphysparis.2005.09.019; Weiskopf N, 2004, IEEE T BIO-MED ENG, V51, P966, DOI 10.1109/TBME.2004.827063; Wundt W, 1882, PHILOS STUDIEN, V1, P251; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921; Zotev V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024522	57	20	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91090	10.1371/journal.pone.0091090	http://dx.doi.org/10.1371/journal.pone.0091090			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609065	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000332485800099
J	Vicens, A; Luke, L; Roldan, ERS				Vicens, Alberto; Lueke, Lena; Roldan, Eduardo R. S.			Proteins Involved in Motility and Sperm-Egg Interaction Evolve More Rapidly in Mouse Spermatozoa	PLOS ONE			English	Article							IPG STRIP PREFRACTIONATION; REPRODUCTIVE PROTEINS; ADAPTIVE EVOLUTION; POSITIVE SELECTION; COMPETITION; GENES; ZONADHESIN; IDENTIFICATION; EXPRESSION; PROTEOMICS	Proteomic studies of spermatozoa have identified a large catalog of integral sperm proteins. Rapid evolution of these proteins may underlie adaptive changes of sperm traits involved in different events leading to fertilization, although the selective forces underlying such rapid evolution are not well understood. A variety of selective forces may differentially affect several steps ending in fertilization, thus resulting in a compartmentalized adaptation of sperm proteins. Here we analyzed the evolution of genes associated to various events in the sperm's life, from sperm formation to sperm-egg interaction. Evolutionary analyses were performed on gene sequences from 17 mouse strains whose genomes have been sequenced. Four of these are derived from wild Mus musculus, M. domesticus, M. castaneus and M. spretus. We found a higher proportion of genes exhibiting a signature of positive selection among those related to sperm motility and sperm-egg interaction. Furthermore, sperm proteins involved in sperm-egg interaction exhibited accelerated evolution in comparison to those involved in other events. Thus, we identified a large set of candidate proteins for future comparative analyses of genotype-phenotype associations in spermatozoa of species subjected to different sexual selection pressures. Adaptive evolution of proteins involved in motility could be driven by sperm competition, since this selective force is known to increase the proportion of motile sperm and their swimming velocity. On the other hand, sperm proteins involved in gamete interaction could be coevolving with their egg partners through episodes of sexual selection or sexual conflict resulting in species-specific sperm-egg interactions and barriers preventing interspecies fertilization.	[Vicens, Alberto; Lueke, Lena; Roldan, Eduardo R. S.] CSIC, Museo Nacl Ciencias Nat, Reprod Ecol & Biol Grp, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Roldan, ERS (corresponding author), CSIC, Museo Nacl Ciencias Nat, Reprod Ecol & Biol Grp, E-28006 Madrid, Spain.	roldane@mncn.csic.es	Roldan, Eduardo R.S./M-7947-2014; Arévalo, Lena/D-8757-2013; Arévalo, Lena/AAM-5277-2020	Roldan, Eduardo R.S./0000-0002-7545-4248; Arévalo, Lena/0000-0002-0681-0392; Arévalo, Lena/0000-0002-0681-0392	Spanish Ministry of Economy and Competitiveness [CGL2011-26341, BES-2009-029239]; Consejo Superior de Investigaciones Cientificas (JAE-Predoc); European Social Fund	Spanish Ministry of Economy and Competitiveness(Spanish Government); Consejo Superior de Investigaciones Cientificas (JAE-Predoc); European Social Fund(European Social Fund (ESF))	This work was funded by the Spanish Ministry of Economy and Competitiveness (grant CGL2011-26341 to E.R.S.R. and postgraduate scholarship BES-2009-029239 to A.V.), and by a postgraduate scholarship from the Consejo Superior de Investigaciones Cientificas (JAE-Predoc) co-funded by the European Social Fund (to L.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Baker MA, 2008, PROTEOMICS, V8, P1720, DOI 10.1002/pmic.200701020; Baker MA, 2008, PROTEOMICS, V8, P2312, DOI 10.1002/pmic.200700876; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Bielawski JP, 2001, MOL BIOL EVOL, V18, P523, DOI 10.1093/oxfordjournals.molbev.a003831; Birkhead TR, 1998, SPERM COMPETITION SE; BOER PH, 1987, MOL CELL BIOL, V7, P3107, DOI 10.1128/MCB.7.9.3107; Cao WL, 2006, MOL CELL PROTEOMICS, V5, P801, DOI 10.1074/mcp.M500322-MCP200; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; Clark NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000570; Clark NL, 2006, REPRODUCTION, V131, P11, DOI 10.1530/rep.1.00357; Coyne JA, 2004, SPECIATION, V37; Dean MD, 2008, MOL BIOL EVOL, V25, P383, DOI 10.1093/molbev/msm265; Dean MD, 2009, MOL BIOL EVOL, V26, P1733, DOI 10.1093/molbev/msp094; Dorus S, 2004, NAT GENET, V36, P1326, DOI 10.1038/ng1471; Dorus S, 2006, NAT GENET, V38, P1440, DOI 10.1038/ng1915; Dorus S, 2012, SYST BIOL REPROD MED, V58, P218, DOI 10.3109/19396368.2012.700442; Dorus S, 2010, MOL BIOL EVOL, V27, P1235, DOI 10.1093/molbev/msq007; Dorus S, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P435, DOI 10.1016/B978-0-12-372568-4.00011-2; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Findlay GD, 2010, BIOESSAYS, V32, P26, DOI 10.1002/bies.200900127; Finn S, 2010, J MOL EVOL, V71, P231, DOI 10.1007/s00239-010-9382-7; Fitzpatrick JL, 2009, P NATL ACAD SCI USA, V106, P1128, DOI 10.1073/pnas.0809990106; Florman HM, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P55; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; Glassey B, 2004, MOL BIOL EVOL, V21, P851, DOI 10.1093/molbev/msh080; Goios A, 2007, GENOME RES, V17, P293, DOI 10.1101/gr.5941007; Gomendio M, 2008, INT J DEV BIOL, V52, P439, DOI 10.1387/ijdb.082595mg; Gomenido Montserrat, 1998, P667, DOI 10.1016/B978-012100543-6/50041-6; Montoto LG, 2011, REPRODUCTION, V142, P819, DOI 10.1530/REP-11-0232; Good JM, 2005, MOL BIOL EVOL, V22, P1044, DOI 10.1093/molbev/msi087; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hamm D, 2007, AM J HUM GENET, V81, P44, DOI 10.1086/518695; Hendriksen PJM, 1997, GENOMICS, V41, P350, DOI 10.1006/geno.1997.4673; Herlyn H, 2005, MOL PHYLOGENET EVOL, V37, P62, DOI 10.1016/j.ympev.2005.04.001; Herlyn H, 2006, J MOL EVOL, V63, P602, DOI 10.1007/s00239-005-0146-8; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Howard DJ, 1999, ANNU REV ECOL SYST, V30, P109, DOI 10.1146/annurev.ecolsys.30.1.109; Howard DJ, 1993, HYBRID ZONES EVOLUTI; Karr TL, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P305, DOI 10.1016/B978-0-12-372568-4.00008-2; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Luke L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029247; Lupold S, 2009, P R SOC B, V276, P1175, DOI 10.1098/rspb.2008.1645; Martin-Coello J, 2009, EVOLUTION, V63, P613, DOI 10.1111/j.1558-5646.2008.00585.x; Martinez-Heredia J, 2008, HUM REPROD, V23, P783, DOI 10.1093/humrep/den024; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Miki Kiyoshi, 2007, Soc Reprod Fertil Suppl, V65, P309; Navarro B, 2008, INT J DEV BIOL, V52, P607, DOI 10.1387/ijdb.072554bn; Palumbi SR, 2009, HEREDITY, V102, P66, DOI 10.1038/hdy.2008.104; Siegel C, 1988, NONPARAMETRIC STAT B, P213; Stein KK, 2006, PROTEOMICS, V6, P3533, DOI 10.1002/pmic.200500845; Sutton KA, 2008, P NATL ACAD SCI USA, V105, P8661, DOI 10.1073/pnas.0800603105; Suzuki H, 2004, MOL PHYLOGENET EVOL, V33, P626, DOI 10.1016/j.ympev.2004.08.003; Swanson WJ, 2004, GENETICS, V168, P1457, DOI 10.1534/genetics.104.030478; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; Tardif S, 2011, MOL HUM REPROD, V17, P661, DOI 10.1093/molehr/gar039; Team R. Core, 2012, R LANG ENV STAT COMP; Torgerson DG, 2002, MOL BIOL EVOL, V19, P1973, DOI 10.1093/oxfordjournals.molbev.a004021; Tourmente M, 2013, EVOLUTION, V67, P1838, DOI 10.1111/evo.12079; Tourmente M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-12; Turner LM, 2008, INT J DEV BIOL, V52, P769, DOI 10.1387/ijdb.082577lt; Turner LM, 2008, GENETICS, V179, P2075, DOI 10.1534/genetics.107.085902; Turner RM, 2006, REPROD FERT DEVELOP, V18, P25, DOI 10.1071/RD05120; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	68	38	38	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91302	10.1371/journal.pone.0091302	http://dx.doi.org/10.1371/journal.pone.0091302			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608277	Green Submitted, Green Published, gold			2022-12-25	WOS:000332485800126
J	Yun, SH; Choi, CW; Lee, SY; Lee, YG; Kwon, J; Leem, SH; Chung, YH; Kahng, HY; Kim, SJ; Kwon, KK; Kim, SI				Yun, Sung Ho; Choi, Chi-Won; Lee, Sang-Yeop; Lee, Yeol Gyun; Kwon, Joseph; Leem, Sun Hee; Chung, Young Ho; Kahng, Hyung-Yeel; Kim, Sang Jin; Kwon, Kae Kyoung; Kim, Seung Il			Proteomic Characterization of Plasmid pLA1 for Biodegradation of Polycyclic Aromatic Hydrocarbons in the Marine Bacterium, Novosphingobium pentaromativorans US6-1	PLOS ONE			English	Article							MYCOBACTERIUM-VANBAALENII PYR-1; PYRENE DEGRADATION; STRAIN; IDENTIFICATION; DIOXYGENASE; EXPRESSION; PREDICTION; PATHWAYS; SEQUENCE	Novosphingobium pentaromativorans US6-1 is a halophilic marine bacterium able to degrade polycyclic aromatic hydrocarbons (PAHs). Genome sequence analysis revealed that the large plasmid pLA1 present in N. pentaromativorans US6-1 consists of 199 ORFs and possess putative biodegradation genes that may be involved in PAH degradation. 1-DE/LC-MS/MS analysis of N. pentaromativorans US6-1 cultured in the presence of different PAHs and monocyclic aromatic hydrocarbons (MAHs) identified approximately 1,000 and 1,400 proteins, respectively. Up-regulated biodegradation enzymes, including those belonging to pLA1, were quantitatively compared. Among the PAHs, phenanthrene induced the strongest up-regulation of extradiol cleavage pathway enzymes such as ring-hydroxylating dioxygenase, putative biphenyl-2,3-diol 1,2-dioxygenase, and catechol 2,3-dioxygenase in pLA1. These enzymes lead the initial step of the lower catabolic pathway of aromatic hydrocarbons through the extradiol cleavage pathway and participate in the attack of PAH ring cleavage, respectively. However, N. pentaromativorans US6-1 cultured with p-hydroxybenzoate induced activation of another extradiol cleavage pathway, the protocatechuate 4,5-dioxygenase pathway, that originated from chromosomal genes. These results suggest that N. pentaromativorans US6-1 utilizes two different extradiol pathways and plasmid pLA1 might play a key role in the biodegradation of PAH in N. pentaromativorans US6-1.	[Yun, Sung Ho; Choi, Chi-Won; Lee, Sang-Yeop; Lee, Yeol Gyun; Kwon, Joseph; Chung, Young Ho; Kim, Seung Il] Korea Basic Sci Inst, Div Life Sci, Taejon, South Korea; [Leem, Sun Hee] Dong A Univ, Dept Biol, Pusan, South Korea; [Kahng, Hyung-Yeel] Sunchon Natl Univ, Dept Environm Educ, Sunchon, South Korea; [Kim, Sang Jin; Kwon, Kae Kyoung] Korea Inst Ocean Sci & Technol, Ansan, South Korea; [Kim, Seung Il] Univ Sci & Technol, Dept Bioanalyt Sci, Taejon, South Korea	Korea Basic Science Institute (KBSI); Dong A University; Sunchon National University; Korea Institute of Ocean Science & Technology (KIOST)	Kim, SI (corresponding author), Korea Basic Sci Inst, Div Life Sci, Taejon, South Korea.	ksi@kbsi.re.kr		Kahng, Hyung-Yeel/0000-0002-3856-0295; Lee, Sang-Yeop/0000-0002-8257-6112	Marine and Extreme Genome Research Center Program of the Ministry of Land, Transportation and Maritime Affairs, Republic of Korea; Korea Basic Science Institute [T32414]; National Research Foundation of Korea (NRF); Korea government (MEST) [2012-0000481]; KBSI [T33417]	Marine and Extreme Genome Research Center Program of the Ministry of Land, Transportation and Maritime Affairs, Republic of Korea(Ministry of Land, Transport and Maritime Affairs (MLTM), Republic of Korea); Korea Basic Science Institute; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); KBSI	This work was supported by the Marine and Extreme Genome Research Center Program of the Ministry of Land, Transportation and Maritime Affairs, Republic of Korea and the Korea Basic Science Institute Grant (T32414). SHL was partially supported by a National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (2012-0000481). YHC was partially supported by a KBSI grant (T33417). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aylward FO, 2013, APPL ENVIRON MICROB, V79, P3724, DOI 10.1128/AEM.00518-13; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Choi CW, 2012, DIAGN MICR INFEC DIS, V72, P318, DOI 10.1016/j.diagmicrobio.2011.12.013; Demaneche S, 2004, APPL ENVIRON MICROB, V70, P6714, DOI 10.1128/AEM.70.11.6714-6725.2004; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Jouanneau Y, 2006, APPL ENVIRON MICROB, V72, P4726, DOI 10.1128/AEM.00395-06; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kasai Y, 2003, APPL ENVIRON MICROB, V69, P6688, DOI 10.1128/AEM.69.11.6688-6697.2003; Kim SJ, 2007, J BACTERIOL, V189, P464, DOI 10.1128/JB.01310-06; Kim SJ, 2009, CURR OPIN MICROBIOL, V12, P301, DOI 10.1016/j.mib.2009.03.006; Kim SI, 2007, OMICS, V11, P280, DOI 10.1089/omi.2007.0019; Kim SJ, 2004, PROTEOMICS, V4, P3899, DOI 10.1002/pmic.200400872; Kim YH, 2006, PROTEOMICS, V6, P1301, DOI 10.1002/pmic.200500329; Kim YH, 2005, APPL MICROBIOL BIOT, V67, P275, DOI 10.1007/s00253-004-1796-y; Kweon O, 2011, J BACTERIOL, V193, P4326, DOI 10.1128/JB.00215-11; Liang Y, 2006, APPL ENVIRON MICROB, V72, P7821, DOI 10.1128/AEM.01274-06; Luo YR, 2012, J BACTERIOL, V194, P907, DOI 10.1128/JB.06476-11; Moon YJ, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015420; Romine MF, 1999, J BACTERIOL, V181, P1585, DOI 10.1128/JB.181.5.1585-1602.1999; Sarma PM, 2010, BIODEGRADATION, V21, P59, DOI 10.1007/s10532-009-9281-z; Shintani M, 2007, J BACTERIOL, V189, P2007, DOI 10.1128/JB.01486-06; Singleton DR, 2012, APPL ENVIRON MICROB, V78, P3552, DOI 10.1128/AEM.00173-12; Sohn JH, 2004, INT J SYST EVOL MICR, V54, P1483, DOI 10.1099/ijs.0.02945-0; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yun SH, 2011, J PROTEOMICS, V74, P620, DOI 10.1016/j.jprot.2011.01.020	25	18	20	3	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90812	10.1371/journal.pone.0090812	http://dx.doi.org/10.1371/journal.pone.0090812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608660	Green Submitted, Green Published, gold			2022-12-25	WOS:000332485800053
J	Almeida, ST; Nunes, S; Paulo, ACS; Valadares, I; Martins, S; Breia, F; Brito-Avo, A; Morais, A; de Lencastre, H; Sa-Leao, R				Almeida, Sonia T.; Nunes, Sonia; Santos Paulo, Ana Cristina; Valadares, Idalina; Martins, Sara; Breia, Fatima; Brito-Avo, Antonio; Morais, Ana; de Lencastre, Herminia; Sa-Leao, Raquel			Low Prevalence of Pneumococcal Carriage and High Serotype and Genotype Diversity among Adults over 60 Years of Age Living in Portugal	PLOS ONE			English	Article							DAY-CARE-CENTERS; STREPTOCOCCUS-PNEUMONIAE; HAEMOPHILUS-INFLUENZAE; NASOPHARYNGEAL CARRIAGE; RAPID IDENTIFICATION; HIGH-RATES; CHILDREN; COLONIZATION; RESISTANCE; SMOKING	Pneumococcal disease is frequent at the extremes of age. While several studies have looked at colonization among young children, much less is known among the elderly. We aimed to evaluate pneumococcal carriage among elderly adults living in Portugal. Between April 2010 and December 2012, nasopharyngeal and oropharyngeal swabs of adults over 60 years of age, living in an urban area (n = 1,945) or in a rural area (n = 1,416), were obtained. Pneumococci were isolated by culture-based standard procedures, identified by optochin susceptibility, bile solubility and PCR screening for lytA and cpsA, and characterized by antibiotype, serotype, and MLST. Associations between pneumococcal carriage, socio-demographic and clinical characteristics were evaluated by univariate analysis and multiple logistic regression. The global prevalence of carriage was 2.3% (95% CI: 1.8-2.8). In the multiple logistic regression analysis, smoking, being at a retirement home, and living in a rural area increased the odds of being a pneumococcal carrier by 4.4-fold (95% CI: 1.9-9.2), 2.0-fold (95% CI: 1.1-3.6) and 2.0-fold (95% CI: 1.2-3.5), respectively. Among the 77 pneumococcal isolates, 26 serotypes and 40 STs were identified. The most prevalent serotypes were (in decreasing order) 19A, 6C, 22F, 23A, 35F, 11A, and 23B, which accounted, in total, for 60.0% of the isolates. Most isolates (93.5%) had STs previously described in the MLST database. Resistance to macrolides, non-susceptibility to penicillin and multidrug resistance were found in 19.5%, 11.7%, and 15.6% of the isolates, respectively. We conclude that the prevalence of pneumococcal carriage in the elderly, in Portugal, as determined by culture-based methods, is low. Serotype and genotype diversity is high. Living in a rural area, in a retirement home, and being a smoker increased the risk of pneumococcal carriage. This study contributes to the establishment of a baseline that may be used to monitor how novel pneumococcal vaccines impact on colonization among the elderly.	[Almeida, Sonia T.; Nunes, Sonia; Santos Paulo, Ana Cristina; Sa-Leao, Raquel] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Mol Microbiol Human Pathogens, Oeiras, Portugal; [Valadares, Idalina; Martins, Sara; Brito-Avo, Antonio; Morais, Ana] Agrupamento Ctr Saude Oeiras Carnaxide, Oeiras, Portugal; [Breia, Fatima] Agrupamento Ctr Sau Alentejo Cent II, Evora, Portugal; [de Lencastre, Herminia] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal; [de Lencastre, Herminia] Rockefeller Univ, Lab Microbiol Infect Dis, New York, NY 10021 USA	Universidade Nova de Lisboa; Universidade Nova de Lisboa; Rockefeller University	Sa-Leao, R (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Mol Microbiol Human Pathogens, Oeiras, Portugal.	rsaleao@itqb.unl.pt	Sá-Leão, Raquel/A-9341-2011	Sá-Leão, Raquel/0000-0001-9804-827X; PAULO, Ana Cristina/0000-0002-9249-2609; /0000-0001-6816-8932; Almeida, Sonia/0000-0002-8143-5254	Pfizer; Fundacao para a Ciencia e Tecnologia (FCT) [PEst-OE/EQB/LA0004/2011]; FCT, Portugal [SFRH/BD/40706/2007]	Pfizer(Pfizer); Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was partially supported by an unrestricted research grant from Pfizer (to RSL) and grant PEst-OE/EQB/LA0004/2011 (to the Oeiras Associated Laboratory) from Fundacao para a Ciencia e Tecnologia (FCT). SN was supported by grant SFRH/BD/40706/2007 from FCT, Portugal. The funders had no role in study design, data collection and analysis, preparation of the manuscript or decision to submit the manuscript for publication.	Abdullahi O, 2008, PEDIATR INFECT DIS J, V27, P59, DOI 10.1097/INF.0b013e31814da70c; Aguiar SI, 2010, VACCINE, V28, P5167, DOI 10.1016/j.vaccine.2010.06.008; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1; [Anonymous], 2000, NEW ENGL J MED, DOI 10.1056/NEJM200003093421002; Carvalho MDG, 2013, PEERJ, V1, DOI 10.7717/peerj.97; Carvalho MD, 2012, J CLIN MICROBIOL, V50, P3146, DOI 10.1128/JCM.01505-12; Chien YW, 2013, PEDIATR INFECT DIS J, V32, P72, DOI 10.1097/INF.0b013e318270d850; de la Campa AG, 2004, EMERG INFECT DIS, V10, P1751, DOI 10.3201/eid1010.040382; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; European Commission, 2006, RTD INFO MAGAZINE EU, V49, P11; Ferreira DM, 2013, AM J RESP CRIT CARE, V187, P855, DOI 10.1164/rccm.201212-2277OC; Flamaing J, 2010, J AM GERIATR SOC, V58, P396, DOI 10.1111/j.1532-5415.2009.02700.x; Garcia-Rodriguez JA, 2002, J ANTIMICROB CHEMOTH, V50, P59, DOI 10.1093/jac/dkf506; Greenberg D, 2006, CLIN INFECT DIS, V42, P897, DOI 10.1086/500935; Horacio AN, 2012, VACCINE, V30, P218, DOI 10.1016/j.vaccine.2011.11.022; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Llull D, 2006, J CLIN MICROBIOL, V44, P1250, DOI 10.1128/JCM.44.4.1250-1256.2006; Lo YC, 2009, J MICROBIOL IMMUNOL, V42, P234; Loddenkemper R, 2003, EUROPEAN LUNG WHITE, P16; Ludwig E, 2012, EUR RESPIR REV, V21, P57, DOI 10.1183/09059180.00008911; Mackenzie GA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-304; Murphy TF, 2006, CLIN INFECT DIS, V42, P904, DOI 10.1086/500942; MURRAY PR, 1979, J CLIN MICROBIOL, V9, P290; Nunes S, 2005, J CLIN MICROBIOL, V43, P1285, DOI 10.1128/JCM.43.3.1285-1293.2005; Nuorti JP, 1998, NEW ENGL J MED, V338, P1861, DOI 10.1056/NEJM199806253382601; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2001, J CLIN MICROBIOL, V39, P1021, DOI 10.1128/JCM.39.3.1021-1024.2001; Ogami M, 2010, EUR J PEDIATR, V169, P1221, DOI 10.1007/s00431-010-1208-5; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Palmu AA, 2012, SCAND J INFECT DIS, V44, P433, DOI 10.3109/00365548.2011.652162; R Development Core Team, 2012, R LANG ENV STAT COMP; Regev-Yochay G, 2004, CLIN INFECT DIS, V38, P632, DOI 10.1086/381547; Rolo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057047; Sa-Leado R, 2008, J CLIN MICROBIOL, V46, P225, DOI 10.1128/JCM.01551-07; Sa-Leao R, 2009, CLIN MICROBIOL INFEC, V15, P1002, DOI 10.1111/j.1469-0691.2009.02775.x; Sa-Leao R, 2000, J CLIN MICROBIOL, V38, P4137; Scholz CFP, 2012, J CLIN MICROBIOL, V50, P1968, DOI 10.1128/JCM.00365-12; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Simoes AS, 2011, DIAGN MICR INFEC DIS, V71, P208, DOI 10.1016/j.diagmicrobio.2011.07.009; Simoes AS, 2011, J CLIN MICROBIOL, V49, P2810, DOI 10.1128/JCM.00517-11; Simoes AS, 2010, J CLIN MICROBIOL, V48, P238, DOI 10.1128/JCM.01313-09; SORENSEN UBS, 1993, J CLIN MICROBIOL, V31, P2097; Trzcinski K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060520; Watt JP, 2004, J CLIN MICROBIOL, V42, P4974, DOI 10.1128/JCM.42.11.4974-4976.2004; Wessels E, 2012, J CLIN MICROBIOL, V50, P1171, DOI 10.1128/JCM.06609-11	46	36	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90974	10.1371/journal.pone.0090974	http://dx.doi.org/10.1371/journal.pone.0090974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24604030	gold, Green Submitted, Green Published			2022-12-25	WOS:000332483600118
J	Berg, K; Ericsson, M; Lindgren, M; Gustafsson, H				Berg, Kirsti; Ericsson, Madelene; Lindgren, Mikael; Gustafsson, Hakan			A High Precision Method for Quantitative Measurements of Reactive Oxygen Species in Frozen Biopsies	PLOS ONE			English	Article							OXIDATIVE STRESS; IN-VIVO; INFLAMMATION; SUPEROXIDE; EPR; DOSIMETRY; RADICALS; HYDROXYLAMINE; PEROXYNITRITE; CANCER	Objective: An electron paramagnetic resonance (EPR) technique using the spin probe cyclic hydroxylamine 1-hydroxy-3-methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine (CMH) was introduced as a versatile method for high precision quantification of reactive oxygen species, including the superoxide radical in frozen biological samples such as cell suspensions, blood or biopsies. Materials and Methods: Loss of measurement precision and accuracy due to variations in sample size and shape were minimized by assembling the sample in a well-defined volume. Measurement was carried out at low temperature (150 K) using a nitrogen flow Dewar. The signal intensity was measured from the EPR 1st derivative amplitude, and related to a sample, 3-carboxy-proxyl (CPN) with known spin concentration. Results: The absolute spin concentration could be quantified with a precision and accuracy better than +/- 10 mu M (k = 1). The spin concentration of samples stored at -80 degrees C could be reproduced after 6 months of storage well within the same error estimate. Conclusion: The absolute spin concentration in wet biological samples such as biopsies, water solutions and cell cultures could be quantified with higher precision and accuracy than normally achievable using common techniques such as flat cells, tissue cells and various capillary tubes. In addition; biological samples could be collected and stored for future incubation with spin probe, and also further stored up to at least six months before EPR analysis, without loss of signal intensity. This opens for the possibility to store and transport incubated biological samples with known accuracy of the spin concentration over time.	[Berg, Kirsti; Ericsson, Madelene] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Ericsson, Madelene] Umea Univ, Dept Med Biosci, Umea, Sweden; [Lindgren, Mikael] Norwegian Univ Sci & Technol, Dept Phys, N-7034 Trondheim, Norway; [Lindgren, Mikael] Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden; [Gustafsson, Hakan] Linkoping Univ, Dept Med & Hlth Sci, Dept Biomed Engn MTO, Cty Council Ostergotland, Linkoping, Sweden	Norwegian University of Science & Technology (NTNU); Umea University; Norwegian University of Science & Technology (NTNU); Linkoping University; City Council Ostergotland; Linkoping University	Ericsson, M (corresponding author), Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway.	madelene.ericsson@medbio.umu.se		Lindgren, Mikael/0000-0001-6649-7871; Ericsson, Madelene/0000-0002-8632-4502	Swedish Research Council [diarienr 2009-5430]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	H. Gustafsson acknowledges The Swedish Research Council (diarienr 2009-5430) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam S, 2010, UROL RES, V38, P179, DOI 10.1007/s00240-010-0256-7; Adolfsson E, 2012, PHYS MED BIOL, V57, P2209, DOI 10.1088/0031-9155/57/8/2209; Anton M, 2006, PHYS MED BIOL, V51, P5419, DOI 10.1088/0031-9155/51/21/003; Berg K, 2013, EUR J CARDIO-THORAC, V43, P1154, DOI 10.1093/ejcts/ezs591; Carl P HP, 2008, QUANTITATIVE EPT TEC, P17; Da Costa LA, 2012, PROG MOL BIOL TRANSL, V108, P179, DOI 10.1016/B978-0-12-398397-8.00008-3; Dikalov S, 1997, BIOCHEM BIOPH RES CO, V230, P54, DOI 10.1006/bbrc.1996.5880; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; Dikalov SI, 2007, BIOCHEM PHARMACOL, V73, P972, DOI 10.1016/j.bcp.2006.12.012; Dikalov SI, 2011, FREE RADICAL RES, V45, P417, DOI 10.3109/10715762.2010.540242; Dikalov SI, 2002, ARCH BIOCHEM BIOPHYS, V402, P218, DOI 10.1016/S0003-9861(02)00064-4; Dikalov SI, 2012, METHODS DETECTION MI; Dikalova A, 2005, CIRCULATION, V112, P2668, DOI 10.1161/CIRCULATIONAHA.105.538934; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Fink B, 2000, FREE RADICAL BIO MED, V28, P121, DOI 10.1016/S0891-5849(99)00228-2; FINKELSTEIN E, 1979, MOL PHARMACOL, V16, P676; FREJAVILLE C, 1995, J MED CHEM, V38, P258, DOI 10.1021/jm00002a007; Gustafsson H, 2008, PHYS MED BIOL, V53, P4667, DOI 10.1088/0031-9155/53/17/014; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Halliwell Barry GJMC, 2007, FREE RADICALS BIOL M; Hofer Peter CP, 2009, METHOD DETERMINING A; IJsselmuiden AJJ, 2008, NAT CLIN PRACT CARD, V5, P811, DOI 10.1038/ncpcardio1364; Khan N, 2005, J BIOCHEM BIOPH METH, V62, P125, DOI 10.1016/j.jbbm.2004.10.001; Kundu JK, 2012, FREE RADICAL BIO MED, V52, P2013, DOI 10.1016/j.freeradbiomed.2012.02.035; Kuzkaya N, 2005, BIOCHEM PHARMACOL, V70, P343, DOI 10.1016/j.bcp.2005.05.009; Lee R, 2012, CURR MED CHEM, V19, P2504, DOI 10.2174/092986712800493057; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Mrakic-Sposta S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/973927; NAGY V, 1994, APPL MAGN RESON, V6, P259, DOI 10.1007/BF03162494; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; Ramzan R, 2012, ADV EXP MED BIOL, V748, P265, DOI 10.1007/978-1-4614-3573-0_11; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Schaeken B, 2011, RADIOTHER ONCOL, V99, P94, DOI 10.1016/j.radonc.2011.01.026; YORDANOV ND, 1994, APPL MAGN RESON, V6, P241, DOI 10.1007/BF03162493	34	28	28	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90964	10.1371/journal.pone.0090964	http://dx.doi.org/10.1371/journal.pone.0090964			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603936	Green Published, Green Submitted, gold			2022-12-25	WOS:000332483600116
J	Korpela, K; Flint, HJ; Johnstone, AM; Lappi, J; Poutanen, K; Dewulf, E; Delzenne, N; de Vos, WM; Salonen, A				Korpela, Katri; Flint, Harry J.; Johnstone, Alexandra M.; Lappi, Jenni; Poutanen, Kaisa; Dewulf, Evelyne; Delzenne, Nathalie; de Vos, Willem M.; Salonen, Anne			Gut Microbiota Signatures Predict Host and Microbiota Responses to Dietary Interventions in Obese Individuals	PLOS ONE			English	Article							HUMAN INTESTINAL MICROBIOTA; DNA-EXTRACTION METHODS; SPECIES RESPONSE; DOUBLE-BLIND; WEIGHT-LOSS; DIFFERENTIATE; METAGENOME; BACTERIAL; IMPACT	Background: Interactions between the diet and intestinal microbiota play a role in health and disease, including obesity and related metabolic complications. There is great interest to use dietary means to manipulate the microbiota to promote health. Currently, the impact of dietary change on the microbiota and the host metabolism is poorly predictable and highly individual. We propose that the responsiveness of the gut microbiota may depend on its composition, and associate with metabolic changes in the host. Methodology: Our study involved three independent cohorts of obese adults (n = 78) from Belgium, Finland, and Britain, participating in different dietary interventions aiming to improve metabolic health. We used a phylogenetic microarray for comprehensive fecal microbiota analysis at baseline and after the intervention. Blood cholesterol, insulin and inflammation markers were analyzed as indicators of host response. The data were divided into four training set - test set pairs; each intervention acted both as a part of a training set and as an independent test set. We used linear models to predict the responsiveness of the microbiota and the host, and logistic regression to predict responder vs. non-responder status, or increase vs. decrease of the health parameters. Principal Findings: Our models, based on the abundance of several, mainly Firmicute species at baseline, predicted the responsiveness of the microbiota (AUC = 0.77-1; predicted vs. observed correlation = 0.67-0.88). Many of the predictive taxa showed a non-linear relationship with the responsiveness. The microbiota response associated with the change in serum cholesterol levels with an AUC of 0.96, highlighting the involvement of the intestinal microbiota in metabolic health. Conclusion: This proof-of-principle study introduces the first potential microbial biomarkers for dietary responsiveness in obese individuals with impaired metabolic health, and reveals the potential of microbiota signatures for personalized nutrition.	[Korpela, Katri; de Vos, Willem M.; Salonen, Anne] Univ Helsinki, Dept Bacteriol & Immunol, Immunobiol Res Program, Helsinki, Finland; [Flint, Harry J.; Johnstone, Alexandra M.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Lappi, Jenni; Poutanen, Kaisa] Univ Eastern Finland, Dept Clin Nutr, Kuopio, Finland; [Poutanen, Kaisa] VTT Tech Res Ctr, Espoo, Finland; [Poutanen, Kaisa] VTT Tech Res Ctr, Kuopio, Finland; [Dewulf, Evelyne; Delzenne, Nathalie] Catholic Univ Louvain, Louvain Drug Res Inst, Brussels, Belgium; [de Vos, Willem M.] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [de Vos, Willem M.] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands	University of Helsinki; University of Aberdeen; University of Eastern Finland; VTT Technical Research Center Finland; VTT Technical Research Center Finland; Universite Catholique Louvain; University of Helsinki; Wageningen University & Research	Salonen, A (corresponding author), Univ Helsinki, Dept Bacteriol & Immunol, Immunobiol Res Program, Helsinki, Finland.	anne.salonen@helsinki.fi	Delzenne, Nathalie/AAC-4628-2019; Salonen, Anne/AAW-1858-2020	Delzenne, Nathalie/0000-0003-2115-6082; Salonen, Anne/0000-0002-6960-7447; Johnstone, Alexandra/0000-0002-5484-292X; Lappi, Jenni/0000-0002-4886-8242	FNRS grant; World Cancer Research Fund; EU 6th Framework Programme in project HEALTHGRAIN; WMdV by Academy of Finland [1141130]; ERC [400795]	FNRS grant(Fonds de la Recherche Scientifique - FNRS); World Cancer Research Fund(World Cancer Research Fund International (WCRF)); EU 6th Framework Programme in project HEALTHGRAIN; WMdV by Academy of Finland(Academy of Finland); ERC(European Research Council (ERC)European Commission)	The study involved samples from previously published studies including the Belgian trial funded the FNRS grant, British study funded by World Cancer Research Fund and the Finnish trials funded by EU 6th Framework Programme in project HEALTHGRAIN. WMdV and AS are funded by the grants to WMdV by Academy of Finland (grant 1141130) http://www.aka.fi/en-GB/A/ and ERC (grant 400795) http://erc.europa.eu/advanced-grants. KK is funded by the Helsinki Biomedical Graduate Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2012, NUTR REV, V70, pS14, DOI 10.1111/j.1753-4887.2012.00496.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bouhnik Y, 2004, AM J CLIN NUTR, V80, P1658, DOI 10.1093/ajcn/80.6.1658; Cheng J, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-113; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Davis LMG, 2010, INT J FOOD MICROBIOL, V144, P285, DOI 10.1016/j.ijfoodmicro.2010.10.007; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; Dewulf EM, 2013, GUT, V62, P1112, DOI 10.1136/gutjnl-2012-303304; Everard A, 2013, BEST PRACT RES CL GA, V27, P73, DOI 10.1016/j.bpg.2013.03.007; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Flint HJ, 2011, J CLIN GASTROENTEROL, V45, pS128, DOI 10.1097/MCG.0b013e31821f44c4; Haiser HJ, 2012, SCIENCE, V336, P1253, DOI 10.1126/science.1224396; Harmon JP, 2009, SCIENCE, V323, P1347, DOI 10.1126/science.1167396; Holmes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004244; Jalanka-Tuovinen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023035; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kolida S, 2007, EUR J CLIN NUTR, V61, P1189, DOI 10.1038/sj.ejcn.1602636; Kootte RS, 2012, DIABETES OBES METAB, V14, P112, DOI 10.1111/j.1463-1326.2011.01483.x; Lahti L, 2013, PEERJ, V1, DOI 10.7717/peerj.32; Lampe JW, 2013, P NUTR SOC, V72, P207, DOI 10.1017/S0029665113000025; Lappi J, 2013, J NUTR, V143, P648, DOI 10.3945/jn.112.172668; Lobley GE, 2013, NUTRIENTS, V5, P2144, DOI 10.3390/nu5062144; Louis P, 2004, J BACTERIOL, V186, P2099, DOI 10.1128/JB.186.7.2099-2106.2004; Louis P, 2012, AGRO FOOD IND HI TEC, V23, P26; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Maeda M, 1998, YAKUGAKU ZASSHI, V118, P150, DOI 10.1248/yakushi1947.118.4_150; Martinez I, 2013, ISME J, V7, P269, DOI 10.1038/ismej.2012.104; Martinez I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015046; Maukonen J, 2012, FEMS MICROBIOL ECOL, V79, P697, DOI 10.1111/j.1574-6941.2011.01257.x; McOrist AL, 2011, J NUTR, V141, P883, DOI 10.3945/jn.110.128504; Million M, 2013, CLIN MICROBIOL INFEC, V19, P305, DOI 10.1111/1469-0691.12172; MOORE WEC, 1974, APPL MICROBIOL, V27, P961, DOI 10.1128/AEM.27.5.961-979.1974; Moosavian M, 2008, PAK J MED SCI, V24, P209; Mutch DM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001344; Nakamura N, 2010, ANNU REV FOOD SCI T, V1, P363, DOI 10.1146/annurev.food.102308.124101; Nikkila J, 2010, J CLIN GASTROENTEROL, V44, pS2, DOI 10.1097/MCG.0b013e3181e5018f; Papa E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039242; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rainey FA, 2009, BERGEYS MANUAL SYSTE, P774; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rydgren K, 2003, J VEG SCI, V14, P869, DOI 10.1111/j.1654-1103.2003.tb02220.x; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Tims S, 2013, ISME J, V7, P707, DOI 10.1038/ismej.2012.146; Velagapudi VR, 2010, J LIPID RES, V51, P1101, DOI 10.1194/jlr.M002774; Walker AW, 2013, PHARMACOL RES, V69, P75, DOI 10.1016/j.phrs.2012.09.008; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Whitford MF, 2001, INT J SYST EVOL MICR, V51, P1977, DOI 10.1099/00207713-51-6-1977; Willems A., 2006, PROKARYOTES; Williams BL, 2012, MBIO, V3, DOI 10.1128/mBio.00261-11; Zeng XQ, 2010, J APPL MICROBIOL, V108, P2059, DOI 10.1111/j.1365-2672.2009.04608.x	53	130	145	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90702	10.1371/journal.pone.0090702	http://dx.doi.org/10.1371/journal.pone.0090702			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603757	Green Published, Green Submitted, gold			2022-12-25	WOS:000332483600073
J	Serasinghe, MN; Missert, DJ; Asciolla, JJ; Podgrabinska, S; Wieder, SY; Izadmehr, S; Belbin, G; Skobe, M; Chipuk, JE				Serasinghe, M. N.; Missert, D. J.; Asciolla, J. J.; Podgrabinska, S.; Wieder, S. Y.; Izadmehr, S.; Belbin, G.; Skobe, M.; Chipuk, J. E.			Anti-apoptotic BCL-2 proteins govern cellular outcome following B-RAF(V600E) inhibition and can be targeted to reduce resistance	ONCOGENE			English	Article							BH3 DOMAINS; BRAF; FAMILY; BAX; DIMERIZATION; RESPONSES; SURVIVAL; PATHWAY; POTENT	In theory, pharmacological inhibition of oncogenic signaling is an effective strategy to halt cellular proliferation, induce apoptosis and eliminate cancer cells. In practice, drugs (for example, PLX-4032) that inhibit oncogenes like B-RAFV600E provide relatively short-term success in patients, owing to a combination of incomplete cellular responses and the development of resistance. To define the relationship between PLX-4032-induced responses and resistance, we interrogated the contributions of anti-apoptotic BCL-2 proteins in determining the fate of B-RAFV600E-inhibited melanoma cells. Although PLX-4032 eliminated B-RAFV600E signaling leading to marked cell cycle arrest, only a fraction of cells eventually underwent apoptosis. These data proposed two hypotheses regarding B-RAFV600E inhibition: (1) only a few cells generate a pro-apoptotic signal, or (2) all the cells generate a pro-apoptotic signal but the majority silences this pathway to ensure survival. Indeed, the latter hypothesis is supported by our observations as the addition of ABT-737, an inhibitor to anti-apoptotic BCL-2 proteins, revealed massive apoptosis following PLX-4032 exposure. B-RAFV600E inhibition alone sensitized cells to the mitochondrial pathway of apoptosis characterized by the rapid accumulation of BIM on the outer mitochondrial membrane, which could be functionally revealed by ABT-737 to promote apoptosis and loss of clonogenic survival. Furthermore, PLX-4032-resistant cells demonstrated collateral resistance to conventional chemotherapy, yet could be re-sensitized to PLX-4032 by BCL-2 family inhibition in vivo and conventional chemotherapies in vitro. Our data suggest that inhibiting anti-apoptotic BCL-2 proteins will enhance primary responses to PLX-4032, along with reducing the development of resistance to both targeted and conventional therapies.	[Serasinghe, M. N.; Missert, D. J.; Asciolla, J. J.; Podgrabinska, S.; Wieder, S. Y.; Belbin, G.; Skobe, M.; Chipuk, J. E.] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Serasinghe, M. N.; Missert, D. J.; Asciolla, J. J.; Wieder, S. Y.; Chipuk, J. E.] Dept Dermatol, New York, NY USA; [Serasinghe, M. N.; Missert, D. J.; Asciolla, J. J.; Podgrabinska, S.; Wieder, S. Y.; Skobe, M.; Chipuk, J. E.] Tisch Canc Inst, New York, NY USA; [Missert, D. J.; Izadmehr, S.; Belbin, G.; Skobe, M.; Chipuk, J. E.] Grad Sch Biomed Sci, New York, NY USA; [Izadmehr, S.] Dept Genet & Genom Sci, New York, NY USA; [Chipuk, J. E.] Diabet Obes & Metab Inst, New York, NY USA	Icahn School of Medicine at Mount Sinai	Chipuk, JE (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, One Gustave L Levy Pl,Box 1130, New York, NY 10029 USA.	jerry.chipuk@mssm.edu		Wieder, Shira/0000-0002-3151-3947; Chipuk, Jerry Edward/0000-0002-1337-842X	NIH [CA157740, KL2TR000069]; JJR Foundation; Breast Cancer Alliance; Fridolin Charitable Trust; March of Dimes Foundation [FY13-238]; Department of Oncological Sciences at Mount Sinai [PO1]; Albert Einstein College of Medicine; American Skin Association Medical Students Grant; William A. Spivak Fund; Chipuk Laboratory; NATIONAL CANCER INSTITUTE [R01CA157740] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000069] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JJR Foundation; Breast Cancer Alliance; Fridolin Charitable Trust; March of Dimes Foundation(March of Dimes); Department of Oncological Sciences at Mount Sinai; Albert Einstein College of Medicine; American Skin Association Medical Students Grant; William A. Spivak Fund; Chipuk Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank everyone in the Chipuk Laboratory for their assistance and support; Dr Stuart Aaronson, Dr Mark Lebwohl, Dr Emily Bernstein, Dr E Premkumar Reddy and Dr Poulikos Poulikakos for mentorship, guidance and/or discussion about the melanoma field; and Dr Suvendu Das, Eliana Sarrou, Rana Elkholi and Andrew Cruz for technical assistance. This work was supported by: NIH CA157740 (to JEC), NIH KL2TR000069 (to SI), the JJR Foundation (to JEC), the Breast Cancer Alliance (MS), the William A. Spivak Fund (to JEC), and the Fridolin Charitable Trust (to JEC). This work was also supported in part by a Research Grant FY13-238 from the March of Dimes Foundation (to JEC), a developmental PO1 grant from the Department of Oncological Sciences at Mount Sinai (to JEC), an Albert Einstein College of Medicine Research Fellowship (to SYW) and an American Skin Association Medical Students Grant (to SYW).	Anvekar RA, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.161; Anvekar RA, 2011, FRONT ONCOL, V1, DOI 10.3389/fonc.2011.00034; Asciolla JJ, 2012, JOVE-J VIS EXP, DOI 10.3791/4291; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chipuk JE, 2008, P NATL ACAD SCI USA, V105, P20327, DOI 10.1073/pnas.0808036105; Cragg MS, 2008, J CLIN INVEST, V118, P3651, DOI 10.1172/JCI35437; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Logue SE, 2009, NAT PROTOC, V4, P1383, DOI 10.1038/nprot.2009.143; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; McArthur GA, 2012, J CLIN ONCOL, V30, P1628, DOI 10.1200/JCO.2011.39.1938; Montagut C, 2009, CANCER LETT, V283, P125, DOI 10.1016/j.canlet.2009.01.022; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Poulikakos PI, 2011, CANCER CELL, V19, P11, DOI 10.1016/j.ccr.2011.01.008; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Whittaker S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000758; Young A, 2009, ADV CANCER RES, V102, P1, DOI 10.1016/S0065-230X(09)02001-6	30	39	39	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 12	2015	34	7					857	867		10.1038/onc.2014.21	http://dx.doi.org/10.1038/onc.2014.21			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CB2QF	24608435	Green Accepted			2022-12-25	WOS:000349472000006
J	Wen, SY; Lin, Y; Yu, YQ; Cao, SJ; Zhang, R; Yang, XM; Li, J; Zhang, YL; Wang, YH; Ma, MZ; Sun, WW; Lou, XL; Wang, JH; Teng, YC; Zhang, ZG				Wen, S-Y; Lin, Y.; Yu, Y-Q; Cao, S-J; Zhang, R.; Yang, X-M; Li, J.; Zhang, Y-L; Wang, Y-H; Ma, M-Z; Sun, W-W; Lou, X-L; Wang, J-H; Teng, Y-C; Zhang, Z-G			miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer	ONCOGENE			English	Article							REGULATORY NETWORK; SONIC HEDGEHOG; UP-REGULATION; EXPRESSION; CELLS; DIFFERENTIATION; MICRORNAS	Although significant advances have recently been made in the diagnosis and treatment of cervical carcinoma, the long-term survival rate for advanced cervical cancer remains low. Therefore, an urgent need exists to both uncover the molecular mechanisms and identify potential therapeutic targets for the treatment of cervical cancer. MicroRNAs (miRNAs) have important roles in cancer progression and could be used as either potential therapeutic agents or targets. miR-506 is a component of an X chromosome-linked miRNA cluster. The biological functions of miR-506 have not been well established. In this study, we found that miR-506 expression was downregulated in approximately 80% of the cervical cancer samples examined and inversely correlated with the expression of Ki-67, a marker of cell proliferation. Gain-of-function and loss-of-function studies in human cervical cancer, Caski and SiHa cells, demonstrated that miR-506 acts as a tumor suppressor by inhibiting cervical cancer growth in vitro and in vivo. Further studies showed that miR-506 induced cell cycle arrest at the G1/S transition, and enhanced apoptosis and chemosensitivity of cervical cancer cell. We subsequently identified Gli3, a hedgehog pathway transcription factor, as a direct target of miR-506 in cervical cancer. Furthermore, Gli3 silencing recapitulated the effects of miR-506, and reintroduction of Gli3 abrogated miR-506-induced cell growth arrest and apoptosis. Taken together, we conclude that miR-506 exerts its anti-proliferative function by directly targeting Gli3. This newly identified miR-506/Gli3 axis provides further insight into the pathogenesis of cervical cancer and indicates a potential novel therapeutic agent for the treatment of cervical cancer.	[Wen, S-Y; Teng, Y-C] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Obstet & Gynecol, Shanghai 200233, Peoples R China; [Wen, S-Y; Lin, Y.] Shanghai Jiao Tong Univ, Sch Med, China Welf Inst, Dept Obstet & Gynecol,Int Peace Matern & Child Hl, Shanghai 200233, Peoples R China; [Wen, S-Y; Yang, X-M; Li, J.; Zhang, Y-L; Wang, Y-H; Ma, M-Z; Zhang, Z-G] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, State Key Lab Oncogenes & Related Genes,Shanghai, Shanghai 200233, Peoples R China; [Yu, Y-Q] China Med Univ, Coll Basic Med Sci, Dept Pathophysiol, Shenyang 110001, Peoples R China; [Cao, S-J; Sun, W-W] Shanghai Songjiang Dist Cent Hosp, Dept Obstet & Gynecol, Shanghai, Peoples R China; [Zhang, R.] Shanghai Fengxian Dist Cent Hosp, Dept Obstet & Gynecol, Shanghai, Peoples R China; [Wang, J-H] Southern Med Univ, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; China Medical University; Southern Medical University - China	Teng, YC (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Obstet & Gynecol, 600 Yisan Rd, Shanghai 200233, Peoples R China.	teng_yc@126.com; zzhang@shsci.org	Ma, Ming-Ze/ABC-4612-2021	Zhang, Yan-Li/0000-0002-8942-5325; Zhang, Zhi-gang/0000-0001-8965-223X	National Science Foundation of China [81071738, 81101600, 81201624]; Songjiang district of Science and Technology Commission of Shanghai Municipality [10SJGG26]; Shanghai Songjiang District Central Hospital [BY10A07]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Songjiang district of Science and Technology Commission of Shanghai Municipality; Shanghai Songjiang District Central Hospital	We are most grateful for Dr Lei-Zhu, Bo-Shi Wang, Ming-Xuan Feng and Doctor XingLin Yang of Medical and Biological Engineering Technology Co. Ltd of Heyuan of Shanghai. This work was supported by the National Science Foundation of China (no. 81071738; no. 81101600; no. 81201624), Songjiang district of Science and Technology Commission of Shanghai Municipality (no. 10SJGG26), and Shanghai Songjiang District Central Hospital (no. BY10A07).	Ambros Victor, 2004, Methods Mol Biol, V265, P131; Banales JM, 2012, HEPATOLOGY, V56, P687, DOI 10.1002/hep.25691; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Castro RE, 2012, CLIN RES HEPATOL GAS, V36, P402, DOI 10.1016/j.clinre.2012.05.019; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Iwasaki H, 2013, CANCER SCI, V104, P328, DOI 10.1111/cas.12073; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kang HN, 2012, EXP CELL RES, V318, P539, DOI 10.1016/j.yexcr.2011.12.010; Kim KH, 2009, PATHOL INT, V59, P279, DOI 10.1111/j.1440-1827.2009.02366.x; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Li KKW, 2009, HUM PATHOL, V40, P1234, DOI 10.1016/j.humpath.2009.02.003; Lim YY, 2013, J CELL SCI, V126, P2256, DOI 10.1242/jcs.122275; Liu KJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/867537; McManus MT, 2003, SEMIN CANCER BIOL, V13, P253, DOI 10.1016/S1044-579X(03)00038-5; Mitra AK, 2012, CANCER DISCOV, V2, P1100, DOI 10.1158/2159-8290.CD-12-0206; Pierson J, 2008, J NEURO-ONCOL, V90, P1, DOI 10.1007/s11060-008-9624-3; Renault MA, 2009, CIRC RES, V105, P818, DOI 10.1161/CIRCRESAHA.109.206706; Roy SS, 2014, ONCOGENE, V33, P3707, DOI 10.1038/onc.2013.332; Scherr M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm971; Sengupta A, 2007, LEUKEMIA, V21, P949, DOI 10.1038/sj.leu.2404657; Shi XB, 2013, ONCOGENE, V32, P4130, DOI 10.1038/onc.2012.425; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Steg A, 2010, CANCER BIOL THER, V10, P897, DOI 10.4161/cbt.10.9.13252; Streicher KL, 2012, ONCOGENE, V31, P1558, DOI 10.1038/onc.2011.345; Sun MM, 2014, ONCOGENE, V33, P2075, DOI 10.1038/onc.2013.165; Tong JL, 2011, FEBS LETT, V585, P3560, DOI 10.1016/j.febslet.2011.10.021; Vale C, 2008, J CLIN ONCOL, V26, P5802, DOI 10.1200/JCO.2008.16.4368; Wang P, 2014, ONCOGENE, V33, P514, DOI 10.1038/onc.2012.598; Wilting SM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-167; Yang D, 2013, CANCER CELL, V23, P186, DOI 10.1016/j.ccr.2012.12.020; Zhao Y, 2011, TOXICOL LETT, V205, P320, DOI 10.1016/j.toxlet.2011.06.022	32	113	117	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 5	2015	34	6					717	725		10.1038/onc.2014.9	http://dx.doi.org/10.1038/onc.2014.9			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CA4DG	24608427				2022-12-25	WOS:000348853800005
J	Baier, A; Winkler, W; Korte, T; Lockau, W; Karradt, A				Baier, Antje; Winkler, Wiebke; Korte, Thomas; Lockau, Wolfgang; Karradt, Anne			Degradation of Phycobilisomes in Synechocystis sp PCC6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyanobacteria; Fluorescence Resonance Energy Transfer (FRET); Protease; Protein Degradation; Protein Synthesis; NblA; Synechocystis; Nitrogen Starvation; Phycobilisome Degradation	CYANOBACTERIAL CLP PROTEASE; ESCHERICHIA-COLI; STRAIN PCC-7942; LIGHT-INTENSITY; ADAPTER PROTEIN; GENE-EXPRESSION; PCC 7120; SYNECHOCOCCUS; NBLA; COMPONENTS	Background: In cyanobacteria, starvation-induced phycobilisome degradation is caused by NblA. Results:Synechocystis expresses two NblA proteins that form a heterodimer. The heterodimer binds phycobiliproteins and ClpC and is degraded by a ClpC-ClpP1ClpR protease in vitro. Conclusion: NblA1/NblA2 is an adaptor protein that mediates degradation of phycobilisomes by the ATP-dependent protease ClpC-ClpP1ClpR. Significance: These findings improve our understanding of the mechanisms by which cyanobacteria adapt to changing environmental conditions. When cyanobacteria acclimate to nitrogen deficiency, they degrade their large (3-5-MDa), light-harvesting complexes, the phycobilisomes. This massive, yet specific, intracellular degradation of the pigmented phycobiliproteins causes a color change of cyanobacterial cultures from blue-green to yellow-green, a process referred to as chlorosis or bleaching. Phycobilisome degradation is induced by expression of the nblA gene, which encodes a protein of approximate to 7 kDa. NblA most likely acts as an adaptor protein that guides a Clp protease to the phycobiliproteins, thereby initiating the degradation process. Most cyanobacteria and red algae possess just one nblA-homologous gene. As an exception, the widely used model organism Synechocystis sp. PCC6803 expresses two such genes, nblA1(6803) and nblA2(6803), both of whose products are required for phycobilisome degradation. Here, we demonstrate that the two NblA proteins heterodimerize in vitro and in vivo using pull-down assays and a Forster energy-transfer approach, respectively. We further show that the NblA proteins form a ternary complex with ClpC (the HSP100 chaperone partner of Clp proteases) and phycobiliproteins in vitro. This complex is susceptible to ATP-dependent degradation by a Clp protease, a finding that supports a proposed mechanism of the degradation process. Expression of the single nblA gene encoded by the genome of the N-2-fixing, filamentous cyanobacterium Nostoc sp. PCC7120 in the nblA1/nblA2 mutant of Synechocystis sp. PCC6803 induced phycobilisome degradation, suggesting that the function of the NblA heterodimer of Synechocystis sp. PCC6803 is combined in the homodimeric protein of Nostoc sp. PCC7120.	[Baier, Antje; Winkler, Wiebke; Lockau, Wolfgang; Karradt, Anne] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Korte, Thomas] Humboldt Univ, Grp Mol Biophys, D-10115 Berlin, Germany	Humboldt University of Berlin; Humboldt University of Berlin	Lockau, W (corresponding author), Humboldt Univ, Inst Biol, Chausseestr 117, D-10115 Berlin, Germany.	wolfgang.lockau@biologie.hu-berlin.de		Winkler, Wiebke/0000-0001-8807-9259				Adir N, 2005, PHOTOSYNTH RES, V85, P15, DOI 10.1007/s11120-004-2143-y; Adir N, 2003, PHOTOSYNTH RES, V76, P343, DOI 10.1023/A:1024969518145; ALLEN MM, 1969, ARCH MIKROBIOL, V69, P114, DOI 10.1007/BF00409755; Andersson FI, 2009, J BIOL CHEM, V284, P13519, DOI 10.1074/jbc.M809588200; Baier K, 2004, MICROBIOL-SGM, V150, P2739, DOI 10.1099/mic.0.27153-0; Baier K, 2001, FEMS MICROBIOL LETT, V195, P35, DOI 10.1111/j.1574-6968.2001.tb10494.x; Bienert R, 2006, J BIOL CHEM, V281, P5216, DOI 10.1074/jbc.M507243200; COLLIER JL, 1994, EMBO J, V13, P1039, DOI 10.1002/j.1460-2075.1994.tb06352.x; COLLIER JL, 1992, J BACTERIOL, V174, P4718, DOI 10.1128/JB.174.14.4718-4726.1992; DELORIMIER RM, 1992, PLANT PHYSIOL, V98, P1003, DOI 10.1104/pp.98.3.1003; DEMARSAC NT, 1977, J BACTERIOL, V130, P82, DOI 10.1128/JB.130.1.82-91.1977; Dines M, 2008, J BIOL CHEM, V283, P30330, DOI 10.1074/jbc.M804241200; Dolganov N, 1999, J BACTERIOL, V181, P610, DOI 10.1128/JB.181.2.610-617.1999; Dougan DA, 2002, FEBS LETT, V529, P6, DOI 10.1016/S0014-5793(02)03179-4; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; Ducret A, 1996, EUR J BIOCHEM, V236, P1010, DOI 10.1111/j.1432-1033.1996.01010.x; Finkenwirth F, 2010, BIOCHEM J, V431, P373, DOI 10.1042/BJ20100813; GLAZER AN, 1982, ANNU REV MICROBIOL, V36, P173, DOI 10.1146/annurev.mi.36.100182.001133; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; GROSSMAN AR, 1993, MICROBIOL REV, V57, P725, DOI 10.1128/MMBR.57.3.725-749.1993; Herskovits T. T., 1966, BIOCHEMISTRY-US, P1018; KALLA R, 1993, GENE, V126, P77, DOI 10.1016/0378-1119(93)90592-Q; Kappell AD, 2006, ARCH MICROBIOL, V186, P403, DOI 10.1007/s00203-006-0154-0; Karradt A, 2008, J BIOL CHEM, V283, P32394, DOI 10.1074/jbc.M805823200; Ke S, 2013, MICROBIOL-SGM, V159, P253, DOI 10.1099/mic.0.064220-0; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; Kirstein J, 2007, EMBO J, V26, P2061, DOI 10.1038/sj.emboj.7601655; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; Li H, 2002, ARCH MICROBIOL, V178, P256, DOI 10.1007/s00203-002-0446-y; Luque I, 2003, MOL MICROBIOL, V50, P1043, DOI 10.1046/j.1365-2958.2003.03768.x; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; MacColl R, 1998, BIOCHEMISTRY-US, V37, P417, DOI 10.1021/bi971453s; Ortega J, 2002, EMBO J, V21, P4938, DOI 10.1093/emboj/cdf483; Persuh M, 2002, J BACTERIOL, V184, P2310, DOI 10.1128/JB.184.8.2310-2313.2002; Piven I, 2005, J BIOL CHEM, V280, P21667, DOI 10.1074/jbc.m412967200; RAPS S, 1985, PLANT PHYSIOL, V79, P983, DOI 10.1104/pp.79.4.983; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Sambrook J, 2001, MOL CLONING LAB MANU; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Scheer H, 2008, MOL MICROBIOL, V68, P263, DOI 10.1111/j.1365-2958.2008.06160.x; Schelin J, 2002, MICROBIOL-SGM, V148, P2255, DOI 10.1099/00221287-148-7-2255; Schlothauer T, 2003, P NATL ACAD SCI USA, V100, P2306, DOI 10.1073/pnas.0535717100; Stanne TM, 2007, J BIOL CHEM, V282, P14394, DOI 10.1074/jbc.M700275200; Tryggvesson A, 2012, BIOCHEM J, V446, P311, DOI 10.1042/BJ20120649; Turgay K, 1997, GENE DEV, V11, P119, DOI 10.1101/gad.11.1.119; van Waasbergen LG, 2002, J BACTERIOL, V184, P2481, DOI 10.1128/JB.184.9.2481-2490.2002; WOLK CP, 1984, P NATL ACAD SCI-BIOL, V81, P1561, DOI 10.1073/pnas.81.5.1561; YAMANAKA G, 1980, J BIOL CHEM, V255, P1004; Zacharias David A, 2002, Sci STKE, V2002, ppe23, DOI 10.1126/stke.2002.131.pe23; Zinchenko VV, 1999, RUSS J GENET+, V35, P228	51	52	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11755	11766		10.1074/jbc.M113.520601	http://dx.doi.org/10.1074/jbc.M113.520601			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24610785	hybrid, Green Published			2022-12-25	WOS:000335010600017
J	Caro, TM; Hermosilla, C; Silva, LMR; Cortes, H; Taubert, A				Caro, Tamara Munoz; Hermosilla, Carlos; Silva, Liliana M. R.; Cortes, Helder; Taubert, Anja			Neutrophil Extracellular Traps as Innate Immune Reaction against the Emerging Apicomplexan Parasite Besnoitia besnoiti	PLOS ONE			English	Article							IN-VITRO ISOLATION; BOVINE BESNOITIOSIS; TOXOPLASMA-GONDII; ANTIMICROBIAL ACTIVITY; EIMERIA-BOVIS; CATTLE; CELLS; BORN	Besnoitia besnoiti infection in cattle is an important emerging protozoan disease in Europe causing economic losses and severe clinical signs, such as generalized dermatitis, orchitis, and vulvitis in affected animals. Neutrophil extracellular trap (NET) formation was recently demonstrated as an important effector mechanism of PMN acting against several invading pathogens. In the present study, interactions of bovine PMN with tachyzoites of B. besnoiti were investigated in this respect in vitro. For the demonstration and quantification of NETs, extracellular DNA was stained by Sytox Orange or Pico Green. Fluorescent illustrations as well as scanning electron microscopy analyses (SEM) showed PMN-promoted NET formation rapidly being induced upon contact with B. besnoiti tachyzoites. Co-localization of extracellular DNA with histones, neutrophil elastase (NE) and myeloperoxidase (MPO) in parasite entrapping structures confirmed the classical characteristics of NET. Exposure of PMN to viable, UV attenuated and dead tachyzoites showed a significant induction of NET formation, but even tachyzoite homogenates significantly promoted NETs when compared to negative controls. NETs were abolished by DNase treatment and were reduced after PMN preincubation with NADPH oxidase-, NE- and MPO-inhibitors. Tachyzoite-triggered NET formation led to parasite entrapment as quantitative assays indicated that about one third of tachyzoites were immobilized in NETs. In consequence, tachyzoites were hampered from active invasion of host cells. Thus, transfer of tachyzoites, previously being confronted with PMN, to adequate host cells resulted in significantly reduced infection rates when compared to PMN-free infection controls. To our knowledge, we here report for the first time B. besnoiti-induced NET formation. Our results indicate that PMN-triggered extracellular traps may represent an important effector mechanism of the host early innate immune response against B. besnoiti which may lead to diminishment of initial parasite infection rates during the acute infection phase.	[Caro, Tamara Munoz; Hermosilla, Carlos; Taubert, Anja] Univ Giessen, Inst Parasitol, D-35390 Giessen, Germany; [Silva, Liliana M. R.; Cortes, Helder] Univ Evora, ICAAM, Evora, Portugal	Justus Liebig University Giessen; University of Evora	Caro, TM (corresponding author), Univ Giessen, Inst Parasitol, D-35390 Giessen, Germany.	Tamara.Munoz-Caro@vetmed.uni-giessen.de		Cortes, Helder/0000-0003-4644-2165; Silva, Liliana M. R./0000-0002-2217-9983	Institute of Parasitology of the Justus Liebig University Giessen	Institute of Parasitology of the Justus Liebig University Giessen	The present work was self-financed by the Institute of Parasitology of the Justus Liebig University Giessen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah DSA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00382; Abdallah DSA, 2012, INFECT IMMUN, V80, P768, DOI 10.1128/IAI.05730-11; Alvarez-Garcia G, 2013, TRENDS PARASITOL, V29, P407, DOI 10.1016/j.pt.2013.06.002; Aulik NA, 2010, INFECT IMMUN, V78, P4454, DOI 10.1128/IAI.00840-10; Baker VS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-41; Behrendt JH, 2008, VET PARASITOL, V151, P97, DOI 10.1016/j.vetpar.2007.11.013; Behrendt JH, 2010, VET IMMUNOL IMMUNOP, V133, P1, DOI 10.1016/j.vetimm.2009.06.012; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; BROWN GB, 1991, VET IMMUNOL IMMUNOP, V28, P201, DOI 10.1016/0165-2427(91)90115-S; Conejeros I, 2011, VET IMMUNOL IMMUNOP, V139, P308, DOI 10.1016/j.vetimm.2010.10.021; Conejeros I, 2012, RES VET SCI, V92, P103, DOI 10.1016/j.rvsc.2010.10.005; Cortes H, 2005, VET REC, V157, P262, DOI 10.1136/vr.157.9.262; EFSA European Food Safety Authority, 2010, EFSA J, V8, P1499, DOI [10.2903/j.efsa.2010.1499, DOI 10.2903/J.EFSA.2010.1499]; Fernandez-Garcia A, 2009, J PARASITOL, V95, P474, DOI 10.1645/GE-1772.1; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gabriel C, 2010, J IMMUNOL, V185, P4319, DOI 10.4049/jimmunol.1000893; Gentile A, 2012, VET PARASITOL, V184, P108, DOI 10.1016/j.vetpar.2011.09.014; Gollnick NS, 2010, VET REC, V166, P599, DOI 10.1136/vr.c2314; Guimaraes-Costa AB, 2009, P NATL ACAD SCI USA, V106, P6748, DOI 10.1073/pnas.0900226106; Hermosilla C, 2008, PARASITOL RES, V102, P777, DOI 10.1007/s00436-007-0849-4; Jacquiet P, 2009, JOURN NAT GTV NANT, P1213; Lesser M, 2012, SCHWEIZ ARCH TIERH, V154, P469, DOI 10.1024/0036-7281/a000389; Linch SN, 2009, INFECT IMMUN, V77, P4976, DOI 10.1128/IAI.00306-09; Lippolis JD, 2006, VET IMMUNOL IMMUNOP, V113, P248, DOI 10.1016/j.vetimm.2006.05.004; MacLaren A, 2004, VET PARASITOL, V125, P301, DOI 10.1016/j.vetpar.2004.07.006; MacLaren A., 2002, Journal of Submicroscopic Cytology and Pathology, V34, P99; Martinelli S, 2004, J BIOL CHEM, V279, P44123, DOI 10.1074/jbc.M405883200; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; Parker H, 2012, J LEUKOCYTE BIOL, V91, P369, DOI 10.1189/jlb.0711387; Rinaldi L, 2013, PARASITOL RES, V112, P1805, DOI 10.1007/s00436-012-3241-y; Saitoh T, 2012, CELL HOST MICROBE, V12, P109, DOI 10.1016/j.chom.2012.05.015; Schares G, 2009, VET PARASITOL, V163, P315, DOI 10.1016/j.vetpar.2009.04.033; Taubert A, 2006, BERL MUNCH TIERARZTL, V119, P274; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; von Kockritz-Blickwede M, 2008, BLOOD, V111, P3070, DOI 10.1182/blood-2007-07-104018; von Kockritz-Blickwede M, 2010, METHOD MICROBIOL, V37, P139, DOI 10.1016/S0580-9517(10)37007-3; Wartha F, 2007, CURR OPIN MICROBIOL, V10, P52, DOI 10.1016/j.mib.2006.12.005; Wartha F, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.121pe25; WILSON CB, 1979, J INFECT DIS, V140, P890, DOI 10.1093/infdis/140.6.890; Zhao Y, 2013, PARASITOL RES, V112, P3151, DOI 10.1007/s00436-013-3491-3	41	51	54	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91415	10.1371/journal.pone.0091415	http://dx.doi.org/10.1371/journal.pone.0091415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618849	Green Published, gold, Green Submitted			2022-12-25	WOS:000332842400089
J	Dangor, Z; Izu, A; Moore, DP; Nunes, MC; Solomon, F; Beylis, N; von Gottberg, A; McAnerney, JM; Madhi, SA				Dangor, Ziyaad; Izu, Alane; Moore, David P.; Nunes, Marta C.; Solomon, Fatima; Beylis, Natalie; von Gottberg, Anne; McAnerney, Johanna M.; Madhi, Shabir A.			Temporal Association in Hospitalizations for Tuberculosis, Invasive Pneumococcal Disease and Influenza Virus Illness in South African Children	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; STREPTOCOCCUS-PNEUMONIAE; MYCOBACTERIUM-TUBERCULOSIS; HUMAN METAPNEUMOVIRUS; BACTERIAL-INFECTIONS; PANDEMIC INFLUENZA; NATURAL-HISTORY; UNITED-STATES; COINFECTION; IMPACT	Introduction: The seasonal variability in hospitalization for tuberculosis may in part relate to super-imposed bacterial or predisposing respiratory viral infections. We aimed to study the temporal association between hospitalization for culture-confirmed pulmonary tuberculosis (PTB), invasive pneumococcal disease (IPD) and influenza virus epidemics in South African children. Methods: We undertook a retrospective analysis which examined seasonal trends, from 2005 to 2008, for hospitalization for culture-confirmed PTB and IPD among children in relation to the influenza epidemics in Soweto, South Africa. Original time-series of the influenza virus epidemics and hospitalization rates for PTB and IPD were decomposed into three components: a trend cycle component, a seasonal component and an irregular component using the X-11 seasonal adjustment method. To compare the seasonality amongst the three series, the trend and irregular components were removed and only seasonal components examined. Results: Across the study period, the influenza virus epidemics peaked during May to July (winter) months, which was closely followed by an increase in the incidence of hospitalization for IPD (August to October) and PTB (August to November). Discussion: Within-and between-year temporal changes associated with childhood TB hospitalization may in part be driven by factors which influence temporal changes in pneumococcal disease, including potential variability in the severity of influenza virus epidemics in temperate climates. The dynamics of the interplay between the host and these infectious agents appears to be complex and multifactorial.	[Dangor, Ziyaad; Izu, Alane; Moore, David P.; Nunes, Marta C.; Solomon, Fatima; Madhi, Shabir A.] Univ Witwatersrand, Fac Hlth Sci, MRC, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; [Dangor, Ziyaad] Univ Witwatersrand, Fac Hlth Sci, Dept Paediat, Johannesburg, South Africa; [Izu, Alane; Moore, David P.; Nunes, Marta C.; Solomon, Fatima; Madhi, Shabir A.] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn Vaccine Preventable Dis, Johannesburg, South Africa; [Beylis, Natalie] Natl Hlth Lab Serv, Mycobacteriol Referral Lab, Johannesburg, South Africa; [von Gottberg, Anne; McAnerney, Johanna M.; Madhi, Shabir A.] Natl Inst Communicable Dis, Ctr Resp & Meningitis Dis, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand; National Research Foundation - South Africa; University of Witwatersrand; National Health Laboratory Service; National Institute for Communicable Diseases (NICD)	Madhi, SA (corresponding author), Univ Witwatersrand, Fac Hlth Sci, MRC, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa.	shabirm@nicd.ac.za	Moore, David/AAU-7186-2020	Moore, David/0000-0001-6091-1605; Dangor, Ziyaad/0000-0003-4089-147X; Nunes, Marta/0000-0003-3788-878X; von Gottberg, Anne/0000-0002-0243-7455	Medical Research Council: Respiratory and Meningeal Pathogens Unit; Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases South African Research Chair Initiative; Carnegie Corporation of New York; National Research Foundation/Department of Science and Technology: South African Research Chair Initiative Program	Medical Research Council: Respiratory and Meningeal Pathogens Unit; Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases South African Research Chair Initiative; Carnegie Corporation of New York; National Research Foundation/Department of Science and Technology: South African Research Chair Initiative Program	The authors acknowledge financial support from the Medical Research Council: Respiratory and Meningeal Pathogens Unit and the Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases South African Research Chair Initiative. ZD is funded in part by the Carnegie Corporation of New York. SAM is funded in part by National Research Foundation/Department of Science and Technology: South African Research Chair Initiative Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actuarial Society of South Africa (ASSA), 2011, ASSA2008 AIDS DEM MO; [Anonymous], STAT S AFR S GAUT SU; Archer B, 2009, EURO SURVEILL, V14; Bradshaw Benjamin S, 2008, Biodemography Soc Biol, V54, P74, DOI 10.1080/19485565.2008.9989133; Brundage JF, 2008, EMERG INFECT DIS, V14, P1193, DOI 10.3201/eid1408.071313; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1071; Dangor Z, 2013, PEDIATR INFECT DIS J, V32, P972, DOI 10.1097/INF.0b013e31828d9aa4; Davis BM, 2012, AM J EPIDEMIOL, V175, P363, DOI 10.1093/aje/kwr402; GRAY BM, 1989, PEDIATR INFECT DIS J, V8, pS23; Haynes L, 2012, J IMMUNOL, V189, P4921, DOI 10.4049/jimmunol.1201916; Jo EK, 2008, CURR OPIN INFECT DIS, V21, P279, DOI 10.1097/QCO.0b013e3282f88b5d; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Klugman KP, 2009, VACCINE, V27, pC9, DOI 10.1016/j.vaccine.2009.06.007; Ladiray D, 2001, SEASONAL ADJUSTMENT; Louw A, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-12; Ludewick HP, 2011, J GEN VIROL, V92, P1662, DOI 10.1099/vir.0.030825-0; Madhi SA, 2006, J INFECT DIS, V193, P1236, DOI 10.1086/503053; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; Madhi SA, 2007, PEDIATR INFECT DIS J, V26, P693, DOI 10.1097/INF.0b013e3180621192; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392; McAnerney JM, 2012, J INFECT DIS, V206, pS153, DOI 10.1093/infdis/jis575; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Moore DP, 2010, PEDIATR INFECT DIS J, V29, P1099, DOI 10.1097/INF.0b013e3181eaefff; Moore DP, 2012, EXPERT REV RESP MED, V6, P451, DOI [10.1586/ers.12.32, 10.1586/ERS.12.32]; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Noh JY, 2013, EMERG INFECT DIS, V19, P165, DOI 10.3201/eid1901.111613; Noymer A, 2011, VACCINE, V29, pB38, DOI 10.1016/j.vaccine.2011.02.053; Nunes MC, 2011, AIDS, V25, P453, DOI 10.1097/QAD.0b013e328341b7f1; Pedrosa J, 2000, INFECT IMMUN, V68, P577, DOI 10.1128/IAI.68.2.577-583.2000; Schleicher GK, 2003, INT J TUBERC LUNG D, V7, P1207; Short KR, 2012, FUTURE MICROBIOL, V7, P609, DOI [10.2217/FMB.12.29, 10.2217/fmb.12.29]; Singhania S, 2010, INT J TUBERC LUNG D, V14, P1497; Stensballe LG, 2008, CLIN INFECT DIS, V46, P1165, DOI 10.1086/529438; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Tasher D, 2011, CLIN INFECT DIS, V53, P1199, DOI 10.1093/cid/cir726; VOLKERT M, 1947, J EXP MED, V86, P203, DOI 10.1084/jem.86.3.203; Weinberger DM, 2014, CLIN INFECT DIS, V58, P188, DOI 10.1093/cid/cit721	37	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91464	10.1371/journal.pone.0091464	http://dx.doi.org/10.1371/journal.pone.0091464			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618667	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400095
J	Jo, M; Yun, HM; Park, KR; Park, MH; Lee, DH; Cho, SH; Yoo, HS; Lee, YM; Jeong, HS; Kim, Y; Jung, JK; Hwang, BY; Lee, MK; Kim, ND; Han, SB; Hong, JT				Jo, Miran; Yun, Hyung-Mun; Park, Kyung-Ran; Park, Mi Hee; Lee, Dong Hun; Cho, Seung Hee; Yoo, Hwan-Soo; Lee, Yong-Moon; Jeong, Heon Sang; Kim, Youngsoo; Jung, Jae Kyung; Hwang, Bang Yeon; Lee, Mi Kyeong; Kim, Nam Doo; Han, Sang Bae; Hong, Jin Tae			Anti-Cancer Effect of Thiacremonone through Down Regulation of Peroxiredoxin 6	PLOS ONE			English	Article							COLON-CANCER CELLS; DIALLYL DISULFIDE; SULFUR-COMPOUNDS; GENE-EXPRESSION; IN-VIVO; APOPTOSIS; LUNG; OVEREXPRESSION; INDUCTION; TUMOR	Thiacremonone (2, 4-dihydroxy-2, 5-dimethyl-thiophene-3-one) is an antioxidant substance as a novel sulfur compound generated from High-Temperature-High-Pressure-treated garlic. Peroxiredoxin 6 (PRDX6) is a member of peroxidases, and has glutathione peroxidase and calcium-independent phospholipase A2 (iPLA2) activities. Several studies have demonstrated that PRDX6 stimulates lung cancer cell growth via an increase of glutathione peroxidase activity. A docking model study and pull down assay showed that thiacremonone completely fits on the active site (cys-47) of glutathione peroxidase of PRDX6 and interacts with PRDX6. Thus, we investigated whether thiacremonone inhibits cell growth by blocking glutathione peroxidase of PRDX6 in the human lung cancer cells, A549 and NCI-H460. Thiacremonone (0-50 mu g/ml) inhibited lung cancer cell growth in a concentration dependent manner through induction of apoptotic cell death accompanied by induction of cleaved caspase-3, -8, -9, Bax, p21 and p53, but decrease of xIAP, cIAP and Bcl2 expression. Thiacremonone further inhibited glutathione peroxidase activity in lung cancer cells. However, the cell growth inhibitory effect of thiacremonone was not observed in the lung cancer cells transfected with mutant PRDX6 (C47S) and in the presence of dithiothreitol and glutathione. In an allograft in vivo model, thiacremonone (30 mg/kg) also inhibited tumor growth accompanied with the reduction of PRDX6 expression and glutathione peroxidase activity, but increased expression of cleaved caspase-3, -8, -9, Bax, p21 and p53. These data indicate that thiacremonone inhibits tumor growth via inhibition of glutathione peroxidase activity of PRDX6 through interaction. These data suggest that thiacremonone may have potentially beneficial effects in lung cancer.	[Jo, Miran; Yun, Hyung-Mun; Park, Kyung-Ran; Park, Mi Hee; Lee, Dong Hun; Cho, Seung Hee; Yoo, Hwan-Soo; Lee, Yong-Moon; Kim, Youngsoo; Jung, Jae Kyung; Hwang, Bang Yeon; Lee, Mi Kyeong; Han, Sang Bae; Hong, Jin Tae] Chungbuk Natl Univ, Coll Pharm, Chungbuk, South Korea; [Jo, Miran; Yun, Hyung-Mun; Park, Kyung-Ran; Park, Mi Hee; Lee, Dong Hun; Cho, Seung Hee; Yoo, Hwan-Soo; Lee, Yong-Moon; Kim, Youngsoo; Jung, Jae Kyung; Hwang, Bang Yeon; Lee, Mi Kyeong; Han, Sang Bae; Hong, Jin Tae] Chungbuk Natl Univ, Med Res Ctr, Chungbuk, South Korea; [Jeong, Heon Sang] Chungbuk Natl Univ, Coll Agr Life & Environm Sci, Chungbuk, South Korea; [Kim, Nam Doo] Daegu Gyeongbuk Med Innovat Fdn, New Drug Dev Ctr, Taegu, South Korea	Chungbuk National University; Chungbuk National University; Chungbuk National University	Hong, JT (corresponding author), Chungbuk Natl Univ, Coll Pharm, Chungbuk, South Korea.	jinthong@chungbuk.ac.kr		Jung, Jae-Kyung/0000-0002-0490-9663	National Research Foundation of Korea (NRF); Korean Government (MSIP) [MRC, 2008-0062275]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean Government (MSIP)	This work was supported by a grant from the National Research Foundation of Korea (NRF) funded by the Korean Government (MSIP) (No. MRC, 2008-0062275). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker AF, 2007, CLIN CANCER RES, V13, P3388, DOI 10.1158/1078-0432.CCR-06-0873; Ban JO, 2007, J PHARMACOL SCI, V104, P374, DOI 10.1254/jphs.FP0070789; Bat-Chen W, 2010, NUTR CANCER, V62, P947, DOI 10.1080/01635581.2010.509837; Cao Min, 2009, Zhongguo Fei Ai Za Zhi, V12, P322, DOI 10.3779/j.issn.1009-3419.2009.04.12; Chang XZ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1789; Chatterjee S, 2011, J BIOL CHEM, V286, P11696, DOI 10.1074/jbc.M110.206623; Chowdhury I, 2009, FREE RADICAL BIO MED, V46, P146, DOI 10.1016/j.freeradbiomed.2008.09.027; Conti A, 2011, AM J PATHOL, V178, P88, DOI 10.1016/j.ajpath.2010.11.035; Dhakshinamoorthy S, 2000, CURR TOP CELL REGUL, V36, P201; Druesne-Pecollo N, 2011, ANTI-CANCER AGENT ME, V11, P254, DOI 10.2174/187152011795347540; Fatma N, 2008, BRAIN RES, V1233, P63, DOI 10.1016/j.brainres.2008.07.076; Fisher AB, 2011, ANTIOXID REDOX SIGN, V15, P831, DOI 10.1089/ars.2010.3412; Flohe L, 2003, BIOFACTORS, V19, P3, DOI 10.1002/biof.5520190102; Ho JN, 2010, MOL CANCER THER, V9, P825, DOI 10.1158/1535-7163.MCT-09-0904; Iciek M, 2012, CELL BIOCHEM FUNCT, V30, P198, DOI 10.1002/cbf.1835; Kang SW, 1998, J BIOL CHEM, V273, P6303, DOI 10.1074/jbc.273.11.6303; Kim SY, 2008, J BIOL CHEM, V283, P33563, DOI 10.1074/jbc.M806578200; Kim SH, 2011, CANCER PREV RES, V4, P897, DOI 10.1158/1940-6207.CAPR-10-0323; Kwon OC, 2006, KOREAN J FOOD SCI TE, V38, P331; Lai KC, 2012, PHYTOMEDICINE, V19, P625, DOI 10.1016/j.phymed.2012.02.004; Lee SB, 2009, MOL CELLS, V28, P583, DOI 10.1007/s10059-009-0152-6; Lee Y, 2011, BIOL PHARM BULL, V34, P677, DOI 10.1248/bpb.34.677; Manevich Y, 2002, P NATL ACAD SCI USA, V99, P11599, DOI 10.1073/pnas.182384499; Nagaraj NS, 2010, J NUTR BIOCHEM, V21, P405, DOI 10.1016/j.jnutbio.2009.01.015; Neumann CA, 2007, CURR OPIN PHARMACOL, V7, P375, DOI 10.1016/j.coph.2007.04.007; Ng KTP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031655; O'Donovan TR, 2011, AUTOPHAGY, V7, P509, DOI 10.4161/auto.7.5.15066; Pak JH, 2011, CANCER INVEST, V29, P21, DOI 10.3109/07357907.2010.535056; Pei YX, 2011, TOXICOL APPL PHARM, V257, P420, DOI 10.1016/j.taap.2011.09.026; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Schremmer Bruno, 2007, V44, P317; Sun M, 2012, PROSTATE, V72, P82, DOI 10.1002/pros.21409; Walsh B, 2009, REDOX REP, V14, P275, DOI 10.1179/135100009X12525712409652; Wang L, 2008, MOL PHARMACOL, V73, P119, DOI 10.1124/mol.107.040873; Xiao D, 2009, ENVIRON MOL MUTAGEN, V50, P201, DOI 10.1002/em.20431; Zhang XZ, 2009, CANCER SCI, V100, P2396, DOI 10.1111/j.1349-7006.2009.01314.x	36	15	16	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91508	10.1371/journal.pone.0091508	http://dx.doi.org/10.1371/journal.pone.0091508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618722	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400099
J	Lim, TW; Frangakis, C; Latkin, C; Ha, TV; Minh, NL; Zelaya, C; Quan, VM; Go, VF				Lim, Travis W.; Frangakis, Constantine; Latkin, Carl; Tran Viet Ha; Nguyen Le Minh; Zelaya, Carla; Vu Minh Quan; Go, Vivian F.			Community-Level Income Inequality and HIV Prevalence among Persons Who Inject Drugs in Thai Nguyen, Vietnam	PLOS ONE			English	Article							SOCIOECONOMIC DETERMINANTS; HEALTH INEQUALITIES; POVERTY; MORTALITY; EPIDEMICS; MATTERS; WEALTH; USERS; RISK; AIDS	Socioeconomic status has a robust positive relationship with several health outcomes at the individual and population levels, but in the case of HIV prevalence, income inequality may be a better predictor than absolute level of income. Most studies showing a relationship between income inequality and HIV have used entire countries as the unit of analysis. In this study, we examine the association between income inequality at the community level and HIV prevalence in a sample of persons who inject drugs (PWID) in a concentrated epidemic setting. We recruited PWID and non-PWID community participants in Thai Nguyen, Vietnam, and administered a cross-sectional questionnaire; PWID were tested for HIV. We used ecologic regression to model HIV burden in our PWID study population on GINI indices of inequality calculated from total reported incomes of non-PWID community members in each commune. We also modeled HIV burden on interaction terms between GINI index and median commune income, and finally used a multi-level model to control for community level inequality and individual level income. HIV burden among PWID was significantly correlated with the commune GINI coefficient (r = 0.53, p = 0.002). HIV burden was also associated with GINI coefficient (beta = 0.082, p = 0.008) and with median commune income (beta = -0.018, p = 0.023) in ecological regression. In the multi-level model, higher GINI coefficient at the community level was associated with higher odds of individual HIV infection in PWID (OR = 1.46 per 0.01, p = 0.003) while higher personal income was associated with reduced odds of infection (OR = 0.98 per $10, p = 0.022). This study demonstrates a context where income inequality is associated with HIV prevalence at the community level in a concentrated epidemic. It further suggests that community level socioeconomic factors, both contextual and compositional, could be indirect determinants of HIV infection in PWID.	[Lim, Travis W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA; [Frangakis, Constantine] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Latkin, Carl] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA; [Tran Viet Ha; Zelaya, Carla; Vu Minh Quan; Go, Vivian F.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Nguyen Le Minh] Thai Nguyen Ctr Prevent Med, Thai Nguyen, Vietnam	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lim, TW (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA.	tlim@jhsph.edu			National Institute on Drug Abuse, NIDA [5R01DA022962-05]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022962] Funding Source: NIH RePORTER	National Institute on Drug Abuse, NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a grant from the National Institute on Drug Abuse, NIDA 5R01DA022962-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett T, 2006, AIDS 21 CENTURY FULL; Bartley M, 1997, BRIT MED J, V314, P1194, DOI 10.1136/bmj.314.7088.1194; Bloom DE, 2000, SCIENCE, V287, P1207, DOI 10.1126/science.287.5456.1207; Commission on the Social Determinants of Health, 2006, CLOS GAP GEN HLTH EQ; Cuong NV, 2010, POVERTY INEQUALITY M; De P, 2007, ADDICTION, V102, P1730, DOI 10.1111/j.1360-0443.2007.01936.x; Deltas G, 2003, REV ECON STAT, V85, P226, DOI 10.1162/rest.2003.85.1.226; Deuchert E, 2007, ANN EPIDEMIOL, V17, P199, DOI 10.1016/j.annepidem.2006.09.005; Durevall D, 2012, WORLD DEV, V40, P1435, DOI 10.1016/j.worlddev.2011.12.003; Farquhar SA, 2005, AM J PUBLIC HEALTH, V95, P596, DOI 10.2105/AJPH.2004.048280; Fox AM, 2012, J BIOSOC SCI, V44, P459, DOI 10.1017/S0021932011000745; Fox AM, 2010, PUBLIC HEALTH REP, V125, P16, DOI 10.1177/00333549101250S405; Gillespie S, 2007, AIDS, V21, pS5, DOI 10.1097/01.aids.0000300531.74730.72; Haughton J., 2009, HDB POVERTY INEQUALI; Hien NT, 2004, AIDS EDUC PREV, V16, P137, DOI 10.1521/aeap.16.3.5.137.35527; Holmqvist G., 2009, HIV INCOME INEQUALIT; Holtgrave DR, 2003, SEX TRANSM INFECT, V79, P62, DOI 10.1136/sti.79.1.62; Israel BA, 2006, J URBAN HEALTH, V83, P1022, DOI 10.1007/s11524-006-9110-1; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; Kennedy BP, 1996, BRIT MED J, V312, P1004, DOI 10.1136/bmj.312.7037.1004; LATKIN C, 1995, DRUG ALCOHOL DEPEN, V38, P1, DOI 10.1016/0376-8716(94)01082-V; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Lobmayer P, 2000, SOCIOL HEALTH ILL, V22, P401, DOI 10.1111/1467-9566.00211; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Mishra D., 2012, TAKING STOCK UPDATE; Msisha WM, 2008, AIDS, V22, P741, DOI 10.1097/QAD.0b013e3282f3947f; National Institute of Hygiene and Epidemiology Family Health International, 2007, HIV STDS BEH BIOL SU; Nepal Binod, 2007, World Health Popul, V9, P73; Pan American Health Organization, 2001, MEAS HLTH IN GIN COE; PAPPAS G, 1993, NEW ENGL J MED, V329, P103, DOI 10.1056/NEJM199307083290207; Pilon R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022245; Piot P, 2007, PLOS MED, V4, P1571, DOI 10.1371/journal.pmed.0040314; Pronyk PM, 2008, SOC SCI MED, V66, P1999, DOI 10.1016/j.socscimed.2008.01.023; Reidpath DD, 2005, SOCIOL HEALTH ILL, V27, P468, DOI 10.1111/j.1467-9566.2005.00452.x; Ruger JP, 2011, GLOBAL HLTH DIS SYSE, P757; Sawers L, 2008, AIDS CARE, V20, P488, DOI 10.1080/09540120701868311; Singh GK, 2006, INT J EPIDEMIOL, V35, P969, DOI 10.1093/ije/dyl083; Talbott JR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000543; *WHO, 2001, REP COMM MACR HLTH; Wilkinson RG, 1997, BRIT MED J, V314, P591, DOI 10.1136/bmj.314.7080.591; Wilkinson RG, 2007, SOC SCI MED, V65, P1965, DOI 10.1016/j.socscimed.2007.05.041	41	7	7	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90723	10.1371/journal.pone.0090723	http://dx.doi.org/10.1371/journal.pone.0090723			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9GM	24618892	Green Published, gold, Green Submitted			2022-12-25	WOS:000332842400026
J	Ma, W; Ma, L; Zhe, H; Bao, CH; Wang, NN; Yang, SQ; Wang, K; Cao, FL; Cheng, YN; Cheng, YF				Ma, Wei; Ma, Lie; Zhe, Hong; Bao, Cihang; Wang, Nana; Yang, Shaoqi; Wang, Kai; Cao, Fangli; Cheng, Yanna; Cheng, Yufeng			Detection of Esophageal Squamous Cell Carcinoma by Cathepsin B Activity in Nude Mice	PLOS ONE			English	Article							STAGE PANCREATIC-CANCER; CYSTEINE CATHEPSINS; IN-VIVO; PROGNOSTIC-SIGNIFICANCE; PROTEASE ACTIVITY; STEFIN-A; ADENOCARCINOMA; METASTASIS; EXPRESSION; ENDOSCOPY	Background and Objective: Despite great progress in treatment, the prognosis for patients with esophageal squamous cell carcinoma (ESCC) remains poor, highlighting the importance of early detection. Although upper endoscopy can be used for the screening of esophagus, it has limited sensitivity for early stage disease. Thus, development of new diagnosis approach to improve diagnostic capabilities for early detection of ESCC is an important need. The aim of this study was to assess the feasibility of using cathepsin B (CB) as a novel imaging target for the detection of human ESCC by near-infrared optical imaging in nude mice. Methods: Initially, we examined specimens from normal human esophageal tissue, intraepithelial neoplasia lesions, tumor in situ, ESCC and two cell lines including one human ESCC cell line (Eca-109) and one normal human esophageal epithelial cell line (HET-1A) for CB expression by immunohistochemistry and western blot, respectively. Next, the ability of a novel CB activatable near-infrared fluorescence (NIRF) probe detecting CB activity presented in Eca-109 cells was confirmed by immunocytochemistry. We also performed in vivo imaging of tumor bearing mice injected with the CB probe and ex vivo imaging of resected tumor xenografts and visceral organs using a living imaging system. Finally, the sources of fluorescence signals in tumor tissue and CB expression in visceral organs were identified by histology. Results: CB was absent in normal human esophageal mucosa, but it was overexpressed in ESCC and its precursor lesions. The novel probe for CB activity specifically detected ESCC xenografts in vivo and in vitro. Conclusions: CB was highly upregulated in human ESCC and its precursor lesions. The elevated CB expression in ESCC allowed in vivo and in vitro detection of ESCC xenografts in nude mice. Our results support the usefulness of CB activity as a potential imaging target for the detection of human ESCC.	[Ma, Wei; Bao, Cihang; Wang, Nana; Cheng, Yufeng] Shandong Univ, Qilu Hosp, Dept Radiat Oncol, Jinan 250100, Peoples R China; [Ma, Wei; Zhe, Hong] Ningxia Med Univ, Gen Hosp, Canc Hosp, Dept Radiat Oncol, Yinchuan, Peoples R China; [Ma, Lie] Ningxia Med Univ, Gen Hosp, Cardiovasc & Cerebrovasc Dis Hosp, Dept Cardiol, Yinchuan, Peoples R China; [Yang, Shaoqi] Ningxia Med Univ, Gen Hosp, Digest Syst Dept, Yinchuan, Peoples R China; [Wang, Kai] Wendeng Ctr Hosp, Dept Oncol, Weihai, Peoples R China; [Cao, Fangli] Liaocheng Peoples Hosp, Dept Oncol, Liaocheng, Peoples R China; [Cheng, Yanna] Shandong Univ, Sch Pharmaceut Sci, Jinan 250100, Peoples R China	Shandong University; Ningxia Medical University; Ningxia Medical University; Ningxia Medical University; Shandong University	Cheng, YF (corresponding author), Shandong Univ, Qilu Hosp, Dept Radiat Oncol, Jinan 250100, Peoples R China.	qilucyf@126.com	Bao, Cihang/AAU-1371-2020		Science and Technology development planning of Shandong province [2012GGE27088]; China Postdoctoral Science Fund [2011M500531]; Laboratory Software Building Project of Shandong University [sy2012417]	Science and Technology development planning of Shandong province; China Postdoctoral Science Fund(China Postdoctoral Science Foundation); Laboratory Software Building Project of Shandong University	This work was supported by Science and Technology development planning of Shandong province (No. 2012GGE27088), China Postdoctoral Science Fund (No. 2011M500531), and Laboratory Software Building Project of Shandong University (sy2012417). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andl CD, 2010, NEOPLASIA, V12, P485, DOI 10.1593/neo.10216; CAMPO E, 1994, AM J PATHOL, V145, P301; Chien CR, 2009, JNCI-J NATL CANCER I, V101, P1428, DOI 10.1093/jnci/djp304; Chwieralski CE, 2006, APOPTOSIS, V11, P143, DOI 10.1007/s10495-006-3486-y; Cruz-Monserrate Z, 2012, GUT, V61, P1315, DOI 10.1136/gutjnl-2011-300544; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Eser S, 2011, P NATL ACAD SCI USA, V108, P9945, DOI 10.1073/pnas.1100890108; Figueiredo JL, 2006, INT J CANCER, V118, P2672, DOI 10.1002/ijc.21713; Foekens JA, 1998, J CLIN ONCOL, V16, P1013, DOI 10.1200/JCO.1998.16.3.1013; Friedrichs B, 2003, J CLIN INVEST, V111, P1733, DOI 10.1172/JCI200315990; Habibollahi P, 2012, THERANOSTICS, V2, P227, DOI 10.7150/thno.4088; Hensley HH, 2012, NEOPLASIA, V14, P451, DOI 10.1596/neo.12480; Jedeszko C, 2004, BIOL CHEM, V385, P1017, DOI 10.1515/BC.2004.132; Kamangar F, 2007, ARCH IRAN MED, V10, P70; Kato H, 2007, DIGEST SURG, V24, P88, DOI 10.1159/000101894; Keereweer S, 2012, INT J CANCER, V131, P1633, DOI 10.1002/ijc.27430; Kobayashi H, 2010, CHEM REV, V110, P2620, DOI 10.1021/cr900263j; Li WD, 2005, CLIN CANCER RES, V11, P8753, DOI 10.1158/1078-0432.CCR-05-0597; Lin YS, 2013, J EPIDEMIOL, V23, P233, DOI 10.2188/jea.JE20120162; Liu JG, 2012, EUR J CARDIO-THORAC, V41, pE7, DOI 10.1093/ejcts/ezr240; Mahmood U, 2003, MOL CANCER THER, V2, P489; Matarrese P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-207; Parsons Simon, 2010, Ann R Coll Surg Engl; Qi YJ, 2012, J PROTEOMICS, V75, P3129, DOI 10.1016/j.jprot.2012.04.025; Shibata A, 2008, JPN J CLIN ONCOL, V38, P464, DOI 10.1093/jjco/hyn064; Sinha AA, 2002, CANCER-AM CANCER SOC, V94, P3141, DOI 10.1002/cncr.10604; Turk B, 2007, FEBS LETT, V581, P2761, DOI 10.1016/j.febslet.2007.05.038; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; von Burstin J, 2008, INT J CANCER, V123, P2138, DOI 10.1002/ijc.23780; Wang LS, 1999, AM J GASTROENTEROL, V94, P1933; Werle B, 2000, CANCER, V89, P2282, DOI 10.1002/1097-0142(20001201)89:11<2282::AID-CNCR17>3.0.CO;2-4; Wu YH, 2013, AM J NUCL MED MOLEC, V3, P1; Yhee JY, 2012, THERANOSTICS, V2, P179, DOI 10.7150/thno.3716; Zavasnik-Bergant T, 2006, TISSUE ANTIGENS, V67, P349, DOI 10.1111/j.1399-0039.2006.00585.x; Zhang H, 2008, GASTROINTEST ENDOSC, V68, P520, DOI 10.1016/j.gie.2008.02.023	35	8	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e92351	10.1371/journal.pone.0092351	http://dx.doi.org/10.1371/journal.pone.0092351			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618814	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400141
J	Powell, TR; McGuffin, P; D'Souza, UM; Cohen-Woods, S; Hosang, GM; Martin, C; Matthews, K; Day, RK; Farmer, AE; Tansey, KE; Schalkwyk, LC				Powell, Timothy R.; McGuffin, Peter; D'Souza, Ursula M.; Cohen-Woods, Sarah; Hosang, Georgina M.; Martin, Charlotte; Matthews, Keith; Day, Richard K.; Farmer, Anne E.; Tansey, Katherine E.; Schalkwyk, Leonard C.			Putative Transcriptomic Biomarkers in the Inflammatory Cytokine Pathway Differentiate Major Depressive Disorder Patients from Control Subjects and Bipolar Disorder Patients	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FUNCTIONAL-CHARACTERIZATION; SEROTONIN TRANSPORTER; MOOD; CLASSIFICATION; METAANALYSIS; RECEPTOR; GENE; PATHOPHYSIOLOGY; ESCITALOPRAM	Mood disorders consist of two etiologically related, but distinctly treated illnesses, major depressive disorder (MDD) and bipolar disorder (BPD). These disorders share similarities in their clinical presentation, and thus show high rates of misdiagnosis. Recent research has revealed significant transcriptional differences within the inflammatory cytokine pathway between MDD patients and controls, and between BPD patients and controls, suggesting this pathway may possess important biomarker properties. This exploratory study attempts to identify disorder-specific transcriptional biomarkers within the inflammatory cytokine pathway, which can distinguish between control subjects, MDD patients and BPD patients. This is achieved using RNA extracted from subject blood and applying synthesized complementary DNA to quantitative PCR arrays containing primers for 87 inflammation-related genes. Initially, we use ANOVA to test for transcriptional differences in a 'discovery cohort' (total n = 90) and then we use t-tests to assess the reliability of any identified transcriptional differences in a 'validation cohort' (total n = 35). The two most robust and reliable biomarkers identified across both the discovery and validation cohort were Chemokine (C-C motif) ligand 24 (CCL24) which was consistently transcribed higher amongst MDD patients relative to controls and BPD patients, and C-C chemokine receptor type 6 (CCR6) which was consistently more lowly transcribed amongst MDD patients relative to controls. Results detailed here provide preliminary evidence that transcriptional measures within inflammation-related genes might be useful in aiding clinical diagnostic decision-making processes. Future research should aim to replicate findings detailed in this exploratory study in a larger medication-free sample and examine whether identified biomarkers could be used prospectively to aid clinical diagnosis.	[Powell, Timothy R.; McGuffin, Peter; D'Souza, Ursula M.; Cohen-Woods, Sarah; Hosang, Georgina M.; Martin, Charlotte; Farmer, Anne E.; Tansey, Katherine E.; Schalkwyk, Leonard C.] Kings Coll London, Inst Psychiat, MRC, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Cohen-Woods, Sarah] Univ Adelaide, Discipline Psychiat, Adelaide, SA, Australia; [Matthews, Keith; Day, Richard K.] Univ Dundee, Ninewells Hosp & Med Sch, Div Neurosci, Dundee DD1 9SY, Scotland	University of London; King's College London; University of Adelaide; University of Dundee	Powell, TR (corresponding author), Kings Coll London, Inst Psychiat, MRC, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England.	timothy.powell@kcl.ac.uk	Cohen-Woods, Sarah/ABF-3768-2021; Tansey, Katherine E/B-1033-2013; Schalkwyk, Leonard C/A-2150-2010; Hosang, Georgina/D-1164-2011; Cohen-Woods, Sarah/F-8674-2014	Tansey, Katherine E/0000-0002-9663-3376; Schalkwyk, Leonard C/0000-0001-7030-5756; Goss, Charlotte/0000-0002-3870-3313; Cohen-Woods, Sarah/0000-0003-2199-6129; Hosang, Georgina/0000-0002-4683-3636; Matthews, Keith/0000-0002-4478-5888; Powell, Timothy/0000-0001-9891-4895	European Commission [LSHB-CT-2003-503428]; GlaxoSmithKline; NIHR Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust; Institute of Psychiatry, Kings College London [BRC 08/09PP]; Medical Research Council [G9817803B] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); GlaxoSmithKline(GlaxoSmithKline); NIHR Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust; Institute of Psychiatry, Kings College London; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The GENDEP project was funded by the European Commission Framework 6 Grant, EC Contract Ref. LSHB-CT-2003-503428. Lundbeck provided both nortriptyline and escitalopram free of charge for the GENDEP project. The BACC Study collection was funded by GlaxoSmithKline. The current study was financially supported by the NIHR Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, Kings College London, under the Grant BRC 08/09PP. The funders had no role in the design and conduct of the study, in data collection, analysis, interpretation or writing the report. Timothy R. Powell is funded by a Medical Research Council PhD studentship.	Ai LS, 2004, J BIOMED SCI, V11, P818, DOI 10.1159/000081829; ALTSHULER LL, 1995, AM J PSYCHIAT, V152, P1130; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Banks WA, 1995, NEUROIMMUNOMODULAT, V2, P241, DOI 10.1159/000097202; BECK AT, 1984, J CLIN PSYCHOL, V40, P1365, DOI 10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D; Bradley RG, 2008, ARCH GEN PSYCHIAT, V65, P190, DOI 10.1001/archgenpsychiatry.2007.26; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cattaneo A, 2013, NEUROPSYCHOPHARMACOL, V38, P377, DOI 10.1038/npp.2012.191; CLARK LA, 1995, ANNU REV PSYCHOL, V46, P121, DOI 10.1146/annurev.ps.46.020195.001005; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen-Woods S, 2010, AM J MED GENET B, V153B, P1298, DOI 10.1002/ajmg.b.31101; Craddock N, 2006, EUR J HUM GENET, V14, P660, DOI 10.1038/sj.ejhg.5201549; FARMER A, 1989, BRIT J PSYCHIAT, V155, P437, DOI 10.1192/bjp.155.4.437; Fisher HL, 2013, J AFFECT DISORDERS, V145, P136, DOI 10.1016/j.jad.2012.05.032; Games P. A., 1976, J EDUCATIONAL STATIS, V1, P113, DOI [10.3102/10769986001002113, DOI 10.2307/1164979]; Hiles SA, 2012, BRAIN BEHAV IMMUN, V26, P1180, DOI 10.1016/j.bbi.2012.06.001; Hirschfeld RMA, 2003, J CLIN PSYCHIAT, V64, P161, DOI 10.4088/JCP.v64n0209; Hosang GM, 2012, BRIT J PSYCHIAT, V201, P458, DOI 10.1192/bjp.bp.112.111047; Isung J, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.123; Jones I, 2002, PSYCHIAT GENETICS GE, P211; Judd Lewis L, 2003, Curr Psychiatry Rep, V5, P417, DOI 10.1007/s11920-003-0077-2; Keers R, 2012, CURR PSYCHIAT REP, V14, P129, DOI 10.1007/s11920-011-0251-x; KENDELL RE, 1976, BRIT J PSYCHIAT, V129, P15, DOI 10.1192/bjp.129.1.15; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kim JM, 2007, BIOL PSYCHIAT, V62, P423, DOI 10.1016/j.biopsych.2006.11.020; Leboyer M, 2012, J AFFECT DISORDERS, V141, P1, DOI 10.1016/j.jad.2011.12.049; Lehto SM, 2010, PSYCHONEUROENDOCRINO, V35, P226, DOI 10.1016/j.psyneuen.2009.06.007; Liu Y, 2012, J AFFECT DISORDERS, V139, P230, DOI 10.1016/j.jad.2011.08.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maes M, 1999, ADV EXP MED BIOL, V461, P25; Maes M, 2008, NEUROENDOCRINOL LETT, V29, P287; Martin C, 2015, BIOMARK MED, V9, P169, DOI [10.2217/bmm.14.29, 10.2217/BMM.14.29]; MCGUFFIN P, 1986, PSYCHOL MED, V16, P461, DOI 10.1017/S0033291700009302; McGuffin P, 2003, ARCH GEN PSYCHIAT, V60, P497, DOI 10.1001/archpsyc.60.5.497; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Morselli PL, 2003, BIPOLAR DISORD, V5, P265, DOI 10.1034/j.1399-5618.2003.00037.x; Murray J.L., 1996, GLOBAL BURDEN DIS CO; Nemeroff CB, 2002, NAT NEUROSCI, V5, P1068, DOI 10.1038/nn943; Padmos RC, 2008, ARCH GEN PSYCHIAT, V65, P395, DOI 10.1001/archpsyc.65.4.395; Pariante CM, 2001, BIOL PSYCHIAT, V49, P391, DOI 10.1016/S0006-3223(00)01088-X; Patel VP, 1997, J EXP MED, V185, P1163, DOI 10.1084/jem.185.7.1163; Perlis RH, 2005, AM J MANAG CARE, V11, pS271; Powell TR, 2013, EUR NEUROPSYCHOPHARM, V23, P1105, DOI 10.1016/j.euroneuro.2012.09.009; Powell TR, 2013, J PSYCHOPHARMACOL, V27, P609, DOI 10.1177/0269881113490329; Powell TR, 2014, INT J METH PSYCH RES, DOI [10.1002mpr.1435, DOI 10.1002/7PR.1435]; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Simon NM, 2008, EUR NEUROPSYCHOPHARM, V18, P230, DOI 10.1016/j.euroneuro.2007.06.004; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Sullivan P, 2012, MOL PSYCHIATR, V17, P2, DOI 10.1038/mp.2011.94; Tsao CW, 2006, PROG NEURO-PSYCHOPH, V30, P899, DOI 10.1016/j.pnpbp.2006.01.029; Uher R, 2010, AM J PSYCHIAT, V167, P555, DOI 10.1176/appi.ajp.2009.09070932; Watson D, 2005, J ABNORM PSYCHOL, V114, P522, DOI 10.1037/0021-843X.114.4.522; WEHR TA, 1979, ARCH GEN PSYCHIAT, V36, P555; White JR, 1997, J LEUKOCYTE BIOL, V62, P667, DOI 10.1002/jlb.62.5.667; Wing JK, 1998, DIAGNOSIS CLIN MEASU; World Health Organization, 1992, INT CLASS DIS 10 REV	56	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91076	10.1371/journal.pone.0091076	http://dx.doi.org/10.1371/journal.pone.0091076			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618828	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000332842400046
J	Cougnard-Gregoire, A; Delyfer, MN; Korobelnik, JF; Rougier, MB; Le Goff, M; Dartigues, JF; Barberger-Gateau, P; Delcourt, C				Cougnard-Gregoire, Audrey; Delyfer, Marie-Noelle; Korobelnik, Jean-Francois; Rougier, Marie-Benedicte; Le Goff, Melanie; Dartigues, Jean-Francois; Barberger-Gateau, Pascale; Delcourt, Cecile			Elevated High-Density Lipoprotein Cholesterol and Age-Related Macular Degeneration: The Alienor Study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; 5-YEAR INCIDENCE; APOLIPOPROTEIN-E; STATIN USE; LOWERING MEDICATIONS; VISUAL IMPAIRMENT; LIPID-METABOLISM; MACULOPATHY; PREVALENCE; ASSOCIATION	Background: Lipid metabolism and particularly high-density lipoprotein (HDL) may be involved in the pathogenic mechanism of age-related macular degeneration (AMD). However, conflicting results have been reported in the associations of AMD with plasma HDL and other lipids, which may be confounded by the recently reported associations of AMD with HDL-related genes. We explored the association of AMD with plasma lipid levels and lipid-lowering medication use, taking into account most of HDL-related genes associated with AMD. Methods: The Alienor study is a population-based study on age-related eye diseases performed in 963 elderly residents of Bordeaux (France). AMD was graded from non mydriatic color retinal photographs in three exclusive stages: no AMD (n = 430 subjects, 938 eyes); large soft distinct drusen and/or large soft indistinct drusen and/or reticular drusen and/or pigmentary abnormalities (early AMD, n = 176, 247); late AMD (n = 40, 61). Associations of AMD with plasma lipids (HDL, total cholesterol (TC), Low-density lipoprotein (LDL), and triglycerides (TG)) were estimated using Generalized Estimating Equation logistic regressions. Statistical analyses included 646 subjects with complete data. Results: After multivariate adjustment for age, sex, educational level, smoking, BMI, lipid-lowering medication use, cardiovascular disease and diabetes, and for all relevant genetic polymorphisms (ApoE2, ApoE4, CFH Y402H, ARMS2 A69S, LIPC rs10468017, LIPC rs493258, LPL rs12678919, ABCA1 rs1883025 and CETP rs3764261), higher HDL was significantly associated with an increased risk of early (OR = 2.45, 95% CI: 1.54-3.90; P = 0.0002) and any AMD (OR = 2.29, 95% CI: 1.46-3.59; P = 0.0003). Association with late AMD was far from statistical significance (OR = 1.58, 95% CI: 0.48-5.17; p = 0.45). No associations were found for any stage of AMD with TC, LDL and TG levels, statin or fibrate drug use. Conclusions: This study suggests that elderly patients with high HDL concentration may be at increased risk for AMD and, further, that HDL dysfunction might be implicated in AMD pathogenesis.	[Cougnard-Gregoire, Audrey; Delyfer, Marie-Noelle; Korobelnik, Jean-Francois; Le Goff, Melanie; Dartigues, Jean-Francois; Barberger-Gateau, Pascale; Delcourt, Cecile] Univ Bordeaux, Bordeaux, France; [Cougnard-Gregoire, Audrey; Delyfer, Marie-Noelle; Korobelnik, Jean-Francois; Le Goff, Melanie; Dartigues, Jean-Francois; Barberger-Gateau, Pascale; Delcourt, Cecile] INSERM, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France; [Delyfer, Marie-Noelle; Korobelnik, Jean-Francois; Rougier, Marie-Benedicte] Ctr Hosp Univ CHU Bordeaux, Serv Ophtalmol, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Bordeaux	Cougnard-Gregoire, A (corresponding author), Univ Bordeaux, Bordeaux, France.	Audrey.Cougnard-Gregoire@isped.u-bordeaux2.fr	COUGNARD-GREGOIRE, Audrey/T-4443-2019; KOROBELNIK, Jean-Francois/A-5448-2016; DARTIGUES, Jean François/T-4513-2019; Delcourt, Cecile/I-2627-2013; LE GOFF, Mélanie/A-3541-2016; Delyfer, Marie-Noelle/T-3304-2019	COUGNARD-GREGOIRE, Audrey/0000-0002-1494-5764; Delcourt, Cecile/0000-0002-2099-0481; LE GOFF, Melanie/0000-0003-2848-6287	Laboratoires Thea (Clermont-Ferrand, France), Fondation Voir et Entendre (Paris, France),	Laboratoires Thea (Clermont-Ferrand, France), Fondation Voir et Entendre (Paris, France),	Laboratoires Thea (Clermont-Ferrand, France), Fondation Voir et Entendre (Paris, France), Laboratoires Thea participated in the design of the study, but no sponsor participated in the collection, management, statistical analysis and interpretation of the data, nor in the preparation, review or approval of the present manuscript.	Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; [Anonymous], 1992, Arch Ophthalmol, V110, P1701; Augood CA, 2006, ARCH OPHTHALMOL-CHIC, V124, P529, DOI 10.1001/archopht.124.4.529; Baird PN, 2006, HUM MUTAT, V27, P337, DOI 10.1002/humu.20288; Bindu GH, 2011, CHOLESTEROL, DOI 10.1155/2011/274629; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; BLUMENKRANZ MS, 1986, OPHTHALMOLOGY, V93, P552; Bretillon L, 2008, INVEST OPHTH VIS SCI, V49, P1307, DOI 10.1167/iovs.07-0808; Buch H, 2005, ACTA OPHTHALMOL SCAN, V83, P400, DOI [10.1111/j.1600-0420.2005.00474.x, 10.1111/j.1600-0420.2005.thesis.x]; Butt AL, 2011, OPHTHALMOLOGY, V118, P1380, DOI 10.1016/j.ophtha.2010.11.007; Cackett P, 2008, AM J OPHTHALMOL, V146, P960, DOI 10.1016/j.ajo.2008.06.026; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Conley YP, 2005, HUM MOL GENET, V14, P1991, DOI 10.1093/hmg/ddi204; Curcio CA, 2011, BRIT J OPHTHALMOL, V95, P1638, DOI 10.1136/bjophthalmol-2011-300344; Curcio CA, 2010, J LIPID RES, V51, P451, DOI 10.1194/jlr.R002238; Davari MH, 2013, J RES HEALTH SCI, V13, P98; Delcourt C, 2001, Ophthalmic Epidemiol, V8, P237, DOI 10.1076/opep.8.4.237.1613; Delcourt C, 2010, J NUTR HEALTH AGING, V14, P854, DOI 10.1007/s12603-010-0131-9; Delcourt C, 2011, INVEST OPHTH VIS SCI, DOI [10.11673443.10-6235, DOI 10.1167/IOVS910-6235]; Drobek-Slowik Monika, 2008, Klin Oczna, V110, P50; Ebrahimi KB, 2011, J LIPIDS, V2011, DOI 10.1155/2011/802059; Eren Esin, 2012, Open Biochem J, V6, P78, DOI 10.2174/1874091X01206010078; Etminan M, 2008, CURR DRUG SAF, V3, P24, DOI 10.2174/157488608783333952; Fisher EA, 2012, ARTERIOSCL THROM VAS, V32, P2813, DOI 10.1161/ATVBAHA.112.300133; Fliesler SJ, 2010, J LIPID RES, V51, P3399, DOI 10.1194/jlr.R010538; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Friedman E, 2005, IOVS, V46, P199; Gehlbach P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006927.pub3; Hall Nigel F, 2002, Expert Opin Pharmacother, V3, P803; Hogg RE, 2008, OPHTHALMOLOGY, V115, P1046, DOI 10.1016/j.ophtha.2007.07.031; Hyman L, 2000, ARCH OPHTHALMOL-CHIC, V118, P351, DOI 10.1001/archopht.118.3.351; Kaiserman N, 2009, CURR EYE RES, V34, P304, DOI 10.1080/02713680902741670; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kishan AU, 2011, SURV OPHTHALMOL, V56, P195, DOI 10.1016/j.survophthal.2010.08.008; Klein R, 2006, OPHTHALMOLOGY, V113, P373, DOI 10.1016/j.ophtha.2005.12.013; Klein R, 2003, ARCH OPHTHALMOL-CHIC, V121, P1151, DOI 10.1001/archopht.121.8.1151; Klein R, 2003, OPHTHALMOLOGY, V110, P25, DOI 10.1016/S0161-6420(02)01565-8; Klein R, 1997, OPHTHALMOLOGY, V104, P1804, DOI 10.1016/S0161-6420(97)30023-2; Klein R, 1999, ARCH OPHTHALMOL-CHIC, V117, P1203; Klein R, 2001, ARCH OPHTHALMOL-CHIC, V119, P1354; KLEIN R, 1993, OPHTHALMOLOGY, V100, P406; Klein R, 2007, AM J OPHTHALMOL, V144, P1, DOI 10.1016/j.ajo.2007.02.047; Klein Ronald, 2003, Ophthalmology, V110, P1273, DOI 10.1016/S0161-6420(03)00599-2; Klein R, 2010, ARCH OPHTHALMOL-CHIC, V128, P750, DOI 10.1001/archophthalmol.2010.92; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Loane E, 2010, INVEST OPHTH VIS SCI, V51, P2636, DOI 10.1167/iovs.09-4397; Maguire MG, 2009, OPHTHALMOLOGY, V116, P2381, DOI 10.1016/j.ophtha.2009.06.055; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; McCarty CA, 2001, MED J AUSTRALIA, V175, P340, DOI 10.5694/j.1326-5377.2001.tb143604.x; McGwin G, 2006, ARCH OPHTHALMOL-CHIC, V124, P33, DOI 10.1001/archopht.124.1.33; McGwin G, 2005, OPHTHALMOLOGY, V112, P488, DOI 10.1016/j.ophtha.2004.10.027; McGwin G, 2003, BRIT J OPHTHALMOL, V87, P1121, DOI 10.1136/bjo.87.9.1121; Merle BM, PLOS ONE IN PRESS; Mitchell P, 2002, OPHTHALMOLOGY, V109, P1092, DOI 10.1016/S0161-6420(02)01055-2; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Nowak M, 2005, CLIN EXP MED, V4, P183, DOI 10.1007/s10238-004-0054-z; Peponis V, 2010, CLIN OPHTHALMOL, V4, P865; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Reynolds R, 2010, OPHTHALMOLOGY, V117, P1989, DOI 10.1016/j.ophtha.2010.07.009; SANDERS TAB, 1993, AM J CLIN NUTR, V57, P428, DOI 10.1093/ajcn/57.3.428; Scholl HPN, 2007, MOL VIS, V13, P196; Seddon JM, 2007, JAMA-J AM MED ASSOC, V297, P1793, DOI 10.1001/jama.297.16.1793; Shalev V, 2011, OPHTHAL EPIDEMIOL, V18, P83, DOI 10.3109/09286586.2011.560746; Smeeth L, 2005, BRIT J OPHTHALMOL, V89, P1171, DOI 10.1136/bjo.2004.064477; Smith W, 1998, ARCH OPHTHALMOL-CHIC, V116, P583, DOI 10.1001/archopht.116.5.583; Souied EH, 1998, AM J OPHTHALMOL, V125, P353, DOI 10.1016/S0002-9394(99)80146-9; Tan JSL, 2007, OPHTHALMOLOGY, V114, P1143, DOI 10.1016/j.ophtha.2006.09.033; Tan JSL, 2007, AM J OPHTHALMOL, V143, P685, DOI 10.1016/j.ajo.2006.11.021; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thakkinstian A, 2006, AM J EPIDEMIOL, V164, P813, DOI 10.1093/aje/kwj279; Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010; TSANG NCK, 1992, DOC OPHTHALMOL, V81, P387; Ulas F, 2013, INT OPHTHALMOL, V33, P485, DOI 10.1007/s10792-013-9728-4; van Leeuwen R, 2004, AM J OPHTHALMOL, V137, P750, DOI 10.1016/S0002-9394(03)01089-4; van Leeuwen R, 2003, BRIT MED J, V326, P255, DOI 10.1136/bmj.326.7383.255; VanderBeek BL, 2013, RETINA-J RET VIT DIS, V33, P414, DOI 10.1097/IAE.0b013e318276e0cf; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; Wang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010329; Wilson HL, 2004, AM J OPHTHALMOL, V137, P615, DOI 10.1016/j.ajo.2003.10.025; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yu Y, 2011, INVEST OPHTH VIS SCI, V52, P4663, DOI 10.1167/iovs.10-7070; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	84	72	75	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90973	10.1371/journal.pone.0090973	http://dx.doi.org/10.1371/journal.pone.0090973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608419	Green Published, Green Submitted, gold			2022-12-25	WOS:000332485800071
J	DiTommaso, A; Morris, SH; Parker, JD; Cone, CL; Agrawal, AA				DiTommaso, Antonio; Morris, Scott H.; Parker, John D.; Cone, Caitlin L.; Agrawal, Anurag A.			Deer Browsing Delays Succession by Altering Aboveground Vegetation and Belowground Seed Banks	PLOS ONE			English	Article							WHITE-TAILED DEER; COMMUNITY STRUCTURE; FOREST ECOSYSTEMS; PLANT-COMMUNITIES; COASTAL-PLAIN; DISTURBANCE; DISPERSAL; DIVERSITY; DYNAMICS; REDUCTIONS	Soil seed bank composition is important to the recovery of natural and semi-natural areas from disturbance and serves as a safeguard against environmental catastrophe. White-tailed deer (Odocoileus virginianus) populations have increased dramatically in eastern North America over the past century and can have strong impacts on aboveground vegetation, but their impacts on seed bank dynamics are less known. To document the long-term effects of deer browsing on plant successional dynamics, we studied the impacts of deer on both aboveground vegetation and seed bank composition in plant communities following agricultural abandonment. In 2005, we established six 15615 m fenced enclosures and paired open plots in recently fallowed agricultural fields near Ithaca, NY, USA. In late October of each of six years (2005-2010), we collected soil from each plot and conducted seed germination cycles in a greenhouse to document seed bank composition. These data were compared to measurements of aboveground plant cover (2005-2008) and tree density (2005-2012). The impacts of deer browsing on aboveground vegetation were severe and immediate, resulting in significantly more bare soil, reduced plant biomass, reduced recruitment of woody species, and relatively fewer native species. These impacts persisted throughout the experiment. The impacts of browsing were even stronger on seed bank dynamics. Browsing resulted in significantly decreased overall species richness (but higher diversity), reduced seed bank abundance, relatively more short-lived species (annuals and biennials), and fewer native species. Both seed bank richness and the relative abundance of annuals/biennials were mirrored in the aboveground vegetation. Thus, deer browsing has long-term and potentially reinforcing impacts on secondary succession, slowing succession by selectively consuming native perennials and woody species and favoring the persistence of short-lived, introduced species that continually recruit from an altered seed bank.	[DiTommaso, Antonio; Morris, Scott H.; Cone, Caitlin L.] Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14850 USA; [Parker, John D.] Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA; [Agrawal, Anurag A.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA	Cornell University; Smithsonian Institution; Smithsonian Environmental Research Center; Cornell University	DiTommaso, A (corresponding author), Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14850 USA.	ad97@cornell.edu	Agrawal, Anurag A/Y-2497-2019; Parker, John D/F-9761-2010	Agrawal, Anurag A/0000-0003-0095-1220; Parker, John D/0000-0002-3632-7625; DiTommaso, Antonio/0000-0001-8215-2777	NSF [DEB-1118783]; United States Department of Agriculture [NYC-183430]	NSF(National Science Foundation (NSF)); United States Department of Agriculture(United States Department of Agriculture (USDA))	This work was funded by NSF DEB-1118783 and federal formula funds from the United States Department of Agriculture (Hatch project NYC-183430) to AAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVERSON WS, 1988, CONSERV BIOL, V2, P348, DOI 10.1111/j.1523-1739.1988.tb00199.x; Augustine DJ, 1998, J WILDLIFE MANAGE, V62, P1165, DOI 10.2307/3801981; Bakker JP, 1996, ACTA BOT NEERL, V45, P461; Bardgett RD, 2003, ECOLOGY, V84, P2258, DOI 10.1890/02-0274; Baskin CC, 2006, WEED SCI, V54, P549, DOI 10.1614/WS-05-034R.1; Bates D., 2011, IME4 LINEAR MIXED EF; BAZZAZ FA, 1968, ECOLOGY, V49, P924, DOI 10.2307/1936544; Bertiller MB, 1996, ENVIRON MANAGE, V20, P123, DOI 10.1007/PL00006692; Boulanger V, 2011, PLANT ECOL, V212, P307, DOI 10.1007/s11258-010-9823-9; BOWERS MA, 1993, OIKOS, V67, P129, DOI 10.2307/3545103; Bressette JW, 2012, OIKOS, V121, P1749, DOI 10.1111/j.1600-0706.2011.20305.x; Cadenasso ML, 2002, J TORREY BOT SOC, V129, P228, DOI 10.2307/3088773; CHAMBERS JC, 1994, ANNU REV ECOL SYST, V25, P263, DOI 10.1146/annurev.es.25.110194.001403; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; DESSAINT F, 1991, J APPL ECOL, V28, P721, DOI 10.2307/2404578; Diaz-Villa MD, 2003, J VEG SCI, V14, P701, DOI 10.1111/j.1654-1103.2003.tb02202.x; Dolle M, 2009, APPL VEG SCI, V12, P415, DOI 10.1111/j.1654-109X.2009.01036.x; DONELAN M, 1980, BIOL CONSERV, V17, P297, DOI 10.1016/0006-3207(80)90029-4; Eschtruth AK, 2008, ECOL APPL, V18, P360, DOI 10.1890/07-0446.1; Fargione MJ, 1991, HOMES GROUNDS GARDEN; Forrester JA, 2006, AM MIDL NAT, V156, P135, DOI 10.1674/0003-0031(2006)156[135:ITEOWD]2.0.CO;2; Gill RMA, 2001, FORESTRY, V74, P209, DOI 10.1093/forestry/74.3.209; Glen-Lewin DC, 1992, PLANT SUCCESSION THE; Grandin U, 2001, ECOGRAPHY, V24, P731, DOI 10.1034/j.1600-0587.2001.240611.x; Hopfensperger KN, 2007, OIKOS, V116, P1438, DOI [10.1111/j.2007.0030-1299.15818.x, 10.1111/j.0030-1299.2007.15818.x]; Horsley SB, 2003, ECOL APPL, V13, P98, DOI 10.1890/1051-0761(2003)013[0098:WTDIOT]2.0.CO;2; Knight TM, 2009, NAT AREA J, V29, P110, DOI 10.3375/043.029.0202; LAVOREL S, 1991, J VEG SCI, V2, P367, DOI 10.2307/3235929; LEVIN MH, 1966, AM MIDL NAT, V75, P101, DOI 10.2307/2423484; Luzuriaga AL, 2005, ACTA OECOL, V27, P57, DOI 10.1016/j.actao.2004.09.003; McCabe TR, 1992, SCI OVERABUNDANCE DE, P11; Mcnicoll MB, 2010, AM MIDL NAT, V164, P136, DOI 10.1674/0003-0031-164.1.136; Myers JA, 2004, OECOLOGIA, V139, P35, DOI 10.1007/s00442-003-1474-2; OOSTING HENRY J., 1940, BULL TORREY BOT CLUB, V67, P253, DOI 10.2307/2481173; Pakeman RJ, 2013, J VEG SCI, V24, P865, DOI 10.1111/j.1654-1103.2012.01484.x; Parker JD, 2006, SCIENCE, V311, P1459, DOI 10.1126/science.1121407; Perdomo P., 2004, LANDSCAPE PLANTS RAT; Rawinski T.J., 2008, IMPACTS WHITE TAILED; Rooney TP, 2003, FOREST ECOL MANAG, V181, P165, DOI 10.1016/S0378-1127(03)00130-0; Rooney TP, 2001, FORESTRY, V74, P201, DOI 10.1093/forestry/74.3.201; Rossell CR, 2007, NORTHEAST NAT, V14, P61, DOI 10.1656/1092-6194(2007)14[61:EODBON]2.0.CO;2; Royo AA, 2010, BIOL CONSERV, V143, P2425, DOI 10.1016/j.biocon.2010.05.020; Russell FL, 2001, AM MIDL NAT, V146, P1, DOI 10.1674/0003-0031(2001)146[0001:EOWTDO]2.0.CO;2; Spellerberg IF, 2003, GLOBAL ECOL BIOGEOGR, V12, P177, DOI 10.1046/j.1466-822X.2003.00015.x; Stromayer KAK, 1997, WILDLIFE SOC B, V25, P227; Tanentzap AJ, 2011, BIOL CONSERV, V144, P376, DOI 10.1016/j.biocon.2010.09.015; THOMPSON K, 1987, NEW PHYTOL, V106, P23; THOMPSON K, 1979, J ECOL, V67, P893, DOI 10.2307/2259220; WARR SJ, 1993, PROG PHYS GEOG, V17, P329, DOI 10.1177/030913339301700303; Webster CR, 2005, BIOL CONSERV, V125, P297, DOI 10.1016/j.biocon.2005.03.027	50	25	25	3	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91155	10.1371/journal.pone.0091155	http://dx.doi.org/10.1371/journal.pone.0091155			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608258	gold, Green Published			2022-12-25	WOS:000332485800108
J	Han, GX; Xing, QH; Luo, YQ; Rafique, R; Yu, JB; Mikle, N				Han, Guangxuan; Xing, Qinghui; Luo, Yiqi; Rafique, Rashad; Yu, Junbao; Mikle, Nate			Vegetation Types Alter Soil Respiration and Its Temperature Sensitivity at the Field Scale in an Estuary Wetland	PLOS ONE			English	Article							CARBON-DIOXIDE FLUX; CO2 EFFLUX; PHOTOSYNTHESIS CONTROLS; TEMPORAL VARIATION; PLANT; WATER; ECOSYSTEM; PATTERNS; MECHANISMS; DYNAMICS	Vegetation type plays an important role in regulating the temporal and spatial variation of soil respiration. Therefore, vegetation patchiness may cause high uncertainties in the estimates of soil respiration for scaling field measurements to ecosystem level. Few studies provide insights regarding the influence of vegetation types on soil respiration and its temperature sensitivity in an estuary wetland. In order to enhance the understanding of this issue, we focused on the growing season and investigated how the soil respiration and its temperature sensitivity are affected by the different vegetation (Phragmites australis, Suaeda salsa and bare soil) in the Yellow River Estuary. During the growing season, there were significant linear relationships between soil respiration rates and shoot and root biomass, respectively. On the diurnal timescale, daytime soil respiration was more dependent on net photosynthesis. A positive correlation between soil respiration and net photosynthesis at the Phragmites australis site was found. There were exponential correlations between soil respiration and soil temperature, and the fitted Q(10) values varied among different vegetation types (1.81, 2.15 and 3.43 for Phragmites australis, Suaeda salsa and bare soil sites, respectively). During the growing season, the mean soil respiration was consistently higher at the Phragmites australis site (1.11 mu mol CO2 m(-2) s(-1)), followed by the Suaeda salsa site (0.77 mu mol CO2 m(-2) s(-1)) and the bare soil site (0.41 mu mol CO2 m(-2) s(-1)). The mean monthly soil respiration was positively correlated with shoot and root biomass, total C, and total N among the three vegetation patches. Our results suggest that vegetation patchiness at a field scale might have a large impact on ecosystem-scale soil respiration. Therefore, it is necessary to consider the differences in vegetation types when using models to evaluate soil respiration in an estuary wetland.	[Han, Guangxuan; Xing, Qinghui; Yu, Junbao] Chinese Acad Sci, Yantai Inst Coastal Zone Res, Key Lab Coastal Environm Proc & Ecol Remediat, Yantai, Peoples R China; [Han, Guangxuan; Luo, Yiqi; Rafique, Rashad; Mikle, Nate] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA	Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS; University of Oklahoma System; University of Oklahoma - Norman	Han, GX (corresponding author), Chinese Acad Sci, Yantai Inst Coastal Zone Res, Key Lab Coastal Environm Proc & Ecol Remediat, Yantai, Peoples R China.	gxhan@yic.ac.cn; jbyu@yic.ac.cn		Yu, Junbao/0000-0002-3433-3538	National Natural Science Foundation of China [41301083]; National Science and Technology Support Program of China [2011BAC02B01]; Chinese Academy of Sciences [KZCX2-YW-223]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program of China; Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was funded by the National Natural Science Foundation of China (No. 41301083), the National Science and Technology Support Program of China (No. 2011BAC02B01), and the Chinese Academy of Sciences (No. KZCX2-YW-223). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahn M, 2010, NEW PHYTOL, V186, P292, DOI 10.1111/j.1469-8137.2010.03237.x; Ball BA, 2009, SOIL BIOL BIOCHEM, V41, P1510, DOI 10.1016/j.soilbio.2009.04.011; Barba J, 2013, FOREST ECOL MANAG, V306, P79, DOI 10.1016/j.foreco.2013.06.025; Barron-Gafford GA, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001442; BhupinderpalSingh, 2003, PLANT CELL ENVIRON, V26, P1287, DOI 10.1046/j.1365-3040.2003.01053.x; Boone RD, 1998, NATURE, V396, P570, DOI 10.1038/25119; Bosatta E, 1999, SOIL BIOL BIOCHEM, V31, P1889, DOI 10.1016/S0038-0717(99)00105-4; Cable JM, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001757; Cable JM, 2009, PLANT SOIL, V320, P153, DOI 10.1007/s11104-008-9880-1; Cardon ZG, 2002, OECOLOGIA, V133, P215, DOI 10.1007/s00442-002-1045-y; Chen QS, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003538; Cui BS, 2010, PLANT ECOL, V209, P279, DOI 10.1007/s11258-010-9723-z; DeForest JL, 2006, INT J BIOMETEOROL, V51, P135, DOI 10.1007/s00484-006-0046-7; Dias ATC, 2010, OECOLOGIA, V163, P805, DOI 10.1007/s00442-010-1569-5; Edwards EJ, 2004, GLOBAL CHANGE BIOL, V10, P209, DOI 10.1111/j.1365-2486.2004.00729.x; Ekblad A, 2005, OECOLOGIA, V143, P136, DOI 10.1007/s00442-004-1776-z; Engels JG, 2010, OIKOS, V119, P679, DOI 10.1111/j.1600-0706.2009.17940.x; Euskirchen ES, 2003, ECOSYSTEMS, V6, P595, DOI 10.1007/s10021-002-0167-8; Fang HL, 1999, THESIS CHINESE ACAD; Gaumont-Guay D, 2008, TREE PHYSIOL, V28, P161, DOI 10.1093/treephys/28.2.161; Geng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034968; Han GX, 2007, PLANT SOIL, V291, P15, DOI 10.1007/s11104-006-9170-8; Han GX, 2007, SOIL BIOL BIOCHEM, V39, P418, DOI 10.1016/j.soilbio.2006.08.009; Heinemeyer A, 2006, NEW PHYTOL, V171, P159, DOI 10.1111/j.1469-8137.2006.01730.x; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Hogberg P, 2002, OECOLOGIA, V132, P579, DOI 10.1007/s00442-002-0983-8; Hogberg P, 2006, TRENDS ECOL EVOL, V21, P548, DOI 10.1016/j.tree.2006.06.004; Jassal RS, 2008, GLOBAL CHANGE BIOL, V14, P1305, DOI 10.1111/j.1365-2486.2008.01573.x; Jenkins M, 2010, GLOBAL CHANGE BIOL, V16, P209, DOI 10.1111/j.1365-2486.2009.01954.x; Jenkins ME, 2011, SOIL BIOL BIOCHEM, V43, P1266, DOI 10.1016/j.soilbio.2011.02.017; Jin HM, 2009, ECOL RES, V24, P731, DOI 10.1007/s11284-008-0544-7; Johnson D, 2008, BIOL LETTERS, V4, P345, DOI 10.1098/rsbl.2008.0121; Kuzyakov Y, 2004, PLANT SOIL, V263, P85, DOI 10.1023/B:PLSO.0000047728.61591.fd; Kuzyakov Y, 2001, SOIL BIOL BIOCHEM, V33, P1915, DOI 10.1016/S0038-0717(01)00117-1; Kuzyakov Y, 2010, GLOBAL CHANGE BIOL, V16, P3386, DOI 10.1111/j.1365-2486.2010.02179.x; Li SN, 2009, ECOL ENG, V35, P1719, DOI 10.1016/j.ecoleng.2009.07.009; Luo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042354; Maestre FT, 2003, APPL SOIL ECOL, V23, P199, DOI 10.1016/S0929-1393(03)00050-7; Metcalfe DB, 2011, BIOGEOSCIENCES, V8, P2047, DOI 10.5194/bg-8-2047-2011; Moyano FE, 2008, AGR FOREST METEOROL, V148, P135, DOI 10.1016/j.agrformet.2007.09.006; Nakano T, 2010, SOIL SCI PLANT NUTR, V56, P773, DOI 10.1111/j.1747-0765.2010.00502.x; Parsons AN, 2004, ECOSYSTEMS, V7, P286, DOI 10.1007/s10021-003-0132-1; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Raich JW, 1997, ECOLOGY, V78, P707; Rey A, 2011, SOIL BIOL BIOCHEM, V43, P393, DOI 10.1016/j.soilbio.2010.11.007; SODERSTROM B, 1987, SOIL BIOL BIOCHEM, V19, P231, DOI 10.1016/0038-0717(87)90002-2; Stoyan H, 2000, PLANT SOIL, V222, P203, DOI 10.1023/A:1004757405147; Tang JW, 2005, BIOGEOCHEMISTRY, V73, P183, DOI 10.1007/s10533-004-5889-6; Tang JW, 2005, GLOBAL CHANGE BIOL, V11, P1298, DOI 10.1111/j.1365-2486.2005.00978.x; Tang YS, 2011, SOIL BIOL BIOCHEM, V43, P638, DOI 10.1016/j.soilbio.2010.11.035; Wan SQ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001971; Wang LX, 2009, CLIMATIC CHANGE, V94, P63, DOI 10.1007/s10584-009-9548-8; Wang XH, 2010, SOIL BIOL BIOCHEM, V42, P1728, DOI 10.1016/j.soilbio.2010.06.008; Xie T, 2011, ECOL MODEL, V222, P241, DOI 10.1016/j.ecolmodel.2010.01.012; Xu M, 2001, GLOBAL CHANGE BIOL, V7, P667, DOI 10.1046/j.1354-1013.2001.00435.x; Yan LM, 2011, GLOBAL CHANGE BIOL, V17, P1990, DOI 10.1111/j.1365-2486.2010.02365.x; Yuste JC, 2007, GLOBAL CHANGE BIOL, V13, P2018, DOI 10.1111/j.1365-2486.2007.01415.x; Yuste JC, 2004, GLOBAL CHANGE BIOL, V10, P161, DOI 10.1111/j.1529-8817.2003.00727.x; Zhang LH, 2010, J ARID ENVIRON, V74, P1200, DOI 10.1016/j.jaridenv.2010.05.031; Zheng ZM, 2009, SOIL BIOL BIOCHEM, V41, P1531, DOI 10.1016/j.soilbio.2009.04.013	61	25	32	7	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91182	10.1371/journal.pone.0091182	http://dx.doi.org/10.1371/journal.pone.0091182			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608636	Green Published, gold, Green Submitted			2022-12-25	WOS:000332485800112
J	Li, X; Suo, J; Shao, SJ; Xue, LY; Chen, W; Dong, LJ; Shi, J; Fu, M; Lu, N; Zhan, QM; Tong, T				Li, Xiao; Suo, Jing; Shao, Shujuan; Xue, Liyan; Chen, Wei; Dong, Lijia; Shi, Ji; Fu, Ming; Lu, Ning; Zhan, Qimin; Tong, Tong			Overexpression of OLC1 Promotes Tumorigenesis of Human Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; CYTOCHROME-C RELEASE; AURORA-A; SACCHAROMYCES-CEREVISIAE; PROGNOSTIC-SIGNIFICANCE; CLINICAL-SIGNIFICANCE; CIGARETTE-SMOKE; PROTEIN SPARTIN; BCL-2 FAMILY; CYCLE ARREST	Purpose: OLC1 was recently identified to be a potential oncogene. However, the role of OLC1 in human esophageal cell carcinoma (ESCC) is unknown. The aim of this study was therefore to evaluate the expression of OLC1 in human ESCC from normal, premalignant, and malignant lesions, and to clarify the mechanisms by which OLC1 contributes to the progression of ESCC. Experimental Design: Two hundred and fourteen paired ESCC specimens, and an independent set from 28 ESCC patients, were used to analyze the correlation between OLC1 expression and the pathological characteristics of tumors using immunohistochemistry. Stable OLC1-overexpressing and OLC1-interfering esophageal cancer cells were established and a series of experimental methods were used to investigate the biological functions and mechanisms of action of OLC1. Results: We showed that OLC1 was overexpressed in 145 of 214 (67.8%) of human ESCC specimens, compared with in only 59 of 214 (27.57%) paired adjacent normal tissues (P<0.001). OLC1 overexpression occurred at a rate of 35% (10/28) at the stage of mild/moderate dysplasia, but was significantly upregulated to 66% (22/33) at the stages of severe dysplasia and in situ carcinoma, while 71% positive staining (22/28) was observed in invasive carcinoma tissues compared with normal tissues (P<0.05). We also provided evidence that OLC1 abnormalities significantly altered the cell proliferation and apoptosis induced by cytotoxic agents. OLC1 overexpression suppressed apoptosis, and was associated with attenuated caspase-3 activation and increased Bcl-2 stability. Conclusion: Our study provides strong evidence suggesting OLC1 abnormalities may contribute to the development of human ESCC and have some important clinical significance.	[Li, Xiao; Chen, Wei; Dong, Lijia; Shi, Ji; Fu, Ming; Zhan, Qimin; Tong, Tong] Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Li, Xiao; Xue, Liyan; Chen, Wei; Dong, Lijia; Shi, Ji; Fu, Ming; Lu, Ning; Zhan, Qimin; Tong, Tong] Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China; [Li, Xiao; Xue, Liyan; Chen, Wei; Dong, Lijia; Shi, Ji; Fu, Ming; Lu, Ning; Zhan, Qimin; Tong, Tong] Peking Union Med Coll, Beijing 100021, Peoples R China; [Xue, Liyan; Lu, Ning] Chinese Acad Med Sci, Inst Canc, Dept Pathol, Beijing 100021, Peoples R China; [Li, Xiao] Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, Dalian, Liaoning, Peoples R China; [Li, Xiao; Suo, Jing; Shao, Shujuan; Shi, Ji] Dalian Med Univ, Dept Histol & Embryol, Dalian, Liaoning, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Dalian Medical University	Zhan, QM (corresponding author), Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.	qiminzhan@163.com; tongt5@yahoo.com			National Natural Science Foundation of China [31250001]; 973 National Key Fundamental Research Program of China [2009CB521801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 National Key Fundamental Research Program of China(National Basic Research Program of China)	This work was supported by the grants from the National Natural Science Foundation of China (31250001), and the 973 National Key Fundamental Research Program of China (2009CB521801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agromayor M, 2009, MOL BIOL CELL, V20, P1374, DOI 10.1091/mbc.E08-05-0474; Bajorek M, 2009, MOL BIOL CELL, V20, P1360, DOI 10.1091/mbc.E08-05-0475; Cao LY, 2009, WORLD J GASTROENTERO, V15, P4183, DOI 10.3748/wjg.15.4183; Chava S, 2012, DIS ESOPHAGUS, V25, P81, DOI 10.1111/j.1442-2050.2011.01213.x; Chung JY, 2006, CANCER EPIDEM BIOMAR, V15, P1403, DOI 10.1158/1055-9965.EPI-05-0651; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Dimaano C, 2008, MOL BIOL CELL, V19, P465, DOI 10.1091/mbc.E07-08-0747; Entian KD, 1999, MOL GEN GENET, V262, P683, DOI 10.1007/PL00013817; Silveira APF, 2011, ANTICANCER RES, V31, P1685; Hu H, 2002, INT J CANCER, V102, P580, DOI 10.1002/ijc.10739; Huang P, 2011, INT J MOL MED, V28, P579, DOI 10.3892/ijmm.2011.727; Hussain S, 2011, MOL CARCINOGEN, V50, P487, DOI 10.1002/mc.20732; Itami A, 1999, ONCOLOGY-BASEL, V57, P311, DOI 10.1159/000012067; Kimura Y, 2003, ONCOL REP, V10, P1747; Kitamura A, 2001, ONCOLOGY-BASEL, V61, P205, DOI 10.1159/000055376; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lan CH, 2010, J DIGEST DIS, V11, P43, DOI 10.1111/j.1751-2980.2009.00412.x; Lee S, 2012, MOL BIOL CELL, V23, P4347, DOI 10.1091/mbc.E12-04-0292; Li YF, 2009, J GENE MED, V11, P3, DOI 10.1002/jgm.1270; Lin DC, 2009, DIS ESOPHAGUS, V22, P9, DOI 10.1111/j.1442-2050.2008.00845.x; Ling Q, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-66; Luo KJ, 2011, J SURG ONCOL, V104, P236, DOI 10.1002/jso.21921; Lyronis ID, 2008, PATHOL ONCOL RES, V14, P267, DOI 10.1007/s12253-008-9032-1; Mathew R, 2002, EUR J CANCER, V38, P832, DOI 10.1016/S0959-8049(02)00007-2; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Matsumoto M, 2004, ONCOLOGY-BASEL, V67, P143, DOI 10.1159/000081001; Mega S, 2005, DIS ESOPHAGUS, V18, P109, DOI 10.1111/j.1442-2050.2005.00463.x; Osawa H, 2004, ANTICANCER RES, V24, P3703; Puhringer-Oppermann F, 2010, INT J COLORECTAL DIS, V25, P515, DOI 10.1007/s00384-009-0867-z; Renvoise B, 2012, HUM MOL GENET, V21, P3604, DOI 10.1093/hmg/dds191; Renvoise B, 2010, MOL BIOL CELL, V21, P3293, DOI 10.1091/mbc.E09-10-0879; Rue SM, 2008, MOL BIOL CELL, V19, P475, DOI 10.1091/mbc.E07-07-0694; Shi Ji, 2010, Zhonghua Zhong Liu Za Zhi, V32, P748; Shih CH, 2000, CLIN CANCER RES, V6, P1161; Shimada H, 2001, CANCER-AM CANCER SOC, V92, P663, DOI 10.1002/1097-0142(20010801)92:3<663::AID-CNCR1368>3.0.CO;2-L; Song YM, 2008, CARCINOGENESIS, V29, P307, DOI 10.1093/carcin/bgm269; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Thepot A, 2010, INT J CANCER, V127, P2051, DOI 10.1002/ijc.25221; Tong T, 2005, MOL CELL BIOL, V25, P4488, DOI 10.1128/MCB.25.11.4488-4500.2005; Tong T, 2004, CLIN CANCER RES, V10, P7304, DOI 10.1158/1078-0432.CCR-04-0806; Tung EWY, 2011, REPROD TOXICOL, V32, P255, DOI 10.1016/j.reprotox.2011.05.020; Tyagi A, 2011, CLIN CANCER RES, V17, P5402, DOI 10.1158/1078-0432.CCR-11-1072; Uchikado Y, 2005, CLIN CANCER RES, V11, P1174; Wagner AK, 2011, J CEREBR BLOOD F MET, V31, P1886, DOI 10.1038/jcbfm.2011.31; Wang XX, 2006, CELL RES, V16, P356, DOI 10.1038/sj.cr.7310046; Wang XX, 2009, CANCER BIOL THER, V8, P1852, DOI 10.4161/cbt.8.19.9550; Wu PP, 2011, INT J ONCOL, V38, P1605, DOI 10.3892/ijo.2011.973; Yuan JS, 2008, JNCI-J NATL CANCER I, V100, P1592, DOI 10.1093/jnci/djn379; Zhang JT, 2011, J PROTEOME RES, V10, P2863, DOI 10.1021/pr200141c; Zhang XJ, 2011, BIOCHEM BIOPH RES CO, V407, P753, DOI 10.1016/j.bbrc.2011.03.095	51	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90958	10.1371/journal.pone.0090958	http://dx.doi.org/10.1371/journal.pone.0090958			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608342	Green Published, Green Submitted, gold			2022-12-25	WOS:000332485800070
J	Sabo, A; Doni, M; Amati, B				Sabo, Arianna; Doni, Mirko; Amati, Bruno			SUMOylation of Myc-Family Proteins	PLOS ONE			English	Article							HUMAN NEUROBLASTOMA-CELLS; C-MYC; BURKITT-LYMPHOMA; N-MYC; TRANSCRIPTIONAL ACTIVATION; GENE AMPLIFICATION; CODING REGION; DNA-BINDING; UBIQUITIN; MUTATIONS	Myc-family proteins are key controllers of the metabolic and proliferative status of the cell, and are subjected to a complex network of regulatory events that guarantee their efficient and fast modulation by extracellular stimuli. Hence, unbalances in regulatory mechanisms leading to altered Myc levels or activities are often reported in cancer cells. Here we show that c- and N-Myc are conjugated to SUMO proteins at conserved lysines in their C-terminal domain. No obvious effects of SUMOylation were detected on bulk N-Myc stability or activities, including the regulation of transcription, proliferation or apoptosis. N-Myc SUMOylation could be induced by cellular stresses, such as heat shock and proteasome inhibition, and in all instances concerned a small fraction of the N-Myc protein. We surmise that, as shown for other substrates, SUMOylation may be part of a quality-control mechanism acting on misfolded Myc proteins.	[Sabo, Arianna; Amati, Bruno] Fdn Ist Italiano Tecnol IIT, Ctr Genom Sci IIT SEMM, Milan, Italy; [Sabo, Arianna; Doni, Mirko; Amati, Bruno] European Inst Oncol IEO, Dept Expt Oncol, Milan, Italy	Istituto Italiano di Tecnologia - IIT; IRCCS European Institute of Oncology (IEO)	Amati, B (corresponding author), Fdn Ist Italiano Tecnol IIT, Ctr Genom Sci IIT SEMM, Milan, Italy.	bruno.amati@iit.it	Sabò, Arianna/J-9531-2018; Doni, Mirko/AAN-6027-2020; Doni, Mirko/ABA-9174-2021; Amati, Bruno/AAM-3418-2020	Sabò, Arianna/0000-0002-9542-0045; Doni, Mirko/0000-0001-7099-2701; Amati, Bruno/0000-0002-2958-1799	EU-FP7 Program (EuroSystem); European Research Council; Italian health ministry; Italian Association for Cancer Research (AIRC)	EU-FP7 Program (EuroSystem)(European Commission); European Research Council(European Research Council (ERC)European Commission); Italian health ministry(Ministry of Health, Italy); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	Work was supported by grants from the EU-FP7 Program (EuroSystem), the European Research Council, the Italian health ministry and the Italian Association for Cancer Research (AIRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; AMATI B, 1992, NATURE, V359, P423, DOI 10.1038/359423a0; Amente S, 2012, AM J CANCER RES, V2, P330; Bahram F, 2000, BLOOD, V95, P2104, DOI 10.1182/blood.V95.6.2104; Bettermann K, 2012, CANCER LETT, V316, P113, DOI 10.1016/j.canlet.2011.10.036; BHATIA K, 1994, BLOOD, V84, P883; BHATIA K, 1993, NAT GENET, V5, P56, DOI 10.1038/ng0993-56; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; Bordow SB, 1998, J CLIN ONCOL, V16, P3286, DOI 10.1200/JCO.1998.16.10.3286; Campaner S, 2010, NAT CELL BIOL, V12, P54, DOI 10.1038/ncb2004; Castoralova M, 2012, BIOCH BIOPHYS ACTA; Chen A, 1998, BIOCHEM MOL BIOL INT, V46, P1161; CLARK HM, 1994, CANCER RES, V54, P3383; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Combaret V, 1996, J CLIN ONCOL, V14, P25, DOI 10.1200/JCO.1996.14.1.25; Cowling VH, 2006, MOL CELL BIOL, V26, P4226, DOI 10.1128/MCB.01959-05; DANI C, 1984, P NATL ACAD SCI-BIOL, V81, P7046, DOI 10.1073/pnas.81.22.7046; Efstratiadis A, 2007, CELL CYCLE, V6, P418, DOI 10.4161/cc.6.4.3838; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Faiola F, 2005, MOL CELL BIOL, V25, P10220, DOI 10.1128/MCB.25.23.10220-10234.2005; Galderisi U, 1999, J CELL BIOCHEM, V73, P97, DOI 10.1002/(SICI)1097-4644(19990401)73:1<97::AID-JCB11>3.0.CO;2-M; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Giulino-Roth L, 2012, BLOOD, V120, P5181, DOI 10.1182/blood-2012-06-437624; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; HANN SR, 1984, MOL CELL BIOL, V4, P2486, DOI 10.1128/MCB.4.11.2486; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; Henriksen JR, BMC DEV BIOL, V11, P1, DOI [10.1186/1471-11-1, DOI 10.1186/1471-11-1]; Jentsch S, 2013, ANNU REV GENET, V47, P167, DOI 10.1146/annurev-genet-111212-133453; Jiang RC, 2011, BIOCHEM BIOPH RES CO, V410, P364, DOI 10.1016/j.bbrc.2011.06.020; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kamitani T, 1998, J BIOL CHEM, V273, P11349, DOI 10.1074/jbc.273.18.11349; Kang JH, 2006, BIOCHEM BIOPH RES CO, V351, P192, DOI 10.1016/j.bbrc.2006.10.020; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Love C, 2012, NAT GENET, V44, P1321, DOI 10.1038/ng.2468; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Miteva M, 2010, SUBCELL BIOCHEM, V54, P195, DOI 10.1007/978-1-4419-6676-6_16; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Neyret-Kahn H, 2013, GENOME RES, V23, P1563, DOI 10.1101/gr.154872.113; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; Popov N, NAT, P765, DOI [10.1038/ncb1601, DOI 10.1038/NCB1601]; Praefcke GJK, 2012, TRENDS BIOCHEM SCI, V37, P23, DOI 10.1016/j.tibs.2011.09.002; RABBITTS TH, 1983, NATURE, V306, P760, DOI 10.1038/306760a0; RAMSAY G, 1984, P NATL ACAD SCI-BIOL, V81, P7742, DOI 10.1073/pnas.81.24.7742; Rubie H, 1997, J CLIN ONCOL, V15, P1171, DOI 10.1200/JCO.1997.15.3.1171; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sharma VM, 2007, CELL CYCLE, V6, P927, DOI 10.4161/cc.6.8.4134; Sur I, 2013, CANCER RES, V73, P4180, DOI 10.1158/0008-5472.CAN-13-0789; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tatham MH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001484; Ulrich HD, 2005, TRENDS CELL BIOL, V15, P525, DOI 10.1016/j.tcb.2005.08.002; Vervoorts J, 2006, J BIOL CHEM, V281, P34725, DOI 10.1074/jbc.R600017200; Wang YG, 2009, J CELL SCI, V122, P4249, DOI 10.1242/jcs.050542; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yu Un-Young, 2008, Cancer Res Treat, V40, P27, DOI 10.4143/crt.2008.40.1.27; Zhang KL, 2005, BIOCHEM BIOPH RES CO, V336, P274, DOI 10.1016/j.bbrc.2005.08.075	65	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91072	10.1371/journal.pone.0091072	http://dx.doi.org/10.1371/journal.pone.0091072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608896	gold, Green Published, Green Submitted			2022-12-25	WOS:000332485800096
J	Ye, Z; Cong, LM; Ding, GQ; Yu, M; Zhang, XW; Hu, RY; Wu, JJ; Fang, L; Wang, H; Zhang, J; He, QF; Su, DT; Zhao, M; Wang, LX; Gong, WW; Xiao, YY; Liang, MB; Pan, J				Ye, Zhen; Cong, Liming; Ding, Gangqiang; Yu, Min; Zhang, Xinwei; Hu, Ruying; Wu, Jianjun; Fang, Le; Wang, Hao; Zhang, Jie; He, Qingfang; Su, Danting; Zhao, Ming; Wang, Lixin; Gong, Weiwei; Xiao, Yuanyuan; Liang, Mingbin; Pan, Jin			Optimal Cut-Off Points for Two-Step Strategy in Screening of Undiagnosed Diabetes: A Population-Based Study in China	PLOS ONE			English	Article							FASTING PLASMA-GLUCOSE; LIFE-STYLE; MELLITUS; DIAGNOSIS; TOLERANCE; IMPROVES	To identify optimal cut-off points of fasting plasma glucose for two-step strategy in screening of undiagnosed diabetes in Chinese people, data were selected from two cross-sectional studies of Metabolic Syndrome in Zhejiang Province of China, Zhejiang Statistical Yearbook (2010), and published literatures. Two-step strategy was used among 17437 subjects sampled from population to screen undiagnosed diabetes. Effectiveness (proportion of cases identified), costs (including medical and non-medical costs), and efficiency (cost per case identified) of these different two-step screening strategies were evaluated. This study found the sensitivities of all the two-step screening strategies with further Oral Glucose Tolerance Test (OGTT) at different Fasting Plasma Glucose (FPG) cut-off points from 5.0 to 7.0 (mmol/L) ranged from 0.66 to 0.91. For the FPG point of 5.0 mmol/L, 91 percent of undiagnosed cases were identified. The total cost of detecting one undiagnosed diabetes case ranged from 547.1 to 1294.5 CNY/case, and the strategy with FPG at cut-off point of 6.1 (mmol/L) resulted in the least cost. Considering both sensitivity and cost of screening diabetes, FPG cut-off point at 5.4 mmol/L was optimized for the two-step strategy. In conclusion, different optimal cut-off points of FPG for two-step strategy in screening of undiagnosed diabetes should be used for different screening purposes.	[Ye, Zhen; Cong, Liming; Ding, Gangqiang; Yu, Min; Zhang, Xinwei; Hu, Ruying; Fang, Le; Wang, Hao; Zhang, Jie; He, Qingfang; Su, Danting; Zhao, Ming; Wang, Lixin; Gong, Weiwei; Xiao, Yuanyuan; Liang, Mingbin; Pan, Jin] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Wu, Jianjun] Zhejiang Univ, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention; Zhejiang University	Yu, M (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.	myu@cdc.zj.cn; lef@cdc.zj.cn	su, dan/GYJ-1940-2022; Wu, Jian/AAU-5221-2020; ding, gangqiang/AHD-5012-2022; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507	Zhejiang Provincial Major Special Project of Science and Technology [2011C13032-1]	Zhejiang Provincial Major Special Project of Science and Technology	This study was supported by Zhejiang Provincial Major Special Project of Science and Technology (2011C13032-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Alqahtani N, 2013, INT J PREVENTIVE MED, V4, P1025; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc12-s064, 10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc11-S062]; [Anonymous], 2011, MATLAB VERS 7 12 COM; Appajigol J, 2011, RECENT RES SCI TECHN, V3; Eborall H, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X630106; Gilmer TP, 2010, DIABETES CARE, V33, P1695, DOI 10.2337/dc10-0855; He YN, 2009, DIABETES CARE, V32, P1972, DOI 10.2337/dc09-0714; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Ma XJ, 2010, CLIN EXP PHARMACOL P, V37, P974, DOI 10.1111/j.1440-1681.2010.05417.x; Nakagami T, 2002, DIABETES RES CLIN PR, V55, P35, DOI 10.1016/S0168-8227(01)00270-4; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Tai ES, 2000, DIABETIC MED, V17, P771, DOI 10.1046/j.1464-5491.2000.00382.x; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wang L, 2005, REPORT CHINA NATIONW, P18; Waugh N, 2007, HEALTH TECHNOL ASSES, V11, P1; Zhang P, 2005, DIABETES CARE, V28, P1321, DOI 10.2337/diacare.28.6.1321; Zhang P, 2003, DIABETES CARE, V26, P2536, DOI 10.2337/diacare.26.9.2536	19	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e87690	10.1371/journal.pone.0087690	http://dx.doi.org/10.1371/journal.pone.0087690			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609110	Green Published, gold, Green Submitted			2022-12-25	WOS:000332485800002
J	Amiya, RM; Poudel, KC; Poudel-Tandukar, K; Pandey, BD; Jimba, M				Amiya, Rachel M.; Poudel, Krishna C.; Poudel-Tandukar, Kalpana; Pandey, Basu D.; Jimba, Masamine			Perceived Family Support, Depression, and Suicidal Ideation among People Living with HIV/AIDS: A Cross-Sectional Study in the Kathmandu Valley, Nepal	PLOS ONE			English	Article							SOCIAL SUPPORT; EMOTIONAL DISTRESS; HIV; LIFE; BEHAVIOR; STIGMA; SATISFACTION; PREVALENCE; DISORDERS; SYMPTOMS	Background: Depression and suicidal thinking occur frequently alongside HIV/AIDS, triggering profound detrimental impacts on quality of life, treatment adherence, disease progression, and mortality. Yet the psychosocial factors contributing to these psychiatric comorbidities remain underexplored, particularly in the developing country context. This study thus examined different dimensions of perceived family support in relation to depression and suicidal ideation among people living with HIV/AIDS (PLWHA) in Nepal. Methods: A cross-sectional survey of 322 adult PLWHA residing in the Kathmandu Valley, Nepal was conducted. Data were analyzed using multiple logistic regressions for correlates of Beck Depression Inventory (BDI)-Ia-defined depressive symptoms and suicidal ideation in the past 2 weeks. Perceived family support, measured using the 10-item Nepali Family Support and Difficulty Scale, was entered into separate models, in turn, as a composite score, for each sub-scale (emotional, instrumental, and negative support), and for each individual item. Results: Overall, 25.5% of participants registered BDI-Ia-defined depression, with significantly lower rates among those with perceived family support scores in the highest (AOR = 0.19; 95% CI = 0.07, 0.55) and middle (AOR = 0.38; 95% CI = 0.17, 0.86) tertiles relative to those with lowest-tertile scores. Meanwhile, 14.0% reported suicidal thinking, with significantly lower rates among those in the highest perceived family support tertile relative to the lowest (AOR = 0.25; 95% CI = 0.07, 0.91). Broken down by support sub-scale, only negative support (i.e. family difficulty) was significant in its correlations with both outcomes - a trend similarly reflected in the item-wise analyses. Conclusions: Our findings highlight an important role for family support in determining experiences of depression and suicidality among PLWHA. Incorporating family counseling and support services - with special focus on ameliorating negative interaction and bolstering emotional support - into HIV care and treatment services may help to improve mental health along with overall wellness and treatment outcomes for HIV-positive populations in Nepal and similar settings.	[Amiya, Rachel M.; Jimba, Masamine] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan; [Poudel, Krishna C.] Univ Massachusetts, Dept Publ Hlth, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA; [Poudel-Tandukar, Kalpana] Waseda Univ, Waseda Inst Adv Study, Tokyo, Japan; [Pandey, Basu D.] Everest Int Clin & Res Ctr, Kathmandu, Nepal	University of Tokyo; University of Massachusetts System; University of Massachusetts Amherst; Waseda University	Amiya, RM (corresponding author), Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan.	rachel.amiya@gmail.com	Jimba, Masamine/AAF-5630-2020		University of Tokyo; National Center for Global Health and Medicine [21A-2]; Japan Society for the Promotion of Science through the Ministry of Education, Culture, Sports, Science and Technology, Japan [22790581]	University of Tokyo; National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Japan Society for the Promotion of Science through the Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by funding from the University of Tokyo; by the Grant for Research on Global Health and Medicine (No. 21A-2) from the National Center for Global Health and Medicine; and by the Grant-in-Aid for Young Scientists (B) (22790581) from the Japan Society for the Promotion of Science through the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe JAA, 2004, PERS RELATIONSHIP, V11, P231, DOI 10.1111/j.1475-6811.2004.00080.x; ABRAM HS, 1971, AM J PSYCHIAT, V127, P1199, DOI 10.1176/ajp.127.9.1199; Amiya RM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-677; Baider L, 2003, J PSYCHOSOM RES, V55, P453, DOI 10.1016/S0022-3999(03)00502-6; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bekele T, 2013, AIDS CARE, V25, P337, DOI 10.1080/09540121.2012.701716; Blashill AJ, 2012, AIDS BEHAV, V16, P2251, DOI 10.1007/s10461-011-0056-2; Center for Substance Abuse Treatment, 2008, SUBST AB SUIC PREV E; Central Bureau of Statistics (CBS), 2011, POP CENS 2011 PREL R; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; COHEN S, 1988, HEALTH PSYCHOL, V7, P269, DOI 10.1037/0278-6133.7.3.269; Demi A, 1998, J FAM PSYCHOL, V12, P344, DOI 10.1037/0893-3200.12.3.344; Gaynes BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041699; Gonzalez JS, 2011, JAIDS-J ACQ IMM DEF, V58, P181, DOI [10.1097/QAI.0B013E31822D490A, 10.1097/QAI.0b013e31822d490a]; Ingram KM, 1999, AIDS CARE, V11, P313, DOI 10.1080/09540129947947; Justice AC, 2001, J CLIN EPIDEMIOL, V54, pS77, DOI 10.1016/S0895-4356(01)00449-8; Kaestner F, 2012, Int J STD AIDS, V23, pe14, DOI 10.1258/ijsa.2009.009451; Kaushik S, 2010, J MENTAL HLTH HUM BE, V15, P77; Kim HS, 2008, AM PSYCHOL, V63, P518, DOI 10.1037/0003-066X; Kohrt B.A., 2002, NEPAL J PSYCHIAT, V2, P123; Kohrt BA, 2010, CULT MED PSYCHIAT, V34, P322, DOI 10.1007/s11013-010-9170-2; Kohrt BA, 2009, ANN HUM BIOL, V36, P261, DOI 10.1080/03014460902839194; Li L, 2009, AIDS CARE, V21, P1007, DOI 10.1080/09540120802614358; Lincoln KD, 2000, SOC SERV REV, V74, P231, DOI 10.1086/514478; Mcdowell TL, 2007, AIDS CARE, V19, P1223, DOI 10.1080/09540120701402830; Milner A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051333; National Centre for AIDS and STD Control (NCASC), 2012, NAT EST HIV INF NEP; NCASC, 2007, NAT EST HIV INF; Nepal VP, 2010, INT J SEX HEALTH, V22, P20, DOI 10.1080/19317610903393142; Neupane D, 2012, J Nepal Health Res Counc, V10, P136; Okun MA, 1998, J GERONTOL B-PSYCHOL, V53, pP4, DOI 10.1093/geronb/53B.1.P4; Poudel Krishna C, 2014, J Int Assoc Provid AIDS Care, V13, P277, DOI 10.1177/2325957413500989; Poudel-Tandukar K, 2013, AIDS RES HUM RETROV, V29, P528, DOI [10.1089/aid.2012.0120, 10.1089/AID.2012.0120]; Rabkin Judith G, 2008, Curr HIV/AIDS Rep, V5, P163, DOI 10.1007/s11904-008-0025-1; Reinhardt J. P, 2001, APPL DEV SCI, V5, P66; Ryan K, 2008, AIDS CARE, V20, P331, DOI 10.1080/09540120701660338; Serovich JM, 2001, AIDS CARE, V13, P335, DOI 10.1080/09540120120043982; Sherr L, 2011, PSYCHOL HEALTH MED, V16, P612, DOI 10.1080/13548506.2011.579991; Shirey KG., 2013, SUICIDE HIV MENTAL H, P405; Shor E, 2013, SOC NETWORKS, V35, P626, DOI 10.1016/j.socnet.2013.08.004; Shrestha Sadhana, 2014, J Int Assoc Provid AIDS Care, V13, P214, DOI 10.1177/1545109712456741; Siddiqui J, 2009, CURR MED RES OPIN, V25, P1307, DOI [10.1185/03007990902902119, 10.1185/03007990902902119 ]; Simbayi LC, 2007, SOC SCI MED, V64, P1823, DOI 10.1016/j.socscimed.2007.01.006; Soykan A, 2003, TRANSPLANT P, V35, P1290, DOI 10.1016/S0041-1345(03)00522-0; Suh E, 1998, J PERS SOC PSYCHOL, V74, P482, DOI 10.1037/0022-3514.74.2.482; Tezel A, 2011, J RES MED SCI, V16, P666; United Nations Development Programme (UNDP), 2014, HUM DEV REP 2013 RIS; Wada N, 2013, AM J EPIDEMIOL, V177, P116, DOI 10.1093/aje/kws321; Waraich P, 2004, CAN J PSYCHIAT, V49, P124, DOI 10.1177/070674370404900208; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; WHO, 2006, MENT HLTH SYST NEP; World Health Organization (WHO), 2011, SUIC PREV SPEC PROGR	52	49	51	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90959	10.1371/journal.pone.0090959	http://dx.doi.org/10.1371/journal.pone.0090959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4ID	24603886	Green Published, gold			2022-12-25	WOS:000332483600114
J	Hee, L; Liao, DH; Sandager, P; Gregersen, H; Uldbjerg, N				Hee, Lene; Liao, Donghua; Sandager, Puk; Gregersen, Hans; Uldbjerg, Niels			Cervical Stiffness Evaluated In Vivo by Endoflip in Pregnant Women	PLOS ONE			English	Article							LIGHT-INDUCED FLUORESCENCE; MECHANICAL-PROPERTIES; UTERINE CERVIX; DISTENSIBILITY; INSTRUMENT; DELIVERY; INDEX	Objective: To determine the stiffness of the pregnant uterine cervix in vivo. Method: Five women in early pregnancy and six women in late pregnancy were included. The EndoFlip is a 1-m-long probe with a 12-cm-long bag mounted on the tip. The tip of the probe was inserted into the cervical canal. Sensors spaced at 0.5-cm intervals along the probe were used to determine 16 serial cross-sectional areas of the bag. The diameter of the cervical canal could thereby be determined during inflation with up to 50 ml saline solution. Tissue stiffness was calculated from the geometric profiles and the pressure-strain elastic modulus (EP) at each sensor site. Three parts of the cervix were defined: the uterus-near part, the middle and the vaginal part. The EPmax was defined as the highest EP detected along the cervical canal. Results: The EPmax was always found in the middle part of the cervix. The median EPmax was 243 kPa (IQR, 67-422 kPa) for the early pregnant women and 5 kPa (IQR, 4-15 kPa) for those at term. In the early pregnant women the stiffness differed along the cervical length (p<0.05) whereas difference along the cervix was not found for late pregnant women. A positive correlation coefficient (Spearman's rho) was established between the EPs of the uterus-near and the middle part (0.84), between the vaginal and the middle part (0.81), and between the uterus-near and the vaginal part (0.85). Conclusion: This new method can estimate the stiffness along the cervical canal in vivo. This method may be useful in the clinical examination of the biomechanical properties of the uterine cervix.	[Hee, Lene; Sandager, Puk; Uldbjerg, Niels] Aarhus Univ Hosp, Dept Obstet & Gynecol, DK-8000 Aarhus, Denmark; [Hee, Lene; Liao, Donghua; Sandager, Puk; Uldbjerg, Niels] Aarhus Univ, Inst Clin Med, Aarhus, Denmark; [Liao, Donghua] Aalborg Univ Hosp, Dept Gastroenterol & Surg, Mech Sense, Aalborg, Denmark; [Gregersen, Hans] Chongqing Univ, Giome Ctr, Coll Bioengn, Chongqing 630044, Peoples R China; [Gregersen, Hans] GIOME FZE, Giome Inst, Ras Al Khaymah, U Arab Emirates	Aarhus University; Aarhus University; Aalborg University; Aalborg University Hospital; Chongqing University	Hee, L (corresponding author), Aarhus Univ Hosp, Dept Obstet & Gynecol, DK-8000 Aarhus, Denmark.	lenehee@ki.au.dk	Gregersen, Hans/AAH-3723-2021; Uldbjerg, Niels/O-2038-2016	Gregersen, Hans/0000-0002-5792-2845; Uldbjerg, Niels/0000-0002-6449-6426	Aase og Ejnar Danielsens Fond; Brodrene Hartmanns Fond [DKK 100.000. 2]; Direktor Jacob Madsens & Hustru Olga Madsens Fond [DKK 100.000. 3]; Kong Christian den Tiendes Fond [DKK 10.000. 4, DKK 50.000. 5]; Linexfonden (Frede Duelund Nielsens Fond) [DKK 10.000. 6]	Aase og Ejnar Danielsens Fond; Brodrene Hartmanns Fond; Direktor Jacob Madsens & Hustru Olga Madsens Fond; Kong Christian den Tiendes Fond; Linexfonden (Frede Duelund Nielsens Fond)	Funding came from: 1) Aase og Ejnar Danielsens Fond (http://www.danielsensfond.dk/), DKK 100.000. 2) Brodrene Hartmanns Fond (http://www.hartmannfonden.dk/), DKK 100.000. 3) Direktor Jacob Madsens & Hustru Olga Madsens Fond DKK 10.000. 4) Fonden af 17-12-1981 http://www.fondenaf17121981.dk/), DKK 50.000. 5) Kong Christian den Tiendes Fond (http://kongehuset.dk/Menu/Fonde-legater/Kong-Christian-den-Tiendes-Fond/kong-christian-den-tiendesfond), DKK 10.000. 6) Linexfonden (Frede Duelund Nielsens Fond) (http://www.farum.eurojuris.dk/dk/filnavn=/dk/linex_fonden__udfyld_ansoegningen_om_stoette_paa_skaermen_ved_at_downloade_skemaet.asp), DKK 5.000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONY GS, 1982, BRIT J OBSTET GYNAEC, V89, P1046, DOI 10.1111/j.1471-0528.1982.tb04662.x; BAKKE T, 1973, ACTA OBSTET GYN SCAN, V52, P277, DOI 10.3109/00016347309158327; Bauer M, 2007, ANN NY ACAD SCI, V1101, P186, DOI 10.1196/annals.1389.004; Bauer M, 2009, EUR J OBSTET GYN R B, V144, pS77, DOI 10.1016/j.ejogrb.2009.02.025; BISHOP EH, 1964, OBSTET GYNECOL, V24, P266; CABROL D, 1990, GYNECOL OBSTET INVES, V29, P32, DOI 10.1159/000293296; CABROL D, 1991, GYNECOL OBSTET INVES, V32, P28, DOI 10.1159/000292987; CABROL D, 1991, GYNECOL OBSTET INVES, V32, P36, DOI 10.1159/000292989; COLSTRUP H, 1983, J UROLOGY, V130, P507, DOI 10.1016/S0022-5347(17)51276-8; DANFORTH DN, 1954, AM J OBSTET GYNECOL, V68, P1261; DANFORTH DN, 1947, AM J OBSTET GYNECOL, V53, P541, DOI 10.1016/0002-9378(47)90273-1; Feltovich H, 2010, ULTRASONIC IMAGING, V32, P131, DOI 10.1177/016173461003200302; GAMBLE G, 1994, STROKE, V25, P11, DOI 10.1161/01.STR.25.1.11; Garfield RE, 2002, J SOC GYNECOL INVEST, V9, P265, DOI 10.1016/S1071-5576(02)00173-9; Gregersen H, 1988, Clin Phys Physiol Meas, V9 Suppl A, P61, DOI 10.1088/0143-0815/9/4A/011; Gregersen H., 2003, BIOMECHANICS GASTROI, DOI [10.1007/978-1-4471-3742-9_9, 10.1007/978-1-4471-3742-9]; Harris J, 1971, URODYNAMICS, P465; KIWI R, 1988, OBSTET GYNECOL, V71, P568; LOSE G, 1986, MED BIOL ENG COMPUT, V24, P488, DOI 10.1007/BF02443964; Maul H, 2003, AM J OBSTET GYNECOL, V188, P537, DOI 10.1067/mob.2003.94; Molina FS, 2012, ULTRASOUND OBST GYN, V39, P685, DOI 10.1002/uog.11067; Nabhani F., 2012, REDUCTION STRESSES C; PETERSEN LK, 1991, OBSTET GYNECOL, V77, P772; RECHBERGER T, 1988, OBSTET GYNECOL, V71, P563; RORIE DK, 1967, AM J OBSTET GYNECOL, V99, P466; Rust OA, 2005, AM J OBSTET GYNECOL, V192, P1060, DOI 10.1016/j.ajog.2005.01.076; SCHWALM H, 1966, AM J OBSTET GYNECOL, V94, P391, DOI 10.1016/0002-9378(66)90661-2; Volumenie JL, 2004, EUR J OBSTET GYN R B, V117, P33, DOI 10.1016/j.ejogrb.2004.02.029	28	23	24	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91121	10.1371/journal.pone.0091121	http://dx.doi.org/10.1371/journal.pone.0091121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603859	gold, Green Published, Green Submitted			2022-12-25	WOS:000332483600132
J	Manninen, O; Laitinen, T; Lehtimaki, KK; Tegelberg, S; Lehesjoki, AE; Grohn, O; Kopra, O				Manninen, Otto; Laitinen, Teemu; Lehtimaki, Kimmo K.; Tegelberg, Saara; Lehesjoki, Anna-Elina; Grohn, Olli; Kopra, Outi			Progressive Volume Loss and White Matter Degeneration in Cstb-Deficient Mice: A Diffusion Tensor and Longitudinal Volumetry MRI Study	PLOS ONE			English	Article							UNVERRICHT-LUNDBORG-DISEASE; CYSTATIN-B DEFICIENCY; MYOCLONUS EPILEPSY; MOUSE-BRAIN; EPM1; EXPRESSION; MUTATION; MODEL; PHENOTYPE; APOPTOSIS	Unverricht-Lundborg type progressive myoclonus epilepsy (EPM1, OMIM 254800) is an autosomal recessive disorder characterized by onset at the age of 6 to 16 years, incapacitating stimulus-sensitive myoclonus and tonic-clonic epileptic seizures. It is caused by mutations in the gene encoding cystatin B. Previously, widespread white matter changes and atrophy has been detected both in adult EPM1 patients and in 6-month-old cystatin B-deficient mice, a mouse model for the EPM1 disease. In order to elucidate the spatiotemporal dynamics of the brain atrophy and white matter changes in EPM1, we conducted longitudinal in vivo magnetic resonance imaging and ex vivo diffusion tensor imaging accompanied with tract-based spatial statistics analysis to compare volumetric changes and fractional anisotropy in the brains of 1 to 6 months of age cystatin B-deficient and control mice. The results reveal progressive but non-uniform volume loss of the cystatin B-deficient mouse brains, indicating that different neuronal populations possess distinct sensitivity to the damage caused by cystatin B deficiency. The diffusion tensor imaging data reveal early and progressive white matter alterations in cystatin B-deficient mice affecting all major tracts. The results also indicate that the white matter damage in the cystatin B-deficient brain is most likely secondary to glial activation and neurodegenerative events rather than a primary result of CSTB deficiency. The data also show that diffusion tensor imaging combined with TBSS analysis provides a feasible approach not only to follow white matter damage in neurodegenerative mouse models but also to detect fractional anisotropy changes related to normal white matter maturation and reorganisation.	[Manninen, Otto; Tegelberg, Saara; Lehesjoki, Anna-Elina; Kopra, Outi] Folkhalsan Inst Genet, Helsinki, Finland; [Manninen, Otto; Tegelberg, Saara; Lehesjoki, Anna-Elina; Kopra, Outi] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Manninen, Otto; Tegelberg, Saara; Lehesjoki, Anna-Elina; Kopra, Outi] Univ Helsinki, Res Programs Unit, Haartman Inst, Helsinki, Finland; [Manninen, Otto; Tegelberg, Saara; Lehesjoki, Anna-Elina; Kopra, Outi] Univ Helsinki, Neurosci Ctr, Helsinki, Finland; [Laitinen, Teemu; Lehtimaki, Kimmo K.; Grohn, Olli] Univ Eastern Finland, Dept Neurobiol, AI Virtanen Inst Mol Sci, Kuopio, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Eastern Finland	Manninen, O (corresponding author), Folkhalsan Inst Genet, Helsinki, Finland.	otto.manninen@helsinki.fi	Lehtimäki, Kimmo K/A-6018-2009	Lehtimäki, Kimmo K/0000-0003-2750-8229	Folkhalsan Research Foundation; Sigrid Juselius Foundation; Academy of Finland [137950]; Finnish Brain Foundation; Finnish Foundation for Epilepsy research; UEF Brain strategic funding from the University of Eastern Finland	Folkhalsan Research Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Finnish Brain Foundation; Finnish Foundation for Epilepsy research; UEF Brain strategic funding from the University of Eastern Finland	This study was funded by the Folkhalsan Research Foundation, the Sigrid Juselius Foundation (http://www.sigridjuselius.fi/foundation) and the Academy of Finland (grant # 137950) (http://www.aka.fi/en-GB/A/), the Finnish Brain Foundation (http://www.aivosaatio.fi/), Finnish Foundation for Epilepsy research (http://www.epilepsia.fi/epilepsiatutkimussaatio/), Oskar O " flund Foundation (http://www.oskaroflund.fi/) and UEF Brain strategic funding from the University of Eastern Finland (http://www.uef.fi/en/home). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buzzi A, 2012, NEUROBIOL DIS, V47, P216, DOI 10.1016/j.nbd.2012.04.005; Canafoglia L, 2012, EPILEPSIA, V53, P2120, DOI 10.1111/j.1528-1167.2012.03718.x; Chahboune H, 2007, NMR BIOMED, V20, P375, DOI 10.1002/nbm.1130; Chew NK, 2008, MOVEMENT DISORD, V23, P107, DOI 10.1002/mds.21812; Cohen NR, 2011, ACTA NEUROPATHOL, V121, P421, DOI 10.1007/s00401-010-0738-2; Danner N, 2013, MOVEMENT DISORD, V28, P1860, DOI 10.1002/mds.25615; ELDRIDGE R, 1983, LANCET, V2, P838, DOI 10.1016/s0140-6736(83)90749-3; Erdinc OO, 2010, J NEUROL SCI-TURK, V27, P1; Franceschetti S, 2007, NEUROBIOL DIS, V25, P675, DOI 10.1016/j.nbd.2006.11.006; HALTIA M, 1969, ACTA NEUROL SCAND, V45, P63; Houseweart MK, 2003, J NEUROBIOL, V56, P315, DOI 10.1002/neu.10253; Joensuu T, 2014, PLOS ONE IN PRESS; Joensuu T, 2007, EUR J HUM GENET, V15, P185, DOI 10.1038/sj.ejhg.5201723; Kalviainen R, 2008, EPILEPSIA, V49, P549, DOI 10.1111/j.1528-1167.2008.01546.x; Korja M, 2007, EPILEPSIA, V48, P1768, DOI 10.1111/j.1528-1167.2007.01118.x; Koskenkorva P, 2009, NEUROLOGY, V73, P606, DOI 10.1212/WNL.0b013e3181b3888b; KOSKINIEMI M, 1974, ACTA NEUROL SCAND, V50, P307; Lalioti MD, 1997, NAT GENET, V17, P17, DOI 10.1038/ng0997-17; Larvaron P, 2007, NMR BIOMED, V20, P413, DOI 10.1002/nbm.1082; Lehtinen MK, 2009, J NEUROSCI, V29, P5910, DOI 10.1523/JNEUROSCI.0682-09.2009; Lieuallen K, 2001, HUM MOL GENET, V10, P1867, DOI 10.1093/hmg/10.18.1867; Ma J, 2007, NEUROCHEM RES, V32, P311, DOI 10.1007/s11064-006-9183-y; Manninen O, 2013, RADIOLOGY, V269, P232, DOI 10.1148/radiol.13122458; Mascalchi M, 2002, NEUROLOGY, V58, P1686, DOI 10.1212/WNL.58.11.1686; MERVAALA E, 1986, EPILEPSIA, V27, P542, DOI 10.1111/j.1528-1157.1986.tb03581.x; MERVAALA E, 1984, J NEUROL SCI, V64, P131, DOI 10.1016/0022-510X(84)90031-5; Parmeggiani A, 1997, EPILEPSIA, V38, P637, DOI 10.1111/j.1528-1157.1997.tb01232.x; Paxinos G, 2007, MOUSE BRAIN STEREOTA; Pennacchio LA, 1998, NAT GENET, V20, P251, DOI 10.1038/3059; Pennacchio LA, 1996, GENOME RES, V6, P1103, DOI 10.1101/gr.6.11.1103; Pinto E, 2012, EPILEPSY RES, V99, P187, DOI 10.1016/j.eplepsyres.2011.11.004; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Rinne R, 2002, ANN MED, V34, P380, DOI 10.1080/078538902320772124; Santoshkumar B, 2008, PEDIATR NEUROL, V38, P252, DOI 10.1016/j.pediatrneurol.2007.11.006; Shannon P, 2002, J NEUROPATH EXP NEUR, V61, P1085, DOI 10.1093/jnen/61.12.1085; Sierra A, 2011, BRAIN STRUCT FUNCT, V216, P123, DOI 10.1007/s00429-010-0299-0; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Tegelberg S, 2012, J NEUROPATH EXP NEUR, V71, P40, DOI 10.1097/NEN.0b013e31823e68e1; Verma R, 2005, P NATL ACAD SCI USA, V102, P6978, DOI 10.1073/pnas.0407828102	39	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90709	10.1371/journal.pone.0090709	http://dx.doi.org/10.1371/journal.pone.0090709			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603771	Green Published, gold, Green Submitted			2022-12-25	WOS:000332483600074
J	Cai, BS; Xie, SW; Liu, FM; Simone, LC; Caplan, S; Qin, XB; Naslavsky, N				Cai, Bishuang; Xie, Shuwei; Liu, Fengming; Simone, Laura C.; Caplan, Steve; Qin, Xuebin; Naslavsky, Naava			Rapid Degradation of the Complement Regulator, CD59, by a Novel Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Complement; Endocytosis; Endosomes; Glycosyl Phosphatidylinositol Anchors; Intracellular Trafficking; Lysosomes; Shedding; CD59; Bacterial Toxin; Degradation	GPI-ANCHORED PROTEIN; ENDOCYTIC PATHWAY; PROTECTIN CD59; LYMPHOMA-CELLS; CANCER-CELLS; MEMBRANE; RITUXIMAB; CYTOTOXICITY; EXPRESSION; ENDOSOMES	Background: Surface expression of complement inhibitors, such as the glycosylphosphatidylinositol-anchored protein CD59, prevent complement-dependent lysis of cancer cells. Results: The non-toxic domain-4 of the bacterial toxin intermedilysin (rILYd4) blocks CD59 complement inhibitory activity. Conclusion: rILYd4 induces CD59 internalization and rapid degradation in lysosomes in non-small lung carcinoma cells. Significance: CD59 serves as a model for glycosylphosphatidylinositol-anchored protein trafficking and rILYd4 shows potential for immunotherapy. There is increased interest in immune-based monoclonal antibody therapies for different malignancies because of their potential specificity and limited toxicity. The activity of some therapeutic monoclonal antibodies is partially dependent on complement-dependent cytolysis (CDC), in which the immune system surveys for invading pathogens, infected cells, and malignant cells and facilitates their destruction. CD59 is a ubiquitously expressed cell-surface glycosylphosphatidylinositol-anchored protein that protects cells from CDC. However, in certain tumors, CD59 expression is enhanced, posing a significant obstacle for treatment, by hindering effective monoclonal antibody-induced CDC. In this study, we used non-small lung carcinoma cells to characterize the mechanism of a novel CD59 inhibitor: the 114-amino acid recombinant form of the 4th domain of intermedilysin (rILYd4), a pore forming toxin secreted by Streptococcus intermedius. We compared the rates of internalization of CD59 in the presence of rILYd4 or anti-CD59 antibodies and determined that rILYd4 induces more rapid CD59 uptake at early time points. Most significantly, upon binding to rILYd4, CD59 is internalized and undergoes massive degradation in lysosomes within minutes. The remaining rILYd4CD59 complexes recycle to the PM and are shed from the cell. In comparison, upon internalization of CD59 via anti-CD59 antibody binding, the antibodyCD59 complex is recycled via early and recycling endosomes, mostly avoiding degradation. Our study supports a novel role for rILYd4 in promoting internalization and rapid degradation of the complement inhibitor CD59, and highlights the potential for improving CDC-based immunotherapy.	[Cai, Bishuang; Xie, Shuwei; Simone, Laura C.; Caplan, Steve; Naslavsky, Naava] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Cai, Bishuang; Xie, Shuwei; Simone, Laura C.; Caplan, Steve; Naslavsky, Naava] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA; [Liu, Fengming; Qin, Xuebin] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19140 USA; [Liu, Fengming; Qin, Xuebin] Temple Univ, Sch Med, Ctr Neurovirol, Philadelphia, PA 19140 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Caplan, S (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	scaplan@unmc.edu; xuebin.qin@temple.edu; nnaslavsky@unmc.edu	Cai, Bishuang/AAE-4334-2020; Cai, Bishuang/ABG-4817-2020; Xie, Shuwei/ABA-4923-2021		National Institutes of Health [NIHR21CA141324, 1R01CA166144, R01GM087455, R01GM074876]; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [5P20GM103489-10]; Nebraska Department of Health; NATIONAL CANCER INSTITUTE [R01CA166144, R21CA141324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087455, P20GM103489, R01GM074876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health; Nebraska Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants NIHR21CA141324 and 1R01CA166144 (to X. B. Q.), R01GM087455, R01GM074876, by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under Grant 5P20GM103489-10 (to S. C. and N. N.), and a grant from the Nebraska Department of Health (to N. N.).	Ajona D, 2007, J IMMUNOL, V178, P5991, DOI 10.4049/jimmunol.178.9.5991; Bjorge L, 1997, INT J CANCER, V70, P14, DOI 10.1002/(SICI)1097-0215(19970106)70:1<14::AID-IJC3>3.0.CO;2-9; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brown Deborah A., 2007, V398, P9, DOI 10.1007/978-1-59745-513-8_2; Cai BS, 2012, MOL BIOL CELL, V23, P1874, DOI 10.1091/mbc.E11-10-0881; Cai BS, 2011, TRAFFIC, V12, P102, DOI 10.1111/j.1600-0854.2010.01135.x; Chadda R, 2007, TRAFFIC, V8, P702, DOI 10.1111/j.1600-0854.2007.00565.x; Cohen D, 2001, TRAFFIC, V2, P556, DOI 10.1034/j.1600-0854.2001.20805.x; Coral S, 2000, J CELL PHYSIOL, V185, P317, DOI 10.1002/1097-4652(200012)185:3<317::AID-JCP1>3.0.CO;2-L; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Fonsatti E, 2000, Clin Ter, V151, P187; Ge XW, 2011, CLIN CANCER RES, V17, P6702, DOI 10.1158/1078-0432.CCR-11-0647; Giddings KS, 2004, NAT STRUCT MOL BIOL, V11, P1173, DOI 10.1038/nsmb862; Golay J, 2000, BLOOD, V95, P3900; Gorter A, 1999, IMMUNOL TODAY, V20, P576, DOI 10.1016/S0167-5699(99)01537-6; Hayashi H, 2012, AM J PHYSIOL-CELL PH, V302, pC781, DOI 10.1152/ajpcell.00165.2011; Hu WG, 2011, CANCER RES, V71, P2298, DOI 10.1158/0008-5472.CAN-10-3016; Hu WG, 2010, J IMMUNOL, V184, P359, DOI 10.4049/jimmunol.0902278; Jarvis GA, 1997, INT J CANCER, V71, P1049, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1049::AID-IJC22>3.0.CO;2-7; Johnston JB, 2006, CURR MED CHEM, V13, P3483, DOI 10.2174/092986706779026174; Juhl H, 1997, J SURG ONCOL, V64, P222, DOI 10.1002/(SICI)1096-9098(199703)64:3<222::AID-JSO9>3.0.CO;2-C; Kalia M, 2006, MOL BIOL CELL, V17, P3689, DOI 10.1091/mbc.E05-10-0980; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Kolev M, 2011, ARCH IMMUNOL THER EX, V59, P407, DOI 10.1007/s00005-011-0146-x; Lauc G, 2006, BBA-GEN SUBJECTS, V1760, P584, DOI 10.1016/j.bbagen.2005.11.014; Lundmark R, 2008, CURR BIOL, V18, P1802, DOI 10.1016/j.cub.2008.10.044; Macor P, 2007, CANCER RES, V67, P10556, DOI 10.1158/0008-5472.CAN-07-1811; MERI S, 1990, IMMUNOLOGY, V71, P1; Mohrmann K, 1999, MOL MEMBR BIOL, V16, P81, DOI 10.1080/096876899294797; Musch A, 2001, EMBO J, V20, P2171, DOI 10.1093/emboj/20.9.2171; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Perez-Torres M, 2008, EXP CELL RES, V314, P2907, DOI 10.1016/j.yexcr.2008.07.013; Ricklin D, 2013, J IMMUNOL, V190, P3839, DOI 10.4049/jimmunol.1203200; ROLLINS SA, 1990, J IMMUNOL, V144, P3478; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; van Veen HA, 2004, EUR J BIOCHEM, V271, P678, DOI 10.1111/j.1432-1033.2003.03965.x; Wang SY, 2008, EXPERT OPIN BIOL TH, V8, P759, DOI [10.1517/14712598.8.6.759, 10.1517/14712598.8.6.759 ]; Wickham SE, 2011, J BIOL CHEM, V286, P20952, DOI 10.1074/jbc.M111.237446; Wu L, 2012, CURR PHARM DESIGN, V18, P4187, DOI 10.2174/138161212802430486; YAMASHINA M, 1990, NEW ENGL J MED, V323, P1184, DOI 10.1056/NEJM199010253231707; Yan J, 2008, ADV EXP MED BIOL, V632, P159, DOI 10.1007/978-0-387-78952-1_12; You T, 2011, CELL MOL IMMUNOL, V8, P157, DOI 10.1038/cmi.2010.35; ZALMAN LS, 1987, J EXP MED, V166, P947, DOI 10.1084/jem.166.4.947; Zhao WP, 2009, ONCOL REP, V21, P1405, DOI 10.3892/or_00000368; Zhou XH, 2008, ONCOLOGIST, V13, P954, DOI 10.1634/theoncologist.2008-0089; Ziller F, 2005, EUR J IMMUNOL, V35, P2175, DOI 10.1002/eji.200425920	47	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					12109	12125		10.1074/jbc.M113.547083	http://dx.doi.org/10.1074/jbc.M113.547083			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24616098	Green Published, hybrid			2022-12-25	WOS:000335010600048
J	Asvadi, NH; Morgan, M; Herath, HM; Hewavitharana, AK; Shaw, PN; Cabot, PJ				Asvadi, Naghmeh Hajarol; Morgan, Michael; Herath, Herath M.; Hewavitharana, Amitha K.; Shaw, P. Nicholas; Cabot, Peter J.			Beta-Endorphin 1-31 Biotransformation and cAMP Modulation in Inflammation	PLOS ONE			English	Article							OPIOID RECEPTOR; GAMMA-ENDORPHIN; CYCLIC-AMP; METABOLISM; PEPTIDASE; TISSUE; PAIN; FRAGMENTS; RELEASE; IDENTIFICATION	A large body of evidence now exists for the immune cell expression, production, and the release of beta-endorphin (BE 1-31) within inflamed tissue. The inflammatory milieu is characterised by increased acidity, temperature and metabolic activity. Within these harsh conditions BE 1-31 is even more susceptible to increased enzymatic degradation over that of plasma or other non-injured tissue. To elucidate the biotransformation pathways of BE 1-31 and provide an insight to the impact of inflamed tissue environments, BE 1-31 and three of its major N-terminal fragments (BE 1-11, BE 1-13 and BE 1-17) were incubated in inflamed tissue homogenates at pH 5.5 for 2 hrs. In addition, the potency of BE 1-31 and five main N - terminal fragments (BE 1-9, BE 1-11, BE 1-13, BE 1-17, BE 1-20) was assessed at mu-opioid receptors (MOR), delta-opioid receptors (DOR), and kappa-opioid receptors (KOR). Opioid receptor potency was investigated by examining the modulation of forskolin induced cAMP accumulation. The majority of the N-terminal fragment of BE 1-31 had similar efficacy to BE 1-31 at MOR. The shortest of the major N-terminal fragments (BE 1-9), had partial agonist activity at MOR but possessed the highest potency of all tested peptides at DOR. There was limited effect for BE 1-31 and the biotransformed peptides at KOR. Major N-terminal fragments produced within inflamed tissue have increased presence within inflamed tissue over that of the parent molecule BE 1-31 and may therefore contribute to BE 1-31 efficacy within disease states that involve inflammation.	[Asvadi, Naghmeh Hajarol; Morgan, Michael; Herath, Herath M.; Hewavitharana, Amitha K.; Shaw, P. Nicholas; Cabot, Peter J.] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia	University of Queensland	Cabot, PJ (corresponding author), Univ Queensland, Sch Pharm, Brisbane, Qld, Australia.	p.cabot@uq.edu.au	Morgan, Michael/AAC-2044-2021; Morgan, Michael/C-1323-2015; Hewavitharana, Amitha K/A-5533-2008; Shaw, Paul N/G-4418-2010; Cabot, Peter John/B-2424-2013; Shaw, Paul/Q-8454-2019	Morgan, Michael/0000-0002-3641-2774; Morgan, Michael/0000-0002-3641-2774; Hewavitharana, Amitha K/0000-0003-2935-9941; Shaw, Paul N/0000-0001-7154-592X; Cabot, Peter John/0000-0003-1778-3753; Shaw, Paul/0000-0001-7154-592X	IPRS Scholarship	IPRS Scholarship	Naghme Asavadi was supported by an IPRS Scholarship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson SE, 1999, J RHEUMATOL, V26, P2018; [Anonymous], 1989, CLIN PHARMACOKINET, V17, P345; Baker DG, 1997, PSYCHONEUROENDOCRINO, V22, P517, DOI 10.1016/S0306-4530(97)00053-X; Berezniuk I, 2011, RECEPT SER, P93, DOI 10.1007/978-1-60761-993-2_5; Binder W, 2004, EUR J NEUROSCI, V20, P92, DOI 10.1111/j.1460-9568.2004.03459.x; BRUDEL M, 1995, J CHROMATOGR A, V712, P169, DOI 10.1016/0021-9673(95)00564-4; BURBACH JPH, 1981, J BIOL CHEM, V256, P2463; BURBACH JPH, 1980, BIOCHEM BIOPH RES CO, V92, P725, DOI 10.1016/0006-291X(80)90393-9; Cabot PJ, 1997, J CLIN INVEST, V100, P142, DOI 10.1172/JCI119506; Cabot PJ, 2001, PAIN, V93, P207, DOI 10.1016/S0304-3959(01)00322-0; Chaturvedi K, 2000, BIOPOLYMERS, V55, P334, DOI 10.1002/1097-0282(2000)55:4<334::AID-BIP1006>3.0.CO;2-S; DEWIED D, 1987, POL J PHARMACOL PHAR, V39, P623; Drolet G, 2001, PROG NEURO-PSYCHOPH, V25, P729, DOI 10.1016/S0278-5846(01)00161-0; Fichna J, 2004, CANCER METAST REV, V23, P351, DOI 10.1023/B:CANC.0000031773.46458.63; FOLEY KM, 1979, P NATL ACAD SCI USA, V76, P5377, DOI 10.1073/pnas.76.10.5377; GAFFORI O, 1985, LIFE SCI, V37, P357, DOI 10.1016/0024-3205(85)90506-5; Herath HMDR, 2012, ANAL BIOANAL CHEM, V402, P2089, DOI 10.1007/s00216-011-5686-8; HOUGHTEN RA, 1980, P NATL ACAD SCI-BIOL, V77, P4588, DOI 10.1073/pnas.77.8.4588; Inceoglu B, 2011, P NATL ACAD SCI USA, V108, P5093, DOI 10.1073/pnas.1101073108; Issberner U, 1996, NEUROSCI LETT, V208, P191, DOI 10.1016/0304-3940(96)12576-3; Jaba IA, 2007, CENT EUR J MED, V2, P417, DOI 10.2478/s11536-007-0036-0; KAROL MD, 1990, BIOPHARM DRUG DISPOS, V11, P179, DOI 10.1002/bdd.2510110210; KAY N, 1987, LIFE SCI, V40, P1083, DOI 10.1016/0024-3205(87)90571-6; LEBOUILLE JLM, 1989, J NEUROCHEM, V52, P1714, DOI 10.1111/j.1471-4159.1989.tb07249.x; LI CH, 1981, INT J PEPT PROT RES, V18, P242; Lin L, 2001, J BIOL CHEM, V276, P2249, DOI 10.1074/jbc.M008562200; MCDONALD JK, 1980, BIOCHIM BIOPHYS ACTA, V616, P68; Miller BC, 1996, IMMUNOPHARMACOLOGY, V31, P151, DOI 10.1016/0162-3109(95)00046-1; Montiel JL, 1997, J NEUROCHEM, V68, P354; Mousa SA, 2001, J NEUROIMMUNOL, V115, P71, DOI 10.1016/S0165-5728(01)00271-5; Noble F, 2007, EXPERT OPIN THER TAR, V11, P145, DOI 10.1517/14728222.11.2.145; Reed B, 2008, J NEUROENDOCRINOL, V20, P606, DOI 10.1111/j.1365-2826.2008.01705.x; Rittner HL, 2001, ANESTHESIOLOGY, V95, P500, DOI 10.1097/00000542-200108000-00036; Roth-Deri I, 2008, PROG NEUROBIOL, V86, P1, DOI 10.1016/j.pneurobio.2008.06.003; Safavi A, 1996, BIOCHEMISTRY-US, V35, P14318, DOI 10.1021/bi960582q; Sakurada C, 2003, BIOCHEM PHARMACOL, V66, P653, DOI 10.1016/S0006-2952(03)00391-5; Sandin J, 1998, REGUL PEPTIDES, V73, P67, DOI 10.1016/S0167-0115(97)01065-3; Sarada B, 1998, J NEUROIMMUNOLOGY, V85, P59; SCARONE S, 1990, PSYCHIAT RES, V32, P159, DOI 10.1016/0165-1781(90)90082-G; Schreiter A, 2012, FASEB J, V26, P5161, DOI 10.1096/fj.12-208678; SHOOK JE, 1988, J PHARMACOL EXP THER, V246, P1018; Steele AD, 2002, CYTOKINE GROWTH F R, V13, P209, DOI 10.1016/S1359-6101(02)00007-2; STEIN C, 1995, NEW ENGL J MED, V332, P1685, DOI 10.1056/NEJM199506223322506; Stein C, 2009, CURR OPIN PHARMACOL, V9, P3, DOI 10.1016/j.coph.2008.12.009; Vetter I, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-22; Yan L, 1997, PEPTIDES, V18, P1399, DOI 10.1016/S0196-9781(97)00207-6; YU VC, 1990, J NEUROCHEM, V55, P1390, DOI 10.1111/j.1471-4159.1990.tb03151.x	47	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90380	10.1371/journal.pone.0090380	http://dx.doi.org/10.1371/journal.pone.0090380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618600	Green Published, gold			2022-12-25	WOS:000332842400015
J	Chen, Q; Zhou, Z; Zhang, L; Xu, SC; Chen, CH; Yu, ZP				Chen, Qian; Zhou, Zhou; Zhang, Lei; Xu, Shangcheng; Chen, Chunhai; Yu, Zhengping			The Cellular Distribution and Ser262 Phosphorylation of Tau Protein Are Regulated by BDNF In Vitro	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASES; MICROTUBULE DYNAMICS; NEUROBLASTOMA-CELLS; NEUROTROPHIC FACTOR; AXONAL-TRANSPORT; DRUG DISCOVERY; RETINOIC ACID; MOUSE MODEL; NEURONS	The brain-enriched microtubule-associated protein tau, a critical regulator of cytoskeletal dynamics, forms insoluble aggregates in a number of neurodegenerative diseases termed tauopathies, including Alzheimer's disease (AD). Hyperphosphorylation of tau protein is an important mechanism for aggregation, so many studies on the pathogenesis of AD and other tauopathies have focused on regulation of tau phosphorylation by kinases and phosphatases. Less studied are mechanisms of tau transcriptional and post-transcriptional regulation by extracellular signals such as BDNF and how such changes alter neuronal function. Previously, we reported that tau is required for morphological plasticity induced by BDNF. Here, we further explore tau modification during BDNF-induced changes in neuronal cell morphology. In undifferentiated SH-SY5Y cells lacking neurites, tau formed a sphere within the soma as revealed by immunocytochemistry. In contrast, tau was enriched in the neurites and sparse in the soma of SH-SY5Y cells induced to differentiate by retinoic acid (RA). Treatment with RA also increased total tau protein levels but decreased expression of tau phosphorylated at Ser262 as determined by Western blot. Both effects were further enhanced by subsequent BDNF treatment. Upregulation of tau protein and downregulation of p-Ser262 tau were correlated with total neurite length (R = .94 and R = -.98, respectively). When primary E18 hippocampal neurons were treated with nocodazole, a blocker of microtubule polymerization, nascent neurites were lost and tau shifted to the soma. This process of retrograde tau movement away from neurites was reversed by BDNF. These results indicate that tau is redistributed to neurites and dephosphorylated during RA-and BDNF-mediated differentiation.	[Chen, Qian; Zhou, Zhou; Zhang, Lei; Xu, Shangcheng; Chen, Chunhai; Yu, Zhengping] Third Mil Med Univ, Dept Occupat Hlth, Chongqing, Peoples R China	Army Medical University	Yu, ZP (corresponding author), Third Mil Med Univ, Dept Occupat Hlth, Chongqing, Peoples R China.	yuzping_tmmu@126.com		Chen, Chunhai/0000-0002-7549-213X	National Natural Science Foundation of China [31370833, 30900274]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Nos. 31370833 and 30900274). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bhaskar K, 2005, J BIOL CHEM, V280, P35119, DOI 10.1074/jbc.M505895200; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; Brunden KR, 2009, NAT REV DRUG DISCOV, V8, P783, DOI 10.1038/nrd2959; Buck KB, 2002, J NEUROSCI, V22, P9358; Bunker JM, 2004, MOL BIOL CELL, V15, P2720, DOI 10.1091/mbc.E04-01-0062; Caccamo A, 2010, P NATL ACAD SCI USA, V107, P22687, DOI 10.1073/pnas.1012851108; Chen Q, 2012, NEUROCHEM INT, V60, P233, DOI 10.1016/j.neuint.2011.12.013; David DC, 2002, J NEUROCHEM, V83, P176, DOI 10.1046/j.1471-4159.2002.01137.x; Dawson HN, 2010, NEUROSCIENCE, V169, P516, DOI 10.1016/j.neuroscience.2010.04.037; DREWES G, 1995, J BIOL CHEM, V270, P7679, DOI 10.1074/jbc.270.13.7679; DRUBIN D, 1988, J CELL BIOL, V106, P1583, DOI 10.1083/jcb.106.5.1583; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Fumagalli F, 2006, PHARMACOGENOMICS J, V6, P8, DOI 10.1038/sj.tpj.6500337; Gordon D, 2008, J NEUROSCI RES, V86, P2591, DOI 10.1002/jnr.21719; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Haque N, 1999, BRAIN RES, V838, P69, DOI 10.1016/S0006-8993(99)01622-4; Hoogenraad CC, 2009, TRENDS CELL BIOL, V19, P669, DOI 10.1016/j.tcb.2009.08.006; Jamsa A, 2004, BIOCHEM BIOPH RES CO, V319, P993, DOI 10.1016/j.bbrc.2004.05.075; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Jinwal UK, 2011, J BIOL CHEM, V286, P16976, DOI 10.1074/jbc.M110.182493; KOSIK KS, 1989, ANN MED, V21, P109, DOI 10.3109/07853898909149195; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Lu B, 2013, NAT REV NEUROSCI, V14, P401, DOI 10.1038/nrn3505; Mazanetz MP, 2007, NAT REV DRUG DISCOV, V6, P464, DOI 10.1038/nrd2111; Miao YY, 2010, J NEUROSCI RES, V88, P102, DOI 10.1002/jnr.22188; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Niewiadomska G, 2005, ANN NY ACAD SCI, V1048, P287, DOI 10.1196/annals.1342.026; Noble W, 2011, EXPERT OPIN DRUG DIS, V6, P797, DOI 10.1517/17460441.2011.586690; Papanikolopoulou K, 2010, BIOCHEM SOC T, V38, P981, DOI 10.1042/BST0380981; Planel E, 2007, J NEUROSCI, V27, P13635, DOI 10.1523/JNEUROSCI.3949-07.2007; Post RM, 2007, J PSYCHIATR RES, V41, P979, DOI 10.1016/j.jpsychires.2006.09.009; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; RIEDERER BM, 1994, BRAIN RES BULL, V33, P155, DOI 10.1016/0361-9230(94)90245-3; SHEA TB, 1992, J NEUROSCI RES, V32, P363, DOI 10.1002/jnr.490320308; Spires-Jones TL, 2009, TRENDS NEUROSCI, V32, P150, DOI 10.1016/j.tins.2008.11.007; STRITTMATTER WJ, 1994, P NATL ACAD SCI USA, V91, P11183, DOI 10.1073/pnas.91.23.11183; Sultan A, 2011, J BIOL CHEM, V286, P4566, DOI 10.1074/jbc.M110.199976; Vasquez RJ, 1997, MOL BIOL CELL, V8, P973, DOI 10.1091/mbc.8.6.973; Vega IE, 2006, EXP NEUROL, V202, P152, DOI 10.1016/j.expneurol.2006.05.026; Wang JZ, 2008, PROG NEUROBIOL, V85, P148, DOI 10.1016/j.pneurobio.2008.03.002; Whiteman IT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020878; Wilson L, 1999, CELL STRUCT FUNCT, V24, P329, DOI 10.1247/csf.24.329; Wolfe MS, 2009, J BIOL CHEM, V284, P6021, DOI 10.1074/jbc.R800013200; Yoshizaki C, 2004, NEUROSCI RES, V49, P363, DOI 10.1016/j.neures.2004.04.005; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010; Zhang B, 2005, P NATL ACAD SCI USA, V102, P227, DOI 10.1073/pnas.0406361102	53	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91793	10.1371/journal.pone.0091793	http://dx.doi.org/10.1371/journal.pone.0091793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618580	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400132
J	Hajrezaie, M; Hassandarvish, P; Moghadamtousi, SZ; Gwaram, NS; Golbabapour, S; NajiHussien, A; Almagrami, AA; Zahedifard, M; Rouhollahi, E; Karimian, H; Fani, S; Kamalidehghan, B; Majid, NA; Ali, HM; Abdulla, MA				Hajrezaie, Maryam; Hassandarvish, Pouya; Moghadamtousi, Soheil Zorofchian; Gwaram, Nura Suleiman; Golbabapour, Shahram; NajiHussien, Abdrabuh; Almagrami, Amel Abdullah; Zahedifard, Maryam; Rouhollahi, Elham; Karimian, Hamed; Fani, Somaye; Kamalidehghan, Behnam; Majid, Nazia Abdul; Ali, Hapipah Mohd; Abdulla, Mahmood Ameen			Chemopreventive Evaluation of a Schiff Base Derived Copper (II) Complex against Azoxymethane-Induced Colorectal Cancer in Rats	PLOS ONE			English	Article							ABERRANT CRYPT FOCI; COLON-CANCER; PROTEASOME INHIBITORS; OXIDATIVE STRESS; APOPTOSIS; INDUCTION; CELLS; CARCINOGENESIS; PROLIFERATION; COMPOUND	Background: Based on the potential of Schiff base compounds to act as sources for the development of cancer chemotherapeutic agents, this in vivo study was performed to investigate the inhibitory properties of the synthetic Schiff base compound Cu(BrHAP)(2) on colonic aberrant crypt foci (ACF). Methodology: This study involved five groups of male rats. The negative control group was injected with normal saline once a week for 2 weeks and fed 10% Tween 20 for 10 weeks, the cancer control group was subcutaneously injected with 15 mg/kg azoxymethane once per week for two consecutive weeks, the positive control group was injected with 15 mg/kg azoxymethane once per week for two consecutive weeks and 35 mg/kg 5-fluorouracil (injected intra-peritoneally) for 4 weeks, and the experimental groups were first injected with 15 mg/kg azoxymethane once per week for two consecutive weeks and then fed 2.5 or 5 mg/kg of the Schiff base compound once a day for 10 weeks. Application of the Schiff base compound suppressed total colonic ACF formation by up to 72% to 74% (P<0.05) when compared with the cancer control group. Analysis of colorectal specimens revealed that treatments with the Schiff base compound decreased the mean crypt scores in azoxymethane-treated rats. Significant elevations of superoxide dismutase, glutathione peroxidase and catalase activities and a reduction in the level of malondialdehyde were also observed. Histologically, all treatment groups exhibited significant decreases in dysplasia compared to the cancer control group (P<0.05). Immunohistochemical staining demonstrated down-regulation of the PCNA protein. Comparative western blot analysis revealed that COX-2 and Bcl2 were up-regulated and Bax was down-regulated compared with the AOM control group. Conclusion: The current study demonstrated that the Cu(BrHAP)(2) compound has promising chemoprotective activities that are evidenced by significant decreases in the numbers of ACFs in azoxymethane-induced colon cancer.	[Hajrezaie, Maryam; Hassandarvish, Pouya; Golbabapour, Shahram; NajiHussien, Abdrabuh; Almagrami, Amel Abdullah; Zahedifard, Maryam; Rouhollahi, Elham; Abdulla, Mahmood Ameen] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia; [Hajrezaie, Maryam; Moghadamtousi, Soheil Zorofchian; Golbabapour, Shahram; Zahedifard, Maryam; Majid, Nazia Abdul] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Gwaram, Nura Suleiman; Ali, Hapipah Mohd] Univ Malaya, Dept Chem, Kuala Lumpur 59100, Malaysia; [Karimian, Hamed; Fani, Somaye; Kamalidehghan, Behnam] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Abdulla, MA (corresponding author), Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia.	ammeen@um.edu.my	MAJID, NAZIA ABDUL/B-9215-2010; Hassandarvish, Pouya/K-8112-2012; Karimian, Hamed/V-2933-2017; Gwaram, Nura Suleiman/AEQ-1882-2022; Karimian, Hamed/A-2324-2014; Kamalidehghan, Behnam/B-5401-2013	MAJID, NAZIA ABDUL/0000-0002-6817-8046; Hassandarvish, Pouya/0000-0003-0364-5587; Karimian, Hamed/0000-0002-8501-9864; Gwaram, Nura Suleiman/0000-0002-8423-6111; Karimian, Hamed/0000-0002-8501-9864; Kamalidehghan, Behnam/0000-0001-8530-8124	University of Malaya [PV069-2012A]	University of Malaya(Universiti Malaya)	The authors would like to thank the University of Malaya for supporting this project PV069-2012A, and HIR-MOHE (F000009-21001) from the Ministry of Higher Education Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adsule S, 2006, J MED CHEM, V49, P7242, DOI 10.1021/jm060712l; Al-Numair NS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S4; Bawa S, 2009, INDIAN J CHEM B, V48, P142; Beaver LM, 2012, TOXICOL APPL PHARM, V263, P345, DOI 10.1016/j.taap.2012.07.007; Bocci V, 2013, ANTIOXID MED SCI, V2, P149; Carrer A, 2013, RECTAL CANC, P41; Carroll RE, 2009, GROWTH HORM IGF RES, V19, P447, DOI 10.1016/j.ghir.2009.02.001; Chakraborty A, 2010, EUR J PHARMACOL, V647, P1, DOI 10.1016/j.ejphar.2010.08.003; Chemicals dofo, 2005, OECD GUID TEST CHEM; da Silveira VC, 2008, J INORG BIOCHEM, V102, P1090, DOI 10.1016/j.jinorgbio.2007.12.033; Datta R, 2012, MAPANA J SCI MJS, V11, P57; DELEON MP, 1988, CANCER RES, V48, P4121; DESCHNER EE, 1983, J NATL CANCER I, V70, P279; Dou QP, 1999, DRUG RESIST UPDATE, V2, P215, DOI 10.1054/drup.1999.0095; Easmon J, 2001, J MED CHEM, V44, P2164, DOI 10.1021/jm000979z; Essa MM, 2012, BIOL TRACE ELEM RES, V147, P25, DOI 10.1007/s12011-011-9280-x; Faris MAIE, 2009, NUTR RES, V29, P355, DOI 10.1016/j.nutres.2009.05.005; Filomeni G, 2007, J BIOL CHEM, V282, P12010, DOI 10.1074/jbc.M610927200; Garber J.C., 2010, COMMITTEE UPDATE GUI, P248; Gupta SC, 2010, CANCER METAST REV, V29, P405, DOI 10.1007/s10555-010-9235-2; Ha HL, 2010, WORLD J GASTROENTERO, V16, P6035, DOI 10.3748/wjg.v16.i48.6035; Hajrezaie M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051537; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hu B, 2010, P NATL ACAD SCI USA, V107, P21635, DOI 10.1073/pnas.1016814108; Illan-Cabeza NA, 2008, J INORG BIOCHEM, V102, P647, DOI 10.1016/j.jinorgbio.2007.10.008; Jaaskelainen M, 2010, MOL CELL ENDOCRINOL, V330, P17, DOI 10.1016/j.mce.2010.07.020; Janakiram NB, 2009, CANCER PREV RES, V2, P52, DOI 10.1158/1940-6207.CAPR-08-0140; Khare S, 2008, NUTR CANCER, V60, P389, DOI 10.1080/01635580701883003; KOHNO H, 1999, J TOXICOL PATHOL, V12, P209; Komiya M, 2013, JPN J CLIN ONCOL; Kostova Irena, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P19, DOI 10.2174/187152006774755500; Kumar VK, 2010, ENVIRON TOXICOL PHAR, V29, P50, DOI 10.1016/j.etap.2009.09.006; Lee JS, 2012, INT J TOXICOL, V31, P70, DOI 10.1177/1091581811423845; Liang F, 2003, BIOORG MED CHEM LETT, V13, P2469, DOI 10.1016/S0960-894X(03)00489-X; LIPKIN M, 1983, CANCER RES, V43, P1899; Ma ZY, 2012, J INORG BIOCHEM, V117, P1, DOI 10.1016/j.jinorgbio.2012.08.007; Majumder A, 2006, POLYHEDRON, V25, P1753, DOI 10.1016/j.poly.2005.11.029; Milacic V, 2006, CANCER RES, V66, P10478, DOI 10.1158/0008-5472.CAN-06-3017; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Paul S, 2010, CARCINOGENESIS, V31, P1272, DOI 10.1093/carcin/bgq004; Poudyal D, 2012, CANCER PREV RES, V5, P685, DOI 10.1158/1940-6207.CAPR-11-0421; Qiao X, 2011, J INORG BIOCHEM, V105, P728, DOI 10.1016/j.jinorgbio.2011.01.004; Rey NA, 2009, J INORG BIOCHEM, V103, P1323, DOI 10.1016/j.jinorgbio.2009.05.008; ROSENBERG B, 1969, NATURE, V222, P385, DOI 10.1038/222385a0; Sheikhshoaie I, 2010, ARAB J SCI ENG, V35, P53; Sondhi SM, 2006, BIOORGAN MED CHEM, V14, P3758, DOI 10.1016/j.bmc.2006.01.054; Sujarania S, 2012, DIG J NANOMATER BIOS, V7, P1843; Suzuki R, 2004, CANCER LETT, V210, P159, DOI 10.1016/j.canlet.2004.01.034; Takayama T, 1998, NEW ENGL J MED, V339, P1277, DOI 10.1056/NEJM199810293391803; Tammali R, 2009, CARCINOGENESIS, V30, P799, DOI 10.1093/carcin/bgn246; Vanco J, 2008, J INORG BIOCHEM, V102, P595, DOI 10.1016/j.jinorgbio.2007.10.003; Velmurugan B, 2010, MOL CARCINOGEN, V49, P641, DOI 10.1002/mc.20643; Xiao Y, 2008, INT J ONCOL, V33, P1073, DOI 10.3892/ijo_00000096; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Zhang X, 2008, INT J MOL MED, V22, P677, DOI 10.3892/ijmm_00000072	55	31	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91246	10.1371/journal.pone.0091246	http://dx.doi.org/10.1371/journal.pone.0091246			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618844	Green Published, gold			2022-12-25	WOS:000332842400066
J	Smith-Ryan, AE; Fultz, SN; Melvin, MN; Wingfield, HL; Woessner, MN				Smith-Ryan, Abbie E.; Fultz, Sarah N.; Melvin, Malia N.; Wingfield, Hailee L.; Woessner, Mary N.			Reproducibility and Validity of A-Mode Ultrasound for Body Composition Measurement and Classification in Overweight and Obese Men and Women	PLOS ONE			English	Article							AIR-DISPLACEMENT PLETHYSMOGRAPHY; SUBCUTANEOUS ADIPOSE-TISSUE; FAT-FREE MASS; WEIGHT-LOSS; US ADULTS; RELIABILITY; SKINFOLD; VALIDATION; PREVALENCE; THICKNESS	Identifying portable methods to measure body composition may be more advantageous than using body mass index (BMI) to categorize associated health consequences. Purpose: To compare the validity and reliability of a portable A-mode ultrasound (US) to a criterion three compartment model (3C) for the measurement of body composition. Methods: Forty-seven overweight and obese subjects participated in this study. Body composition was measured once via air displacement plethysmography for body density (Bd) and bioelectrical impedance spectroscopy for total body water (TBW) for the 3C calculations. Ultrasound measurements (BodyMetrix, Intelametrix) were made using an A mode, 2.5- MHz transmitter. All measurements were made on the right side of the body at 7 skinfold sites. The US software calculated percent body fat (%BF), fat mass (FM) and fat free mass (FFM) from the 7-site Jackson and Pollock equation. Results: %BF and FM, respectively, measured by the US (29.1 +/- 6.5%; 27.4 +/- 8.1 kg) was significantly lower compared to the 3C model (33.7 +/- 7.6%; 31.8 +/- 9.8 kg; p<0.0005). Fat free mass was significantly higher for the US (66.7 +/- 13.0 kg) compared to the 3C model (62.3 +/- 12.6; p = 0.001). The US demonstrated respectable reliability for %BF, FM, and FFM with intraclass correlation coefficients (ICC) ranging from 0.84-0.98 and standard error of the measurement (SEM) values and 2.2%BF, 1.9 kg, 1.9 kg, respectively. Discussion: The US was found to under predict %BF and FM with large deviations from the criterion (n = 10>4%BF error). While the US was not valid in this population, it was reliable producing results with minimal error, suggesting this technique may be effective for tracking changes in a weight loss or clinical setting.	[Smith-Ryan, Abbie E.; Fultz, Sarah N.; Melvin, Malia N.; Wingfield, Hailee L.; Woessner, Mary N.] Univ N Carolina, Dept Exercise & Sport Sci, Appl Physiol Lab, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Smith-Ryan, AE (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, Appl Physiol Lab, Chapel Hill, NC 27515 USA.	abbsmith@email.unc.edu	Woessner, Mary/O-1050-2015	Woessner, Mary/0000-0001-7001-8407; Smith-Ryan, Abbie/0000-0002-5405-304X	Nutrition Obesity Research Center [P30DK056350]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER	Nutrition Obesity Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the Nutrition Obesity Research Center (P30DK056350). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackland TR, 2012, SPORTS MED, V42, P227, DOI 10.2165/11597140-000000000-00000; BELLISARI A, 1993, INT J OBESITY, V17, P475; Borrud Lori G, 2010, Vital Health Stat 11, P1; Bosy-Westphal A, 2008, OBESITY FACTS, V1, P319, DOI 10.1159/000176061; BULLEN BA, 1965, HUM BIOL, V37, P375; Da Silva, 2010, INTRO ULTRASOUND BOD; Das SK, 2003, AM J PHYSIOL-ENDOC M, V284, pE1080, DOI 10.1152/ajpendo.00185.2002; Demerath EW, 2002, INT J OBESITY, V26, P389, DOI 10.1038/sj.ijo.0801898; DEMPSTER P, 1995, MED SCI SPORT EXER, V27, P1692; FANELLI MT, 1984, AM J CLIN NUTR, V39, P703, DOI 10.1093/ajcn/39.5.703; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Gallagher D, 2000, AM J CLIN NUTR, V72, P694, DOI 10.1093/ajcn/72.3.694; Ginde SR, 2005, OBES RES, V13, P1232, DOI 10.1038/oby.2005.146; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; JACKSON AS, 1978, RES QUART, V49, P546, DOI 10.1080/10671315.1978.10615569; Johnson Kelly E, 2012, Int J Exerc Sci, V5, P205; KUCZMARSKI RJ, 1987, AM J CLIN NUTR, V45, P717, DOI 10.1093/ajcn/45.4.717; Leahy S, 2012, ULTRASOUND MED BIOL, V38, P28, DOI 10.1016/j.ultrasmedbio.2011.10.011; LUKASKI HC, 1985, AM J CLIN NUTR, V41, P810, DOI 10.1093/ajcn/41.4.810; Matthie J, 1998, J APPL PHYSIOL, V84, P1801, DOI 10.1152/jappl.1998.84.5.1801; McCrory MA, 1998, J APPL PHYSIOL, V84, P1475, DOI 10.1152/jappl.1998.84.4.1475; Minderico CS, 2008, BRIT J NUTR, V99, P432, DOI 10.1017/S0007114507815789; Moon JR, 2009, CLIN NUTR, V28, P516, DOI 10.1016/j.clnu.2009.04.025; Moon JR, 2007, J INT SOC SPORT NUTR, V4, DOI 10.1186/1550-2783-4-16; Moon JR, 2009, EUR J APPL PHYSIOL, V105, P119, DOI 10.1007/s00421-008-0881-9; Muller W, 2013, BRIT J SPORT MED, V47, P1028, DOI 10.1136/bjsports-2013-092232; Pateyjohns IR, 2006, OBESITY, V14, P2064, DOI 10.1038/oby.2006.241; Pineau JC, 2007, ANN NUTR METAB, V51, P421, DOI 10.1159/000111161; Pineau JC, 2009, J ATHL TRAINING, V44, P142, DOI 10.4085/1062-6050-44.2.142; Ramsey R, 2012, J NUTR HEALTH AGING, V16, P26, DOI 10.1007/s12603-011-0085-6; Ritz P, 2007, DIABETES RES CLIN PR, V77, P405, DOI 10.1016/j.diabres.2007.01.007; Rolfe ED, 2010, OBESITY, V18, P625, DOI 10.1038/oby.2009.309; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; SIRI WE, 1993, NUTRITION, V9, P481; Stolk RP, 2003, AM J CLIN NUTR, V77, P857, DOI 10.1093/ajcn/77.4.857; Stolk RP, 2001, INT J OBESITY, V25, P1346, DOI 10.1038/sj.ijo.0801734; Ulbricht L, 2012, IEEE ENG MED BIO, P1952, DOI 10.1109/EMBC.2012.6346337; Utter AC, 2008, MED SCI SPORT EXER, V40, P943, DOI 10.1249/MSS.0b013e318163f29e; Van der Ploeg GE, 2003, J APPL PHYSIOL, V94, P499, DOI 10.1152/japplphysiol.00436.2002; Verdich C, 2011, DIABETES METAB, V37, P222, DOI 10.1016/j.diabet.2010.10.007; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Wang ZM, 1998, INT J OBESITY, V22, P329, DOI 10.1038/sj.ijo.0800590; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; [No title captured], DOI DOI 10.1155/2013/280713	45	36	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91750	10.1371/journal.pone.0091750	http://dx.doi.org/10.1371/journal.pone.0091750			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618841	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000332842400124
J	Vergun, AA; Martirosyan, IA; Semyenova, SK; Omelchenko, AV; Petrosyan, VG; Lazebny, OE; Tokarskaya, ON; Korchagin, VI; Ryskov, AP				Vergun, Andrey A.; Martirosyan, Irena A.; Semyenova, Seraphima K.; Omelchenko, Andrey V.; Petrosyan, Varos G.; Lazebny, Oleg E.; Tokarskaya, Olga N.; Korchagin, Vitaly I.; Ryskov, Alexey P.			Clonal Diversity and Clone Formation in the Parthenogenetic Caucasian Rock Lizard Darevskia dahlia	PLOS ONE			English	Article							HETERONOTIA-BINOEI GEKKONIDAE; CNEMIDOPHORUS-NEOMEXICANUS; MICROSATELLITE LOCI; LACERTA; ORIGIN; AGE; EVOLUTION; POLYMORPHISM; SAURIA	The all-female Caucasian rock lizard species Darevskia dahli and other parthenogenetic species of this genus reproduce normally via true parthenogenesis. Previously, the genetic diversity of this species was analyzed using allozymes, mitochondrial DNA, and DNA fingerprint markers. In the present study, variation at three microsatellite loci was studied in 111 specimens of D. dahli from five populations from Armenia, and new information regarding clonal diversity and clone formation in D. dahli was obtained that suggests a multiple hybridization origin. All individuals but one were heterozygous at the loci studied. Based on specific allele combinations, 11 genotypes were identified among the individuals studied. Individuals with the same genotypes formed distinct clonal lineages: one major clone was represented by 72 individuals, an intermediate clone was represented by 21 individuals, and nine other clones were rare and represented by one or several individuals. A new approach based on the detection and comparison of genotype-specific markers formed by combinations of parental-specific markers was developed and used to identify at least three hybridization founder events that resulted in the initial formation of one major and two rare clones. All other clones, including the intermediate and seven rare clones, probably arose through postformation microsatellite mutations of the major clone. This approach can be used to identify hybridization founder events and to study clone formation in other unisexual taxa.	[Vergun, Andrey A.; Martirosyan, Irena A.; Semyenova, Seraphima K.; Tokarskaya, Olga N.; Korchagin, Vitaly I.; Ryskov, Alexey P.] Russian Acad Sci, Inst Gene Biol, Lab Genome Org, Moscow, Russia; [Vergun, Andrey A.] Moscow State Pedag Univ, Dept Organ & Biol Chem, Moscow 119435, Russia; [Omelchenko, Andrey V.; Petrosyan, Varos G.] Russian Acad Sci, Severtsov Inst Ecol & Evolut, Grp Bioinformat & Modeling Biol Proc, Moscow, Russia; [Lazebny, Oleg E.] Russian Acad Sci, Koltsov Inst Dev Biol, Dept Genet, Moscow, Russia	Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Moscow State University of Education; Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences	Ryskov, AP (corresponding author), Russian Acad Sci, Inst Gene Biol, Lab Genome Org, Moscow, Russia.	ryskov@mail.ru	Omelchenko, Andrey V/E-8887-2014; Lazebny, Oleg/R-9208-2016; Vergun, Andrey/I-4829-2016; Ryskov, Alexey/F-1179-2016	Omelchenko, Andrey V/0000-0003-4512-4413; Lazebny, Oleg/0000-0003-3136-0415; Vergun, Andrey/0000-0001-5255-7802; Petrosyan, Varos/0000-0002-7483-5102; Ryskov, Alexey/0000-0002-4159-0671	Russian Foundation for Basic Research [11-04-00754-a]; RAS; President RF Program [5233.2012.4, 2501.2014.4, 2349.2014.4]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); RAS(Russian Academy of SciencesRegione Sardegna); President RF Program	This study was partly supported by the Russian Foundation for Basic Research (grant No. 11-04-00754-a), the RAS Programs "Molecular and Cell Biology'' and "Living Nature,'' and the President RF Program (grant Nos. 5233.2012.4; 2501.2014.4; 2349.2014.4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakelyan M.S., 2011, HERPETOFAUNA ARMENIA; Badaeva TN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002730; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cole CJ, 1988, AM MUS NOVIT, V2905, P1; Darevsky I.S., 1967, ROCK LIZARDS CAUCASU, P1; DAREVSKY IS, 1958, DOKL AKAD NAUK SSSR+, V122, P730; Darevsky IS, 1985, BIOL REPTILIA, V15, P413; Davoyan A, 2007, THESIS YEREVAN; Davoyan AG, 2007, RUSS J GENET+, V43, P20, DOI 10.1134/S1022795407010036; DENSMORE LD, 1989, EVOLUTION, V43, P969, DOI 10.1111/j.1558-5646.1989.tb02543.x; DENSMORE LD, 1989, EVOLUTION, V43, P943, DOI 10.1111/j.1558-5646.1989.tb02541.x; Dessauer Herbert C., 1989, New York State Museum Bulletin, V466, P49; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Fu JZ, 2000, AMPHIBIA-REPTILIA, V21, P83, DOI 10.1163/156853800507291; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Kan NG, 1998, MOL BIOL+, V32, P672; Karakhanian A, 2002, J VOLCANOL GEOTH RES, V113, P319, DOI 10.1016/S0377-0273(01)00264-5; Korchagin VI, 2007, GENE, V392, P126, DOI 10.1016/j.gene.2006.11.020; KUPRIYAN.LA, 1974, TSITOLOGIYA+, V16, P1519; Lyapunova EA, 1988, RUSS J GENET, V9, P480; MacCulloch RD, 1997, BIOCHEM SYST ECOL, V25, P33, DOI 10.1016/S0305-1978(96)00085-3; MORITZ C, 1989, EVOLUTION, V43, P994, DOI 10.1111/j.1558-5646.1989.tb02545.x; MORITZ C, 1992, GENETICA, V87, P53, DOI 10.1007/BF00128773; Moritz C., 1989, New York State Museum Bulletin, V466, P87; MORITZ C, 1991, GENETICS, V129, P211; Murphy RW, 1997, GENETICA, V101, P125, DOI 10.1023/A:1018392603062; Parker E. Davis Jr, 1989, New York State Museum Bulletin, V466, P72; PARKER ED, 1984, HERPETOLOGICA, V40, P245; PARKER ED, 1979, AM ZOOL, V19, P753; PARKER ED, 1976, GENETICS, V84, P791; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Ryskov AR, 2008, INT REV CEL MOL BIO, V270, P319, DOI 10.1016/S1937-6448(08)01407-X; SAVIC I, 1979, J BIOGEOGR, V6, P363, DOI 10.2307/3038088; Simon JC, 2003, BIOL J LINN SOC, V79, P151, DOI 10.1046/j.1095-8312.2003.00175.x; Sinclair EA, 2010, EVOLUTION, V64, P1346, DOI 10.1111/j.1558-5646.2009.00893.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarkhnishvili D, 2010, BIOL J LINN SOC, V101, P447, DOI 10.1111/j.1095-8312.2010.01498.x; TEMPLETON AR, 1992, GENETICS, V132, P619; UZZELL T, 1975, COPEIA, P204; Vergun AA, 2007, DOKL BIOCHEM BIOPHYS, V416, P278, DOI 10.1134/S1607672907050146; Vrijenhoek RC, 1989, EVOLUTION ECOLOGY UN, P19; VYAS DK, 1990, EVOLUTION, V44, P922, DOI 10.1111/j.1558-5646.1990.tb03814.x; WAHRMAN J, 1969, SCIENCE, V164, P82, DOI 10.1126/science.164.3875.82	43	18	21	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91674	10.1371/journal.pone.0091674	http://dx.doi.org/10.1371/journal.pone.0091674			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618670	Green Published, gold, Green Submitted			2022-12-25	WOS:000332842400115
J	Geerts, CJ; Jacobsen, L; van de Bospoort, R; Verhage, M; Groffen, AJA				Geerts, Cornelia J.; Jacobsen, Linda; van de Bospoort, Rhea; Verhage, Matthijs; Groffen, Alexander J. A.			Tomosyn Interacts with the SUMO E3 Ligase PIAS gamma	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; SNARE COMPLEX-FORMATION; PROTEIN SUMOYLATION; NEUROTRANSMITTER RELEASE; SYNAPTIC-TRANSMISSION; DEPENDENT ACTIVATION; CONJUGATION; EXOCYTOSIS; RECEPTOR; MOTIF	Protein modification by Small Ubiquitin-like MOdifier (SUMO) entities is involved in a number of neuronal functions, including synaptogenesis and synaptic plasticity. Tomosyn-1 (syntaxin-binding protein 5; STXPB5) binds to t-SNARE (Soluble NSF Attachment Protein Receptor) proteins to regulate neurotransmission and is one of the few neuronal SUMO substrate proteins identified. Here we used yeast two-hybrid screening to show that tomosyn-1 interacts with the SUMO E3 ligase PIAS gamma (Protein Inhibitor of Activated STAT; PIAS4 or ZMIZ6). This novel interaction involved the C-terminus of tomosyn-1 and the N-terminus of PIAS gamma. It was confirmed by two-way immunoprecipitation experiments using the full-length proteins expressed in HEK293T cells. Tomosyn-1 was preferentially modified by the SUMO-2/3 isoform. PIAS gamma-dependent modification of tomosyn-1 with SUMO-2/3 presents a novel mechanism to adapt secretory strength to the dynamic synaptic environment.	[Geerts, Cornelia J.; Jacobsen, Linda; van de Bospoort, Rhea; Verhage, Matthijs; Groffen, Alexander J. A.] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Funct Genom, Amsterdam, Netherlands; [Verhage, Matthijs; Groffen, Alexander J. A.] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Groffen, AJA (corresponding author), Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Funct Genom, Neurosci Campus Amsterdam, Amsterdam, Netherlands.	sander.groffen@cncr.vu.nl	Groffen, A.J.A./C-1118-2009	Groffen, A.J.A./0000-0003-0046-4027; verhage, matthijs/0000-0002-6085-7503	Centre for Medical Systems Biology [CMSB2] [3.3.5]	Centre for Medical Systems Biology [CMSB2]	This study was supported by the Centre for Medical Systems Biology [CMSB2 project 3.3.5; http://www.cmsb.nl/research/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2005, J CELL BIOL, V170, P1113, DOI 10.1083/jcb.200504055; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bohren KM, 2007, PROTEIN EXPRES PURIF, V54, P289, DOI 10.1016/j.pep.2007.03.013; Cai QL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009720; Chamberlain SEL, 2012, NAT NEUROSCI, V15, P845, DOI 10.1038/nn.3089; Chen KY, 2011, P NATL ACAD SCI USA, V108, P18482, DOI 10.1073/pnas.1110184108; Cheviet S, 2006, J CELL SCI, V119, P2912, DOI 10.1242/jcs.03037; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Cimarosti H, 2008, NEUROPHARMACOLOGY, V54, P280, DOI 10.1016/j.neuropharm.2007.09.010; Cimarosti H, 2012, J CEREBR BLOOD F MET, V32, P17, DOI 10.1038/jcbfm.2011.146; Craig TJ, 2012, CURR OPIN NEUROBIOL, V22, P480, DOI 10.1016/j.conb.2011.10.017; Datwyler AL, 2011, J CEREBR BLOOD F MET, V31, P2152, DOI 10.1038/jcbfm.2011.112; Di Filippo M, 2008, NEUROPHARMACOLOGY, V55, P353, DOI 10.1016/j.neuropharm.2008.01.012; Feligioni M, 2009, EUR J NEUROSCI, V29, P1348, DOI 10.1111/j.1460-9568.2009.06692.x; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Gladycheva SE, 2007, J BIOL CHEM, V282, P22887, DOI 10.1074/jbc.M701787200; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Groffen AJA, 2005, J NEUROCHEM, V92, P554, DOI 10.1111/j.1471-4159.2004.02890.x; Gross M, 2004, ONCOGENE, V23, P3059, DOI 10.1038/sj.onc.1207443; Hatsuzawa K, 2003, J BIOL CHEM, V278, P31159, DOI 10.1074/jbc.M305500200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Ihara M, 2005, MOL CELL BIOL, V25, P3506, DOI 10.1128/MCB.25.9.3506-3518.2005; James P, 1996, GENETICS, V144, P1425; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kraut R, 2001, CURR BIOL, V11, P417, DOI 10.1016/S0960-9822(01)00124-5; Krumova P, 2013, CELL MOL LIFE SCI, V70, P2123, DOI 10.1007/s00018-012-1158-3; Li TW, 2006, J BIOL CHEM, V281, P36221, DOI 10.1074/jbc.M608236200; Liu B, 2001, P NATL ACAD SCI USA, V98, P3203, DOI 10.1073/pnas.051489598; Loriol C, 2013, BIOL CELL, V105, P30, DOI 10.1111/boc.201200016; Lu H, 2009, BIOCHEM BIOPH RES CO, V390, P872, DOI 10.1016/j.bbrc.2009.10.065; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Renner F, 2011, EMBO REP, V12, P129, DOI 10.1038/embor.2010.207; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Sakisaka T, 2004, J CELL BIOL, V166, P17, DOI 10.1083/jcb.200405002; Sakisaka T, 2008, J CELL BIOL, V183, P323, DOI 10.1083/jcb.200805150; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Shilo Y, 2003, P NATL ACAD SCI USA, V100, P13225, DOI 10.1073/pnas.1735528100; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Sturm S, 2000, J MOL NEUROSCI, V14, P107, DOI 10.1385/JMN:14:1-2:107; Tahk S, 2007, P NATL ACAD SCI USA, V104, P11643, DOI 10.1073/pnas.0701877104; Wilkinson KA, 2008, NEUROSCI LETT, V436, P239, DOI 10.1016/j.neulet.2008.03.029; Wilkinson KA, 2010, BRAIN RES REV, V64, P195, DOI 10.1016/j.brainresrev.2010.04.002; Williams AL, 2011, J BIOL CHEM, V286, P14542, DOI 10.1074/jbc.M110.215624; Wong KA, 2004, MOL CELL BIOL, V24, P5577, DOI 10.1128/MCB.24.12.5577-5586.2004; Yamamoto H, 2003, EMBO J, V22, P2047, DOI 10.1093/emboj/cdg204; Yamamoto Y, 2010, BIOCHEM BIOPH RES CO, V399, P24, DOI 10.1016/j.bbrc.2010.07.026; Yamamoto Y, 2009, J BIOL CHEM, V284, P12480, DOI 10.1074/jbc.M807182200; Yang SH, 2003, CELL CYCLE, V2, P528, DOI 10.4161/cc.2.6.597; Yang W, 2008, J CEREBR BLOOD F MET, V28, P892, DOI 10.1038/sj.jcbfm.9600601; Yang W, 2008, J CEREBR BLOOD F MET, V28, P269, DOI 10.1038/sj.jcbfm.9600523; Yizhar O, 2004, P NATL ACAD SCI USA, V101, P2578, DOI 10.1073/pnas.0308700100; Zhang W, 2006, DIABETES, V55, P574, DOI 10.2337/diabetes.55.03.06.db05-0015; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752	63	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91697	10.1371/journal.pone.0091697	http://dx.doi.org/10.1371/journal.pone.0091697			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614299	Green Submitted, gold, Green Published			2022-12-25	WOS:000332839300150
J	Khurana, P; Aggarwal, A; Mitra, S; Italia, YM; Saraswathy, KN; Chandrasekar, A; Kshatriya, GK				Khurana, Priyanka; Aggarwal, Aastha; Mitra, Siuli; Italia, Yazdi M.; Saraswathy, Kallur N.; Chandrasekar, Adimoolam; Kshatriya, Gautam K.			Y Chromosome Haplogroup Distribution in Indo-European Speaking Tribes of Gujarat, Western India	PLOS ONE			English	Article							CASTE POPULATIONS; DNA; DIVERSITY; PEOPLE; PLEISTOCENE; PERSPECTIVE; AFFINITIES; RESOLUTION; ORIGINS; POLYMORPHISMS	The present study was carried out in the Indo-European speaking tribal population groups of Southern Gujarat, India to investigate and reconstruct their paternal population structure and population histories. The role of language, ethnicity and geography in determining the observed pattern of Y haplogroup clustering in the study populations was also examined. A set of 48 bi-allelic markers on the non-recombining region of Y chromosome (NRY) were analysed in 284 males; representing nine Indo-European speaking tribal populations. The genetic structure of the populations revealed that none of these groups was overtly admixed or completely isolated. However, elevated haplogroup diversity and F-ST value point towards greater diversity and differentiation which suggests the possibility of early demographic expansion of the study groups. The phylogenetic analysis revealed 13 paternal lineages, of which six haplogroups: C5, H1a*, H2, J2, R1a1* and R2 accounted for a major portion of the Y chromosome diversity. The higher frequency of the six haplogroups and the pattern of clustering in the populations indicated overlapping of haplogroups with West and Central Asian populations. Other analyses undertaken on the population affiliations revealed that the Indo-European speaking populations along with the Dravidian speaking groups of southern India have an influence on the tribal groups of Gujarat. The vital role of geography in determining the distribution of Y lineages was also noticed. This implies that although language plays a vital role in determining the distribution of Y lineages, the present day linguistic affiliation of any population in India for reconstructing the demographic history of the country should be considered with caution.	[Khurana, Priyanka] Dr Hari Singh Gour Vishwavidyalaya, Sch Appl Sci, Dept Anthropol, Sagar, Madhya Pradesh, India; [Aggarwal, Aastha] Publ Hlth Fdn India, South Asia Network Chron Dis, Delhi, India; [Mitra, Siuli; Saraswathy, Kallur N.; Kshatriya, Gautam K.] Univ Delhi, Dept Anthropol, Delhi 110007, India; [Italia, Yazdi M.] Valsad Raktdan Kendra, Valsad, Gujarat, India; [Chandrasekar, Adimoolam] Anthropol Survey India, Southern Reg Ctr, Mysore, Karnataka, India	Dr. Hari Singh Gour University; Public Health Foundation of India; University of Delhi	Kshatriya, GK (corresponding author), Univ Delhi, Dept Anthropol, Delhi 110007, India.	g26_51@yahoo.co.in	Aggarwal, Aastha/AAT-1347-2020	Aggarwal, Aastha/0000-0002-8180-8743	Department of Biotechnology (DBT) [BT/PR9840/MED/12/366/2007]	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India)	The work was funded by Department of Biotechnology (DBT) grant (vide letter BT/PR9840/MED/12/366/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamshad M, 2001, GENOME RES, V11, P994, DOI 10.1101/gr.GR-1733RR; Barbujani G, 2000, HUM BIOL, V72, P133; Basu A, 2003, GENOME RES, V13, P2277, DOI 10.1101/gr.1413403; Brahmachari SK, 2008, J GENET, V87, P3; Cameron D, 2004, INT J OSTEOARCHAEOL, V14, P419, DOI 10.1002/oa.725; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; CAVALLISFORZA LL, 1992, P NATL ACAD SCI USA, V89, P5620, DOI 10.1073/pnas.89.12.5620; Census, 2011, CENS IND WEBS; Census of India, 2001, REG GEN CENS COMM; Chandrasekar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007447; Chaubey G, 2008, INT J HUM GENET, V8, P41, DOI 10.1080/09723757.2008.11886018; Chaubey G, 2011, MOL BIOL EVOL, V28, P1013, DOI 10.1093/molbev/msq288; Cordaux R, 2004, CURR BIOL, V14, P231, DOI 10.1016/j.cub.2004.01.024; Cordaux R, 2003, EUR J HUM GENET, V11, P253, DOI 10.1038/sj.ejhg.5200949; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Flores C, 2005, J HUM GENET, V50, P435, DOI 10.1007/s10038-005-0274-4; FUCHS S, 1964, TRIBAL LIFE GUJARAT, P263; GADGIL M, 1983, ANN HUM BIOL, V10, P465, DOI 10.1080/03014468300006671; Gadgil M., 1997, INDIAN HUMAN HERITAG, P100; Gadgil M., 1998, INDIAN HUMAN HERITAG, P100; Haber M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034288; Harpending H.C., 1982, BIOCH ASPECTS EVOLUT, P213; JOSHI NV, 1993, CURR SCI INDIA, V64, P10; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Karafet TM, 2002, HUM BIOL, V74, P761, DOI 10.1353/hub.2003.0006; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; KENNEDY KAR, 1989, CURR ANTHROPOL, V30, P394, DOI 10.1086/203757; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Kshatriya GK, 2011, ANN HUM BIOL, V38, P583, DOI 10.3109/03014460.2011.577455; Kshatriya GK, 2010, GENET TEST MOL BIOMA, V14, P215, DOI 10.1089/gtmb.2009.0166; Kumar V, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-47; Majumder PP, 1999, EUR J HUM GENET, V7, P435, DOI 10.1038/sj.ejhg.5200317; Majumder PP, 1998, EVOL ANTHROPOL, V6, P100, DOI 10.1002/(SICI)1520-6505(1998)6:3<100::AID-EVAN4>3.0.CO;2-I; MALHOTRA KC, 1993, HUMAN POPULATION GENETICS, P207; Meenakshi K., 1995, RECENT PERSPECTIVES, P53; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Misra V.N., 1990, MAN ENV, V14, P17; PATTANAYAK DP, 1998, INDIAN HUMAN HERITAG, P95; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; Rai N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048477; RATNAGAR S, 1995, RECENT PERSPECTIVES, P1; Ray N., 1973, NATL INDIA; Regueiro M, 2006, HUM HERED, V61, P132, DOI 10.1159/000093774; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Roychoudhury S, 2001, HUM GENET, V109, P339, DOI 10.1007/s004390100577; Sahoo S, 2006, P NATL ACAD SCI USA, V103, P843, DOI 10.1073/pnas.0507714103; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Sharma G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032546; SINGH KS, 1993, CURR SCI INDIA, V64, P5; SONAKIA A, 1985, AM ANTHROPOL, V87, P612, DOI 10.1525/aa.1985.87.3.02a00060; Thangaraj K, 2003, CURR BIOL, V13, P86, DOI 10.1016/S0960-9822(02)01336-2; Thangaraj K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015283; Thapar, 1966, HIST INDIA DISCOVERY; Trivedi R, 2008, INT J HUM GENET, V8, P97, DOI 10.1080/09723757.2008.11886023; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Zhong H, 2010, J HUM GENET, V55, P428, DOI 10.1038/jhg.2010.40	59	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90414	10.1371/journal.pone.0090414	http://dx.doi.org/10.1371/journal.pone.0090414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614885	Green Published, gold, Green Submitted			2022-12-25	WOS:000332839300024
J	Otto, SA; Diekmann, R; Flinkman, J; Kornilovs, G; Mollmann, C				Otto, Saskia A.; Diekmann, Rabea; Flinkman, Juha; Kornilovs, Georgs; Mollmann, Christian			Habitat Heterogeneity Determines Climate Impact on Zooplankton Community Structure and Dynamics	PLOS ONE			English	Article							CENTRAL BALTIC SEA; CALANOID COPEPODS; SPECIES-DIVERSITY; LIFE-CYCLE; POPULATION-DYNAMICS; TEMORA-LONGICORNIS; BORNHOLM BASIN; EGG-PRODUCTION; REGIME SHIFTS; ECOSYSTEM	Understanding and predicting species distribution in space and time and consequently community structure and dynamics is an important issue in ecology, and particularly in climate change research. A crucial factor determining the composition and dynamics of animal populations is habitat heterogeneity, i.e., the number of structural elements in a given locality. In the marine pelagic environment habitat heterogeneity is represented by the distribution of physical oceanographic parameters such as temperature, salinity and oxygen that are closely linked to atmospheric conditions. Little attention has been given, however, to the role of habitat heterogeneity in modulating the response of animal communities to external climate forcing. Here we investigate the long-term dynamics of Acartia spp., Temora longicornis, and Pseudocalanus acuspes, three dominant zooplankton species inhabiting different pelagic habitats in the Central Baltic Sea (CBS). We use the three copepods as indicator species for changes in the CBS zooplankton community and apply non-linear statistical modeling techniques to compare spatial population trends and to identify their drivers. We demonstrate that effects of climate variability and change depend strongly on species-specific habitat utilization, being more direct and pronounced at the upper water layer. We propose that the differential functional response to climate-related drivers in relation to strong habitat segregation is due to alterations of the species' environmental niches. We stress the importance of understanding how anticipated climate change will affect ecological niches and habitats in order to project spatio-temporal changes in species abundance and distribution.	[Otto, Saskia A.] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden; [Otto, Saskia A.; Diekmann, Rabea; Mollmann, Christian] Univ Hamburg, Inst Hydrobiol & Fisheries Sci, Ctr Earth Syst Res & Sustainabil CEN, Hamburg, Germany; [Flinkman, Juha] Finnish Environm Inst SYKE, Ctr Marine Res, Helsinki, Finland; [Kornilovs, Georgs] Inst Food Safety Anim Hlth & Environm, Dept Fish Resources Res, Riga, Latvia	Stockholm University; University of Hamburg; Finnish Environment Institute; Institute of Food Safety, Animal Health & Environment "BIOR"	Otto, SA (corresponding author), Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden.	saskia.otto@stockholmresilience.su.se	Möllmann, Christian/C-4788-2011; Möllmann, Christian/M-8006-2019	Möllmann, Christian/0000-0001-9161-6342; 	BONUS project AMBER; Stockholm University's strategic marine environmental research funds through the Baltic Ecosystem Adaptive Management Program	BONUS project AMBER; Stockholm University's strategic marine environmental research funds through the Baltic Ecosystem Adaptive Management Program	This study has been carried out with financial support from the BONUS project AMBER (http://www.io-warnemuende.de/amber.html) and the Stockholm University's strategic marine environmental research funds through the Baltic Ecosystem Adaptive Management Program (http://www.smf.su.se/beam). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; BARTLEIN PJ, 1986, J BIOGEOGR, V13, P35, DOI 10.2307/2844848; BAZZAZ FA, 1975, ECOLOGY, V56, P485, DOI 10.2307/1934981; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Casini M, 2008, P ROY SOC B-BIOL SCI, V275, P1793, DOI 10.1098/rspb.2007.1752; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Chiba S, 2009, GLOBAL CHANGE BIOL, V15, P1846, DOI 10.1111/j.1365-2486.2009.01890.x; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; DICKSON RR, 1988, J PLANKTON RES, V10, P151, DOI 10.1093/plankt/10.1.151; Diekmann ABS, 2012, MAR BIOL, V159, P2399, DOI 10.1007/s00227-012-1955-0; Dippner JW, 2000, J MARINE SYST, V25, P23, DOI 10.1016/S0924-7963(00)00006-3; Dutz J, 2010, MAR ECOL PROG SER, V406, P223, DOI 10.3354/meps08545; Dzierzbicka-Glowacka L, 2010, BIOGEOSCIENCES, V7, P2247, DOI 10.5194/bg-7-2247-2010; Eero M, 2007, ICES J MAR SCI, V64, P1257, DOI 10.1093/icesjms/fsm114; Gaedke U, 2010, GLOBAL CHANGE BIOL, V16, P1122, DOI 10.1111/j.1365-2486.2009.02009.x; Gulati RD, 1997, FRESHWATER BIOL, V38, P753, DOI 10.1046/j.1365-2427.1997.00275.x; Hansen FC, 2006, J PLANKTON RES, V28, P39, DOI 10.1093/plankt/fbi097; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; Hastie TJ., 1990, GEN ADDITIVE MODELS; HECK KL, 1977, J BIOGEOGR, V4, P135, DOI 10.2307/3038158; Helaouet P, 2009, ECOSYSTEMS, V12, P1235, DOI 10.1007/s10021-009-9261-5; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hirzel AH, 2008, J APPL ECOL, V45, P1372, DOI 10.1111/j.1365-2664.2008.01524.x; Holste L, 2006, MAR BIOL, V148, P1061, DOI 10.1007/s00227-005-0132-0; Holste L, 2009, MAR BIOL, V156, P527, DOI 10.1007/s00227-008-1101-1; HOLT RD, 1985, THEOR POPUL BIOL, V28, P181, DOI 10.1016/0040-5809(85)90027-9; Hsieh CH, 2009, GLOBAL CHANGE BIOL, V15, P2137, DOI 10.1111/j.1365-2486.2009.01875.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; ICES, 2011, CM2011ACOM10 ICES WG; Jackson ST, 2000, PALEOBIOLOGY, V26, P194, DOI 10.1666/0094-8373(2000)26[194:ROPPAC]2.0.CO;2; Jackson ST, 1999, P NATL ACAD SCI USA, V96, P13847, DOI 10.1073/pnas.96.24.13847; KLOPFER PH, 1960, AM NAT, V94, P293, DOI 10.1086/282130; Koski M, 1999, J PLANKTON RES, V21, P1779, DOI 10.1093/plankt/21.9.1779; Koster FW, 2005, ICES J MAR SCI, V62, P1408, DOI 10.1016/j.icesjms.2005.05.004; Lehmann A, 2002, TELLUS A, V54, P299, DOI 10.1034/j.1600-0870.2002.00289.x; Lehmann A, 2000, PHYS CHEM EARTH PT B, V25, P183, DOI 10.1016/S1464-1909(99)00140-9; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; MAC ARTHUR ROBERT H., 1967; Mackas DL, 2010, J MARINE SYST, V79, P286, DOI 10.1016/j.jmarsys.2008.11.030; MacKenzie BR, 2004, ECOLOGY, V85, P784, DOI 10.1890/02-0780; MAGUIRE B, 1973, AM NAT, V107, P213, DOI 10.1086/282827; MCGUINNESS KA, 1986, J EXP MAR BIOL ECOL, V104, P97, DOI 10.1016/0022-0981(86)90099-7; MENGE BA, 1976, AM NAT, V110, P351, DOI 10.1086/283073; Mollmann C, 2008, ICES J MAR SCI, V65, P302, DOI 10.1093/icesjms/fsm197; Mollmann C, 2009, GLOBAL CHANGE BIOL, V15, P1377, DOI 10.1111/j.1365-2486.2008.01814.x; Moller KA, 2013, THESIS U HAMBURG HAM; Mollmann C, 2000, J PLANKTON RES, V22, P2015, DOI 10.1093/plankt/22.11.2015; Mollmann C, 2004, J FISH BIOL, V65, P1563, DOI 10.1111/j.0022-1112.2004.00566.x; Mollmann C, 2002, J PLANKTON RES, V24, P959, DOI 10.1093/plankt/24.10.959; Munguia P, 2011, ECOL APPL, V21, P925, DOI 10.1890/09-2398.1; OCONNOR NA, 1991, OECOLOGIA, V85, P504, DOI 10.1007/BF00323762; Ojaveer E, 1998, ICES J MAR SCI, V55, P748, DOI 10.1006/jmsc.1998.0393; Ottersen G, 2010, J MARINE SYST, V79, P343, DOI 10.1016/j.jmarsys.2008.12.013; Otto SA, 2014, MAR ECOL PO IN PRESS; Peters J, 2013, J PLANKTON RES, V35, P595, DOI 10.1093/plankt/fbt004; PIANKA ER, 1969, ECOLOGY, V50, P498, DOI 10.2307/1933908; Planque B, 1998, ICES J MAR SCI, V55, P644, DOI 10.1006/jmsc.1998.0390; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; R Development Core Team, 2009, R FDN STAT COMP; Reid PC, 2001, FISH RES, V50, P163, DOI 10.1016/S0165-7836(00)00249-6; Renz J, 2006, MAR BIOL, V148, P567, DOI 10.1007/s00227-005-0103-5; Schmidt JO, 2006, THESIS CHRISTIAN ALB; Schulz J, 2007, J PLANKTON RES, V29, P881, DOI 10.1093/plankt/fbm066; Schulz J, 2012, PROG OCEANOGR, V107, P3, DOI 10.1016/j.pocean.2012.07.002; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; TILZER MM, 1986, POLAR BIOL, V5, P105, DOI 10.1007/BF00443382; TONN WM, 1982, ECOLOGY, V63, P1149, DOI 10.2307/1937251; VanDerWal J, 2013, NAT CLIM CHANGE, V3, P239, DOI [10.1038/nclimate1688, 10.1038/NCLIMATE1688]; Vuorinen I, 1998, ICES J MAR SCI, V55, P767, DOI 10.1006/jmsc.1998.0398; Walker BK, 2009, J COASTAL RES, V25, P39, DOI [10.2112/S153-005.1, 10.2112/SI53-005.1]; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Wasmund N, 2003, ICES J MAR SCI, V60, P177, DOI 10.1016/S1054-3139(02)00280-1; Wasmund N, 2011, J MARINE SYST, V87, P145, DOI 10.1016/j.jmarsys.2011.03.010; Winder M, 2012, HYDROBIOLOGIA, V698, P5, DOI 10.1007/s10750-012-1149-2; Wood S.N., 2017, GEN ADDITIVE MODELS, V2, P1, DOI [DOI 10.1201/9781315370279, 10.1201/9781315370279]; Zuur A.F., 2007, ANAL ECOLOGICAL DATA; Zuur Alain F., 2009, P1	78	21	21	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90875	10.1371/journal.pone.0090875	http://dx.doi.org/10.1371/journal.pone.0090875			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614110	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300048
J	Hu, LB; Yao, WX; Wang, F; Rong, X; Peng, T				Hu, Longbo; Yao, Wenxia; Wang, Fang; Rong, Xia; Peng, Tao			GP73 Is Upregulated by Hepatitis C Virus (HCV) Infection and Enhances HCV Secretion	PLOS ONE			English	Article							NONSTRUCTURAL PROTEIN 5A; GOLGI PHOSPHOPROTEIN 2; APOLIPOPROTEIN-E; LIVER-CANCER; SERUM MARKER; ASSOCIATION; EXPRESSION; REPLICATION; DISEASE	Hepatitis C virus (HCV) is a major cause of chronic liver disease. However, little is known about the details of its assembly and secretion. Golgi-related proteins have been recently proven to have a key function in HCV secretion. Golgi protein 73 (GP73), a resident Golgi membrane protein, is a potential serum biomarker for the diagnosis of liver diseases and hepatocellular carcinoma. Previous studies have demonstrated the upregulation of GP73 in the liver samples and sera of HCV-infected patients. However, the function and regulatory mechanism of GP73 in HCV infection at the cellular level remain unknown. In this study, we examined the expression level of GP73 in HCV infected cells and its effect on HCV life cycle in cell culture systems. Both the protein expression and mRNA levels of GP73 significantly increased in HCV subgenomic replicon-harboring cells and HCV-infected cells, which imply that GP73 was upregulated by HCV infection. HCV production was significantly enhanced when GP73 was overexpressed, but dramatically inhibited when GP73 was silenced. However, the overexpression and knockdown of GP73 showed no evident effect on the entry, protein translation, RNA replication, and assembly of HCV, which indicates that GP73 enhanced the secretion process. Moreover, the coiled-coil domain of GP73 was required to increase HCV secretion. GP73 increased and interacted with apolipoprotein E, an identified host factor that assists in HCV secretion. These results demonstrate the critical function of GP73 in HCV secretion and provide new insights into the therapeutic design of antiviral strategies.	[Hu, Longbo; Yao, Wenxia; Wang, Fang; Peng, Tao] Chinese Acad Sci, State Key Lab Resp Dis, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China; [Rong, Xia] Guangzhou Blood Ctr, Guangzhou, Guangdong, Peoples R China; [Peng, Tao] South China United Vaccine Insititute, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease; Guangzhou Blood Center	Peng, T (corresponding author), Chinese Acad Sci, State Key Lab Resp Dis, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China.	peng_tao@gibh.ac.cn	hu, longbo/S-7060-2018; wang, fang/GYD-4295-2022	hu, longbo/0000-0002-3495-6268; Peng, Tao/0000-0001-5260-7128	National Basic Research Program (973) [2009CB522306, 2010CB530100]; National Science Foundation [309701647]	National Basic Research Program (973)(National Basic Research Program of China); National Science Foundation(National Science Foundation (NSF))	This work was supported by National Basic Research Program (973) (Grant Nos. 2009CB522306 and 2010CB530100) and National Science Foundation (309701647). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou A, 2012, WORLD J GASTROENTERO, V18, P6060, DOI 10.3748/wjg.v18.i42.6060; Amako Y, 2011, J BIOL CHEM, V286, P11265, DOI 10.1074/jbc.M110.182097; [Anonymous], PSYCHIAT GENET, V20, P190; BARRERA JM, 1995, HEPATOLOGY, V21, P639, DOI 10.1016/0270-9139(95)90511-1; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Benga WJA, 2010, HEPATOLOGY, V51, P43, DOI 10.1002/hep.23278; Bishe B, 2012, VIRUSES-BASEL, V4, P2340, DOI 10.3390/v4102340; Bishe B, 2012, J BIOL CHEM, V287, P27637, DOI 10.1074/jbc.M112.346569; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Coller KE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002466; Cun W, 2010, J VIROL, V84, P11532, DOI 10.1128/JVI.01021-10; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Giannelli G, 2006, DIGEST LIVER DIS, V38, P854, DOI 10.1016/j.dld.2006.05.007; Gomaa AI, 2009, WORLD J GASTROENTERO, V15, P1301, DOI 10.3748/wjg.15.1301; Gu YL, 2009, ANN CLIN BIOCHEM, V46, P38, DOI 10.1258/acb.2008.008088; Hishiki T, 2010, J VIROL, V84, P12048, DOI 10.1128/JVI.01063-10; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Iftikhar R, 2004, AM J GASTROENTEROL, V99, P1087, DOI 10.1111/j.1572-0241.2004.30572.x; Inkster B, 2012, NEUROBIOL AGING, V33, P457, DOI 10.1016/j.neurobiolaging.2010.04.018; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Kato N, 2001, ACTA MED OKAYAMA, V55, P133; Kim HJ, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-31; Kladney RD, 2002, HEPATOLOGY, V35, P1431, DOI 10.1053/jhep.2002.32525; Kladney RD, 2000, GENE, V249, P53, DOI 10.1016/S0378-1119(00)00136-0; Leone N, 2005, Minerva Gastroenterol Dietol, V51, P31; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; Li H, 2008, ARCH NEUROL-CHICAGO, V65, P45, DOI 10.1001/archneurol.2007.3; Li XL, 2014, J VIROL, V88, P612, DOI 10.1128/JVI.02068-13; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Malaguarnera G, 2010, DIGEST DIS SCI, V55, P2744, DOI 10.1007/s10620-010-1184-7; Mao Y, 2010, GUT; Marrero JA, 2005, J HEPATOL, V43, P1007, DOI 10.1016/j.jhep.2005.05.028; Moradpour D, 2004, J VIROL, V78, P7400, DOI 10.1128/JVI.78.14.7400-7409.2004; Nahmias Y, 2008, HEPATOLOGY, V47, P1437, DOI 10.1002/hep.22197; Norton PA, 2008, J CELL BIOCHEM, V104, P136, DOI 10.1002/jcb.21610; Owen DM, 2009, VIROLOGY, V394, P99, DOI 10.1016/j.virol.2009.08.037; Ozkan H, 2011, DIGESTION, V83, P83, DOI 10.1159/000320379; Ploss A, 2012, CURR OPIN VIROL, V2, P14, DOI 10.1016/j.coviro.2011.12.007; Popescu CI, 2010, BIOL CELL, V102, P63, DOI 10.1042/BC20090125; Rice Charles M, 2011, Top Antivir Med, V19, P117; Riener MO, 2009, HEPATOLOGY, V49, P1602, DOI 10.1002/hep.22843; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Sundaram M, 2012, ARTERIOSCL THROM VAS, V32, P1073, DOI 10.1161/ATVBAHA.111.241455; Suzuki T, 2007, J GASTROENTEROL, V42, P411, DOI 10.1007/s00535-007-2030-3; Suzuki T, 2007, ADV DRUG DELIVER REV, V59, P1200, DOI 10.1016/j.addr.2007.04.014; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yuan Q, 2012, NEUROL SCI, V33, P1021, DOI 10.1007/s10072-011-0881-0; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06; Zhou Y, 2011, MOL BIOL REP, V38, P1457, DOI 10.1007/s11033-010-0251-7; Zlokovic BV, 2013, JAMA NEUROL, V70, P440, DOI 10.1001/jamaneurol.2013.2152	54	21	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90553	10.1371/journal.pone.0090553	http://dx.doi.org/10.1371/journal.pone.0090553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608522	Green Submitted, Green Published, gold			2022-12-25	WOS:000332485800033
J	Kim, HR; Lee, A; Choi, EJ; Hong, MP; Kie, JH; Lim, W; Lee, HK; Moon, BI; Seoh, JY				Kim, Hyung-Ran; Lee, Anbok; Choi, Eun-Jeong; Hong, Min-Pyo; Kie, Jeong-Hae; Lim, Woosung; Lee, Hyeon Kook; Moon, Byung-In; Seoh, Ju-Young			Reactive Oxygen Species Prevent Imiquimod-Induced Psoriatic Dermatitis through Enhancing Regulatory T Cell Function	PLOS ONE			English	Article							DELAYED RADIATION INJURIES; HYPERBARIC-OXYGEN; INDOLEAMINE 2,3-DIOXYGENASE; GLUTATHIONE PEROXIDASE-1; OXIDATIVE DAMAGE; MICE DEFICIENT; DNA-DAMAGE; THERAPY; INFLAMMATION; RESPONSES	Psoriasis is a chronic inflammatory skin disease resulting from immune dysregulation. Regulatory T cells (Tregs) are important in the prevention of psoriasis. Traditionally, reactive oxygen species (ROS) are known to be implicated in the progression of inflammatory diseases, including psoriasis, but many recent studies suggested the protective role of ROS in immune-mediated diseases. In particular, severe cases of psoriasis vulgaris have been reported to be successfully treated by hyperbaric oxygen therapy (HBOT), which raises tissue level of ROS. Also it was reported that Treg function was closely associated with ROS level. However, it has been only investigated in lowered levels of ROS so far. Thus, in this study, to clarify the relationship between ROS level and Treg function, as well as their role in the pathogenesis of psoriasis, we investigated imiquimod-induced psoriatic dermatitis (PD) in association with Treg function both in elevated and lowered levels of ROS by using knockout mice, such as glutathione peroxidase-1(-/-) and neutrophil cytosolic factor-1(-/-) mice, as well as by using HBOT or chemicals, such as 2,3-dimethoxy-1,4-naphthoquinone and N-acetylcysteine. The results consistently showed Tregs were hyperfunctional in elevated levels of ROS, whereas hypofunctional in lowered levels of ROS. In addition, imiquimod-induced PD was attenuated in elevated levels of ROS, whereas aggravated in lowered levels of ROS. For the molecular mechanism that may link ROS level and Treg function, we investigated the expression of an immunoregulatory enzyme, indoleamine 2,3-dioxygenase (IDO) which is induced by ROS, in PD lesions. Taken together, it was implied that appropriately elevated levels of ROS might prevent psoriasis through enhancing IDO expression and Treg function.	[Kim, Hyung-Ran; Choi, Eun-Jeong; Seoh, Ju-Young] Ewha Womans Univ, Grad Sch Med, Dept Microbiol, Seoul, South Korea; [Lee, Anbok; Lim, Woosung; Lee, Hyeon Kook; Moon, Byung-In] Ewha Womans Univ, Grad Sch Med, Dept Surg, Seoul, South Korea; [Hong, Min-Pyo] Boston Coll, Coll Arts & Sci, Chestnut Hill, MA 02167 USA; [Kie, Jeong-Hae] Natl Hlth Insurance Cooperat Ilsan Hosp, Koyang, South Korea	Ewha Womans University; Ewha Womans University; Boston College	Seoh, JY (corresponding author), Ewha Womans Univ, Grad Sch Med, Dept Microbiol, Seoul, South Korea.	jyseoh@ewha.ac.kr		SEOH, JU-YOUNG/0000-0002-1168-5354; Kie, Jeong Hae/0000-0003-1782-5650	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI12C0050]; Ewha Womans University	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Ewha Womans University	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI12C0050) and RP-Grant 2011 of Ewha Womans University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2012, SUPPORT CARE CANCER, V20, P2467, DOI 10.1007/s00520-012-1379-x; Banham NDG, 2011, DIVING HYPERB MED, V41, P202; Bovenschen HJ, 2011, J INVEST DERMATOL, V131, P1853, DOI 10.1038/jid.2011.139; Briganti S, 2008, FREE RADICAL BIO MED, V45, P636, DOI 10.1016/j.freeradbiomed.2008.05.006; Buchman AL, 2001, J CLIN GASTROENTEROL, V33, P289, DOI 10.1097/00004836-200110000-00006; Butler Glenn, 2009, J Med Case Rep, V3, P7023, DOI 10.4076/1752-1947-3-7023; Chen AF, 2012, CLIN SCI, V123, P73, DOI 10.1042/CS20110562; Chen SY, 2003, CLIN IMMUNOL, V108, P103, DOI 10.1016/S1521-6616(03)00091-3; de Haan JB, 2006, J LIPID RES, V47, P1157, DOI 10.1194/jlr.M500377-JLR200; De Ravin SS, 2008, J ALLERGY CLIN IMMUN, V122, P1097, DOI 10.1016/j.jaci.2008.07.050; Dennog C, 1996, MUTAGENESIS, V11, P605, DOI 10.1093/mutage/11.6.605; Dennog C, 1999, MUTAT RES-FUND MOL M, V431, P351, DOI 10.1016/S0027-5107(99)00178-5; Efimova O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016013; Esworthy RS, 2001, AM J PHYSIOL-GASTR L, V281, pG848, DOI 10.1152/ajpgi.2001.281.3.G848; Faleo G, 2012, DIABETES, V61, P1769, DOI 10.2337/db11-0516; Fallarino F, 2006, TRANSPL IMMUNOL, V17, P58, DOI 10.1016/j.trim.2006.09.017; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Feldmeier JJ, 2012, UNDERSEA HYPERBAR M, V39, P1121; Furuhashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054895; Guzman JA, 2012, CRIT CARE CLIN, V28, P537, DOI 10.1016/j.ccc.2012.07.007; Hampson NB, 2011, CANCER, V118, P3860; Ho YS, 1997, J BIOL CHEM, V272, P16644, DOI 10.1074/jbc.272.26.16644; Hultqvist M, 2004, P NATL ACAD SCI USA, V101, P12646, DOI 10.1073/pnas.0403831101; Hultqvist M, 2009, TRENDS IMMUNOL, V30, P201, DOI 10.1016/j.it.2009.03.004; Jung YJ, 2009, IMMUNOBIOLOGY, V214, P291, DOI 10.1016/j.imbio.2008.09.004; Kahles T, 2012, CELL MOL LIFE SCI, V69, P2345, DOI 10.1007/s00018-012-1011-8; Kim HR, 2012, RHEUMATOLOGY, V51, P1357, DOI 10.1093/rheumatology/kes058; Korhonen K, 2000, ANN CHIR GYNAECOL, V89, P7; Kudchodkar B, 2008, CLIN IMMUNOL, V128, P435, DOI 10.1016/j.clim.2008.05.004; Kurien BT, 2008, AUTOIMMUN REV, V7, P567, DOI 10.1016/j.autrev.2008.04.019; Lee K, 2011, P NATL ACAD SCI USA, V108, P9548, DOI 10.1073/pnas.1012645108; Lin H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074130; Liu R, 2013, MAYO CLIN PROC, V88, P166, DOI 10.1016/j.mayocp.2012.10.021; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Nagatomo F, 2010, CLIN EXP MED, V10, P7, DOI 10.1007/s10238-009-0064-y; NARKOWICZ CK, 1993, FREE RADICAL RES COM, V19, P71, DOI 10.3109/10715769309056501; Novo E, 2011, J HEPATOL, V54, P964, DOI 10.1016/j.jhep.2010.09.022; Ogasawara N, 2009, J CELL BIOCHEM, V108, P716, DOI 10.1002/jcb.22308; Olivieri AN, 2010, ITAL J PEDIATR, V36, DOI 10.1186/1824-7288-36-72; Olszanski Romuald, 1992, Bulletin of the Institute of Maritime and Tropical Medicine in Gdynia, V43, P79; Ozturk F, 2013, CUTAN OCUL TOXICOL, V32, P72, DOI 10.3109/15569527.2012.705407; Palomares O, 2010, EUR J IMMUNOL, V40, P1232, DOI 10.1002/eji.200940045; Plafki C, 2000, AVIAT SPACE ENVIR MD, V71, P119; Pouplard C, 2013, J EUR ACAD DERMATOL, V27, P36, DOI 10.1111/jdv.12165; Quaglino P, 2011, DERMATOLOGY, V223, P57, DOI 10.1159/000330330; Rachmilewitz D, 1998, GUT, V43, P512, DOI 10.1136/gut.43.4.512; Ralainirina N, 2007, J LEUKOCYTE BIOL, V81, P144, DOI 10.1189/jlb.0606409; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Saito C, 2009, J DERMATOL SCI, V53, P231, DOI 10.1016/j.jdermsci.2008.09.011; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Selman C, 2012, TRENDS ECOL EVOL, V27, P570, DOI 10.1016/j.tree.2012.06.006; Si CL, 2013, FOOD CHEM TOXICOL, V59, P145, DOI 10.1016/j.fct.2013.05.051; Sohal RS, 2012, FREE RADICAL BIO MED, V52, P539, DOI 10.1016/j.freeradbiomed.2011.10.445; Soyland E, 2011, BRIT J DERMATOL, V164, P344, DOI 10.1111/j.1365-2133.2010.10149.x; Sugiyama H, 2005, J IMMUNOL, V174, P164, DOI 10.4049/jimmunol.174.1.164; Takeshima F, 1999, AM J GASTROENTEROL, V94, P3374, DOI 10.1111/j.1572-0241.1999.03374.x; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; Thom SR, 2011, PLAST RECONSTR SURG, V127, p131S, DOI 10.1097/PRS.0b013e3181fbe2bf; Thom SR, 2009, J APPL PHYSIOL, V106, P988, DOI 10.1152/japplphysiol.91004.2008; Thomas SR, 1999, REDOX REP, V4, P199, DOI 10.1179/135100099101534927; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; van Horssen J, 2011, BBA-MOL BASIS DIS, V1812, P141, DOI 10.1016/j.bbadis.2010.06.011; Vann RD, 2011, LANCET, V377, P153, DOI 10.1016/S0140-6736(10)61085-9; Weigle N, 2013, AM FAM PHYSICIAN, V87, P626; Won HY, 2013, J IMMUNOL, V191, P4029, DOI 10.4049/jimmunol.1203247; Won Hee Yeon, 2011, Immune Netw, V11, P169, DOI 10.4110/in.2011.11.3.169; Won HY, 2010, ANTIOXID REDOX SIGN, V13, P575, DOI 10.1089/ars.2009.2989; Yan YP, 2010, J IMMUNOL, V185, P5953, DOI 10.4049/jimmunol.1001628; Yildiz S, 2004, AVIAT SPACE ENVIR MD, V75, P992; Zaba LC, 2009, J INVEST DERMATOL, V129, P79, DOI 10.1038/jid.2008.194; Zhang YQ, 2009, J GERONTOL A-BIOL, V64, P1212, DOI 10.1093/gerona/glp132	72	55	56	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91146	10.1371/journal.pone.0091146	http://dx.doi.org/10.1371/journal.pone.0091146			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608112	gold, Green Published, Green Submitted			2022-12-25	WOS:000332485800104
J	Resch, MC; Shrubovych, J; Bartel, D; Szucsich, NU; Timelthaler, G; Bu, Y; Walzl, M; Pass, G				Resch, Monika Carol; Shrubovych, Julia; Bartel, Daniela; Szucsich, Nikolaus U.; Timelthaler, Gerald; Bu, Yun; Walzl, Manfred; Pass, Guenther			Where Taxonomy Based on Subtle Morphological Differences Is Perfectly Mirrored by Huge Genetic Distances: DNA Barcoding in Protura (Hexapoda)	PLOS ONE			English	Article							RIBOSOMAL-RNA; ACERENTOMATA ACERENTOMIDAE; MOLECULAR SYSTEMATICS; SEQUENCE; IDENTIFICATION; COLLEMBOLA; 18S; 28S; VARIABILITY; ARTHROPODS	Background: Protura is a group of tiny, primarily wingless hexapods living in soil habitats. Presently about 800 valid species are known. Diagnostic characters are very inconspicuous and difficult to recognize. Therefore taxonomic work constitutes an extraordinary challenge which requires special skills and experience. Aim of the present pilot project was to examine if DNA barcoding can be a useful additional approach for delimiting and determining proturan species. Methodology and Principal Findings: The study was performed on 103 proturan specimens, collected primarily in Austria, with additional samples from China and Japan. The animals were examined with two markers, the DNA barcoding region of the mitochondrial COI gene and a fragment of the nuclear 285 rDNA (Divergent Domain 2 and 3). Due to the minuteness of Protura a modified non-destructive DNA-extraction method was used which enables subsequent species determination. Both markers separated the examined proturans into highly congruent well supported clusters. Species determination was performed without knowledge of the results of the molecular analyses. The investigated specimens comprise a total of 16 species belonging to 8 genera. Remarkably, morphological determination in all species exactly mirrors molecular clusters. The investigation revealed unusually huge genetic COI distances among the investigated proturans, both maximal intraspecific distances (0-21.3%), as well as maximal congeneric interspecifical distances (up to 44.7%). Conclusions: The study dearly demonstrates that the tricky morphological taxonomy in Protura has a solid biological background and that accurate species delimitation is possible using both markers, COI and 28S rDNA. The fact that both molecular and morphological analyses can be performed on the same individual will be of great importance for the description of new species and offers a valuable new tool for biological and ecological studies, in which proturans have generally remained undetermined at species level.	[Resch, Monika Carol; Bartel, Daniela; Szucsich, Nikolaus U.; Timelthaler, Gerald; Walzl, Manfred; Pass, Guenther] Univ Vienna, Dept Integrat Zool, Vienna, Austria; [Shrubovych, Julia] Polish Acad Sci, Inst Systemat & Evolut Anim, Krakow, Poland; [Bu, Yun] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China	University of Vienna; Polish Academy of Sciences; Institute of Systematics & Evolution of Animals of the Polish Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Szucsich, NU (corresponding author), Univ Vienna, Dept Integrat Zool, Vienna, Austria.	nikola.szucsich@univie.ac.at	Szucsich, Nikolaus/O-1776-2017; Shrubovych, Julia/F-9767-2014	Szucsich, Nikolaus/0000-0002-8945-5153; Shrubovych, Julia/0000-0002-8880-0007; Timelthaler, Gerald/0000-0002-0260-089X	FWF [P 23251-B17, P 20497-B17]; Austrian Science Fund (FWF) [P 23251] Funding Source: researchfish	FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	DB and GP are supported by grant number P 23251-B17 of the FWF, and MCR by grant number P 20497-B17 of the FWF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Y, 2013, ZOOKEYS, P29, DOI 10.3897/zookeys.338.6099; Balkenhol B, 1996, PEDOBIOLOGIA, V40, P212; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Ben Ali A, 1999, NUCLEIC ACIDS RES, V27, P2825; Blaxter M, 2003, NATURE, V421, P122, DOI 10.1038/421122a; Boehm Alexander, 2011, Soil Organisms, V83, P335; Bu Y, 2012, FLA ENTOMOL, V95, P839, DOI 10.1653/024.095.0404; [卜云 Bu Yun], 2012, [生命科学, Chinese Bulletin of Life Sciences], V24, P130; Busse HJ, 1996, J BIOTECHNOL, V47, P3, DOI 10.1016/0168-1656(96)01379-X; Carapelli A, 2000, PEDOBIOLOGIA, V44, P361, DOI 10.1078/S0031-4056(04)70055-4; Chen WJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-246; Christian E, 2004, PEDOBIOLOGIA, V48, P445, DOI 10.1016/j.pedobi.2004.05.009; Chu KH, 2006, BIOINFORMATICS, V22, P1690, DOI 10.1093/bioinformatics/btl146; Coulson SJ, 2002, FUNCT ECOL, V16, P353, DOI 10.1046/j.1365-2435.2002.00636.x; Dell'Ampio Emiliano, 2011, Soil Organisms, V83, P347; Dell'Ampio E, 2009, ZOOL SCR, V38, P155, DOI 10.1111/j.1463-6409.2008.00368.x; Dunger W, 2002, PEDOBIOLOGIA, V46, P316, DOI 10.1078/0031-4056-00139; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gao Y, 2008, ZOOL SCI, V25, P1139, DOI 10.2108/zsj.25.1139; Grimaldi DA, 2010, ARTHROPOD STRUCT DEV, V39, P191, DOI 10.1016/j.asd.2009.10.008; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Imadate G, 1974, PROTURA INSECTA FAUN; Ionesco MA, 1932, PUBLICATIUNILE SOC N, V11, P167; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jinbo U, 2011, ENTOMOL SCI, V14, P107, DOI 10.1111/j.1479-8298.2011.00449.x; Kaneko Nobuhiro, 2012, Diversity-Basel, V4, P318; Kasapidis P, 2005, MOL PHYLOGENET EVOL, V35, P612, DOI 10.1016/j.ympev.2005.02.005; Kjer KM, 2004, SYST BIOL, V53, P506, DOI 10.1080/10635150490445922; Luan YX, 2005, MOL BIOL EVOL, V22, P1579, DOI 10.1093/molbev/msi148; Mallatt J, 2006, MOL PHYLOGENET EVOL, V40, P772, DOI 10.1016/j.ympev.2006.04.021; Marx MT, 2009, PESQUI AGROPECU BRAS, V44, P1002, DOI 10.1590/S0100-204X2009000800032; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Misof B, 2009, SYST BIOL, V58, P21, DOI 10.1093/sysbio/syp006; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Nosek J, 1973, EUROPEAN PROTURA THE; Pass Guenther, 2011, Soil Organisms, V83, P309; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Rimskij-Korsakov M., 1912, Revue Russe d'Entomologie, V11; Roe AD, 2007, MOL PHYLOGENET EVOL, V44, P325, DOI 10.1016/j.ympev.2006.12.005; Rubinoff D, 2005, SYST BIOL, V54, P952, DOI 10.1080/10635150500234674; RUSEK J, 1989, REV ECOL BIOL SOL, V26, P527; Shao HG, 1999, CHINESE SCI BULL, V44, P2031, DOI 10.1007/BF02884915; Shrubovych J, 2012, ANN SOC ENTOMOL FR, V48, P1; Southwood TRE, 2000, ECOLOGICAL METHODS P; Sterzynska M, 2012, ANN ZOOL FENN, V49, P309, DOI 10.5735/086.049.0504; Sturm H, 2001, HDB ZOOLOGY 37, VIV; Szeptycki A, 2000, FOLIA BIOL-KRAKOW, V48, P65; SZEPTYCKI A, 1988, Acta Zoologica Cracoviensia, V31, P297; Szeptycki A., 2000, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V102B, P83; SZEPTYCKI A, 1991, Acta Zoologica Cracoviensia, V34, P1; Szeptycki Andrzej, 2007, Acta Zoologica Cracoviensia Ser B-Invertebrata, V50B; Szeptycki Andrzej, 1997, Fragmenta Faunistica (Warsaw), V40, P307; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TICHY H, 1988, J EXP ZOOL, V245, P130, DOI 10.1002/jez.1402450203; Tuxen S. L., 1931, Zeitschrift fuer Morphologie und Oekologie der Tiere Berlin, V22, P671, DOI 10.1007/BF00446572; Tuxen SL, 1964, PROTURA REVISION SPE; Vences M, 2005, PHILOS T R SOC B, V360, P1859, DOI 10.1098/rstb.2005.1717; Vences Miguel, 2005, Front Zool, V2, P5, DOI 10.1186/1742-9994-2-5; Villani MG, 1999, ANNU REV ENTOMOL, V44, P233, DOI 10.1146/annurev.ento.44.1.233; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Wiens JJ, 2002, SYST BIOL, V51, P69, DOI 10.1080/106351502753475880; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yin W, 1996, P 20 INT C ENT 25 31, P60; Yin W-Y, 1999, ARTHROPODA PROTURA F	70	22	25	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90653	10.1371/journal.pone.0090653	http://dx.doi.org/10.1371/journal.pone.0090653			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609003	Green Published, gold, Green Submitted			2022-12-25	WOS:000332485800041
J	Xing, DJ; Zhang, HX; Huang, N; Wu, KC; Huang, XF; Huang, F; Tong, Y; Pang, CP; Qu, J; Jin, ZB				Xing, Dong-Jun; Zhang, Hong-Xing; Huang, Na; Wu, Kun-Chao; Huang, Xiu-Feng; Huang, Fang; Tong, Yi; Pang, Chi-Pui; Qu, Jia; Jin, Zi-Bing			Comprehensive Molecular Diagnosis of Bardet-Biedl Syndrome by High-Throughput Targeted Exome Sequencing	PLOS ONE			English	Article							MUTATION	Bardet-Biedl syndrome (BBS) is an autosomal recessive disorder with significant genetic heterogeneity. BBS is linked to mutations in 17 genes, which contain more than 200 coding exons. Currently, BBS is diagnosed by direct DNA sequencing for mutations in these genes, which because of the large genomic screening region is both time-consuming and expensive. In order to develop a practical method for the clinic diagnosis of BBS, we have developed a high-throughput targeted exome sequencing (TES) for genetic diagnosis. Five typical BBS patients were recruited and screened for mutations in a total of 144 known genes responsible for inherited retinal diseases, a hallmark symptom of BBS. The genomic DNA of these patients and their families were subjected to high-throughput DNA re-sequencing. Deep bioinformatics analysis was carried out to filter the massive sequencing data, which were further confirmed through co-segregation analysis. TES successfully revealed mutations in BBS genes in each patient and family member. Six pathological mutations, including five novel mutations, were revealed in the genes BBS2, MKKS, ARL6, MKS1. This study represents the first report of targeted exome sequencing in BBS patients and demonstrates that high-throughput TES is an accurate and rapid method for the genetic diagnosis of BBS.	[Xing, Dong-Jun; Huang, Na; Wu, Kun-Chao; Huang, Xiu-Feng; Huang, Fang; Jin, Zi-Bing] Wenzhou Med Univ, Hosp Eye, Lab Stem Cell & Retinal Regenerat, Div Ophthalm Genet, Wenzhou, Peoples R China; [Xing, Dong-Jun; Huang, Na; Wu, Kun-Chao; Huang, Xiu-Feng; Huang, Fang; Qu, Jia; Jin, Zi-Bing] Minist Hlth PR China, State Key Lab Cultivat Base, Wenzhou, Peoples R China; [Xing, Dong-Jun; Huang, Na; Wu, Kun-Chao; Huang, Xiu-Feng; Huang, Fang; Qu, Jia; Jin, Zi-Bing] Minist Hlth PR China, Key Lab Vis Sci, Wenzhou, Peoples R China; [Zhang, Hong-Xing] Second Peoples Hosp, Jinan Eye Hosp, Jinan, Peoples R China; [Tong, Yi] Fuzhou Southeastern Eye Hosp, Fuzhou, Peoples R China; [Pang, Chi-Pui] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China	Wenzhou Medical University; Chinese University of Hong Kong	Qu, J (corresponding author), Minist Hlth PR China, State Key Lab Cultivat Base, Wenzhou, Peoples R China.	jqu@mail.eye.ac.cn; jinzb@mail.eye.ac.cn	Pang, Chi P/I-5388-2014; Jin, Zi-Bing/J-6810-2014; Jin, Zi-Bing/AAE-4106-2019	Jin, Zi-Bing/0000-0003-0515-698X; Jin, Zi-Bing/0000-0003-0515-698X; Huang, Xiu-Feng/0000-0002-7852-6358	National Key Basic Research Program [2013CB967502, 2011CB504600]; National Natural Science Foundation of China [81371059]; MOST Projects [2012YQ12008004]; Qianjiang Scholarship; Qianjiang Talents Project [2012R10072]; Zhejiang Provincial Natural Science Foundation of China [LR13H120001]	National Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MOST Projects; Qianjiang Scholarship; Qianjiang Talents Project; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Key Basic Research Program (2013CB967502 to ZBJ, 2011CB504600 to JQ), National Natural Science Foundation of China (81371059 to ZBJ), MOST Projects (2012YQ12008004 to ZBJ), and partly funded by a Qianjiang Scholarship (to ZBJ) and Qianjiang Talents Project (2012R10072 to ZBJ), Zhejiang Provincial Natural Science Foundation of China under Grant No. LR13H120001 (to ZBJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Safieh L, 2012, EUR J HUM GENET, V20, P420, DOI 10.1038/ejhg.2011.205; Badano JL, 2003, HUM MOL GENET, V12, P1651, DOI 10.1093/hmg/ddg188; Beales PL, 1999, J MED GENET, V36, P437; Chen XJ, 2013, INVEST OPHTH VIS SCI, V54, P2186, DOI 10.1167/iovs.12-10967; Chou J, 2012, CURR OPIN ALLERGY CL, V12, P623, DOI 10.1097/ACI.0b013e3283588ca6; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Forsythe E, 2013, EUR J HUM GENET, V21, P8, DOI 10.1038/ejhg.2012.115; GREEN JS, 1989, NEW ENGL J MED, V321, P1002, DOI 10.1056/NEJM198910123211503; He J, 2011, ONCOTARGET, V2, P178; Hou HB, 2010, NUCLEIC ACIDS RES, V38, pW732, DOI 10.1093/nar/gkq302; Huang XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063832; Janssen S, 2011, HUM GENET, V129, P79, DOI 10.1007/s00439-010-0902-8; Jin ZB, 2008, J MED GENET, V45, P465, DOI 10.1136/jmg.2007.056416; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Kuehn BM, 2008, JAMA-J AM MED ASSOC, V300, P2715, DOI 10.1001/jama.2008.823; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40; M'hamdi O, 2011, J COMMUN GENET, V2, P97, DOI 10.1007/s12687-011-0040-6; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Redin C, 2012, J MED GENET, V49, P502, DOI 10.1136/jmedgenet-2012-100875; Sheffield VC, 2011, NEW ENGL J MED, V364, P1932, DOI 10.1056/NEJMra1012354; Summerer D, 2010, GENOMICS, V95, P241, DOI 10.1016/j.ygeno.2010.01.006; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543; Yang ZL, 2008, MOL VIS, V14, P2304	27	23	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90599	10.1371/journal.pone.0090599	http://dx.doi.org/10.1371/journal.pone.0090599			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608809	Green Submitted, Green Published, gold			2022-12-25	WOS:000332485800037
J	Komar-Stossel, C; Gross, E; Dery, E; Corchia, N; Meir, K; Fried, I; Abramovitch, R				Komar-Stossel, Chani; Gross, Eitan; Dery, Elia; Corchia, Nathalie; Meir, Karen; Fried, Iris; Abramovitch, Rinat			TL-118 and Gemcitabine Drug Combination Display Therapeutic Efficacy in a MYCN Amplified Orthotopic Neuroblastoma Murine Model - Evaluation by MRI	PLOS ONE			English	Article							RETINOIC ACID; INHIBITS ANGIOGENESIS; TUMOR ANGIOGENESIS; GROWTH; CHEMOTHERAPY; MIGRATION; EXPRESSION; RECEPTORS; HYPEROXIA; CHILDREN	Neuroblastoma (NB) is the most common extra-cranial pediatric solid tumor with up to 50% of NB patients classified as having high-risk disease with poor long-term survival rates. The poor clinical outcome and aggressiveness of high-risk NB strongly correlates with enhanced angiogenesis, suggesting anti-angiogenic agents as attractive additions to the currently insufficient therapeutics. TL-118, a novel drug combination has been recently developed to inhibit tumor angiogenesis. In the current study, we used the SK-N-BE (2) cell line to generate orthotopic NB tumors in order to study the combinational therapeutic potential of TL-118 with either Gemcitabine (40 mg/kg; IP) or Retinoic acid (40 mg/kg; IP). We show that TL-118 treatment (n = 9) significantly inhibited tumor growth, increased cell apoptosis, reduced proliferation and extended mouse survival. Moreover, the reciprocal effect of TL-118 and Gemcitabine treatment (n = 10) demonstrated improved anti-tumor activity. The synergistic effect of these drugs in combination was more effective than either TL or Gemcitabine alone (n = 9), via significantly reduced cell proliferation (p<0.005), increased apoptosis (p<0.05) and significantly prolonged survival (2-fold; p<0.00001). To conclude, we demonstrate that the novel drug combination TL-118 has the ability to suppress the growth of an aggressive NB tumor. The promising results with TL-118 in this aggressive animal model may imply that this drug combination has therapeutic potential in the clinical setting.	[Komar-Stossel, Chani; Dery, Elia; Corchia, Nathalie; Abramovitch, Rinat] Hadassah Hebrew Univ Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel; [Komar-Stossel, Chani; Dery, Elia; Corchia, Nathalie; Abramovitch, Rinat] Hadassah Hebrew Univ Med Ctr, MRI MRS Lab HBRC, Jerusalem, Israel; [Gross, Eitan; Meir, Karen; Fried, Iris] Hadassah Hebrew Univ Med Ctr, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Abramovitch, R (corresponding author), Hadassah Hebrew Univ Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel.	rinat@hadassah.org.il			Israeli Cancer Association [20130099]; Manferd and Sabine Landau (London)	Israeli Cancer Association; Manferd and Sabine Landau (London)	This research was supported by a grant from the Israeli Cancer Association (20130099) and a financial support from Manferd and Sabine Landau (London). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alique M, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-1; Barash H, 2007, RADIOLOGY, V243, P727, DOI 10.1148/radiol.2433060433; Barasli H, 2008, HEPATOLOGY, V48, P1232, DOI 10.1002/hep.22394; Ben-Sasson SA, 2008, US Patent, Patent No. [7 838 513, 7838513]; Browder T, 2000, CANCER RES, V60, P1878; Canete A, 2000, J CLIN ONCOL, V18, P27, DOI 10.1200/JCO.2000.18.1.27; Choudhury SR, 2012, J ONCOL, V2012, DOI 10.1155/2012/782020; Chung CH, 2009, BRIT J PHARMACOL, V156, P846, DOI 10.1111/j.1476-5381.2008.00095.x; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Edrei Y, 2012, BRIT J CANCER, V107, P658, DOI 10.1038/bjc.2012.322; Edrei Y, 2011, NEOPLASIA, V13, P244, DOI 10.1593/neo.101354; Eggert A, 2000, CLIN CANCER RES, V6, P1900; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Geoerger B, 2011, EUR J CANCER, V47, P230, DOI 10.1016/j.ejca.2010.09.015; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Hoffmann S, 2007, MOL CELL ENDOCRINOL, V264, P74, DOI 10.1016/j.mce.2006.10.009; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kubecova M, 2011, EUR J PHARM SCI, V42, P439, DOI 10.1016/j.ejps.2011.02.004; Laquente B, 2008, MOL CANCER THER, V7, P638, DOI 10.1158/1535-7163.MCT-07-2122; Li B, 2009, MOL CANCER THER, V8, P2635, DOI 10.1158/1535-7163.MCT-09-0162; Lingen MW, 1998, CANCER RES, V58, P5551; Ma J, 2008, MOL CANCER THER, V7, P3670, DOI 10.1158/1535-7163.MCT-08-0715; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Masia S, 2007, MOL ENDOCRINOL, V21, P2391, DOI 10.1210/me.2007-0062; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; Mayorek N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012715; Megison ML, 2013, CLIN EXP METASTAS, V30, P555, DOI 10.1007/s10585-012-9560-7; Meitar D, 1996, J CLIN ONCOL, V14, P405, DOI 10.1200/JCO.1996.14.2.405; Messi E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-30; Mora J, 2009, J PEDIAT HEMATOL ONC, V31, P723, DOI 10.1097/MPH.0b013e3181b2598c; Natori T, 2005, BIOMED PHARMACOTHER, V59, P56, DOI 10.1016/j.biopha.2004.05.018; Nevo I, 2008, NEOPLASIA, V10, P817, DOI 10.1593/neo.08402; O'Connor JPB, 2008, LANCET ONCOL, V9, P766, DOI 10.1016/S1470-2045(08)70196-7; Ogawa M, 2005, CLIN CANCER RES, V11, P3485, DOI 10.1158/1078-0432.CCR-04-1781; Park JR, 2010, HEMATOL ONCOL CLIN N, V24, P65, DOI 10.1016/j.hoc.2009.11.011; Pasquier E, 2010, NAT REV CLIN ONCOL, V7, P455, DOI 10.1038/nrclinonc.2010.82; Pili R, 2001, CANCER RES, V61, P1477; Rapkin L, 2012, PEDIATR BLOOD CANCER, V59, P854, DOI 10.1002/pbc.24101; Ribatti D, 2002, INT J CANCER, V102, P351, DOI 10.1002/ijc.10742; Ribattia Domenico, 2005, Cancer Treatment Reviews, V31, P27, DOI 10.1016/j.ctrv.2004.09.006; Rossler J, 2011, INT J CANCER, V128, P2748, DOI 10.1002/ijc.25611; SORBO J, 1994, INT J EXP PATHOL, V75, P43; Warner TD, 2004, FASEB J, V18, P790, DOI 10.1096/fj.03-0645rev; Weber CK, 2000, GASTROENTEROLOGY, V119, P1209, DOI 10.1053/gast.2000.19458; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Weninger W, 1998, J INVEST DERMATOL, V111, P907, DOI 10.1046/j.1523-1747.1998.00393.x; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123; Zage PE, 2010, CANCER-AM CANCER SOC, V116, P2465, DOI 10.1002/cncr.25017	49	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90224	10.1371/journal.pone.0090224	http://dx.doi.org/10.1371/journal.pone.0090224			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603724	gold, Green Published			2022-12-25	WOS:000332483600032
J	Fye, JM; Coffin, SR; Orebaugh, CD; Hollis, T; Perrino, FW				Fye, Jason M.; Coffin, Stephanie R.; Orebaugh, Clinton D.; Hollis, Thomas; Perrino, Fred W.			The Arg-62 Residues of the TREX1 Exonuclease Act Across the Dimer Interface Contributing to Catalysis in the Opposing Protomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autoimmune Diseases; DNA; DNase; Enzyme Mechanisms; Nucleic Acid; TREX1; Dimer; Exonuclease	AICARDI-GOUTIERES-SYNDROME; FAMILIAL CHILBLAIN LUPUS; DOMINANT MUTATIONS; GENE; TERMINI; IDENTIFICATION; ERYTHEMATOSUS; ENCEPHALITIS; EXPRESSION; REVEALS	Background: The structure of TREX1 exonuclease identifies key residues positioned at the stable dimer interface. Results: The TREX1 Arg-62 acts across the dimer interface to affect DNA binding and catalysis in the opposing protomer. Conclusion: TREX1 is a functional dimer. Significance: These data help us understand how heterozygous TREX1 mutations can contribute to disease. TREX1 is a 3-deoxyribonuclease that degrades single- and double-stranded DNA (ssDNA and dsDNA) to prevent inappropriate nucleic acid-mediated immune activation. More than 40 different disease-causing TREX1 mutations have been identified exhibiting dominant and recessive genetic phenotypes in a spectrum of autoimmune disorders. Mutations in TREX1 at positions Asp-18 and Asp-200 to His and Asn exhibit dominant autoimmune phenotypes associated with the clinical disorders familial chilblain lupus and Aicardi-Goutieres syndrome. Our previous biochemical studies showed that the TREX1 dominant autoimmune disease phenotype depends upon an intact DNA-binding process coupled with dysfunctional active site chemistry. Studies here show that the TREX1 Arg-62 residues extend across the dimer interface into the active site of the opposing protomer to coordinate substrate DNA and to affect catalysis in the opposing protomer. The TREX1(R62A/R62A) homodimer exhibits approximate to 50-fold reduced ssDNA and dsDNA degradation activities relative to TREX1(WT). The TREX1 D18H, D18N, D200H, and D200N dominant mutant enzymes were prepared as compound heterodimers with the TREX1 R62A substitution in the opposing protomer. The TREX1(D18H/R62A), TREX1(D18N/R62A), TREX1(D200H/R62A), and TREX1(D200N/R62A) compound heterodimers exhibit higher levels of ss- and dsDNA degradation activities than the homodimers demonstrating the requirement for TREX1 Arg-62 residues to provide necessary structural elements for full catalytic activity in the opposing TREX1 protomer. This concept is further supported by the loss of dominant negative effects in the TREX1 D18H, D18N, D200H, and D200N compound heterodimers. These data provide compelling evidence for the required TREX1 dimeric structure for full catalytic function.	[Fye, Jason M.; Coffin, Stephanie R.; Orebaugh, Clinton D.; Hollis, Thomas; Perrino, Fred W.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA	Wake Forest University	Perrino, FW (corresponding author), Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA.	fperrino@wakehealth.edu			National Institutes of Health [GM069962]; Alliance for Lupus Research [257437]; American Heart Association [10GRNT3650033]; Wake Forest School of Medicine Postdoctoral Fellowship Award [F32GM095290]; NATIONAL CANCER INSTITUTE [P30CA012197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM095290, R01GM069962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; American Heart Association(American Heart Association); Wake Forest School of Medicine Postdoctoral Fellowship Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM069962 (to F. W. P.), Alliance for Lupus Research Grant 257437 (to F. W. P.), American Heart Association Grant 10GRNT3650033 (to T. H.), and by Wake Forest School of Medicine Postdoctoral Fellowship Award F32GM095290 (to S. R. C.).	Bailey SL, 2012, DNA REPAIR, V11, P65, DOI 10.1016/j.dnarep.2011.10.007; BLACK DN, 1988, ANN NEUROL, V24, P483, DOI 10.1002/ana.410240402; Bujalowski W, 2006, CHEM REV, V106, P556, DOI 10.1021/cr040462l; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; Crow YJ, 2003, J MED GENET, V40, P183, DOI 10.1136/jmg.40.3.183; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; de Vries B, 2010, ANN RHEUM DIS, V69, P1886, DOI 10.1136/ard.2009.114157; Fye JM, 2011, J BIOL CHEM, V286, P32373, DOI 10.1074/jbc.M111.276287; Gruver AM, 2011, J NEURO-OPHTHALMOL, V31, P20, DOI 10.1097/WNO.0b013e3181f45dba; Gunther C, 2009, DERMATOLOGY, V219, P162, DOI 10.1159/000222430; Harrigan JA, 2007, MECH AGEING DEV, V128, P259, DOI 10.1016/j.mad.2006.12.005; Hedrich CM, 2008, CLIN RHEUMATOL, V27, P949, DOI 10.1007/s10067-008-0942-9; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; Jezewska MJ, 1996, BIOCHEMISTRY-US, V35, P2117, DOI 10.1021/bi952344l; Jezewska MJ, 2003, BIOCHEMISTRY-US, V42, P5955, DOI 10.1021/bi030046f; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lee-Kirsch MA, 2007, J MOL MED-JMM, V85, P531, DOI 10.1007/s00109-007-0199-9; Lee-Kirsch MA, 2006, AM J HUM GENET, V79, P731, DOI 10.1086/507848; Lehtinen DA, 2008, J BIOL CHEM, V283, P31649, DOI 10.1074/jbc.M806155200; LINDAHL T, 1969, J BIOL CHEM, V244, P5014; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mazur DJ, 2001, J BIOL CHEM, V276, P14718, DOI 10.1074/jbc.M010051200; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; Namjou B, 2011, GENES IMMUN, V12, P270, DOI 10.1038/gene.2010.73; Orebaugh CD, 2013, J BIOL CHEM, V288, P28881, DOI 10.1074/jbc.M113.503391; Orebaugh CD, 2011, J BIOL CHEM, V286, P40246, DOI 10.1074/jbc.M111.297903; Perrino FW, 2008, J BIOL CHEM, V283, P21441, DOI 10.1074/jbc.M803629200; Perrino Fred W., 1999, Cell Biochemistry and Biophysics, V30, P331, DOI 10.1007/BF02738118; PERRINO FW, 1994, J BIOL CHEM, V269, P16357; Perrino FW, 2005, J BIOL CHEM, V280, P15212, DOI 10.1074/jbc.M500108200; Prendiville JS, 2009, J AM ACAD DERMATOL, V61, P727, DOI 10.1016/j.jaad.2009.05.002; Ramantani G, 2010, ARTHRITIS RHEUM-US, V62, P1469, DOI 10.1002/art.27367; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Richards A, 2007, NAT GENET, V39, P1068, DOI 10.1038/ng2082; Stam AH, 2009, CEPHALALGIA, V29, P1006, DOI 10.1111/j.1468-2982.2009.01940.x; Stephenson JBP, 2008, EUR J PAEDIATR NEURO, V12, P355, DOI 10.1016/j.ejpn.2007.11.010; Tungler V, 2012, BRIT J DERMATOL, V167, P212, DOI 10.1111/j.1365-2133.2012.10813.x	39	10	10	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11556	11565		10.1074/jbc.M114.559252	http://dx.doi.org/10.1074/jbc.M114.559252			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24616097	Green Published, hybrid			2022-12-25	WOS:000334638500055
J	Baho, DL; Drakare, S; Johnson, RK; Allen, CR; Angeler, DG				Baho, Didier L.; Drakare, Stina; Johnson, Richard K.; Allen, Craig R.; Angeler, David G.			Similar Resilience Attributes in Lakes with Different Management Practices	PLOS ONE			English	Article							ACIDIFIED LAKES; BOREAL LAKES; FOOD-WEB; ZOOPLANKTON COMMUNITIES; RELATIVE RESILIENCE; FUNCTIONAL-GROUPS; REGIME SHIFTS; RECOVERY; ACIDIFICATION; DIVERSITY	Liming has been used extensively in Scandinavia and elsewhere since the 1970s to counteract the negative effects of acidification. Communities in limed lakes usually return to acidified conditions once liming is discontinued, suggesting that liming is unlikely to shift acidified lakes to a state equivalent to pre-acidification conditions that requires no further management intervention. While this suggests a low resilience of limed lakes, attributes that confer resilience have not been assessed, limiting our understanding of the efficiency of costly management programs. In this study, we assessed community metrics (diversity, richness, evenness, biovolume), multivariate community structure and the relative resilience of phytoplankton in limed, acidified and circum-neutral lakes from 1997 to 2009, using multivariate time series modeling. We identified dominant temporal frequencies in the data, allowing us to track community change at distinct temporal scales. We assessed two attributes of relative resilience (cross-scale and within-scale structure) of the phytoplankton communities, based on the fluctuation frequency patterns identified. We also assessed species with stochastic temporal dynamics. Liming increased phytoplankton diversity and richness; however, multivariate community structure differed in limed relative to acidified and circum-neutral lakes. Cross-scale and within-scale attributes of resilience were similar across all lakes studied but the contribution of those species exhibiting stochastic dynamics was higher in the acidified and limed compared to circum-neutral lakes. From a resilience perspective, our results suggest that limed lakes comprise a particular condition of an acidified lake state. This explains why liming does not move acidified lakes out of a "degraded'' basin of attraction. In addition, our study demonstrates the potential of time series modeling to assess the efficiency of restoration and management outcomes through quantification of the attributes contributing to resilience in ecosystems.	[Baho, Didier L.; Drakare, Stina; Johnson, Richard K.; Angeler, David G.] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden; [Allen, Craig R.] Univ Nebraska, Sch Nat Resources, Nebraska Cooperat Fish & Wildlife Res Unit, US Geol Survey, Lincoln, NE USA	Swedish University of Agricultural Sciences; United States Department of the Interior; United States Geological Survey; University of Nebraska System; University of Nebraska Lincoln	Baho, DL (corresponding author), Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden.	didier.baho@slu.se	Johnson, Richard K./P-4991-2014; Drakare, Stina/ABF-1259-2020; Drakare, Stina/D-4532-2016	Johnson, Richard K./0000-0001-7979-6563; Drakare, Stina/0000-0002-7389-2105; Drakare, Stina/0000-0002-7389-2105	August T. Larsson Foundation (NL Faculty, Swedish University of Agricultural Sciences); U.S. Geological Survey; Nebraska Game and Parks Commission; University of Nebraska-Lincoln; United States Fish and Wildlife Service; Wildlife Management Institute	August T. Larsson Foundation (NL Faculty, Swedish University of Agricultural Sciences); U.S. Geological Survey(United States Geological Survey); Nebraska Game and Parks Commission; University of Nebraska-Lincoln; United States Fish and Wildlife Service(US Fish & Wildlife Service); Wildlife Management Institute	Financial support was provided by the August T. Larsson Foundation (NL Faculty, Swedish University of Agricultural Sciences). The Nebraska Cooperative Fish and Wildlife Research Unit are jointly supported by a cooperative agreement between the U.S. Geological Survey, the Nebraska Game and Parks Commission, the University of Nebraska-Lincoln, the United States Fish and Wildlife Service, and the Wildlife Management Institute. Reference to trade names does not imply endorsement by the authors or the U.S. government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CR, 2006, ECOL LETT, V9, P630, DOI 10.1111/j.1461-0248.2006.00902.x; Allen CR, 2005, ECOSYSTEMS, V8, P958, DOI 10.1007/s10021-005-0147-x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Angeler DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077338; Angeler DG, 2013, J APPL ECOL, V50, P572, DOI 10.1111/1365-2664.12092; Angeler DG, 2012, ECOL SOC, V17, DOI 10.5751/ES-04928-170232; Angeler DG, 2012, ECOL APPL, V22, P1172, DOI 10.1890/11-1474.1; Angeler DG, 2010, J APPL ECOL, V47, P478, DOI 10.1111/j.1365-2664.2010.01794.x; Angeler DG, 2009, ECOLOGY, V90, P3245, DOI 10.1890/07-0391.1; [Anonymous], 2001, PANARCHY UNDERSTANDI; Appelberg M, 2001, WATER AIR SOIL POLL, V130, P1745, DOI 10.1023/A:1013908003052; Beisner BE, 2003, FRONT ECOL ENVIRON, V1, P376, DOI 10.1890/1540-9295(2003)001[0376:ASSIE]2.0.CO;2; Bertills U, 2007, NATURAL ACIDIFICATIO; Binks JA, 2005, ECOL APPL, V15, P2025, DOI 10.1890/04-1726; Bishop K, 2001, WATER AIR SOIL POLL, V130, P1415, DOI 10.1023/A:1013936224549; Blanchet FG, 2008, ECOL MODEL, V215, P325, DOI 10.1016/j.ecolmodel.2008.04.001; Blanchet FG, 2011, OECOLOGIA, V166, P357, DOI 10.1007/s00442-010-1867-y; Blomqvist P, 1998, 4861 SWED ENV PROT 2; Bostedt G, 2010, AMBIO, V39, P40, DOI 10.1007/s13280-009-0004-9; Bradley DC, 2002, FRESHWATER BIOL, V47, P161, DOI 10.1046/j.1365-2427.2002.00770.x; Carpenter S, 2001, ECOSYSTEMS, V4, P765, DOI 10.1007/s10021-001-0045-9; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Carpenter SR, 1999, ECOL APPL, V9, P751, DOI 10.1890/1051-0761(1999)009[0751:MOEFLS]2.0.CO;2; CARPENTER SR, 1992, AM NAT, V140, P781, DOI 10.1086/285440; Clair Thomas A., 2005, Environmental Reviews, V13, P91, DOI 10.1139/a05-009; COOKE G. D., 1993, RESTORATION MANAGEME; ERIKSSON F, 1983, HYDROBIOLOGIA, V101, P145, DOI 10.1007/BF00008667; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Gray DK, 2011, ECOL APPL, V21, P2652, DOI 10.1890/10-2067.1; Gray DK, 2011, ECOL APPL, V21, P1241, DOI 10.1890/10-0364.1; Gunn J, 2001, WATER AIR SOIL POLL, V130, P1439, DOI 10.1023/A:1013908913162; Hagley CA, 1996, RESTOR ECOL, V4, P307, DOI 10.1111/j.1526-100X.1996.tb00182.x; Henrikson Lennart, 1995, P1; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Holling CS, 1996, CONSERV BIOL, V10, P328, DOI 10.1046/j.1523-1739.1996.10020328.x; Huynh H, 1976, J EDUC STATIST, V1, P69, DOI DOI 10.3102/10769986001001069; JACKS G, 1994, AMBIO, V23, P358; Jarvinen M, 1995, WATER AIR SOIL POLL, V85, P943, DOI 10.1007/BF00476951; Jeppesen E, 2007, HYDROBIOLOGIA, V581, P269, DOI 10.1007/s10750-006-0507-3; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Keller W, 1998, RESTOR ECOL, V6, P364, DOI 10.1046/j.1526-100X.1998.06407.x; KopuYek J., 2002, WATER AIR SOIL POLL, V2, P91, DOI DOI 10.1023/A:1020190205652; Kreyling J, 2011, ECOL LETT, V14, P758, DOI 10.1111/j.1461-0248.2011.01637.x; KULLBERG A, 1987, FRESHWATER BIOL, V17, P553, DOI 10.1111/j.1365-2427.1987.tb01076.x; Layer K, 2010, GLOBAL CHANGE BIOL, V16, P3133, DOI 10.1111/j.1365-2486.2010.02195.x; Ledger ME, 2005, ENVIRON POLLUT, V137, P103, DOI 10.1016/j.envpol.2004.12.024; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; LEWIS WM, 1982, LIMNOL OCEANOGR, V27, P167, DOI 10.4319/lo.1982.27.1.0167; MARMOREK DR, 1993, WATER AIR SOIL POLL, V69, P223, DOI 10.1007/BF00478160; McKie BG, 2006, J APPL ECOL, V43, P780, DOI 10.1111/j.1365-2664.2006.01196.x; Mori AS, 2013, BIOL REV, V88, P349, DOI 10.1111/brv.12004; Newbery DM, 2009, PLANT ECOL, V201, P147, DOI 10.1007/s11258-008-9533-8; Nystrom M, 2001, ECOSYSTEMS, V4, P406, DOI 10.1007/s10021-001-0019-y; Olrik K.P., 1989, METHODS QUANTITATI 1; Ormerod SJ, 2009, J APPL ECOL, V46, P164, DOI 10.1111/j.1365-2664.2008.01587.x; Peterson G, 1998, ECOSYSTEMS, V1, P6, DOI 10.1007/s100219900002; R Development Core Team, 2012, R LANG ENV STAT COMP; RAITANIEMI J, 1990, Aqua Fennica, V20, P115; ROSSELAND BO, 1992, ENVIRON POLLUT, V78, P3, DOI 10.1016/0269-7491(92)90003-S; Sandoy S, 1995, WATER AIR SOIL POLL, V85, P997, DOI 10.1007/BF00476960; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Schindler DW, 1997, RESTOR ECOL, V5, P1, DOI 10.1046/j.1526-100X.1997.09701.x; Scott KA, 2010, J LIMNOL, V69, P33, DOI 10.4081/jlimnol.2010.s1.33; Soltero R, 1992, WATERSHED MANAGEMENT, P458; Stendera S, 2008, J N AM BENTHOL SOC, V27, P529, DOI 10.1899/07-125.1; Sundstrom SM, 2012, CONSERV BIOL, V26, P305, DOI 10.1111/j.1523-1739.2011.01822.x; Tuomisto H, 2012, OIKOS, V121, P1203, DOI 10.1111/j.1600-0706.2011.19897.x; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Walker B., 2004, Ecology and Society, V9, P5; Wallstedt T, 2008, SCI TOTAL ENVIRON, V407, P405, DOI 10.1016/j.scitotenv.2008.07.062; Wardwell DA, 2008, ECOL COMPLEX, V5, P165, DOI 10.1016/j.ecocom.2007.11.001; WEATHERLEY NS, 1988, WATER AIR SOIL POLL, V39, P421; Wilander A, 2003, SYNOPTISK STUDIE VAT; Yan ND, 2003, AMBIO, V32, P165, DOI 10.1639/0044-7447(2003)032[0165:DCFFTR]2.0.CO;2; Yan ND, 1996, CAN J FISH AQUAT SCI, V53, P1301, DOI 10.1139/f96-065; Zaccarelli N, 2008, ECOL SOC, V13	77	23	23	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91881	10.1371/journal.pone.0091881	http://dx.doi.org/10.1371/journal.pone.0091881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618720	Green Submitted, gold, Green Published			2022-12-25	WOS:000332842400139
J	Hou, CX; Qin, GX; Liu, T; Geng, T; Gao, K; Pan, ZH; Qian, HY; Guo, XJ				Hou, Chengxiang; Qin, Guangxing; Liu, Ting; Geng, Tao; Gao, Kun; Pan, Zhonghua; Qian, Heying; Guo, Xijie			Transcriptome Analysis of Silkworm, Bombyx mori, during Early Response to Beauveria bassiana Challenges	PLOS ONE			English	Article							GENE-EXPRESSION PROFILE; HEAT-SHOCK PROTEINS; MICROARRAY ANALYSIS; INVOLVEMENT; PROTEASE; RECEPTOR; SYSTEM; NUCLEOPOLYHEDROVIRUS; IDENTIFICATION; RESISTANT	Host-pathogen interactions are complex processes and it is a central challenge to reveal these interactions. Fungal infection of silkworm, Bombyx mori, may induce a variety of responsive reaction. However, little is known about the molecular mechanism of silkworm immune response against the fungal infection. To obtain an overview of the interaction between silkworm and an entomopathogenic fungus Beauveria bassiana, Digital Gene Expression profiling, a tag based high-throughput transcriptome sequencing method, was employed to screen and identify differentially expressed genes (DEGs, FDR <= 0.001, log(2)ratio >= 1) of silkworm larvae during early response against B. bassiana infection. Total 1430 DEGs including 960 up-regulated and 470 down-regulated ones were identified, of which 627 DEGs can be classified into GO categories by Gene Ontology (GO) analysis. KEGG pathways analysis of these DEGs suggested that many biological processes, such as defense and response, signal transduction, phagocytosis, regulation of gene expression, RNA splicing, biosynthesis and metabolism, protein transport etc. were involved in the interaction between the silkworm and B. bassiana. A number of differentially expressed fungal genes were also identified by mapping the sequencing tags to B. bassiana genome. These results provided new insights to the molecular mechanism of silkworm immune response to B. bassiana infection.	[Hou, Chengxiang; Qin, Guangxing; Liu, Ting; Geng, Tao; Gao, Kun; Pan, Zhonghua; Qian, Heying; Guo, Xijie] Jiangsu Univ Sci & Technol, Sericultural Res Inst, Zhenjiang, Jiangsu, Peoples R China; [Hou, Chengxiang; Qin, Guangxing; Liu, Ting; Qian, Heying; Guo, Xijie] Chinese Acad Agr Sci, Sericultural Res Inst, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University of Science & Technology; Chinese Academy of Agricultural Sciences	Guo, XJ (corresponding author), Jiangsu Univ Sci & Technol, Sericultural Res Inst, Zhenjiang, Jiangsu, Peoples R China.	guoxijie@just.edu.cn	Guo, Xijie/GPX-9247-2022		National Natural Science Foundation of China [31272498]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20123220110003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (Grant No. 31272498) (http://www.nsfc.gov.cn/Portal0/default152.htm) and the Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20123220110003)(http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai JW, 2010, MOL BIOL REP, V37, P1657, DOI 10.1007/s11033-009-9580-9; Altincicek B, 2008, DEV COMP IMMUNOL, V32, P585, DOI 10.1016/j.dci.2007.09.005; Arrigo AP, 2007, FEBS LETT, V581, P3665, DOI 10.1016/j.febslet.2007.04.033; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Bao YY, 2009, GENOMICS, V94, P138, DOI 10.1016/j.ygeno.2009.04.003; Basu S, 2000, CELL STRESS CHAPERON, V5, P443, DOI 10.1379/1466-1268(2000)005<0443:HSPTFO>2.0.CO;2; Bennett ST, 2005, PHARMACOGENOMICS, V6, P373, DOI 10.1517/14622416.6.4.373; Buchon N, 2009, P NATL ACAD SCI USA, V106, P12442, DOI 10.1073/pnas.0901924106; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; Charnley AK, 2003, ADV BOT RES, V40, P241, DOI 10.1016/S0065-2296(05)40006-3; Chengxiang H, 2011, GENE, V484, P35, DOI 10.1016/j.gene.2011.05.023; Clarke TE, 2002, J GEN VIROL, V83, P1565, DOI 10.1099/0022-1317-83-7-1565; Clarkson JM, 1996, TRENDS MICROBIOL, V4, P197, DOI 10.1016/0966-842X(96)10022-6; Du MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031045; Du X, 2012, CARBOHYD POLYM, V92, P1302; Erban T, 2008, EXP APPL ACAROL, V44, P199, DOI 10.1007/s10493-008-9138-x; Feyereisen R., 2005, P1; Goldsmith MR, 2005, ANNU REV ENTOMOL, V50, P71, DOI 10.1146/annurev.ento.50.071803.130456; Gorman MJ, 2007, J BIOL CHEM, V282, P11742, DOI 10.1074/jbc.M611243200; Grogan GJ, 2000, J MOL CATAL B-ENZYM, V9, P1, DOI 10.1016/S1381-1177(99)00080-6; Gurer C, 2002, J VIROL, V76, P4666, DOI 10.1128/JVI.76.9.4666-4670.2002; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Iordanskiy S, 2004, J VIROL, V78, P9697, DOI 10.1128/JVI.78.18.9697-9704.2004; Ji SJ, 2003, NUCLEIC ACIDS RES, V31, P2534, DOI 10.1093/nar/gkg358; Jiang HB, 2005, INSECT BIOCHEM MOLEC, V35, P931, DOI 10.1016/j.ibmb.2005.03.009; Jin LH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000168; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Le Floc'h N, 2004, LIVEST PROD SCI, V87, P37, DOI 10.1016/j.livprodsci.2003.09.005; Li B, 2006, J INSECT PHYSIOL, V52, P936, DOI 10.1016/j.jinsphys.2006.06.002; Li MW, 2005, GENOME, V48, P802, DOI 10.1139/g05-053; Liu WM, 2010, MOL BIOL REP, V37, P1801, DOI 10.1007/s11033-009-9614-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo M, 2005, PLANT SCI, V169, P695, DOI 10.1016/j.plantsci.2005.05.020; Luo Y, 2010, MOL BIOL REP, V37, P875, DOI 10.1007/s11033-009-9694-0; Maki N, 1997, INSECT BIOCHEM MOLEC, V27, P721, DOI 10.1016/S0965-1748(97)00050-7; Maki N, 2001, INSECT BIOCHEM MOLEC, V31, P407, DOI 10.1016/S0965-1748(00)00135-1; McBride WH, 2003, ONCOGENE, V22, P5755, DOI 10.1038/sj.onc.1206676; Pradeepa MM, 2008, MOL CELL BIOL, V28, P4331, DOI 10.1128/MCB.00519-07; Roh Kyung-Baeg, 2009, J Biol Chem, V284, P19474, DOI 10.1074/jbc.M109.007419; Sagisaka A, 2010, VIRUS RES, V147, P166, DOI 10.1016/j.virusres.2009.10.015; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199; Tanaka H, 2009, INSECT MOL BIOL, V18, P71, DOI 10.1111/j.1365-2583.2009.00851.x; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Ujita M, 2005, BIOSCI BIOTECH BIOCH, V69, P1178, DOI 10.1271/bbb.69.1178; Vabulas RM, 2002, J BIOL CHEM, V277, P20847, DOI 10.1074/jbc.M200425200; Veitch NJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-124; Wang JS, 2006, CELL MOL IMMUNOL, V3, P255; Wieten L, 2010, CELL STRESS CHAPERON, V15, P25, DOI 10.1007/s12192-009-0119-8; Williams JHH, 2008, J LEUKOCYTE BIOL, V83, P489, DOI 10.1189/jlb.0607356; Wu P, 2011, MOL BIOL REP, V38, P333, DOI 10.1007/s11033-010-0112-4; Wu S, 2010, DEV COMP IMMUNOL, V34, P93, DOI 10.1016/j.dci.2009.08.010; Xiao Guohua, 2012, Sci Rep, V2, P483, DOI 10.1038/srep00483; Yamamoto K, 2010, PESTIC BIOCHEM PHYS, V97, P1, DOI 10.1016/j.pestbp.2009.11.006; Yao HP, 2006, J ZHEJIANG U SC A S2, V7, P350, DOI DOI 10.1631/JZUS.2006.AS0350; Yasuharaa N, 2009, SEMIN CELL DEV BIOL, V20, P590, DOI 10.1016/j.semcdb.2009.05.003; Zaitseva L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-11; Zhou Y, 2013, GENOMICS, V101, P256, DOI 10.1016/j.ygeno.2013.02.004	59	41	45	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91189	10.1371/journal.pone.0091189	http://dx.doi.org/10.1371/journal.pone.0091189			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618587	Green Submitted, Green Published, gold			2022-12-25	WOS:000332842400054
J	Ye, CX; Zhang, LC; Liu, TS; Li, H; Liu, Q				Ye, Chaoxiong; Zhang, Lingcong; Liu, Taosheng; Li, Hong; Liu, Qiang			Visual Working Memory Capacity for Color Is Independent of Representation Resolution	PLOS ONE			English	Article							SHORT-TERM-MEMORY; INDIVIDUAL-DIFFERENCES; FEATURES; NUMBER; INFORMATION; PRECISION; STORAGE; CONSOLIDATION; ALLOCATION; RESOURCES	Background: The relationship between visual working memory (VWM) capacity and resolution of representation have been extensively investigated. Several recent ERP studies using orientation (or arrow) stimuli suggest that there is an inverse relationship between VWM capacity and representation resolution. However, different results have been obtained in studies using color stimuli. This could be due to important differences in the experimental paradigms used in previous studies. Methodology/Principal Findings: We examined whether the same relationship between capacity and resolution holds for color information. Participants performed a color change detection task while their electroencephalography was recorded. We manipulated representation resolution by asking participants to detect either a salient change (low-resolution) or a subtle change (high-resolution) in color. We used an ERP component known as contralateral delay activity (CDA) to index the amount of information maintained in VWM. The result demonstrated the same pattern for both low- and high-resolution conditions, with no difference between conditions. Conclusions/Significance: This result suggests that VWM always represents a fixed number of approximately 3-4 colors regardless of the resolution of representation.	[Ye, Chaoxiong; Zhang, Lingcong] Minnan Normal Univ, Dept Educ Sci & Technol, Zhangzhou, Peoples R China; [Liu, Taosheng] Michigan State Univ, Dept Psychol, E Lansing, MI 48824 USA; [Liu, Taosheng] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA; [Li, Hong; Liu, Qiang] Liaoning Normal Univ, Sch Psychol, Dalian, Peoples R China	MinNan Normal University; Michigan State University; Michigan State University; Liaoning Normal University	Liu, Q (corresponding author), Liaoning Normal Univ, Sch Psychol, Dalian, Peoples R China.	lq780614@163.com	Ye, Chaoxiong/T-1953-2019; Liu, Qiang/AAA-2260-2020; Liu, Taosheng/K-9148-2013; Ye, Chaoxiong/S-9025-2018	Ye, Chaoxiong/0000-0002-8301-7582; Liu, Taosheng/0000-0002-9768-0393; Ye, Chaoxiong/0000-0002-8301-7582	National Natural Science Foundation of China [NSFC 31170982]; NATIONAL EYE INSTITUTE [R01EY022727] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by awards from the National Natural Science Foundation of China (NSFC 31170982) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GA, 2008, PERCEPT PSYCHOPHYS, V70, P346, DOI 10.3758/PP.70.2.346; Anderson DE, 2011, J NEUROSCI, V31, P1128, DOI 10.1523/JNEUROSCI.4125-10.2011; Awh E, 2007, PSYCHOL SCI, V18, P622, DOI 10.1111/j.1467-9280.2007.01949.x; Baddeley A, 1998, CURR OPIN NEUROBIOL, V8, P234, DOI 10.1016/S0959-4388(98)80145-1; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Barton B, 2009, J EXP PSYCHOL HUMAN, V35, P1359, DOI 10.1037/a0015792; Bays PM, 2008, SCIENCE, V321, P851, DOI 10.1126/science.1158023; Bays PM, 2009, J VISION, V9, DOI 10.1167/9.10.7; Becker MW, 2013, ATTEN PERCEPT PSYCHO, V75, P415, DOI 10.3758/s13414-012-0410-0; Brouwer AM, 2007, J VISION, V7, DOI 10.1167/7.5.6; Conway ARA, 2002, INTELLIGENCE, V30, P163, DOI 10.1016/S0160-2896(01)00096-4; Cowan N, 2005, COGNITIVE PSYCHOL, V51, P42, DOI 10.1016/j.cogpsych.2004.12.001; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Diamantopoulou S, 2011, EXP BRAIN RES, V209, P501, DOI 10.1007/s00221-011-2536-z; Fukuda K, 2010, CURR OPIN NEUROBIOL, V20, P177, DOI 10.1016/j.conb.2010.03.005; Gao ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057913; Gao ZF, 2011, BRAIN RES, V1406, P30, DOI 10.1016/j.brainres.2011.06.049; Gao ZF, 2011, BIOL PSYCHOL, V87, P296, DOI 10.1016/j.biopsycho.2011.03.013; Gao ZF, 2009, J VISION, V9, DOI 10.1167/9.7.17; Gorgoraptis N, 2011, J NEUROSCI, V31, P8502, DOI 10.1523/JNEUROSCI.0208-11.2011; Hayhoe M, 2005, TRENDS COGN SCI, V9, P188, DOI 10.1016/j.tics.2005.02.009; Hollingworth A, 2009, ATTEN PERCEPT PSYCHO, V71, P936, DOI 10.3758/APP.71.4.936; Ikkai A, 2010, J NEUROPHYSIOL, V103, P1963, DOI 10.1152/jn.00978.2009; Jonides J, 2008, ANNU REV PSYCHOL, V59, P193, DOI 10.1146/annurev.psych.59.103006.093615; Keshvari S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002927; Klaver P, 1999, NEUROREPORT, V10, P2001, DOI 10.1097/00001756-199907130-00002; Liu T, 2013, PSYCHOL SCI; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Luria R, 2011, NEUROPSYCHOLOGIA, V49, P1632, DOI 10.1016/j.neuropsychologia.2010.11.031; Luria R, 2010, J COGNITIVE NEUROSCI, V22, P496, DOI 10.1162/jocn.2009.21214; Machizawa MG, 2012, PSYCHOL SCI, V23, P554, DOI 10.1177/0956797611431988; Machizawa MG, 2011, NEUROPSYCHOLOGIA, V49, P1518, DOI 10.1016/j.neuropsychologia.2010.11.032; Mance I, 2012, J EXP PSYCHOL HUMAN, V38, P429, DOI 10.1037/a0023925; McCollough AW, 2007, CORTEX, V43, P77, DOI 10.1016/S0010-9452(08)70447-7; Murray AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041223; Oh H, 2010, J COGNITIVE NEUROSCI, V22, P292, DOI 10.1162/jocn.2009.21250; Perron R, 2009, PSYCHOL RES-PSYCH FO, V73, P222, DOI 10.1007/s00426-008-0214-y; Scolari M, 2008, PSYCHON B REV, V15, P215, DOI 10.3758/PBR.15.1.215; Stevanovski B, 2011, ATTEN PERCEPT PSYCHO, V73, P1108, DOI 10.3758/s13414-011-0099-5; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Vogel EK, 2001, J EXP PSYCHOL HUMAN, V27, P92, DOI 10.1037/0096-1523.27.1.92; Woodman GF, 2008, PSYCHON B REV, V15, P223, DOI 10.3758/PBR.15.1.223; Woodman GF, 2007, CEREB CORTEX, V17, pI118, DOI 10.1093/cercor/bhm065; Zhang WW, 2008, NATURE, V453, P233, DOI 10.1038/nature06860; Zhang WW, 2009, PSYCHOL SCI, V20, P423, DOI 10.1111/j.1467-9280.2009.02322.x	47	21	24	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91681	10.1371/journal.pone.0091681	http://dx.doi.org/10.1371/journal.pone.0091681			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9GM	24618685	Green Submitted, Green Published, gold			2022-12-25	WOS:000332842400117
J	Chien, MH; Guo, HR				Chien, Ming-Hung; Guo, How-Ran			Nutritional Status and Falls in Community-Dwelling Older People: A Longitudinal Study of a Population-Based Random Sample	PLOS ONE			English	Article							MASS INDEX BMI; RISK-FACTORS; ASSESSMENT MNA; ELDERLY-PATIENTS; INJURIOUS FALLS; PREDICTORS; MORTALITY; FUNCTIONALITY; PREVENTION; CARE	Background: Falls are common in older people and may lead to functional decline, disability, and death. Many risk factors have been identified, but studies evaluating effects of nutritional status are limited. To determine whether nutritional status is a predictor of falls in older people living in the community, we analyzed data collected through the Survey of Health and Living Status of the Elderly in Taiwan (SHLSET). Methods: SHLSET include a series of interview surveys conducted by the government on a random sample of people living in community dwellings in the nation. We included participants who received nutritional status assessment using the Mini Nutritional Assessment Taiwan Version 2 (MNA-T2) in the 1999 survey when they were 53 years or older and followed up on the cumulative incidence of falls in the one-year period before the interview in the 2003 survey. Results: At the beginning of follow-up, the 4440 participants had a mean age of 69.5 (standard deviation = 9.1) years, and 467 participants were "not well-nourished," which was defined as having an MNA-T2 score of 23 or less. In the one-year study period, 659 participants reported having at least one fall. After adjusting for other risk factors, we found the associated odds ratio for falls was 1.73 (95% confidence interval, 1.23, 2.42) for "not well-nourished," 1.57 (1.30, 1.90) for female gender, 1.03 (1.02, 1.04) for one-year older, 1.55 (1.22, 1.98) for history of falls, 1.34 (1.05, 1.72) for hospital stay during the past 12 months, 1.66 (1.07, 2.58) for difficulties in activities of daily living, and 1.53 (1.23, 1.91) for difficulties in instrumental activities of daily living. Conclusion: Nutritional status is an independent predictor of falls in older people living in the community. Further studies are warranted to identify nutritional interventions that can help prevent falls in the elderly.	[Chien, Ming-Hung] Chung Hwa Univ Med Technol, Dept Hlth Care Adm, Tainan, Taiwan; [Guo, How-Ran] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Guo, How-Ran] Natl Cheng Kung Univ Hosp, Dept Occupat & Environm Med, Tainan 70428, Taiwan	Chung Hua University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital	Guo, HR (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan.	hrguo@mail.ncku.edu.tw	Guo, How-Ran/AAK-9063-2020	Guo, How-Ran/0000-0003-3343-3446				Ahmed T, 2010, CLIN INTERV AGING, V5, P207; Avila-Funes JA, 2008, J AM COLL NUTR, V27, P492, DOI 10.1080/07315724.2008.10719730; Beck AM, 1999, BRIT J NUTR, V81, P31, DOI 10.1017/S0007114599000860; Cairella G, 2005, Ann Ig, V17, P35; CAMPBELL AJ, 1989, J GERONTOL, V44, pM112, DOI 10.1093/geronj/44.4.m112; Cereda E, 2008, CLIN NUTR, V27, P700, DOI 10.1016/j.clnu.2008.06.001; Chan K. M., 1997, SMJ, V38, P427; Chang HH, 2010, ARCH GERONTOL GERIAT, V50, pS30, DOI 10.1016/S0167-4943(10)70009-1; Charlton KE, 2005, PUBLIC HEALTH NUTR, V8, P468, DOI 10.1079/PHN2005783; Chu LW, 2005, ANN ACAD MED SINGAP, V34, P60; Close JCT, 2012, EMERG MED J, V29, P742, DOI 10.1136/emermed-2011-200380; Lantigua MC, 2007, ARCH LATINOAM NUTR, V57, P255; Duh MS, 2008, DRUG AGING, V25, P325, DOI 10.2165/00002512-200825040-00005; Ganz DA, 2007, JAMA-J AM MED ASSOC, V297, P77, DOI 10.1001/jama.297.1.77; Gill T, 2005, GERONTOLOGY, V51, P340, DOI 10.1159/000086372; Graafmans WC, 1996, AM J EPIDEMIOL, V143, P1129; Grundstrom AC, 2012, ARCH GERONTOL GERIAT, V54, P421, DOI 10.1016/j.archger.2011.06.008; Guigoz Y, 1997, Ther Umsch, V54, P345; Guigoz Y, 2006, J NUTR HEALTH AGING, V10, P466; Guigoz Y, 1996, NUTR REV, V54, pS59; Iizaka S, 2008, GERIATR GERONTOL INT, V8, P24, DOI 10.1111/j.1447-0594.2008.00443.x; Johnson C Shanthi, 2003, J Nutr Health Aging, V7, P247; Kannus P, 2005, LANCET, V366, P1885, DOI 10.1016/S0140-6736(05)67604-0; Kearns WD, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2012.06.010; Kool B, 2009, INJURY PREV, V15, P341, DOI 10.1136/ip.2008.021303; Koski K, 1998, GERONTOLOGY, V44, P232, DOI 10.1159/000022017; Kwan MMS, 2011, J AM GERIATR SOC, V59, P536, DOI 10.1111/j.1532-5415.2010.03286.x; Lee LC, 2012, ARCH GERONTOL GERIAT, V54, pE405, DOI 10.1016/j.archger.2011.12.006; Lin CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018976; Meijers JMM, 2012, J NUTR HEALTH AGING, V16, P654, DOI 10.1007/s12603-012-0010-7; Muraki S, 2013, BONE, V52, P516, DOI 10.1016/j.bone.2012.10.020; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; Newton Mel, 2013, Nurs Older People, V25, P16, DOI 10.7748/nop2013.10.25.8.16.e489; Neyens J, 2013, ARCH GERONTOL GERIAT, V56, P265, DOI 10.1016/j.archger.2012.08.005; ROBBINS AS, 1989, ARCH INTERN MED, V149, P1628, DOI 10.1001/archinte.1989.00390070138022; Robertson MC, 2013, JAMA-J AM MED ASSOC, V309, P1406, DOI 10.1001/jama.2013.3130; Rubenstein LZ, 2002, CLIN GERIATR MED, V18, P141, DOI 10.1016/S0749-0690(02)00002-2; RYYNANEN OP, 1991, PUBLIC HEALTH, V105, P373, DOI 10.1016/S0033-3506(05)80597-9; Sai AJ, 2010, J MUSCULOSKEL NEURON, V10, P142; Salvi F, 2008, AGING CLIN EXP RES, V20, P322; Sherrington C, 2008, J AM GERIATR SOC, V56, P2234, DOI 10.1111/j.1532-5415.2008.02014.x; Stevens JA, 2008, J SAFETY RES, V39, P345, DOI 10.1016/j.jsr.2008.05.002; *TAIW PROV I FAM P, 1989, 1 U MICH POP STUD CT; Tinetti ME, 1998, J GERONTOL A-BIOL, V53, pM112, DOI 10.1093/gerona/53A.2.M112; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Tsai AC, 2010, J NUTR HEALTH AGING, V14, P183, DOI 10.1007/s12603-010-0046-5; Tsai AC, 2008, J NUTR HEALTH AGING, V12, P696; Tsai AC, 2008, BRIT J NUTR, V100, P152, DOI 10.1017/S0007114507873600; Tsai AC, 2011, J CLIN NURS, V20, P341, DOI 10.1111/j.1365-2702.2010.03467.x; Tsai AC, 2010, BRIT J NUTR, V104, P93, DOI 10.1017/S0007114510000188; Tsai AC, 2009, INT J NURS STUD, V46, P1431, DOI 10.1016/j.ijnurstu.2009.05.004; Tsai AC, 2009, J CLIN NURS, V18, P82, DOI 10.1111/j.1365-2702.2008.02319.x; Tsai ACH, 2007, ASIA PAC J CLIN NUTR, V16, P656; Tsai ACH, 2012, ARCH GERONTOL GERIAT, V54, P443, DOI 10.1016/j.archger.2011.05.015; Vellas B, 1999, NUTRITION, V15, P116, DOI 10.1016/S0899-9007(98)00171-3; Vellas BJ, 1998, J GERONTOL A-BIOL, V53, pM264, DOI 10.1093/gerona/53A.4.M264; Vivanti A, 2011, J NUTR HEALTH AGING, V15, P388, DOI 10.1007/s12603-010-0302-8; Wikby K, 2008, J CLIN NURS, V17, P1211, DOI 10.1111/j.1365-2702.2007.02012.x	58	34	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91044	10.1371/journal.pone.0091044	http://dx.doi.org/10.1371/journal.pone.0091044			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9FH	24614184	Green Published, gold			2022-12-25	WOS:000332839300070
J	Degroote, RL; Hauck, SM; Amann, B; Hirmer, S; Ueffing, M; Deeg, CA				Degroote, Roxane L.; Hauck, Stefanie M.; Amann, Barbara; Hirmer, Sieglinde; Ueffing, Marius; Deeg, Cornelia A.			Unraveling the Equine Lymphocyte Proteome: Differential Septin 7 Expression Associates with Immune Cells in Equine Recurrent Uveitis	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; RETINAL S-ANTIGEN; AUTOIMMUNE UVEITIS; MEMBRANE-PROTEINS; MAMMALIAN SEPTINS; BINDING PROTEIN; T-LYMPHOCYTES; TARGET TISSUE; IDENTIFICATION; AUTOANTIGENS	Equine recurrent uveitis is a spontaneous, lymphocyte-driven autoimmune disease. It affects horses worldwide and presents with painful remitting-relapsing inflammatory attacks of inner eye structures eventually leading to blindness. Since lymphocytes are the key players in equine recurrent uveitis, we were interested in potential changes of their protein repertoire which may be involved in disease pathogenesis. To create a reference for differential proteome analysis, we first unraveled the equine lymphocyte proteome by two-dimensional sodium dodecyl sulfate - polyacrylamide gel electrophoresis and subsequently identified 352 protein spots. Next, we compared lymphocytes from ERU cases and healthy horses with a two-dimensional fluorescence difference in gel electrophoresis approach. With this technique, we identified seven differentially expressed proteins between conditions. One of the significantly lower expressed candidates, septin 7, plays a role in regulation of cell shape, motility and migration. Further analyses revealed T cells as the main cell type with decreased septin 7 abundance in equine recurrent uveitis. These findings point to a possible pathogenetic role of septin 7 in this sight-threatening disease.	[Degroote, Roxane L.; Amann, Barbara; Hirmer, Sieglinde; Deeg, Cornelia A.] Univ Munich, Dept Vet Sci, Inst Anim Physiol, Munich, Germany; [Hauck, Stefanie M.; Ueffing, Marius] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Res Unit Prot Sci, Neuherberg, Germany; [Ueffing, Marius] Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Tubingen, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Deeg, CA (corresponding author), Univ Munich, Dept Vet Sci, Inst Anim Physiol, Munich, Germany.	deeg@tiph.vetmed.uni-muenchen.de	Deeg, Cornelia A/G-4940-2010; Deeg, Cornelia/U-4216-2019; Hauck, Stefanie/B-3300-2013	Deeg, Cornelia A/0000-0003-0375-3190; Hauck, Stefanie/0000-0002-1630-6827; Degroote, Roxane/0000-0003-2680-7227	Deutsche Forschungsgemeinschaft [DFG SFB 571-3 A5, DE 719/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Research was supported by grants of the Deutsche Forschungsgemeinschaft to CD; DFG SFB 571-3 A5 and DE 719/4-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonilha VL, 2007, EXP EYE RES, V84, P613, DOI 10.1016/j.exer.2006.01.011; BYERS B, 1976, J CELL BIOL, V69, P717, DOI 10.1083/jcb.69.3.717; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Caspi R, 2008, IMMUNOL RES, V42, P41, DOI 10.1007/s12026-008-8031-3; Caspi RR, 2006, IMMUNOL REV, V213, P23, DOI 10.1111/j.1600-065X.2006.00439.x; Chae JI, 2012, ANIM REPROD SCI, V134, P164, DOI 10.1016/j.anireprosci.2012.07.008; Deeg CA, 2006, INVEST OPHTH VIS SCI, V47, P652, DOI 10.1167/iovs.05-0789; Deeg CA, 2004, INVEST OPHTH VIS SCI, V45, P2286, DOI 10.1167/iovs.03-1226; Deeg CA, 2002, EXP EYE RES, V75, P127, DOI 10.1006/exer.2002.2011; Deeg CA, 2002, EUR J IMMUNOL, V32, P2598, DOI 10.1002/1521-4141(200209)32:9&lt;2598::AID-IMMU2598&gt;3.0.CO;2-#; Deeg CA, 2001, INVEST OPHTH VIS SCI, V42, P393; Deeg CA, 2008, OPHTHAL RES, V40, P151, DOI 10.1159/000119867; Deeg CA, 2006, MOL CELL PROTEOMICS, V5, P1462, DOI 10.1074/mcp.M500352-MCP200; Deeg CA, 2007, CLIN DEV IMMUNOL, DOI 10.1155/2007/39245; Degroote RL, 2013, J PROTEOME RES; Degroote RL, 2012, J PROTEOMICS, V75, P4536, DOI 10.1016/j.jprot.2012.01.023; DESMET MD, 1993, J AUTOIMMUN, V6, P587, DOI 10.1006/jaut.1993.1048; Engidawork E, 2003, NEUROSCIENCE, V122, P145, DOI 10.1016/S0306-4522(03)00605-5; Eriksen KW, 2010, J INVEST DERMATOL, V130, P1590, DOI 10.1038/jid.2010.6; Finlay DK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00247; Fischer R, 2006, BIOCHEM CELL BIOL, V84, P303, DOI 10.1139/O06-058; Fruhauf B., 1998, Vet Ophthalmol, V1, P137, DOI 10.1046/j.1463-5224.1998.00030.x; Gerling IC, 2006, MOL CELL PROTEOMICS, V5, P293, DOI 10.1074/mcp.M500197-MCP200; Gilger BC, 2006, INVEST OPHTH VIS SCI, V47, P2596, DOI 10.1167/iovs.05-1540; Gilger BC, 2004, VET CLIN N AM-EQUINE, V20, P417, DOI 10.1016/j.cveq.2004.04.010; Gilger BC, 1999, VET IMMUNOL IMMUNOP, V71, P17, DOI 10.1016/S0165-2427(99)00082-3; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; HASHIZUME S, 1983, BIOCHIM BIOPHYS ACTA, V763, P377, DOI 10.1016/0167-4889(83)90099-X; Hauck SM, 2010, MOL CELL PROTEOMICS, V9, P2292, DOI 10.1074/mcp.M110.001073; Haudek VJ, 2009, J PROTEOME RES, V8, P3834, DOI 10.1021/pr801085g; Jia ZF, 2010, J NEURO-ONCOL, V98, P329, DOI 10.1007/s11060-009-0092-1; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kremer BE, 2005, MOL BIOL CELL, V16, P4648, DOI 10.1091/mbc.E05-03-0267; Kremer BE, 2007, CELL, V130, P837, DOI 10.1016/j.cell.2007.06.053; LeHoang P, 2008, OPHTHAL RES, V40, P181, DOI 10.1159/000119873; Lenchik NI, 2005, PROTEOMICS, V5, P2202, DOI 10.1002/pmic.200401107; Li S, 2012, CELL CYCLE, V11, P3211, DOI 10.4161/cc.21553; Lilley KS, 2004, EXPERT REV PROTEOMIC, V1, P401, DOI 10.1586/14789450.1.4.401; Maldonado EN, 2012, J PHARMACOL EXP THER, V342, P637, DOI 10.1124/jpet.112.192153; Marko AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015425; MAZURIER J, 1989, EUR J BIOCHEM, V179, P481, DOI 10.1111/j.1432-1033.1989.tb14578.x; Nagaraj N, 2008, J PROTEOME RES, V7, P5028, DOI 10.1021/pr800412j; Okunuki Y, 2008, MOL VIS, V14, P1094; Pao LI, 2007, ANNU REV IMMUNOL, V25, P473, DOI 10.1146/annurev.immunol.23.021704.115647; Pore D, 2013, J IMMUNOL; Ramirez-Boo M, 2006, PROTEOMICS, V6, pS215, DOI 10.1002/pmic.200500386; Sampson MJ, 1997, J BIOL CHEM, V272, P18966, DOI 10.1074/jbc.272.30.18966; Santoni V, 2000, ELECTROPHORESIS, V21, P1054, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1054::AID-ELPS1054>3.3.CO;2-#; Santos J, 2009, LEUK RES; Schulz M, 2007, J PROTEOME RES, V6, P3752, DOI 10.1021/pr070285f; SCHWINK KL, 1992, VET CLIN N AM-EQUINE, V8, P557, DOI 10.1016/S0749-0739(17)30441-8; Spiess B M, 2010, Equine Vet J Suppl, P50; Tatton WG, 2000, ADV RES NEURODEGENER, V8, P77; Tooley AJ, 2009, NAT CELL BIOL, V11, P17, DOI 10.1038/ncb1808; Vergara D, 2008, PROTEOMICS, V8, P2045, DOI 10.1002/pmic.200700726; Wasik AA, 2012, MOL BIOL CELL, V23, P3370, DOI 10.1091/mbc.E11-12-1010; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407; Wildner G, 2008, OPHTHAL RES, V40, P141, DOI 10.1159/000119865; Zipplies JK, 2010, INVEST OPHTH VIS SCI, V51, P375, DOI 10.1167/iovs.09-4094	60	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91684	10.1371/journal.pone.0091684	http://dx.doi.org/10.1371/journal.pone.0091684			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614191	Green Published, gold, Green Submitted			2022-12-25	WOS:000332839300149
J	Jeong, MH; Tran, NKS; Kwak, TH; Park, BK; Lee, CS; Park, TS; Lee, YH; Park, WJ; Yang, DK				Jeong, Moon Hee; Nguyen Khoi Song Tran; Kwak, Tae Hwan; Park, Byung Keon; Lee, Chul Soon; Park, Tae-Sik; Lee, Young-Hoon; Park, Woo Jin; Yang, Dong Kwon			beta-Lapachone Ameliorates Lipotoxic Cardiomyopathy in Acyl CoA Synthase Transgenic Mice	PLOS ONE			English	Article							FATTY-ACID OXIDATION; MITOCHONDRIAL-FUNCTION; RAT-HEART; SIRT1; ACTIVATION; OBESITY; METABOLISM; RESVERATROL; DYSFUNCTION; STRESS	Lipotoxic cardiomyopathy is caused by myocardial lipid accumulation and often occurs in patients with diabetes and obesity. This study investigated the effects of beta-lapachone (beta-lap), a natural compound that activates Sirt1 through elevation of the intracellular NAD(+) level, on acyl CoA synthase (ACS) transgenic (Tg) mice, which have lipotoxic cardiomyopathy. Oral administration of beta-lap to ACS Tg mice significantly attenuated heart failure and inhibited myocardial accumulation of triacylglycerol. Electron microscopy and measurement of mitochondrial complex II protein and mitochondrial DNA revealed that administration of beta-lap restored mitochondrial integrity and biogenesis in ACS Tg hearts. Accordingly, beta-lap administration significantly increased the expression of genes associated with mitochondrial biogenesis and fatty acid metabolism that were down-regulated in ACS Tg hearts. beta-lap also restored the activities of Sirt1 and AMP-activated protein kinase (AMPK), the two key regulators of metabolism, which were suppressed in ACS Tg hearts. In H9C2 cells, beta-lap-mediated elevation of AMPK activity was retarded when the level of Sirt1 was reduced by transfection of siRNA against Sirt1. Taken together, these results indicate that beta-lap exerts cardioprotective effects against cardiac lipotoxicity through the activation of Sirt1 and AMPK. beta-lap may be a novel therapeutic agent for the treatment of lipotoxic cardiomyopathy.	[Jeong, Moon Hee; Park, Woo Jin; Yang, Dong Kwon] Gwangju Inst Sci & Technol, Coll Life Sci, Kwangju, South Korea; [Nguyen Khoi Song Tran; Lee, Chul Soon; Park, Tae-Sik] Gachon Univ, Dept Life Sci, Songnam, South Korea; [Kwak, Tae Hwan] KT&G Life Sci Corp, R&D Ctr, Suwon, South Korea; [Park, Byung Keon; Lee, Young-Hoon] Chonbuk Natl Univ, Dept Oral Anat, Sch Dent, Jeonju, South Korea; [Park, Byung Keon; Lee, Young-Hoon] Chonbuk Natl Univ, Inst Oral Biosci, Jeonju, South Korea	Gwangju Institute of Science & Technology (GIST); Gachon University; Samsung; Jeonbuk National University; Jeonbuk National University	Park, WJ (corresponding author), Gwangju Inst Sci & Technol, Coll Life Sci, Kwangju, South Korea.	woojinpark@me.com; dkyang0502@gmail.com			Global Research Laboratory Program of the Korean Ministry of Education, Science and Technology [M6-0605-00-0001]; Korean Health Technology R&D Project of Korean Ministry of Health, Welfare Family Affairs [A101749]; Systems Biology Infrastructure Establishment Program of GIST; Korean Ministry of Education, Science and Technology [2010-0010754]	Global Research Laboratory Program of the Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korean Health Technology R&D Project of Korean Ministry of Health, Welfare Family Affairs; Systems Biology Infrastructure Establishment Program of GIST; Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	WJP was supported by a grant (M6-0605-00-0001) from the Global Research Laboratory Program of the Korean Ministry of Education, Science and Technology, a grant (A101749) from the Korean Health Technology R&D Project of Korean Ministry of Health, Welfare & Family Affairs, and a grant from the Systems Biology Infrastructure Establishment Program of GIST. DKY was supported by a grant (2010-0010754) from the Basic Science Research Program of the Korean Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; BISHOP SP, 1970, AM J PHYSIOL, V218, P153, DOI 10.1152/ajplegacy.1970.218.1.153; Boudina S, 2007, DIABETES, V56, P2457, DOI 10.2337/db07-0481; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Choi YH, 2003, J BIOCHEM MOL BIOL, V36, P223; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Goodwin GW, 1998, J BIOL CHEM, V273, P29530, DOI 10.1074/jbc.273.45.29530; Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; Hwang JH, 2009, DIABETES, V58, P965, DOI 10.2337/db08-1183; Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003; Jaiswal AK, 2000, FREE RADICAL BIO MED, V29, P254, DOI 10.1016/S0891-5849(00)00306-3; KANNEL WB, 1974, AM J CARDIOL, V34, P29, DOI 10.1016/0002-9149(74)90089-7; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Khan RS, 2010, CURR OPIN CLIN NUTR, V13, P145, DOI 10.1097/MCO.0b013e3283357272; Kim SY, 2009, CIRC RES, V104, P842, DOI 10.1161/CIRCRESAHA.108.189837; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Molavi B, 2006, CURR OPIN CARDIOL, V21, P479, DOI 10.1097/01.hco.0000240586.76344.f5; Pink JJ, 2000, EXP CELL RES, V255, P144, DOI 10.1006/excr.1999.4790; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rajamohan SB, 2009, MOL CELL BIOL, V29, P4116, DOI 10.1128/MCB.00121-09; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; SCHAFFNERSABBA K, 1984, J MED CHEM, V27, P990, DOI 10.1021/jm00374a010; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; Shin BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064953; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Taegtmeyer H, 2004, ANN NY ACAD SCI, V1015, P202, DOI 10.1196/annals.1302.017; Tsutsui H, 2009, CARDIOVASC RES, V81, P449, DOI 10.1093/cvr/cvn280; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867; WITTELS B, 1968, J CLIN INVEST, V47, P1787, DOI 10.1172/JCI105868; Young ME, 2002, DIABETES, V51, P2587, DOI 10.2337/diabetes.51.8.2587; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	37	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91039	10.1371/journal.pone.0091039	http://dx.doi.org/10.1371/journal.pone.0091039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614171	gold, Green Published, Green Submitted			2022-12-25	WOS:000332839300069
J	Jones, CB; Filippi, C; Sachithanantham, S; Rodriguez-Calvo, T; Ehrhardt, K; von Herrath, M				Jones, Carmen Baca; Filippi, Christophe; Sachithanantham, Sowbarnika; Rodriguez-Calvo, Teresa; Ehrhardt, Katrin; von Herrath, Matthias			Direct Infection of Dendritic Cells during Chronic Viral Infection Suppresses Antiviral T Cell Proliferation and Induces IL-10 Expression in CD4 T Cells	PLOS ONE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; AMINO-ACID CHANGE; CROSS-PRESENTATION; IN-VIVO; TRANSGENIC MICE; PERSISTENCE; ANTIGEN; INTERLEUKIN-10; GLYCOPROTEIN; EXHAUSTION	Elevated levels of systemic IL-10 have been associated with several chronic viral infections, including HCV, EBV, HCMV and LCMV. In the chronic LCMV infection model, both elevated IL-10 and enhanced infection of dendritic cells (DCs) are important for viral persistence. This report highlights the relationship between enhanced viral tropism for DCs and the induction of IL-10 in CD4 T cells, which we identify as the most frequent IL-10-expressing cell type in chronic LCMV infection. Here we report that infected CD8 alpha(neg) DCs express elevated IL-10, induce IL-10 expression in LCMV specific CD4 T cells, and suppress LCMV-specific T cell proliferation. DCs exposed in vivo to persistent LCMV retain the capacity to stimulate CD4 T cell proliferation but induce IL-10 production by both polyclonal and LCMV-specific CD4 T cells. Our study delineates the unique effects of direct infection versus viral exposure on DCs. Collectively these data point to enhanced infection of DCs as a key trigger of the IL-10 induction cascade resulting in maintenance of elevated IL-10 expression in CD4 T cells and inhibition of LCMV-specific CD4 and CD8 T cell proliferation.	[Jones, Carmen Baca; Filippi, Christophe; Sachithanantham, Sowbarnika; Rodriguez-Calvo, Teresa; Ehrhardt, Katrin; von Herrath, Matthias] La Jolla Inst Allergy & Immunol, Type Diabet Ctr 1, La Jolla, CA 92037 USA	La Jolla Institute for Immunology	von Herrath, M (corresponding author), La Jolla Inst Allergy & Immunol, Type Diabet Ctr 1, La Jolla, CA 92037 USA.	matthias@liai.org	Rodriguez-Calvo, Teresa/AAH-2365-2019	Ehrhardt, Katrin/0000-0003-0471-2008	National Institutes of Health [R01AI068818, 3R01AI068818-03S1]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068818, P01AI089624] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants R01AI068818 and 3R01AI068818-03S1. This work was supported by National Institutes of Health grants R01AI068818 and 3R01AI068818-03S1. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatery A, 2010, EUR J IMMUNOL, V40, P2190, DOI 10.1002/eji.200939973; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Basta S, 2005, J IMMUNOL, V175, P796, DOI 10.4049/jimmunol.175.2.796; Belz GT, 2005, J IMMUNOL, V175, P196, DOI 10.4049/jimmunol.175.1.196; Blackburn SD, 2007, TRENDS MICROBIOL, V15, P143, DOI 10.1016/j.tim.2007.02.006; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; BORROW P, 1992, J VIROL, V66, P7270, DOI 10.1128/JVI.66.12.7270-7281.1992; Brady MT, 2003, EUR J IMMUNOL, V33, P3448, DOI 10.1002/eji.200324251; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; CLERICI M, 1994, J CLIN INVEST, V93, P768, DOI 10.1172/JCI117031; den Haan JMM, 2002, J EXP MED, V196, P817, DOI 10.1084/jem.20020295; Eisen HN, 2012, P NATL ACAD SCI USA, V109, P4580, DOI 10.1073/pnas.1201586109; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Freigang S, 2007, P NATL ACAD SCI USA, V104, P13426, DOI 10.1073/pnas.0704423104; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Kotenko SV, 2000, P NATL ACAD SCI USA, V97, P1695, DOI 10.1073/pnas.97.4.1695; MATLOUBIAN M, 1990, J EXP MED, V172, P1043, DOI 10.1084/jem.172.4.1043; McCausland MM, 2008, J VIROL METHODS, V147, P167, DOI 10.1016/j.jviromet.2007.08.025; Ng CT, 2012, P NATL ACAD SCI USA, V109, P14116, DOI 10.1073/pnas.1211910109; Nopora K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00348; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.0.CO;2-O; Pavelic V, 2009, EUR J IMMUNOL, V39, P704, DOI 10.1002/eji.200838901; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Redpath S, 1999, J IMMUNOL, V162, P6701; Redpath S, 2001, TRENDS MICROBIOL, V9, P86, DOI 10.1016/S0966-842X(00)01919-3; Richter K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003735; SALVATO M, 1988, VIROLOGY, V164, P517, DOI 10.1016/0042-6822(88)90566-1; SALVATO M, 1991, J VIROL, V65, P1863, DOI 10.1128/JVI.65.4.1863-1869.1991; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Sevilla N, 2000, J EXP MED, V192, P1249, DOI 10.1084/jem.192.9.1249; Sevilla N, 2004, J CLIN INVEST, V113, P737, DOI 10.1172/JCI20243; Sullivan BM, 2011, P NATL ACAD SCI USA, V108, P2969, DOI 10.1073/pnas.1019304108; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wilson EB, 2012, CELL HOST MICROBE, V11, P481, DOI 10.1016/j.chom.2012.03.009; Yewdell JW, 1999, ANNU REV CELL DEV BI, V15, P579, DOI 10.1146/annurev.cellbio.15.1.579; Yewdell JW, 2002, NAT IMMUNOL, V3, P1019, DOI 10.1038/ni1102-1019; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; ZELLER W, 1988, VIROLOGY, V162, P90, DOI 10.1016/0042-6822(88)90397-2; Zuniga EI, 2008, CELL HOST MICROBE, V4, P374, DOI 10.1016/j.chom.2008.08.016	43	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90855	10.1371/journal.pone.0090855	http://dx.doi.org/10.1371/journal.pone.0090855			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24613988	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300045
J	O'Connell, JL; Byrd, KB; Kelly, M				O'Connell, Jessica L.; Byrd, Kristin B.; Kelly, Maggi			Remotely-Sensed Indicators of N-Related Biomass Allocation in Schoenoplectus acutus	PLOS ONE			English	Article							OPTIMAL PARTITIONING THEORY; SAN-JOAQUIN DELTA; NITROGEN CONCENTRATION; CANOPY NITROGEN; CARBON SEQUESTRATION; VEGETATION INDEXES; SALT-MARSH; PATTERNS; LEAF; BAND	Coastal marshes depend on belowground biomass of roots and rhizomes to contribute to peat and soil organic carbon, accrete soil and alleviate flooding as sea level rises. For nutrient-limited plants, eutrophication has either reduced or stimulated belowground biomass depending on plant biomass allocation response to fertilization. Within a freshwater wetland impoundment receiving minimal sediments, we used experimental plots to explore growth models for a common freshwater macrophyte, Schoenoplectus acutus. We used N-addition and control plots (4 each) to test whether remotely sensed vegetation indices could predict leaf N concentration, root: shoot ratios and belowground biomass of S. acutus. Following 5 months of summer growth, we harvested whole plants, measured leaf N and total plant biomass of all above and belowground vegetation. Prior to harvest, we simulated measurement of plant spectral reflectance over 164 hyperspectral Hyperion satellite bands (350-2500 nm) with a portable spectroradiometer. N-addition did not alter whole plant, but reduced belowground biomass 36% and increased aboveground biomass 71%. We correlated leaf N concentration with known N-related spectral regions using all possible normalized difference (ND), simple band ratio (SR) and first order derivative ND (FDN) and SR (FDS) vegetation indices. FDN1235, (549) was most strongly correlated with leaf N concentration and also was related to belowground biomass, the first demonstration of spectral indices and belowground biomass relationships. While S. acutus exhibited balanced growth (reduced root: shoot ratio with respect to nutrient addition), our methods also might relate N-enrichment to biomass point estimates for plants with isometric root growth. For isometric growth, foliar N indices will scale equivalently with above and belowground biomass. Leaf N vegetation indices should aid in scaling-up field estimates of biomass and assist regional monitoring.	[O'Connell, Jessica L.; Kelly, Maggi] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Byrd, Kristin B.] US Geol Survey, Menlo Pk, CA 94025 USA	University of California System; University of California Berkeley; United States Department of the Interior; United States Geological Survey	Kelly, M (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	maggi@berkeley.edu	O'Connell, Jessica/D-3220-2019	O'Connell, Jessica/0000-0002-2814-0668; Kelly, Nina Maggi/0000-0002-0198-2822; Byrd, Kristin/0000-0002-5725-7486	NASA [NNH10A086I]	NASA(National Aeronautics & Space Administration (NASA))	This research was supported by K. Byrd's NASA New Investigator Program in Earth Sciences Grant Number: NNH10A086I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman EM, 2013, INT J REMOTE SENS, V34, P712, DOI 10.1080/01431161.2012.713142; Abdel-Rahman EM, 2010, INT J APPL EARTH OBS, V12, pS52, DOI 10.1016/j.jag.2009.11.003; ASD Inc, 2008, VIEWSPEC PROTM US MA; Bedford BL, 1999, ECOLOGY, V80, P2151, DOI 10.1890/0012-9658(1999)080[2151:PINAAP]2.0.CO;2; Belyea LR, 2004, GLOBAL CHANGE BIOL, V10, P1043, DOI 10.1111/j.1529-8817.2003.00783.x; Boyer KE, 2001, WETLANDS, V21, P315, DOI 10.1672/0277-5212(2001)021[0315:SVIASC]2.0.CO;2; Cahoon DR, 2006, ESTUAR COAST, V29, P889, DOI 10.1007/BF02798648; Carnegie Museum of Natural History, 2005, CRAYF LINKS CARN MUS; Cohen RA, 2005, J PHYCOL, V41, P287, DOI 10.1111/j.1529-8817.2005.04022.x; Cohen RA, 2006, ECOL APPL, V16, P1405, DOI 10.1890/1051-0761(2006)016[1405:UOGMAI]2.0.CO;2; CURRAN PJ, 1989, REMOTE SENS ENVIRON, V30, P271, DOI 10.1016/0034-4257(89)90069-2; Darby FA, 2008, ESTUAR COAST, V31, P223, DOI 10.1007/s12237-007-9014-7; Dawson TP, 1998, INT J REMOTE SENS, V19, P2133, DOI 10.1080/014311698214910; Deegan LA, 2012, NATURE, V490, P388, DOI 10.1038/nature11533; DELAUNE RD, 1994, J COASTAL RES, V10, P1021; DEMETRIADESSHAH TH, 1990, REMOTE SENS ENVIRON, V33, P55, DOI 10.1016/0034-4257(90)90055-Q; Deverel SJ, 2010, SAN FRANCISCO ESTUAR, V8; Drexler JZ, 2009, ESTUAR COAST, V32, P871, DOI 10.1007/s12237-009-9202-8; Drexler JZ, 2009, WETLANDS, V29, P372, DOI 10.1672/08-97.1; Environmental Protection Agency, 2002, MID INT ASS MAIA EST; Ernst MD, 2004, STAT SCI, V19, P676, DOI 10.1214/088342304000000396; GAO BC, 1995, REMOTE SENS ENVIRON, V52, P155, DOI 10.1016/0034-4257(95)00039-4; Gorham E, 2012, QUATERNARY SCI REV, V58, P77, DOI 10.1016/j.quascirev.2012.09.018; Guyot G., 1988, J CHEM INF MODEL, P279; Jong SM, 1998, ITC J, P1; Kao JT, 2003, WETLANDS, V23, P979, DOI 10.1672/0277-5212(2003)023[0979:DNAPRB]2.0.CO;2; Kim MS, 1994, USE HIGH SPECTRAL RE, P229; Knyazikhin Y, 2013, P NATL ACAD SCI USA, V110, pE185, DOI 10.1073/pnas.1210196109; Kobe RK, 2010, ECOLOGY, V91, P166, DOI 10.1890/09-0027.1; Kochubey SM, 2012, FRONT EARTH SCI-PRC, V6, P188, DOI 10.1007/s11707-012-0325-z; Kokaly RF, 2009, REMOTE SENS ENVIRON, V113, pS78, DOI 10.1016/j.rse.2008.10.018; Kokaly RF, 1999, REMOTE SENS ENVIRON, V67, P267, DOI 10.1016/S0034-4257(98)00084-4; Larkin DJ, 2012, AQUAT BOT, V100, P62, DOI 10.1016/j.aquabot.2012.03.001; Lu DS, 2006, INT J REMOTE SENS, V27, P1297, DOI 10.1080/01431160500486732; Martin ME, 2008, REMOTE SENS ENVIRON, V112, P3511, DOI 10.1016/j.rse.2008.04.008; McCarthy MC, 2007, FUNCT ECOL, V21, P713, DOI 10.1111/j.1365-2435.2007.01276.x; Merino JH, 2010, WETL ECOL MANAG, V18, P111, DOI 10.1007/s11273-008-9124-4; Miller R. L., 2008, SAN FRANCISCO ESTUAR, V6; Miphokasap P, 2012, REMOTE SENS-BASEL, V4, P1651, DOI 10.3390/rs4061651; Mitsch W.J., 2007, WETLANDS, V4th ed., DOI DOI 10.1017/CBO9781107415324.004; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Mokhele TA, 2010, J APPL REMOTE SENS, V4, DOI 10.1117/1.3525241; Moore P. D., 1987, GEOL SOC SPEC PUBL, V32, P7, DOI DOI 10.1144/GSL.SP.1987.032.01.02; Morris JT, 2013, WETLANDS, V33, P975, DOI 10.1007/s13157-013-0480-3; Nungesser MK, 2011, WETL ECOL MANAG, V19, P475, DOI 10.1007/s11273-011-9229-z; NYMAN JA, 1993, MAR ECOL PROG SER, V96, P269, DOI 10.3354/meps096269; Nyman JA, 2006, ESTUAR COAST SHELF S, V69, P370, DOI 10.1016/j.ecss.2006.05.041; Ollinger SV, 2011, NEW PHYTOL, V189, P375, DOI 10.1111/j.1469-8137.2010.03536.x; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Prokopovich N.P., 1985, B ASS ENG GEOL, V22, P395; Ramoelo A, 2012, INT J APPL EARTH OBS, V19, P151, DOI 10.1016/j.jag.2012.05.009; Rasse DP, 2005, PLANT SOIL, V269, P341, DOI 10.1007/s11104-004-0907-y; Ryu C, 2009, BIOSYST ENG, V104, P465, DOI 10.1016/j.biosystemseng.2009.09.002; Sartoris JJ, 2000, ECOL ENG, V14, P49; Serrano L, 2002, REMOTE SENS ENVIRON, V81, P355, DOI 10.1016/S0034-4257(02)00011-1; Sheppard JK, 2008, CONT SHELF RES, V28, P2282, DOI 10.1016/j.csr.2008.03.033; Shipley B, 2002, FUNCT ECOL, V16, P326, DOI 10.1046/j.1365-2435.2002.00626.x; Siciliano D, 2008, REMOTE SENS ENVIRON, V112, P4020, DOI 10.1016/j.rse.2008.05.019; Sims NC, 2013, IEEE J-STARS, V6, P320, DOI 10.1109/JSTARS.2013.2251610; Smith ML, 2002, ECOL APPL, V12, P1286; Stralberg D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027388; Stroppiana D, 2012, HYPERSPECTRAL REMOTE SENSING OF VEGETATION, P245; Stroppiana D, 2009, FIELD CROP RES, V111, P119, DOI 10.1016/j.fcr.2008.11.004; Suwandana E, 2012, J COASTAL RES, V28, P956, DOI 10.2112/JCOASTRES-D-11-00222.1; Thenkabail PS, 2012, HYPERSPECTRAL REMOTE SENSING OF VEGETATION, P3; Thenkabail PS, 2013, IEEE J-STARS, V6, P427, DOI 10.1109/JSTARS.2013.2252601; Thenkabail PS, 2004, REMOTE SENS ENVIRON, V91, P354, DOI 10.1016/j.rse.2004.03.013; Thenkabail PS, 2002, PHOTOGRAMM ENG REM S, V68, P607; Tian YC, 2011, FIELD CROP RES, V120, P299, DOI 10.1016/j.fcr.2010.11.002; Titus J. G., 1988, Greenhouse effect, sea level rise and coastal wetlands, P1; Tornqvist TE, 2008, NAT GEOSCI, V1, P173, DOI 10.1038/ngeo129; Townsend PA, 2003, IEEE T GEOSCI REMOTE, V41, P1347, DOI 10.1109/TGRS.2003.813205; Turner RE, 2009, LIMNOL OCEANOGR, V54, P1634, DOI 10.4319/lo.2009.54.5.1634; USDA NRCS, 2010, PLANTS DAT; Wankel SD, 2006, LIMNOL OCEANOGR, V51, P1654, DOI 10.4319/lo.2006.51.4.1654; WESSMAN CA, 1988, NATURE, V335, P154, DOI 10.1038/335154a0; Xue LH, 2004, AGRON J, V96, P135, DOI 10.2134/agronj2004.0135; Yang YH, 2009, J VEG SCI, V20, P177, DOI 10.1111/j.1654-1103.2009.05566.x; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248; Zhao GY, 2009, J ENVIRON SCI, V21, P1393, DOI 10.1016/S1001-0742(08)62431-6	80	16	16	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90870	10.1371/journal.pone.0090870	http://dx.doi.org/10.1371/journal.pone.0090870			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614037	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300046
J	Rubin-Blum, M; Antler, G; Tsadok, R; Shemesh, E; Austin, JA; Coleman, DF; Goodman-Tchernov, BN; Ben-Avraham, Z; Tchernov, D				Rubin-Blum, Maxim; Antler, Gilad; Tsadok, Rami; Shemesh, Eli; Austin, James A., Jr.; Coleman, Dwight F.; Goodman-Tchernov, Beverly N.; Ben-Avraham, Zvi; Tchernov, Dan			First Evidence for the Presence of Iron Oxidizing Zetaproteobacteria at the Levantine Continental Margins	PLOS ONE			English	Article							HYDROTHERMAL FIELDS; MEDITERRANEAN SEA; MICROBIAL MATS; WATER; FLUX; AVAILABILITY; DIVERSITY; BASIN; BIOGEOCHEMISTRY; METAGENOMICS	During the 2010-2011 E/V Nautilus exploration of the Levantine basin's sediments at the depth of 300-1300 m, densely patched orange-yellow flocculent mats were observed at various locations along the continental margin of Israel. Cores from the mat and the control locations were collected by remotely operated vehicle system (ROV) operated by the E/V Nautilus team. Microscopic observation and phylogenetic analysis of microbial 16S and 23S rRNA gene sequences indicated the presence of zetaproteobacterial stalk forming Mariprofundus spp. - like prokaryotes in the mats. Bacterial tag-encoded FLX amplicon pyrosequencing determined that zetaproteobacterial populations were a dominant fraction of microbial community in the biofilm. We show for the first time that zetaproteobacterial may thrive at the continental margins, regardless of crustal iron supply, indicating significant fluxes of ferrous iron to the sediment-water interface. In light of this discovery, we discuss the potential bioavailability of sediment-water interface iron for organisms in the overlying water column.	[Rubin-Blum, Maxim; Tsadok, Rami; Shemesh, Eli; Goodman-Tchernov, Beverly N.; Ben-Avraham, Zvi; Tchernov, Dan] Univ Haifa, Leon H Charney Sch Marine Sci, IL-31999 Haifa, Israel; [Antler, Gilad] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Austin, James A., Jr.] Univ Texas Austin, Inst Geophys, Jackson Sch Geosci, Austin, TX USA; [Coleman, Dwight F.] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA; [Ben-Avraham, Zvi] Tel Aviv Univ, Fac Exact Sci, Dept Geophys Atmospher & Planetary Sci, Ramat Aviv, Israel	University of Haifa; University of Cambridge; University of Texas System; University of Texas Austin; University of Rhode Island; Tel Aviv University	Rubin-Blum, M (corresponding author), Univ Haifa, Leon H Charney Sch Marine Sci, IL-31999 Haifa, Israel.	mrubin.deepmed@gmail.com	Antler, Gilad/AFO-2996-2022; Tchernov, Dan/AAE-2545-2021; Antler, Gilad/T-5497-2017	Antler, Gilad/0000-0002-6865-5412; Tchernov, Dan/0000-0003-1135-8270; Antler, Gilad/0000-0002-6865-5412; Rubin Blum, Maxim/0000-0003-2953-3161; Goodman Tchernov, Beverly/0000-0003-3660-9240	European Commission [Assemble 227799]; Leon H. Charney School for Marine Sciences	European Commission(European CommissionEuropean Commission Joint Research Centre); Leon H. Charney School for Marine Sciences	Support for this project was provided by European Commission FP7 research infrastructure initiative program "Assemble 227799'' and The Leon H. Charney School for Marine Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achterberg EP, 2001, ANAL CHIM ACTA, V442, P1, DOI 10.1016/S0003-2670(01)01091-1; Azetsu-Scott K, 2004, LIMNOL OCEANOGR, V49, P741, DOI 10.4319/lo.2004.49.3.0741; Bazylinski DA, 2013, INT J SYST EVOL MICR, V63, P1824, DOI 10.1099/ijs.0.044453-0; Berman-Frank I, 2001, LIMNOL OCEANOGR, V46, P1249, DOI 10.4319/lo.2001.46.6.1249; Boyd PW, 2010, NAT GEOSCI, V3, P675, DOI [10.1038/NGEO964, 10.1038/ngeo964]; Breitbarth E, 2010, BIOGEOSCIENCES, V7, P1075, DOI 10.5194/bg-7-1075-2010; BRULAND KW, 1994, GEOCHIM COSMOCHIM AC, V58, P3171, DOI 10.1016/0016-7037(94)90044-2; Capone KA, 2011, J INVEST DERMATOL, V131, P2026, DOI 10.1038/jid.2011.168; Chan CS, 2011, ISME J, V5, P717, DOI 10.1038/ismej.2010.173; Chase Z, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002590; Coleman D, 2011, EOS T AGU, V92; Coleman DF, 2012, OCEANOGRAPHY, V25, P40; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; Dang HY, 2011, ENVIRON MICROBIOL, V13, P3059, DOI 10.1111/j.1462-2920.2011.02583.x; Danovaro R, 1999, PROG OCEANOGR, V44, P287, DOI 10.1016/S0079-6611(99)00030-0; Danovaro R, 2001, TRENDS ECOL EVOL, V16, P505, DOI 10.1016/S0169-5347(01)02215-7; Danovaro R, 1995, PROG OCEANOGR, V36, P329, DOI 10.1016/0079-6611(96)00002-X; De Rijk S, 2000, MAR MICROPALEONTOL, V40, P151, DOI 10.1016/S0377-8398(00)00037-2; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Elrod VA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020216; Emerson D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000667; Emerson D, 2010, ANNU REV MICROBIOL, V64, P561, DOI 10.1146/annurev.micro.112408.134208; Emerson D, 2010, OCEANOGRAPHY, V23, P148, DOI 10.5670/oceanog.2010.67; Eren AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026732; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P8, DOI 10.2174/1874285801004010008; Guieu C, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014454; Herut B, 2000, OCEANOL ACTA, V23, P771, DOI 10.1016/S0399-1784(00)01118-X; Hodges TW, 2009, APPL ENVIRON MICROB, V75, P1650, DOI 10.1128/AEM.01835-08; Iversen MH, 2010, BIOGEOSCIENCES, V7, P2613, DOI 10.5194/bg-7-2613-2010; Kato S, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00089; Kato S, 2009, ENVIRON MICROBIOL, V11, P3210, DOI 10.1111/j.1462-2920.2009.02031.x; Katz T, 2012, LIMNOL OCEANOGR, V57, P945, DOI 10.4319/lo.2012.57.4.0945; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Konstantinidis KT, 2003, MICROB ECOL, V45, P191, DOI 10.1007/s00248-002-1035-y; Lam PJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033294; Lam PJ, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002557; Lohan MC, 2008, ENVIRON SCI TECHNOL, V42, P6462, DOI 10.1021/es800144j; McAllister SM, 2011, APPL ENVIRON MICROB, V77, P5445, DOI 10.1128/AEM.00533-11; McBeth JM, 2013, ENV MICROBIOL REP, V5, P453, DOI 10.1111/1758-2229.12033; McBeth JM, 2011, APPL ENVIRON MICROB, V77, P1405, DOI 10.1128/AEM.02095-10; Nei M., 2000, MOL EVOLUTION PHYLOG; Omoregie EO, 2008, APPL ENVIRON MICROB, V74, P3198, DOI 10.1128/AEM.01751-07; Ortega-Osorio A, 2001, CAN MINERAL, V39, P17, DOI 10.2113/gscanmin.39.1.17; Pakhornova SV, 2007, MAR CHEM, V107, P319, DOI 10.1016/j.marchem.2007.06.001; RICH HW, 1990, LIMNOL OCEANOGR, V35, P652, DOI 10.4319/lo.1990.35.3.0652; Sanchez E, 2004, GLOBAL PLANET CHANGE, V44, P163, DOI 10.1016/j.gloplacha.2004.06.010; Sarthou G, 2001, MAR CHEM, V74, P115, DOI 10.1016/S0304-4203(00)00119-5; Severmann S, 2010, GEOCHIM COSMOCHIM AC, V74, P3984, DOI 10.1016/j.gca.2010.04.022; Shaked Y, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00123; Singer E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025386; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Sundby B, 2006, MAR CHEM, V102, P2, DOI 10.1016/j.marchem.2005.09.016; Swanson KS, 2011, ISME J, V5, P639, DOI 10.1038/ismej.2010.162; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka T, 2007, DEEP-SEA RES PT I, V54, P1721, DOI 10.1016/j.dsr.2007.06.008; Theodosi C, 2010, MAR CHEM, V120, P100, DOI 10.1016/j.marchem.2008.05.004; Tolika K, 2013, EGU GEN ASS 2013, P2922; Toner BM, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00118; Viollier E, 2000, APPL GEOCHEM, V15, P785, DOI 10.1016/S0883-2927(99)00097-9; WESTERLUND S, 1991, MAR CHEM, V35, P199, DOI 10.1016/S0304-4203(09)90018-4; Wommack KE, 2008, APPL ENVIRON MICROB, V74, P1453, DOI 10.1128/AEM.02181-07; Wu JF, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001453; Yogev T, 2011, ENVIRON MICROBIOL, V13, P854, DOI 10.1111/j.1462-2920.2010.02402.x; Zhang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006108	67	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91456	10.1371/journal.pone.0091456	http://dx.doi.org/10.1371/journal.pone.0091456			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614177	Green Published, gold, Green Submitted			2022-12-25	WOS:000332839300129
J	Schacht, A; Sommer, W; Shmuilovich, O; Martienz, PC; Martin-Loeches, M				Schacht, Annekathrin; Sommer, Werner; Shmuilovich, Olga; Casado Martienz, Pilar; Martin-Loeches, Manuel			Differential Task Effects on N400 and P600 Elicited by Semantic and Syntactic Violations	PLOS ONE			English	Article							SENTENCE COMPREHENSION; BRAIN POTENTIALS; WORKING-MEMORY; POSITIVE SHIFT; ERP; P300; INDEPENDENCE; SPECIFICITY; LEVEL	Syntactic violations in sentences elicit a P600 component in the event-related potential, which is frequently interpreted as signaling reanalysis or repair of the sentence structure. However, P600 components have been reported also for semantic and combined semantic and syntactic violations, giving rise to still other interpretations. In many of these studies, the violation might be of special significance for the task of the participants; however there is a lack of studies directly targeting task effects on the P600. Here we repeated a previously published study but using a probe verification task, focusing on individual words rather than on sentence correctness and directly compared the results with the previous ones. Although a (somewhat smaller) N400 component occurred also in the present study, we did not observe a parietal P600 component. Instead, we found a late anterior negativity. Possibly, the parietal P600 observed in sentence acceptability paradigms relates to the target value of the violations or to late sentence structure-specific processes that are more task-sensitive than the N400 and which are or not initiated in the probe verification task. In any case the present findings show a strong dependency of P600-eliciting processes from attention to the sentences context whereas the N400 eliciting processes appear relatively robust.	[Schacht, Annekathrin] Univ Gottingen, CRC Text Struct, D-37073 Gottingen, Germany; [Sommer, Werner; Shmuilovich, Olga] Humboldt Univ, Dept Psychol, D-10099 Berlin, Germany; [Casado Martienz, Pilar; Martin-Loeches, Manuel] UCM ISCIII, Ctr Human Evolut & Behav, Madrid, Spain	University of Gottingen; Humboldt University of Berlin	Sommer, W (corresponding author), Humboldt Univ, Dept Psychol, D-10099 Berlin, Germany.	Werner.Sommer@cms.HU-Berlin.de	Sommer, Werner/N-1945-2019; Schacht, Annekathrin/B-2521-2014; Sommer, Werner/H-4672-2011; Martin-Loeches, Manuel/G-4288-2017	Sommer, Werner/0000-0001-5266-3445; Sommer, Werner/0000-0001-5266-3445; Martin-Loeches, Manuel/0000-0002-3487-8423; Schacht, Anne/0000-0001-9471-3842	Erasmus exchange program of the European Union; German Initiative of Excellence	Erasmus exchange program of the European Union; German Initiative of Excellence	This research was supported by a grant of the Erasmus exchange program of the European Union to OS and by the German Initiative of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggio G, 2008, J MEM LANG, V59, P36, DOI 10.1016/j.jml.2008.02.005; Bargh J.A., 1994, HDB SOCIAL COGNITION, P1; CHWILLA DJ, 1995, PSYCHOPHYSIOLOGY, V32, P274, DOI 10.1111/j.1469-8986.1995.tb02956.x; Coulson S, 1998, LANG COGNITIVE PROC, V13, P21, DOI 10.1080/016909698386582; Deacon D, 2000, FRONT BIOSCI, V5, pE82, DOI 10.2741/deacon; Friederici AD, 1999, MEM COGNITION, V27, P438, DOI 10.3758/BF03211539; Friederici AD, 2001, COGNITIVE BRAIN RES, V11, P305, DOI 10.1016/S0926-6410(00)00065-3; Gunter TC, 1999, PSYCHOPHYSIOLOGY, V36, P126, DOI 10.1017/S004857729997155X; Gunter TC, 1997, PSYCHOPHYSIOLOGY, V34, P660, DOI 10.1111/j.1469-8986.1997.tb02142.x; Hagoort P, 2003, J COGNITIVE NEUROSCI, V15, P883, DOI 10.1162/089892903322370807; HAGOORT P, 1993, LANG COGNITIVE PROC, V8, P439, DOI 10.1080/01690969308407585; Hahne A, 1999, J COGNITIVE NEUROSCI, V11, P194, DOI 10.1162/089892999563328; Ille N, 2002, J CLIN NEUROPHYSIOL, V19, P113, DOI 10.1097/00004691-200203000-00002; Jiang XM, 2009, NEUROPSYCHOLOGIA, V47, P1799, DOI 10.1016/j.neuropsychologia.2009.02.020; JOHNSON R, 1986, PSYCHOPHYSIOLOGY, V23, P367, DOI 10.1111/j.1469-8986.1986.tb00649.x; JONIDES J, 1985, ACTA PSYCHOL, V60, P157, DOI 10.1016/0001-6918(85)90053-8; Kim A, 2005, J MEM LANG, V52, P205, DOI 10.1016/j.jml.2004.10.002; KING JW, 1995, J COGNITIVE NEUROSCI, V7, P376, DOI 10.1162/jocn.1995.7.3.376; Kolk HHJ, 2003, BRAIN LANG, V85, P1, DOI 10.1016/S0093-934X(02)00548-5; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; Kuperberg GR, 2003, COGNITIVE BRAIN RES, V17, P117, DOI 10.1016/S0926-6410(03)00086-7; Kutas M., 2006, HDB PSYCHOLINGUISTIC; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Martin-Loeches M, 2006, BRAIN RES, V1093, P178, DOI 10.1016/j.brainres.2006.03.094; Martin-Loeches M, 2009, J COGNITIVE NEUROSCI, V21, P1365, DOI 10.1162/jocn.2009.21106; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; Munte TF, 1998, NEUROPSYCHOLOGIA, V36, P217, DOI 10.1016/S0028-3932(97)00119-X; NEVILLE H, 1991, J COGNITIVE NEUROSCI, V3, P151, DOI 10.1162/jocn.1991.3.2.151; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; Osterhout L, 1999, LANG COGNITIVE PROC, V14, P283, DOI 10.1080/016909699386310; Osterhout L, 1996, J COGNITIVE NEUROSCI, V8, P507, DOI 10.1162/jocn.1996.8.6.507; Osterhout L, 1995, J MEM LANG, V34, P739, DOI 10.1006/jmla.1995.1033; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Schacht A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009742; Sebastian N., 2000, LEXESP LEXICO INFORM; Steinhauer K, 1997, Z EXP PSYCHOL, V44, P305; VANPETTEN C, 1991, MEM COGNITION, V19, P95, DOI 10.3758/BF03198500	39	44	46	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91226	10.1371/journal.pone.0091226	http://dx.doi.org/10.1371/journal.pone.0091226			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9FH	24614675	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300099
J	Hawker, GA; Croxford, R; Bierman, AS; Harvey, PJ; Ravi, B; Stanaitis, I; Lipscombe, LL				Hawker, Gillian A.; Croxford, Ruth; Bierman, Arlene S.; Harvey, Paula J.; Ravi, Bheeshma; Stanaitis, Ian; Lipscombe, Lorraine L.			All-Cause Mortality and Serious Cardiovascular Events in People with Hip and Knee Osteoarthritis: A Population Based Cohort Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; OLDER-ADULTS; PREVALENCE; MANAGEMENT; HEALTH; PAIN; RECOMMENDATIONS; HYPERTENSION; DEPRESSION; ARTHRITIS	Background: Because individuals with osteoarthritis (OA) avoid physical activities that exacerbate symptoms, potentially increasing risk for cardiovascular disease (CVD) and death, we assessed the relationship between OA disability and these outcomes. Methods: In a population cohort aged 55+ years with at least moderately severe symptomatic hip and/or knee OA, OA disability (Western Ontario McMaster Universities (WOMAC) OA scores; Health Assessment Questionnaire (HAQ) walking score; use of walking aids) and other covariates were assessed by questionnaire. Survey data were linked to health administrative data to determine the relationship between baseline OA symptom severity to all-cause mortality and occurrence of a composite CVD outcome (acute myocardial infarction, coronary revascularization, heart failure, stroke or transient ischemic attack) over a median follow-up of 13.2 and 9.2 years, respectively. Results: Of 2156 participants, 1,236 (57.3%) died and 822 (38.1%) experienced a CVD outcome during follow-up. Higher (worse) baseline WOMAC function scores and walking disability were independently associated with a higher all-cause mortality (adjusted hazard ratio, aHR, per 10-point increase in WOMAC function score 1.04, 95% confidence interval, CI 1.01-1.07, p = 0.004; aHR per unit increase in HAQ walking score 1.30, 95% CI 1.22-1.39, p<0.001; and aHR for those using versus not using a walking aid 1.51, 95% CI 1.34-1.70, p<0.001). In survival analysis, censoring on death, risk of our composite CVD outcome was also significantly and independently associated with greater baseline walking disability ((aHR for use of a walking aid = 1.27, 95% CI 1.10-1.47, p = 0.001; aHR per unit increase in HAQ walking score = 1.17, 95% CI 1.08-1.27, p<0.001). Conclusions: Among individuals with hip and/or knee OA, severity of OA disability was associated with a significant increase in all-cause mortality and serious CVD events after controlling for multiple confounders. Research is needed to elucidate modifiable mechanisms.	[Hawker, Gillian A.; Harvey, Paula J.; Stanaitis, Ian; Lipscombe, Lorraine L.] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [Hawker, Gillian A.; Bierman, Arlene S.; Ravi, Bheeshma; Lipscombe, Lorraine L.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Hawker, Gillian A.; Croxford, Ruth; Bierman, Arlene S.; Lipscombe, Lorraine L.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Hawker, Gillian A.; Bierman, Arlene S.; Harvey, Paula J.; Lipscombe, Lorraine L.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Bierman, Arlene S.] Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON, Canada; [Ravi, Bheeshma] Univ Toronto, Dept Surg, Div Orthopaed, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Hawker, GA (corresponding author), Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada.	g.hawker@utoronto.ca		Lipscombe, Lorraine/0000-0001-7412-7993	Canadian Institutes of Health Research [MOP-15468]; Institute for Clinical Evaluative Sciences (ICES); Ontario Ministry of Health and Long-Term Care	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario)	This study was funded by an operating grant from the Canadian Institutes of Health Research, grant # MOP-15468. This study was also supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No endorsement by ICES or the Ontario Ministry of Health and Long-Term Care is intended or should be inferred. ICES had no role in the study design, collection, analysis, or interpretation of the data, writing of the report, or in the decision to submit the report for publication.	Alter DA, 2006, ANN INTERN MED, V144, P82, DOI 10.7326/0003-4819-144-2-200601170-00005; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Butchart A, 2009, CLIN J PAIN, V25, P293, DOI 10.1097/AJP.0b013e31818bf574; Centers for Medicare & Medicaid Services, 2012, CHRONIC CONDITIONS M; Choodari-Oskooei B, 2012, STAT MED, V31, P2627, DOI 10.1002/sim.4242; Freedman VA, 2000, AM J PUBLIC HEALTH, V90, P1755, DOI 10.2105/AJPH.90.11.1755; Friedman B, 2005, J AM GERIATR SOC, V53, P1978, DOI 10.1111/j.1532-5415.2005.00469.x; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Gulati M, 2005, NEW ENGL J MED, V353, P468, DOI 10.1056/NEJMoa044154; Gunther JP, 2001, BEST PRACT RES CL RH, V15, P627, DOI 10.1053/berh.2001.0178; Hackam DG, 2010, CAN J CARDIOL, V26, P249, DOI 10.1016/S0828-282X(10)70379-2; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1161/CIRCULATIONAHA.107.185649; Hawker GA, 2001, MED CARE, V39, P206, DOI 10.1097/00005650-200103000-00002; Hawker GA, 2011, ARTHRIT CARE RES, V63, P1382, DOI 10.1002/acr.20298; Hawker GA, 2009, MED CARE, V47, P732, DOI 10.1097/MLR.0b013e3181934553; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Lee DS, 2009, CAN MED ASSOC J, V181, pE55, DOI 10.1503/cmaj.081629; Leffondre K, 2004, J CLIN EPIDEMIOL, V57, P1049, DOI 10.1016/j.jclinepi.2004.02.012; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Nuesch E, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1165; Paterson MJ, 2006, TOTAL HIP KNEE REPLA; Perruccio AV, 2006, J RHEUMATOL, V33, P1856; Rankin EA, 2004, J BONE JOINT SURG AM, V86A, P1328; Ravi B, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6187; Sale JEM, 2006, ARTHRIT RHEUM-ARTHR, V55, P272, DOI 10.1002/art.21853; Statistics Canada, 2011, HLTH TRENDS; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; Tu JV, 2009, CAN MED ASSOC J, V180, pE118, DOI 10.1503/cmaj.081197; Tu K, 2008, CAN MED ASSOC J, V178, P1429, DOI 10.1503/cmaj.071283; Tu Karen, 2007, Open Med, V1, pe18; Vinluan CM, 2012, METABOLISM, V61, P302, DOI 10.1016/j.metabol.2011.07.002; Weiner J., 2011, J HOPKINS ACG SYSTEM; World Health Organization, 2012, WORLD HLTH STAT 2012; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013	37	144	152	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91286	10.1371/journal.pone.0091286	http://dx.doi.org/10.1371/journal.pone.0091286			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608134	Green Published, gold			2022-12-25	WOS:000332485800123
J	Mukherjee, R; Kim, SW; Choi, MS; Yun, JW				Mukherjee, Rajib; Kim, Sang Woo; Choi, Myung Sook; Yun, Jong Won			Sex-Dependent Expression of Caveolin 1 in Response to Sex Steroid Hormones Is Closely Associated with Development of Obesity in Rats	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; BROWN ADIPOSE-TISSUE; DIET-INDUCED OBESITY; INSULIN SENSITIVITY; ANDROGEN RECEPTOR; SKELETAL-MUSCLE; CAVEOLIN-1-DEFICIENT MICE; PROTEIN EXPRESSION; LIPID-METABOLISM; GENE-EXPRESSION	Caveolin-1 (CAV1) is a conserved group of structural membrane proteins that form special cholesterol and sphingolipid-rich compartments, especially in adipocytes. Recently, it has been reported that CAV1 is an important target protein in sex hormone-dependent regulation of various metabolic pathways, particularly in cancer and diabetes. To clarify distinct roles of CAV1 in sex-dependent obesity development, we investigated the effects of high fat diet (HFD) and sex steroid hormones on CAV1 expression in adipose tissues of male and female rats. Results of animal experiments revealed that estrogen (17-beta-estradiol, E2) and androgen (dihydrotestosterone, DHT) had opposite effects on body weight gain as well as on the regulation of CAV1, hormone sensitive lipase (HSL) and uncoupling protein 1 (UCP1) in adipose tissues. Furthermore, sex hormone receptors and aromatase were differentially expressed in a sex-dependent manner in response to E2 and DHT treatments. In vivo data were confirmed using 3T3-L1 and HIB1B cell lines, where Cav1 knock down stimulated lipogenesis but suppressed sex hormone receptor signaling proteins. Most importantly, co-immunoprecipitation enabled the identification of previously unrecognized CAV1-interacting mitochondrial or lipid oxidative pathway proteins in adipose tissues. Taken together, current data showed that CAV1 may play important preventive role in the development of obesity, with more prominent effects in females, and proved to be an important target protein for the hormonal regulation of adipose tissue metabolism by manipulating sex hormone receptors and mitochondrial oxidative pathways. Therefore, we can report, for the first time, the molecular mechanism underlying the effects of sex steroid hormones in the sex-dimorphic regulation of CAV1.	[Mukherjee, Rajib; Kim, Sang Woo; Yun, Jong Won] Daegu Univ, Dept Biotechnol, Kyungsan, South Korea; [Choi, Myung Sook] Kyungpook Natl Univ, Ctr Food & Nutr Genom Res, Taegu, South Korea; [Choi, Myung Sook] Kyungpook Natl Univ, Dept Food Sci & Nutr, Taegu, South Korea	Daegu University; Kyungpook National University; Kyungpook National University	Yun, JW (corresponding author), Daegu Univ, Dept Biotechnol, Kyungsan, South Korea.	jwyun@daegu.ac.kr	Mukherjee, Rajib/J-9195-2019	Mukherjee, Rajib/0000-0002-3509-4997; Kim, Sang Woo/0000-0002-3144-4822; Yun, Jong Won/0000-0003-2453-2282	Mid-career Researcher Program through NRF [2013R1A2A2A05004195]; SRC Program (Center for Food & Nutritional Genomics) through NRF [2008-0062157]; Ministry of Science, ICT and Future Planning, Korea	Mid-career Researcher Program through NRF; SRC Program (Center for Food & Nutritional Genomics) through NRF; Ministry of Science, ICT and Future Planning, Korea	This work was supported by the Mid-career Researcher Program (2013R1A2A2A05004195) and SRC Program (Center for Food & Nutritional Genomics: grant number 2008-0062157) through NRF grant funded by the Ministry of Science, ICT and Future Planning, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LA, 2002, DIABETES OBES METAB, V4, P209, DOI 10.1046/j.1463-1326.2002.00214.x; Asterholm IW, 2012, CELL METAB, V15, P171, DOI 10.1016/j.cmet.2012.01.004; Babaei Parvin, 2010, Menopause Int, V16, P100, DOI 10.1258/mi.2010.010028; Baghaei F, 2003, OBES RES, V11, P578, DOI 10.1038/oby.2003.81; Basu R, 2007, DIABETES CARE, V30, P1972, DOI 10.2337/dc07-0359; Bosch M, 2011, CURR BIOL, V21, P681, DOI 10.1016/j.cub.2011.03.030; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Briand N, 2011, DIABETES, V60, P448, DOI 10.2337/db10-0856; Bryzgalova G, 2008, AM J PHYSIOL-ENDOC M, V295, pE904, DOI 10.1152/ajpendo.90248.2008; Butera PC, 2010, PHYSIOL BEHAV, V99, P142, DOI 10.1016/j.physbeh.2009.10.009; Campbell L, 2001, ADV DRUG DELIVER REV, V49, P325, DOI 10.1016/S0169-409X(01)00145-4; Catalan V, 2008, CLIN ENDOCRINOL, V68, P213, DOI 10.1111/j.1365-2265.2007.03021.x; Choi DK, 2011, CELL PHYSIOL BIOCHEM, V28, P933, DOI 10.1159/000335807; Choi HR, 2012, J MICROBIOL BIOTECHN, V22, P1029, DOI 10.4014/jmb.1112.12059; Choi JW, 2010, PROTEOMICS, V10, P4386, DOI 10.1002/pmic.201000391; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Cohen AW, 2005, DIABETES, V54, P679, DOI 10.2337/diabetes.54.3.679; Cohen AW, 2004, DIABETES, V53, P1261, DOI 10.2337/diabetes.53.5.1261; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V285, pC222, DOI 10.1152/ajpcell.00006.2003; D'Eon TM, 2005, J BIOL CHEM, V280, P35983, DOI 10.1074/jbc.M507339200; Dieudonne MN, 2004, AM J PHYSIOL-CELL PH, V286, pC655, DOI 10.1152/ajpcell.00321.2003; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Fan WQ, 2005, DIABETES, V54, P1000, DOI 10.2337/diabetes.54.4.1000; Faulds MH, 2012, J ENDOCRINOL, V212, P3, DOI 10.1530/JOE-11-0044; Fernandez MA, 2006, SCIENCE, V313, P1628, DOI 10.1126/science.1130773; Fernandez-Real JM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-20; Foryst-Ludwig A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000108; Fujioka K, 2012, AM J PHYSIOL-ENDOC M, V302, pE694, DOI 10.1152/ajpendo.00112.2011; Gao H, 2006, MOL ENDOCRINOL, V20, P1287, DOI 10.1210/me.2006-0012; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Haring R, 2009, DIABETES, V58, P2027, DOI 10.2337/db09-0031; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Jayachandran M, 2001, AM J PHYSIOL-HEART C, V281, pH1327, DOI 10.1152/ajpheart.2001.281.3.H1327; Jedrzejuk D, 2003, Aging Male, V6, P151, DOI 10.1080/713604785; Jeong S, 2011, ACTA PHARMACOL SIN, V32, P230, DOI 10.1038/aps.2010.198; Jones MEE, 2000, P NATL ACAD SCI USA, V97, P12735, DOI 10.1073/pnas.97.23.12735; Joo JI, 2011, CELL PHYSIOL BIOCHEM, V27, P327, DOI 10.1159/000327959; Joo JI, 2011, PROTEOMICS, V11, P1429, DOI 10.1002/pmic.201000515; Kanaya N, 2013, J STEROID BIOCHEM, V138, P100, DOI 10.1016/j.jsbmb.2013.04.001; Karamanlidis G, 2007, J BIOL CHEM, V282, P24660, DOI 10.1074/jbc.M703101200; Kim DH, 2011, J PROTEOME RES, V10, P1281, DOI 10.1021/pr101048q; Kramarova TV, 2009, METABOLISM, V6, pe49, DOI DOI 10.1016/J.DDMEC.2009.11.001; Le Lay S, 2009, BBA-MOL CELL BIOL L, V1791, P514, DOI 10.1016/j.bbalip.2008.10.008; Li WP, 2001, J CELL SCI, V114, P1397; Liu H, 2012, PROTEOMICS, V12, P269, DOI 10.1002/pmic.201100127; Liu PS, 2002, J BIOL CHEM, V277, P41295, DOI 10.1074/jbc.R200020200; Lu ML, 2001, J BIOL CHEM, V276, P13442, DOI 10.1074/jbc.M006598200; Mahmoudi M, 2003, J PATHOL, V200, P396, DOI 10.1002/path.1368; Mattiasson I, 2002, HORM METAB RES, V34, P583, DOI 10.1055/s-2002-35420; Mattsson CL, 2010, BBA-MOL CELL RES, V1803, P983, DOI 10.1016/j.bbamcr.2010.03.015; McInnes KJ, 2012, DIABETES, V61, P1072, DOI 10.2337/db11-1136; Monjo M, 2003, ENDOCRINOLOGY, V144, P4923, DOI 10.1210/en.2003-0537; Moverare-Skrtic S, 2006, OBESITY, V14, P662, DOI 10.1038/oby.2006.75; Mukherjee R, 2013, MOL BIOL REP, V40, P3783, DOI 10.1007/s11033-012-2455-5; Mukherjee R, 2012, CELL PHYSIOL BIOCHEM, V29, P617, DOI 10.1159/000338515; Nadal A, 2001, NEWS PHYSIOL SCI, V16, P251; Oh TS, 2011, CELL PHYSIOL BIOCHEM, V28, P981, DOI 10.1159/000335811; Oh YS, 2008, DIABETOLOGIA, V51, P1025, DOI 10.1007/s00125-008-0993-0; Oh YS, 2011, MOL MED, V17, P4, DOI 10.2119/molmed.2009.00105; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Oliveira PJ, 2012, J LIPIDS, V2012, DOI 10.1155/2012/365798; Palin SL, 2003, METABOLISM, V52, P383, DOI 10.1053/meta.2003.50088; Pedersen SB, 2001, BIOCHEM BIOPH RES CO, V288, P191, DOI 10.1006/bbrc.2001.5763; Pirwany IR, 2002, HUM REPROD, V17, P825, DOI 10.1093/humrep/17.3.825; Quarta C, 2012, J MOL ENDOCRINOL, V49, pR1, DOI 10.1530/JME-12-0043; Razandi M, 2002, MOL ENDOCRINOL, V16, P100, DOI 10.1210/me.16.1.100; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Razani B, 2001, J CLIN INVEST, V108, P1553, DOI 10.1172/JCI14611; Relling DP, 2006, J HYPERTENS, V24, P549, DOI 10.1097/01.hjh.0000203846.34314.94; Rodriguez AM, 2002, CELL MOL LIFE SCI, V59, P1714, DOI 10.1007/PL00012499; Schlegel A, 1999, J BIOL CHEM, V274, P33551, DOI 10.1074/jbc.274.47.33551; Schwencke C, 2006, CARDIOVASC RES, V70, P42, DOI 10.1016/j.cardiores.2005.11.029; Slocum N, 2013, EXP TOXICOL PATHOL, V65, P549, DOI 10.1016/j.etp.2012.04.001; Sonnino S, 2009, FEBS LETT, V583, P597, DOI 10.1016/j.febslet.2009.01.007; Sud N, 2010, MOL ENDOCRINOL, V24, P1637, DOI 10.1210/me.2010-0043; Wang X, 2012, PROTEOMICS, V12, P284, DOI 10.1002/pmic.201100271; Wang X, 2011, BRIT J NUTR, V106, P612, DOI 10.1017/S0007114511000651; Weigt C, 2013, MOL CELL ENDOCRINOL, V377, P147, DOI 10.1016/j.mce.2013.07.007; YAMADA K, 1990, BIOCHEM BIOPH RES CO, V169, P531, DOI 10.1016/0006-291X(90)90363-R; Yamamoto M, 1998, J BIOL CHEM, V273, P26962, DOI 10.1074/jbc.273.41.26962	81	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90918	10.1371/journal.pone.0090918	http://dx.doi.org/10.1371/journal.pone.0090918			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608114	gold, Green Submitted, Green Published			2022-12-25	WOS:000332485800066
J	Pei, ZJ; Lan, XL; Cheng, Z; Qin, CX; Xia, XT; Yuan, H; Ding, ZL; Zhang, YX				Pei, Zhijun; Lan, Xiaoli; Cheng, Zhen; Qin, Chunxia; Xia, Xiaotian; Yuan, Hui; Ding, Zhiling; Zhang, Yongxue			Multimodality Molecular Imaging to Monitor Transplanted Stem Cells for the Treatment of Ischemic Heart Disease	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; TYPE-1 THYMIDINE KINASE; REPORTER GENE; MYOCARDIAL-INFARCTION; BIOLUMINESCENCE; SURVIVAL; THERAPY; PET; DELIVERY; SIZE	Purpose: Non-invasive techniques to monitor the survival and migration of transplanted stem cells in real-time is crucial for the success of stem cell therapy. The aim of this study was to explore multimodality molecular imaging to monitor transplanted stem cells with a triple-fused reporter gene [TGF; herpes simplex virus type 1 thymidine kinase (HSV1-tk), enhanced green fluorescence protein (eGFP), and firefly luciferase (FLuc)] in acute myocardial infarction rat models. Methods: Rat myocardial infarction was established by ligating the left anterior descending coronary artery. A recombinant adenovirus carrying TGF (Ad5-TGF) was constructed. After transfection with Ad5-TGF, 5x10(6) bone marrow mesenchymal stem cells (BMSCs) were transplanted into the anterior wall of the left ventricle (n = 14). Untransfected BMSCs were as controls (n = 8). MicroPET/CT, fluorescence and bioluminescence imaging were performed. Continuous images were obtained at day 2, 3 and 7 after transplantation with all three imaging modalities and additional images were performed with bioluminescence imaging until day 15 after transplantation. Results: High signals in the heart area were observed using microPET/CT, fluorescence and bioluminescence imaging of infarcted rats injected with Ad5-TGF-transfected BMSCs, whereas no signals were observed in controls. Semi-quantitative analysis showed the gradual decrease of signals in all three imaging modalities with time. Immunohistochemistry assays confirmed the location of the TGF protein expression was the same as the site of stem cell-specific marker expression, suggesting that TGF tracked the stem cells in situ. Conclusions: We demonstrated that TGF could be used as a reporter gene to monitor stem cells in a myocardial infarction model by multimodality molecular imaging.	[Pei, Zhijun; Lan, Xiaoli; Qin, Chunxia; Xia, Xiaotian; Yuan, Hui; Ding, Zhiling; Zhang, Yongxue] Huazhong Univ Sci & Technol, Tongji Med Coll, Hubei Prov Key Lab Mol Imaging, Dept Nucl Med,Union Hosp, Wuhan 430074, Peoples R China; [Pei, Zhijun] Hubei Univ Med, Taihe Hosp, Dept PET Ctr, Shiyan City, Hubei Province, Peoples R China; [Cheng, Zhen] Stanford Univ, Mol Imaging Program, Stanford & Biox Program, Stanford, CA 94305 USA	Huazhong University of Science & Technology; Hubei University of Medicine; Stanford University	Lan, XL (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Hubei Prov Key Lab Mol Imaging, Dept Nucl Med,Union Hosp, Wuhan 430074, Peoples R China.	LXL730724@hotmail.com; zhyx1229@163.com	qin, chunxia/GPG-1369-2022; Xia, Xiaotian/GWK-0088-2022; Cheng, Zhen/K-2843-2012	Cheng, Zhen/0000-0001-8177-9463; Pei, Zhijun/0000-0001-6125-0626; Yuan, Hui/0000-0002-9122-3407	National Natural Science Foundation of China [30830041, 30571816, 30772208, 30970853]; China Postdoctoral Science Foundation [2005037194]; Hubei Province Science Fund for Distinguished Young Scholars [2010CDA094]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Hubei Province Science Fund for Distinguished Young Scholars	This study was supported by the National Natural Science Foundation of China (No. 30830041, 30571816, 30772208, and 30970853) (http://www.nsfc.gov.cn/Portal0/default152.htm), the China Postdoctoral Science Foundation (2005037194) (http://211.166.12.38/V1/Program1/Default.aspx), and Hubei Province Science Fund for Distinguished Young Scholars (2010CDA094) (http://www.hbstd.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao F, 2006, CIRCULATION, V113, P1005, DOI 10.1161/CIRCULATIONAHA.105.588954; Clifford DM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006536.pub3; Contag CH, 2007, ANNU REV PATHOL-MECH, V2, P277, DOI 10.1146/annurev.pathol.2.010506.091930; Copland IB, 2009, STEM CELLS, V27, P467, DOI 10.1634/stemcells.2008-0520; Deuse T, 2009, CIRCULATION, V120, pS247, DOI 10.1161/CIRCULATIONAHA.108.843680; FISHBEIN MC, 1978, AM J PATHOL, V90, P57; Gyongyosi M, 2008, CIRC-CARDIOVASC IMAG, V1, P94, DOI 10.1161/CIRCIMAGING.108.797449; Higuchi T, 2009, J NUCL MED, V50, P1088, DOI 10.2967/jnumed.108.060665; Higuchi T, 2009, J NUCL MED, V50, P1881, DOI 10.2967/jnumed.109.067801; Hu S, 2011, MOL IMAGING, V10, P227, DOI 10.2310/7290.2010.00051; Inubushi M, 2007, EUR J NUCL MED MOL I, V34, pS27, DOI 10.1007/s00259-007-0438-x; Jaffer FA, 2007, CIRCULATION, V116, P1052, DOI 10.1161/CIRCULATIONAHA.106.647164; Jang YY, 2012, MOL IMAGING, V11, P1; JOHNS TNP, 1954, ANN SURG, V140, P675, DOI 10.1097/00000658-195411000-00006; Krause U, 2007, STEM CELLS DEV, V16, P31, DOI 10.1089/scd.2006.0089; Li WZ, 2007, STEM CELLS, V25, P2118, DOI 10.1634/stemcells.2006-0771; Love Z, 2007, J NUCL MED, V48, P2011, DOI 10.2967/jnumed.107.043166; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Min JJ, 2006, ANN NUCL MED, V20, P165, DOI 10.1007/BF03027425; Orlic D, 2003, PEDIATR TRANSPLANT, V7, P86, DOI 10.1034/j.1399-3046.7.s3.13.x; Pei ZJ, 2012, NUCL MED BIOL, V39, P813, DOI 10.1016/j.nucmedbio.2011.12.014; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; Picinich SC, 2007, EXPERT OPIN BIOL TH, V7, P965, DOI 10.1517/14712598.7.7.965; Plewka M, 2011, KARDIOL POL, V69, P1234; Price MJ, 2006, INT J CARDIOL, V111, P231, DOI 10.1016/j.ijcard.2005.07.036; Rodriguez-Porcel M., 2008, STEMBOOK; Roelants V, 2008, J NUCL MED, V49, P1836, DOI 10.2967/jnumed.108.052175; Schafer R, 2008, PANMINERVA MED, V50, P31; Sheikh AY, 2007, STEM CELLS, V25, P2677, DOI 10.1634/stemcells.2007-0041; Song SW, 2009, STEM CELLS, V27, P1358, DOI 10.1002/stem.47; Sun LJ, 2007, BIOCHEM BIOPH RES CO, V357, P779, DOI 10.1016/j.bbrc.2007.04.010; Tarnavski O, 2004, PHYSIOL GENOMICS, V16, P349, DOI 10.1152/physiolgenomics.00041.2003; Wang HE, 2006, J NUCL MED, V47, P1161; Weissleder R, 1999, RADIOLOGY, V212, P609, DOI 10.1148/radiology.212.3.r99se18609; Willmann JK, 2009, RADIOLOGY, V252, P117, DOI 10.1148/radiol.2513081616; Wolf D, 2007, J AM SOC ECHOCARDIOG, V20, P512, DOI 10.1016/j.echo.2006.11.008; Wu JC, 2006, PHYSIOL GENOMICS, V25, P29, DOI 10.1152/physiolgenomics.00254.2005; Wu JC, 2003, CIRCULATION, V108, P1302, DOI 10.1161/01.CIR.0000091252.20010.6E; Yaghoubi SS, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2821415; Yaghoubi SS, 2006, J NUCL MED, V47, P706	40	17	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90543	10.1371/journal.pone.0090543	http://dx.doi.org/10.1371/journal.pone.0090543			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608323	gold, Green Published, Green Submitted			2022-12-25	WOS:000332485800031
J	Thierfelder, KM; Meimarakis, G; Nikolaou, K; Sommer, WH; Schmitt, P; Kazmierczak, PM; Reiser, MF; Theisen, D				Thierfelder, Kolja M.; Meimarakis, Georgios; Nikolaou, Konstantin; Sommer, Wieland H.; Schmitt, Peter; Kazmierczak, Philipp M.; Reiser, Maximilian F.; Theisen, Daniel			Non-Contrast-Enhanced MR Angiography at 3 Tesla in Patients with Advanced Peripheral Arterial Occlusive Disease	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; NEPHROGENIC SYSTEMIC FIBROSIS; VASCULAR-DISEASE; METAANALYSIS; EXPERIENCE; ACCURACY; CT	Purpose: The aim of this study was to assess the diagnostic performance of ECG-gated non-contrast-enhanced quiescent interval single-shot (QISS) magnetic resonance angiography at a magnetic field strength of 3 Tesla in patients with advanced peripheral arterial occlusive disease (PAOD). Method and Materials: A total of 21 consecutive patients with advanced PAOD (Fontaine stage IIb and higher) referred for peripheral magnetic resonance angiography (MRA) were included. Imaging was performed on a 3 T whole body MR. Image quality and stenosis diameter were evaluated in comparison to contrast-enhanced continuous table and TWIST MRA (CE-MRA) as standard of reference. QISS images were acquired with a thickness of 1.5 mm each (high-resolution QISS, HR-QISS). Two blinded readers rated the image quality and the degree of stenosis for both HR-QISS and CE-MRA in 26 predefined arterial vessel segments on 5-point Likert scales. Results: With CE-MRA as the reference standard, HR-QISS showed high sensitivity (94.1%), specificity (97.8%), positive (95.1%), and negative predictive value (97.2%) for the detection of significant (>= 50%) stenosis. Interreader agreement for stenosis assessment of both HR-QISS and CE-MRA was excellent (kappa-values of 0.951 and 0.962, respectively). As compared to CR-MRA, image quality of HR-QISS was significantly lower for the distal aorta, the femoral and iliac arteries (each with p<0.01), while no significant difference was found in the popliteal (p = 0.09) and lower leg arteries (p = 0.78). Conclusion: Non-enhanced ECG-gated HR-QISS performs very well in subjects with severe PAOD and is a good alternative for patients with a high risk of nephrogenic systemic fibrosis.	[Thierfelder, Kolja M.; Nikolaou, Konstantin; Sommer, Wieland H.; Kazmierczak, Philipp M.; Reiser, Maximilian F.; Theisen, Daniel] Ludwig Maximilians Univ Hosp, Dept Clin Radiol, Munich, Germany; [Meimarakis, Georgios] Ludwig Maximilians Univ Hosp, Dept Vasc & Endovasc Surg, Munich, Germany; [Schmitt, Peter] Siemens AG, Healthcare Sect, Erlangen, Germany	University of Munich; University of Munich; Siemens AG; Siemens Germany	Thierfelder, KM (corresponding author), Ludwig Maximilians Univ Hosp, Dept Clin Radiol, Munich, Germany.	kolja.thierfelder@med.uni-muenchen.de		Nikolaou, Konstantin/0000-0003-2668-7325				Bongartz G, 2008, EUR J RADIOL, V66, P213, DOI 10.1016/j.ejrad.2008.01.031; Bridges MD, 2009, AM J ROENTGENOL, V192, P1538, DOI 10.2214/AJR.07.3895; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Edelman RR, 2013, MAGN RESON MED, V70, P1662, DOI 10.1002/mrm.24596; Edelman RR, 2010, MAGN RESON MED, V63, P951, DOI 10.1002/mrm.22287; FELBLINGER J, 1994, MAGNET RESON MED, V32, P523, DOI 10.1002/mrm.1910320416; FONTAINE R, 1954, Helv Chir Acta, V21, P499; Guerrero A, 2006, NEPHROL DIAL TRANSPL, V21, P3525, DOI 10.1093/ndt/gfl470; Haneder S, 2011, EUR RADIOL, V21, P1452, DOI 10.1007/s00330-011-2063-0; Hodnett PA, 2011, AM J ROENTGENOL, V197, P1466, DOI 10.2214/AJR.10.6091; Hodnett PA, 2011, RADIOLOGY, V260, P282, DOI 10.1148/radiol.11101336; Klasen J, 2011, CLIN RADIOL; Koelemay MJW, 2001, JAMA-J AM MED ASSOC, V285, P1338, DOI 10.1001/jama.285.10.1338; Kuo PH, 2007, RADIOLOGY, V242, P647, DOI 10.1148/radiol.2423061640; Li D, 2011, EUR RADIOL, V21, P1311, DOI 10.1007/s00330-010-2028-8; Lim RP, 2008, J MAGN RESON IMAGING, V28, P181, DOI 10.1002/jmri.21416; MCCAULEY TR, 1994, RADIOLOGY, V192, P351, DOI 10.1148/radiology.192.2.8029396; Menke J, 2010, ANN INTERN MED, V153, P325, DOI 10.7326/0003-4819-153-5-201009070-00007; Merkx MAG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053615; Napoli A, 2011, RADIOLOGY, V261, P976, DOI 10.1148/radiol.11103564; O'Hare A, 2001, J AM SOC NEPHROL, V12, P2838, DOI 10.1681/ASN.V12122838; Offerman EJ, 2013, MAGN RESON MED, V69, P158, DOI 10.1002/mrm.24240; Offerman EJ, 2011, J MAGN RESON IMAGING, V33, P401, DOI 10.1002/jmri.22457; Rapp JH, 2005, RADIOLOGY, V236, P71, DOI 10.1148/radiol.2361040148; Reimer P, 1999, EUR RADIOL, V9, P122, DOI 10.1007/s003300050642; Sandhu GS, 2012, AM J ROENTGENOL, V198, P686, DOI 10.2214/AJR.11.7065; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Ward EV, 2013, J MAGN RESON IMAGING	28	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91078	10.1371/journal.pone.0091078	http://dx.doi.org/10.1371/journal.pone.0091078			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608937	Green Published, Green Submitted, gold			2022-12-25	WOS:000332485800097
J	Wang, T; Green, LA; Gupta, SK; Kim, C; Wang, L; Almodovar, S; Flores, SC; Prudovsky, IA; Jolicoeur, P; Liu, ZY; Clauss, M				Wang, Ting; Green, Linden A.; Gupta, Samir K.; Kim, Chul; Wang, Liang; Almodovar, Sharilyn; Flores, Sonia C.; Prudovsky, Igor A.; Jolicoeur, Paul; Liu, Ziyue; Clauss, Matthias			Transfer of Intracellular HIV Nef to Endothelium Causes Endothelial Dysfunction	PLOS ONE			English	Article							NADPH OXIDASE ACTIVATION; OXIDATIVE STRESS; PULMONARY-HYPERTENSION; INFLAMMATORY PATHWAYS; HEART-DISEASE; VITAMIN-E; T-CELLS; B-CELLS; ATHEROSCLEROSIS; CORONARY	With effective antiretroviral therapy (ART), cardiovascular diseases (CVD) are emerging as a major cause of morbidity and death in the aging HIV-infected population. To address whether HIV-Nef, a viral protein produced in infected cells even when virus production is halted by ART, can lead to endothelial activation and dysfunction, we tested Nef protein transfer to and activity in endothelial cells. We demonstrated that Nef is essential for major endothelial cell activating effects of HIV-infected Jurkat cells when in direct contact with the endothelium. In addition, we found that Nef protein in endothelial cells is sufficient to cause apoptosis, ROS generation and release of monocyte attractant protein-1 (MCP-1). The Nef protein-dependent endothelial activating effects can be best explained by our observation that Nef protein rapidly transfers from either HIV-infected or Nef-transfected Jurkat cells to endothelial cells between these two cell types. These results are of in vivo relevance as we demonstrated that Nef protein induces GFP transfer from T cells to endothelium in CD4.Nef.GFP transgenic mice and Nef is present in chimeric SIV-infected macaques. Analyzing the signal transduction effects of Nef in endothelial cells, we found that Nef-induced apoptosis is mediated through ROS-dependent mechanisms, while MCP-1 production is NF-kB dependent. Together, these data indicate that inhibition of Nef-associated pathways may be promising new therapeutic targets for reducing the risk for cardiovascular disease in the HIV-infected population.	[Wang, Ting; Clauss, Matthias] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Wang, Ting; Green, Linden A.; Kim, Chul; Wang, Liang; Clauss, Matthias] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Wang, Ting; Green, Linden A.; Kim, Chul; Wang, Liang; Clauss, Matthias] Indiana Univ Sch Med, Indiana Ctr Vasc Biol & Med, Indianapolis, IN 46202 USA; [Wang, Ting; Green, Linden A.; Wang, Liang; Clauss, Matthias] RL Roudebush VA Med Ctr, Indianapolis, IN USA; [Gupta, Samir K.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Almodovar, Sharilyn; Flores, Sonia C.] Univ Colorado, Dept Med Pulm Sci & Crit Care Med, Denver, CO 80202 USA; [Prudovsky, Igor A.] Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME USA; [Jolicoeur, Paul] Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ, Canada; [Liu, Ziyue] Indiana Univ Sch Med, Dept Biostat, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University Bloomington; University of Colorado System; University of Colorado Denver; Maine Medical Center; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Indiana University System; Indiana University Bloomington	Clauss, M (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	mclauss@iupui.edu	Almodovar, Sharilyn/ABI-9237-2022; Prudovsky, Igor/GVU-1521-2022; Wang, Ting/H-1075-2015	Almodovar, Sharilyn/0000-0002-4769-1924; Clauss, Matthias/0000-0001-5180-3899; Wang, Liang/0000-0002-4052-1316	NIH-NHLBI; American Heart Association [R01 HL095149, R01-HL083491, T32 HL079995, AHA 13PRE14780025]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108, UL1TR002529, UL1TR001082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL079995, R01HL095149, R01HL083491] Funding Source: NIH RePORTER	NIH-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the NIH-NHLBI and American Heart Association, contract grant no. R01 HL095149 (MC and SG), R01-HL083491 (SCF), T32 HL079995 (LG) and AHA 13PRE14780025 (TW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almodovar Sharilyn, 2011, Proc Am Thorac Soc, V8, P308, DOI 10.1513/pats.201006-046WR; Alonso-Villaverde C, 2004, CIRCULATION, V110, P2204, DOI 10.1161/01.CIR.0000143835.95029.7D; Appay V, 2002, AIDS, V16, P161, DOI 10.1097/00002030-200201250-00004; Arts MJTJ, 2004, FOOD CHEM TOXICOL, V42, P45, DOI 10.1016/j.fct.2003.08.004; Astern JM, 2007, AM J PATHOL, V171, P349, DOI 10.2353/ajpath.2007.060831; Baliga RS, 2005, AM J PHYSIOL-HEART C, V289, pH1373, DOI 10.1152/ajpheart.00304.2005; Chen XL, 2004, AM J PHYSIOL-HEART C, V286, pH1001, DOI 10.1152/ajpheart.00716.2003; Clauss M, 2011, J CLIN INVEST, V121, P2470, DOI 10.1172/JCI43881; Csanyi G, 2011, FREE RADICAL BIO MED, V51, P1116, DOI 10.1016/j.freeradbiomed.2011.04.025; Currier Judith S, 2008, Circulation, V118, pe29, DOI 10.1161/CIRCULATIONAHA.107.189624; De Proost I, 2008, AM J RESP CELL MOL, V39, P180, DOI 10.1165/rcmb.2008-0011OC; Duffy P, 2009, J SURG RES; Duffy P, 2009, J SURG RES, V156, P257, DOI 10.1016/j.jss.2009.02.005; Eugenin EA, 2009, CELL IMMUNOL, V254, P142, DOI 10.1016/j.cellimm.2008.08.005; Foster JL, 2011, J NEUROIMMUNE PHARM, V6, P230, DOI 10.1007/s11481-011-9262-y; Foster JL, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-84; Foti M, 1999, J BIOL CHEM, V274, P34765, DOI 10.1074/jbc.274.49.34765; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Freiberg MS, 2011, CIRC-CARDIOVASC QUAL, V4, P425, DOI 10.1161/CIRCOUTCOMES.110.957415; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Green LA, 2012, AIDS RES HUM RETROVI; Green LA, 2012, AM J RESP CELL MOL, V47, P807, DOI 10.1165/rcmb.2012-0132OC; Grunfeld C, 2009, AIDS, V23, P1841, DOI 10.1097/QAD.0b013e32832d3b85; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; Heumuller S, 2008, HYPERTENSION, V51, P211, DOI 10.1161/HYPERTENSIONAHA.107.100214; Hodis HN, 2002, CIRCULATION, V106, P1453, DOI 10.1161/01.CIR.0000029092.99946.08; Johnson DK, 2002, ENDOTHELIUM-J ENDOTH, V9, P191, DOI 10.1080/10623320213638; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kim C, 2011, ANTIVIR THER, V16, P1335, DOI 10.3851/IMP1891; Kinlay S, 2004, J AM COLL CARDIOL, V43, P629, DOI 10.1016/j.jacc.2003.08.051; Kline ER, 2008, AM J PHYSIOL-HEART C, V294, pH2792, DOI 10.1152/ajpheart.91447.2007; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Liu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033497; Mandell CP, 1999, VIROLOGY, V265, P235, DOI 10.1006/viro.1999.0051; Manninen A, 1998, VIROLOGY, V250, P273, DOI 10.1006/viro.1998.9381; Merchant AT, 2005, J NUTR, V135, P1776, DOI 10.1093/jn/135.7.1776; Muratori C, 2009, CELL HOST MICROBE, V6, P218, DOI 10.1016/j.chom.2009.06.009; Obel N, 2007, CLIN INFECT DIS, V44, P1625, DOI 10.1086/518285; Ohman MK, 2010, ARTERIOSCL THROM VAS, V30, P1151, DOI 10.1161/ATVBAHA.110.205914; Olivetta E, 2005, BIOCHEM J, V390, P591, DOI 10.1042/BJ20042139; Qi ML, 2008, VIROLOGY, V373, P287, DOI 10.1016/j.virol.2007.12.001; Qiao XG, 2006, NAT IMMUNOL, V7, P302, DOI 10.1038/ni1302; Rajashekhar G, 2008, STEM CELLS, V26, P2674, DOI 10.1634/stemcells.2008-0277; Riccioni Graziano, 2012, Front Biosci (Elite Ed), V4, P373; Salmen S, 2010, CELL IMMUNOL, V263, P166, DOI 10.1016/j.cellimm.2010.03.012; Schluter T, 2008, CARDIOVASC RES, V80, P271, DOI 10.1093/cvr/cvn185; Sehgal PB, 2009, AM J PHYSIOL-LUNG C, V297, pL729, DOI 10.1152/ajplung.00087.2009; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Stolp B, 2012, P NATL ACAD SCI USA, V109, P18541, DOI 10.1073/pnas.1204322109; Subramanian S, 2012, JAMA-J AM MED ASSOC, V308, P379, DOI 10.1001/jama.2012.6698; Toborek M, 2003, J NEUROCHEM, V84, P169, DOI 10.1046/j.1471-4159.2003.01543.x; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Ullrich CK, 2000, BLOOD, V96, P1438, DOI 10.1182/blood.V96.4.1438.h8001438_1438_1442; Vilhardt F, 2002, J BIOL CHEM, V277, P42136, DOI 10.1074/jbc.M200862200; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753; Yang Fan, 2010, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V26, P44	57	45	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91063	10.1371/journal.pone.0091063	http://dx.doi.org/10.1371/journal.pone.0091063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608713	Green Submitted, Green Published, gold			2022-12-25	WOS:000332485800093
J	Yan, L; Gu, YH; Tao, X; Lai, XJ; Zhang, YZ; Tan, XM; Wang, HY				Yan, Lang; Gu, Ying-Hong; Tao, Xiang; Lai, Xian-Jun; Zhang, Yi-Zheng; Tan, Xue-Mei; Wang, Haiyan			Scanning of Transposable Elements and Analyzing Expression of Transposase Genes of Sweet Potato [Ipomoea batatas]	PLOS ONE			English	Article							EVOLUTIONARY DYNAMICS; SINGLE-COPY; ARABIDOPSIS; IDENTIFICATION; DIVERSITY; RESOURCE; SEQUENCE; FAMILY; DNA; ANNOTATION	Background: Transposable elements (TEs) are the most abundant genomic components in eukaryotes and affect the genome by their replications and movements to generate genetic plasticity. Sweet potato performs asexual reproduction generally and the TEs may be an important genetic factor for genome reorganization. Complete identification of TEs is essential for the study of genome evolution. However, the TEs of sweet potato are still poorly understood because of its complex hexaploid genome and difficulty in genome sequencing. The recent availability of the sweet potato transcriptome databases provides an opportunity for discovering and characterizing the expressed TEs. Methodology/Principal Findings: We first established the integrated-transcriptome database by de novo assembling four published sweet potato transcriptome databases from three cultivars in China. Using sequence-similarity search and analysis, a total of 1,405 TEs including 883 retrotransposons and 522 DNA transposons were predicted and categorized. Depending on mapping sets of RNA-Seq raw short reads to the predicted TEs, we compared the quantities, classifications and expression activities of TEs inter-and intra-cultivars. Moreover, the differential expressions of TEs in seven tissues of Xushu 18 cultivar were analyzed by using Illumina digital gene expression (DGE) tag profiling. It was found that 417 TEs were expressed in one or more tissues and 107 in all seven tissues. Furthermore, the copy number of 11 transposase genes was determined to be 1-3 copies in the genome of sweet potato by Real-time PCR-based absolute quantification. Conclusions/Significance: Our result provides a new method for TE searching on species with transcriptome sequences while lacking genome information. The searching, identification and expression analysis of TEs will provide useful TE information in sweet potato, which are valuable for the further studies of TE-mediated gene mutation and optimization in asexual reproduction. It contributes to elucidating the roles of TEs in genome evolution.	[Yan, Lang; Gu, Ying-Hong; Lai, Xian-Jun; Zhang, Yi-Zheng; Tan, Xue-Mei; Wang, Haiyan] Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Sichuan Key Lab Mol Biol & Biotechnol,Minist Educ, Ctr Funct Genom & Bioinformat,Coll Life Sci, Chengdu 610064, Sichuan, Peoples R China; [Tao, Xiang] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China	Sichuan University; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS	Tan, XM (corresponding author), Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Sichuan Key Lab Mol Biol & Biotechnol,Minist Educ, Ctr Funct Genom & Bioinformat,Coll Life Sci, Chengdu 610064, Sichuan, Peoples R China.	txmyyf@scu.edu.cn; hayawang@scu.edu.cn	GU, Yinghong/D-2433-2010	GU, Yinghong/0000-0002-9364-1389	National Science and Technology Pillar Program of China [2007BAD78B03]; "Eleventh-Five" Key Project of Sichuan Province, China [07SG111-003-1]	National Science and Technology Pillar Program of China; "Eleventh-Five" Key Project of Sichuan Province, China	This work was supported by funds from the National Science and Technology Pillar Program of China (No. 2007BAD78B03, http://kjzc.jhgl.org/) and the "Eleventh-Five" Key Project of Sichuan Province, China (No. 07SG111-003-1, http://www.scst.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Beltran J, 2009, IN VITRO CELL DEV-PL, V45, P48, DOI 10.1007/s11627-008-9159-5; Bennetzen JL, 2000, PLANT MOL BIOL, V42, P251, DOI 10.1023/A:1006344508454; Biemont C, 2010, GENETICS, V186, P1085, DOI 10.1534/genetics.110.124180; Bundock P, 2005, NATURE, V436, P282, DOI 10.1038/nature03667; Carpena A. L., 2009, P27, DOI 10.1007/978-1-4020-9475-0_4; Casacuberta E, 2013, MOL ECOL, V22, P1503, DOI 10.1111/mec.12170; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cowley M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003234; de Souza FSJ, 2013, MOL BIOL EVOL, V30, P1239, DOI 10.1093/molbev/mst045; Diao Xian-Min, 2006, Acta Genetica Sinica, V33, P477, DOI 10.1016/S0379-4172(06)60075-9; Dolgin E, 2009, NATURE NEWS, P1098; Du JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-113; Duarte JM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-61; Firon N., 2009, P13, DOI 10.1007/978-1-4020-9475-0_3; Gaba V., 2009, P65, DOI 10.1007/978-1-4020-9475-0_6; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; He XJ, 2011, J TROPICAL AGR, V31, P10; HERSHBERGER RJ, 1995, GENETICS, V140, P1087; Hillman-Jackson Jennifer, 2012, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1005s38; Hoen DR, 2006, MOL BIOL EVOL, V23, P1254, DOI 10.1093/molbev/msk015; Holligan D, 2006, GENETICS, V174, P2215, DOI 10.1534/genetics.106.062752; Hollister JD, 2007, MOL BIOL EVOL, V24, P2515, DOI 10.1093/molbev/msm197; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kihara T, 2006, BIOSCI BIOTECH BIOCH, V70, P1780, DOI 10.1271/bbb.50687; Knip M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-192; Lal SK, 2005, HEREDITY, V95, P421, DOI 10.1038/sj.hdy.6800764; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Le QH, 2000, P NATL ACAD SCI USA, V97, P7376, DOI 10.1073/pnas.97.13.7376; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lisch D, 2013, NAT REV GENET, V14, P49, DOI 10.1038/nrg3374; Loebenstein G., 2009, P9, DOI 10.1007/978-1-4020-9475-0_2; Luo WL, 2012, J AGR SCI, V2, P135; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Morgante M, 2006, CURR OPIN BIOTECH, V17, P168, DOI 10.1016/j.copbio.2006.03.001; Nagy Z, 2004, RES MICROBIOL, V155, P387, DOI 10.1016/j.resmic.2004.01.008; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rossi M, 2001, GENET MOL BIOL, V24, P147, DOI 10.1590/S1415-47572001000100020; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shapiro JA, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-4; Shimatani Z, 2009, MOL GENET GENOMICS, V281, P329, DOI 10.1007/s00438-008-0410-x; Srinivas T., 2009, P235, DOI 10.1007/978-1-4020-9475-0_12; Tao X, 2013, BIOSCI BIOTECH BIOCH, V77, P2169, DOI 10.1271/bbb.130218; Tao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036234; Thottappilly G., 2009, P3, DOI 10.1007/978-1-4020-9475-0_1; Tollis M, 2012, GENOME DYNAM, V7, P68, DOI 10.1159/000337126; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wall PK, 2008, NUCLEIC ACIDS RES, V36, pD970, DOI 10.1093/nar/gkm972; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wu QY, 2011, HUNAN AGR SCI, V5, P4; Xie FL, 2012, PLANTA, V236, P101, DOI 10.1007/s00425-012-1591-4; Xu ZN, 2005, PLANT CELL, V17, P375, DOI 10.1105/tpc.104.027797; Yi CX, 2008, ANAL BIOCHEM, V375, P150, DOI 10.1016/j.ab.2007.11.022; Yurchenko N.N., 2011, RUSS J GENET APPL RE, V1, P489, DOI [10.1134/S2079059711060141, DOI 10.1134/S2079059711060141]; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	62	6	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90895	10.1371/journal.pone.0090895	http://dx.doi.org/10.1371/journal.pone.0090895			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608103	Green Submitted, gold, Green Published			2022-12-25	WOS:000332485800064
J	Baldan, R; Cigana, C; Testa, F; Bianconi, I; De Simone, M; Pellin, D; Di Serio, C; Bragonzi, A; Cirillo, DM				Baldan, Rossella; Cigana, Cristina; Testa, Francesca; Bianconi, Irene; De Simone, Maura; Pellin, Danilo; Di Serio, Clelia; Bragonzi, Alessandra; Cirillo, Daniela M.			Adaptation of Pseudomonas aeruginosa in Cystic Fibrosis Airways Influences Virulence of Staphylococcus aureus In Vitro and Murine Models of Co-Infection	PLOS ONE			English	Article							GENOME SEQUENCE; INFECTIONS; EXPRESSION; GROWTH	Cystic fibrosis (CF) airways disease represents an example of polymicrobial infection whereby different bacterial species can interact and influence each other. In CF patients Staphylococcus aureus is often the initial pathogen colonizing the lungs during childhood, while Pseudomonas aeruginosa is the predominant pathogen isolated in adolescents and adults. During chronic infection, P. aeruginosa undergoes adaptation to cope with antimicrobial therapy, host response and co-infecting pathogens. However, S. aureus and P. aeruginosa often co-exist in the same niche influencing the CF pathogenesis. The goal of this study was to investigate the reciprocal interaction of P. aeruginosa and S. aureus and understand the influence of P. aeruginosa adaptation to the CF lung in order to gain important insight on the interplay occurring between the two main pathogens of CF airways, which is still largely unknown. P. aeruginosa reference strains and eight lineages of clinical strains, including early and late clonal isolates from different patients with CF, were tested for growth inhibition of S. aureus. Next, P. aeruginosa/S. aureus competition was investigated in planktonic co-culture, biofilm, and mouse pneumonia model. P. aeruginosa reference and early strains, isolated at the onset of chronic infection, outcompeted S. aureus in vitro and in vivo models of co-infection. On the contrary, our results indicated a reduced capacity to outcompete S. aureus of P. aeruginosa patho-adaptive strains, isolated after several years of chronic infection and carrying several phenotypic changes temporally associated with CF lung adaptation. Our findings provide relevant information with respect to interspecies interaction and disease progression in CF.	[Baldan, Rossella; Testa, Francesca; Cirillo, Daniela M.] Ist Sci San Raffaele, Emerging Bacterial Pathogens Unit, I-20132 Milan, Italy; [Cigana, Cristina; Bianconi, Irene; De Simone, Maura; Bragonzi, Alessandra] Ist Sci San Raffaele, Infect & Cyst Fibrosis Unit, I-20132 Milan, Italy; [Pellin, Danilo; Di Serio, Clelia] Univ Vita Salute San Raffaele, Univ Ctr Stat Biomed Sci, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Cirillo, DM (corresponding author), Ist Sci San Raffaele, Emerging Bacterial Pathogens Unit, I-20132 Milan, Italy.	cirillo.daniela@hsr.it	Di Serio, Clelia/AAO-5494-2020; Bragonzi, Alessandra/AAC-6751-2022; Cirillo, Daniela Maria/AAB-3646-2019; Cigana, Cristina/D-2883-2016	Cirillo, Daniela Maria/0000-0001-6415-1535; Cigana, Cristina/0000-0003-0436-9721; Baldan, Rossella/0000-0002-4674-4326; Bianconi, Irene/0000-0002-5923-4296; Bragonzi, Alessandra/0000-0002-5808-7669; DI SERIO, Mariaclelia Stefania/0000-0001-6385-6058	Fondazione per la ricerca sulla Fibrosi Cistica (project FFC) [9/2010]	Fondazione per la ricerca sulla Fibrosi Cistica (project FFC)	This study was supported to DMC and AB by Fondazione per la ricerca sulla Fibrosi Cistica (project FFC#9/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CYST FIBR FDN PAT RE; Armougom F, 2009, EUR J CLIN MICROBIOL, V28, P1151, DOI 10.1007/s10096-009-0749-x; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Baldan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043153; Bianconi I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001270; Biswas L, 2009, APPL ENVIRON MICROB, V75, P6910, DOI 10.1128/AEM.01211-09; Bittar F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002908; Bouchara JP, 2009, J CLIN MICROBIOL, V47, P142, DOI 10.1128/JCM.01668-08; Bragonzi A, 2006, MICROBIOL-SGM, V152, P3261, DOI 10.1099/mic.0.29175-0; Bragonzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052330; Bragonzi A, 2009, AM J RESP CRIT CARE, V180, P138, DOI 10.1164/rccm.200812-1943OC; Brogden KA, 2005, LANCET, V365, P253, DOI 10.1016/S0140-6736(05)70155-0; Cigana C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008439; Dalton T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027317; Doring G, 1997, PEDIATR PULM, P235; Doring Gerd, 2004, J Cyst Fibros, V3, P67, DOI 10.1016/j.jcf.2004.03.008; Ecker DJ, 2008, NAT REV MICROBIOL, V6, P553, DOI 10.1038/nrmicro1918; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; Goss CH, 2011, J CYST FIBROS, V10, P298, DOI 10.1016/j.jcf.2011.06.002; Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Hoffman LR, 2006, P NATL ACAD SCI USA, V103, P19890, DOI 10.1073/pnas.0606756104; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Jarry TM, 2006, INFECT IMMUN, V74, P2568, DOI 10.1128/IAI.74.5.2568-2577.2006; Johnson AP, 2011, J ANTIMICROB CHEMOTH, V66, pIV43, DOI 10.1093/jac/dkr076; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Lore NI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035648; Macho AP, 2007, MOL PLANT PATHOL, V8, P437, DOI 10.1111/J.1364-3703.2007.00404.X; Mann EE, 2012, FEMS MICROBIOL REV, V36, P893, DOI 10.1111/j.1574-6976.2011.00322.x; Maselli JH, 2003, PEDIATR PULM, V35, P257, DOI 10.1002/ppul.10230; Mashburn LM, 2005, J BACTERIOL, V187, P554, DOI 10.1128/JB.187.2.554-566.2005; Montanari S, 2007, MICROBIOL-SGM, V153, P1445, DOI 10.1099/mic.0.2006/003400-0; Nocker A, 2007, MICROB ECOL, V54, P276, DOI 10.1007/s00248-006-9199-5; Pastar I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056846; Peters BM, 2012, CLIN MICROBIOL REV, V25, P193, DOI 10.1128/CMR.00013-11; Qazi S, 2006, INFECT IMMUN, V74, P910, DOI 10.1128/IAI.74.2.910-919.2006; Qin ZQ, 2009, MICROBIOL-SGM, V155, P2148, DOI 10.1099/mic.0.028001-0; Ratjen F, 2012, AM J RESP CRIT CARE, V185, P933, DOI 10.1164/rccm.201202-0306UP; Razvi S, 2009, CHEST, V136, P1554, DOI 10.1378/chest.09-0132; Rogers GB, 2010, TRENDS MICROBIOL, V18, P357, DOI 10.1016/j.tim.2010.04.005; Rogers GB, 2010, EXPERT REV MOL DIAGN, V10, P187, DOI 10.1586/ERM.09.81; Rogers GB, 2009, J MED MICROBIOL, V58, P1401, DOI 10.1099/jmm.0.013334-0; Ryan RP, 2008, MOL MICROBIOL, V68, P75, DOI 10.1111/j.1365-2958.2008.06132.x; Sibley CD, 2006, FUTURE MICROBIOL, V1, P53, DOI 10.2217/17460913.1.1.53; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Yang L, 2011, FEMS IMMUNOL MED MIC, V62, P339, DOI 10.1111/j.1574-695X.2011.00820.x	49	100	103	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89614	10.1371/journal.pone.0089614	http://dx.doi.org/10.1371/journal.pone.0089614			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603807	Green Published, gold, Green Submitted			2022-12-25	WOS:000332483600015
J	Lopez-Ramirez, MA; Wu, D; Pryce, G; Simpson, JE; Reijerkerk, A; King-Robson, J; Kay, O; De Vries, HE; Hirst, MC; Sharrack, B; Baker, D; Male, DK; Michael, GJ; Romero, IA				Lopez-Ramirez, Miguel Alejandro; Wu, Dongsheng; Pryce, Gareth; Simpson, Julie E.; Reijerkerk, Arie; King-Robson, Josh; Kay, Oliver; de Vries, Helga E.; Hirst, Mark C.; Sharrack, Basil; Baker, David; Male, David Kingsley; Michael, Gregory J.; Romero, Ignacio Andres			MicroRNA-155 negatively affects blood-brain barrier function during neuroinflammation	FASEB JOURNAL			English	Article						multiple sclerosis; neurovascular dysfunction; junctional complex molecules; focal adhesion	GROWTH-FACTOR; CLAUDIN-5 EXPRESSION; ADHESION; ALPHA; CONTRIBUTES; CELLS; TRANSCRIPTOME; MORPHOGENESIS; INFLAMMATION; ACTIVATION	Blood-brain barrier (BBB) dysfunction is a hallmark of neurological conditions such as multiple sclerosis (MS) and stroke. However, the molecular mechanisms underlying neurovascular dysfunction during BBB breakdown remain elusive. MicroRNAs (miRNAs) have recently emerged as key regulators of pathogenic responses, although their role in central nervous system (CNS) microvascular disorders is largely unknown. We have identified miR-155 as a critical miRNA in neuro-inflammation at the BBB. miR-155 is expressed at the neurovascular unit of individuals with MS and of mice with experimental autoimmune encephalomyelitis (EAE). In mice, loss of miR-155 reduced CNS extravasation of systemic tracers, both in EAE and in an acute systemic inflammation model induced by lipopolysaccharide. In cultured human brain endothelium, miR-155 was strongly and rapidly upregulated by inflammatory cytokines. miR-155 up-regulation mimicked cytokine-induced alterations in junctional organization and permeability, whereas inhibition of endogenous miR-155 partially prevented a cytokine-induced increase in permeability. Furthermore, miR-155 modulated brain endothelial barrier function by targeting not only cell-cell complex molecules such as annexin-2 and claudin-1, but also focal adhesion components such as DOCK-1 and syntenin-1. We propose that brain endothelial miR-155 is a negative regulator of BBB function that may constitute a novel therapeutic target for CNS neuroinflammatory disorders.	[Lopez-Ramirez, Miguel Alejandro; Wu, Dongsheng; Hirst, Mark C.; Male, David Kingsley; Romero, Ignacio Andres] Open Univ, Dept Life Hlth & Chem Sci, Biomed Res Network, Milton Keynes MK7 6AA, Bucks, England; [Pryce, Gareth; King-Robson, Josh; Kay, Oliver; Baker, David; Michael, Gregory J.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Neurosci & Trauma, London, England; [Simpson, Julie E.] Univ Sheffield, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England; [Sharrack, Basil] Univ Sheffield, Sheffield Teaching Hosp, Dept Neurol, Natl Hlth Serv NHS, Sheffield, S Yorkshire, England; [Reijerkerk, Arie; de Vries, Helga E.] Vrije Univ Amsterdam, Med Ctr, Blood Brain Barrier Res Grp, Amsterdam, Netherlands	Open University - UK; University of London; Queen Mary University London; University of Sheffield; University of Sheffield; Vrije Universiteit Amsterdam	Romero, IA (corresponding author), Open Univ, Dept Life Hlth & Chem Sci, Biomed Res Network, Walton Hall, Milton Keynes MK7 6AA, Bucks, England.	nacho.romero@open.ac.uk	Simpson, Julie/C-7914-2009	Simpson, Julie/0000-0002-3753-4271; Male, David/0000-0002-1242-3137; de Vries, Helga/0000-0001-7904-7124; King-Robson, Josh/0000-0002-3662-9404; Hirst, Mark/0000-0003-3851-9740; Romero, Ignacio/0000-0002-0322-9180	Multiple Sclerosis Society	Multiple Sclerosis Society(National Multiple Sclerosis Society)	The authors thank J. Barkans for general laboratory infrastructure assistance; J. Brown and P. Rezaie for preparation of the MS samples for histological characterization; R. Waller for preparation of samples for LCM; and C. Hare and C. O'Rourke for reviewing the manuscript. This work was funded by the Multiple Sclerosis Society. Tissue samples and associated clinical and neuropathological data were supplied by the UK MS Tissue Bank.	ABBOTT NJ, 1992, J CELL SCI, V103, P23; Al-Izki S, 2011, MULT SCLER J, V17, P939, DOI 10.1177/1352458511400476; Lopez-Ramirez MA, 2012, J IMMUNOL, V189, P3130, DOI 10.4049/jimmunol.1103460; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Beekman JM, 2008, J CELL SCI, V121, P1349, DOI 10.1242/jcs.026401; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Dunand-Sauthier I, 2011, BLOOD, V117, P4490, DOI 10.1182/blood-2010-09-308064; Epting D, 2010, CIRC RES, V107, P45, DOI 10.1161/CIRCRESAHA.109.213983; Fabis MJ, 2008, P NATL ACAD SCI USA, V105, P15511, DOI 10.1073/pnas.0807656105; Fletcher NF, 2012, GASTROENTEROLOGY, V142, P634, DOI 10.1053/j.gastro.2011.11.028; Forster C, 2008, J PHYSIOL-LONDON, V586, P1937, DOI 10.1113/jphysiol.2007.146852; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hoffmann A, 2011, TRANSL STROKE RES, V2, P106, DOI 10.1007/s12975-010-0049-x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hwangbo C, 2010, CANCER RES, V70, P1645, DOI 10.1158/0008-5472.CAN-09-2447; Inai T, 1999, EUR J CELL BIOL, V78, P849, DOI 10.1016/S0171-9335(99)80086-7; Junker A, 2009, BRAIN, V132, P3342, DOI 10.1093/brain/awp300; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Kong W, 2010, J BIOL CHEM, V285, P17869, DOI 10.1074/jbc.M110.101055; Liebner S, 2000, ACTA NEUROPATHOL, V100, P323, DOI 10.1007/s004010000180; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Ramirez MA, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-27; Manaenko A, 2011, J NEUROSCI METH, V195, P206, DOI 10.1016/j.jneumeth.2010.12.013; Mankertz J, 2000, J CELL SCI, V113, P2085; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Murugaiyan G, 2011, J IMMUNOL, V187, P2213, DOI 10.4049/jimmunol.1003952; Nayal A, 2004, CURR OPIN CELL BIOL, V16, P94, DOI 10.1016/j.ceb.2003.11.007; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Osada T, 2011, J CEREBR BLOOD F MET, V31, P1972, DOI 10.1038/jcbfm.2011.99; Pfeiffer F, 2011, ACTA NEUROPATHOL, V122, P601, DOI 10.1007/s00401-011-0883-2; Pottier N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006718; Reijerkerk A, 2013, J NEUROSCI, V33, P6857, DOI 10.1523/JNEUROSCI.3965-12.2013; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Schlegel N, 2009, J CELL PHYSIOL, V220, P357, DOI 10.1002/jcp.21772; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Simpson JE, 2011, NEUROBIOL AGING, V32, P1795, DOI 10.1016/j.neurobiolaging.2011.04.013; Su SC, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M110.157271; Sun HX, 2012, HYPERTENSION, V60, P1407, DOI 10.1161/HYPERTENSIONAHA.112.197301; Wolburg H, 2003, ACTA NEUROPATHOL, V105, P586, DOI 10.1007/s00401-003-0688-z; Xu GR, 2010, RNA, V16, P1610, DOI 10.1261/rna.2194910; Yao R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046082; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Ziegler WH, 2008, BIOCHEM SOC T, V36, P235, DOI 10.1042/BST0360235	47	191	197	2	55	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2014	28	6					2551	2565		10.1096/fj.13-248880	http://dx.doi.org/10.1096/fj.13-248880			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AM5GA	24604078	Green Submitted, Green Accepted			2022-12-25	WOS:000339883600015
J	Ding, JZ; Mooers, BHM; Zhang, Z; Kale, J; Falcone, D; McNichol, J; Huang, B; Zhang, XJC; Xing, CG; Andrews, DW; Lin, JL				Ding, Jingzhen; Mooers, Blaine H. M.; Zhang, Zhi; Kale, Justin; Falcone, Domina; McNichol, Jamie; Huang, Bo; Zhang, Xuejun C.; Xing, Chengguo; Andrews, David W.; Lin, Jialing			After Embedding in Membranes Antiapoptotic Bcl-XL Protein Binds Both Bcl-2 Homology Region 3 and Helix 1 of Proapoptotic Bax Protein to Inhibit Apoptotic Mitochondrial Permeabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bax; Bcl-2 Proteins; Membrane Proteins; Mitochondrial Apoptosis; Protein Cross-linking; Bcl-XL	CROSS-LINKING; CONFORMATIONAL-CHANGE; BH3 DOMAINS; FAMILY; ACTIVATION; BCL-X(L); OLIGOMERIZATION; INTERFACE; DIMER; FORMS	Background: Bcl-XL binds Bax at mitochondria, inhibiting Bax oligomerization and apoptosis. Results: Anchored in membranes, Bcl-XLBax heterodimer is formed from a rigid helix-in-groove interface plus a flexible helical dimer interface. Conclusion: Two interfaces contribute equally to the heterodimer stability required to inhibit Bax. Significance: This novel kind of protein-protein interaction stabilizes the membrane-bound heterodimer that is pivotal to apoptosis regulation. Bcl-XL binds to Bax, inhibiting Bax oligomerization required for mitochondrial outer membrane permeabilization (MOMP) during apoptosis. How Bcl-XL binds to Bax in the membrane is not known. Here, we investigated the structural organization of Bcl-XLBax complexes formed in the MOM, including the binding interface and membrane topology, using site-specific cross-linking, compartment-specific labeling, and computational modeling. We found that one heterodimer interface is formed by a specific interaction between the Bcl-2 homology 1-3 (BH1-3) groove of Bcl-XL and the BH3 helix of Bax, as defined previously by the crystal structure of a truncated Bcl-XL protein and a Bax BH3 peptide (Protein Data Bank entry 3PL7). We also discovered a novel interface in the heterodimer formed by equivalent interactions between the helix 1 regions of Bcl-XL and Bax when their helical axes are oriented either in parallel or antiparallel. The two interfaces are located on the cytosolic side of the MOM, whereas helix 9 of Bcl-XL is embedded in the membrane together with helices 5, 6, and 9 of Bax. Formation of the helix 1helix 1 interface partially depends on the formation of the grooveBH3 interface because point mutations in the latter interface and the addition of ABT-737, a groove-binding BH3 mimetic, blocked the formation of both interfaces. The mutations and ABT-737 also prevented Bcl-XL from inhibiting Bax oligomerization and subsequent MOMP, suggesting that the structural organization in which interactions at both interfaces contribute to the overall stability and functionality of the complex represents antiapoptotic Bcl-XLBax complexes in the MOM.	[Ding, Jingzhen; Mooers, Blaine H. M.; Zhang, Zhi; Lin, Jialing] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73126 USA; [Mooers, Blaine H. M.; Lin, Jialing] Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK 73126 USA; [Kale, Justin; Falcone, Domina; McNichol, Jamie; Andrews, David W.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Huang, Bo; Zhang, Xuejun C.] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; [Xing, Chengguo] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA; [Andrews, David W.] Univ Toronto, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Andrews, David W.] Univ Toronto, Dept Biochem, Toronto, ON M4N 3M5, Canada	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; McMaster University; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Minnesota System; University of Minnesota Twin Cities; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Lin, JL (corresponding author), 940 Stanton L Young Blvd,Biomed Sci Bldg 935, Oklahoma City, OK 73126 USA.	jialing-lin@ouhsc.edu	ding, Jingzhen/B-5427-2015; Kale, Justin/AAO-6023-2020; Mooers, Blaine/S-4383-2017	Kale, Justin/0000-0002-4915-0806; Mooers, Blaine/0000-0001-8181-8987; Huang, Bo/0000-0003-3822-9110; Andrews, David/0000-0002-9266-7157	National Institutes of Health [R01GM062964, R01AI088011, P20GM103640]; OCAST [HR10-121]; Canadian Institutes of Health Research [FRN 12517]; NATIONAL CANCER INSTITUTE [R01CA163864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103640, R01GM062964] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OCAST; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM062964 (to J. L.) and R01AI088011 and P20GM103640 (to B. H. M. M.). This work was also supported by OCAST Grant HR10-121 (to J. L.), and Canadian Institutes of Health Research Grant FRN 12517 (to D. W. A. and Brian Leber).	Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Aranovich A, 2012, MOL CELL, V45, P754, DOI 10.1016/j.molcel.2012.01.030; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Bleicken S, 2010, J BIOL CHEM, V285, P6636, DOI 10.1074/jbc.M109.081539; Braun TF, 2001, BIOCHEMISTRY-US, V40, P13051, DOI 10.1021/bi011264g; BRUNNER J, 1993, ANNU REV BIOCHEM, V62, P483, DOI 10.1146/annurev.bi.62.070193.002411; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Czabotar PE, 2011, J BIOL CHEM, V286, P7123, DOI 10.1074/jbc.M110.161281; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Dewson G, 2012, CELL DEATH DIFFER, V19, P661, DOI 10.1038/cdd.2011.138; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Ding JZ, 2010, J BIOL CHEM, V285, P28749, DOI 10.1074/jbc.M110.148361; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; DUNBRACK RL, 1993, J MOL BIOL, V230, P543, DOI 10.1006/jmbi.1993.1170; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fiebig AA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-213; Fletchera JI, 2008, P NATL ACAD SCI USA, V105, P18081, DOI 10.1073/pnas.0808691105; Gautier F, 2011, MOL CELL BIOL, V31, P832, DOI 10.1128/MCB.00161-10; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gavathiotis E, 2010, MOL CELL, V40, P481, DOI 10.1016/j.molcel.2010.10.019; Hoppins S, 2011, MOL CELL, V41, P150, DOI 10.1016/j.molcel.2010.11.030; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kim PK, 2004, MOL CELL, V14, P523, DOI 10.1016/S1097-2765(04)00263-1; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kvansakul M, 2008, CELL DEATH DIFFER, V15, P1564, DOI 10.1038/cdd.2008.83; Leber B, 2010, ONCOGENE, V29, P5221, DOI 10.1038/onc.2010.283; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Lee EF, 2007, CELL DEATH DIFFER, V14, P1711, DOI 10.1038/sj.cdd.4402178; Lin JL, 2001, J BIOL CHEM, V276, P41733, DOI 10.1074/jbc.M103475200; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; London N, 2012, BIOCHEMISTRY-US, V51, P5841, DOI 10.1021/bi3003567; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ottilie S, 1997, J BIOL CHEM, V272, P16955, DOI 10.1074/jbc.272.27.16955; Ozhogina OA, 2009, J STRUCT BIOL, V168, P223, DOI 10.1016/j.jsb.2009.06.003; Peng J, 2006, J BIOL CHEM, V281, P35802, DOI 10.1074/jbc.M608303200; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Sheridan C, 2008, MOL CELL, V31, P570, DOI 10.1016/j.molcel.2008.08.002; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P3100, DOI 10.1073/pnas.97.7.3100; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tan CB, 2006, J BIOL CHEM, V281, P14764, DOI 10.1074/jbc.M602374200; Trakselis MA, 2005, BIOCONJUGATE CHEM, V16, P741, DOI 10.1021/bc050043a; Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang Z, 2004, J BIOL CHEM, V279, P43920, DOI 10.1074/jbc.M406412200; Zhang Z, 2010, J BIOL CHEM, V285, P17614, DOI 10.1074/jbc.M110.113456; Zhao LX, 2012, J BIOL CHEM, V287, P1054, DOI 10.1074/jbc.M111.264481; Zhou H, 2005, EXP CELL RES, V309, P316, DOI 10.1016/j.yexcr.2005.06.014	61	60	62	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11873	11896		10.1074/jbc.M114.552562	http://dx.doi.org/10.1074/jbc.M114.552562			24	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24616095	Green Published, hybrid			2022-12-25	WOS:000335010600029
J	Sobolewska-Stawiarz, A; Leferink, NGH; Fisher, K; Heyes, DJ; Hay, S; Rigby, SEJ; Scrutton, NS				Sobolewska-Stawiarz, Anna; Leferink, Nicole G. H.; Fisher, Karl; Heyes, Derren J.; Hay, Sam; Rigby, Stephen E. J.; Scrutton, Nigel S.			Energy Landscapes and Catalysis in Nitric-oxide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calmodulin; Enzyme Kinetics; Flavoproteins; Nitric-oxide Synthase; Protein Dynamics; PELDOR Spectroscopy; Free Energy Landscapes; High Pressure Stopped Flow	REGULATE ELECTRON-TRANSFER; C-TERMINAL TAIL; CYTOCHROME-P450 REDUCTASE; KINETIC-PARAMETERS; HYDRIDE TRANSFER; STRUCTURAL BASIS; DOMAIN; CALMODULIN; MECHANISM; NADPH	Background: Protein domain dynamics and calmodulin binding are implicated in regulating electron flow in NO synthase. Results: A dynamic conformational landscape important for enzyme catalysis is demonstrated. Conclusion: NO synthesis requires a complex landscape of conformations, with calmodulin as a key driver of chemistry through modulation of the dynamic landscape. Significance: Detailed understanding of conformational landscapes provides new opportunities for inhibitor discovery targeted at the dynamic interfaces. Nitric oxide (NO) plays diverse roles in mammalian physiology. It is involved in blood pressure regulation, neurotransmission, and immune response, and is generated through complex electron transfer reactions catalyzed by NO synthases (NOS). In neuronal NOS (nNOS), protein domain dynamics and calmodulin binding are implicated in regulating electron flow from NADPH, through the FAD and FMN cofactors, to the heme oxygenase domain, the site of NO generation. Simple models based on crystal structures of nNOS reductase have invoked a role for large scale motions of the FMN-binding domain in shuttling electrons from the FAD-binding domain to the heme oxygenase domain. However, molecular level insight of the dynamic structural transitions in NOS enzymes during enzyme catalysis is lacking. We use pulsed electron-electron double resonance spectroscopy to derive inter-domain distance relationships in multiple conformational states of nNOS. These distance relationships are correlated with enzymatic activity through variable pressure kinetic studies of electron transfer and turnover. The binding of NADPH and calmodulin are shown to influence interdomain distance relationships as well as reaction chemistry. An important effect of calmodulin binding is to suppress adventitious electron transfer from nNOS to molecular oxygen and thereby preventing accumulation of reactive oxygen species. A complex landscape of conformations is required for nNOS catalysis beyond the simple models derived from static crystal structures of nNOS reductase. Detailed understanding of this landscape advances our understanding of nNOS catalysis/electron transfer, and could provide new opportunities for the discovery of small molecule inhibitors that bind at dynamic protein interfaces of this multidimensional energy landscape.	[Scrutton, Nigel S.] Univ Manchester, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England; Univ Manchester, Fac Life Sci, Manchester M1 7DN, Lancs, England	University of Manchester; University of Manchester	Scrutton, NS (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England.	nigel.scrutton@manchester.as.uk	Hay, Sam/D-5974-2012; Fisher, Karl/A-5956-2013; Leferink, Nicole G H/I-6867-2012; Scrutton, Nigel/B-7352-2017	Hay, Sam/0000-0003-3274-0938; Fisher, Karl/0000-0003-3539-8939; Leferink, Nicole G H/0000-0003-4134-4339; Scrutton, Nigel/0000-0002-4182-3500; Heyes, Derren/0000-0002-7453-1571	United Kingdom Biotechnological Sciences Research Council [BB/1019928]; Bruker UK; BBSRC [BB/E013007/1, BB/I019928/1, BB/H021523/1] Funding Source: UKRI; EPSRC [EP/J020192/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I019928/1, BB/E013007/1, BB/H021523/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J020192/1] Funding Source: researchfish	United Kingdom Biotechnological Sciences Research Council; Bruker UK; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by United Kingdom Biotechnological Sciences Research Council Grant BB/1019928 and Bruker UK.	Adak S, 2001, J BIOL CHEM, V276, P23246, DOI 10.1074/jbc.M102509200; Brenner S, 2008, FEBS J, V275, P4540, DOI 10.1111/j.1742-4658.2008.06597.x; Craig DH, 2002, J BIOL CHEM, V277, P33987, DOI 10.1074/jbc.M203118200; Daff S, 1999, J BIOL CHEM, V274, P30589, DOI 10.1074/jbc.274.43.30589; Davidson VL, 2000, ACCOUNTS CHEM RES, V33, P87, DOI 10.1021/ar9900616; Dunford AJ, 2007, BIOCHEMISTRY-US, V46, P5018, DOI 10.1021/bi7001339; Dunford AJ, 2004, EUR J BIOCHEM, V271, P2548, DOI 10.1111/j.1432-1033.2004.04185.x; Dutton P L, 1978, Methods Enzymol, V54, P411; Ellis J, 2009, J BIOL CHEM, V284, P36628, DOI 10.1074/jbc.M109.054304; Feng CJ, 2007, J AM CHEM SOC, V129, P5621, DOI 10.1021/ja068685b; Feng CJ, 2012, COORDIN CHEM REV, V256, P393, DOI 10.1016/j.ccr.2011.10.011; Gao YT, 2007, J BIOL CHEM, V282, P7921, DOI 10.1074/jbc.M609814200; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Ghosh DK, 2003, FRONT BIOSCI-LANDMRK, V8, pD193, DOI 10.2741/959; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Haque MM, 2013, FEBS J, V280, P4439, DOI 10.1111/febs.12404; Haque MM, 2012, J BIOL CHEM, V287, P30105, DOI 10.1074/jbc.M112.339697; Hay S, 2007, P NATL ACAD SCI USA, V104, P507, DOI 10.1073/pnas.0608408104; Hay S, 2010, J AM CHEM SOC, V132, P9738, DOI 10.1021/ja1016206; Huang WC, 2013, STRUCTURE, V21, P1581, DOI 10.1016/j.str.2013.06.022; Kay CWM, 2006, J AM CHEM SOC, V128, P76, DOI 10.1021/ja057308g; Knight K, 2002, BIOCHEM J, V367, P19, DOI 10.1042/BJ20020667; Leys D, 2003, NAT STRUCT BIOL, V10, P219, DOI 10.1038/nsb894; Leys D, 2004, CURR OPIN STRUC BIOL, V14, P642, DOI 10.1016/j.sbi.2004.10.002; Matter H, 2005, J MED CHEM, V48, P4783, DOI 10.1021/jm050007x; Miller RT, 1999, BIOCHEM BIOPH RES CO, V265, P184, DOI 10.1006/bbrc.1999.1643; Miller RT, 1997, BIOCHEMISTRY-US, V36, P15277, DOI 10.1021/bi972022c; Northrop DB, 2002, BBA-PROTEIN STRUCT M, V1595, P71, DOI 10.1016/S0167-4838(01)00335-1; Panda K, 2001, J BIOL CHEM, V276, P23349, DOI 10.1074/jbc.M100687200; Panda K, 2006, J BIOL CHEM, V281, P36819, DOI 10.1074/jbc.M606129200; Persechini A, 2013, FEBS LETT, V587, P297, DOI 10.1016/j.febslet.2012.12.012; Pudney CR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001222; Pudney CR, 2009, CHEMBIOCHEM, V10, P1379, DOI 10.1002/cbic.200900071; Rigby SEJ, 2011, CHEMBIOCHEM, V12, P863, DOI 10.1002/cbic.201000630; SALERNO JC, 1995, J BIOL CHEM, V270, P27423, DOI 10.1074/jbc.270.46.27423; SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4; SCHWEIGER A, 2001, PRINCIPLES PULSE ELE, P183; SHETA EA, 1994, J BIOL CHEM, V269, P15147; Smith BC, 2013, P NATL ACAD SCI USA, V110, pE3577, DOI 10.1073/pnas.1313331110; Stuehr DJ, 2009, FEBS J, V276, P3959, DOI 10.1111/j.1742-4658.2009.07120.x; Stuehr DJ, 1996, METHOD ENZYMOL, V268, P324; Sugishima M, 2014, P NATL ACAD SCI USA, V111, P2524, DOI 10.1073/pnas.1322034111; Tejero J, 2010, J BIOL CHEM, V285, P27232, DOI 10.1074/jbc.M110.138842; Tejero J, 2010, J BIOL CHEM, V285, P25941, DOI 10.1074/jbc.M110.126797; Tiso M, 2005, J BIOL CHEM, V280, P39208, DOI 10.1074/jbc.M507775200; Tiso M, 2007, BIOCHEMISTRY-US, V46, P14418, DOI 10.1021/bi701646k; Toogood HS, 2007, FEBS J, V274, P5481, DOI 10.1111/j.1742-4658.2007.06107.x; Toogood HS, 2004, J BIOL CHEM, V279, P32904, DOI 10.1074/jbc.M404884200; Weber S, 2001, J AM CHEM SOC, V123, P3790, DOI 10.1021/ja003426m; Welland A, 2010, FEBS J, V277, P3833, DOI 10.1111/j.1742-4658.2010.07787.x; Wilson MA, 2000, J MOL BIOL, V301, P1237, DOI 10.1006/jmbi.2000.4029; Wolthers KR, 2002, BIOCHEMISTRY-US, V41, P196, DOI 10.1021/bi0109461	52	25	25	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11725	11738		10.1074/jbc.M114.548834	http://dx.doi.org/10.1074/jbc.M114.548834			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24610812	Green Published, hybrid			2022-12-25	WOS:000335010600015
J	Yu, SZ; Li, FN; Yan, N; Yuan, CQ; He, SS; Hou, TS				Yu, Shunzhi; Li, Fengning; Yan, Ning; Yuan, Chaoqun; He, Shisheng; Hou, Tiesheng			Anterior Fusion Technique for Multilevel Cervical Spondylotic Myelopathy: A Retrospective Analysis of Surgical Outcome of Patients with Different Number of Levels Fused	PLOS ONE			English	Article							SPINE SURGERY; INTERBODY FUSION; PLATE FIXATION; RISK-FACTORS; NECK PAIN; CORPECTOMY; DISKECTOMY; LAMINOPLASTY; DYSPHAGIA; MANAGEMENT	Objective: The anterior approach for multilevel CSM has been developed and obtained favorable outcomes. However, the operation difficulty, invasiveness and operative risks increase when multi-level involved. This study was to assess surgical parameters, complications, clinical and radiological outcomes in the treatment of 2-, 3- and 4-level CSM. Methods: A total of 248 patients with 2-, 3- or 4-level CSM who underwent anterior decompression and fusion procedures between October 2005 and June 2011 were divided into three groups, the 2-level group (106 patients), the 3-level group (98 patients) and the 4-level group (44 patients). The clinical and Radiographic outcomes including Japanese Orthopedic Association (JOA) score, Neck Disability Index (NDI) score, Odom's Scale, hospital stay, blood loss, operation time, fusion rate, cervical lordosis, cervical range of motion (ROM), and complications were compared. Results: At a minimum of 2-year follow-up, no statistical differences in JOA score, NDI score, Odom's Scale, hospital stay, fusion rate and cervical lordosis were found among the 3 groups. However, the mean postoperative NDI score of the 4-level group was significantly higher than that in the other two groups (P < 0.05), and in terms of postoperative total ROM, the 3-level group was superior to the 4-level group and inferior to 2-level group (P < 0.05). The decrease rate of ROM in the 3-level group was significantly higher than that in the 2-level group, and lower than that in the 4-level group (P < 0.05). Conclusions: As the number of involved levels increased, surgical results become worse in terms of operative time, blood loss, NDI score, cervical ROM and complication rates postoperatively. An appropriate surgical procedure for multilevel CSM should be chosen according to comprehensive clinical evaluation before operation, thus reducing fusion and decompression levels if possible.	[Yu, Shunzhi; Yan, Ning; Yuan, Chaoqun; He, Shisheng; Hou, Tiesheng] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Orthoped, Shanghai 200092, Peoples R China; [Li, Fengning] PLA Second Mil Med Univ, Affiliated Hosp 3, Dept Orthoped, Shanghai, Peoples R China	Tongji University; Naval Medical University	Hou, TS (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Orthoped, Shanghai 200092, Peoples R China.	houzhuren@126.com		Yuan, Chaoqun/0000-0003-4354-422X				Chang SW, 2010, NEUROSURGERY, V66, P639, DOI 10.1227/01.NEU.0000367449.60796.94; Chen Z, 2012, SPINE, V37, P1292, DOI 10.1097/BRS.0b013e3182477f26; CLOWARD RB, 1958, J NEUROSURG, V15, P602, DOI 10.3171/jns.1958.15.6.0602; Danto J, 2012, J NEUROSURG ANESTH, V24, P350, DOI 10.1097/ANA.0b013e3182622843; David KS, 2006, CLIN NEUROL NEUROSUR, V108, P675, DOI 10.1016/j.clineuro.2005.04.005; Grabowski G, 2012, ORTHOP CLIN N AM, V43, P63, DOI 10.1016/j.ocl.2011.08.008; Guo QF, 2011, EUR SPINE J, V20, P1539, DOI 10.1007/s00586-011-1735-4; Ha SM, 2013, J KOREAN NEUROSURG S, V53, P288, DOI 10.3340/jkns.2013.53.5.288; Hacker RJ, 2000, SPINE, V25, P2646, DOI 10.1097/00007632-200010150-00017; Hacker RJ, 2000, J NEUROSURG, V93, P222, DOI 10.3171/spi.2000.93.2.0222; HERKOWITZ HN, 1988, SPINE, V13, P774, DOI 10.1097/00007632-198807000-00011; Jiang JL, 2012, J CLIN NEUROSCI, V19, P804, DOI 10.1016/j.jocn.2011.09.021; Kang SH, 2011, J CLIN NEUROSCI, V18, P1369, DOI 10.1016/j.jocn.2011.02.033; Konya D, 2009, J CLIN NEUROSCI, V16, P404, DOI 10.1016/j.jocn.2008.07.070; Kou J, 2002, SPINE, V27, P1670, DOI 10.1097/00007632-200208010-00016; Lebl Darren R, 2011, HSS J, V7, P170, DOI 10.1007/s11420-011-9208-1; Lee KE, 2004, J NEUROSCI METH, V137, P151, DOI 10.1016/j.jneumeth.2004.02.021; Lin QS, 2012, EUR SPINE J, V21, P474, DOI 10.1007/s00586-011-1961-9; Liu T, 2011, EUR SPINE J, V20, P224, DOI 10.1007/s00586-010-1486-7; Liu Y, 2012, SPINE, V37, pE1450, DOI 10.1097/BRS.0b013e31826c72b4; Liu Y, 2009, J ZHEJIANG UNIV-SC B, V10, P696, DOI 10.1631/jzus.B0960001; Majd ME, 1999, SPINE, V24, P1604, DOI 10.1097/00007632-199908010-00016; Manchikanti L, 2008, SPINE, V33, P1813, DOI 10.1097/BRS.0b013e31817b8f88; Manzano GR, 2012, NEUROSURGERY, V70, P264, DOI 10.1227/NEU.0b013e3182305669; Oh MC, 2009, SPINE, V34, P692, DOI 10.1097/BRS.0b013e318199690a; Panjabi MM, 1999, SPINE, V24, P2383, DOI 10.1097/00007632-199911150-00016; Park Y, 2010, SPINE J, V10, P193, DOI 10.1016/j.spinee.2009.09.006; PENNING L, 1978, AM J ROENTGENOL, V130, P317, DOI 10.2214/ajr.130.2.317; Reitman CA, 2004, SPINE, V29, pE221, DOI 10.1097/00007632-200406010-00022; ROBINSON RA, 1955, B JOHNS HOPKINS HOSP, V96, P223; Sagi HC, 2002, SPINE, V27, P949, DOI 10.1097/00007632-200205010-00013; Sakaura H, 2003, SPINE, V28, P2447, DOI 10.1097/01.BRS.0000090833.96168.3F; Sasso RC, 2003, SPINE, V28, P140, DOI 10.1097/00007632-200301150-00009; Sevki K, 2004, SPINE, V29, P2493, DOI 10.1097/01.brs.0000145412.93407.c3; Stewart TJ, 2007, NEUROSURGERY, V60, P143, DOI 10.1227/01.NEU.0000217015.96212.1B; Vaccaro AR, 1998, J SPINAL DISORD, V11, P410; Winkelstein BA, 2008, SPINE, V33, P856, DOI 10.1097/BRS.0b013e31816b4710; Wu XD, 2012, EUR SPINE J, V21, P1368, DOI 10.1007/s00586-012-2157-7; Yalamanchili PK, 2012, ADV ORTHOP, V2012, DOI 10.1155/2012/783762; YONENOBU K, 1992, SPINE, V17, P1281, DOI 10.1097/00007632-199211000-00004; Yu SZ, 2013, ORTHOPEDICS, V36, pE613, DOI 10.3928/01477447-20130426-24; Zeng JH, 2013, ARCH ORTHOP TRAUM SU, V133, P1067, DOI 10.1007/s00402-013-1773-y	42	25	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91329	10.1371/journal.pone.0091329	http://dx.doi.org/10.1371/journal.pone.0091329			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618678	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400077
J	Bandholm, T; Thorborg, K; Lunn, TH; Kehlet, H; Jakobsen, TL				Bandholm, Thomas; Thorborg, Kristian; Lunn, Troels Haxholdt; Kehlet, Henrik; Jakobsen, Thomas Linding			Knee Pain during Strength Training Shortly following Fast-Track Total Knee Arthroplasty: A Cross-Sectional Study	PLOS ONE			English	Article							ACUTE POSTOPERATIVE PAIN; QUADRICEPS STRENGTH; EXERCISE; REHABILITATION; ACTIVATION; HIP; FORCES	Background: Loading and contraction failure (muscular exhaustion) are strength training variables known to influence neural activation of the exercising muscle in healthy subjects, which may help reduce neural inhibition of the quadriceps muscle following total knee arthroplasty (TKA). It is unknown how these exercise variables influence knee pain after TKA. Objective: To investigate the effect of loading and contraction failure on knee pain during strength training, shortly following TKA. Design: Cross-sectional study. Setting: Consecutive sample of patients from the Copenhagen area, Denmark, receiving a TKA, between November 2012 and April 2013. Participants: Seventeen patients, no more than 3 weeks after their TKA. Main outcome measures: In a randomized order, the patients performed 1 set of 4 standardized knee extensions, using relative loads of 8, 14, and 20 repetition maximum (RM), and ended with 1 single set to contraction failure (14 RM load). The individual loadings (kilograms) were determined during a familiarization session >72 hours prior. The patients rated their knee pain during each repetition, using a numerical rating scale (0-10). Results: Two patients were lost to follow up. Knee pain increased with increasing load (20 RM: 3.1+/-2.0 points, 14 RM: 3.5+/-1.8 points, 8 RM: 4.3+/-2.5 points, P = 0.006), and repetitions to contraction failure (10% failure: 3.2+/-1.9 points, 100% failure: 5.4+/-1.6 points, P < 0.001). Resting knee pain 60 seconds after the final repetition (2.7+/-2.4 points) was not different from that recorded before strength training (2.7+/-1.8 points, P = 0.88). Conclusion: Both loading and repetitions performed to contraction failure during knee-extension strength-training, increased post-operative knee pain during strength training implemented shortly following TKA. However, only the increase in pain during repetitions to contraction failure exceeded that defined as clinically relevant, and was very short-lived.	[Bandholm, Thomas; Thorborg, Kristian] Univ Copenhagen, Hvidovre Hosp, Dept Phys Therapy, Phys Med & Rehabil Res Copenhagen PMR C, Copenhagen, Denmark; [Bandholm, Thomas; Jakobsen, Thomas Linding] Univ Copenhagen, Clin Res Ctr, Hvidovre Hosp, Copenhagen, Denmark; [Bandholm, Thomas; Thorborg, Kristian] Univ Copenhagen, Dept Orthoped Surg, Hvidovre Hosp, Copenhagen, Denmark; [Thorborg, Kristian] Univ Copenhagen, Amager Hosp, Arthroscop Ctr Amager, Copenhagen, Denmark; [Lunn, Troels Haxholdt] Univ Copenhagen, Dept Anaesthesiol, Hvidovre Hosp, Copenhagen, Denmark; [Lunn, Troels Haxholdt; Kehlet, Henrik; Jakobsen, Thomas Linding] Univ Copenhagen, Lundbeckfdn Ctr Fast Track Hip & Knee Surg, Hvidovre Hosp, Copenhagen, Denmark; [Kehlet, Henrik] Univ Copenhagen, Rigshosp, Sect Surg Pathophysiol, DK-2100 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Bandholm, T (corresponding author), Univ Copenhagen, Hvidovre Hosp, Dept Phys Therapy, Phys Med & Rehabil Res Copenhagen PMR C, Copenhagen, Denmark.	thomas.bandholm@hvh.regionh.dk	Bandholm, Thomas/AAZ-8632-2020	Bandholm, Thomas/0000-0001-6884-1971; Kehlet, Henrik/0000-0002-2209-1711	Lundbeck Foundation, Hellerup, Denmark	Lundbeck Foundation, Hellerup, Denmark(Lundbeckfonden)	The study was supported partly by a grant from the Lundbeck Foundation, Hellerup, Denmark (www.lundbeckfonden.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LO, 2009, ANAESTHESIA, V64, P508, DOI 10.1111/j.1365-2044.2008.05831.x; Bade MJ, 2012, CURR OPIN RHEUMATOL, V24, P208, DOI 10.1097/BOR.0b013e32834ff26d; Bandholm T, 2012, ARCH PHYS MED REHAB, V93, P1292, DOI 10.1016/j.apmr.2012.02.014; Breivik H, 2008, BRIT J ANAESTH, V101, P17, DOI 10.1093/bja/aen103; Brzycki M., 1993, J PHYS ED REC DANCE, V64, P88, DOI [DOI 10.1080/07303084.1993.10606684, 10.1080/07303084.1993.10606684]; Carr AJ, 2012, LANCET, V379, P1331, DOI 10.1016/S0140-6736(11)60752-6; Chan EY, 2013, OSTEOARTHR CARTILAGE, V21, P1257, DOI 10.1016/j.joca.2013.06.011; Chen YW, 2013, REGION ANESTH PAIN M, V38, P282, DOI 10.1097/AAP.0b013e31828df3f9; D'Lima DD, 2008, CLIN ORTHOP RELAT R, V466, P2605, DOI 10.1007/s11999-008-0345-x; HODGES JL, 1962, ANN MATH STAT, V33, P482, DOI 10.1214/aoms/1177704575; Holm B, 2010, ARCH PHYS MED REHAB, V91, P1770, DOI 10.1016/j.apmr.2010.07.229; Holm B, 2010, DISABIL REHABIL, V32, P300, DOI 10.3109/09638280903095965; Jakobsen MD, 2013, HUM MOVEMENT SCI, V32, P65, DOI 10.1016/j.humov.2012.07.002; Jakobsen TL, 2010, PHYSIOTHER RES INT, V15, P126, DOI 10.1002/pri.450; Jakobsen TL, 2012, DISABIL REHABIL, V34, P1034, DOI 10.3109/09638288.2011.629019; Kehlet H, 2013, LANCET, V381, P1600, DOI 10.1016/S0140-6736(13)61003-X; Lin CWC, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-69; Lunn TH, 2012, ACTA ANAESTH SCAND, V56, P1234, DOI 10.1111/j.1399-6576.2012.02744.x; McNair PJ, 1996, ARCH PHYS MED REHAB, V77, P896, DOI 10.1016/S0003-9993(96)90277-4; Mizner RL, 2005, J BONE JOINT SURG AM, V87A, P1047, DOI 10.2106/JBJS.D.01992; Moffet H, 2004, ARCH PHYS MED REHAB, V85, P546, DOI 10.1016/j.apmr.2003.08.080; Naugle KM, 2012, J PAIN, V13, P1139, DOI 10.1016/j.jpain.2012.09.006; Ratamess NA, 2009, MED SCI SPORT EXER, V41, P687, DOI 10.1249/MSS.0b013e3181915670; Rice DA, 2010, SEMIN ARTHRITIS RHEU, V40, P250, DOI 10.1016/j.semarthrit.2009.10.001; Stevens JE, 2003, J ORTHOPAED RES, V21, P775, DOI 10.1016/S0736-0266(03)00052-4; Sundstrup E, 2012, J STRENGTH COND RES, V26, P1897, DOI 10.1519/JSC.0b013e318239c38e; Thomas AC, 2012, EXERC SPORT SCI REV, V40, P95, DOI 10.1097/JES.0b013e31824a732b; Thomee R, 1997, PHYS THER, V77, P1690, DOI 10.1093/ptj/77.12.1690; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wilk KE, 1996, AM J SPORT MED, V24, P518, DOI 10.1177/036354659602400418	30	9	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91107	10.1371/journal.pone.0091107	http://dx.doi.org/10.1371/journal.pone.0091107			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614574	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300076
J	Heaf, JG; Wehberg, S				Heaf, James G.; Wehberg, Sonja			Relative Survival of Peritoneal Dialysis and Haemodialysis Patients: Effect of Cohort and Mode of Dialysis Initiation	PLOS ONE			English	Article							RESIDUAL RENAL-FUNCTION; MORTALITY-RATES; COMPARING MORTALITY; MEMBRANE-TRANSPORT; HOME HEMODIALYSIS; TECHNIQUE FAILURE; SIMILAR OUTCOMES; ESRD PATIENTS; RISK-FACTORS; MODALITY	Introduction: Epidemiological studies consistently show an initial survival advantage for PD patients compared to HD. It has recently been suggested that this is due to the fact that many HD patients are referred late, and start dialysis on an acute, inpatient basis. The present study was performed to investigate (1) whether, and if so, how, PD and HD prognosis had changed in recent years, (2) whether a potential survival advantage of PD versus HD is constant over dialysis duration, and (3) whether differences in prognosis could be explained by patient age, renal diagnosis of diabetic nephropathy, or mode of dialysis initiation. Patients and Methods: 12095 patients starting dialysis therapy between 1990 and 2010 in Denmark were studied. Prognosis was assessed according to initial dialysis modality on an intention-to-treat basis, censored for transplantation. Results were adjusted for age, sex, renal diagnosis, Charlson Comorbidity Index (CCI), and mode of dialysis initiation. Results: Overall adjusted prognosis improved by 34% (HD 30%, PD 42%). PD prognosis relative to HD improved, and was 16% better at the end of the period. Final PD prognosis improved consistently from 1990-99 to 2000-10 in all subgroups. PD was associated with a significant initial survival advantage, both overall and for all subgroups For the latter cohort, overall PD prognosis was better than HD for the first 4 years, after which it was insignificantly worse. The initial survival advantage was also present in a subgroup analysis of patients with early & routine ESRD initiation. Conclusions: Dialysis survival has increased during the past 20 years. PD survival since 2000 has been better than HD, overall and for all subgroups. The difference in survival is not explained by mode of dialysis initiation.	[Heaf, James G.] Copenhagen Univ Hosp Herlev, Dept Nephrol B, Herlev, Denmark; [Wehberg, Sonja] Odense Univ Hosp, Dept Epidemiol, DK-5000 Odense, Denmark	University of Copenhagen; University of Southern Denmark; Odense University Hospital	Heaf, JG (corresponding author), Copenhagen Univ Hosp Herlev, Dept Nephrol B, Herlev, Denmark.	heaf@dadlnet.dk		Wehberg, Sonja/0000-0003-1503-2649	Baxter; Fresenius	Baxter; Fresenius	The authors have read the journal's policy and have the following conflicts. James Heaf has received travel funding and lecture fees from Baxter and Fresenius, and a research grant from Fresenius. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Andersen TF, 1999, DAN MED BULL, V46, P263; Brimble KS, 2006, J AM SOC NEPHROL, V17, P2591, DOI 10.1681/ASN.2006030194; Burton JO, 2009, CLIN J AM SOC NEPHRO, V4, P914, DOI 10.2215/CJN.03900808; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Churchill DN, 1998, J AM SOC NEPHROL, V9, P1285; Collins AJ, 2002, SEMIN DIALYSIS, V15, P98, DOI 10.1046/j.1525-139X.2002.00032.x; Collins AJ, 2012, AM J KIDNEY DIS, V59, pEVII, DOI 10.1053/j.ajkd.2011.11.015; Davies SJ, 2006, KIDNEY INT, V70, pS76, DOI 10.1038/sj.ki.5001920; Eknoyan G, 2002, NEW ENGL J MED, V347, P2010, DOI 10.1056/NEJMoa021583; Fenton SSA, 1997, AM J KIDNEY DIS, V30, P334, DOI 10.1016/S0272-6386(97)90276-6; Foley RN, 2011, NEW ENGL J MED, V365, P1099, DOI 10.1056/NEJMoa1103313; Frimat L, 2006, PERITON DIALYSIS INT, V26, P231; Ganesh SK, 2003, J AM SOC NEPHROL, V14, P415, DOI 10.1097/01.ASN.0000043140.23422.4F; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Grooteman MPC, 2012, J AM SOC NEPHROL, V23, P1087, DOI 10.1681/ASN.2011121140; Heaf JG, 2002, NEPHROL DIAL TRANSPL, V17, P112, DOI 10.1093/ndt/17.1.112; Heaf JG, 2011, DANISH NEPHROLOGY RE, P1; Huang CC, 2008, PERITON DIALYSIS INT, V28, pS15; Jaar BG, 2005, ANN INTERN MED, V143, P174, DOI 10.7326/0003-4819-143-3-200508020-00003; Jansen MAM, 2002, KIDNEY INT, V62, P1046, DOI 10.1046/j.1523-1755.2002.00505.x; Johnson DW, 2012, NEPHROL DIAL TRANSPL, V27, P4445, DOI 10.1093/ndt/gfs314; Johnson DW, 2012, J AM SOC NEPHROL, V23, P1097, DOI 10.1681/ASN.2011121201; Johnson DW, 2010, NEPHROL DIAL TRANSPL, V25, P1973, DOI 10.1093/ndt/gfp780; Lang SM, 2001, PERITON DIALYSIS INT, V21, P52; Lee CC, 2009, PERITON DIALYSIS INT, V29, P182; Liem YS, 2007, KIDNEY INT, V71, P153, DOI 10.1038/sj.ki.5002014; Locatelli F, 2001, J AM SOC NEPHROL, V12, P2411, DOI 10.1681/ASN.V12112411; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Marshall MR, 2011, AM J KIDNEY DIS, V58, P782, DOI 10.1053/j.ajkd.2011.04.027; McDonald SP, 2009, J AM SOC NEPHROL, V20, P155, DOI 10.1681/ASN.2007111188; Mehrotra R, 2011, ARCH INTERN MED, V171, P110, DOI 10.1001/archinternmed.2010.352; Mircescu G, 2006, PERITON DIALYSIS INT, V26, P266; Moist LM, 2000, J AM SOC NEPHROL, V11, P556, DOI 10.1681/ASN.V113556; Paniagua R, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1351307; Pauly RP, 2009, NEPHROL DIAL TRANSPL, V24, P2915, DOI 10.1093/ndt/gfp295; Pedersen CB, 2006, DAN MED BULL, V53, P441; Port FK, 2006, CLIN J AM SOC NEPHRO, V1, P246, DOI 10.2215/CJN.01050905; Quinn RR, 2011, J AM SOC NEPHROL, V22, P1534, DOI 10.1681/ASN.2010121232; Sanabria M, 2008, KIDNEY INT, V73, pS165, DOI 10.1038/sj.ki.5002619; Schaubel DE, 1998, PERITON DIALYSIS INT, V18, P478; Sens F, 2011, KIDNEY INT, V80, P970, DOI 10.1038/ki.2011.233; Stack AG, 2003, KIDNEY INT, V64, P1071, DOI 10.1046/j.1523-1755.2003.00165.x; Termorshuizen F, 2003, J AM SOC NEPHROL, V14, P2851, DOI 10.1097/01.ASN.0000091585.45723.9E; van de Luijtgaarden MWM, 2011, NEPHROL DIAL TRANSPL, V26, P2940, DOI 10.1093/ndt/gfq845; Vilar E, 2009, NEPHROL DIAL TRANSPL, V24, P2502, DOI 10.1093/ndt/gfp071; Vonesh EF, 2004, KIDNEY INT, V66, P2389, DOI 10.1111/j.1523-1755.2004.66028.x; Vonesh EF, 1999, J AM SOC NEPHROL, V10, P354; Wehberg S, 2010, DATAGRUNDLAG ANALYSE, P14; Weinhandl ED, 2010, J AM SOC NEPHROL, V21, P499, DOI 10.1681/ASN.2009060635; Winkelmayer WC, 2002, J AM SOC NEPHROL, V13, P2353, DOI 10.1097/01.ASN.0000025785.41314.76; Yang X, 2008, PERITON DIALYSIS INT, V28, P82; Yeates K, 2012, NEPHROL DIAL TRANSPL, V27, P3568, DOI 10.1093/ndt/gfr674	52	61	67	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90119	10.1371/journal.pone.0090119	http://dx.doi.org/10.1371/journal.pone.0090119			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614569	gold, Green Published, Green Submitted			2022-12-25	WOS:000332839300018
J	Kim, SH; Kim, DH; Lee, KH; Im, SK; Hur, EM; Chung, KC; Rhim, H				Kim, Soon-Hee; Kim, Dong Hyuk; Lee, Kang Ho; Im, Sun-Kyoung; Hur, Eun-Mi; Chung, Kwang Chul; Rhim, Hyewhon			Direct Interaction and Functional Coupling between Human 5-HT6 Receptor and the Light Chain 1 Subunit of the Microtubule-Associated Protein 1B (MAP1B-LC1)	PLOS ONE			English	Article							SEROTONIN RECEPTORS; MECHANISM; CLONING; CHANNEL; FAMILY; TAU	Serotonin (5-HT) receptors of type 6 (5-HT6R) play important roles in mood, psychosis, and eating disorders. Recently, a growing number of studies support the use of 5-HT6R-targeting compounds as promising drug candidates for treating cognitive dysfunction associated with Alzheimer's disease. However, the mechanistic linkage between 5-HT6R and such functions remains poorly understood. By using yeast two-hybrid, GST pull-down, and co-immunoprecipitation assays, here we show that human 5-HT6R interacts with the light chain 1 (LC1) subunit of MAP1B protein (MAP1B-LC1), a classical microtubule-associated protein highly expressed in the brain. Functionally, we have found that expression of MAP1B-LC1 regulates serotonin signaling in a receptor subtype-specific manner, specifically controlling the activities of 5-HT6(R), but not those of 5-HT4R and 5-HT7R. In addition, we have demonstrated that MAP1B-LC1 increases the surface expression of 5-HT6R and decreases its endocytosis, suggesting that MAP1B-LC1 is involved in the desensitization and trafficking of 5-HT6R via a direct interaction. Together, we suggest that signal transduction pathways downstream of 5-HT6R are regulated by MAP1B, which might play a role in 5-HT6R-mediated signaling in the brain.	[Kim, Soon-Hee; Kim, Dong Hyuk; Lee, Kang Ho; Im, Sun-Kyoung; Hur, Eun-Mi; Rhim, Hyewhon] Korea Inst Sci & Technol, Ctr Neurosci, Brain Sci Inst, Seoul, South Korea; [Lee, Kang Ho; Rhim, Hyewhon] Univ Sci & Technol, Dept Neurosci, Taejon, South Korea; [Chung, Kwang Chul] Yonsei Univ, Dept Syst Biol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea	Korea Institute of Science & Technology (KIST); Yonsei University	Rhim, H (corresponding author), Korea Inst Sci & Technol, Ctr Neurosci, Brain Sci Inst, Seoul, South Korea.	hrhim@kist.re.kr	Hur, Eun Mi/AAU-4906-2021		Pioneer Research Program [2013008915]; Korea Institute of Science and Technology, the Republic of Korea [2E24480]	Pioneer Research Program; Korea Institute of Science and Technology, the Republic of Korea	This work was supported by grants from the Pioneer Research Program (No. 2013008915) and Korea Institute of Science and Technology (2E24480), the Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Codony X, 2011, CURR OPIN PHARMACOL, V11, P94, DOI 10.1016/j.coph.2011.01.004; East SZ, 2002, SYNAPSE, V45, P191, DOI 10.1002/syn.10097; Filip M, 2009, PHARMACOL REP, V61, P761, DOI 10.1016/S1734-1140(09)70132-X; Fujiwara Y, 2011, BIOCHIMIE, V93, P817, DOI 10.1016/j.biochi.2011.01.008; GARNER CC, 1990, J NEUROCHEM, V55, P146, DOI 10.1111/j.1471-4159.1990.tb08832.x; Gonzalez-Billault C, 2004, J NEUROBIOL, V58, P48, DOI 10.1002/neu.10283; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Henriquez DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053123; Hur EM, 2011, GENE DEV, V25, P1968, DOI 10.1101/gad.17015911; Kim DH, 2010, BIOL PHARM BULL, V33, P2024, DOI 10.1248/bpb.33.2024; Kim HJ, 2008, COMB CHEM HIGH T SCR, V11, P316, DOI 10.2174/138620708784246059; Kim S, 2007, J BIOL CHEM, V282, P32877, DOI 10.1074/jbc.M701418200; Kohen R, 1996, J NEUROCHEM, V66, P47; Lee G, 1998, J CELL SCI, V111, P3167; Lee G, 2004, J NEUROSCI, V24, P2304, DOI 10.1523/JNEUROSCI.4162-03.2004; Lee SY, 2008, FEBS LETT, V582, P2826, DOI 10.1016/j.febslet.2008.07.021; Marazziti D, 2011, CURR MED CHEM, V18, P2783, DOI 10.2174/092986711796011283; Meffre J, 2012, EMBO MOL MED, V4, P1043, DOI 10.1002/emmm.201201410; Mnie-Filali O, 2010, CELL SIGNAL, V22, P501, DOI 10.1016/j.cellsig.2009.11.004; Moritz A, 2009, BIOCHEM BIOPH RES CO, V390, P82, DOI 10.1016/j.bbrc.2009.09.070; Norum JH, 2003, J BIOL CHEM, V278, P3098, DOI 10.1074/jbc.M206237200; O'Brien JE, 2012, J BIOL CHEM, V287, P18459, DOI 10.1074/jbc.M111.336024; Riccioni T, 2011, EUR J PHARMACOL, V661, P8, DOI 10.1016/j.ejphar.2011.04.028; Sun H, 2008, J PHYSIOL-LONDON, V586, P751, DOI 10.1113/jphysiol.2007.136440; WICHE G, 1991, INT REV CYTOL, V124, P217; Woolley ML, 2004, CNS NEUROL DISORD-DR, V3, P59, DOI 10.2174/1568007043482561; Yun HM, 2007, J BIOL CHEM, V282, P5496, DOI 10.1074/jbc.M606215200; Yun Hyung-Mun, 2011, Exp Neurobiol, V20, P159, DOI 10.5607/en.2011.20.4.159; Yun HM, 2010, J BIOL CHEM, V285, P10016, DOI 10.1074/jbc.M109.068759	29	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91402	10.1371/journal.pone.0091402	http://dx.doi.org/10.1371/journal.pone.0091402			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614691	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300120
J	Mitchell, AL; Macarthur, KDR; Gan, EH; Baggott, LE; Wolff, ASB; Skinningsrud, B; Platt, H; Short, A; Lobell, A; Kampe, O; Bensing, S; Betterle, C; Kasperlik-Zaluska, A; Zurawek, M; Fichna, M; Kockum, I; Eriksson, GN; Ekwall, O; Wahlberg, J; Dahlqvist, P; Hulting, AL; Penna-Martinez, M; Meyer, G; Kahles, H; Badenhoop, K; Hahner, S; Quinkler, M; Falorni, A; Phipps-Green, A; Merriman, TR; Ollier, W; Cordell, HJ; Undlien, D; Czarnocka, B; Husebye, E; Pearce, SHS				Mitchell, Anna L.; Macarthur, Katie D. R.; Gan, Earn H.; Baggott, Lucy E.; Wolff, Anette S. B.; Skinningsrud, Beate; Platt, Hazel; Short, Andrea; Lobell, Anna; Kampe, Olle; Bensing, Sophie; Betterle, Corrado; Kasperlik-Zaluska, Anna; Zurawek, Magdalena; Fichna, Marta; Kockum, Ingrid; Eriksson, Gabriel Nordling; Ekwall, Olov; Wahlberg, Jeanette; Dahlqvist, Per; Hulting, Anna-Lena; Penna-Martinez, Marissa; Meyer, Gesine; Kahles, Heinrich; Badenhoop, Klaus; Hahner, Stephanie; Quinkler, Marcus; Falorni, Alberto; Phipps-Green, Amanda; Merriman, Tony R.; Ollier, William; Cordell, Heather J.; Undlien, Dag; Czarnocka, Barbara; Husebye, Eystein; Pearce, Simon H. S.			Association of Autoimmune Addison's Disease with Alleles of STAT4 and GATA3 in European Cohorts	PLOS ONE			English	Article							GRAVES-DISEASE; HASHIMOTOS-THYROIDITIS; RHEUMATOID-ARTHRITIS; GENE; SUSCEPTIBILITY; POLYMORPHISM; HAPLOTYPE; PREVALENCE; PROMOTER; RISK	Background: Gene variants known to contribute to Autoimmune Addison's disease (AAD) susceptibility include those at the MHC, MICA, CIITA, CTLA4, PTPN22, CYP27B1, NLRP-1 and CD274 loci. The majority of the genetic component to disease susceptibility has yet to be accounted for. Aim: To investigate the role of 19 candidate genes in AAD susceptibility in six European case-control cohorts. Methods: A sequential association study design was employed with genotyping using Sequenom iPlex technology. In phase one, 85 SNPs in 19 genes were genotyped in UK and Norwegian AAD cohorts (691 AAD, 715 controls). In phase two, 21 SNPs in 11 genes were genotyped in German, Swedish, Italian and Polish cohorts (1264 AAD, 1221 controls). In phase three, to explore association of GATA3 polymorphisms with AAD and to determine if this association extended to other autoimmune conditions, 15 SNPs in GATA3 were studied in UK and Norwegian AAD cohorts, 1195 type 1 diabetes patients from Norway, 650 rheumatoid arthritis patients from New Zealand and in 283 UK Graves' disease patients. Meta-analysis was used to compare genotype frequencies between the participating centres, allowing for heterogeneity. Results: We report significant association with alleles of two STAT4 markers in AAD cohorts (rs4274624: P = 0.00016; rs10931481: P = 0.0007). In addition, nominal association of AAD with alleles at GATA3 was found in 3 patient cohorts and supported by meta-analysis. Association of AAD with CYP27B1 alleles was also confirmed, which replicates previous published data. Finally, nominal association was found at SNPs in both the NF-kappa B1 and IL23A genes in the UK and Italian cohorts respectively. Conclusions: Variants in the STAT4 gene, previously associated with other autoimmune conditions, confer susceptibility to AAD. Additionally, we report association of GATA3 variants with AAD: this adds to the recent report of association of GATA3 variants with rheumatoid arthritis.	[Mitchell, Anna L.; Macarthur, Katie D. R.; Gan, Earn H.; Baggott, Lucy E.; Cordell, Heather J.; Pearce, Simon H. S.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Wolff, Anette S. B.; Husebye, Eystein] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Skinningsrud, Beate; Undlien, Dag] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Skinningsrud, Beate; Undlien, Dag] Univ Oslo, Oslo, Norway; [Platt, Hazel; Short, Andrea; Ollier, William] Univ Manchester, Inst Populat Hlth, CIGMR, Manchester, Lancs, England; [Lobell, Anna; Kampe, Olle; Bensing, Sophie] Uppsala Univ, Uppsala, Sweden; [Bensing, Sophie; Hulting, Anna-Lena] Karolinska Inst, Stockholm, Sweden; [Betterle, Corrado] Univ Padua, Sch Med, Dept Med, Padua, Italy; [Kasperlik-Zaluska, Anna] Med Ctr Postgrad Educ, Dept Endocrinol, Warsaw, Poland; [Zurawek, Magdalena; Fichna, Marta] Polish Acad Sci, Inst Human Genet, PL-60479 Poznan, Poland; [Kockum, Ingrid] Karolinska Inst, Dept Clin Neurosci, Neuroimmunol Unit, Stockholm, Sweden; [Kockum, Ingrid] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Eriksson, Gabriel Nordling] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Ekwall, Olov] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Wahlberg, Jeanette] Linkoping Univ, Fac Hlth Sci, Div Endocrinol, Dept Med & Hlth Sci, Linkoping, Sweden; [Dahlqvist, Per] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Penna-Martinez, Marissa; Meyer, Gesine; Kahles, Heinrich; Badenhoop, Klaus] Goethe Univ Frankfurt, Univ Hosp Frankfurt, Dept Med, Div Endocrinol, D-60054 Frankfurt, Germany; [Hahner, Stephanie] Univ Hosp Wuerzburg, Dept Med Endocrinol & Diabetol, Wurzburg, Germany; [Quinkler, Marcus] Charite, Charite Campus Mitte, D-13353 Berlin, Germany; [Falorni, Alberto] Univ Perugia, Dept Internal Med, I-06100 Perugia, Italy; [Phipps-Green, Amanda; Merriman, Tony R.] Univ Otago, Dept Biochem, Otago, New Zealand; [Czarnocka, Barbara] Med Ctr Postgrad Educ, Dept Biochem & Mol Biol, Warsaw, Poland; [Husebye, Eystein] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway	Newcastle University - UK; University of Bergen; University of Oslo; University of Oslo; University of Manchester; Uppsala University; Karolinska Institutet; University of Padua; Centre of Postgraduate Medical Education - Poland; Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; University of Gothenburg; Linkoping University; Umea University; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Wurzburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Perugia; University of Otago; Centre of Postgraduate Medical Education - Poland; University of Bergen; Haukeland University Hospital	Mitchell, AL (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	annamitchell@doctors.org.uk	Wolff, Anette/AAN-5981-2020; Phipps-Green, Mandy/HDN-5829-2022; Meyer, Gesine/ABD-7219-2021; Pearce, Simon/AAB-3692-2019; Kockum, Ingrid/O-8781-2018; Czarnocka, Barbara/V-1048-2019	Phipps-Green, Mandy/0000-0002-1763-9623; Pearce, Simon/0000-0001-8384-8063; Kockum, Ingrid/0000-0002-0867-4726; Czarnocka, Barbara/0000-0001-7701-760X; Gan, Earn/0000-0003-1707-130X; Ekwall, Olov/0000-0002-4506-9955; Hahner, Stefanie/0000-0003-1616-8986; Quinkler, Marcus/0000-0003-4028-1671; Cordell, Heather/0000-0002-1879-5572; Wolff, Anette Susanne Boe/0000-0002-8485-2248; Merriman, Tony/0000-0003-0844-8726; Zurawek, Magdalena/0000-0002-0345-4054; Fichna, Marta/0000-0003-2865-7074; Kampe, Olle/0000-0001-6091-9914	European Union [201167]; Stockholm County Council; Karolinska Institutet; Swedish Society for Medical Research; Swedish Society of Medicine; NovoNordisk Foundation; Ake Wiberg Foundation; MRC [G0100594, G0600237, MR/K002279/1, G0901461, G0900390, G0900753] Funding Source: UKRI; Medical Research Council [MR/K002279/1, G0900753, G0900390, G0100594, G0600237, G0901461] Funding Source: researchfish; National Institute for Health Research [ACF-2007-01-004] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0011003, NNF13OC0005975] Funding Source: researchfish	European Union(European Commission); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Swedish Society for Medical Research; Swedish Society of Medicine; NovoNordisk Foundation(Novo Nordisk Foundation); Ake Wiberg Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was funded by a European Union Framework 7 grant 201167 to the Euradrenal Consortium. Financial support for the Swedish contribution was also provided through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet, The Swedish Society for Medical Research, the Swedish Society of Medicine, the NovoNordisk Foundation, Karolinska Institutet, and the Ake Wiberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, REV MAN REVMAN COMP; Badenhoop K, 2012, CURR DIABETES REP, V12, P635, DOI 10.1007/s11892-012-0322-3; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Blomhoff A, 2004, J CLIN ENDOCR METAB, V89, P3474, DOI 10.1210/jc.2003-031854; Cooper JD, 2011, DIABETES, V60, P1624, DOI 10.2337/db10-1656; Cross DS, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-51; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; FAIRCHILD RS, 1980, J CLIN ENDOCR METAB, V51, P1074, DOI 10.1210/jcem-51-5-1074; Fichna M, 2010, EXP CLIN ENDOCR DIAB, V118, P544, DOI 10.1055/s-0029-1241206; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gombos Z, 2007, EUR J ENDOCRINOL, V157, P757, DOI 10.1530/EJE-07-0290; HEGGARTY H, 1968, BMJ-BRIT MED J, V1, P559, DOI 10.1136/bmj.1.5591.559; HEWITT PH, 1957, BMJ-BRIT MED J, V2, P1530, DOI 10.1136/bmj.2.5060.1530; Jennings CE, 2005, J MOL ENDOCRINOL, V34, P859, DOI 10.1677/jme.1.01760; Kahles H, 2005, EUR J ENDOCRINOL, V153, P895, DOI 10.1530/eje.1.02035; Korman BD, 2008, GENES IMMUN, V9, P267, DOI 10.1038/gene.2008.1; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Laureti S, 1999, J CLIN ENDOCR METAB, V84, P1762, DOI 10.1210/jc.84.5.1762; Lee HS, 2007, MOL MED, V13, P455, DOI 10.2119/2007-00072.Lee; Lopez ER, 2004, EUR J ENDOCRINOL, V151, P193, DOI 10.1530/eje.0.1510193; Lovas K, 2002, CLIN ENDOCRINOL, V56, P787, DOI 10.1046/j.1365-2265.2002.t01-1-01552.x; MACLAREN NK, 1986, J CLIN ENDOCR METAB, V62, P455, DOI 10.1210/jcem-62-3-455; Myhre AG, 2002, J CLIN ENDOCR METAB, V87, P618, DOI 10.1210/jc.87.2.618; Pani MA, 2002, J CLIN ENDOCR METAB, V87, P2564, DOI 10.1210/jc.87.6.2564; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; RUSSELL GAB, 1991, ARCH DIS CHILD, V66, P350, DOI 10.1136/adc.66.3.350; SIMMONDS JP, 1978, POSTGRAD MED J, V54, P552, DOI 10.1136/pgmj.54.634.552; Skinningsrud B, 2011, J CLIN ENDOCR METAB, V96, pE1703, DOI 10.1210/jc.2011-0645; Skinningsrud B, 2010, ANN RHEUM DIS, V69, P1471, DOI 10.1136/ard.2009.114934; SMITH ME, 1963, BRIT MED J, P1316, DOI 10.1136/bmj.2.5368.1316; Tai TS, 2013, J IMMUNOL, V190, P428, DOI 10.4049/jimmunol.1201361; Vaidya B, 2000, J CLIN ENDOCR METAB, V85, P688, DOI 10.1210/jc.85.2.688; Velaga MR, 2004, J CLIN ENDOCR METAB, V89, P5862, DOI 10.1210/jc.2004-1108	34	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e88991	10.1371/journal.pone.0088991	http://dx.doi.org/10.1371/journal.pone.0088991			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614117	Green Published, gold			2022-12-25	WOS:000332839300009
J	Olofsson, B; Porsch, H; Heldin, P				Olofsson, Berit; Porsch, Helena; Heldin, Paraskevi			Knock-Down of CD44 Regulates Endothelial Cell Differentiation via NF kappa B-Mediated Chemokine Production	PLOS ONE			English	Article							MOLECULAR-WEIGHT HYALURONAN; IN-VITRO; ANGIOGENIC OLIGOSACCHARIDES; ADHESION MOLECULES; SIGNALING PATHWAYS; RECEPTORS CD44; UP-REGULATION; CANCER CELLS; ACID; PROLIFERATION	A striking feature of microvascular endothelial cells is their capacity to fuse and differentiate into tubular structures when grown in three-dimensional (3D) extracellular matrices, in collagen or Matrigel, mimicking the in vivo blood vessel formation. In this study we demonstrate that human telomerase-immortalised foreskin microvascular endothelial (TIME) cells express high levels of the hyaluronan receptor CD44 and the hyaluronidase HYAL2. Knock-down of CD44 or HYAL2 resulted in an inability of TIME cells to form a tubular network, suggesting a key regulatory role of hyaluronan in controlling TIME cell tubulogenesis in 3D matrices. Knock-down of CD44 resulted in an upregulation of mRNA expression of the chemokines CXCL9 and CXCL12, as well as their receptors CXCR3 and CXCR4. This was accompanied by a defect maturation of the tubular structure network and increased phosphorylation of the inhibitor of NF kappa B kinase (IKK) complex and thus translocation of NF kappa B into the nucleus and activation of chemokine targed genes. Furthermore, the interaction between CD44 and hyaluronan determines the adhesion of breast cancer cells. In summary, our observations support the notion that the interaction between CD44 and hyaluronan regulates microvascular endothelial cell tubulogenesis by affecting the expression of cytokines and their receptors, as well as breast cancer dissemination.	[Olofsson, Berit; Porsch, Helena; Heldin, Paraskevi] Uppsala Univ, Ludwig Inst Canc Res, Sci Life Lab, Biomed Ctr, Uppsala, Sweden	Ludwig Institute for Cancer Research; Uppsala University	Heldin, P (corresponding author), Uppsala Univ, Ludwig Inst Canc Res, Sci Life Lab, Biomed Ctr, Uppsala, Sweden.	Evi.Heldin@LICR.uu.se			Swedish Cancer Society; Agnes and Mac Rudbergs Foundation; Gurli and Edward Brunnberg Foundation (Uppsala University); Ludwig Cancer Research	Swedish Cancer Society(Swedish Cancer Society); Agnes and Mac Rudbergs Foundation; Gurli and Edward Brunnberg Foundation (Uppsala University); Ludwig Cancer Research	The work was supported by grants from the Swedish Cancer Society (www.cancerfonden.se); Agnes and Mac Rudbergs Foundation Gurli and Edward Brunnberg Foundation (Uppsala University, www.uu.se); Ludwig Cancer Research (www.ludwigcancerresearch.org/location/uppsala-branch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Maxwell CA, 2008, J CELL SCI, V121, P925, DOI 10.1242/jcs.022038; AUSPRUNK DH, 1986, AM J ANAT, V177, P313, DOI 10.1002/aja.1001770304; Bernert B, 2011, J BIOL CHEM, V286, P42349, DOI 10.1074/jbc.M111.278598; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Bourguignon LYW, 2001, J BIOL CHEM, V276, P7327, DOI 10.1074/jbc.M006498200; Cao GY, 2006, AM J PATHOL, V169, P325, DOI 10.2353/ajpath.2006.060206; Cichy J, 2003, J CELL BIOL, V161, P839, DOI 10.1083/jcb.200302098; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Deed R, 1997, INT J CANCER, V71, P251, DOI 10.1002/(SICI)1097-0215(19970410)71:2<251::AID-IJC21>3.0.CO;2-J; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Duterme C, 2009, J BIOL CHEM, V284, P33495, DOI 10.1074/jbc.M109.044362; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Foster RR, 2013, AM J PATHOL, V183, P604, DOI 10.1016/j.ajpath.2013.04.019; Fuchs K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.364; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; Goodison S, 1999, J CLIN PATHOL-MOL PA, V52, P189; Hamilton SR, 2007, J BIOL CHEM, V282, P16667, DOI 10.1074/jbc.M702078200; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; Heldin P, 2013, GROWTH FACTOR REGULA; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Kozlova I, 2012, CELL SIGNAL, V24, P1856, DOI 10.1016/j.cellsig.2012.05.013; Kukreja P, 2005, CANCER RES, V65, P9891, DOI 10.1158/0008-5472.CAN-05-1293; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Lataillade JJ, 2004, EUR CYTOKINE NETW, V15, P177; Lennon FE, 2011, AM J CARDIOVASC DIS, V1, P200; Lesley Jayne, 1998, Frontiers in Bioscience, V3, pD616; Li LL, 2007, BIOCHEM J, V404, P327, DOI 10.1042/BJ20061757; Li LL, 2006, J BIOL CHEM, V281, P26512, DOI 10.1074/jbc.M605607200; Li Y, 2001, BRIT J CANCER, V85, P600, DOI 10.1054/bjoc.2001.1922; Lokeshwar VB, 1996, J BIOL CHEM, V271, P23853, DOI 10.1074/jbc.271.39.23853; Lokeshwar VB, 2000, J BIOL CHEM, V275, P27641; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; LUSTER AD, 1995, J EXP MED, V182, P219, DOI 10.1084/jem.182.1.219; Maiti A, 1998, SCIENCE, V282, P941, DOI 10.1126/science.282.5390.941; Maxwell PJ, 2007, ONCOGENE, V26, P7333, DOI 10.1038/sj.onc.1210536; Mierke CT, 2008, J BIOPHYS, V2008; Milinkovic M, 2004, BLOOD, V103, P740, DOI 10.1182/blood-2003-05-1500; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; Monzon ME, 2008, AM J RESP CELL MOL, V39, P289, DOI 10.1165/rcmb.2007-0361OC; Monzon ME, J BIOL CHEM, V285, P26126; Moore MAS, 2002, J CELL BIOCHEM, P29, DOI 10.1002/jcb.10105; Murphy JF, 2005, FASEB J, V19, P446, DOI 10.1096/fj.03-1376fje; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Orian-Rousseau V, 2008, ADV CANCER RES, V101, P63, DOI 10.1016/S0065-230X(08)00404-1; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Rahmanian M, 2002, INT J CANCER, V97, P601, DOI 10.1002/ijc.10087; Rahmanian M, 1997, EXP CELL RES, V237, P223, DOI 10.1006/excr.1997.3792; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Romagnani P, 2001, J CLIN INVEST, V107, P53, DOI 10.1172/JCI9775; Romagnani P, 2004, TRENDS IMMUNOL, V25, P201, DOI 10.1016/j.it.2004.02.006; ROONEY P, 1995, INT J CANCER, V60, P632, DOI 10.1002/ijc.2910600511; Salcedo R, 2003, MICROCIRCULATION, V10, P359, DOI 10.1038/sj.mn.7800200; Savani RC, 2001, J BIOL CHEM, V276, P36770, DOI 10.1074/jbc.M102273200; SHERMAN L, 1994, CURR OPIN CELL BIOL, V6, P726, DOI 10.1016/0955-0674(94)90100-7; Singh AK, 2013, CYTOKINE GROWTH F R, V24, P41, DOI 10.1016/j.cytogfr.2012.08.007; Singleton PA, 2002, CELL MOTIL CYTOSKEL, V53, P293, DOI 10.1002/cm.10078; Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200; Slevin M, 2007, MATRIX BIOL, V26, P58, DOI 10.1016/j.matbio.2006.08.261; Sorriento D, 2012, TRANSL MED UNISA, V4, P73; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Stern R, 2013, MAMMALIAN HYALURONID; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Takahashi Y, 2005, J BIOL CHEM, V280, P24195, DOI 10.1074/jbc.M411913200; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; Tolg C, 2010, J BIOL CHEM, V285, P26461, DOI 10.1074/jbc.M110.121491; Tremmel M, 2009, BLOOD, V114, P5236, DOI 10.1182/blood-2009-04-219204; Trochon V, 1996, INT J CANCER, V66, P664, DOI 10.1002/(SICI)1097-0215(19960529)66:5<664::AID-IJC14>3.0.CO;2-4; TURLEY EA, 1985, J CELL SCI, V78, P133; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Venetsanakos E, 2002, EXP CELL RES, V273, P21, DOI 10.1006/excr.2001.5424; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; WEST DC, 1989, BIOL HYALURONAN, V143, P187; Zhou LP, 2010, BIOCELL, V34, P91; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	76	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90921	10.1371/journal.pone.0090921	http://dx.doi.org/10.1371/journal.pone.0090921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614402	Green Published, gold, Green Submitted			2022-12-25	WOS:000332839300056
J	Shet, A; Antony, J; Arumugam, K; Dodderi, SK; Rodrigues, R; DeCosta, A				Shet, Anita; Antony, Jimmy; Arumugam, Karthika; Dodderi, Sunil Kumar; Rodrigues, Rashmi; DeCosta, Ayesha			Influence of Adverse Drug Reactions on Treatment Success: Prospective Cohort Analysis of HIV-Infected Individuals Initiating First-Line Antiretroviral Therapy in India	PLOS ONE			English	Article							VIRUS POSITIVE PATIENTS; HAART REGIMEN; SEX-DIFFERENCES; RISK-FACTORS; DISCONTINUATION; ANEMIA; COMBINATION; EVENTS; PREDICTORS; TOXICITIES	Introduction: Adverse drug reactions related to antiretroviral therapy (ART) remain a challenge in resource-limited settings, often causing significant morbidity and impaired adherence leading to treatment failure. This 2-year prospective study aimed to describe patterns and predictors of adverse reactions to first-line ART and assess the impact of these events on treatment success. Methods: Between 2010-2013, 321 ART-naive eligible adults were enrolled at two clinics in southern India. ART regimens included zidovudine or stavudine plus lamivudine, plus nevirapine or efavirenz. Pill count adherence, immunological and virological monitoring, and laboratory-based adverse drug reactions were measured prospectively and analyzed. Results: Among 321 patients in the study, 289 (90.0%) patients experienced at least 1 adverse reaction, and 85 (26.5%) experienced at least 1 severe reaction. The incidence rate was 52 and 15 per 100 person-years for all reactions and severe reactions respectively. The cumulative incidence of zidovudine-induced anemia was 37.1% over 2 years. At 12 and 24 months, the proportion of patients with optimal adherence, undetectable viral load and CD4 counts >350 cells/mm(3) were similar between patients who experienced or did not experience severe adverse drug reactions. Conclusions: Our results highlight the high frequency of ART-related adverse drug reactions among individuals initiating first-line ART in India, underscoring the importance of detailed counseling and monitoring for maintaining ART durability. Severe drug-induced anemia needs to be addressed urgently with alternative first-line agents, and close laboratory surveillance. High treatment efficacy despite decreased drug safety seen here may be because patients have limited treatment options. Our results support the use of currently recommended safer first-line ART regimens that minimize the risk of severe life-threatening toxicities and provide for a better quality of life.	[Shet, Anita] St Johns Med Coll Hosp, Dept Pediat, Bangalore, Karnataka, India; [Antony, Jimmy] St Johns Res Inst, Div Publ Hlth & Infect, Bangalore, Karnataka, India; [Arumugam, Karthika] St Johns Res Inst, Div Biostat, Bangalore, Karnataka, India; [Dodderi, Sunil Kumar] Govt India, Natl AIDS Control Org, Minist Hlth & Family Welf, New Delhi, India; [Rodrigues, Rashmi] St Johns Med Coll Hosp, Dept Community Med, Bangalore, Karnataka, India; [Shet, Anita; DeCosta, Ayesha] Karolinska Inst, Div Global Hlth, Stockholm, Sweden	St. John's National Academy of Health Sciences; St. John's Medical College; St. John's National Academy of Health Sciences; St. John's Research Institute; St. John's National Academy of Health Sciences; St. John's Research Institute; St. John's National Academy of Health Sciences; St. John's Medical College; Karolinska Institutet	Shet, A (corresponding author), St Johns Med Coll Hosp, Dept Pediat, Bangalore, Karnataka, India.	anitashet@stjohns.in	Rodrigues, Rashmi J/H-1901-2012	Rodrigues, Rashmi J/0000-0002-0656-0178; Shet, Anita/0000-0002-7204-8164	European Union [222946]	European Union(European Commission)	The study was financially supported by a grant under the European Union Framework Program 7 (project no: 222946). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agu Kenneth A, 2013, Perspect Clin Res, V4, P117, DOI 10.4103/2229-3485.111784; [Anonymous], 2007, ANT THER GUID HIV IN; [Anonymous], 2012, NAT AIDS CONTR ORG A; Antinori A, 2001, AIDS, V15, P1579, DOI 10.1097/00002030-200108170-00018; Anuradha S, 2013, J Int Assoc Provid AIDS Care, V12, P195, DOI 10.1177/1545109711431344; Bersoff-Matcha SJ, 2001, CLIN INFECT DIS, V32, P124, DOI 10.1086/317536; Blake M, 2000, CLIN INFECT DIS, V30, pS96, DOI 10.1086/313859; Campbell TB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001290; Cicconi P, 2010, HIV MED, V11, P104, DOI 10.1111/j.1468-1293.2009.00750.x; De Costa A, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-25; Division of AIDS (DAIDS), 2004, TABL GRAD SEV AD PED; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Eluwa George I, 2012, BMC Clin Pharmacol, V12, P7, DOI 10.1186/1472-6904-12-7; Elzi L, 2010, ARCH INTERN MED, V170, P57, DOI 10.1001/archinternmed.2009.432; Keiser O, 2007, ANTIVIR THER, V12, P1157; Kesselring AM, 2009, AIDS, V23, P1689, DOI 10.1097/QAD.0b013e32832d3b54; Khalili H, 2009, PHARMACOEPIDEM DR S, V18, P848, DOI 10.1002/pds.1793; Kumarasamy N, 2008, AIDS PATIENT CARE ST, V22, P337, DOI 10.1089/apc.2007.0093; Lichtenstein KA, 2008, JAIDS-J ACQ IMM DEF, V47, P27, DOI 10.1097/QAI.0b013e31815acacc; Lodwick RK, 2008, AIDS, V22, P1039, DOI 10.1097/QAD.0b013e3282fec415; Luma HN, 2012, PAN AFR MED J, V12; Mihanovic MP, 2013, MED SCI MONITOR, V19, P483, DOI 10.12659/MSM.889283; Modayil RR, 2010, PHARMACOEPIDEM DR S, V19, P247, DOI 10.1002/pds.1907; Moh R, 2005, ANTIVIR THER, V10, P615; Monforte AD, 2000, AIDS, V14, P499, DOI 10.1097/00002030-200003310-00005; Murphy RA, 2007, J INFECT DIS, V196, pS449, DOI 10.1086/521112; O'Brien ME, 2003, JAIDS-J ACQ IMM DEF, V34, P407, DOI 10.1097/00126334-200312010-00008; Ofotokun I, 2007, GENDER MED, V4, P106, DOI 10.1016/S1550-8579(07)80025-8; Phe T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060206; Prosperi MCF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-296; Rajesh Radhakrishnan, 2011, Int J Risk Saf Med, V23, P171, DOI 10.3233/JRS-2011-0531; Robison LS, 2008, AIDS RES HUM RETROV, V24, P1347, DOI 10.1089/aid.2008.0083; Ruud KW, 2012, EUR J CLIN PHARMACOL, V68, P1321, DOI 10.1007/s00228-012-1254-1; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Sivadasan Ajith, 2009, J Assoc Physicians India, V57, P384; Srikanth BA, 2012, J ADV PHARM TECHNOL, V3, P62, DOI 10.4103/2231-4040.93557; Ssali F, 2006, ANTIVIR THER, V11, P741; WHO, 2001, IRON DEFICIENCY ANAE; World Health Organisation, 2021, CONSOLIDATED GUIDELI; World Health Organization, 1972, WHO TECHN REP SER, V498; Yuan Y, 2006, HIV MED, V7, P156, DOI 10.1111/j.1468-1293.2006.00355.x; Zhou JL, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-5	42	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91028	10.1371/journal.pone.0091028	http://dx.doi.org/10.1371/journal.pone.0091028			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614165	gold, Green Published, Green Submitted			2022-12-25	WOS:000332839300068
J	Abedini, A; Daud, AR; Hamid, MAA; Othman, NK				Abedini, Alam; Daud, Abdul Razak; Hamid, Muhammad Azmi Abdul; Othman, Norinsan Kamil			Radiolytic Formation of Fe3O4 Nanoparticles: Influence of Radiation Dose on Structure and Magnetic Properties	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; SPIN DISORDER; SIZE; TEMPERATURE; NANOCLUSTERS; SPECTROSCOPY	Colloidal Fe3O4 nanoparticles were synthesized using a gamma-radiolysis method in an aqueous solution containing iron chloride in presence of polyvinyl alcohol and isopropanol as colloidal stabilizer and hydroxyl radical scavenger, respectively. Gamma irradiation was carried out in a Co-60 gamma source chamber at different absorbed doses. Increasing the radiation dose above a certain critical dose (100 kGy) leads to particle agglomeration enhancement, and this can influence the structure and crystallinity, and consequently the magnetic properties of the resultant particles. The optimal condition for formation of Fe3O4 nanoparticles with a uniform and narrow size distribution occurred at a dose of 100 kGy, as confirmed by X-ray diffractometry and transmission electron microscopy. A vibrating sample magnetometry study showed that, when radiation dose increased, the saturation and remanence magnetization decreased, whereas the coercivity and the remanence ratio increased. This magnetic behavior results from variations in crystallinity, surface effects, and particle size effects, which are all dependent on the radiation dose. In addition, Fourier transform infrared spectroscopy was performed to investigate the nature of the bonds formed between the polymer chains and the metal surface at different radiation doses.	[Abedini, Alam; Daud, Abdul Razak; Hamid, Muhammad Azmi Abdul; Othman, Norinsan Kamil] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Appl Phys, Bangi 43600, Selangor, Malaysia	Universiti Kebangsaan Malaysia	Abedini, A (corresponding author), Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Appl Phys, Bangi 43600, Selangor, Malaysia.	alamabedini@gmail.com	othman, Norinsan kamil/M-3583-2019; Al-Douri, Yarub/W-4147-2017	Al-Douri, Yarub/0000-0002-5175-6372; Othman, Norinsan kamil/0000-0002-6214-4400	Universiti Kebangsaan Malaysia [DIP-2012-14, FRGS/2/2013/SG06/UKM/02/4]	Universiti Kebangsaan Malaysia	This work is supported by Universiti Kebangsaan Malaysia through grants No. DIP-2012-14 and FRGS/2/2013/SG06/UKM/02/4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Abbas M, 2013, CERAM INT, V39, P7605, DOI 10.1016/j.ceramint.2013.03.015; Abedini A, 2012, RADIAT PHYS CHEM, V81, P1653, DOI 10.1016/j.radphyschem.2012.05.015; Belloni J, 2006, CATAL TODAY, V113, P141, DOI 10.1016/j.cattod.2005.11.082; Billotey C, 2003, MAGN RESON MED, V49, P646, DOI 10.1002/mrm.10418; Chen YZ, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/50/505703; Compean-Jasso ME, 2008, MATER LETT, V62, P4248, DOI 10.1016/j.matlet.2008.06.053; Darbandi M, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/19/195001; Deng YH, 2005, COLLOID SURFACE A, V262, P87, DOI 10.1016/j.colsurfa.2005.04.009; El-Sawy NM, 2010, POLYM-PLAST TECHNOL, V49, P169, DOI 10.1080/03602550903284248; Faraji M, 2010, J IRAN CHEM SOC, V7, P1, DOI 10.1007/BF03245856; Finkelstein G, 2000, SCIENCE, V289, P90, DOI 10.1126/science.289.5476.90; Fortin JP, 2007, J AM CHEM SOC, V129, P2628, DOI 10.1021/ja067457e; Frey NA, 2009, CHEM SOC REV, V38, P2532, DOI 10.1039/b815548h; Gohil JM, 2006, J POLYM RES, V13, P161, DOI 10.1007/s10965-005-9023-9; Gonzales-Weimuller M, 2009, J MAGN MAGN MATER, V321, P1947, DOI 10.1016/j.jmmm.2008.12.017; Gu HW, 2005, CHEM COMMUN, P4270, DOI 10.1039/b507779f; Gubin SP, 2005, USP KHIM+, V74, P539, DOI 10.1070/RC2005V074N06ABEH000897; Hafeli U, 2001, J MAGN MAGN MATER, V225, P73, DOI 10.1016/S0304-8853(00)01230-0; He SL, 2005, CHINESE PHYS, V14, P1055, DOI 10.1088/1009-1963/14/5/036; Hogemann D, 2000, BIOCONJUGATE CHEM, V11, P941, DOI 10.1021/bc000079x; Hou YL, 2003, J MATER CHEM, V13, P1983, DOI 10.1039/b305526d; Issa B, 2013, INT J MOL SCI, V14, P21266, DOI 10.3390/ijms141121266; Johannsen M, 2010, INT J HYPERTHER, V26, P790, DOI 10.3109/02656731003745740; JOLIVET JP, 1992, CLAY CLAY MINER, V40, P531, DOI 10.1346/CCMN.1992.0400506; Kayal S, 2010, MAT SCI ENG C-MATER, V30, P484, DOI 10.1016/j.msec.2010.01.006; Kim SW, 2010, B KOREAN CHEM SOC, V31, P910, DOI 10.5012/bkcs.2010.31.04.910; Kim YI, 2003, PHYSICA B, V337, P42, DOI 10.1016/S0921-4526(03)00322-3; LABIDI N.S., 2008, JMMCE, V07, P147, DOI [10.4236/jmmce.2008.72012, DOI 10.4236/JMMCE.2008.72012]; Lima E, 2006, J APPL PHYS, V99, DOI 10.1063/1.2191471; Lodhia J, 2010, Biomed Imaging Interv J, V6, pe12, DOI 10.2349/biij.6.2.e12; Lu HM, 2007, J PHYS D APPL PHYS, V40, P320, DOI 10.1088/0022-3727/40/2/006; Lu Y, 2002, NANO LETT, V2, P183, DOI 10.1021/nl015681q; Mansur HS, 2008, MAT SCI ENG C-BIO S, V28, P539, DOI 10.1016/j.msec.2007.10.088; Mathew DS, 2007, CHEM ENG J, V129, P51, DOI 10.1016/j.cej.2006.11.001; Naseri MG, 2010, J NANOMATER, V2010, DOI 10.1155/2010/907686; Ni YH, 2002, CHEM MATER, V14, P1048, DOI 10.1021/cm010446u; Nikolic VM, 2007, ELECTROCHEM COMMUN, V9, P2661, DOI 10.1016/j.elecom.2007.08.022; Ozkaya T, 2009, J ALLOY COMPD, V472, P18, DOI 10.1016/j.jallcom.2008.04.101; Pal S, 2007, IEEE T MAGN, V43, P3091, DOI 10.1109/TMAG.2007.894000; Qu YQ, 2006, MATER LETT, V60, P3548, DOI 10.1016/j.matlet.2006.03.055; Rao YN, 2010, RADIAT PHYS CHEM, V79, P1240, DOI 10.1016/j.radphyschem.2010.07.004; Respaud M, 1998, PHYS REV B, V57, P2925, DOI 10.1103/PhysRevB.57.2925; Roca AG, 2006, NANOTECHNOLOGY, V17, P2783, DOI 10.1088/0957-4484/17/11/010; Saeed R, 2008, PHYS CHEM LIQ, V46, P9, DOI 10.1080/00319100601188703; Seino S, 2008, J NANOPART RES, V10, P1071, DOI 10.1007/s11051-007-9334-3; Sohn BH, 1998, J MAGN MAGN MATER, V182, P216, DOI 10.1016/S0304-8853(97)00675-6; Xu CJ, 2004, J AM CHEM SOC, V126, P9938, DOI 10.1021/ja0464802; Yan AG, 2008, J ALLOY COMPD, V458, P487, DOI 10.1016/j.jallcom.2007.04.019; Yang TZ, 2005, J PHYS CHEM B, V109, P23233, DOI 10.1021/jp054291f	49	48	52	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90055	10.1371/journal.pone.0090055	http://dx.doi.org/10.1371/journal.pone.0090055			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608715	Green Published, Green Submitted, gold			2022-12-25	WOS:000332485800015
J	Previlon, M; Pezet, M; Vinet, L; Mercadier, JJ; Rouet-Benzineb, P				Previlon, Miresta; Pezet, Mylene; Vinet, Laurent; Mercadier, Jean-Jacques; Rouet-Benzineb, Patricia			Gender-Specific Potential Inhibitory Role of Ca2+/Calmodulin Dependent Protein Kinase Phosphatase (CaMKP) in Pressure-Overloaded Mouse Heart	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; HISTONE DEACETYLASE-4; ESTROGEN-RECEPTOR; ACTIN GENE; IN-VIVO; CALCIUM; MICE; TRANSCRIPTION; CALCINEURIN; MYOCYTES	Background: Ca2+/calmodulin-dependent protein kinase phosphatase (CaMKP) has been proposed as a potent regulator of multifunctional Ca2+/calmodulin-dependent protein kinases (i.e., CaMKII). The CaMKII-dependent activation of myocyte enhancer factor 2 (MEF2) disrupts interactions between MEF2-histone deacetylases (HDACs), thereby de-repressing downstream gene transcription. Whether CaMKP modulates the CaMKII-MEF2 pathway in the heart is unknown. Here, we investigated the molecular and functional consequences of left ventricular (LV) pressure overload in the mouse of both genders, and in particular we evaluated the expression levels and localization of CaMKP and its association with CaMKII-MEF2 signaling. Methodology and Principal Findings: Five week-old B6D1/F1 mice of both genders underwent a sham-operation or thoracic aortic constriction (TAC). Thirty days later, TAC was associated with pathological LV hypertrophy characterized by systolic and diastolic dysfunction. Gene expression was assessed by real-time PCR. Fetal gene program re-expression comprised increased RNA levels of brain natriuretic peptide and alpha-skeletal actin. Mouse hearts of both genders expressed both CaMKP transcript and protein. Activation of signalling pathways was studied by Western blot in LV lysates or subcellular fractions (nuclear and cytoplasmic). TAC was associated with increased CaMKP expression in male LVs whereas it tended to be decreased in females. The DNA binding activity of MEF2 was determined by spectrophotometry. CaMKP compartmentalization differed according to gender. In male TAC mice, nuclear CaMKP was associated with inactive CaMKII resulting in less MEF2 activation. In female TAC mice, active CaMKII (phospho-CaMKII) detected in the nuclear fraction, was associated with a strong MEF2 transcription factor-binding activity. Conclusions/Significance: Gender-specific CaMKP compartmentalization is associated with CaMKII-mediated MEF2 activation in pressure-overloaded hearts. Therefore, CaMKP could be considered as an important novel cellular target for the development of new therapeutic strategies for heart diseases.	[Previlon, Miresta; Vinet, Laurent; Rouet-Benzineb, Patricia] Univ Paris Diderot, Sorbonne Paris Cite, INSERM, UMRS 698, Paris, France; [Pezet, Mylene] CEFI Inst Claude Bernard IFR02, Paris, France; [Pezet, Mylene] Inst Albert Bonniot Site Sante, INSERM, U823, F-38042 Grenoble, France; [Vinet, Laurent] Univ Geneva, Sch Med, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland; [Mercadier, Jean-Jacques] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Mercadier, Jean-Jacques] Univ Paris 11, INSERM, UMRS 769, IFR141,LabEx LERMIT, Chatenay Malabry, France; [Mercadier, Jean-Jacques] Hop Bichat Claude Bernard, AP HP, F-75877 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Geneva; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Rouet-Benzineb, P (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, INSERM, UMRS 698, Paris, France.	patricia.rouetbenzineb@inserm.fr	Pezet, Mylene/N-1833-2013	Pezet, Mylene/0000-0002-4365-7454	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Diderot (Paris 7); EU [LSHM-CT-2005-018833]; Ministere de l'Enseignement Superieur et de la Recherche	Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Paris Diderot (Paris 7); EU(European Commission); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission)	This study was funded by the Institut National de la Sante et de la Recherche Medicale (Inserm), Universite Paris Diderot (Paris 7), and by EU FP6 grant LSHM-CT-2005-018833, EUGeneHeart. Miresta Previlon was supported by a scholarship of the Ministere de l'Enseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; [Anonymous], 2008, CHIN J PHYSL, V51, P261; Awad S, 2013, NUCLEIC ACIDS RES, V41, P7656, DOI 10.1093/nar/gkt500; Baba H, 2012, ARCH BIOCHEM BIOPHYS, V526, P9, DOI 10.1016/j.abb.2012.06.005; Backs J, 2008, MOL CELL BIOL, V28, P3437, DOI 10.1128/MCB.01611-07; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Bers DM, 2005, ANN NY ACAD SCI, V1047, P86, DOI 10.1196/annals.1341.008; Bers DM, 2011, HEART RHYTHM, V8, P1101, DOI 10.1016/j.hrthm.2011.01.030; Domnguez-Rodriguez A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00452; el Azzouzi H, 2010, EUR J HEART FAIL, V12, P4, DOI 10.1093/eurjhf/hfp165; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Erickson JR, 2011, PHYSIOL REV, V91, P889, DOI 10.1152/physrev.00018.2010; Fliegner D, 2010, AM J PHYSIOL-REG I, V298, pR1597, DOI 10.1152/ajpregu.00825.2009; Grimm M, 2010, J MOL CELL CARDIOL, V48, P322, DOI 10.1016/j.yjmcc.2009.10.016; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hori Y, 2008, CHINESE J PHYSIOL, V51, P146; Houser SR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.125pe31; Ishida A, 2008, BRIT J PHARMACOL, V154, P729, DOI 10.1038/bjp.2008.127; Ishida A, 2005, ARCH BIOCHEM BIOPHYS, V435, P134, DOI 10.1016/j.abb.2004.11.022; Ishida A, 2003, PHARMACOL THERAPEUT, V100, P291, DOI 10.1016/j.pharmthera.2003.09.003; Ishida A, 1998, J BIOL CHEM, V273, P1904, DOI 10.1074/jbc.273.4.1904; Kameshita I, 2010, ANAL BIOCHEM, V400, P118, DOI 10.1016/j.ab.2009.12.035; Kitani T, 1999, J BIOCHEM-TOKYO, V125, P1022, DOI 10.1093/oxfordjournals.jbchem.a022381; Konhilas JP, 2004, AM J PHYSIOL-HEART C, V287, pH2768, DOI 10.1152/ajpheart.00292.2004; Lemonnier M, 2004, J BIOL CHEM, V279, P55651, DOI 10.1074/jbc.M411082200; Li YH, 2004, ENDOCRINOLOGY, V145, P951, DOI 10.1210/en.2003-0816; Little GH, 2007, J BIOL CHEM, V282, P7219, DOI 10.1074/jbc.M604281200; MacDonnell SM, 2009, CIRC RES, V105, P316, DOI 10.1161/CIRCRESAHA.109.194035; Maier LS, 2012, ADV EXP MED BIOL, V740, P685, DOI 10.1007/978-94-007-2888-2_30; Maier LS, 2009, FRONT BIOSCI-LANDMRK, V14, P486, DOI 10.2741/3257; Montalvo C, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035635, DOI 10.1371/J0URNAL.P0NE.0035635.EPUB]; Muscat George E. O., 1992, Gene Expression, V2, P111; Nimura T, 2007, ARCH BIOCHEM BIOPHYS, V457, P205, DOI 10.1016/j.abb.2006.09.034; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Prasad AM, 2011, AM J PHYSIOL-HEART C, V300, pH173, DOI 10.1152/ajpheart.00841.2010; Previlon M, 2011, CAN J PHYSIOL PHARM, V89, P769, DOI 10.1139/Y11-075; Previlon M, 2010, CAN J PHYSIOL PHARM, V88, P1093, DOI [10.1139/Y10-087, 10.1139/y10-087]; Santana LF, 2008, CIRC RES, V103, P681, DOI 10.1161/CIRCRESAHA.108.185090; Sueyoshi N, 2012, ARCH BIOCHEM BIOPHYS, V517, P43, DOI 10.1016/j.abb.2011.10.017; Sueyoshi N, 2009, ARCH BIOCHEM BIOPHYS, V488, P48, DOI 10.1016/j.abb.2009.06.003; Swaminathan PD, 2012, CIRC RES, V110, P1661, DOI 10.1161/CIRCRESAHA.111.243956; Takeuchi M, 2001, J BIOCHEM, V130, P833, DOI 10.1093/oxfordjournals.jbchem.a003055; Tan KML, 2001, J BIOL CHEM, V276, P44193, DOI 10.1074/jbc.M105880200; van Rooij E, 2010, CIRC RES, V106, P155, DOI 10.1161/CIRCRESAHA.109.207084; Vinet L, 2008, AM J PHYSIOL-HEART C, V295, pH352, DOI 10.1152/ajpheart.01101.2007; Vinet L, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0246-8; Wagner S, 2013, ANTIOXID REDOX SIGN, V18, P1063, DOI 10.1089/ars.2012.4818; Wang W, 2004, CIRC RES, V95, P798, DOI 10.1161/01.RES.0000145361.50017.aa; Westphal C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050802; Zarain-Herzberg A, 2011, IUBMB LIFE, V63, P847, DOI 10.1002/iub.545; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang T, 2007, J BIOL CHEM, V282, P35078, DOI 10.1074/jbc.M707083200; Zhong X, 2012, CELL BIOL INT, V36, P937, DOI 10.1042/CBI20110594	53	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90822	10.1371/journal.pone.0090822	http://dx.doi.org/10.1371/journal.pone.0090822			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608696	Green Submitted, Green Published, gold			2022-12-25	WOS:000332485800054
J	Savage, AL; Wilm, TP; Khursheed, K; Shatunov, A; Morrison, KE; Shaw, PJ; Shaw, CE; Smith, B; Breen, G; Al-Chalabi, A; Moss, D; Bubb, VJ; Quinn, JP				Savage, Abigail L.; Wilm, Thomas P.; Khursheed, Kejhal; Shatunov, Aleksey; Morrison, Karen E.; Shaw, Pamela J.; Shaw, Christopher E.; Smith, Bradley; Breen, Gerome; Al-Chalabi, Ammar; Moss, Diana; Bubb, Vivien J.; Quinn, John P.			An Evaluation of a SVA Retrotransposon in the FUS Promoter as a Transcriptional Regulator and Its Association to ALS	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; VARIABLE NUMBER; FUNCTIONAL VARIANT; TANDEM REPEATS; EXPRESSION; ENHANCER; MUTATIONS; ELEMENTS; POLYMORPHISMS; DEPRESSION	Genetic mutations of FUS have been linked to many diseases including Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Lobar Degeneration. A primate specific and polymorphic retrotransposon of the SINE-VNTR-Alu (SVA) family is present upstream of the FUS gene. Here we have demonstrated that this retrotransposon can act as a classical transcriptional regulatory domain in the context of a reporter gene construct both in vitro in the human SK-N-AS neuroblastoma cell line and in vivo in a chick embryo model. We have also demonstrated that the SVA is composed of multiple distinct regulatory domains, one of which is a variable number tandem repeat (VNTR). The ability of the SVA and its component parts to direct reporter gene expression supported a hypothesis that this region could direct differential FUS expression in vivo. The SVA may therefore contribute to the modulation of FUS expression exhibited in and associated with neurological disorders including ALS where FUS regulation may be an important parameter in progression of the disease. As VNTRs are often clinical associates for disease progression we determined the extent of polymorphism within the SVA. In total 2 variants of the SVA were identified based within a central VNTR. Preliminary analysis addressed the association of these SVA variants within a small sporadic ALS cohort but did not reach statistical significance, although we did not include other parameters such as SNPs within the SVA or an environmental factor in this analysis. The latter may be particularly important as the transcriptional and epigenetic properties of the SVA are likely to be directed by the environment of the cell.	[Savage, Abigail L.; Wilm, Thomas P.; Khursheed, Kejhal; Bubb, Vivien J.; Quinn, John P.] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England; [Shatunov, Aleksey; Shaw, Christopher E.; Smith, Bradley; Breen, Gerome; Al-Chalabi, Ammar] Kings Coll London, Inst Psychiat, London, England; [Morrison, Karen E.] Univ Birmingham, Coll Med & Dent, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Morrison, Karen E.] Univ Hosp Birmingham NHS Fdn Trust, Div Neurosci, Birmingham, W Midlands, England; [Shaw, Pamela J.] Univ Sheffield, Acad Unit Neurol, Dept Neurosci, Sheffield Inst Translat Res, Sheffield, S Yorkshire, England; [Breen, Gerome] Kings Coll London, Inst Psychiat, MRC Social Genet & Dev Psychiat Res Ctr, London, England; [Breen, Gerome] Natl Inst Hlth Res Biomed Res, Ctr Mental Hlth, South London, England; [Breen, Gerome] Maudsley NHS Fdn Trust, London, England; [Moss, Diana] Univ Liverpool, Dept Cellular & Mol Physiol, Inst Translat Med, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of London; King's College London; University of Birmingham; University of Birmingham; University of Sheffield; University of London; King's College London; South London & Maudsley NHS Trust; University of Liverpool	Quinn, JP (corresponding author), Univ Liverpool, Inst Translat Med, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England.	jquinn@liv.ac.uk	Breen, Gerome/Y-2706-2019; Smith, Bradley/H-6107-2013; Quinn, John P/A-2972-2010; Al-Chalabi, Ammar/E-5361-2010	Breen, Gerome/0000-0003-2053-1792; Quinn, John P/0000-0003-3551-7803; Shaw, Christopher/0000-0003-0251-0146; Smith, Bradley/0000-0002-6980-2453; Morrison, Karen Elaine/0000-0003-0216-5717; Pfaff, Abigail/0000-0002-2231-9800; Shaw, Pamela/0000-0002-8925-2567; Shatunov, Aleksey/0000-0002-2671-8040; Al-Chalabi, Ammar/0000-0002-4924-7712	Motor Neurone Disease Association [Quinn/Mar09/RF/6056]; University of Liverpool; European Community [259867]; National Institute for Health Research (NIHR) Dementia Biomedical Research Unit at South London and Maudsley National Health Service (NHS) Foundation Trust; King's College London; NIHR Biomedical Research Centre for Mental Health at South London and Maudsley NHS Foundation Trust; [Institute of Psychiatry] King's College London; National Institute for Health Research; MRC [MC_G1000733, G0900635, G0600974, G0500289, G1100695, G0900688] Funding Source: UKRI; Medical Research Council [G0500289, G0900688, MC_G1000733, G0500289B, G9817803B, G0600974, G1100695, G0900635, MR/L501529/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10082] Funding Source: researchfish	Motor Neurone Disease Association; University of Liverpool; European Community(European Commission); National Institute for Health Research (NIHR) Dementia Biomedical Research Unit at South London and Maudsley National Health Service (NHS) Foundation Trust; King's College London; NIHR Biomedical Research Centre for Mental Health at South London and Maudsley NHS Foundation Trust; [Institute of Psychiatry] King's College London; National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work is funded by the Motor Neurone Disease Association (Grant Ref: Quinn/Mar09/RF/6056: Prediction and analysis of genetic variation which would affect expression of candidate genes associated with Motor Neurone Disease). ALS is funded by the University of Liverpool Anatomy Demonstratorship program. This work also received funding from the European Community's Health Seventh Framework Programme (FP7/2007-2013) [259867 (to AAC, CES and PJS)]. AAC receives salary support from the National Institute for Health Research (NIHR) Dementia Biomedical Research Unit at South London and Maudsley National Health Service (NHS) Foundation Trust and King's College London. PJS is supported as an NIHR Senior Investigator. Lab work was funded in part by the NIHR Biomedical Research Centre for Mental Health at South London and Maudsley NHS Foundation Trust and [Institute of Psychiatry] King's College London. This article presents independent research in part funded by the National Institute for Health Research. The views expressed are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel O, 2012, HUM MUTAT, V33, P1345, DOI 10.1002/humu.22157; Alfahad T, 2013, ANTIVIR RES, V99, P180, DOI 10.1016/j.antiviral.2013.05.006; Ali FR, 2010, J NEUROCHEM, V112, P296, DOI 10.1111/j.1471-4159.2009.06453.x; Andrews WD, 2000, J MED VIROL, V61, P527, DOI 10.1002/1096-9071(200008)61:4&lt;527::AID-JMV17&gt;3.0.CO;2-A; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Bantysh OB, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1393, DOI 10.1134/S0006297909120153; Brotons O, 2011, MOL PSYCHIATR, V16, P124, DOI 10.1038/mp.2009.6; Chio A, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.016; Corrado L, 2010, J MED GENET, V47, P190, DOI 10.1136/jmg.2009.071027; Damert A, 2009, GENOME RES, V19, P1992, DOI 10.1101/gr.093435.109; Davidson S, 2011, NEUROPSYCHOPHARMACOL, V36, P2211, DOI 10.1038/npp.2011.93; Deng HX, 2010, ANN NEUROL, V67, P739, DOI 10.1002/ana.22051; Doolittle WF, 2013, P NATL ACAD SCI US; Douville R, 2011, ANN NEUROL, V69, P141, DOI 10.1002/ana.22149; Faulkner GJ, 2011, FEBS LETT, V585, P1589, DOI 10.1016/j.febslet.2011.03.061; Guindalini C, 2006, P NATL ACAD SCI USA, V103, P4552, DOI 10.1073/pnas.0504789103; Haddley K, 2008, NEUROCHEM RES, V33, P652, DOI 10.1007/s11064-007-9521-8; Haddley K, 2012, CURR TOP BEHAV NEURO; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Hancks DC, 2009, GENOME RES, V19, P1983, DOI 10.1101/gr.093153.109; Hing B, 2012, BIOL PSYCHIAT, V71, P618, DOI 10.1016/j.biopsych.2011.11.030; Kavanagh DH, 2013, MOL PSYCHIAT; Klenova E, 2004, J NEUROSCI, V24, P5966, DOI 10.1523/JNEUROSCI.1150-04.2004; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lai SL, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2009.12.020; MacKenzie A, 2004, NEUROPEPTIDES, V38, P1, DOI 10.1016/j.npep.2003.09.004; MacKenzie A, 1999, P NATL ACAD SCI USA, V96, P15251, DOI 10.1073/pnas.96.26.15251; Michelhaugh SK, 2001, J NEUROCHEM, V79, P1033, DOI 10.1046/j.1471-4159.2001.00647.x; Mitchell JC, 2013, ACTA NEUROPATHOL, V125, P273, DOI 10.1007/s00401-012-1043-z; Miyajima F, 2008, GENES BRAIN BEHAV, V7, P714, DOI 10.1111/j.1601-183X.2008.00409.x; Paredes UM, 2012, GENES BRAIN BEHAV; Paredes UM, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-46; Roberts J, 2007, J NEUROSCI, V27, P2793, DOI 10.1523/JNEUROSCI.0892-06.2007; Savage AL, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-101; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; Shanley L, 2010, NEUROSIGNALS, V18, P173, DOI 10.1159/000322010; Sproviero W, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.005; Steele AJ, 2005, NEUROLOGY, V64, P454, DOI 10.1212/01.WNL.0000150899.76130.71; Szpakowski S, 2009, GENE, V448, P151, DOI 10.1016/j.gene.2009.08.006; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; Uchikawa M, 2008, DEV GROWTH DIFFER, V50, P467, DOI [10.1111/j.1440-169x.2008.01028.x, 10.1111/j.1440-169X.2008.01028.x]; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vasiliou SA, 2012, ADDICT BIOL, V17, P156, DOI 10.1111/j.1369-1600.2010.00288.x; Wang H, 2005, J MOL BIOL, V354, P994, DOI 10.1016/j.jmb.2005.09.085; Wendland JR, 2006, MOL PSYCHIATR, V11, P224, DOI 10.1038/sj.mp.4001789; Wray NR, 2009, BIOL PSYCHIAT, V66, P468, DOI 10.1016/j.biopsych.2009.04.030	47	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90833	10.1371/journal.pone.0090833	http://dx.doi.org/10.1371/journal.pone.0090833			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608899	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000332485800058
J	Smulders, K; Esselink, RA; Cools, R; Bloem, BR				Smulders, Katrijn; Esselink, Rianne A.; Cools, Roshan; Bloem, Bastiaan R.			Trait Impulsivity Is Associated with the Risk of Falls in Parkinson's Disease	PLOS ONE			English	Article							RECURRENT FALLERS; PHYSICAL-ACTIVITY; CONTROL DISORDERS; STROKE; TESTS; TRIAL; SCALE	Objective: Impulsivity is a "tendency to act prematurely without foresight." Clinical experience suggests that such impulsive behavior can impact on the fall risk in Parkinson's disease (PD), but this has never been tested. We investigated whether trait impulsivity is related to fall risk in a large cohort of PD patients. We also investigated whether trait impulsivity affects the fall risk differently for patients with more or less postural instability and gait disability (PIGD). Methods: 388 patients with PD (H&Y&LE; 3) completed the Barratt Impulsiveness Scale (BIS-11, higher scores indicating greater impulsivity) to assess trait impulsivity, including three subscales: motor impulsivity (e. g. "I do things without thinking"), attentional impulsivity (e. g. "I concentrate easily") and non-planning (e. g. "I plan tasks carefully"). Falls were registered prospectively for 6 months. Patients classified as non-fallers (0 falls, n = 237) were compared to recurrent PD fallers (>1 fall, n = 78). Results: Total impulsivity scores were higher for recurrent fallers (59.5) compared to non-fallers (56.8; p = .012). This effect was predominantly driven by higher scores on the subscale for attentional impulsivity (p = .003). The difference in attentional impulsivity was independent of gender, disease severity, dopaminergic medication, and cognitive function. Motor and non-planning impulsivity did not differ between recurrent fallers and non-fallers. There was no evidence that impulsivity modulated the association between PIGD and fall risk. Discussion: This is the first evidence that impulsivity, in particular in the attentional domain, is related to fall risk in PD.	[Smulders, Katrijn; Esselink, Rianne A.; Bloem, Bastiaan R.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Smulders, Katrijn] HAN Univ Appl Sci, Inst Studies Sports & Exercise, Nijmegen, Netherlands; [Cools, Roshan] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Psychiat, NL-6525 ED Nijmegen, Netherlands; [Cools, Roshan] Radboud Univ Nijmegen, Ctr Cognit Neuroimaging, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Smulders, K (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, NL-6525 ED Nijmegen, Netherlands.	katrijn.smulders@gmail.com	Bloem, Bastiaan/H-8013-2014; Cools, Roshan/D-1905-2010; Smulders, Katrijn/K-9939-2019; Esselink, R.A.J./L-4298-2015	Bloem, Bastiaan/0000-0002-6371-3337; Smulders, Katrijn/0000-0001-9338-5277; Cools, Roshan/0000-0001-8994-5534	ZonMw; Netherlands Organization for Health Research and Development [75020012]; Michael J. Fox Foundation for Parkinson's Research	ZonMw(Netherlands Organization for Health Research and Development); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Michael J. Fox Foundation for Parkinson's Research	This study was supported by ZonMw, the Netherlands Organization for Health Research and Development (75020012 to BRB), and the Michael J. Fox Foundation for Parkinson's Research (to BRB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlskog JE, 2010, NEUROLOGY, V75, P1226, DOI 10.1212/WNL.0b013e3181f5d507; Allcock LM, 2009, PARKINSONISM RELAT D, V15, P110, DOI 10.1016/j.parkreldis.2008.03.010; Anstey KJ, 2009, NEUROPSYCHOLOGY, V23, P500, DOI 10.1037/a0015389; Antonini A, 2011, MOVEMENT DISORD, V26, P464, DOI 10.1002/mds.23501; Barratt ES., 1985, MOTIVATION EMOTION P, P137, DOI DOI 10.1371/JOURNAL.PONE.0129139; Bloem BR, 2004, MOVEMENT DISORD, V19, P359; Bloem BR, 2004, CLIN DISORDERS BALAN, V2, P173; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Daruna J.H., 1993, IMPULSIVE CLIENT THE, P23, DOI DOI 10.1037/10500-002; Esselink RAJ, 2004, NEUROLOGY, V62, P201, DOI 10.1212/01.WNL.0000103235.12621.C3; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goudriaan AE, 2008, PSYCHOL MED, V38, P41, DOI 10.1017/S0033291707000694; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Holtzer R, 2007, NEUROPSYCHOLOGY, V21, P540, DOI 10.1037/0894-4105.21.5.540; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Keilp JG, 2005, PSYCHIAT RES, V135, P191, DOI 10.1016/j.psychres.2005.03.006; Lamb SE, 2003, STROKE, V34, P494, DOI 10.1161/01.STR.0000053444.00582.B7; Mak MKY, 2010, J NEUROL, V257, P1543, DOI 10.1007/s00415-010-5573-9; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pickering RM, 2007, MOVEMENT DISORD, V22, P1892, DOI 10.1002/mds.21598; RAPPORT LJ, 1993, ARCH PHYS MED REHAB, V74, P621, DOI 10.1016/0003-9993(93)90160-C; ROBBINS TW, 1994, DEMENTIA, V5, P266, DOI 10.1159/000106735; Smulders K, 2012, J NEUROL; Stanford MS, 2009, PERS INDIV DIFFER, V47, P385, DOI 10.1016/j.paid.2009.04.008; Stel VS, 2004, J CLIN EPIDEMIOL, V57, P252, DOI 10.1016/j.jclinepi.2003.07.008; van den Wildenberg WPM, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00222; Van der Elst W, 2006, J INT NEUROPSYCH SOC, V12, P80, DOI 10.1017/S1355617706060115; van der Marck MA, 2011, J AM GERIATR SOC, V59, P340, DOI 10.1111/j.1532-5415.2010.03263.x; van Nimwegen M, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-70; Voon V, 2007, ARCH NEUROL-CHICAGO, V64, P1089, DOI 10.1001/archneur.64.8.1089; Voon V, 2011, BRAIN, V134, P1438, DOI 10.1093/brain/awr080; Weintraub D, 2010, ARCH NEUROL-CHICAGO, V67, P589, DOI 10.1001/archneurol.2010.65; Wylie SA, 2012, J NEUROLOGY NEUROSUR	34	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91190	10.1371/journal.pone.0091190	http://dx.doi.org/10.1371/journal.pone.0091190			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4IY	24608747	Green Published, Green Submitted, gold			2022-12-25	WOS:000332485800114
J	Zhang, X; Bao, T; Rao, ZM; Yang, TW; Xu, ZH; Yang, ST; Li, HZ				Zhang, Xian; Bao, Teng; Rao, Zhiming; Yang, Taowei; Xu, Zhenghong; Yang, Shangtian; Li, Huazhong			Two-Stage pH Control Strategy Based on the pH Preference of Acetoin Reductase Regulates Acetoin and 2,3-Butanediol Distribution in Bacillus subtilis	PLOS ONE			English	Article							SERRATIA-MARCESCENS H32; STATISTICAL OPTIMIZATION; DEHYDROGENASE; DIACETYL; CITRATE; GENE; METABOLISM; LACTIS	Acetoin reductase/2,3-butanediol dehydrogenase (AR/BDH), which catalyzes the interconversion between acetoin and 2,3-butanediol, plays an important role in distribution of the products pools. This work characterized the Bacillus subtilis AR/BDH for the first time. The enzyme showed very different pH preferences of pH 6.5 for reduction and pH 8.5 for oxidation. Based on these above results, a two-stage pH control strategy was optimized for acetoin production, in which the pH was controlled at 6.5 for quickly converting glucose to acetoin and 2,3-butanediol, and then 8.0 for reversely transforming 2,3-butanediol to acetoin. By over-expression of AR/BDH in the wild-type B. subtilis JNA 3-10 and applying fed-batch fermentation based on the two-stage pH control strategy, acetoin yield of B. subtilis was improved to a new record of 73.6 g/l, with the productivity of 0.77 g/(l? h). The molar yield of acetoin was improved from 57.5% to 83.5% and the ratio of acetoin/2,3-butanediol was switched from 2.7:1 to 18.0:1.	[Zhang, Xian; Bao, Teng; Rao, Zhiming; Yang, Taowei; Li, Huazhong] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Jiangsu, Peoples R China; [Xu, Zhenghong] Jiangnan Univ, Sch Med & Pharmaceut, Wuxi, Jiangsu, Peoples R China; [Yang, Shangtian] Ohio State Univ, Dept Chem Engn, Columbus, OH 43210 USA	Jiangnan University; Jiangnan University; University System of Ohio; Ohio State University	Rao, ZM (corresponding author), Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Jiangsu, Peoples R China.	raozhm@jiangnan.edu.cn; hzhli@jiangnan.edu.cn	Yang, Shang-Tian/A-7892-2009		Program for New Century Excellent Talents in University [NCET-10-0459]; National Basic Research Program of China (973 Program) [2012CB725202]; National Natural Science Foundation of China [21276110]; Research Project of Chinese Ministry of Education [113033A]; Fundamental Research Funds for the Central Universities [JUSRP51306A, JUSRP21121]; 111 Project [111-2-06]; Priority Academic Program Development of Jiangsu Higher Education Institution	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Project of Chinese Ministry of Education(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); 111 Project(Ministry of Education, China - 111 Project); Priority Academic Program Development of Jiangsu Higher Education Institution	This work was supported by the Program for New Century Excellent Talents in University (NCET-10-0459), the National Basic Research Program of China (973 Program) (2012CB725202), the National Natural Science Foundation of China (21276110), the Research Project of Chinese Ministry of Education (No. 113033A), the Fundamental Research Funds for the Central Universities (JUSRP51306A and JUSRP21121), the 111 Project (111-2-06) and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cho S, 2013, APPL BIOCHEM BIOTECH, V170, P1922, DOI 10.1007/s12010-013-0291-2; COGAN TM, 1981, APPL ENVIRON MICROB, V41, P1; CROW VL, 1990, APPL ENVIRON MICROB, V56, P1656, DOI 10.1128/AEM.56.6.1656-1665.1990; Ehsani M, 2009, BIOTECHNOL BIOENG, V104, P381, DOI 10.1002/bit.22391; Gao J, 2013, LETT APPL MICROBIOL, V57, P274, DOI 10.1111/lam.12107; Geckil H, 2004, BIOPROC BIOSYST ENG, V26, P325, DOI 10.1007/s00449-004-0373-1; Gonzalez E, 2000, J BIOL CHEM, V275, P35876, DOI 10.1074/jbc.M003035200; HEIDLAS J, 1990, ARCH MICROBIOL, V154, P267, DOI 10.1007/BF00248966; HOHNBENTZ H, 1978, ARCH MICROBIOL, V116, P197, DOI 10.1007/BF00406037; Ji XJ, 2011, BIOTECHNOL ADV, V29, P351, DOI 10.1016/j.biotechadv.2011.01.007; KAVADZE A V, 1979, Biology Bulletin of the Academy of Sciences of the USSR, V6, P356; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Machielsen R, 2006, APPL ENVIRON MICROB, V72, P233, DOI 10.1128/AEM.72.1.233-238.2006; Nicholson WL, 2008, APPL ENVIRON MICROB, V74, P6832, DOI 10.1128/AEM.00881-08; Passerini D, 2013, INT J FOOD MICROBIOL, V160, P329, DOI 10.1016/j.ijfoodmicro.2012.10.023; ROMANO P, 1993, FEMS MICROBIOL LETT, V108, P23; Schallmey M, 2004, CAN J MICROBIOL, V50, P1, DOI 10.1139/W03-076; Schmitt P, 1997, APPL MICROBIOL BIOT, V47, P715, DOI 10.1007/s002530051000; Siemerink MAJ, 2011, APPL ENVIRON MICROB, V77, P2582, DOI 10.1128/AEM.01616-10; Sun JA, 2012, BIORESOURCE TECHNOL, V119, P94, DOI 10.1016/j.biortech.2012.05.108; Sun JN, 2012, BIOTECHNOL BIOPROC E, V17, P598, DOI 10.1007/s12257-011-0587-4; Wang Z, 2014, APPL MICROBIOL BIOT, V98, P641, DOI 10.1007/s00253-013-4870-5; Xiao ZJ, 2007, APPL MICROBIOL BIOT, V74, P61, DOI 10.1007/s00253-006-0646-5; Xiao ZJ, 2007, CRIT REV MICROBIOL, V33, P127, DOI 10.1080/10408410701364604; Xiao ZJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-88; Xiao ZJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008860; Zhang X, 2013, J IND MICROBIOL BIOT; Zhang X, 2011, WORLD J MICROB BIOT, V27, P2785, DOI 10.1007/s11274-011-0754-y; Zhang YJ, 2013, BIORESOURCE TECHNOL, V130, P256, DOI 10.1016/j.biortech.2012.10.036	31	5	8	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91187	10.1371/journal.pone.0091187	http://dx.doi.org/10.1371/journal.pone.0091187			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608678	gold, Green Published, Green Submitted			2022-12-25	WOS:000332485800113
J	Dozio, E; Malavazos, AE; Vianello, E; Briganti, S; Dogliotti, G; Bandera, F; Giacomazzi, F; Castelvecchio, S; Menicanti, L; Sigruener, A; Schmitz, G; Romanelli, MMC				Dozio, Elena; Malavazos, Alexis Elias; Vianello, Elena; Briganti, Silvia; Dogliotti, Giada; Bandera, Francesco; Giacomazzi, Francesca; Castelvecchio, Serenella; Menicanti, Lorenzo; Sigrueener, Alexander; Schmitz, Gerd; Romanelli, Massimiliano Marco Corsi			Interleukin-15 and Soluble Interleukin-15 Receptor alpha in Coronary Artery Disease Patients: Association with Epicardial Fat and Indices of Adipose Tissue Distribution	PLOS ONE			English	Article							CARDIAC ABNORMALITIES; IL-15; IL-15R-ALPHA; OBESITY; CHAIN; CELL; EXPRESSION; BIOLOGY; MUSCLE; FORM	Interleukin-15 (IL-15) is a pro-inflammatory cytokine which signals via a specific alpha receptor subunit (IL-15R alpha). Increased IL-15 level has been observed in cardiovascular patients and IL-15 immunoreactivity has been detected at vulnerable atherosclerotic plaques. Due to the association between adipose tissue distribution, inflammation and coronary artery disease (CAD), we quantified IL-15 and IL-15R alpha in CAD patients with different adiposity and adipose tissue distribution and we evaluated whether epicardial adipose tissue (EAT), a visceral fat depot surrounding and infiltrating myocardium, may be a source of both molecules. IL-15 and IL-15R alpha proteins were quantified by enzyme-linked immunosorbent assays. Gene expression of IL-15 and IL-15R alpha in EAT depots was evaluated by one colour microarray platform. EAT thickness was measured by echocardiography. Plasmatic IL-15 and IL-15R alpha levels were higher in CAD than non-CAD patients. After classification according to adipose tissue distribution, IL-15 was higher in CAD patients with increased abdominal adiposity. Increased level of IL-15R alpha was observed both in CAD and non-CAD patients with increased abdominal fat. EAT was a source of IL-15 and IL-15R alpha and their expression was higher in CAD patients with increased EAT thickness. In conclusion, our data suggest that circulating levels of IL-15 and IL-15R alpha seem to reflect visceral distribution of adipose tissue and that EAT may be a potential source of both IL-15 and IL-15R alpha. Future studies on the relationship between IL-15, visceral fat and characteristics of atherosclerotic plaques could help to better understand the complex biology of this cytokine.	[Dozio, Elena; Vianello, Elena; Dogliotti, Giada; Romanelli, Massimiliano Marco Corsi] Univ Milan, Chair Clin Pathol, Dept Biomed Sci Hlth, Milan, Italy; [Malavazos, Alexis Elias; Briganti, Silvia] IRCCS Policlin San Donato, Diabetol & Metab Dis Unit, Milan, Italy; [Bandera, Francesco] IRCCS Policlin San Donato, Cardiol Unit, Milan, Italy; [Giacomazzi, Francesca; Castelvecchio, Serenella; Menicanti, Lorenzo] IRCCS Policlin San Donato, Cardiac Surg Unit, Milan, Italy; [Sigrueener, Alexander; Schmitz, Gerd] Univ Regensburg, Inst Clin Chem & Lab Med, D-93053 Regensburg, Germany; [Romanelli, Massimiliano Marco Corsi] IRCCS Policlin San Donato, Dept Hlth Serv Diag & Treatment Lab Med, Serv Lab Med Clin Pathol 1, Milan, Italy	University of Milan; IRCCS Policlinico San Donato; IRCCS Policlinico San Donato; IRCCS Policlinico San Donato; University of Regensburg; IRCCS Policlinico San Donato	Dozio, E (corresponding author), Univ Milan, Chair Clin Pathol, Dept Biomed Sci Hlth, Milan, Italy.	elena.dozio@unimi.it	Malavazos, Alexis Elias/AAB-2370-2021; , CASTELVECCHIO/J-9091-2016; Bandera, Francesco/K-6532-2016; Bandera, Francesco/HGB-0711-2022; menicanti, lorenzo/K-5649-2018; , ele/ABG-3014-2020; Romanelli, Massimiliano M Corsi/K-9359-2016	Malavazos, Alexis Elias/0000-0002-0852-9625; , CASTELVECCHIO/0000-0001-5365-7063; Bandera, Francesco/0000-0002-5821-7371; menicanti, lorenzo/0000-0001-8530-6284; , ele/0000-0001-5833-0780; Romanelli, Massimiliano M Corsi/0000-0001-7928-7697; VIANELLO, ELENA/0000-0001-6461-654X	Italian Ministry for Health "Ricerca Corrente" I.R.C.C.S. Policlinico San Donato; University of Regensburg; EU Framework/project 'LipidomicNet'	Italian Ministry for Health "Ricerca Corrente" I.R.C.C.S. Policlinico San Donato; University of Regensburg; EU Framework/project 'LipidomicNet'	The study was supported by funds from Italian Ministry for Health "Ricerca Corrente" I.R.C.C.S. Policlinico San Donato, internal funds from University of Regensburg and the EU Framework/project 'LipidomicNet'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Bergamaschi C, 2008, J BIOL CHEM, V283, P4189, DOI 10.1074/jbc.M705725200; Bergamaschi C, 2012, BLOOD, V120, pE1, DOI 10.1182/blood-2011-10-384362; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; Despres JP, 2012, CIRCULATION, V126, P1301, DOI 10.1161/CIRCULATIONAHA.111.067264; Djaberi R, 2008, AM J CARDIOL, V102, P1602, DOI 10.1016/j.amjcard.2008.08.010; Dozio E, 2012, INT J IMMUNOPATH PH, V25, P1011, DOI 10.1177/039463201202500418; Dubois S, 1999, J BIOL CHEM, V274, P26978, DOI 10.1074/jbc.274.38.26978; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; Gokkusu C, 2010, CYTOKINE, V49, P58, DOI 10.1016/j.cyto.2009.09.004; Houtkamp MA, 2001, ARTERIOSCL THROM VAS, V21, P1208, DOI 10.1161/hq0701.092162; Iacobellis G, 2003, OBES RES, V11, P304, DOI 10.1038/oby.2003.45; Iacobellis G, 2011, INT J CARDIOL, V146, P452, DOI 10.1016/j.ijcard.2010.10.117; Ikeoka D, 2010, REV ASSOC MED BRAS, V56, P116, DOI 10.1590/S0104-42302010000100026; Kaibe M, 2005, AM J HYPERTENS, V18, P1019, DOI 10.1016/j.amjhyper.2005.02.014; Diaz ACM, 2012, ARTHRITIS, DOI 10.1155/2012/943156; Malavazos AE, 2007, INT J CARDIOL, V121, P132, DOI 10.1016/j.ijcard.2006.08.061; Malavazos AE, 2007, NUTR METAB CARDIOVAS, V17, P294, DOI 10.1016/j.numecd.2006.01.001; Mariner JM, 2001, J IMMUNOL, V166, P2602, DOI 10.4049/jimmunol.166.4.2602; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; Mortier E, 2004, J IMMUNOL, V173, P1681, DOI 10.4049/jimmunol.173.3.1681; Neely GG, 2004, J IMMUNOL, V172, P4225, DOI 10.4049/jimmunol.172.7.4225; Pistilli EE, 2008, CYTOKINE, V43, P45, DOI 10.1016/j.cyto.2008.04.008; Qiao Q, 2010, EUR J CLIN NUTR, V64, P23, DOI 10.1038/ejcn.2009.92; Quinn LBS, 2005, CELL BIOL INT, V29, P449, DOI 10.1016/j.cellbi.2005.02.005; Sacks HS, 2011, METAB SYNDR RELAT D, V9, P433, DOI 10.1089/met.2011.0024; Schejbal V, 1989, Pneumologie, V43, P490; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246	32	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90960	10.1371/journal.pone.0090960	http://dx.doi.org/10.1371/journal.pone.0090960			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603895	gold, Green Published, Green Submitted			2022-12-25	WOS:000332483600115
J	Dragoni, S; Laforenza, U; Bonetti, E; Reforgiato, M; Poletto, V; Lodola, F; Bottino, C; Guido, D; Rappa, A; Pareek, S; Tomasello, M; Guarrera, MR; Cinelli, MP; Aronica, A; Guerra, G; Barosi, G; Tanzi, F; Rosti, V; Moccia, F				Dragoni, Silvia; Laforenza, Umberto; Bonetti, Elisa; Reforgiato, Marta; Poletto, Valentina; Lodola, Francesco; Bottino, Cinzia; Guido, Daniele; Rappa, Alessandra; Pareek, Sumedha; Tomasello, Mario; Guarrera, Maria Rosa; Cinelli, Maria Pia; Aronica, Adele; Guerra, Germano; Barosi, Giovanni; Tanzi, Franco; Rosti, Vittorio; Moccia, Francesco			Enhanced Expression of Stim, Orai, and TRPC Transcripts and Proteins in Endothelial Progenitor Cells Isolated from Patients with Primary Myelofibrosis	PLOS ONE			English	Article							OPERATED CA2+ ENTRY; CALCIUM-ENTRY; HEMATOPOIETIC PROGENITOR; STORE; CHANNELS; CANCER; PROLIFERATION; TARGETS; IDENTIFICATION; OSCILLATIONS	Background: An increase in the frequency of circulating endothelial colony forming cells (ECFCs), the only subset of endothelial progenitor cells (EPCs) truly belonging to the endothelial phenotype, occurs in patients affected by primary myelofibrosis (PMF). Herein, they might contribute to the enhanced neovascularisation of fibrotic bone marrow and spleen. Store-operated Ca2+ entry (SOCE) activated by the depletion of the inositol-1,4,5-trisphosphate (InsP(3))-sensitive Ca2+ store drives proliferation in ECFCs isolated from both healthy donors (N-ECFCs) and subjects suffering from renal cellular carcinoma (RCC-ECFCs). SOCE is up-regulated in RCC-ECFCs due to the over-expression of its underlying molecular components, namely Stim1, Orai1, and TRPC1. Methodology/Principal Findings: We utilized Ca2+ imaging, real-time polymerase chain reaction, western blot analysis and functional assays to evaluate molecular structure and the functional role of SOCE in ECFCs derived from PMF patients (PMF-ECFCs). SOCE, induced by either pharmacological (i.e. cyclopiazonic acid or CPA) or physiological (i.e. ATP) stimulation, was significantly higher in PMF-ECFCs. ATP-induced SOCE was inhibited upon blockade of the phospholipase C/InsP(3) signalling pathway with U73111 and 2-APB. The higher amplitude of SOCE was associated to the over-expression of the transcripts encoding for Stim2, Orai2-3, and TRPC1. Conversely, immunoblotting revealed that Stim2 levels remained constant as compared to N-ECFCs, while Stim1, Orai1, Orai3, TRPC1 and TRPC4 proteins were over-expressed in PMF-ECFCs. ATP-induced SOCE was inhibited by BTP-2 and low micromolar La3+ and Gd3+, while CPA-elicited SOCE was insensitive to Gd3+. Finally, BTP-2 and La3+ weakly blocked PMF-ECFC proliferation, while Gd3+ was ineffective. Conclusions: Two distinct signalling pathways mediate SOCE in PMF-ECFCs; one is activated by passive store depletion and is Gd3+-resistant, while the other one is regulated by the InsP(3)-sensitive Ca2+ pool and is inhibited by Gd3+. Unlike N- and RCC-ECFCs, the InsP(3)-dependent SOCE does not drive PMF-ECFC proliferation.	[Dragoni, Silvia; Reforgiato, Marta; Lodola, Francesco; Guido, Daniele; Rappa, Alessandra; Pareek, Sumedha; Tomasello, Mario; Guarrera, Maria Rosa; Tanzi, Franco; Moccia, Francesco] Univ Pavia, Lab Gen Physioloy, Dept Biol & Biotechnol Lazzaro Spallanzani, I-27100 Pavia, Italy; [Laforenza, Umberto; Bottino, Cinzia] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy; [Bonetti, Elisa; Poletto, Valentina; Aronica, Adele; Barosi, Giovanni; Rosti, Vittorio] Fdn IRCCS Policlin San Matteo, Ctr Study Myelofibrosis, Biotechnol Lab, Pavia, Italy; [Cinelli, Maria Pia] Univ Naples Federico II, Dept Publ Hlth, Naples, Italy; [Guerra, Germano] Univ Molise, Dept Hlth Sci, Campobasso, Italy	University of Pavia; University of Pavia; IRCCS Fondazione San Matteo; University of Naples Federico II; University of Molise	Rosti, V (corresponding author), Fdn IRCCS Policlin San Matteo, Ctr Study Myelofibrosis, Biotechnol Lab, Pavia, Italy.	v.rosti@smatteo.pv.it; francesco.moccia@unipv.it	Rosti, Vittorio/K-1743-2018; Bonetti, Elisa/D-4478-2016; Barosi, Giovanni/AAI-1714-2019; Moccia, Francesco/AAX-6447-2020; Lodola, Francesco/J-8129-2018; Rappa, Alessandra/AAB-1778-2021	Rosti, Vittorio/0000-0003-4195-2289; Bonetti, Elisa/0000-0002-8406-5252; Moccia, Francesco/0000-0003-0010-0098; Lodola, Francesco/0000-0002-3506-5619; Laforenza, Umberto/0000-0003-2951-5983; Dragoni, Silvia/0000-0002-9107-6291; Pareek, Sumedha/0000-0001-6492-3849	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano) Special Program Molecular Clinical Oncology [561000]	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano) Special Program Molecular Clinical Oncology(Fondazione AIRC per la ricerca sul cancro)	This work was supported by a grant from Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano) Special Program Molecular Clinical Oncology 561000 to AIRC-Gruppo Italiano Malattie Mieloproliferative (AGIMM). A detailed description of the AGIMM project is available at (http://www.progettoagimm.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Aytes A, 2012, MOL CARCINOGEN, V51, P746, DOI 10.1002/mc.20843; Badalucco S, 2013, HAEMATOLOGICA, V98, P514, DOI 10.3324/haematol.2012.076752; Barosi G, 2004, BRIT J HAEMATOL, V124, P618, DOI 10.1111/j.1365-2141.2004.04829.x; Barosi G, 2001, BLOOD, V98, P3249, DOI 10.1182/blood.V98.12.3249; Barosi G, 2007, BLOOD, V110, P4030, DOI 10.1182/blood-2007-07-099184; Barritt GJ, 2009, CLIN EXP PHARMACOL P, V36, P77, DOI 10.1111/j.1440-1681.2008.05095.x; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bird GS, 2008, METHODS, V46, P204, DOI 10.1016/j.ymeth.2008.09.009; Boyd RS, 2009, MOL CELL PROTEOMICS, V8, P1501, DOI 10.1074/mcp.M800515-MCP200; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Capiod T, 2013, RECENT PAT ANTI-CANC, V8, P4; Case J, 2007, EXP HEMATOL, V35, P1109, DOI 10.1016/j.exphem.2007.04.002; Cheng KT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001025; Ciarcia R, 2010, J CELL PHYSIOL, V224, P443, DOI 10.1002/jcp.22140; Clemens MJ, 2004, ONCOGENE, V23, P3180, DOI 10.1038/sj.onc.1207544; Courjaret Raphael, 2012, Front Biosci (Elite Ed), V4, P331; Davis FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036923; Dragoni S, 2013, STEM CELLS DEV, V22, P2561, DOI 10.1089/scd.2013.0032; Dragoni S, 2011, STEM CELLS, V29, P1898, DOI 10.1002/stem.734; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; Feske S, 2009, IMMUNOL REV, V231, P189, DOI 10.1111/j.1600-065X.2009.00818.x; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Gusev K, 2003, J GEN PHYSIOL, V122, P81, DOI 10.1085/jgp.200308815; Han S, 2012, HUM IMMUNOL, V73, P316, DOI 10.1016/j.humimm.2011.12.018; He BF, 2012, ONCOL REP, V27, P1548, DOI 10.3892/or.2012.1695; Hollywood MA, 2010, BRIT J PHARMACOL, V160, P1293, DOI 10.1111/j.1476-5381.2010.00795.x; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Jaffe LF, 2005, ADV CANCER RES, V94, P231, DOI 10.1016/S0065-230X(05)94006-2; Jang SS, 2011, AM J PHYSIOL-CELL PH, V301, pC150, DOI 10.1152/ajpcell.00002.2010; Jiang HN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067637; Lehen'kyi V, 2011, AM J PHYSIOL-CELL PH, V301, pC1281, DOI 10.1152/ajpcell.00249.2011; Li J, 2011, CIRC RES, V108, P1190, DOI 10.1161/CIRCRESAHA.111.243352; Liao YY, 2009, P NATL ACAD SCI USA, V106, P3202, DOI 10.1073/pnas.0813346106; Lodola F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042541; Massa M, 2005, BLOOD, V106, p79A; Mesa RA, 2000, BLOOD, V96, P3374; Misquitta CM, 2006, CELL CALCIUM, V40, P329, DOI 10.1016/j.ceca.2006.04.004; Moccia F, 2012, CURR MED CHEM, V19, P5802, DOI 10.2174/092986712804143240; Moccia F, 2014, ANTI-CANCER AGENT ME, V14, P296, DOI 10.2174/18715206113139990315; Moccia F, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-S2-S46; Moccia Francesco, 2012, World J Biol Chem, V3, P127, DOI 10.4331/wjbc.v3.i7.127; Moccia F, 2012, CURR SIGNAL TRANSD T, V7, P161, DOI 10.2174/157436212800376672; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Monteith GR, 2012, J BIOL CHEM, V287, P31666, DOI 10.1074/jbc.R112.343061; Morita T, 2009, J CELL SCI, V122, P1220, DOI 10.1242/jcs.041640; Motiani RK, 2013, PFLUG ARCH EUR J PHY, V465, P1249, DOI 10.1007/s00424-013-1254-8; Motiani RK, 2010, J BIOL CHEM, V285, P19173, DOI 10.1074/jbc.M110.102582; Ouadid-Ahidouch H, 2013, TRENDS MOL MED, V19, P117, DOI 10.1016/j.molmed.2012.11.004; Papp B, 2004, BIOCHEM BIOPH RES CO, V322, P1223, DOI 10.1016/j.bbrc.2004.08.030; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Piaggio G, 2009, BLOOD, V114, P3127, DOI 10.1182/blood-2008-12-190991; Plant TD, 2005, N-S ARCH PHARMACOL, V371, P266, DOI 10.1007/s00210-005-1055-5; Prevarskaya N, 2010, TRENDS MOL MED, V16, P107, DOI 10.1016/j.molmed.2010.01.005; Ritchie MF, 2011, CELL CALCIUM, V49, P314, DOI 10.1016/j.ceca.2010.10.001; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Rosti V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015277; Ruano Y, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-39; Sanchez-Hernandez Y, 2010, STEM CELLS DEV, V19, P1967, DOI 10.1089/scd.2010.0047; Sozer S, 2008, BLOOD CELL MOL DIS, V41, P284, DOI 10.1016/j.bcmd.2008.06.008; Teofili L, 2011, BLOOD, V117, P2700, DOI 10.1182/blood-2010-07-297598; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Vanden Abeele F, 2004, J BIOL CHEM, V279, P30326, DOI 10.1074/jbc.M400106200; Yang N, 2013, CANCER LETT, V330, P163, DOI 10.1016/j.canlet.2012.11.040; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yoder MC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006692; Zarayskiy V, 2007, CHANNELS, V1, P246, DOI 10.4161/chan.4835; Zeng B, 2013, CURR CANCER DRUG TAR, V13, P103, DOI 10.2174/156800913804486629	68	60	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91099	10.1371/journal.pone.0091099	http://dx.doi.org/10.1371/journal.pone.0091099			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603752	Green Published, gold, Green Submitted			2022-12-25	WOS:000332483600129
J	Zhou, HT; Ji, XM; Wu, Y; Xuan, J; Qi, ZL; Shen, L; Lan, L; Li, Q; Yin, ZM; Li, ZJ; Zhao, ZH				Zhou, HuiTing; Ji, XueMei; Wu, Yun; Xuan, Ju; Qi, ZhiLin; Shen, Lei; Lan, Lei; Li, Qing; Yin, ZhiMin; Li, ZhongJun; Zhao, ZhiHui			A Dual-Role of Gu-4 in Suppressing HMGB1 Secretion and Blocking HMGB1 Pro-Inflammatory Activity during Inflammation	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; CHROMATIN PROTEIN HMGB1; TUMOR-NECROSIS-FACTOR; DOUBLE-BLIND; SYSTEMIC INFLAMMATION; LACTOSYL DERIVATIVES; MONOCLONAL-ANTIBODY; CYTOKINE ACTIVITY; CELL RECRUITMENT; CONTROLLED-TRIAL	Background: High mobility group box 1(HMGB1) was first recognized as a nuclear protein that increased the chromatin remodeling and regulates transcription of many genes. In recent years, HMGB1 has been identified as a critical "late'' proinflammatory mediator due to its unique secretion pattern and lethal effects in sepsis. Therefore, preventing the active release and inhibiting the pro-inflammatory activity of HMGB1 become promising strategies for the treatment of sepsis. Here, we reported the therapeutic effects of Gu-4, a lactosyl derivative, on sepsis and the underlying molecular mechanisms. Methodology/Principal Findings: In an experimental rat model of sepsis caused by cecal ligation and puncture (CLP), Gu-4 administration prominently attenuated lung injury and improved the survival of the septic animals, which was positively correlated with the decrease of the serum HMGB1 level. Using RAW264.7 macrophage cell line, we further showed that Gu-4 significantly suppressed the lipopolysaccharide (LPS)-induced release and cytoplasmic translocation of HMGB1. Moreover, Gu-4 not only dose-dependently attenuated recombinant human (rhHMGB1)-induced production of TNF-alpha, IL-6, and IL-1 beta in THP-1 cells, but also greatly inhibited the adhesion of rhHMGB1-challenged THP-1 cells to HUVECs. Analyses of flow cytometry demonstrated that Gu-4 could effectively reduce the activation of CD11b elicited by rhHMGB1. Western blot analyses revealed that Gu-4 treatment could partially block the rhHMGB1-induced activation of ERK and NF-kappa B signalings. Meanwhile, CD11b knockdown also obviously attenuated the rhHMGB1-induced phosphorylations of ERK and IKK alpha/beta. Conclusions/Significance: Taken together, our results suggest that Gu-4 possesses a therapeutic potential in the treatment of sepsis probably via inhibiting the LPS-induced release of HMGB1 from macrophages and via suppressing the proinflammatory activity of HMGB1.	[Zhou, HuiTing; Ji, XueMei; Wu, Yun; Xuan, Ju; Qi, ZhiLin; Shen, Lei; Lan, Lei; Yin, ZhiMin; Zhao, ZhiHui] Nanjing Normal Univ, Coll Life Sci, Jiangsu Prov Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China; [Li, Qing; Li, ZhongJun] Peking Univ, State Key Lab Nat & Biomimet Drugs, Sch Pharmaceut Sci, Beijing 100871, Peoples R China; [Lan, Lei; Yin, ZhiMin; Zhao, ZhiHui] Collaborat Innovat Ctr Biomed Publ Hyg Emergency, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University; Peking University	Zhao, ZH (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Prov Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China.	zhaozhihui_1964@aliyun.com			Natural Science Foundation of China (NSFC) [81273232, 91213301]; Priority Academic Program Development of Jiangsu Higher Education Institutions [164320H106]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was financially supported by the Natural Science Foundation of China (NSFC: 81273232 and 91213301), and a project from the Priority Academic Program Development of Jiangsu Higher Education Institutions (No. 164320H106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM E, 1995, JAMA-J AM MED ASSOC, V273, P934, DOI 10.1001/jama.273.12.934; Abraham E, 1998, LANCET, V351, P929; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Dave SH, 2009, J LEUKOCYTE BIOL, V86, P633, DOI 10.1189/jlb.1008662; Diener KR, 2013, IMMUNOL CELL BIOL, V91, P443, DOI 10.1038/icb.2013.25; Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506; Fan J, 2012, GLYCOCONJUGATE J, V29, P305, DOI 10.1007/s10719-012-9407-0; FISHER CJ, 1994, JAMA-J AM MED ASSOC, V271, P1836, DOI 10.1001/jama.271.23.1836; Fiuza C, 2003, BLOOD, V101, P2652, DOI 10.1182/blood-2002-05-1300; Gao HM, 2011, J NEUROSCI, V31, P1081, DOI 10.1523/JNEUROSCI.3732-10.2011; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Hagiwara S, 2008, CRIT CARE, V12, DOI 10.1186/cc6851; Harris HE, 2006, EMBO REP, V7, P774, DOI 10.1038/sj.embor.7400759; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; LaRosa S. P., 2011, Clinical Investigation, V1, P195, DOI 10.4155/cli.10.19; Li H, 2000, CARBOHYD RES, V328, P611, DOI 10.1016/S0008-6215(00)00137-3; Li JH, 2004, J IMMUNOL METHODS, V289, P211, DOI 10.1016/j.jim.2004.04.019; Li JH, 2003, MOL MED, V9, P37, DOI 10.1007/BF03402105; Li Q, 2003, CARBOHYD RES, V338, P207, DOI 10.1016/S0008-6215(02)00438-X; Li W, 2007, J IMMUNOL, V178, P3856, DOI 10.4049/jimmunol.178.6.3856; Li W, 2011, BIOCHEM PHARMACOL, V81, P1152, DOI 10.1016/j.bcp.2011.02.015; Liu ZW, 2008, FEBS LETT, V582, P1643, DOI 10.1016/j.febslet.2008.04.016; Orlova VV, 2007, EMBO J, V26, P1129, DOI 10.1038/sj.emboj.7601552; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Park JS, 2003, AM J PHYSIOL-CELL PH, V284, pC870, DOI 10.1152/ajpcell.00322.2002; PRUITT JH, 1995, SHOCK, V3, P235, DOI 10.1097/00024382-199504000-00001; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Soriano FG, 2011, SHOCK, V35, P560, DOI 10.1097/SHK.0b013e31820fe5d5; Ulloa L, 2002, P NATL ACAD SCI USA, V99, P12351, DOI 10.1073/pnas.192222999; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Yamada S, 2007, CLIN CHIM ACTA, V375, P36, DOI 10.1016/j.cca.2006.07.019; Yan TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030110; Yang D, 2007, J LEUKOCYTE BIOL, V81, P59, DOI 10.1189/jlb.0306180; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Yang H, 2012, MOL MED, V18, P250, DOI 10.2119/molmed.2011.00389; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Yang H, 2010, BBA-GENE REGUL MECH, V1799, P149, DOI 10.1016/j.bbagrm.2009.11.019; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Zhao ZH, 2009, GLYCOCONJUGATE J, V26, P173, DOI 10.1007/s10719-008-9174-0	45	12	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89634	10.1371/journal.pone.0089634	http://dx.doi.org/10.1371/journal.pone.0089634			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603876	Green Published, Green Submitted, gold			2022-12-25	WOS:000332483600017
J	Kim, SJ; Cho, J; Song, EJ; Kim, SJ; Kim, HM; Lee, KE; Suh, SW; Kim, EE				Kim, Su Jin; Cho, Jinhong; Song, Eun Joo; Kim, Soo Jin; Kim, Ho Min; Lee, Kyung Eun; Suh, Se Won; Kim, Eunice EunKyeong			Structural Basis for Ovarian Tumor Domain-containing Protein 1 ( OTU1) Binding to p97/Valosin-containing Protein ( VCP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; Crystal Structure; Deubiquitination; Electron Microscopy (EM); ER-associated Degradation; Isothermal Titration Calorimetry; Protein-Protein Interactions; Site-directed Mutagenesis	UBIQUITIN-PROTEASOME SYSTEM; AAA ATPASE P97/VCP; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; DEGRADATION ERAD; QUALITY CONTROL; P97; COMPLEX; COFACTORS; SUITE	Background: Ovarian tumor domain-containing protein 1 (OTU1) acts as a deubiquitinating enzyme in the endoplasmic reticulum-associated degradation (ERAD) pathway by associating with valosin-containing protein (VCP). Results: One OTU1 binds to a VCP hexamer with a K-D of 0.71 m. Conclusion: The (39)GYPP(42) (S3/S4) loop of OTU1 is critical for interaction with VCP. Significance: This is the first structural study of VCP and OTU1 complex. Valosin-containing protein (VCP), also known as p97, is an AAA(+) ATPase that plays an essential role in a broad array of cellular processes including the endoplasmic reticulum-associated degradation (ERAD) pathway. Recently, ERAD-specific deubiquitinating enzymes have been reported to be physically associated with VCP, although the exact mechanism is not yet clear. Among these enzymes is ovarian tumor domain-containing protein 1 (OTU1). Here, we report the structural basis for interaction between VCP and OTU1. The crystal structure of the ubiquitin regulatory X-like (UBXL) domain of OTU1 (UBXLOTU1) complexed to the N-terminal domain of VCP (N-VCP) at 1.8- resolution reveals that UBXLOTU1 adopts a ubiquitin-like fold and binds at the interface of two subdomains of N-VCP using the (39)GYPP(42) loop of UBXLOTU1 with the two prolines in cis- and trans-configurations, respectively. A mutagenesis study shows that this loop is not only critical for the interaction with VCP but also for its role in the ERAD pathway. Negative staining EM shows that one molecule of OTU1 binds to one VCP hexamer, and isothermal titration calorimetry suggests that the two proteins bind with a K-D of 0.71 m. Analytical size exclusion chromatography and isothermal titration calorimetry demonstrates that OTU1 can bind VCP in both the presence and absence of a heterodimer formed by ubiquitin fusion degradation protein 1 and nuclear localization protein 4.	[Kim, Su Jin; Cho, Jinhong; Song, Eun Joo; Lee, Kyung Eun; Kim, Eunice EunKyeong] Korea Inst Sci & Technol, Biomed Res Inst, Seoul 136791, South Korea; [Kim, Su Jin; Suh, Se Won] Seoul Natl Univ, Dept Chem, Coll Nat Sci, Seoul 151747, South Korea; [Kim, Soo Jin; Kim, Ho Min] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea	Korea Institute of Science & Technology (KIST); Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST)	Suh, SW (corresponding author), Korea Inst Sci & Technol, Biomed Res Inst, Seoul 136791, South Korea.	sewonsuh@snu.ac.kr; eunice@kist.re.kr	Kim, Ho Min/G-2712-2011	Song, Eun Joo/0000-0002-2420-6666	Global Research Laboratory Program Grant of the Ministry of Science, Information and Communication Technology and Future Planning of Korea [2013056409]; Korea Institute of Science and Technology	Global Research Laboratory Program Grant of the Ministry of Science, Information and Communication Technology and Future Planning of Korea; Korea Institute of Science and Technology(Korea Institute of Science & Technology (KIST))	This work was supported by Global Research Laboratory Program Grant 2013056409 of the Ministry of Science, Information and Communication Technology and Future Planning of Korea and an institutional grant from the Korea Institute of Science and Technology.	Alberts SM, 2009, J BIOL CHEM, V284, P16082, DOI 10.1074/jbc.M809282200; Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Bang D, 2005, ANGEW CHEM INT EDIT, V44, P3852, DOI 10.1002/anie.200463040; Bebeacua C, 2012, P NATL ACAD SCI USA, V109, P1098, DOI 10.1073/pnas.1114341109; Bernardi KM, 2013, MOL BIOL CELL, V24, P3545, DOI 10.1091/mbc.E13-06-0332; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Bruderer RM, 2004, J BIOL CHEM, V279, P49609, DOI 10.1074/jbc.M408695200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chia WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050490; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; de Virgilio M, 1999, MOL BIOL CELL, V10, P4059, DOI 10.1091/mbc.10.12.4059; de Vrij FMS, 2004, PROG NEUROBIOL, V74, P249, DOI 10.1016/j.pneurobio.2004.10.001; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Gille C, 2003, BIOINFORMATICS, V19, P2489, DOI 10.1093/bioinformatics/btg354; Goder V, 2012, CURR PROTEIN PEPT SC, V13, P425, DOI 10.2174/138920312802430572; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hanzelmann P, 2011, J BIOL CHEM, V286, P38679, DOI 10.1074/jbc.M111.274506; Hanzelmann P, 2011, STRUCTURE, V19, P833, DOI 10.1016/j.str.2011.03.018; Huyton T, 2003, J STRUCT BIOL, V144, P337, DOI 10.1016/j.jsb.2003.10.007; Isaacson RL, 2007, J BIOL CHEM, V282, P21361, DOI 10.1074/jbc.M610069200; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Kern M, 2009, BIOCHEM BIOPH RES CO, V380, P303, DOI 10.1016/j.bbrc.2009.01.076; Kloppsteck P, 2012, BBA-MOL CELL RES, V1823, P125, DOI 10.1016/j.bbamcr.2011.09.006; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JJ, 2013, J BIOL CHEM, V288, P6998, DOI 10.1074/jbc.M112.417576; Liu YF, 2012, CURR PROTEIN PEPT SC, V13, P436, DOI 10.2174/138920312802430608; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Messick TE, 2008, J BIOL CHEM, V283, P11038, DOI 10.1074/jbc.M704398200; Mevissen TET, 2013, CELL, V154, P169, DOI 10.1016/j.cell.2013.05.046; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pye VE, 2007, P NATL ACAD SCI USA, V104, P467, DOI 10.1073/pnas.0603408104; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112; Uchiyama K, 2006, DEV CELL, V11, P803, DOI 10.1016/j.devcel.2006.10.016; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Yamanaka K, 2012, BBA-MOL CELL RES, V1823, P130, DOI 10.1016/j.bbamcr.2011.07.001; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	49	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12264	12274		10.1074/jbc.M113.523936	http://dx.doi.org/10.1074/jbc.M113.523936			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24610782	hybrid, Green Published			2022-12-25	WOS:000335581400007
J	de Souza, LB; da Silva, LLP; Jamur, MC; Oliver, C				de Souza, Lorena Brito; Pinto da Silva, Luis Lamberti; Jamur, Maria Celia; Oliver, Constance			Phospholipase D Is Involved in the Formation of Golgi Associated Clathrin Coated Vesicles in Human Parotid Duct Cells	PLOS ONE			English	Article							PHOSPHATIDIC-ACID; CYTOSKELETAL REORGANIZATION; MAMMALIAN-CELLS; PLASMA-MEMBRANE; GENE FAMILY; RECEPTOR; ENDOCYTOSIS; APPARATUS; LOCALIZATION; ISOFORM	Phospholipase D (PLD) has been implicated in many cellular functions, such as vesicle trafficking, exocytosis, differentiation, and proliferation. The aim of this study was to characterize the role of PLD in HSY cells, a human cell line originating from the intercalated duct of the parotid gland. As the function and intracellular localization of PLD varies according to cell type, initially, the intracellular localization of PLD1 and PLD2 was determined. By immunofluorescence, PLD1 and PLD2 both showed a punctate cytoplasmic distribution with extensive co-localization with TGN-46. PLD1 was also found in the nucleus, while PLD2 was associated with the plasma membrane. Treatment of cells with the primary alcohol 1-butanol inhibits the hydrolysis of phosphatidylcoline by PLD thereby suppressing phosphatidic acid (PA) production. In untreated HSY cells, there was only a slight co-localization of PLD with the clathrin coated vesicles. When HSY cells were incubated with 1-butanol the total number of clathrin coated vesicles increased, especially in the juxtanuclear region and the co-localization of PLD with the clathrin coated vesicles was augmented. Transmission electron microscopy confirmed that the number of Golgi-associated coated vesicles was greater. Treatment with 1-butanol also affected the Golgi apparatus, increasing the volume of the Golgi saccules. The decrease in PA levels after treatment with 1-butanol likewise resulted in an accumulation of enlarged lysosomes in the perinuclear region. Therefore, in HSY cells PLD appears to be involved in the formation of Golgi associated clathrin coated vesicles as well as in the structural maintenance of the Golgi apparatus.	[de Souza, Lorena Brito; Pinto da Silva, Luis Lamberti; Jamur, Maria Celia; Oliver, Constance] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Cell & Mol Biol, BR-14049 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo	Oliver, C (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Cell & Mol Biol, BR-14049 Ribeirao Preto, SP, Brazil.	coliver@fmrp.usp.br	daSilva, Luis LP/AAD-5657-2019; Brito de Souza, Lorena/N-3385-2014; LP daSilva, Luis/A-9949-2010	daSilva, Luis LP/0000-0003-3558-0087; Brito de Souza, Lorena/0000-0002-2462-6759; LP daSilva, Luis/0000-0003-3558-0087	CAPES (Coordenacao de Aperfeicoamento de Pessoa de Nivel Superior) [BEX 4085/09-4]; FAEPA (Fundacao de Apoio ao Ensino, Pesquisa e Assistencia); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [06/55650-6]	CAPES (Coordenacao de Aperfeicoamento de Pessoa de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAEPA (Fundacao de Apoio ao Ensino, Pesquisa e Assistencia); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Financial support was received from the following agencies: CAPES (Coordenacao de Aperfeicoamento de Pessoa de Nivel Superior; http://www.capes.gov.br/-Individual Grant BEX 4085/09-4, FAEPA (Fundacao de Apoio ao Ensino, Pesquisa e Assistencia; http://www.faepa.br/) and FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; http://www.fapesp.br/-Individual Grant 06/55650-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chapuy B, 2008, TRAFFIC, V9, P1157, DOI 10.1111/j.1600-0854.2008.00745.x; Chen YG, 1997, J CELL BIOL, V138, P495, DOI 10.1083/jcb.138.3.495; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Dohke Y, 2002, BIOCHEM BIOPH RES CO, V299, P663, DOI 10.1016/S0006-291X(02)02713-4; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Exton JH, 2002, FEBS LETT, V531, P58, DOI 10.1016/S0014-5793(02)03405-1; Faugaret D, 2011, BIOCHEM PHARMACOL, V81, P144, DOI 10.1016/j.bcp.2010.09.014; Freyberg Z, 2003, TRENDS CELL BIOL, V13, P540, DOI 10.1016/j.tcb.2003.08.004; Freyberg Z, 2002, MOL BIOL CELL, V13, P3930, DOI 10.1091/mbc.02-04-0059; Freyberg Z, 2001, MOL BIOL CELL, V12, P943, DOI 10.1091/mbc.12.4.943; Garrido JL, 2009, MOL ENDOCRINOL, V23, P2048, DOI 10.1210/me.2008-0436; Gayral S, 2006, CIRC RES, V99, P132, DOI 10.1161/01.RES.0000232323.86227.8b; Ghosh P, 2003, J CELL BIOL, V163, P755, DOI 10.1083/jcb.200308038; Gibbs TC, 2000, J CELL PHYSIOL, V182, P77, DOI 10.1002/(SICI)1097-4652(200001)182:1<77::AID-JCP9>3.0.CO;2-B; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Hitomi T, 2004, BLOOD, V104, P4122, DOI 10.1182/blood-2004-06-2091; Jang JH, 2012, PROG LIPID RES, V51, P71, DOI 10.1016/j.plipres.2011.12.003; Jang YH, 2011, J BIOL CHEM, V286, P4680, DOI 10.1074/jbc.M110.162602; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Koch T, 2006, J NEUROCHEM, V97, P365, DOI 10.1111/j.1471-4159.2006.03736.x; Kooijman EE, 2009, BBA-MOL CELL BIOL L, V1791, P881, DOI 10.1016/j.bbalip.2009.04.001; Lavieri R, 2009, BIOORG MED CHEM LETT, V19, P2240, DOI 10.1016/j.bmcl.2009.02.125; Lee CS, 2006, NAT CELL BIOL, V8, P477, DOI 10.1038/ncb1401; Lewis JA, 2009, BIOORG MED CHEM LETT, V19, P1916, DOI 10.1016/j.bmcl.2009.02.057; Liscovitch M, 1999, BBA-MOL CELL BIOL L, V1439, P245, DOI 10.1016/S1388-1981(99)00098-0; Liscovitch M, 2000, BIOCHEM J, V345, P401, DOI 10.1042/0264-6021:3450401; LUDWIG T, 1991, J CELL BIOL, V115, P1561, DOI 10.1083/jcb.115.6.1561; Manifava M, 2001, J BIOL CHEM, V276, P8987, DOI 10.1074/jbc.M010308200; Mateos MV, 2010, BBA-BIOMEMBRANES, V1798, P624, DOI 10.1016/j.bbamem.2009.12.008; Marchini-Alves CMM, 2012, J HISTOCHEM CYTOCHEM, V60, P386, DOI 10.1369/0022155412438886; Metcalf DJ, 2008, TRAFFIC, V9, P1905, DOI 10.1111/j.1600-0854.2008.00807.x; Padron D, 2006, MOL BIOL CELL, V17, P598, DOI 10.1091/mbc.E05-05-0389; Park MH, 2009, CARCINOGENESIS, V30, P356, DOI 10.1093/carcin/bgn287; Peng X, 2012, ACTA PHYSIOL, V204, P219, DOI 10.1111/j.1748-1716.2011.02298.x; Perez-Victoria FJ, 2008, MOL BIOL CELL, V19, P2350, DOI 10.1091/mbc.E07-11-1189; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Riebeling C, 2009, BBA-MOL CELL BIOL L, V1791, P876, DOI 10.1016/j.bbalip.2009.04.003; Roach AN, 2012, J LIPID RES, V53, P2598, DOI 10.1194/jlr.M028597; Roth MG, 2008, TRAFFIC, V9, P1233, DOI 10.1111/j.1600-0854.2008.00742.x; Shen YJ, 2001, MOL CELL BIOL, V21, P595, DOI 10.1128/MCB.21.2.595-602.2001; Siddhanta A, 2000, J BIOL CHEM, V275, P12023, DOI 10.1074/jbc.275.16.12023; Sweeney DA, 2002, J BIOL CHEM, V277, P3030, DOI 10.1074/jbc.M104639200; Vorland M, 2008, PLATELETS, V19, P582, DOI 10.1080/09537100802454992; YANAGAWA T, 1986, VIRCHOWS ARCH B, V51, P187, DOI 10.1007/BF02899028; Yang JS, 2008, NAT CELL BIOL, V10, P1146, DOI 10.1038/ncb1774; Zeniou-Meyer M, 2007, J BIOL CHEM, V282, P21746, DOI 10.1074/jbc.M702968200	47	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91868	10.1371/journal.pone.0091868	http://dx.doi.org/10.1371/journal.pone.0091868			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618697	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400138
J	Pan, T; Sun, JF; Hu, JY; Hu, YW; Zhou, J; Chen, ZG; Xu, D; Xu, WH; Zheng, S; Zhang, SZ				Pan, Tao; Sun, Junfeng; Hu, Jiyi; Hu, Yiwang; Zhou, Jun; Chen, Zhigang; Xu, Dong; Xu, Wenhong; Zheng, Shu; Zhang, Suzhan			Cytohesins/ARNO: The Function in Colorectal Cancer Cells	PLOS ONE			English	Article							FACTOR RECEPTOR EGFR; GROWTH-FACTOR SYSTEM; INHIBITION; CETUXIMAB; PATHWAY	Epidermal growth factor (EGF) and insulin-like growth factor-I (IGF-I) are critical regulators of cell differentiation, survival, proliferation, and migration in cancers. This study found that ARNO (cytohesin-2), an activator of the EGF and IGF-I pathways, was more highly expressed in colorectal cancer tissue than in benign adjacent colorectal tissue. When ARNO-siRNA or the chemical inhibitor SecinH3 blocked ARNO, the downstream of the EGF and IGF-I pathways decreased in colorectal cell lines HT29 and HCT116. This blocking also weakened cell proliferation, invasion, and migration in vitro. Furthermore, EGF receptor (EGFR)-dependent colorectal tumor xenografts in nude mouse exerted anti-proliferative and growth suppression effects by injecting secineH3. These data suggested that inhibiting cytohesins or ARNO as cytoplasmic activators of EGFR and IGF-I in colorectal cancer resulted in anti-proliferation, reduced invasion, decreased migration, and suppressed growth in vivo and in vitro. Therefore, cytohesins or ARNO may be a potential therapy target for some colorectal cancer.	[Pan, Tao; Hu, Jiyi; Hu, Yiwang; Zhou, Jun; Chen, Zhigang; Zheng, Shu; Zhang, Suzhan] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Surg Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Pan, Tao; Xu, Dong; Xu, Wenhong] Zhejiang Univ, Sch Med, Key Lab Canc Prevent & Intervent, Canc Inst,Natl Minist Educ,Prov Key Lab Mol Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Junfeng] Zhengzhou Univ, Henan Canc Hosp, Dept Gastrointestinal Surg, Zhengzhou 450052, Peoples R China	Zhejiang University; Zhejiang University; Zhengzhou University	Zhang, SZ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Surg Oncol, Hangzhou 310003, Zhejiang, Peoples R China.	suzhan_zhang@163.com			National High Technology Research and Development Program of China [2012AA02A506]; Zhejiang Provincial Natural Science Foundation of China [LD13H160015]; Zhejiang Provincial Key Scientific and Technological Research Projects of International Cooperation [2009C14010]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Key Scientific and Technological Research Projects of International Cooperation	This research was supported from National High Technology Research and Development Program of China (No. 2012AA02A506), Zhejiang Provincial Natural Science Foundation of China (LD13H160015) and Zhejiang Provincial Key Scientific and Technological Research Projects of International Cooperation (No. 2009C14010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertotti A, 2011, CANCER DISCOV, V1, P508, DOI 10.1158/2159-8290.CD-11-0109; Bill A, 2010, CELL, V143, P201, DOI 10.1016/j.cell.2010.09.011; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Chi F, 2013, MOL BIOL REP, V40, P3583, DOI 10.1007/s11033-012-2432-z; Choi YJ, 2010, CANCER CHEMOTH PHARM, V66, P381, DOI 10.1007/s00280-009-1174-7; Dey BR, 1996, MOL ENDOCRINOL, V10, P631, DOI 10.1210/me.10.6.631; Dutta PR, 2007, CANCER LETT, V254, P165, DOI 10.1016/j.canlet.2007.02.006; Gibson TB, 2006, CLIN COLORECTAL CANC, V6, P29, DOI 10.3816/CCC.2006.n.01; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Heuckmann JM, 2012, J CLIN ONCOL, V30, P3417, DOI 10.1200/JCO.2012.43.1825; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Ludovini V, 2009, ANN ONCOL, V20, P842, DOI 10.1093/annonc/mdn727; McLeod HL, 2000, EUR J CANCER, V36, P1706, DOI 10.1016/S0959-8049(00)00150-7; Montagut C, 2012, NAT MED, V18, P221, DOI 10.1038/nm.2609; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Oh SJ, 2010, J BIOL CHEM, V285, P14610, DOI 10.1074/jbc.M109.043935; Pan T, 2013, ONCOL LETT, V5, P521, DOI 10.3892/ol.2012.1064; Park JHY, 2008, ASIA PAC J CLIN NUTR, V17, P257; Rosenzweig SA, 2010, BIOCHEM PHARMACOL, V80, P1115, DOI 10.1016/j.bcp.2010.06.013; Scartozzi M, 2011, ONCOLOGIST, V16, P53, DOI 10.1634/theoncologist.2010-0119; Sung FL, 2006, J PROTEOME RES, V5, P3260, DOI 10.1021/pr050452g; Ullrich RT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003908; Weroha SJ, 2012, ENDOCRIN METAB CLIN, V41, P335, DOI 10.1016/j.ecl.2012.04.014; Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442; Zhang WZ, 2011, BRAZ J MED BIOL RES, V44, P642, DOI [10.1590/S0100-879X2011007500072, 10.1590/S0100-879X2011000700005]; Zhu WQ, 2012, NATURE, V492, P252, DOI 10.1038/nature11603; Zimmer S, 2009, J CANCER RES CLIN, V135, P723, DOI 10.1007/s00432-008-0509-9	27	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90997	10.1371/journal.pone.0090997	http://dx.doi.org/10.1371/journal.pone.0090997			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618737	Green Published, gold, Green Submitted			2022-12-25	WOS:000332842400042
J	Chen, L; Shi, Y; Yuan, J; Han, YL; Qin, R; Wu, Q; Jia, BQ; Wei, B; Wei, LX; Dai, GH; Jiao, SC				Chen, Li; Shi, Yan; Yuan, Jing; Han, Yalin; Qin, Rui; Wu, Qian; Jia, Baoqing; Wei, Bo; Wei, Lixin; Dai, Guanghai; Jiao, Shunchang			HIF-1 Alpha Overexpression Correlates with Poor Overall Survival and Disease-Free Survival in Gastric Cancer Patients Post-Gastrectomy	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTORS; TRANSFORMING GROWTH-FACTOR-BETA-1; TUMOR ANGIOGENESIS; BREAST-CANCER; GROWTH; METASTASIS; HIF-1-ALPHA; INVASION; EXPRESSION; CELLS	Background: Overall, gastric cancer prognosis remains poor. Detailed characterization of molecular markers that govern gastric cancer pathogenesis is warranted to establish innovative therapeutic options. HIF-1 alpha overexpression has been linked to poor gastric cancer prognosis. However, though researched for years, the prognostic role of HIF-1 alpha in gastric cancer is still controversial. Hence, the objective of the present study was to analyze the prognostic values of HIF-1 alpha, TGF-beta, VEGF and pERK1/2 in gastric cancer patients following gastrectomy. Methods: This study included 446 patients with confirmed gastric cancer who underwent gastrectomy in a single Chinese Cancer Center between 2005 and 2006. Clinicopathologic features, as well as immunohistochemical analysis of TGF-beta, HIF-1 alpha, VEGF and pERK1/2 were determined. Long-term survival of these patients was analyzed using univariate and multivariate analyses. Results: HIF-1 alpha overexpression was more frequent in patients with hepatic metastases (71.6% versus 43.0% in those without hepatic metastases, P = 0.000, chi(2) = 23.086) and more frequent in patients with peritoneum cavity metastasis (62.3% versus 43.0% in those without such metastasis, P = 0.000, chi(2) = 13.691). In univariate analysis, patients with HIF-1 alpha overexpression had a shorter disease-free survival (DFS) and overall survival (OS) than patients with weak-expression (DFS: NA VS. 16.8 m, P = 0.000, chi(2) = 74.937; OS: NA VS. 25.5 m, P = 0.000, chi(2) = 90.594). Importantly, HIF-1 alpha overexpression was a promising prognostic marker for poor survival by multivariate analysis (DFS: HR 2.766, 95% CI 2.136-2.583, P = 0.000; OS: HR 3.529, 95% CI 2.663-4.667, P = 0.000). Conclusions: HIF-1 alpha overexpression could be considered a useful independent prognostic biomarker in gastric cancer after gastrectomy, and is correlated to both a poor overall survival and disease-free survival in these patients. HIF-1 alpha expression can be used to stratify patients at higher risk for poor prognosis, and is potentially an important therapeutic target in gastric cancer patients.	[Chen, Li; Shi, Yan; Han, Yalin; Qin, Rui; Wu, Qian; Dai, Guanghai] Chinese Peoples Liberat Army Gen Hosp, Dept Comprehens Treatment Oncol, Beijing, Peoples R China; [Yuan, Jing; Wei, Lixin] Chinese Peoples Liberat Army Gen Hosp, Dept Pathol, Beijing, Peoples R China; [Jia, Baoqing] Chinese Peoples Liberat Army Gen Hosp, Dept Surg Oncol, Beijing, Peoples R China; [Wei, Bo] Chinese Peoples Liberat Army Gen Hosp, Dept Gen Surg, Beijing, Peoples R China; [Jiao, Shunchang] Chinese Peoples Liberat Army Gen Hosp, Dept Med Oncol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Jiao, SC (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Med Oncol, Beijing, Peoples R China.	jiaosc@vip.sina.com		Shi, Yan/0000-0001-9777-8836	Doctor Fund of People's Liberation Army General Hospital [10BCZ04]	Doctor Fund of People's Liberation Army General Hospital	We are grateful to all the subjects who participated in this study. This study was supported by the Doctor Fund of People's Liberation Army General Hospital (10BCZ04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay A, 2006, CANCER RES, V66, P6714, DOI 10.1158/0008-5472.CAN-05-3565; Brown NS, 2001, BREAST CANCER RES, V3, P323, DOI 10.1186/bcr315; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Chen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066524; Comerci JT, 1996, CANCER, V77, P1107, DOI 10.1002/(SICI)1097-0142(19960315)77:6<1107::AID-CNCR16>3.3.CO;2-A; Dornagafa-Kulawik J, 2006, ARCH IMMUNOL THER EX, V54, P143, DOI 10.1007/s00005-006-0016-0; Ehata S, 2007, CANCER SCI, V98, P127, DOI 10.1111/j.1349-7006.2006.00357.x; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; FOLKMAN J, 1974, CANCER RES, V34, P2109; Fu H, 2009, ACTA BIOCH BIOPH SIN, V41, P648, DOI 10.1093/abbs/gmp053; Gu JW, 2013, VASC CELL, V5, DOI 10.1186/2045-824X-5-9; Halon Agnieszka, 2012, ScientificWorldJournal, V2012, P941259, DOI 10.1100/2012/941259; IVANOVIC V, 1995, NAT MED, V1, P282, DOI 10.1038/nm0495-282; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Lin EY, 2007, MOL ONCOL, V1, P288, DOI 10.1016/j.molonc.2007.10.003; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Ma GF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054249; Maehara Y, 1999, J CLIN ONCOL, V17, P607, DOI 10.1200/JCO.1999.17.2.607; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Matsuo Y, 2013, J HEPATOBILIARY PANC, V21, P105, DOI [10.1002/jhbp.6, DOI 10.1002/JHBP.6.[]; Miyake S, 2013, INT J ONCOL, V43, P1431, DOI 10.3892/ijo.2013.2068; Nam SY, 2011, BRIT J CANCER, V104, P166, DOI 10.1038/sj.bjc.6606020; Ottaviano AJ, 2006, CANCER RES, V66, P7032, DOI 10.1158/0008-5472.CAN-05-4421; REMMELE W, 1987, PATHOLOGE, V8, P138; Saito H, 2000, ANTICANCER RES, V20, P4489; Saji Hisashi, 2003, Ann Thorac Cardiovasc Surg, V9, P295; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Shimomura M, 2013, ANN SURG ONCOL, V20, pS527, DOI 10.1245/s10434-013-2945-2; Stoeltzing O, 2004, JNCI-J NATL CANCER I, V96, P946, DOI 10.1093/jnci/djh168; Tsai YP, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-102; Wang YX, 2010, CANCER BIOL THER, V10, P376, DOI 10.4161/cbt.10.4.12441; Wei H, 2013, EUR REV MED PHARMACO, V17, P436; Yang Shang-You, 2007, Sarcoma, V2007, P95628, DOI 10.1155/2007/95628; Yeo EJ, 2003, J NATL CANCER I, V95, P516, DOI 10.1093/jnci/95.7.516; Yuan XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065659; Zhang Q, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070961, DOI 10.1371/J0URNAL.P0NE.0070961]; Zhang ZG, 2013, ASIAN PAC J CANCER P, V14, P4195, DOI 10.7314/APJCP.2013.14.7.4195	39	37	40	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90678	10.1371/journal.pone.0090678	http://dx.doi.org/10.1371/journal.pone.0090678			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614305	gold, Green Published, Green Submitted			2022-12-25	WOS:000332839300033
J	Chen, YZ; Bogema, DR; Barchia, IM; Herron, GA				Chen, Yizhou; Bogema, Daniel R.; Barchia, Idris M.; Herron, Grant A.			Quantification of the Pirimicarb Resistance Allele Frequency in Pooled Cotton Aphid (Aphis gossypii Glover) Samples by TaqMan SNP Genotyping Assay	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; SINGLE-NUCLEOTIDE POLYMORPHISMS; CONFERS INSECTICIDE RESISTANCE; HIGH-THROUGHPUT; DNA; VALIDATION; DROSOPHILA; HEMIPTERA; KINETICS	Background: Pesticide resistance monitoring is a crucial part to achieving sustainable integrated pest management (IPM) in agricultural production systems. Monitoring of resistance in arthropod populations is initially performed by bioassay, a method that detects a phenotypic response to pesticides. Molecular diagnostic assays, offering speed and cost improvements, can be developed when the causative mutation for resistance has been identified. However, improvements to throughput are limited as genotyping methods cannot be accurately applied to pooled DNA. Quantifying an allele frequency from pooled DNA would allow faster and cheaper monitoring of pesticide resistance. Methodology/Principal Findings: We demonstrate a new method to quantify a resistance allele frequency (RAF) from pooled insects via TaqMan assay by using raw fluorescence data to calculate the transformed fluorescence ratio k' at the inflexion point based on a four parameter sigmoid curve. Our results show that k' is reproducible and highly correlated with RAF (r>0.99). We also demonstrate that k' has a non-linear relationship with RAF and that five standard points are sufficient to build a prediction model. Additionally, we identified a non-linear relationship between runs for k', allowing the combination of samples across multiple runs in a single analysis. Conclusions/Significance: The transformed fluorescence ratio (k') method can be used to monitor pesticide resistance in IPM and to accurately quantify allele frequency from pooled samples. We have determined that five standards (0.0, 0.2, 0.5, 0.8, and 1.0) are sufficient for accurate prediction and are statistically-equivalent to the 13 standard points used experimentally	[Chen, Yizhou; Bogema, Daniel R.; Barchia, Idris M.; Herron, Grant A.] NSW Dept Primary Ind, Elizabeth Macarthur Agr Inst, Menangle, NSW, Australia	NSW Department of Primary Industries	Chen, YZ (corresponding author), NSW Dept Primary Ind, Elizabeth Macarthur Agr Inst, Menangle, NSW, Australia.	yizhou.chen@dpi.nsw.gov.au	Chen, Yizhou/K-7095-2012; Bogema, Daniel/ABE-8287-2020; Bogema, Daniel/B-4629-2011; Bogema, Daniel/AAE-2935-2020; Herron, Grant Alexander/H-4413-2012	Chen, Yizhou/0000-0002-1273-0348; Bogema, Daniel/0000-0001-7013-7326; Bogema, Daniel/0000-0001-7013-7326; Bogema, Daniel/0000-0001-7013-7326; Herron, Grant Alexander/0000-0002-9104-6535	CRDC [DAN1203]	CRDC(Cotton R&D Corp)	This study is funded by the CRDC (DAN1203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews MC, 2004, INSECT MOL BIOL, V13, P555, DOI 10.1111/j.0962-1075.2004.00517.x; Bar T, 2012, NUCLEIC ACIDS RES, V40, P1395, DOI 10.1093/nar/gkr778; BARBAGALLO S., 1997, APHIDS PRINCIPAL FRU; Billard A, 2012, APPL ENVIRON MICROB, V78, P1063, DOI 10.1128/AEM.06957-11; Breen G, 2000, BIOTECHNIQUES, V28, P464, DOI 10.2144/00283st03; Busvine J.R., 1971, CRITICAL REV TECHNIQ; Carr AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037640; Chen J, 2002, CANCER EPIDEM BIOMAR, V11, P131; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; FFRENCHCONSTANT RH, 1993, NATURE, V363, P449, DOI 10.1038/363449a0; FFRENCHCONSTANT RH, 1991, PESTICIDE RESISTANCE, P4; Georghiou G. P., 1983, Pest resistance to pesticides, P1; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; Herron GA, 2001, AUST J ENTOMOL, V40, P85, DOI 10.1046/j.1440-6055.2001.00200.x; Johnson MP, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh046; Karlen Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-131; Liu WH, 2002, BIOCHEM BIOPH RES CO, V294, P347, DOI 10.1016/S0006-291X(02)00478-3; Mass S, 2012, COTTON PEST MANAGEME; McLoon MO, 2009, AUST J ENTOMOL, V48, P65, DOI 10.1111/j.1440-6055.2008.00685.x; Newcomb RD, 1997, P NATL ACAD SCI USA, V94, P7464, DOI 10.1073/pnas.94.14.7464; Oliver DH, 2000, J MOL DIAGN, V2, P202, DOI 10.1016/S1525-1578(10)60638-1; PAYNE RW, 2007, GENSTAT RELEASE 10 R; Psifidi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014560; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rutledge RG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh177; Spiess AN, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-221; Swillens S, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh053; Toda S, 2004, INSECT MOL BIOL, V13, P549, DOI 10.1111/j.0962-1075.2004.00513.x; Weill M, 2002, P ROY SOC B-BIOL SCI, V269, P2007, DOI 10.1098/rspb.2002.2122; Yu AR, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-143; Yu S., 2008, TOXICOLOGY BIOCH INS, DOI 10.1201/9781420059762	31	104	104	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91104	10.1371/journal.pone.0091104	http://dx.doi.org/10.1371/journal.pone.0091104			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614533	gold, Green Published, Green Submitted			2022-12-25	WOS:000332839300075
J	Kraaijenbrink, T; van der Gaag, KJ; Zuniga, SB; Xue, YL; Carvalho-Silva, DR; Tyler-Smith, C; Jobling, MA; Parkin, EJ; Su, B; Shi, H; Xiao, CJ; Tang, WR; Kashyap, VK; Trivedi, R; Sitalaximi, T; Banerjee, J; Gaselo, KTO; Tuladhar, NM; Opgenort, JRML; van Driem, GL; Barbujani, G; de Knijff, P				Kraaijenbrink, Thirsa; van der Gaag, Kristiaan J.; Zuniga, Sofia B.; Xue, Yali; Carvalho-Silva, Denise R.; Tyler-Smith, Chris; Jobling, Mark A.; Parkin, Emma J.; Su, Bing; Shi, Hong; Xiao, Chun-Jie; Tang, Wen-Ru; Kashyap, V. K.; Trivedi, R.; Sitalaximi, T.; Banerjee, Jheelam; Gaselo, Karma Tshering Of; Tuladhar, Nirmal M.; Opgenort, Jean-Robert M. L.; van Driem, George L.; Barbujani, Guido; de Knijff, Peter			A Linguistically Informed Autosomal STR Survey of Human Populations Residing in the Greater Himalayan Region	PLOS ONE			English	Article							ALLELE FREQUENCY-DISTRIBUTION; TIBETO-BURMAN POPULATIONS; MULTILOCUS GENOTYPE DATA; GENETIC-STRUCTURE; DIVERSITY; LOCI; INFERENCE; INDIA; SOUTH; SOFTWARE	The greater Himalayan region demarcates two of the most prominent linguistic phyla in Asia: Tibeto-Burman and Indo-European. Previous genetic surveys, mainly using Y-chromosome polymorphisms and/or mitochondrial DNA polymorphisms suggested a substantially reduced geneflow between populations belonging to these two phyla. These studies, however, have mainly focussed on populations residing far to the north and/or south of this mountain range, and have not been able to study geneflow patterns within the greater Himalayan region itself. We now report a detailed, linguistically informed, genetic survey of Tibeto-Burman and Indo-European speakers from the Himalayan countries Nepal and Bhutan based on autosomal microsatellite markers and compare these populations with surrounding regions. The genetic differentiation between populations within the Himalayas seems to be much higher than between populations in the neighbouring countries. We also observe a remarkable genetic differentiation between the Tibeto-Burman speaking populations on the one hand and Indo-European speaking populations on the other, suggesting that language and geography have played an equally large role in defining the genetic composition of present-day populations within the Himalayas.	[Kraaijenbrink, Thirsa; van der Gaag, Kristiaan J.; Zuniga, Sofia B.; de Knijff, Peter] Leiden Univ, Med Ctr, MGC Dept Human & Clin Genet, Leiden, Netherlands; [Xue, Yali; Carvalho-Silva, Denise R.; Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Jobling, Mark A.; Parkin, Emma J.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Su, Bing; Shi, Hong] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Su, Bing; Shi, Hong] Chinese Acad Sci, Kunming Primate Res Ctr, Kunming, Yunnan, Peoples R China; [Xiao, Chun-Jie; Tang, Wen-Ru] Yunnan Univ, Ctr Human Genet, Kunming, Yunnan, Peoples R China; [Kashyap, V. K.; Trivedi, R.; Sitalaximi, T.; Banerjee, Jheelam] Cent Forens Sci Lab, Natl DNA Anal Ctr, Kolkata, India; [Gaselo, Karma Tshering Of; Opgenort, Jean-Robert M. L.; van Driem, George L.] Univ Bern, Sprachwissensch Inst, Himalayan Languages Project, Bern, Switzerland; [Tuladhar, Nirmal M.] Tribhuvan Univ, Ctr Nepal & Asian Studies, Kirtipur, Nepal; [Barbujani, Guido] Univ Ferrara, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Wellcome Trust Sanger Institute; University of Leicester; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Yunnan University; University of Bern; Tribhuvan University; University of Ferrara	de Knijff, P (corresponding author), Leiden Univ, Med Ctr, MGC Dept Human & Clin Genet, Leiden, Netherlands.	knijff@lumc.nl	de Knijff, Peter/Y-2519-2018; Barbujani, Guido/ABE-9998-2020	de Knijff, Peter/0000-0002-0899-771X; Barbujani, Guido/0000-0001-7854-6669; Kraaijenbrink, Thirsa/0000-0002-1771-8401; van Driem, George/0000-0002-7185-0657; Carvalho-Silva, Dr D/0000-0001-5662-1840; Jobling, Mark/0000-0002-8061-1308; van der Gaag, Kristiaan/0000-0001-7976-1977	NWO (Netherlands Organisation for Scientific Research) [231-70-001]; Arts and Humanities Research Board of Great Britain [AN/9585/APN15314]; EC Sixth Framework Programme [ERAS-CT-2003-980409]; Wellcome Trust [WT 098051]; MAJ by a Wellcome Trust Senior Fellowship in Basic Biomedical Science [WT 087576]	NWO (Netherlands Organisation for Scientific Research)(Netherlands Organization for Scientific Research (NWO)); Arts and Humanities Research Board of Great Britain; EC Sixth Framework Programme(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome TrustEuropean Commission); MAJ by a Wellcome Trust Senior Fellowship in Basic Biomedical Science	This work, as part of the European Science Foundation EUROCORES Programme OMLL, was supported by funds from NWO (Netherlands Organisation for Scientific Research, grant no. 231-70-001), the Arts and Humanities Research Board of Great Britain (grant no. AN/9585/APN15314) and the EC Sixth Framework Programme (Contract no. ERAS-CT-2003-980409). YX and CTS are supported by The Wellcome Trust (WT 098051), and MAJ by a Wellcome Trust Senior Fellowship in Basic Biomedical Science (WT 087576). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, GRAPHPAD PRISM 6; Bertoni B., 2014, ADMIX95; Bindu GH, 2007, FORENSIC SCI INT, V170, P76, DOI 10.1016/j.forsciint.2006.04.012; Bindu GH, 2005, J FORENSIC SCI, V50, P978; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Bosch E, 2000, EUR J HUM GENET, V8, P360, DOI 10.1038/sj.ejhg.5200464; Cai XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024282; Cann HM, 2002, SCIENCE, V296, P261; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza LL, 2005, NAT REV GENET, V6, P333, DOI 10.1038/nrg1579; Chatterji SK, 1926, ORGIN DEV BEGALI LAN; Cordaux R, 2004, MOL BIOL EVOL, V21, P1525, DOI 10.1093/molbev/msh151; Corunet JM, 1996, GENETICS; Duchesne P, 2009, MOL ECOL RESOUR, V9, P1333, DOI 10.1111/j.1755-0998.2009.02571.x; Duchesne P, 2012, J HERED, V103, P734, DOI 10.1093/jhered/ess038; Ersts PJ, 2014, GEOGRAPHIC DISTANCE; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Frasier TR, 2008, MOL ECOL RESOUR, V8, P1263, DOI 10.1111/j.1755-0998.2008.02358.x; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; Gaikwad S, 2003, FORENSIC SCI INT, V134, P225, DOI 10.1016/S0379-0738(03)00166-X; Gayden T, 2007, AM J HUM GENET, V80, P884, DOI 10.1086/516757; Gayden T, 2009, J HUM GENET, V54, P216, DOI 10.1038/jhg.2009.14; Gordon R. G., 2005, ETHNOLOGUE LANGUAGES, V15th; Greenhill SJ, 2010, P ROY SOC B-BIOL SCI, V277, P2443, DOI 10.1098/rspb.2010.0051; Hoernle August Friedrich Rudolf, 1880, COMP GRAMMAR GAUDIAN; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hunley KL, 2009, AM J PHYS ANTHROPOL, V139, P35, DOI 10.1002/ajpa.20932; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Joshi DM, 1975, INDIAN LINGUISTICS, V36, P285; Kang LL, 2012, ANN HUM GENET, V76, P92, DOI 10.1111/j.1469-1809.2011.00690.x; Kashyap VK, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-28; Kashyap VK, 2004, J GENET, V83, P49, DOI 10.1007/BF02715829; Kayser M, 2001, AM J HUM GENET, V68, P990, DOI 10.1086/319510; Kraaijenbrink T, 2007, FORENSIC SCI INT, V168, P227, DOI 10.1016/j.forsciint.2006.02.014; Kraaijenbrink T, 2007, FORENSIC SCI INT, V170, P68, DOI 10.1016/j.forsciint.2006.04.006; Kraaijenbrink T, 2009, BECOMING ELOQUENT: ADVANCES IN THE EMERGENCE OF LANGUAGE, HUMAN COGNITION, AND MODERN CULTURES, P181; Kraaijenbrink T, 2008, FORENSIC SCI INT-GEN, V3, pE11, DOI 10.1016/j.fsigen.2008.02.007; Krithika S, 2006, ANN HUM BIOL, V33, P26, DOI 10.1080/03014460500424043; Lee AC, 2004, EUR J HUM GENET, V12, P1077, DOI 10.1038/sj.ejhg.5201271; LI CC, 1993, HUM HERED, V43, P45, DOI 10.1159/000154113; Majumdar PC, 1979, HIST PHONOLOGY ORIYA; Majumder PP, 2008, CURR OPIN GENET DEV, V18, P280, DOI 10.1016/j.gde.2008.07.003; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Martinez-Cruz B, 2011, EUR J HUM GENET, V19, P216, DOI 10.1038/ejhg.2010.153; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Neeta S, 2004, J FORENSIC SCI, V49, P184; Number Cruncher Statistical Software, 1997, US GUID 1 NCSS97 STA; Pandit P.B., 1954, INDIAN LINGUISTICS, V14, P36; PANDIT PB, 1961, LANGUAGE, V37, P54, DOI 10.2307/411249; Pandit PB, 1955, INDIAN LINGUISTICS, V17, P165; Park S.D.E., 2001, TRYPANOTOLERANCE W A; Pattanayak DP, 1966, CONTROLLED HIST RECO; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; Quintana-Murci L, 2001, AM J HUM GENET, V68, P537, DOI 10.1086/318200; Rajkumar R, 2003, AM J FOREN MED PATH, V24, P187, DOI 10.1097/00000433-200306000-00018; Rousset F, 1997, GENETICS, V145, P1219; Shepard EM, 2006, J HUM GENET, V51, P467, DOI 10.1007/s10038-006-0387-4; Shi H, 2005, AM J HUM GENET, V77, P408, DOI 10.1086/444436; Turner R. L., 1921, J ROY ASIATIC SOC, P329; Turner Ralph Lilley, 1931, COMP ETYMOLOGICAL DI; Turner RL, 1914, J ROY ASIATIC SOC, V1914, P1033; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; Zerjal T, 2002, AM J HUM GENET, V71, P466, DOI 10.1086/342096	67	16	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91534	10.1371/journal.pone.0091534	http://dx.doi.org/10.1371/journal.pone.0091534			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614536	gold, Green Submitted, Green Published			2022-12-25	WOS:000332839300135
J	Ng, HY; Yisireyili, M; Saito, S; Lee, CT; Adelibieke, Y; Nishijima, F; Niwa, T				Ng, Hwee-Yeong; Yisireyili, Maimaiti; Saito, Shinichi; Lee, Chien-Te; Adelibieke, Yelixiati; Nishijima, Fuyuhiko; Niwa, Toshimitsu			Indoxyl Sulfate Downregulates Expression of Mas Receptor via OAT3/AhR/Stat3 Pathway in Proximal Tubular Cells	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; CONVERTING ENZYME 2; GENE-EXPRESSION; NITRIC-OXIDE; ANGIOTENSIN-II; PROGRESSION; SENESCENCE; KIDNEY; ACE2; DYSFUNCTION	Renin-angiotensin system (RAS) plays a pivotal role in chronic kidney disease (CKD). Angiotensin converting enzyme-related carboxypeptidase 2 (ACE2)/angiotensin (Ang)-(1-7)/Mas receptor axis counteracts the deleterious actions of Ang II. ACE2 exerts its actions by cleaving Ang II into Ang-(1-7) which activates Mas receptor. This study aimed to determine if the expression of Mas receptor is altered in the kidneys of CKD rats, and if indoxyl sulfate (IS), a uremic toxin, affects the expression of Mas receptor in rat kidneys and cultured human proximal tubular cells (HK-2 cells). The expression of Mas receptor was examined in the kidneys of CKD and AST-120-treated CKD rats using immunohistochemistry. Further, the effects of IS on Mas receptor expression in the kidneys of normotensive and hypertensive rats were examined. The effects of IS on the expression of Mas receptor and phosphorylation of endothelial nitric oxide synthase (eNOS) in HK-2 cells were examined using immunoblotting. CKD rats showed reduced renal expression of Mas receptor, while AST-120 restored its expression. Administration of IS downregulated Mas receptor expression in the kidneys of normotensive and hypertensive rats. IS downregulated Mas receptor expression in HK-2 cells in a time-and dose-dependent manner. Knockdown of organic anion transporter 3 (OAT3), aryl hydrocarbon receptor (AhR), and signal transducer and activator of transcription 3 (Stat3) inhibited IS-induced downregulation of Mas receptor and phosphorylated eNOS. N-acetylcysteine, an antioxidant, also inhibited IS-induced downregulation of Mas receptor and phosphorylated eNOS. Ang-(1-7) attenuated IS-induced transforming growth factor-beta 1 (TGF-beta 1) expression. Conclusion: Mas receptor expression is reduced in the kidneys of CKD rats. IS downregulates renal expression of Mas receptor via OAT3/AhR/Stat3 pathway in proximal tubular cells. IS-induced downregulation of Mas receptor might be involved in upregulation of TGF-beta 1 in proximal tubular cells.	[Ng, Hwee-Yeong; Yisireyili, Maimaiti; Saito, Shinichi; Adelibieke, Yelixiati; Niwa, Toshimitsu] Nagoya Univ, Grad Sch Med, Dept Adv Med Uremia, Nagoya, Aichi 4648601, Japan; [Ng, Hwee-Yeong; Lee, Chien-Te] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan; [Ng, Hwee-Yeong; Lee, Chien-Te] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Nishijima, Fuyuhiko] Kureha Co, Biomed Res Labs, Tokyo, Japan	Nagoya University; Chang Gung Memorial Hospital; Chang Gung University	Niwa, T (corresponding author), Nagoya Univ, Grad Sch Med, Dept Adv Med Uremia, Nagoya, Aichi 4648601, Japan.	tniwa@med.nagoya-u.ac.jp			Aichi Kidney Foundation; Kureha Corporation, Japan	Aichi Kidney Foundation; Kureha Corporation, Japan	This work was supported by the research grant from Aichi Kidney Foundation, and a grant from Kureha Corporation, Japan. The funder provided support in the form of salaries for FN, but did not have additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of these authors are articulated in the 'author contributions' section.	Adijiang A, 2011, J RENAL NUTR, V21, P105, DOI 10.1053/j.jrn.2010.10.020; Bolati D, 2012, J RENAL NUTR, V22, P176, DOI 10.1053/j.jrn.2011.10.015; Pinheiro SVB, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/414128; de Godoy MAF, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/121740; Enomoto A, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022017.96399.B2; Esteban V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005406; Gondouin B, 2013, KIDNEY INT, V84, P733, DOI 10.1038/ki.2013.133; Hankinson O, 2005, ARCH BIOCHEM BIOPHYS, V433, P379, DOI 10.1016/j.abb.2004.09.031; Hayashi T, 2006, P NATL ACAD SCI USA, V103, P17018, DOI 10.1073/pnas.0607873103; Ishimura T, 2002, TRANSPLANT INT, V15, P635, DOI 10.1007/s00147-002-0473-2; Soler MJ, 2013, NEPHROL DIAL TRANSPL, V28, P2687, DOI 10.1093/ndt/gft320; Katovich MJ, 2008, CURR HYPERTENS REP, V10, P227, DOI 10.1007/s11906-008-0043-9; Koka V, 2008, AM J PATHOL, V172, P1174, DOI 10.2353/ajpath.2008.070762; Li YW, 2009, HYPERTENS RES, V32, P369, DOI 10.1038/hr.2009.25; Manucha W, 2004, KIDNEY INT, V65, P2091, DOI 10.1111/j.1523-1755.2004.00643.x; Miyazaki T, 2000, NEPHROL DIAL TRANSPL, V15, P1773, DOI 10.1093/ndt/15.11.1773; Nadarajah R, 2012, KIDNEY INT, V82, P292, DOI 10.1038/ki.2012.83; Ng HY, 2011, AM J NEPHROL, V34, P55, DOI 10.1159/000328742; Niwa T, 1997, KIDNEY INT, V52, pS23; NIWA T, 1994, J LAB CLIN MED, V124, P96; Niwa T, 2010, J RENAL NUTR, V20, pS2, DOI 10.1053/j.jrn.2010.05.002; Palm F, 2010, AM J PHYSIOL-RENAL, V299, pF380, DOI 10.1152/ajprenal.00175.2010; Patel RD, 2009, LAB INVEST, V89, P695, DOI 10.1038/labinvest.2009.24; Pinheiro SVB, 2009, KIDNEY INT, V75, P1184, DOI 10.1038/ki.2009.61; Plato CF, 2000, HYPERTENSION, V35, P319, DOI 10.1161/01.HYP.35.1.319; Quintana FJ, 2013, IMMUNOLOGY, V138, P183, DOI 10.1111/imm.12046; RAIJ L, 1995, KIDNEY INT, V48, P20, DOI 10.1038/ki.1995.262; Ruster C, 2006, J AM SOC NEPHROL, V17, P2985, DOI 10.1681/ASN.2006040356; Santos RAS, 2013, J ENDOCRINOL, V216, pR1, DOI 10.1530/JOE-12-0341; Shimizu H, 2013, AM J PHYSIOL-CELL PH, V304, pC685, DOI 10.1152/ajpcell.00236.2012; Shimizu H, 2012, AM J NEPHROL, V36, P184, DOI 10.1159/000341515; Shimizu H, 2010, AM J PHYSIOL-CELL PH, V299, pC1110, DOI 10.1152/ajpcell.00217.2010; Silva ACSE, 2013, BRIT J PHARMACOL, V169, P477, DOI 10.1111/bph.12159; Sun CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034026; Tassone EJ, 2013, CARDIOVASC RES, V99, P129, DOI 10.1093/cvr/cvt065; Velkoska E, 2011, CLIN SCI, V120, P335, DOI 10.1042/CS20100280; Wang H, 2002, HYPERTENSION, V39, P662, DOI 10.1161/hy0202.103470	37	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91517	10.1371/journal.pone.0091517	http://dx.doi.org/10.1371/journal.pone.0091517			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614509	gold, Green Published, Green Submitted			2022-12-25	WOS:000332839300134
J	Unates, DR; Guidobaldi, HA; Gatica, LV; Cubilla, MA; Teves, ME; Moreno, A; Giojalas, LC				Rafael Unates, Diego; Alejandro Guidobaldi, Hector; Virginia Gatica, Laura; Angelica Cubilla, Marisa; Eugenia Teves, Maria; Moreno, Ayelen; Cecilia Giojalas, Laura			Versatile Action of Picomolar Gradients of Progesterone on Different Sperm Subpopulations	PLOS ONE			English	Article							CAPACITATED HUMAN SPERMATOZOA; IN-VITRO FERTILIZATION; ACROSOME REACTION; ZONA-PELLUCIDA; MOUSE SPERMATOZOA; CALCIUM-CHANNELS; FOLLICULAR-FLUID; CUMULUS CELLS; OOCYTE; ACTIVATION	High step concentrations of progesterone may stimulate various sperm physiological processes, such as priming and the acrosome reaction. However, approaching the egg, spermatozoa face increasing concentrations of the hormone, as it is secreted by the cumulus cells and then passively diffuses along the cumulus matrix and beyond. In this context, several questions arise: are spermatozoa sensitive to the steroid gradients as they undergo priming and the acrosome reaction? If so, what are the functional gradual concentrations of progesterone? Do spermatozoa in different physiological states respond differentially to steroid gradients? To answer these questions, spermatozoa were confronted with progesterone gradients generated by different hormone concentrations (1 pM to 100 mu M). Brief exposure to a 10 pM progesterone gradient stimulated priming for the acrosome reaction in one sperm subpopulation, and simultaneously induced the acrosome reaction in a different sperm subpopulation. This effect was not observed in non-capacitated cells or when progesterone was homogeneously distributed. The results suggest a versatile role of the gradual distribution of very low doses of progesterone, which selectively stimulate the priming and the acrosome reaction in different sperm subpopulations.	[Cecilia Giojalas, Laura] Ctr Biol Celular & Mol UNC, Cordoba, Argentina; Inst Invest Biol & Tecnol UNC CONICET, Cordoba, Argentina		Giojalas, LC (corresponding author), Ctr Biol Celular & Mol UNC, Cordoba, Argentina.	lcgiojalas@com.uncor.edu	Teves, Maria/AAJ-9523-2020; Guidobaldi, Héctor Alejandro/K-6724-2017	Teves, Maria/0000-0001-7035-2202; Guidobaldi, Héctor Alejandro/0000-0002-5033-2981; Moreno, Ayelen/0000-0001-6810-6475; Giojalas, Laura/0000-0002-1036-1251; Cubilla, Marisa Angelica/0000-0002-9862-8933	Fondo para la Investigacion Cientifica y Tecnologica; Consejo Nacional de Investigaciones Cientificas y Tecnicas from Argentina; Universidad Nacional de Cordoba [38062-2005]	Fondo para la Investigacion Cientifica y Tecnologica; Consejo Nacional de Investigaciones Cientificas y Tecnicas from Argentina; Universidad Nacional de Cordoba	Fondo para la Investigacion Cientifica y Tecnologica, #38062-2005 by Universidad Nacional de Cordoba and Consejo Nacional de Investigaciones Cientificas y Tecnicas from Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Haila A, 2003, HISTOCHEM CELL BIOL, V119, P179, DOI 10.1007/s00418-003-0504-9; Aitken R J, 2007, Soc Reprod Fertil Suppl, V63, P273; Aitken RJ, 2013, MOL HUM REPROD, V19, P785, DOI 10.1093/molehr/gat067; Alasmari W, 2013, J BIOL CHEM, V288, P6248, DOI 10.1074/jbc.M112.439356; Guidobaldi HA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003040; Avella MA, 2013, MOL HUM REPROD, V19, P279, DOI 10.1093/molehr/gat004; BALDI E, 1991, J ANDROL, V12, P323; Baldi E, 2009, MOL CELL ENDOCRINOL, V308, P39, DOI 10.1016/j.mce.2009.02.006; Blengini CS, 2011, ASIAN J ANDROL, V13, P769, DOI 10.1038/aja.2011.27; Bonaccorsi L, 2001, INT J ANDROL, V24, P341, DOI 10.1046/j.1365-2605.2001.00313.x; Bronson RA, 1999, MOL HUM REPROD, V5, P507, DOI 10.1093/molehr/5.6.507; CARDULLO RA, 2002, FERTILIZATION, P57; CarverWard JA, 1996, HUM REPROD, V11, P121; COHENDAYAG A, 1995, P NATL ACAD SCI USA, V92, P11039, DOI 10.1073/pnas.92.24.11039; Costello S, 2009, REPRODUCTION, V138, P425, DOI 10.1530/REP-09-0134; Darszon A, 2011, PHYSIOL REV, V91, P1305, DOI 10.1152/physrev.00028.2010; DASGUPTA S, 1994, HUM REPROD, V9, P2103, DOI 10.1093/oxfordjournals.humrep.a138400; de Lamirande E, 1998, J ANDROL, V19, P215; Eisenbach M, 2006, NAT REV MOL CELL BIO, V7, P276, DOI 10.1038/nrm1893; Eisenbach M, 1999, REV REPROD, V4, P56, DOI 10.1530/revreprod/4.1.56; Emiliozzi C, 1996, INT J ANDROL, V19, P39, DOI 10.1111/j.1365-2605.1996.tb00433.x; Teves ME, 2010, FERTIL STERIL, V93, P2450, DOI 10.1016/j.fertnstert.2009.09.012; Fabro G, 2002, BIOL REPROD, V67, P1565, DOI 10.1095/biolreprod.102.006395; Familiari G, 1996, MOL REPROD DEV, V43, P392, DOI 10.1002/(SICI)1098-2795(199603)43:3<392::AID-MRD14>3.0.CO;2-3; FORESTA C, 1992, ANDROLOGIA, V24, P33; Francavilla F, 2002, INT J ANDROL, V25, P106, DOI 10.1046/j.1365-2605.2002.00333.x; Garcia MA, 1999, J ANDROL, V20, P88; Gatica LV, 2013, MOL HUM REPROD, V19, P559, DOI 10.1093/molehr/gat037; Giojalas LC, 2004, FERTIL STERIL, V82, P247, DOI 10.1016/j.fertnstert.2003.11.046; Harper CV, 2005, HUM REPROD, V20, P2675, DOI 10.1093/humrep/dei158; Harper CV, 2004, J BIOL CHEM, V279, P46315, DOI 10.1074/jbc.M401194200; Inoue N, 2011, P NATL ACAD SCI USA, V108, P20008, DOI 10.1073/pnas.1116965108; Jin M, 2011, P NATL ACAD SCI USA, V108, P4892, DOI 10.1073/pnas.1018202108; KAY VJ, 1994, HUM REPROD, V9, P2318, DOI 10.1093/oxfordjournals.humrep.a138445; Keenan TM, 2008, LAB CHIP, V8, P34, DOI 10.1039/b711887b; Kirkman-Brown JC, 2000, DEV BIOL, V222, P326, DOI 10.1006/dbio.2000.9729; Larson JL, 1999, MOL REPROD DEV, V52, P445, DOI 10.1002/(SICI)1098-2795(199904)52:4&lt;445::AID-MRD14&gt;3.0.CO;2-6; Lishko PV, 2011, NATURE, V471, P387, DOI 10.1038/nature09767; Nishigaki T, 2006, BIOTECHNIQUES, V41, P191, DOI 10.2144/000112220; Oren-Benaroya R, 2007, HUM REPROD, V22, P2947, DOI 10.1093/humrep/dem273; OSMAN RA, 1989, BIOCHEM BIOPH RES CO, V160, P828, DOI 10.1016/0006-291X(89)92508-4; Park KH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001595; Ren DJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002102; ROLDAN ERS, 1994, SCIENCE, V266, P1578, DOI 10.1126/science.7985030; SABEUR K, 1995, J ANDROL, V16, P266; Sabeur K, 1996, BIOL REPROD, V54, P993, DOI 10.1095/biolreprod54.5.993; Sagare-Patil V, 2012, INT J ANDROL, V35, P633, DOI 10.1111/j.1365-2605.2012.01291.x; Schuffner AA, 2002, MOL HUM REPROD, V8, P722, DOI 10.1093/molehr/8.8.722; Strunker T, 2011, NATURE, V471, P382, DOI 10.1038/nature09769; SUELDO CE, 1993, FERTIL STERIL, V60, P137; TESARIK J, 1988, FERTIL STERIL, V50, P133; TESARIK J, 1990, DEVELOPMENT, V110, P391; Tesarik J, 1996, MOL HUM REPROD, V2, P225, DOI 10.1093/molehr/2.4.225; Teves ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008211; Teves ME, 2006, FERTIL STERIL, V86, P745, DOI 10.1016/j.fertnstert.2006.02.080; Thundathil J, 2002, MOL HUM REPROD, V8, P811, DOI 10.1093/molehr/8.9.811; Tsai PS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011204; UHLER ML, 1992, FERTIL STERIL, V58, P1191; VANDERHYDEN BC, 1995, BIOL REPROD, V53, P1243, DOI 10.1095/biolreprod53.6.1243; Wassarman PM, 2008, J BIOL CHEM, V283, P24285, DOI 10.1074/jbc.R800027200; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Yamashita Y, 2003, BIOL REPROD, V68, P1193, DOI 10.1095/biolreprod.102.010934; Yanagimachi R, 1994, PHYSL REPRODUCTION, V1, P189	63	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91181	10.1371/journal.pone.0091181	http://dx.doi.org/10.1371/journal.pone.0091181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614230	Green Published, gold, Green Submitted			2022-12-25	WOS:000332839300091
J	Wiley, L; Ashok, D; Martin-Ruiz, C; Talbot, DCS; Collerton, J; Kingston, A; Davies, K; Chinnery, PF; Catt, M; Jagger, C; Kirkwood, TBL; von Zglinicki, T				Wiley, Laura; Ashok, Deepthi; Martin-Ruiz, Carmen; Talbot, Duncan C. S.; Collerton, Joanna; Kingston, Andrew; Davies, Karen; Chinnery, Patrick F.; Catt, Michael; Jagger, Carol; Kirkwood, Thomas B. L.; von Zglinicki, Thomas			Reactive Oxygen Species Production and Mitochondrial Dysfunction in White Blood Cells Are Not Valid Biomarkers of Ageing in the Very Old	PLOS ONE			English	Article							PERMEABILITY TRANSITION; OXIDATIVE STRESS; SENESCENCE; DAMAGE; DNA; DISEASE; ONSET; RATS	Reliable and valid biomarkers of ageing (BoA) are needed to understand mechanisms, test interventions and predict the timing of adverse health events associated with ageing. Since increased reactive oxygen species (ROS) production and mitochondrial dysfunction are consequences of cellular senescence and may contribute causally to the ageing of organisms, we focused on these parameters as candidate BoA. Superoxide levels, mitochondrial mass and mitochondrial membrane potential in human peripheral blood mononuclear cells (PBMCs) and subpopulations (lymphocytes and monocytes) were measured in participants from the Newcastle 85+ study, a population-based study of the very old (aged 85 years and older). The intra-and inter-assay precision expressed as coefficient of variation (CV) for all parameters was acceptable (3% to 12% and 5 to 22% respectively). All parameters were stable in the short-term (1 week interval) in a sample of control individuals in the PBMCs and lymphocyte subpopulation, however they were unstable in the monocyte subpopulation; this rendered monocytes unreliable for further analysis. There was a significant association between superoxide levels and mitochondrial mass (positive in lymphocytes, p = 0.01) and between superoxide levels and mitochondrial membrane potential (negative in PBMCs, p = 0.01; positive in lymphocytes, p = 0.05). There were also significant associations between superoxide levels and mitochondrial parameters with other markers of oxidative stress-induced cellular senescence (p <= 0.04), however some were in the opposite direction to expected. No associations were found between the measured parameters and age-related outcomes, including cognitive impairment, disability, co-morbidity and survival - questioning the validity of these parameters as candidate BoA in the very old.	[Wiley, Laura; Ashok, Deepthi; Martin-Ruiz, Carmen; Collerton, Joanna; Kingston, Andrew; Davies, Karen; Catt, Michael; Jagger, Carol; Kirkwood, Thomas B. L.; von Zglinicki, Thomas] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Talbot, Duncan C. S.] Colworth Sci Pk, Unilever Discover, Sharnbrook, Beds, England; [Chinnery, Patrick F.] Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Unilever; Newcastle University - UK	von Zglinicki, T (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Campus Ageing & Vital, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	t.vonzglinicki@newcastle.ac.uk		Chinnery, Patrick/0000-0002-7065-6617; Martin-Ruiz, Carmen/0000-0002-3361-6974; von Zglinicki, Thomas/0000-0002-5939-0248; Kingston, Andrew/0000-0003-4211-7007; Catt, Michael/0000-0003-0935-7973; Davies, Karen/0000-0002-2820-9397; Ashok, Deepthi/0000-0003-0252-4716; Jagger, Carol/0000-0002-6377-9926; Wiley, Laura/0000-0001-9619-4484	Medical Research Council [G0500997]; MRC/Unilever grant [G0601333]; Unilever/BBSRC CASE studentship [BH092279]; Dunhill Medical Trust grant [R124/0509]; National Institute for Health Research Newcastle Biomedical Research Centre; Biomedical Research Unit based at Newcastle Hospitals NHS Foundation Trust; Newcastle University; MRC [G0601333, MR/K000608/1, MR/K006312/1, G0500997, MR/J50001X/1] Funding Source: UKRI; Medical Research Council [MR/K006312/1, G0601333, MR/J50001X/1, MR/K000608/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC/Unilever grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Unilever/BBSRC CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Dunhill Medical Trust grant(Dunhill Medical Trust); National Institute for Health Research Newcastle Biomedical Research Centre; Biomedical Research Unit based at Newcastle Hospitals NHS Foundation Trust; Newcastle University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the Medical Research Council grant G0500997, MRC/Unilever grant G0601333, Unilever/BBSRC CASE studentship BH092279, the Dunhill Medical Trust grant R124/0509 and by the National Institute for Health Research Newcastle Biomedical Research Centre and Biomedical Research Unit based at Newcastle Hospitals NHS Foundation Trust and Newcastle University. The funder provided support in the form of salaries/stipend for authors DCST and LW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Ackermann K, 2012, SLEEP, V35, P933, DOI 10.5665/sleep.1954; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Batandier C, 2004, J BIOL CHEM, V279, P17197, DOI 10.1074/jbc.M310329200; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Chen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046473; Collerton J, 2012, MECH AGEING DEV; COLLERTON J, 2009, BMJ-BRIT MED J, V399, P1; Collerton J, 2007, BMC GERIATR, V7, P1, DOI DOI 10.1186/1471-2318-7-1; Collerton J, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.04.001; Davies K, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-64; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Fleisher TA, 2001, CURR PROTOC IMMUNOL, V7, DOI DOI 10.1002/0471142735.IM0707S08; Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425; Hagen TM, 1999, FASEB J, V13, P411, DOI 10.1096/fasebj.13.2.411; Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064; Houston DK, 2013, J GERONTOL A-BIOL, V68, P181, DOI 10.1093/gerona/gls136; Kirkwood TBL, 1998, EXP GERONTOL, V33, P135, DOI 10.1016/S0531-5565(97)00114-9; Kirkwood TBL, 2008, NATURE, V451, P644, DOI 10.1038/451644a; Kofler B, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-35; Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098; Litwin V, 2001, FLOW CYTOMETRY DRUG; Martin-Ruiz C, 2013, LIFE COURSE IN RPESS; Martin-Ruiz C, 2011, MECH AGEING DEV, V132, P496, DOI 10.1016/j.mad.2011.08.001; Mayeux Richard, 2004, NeuroRx, V1, P182, DOI 10.1602/neurorx.1.2.182; Meng JE, 2012, CANCER EPIDEM BIOMAR, V21, P916, DOI 10.1158/1055-9965.EPI-12-0026; Moiseeva O, 2009, MOL CELL BIOL, V29, P4495, DOI 10.1128/MCB.01868-08; Mueller EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052367; Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x; Nesselroade J. R., 2004, RES HUMAN DEV, V1, P9, DOI [DOI 10.1080/15427609.2004.9683328, 10.1207/s15427617rhd0101&2_3]; Office-for-National-Statistics, 2010, UK HLTH STAT 2010; Office-for-National-Statistics, 2011, UK INT LIF TABL 1980; Passes JF, 2007, BIOESSAYS, V29, P908, DOI 10.1002/bies.20634; Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Schwartz LM, 2001, METHOD CELL BIOL, V66, P82; Sprott RL, 2010, EXP GERONTOL, V45, P2, DOI 10.1016/j.exger.2009.07.008; Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x; van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; Wang CF, 2010, AGING-US, V2, P555, DOI 10.18632/aging.100196; Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x; Wolf C, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-8; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	46	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91005	10.1371/journal.pone.0091005	http://dx.doi.org/10.1371/journal.pone.0091005			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614678	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300062
J	Carciofo, R; Du, F; Song, N; Zhang, K				Carciofo, Richard; Du, Feng; Song, Nan; Zhang, Kan			Mind Wandering, Sleep Quality, Affect and Chronotype: An Exploratory Study	PLOS ONE			English	Article							DAYTIME SLEEPINESS; OLDER-ADULTS; CIRCADIAN PREFERENCE; MINDFULNESS; LIFE; CONSEQUENCES; PATTERNS; INSOMNIA; CHINESE; THOUGHT	Poor sleep quality impairs cognition, including executive functions and concentration, but there has been little direct research on the relationships between sleep quality and mind wandering or daydreaming. Evening chronotype is associated with poor sleep quality, more mind wandering and more daydreaming; negative affect is also a mutual correlate. This exploratory study investigated how mind wandering and daydreaming are related to different aspects of sleep quality, and whether sleep quality influences the relationships between mind wandering/daydreaming and negative affect, and mind wandering/daydreaming and chronotype. Three surveys (Ns = 213; 190; 270) were completed with Chinese adults aged 1850, including measures of sleep quality, daytime sleepiness, mind wandering, daydreaming, chronotype and affect (positive and negative). Higher frequencies of mind wandering and daydreaming were associated with poorer sleep quality, in particular with poor subjective sleep quality and increased sleep latency, night-time disturbance, daytime dysfunction and daytime sleepiness. Poor sleep quality was found to partially mediate the relationships between daydreaming and negative affect, and mind wandering and negative affect. Additionally, low positive affect and poor sleep quality, in conjunction, fully mediated the relationships between chronotype and mind wandering, and chronotype and daydreaming. The relationships between mind wandering/daydreaming and positive affect were also moderated by chronotype, being weaker in those with a morning preference. Finally, while daytime sleepiness was positively correlated with daydream frequency, it was negatively correlated with a measure of problem-solving daydreams, indicating that more refined distinctions between different forms of daydreaming or mind wandering are warranted. Overall, the evidence is suggestive of a bi-directional relationship between poor sleep quality and mind wandering/daydreaming, which may be important in attempts to deal with sleep problems and improve sleep quality. These findings and further research on this topic may also have implications for definitions and theories of mind wandering and daydreaming.	[Carciofo, Richard; Du, Feng; Zhang, Kan] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Carciofo, Richard] Chinese Acad Sci, Grad Univ, Coll Humanities & Social Sci, Beijing, Peoples R China; [Song, Nan] Beijing Foreign Studies Univ, Training Coll, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing Foreign Studies University	Du, F (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	duf@psych.ac.cn		Du, Feng/0000-0002-5900-8002	National Natural Science Foundation of China [31200766, 91124003]; Chinese Academy of Sciences [KJZD-EW-L04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by grants from the National Natural Science Foundation of China (No. 31200766 and 91124003) and the key project of the Chinese Academy of Sciences (KJZD-EW-L04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAN A, 1991, PERS INDIV DIFFER, V12, P241, DOI 10.1016/0191-8869(91)90110-W; Adan A, 2012, CHRONOBIOL INT, V29, P1153, DOI 10.3109/07420528.2012.719971; Akerstedt T, 2007, PHYSIOL BEHAV, V90, P209, DOI 10.1016/j.physbeh.2006.09.007; Alapin I, 2000, J PSYCHOSOM RES, V49, P381, DOI 10.1016/S0022-3999(00)00194-X; Alhola Paula, 2007, Neuropsychiatr Dis Treat, V3, P553; ANTROBUS JS, 1966, PERCEPT MOTOR SKILL, V23, P399, DOI 10.2466/pms.1966.23.2.399; Barclay NL, 2010, CHRONOBIOL INT, V27, P278, DOI 10.3109/07420521003663801; Biss RK, 2012, EMOTION, V12, P437, DOI 10.1037/a0027071; Bixler EO, 2005, J CLIN ENDOCR METAB, V90, P4510, DOI 10.1210/jc.2005-0035; Braboszcz C, 2011, NEUROIMAGE, V54, P3040, DOI 10.1016/j.neuroimage.2010.10.008; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Buysse DJ, 2008, J CLIN SLEEP MED, V4, P563; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carciofo R, 2014, BIOL RHYTHM RES, V45, P37, DOI 10.1080/09291016.2013.790651; Carciofo R, 2012, SLEEP BIOL RHYTHMS, V10, P310, DOI 10.1111/j.1479-8425.2012.00577.x; Cheng SH, 2012, PSYCHIAT RES, V197, P270, DOI 10.1016/j.psychres.2011.08.011; Chung KF, 2008, SLEEP, V31, P185, DOI 10.1093/sleep/31.2.185; Curcio G, 2006, SLEEP MED REV, V10, P323, DOI 10.1016/j.smrv.2005.11.001; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Fernandez-Mendoza J, 2010, SLEEP BIOL RHYTHMS, V8, P52, DOI 10.1111/j.1479-8425.2010.00430.x; Franklin MS, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00583; GIAMBRA LM, 1974, INT J AGING HUM DEV, V5, P115, DOI 10.2190/7AEJ-T3MA-QLGD-CCF5; GIAMBRA LM, 1978, J CLIN PSYCHOL, V34, P14; GIAMBRA LM, 1989, PSYCHOL AGING, V4, P136, DOI 10.1037/0882-7974.4.2.136; Giannotti F, 2002, J SLEEP RES, V11, P191, DOI 10.1046/j.1365-2869.2002.00302.x; Grossman P, 2011, CONTEMP BUDDHISM, V12, P219, DOI 10.1080/14639947.2011.564841; Harvey AG, 2002, BEHAV RES THER, V40, P267, DOI 10.1016/S0005-7967(01)00012-2; Harvey AG, 2005, CLIN PSYCHOL REV, V25, P593, DOI 10.1016/j.cpr.2005.04.005; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Howell AJ, 2008, PERS INDIV DIFFER, V45, P773, DOI 10.1016/j.paid.2008.08.005; [黄丽 Huang Li], 2003, [中国心理卫生杂志, Chinese Mental Health Journal], V17, P54; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Johns MW, 2000, J SLEEP RES, V9, P5, DOI 10.1046/j.1365-2869.2000.00177.x; Johnson EO, 2006, J PSYCHIATR RES, V40, P700, DOI 10.1016/j.jpsychires.2006.07.008; Kenney SR, 2012, ADDICT BEHAV, V37, P507, DOI 10.1016/j.addbeh.2012.01.006; Killgore WDS, 2012, NEUROREPORT, V23, P741, DOI 10.1097/WNR.0b013e3283565056; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Klinger E, 1999, AT PLAY IN THE FIELDS OF CONSCIOUSNESS, P29; Klinger E., 1978, STREAM CONSCIOUSNESS, P225, DOI [10.1007/978-1-4684-2466-9_9, DOI 10.1007/978-1-4684-2466-9_9]; KUNZENDORF R, 1983, PSYCHOL REP, V53, P406, DOI 10.2466/pr0.1983.53.2.406; Levinson DB, 2012, PSYCHOL SCI, V23, P375, DOI 10.1177/0956797611431465; Li SX, 2011, SLEEP BIOL RHYTHMS, V9, P19, DOI 10.1111/j.1479-8425.2010.00480.x; Liu X., 1996, CHIN J PSYCHIAT, V29, P103; Lund HG, 2010, J ADOLESCENT HEALTH, V46, P124, DOI 10.1016/j.jadohealth.2009.06.016; Mallis MM, 2008, NEUROERGONOMICS BRAI, P207; Mar RA, 2012, CONSCIOUS COGN, V21, P401, DOI 10.1016/j.concog.2011.08.001; Marchetti I, 2012, CONSCIOUS COGN, V21, P1517, DOI 10.1016/j.concog.2012.05.013; Mason MF, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00477; McMillan RL, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00626; Mcvay JC, 2010, PSYCHOL BULL, V136, P188, DOI 10.1037/a0018298; McVay JC, 2009, PSYCHON B REV, V16, P857, DOI 10.3758/PBR.16.5.857; MIKULINCER M, 1990, PSYCHOL RES-PSYCH FO, V52, P80, DOI 10.1007/BF00867216; Mooneyham BW, 2013, CAN J EXP PSYCHOL, V67, P11, DOI 10.1037/a0031569; Mrazek MD, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00560; Mrazek MD, 2012, EMOTION, V12, P442, DOI 10.1037/a0026678; Norlander T, 2005, SOC BEHAV PERSONAL, V33, P709, DOI 10.2224/sbp.2005.33.7.709; Ong JC, 2009, EXPLORE-NY, V5, P30, DOI 10.1016/j.explore.2008.10.004; Ottaviani C, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00524; Ottaviani C, 2013, BIOL PSYCHOL, V94, P38, DOI 10.1016/j.biopsycho.2013.05.003; Peng Li-Li, 2011, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V46, P44; Poerio GL, 2013, CONSCIOUS COGN, V22, P1412, DOI 10.1016/j.concog.2013.09.012; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Pritzl T. J, 2003, EFFECT EXPT ENHANCED; Riemann D, 2010, SLEEP MED REV, V14, P19, DOI 10.1016/j.smrv.2009.04.002; Sayette MA, 2009, PSYCHOL SCI, V20, P747, DOI 10.1111/j.1467-9280.2009.02351.x; Schooler JW, 2011, TRENDS COGN SCI, V15, P319, DOI 10.1016/j.tics.2011.05.006; Selvi Y, 2012, SLEEP BIOL RHYTHMS, V10, P14, DOI 10.1111/j.1479-8425.2011.00511.x; Sheehan, 1972, FUNCTION NATURE IMAG, P175; SINGER J L, 1963, Percept Mot Skills, V17, P187; Singer J.L., 1966, DAYDREAMING INTRO EX; Singer JL, 1978, STREAM CONSCIOUSNESS, P187; Smallwood J, 2007, COGNITION EMOTION, V21, P816, DOI 10.1080/02699930600911531; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smallwood J, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00441; Smallwood J, 2013, PSYCHOL BULL, V139, P519, DOI 10.1037/a0030010; Smallwood J, 2010, PSYCHOL BULL, V136, P202, DOI 10.1037/a0018673; Smallwood J, 2009, EMOTION, V9, P271, DOI 10.1037/a0014855; Song XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044423; Stawarczyk D, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00363; Suen LKP, 2008, CHRONOBIOL INT, V25, P760, DOI 10.1080/07420520802397186; Sukegawa M, 2009, BIOL RHYTHM RES, V40, P121, DOI 10.1080/09291010701794404; Taillard J, 1999, J SLEEP RES, V8, P291, DOI 10.1046/j.1365-2869.1999.00176.x; Vardar E, 2008, BIOL RHYTHM RES, V39, P493, DOI 10.1080/09291010701736884; Verlander LA, 1999, PERCEPT MOTOR SKILL, V88, P893, DOI 10.2466/pms.1999.88.3.893; Vitiello MV, 2009, CURR DIR PSYCHOL SCI, V18, P316, DOI 10.1111/j.1467-8721.2009.01659.x; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; Zoccola PM, 2009, PSYCHOSOM MED, V71, P771, DOI 10.1097/PSY.0b013e3181ae58e8	89	51	51	5	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91285	10.1371/journal.pone.0091285	http://dx.doi.org/10.1371/journal.pone.0091285			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4IY	24609107	gold, Green Published, Green Submitted			2022-12-25	WOS:000332485800122
J	Chiang, TY; Kuo, MC; Chen, CH; Yang, JY; Kao, CF; Ji, DD; Fang, CT				Chiang, Ting-Yi; Kuo, Ming-Chu; Chen, Chang-Hsun; Yang, Jyh-Yuan; Kao, Cheng-Feng; Ji, Dar-Der; Fang, Chi-Tai			Risk Factors for Acute Toxoplasma gondii Diseases in Taiwan: A Population-Based Case-Control Study	PLOS ONE			English	Article							PREGNANT-WOMEN; INFECTION; SEROPREVALENCE; SEROEPIDEMIOLOGY; TRANSMISSION; ETHIOPIA; CATS	Although human toxoplasmosis is a notifiable disease in Taiwan since 2007, little is known about its risk factors. This study aimed to investigate the risk factors for acute Toxoplasma gondii diseases in Taiwan. We conducted a nationwide population-based case-control study. Cases of acute human toxoplasmosis notified to the Taiwan Centers for Diseases Control (Taipei, Taiwan) during 2008-2013 were compared with controls that were randomly selected from healthy T. gondii-seronegative blood donors who participated in a nationwide T. gondii seroepidemiologic study during 2009-2010. Cases and controls were matched according to age, gender and residency at an 1: 8 ratio. Structured questionnaires were used to gather information regarding risk factors. A total of 30 laboratory-confirmed acute T. gondii disease cases and 224 controls were enrolled. The most common clinical manifestation of the cases was flu-like symptoms (n = 20), followed by central nervous system disease (n = 4), ocular diseases (n = 3), abortion (n = 2), and congenital infection (n = 1). Multivariate conditional logistic regression showed that raw clam consumption (adjusted odds ratio [OR] = 3.7; 95% confidence interval [CI] = 1.4-9.9) and having a cat in the household (adjusted OR = 2.9; 95% CI = 1.1-7.9) were two independent risk factors for acute T. gondii disease. We conclude that raw shellfish consumption and domestic cat exposure were risk factors for acquiring acute T. gondii diseases in Taiwan. This finding may guide future research and control policies.	[Chiang, Ting-Yi; Kuo, Ming-Chu; Yang, Jyh-Yuan; Kao, Cheng-Feng; Ji, Dar-Der] Minist Hlth & Welf, Ctr Dis Control, Ctr Res Diagnost & Vaccine Dev, Taipei, Taiwan; [Chiang, Ting-Yi; Fang, Chi-Tai] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Chen, Chang-Hsun] Minist Hlth & Welf, Ctr Dis Control, Div HIV AIDS & TB, Taipei, Taiwan; [Ji, Dar-Der] Natl Yang Ming Univ, Dept Trop Med, Taipei 112, Taiwan; [Fang, Chi-Tai] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Fang, Chi-Tai] Minist Hlth & Welf, Taipei, Taiwan; [Fang, Chi-Tai] Natl Taiwan Univ, Infect Dis Res & Educ Ctr, Taipei 10764, Taiwan	Centers For Disease Control - Taiwan; National Taiwan University; Centers For Disease Control - Taiwan; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Ji, DD (corresponding author), Minist Hlth & Welf, Ctr Dis Control, Ctr Res Diagnost & Vaccine Dev, Taipei, Taiwan.	jidarder@cdc.gov.tw; fangct@ntu.edu.tw	Fang, Chi-Tai/P-2908-2016	Fang, Chi-Tai/0000-0002-7380-1699	Centers for Disease Control, Ministry of Health and Welfare, Taiwan	Centers for Disease Control, Ministry of Health and Welfare, Taiwan	This work was supported by the Centers for Disease Control, Ministry of Health and Welfare, Taiwan. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript, but did have a role in data collection.	Alvarado-Esquivel C, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-75; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], ANIM HLTH RES REV, V6, P41; Baril L, 1999, SCAND J INFECT DIS, V31, P305, DOI 10.1080/00365549950163626; Bowie WR, 1997, LANCET, V350, P173, DOI 10.1016/S0140-6736(96)11105-3; Buffolano W, 1996, EPIDEMIOL INFECT, V116, P347, DOI 10.1017/S0950268800052675; Centers for Disease Control Department of Health R.O.C., 2010, GUID NOT COMM DIS SU; Chiang TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048139; Cook AJC, 2000, BRIT MED J, V321, P142, DOI 10.1136/bmj.321.7254.142; Dattoli VCC, 2011, J PARASITOL, V97, P1080, DOI 10.1645/GE-2836.1; Derouin F, 2008, CLIN MICROBIOL INFEC, V14, P1089, DOI 10.1111/j.1469-0691.2008.02091.x; Dubey JP, 2004, VET PARASITOL, V126, P57, DOI 10.1016/j.vetpar.2004.09.005; DUBEY JP, 1972, J PROTOZOOL, V19, P155, DOI 10.1111/j.1550-7408.1972.tb03431.x; Edvinsson B, 2006, CLIN MICROBIOL INFEC, V12, P131, DOI 10.1111/j.1469-0691.2005.01332.x; Fan CK, 2002, J PARASITOL, V88, P411, DOI 10.1645/0022-3395(2002)088[0411:SOTGIA]2.0.CO;2; Fan CK, 1998, JPN J MED SCI BIOL, V51, P35, DOI 10.7883/yoken1952.51.35; FRENKEL JK, 1970, SCIENCE, V167, P893, DOI 10.1126/science.167.3919.893; Havelaar AH, 2007, CLIN INFECT DIS, V44, P1467, DOI 10.1086/517511; Jones JL, 2009, CLIN INFECT DIS, V49, P878, DOI 10.1086/605433; Kolbekova P, 2007, CLIN MICROBIOL INFEC, V13, P1012, DOI 10.1111/j.1469-0691.2007.01771.x; Lin YL, 2008, PARASITOL RES, V103, P67, DOI 10.1007/s00436-008-0928-1; Lopes AP, 2012, EPIDEMIOL INFECT, V140, P872, DOI 10.1017/S0950268811001658; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Pappas G, 2009, INT J PARASITOL, V39, P1385, DOI 10.1016/j.ijpara.2009.04.003; Putignani L, 2011, EXP PARASITOL, V127, P409, DOI 10.1016/j.exppara.2010.09.007; Remington JS, 2001, INFECT DIS FETUS NEW, pXiv; Robert-Gangneux F, 2012, CLIN MICROBIOL REV, V25, P264, DOI 10.1128/CMR.05013-11; SIEGEL SE, 1971, BLOOD-J HEMATOL, V37, P388, DOI 10.1182/blood.V37.4.388.388; Walle F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-15; Zemene E, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-337	30	32	32	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90880	10.1371/journal.pone.0090880	http://dx.doi.org/10.1371/journal.pone.0090880			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609112	Green Submitted, gold, Green Published			2022-12-25	WOS:000332485800063
J	Gordoa, A; Carreras, G				Gordoa, Ana; Carreras, Gustavo			Determination of Temporal Spawning Patterns and Hatching Time in Response to Temperature of Atlantic Bluefin Tuna (Thunnus thynnus) in the Western Mediterranean	PLOS ONE			English	Article							PELAGIA-NOCTILUCA CNIDARIA; GULF-OF-MEXICO; POPULATION-STRUCTURE; YELLOWFIN TUNA; BIRTH DATE; EASTERN; L.; SEA; MIGRATION; DIET	This study analysed the temporal pattern of Atlantic bluefin tuna (ABFT) spawning in the Balearic spawning ground and examined its reproductive performance after years in captivity. Furthermore, ABFT hatching time at different on-site temperatures was determined for the first time. Spawning surveys carried out in 4 spawning seasons (2009-2012) aboard tuna transport vessels. Three groups of spawners were monitored: a captive group transported to the spawning region and monitored throughout the four spawning seasons and two wild groups caught in 2009 and 2010 which were transferred to a monitoring transport cage immediately after being caught. Surface plankton samples were collected nightly, beginning immediately after the first purse seine catches were made and concluding after spawning was observe have ended. All groups displayed the same spawning hours, restricted between 2:00-5:00 a.m. The captive group, as they got older, shifted towards the earliest hour, suggesting an age influence on reproductive time. The onset of spawning varied annually from the end of May to the at temperatures around 19 degrees C-20 degrees C ending by weak of July. The peak of spawning was consistently around the um er solstice, June negative effect of unstable oceanographic conditions in the spawning process which productive success of ABFT. The influence of temperature on hatching time was higher species, twice as fast at 26 degrees C (23 h) as at 19.5 degrees C (49 h) Overall his study shows the strength of ABFT that controls spawning traits. Spawning in ABFT is cyclical and highly synchronised on diel and annual scales consider that h timing of spawning rather influenced by day length and its adaptive significance is discussed.	[Gordoa, Ana; Carreras, Gustavo] CSIC, Ctr Estudios Avanzados Blanes, Dept Marine Ecol, Blanes, Gerona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	Gordoa, A (corresponding author), CSIC, Ctr Estudios Avanzados Blanes, Dept Marine Ecol, Blanes, Gerona, Spain.	gordoa@ceab.csic.es	Gordoa, Ana/A-1470-2013	Gordoa, Ana/0000-0003-1822-8196	Balfego Group; Spanish Ministry of the Economy and Competitiveness [CTM2011-29525-004-04]	Balfego Group; Spanish Ministry of the Economy and Competitiveness(Spanish Government)	This study was funded by the Balfego Group under a programme of scientific cooperation with the Spanish National Research Council and by the Spanish Ministry of the Economy and Competitiveness (CTM2011-29525-004-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal FJ, 2004, FISH B-NOAA, V102, P407; Alemany F, 2010, PROG OCEANOGR, V86, P21, DOI 10.1016/j.pocean.2010.04.014; Aranda G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076445; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Boustany AM, 2008, MAR BIOL, V156, P13, DOI 10.1007/s00227-008-1058-0; Brill Richard W., 2001, Fish Physiology, V19, P79; Butler CM, 2010, FISH B-NOAA, V108, P56; Compte J, 2010, MAR ECOL PROG SER, V402, P147, DOI 10.3354/meps08453; Corriero A, 2003, J FISH BIOL, V63, P108, DOI 10.1046/j.1095-8649.2003.00132.x; Cort J. L., 1991, COL VOL SCI PAP ICCA, V35, P213; CUSHING DH, 1969, J CONSEIL, V33, P81; Cushing DH, 1975, MARINE ECOLOGY FISHE; de la Serna J.M., 1992, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V39, P704; de Metrio G., 2005, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V58, P1337; Desse J, 1994, FISH EXPLOITATION, V274, P69; Dicenta A, 1977, B I ESP OCEANOGR, V234, P109; Duclerc J., 1973, Revue Trav Inst Peches Marit, V37, P163; Ferraris M, 2012, J PLANKTON RES, V34, P874, DOI 10.1093/plankt/fbs049; Galuardi B, 2010, CAN J FISH AQUAT SCI, V67, P966, DOI 10.1139/F10-033; Garcia A, 2005, COLLECTIVE VOLUME SC, V58, P1261; Gordoa A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074721; Gordoa A, 2009, ICES J MAR SCI, V66, P2205, DOI 10.1093/icesjms/fsp211; Hattour A., 2002, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V54, P545; Heinisch G, 2008, MAR BIOL, V154, P623, DOI 10.1007/s00227-008-0955-6; Hendry AP, 2005, MOL ECOL, V14, P901, DOI 10.1111/j.1365-294X.2005.02480.x; Karakulak S, 2004, J APPL ICHTHYOL, V20, P318, DOI 10.1111/j.1439-0426.2004.00561.x; Korsmeyer K.E., 2001, TUNA PHYSL ECOLOGY E, P35, DOI DOI 10.1016/S1546-5098(01)19003-5; LAMBERT TC, 1987, MAR ECOL PROG SER, V39, P209, DOI 10.3354/meps039209; LARSON R J, 1987, Biological Oceanography, V4, P447; Licandro P, 2010, BIOL LETTERS, V6, P688, DOI 10.1098/rsbl.2010.0150; Logan JM, 2011, MAR BIOL, V158, P73, DOI 10.1007/s00227-010-1543-0; Margulies D, 2007, FISH B-NOAA, V105, P249; Masuma Shukei, 2006, Bulletin of Fisheries Research Agency, P157; Mather FJ, 1995, NMFSSEFSC370 NOAA; Medina A, 2002, J FISH BIOL, V60, P203, DOI [10.1111/j.1095-8649.2002.tb02398.x, 10.1006/jfbi.2001.1835]; Miyashita M, 2000, SUISAN ZOSHOKU, V48, P475; MORAND P, 1992, ANN I OCEANOGR PARIS, V68, P151; Mourente G, 2001, FISH PHYSIOL BIOCHEM, V24, P351, DOI 10.1023/A:1015011609017; Muhling BA, 2013, MAR ECOL PROG SER, V486, P257, DOI 10.3354/meps10397; NIKAIDO H, 1991, B NATL RES I FAR SEA, V28, P47; Nishida T., 1998, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V48, P107; Oray IK, 2005, J APPL ICHTHYOL, V21, P236, DOI 10.1111/j.1439-0426.2005.00658.x; PAULY D, 1988, ENVIRON BIOL FISH, V22, P261, DOI 10.1007/BF00004892; Pinot JM, 2001, DEEP-SEA RES PT I, V48, P1651, DOI 10.1016/S0967-0637(00)00095-9; Reglero P, 2012, MAR ECOL PROG SER, V463, P273, DOI 10.3354/meps09800; RODRIGUEZ-RODA JULIO, 1964, INVEST PESQUERA, V25, P33; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; SARA R, 1973, Bollettino di Pesca Piscicoltura e Idrobiologia, V28, P217; Schaefer KM, 1996, FISH B-NOAA, V94, P98; Schaefer Kurt M., 2001, Fish Physiology, V19, P225; Schick RS, 2009, FISH OCEANOGR, V18, P77, DOI 10.1111/j.1365-2419.2008.00499.x; SCHULTZ ET, 1993, EVOLUTION, V47, P520, DOI 10.1111/j.1558-5646.1993.tb02111.x; Scott D.B.C., 1979, Symposia of the Zoological Society of London, P105; Stokesbury MJW, 2007, HYDROBIOLOGIA, V582, P91, DOI 10.1007/s10750-006-0552-y; Susca V, 2001, J FISH BIOL, V58, P815, DOI 10.1111/j.1095-8649.2001.tb00533.x; Teo SLH, 2007, MAR BIOL, V152, P1105, DOI 10.1007/s00227-007-0758-1; Trippel Edward A., 1997, Fish and Fisheries Series, V21, P31; Ultimatun, 2011, DOC PROD F LOP; Walli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006151; Wright PJ, 2009, FISH FISH, V10, P283, DOI 10.1111/j.1467-2979.2008.00322.x; Wright PJ, 2005, J ANIM ECOL, V74, P303, DOI 10.1111/j.1365-2656.2005.00924.x	61	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90691	10.1371/journal.pone.0090691	http://dx.doi.org/10.1371/journal.pone.0090691			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608107	gold, Green Published, Green Submitted			2022-12-25	WOS:000332485800045
J	Isaac, B; White, J; Ierodiaconou, D; Cooke, R				Isaac, Bronwyn; White, John; Ierodiaconou, Daniel; Cooke, Raylene			Simplification of Arboreal Marsupial Assemblages in Response to Increasing Urbanization	PLOS ONE			English	Article							POSSUMS TRICHOSURUS-VULPECULA; OWLS NINOX-STRENUA; HOME-RANGE; SPECIES DISTRIBUTION; DEN-USE; URBAN; FOREST; CONSERVATION; POPULATION; MELBOURNE	Arboreal marsupials play an essential role in ecosystem function including regulating insect and plant populations, facilitating pollen and seed dispersal and acting as a prey source for higher-order carnivores in Australian environments. Primarily, research has focused on their biology, ecology and response to disturbance in forested and urban environments. We used presence-only species distribution modelling to understand the relationship between occurrences of arboreal marsupials and eco-geographical variables, and to infer habitat suitability across an urban gradient. We used post-proportional analysis to determine whether increasing urbanization affected potential habitat for arboreal marsupials. The key eco-geographical variables that influenced disturbance intolerant species and those with moderate tolerance to disturbance were natural features such as tree cover and proximity to rivers and to riparian vegetation, whereas variables for disturbance tolerant species were anthropogenic-based (e. g., road density) but also included some natural characteristics such as proximity to riparian vegetation, elevation and tree cover. Arboreal marsupial diversity was subject to substantial change along the gradient, with potential habitat for disturbance-tolerant marsupials distributed across the complete gradient and potential habitat for less tolerant species being restricted to the natural portion of the gradient. This resulted in highly-urbanized environments being inhabited by a few generalist arboreal marsupial species. Increasing urbanization therefore leads to functional simplification of arboreal marsupial assemblages, thus impacting on the ecosystem services they provide.	[Isaac, Bronwyn; White, John; Cooke, Raylene] Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia; [Ierodiaconou, Daniel] Deakin Univ, Sch Life & Environm Sci, Warrnambool, Vic, Australia	Deakin University; Deakin University	Cooke, R (corresponding author), Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia.	raylene.cooke@deakin.edu.au	White, John/A-4285-2008	White, John/0000-0002-7375-5944; Ierodiaconou, Daniel/0000-0002-7832-4801	Holsworth Wildlife Research Endowment; Parks Victoria Research Partners Scheme	Holsworth Wildlife Research Endowment; Parks Victoria Research Partners Scheme	Funding for this project was supplied by the Holsworth Wildlife Research Endowment and the Parks Victoria Research Partners Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2000, TRENDS ECOL EVOL, V15, P337, DOI 10.1016/S0169-5347(00)01908-X; Banaszak-Cibicka W, 2012, J INSECT CONSERV, V16, P331, DOI 10.1007/s10841-011-9419-2; Beyer GL, 2006, WILDLIFE RES, V33, P161, DOI 10.1071/WR04109; Brenden TO, 2008, ENVIRON MANAGE, V42, P821, DOI 10.1007/s00267-008-9150-2; Broome LS, 2001, AUSTRAL ECOL, V26, P275, DOI 10.1046/j.1442-9993.2001.01114.x; Carthew SM, 1999, WILDLIFE RES, V26, P199, DOI 10.1071/WR98021; Caryl FM, 2013, AUSTRAL ECOL, V38, P609, DOI 10.1111/aec.12006; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; Comport SS, 1996, WILDLIFE RES, V23, P401, DOI 10.1071/WR9960401; Cooke R, 2006, WILDLIFE RES, V33, P199, DOI 10.1071/WR05058; Corp IBM., 2017, IBM SPSS STAT WINDOW; Department of Environment and Primary Industries (DEPI), 2013, EC VEG CLASS EVC BEN; Duguay S, 2007, LANDSCAPE ECOL, V22, P589, DOI 10.1007/s10980-006-9050-x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Environmental Systems Research Institute, 2010, ARCGIS 10 0; Eyre TJ, 2006, FOREST ECOL MANAG, V235, P270, DOI 10.1016/j.foreco.2006.08.338; Fitzsimons James A., 2010, Australian Field Ornithology, V27, P76; Gibbons P., 2002, TREE HOLLOWS WILDLIF, DOI [10.1071/9780643090033, DOI 10.1071/9780643090033]; Gillies CS, 2008, P NATL ACAD SCI USA, V105, P19774, DOI 10.1073/pnas.0803530105; Goldingay Ross L., 2004, P376; Goldingay Ross L., 2004, P298; Goldingay RL, 2011, AUST J ZOOL, V59, P277, DOI 10.1071/ZO11081; Happold D.C.D., 2008, MAMMALS AUSTR, P589; Harper MJ, 2008, AUSTRAL ECOL, V33, P243, DOI 10.1111/j.1442-9993.2007.01689.x; Harper MJ, 2005, WILDLIFE RES, V32, P681, DOI 10.1071/WR04072; Harris Jamie M., 2008, Mammalian Species, P1, DOI 10.1644/815.1; How RA, 1995, MAMMALS AUSTR, P273; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Kark S, 2007, J BIOGEOGR, V34, P638, DOI 10.1111/j.1365-2699.2006.01638.x; Kavanagh Rodney P., 2004, P413; Kerle J. A, 2001, POSSUMS BRUSHTAILS R; Kuhn I, 2006, BIOL CONSERV, V127, P292, DOI 10.1016/j.biocon.2005.06.033; LAVAZANIAN E, 1994, WILDLIFE RES, V21, P643, DOI 10.1071/WR9940643; Lindenmayer D, 2002, GLIDERS AUSTR NATURA; Lindenmayer DB, 2000, FOREST ECOL MANAG, V137, P139, DOI 10.1016/S0378-1127(99)00322-9; Lindenmayer DB, 1997, ECOL APPL, V7, P625, DOI 10.1890/1051-0761(1997)007[0625:DACOTW]2.0.CO;2; Lindenmayer DB, 1996, WILDLIFE WOODCHIPS L; Magle SB, 2012, BIOL CONSERV, V155, P23, DOI 10.1016/j.biocon.2012.06.018; Martin JK, 2006, AUST J ZOOL, V54, P225, DOI 10.1071/ZO06023; McDonnell MJ, 2009, ECOLOGY OF CITIES AND TOWNS: A COMPARATIVE APPROACH, P1, DOI 10.1017/CBO9780511609763; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Melles S, 2003, CONSERV ECOL, V7; Menkhorst Peter W., 2011, Victorian Naturalist (Blackburn), V128, P233; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Nelson J.L., 1996, Australian Forestry, V59, P189; Njoroge JB, 2014, URBAN ECOSYST, V17, P61, DOI 10.1007/s11252-013-0296-1; Olden JD, 2006, GLOBAL ECOL BIOGEOGR, V15, P113, DOI [10.1111/j.1466-822X.2006.00214.x, 10.1111/j.1466-822x.2006.00214.x]; Ordenana MA, 2010, J MAMMAL, V91, P1322, DOI 10.1644/09-MAMM-A-312.1; Pahl L., 1984, POSSUMS GLIDERS, P252; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Razgour O, 2011, BIOL CONSERV, V144, P2922, DOI 10.1016/j.biocon.2011.08.010; Redon M., 2010, 6 SPAT AN GEOM INT C; Robertson OJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065299, DOI 10.1371/J0URNAL.P0NE.0065299]; Sewell SR, 1998, WILDLIFE RES, V25, P41, DOI 10.1071/WR96078; Smith A, 1997, KEY FIELD GUIDE AUST; SMITH AP, 1989, AUST WILDLIFE RES, V16, P575; Soderquist TR, 2000, BIOL CONSERV, V93, P281, DOI 10.1016/S0006-3207(99)00153-6; Statham M, 1997, WILDLIFE RES, V24, P715, DOI 10.1071/WR96092; SUCKLING GC, 1984, AUST WILDLIFE RES, V11, P49; Taylor BD, 2009, ECOL SOC, V14; Temby I. D., 2004, P 4 INT S URB WILDL, P26; Threlfall CG, 2012, BIOL CONSERV, V146, P41, DOI 10.1016/j.biocon.2011.11.026; Trollope ST, 2009, LANDSCAPE URBAN PLAN, V93, P142, DOI 10.1016/j.landurbplan.2009.06.013; van der Ree Rodney, 2004, P91; van Rensburg BJ, 2009, LANDSCAPE URBAN PLAN, V92, P233, DOI 10.1016/j.landurbplan.2009.05.002; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; WOODWARD JC, 1994, BRIT GEOMOR, P259; Wormington KR, 2002, FOREST SCI, V48, P217	74	15	15	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91049	10.1371/journal.pone.0091049	http://dx.doi.org/10.1371/journal.pone.0091049			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608165	Green Published, Green Submitted, gold			2022-12-25	WOS:000332485800087
J	Kirenga, BJ; Levin, J; Ayakaka, I; Worodria, W; Reilly, N; Mumbowa, F; Nabanjja, H; Nyakoojo, G; Fennelly, K; Nakubulwa, S; Joloba, M; Okwera, A; Eisenach, KD; McNerney, R; Elliott, AM; Mugerwa, RD; Smith, PG; Ellner, JJ; Jones-Lopez, EC				Kirenga, Bruce J.; Levin, Jonathan; Ayakaka, Irene; Worodria, William; Reilly, Nancy; Mumbowa, Francis; Nabanjja, Helen; Nyakoojo, Grace; Fennelly, Kevin; Nakubulwa, Susan; Joloba, Moses; Okwera, Alphonse; Eisenach, Kathleen D.; McNerney, Ruth; Elliott, Alison M.; Mugerwa, Roy D.; Smith, Peter G.; Ellner, Jerrold J.; Jones-Lopez, Edward C.			Treatment Outcomes of New Tuberculosis Patients Hospitalized in Kampala, Uganda: A Prospective Cohort Study	PLOS ONE			English	Article							HIV-INFECTED ADULTS; SUB-SAHARAN AFRICA; PULMONARY TUBERCULOSIS; RISK-FACTORS; ANTIRETROVIRAL THERAPY; COTRIMOXAZOLE PROPHYLAXIS; ACTIVE TUBERCULOSIS; MORTALITY; IMPACT; DEATH	Background: In most resource limited settings, new tuberculosis (TB) patients are usually treated as outpatients. We sought to investigate the reasons for hospitalisation and the predictors of poor treatment outcomes and mortality in a cohort of hospitalized new TB patients in Kampala, Uganda Methods and findings: Ninety-six new TB patients hospitalised between 2003 and 2006 were enrolled and followed for two years. Thirty two were HIV-uninfected and 64 were HIV-infected. Among the HIV-uninfected, the commonest reasons for hospitalization were low Karnofsky score (47%) and need for diagnostic evaluation (25%). HIV-infected patients were commonly hospitalized due to low Karnofsky score (72%), concurrent illness (16%) and diagnostic evaluation (14%). Eleven HIV uninfected patients died (mortality rate 19.7 per 100 person-years) while 41 deaths occurred among the HIV-infected patients (mortality rate 46.9 per 100 person years). In all patients an unsuccessful treatment outcome (treatment failure, death during the treatment period or an unknown outcome) was associated with duration of TB symptoms, with the odds of an unsuccessful outcome decreasing with increasing duration. Among HIV-infected patients, an unsuccessful treatment outcome was also associated with male sex (P = 0.004) and age (P = 0.034). Low Karnofsky score (aHR = 8.93, 95% CI 1.88 - 42.40, P = 0.001) was the only factor significantly associated with mortality among the HIV-uninfected. Mortality among the HIV-infected was associated with the composite variable of CD4 and ART use, with patients with baseline CD4 below 200 cells/mu L who were not on ART at a greater risk of death than those who were on ART, and low Karnofsky score (aHR = 2.02, 95% CI 1.02 - 4.01, P = 0.045). Conclusion: Poor health status is a common cause of hospitalisation for new TB patients. Mortality in this study was very high and associated with advanced HIV Disease and no use of ART.	[Kirenga, Bruce J.; Worodria, William; Elliott, Alison M.; Mugerwa, Roy D.] Makerere Univ, Dept Med, Coll Hlth Sci, Kampala, Uganda; [Levin, Jonathan; Nakubulwa, Susan; Okwera, Alphonse; Elliott, Alison M.] Uganda Virus Res Inst, MRC, Uganda Res Unit AIDS, Entebbe, Uganda; [Levin, Jonathan] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, Gauteng, South Africa; [Ayakaka, Irene; Nabanjja, Helen; Nyakoojo, Grace; Fennelly, Kevin; Mugerwa, Roy D.; Ellner, Jerrold J.; Jones-Lopez, Edward C.] Makerere Univ, Boston Med Ctr Res Collaborat, Kampala, Uganda; [Reilly, Nancy] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA; [Mumbowa, Francis; Joloba, Moses] Makerere Univ, Dept Microbiol, Coll Hlth Sci, Kampala, Uganda; [Fennelly, Kevin] Univ Florida, Dept Med, Div Mycobacteriol, Southeastern Natl TB Ctr, Gainesville, FL USA; [Okwera, Alphonse] Mulago Hosp, TB Clin, Kampala, Uganda; [Eisenach, Kathleen D.] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA; [Eisenach, Kathleen D.] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA; [McNerney, Ruth; Elliott, Alison M.] London Sch Hyg & Trop Med, Dept Clin Res, Fac Infect & Trop Dis, London WC1, England; [Smith, Peter G.] London Sch Hyg & Trop Med, MRC, Trop Epidemiol Grp, London WC1, England; [Ellner, Jerrold J.; Jones-Lopez, Edward C.] Boston Med Ctr, Dept Med, Infect Dis Sect, Boston, MA 02118 USA; [Ellner, Jerrold J.; Jones-Lopez, Edward C.] Boston Univ, Sch Med, Boston, MA 02118 USA	Makerere University; Uganda Virus Research Institute; University of Witwatersrand; Makerere University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Makerere University; State University System of Florida; University of Florida; Mulago National Referral Hospital; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Boston Medical Center; Boston University	Jones-Lopez, EC (corresponding author), Boston Med Ctr, Dept Med, Infect Dis Sect, Boston, MA 02118 USA.	edward.jones@bmc.org	smith, peter/ABH-9627-2020	smith, peter/0000-0003-0080-7560; Elliott, Alison/0000-0003-2818-9549; Jones Lopez, Edward/0000-0001-6323-286X; Joloba, Moses/0000-0002-0334-9983; Kirenga, Bruce/0000-0002-2023-2840	Wellcome Trust - Burroughs Wellcome Fund Infectious Diseases Initiative [063410/ABC/00/Z]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Wellcome Trust - Burroughs Wellcome Fund Infectious Diseases Initiative; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by Wellcome Trust - Burroughs Wellcome Fund Infectious Diseases Initiative grant 063410/ABC/00/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abos-Hernandez R, 2002, INT J TUBERC LUNG D, V6, P470; [Anonymous], 1996, BACT 460 SYST PROD P; [Anonymous], 2010, MANUAL NATL TUBERCUL; [Anonymous], 1999, BACT MGIT 960 SYST U; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Burton NT, 2011, T ROY SOC TROP MED H, V105, P675, DOI 10.1016/j.trstmh.2011.07.017; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Davis JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009859; Dheda K, 2004, J INFECT DIS, V190, P1670, DOI 10.1086/424676; Duarte EC, 2009, J EPIDEMIOL COMMUN H, V63, P233, DOI 10.1136/jech.2008.078972; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Erhabor G E, 2006, Indian J Chest Dis Allied Sci, V48, P253; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Greenaway C, 2002, AM J RESP CRIT CARE, V165, P927, DOI 10.1164/ajrccm.165.7.2107040; Greenland S, 2008, STAT MED, V27, P199, DOI 10.1002/sim.2995; Grimwade K, 2005, AIDS, V19, P163, DOI 10.1097/00002030-200501280-00008; Hansel NN, 2004, CHEST, V126, P1079, DOI 10.1378/chest.126.4.1079; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Henegar C, 2012, INT J TUBERC LUNG D, V16, P1199, DOI 10.5588/ijtld.11.0613; Jones-Lopez EC, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000427; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Lawn SD, 2006, AIDS, V20, P1787, DOI 10.1097/01.aids.0000242831.27990.da; Lopez-Gatell H, 2007, AM J EPIDEMIOL, V165, P1134, DOI 10.1093/aje/kwk116; Lubart E, 2007, ISR MED ASSOC J, V9, P870; Mosimaneotsile B, 2003, LANCET, V362, P1551, DOI 10.1016/S0140-6736(03)14745-9; Muhumuza J, 2006, INT J TUBERC LUNG D, V10, P1262; Naidoo S, 2008, SO AFRICAN J EPIDEMI, V22, P8; Nunn AJ, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a257; PablosMendez A, 1996, JAMA-J AM MED ASSOC, V276, P1223, DOI 10.1001/jama.276.15.1223; Palmieri F, 2002, INFECTION, V30, P68, DOI 10.1007/s15010-002-2062-9; Rao VK, 1998, CHEST, V114, P1244, DOI 10.1378/chest.114.5.1244; Shimazaki T, 2013, INT J TUBERC LUNG D, V17, P1420, DOI 10.5588/ijtld.12.0848; Silva DR, 2010, LUNG, V188, P33, DOI 10.1007/s00408-009-9224-9; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Tabarsi P, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-14; Taylor Z, 2000, INT J TUBERC LUNG D, V4, P931; van't Hoog AH, 2012, INT J TUBERC LUNG D, V16, P1649, DOI 10.5588/ijtld.12.0135; Volmink J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub2; Waitt CJ, 2011, INT J TUBERC LUNG D, V15, P871, DOI 10.5588/ijtld.10.0352; Whalen CC, 2000, AIDS, V14, P1219, DOI 10.1097/00002030-200006160-00020; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO, 2009, TREATM TUB GUID; Yen YF, 2012, T ROY SOC TROP MED H, V106, P303, DOI 10.1016/j.trstmh.2012.01.011	45	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90614	10.1371/journal.pone.0090614	http://dx.doi.org/10.1371/journal.pone.0090614			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608875	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000332485800039
J	Kuwajima, M; Kumano, G; Nishida, H				Kuwajima, Mami; Kumano, Gaku; Nishida, Hiroki			Regulation of the Number of Cell Division Rounds by Tissue-Specific Transcription Factors and Cdk Inhibitor during Ascidian Embryogenesis	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE; T-BOX GENE; INTRACELLULAR INJECTION; POSTPLASMIC/PEM RNAS; HALOCYNTHIA-RORETZI; CIONA-INTESTINALIS; MESODERMAL TISSUES; LINEAGE ANALYSIS; TRACER ENZYME; EXPRESSION	Mechanisms that regulate the number of cell division rounds during embryogenesis have remained largely elusive. To investigate this issue, we used the ascidian, which develops into a tadpole larva with a small number of cells. The embryonic cells divide 11.45 times on average from fertilization to hatching. The number of cell division rounds varies depending on embryonic lineages. Notochord and muscle consist of large postmitotic cells and stop dividing early in developing embryos. Here we show that conversion of mesenchyme to muscle cell fates by inhibition of inductive FGF signaling or mis-expression of a muscle-specific key transcription factor for muscle differentiation, Tbx6, changed the number of cell divisions in accordance with the altered fate. Tbx6 likely activates a putative mechanism to halt cell division at a specific stage. However, precocious expression of Tbx6 has no effect on progression of the developmental clock itself. Zygotic expression of a cyclin-dependent kinase inhibitor, CKI-b, is initiated in muscle and then in notochord precursors. CKI-b is possibly downstream of tissue-specific key transcription factors of notochord and muscle. In the two distinct muscle lineages, postmitotic muscle cells are generated after 9 and 8 rounds of cell division depending on lineage, but the final cell divisions occur at a similar developmental stage. CKI-b gene expression starts simultaneously in both muscle lineages at the 110-cell stage, suggesting that CKI-b protein accumulation halts cell division at a similar stage. The difference in the number of cell divisions would be due to the cumulative difference in cell cycle length. These results suggest that muscle cells do not count the number of cell division rounds, and that accumulation of CKI-b protein triggered by tissue-specific key transcription factors after cell fate determination might act as a kind of timer that measures elapsed time before cell division termination.	[Kuwajima, Mami; Kumano, Gaku; Nishida, Hiroki] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 560, Japan	Osaka University	Nishida, H (corresponding author), Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 560, Japan.	hnishida@bio.sci.osaka-u.ac.jp	Nishida, Hiroki/B-1851-2008; Kumano, Gaku/AAE-1527-2019	Nishida, Hiroki/0000-0002-7249-1668; 	JSPS; MEXT; Grants-in-Aid for Scientific Research [23570252, 25113518] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants in Aid from JSPS and MEXT to H.N. and G.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Clayton JE, 2008, DEV BIOL, V313, P603, DOI 10.1016/j.ydbio.2007.10.051; Deng XB, 2004, J BIOL CHEM, V279, P22498, DOI 10.1074/jbc.M400479200; deNooij JC, 1996, CELL, V87, P1237, DOI 10.1016/S0092-8674(00)81819-X; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fujikawa T, 2011, DEV BIOL, V355, P313, DOI 10.1016/j.ydbio.2011.04.033; Hirano T, 1997, DEV BIOL, V192, P199, DOI 10.1006/dbio.1997.8772; Kawashima T, 2003, DEV GENES EVOL, V213, P284, DOI 10.1007/s00427-003-0323-y; Kim GJ, 2007, DEVELOPMENT, V134, P1509, DOI 10.1242/dev.02825; Kim GJ, 2000, DEVELOPMENT, V127, P2853; Kim GJ, 2001, DEV GROWTH DIFFER, V43, P521; Kumano G, 2007, DEV DYNAM, V236, P1732, DOI 10.1002/dvdy.21108; Kumano G, 2006, DEV BIOL, V300, P770, DOI 10.1016/j.ydbio.2006.07.033; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; LEMAIRE P, 1995, CELL, V81, P85, DOI 10.1016/0092-8674(95)90373-9; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Makabe KW, 2012, WIRES DEV BIOL, V1, P501, DOI 10.1002/wdev.54; Makabe KW, 2001, DEVELOPMENT, V128, P2555; Matsumoto J, 2007, DEV BIOL, V306, P870, DOI 10.1016/j.ydbio.2007.03.034; Mitani Y, 1999, DEV DYNAM, V215, P62, DOI 10.1002/(SICI)1097-0177(199905)215:1<62::AID-DVDY7>3.0.CO;2-X; Mitani Y, 2001, DEVELOPMENT, V128, P3717; Nakatani Y, 1996, DEVELOPMENT, V122, P2023; Negishi T, 2007, CURR BIOL, V17, P1014, DOI 10.1016/j.cub.2007.05.047; NISHIDA H, 1992, ROUX ARCH DEV BIOL, V201, P81, DOI 10.1007/BF00420418; Nishida H, 2005, DEV DYNAM, V233, P1177, DOI 10.1002/dvdy.20469; NISHIDA H, 1987, DEV BIOL, V121, P526, DOI 10.1016/0012-1606(87)90188-6; NISHIDA H, 1983, DEV BIOL, V99, P382, DOI 10.1016/0012-1606(83)90288-9; Prodon F, 2007, DEV DYNAM, V236, P1698, DOI 10.1002/dvdy.21109; Sardet C, 2005, BIOL CELL, V97, P35; Sawada K, 2005, GENE EXPR PATTERNS, V5, P429, DOI 10.1016/j.modgep.2004.09.003; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Slack JMW, 1996, CURR BIOL, V6, P348, DOI 10.1016/S0960-9822(02)00487-6; Takahashi H, 2005, DEV GROWTH DIFFER, V47, P173; Takatori N, 2010, DEV CELL, V19, P589, DOI 10.1016/j.devcel.2010.09.003; Vervoorts J, 2008, CELL MOL LIFE SCI, V65, P3255, DOI 10.1007/s00018-008-8296-7; Yagi K, 2005, DEV BIOL, V282, P535, DOI 10.1016/j.ydbio.2005.03.029; Yamada A, 1999, J EXP ZOOL, V284, P379; Yasuo H, 1996, DEV BIOL, V180, P773, DOI 10.1006/dbio.1996.0345	38	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90188	10.1371/journal.pone.0090188	http://dx.doi.org/10.1371/journal.pone.0090188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608898	Green Published, Green Submitted, gold			2022-12-25	WOS:000332485800019
J	Liu, P; Pieper, R; Rieger, J; Vahjen, W; Davin, R; Plendl, J; Meyer, W; Zentek, J				Liu, Ping; Pieper, Robert; Rieger, Juliane; Vahjen, Wilfried; Davin, Roger; Plendl, Johanna; Meyer, Wilfried; Zentek, Juergen			Effect of Dietary Zinc Oxide on Morphological Characteristics, Mucin Composition and Gene Expression in the Colon of Weaned Piglets	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-2; FEED PARTICLE-SIZE; LARGE-INTESTINE; INFLAMMATORY CYTOKINES; GASTROINTESTINAL-TRACT; LYMPHOID-TISSUES; EPITHELIAL-CELLS; PROTEIN; COPPER; PIGS	The trace element zinc is often used in the diet of weaned piglets, as high doses have resulted in positive effects on intestinal health. However, the majority of previous studies evaluated zinc supplementations for a short period only and focused on the small intestine. The hypothesis of the present study was that low, medium and high levels of dietary zinc (57, 164 and 2,425 mg Zn/kg from zinc oxide) would affect colonic morphology and innate host defense mechanisms across 4 weeks post-weaning. Histological examinations were conducted regarding the colonic morphology and neutral, acidic, sialylated and sulphated mucins. The mRNA expression levels of mucin (MUC) 1, 2, 13, 20, toll-like receptor (TLR) 2, 4, interleukin (IL)-1 beta, 8, 10, interferon-gamma (IFN-gamma) and transforming growth factor-beta (TGF-beta) were also measured. The colonic crypt area increased in an age-depending manner, and the greatest area was found with medium concentration of dietary zinc. With the high concentration of dietary zinc, the number of goblet cells containing mixed neutral-acidic mucins and total mucins increased. Sialomucin containing goblet cells increased age-dependently. The expression of MUC2 increased with age and reached the highest level at 47 days of age. The expression levels of TLR2 and 4 decreased with age. The mRNA expression of TLR4 and the pro-inflammatory cytokine IL-8 were down-regulated with high dietary zinc treatment, while piglets fed with medium dietary zinc had the highest expression. It is concluded that dietary zinc level had a clear impact on colonic morphology, mucin profiles and immunological traits in piglets after weaning. Those changes might support local defense mechanisms and affect colonic physiology and contribute to the reported reduction of post-weaning diarrhea.	[Liu, Ping; Pieper, Robert; Vahjen, Wilfried; Zentek, Juergen] Free Univ Berlin, Dept Vet Med, Inst Anim Nutr, Berlin, Germany; [Rieger, Juliane; Plendl, Johanna] Free Univ Berlin, Dept Vet Med, Inst Vet Anat, Berlin, Germany; [Davin, Roger] Univ Autonoma Barcelona, Fac Vet, Dept Ciencia Anim & Aliment, Grp Nutr Maneig & Benestar Anim, E-08193 Barcelona, Spain; [Meyer, Wilfried] Univ Vet Med Hannover, Inst Anat, Hannover, Germany	Free University of Berlin; Free University of Berlin; Autonomous University of Barcelona; University of Veterinary Medicine Hannover, Foundation	Zentek, J (corresponding author), Free Univ Berlin, Dept Vet Med, Inst Anim Nutr, Berlin, Germany.	juergen.zentek@fu-berlin.de	Davin, Roger/D-1949-2013; Rieger, Juliane/G-8878-2015	Davin, Roger/0000-0003-2391-4879; Rieger, Juliane/0000-0003-1659-9460; Pieper, Robert/0000-0002-0292-1482	Deutsche Forschungsgemeinschaft (DFG) through a grant of the Collaborative Research Group [SFB 852]	Deutsche Forschungsgemeinschaft (DFG) through a grant of the Collaborative Research Group(German Research Foundation (DFG))	This study has been supported by the Deutsche Forschungsgemeinschaft (DFG) through a grant of the Collaborative Research Group SFB 852/Project C3, "Nutrition and Intestinal Microbiota - Host Interactions in the pig." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anguita M, 2007, LIVEST SCI, V107, P182, DOI 10.1016/j.livsci.2006.09.016; Badia R, 2012, J ANIM SCI, V90, P260, DOI 10.2527/jas.53894; Barnett AM, 2012, FOOD FUNCT, V3, P690, DOI 10.1039/c2fo30017f; Bering SB, 2012, BRIT J NUTR, V108, P672, DOI 10.1017/S0007114511006404; BROWN PJ, 1988, J COMP PATHOL, V98, P313, DOI 10.1016/0021-9975(88)90040-0; Brunsgaard G, 1998, J ANIM SCI, V76, P2787; Carlson D, 2007, LIVEST SCI, V108, P45, DOI 10.1016/j.livsci.2007.01.026; Carlson D, 2004, COMP BIOCHEM PHYS A, V137, P757, DOI 10.1016/j.cbpb.2004.02.011; Castellano R, 2013, ANIM FEED SCI TECH, V180, P101, DOI 10.1016/j.anifeedsci.2013.01.010; Corfield AP, 2001, FRONT BIOSCI-LANDMRK, V6, pD1321, DOI 10.2741/Corfield; Croix JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024447; Davin R, 2012, J ANIM SCI, V90, P248, DOI 10.2527/jas.53999; DOBESH GD, 1987, AM J VET RES, V48, P862; Dreno B, 2001, DERMATOLOGY, V203, P135, DOI 10.1159/000051728; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Feng Z, 2006, COMP BIOCHEM PHYS A, V145, P328, DOI 10.1016/j.cbpa.2006.07.006; FILIPE MI, 1979, INVEST CELL PATHOL, V2, P195; Geiser J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002766; GENDLER SJ, 1995, ANNU REV PHYSIOL, V57, P607, DOI 10.1146/annurev.ph.57.030195.003135; Glitso LV, 1998, BRIT J NUTR, V80, P457, DOI 10.1017/S0007114598001536; Hedemann MS, 2006, J ANIM SCI, V84, P3310, DOI 10.2527/jas.2005-701; Hedemann MS, 2009, BRIT J NUTR, V102, P117, DOI 10.1017/S0007114508143549; Hedemann MS, 2005, J ANIM SCI, V83, P1554; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hojberg O, 2005, APPL ENVIRON MICROB, V71, P2267, DOI 10.1128/AEM.71.5.2267-2277.2005; Hu CH, 2013, ANIM FEED SCI TECH, V181, P65, DOI 10.1016/j.anifeedsci.2013.02.003; Hu CH, 2013, BRIT J NUTR, V110, P681, DOI 10.1017/S0007114512005508; Jansman AJM, 2012, J ANIM SCI, V90, P161, DOI 10.2527/jas.53848; Ji HY, 2011, MOL BIOL REP, V38, P1593, DOI 10.1007/s11033-010-0268-y; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Katouli M, 1999, J APPL MICROBIOL, V87, P564, DOI 10.1046/j.1365-2672.1999.00853.x; Kawashima H, 2012, BIOL PHARM BULL, V35, P1637, DOI 10.1248/bpb.b12-00412; Kelly D, 2005, MOL IMMUNOL, V42, P895, DOI 10.1016/j.molimm.2004.12.003; Kreuzer S., 2013, Proceedings of the Society of Nutrition Physiology, V22, P52; Lalles JP, 2007, P NUTR SOC, V66, P260, DOI 10.1017/S0029665107005484; LAWSON MJ, 1988, BIOL TRACE ELEM RES, V18, P115, DOI 10.1007/BF02917495; Liu Y, 2008, BRIT J NUTR, V100, P552, DOI 10.1017/S0007114508911612; Liu YL, 2012, J NUTR, V142, P2017, DOI 10.3945/jn.112.164947; Martin L, 2013, J NUTR, V143, P1205, DOI 10.3945/jn.113.177881; Martin L, 2013, ARCH ANIM NUTR, V67, P248, DOI 10.1080/1745039X.2013.801138; Martin L, 2012, ANIM FEED SCI TECH, V175, P65, DOI 10.1016/j.anifeedsci.2012.04.002; McKay DM, 1999, GUT, V44, P283, DOI 10.1136/gut.44.2.283; Mentschel J, 2003, METABOLISM, V52, P1400, DOI 10.1016/S0026-0495(03)00318-4; Moncada DM, 2003, TRENDS PARASITOL, V19, P305, DOI 10.1016/S1471-4922(03)00122-3; MOWRY RW, 1963, ANN NY ACAD SCI, V106, P402; MUNCHOW H, 1989, ARCH TIERERNAHR, V39, P893, DOI 10.1080/17450398909432971; National Research Council (NRC), 2012, NUTR REQ SWIN, V11, DOI [10.17226/13298, DOI 10.17226/13298]; Nofrarias M, 2006, J ANIM SCI, V84, P2735, DOI 10.2527/jas.2005-414; Pie S, 2004, J NUTR, V134, P641, DOI 10.1093/jn/134.3.641; Piel C, 2005, J NUTR, V135, P86, DOI 10.1093/jn/135.1.86; Pieper R, 2012, J NUTR, V142, P661, DOI 10.3945/jn.111.156190; POULSEN HD, 1995, ACTA AGR SCAND A-AN, V45, P159, DOI 10.1080/09064709509415847; Prasad AS, 2012, J TRACE ELEM MED BIO, V26, P66, DOI 10.1016/j.jtemb.2012.04.004; Puiman PJ, 2011, J NUTR, V141, P1306, DOI 10.3945/jn.110.135145; Rojas M, 1996, J APPL BACTERIOL, V81, P474; Romeis B., 1989, MIKROSKOPISCHE TECHN; Roos S, 2002, MICROBIOL-SGM, V148, P433, DOI 10.1099/00221287-148-2-433; Roselli M, 2003, J NUTR, V133, P4077, DOI 10.1093/jn/133.12.4077; Sales J, 2013, BIOL TRACE ELEM RES, V152, P343, DOI 10.1007/s12011-013-9638-3; Smith AG, 2011, BRIT J NUTR, V105, P669, DOI 10.1017/S0007114510004277; SOUTHON S, 1985, BRIT J NUTR, V53, P595, DOI 10.1079/BJN19850069; SPICER SS, 1965, J HISTOCHEM CYTOCHEM, V13, P211, DOI 10.1177/13.3.211; Starke IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056405; Swiech E, 2010, LIVEST SCI, V134, P172, DOI 10.1016/j.livsci.2010.06.129; Tohno M, 2005, BIOCHEM BIOPH RES CO, V330, P547, DOI 10.1016/j.bbrc.2005.03.017; Tohno M, 2006, VET RES, V37, P791, DOI 10.1051/vetres:2006036; Tsukahara T, 2003, J NUTR SCI VITAMINOL, V49, P414, DOI 10.3177/jnsv.49.414; TURCK D, 1993, PEDIATR RES, V33, P564, DOI 10.1203/00006450-199306000-00005; Uddin MJ, 2013, RES VET SCI, V95, P92, DOI 10.1016/j.rvsc.2013.01.027; Vahjen W, 2011, J ANIM SCI, V89, P2430, DOI 10.2527/jas.2010-3270; Vahjen W, 2010, APPL ENVIRON MICROB, V76, P6689, DOI 10.1128/AEM.03075-09; van der Sluis M, 2004, BIOCHEM BIOPH RES CO, V325, P952, DOI 10.1016/j.bbrc.2004.10.108	72	50	55	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91091	10.1371/journal.pone.0091091	http://dx.doi.org/10.1371/journal.pone.0091091			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609095	gold, Green Published, Green Submitted			2022-12-25	WOS:000332485800100
J	Sajgo, S; Ghinia, MG; Shi, M; Liu, P; Dong, LJ; Parmhans, N; Popescu, O; Badea, TC				Sajgo, Szilard; Ghinia, Miruna Georgiana; Shi, Melody; Liu, Pinghu; Dong, Lijin; Parmhans, Nadia; Popescu, Octavian; Badea, Tudor Constantin			Dre - Cre Sequential Recombination Provides New Tools for Retinal Ganglion Cell Labeling and Manipulation in Mice	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; TRANSCRIPTION FACTORS BRN3A; TRANSGENIC MOUSE LINE; MEDIATED RECOMBINATION; DNA RECOMBINATION; MAMMALIAN-CELLS; COMBINATORIAL EXPRESSION; SOMATOSENSORY NEURONS; FLUORESCENT PROTEINS; COMPETENCE STATE	Background: Genetic targeting methods have greatly advanced our understanding of many of the 20 Retinal Ganglion Cell (RGC) types conveying visual information from the eyes to the brain. However, the complexity and partial overlap of gene expression patterns in RGCs call for genetic intersectional or sparse labeling strategies. Loci carrying the Cre recombinase in conjunction with conditional knock-out, reporter or other genetic tools can be used for targeted cell type ablation and functional manipulation of specific cell populations. The three members of the Pou4f family of transcription factors, Brn3a, Brn3b and Brn3c, expressed early during RGC development and in combinatorial pattern amongst RGC types are excellent candidates for such gene manipulations. Methods and Findings: We generated conditional Cre knock-in alleles at the Brn3a and Brn3b loci, Brn3a(CKOCre) and Brn3b(CKOCre). When crossed to mice expressing the Dre recombinase, the endogenous Brn3 gene expressed by Brn3a(CKOCre) or Brn3b(CKOCre) is removed and replaced with a Cre recombinase, generating Brn3a(Cre) and Brn3b(Cre) knock-in alleles. Surprisingly both Brn3a(Cre) and Brn3b(Cre) knock-in alleles induce early ubiquitous recombination, consistent with germline expression. However in later stages of development, their expression is limited to the expected endogenous pattern of the Brn3a and Brn3b genes. We use the Brn3a(Cre) and Brn3b(Cre) alleles to target a Cre dependent Adeno Associated Virus (AAV) reporter to RGCs and demonstrate its use in morphological characterization, early postnatal gene delivery and tracing the expression of Brn3 genes in RGCs. Conclusions: Dre recombinase effectively recombines the Brn3a(CKOCre) and Brn3b(CKOCre) alleles containing its roxP target sites. Sequential Dre to Cre recombination reveals Brn3a and Brn3b expression in early mouse development. The generated Brn3a(Cre) and Brn3b(Cre) alleles are useful tools that can target exogenously delivered Cre dependent reagents to RGCs in early postnatal development, opening up a large range of potential applications.	[Sajgo, Szilard; Ghinia, Miruna Georgiana; Shi, Melody; Liu, Pinghu; Dong, Lijin; Parmhans, Nadia; Badea, Tudor Constantin] NEI, NIH, Bethesda, MD 20892 USA; [Sajgo, Szilard; Ghinia, Miruna Georgiana; Popescu, Octavian] Univ Babes Bolyai, Dept Biol, R-3400 Cluj Napoca, Romania; [Popescu, Octavian] Romanian Acad, Inst Biol, Bucharest, Romania	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Babes Bolyai University from Cluj; Romanian Academy of Sciences	Badea, TC (corresponding author), NEI, NIH, Bethesda, MD 20892 USA.	badeatc@mail.nih.gov	Popescu, Octavian/E-4942-2010; Popescu, Octavian/O-2134-2019; Badea, Tudor Constantin/B-1654-2018	Popescu, Octavian/0000-0002-2597-7155; Popescu, Octavian/0000-0002-2597-7155; Badea, Tudor Constantin/0000-0003-3086-6713; Tegla, Miruna G./0000-0001-6898-1886	National Institutes of Health; European Union doctoral fellowship system through POSDRU Program [107/1.5/S/76841]; NATIONAL EYE INSTITUTE [ZIAEY000504, ZICEY000458] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union doctoral fellowship system through POSDRU Program; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the National Institutes of Health. Partial funding was provided to M.G.G. by the European Union doctoral fellowship system through POSDRU Program 107/1.5/S/76841. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2008, PHYSIOL GENOMICS, V34, P225, DOI 10.1152/physiolgenomics.90242.2008; Anastassiadis K, 2010, METHOD ENZYMOL, V477, P109, DOI 10.1016/S0076-6879(10)77007-5; Anastassiadis K, 2009, DIS MODEL MECH, V2, P508, DOI 10.1242/dmm.003087; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Auricchio A, 2001, HUM MOL GENET, V10, P3075, DOI 10.1093/hmg/10.26.3075; Badea TC, 2003, J NEUROSCI, V23, P2314; Badea TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007859; Badea TC, 2009, NEURON, V61, P852, DOI 10.1016/j.neuron.2009.01.020; Badea TC, 2012, J NEUROSCI, V32, P995, DOI 10.1523/JNEUROSCI.4755-11.2012; Badea TC, 2011, VISION RES, V51, P269, DOI 10.1016/j.visres.2010.08.039; Belteki G, 2003, NAT BIOTECHNOL, V21, P321, DOI 10.1038/nbt787; Betley JN, 2011, HUM GENE THER, V22, P669, DOI 10.1089/hum.2010.204; Borghuis BG, 2011, J NEUROSCI, V31, P2855, DOI 10.1523/JNEUROSCI.6064-10.2011; Brzezinski JA, 2012, DEV BIOL, V365, P395, DOI 10.1016/j.ydbio.2012.03.006; Buchholz F, 1996, NUCLEIC ACIDS RES, V24, P4256, DOI 10.1093/nar/24.21.4256; Budhram-Mahadeo V, 2001, INT J BIOCHEM CELL B, V33, P1027, DOI 10.1016/S1357-2725(01)00069-3; Chen SK, 2011, NATURE, V476, P92, DOI 10.1038/nature10206; Davies Jamie A, 2012, Methods Mol Biol, V886, P185, DOI 10.1007/978-1-61779-851-1_17; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Eng SR, 2001, J NEUROSCI, V21, P541, DOI 10.1523/JNEUROSCI.21-02-00541.2001; Erkman L, 1996, NATURE, V381, P603, DOI 10.1038/381603a0; Farago AF, 2006, NEURON, V50, P205, DOI 10.1016/j.neuron.2006.03.014; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Harding SD, 2011, DEVELOPMENT, V138, P2845, DOI 10.1242/dev.063594; Harris JA., 2012, CURR PROTOC NEUROSCI, V20, P21, DOI [10.1002/0471142301.ns0120-59, DOI 10.1002/0471142301.NS0120-59, 10.1002/0471142301.ns0120s59, DOI 10.1002/0471142301.NS0120S59]; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hirsch MR, 2013, GENESIS, V51, P506, DOI 10.1002/dvg.22393; Huang CC, 2013, ELIFE, V2, DOI 10.7554/eLife.00400; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Ivanova E, 2013, J COMP NEUROL, V521, P2165, DOI 10.1002/cne.23279; Jameson SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002575; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Knopfel T, 2012, NAT REV NEUROSCI, V13, P687, DOI 10.1038/nrn3293; Lebherz C, 2008, J GENE MED, V10, P375, DOI 10.1002/jgm.1126; Lee G, 1998, GENE, V216, P55, DOI 10.1016/S0378-1119(98)00325-4; Liu CY, 2013, METHODS MOL BIOL, V1027, P183, DOI 10.1007/978-1-60327-369-5_8; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Masland RH, 2001, CURR OPIN NEUROBIOL, V11, P431, DOI 10.1016/S0959-4388(00)00230-0; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; MCLEOD M, 1986, MOL CELL BIOL, V6, P3357, DOI 10.1128/MCB.6.10.3357; Mu XQ, 2004, DEVELOPMENT, V131, P1197, DOI 10.1242/dev.01010; Munch TA, 2009, NAT NEUROSCI, V12, P1308, DOI 10.1038/nn.2389; Nern A, 2011, P NATL ACAD SCI USA, V108, P14198, DOI 10.1073/pnas.1111704108; Ohinata Y, 2008, REPRODUCTION, V136, P503, DOI 10.1530/REP-08-0053; Pang JJ, 2008, VISION RES, V48, P377, DOI 10.1016/j.visres.2007.08.009; Qiu F, 2008, J NEUROSCI, V28, P3392, DOI 10.1523/JNEUROSCI.0043-08.2008; Quina LA, 2005, J NEUROSCI, V25, P11595, DOI 10.1523/JNEUROSCI.2837-05.2005; Rabinowitz JE, 2002, J VIROL, V76, P791, DOI 10.1128/JVI.76.2.791-801.2002; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Rossant J, 2011, P NATL ACAD SCI USA, V108, P7659, DOI 10.1073/pnas.1104844108; Sauer B, 2004, NUCLEIC ACIDS RES, V32, P6086, DOI 10.1093/nar/gkh941; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sosa MAG, 2010, BRAIN STRUCT FUNCT, V214, P91, DOI 10.1007/s00429-009-0230-8; Suzuki E, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1280; Szobota S, 2010, ANNU REV BIOPHYS, V39, P329, DOI 10.1146/annurev.biophys.093008.131400; Tasic B, 2011, P NATL ACAD SCI USA, V108, P7902, DOI 10.1073/pnas.1019507108; Troy JB, 2002, PROG RETIN EYE RES, V21, P263, DOI 10.1016/S1350-9462(02)00002-2; Wang SW, 2002, DEVELOPMENT, V129, P467; Wang SW, 2000, MOL CELL NEUROSCI, V16, P141, DOI 10.1006/mcne.2000.0860; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Watanabe S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054146; Xiang M, 1997, COLD SPRING HARB SYM, V62, P325; Xiang MQ, 1996, P NATL ACAD SCI USA, V93, P11950, DOI 10.1073/pnas.93.21.11950; Xiang MQ, 1998, DEV BIOL, V197, P155, DOI 10.1006/dbio.1998.8868; Xiang MQ, 1997, P NATL ACAD SCI USA, V94, P9445, DOI 10.1073/pnas.94.17.9445; XIANG MQ, 1995, J NEUROSCI, V15, P4762; Yang ZY, 2003, DEV BIOL, V264, P240, DOI 10.1016/j.ydbio.2003.08.005; Yonehara K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001533; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	76	20	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91435	10.1371/journal.pone.0091435	http://dx.doi.org/10.1371/journal.pone.0091435			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608965	Green Submitted, Green Published, gold			2022-12-25	WOS:000332485800136
J	Carrillo, AM; Bouska, A; Arrate, MP; Eischen, CM				Carrillo, A. M.; Bouska, A.; Arrate, M. P.; Eischen, C. M.			Mdmx promotes genomic instability independent of p53 and Mdm2	ONCOGENE			English	Article							STRAND BREAK REPAIR; DNA-DAMAGE; TUMOR-FORMATION; ATM ACTIVATION; HISTONE H2AX; S-PHASE; EXPRESSION; COMPLEX; DEGRADATION; PROTEIN	The oncogene Mdmx is overexpressed in many man malignancies, and together with Mdm2, negatively regulates the p53 tumor suppressor. However, a p53-independent function of Mdmx that impacts genome stability has been described, but this function is not well understood. In the present study, we determined that of the 13 different cancer types evaluated, 6-90% of those that had elevated levels of Mdmx had concurrent inactivation (mutated or deleted) of p53. We show elevated levels of Mdmx-inhibited double-strand DNA break repair and induced chromosome and chromatid breaks independent of p53, leading to genome instability. Mdmx impaired early DNA damage-response signaling, such as phosphorylation of the serine/threonine-glutamine motif, mediated by the ATM kinase. Moreover, we identified Mdmx associated with Nbs1 of the Mre11-Rad50-Nbs1 (MRN) DNA repair complex, and this association increased upon DNA damage and was detected at chromatin. Elevated Mdmx levels also increased cellular transformation in a p53-independent manner. Unexpectedly, all Mdmx-mediated phenotypes also occurred in cells lacking Mdm2 and were independent of the Mdm2-binding domain (RING) of Mdmx. Therefore, Mdmx-mediated inhibition of the DNA damage response resulted in delayed DNA repair and increased genome instability and transformation independent of p53 and Mdm2. Our results reveal a novel p53- and Mdm2-independent oncogenic function of Mdmx that provides new insight into the many cancers that overexpress Mdmx.	[Carrillo, A. M.; Arrate, M. P.; Eischen, C. M.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Bouska, A.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA	Vanderbilt University; University of Nebraska System; University of Nebraska Medical Center	Eischen, CM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, MCN C3321 1161 21st Ave South, Nashville, TN 37232 USA.	christine.eischen@vanderbilt.edu		Bouska, Alyssa/0000-0003-1324-6678; Carrillo, Alexia/0000-0002-2827-6952	NCI [F31CA150546, T32CA009582, R01CA117935, R01CA160432]; NCI Cancer Center [P30CA068485]; NATIONAL CANCER INSTITUTE [R01CA160432, F31CA150546, R01CA117935, P30CA068485, T32CA009582] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Brandon Metge for technical expertise; Dr Jean-Christophe Marine for providing the Mdmx vector; Dr Stephen Jones for providing the Mdmx<SUP>-/-</SUP>p53<SUP>-/-</SUP>MEFs; members of the Eischen lab for thoughtful discussions and critical review of this manuscript. This work was supported by NCI grants F31CA150546 (AMC), T32CA009582 (AMC), R01CA117935 (CME) and R01CA160432 (CME), and NCI Cancer Center Support Grant P30CA068485 utilizing the Flow Cytometry Shared Resource.	Alt JR, 2005, J BIOL CHEM, V280, P18771, DOI 10.1074/jbc.M413387200; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Bouska A, 2008, MOL CELL BIOL, V28, P4862, DOI 10.1128/MCB.01584-07; Braden WA, 2006, MOL CELL BIOL, V26, P7667, DOI 10.1128/MCB.00045-06; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Danovi D, 2004, MOL CELL BIOL, V24, P5835, DOI 10.1128/MCB.24.13.5835-5843.2004; De Clercq S, 2010, MOL CELL BIOL, V30, P5394, DOI 10.1128/MCB.00330-10; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gembarska A, 2012, NAT MED, V18, P1239, DOI 10.1038/nm.2863; Giglio S, 2005, CANCER RES, V65, P9687, DOI 10.1158/0008-5472.CAN-05-0450; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang L, 2011, P NATL ACAD SCI USA, V108, P12001, DOI 10.1073/pnas.1102309108; Jones SN, 1998, P NATL ACAD SCI USA, V95, P15608, DOI 10.1073/pnas.95.26.15608; Kamijo T, 1999, CANCER RES, V59, P2464; Kawai H, 2003, J BIOL CHEM, V278, P45946, DOI 10.1074/jbc.M308295200; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Lam S, 2010, ONCOGENE, V29, P2415, DOI 10.1038/onc.2009.522; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Leventaki V, 2012, BRIT J HAEMATOL, V158, P763, DOI 10.1111/j.1365-2141.2012.09243.x; Li X, 2012, ONCOGENE, V31, P3721, DOI 10.1038/onc.2011.534; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Lundgren K, 1997, GENE DEV, V11, P714, DOI 10.1101/gad.11.6.714; Marine JCW, 2007, J CELL SCI, V120, P371, DOI 10.1242/jcs.03362; Matijasevic Z, 2008, CELL CYCLE, V7, P2967, DOI 10.4161/cc.7.19.6797; Matijasevic Z, 2008, MOL CELL BIOL, V28, P1265, DOI 10.1128/MCB.01108-07; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Melo Alexia N, 2012, Genes Cancer, V3, P283, DOI 10.1177/1947601912454139; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Pant V, 2011, P NATL ACAD SCI USA, V108, P11995, DOI 10.1073/pnas.1102241108; Pei DS, 2012, ONCOTARGET, V3, P228; Pereg Y, 2005, P NATL ACAD SCI USA, V102, P5056, DOI 10.1073/pnas.0408595102; Ramos YFM, 2001, CANCER RES, V61, P1839; Rayburn E, 2005, CURR CANCER DRUG TAR, V5, P27, DOI 10.2174/1568009053332636; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sharp DA, 1999, J BIOL CHEM, V274, P38189, DOI 10.1074/jbc.274.53.38189; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Stad R, 2001, EMBO REP, V2, P1029, DOI 10.1093/embo-reports/kve227; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Wang P, 2008, ONCOGENE, V27, P1590, DOI 10.1038/sj.onc.1210788; White JS, 2008, CELL CYCLE, V7, P1277, DOI 10.4161/cc.7.9.5961; White JS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000758; Xiong SB, 2010, CANCER RES, V70, P7148, DOI 10.1158/0008-5472.CAN-10-1457; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	55	40	40	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 12	2015	34	7					846	856		10.1038/onc.2014.27	http://dx.doi.org/10.1038/onc.2014.27			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CB2QF	24608433	Green Accepted			2022-12-25	WOS:000349472000005
J	Colangeli, R; Arcus, VL; Cursons, RT; Ruthe, A; Karalus, N; Coley, K; Manning, SD; Kim, S; Marchiano, E; Alland, D				Colangeli, Roberto; Arcus, Vic L.; Cursons, Ray T.; Ruthe, Ali; Karalus, Noel; Coley, Kathy; Manning, Shannon D.; Kim, Soyeon; Marchiano, Emily; Alland, David			Whole Genome Sequencing of Mycobacterium tuberculosis Reveals Slow Growth and Low Mutation Rates during Latent Infections in Humans	PLOS ONE			English	Article							RECOMMENDATIONS	Very little is known about the growth and mutation rates of Mycobacterium tuberculosis during latent infection in humans. However, studies in rhesus macaques have suggested that latent infections have mutation rates that are higher than that observed during active tuberculosis disease. Elevated mutation rates are presumed risk factors for the development of drug resistance. Therefore, the investigation of mutation rates during human latency is of high importance. We performed whole genome mutation analysis of M. tuberculosis isolates from a multi-decade tuberculosis outbreak of the New Zealand Rangipo strain. We used epidemiological and phylogenetic analysis to identify four cases of tuberculosis acquired from the same index case. Two of the tuberculosis cases occurred within two years of exposure and were classified as recently transmitted tuberculosis. Two other cases occurred more than 20 years after exposure and were classified as reactivation of latent M. tuberculosis infections. Mutation rates were compared between the two recently transmitted pairs versus the two latent pairs. Mean mutation rates assuming 20 hour generation times were 5.5X10(-10) mutations/bp/generation for recently transmitted tuberculosis and 7.3X10(-11) mutations/bp/generation for latent tuberculosis. Generation time versus mutation rate curves were also significantly higher for recently transmitted tuberculosis across all replication rates ( p = 0.006). Assuming identical replication and mutation rates among all isolates in the final two years before disease reactivation, the u20hr mutation rate attributable to the remaining latent period was 1.6x10(-11) mutations/bp/generation, or approximately 30 fold less than that calculated during the two years immediately before disease. Mutations attributable to oxidative stress as might be caused by bacterial exposure to the host immune system were not increased in latent infections. In conclusion, we did not find any evidence to suggest elevated mutation rates during tuberculosis latency in humans, unlike the situation in rhesus macaques.	[Colangeli, Roberto; Marchiano, Emily; Alland, David] Rutgers New Jersey Med Sch, Dept Med, Newark, NJ USA; [Arcus, Vic L.; Cursons, Ray T.; Ruthe, Ali] Univ Waikato, Dept Biol Sci, Hamilton, New Zealand; [Kim, Soyeon] Rutgers New Jersey Med Sch, Dept Prevent Med, Newark, NJ USA; [Manning, Shannon D.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Karalus, Noel] Waikato Hosp, Resp Res Unit, Hamilton, New Zealand; [Coley, Kathy] Waikato Hosp, Dept Pathol, Hamilton, New Zealand	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Waikato; Rutgers State University New Brunswick; Rutgers State University Medical Center; Michigan State University; Waikato Hospital; Waikato Hospital	Alland, D (corresponding author), Rutgers New Jersey Med Sch, Dept Med, Newark, NJ USA.	allandda@njms.rutgers.edu	Manning, Shannon/GXA-0622-2022	Manning, Shannon/0000-0001-9581-0660; ROBERTO, COLANGELI/0000-0003-3263-7404	NIAID [AI49352, AI065663]; University of Waikato Strategic Investment Fund; Waikato Medical Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI065663, R01AI049352] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Waikato Strategic Investment Fund; Waikato Medical Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially funded by NIAID grants AI49352, AI065663 and by the University of Waikato Strategic Investment Fund. The authors also would like to thank the Waikato Medical Research Foundation for funding and the Molecular Microbiology Section, LabPlus, Auckland City Hospital for the MIRU typing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Chin DP, 1996, CLIN CHEST MED, V17, P697, DOI 10.1016/S0272-5231(05)70340-3; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Gupta A, 2012, IMMUNOBIOLOGY, V217, P363, DOI 10.1016/j.imbio.2011.07.008; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; McElnay Caroline, 2004, N Z Med J, V117, pU1019; Namouchi A, 2012, GENOME RES, V22, P721, DOI 10.1101/gr.129544.111; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nei M, 2000, MOL EVOLUTION PHYLOG; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandegren L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016647; Sexton KS, 2008, 5 YEARS MOL TYPING M; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Walker TM, 2012, LANCET INFECT DIS; Zhang Y, 2004, FRONT BIOSCI-LANDMRK, V9, P1136, DOI 10.2741/1291	24	55	56	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91024	10.1371/journal.pone.0091024	http://dx.doi.org/10.1371/journal.pone.0091024			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618815	Green Submitted, Green Published, gold			2022-12-25	WOS:000332842400044
J	Nizza, ST; Campbell, JJ				Nizza, Suzanne T.; Campbell, James J.			CD11b(+) Migratory Dendritic Cells Mediate CD8 T Cell Cross-Priming and Cutaneous Imprinting after Topical Immunization	PLOS ONE			English	Article							EPIDERMAL LANGERHANS CELLS; IN-VIVO; LYMPH-NODE; SELF-ANTIGENS; INFLAMED SKIN; TISSUE; SUBSETS; MICROENVIRONMENT; PROLIFERATION; ACCUMULATION	Topical antigen application is a focus of current vaccine research. This immunization route mimics natural antigen exposure across a barrier tissue and generates T cells imprinted for skin-selective homing. Soluble antigens introduced through this route require cross-presentation by DC to generate CD8 T cell responses. Here we have explored the relative contribution of various skin-derived DC subsets to cross-priming and skin-selective imprinting. In our model, DC acquire soluble Ag in vivo from immunized murine skin for cross-presentation to naive CD8 T cells ex vivo. We find CD11b(+) migratory DC to be the relevant cross-priming DC in this model. Both Langerin(+) and Langerin(-) CD11b(+) migratory DC can cross-present antigen in our system, but only the Langerin(+) subset can induce expression of the skin-selective addressin E-selectin ligand. Thus, the CD11b(+) Langerin(+) migratory DC population, comprised primarily of Langerhans cells, both cross-primes naive CD8 T cells and imprints them with skin-homing capabilities.	[Nizza, Suzanne T.; Campbell, James J.] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Nizza, Suzanne T.] Harvard Univ, Sch Med, Grad Program Biol & Biomed Sci, Boston, MA USA; [Campbell, James J.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Campbell, JJ (corresponding author), Brigham & Womens Hosp, Dept Dermatol, 75 Francis St, Boston, MA 02115 USA.	jcampbell@chemocentryx.com		Campbell, James/0000-0003-4252-5182	NIH [R21AI092388, R21AI097468]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI092388, R21AI097468] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH and R21AI092388 & R21AI097468 (to J. J. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Anderson AO, 2005, IMMUNITY, V22, P3, DOI 10.1016/j.immuni.2005.01.003; Baekkevold ES, 2005, J EXP MED, V201, P1045, DOI 10.1084/jem.20041059; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Burgdorf S, 2008, CURR OPIN IMMUNOL, V20, P89, DOI 10.1016/j.coi.2007.12.002; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Bursch LS, 2009, J IMMUNOL, V182, P4657, DOI 10.4049/jimmunol.0803656; Butcher EC, 1999, ADV IMMUNOL, V72, P209, DOI 10.1016/S0065-2776(08)60022-X; Campbell JJ, 2007, J IMMUNOL, V178, P3358, DOI 10.4049/jimmunol.178.6.3358; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Cao T, 2007, EUR J IMMUNOL, V37, P2657, DOI 10.1002/eji.200636499; del Rio ML, 2010, IMMUNOL REV, V234, P268, DOI 10.1111/j.0105-2896.2009.00874.x; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dudda JC, 2004, J IMMUNOL, V172, P857, DOI 10.4049/jimmunol.172.2.857; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Edele F, 2008, J IMMUNOL, V181, P3745, DOI 10.4049/jimmunol.181.6.3745; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Geissmann F, 2002, J EXP MED, V196, P417, DOI 10.1084/jem.20020018; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; Goldwich A, 2011, J LEUKOCYTE BIOL, V89, P973, DOI 10.1189/jlb.0310180; Hammerschmidt SI, 2008, J EXP MED, V205, P2483, DOI 10.1084/jem.20080039; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Kaplan DH, 2008, EUR J IMMUNOL, V38, P2369, DOI 10.1002/eji.200838397; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kurts C, 2010, NAT REV IMMUNOL, V10, P403, DOI 10.1038/nri2780; Lee HK, 2009, J EXP MED, V206, P359, DOI 10.1084/jem.20080601; Liu LZ, 2010, NAT MED, V16, P224, DOI 10.1038/nm.2078; Lutz MB, 2010, IMMUNOL CELL BIOL, V88, P381, DOI 10.1038/icb.2010.17; Masopust D, 2004, J IMMUNOL, V172, P4875, DOI 10.4049/jimmunol.172.8.4875; Mora JR, 2005, J EXP MED, V201, P303, DOI 10.1084/jem.20041645; Morelli AE, 2001, SEMIN IMMUNOL, V13, P323, DOI 10.1006/smim.2001.0328; Olvera-Gomez I, 2012, P NATL ACAD SCI USA, V109, P2072, DOI 10.1073/pnas.1105771109; Poulin LF, 2007, J EXP MED, V204, P3119, DOI 10.1084/jem.20071724; Shklovskaya E, 2008, J IMMUNOL, V181, P418, DOI 10.4049/jimmunol.181.1.418; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Stoitzner P, 2006, P NATL ACAD SCI USA, V103, P7783, DOI 10.1073/pnas.0509307103; Wang XQ, 2008, J IMMUNOL, V180, P6703, DOI 10.4049/jimmunol.180.10.6703	39	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91054	10.1371/journal.pone.0091054	http://dx.doi.org/10.1371/journal.pone.0091054			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618819	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400045
J	Price, GL; Davis, KL; Karve, S; Pohl, G; Walgren, RA				Price, Gregory L.; Davis, Keith L.; Karve, Sudeep; Pohl, Gerhardt; Walgren, Richard A.			Survival Patterns in United States (US) Medicare Enrollees with Non-CML Myeloproliferative Neoplasms (MPN)	PLOS ONE			English	Article							ESSENTIAL THROMBOCYTHEMIA; POLYCYTHEMIA-VERA; PRIMARY MYELOFIBROSIS; MYELOID MALIGNANCIES; LIFE EXPECTANCY; PROGNOSTIC-FACTORS; OLMSTED COUNTY; DISORDERS; POPULATION; MUTATION	Purpose: Non-CML myeloproliferative neoplasms (MPN) include essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF). Reported median overall survival (OS) ranges from a few to several years for MF, a decade or more for ET and PV. The study objective was to compare US survival rates of ET, PV, and MF patients with matched non-MPN/non-cancer controls in a nationally representative database. Patients and Methods: Data were taken retrospectively from the Survey, Epidemiology, and End Results (SEER)-Medicare linked database. Medicare enrollees with a new SEER MPN diagnosis between Jan 1, 2001 and Dec 31, 2007 were eligible. First MPN diagnosis was required at or after Medicare enrollment to allow for continuous follow-up. Non-MPN/non-cancer control groups were selected from Medicare separately for each MPN subtype and demographically matched to cases at a ratio of 5:1. Survival was determined starting from the case diagnosis date using the Kaplan-Meier method. Results: A total of 3,364 MPN patients (n = 1,217 ET; 1,625 PV; 522 MF) met the inclusion criteria and were matched to controls. Mean age was 78.4, 76.1, and 77.4 years for ET, PV, and MF, respectively, and percent female was 63, 50, and 41. Median OS was significantly (p<0.05) lower for MPN cases vs. controls (ET: 68 vs. 101 months; PV: 65 vs. 104; MF: 24 vs. 106). Conclusions: In the US Medicare population, survival in MF patients was worse than that of patients with ET or PV and significantly worse than matched controls. Survival of patients with ET or PV was substantially inferior to matched controls. These findings have implications for the clinical management of MPN patients and underscore the need for effective therapies in all MPN subtypes.	[Price, Gregory L.; Pohl, Gerhardt; Walgren, Richard A.] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Davis, Keith L.; Karve, Sudeep] RTI Hlth Solut, Res Triangle Pk, NC USA	Eli Lilly; Research Triangle Institute	Price, GL (corresponding author), Eli Lilly & Co, Indianapolis, IN 46285 USA.	glp@lilly.com		Davis, Keith/0000-0002-0044-7107	Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	Gregory L. Price, Gerhardt Pohl, and Richard A. Walgren are employees of Eli Lilly and Company, whose company funded this study. Keith L. Davis and Sudeep Karve are employees of RTI Health Solutions. Eli Lilly and Company is pursuing innovative drug development in the MPNs. There are no other relevant patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	ANIA BJ, 1994, AM J HEMATOL, V47, P89, DOI 10.1002/ajh.2830470205; Campo E, 2011, BLOOD, V117, P5019, DOI 10.1182/blood-2011-01-293050; Cervantes F, 2012, J CLIN ONCOL, V30, P2981, DOI 10.1200/JCO.2012.42.0240; Craig BM, 2012, CANCER EPIDEM BIOMAR, V21, P474, DOI 10.1158/1055-9965.EPI-11-1087; Gangat N, 2011, J CLIN ONCOL, V29, P392, DOI 10.1200/JCO.2010.32.2446; Hultcrantz M, 2012, J CLIN ONCOL, V30, P2995, DOI 10.1200/JCO.2012.42.1925; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Koopmans SM, 2012, NETH J MED, V70, P159; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Leukemia and Lymphoma Society, DIS INF SUPP MYEL NE; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Maynadie M, 2013, HAEMATOLOGICA, V98, P230, DOI 10.3324/haematol.2012.064014; Maynadie M, 2011, HAEMATOL-HEMATOL J, V96, P55, DOI 10.3324/haematol.2010.026252; Mesa RA, 1999, AM J HEMATOL, V61, P10, DOI 10.1002/(SICI)1096-8652(199905)61:1<10::AID-AJH3>3.3.CO;2-9; Murray J, 2005, CLIN MED, V5, P328, DOI 10.7861/clinmedicine.5-4-328; Nattinger AB, 1997, J CLIN EPIDEMIOL, V50, P939, DOI 10.1016/S0895-4356(97)00099-1; Palandri F, 2009, AM J HEMATOL, V84, P215, DOI 10.1002/ajh.21360; Passamonti F, 2004, AM J MED, V117, P755, DOI 10.1016/j.amjmed.2004.06.032; Passamonti F, 2010, BLOOD, V115, P1703, DOI 10.1182/blood-2009-09-245837; Rollison DE, 2008, BLOOD, V112, P45, DOI 10.1182/blood-2008-01-134858; ROZMAN C, 1991, CANCER, V67, P2658, DOI 10.1002/1097-0142(19910515)67:10<2658::AID-CNCR2820671042>3.0.CO;2-C; Silver RT, 2013, BLOOD, V122, P1881, DOI 10.1182/blood-2013-06-508416; Steven H., 2008, WHO CLASSIFICATION T, P40; Tefferi A, 2008, LEUKEMIA, V22, P756, DOI 10.1038/sj.leu.2405097; Thiele J, 1999, LEUKEMIA LYMPHOMA, V33, P207, DOI 10.3109/10428199909058421; Visser O, 2012, EUR J CANCER, V48, P3257, DOI 10.1016/j.ejca.2012.05.024; Warren JL, 2002, MED CARE, V40, P3; Wolanskyj AP, 2006, MAYO CLIN PROC, V81, P159, DOI 10.4065/81.2.159; Xu ZF, 2012, BLOOD, V119, P2469, DOI 10.1182/blood-2011-11-389866	29	37	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90299	10.1371/journal.pone.0090299	http://dx.doi.org/10.1371/journal.pone.0090299			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618579	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400012
J	Velayutham, BRV; Nair, D; Chandrasekaran, V; Raman, B; Sekar, G; Watson, B; Charles, N; Malaisamy, M; Thomas, A; Swaminathan, S				Velayutham, Banu Rekha Vaithilingam; Nair, Dina; Chandrasekaran, Vedachalam; Raman, Balambal; Sekar, Gomathy; Watson, Basilea; Charles, Niruparani; Malaisamy, Muniyandi; Thomas, Aleyamma; Swaminathan, Soumya			Profile and Response to Anti-Tuberculosis Treatment among Elderly Tuberculosis Patients Treated under the TB Control Programme in South India	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; RISK-FACTORS	Introduction: The demographic transition in India has resulted in an increase in the elderly population. There is limited data on the profile of elderly tuberculosis (TB) patients and their treatment outcomes in India. Objective: To compare the clinical profile, presentation and response to anti-TB treatment among elderly (>= 60 yrs) and younger (15-59 yrs) TB patients treated under the Revised National TB Control programme. Methodology: Retrospective cohort analysis of TB patients treated from May 1999 to December 2004 in one Tuberculosis Unit of Tiruvallur district, South India. Results: Records of 865 elderly and 4343 younger TB patients were examined: elderly were more likely to be male (84% vs. 71%), smokers (46% vs. 37%), illiterate (63% vs. 45%), identified by active case finding through survey (19% vs. 11%), have pulmonary TB (96% vs. 91%) and initial smear negative disease (46% vs. 36%) compared to younger (for all p<0.001). Among a total of 352 elderly and 1933 younger new smear positive pulmonary TB, the elderly had higher loss to follow-up (15% vs. 11%; p = 0.03) and death rates (9% vs. 4%; p<0.001). Mycobacterium tuberculosis susceptibility to first line anti-TB drugs did not differ (elderly 87% vs. younger 84%) (p = 0.20). Side effects related to anti-TB drugs were reported by a higher proportion of elderly patients (63% vs. 54%) (p = 0.005). Previously treated patients had similar treatment outcomes in both the groups. Conclusion: Elderly TB patients are less likely to have smear positive disease. Newly diagnosed elderly TB patients are more likely to be lost to follow-up or die and report drug side effects. Suitable interventions need to be developed for effective management and better treatment outcomes of TB in the elderly.	[Velayutham, Banu Rekha Vaithilingam; Nair, Dina; Chandrasekaran, Vedachalam; Raman, Balambal; Sekar, Gomathy; Watson, Basilea; Charles, Niruparani; Malaisamy, Muniyandi; Thomas, Aleyamma; Swaminathan, Soumya] Natl Inst Res TB, Chennai, Tamil Nadu, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Swaminathan, S (corresponding author), Natl Inst Res TB, Chennai, Tamil Nadu, India.	doctorsoumya@yahoo.com	Watson, Basilea/AGH-6965-2022		United States Agency for International Development through the World Health Organization; Indian Council of Medical Research, India	United States Agency for International Development through the World Health Organization(United States Agency for International Development (USAID)); Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR))	This report was funded in part by a grant from the United States Agency for International Development provided through the World Health Organization. Additional funding was from the Indian Council of Medical Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen B W, 1968, MYCOBACTERIA ISOLATI; Ananthakrishnan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067288; [Anonymous], 1983, TUBERCLE, V64, P73; Arora V K, 2003, Indian J Chest Dis Allied Sci, V45, P231; Arora V K, 1989, J Assoc Physicians India, V37, P205; Bhushan B, 2012, INT J TUBERC LUNG D, V16, P1210, DOI 10.5588/ijtld.11.0778; Brinkmann B, 2002, DEUT MED WOCHENSCHR, V127, P791, DOI 10.1055/s-2002-25021; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Central Statistics Office Government of India, 2011, SIT AN ELD IND; Central TB Division (CTD) Directorate General of Health Services Ministry of Health and Family Welfare Government of India, 2005, MAN REV NAT TB CONTR, P77; Central TB Division (CTD) Directorate General of Health Services Ministry of Health and Family Welfare Government of India. Revised National Tuberculosis Control Programme (RNTCP), 2010, TRAIN MOD MED PRACT, P27; Gaur S. N., 2004, Indian Journal of Tuberculosis, V51, P83; Geeta Pardeshi, 2007, Indian Journal of Community Medicine, V32, P292; Hauer B, 2011, EUR RESPIR J, V38, P467, DOI 10.1183/09031936.00199910; Holt PR, 2001, GASTROENTEROL CLIN N, V30, P427, DOI 10.1016/S0889-8553(05)70189-8; Ingle Gopal K, 2008, Indian J Community Med, V33, P214, DOI 10.4103/0970-0218.43225; Kolappan C, 2002, THORAX, V57, P964, DOI 10.1136/thorax.57.11.964; Kwon YS, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-121; Lee JH, 2005, J KOREAN MED SCI, V20, P784, DOI 10.3346/jkms.2005.20.5.784; Pande JN, 1996, THORAX, V51, P132, DOI 10.1136/thx.51.2.132; Rath SP, 2011, INT J BUSINESS MANAG, V1, P1; Rawat Jagdish, 2008, Indian J Tuberc, V55, P84; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; Schaaf HS, 2010, RESPIROLOGY, V15, P747, DOI 10.1111/j.1440-1843.2010.01784.x; Sood R, 2000, J INDIAN ACAD CLIN M, V5, P156; STEAD WW, 1965, AM REV RESPIR DIS, V91, P811; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; TEALE C, 1993, AGE AGEING, V22, P289, DOI 10.1093/ageing/22.4.289; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Zhao FZ, 1997, INT J TUBERC LUNG D, V1, P570	30	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e88045	10.1371/journal.pone.0088045	http://dx.doi.org/10.1371/journal.pone.0088045			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618888	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000332842400003
J	Ciocalteu, A; Saftoiu, A; Cartana, T; Gruionu, LG; Pirici, D; Georgescu, CC; Georgescu, CV; Gheonea, DI; Gruionu, G				Ciocalteu, Adriana; Saftoiu, Adrian; Cartana, Tatiana; Gruionu, Lucian Gheorghe; Pirici, Daniel; Georgescu, Corneliu Cristian; Georgescu, Claudia-Valentina; Gheonea, Dan Ionut; Gruionu, Gabriel			Evaluation of New Morphometric Parameters of Neoangiogenesis in Human Colorectal Cancer Using Confocal Laser Endomicroscopy (CLE) and Targeted Panendothelial Markers	PLOS ONE			English	Article							ANTI-ANGIOGENIC THERAPY; IN-VIVO; VASCULATURE; MICROVASCULATURE; VASCULARIZATION; NORMALIZATION; ARCHITECTURE; TORTUOSITY; TUMORS; MODEL	The tumor microcirculation is characterized by an abnormal vascular network with dilated, tortuous and saccular vessels. Therefore, imaging the tumor vasculature and determining its morphometric characteristics represent a critical goal for optimizing the cancer treatment that targets the blood vessels (i.e. antiangiogenesis therapy). The aim of this study was to evaluate new vascular morphometric parameters in colorectal cancer, difficult to achieve through conventional immunohistochemistry, by using the confocal laser endomicroscopy method. Fresh biopsies from tumor and normal tissue were collected during colonoscopy from five patients with T3 colorectal carcinoma without metastasis and were marked with fluorescently labeled anti-CD31 antibodies. A series of optical slices spanning 250 mm inside the tissue were immediately collected for each sample using a confocal laser endomicroscope. All measurements were expressed as the mean +/- standard error. The mean diameter of tumor vessels was significantly larger than the normal vessels (9.46 +/- 0.4 mu m vs. 7.60 +/- 0.3 mu m, p = 0.0166). The vessel density was also significantly higher in the cancer vs. normal tissue samples (5541.05 +/- 262.81 vs. 3755.79 +/- 194.96 vessels/mm(3), p = 0.0006). These results were confirmed by immunohistochemistry. In addition, the tortuosity index and vessel lengths were not significantly different (1.05 +/- 0.016 and 28.30 +/- 3.27 mu m in normal tissue, vs. 1.07 +/- 0.008 and 26.49 +/- 3.18 mu m in tumor tissue respectively, p = 0.5357 and p = 0.7033). The daughter/mother ratio (ratio of the sum of the squares of daughter vessel radii over the square of the mother vessel radius) was 1.15 +/- 0.09 in normal tissue, and 1.21 +/- 0.08 in tumor tissue (p = 0.6531). The confocal laser endomicroscopy is feasible for measuring more vascular parameters from fresh tumor biopsies than conventional immunohistochemistry alone. Provided new contrast agents will be clinically available, future in vivo use of CLE could lead to identification of novel biomarkers based on the morphometric characteristics of tumor vasculature.	[Ciocalteu, Adriana; Saftoiu, Adrian; Cartana, Tatiana; Gruionu, Lucian Gheorghe; Gheonea, Dan Ionut; Gruionu, Gabriel] Univ Med & Pharm Craiova, Res Ctr Gastroenterol & Hepatol, Craiova, Romania; [Gruionu, Lucian Gheorghe] Univ Craiova, Dept Mech Engn, Craiova, Romania; [Pirici, Daniel] Univ Med & Pharm Craiova, Dept Histol, Craiova, Romania; [Georgescu, Corneliu Cristian] Univ Med & Pharm Craiova, Dept Pharmacol, Craiova, Romania; [Georgescu, Corneliu Cristian] Emergency Cty Hosp, Dept Anesthesiol & Intens Care, Craiova, Romania; [Georgescu, Claudia-Valentina] Emergency Cty Hosp, Dept Pathol, Craiova, Romania; [Gruionu, Gabriel] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiat Oncol,Edwin L Steele Lab Tumor Biol, Boston, MA USA	University of Medicine & Pharmacy of Craiova; University of Craiova; University of Medicine & Pharmacy of Craiova; University of Medicine & Pharmacy of Craiova; Harvard University; Harvard Medical School; Massachusetts General Hospital	Saftoiu, A (corresponding author), Univ Med & Pharm Craiova, Res Ctr Gastroenterol & Hepatol, Craiova, Romania.	adrian.saftoiu@umfcv.ro	GRUIONU, Lucian Gheorghe/F-6121-2011; Gruionu, Gabriel/C-5152-2011; Ciocalteu, Adriana/AAF-8592-2021; Gheonea, Dan Ionut/C-3578-2012; Saftoiu, Adrian/C-2792-2011; Pirici, Daniel/C-5760-2012	GRUIONU, Lucian Gheorghe/0000-0002-4526-0864; Saftoiu, Adrian/0000-0001-7993-8269; Pirici, Daniel/0000-0001-9192-7319; Pirici, Daniel/0000-0002-0196-0949; Ciocalteu, Adriana/0000-0002-8668-4946	National Research Council (CNCS), Romania [PN-II-ID-PCE-2011-3-0664, PN-II-CT-ERC-2012-1]	National Research Council (CNCS), Romania	This work was supported from two research grants funded by the National Research Council (CNCS), Romania, entitled "Clinical and Biomathematical Modeling of Vascular Changes Following Anti-Angiogenic Therapy in Advanced Colorectal Carcinoma," contract number PN-II-ID-PCE-2011-3-0664, and "Real-time Evaluation of Treatment Effects in Advanced Colorectal Carcinoma," contract number PN-II-CT-ERC-2012-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baish JW, 2000, CANCER RES, V60, P3683; Bullitt E, 2005, ACAD RADIOL, V12, P1232, DOI 10.1016/j.acra.2005.05.027; Bullitt E, 2003, IEEE T MED IMAGING, V22, P1163, DOI 10.1109/TMI.2003.816964; Cartana T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052815; Cheong LS, 2009, J SIGNAL PROCESS SYS, V55, P217, DOI 10.1007/s11265-008-0204-8; Cheung ATW, 1997, INT J ONCOL, V11, P69; Ehling J, 2013, THROMB HAEMOSTASIS, V109, P375, DOI 10.1160/TH12-10-0721; Ellis LM, 1998, EUR J CANCER, V34, P609, DOI 10.1016/S0959-8049(97)10040-5; Fukumura D, 2010, MICROCIRCULATION, V17, P206, DOI 10.1111/j.1549-8719.2010.00029.x; Gheonea DI, 2011, WORLD J GASTROENTERO, V17, P21, DOI 10.3748/wjg.v17.i1.21; Goel S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006486; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Goetz M, 2008, EUR SURG RES, V41, P290, DOI 10.1159/000148242; Gruionu G, 2005, AM J PHYSIOL-HEART C, V288, pH2047, DOI 10.1152/ajpheart.00496.2004; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; JAIN RK, 1988, CANCER RES, V48, P2641; Kachlik D, 2010, J ANAT, V216, P335, DOI 10.1111/j.1469-7580.2009.01199.x; Konerding MA, 2001, BRIT J CANCER, V84, P1354, DOI 10.1054/bjoc.2001.1809; Lang S, 2012, MICROVASC RES, V84, P314, DOI 10.1016/j.mvr.2012.07.002; Lee CG, 2000, CANCER RES, V60, P5565; Less JR, 1997, MICROCIRCULATION-LON, V4, P25, DOI 10.3109/10739689709148315; Li M, 2013, GUT, V62, P1547, DOI 10.1136/gutjnl-2011-301946; Magnon C, 2007, GENE THER, V14, P108, DOI 10.1038/sj.gt.3302849; Meining A, 2008, GASTROENTEROLOGY, V134, P915, DOI 10.1053/j.gastro.2008.02.049; Mizuno K, 2011, DIGEST DIS SCI, V56, P1811, DOI 10.1007/s10620-010-1519-4; Savai R, 2009, NEOPLASIA, V11, P48, DOI 10.1593/neo.81036; SHERMAN TF, 1981, J GEN PHYSIOL, V78, P431, DOI 10.1085/jgp.78.4.431; Tatum JL, 2000, ACAD RADIOL, V7, P798, DOI 10.1016/S1076-6332(00)80628-5; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; Yuan F, 1996, P NATL ACAD SCI USA, V93, P14765, DOI 10.1073/pnas.93.25.14765	30	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91084	10.1371/journal.pone.0091084	http://dx.doi.org/10.1371/journal.pone.0091084			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614504	Green Published, gold			2022-12-25	WOS:000332839300074
J	Korrer, MJ; Routes, JM				Korrer, Michael J.; Routes, John M.			Possible Role of Arginase-1 in Concomitant Tumor Immunity	PLOS ONE			English	Article							ADENOVIRUS E1A ONCOGENE; HUMAN-PAPILLOMAVIRUS E7; L-ARGININE; T-CELLS; CYTOLYTIC SUSCEPTIBILITY; BREAST-CANCER; MOUSE MODEL; TNF-ALPHA; NK-CELL; EXPRESSION	The expression of Adenovirus serotype 2 or serotype 5 (Ad2/5) E1A in tumor cells reduces their tumorigenicity in vivo by enhancing the NK cell mediated and T cell mediated anti-tumor immune response, an activity that correlates with the ability of E1A to bind p300. We determined if E1A could be used as a molecular adjuvant to enhance antigen-specific T cell responses to a model tumor antigen, ovalbumin (OVA). To achieve this goal, we stably expressed a fusion protein of E1A and OVA (MCA-205-E1A-OVA), OVA (MCA-205-OVA) or a mutant version of E1A unable to bind p300 and OVA (E1A-Delta p300-OVA) in the B6-derived, highly tumorigenic MCA-205 tumor cell line. MCA-205-E1A-OVA tumor cells were over 10,000 fold less tumorigenic than MCA-205-OVA, MCA-205-E1A-Delta p300-OVA, or MCA-205 in B6 mice. However, immunization of B6 mice with live MCA-205-OVA, MCA-205-E1A-Delta p300-OVA and MCA-E1A-OVA tumor cells induced nearly equivalent OVA-specific CD4 T cells and CD8 CTL responses. Further studies revealed that mice with primary, enlarging MCA-205-OVA or MCA-205-E1A-Delta p300-OVA tumors on one flank exhibited OVA-specific anti-tumor T cell responses that rejected a tumorigenic dose of MCA-205-OVA cells on the contralateral flank (concomitant tumor immunity). Next we found that tumor associated macrophages (TAMs) in progressive MCA-205-OVA tumors, but not MCA-205-E1A-OVA tumors that expressed high levels of arginase-1, which is known to have local immunosuppressive activities. In summary, immunization of mice with MCA-205 cells expressing OVA, E1A-Delta p300-OVA or E1A-OVA induced equivalent OVA-specific CD4 and CD8 anti-tumor responses. TAMs found in MCA-205-OVA, but not MCA-205-E1A-OVA, tumors expressed high levels of arginase-1. We hypothesize that the production of arginase-1 by TAMs in MCA-205-OVA or MCA-205-E1A-Delta p300-OVA tumor cells leads to an ineffective antitumor immune response in the tumor microenvironment, but does not result in inhibition of a systemic anti-tumor immunity.	[Korrer, Michael J.; Routes, John M.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Korrer, Michael J.; Routes, John M.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [Korrer, Michael J.; Routes, John M.] Childrens Res Inst, Milwaukee, WI USA; [Korrer, Michael J.; Routes, John M.] Med Coll Wisconsin, Ctr Canc, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Korrer, MJ (corresponding author), Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	mjkorrer@gmail.com; jroutes@mcw.edu	Routes, john/AAA-4833-2021	Routes, john/0000-0001-8378-3773; Korrer, Michael/0000-0001-8477-8810	National Institutes of Health [CA125666-05]; NATIONAL CANCER INSTITUTE [R01CA125666] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant CA125666-05 to J. M. Routes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; COOK JL, 1984, SCIENCE, V224, P612, DOI 10.1126/science.6710160; COOK JL, 1986, P NATL ACAD SCI USA, V83, P6965, DOI 10.1073/pnas.83.18.6965; Cook JL, 1996, P NATL ACAD SCI USA, V93, P13985, DOI 10.1073/pnas.93.24.13985; COOK JL, 1979, CANCER RES, V39, P3335; COOK JL, 1989, J IMMUNOL, V142, P4527; EGAN C, 1988, MOL CELL BIOL, V8, P3955, DOI 10.1128/MCB.8.9.3955; GALLIMORE PH, 1977, CELL, V10, P669, DOI 10.1016/0092-8674(77)90100-3; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Iyer RK, 2002, MOL CELL BIOL, V22, P4491, DOI 10.1128/MCB.22.13.4491-4498.2002; Kasten J, 2013, MOL GENET METAB, V110, P222, DOI 10.1016/j.ymgme.2013.06.020; KELEKAR A, 1987, MOL CELL BIOL, V7, P3899, DOI 10.1128/MCB.7.11.3899; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Loubaki L, 2013, J IMMUNOL METHODS, V393, P38, DOI 10.1016/j.jim.2013.04.004; Marzo AL, 2000, J IMMUNOL, V165, P6047, DOI 10.4049/jimmunol.165.11.6047; Miura TA, 2003, J IMMUNOL, V170, P4119, DOI 10.4049/jimmunol.170.8.4119; Prati C, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3860; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Rodriguez PC, 2007, BLOOD, V109, P1568, DOI 10.1182/blood-2006-06-031856; Rodriguez PC, 2010, J IMMUNOL, V185, P5198, DOI 10.4049/jimmunol.1001224; Rodriguez PC, 2002, J BIOL CHEM, V277, P21123, DOI 10.1074/jbc.M110675200; Routes JM, 2000, VIROLOGY, V277, P48, DOI 10.1006/viro.2000.0571; Routes JM, 2005, J EXP MED, V202, P1477, DOI 10.1084/jem.20050240; Routes JM, 2000, J IMMUNOL, V165, P4522, DOI 10.4049/jimmunol.165.8.4522; SPIESS PJ, 1987, JNCI-J NATL CANCER I, V79, P1067; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Taheri F, 2001, CLIN CANCER RES, V7, p958S; Torisu H, 2000, INT J CANCER, V85, P182, DOI 10.1002/(SICI)1097-0215(20000115)85:2<182::AID-IJC6>3.3.CO;2-D; Turk MJ, 2004, J EXP MED, V200, P771, DOI 10.1084/jem.20041130; WALKER TA, 1991, P NATL ACAD SCI USA, V88, P6491, DOI 10.1073/pnas.88.15.6491; Wang F, 2013, CELL MOL LIFE SCI, V70, P3989, DOI 10.1007/s00018-012-1254-4	31	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91370	10.1371/journal.pone.0091370	http://dx.doi.org/10.1371/journal.pone.0091370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614600	Green Published, gold, Green Submitted			2022-12-25	WOS:000332839300117
J	Niedermeyer, THJ; Daily, A; Swiatecka-Hagenbruch, M; Moscow, JA				Niedermeyer, Timo H. J.; Daily, Abigail; Swiatecka-Hagenbruch, Monika; Moscow, Jeffrey A.			Selectivity and Potency of Microcystin Congeners against OATP1B1 and OATP1B3 Expressing Cancer Cells	PLOS ONE			English	Article							ANION-TRANSPORTING POLYPEPTIDES; CYCLIC HEPTAPEPTIDE HEPATOTOXINS; STRUCTURAL-CHARACTERIZATION; CYANOBACTERIAL TOXINS; PROTEIN PHOSPHATASE-1; OSCILLATORIA-AGARDHII; MASS-SPECTROMETRY; GENERAL-METHOD; WATER BLOOM; 1ST REPORT	Microcystins are potent phosphatase inhibitors and cellular toxins. They require active transport by OATP1B1 and OATP1B3 transporters for uptake into human cells, and the high expression of these transporters in the liver accounts for their selective hepatic toxicity. Several human tumors have been shown to have high levels of expression of OATP1B3 but not OATP1B1, the main transporter in liver cells. We hypothesized that microcystin variants could be isolated that are transported preferentially by OATP1B3 relative to OATP1B1 to advance as anticancer agents with clinically tolerable hepatic toxicity. Microcystin variants have been isolated and tested for cytotoxicity in cancer cells stably transfected with OATP1B1 and OATP1B3 transporters. Microcystin variants with cytotoxic OATP1B1/OATP1B3 IC50 ratios that ranged between 0.2 and 32 were found, representing a 150-fold range in transporter selectivity. As microcystin structure has a significant impact on transporter selectivity, it is potentially possible to develop analogs with even more pronounced OATP1B3 selectivity and thus enable their development as anticancer drugs.	[Niedermeyer, Timo H. J.; Swiatecka-Hagenbruch, Monika] Cyano Biotech GmbH, Berlin, Germany; [Niedermeyer, Timo H. J.] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Tubingen, Germany; [Daily, Abigail; Moscow, Jeffrey A.] Univ Kentucky, Dept Pediat, Lexington, KY USA	Eberhard Karls University of Tubingen; University of Kentucky	Niedermeyer, THJ (corresponding author), Cyano Biotech GmbH, Berlin, Germany.	timo.niedermeyer@uni-tuebingen.de		Niedermeyer, Timo/0000-0003-1779-7899	DanceBlue; University of Kentucy; German Federal Ministry of Economics and Technology [KF2766301SB0]; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Tuebingen University	DanceBlue; University of Kentucy; German Federal Ministry of Economics and Technology(Federal Ministry for Economic Affairs and Energy (BMWi)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Tuebingen University	This work was supported in part by DanceBlue, a student-run effort that supports clinical care and research in pediatric oncology at the University of Kentucy, and in part by the German Federal Ministry of Economics and Technology (KF2766301SB0). Open Access publishing is supported by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN JS, 1994, TOXICON, V32, P1495, DOI 10.1016/0041-0101(94)90308-5; Andersen R. A., 2005, ALGAL CULTURING TECH; AZEVEDO SMFO, 1994, J APPL PHYCOL, V6, P261, DOI 10.1007/BF02181936; Bagu JR, 1997, J BIOL CHEM, V272, P5087, DOI 10.1074/jbc.272.8.5087; BATEMAN KP, 1995, J CHROMATOGR A, V712, P253, DOI 10.1016/0021-9673(95)00438-S; Beattie KA, 1998, PHYTOCHEMISTRY, V47, P1289, DOI 10.1016/S0031-9422(97)00769-3; Beattie KA, 2000, PHYTOCHEMISTRY, V54, P57, DOI 10.1016/S0031-9422(00)00045-5; Blom JF, 2005, TOXICON, V46, P465, DOI 10.1016/j.toxicon.2005.06.013; Boaru DA, 2006, TOXICOLOGY, V218, P134, DOI 10.1016/j.tox.2005.10.005; BOTES DP, 1985, J CHEM SOC PERK T 1, P2747, DOI 10.1039/p19850002747; BOTES DP, 1984, J CHEM SOC PERK T 1, P2311, DOI 10.1039/p19840002311; Brittain S, 2000, TOXICON, V38, P1759, DOI 10.1016/S0041-0101(00)00105-7; Butler N., 2009, MICROCYSTINS BRIEF O; Buxhofer-Ausch V, 2013, J DRUG DELIV, V2013, P1; Campos A, 2010, INT J MOL SCI, V11, P268, DOI 10.3390/ijms11010268; Chen YM, 2006, TOXICON, V47, P742, DOI 10.1016/j.toxicon.2006.01.026; Christiansen G, 2003, J BACTERIOL, V185, P564, DOI 10.1128/JB.185.2.564-572.2003; Christiansen G, 2008, J NAT PROD, V71, P1881, DOI 10.1021/np800397u; Colby DA, 2006, MINI-REV MED CHEM, V6, P109; CRAIG M, 1993, TOXICON, V31, P1541, DOI 10.1016/0041-0101(93)90338-J; Daily A, 2010, TOXICON, V55, P827, DOI 10.1016/j.toxicon.2009.11.019; Dawson RM, 1998, TOXICON, V36, P953, DOI 10.1016/S0041-0101(97)00102-5; del Campo FF, 2010, ENVIRON POLLUT, V158, P2906, DOI 10.1016/j.envpol.2010.06.018; Diehnelt CW, 2006, ANAL CHEM, V78, P501, DOI 10.1021/ac051556d; Diehnelt CW, 2005, TRAC-TREND ANAL CHEM, V24, P622, DOI 10.1016/j.trac.2005.04.013; Dittmann E, 2006, MOL NUTR FOOD RES, V50, P7, DOI 10.1002/mnfr.200500162; Fischer A, 2010, TOXICOL APPL PHARM, V245, P9, DOI 10.1016/j.taap.2010.02.006; GATHERCOLE PS, 1987, J CHROMATOGR, V408, P435, DOI 10.1016/S0021-9673(01)81837-9; GOLDBERG J, 1995, NATURE, V376, P745, DOI 10.1038/376745a0; Grach-Pogrebinsky O, 2004, J NAT PROD, V67, P337, DOI 10.1021/np034036r; Gulledge BM, 2003, BIOORG MED CHEM LETT, V13, P2907, DOI 10.1016/S0960-894X(03)00588-2; Hagenbuch B, 2008, XENOBIOTICA, V38, P778, DOI [10.1080/00498250801986951, 10.1080/00498250801986951 ]; HARADA K, 1991, CHEM RES TOXICOL, V4, P535, DOI 10.1021/tx00023a008; HARADA K, 1991, TOXICON, V29, P479, DOI 10.1016/0041-0101(91)90022-J; Harada K, 2004, CHEM PHARM BULL, V52, P889, DOI 10.1248/cpb.52.889; HARADA K, 1990, CHEM RES TOXICOL, V3, P473, DOI 10.1021/tx00017a014; Hays A, 2013, PHARM RES-DORDR, V30, P2260, DOI 10.1007/s11095-012-0962-7; Herfindal L, 2011, MOL PHARMACEUT, V8, P360, DOI 10.1021/mp1002224; Hicks LM, 2006, ACS CHEM BIOL, V1, P93, DOI 10.1021/cb500007v; Kalliokoski A, 2009, BRIT J PHARMACOL, V158, P693, DOI 10.1111/j.1476-5381.2009.00430.x; KIVIRANTA J, 1992, TOXICON, V30, P1093, DOI 10.1016/0041-0101(92)90054-9; Konig J, 2006, N-S ARCH PHARMACOL, V372, P432, DOI 10.1007/s00210-006-0040-y; KRISHNAMURTHY T, 1989, P NATL ACAD SCI USA, V86, P770, DOI 10.1073/pnas.86.3.770; KUSUMI T, 1987, TETRAHEDRON LETT, V28, P4695, DOI 10.1016/S0040-4039(00)96600-0; Lee TH, 1998, TOXICON, V36, P247, DOI 10.1016/S0041-0101(97)00128-1; Lee TH, 2000, BOT BULL ACAD SINICA, V41, P197; Lee W, 2008, CANCER RES, V68, P10315, DOI 10.1158/0008-5472.CAN-08-1984; Liu TY, 2014, J DRUG TARGET, V22, P14, DOI 10.3109/1061186X.2013.832767; LUUKKAINEN R, 1994, TOXICON, V32, P133, DOI 10.1016/0041-0101(94)90030-2; LUUKKAINEN R, 1993, APPL ENVIRON MICROB, V59, P2204, DOI 10.1128/AEM.59.7.2204-2209.1993; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; Matthiensen A, 2000, PHYTOCHEMISTRY, V55, P383, DOI 10.1016/S0031-9422(00)00335-6; Mayumi T, 2006, J ANTIBIOT, V59, P710, DOI 10.1038/ja.2006.95; Mazur-Marzec H, 2006, RAPID COMMUN MASS SP, V20, P2023, DOI 10.1002/rcm.2558; McCluskey A, 2002, J MED CHEM, V45, P1151, DOI 10.1021/jm010066k; McConnell JL, 2009, MOL PHARMACOL, V75, P1249, DOI 10.1124/mol.108.053140; MERILUOTO JAO, 1989, TOXICON, V27, P1021, DOI 10.1016/0041-0101(89)90153-0; Monks NR, 2007, MOL CANCER THER, V6, P587, DOI 10.1158/1535-7163.MCT-06-0500; Moscow JA, 1997, INT J CANCER, V72, P184, DOI 10.1002/(SICI)1097-0215(19970703)72:1<184::AID-IJC26>3.0.CO;2-I; MOSCOW JA, 1993, BRIT J CANCER, V68, P732, DOI 10.1038/bjc.1993.419; Muto M, 2007, CANCER SCI, V98, P1570, DOI 10.1111/j.1349-7006.2007.00570.x; NAMIKOSHI M, 1992, CHEM RES TOXICOL, V5, P661, DOI 10.1021/tx00029a011; Namikoshi M, 1998, CHEM RES TOXICOL, V11, P143, DOI 10.1021/tx970120t; NAMIKOSHI M, 1992, J ORG CHEM, V57, P866, DOI 10.1021/jo00029a016; NAMIKOSHI M, 1994, J ORG CHEM, V59, P2349, DOI 10.1021/jo00088a014; NAMIKOSHI M, 1995, J ORG CHEM, V60, P3671, DOI 10.1021/jo00117a017; NAMIKOSHI M, 1992, TOXICON, V30, P1457, DOI 10.1016/0041-0101(92)90521-6; NAMIKOSHI M, 1992, TOXICON, V30, P1473, DOI 10.1016/0041-0101(92)90523-8; Niedermeyer THJ, 2014, NAT PRODUCT IN PRESS; Niedermeyer THJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044913; NISHIWAKIMATSUSHIMA R, 1992, J CANCER RES CLIN, V118, P420, DOI 10.1007/BF01629424; Okello W, 2010, ENVIRON TOXICOL, V25, P367, DOI 10.1002/tox.20522; Oksanen I, 2004, APPL ENVIRON MICROB, V70, P5756, DOI 10.1128/AEM.70.10.5756-5763.2004; Pearson L, 2010, MAR DRUGS, V8, P1650, DOI 10.3390/md8051650; Pegram RA, 2008, ADV EXP MED BIOL, V619, P317, DOI 10.1007/978-0-387-75865-7_15; PIANTINI U, 1982, J AM CHEM SOC, V104, P6800, DOI 10.1021/ja00388a062; RINEHART KL, 1988, J AM CHEM SOC, V110, P8557, DOI 10.1021/ja00233a049; Robillot C, 2000, ENVIRON SCI TECHNOL, V34, P3372, DOI 10.1021/es991294v; Sainis I, 2010, MAR DRUGS, V8, P629, DOI 10.3390/md8030629; Sano T, 2004, PHYTOCHEMISTRY, V65, P2159, DOI 10.1016/j.phytochem.2004.03.034; Sano T, 1998, J NAT PROD, V61, P851, DOI 10.1021/np980047m; SANO T, 1995, TETRAHEDRON LETT, V36, P8603, DOI 10.1016/0040-4039(95)01824-2; Sano T, 1998, TETRAHEDRON, V54, P463, DOI 10.1016/S0040-4020(97)10291-5; SIVONEN K, 1990, APPL ENVIRON MICROB, V56, P2650, DOI 10.1128/AEM.56.9.2650-2657.1990; SIVONEN K, 1992, TOXICON, V30, P1465, DOI 10.1016/0041-0101(92)90522-7; SIVONEN K, 1992, TOXICON, V30, P1481, DOI 10.1016/0041-0101(92)90524-9; SIVONEN K, 1992, CHEM RES TOXICOL, V5, P464, DOI 10.1021/tx00028a003; STONER RD, 1989, TOXICON, V27, P825, DOI 10.1016/0041-0101(89)90051-2; Taylor C, 1996, BIOORG MED CHEM LETT, V6, P2113, DOI 10.1016/0960-894X(96)00378-2; Tillett D, 2000, CHEM BIOL, V7, P753, DOI 10.1016/S1074-5521(00)00021-1; Toivola DM, 1999, TOXICOL IN VITRO, V13, P521, DOI 10.1016/S0887-2333(99)00024-7; Tsakalozou E, 2013, DRUG METAB DISPOS, V41, P1404, DOI 10.1124/dmd.112.050021; van Apeldoorn ME, 2007, MOL NUTR FOOD RES, V51, P7, DOI 10.1002/mnfr.200600185; Watanabe MF, 1995, TOXIC MICROCYSTIS; Zurawell RW, 2005, J TOXICOL ENV HEAL B, V8, P1, DOI 10.1080/10937400590889412	95	47	48	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91476	10.1371/journal.pone.0091476	http://dx.doi.org/10.1371/journal.pone.0091476			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614281	Green Submitted, gold, Green Published			2022-12-25	WOS:000332839300131
J	de Macedo-Soares, LCP; Garcia, CAE; Freire, AS; Muelbert, JH				Pinto de Macedo-Soares, Luis Carlos; Eiras Garcia, Carlos Alberto; Freire, Andrea Santarosa; Muelbert, Jose Henrique			Large-Scale Ichthyoplankton and Water Mass Distribution along the South Brazil Shelf	PLOS ONE			English	Article							LARVAL FISH ASSEMBLAGES; ANCHOVY ENGRAULIS-ANCHOITA; OCEANOGRAPHIC CONDITIONS; REPRODUCTIVE HABITATS; LATITUDINAL GRADIENTS; CONTINENTAL-SHELF; COASTAL LAGOON; PATTERNS; MYCTOPHIDAE; DIVERSITY	Ichthyoplankton is an essential component of pelagic ecosystems, and environmental factors play an important role in determining its distribution. We have investigated simultaneous latitudinal and cross-shelf gradients in ichthyoplankton abundance to test the hypothesis that the large-scale distribution of fish larvae in the South Brazil Shelf is associated with water mass composition. Vertical plankton tows were collected between 21 degrees 27' and 34 degrees 51'S at 107 stations, in austral late spring and early summer seasons. Samples were taken with a conical-cylindrical plankton net from the depth of chlorophyll maxima to the surface in deep stations, or from 10 m from the bottom to the surface in shallow waters. Salinity and temperature were obtained with a CTD/rosette system, which provided seawater for chlorophyll-a and nutrient concentrations. The influence of water mass on larval fish species was studied using Indicator Species Analysis, whereas environmental effects on the distribution of larval fish species were analyzed by Distance-based Redundancy Analysis. Larval fish species were associated with specific water masses: in the north, Sardinella brasiliensis was found in Shelf Water; whereas in the south, Engraulis anchoita inhabited the Plata Plume Water. At the slope, Tropical Water was characterized by the bristlemouth Cyclothone acclinidens. The concurrent analysis showed the importance of both cross-shelf and latitudinal gradients on the large-scale distribution of larval fish species. Our findings reveal that ichthyoplankton composition and large-scale spatial distribution are determined by water mass composition in both latitudinal and cross-shelf gradients.	[Pinto de Macedo-Soares, Luis Carlos; Freire, Andrea Santarosa] Univ Fed Santa Catarina, Dept Ecol & Zool, Lab Crustaceos & Plancton, Programa Posgrad Ecol, Florianopolis, SC, Brazil; [Pinto de Macedo-Soares, Luis Carlos; Muelbert, Jose Henrique] Univ Fed Rio Grande, Inst Oceanog, Lab Ecol Ictioplancton, Rio Grande, RS, Brazil; [Eiras Garcia, Carlos Alberto] Univ Fed Rio Grande, Inst Oceanog, Lab Estudos Oceanos & Clima, Rio Grande, RS, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal do Rio Grande; Universidade Federal do Rio Grande	de Macedo-Soares, LCP (corresponding author), Univ Fed Santa Catarina, Dept Ecol & Zool, Lab Crustaceos & Plancton, Programa Posgrad Ecol, Florianopolis, SC, Brazil.	luismacedosoares@gmail.com	Freire, Andrea/AAQ-9863-2021; de Macedo Soares, Luis Carlos Pinto/R-4883-2019; Freire, Andrea S/J-6226-2018; Muelbert, Jose H/J-5110-2014; Garcia, Carlos A. E./K-7382-2012	de Macedo Soares, Luis Carlos Pinto/0000-0003-4993-2901; Freire, Andrea S/0000-0001-6280-7254; Muelbert, Jose H/0000-0002-2319-2469; 	MCTI; Brazilian Navy; CNPq [482059/2010-9, Proc. 310931/2012-6]; CAPES	MCTI; Brazilian Navy; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study is part of the project "Fronts dynamics in the south and southeast Brazilian shelf and upper slope and its influence on carbon fluxes between ocean and atmosphere", and was supported by MCTI, Brazilian Navy, CNPq (Grant 482059/2010-9) and by a post-graduate fellowship from CAPES. JHM benefited from a CNPq grant (Proc. 310931/2012-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha EM, 2004, J MARINE SYST, V44, P83, DOI 10.1016/j.jmarsys.2003.09.005; Ahlstrom E.H., 1980, California Cooperative Oceanic Fisheries Investigations Reports, V21, P121; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; BAKUN A, 1991, ICES J MAR SCI, V48, P343, DOI 10.1093/icesjms/48.3.343; BAKUN A, 1990, J CONSEIL, V46, P269; Berasategui AD, 2004, ESTUAR COAST SHELF S, V60, P599, DOI 10.1016/j.ecss.2004.02.015; BOEHLERT GW, 1994, MAR ECOL PROG SER, V107, P1, DOI 10.3354/meps107001; Bonecker ACT, 2006, SERIE LIVROS DOCUMEN, V19; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Braga ES, 2008, CONT SHELF RES, V28, P1649, DOI 10.1016/j.csr.2007.06.018; Calado L, 2010, CONT SHELF RES, V30, P1181, DOI 10.1016/j.csr.2010.03.007; Campos EJD, 2000, GEOPHYS RES LETT, V27, P751, DOI 10.1029/1999GL010502; Campos PC, 2013, J GEOPHYS RES-OCEANS, V118, P1420, DOI 10.1002/jgrc.20131; Castello JP, 2009, J APPL ICHTHYOL, V25, P287, DOI 10.1111/j.1439-0426.2009.01229.x; Castello L, 2003, FISH RES, V59, P409, DOI 10.1016/S0165-7836(02)00014-0; Castro BM., 2006, AMBIENTE OCEANOGR FI, P11; Ciechomski JD, 1965, B I BIOL MAR, V9, P1; CIOTTI AM, 1995, CONT SHELF RES, V15, P1737, DOI 10.1016/0278-4343(94)00091-Z; Clarke K., 2005, PRIMER 6 COMPUTER PR; de Castro MS, 2005, BRAZ ARCH BIOL TECHN, V48, P121, DOI 10.1590/S1516-89132005000100016; de Freitas WM, 2004, BRAZ ARCH BIOL TECHN, V47, P601, DOI 10.1590/S1516-89132004000400014; Derisio C, 2012, SCI MAR, V76, P29, DOI 10.3989/scimar.2012.76n1029; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Ekau W, 1999, ARCH FISH MAR RES, V47, P183; Fahay M.P., 1983, Journal of Northwest Atlantic Fishery Science, V4, P1; FIELD JG, 1982, MAR ECOL PROG SER, V8, P37, DOI 10.3354/meps008037; Floeter SR, 2004, J FISH BIOL, V64, P1680, DOI 10.1111/j.0022-1112.2004.00428.x; Floeter SR, 2001, GLOBAL ECOL BIOGEOGR, V10, P423, DOI 10.1046/j.1466-822X.2001.00245.x; Franco BC, 2006, FISH OCEANOGR, V15, P37, DOI 10.1111/j.1365-2419.2005.00359.x; Franco-Gordo C, 2008, FISH OCEANOGR, V17, P178, DOI 10.1111/j.1365-2419.2008.00463.x; Franco-Gordo C, 2002, J PLANKTON RES, V24, P775, DOI 10.1093/plankt/24.8.775; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Grasshoff K., 1983, METHODS SEAWATER ANA, V2nd, DOI DOI 10.15359/REVMAR.3.2; Heiberger R, 2013, HH STAT ANAL DATA DI; Hernandez-Miranda E, 2003, ESTUAR COAST SHELF S, V56, P1075, DOI 10.1016/S0272-7714(02)00308-6; Hjort J., 1914, RAPP P V REUN CONS I, V20, P1; Katsuragawa M, 2006, AMBIENTE OCEANOGRAFI, P359; LASKER R, 1975, FISH B-NOAA, V73, P453; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Llanos-Rivera A, 2004, FISH B-NOAA, V102, P207; Lopes RM, 2006, SCI MAR, V70, P189, DOI 10.3989/scimar.2006.70n2189; Macedo-Soares LCP, 2012, MAR ECOL PROG SER, V444, P207, DOI 10.3354/meps09436; Macedo-Soares LCP, 2009, NEOTROP ICHTHYOL, V7, P231, DOI 10.1590/S1679-62252009000200015; Mafalda JR PO, 2006, ATLANTICA, V28, P5; Mafalda Jr PO, 2009, BIOMASSA FITOPLANCTO, P103; Martins IM, 2007, J MARINE SYST, V68, P537, DOI 10.1016/j.jmarsys.2007.02.004; MATSUURA Y, 1975, Boletim do Instituto Oceanografico, V24, P17; MATSUURA Y, 1995, ARCH FISH MAR RES, V42, P239; Matsuura Y, 1997, ICHTHYOL RES, V44, P369, DOI 10.1007/BF02671988; Matsuura Y, 1996, S AFR J MARINE SCI, V17, P29; Matsuura Yasunobu, 1992, Boletim do Instituto Oceanografico, V40, P101, DOI 10.1590/S1679-87591992000100009; Moller OO, 2008, CONT SHELF RES, V28, P1607, DOI 10.1016/j.csr.2008.03.012; Moser H.G., 1996, CALCOFI ATLAS, V33, P1; MOSER HG, 1993, B MAR SCI, V53, P645; Moser HG, 1984, ONTOGENY SYSTEMATICS, V1; Muelbert J.H., 1991, Larval Fish Recruitment in the Americas, P43; Muelbert JH, 2008, CONT SHELF RES, V28, P1662, DOI 10.1016/j.csr.2007.08.011; Muhling BA, 2008, FISH OCEANOGR, V17, P16, DOI 10.1111/j.1365-2419.2007.00452.x; Muhling BA, 2013, FISH OCEANOGR, V22, P409, DOI 10.1111/fog.12031; NELSON J S, 1976, P416; Niencheski LFH, 2007, MAR CHEM, V106, P546, DOI 10.1016/j.marchem.2007.06.004; Nonaka RH, 2000, FISH B-NOAA, V98, P767; Oksanen J., 2013, VEGAN COMMUNITY ECOL; Olivar MP, 2010, FISH OCEANOGR, V19, P209, DOI 10.1111/j.1365-2419.2010.00538.x; OLIVAR M-P, 1991, Scientia Marina, V55, P1; Olivar MP, 1999, SCI MAR, V63, P101; OLIVAR MP, 1993, B MAR SCI, V53, P450; Olivar MP, 1995, S AFR J MARINE SCI, V16, P129; Olivar MP, 1997, B MAR SCI, V60, P47; OLNEY J E, 1976, Chesapeake Science, V17, P229, DOI 10.2307/1350510; Piola AR, 2008, CONT SHELF RES, V28, P1639, DOI 10.1016/j.csr.2008.03.013; R Core Team, 2021, R LANG ENV STAT COMP; Richards W. J., 2005, EARLY STAGES ATLANTI; Rodrigues RR, 2001, CONT SHELF RES, V21, P371, DOI 10.1016/S0278-4343(00)00094-7; Sabates A, 2007, PROG OCEANOGR, V74, P355, DOI 10.1016/j.pocean.2007.04.017; Sanvicente-Anorve L, 1998, B MAR SCI, V62, P17; Sassa C, 2003, ICHTHYOL RES, V50, P94, DOI 10.1007/s102280300015; Schmidt A, 2011, J HYDROL, V406, P66, DOI 10.1016/j.jhydrol.2011.06.001; Schwartzlose RA, 1999, S AFR J MARINE SCI, V21, P289; Silveira I.C.A., 2000, REV BRAS OCEANOGR, V48, P171, DOI [10.1590/S1413-77392000000200008, DOI 10.1590/S1413-77392000000200008]; SMITH P E, 1977, FAO (Food and Agriculture Organization of the United Nations) Fisheries Technical Paper, V175, P1; Strickland J. D. H., 1968, B FISH RES BOARD CAN, V167; VALENTIN JL, 1984, HYDROBIOLOGIA, V113, P183, DOI 10.1007/BF00026607; Vinagre C, 2009, ESTUAR COAST SHELF S, V81, P375, DOI 10.1016/j.ecss.2008.11.015; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Woodd-Walker RS, 2002, MAR ECOL PROG SER, V236, P189, DOI 10.3354/meps236189	88	36	37	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91241	10.1371/journal.pone.0091241	http://dx.doi.org/10.1371/journal.pone.0091241			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614798	Green Published, gold, Green Submitted			2022-12-25	WOS:000332839300101
J	Rathe, AA; Pilkington, LJ; Hoddle, MS; Spohr, LJ; Daugherty, MP; Gurr, GM				Rathe, Anna A.; Pilkington, Leigh J.; Hoddle, Mark S.; Spohr, Lorraine J.; Daugherty, Matthew P.; Gurr, Geoff M.			Feeding and Development of the Glassy-Winged Sharpshooter, Homalodisca vitripennis, on Australian Native Plant Species and Implications for Australian Biosecurity	PLOS ONE			English	Article							GONATOCERUS-TRIGUTTATUS HYMENOPTERA; HEMIPTERA CICADELLIDAE; HOST PLANTS; XYLEM FLUID; COAGULATA HOMOPTERA; GERMAR HEMIPTERA; FRENCH-POLYNESIA; LEAFHOPPER; MYMARIDAE; ASHMEADI	In any insect invasion the presence or absence of suitable food and oviposition hosts in the invaded range is a key factor determining establishment success. The glassy-winged sharpshooter, Homalodisca vitripennis, is an important insect vector of the xylem-limited bacterial plant pathogen, Xylella fastidiosa, which causes disease in numerous host plants including food and feedstock crops, ornamentals and weeds. Both the pathogen and the vector are native to the Americas and are considered to be highly invasive. Neither has been detected in Australia. Twelve Australian native plant species present in the USA were observed over two years for suitability as H. vitripennis feeding, oviposition and nymph development hosts. Hosts providing evidence of adult or nymph presence were Leptospermum laevigatum, Acacia cowleana, Eremophila divaricata, Eucalyptus wandoo, Hakea laurina, Melaleuca laterita and Swainsona galegifolia. An oviposition-suitability field study was conducted with citrus, a favoured oviposition host, as a positive control. Citrus and L. laevigatum, A. cowleana, B. ericifoliaxB. spinulosa, C. pulchella, E. divaricata, E. wandoo, H. laurina, and S. galegifolia were found to be oviposition hosts. Egg parasitism by the mymarid parasitoid Gonatocerus ashmeadi was observed on all Australian plants. A number of Australian plants that may facilitate H. vitripennis invasion have been identified and categorised as 'high risk' due to their ability to support all three life stages (egg, nymph and adult) of the insect in the field (L. laevigatum, A. cowleana, E. divaricata, H. laurina, and S. galegifolia). The implications of these host status and natural enemy research findings are discussed and placed in an Australian invasion context.	[Rathe, Anna A.; Pilkington, Leigh J.] Plant Biosecur Cooperat Res Ctr, Bruce, ACT, Australia; [Rathe, Anna A.; Pilkington, Leigh J.] NSW Dept Primary Ind, Graham Ctr Agr Innovat, Gosford, NSW, Australia; [Rathe, Anna A.; Pilkington, Leigh J.] Charles Sturt Univ, Cent Coast Primary Ind Ctr, NSW Dept Primary Ind, Gosford, NSW, Australia; [Rathe, Anna A.; Gurr, Geoff M.] NSW Dept Primary Ind, Graham Ctr Agr Innovat, Orange, NSW, Australia; [Rathe, Anna A.; Gurr, Geoff M.] Charles Sturt Univ, Orange, NSW, Australia; [Hoddle, Mark S.; Daugherty, Matthew P.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Spohr, Lorraine J.] NSW Dept Primary Ind, Cent Coast Primary Ind Ctr, Gosford, NSW, Australia	NSW Department of Primary Industries; Charles Sturt University; NSW Department of Primary Industries; NSW Department of Primary Industries; Charles Sturt University; University of California System; University of California Riverside; NSW Department of Primary Industries	Pilkington, LJ (corresponding author), Plant Biosecur Cooperat Res Ctr, Bruce, ACT, Australia.	leigh.pilkington@dpi.nsw.gov.au	Spohr, Lorraine/N-8611-2016; GURR, GEOFFREY M/F-3519-2011	Spohr, Lorraine/0000-0002-0205-6302; Gurr, Geoff/0000-0001-5008-7966	Australian Government's Cooperative Research Centres Program; Grape and Wine Research and Development Corporation; EH Graham Centre for Agricultural Innovation	Australian Government's Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Grape and Wine Research and Development Corporation; EH Graham Centre for Agricultural Innovation	This study was supported by the Australian Government's Cooperative Research Centres Program (http://www.crcplantbiosecurity.com.au), the Grape and Wine Research and Development Corporation (http://www.gwrdc.com.au) and the EH Graham Centre for Agricultural Innovation (http://www.csu.edu.au/research/grahamcentre/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RPP, 2005, ANN ENTOMOL SOC AM, V98, P775, DOI 10.1603/0013-8746(2005)098[0775:VTOXFA]2.0.CO;2; ANDERSEN PC, 1992, J INSECT PHYSIOL, V38, P611, DOI 10.1016/0022-1910(92)90113-R; ANDERSEN PC, 1989, ENTOMOL EXP APPL, V50, P149, DOI 10.1007/BF00365399; Blua M. J., 1999, California Agriculture, V53, P22, DOI 10.3733/ca.v053n02p22; Boyd EA, 2007, SOUTHWEST ENTOMOL, V32, P177, DOI 10.3958/0147-1724-32.3.177; Brodbeck BV, 2007, ENVIRON ENTOMOL, V36, P1512, DOI 10.1603/0046-225X(2007)36[1512:PLOTXF]2.0.CO;2; BRODBECK BV, 1993, J INSECT PHYSIOL, V39, P73, DOI 10.1016/0022-1910(93)90020-R; Butler D, 2011, ASREML R REFERENCE M; California Department of Food and Agriculture, 2005, PLANT QUAR MAN PIERC; Chen WL, 2010, ENVIRON ENTOMOL, V39, P1545, DOI 10.1603/EN10098; Grandgirard J, 2008, BIOL INVASIONS, V10, P135, DOI 10.1007/s10530-007-9116-y; Hoddle MS, 2003, FLA ENTOMOL, V86, P89, DOI 10.1653/0015-4040(2003)086[0089:DAPARF]2.0.CO;2; Hoddle MS, 2009, CDFA PIERC DIS CONTR; Hummel NA, 2006, ENVIRON ENTOMOL, V35, P901, DOI 10.1603/0046-225X-35.4.901; Irvin NA, 2004, FLA ENTOMOL, V87, P504, DOI 10.1653/0015-4040(2004)087[0504:OPOHCF]2.0.CO;2; Johnson MW, 2006, CDFA PIERC DIS CONTR; Krugner R, 2008, BIOL CONTROL, V47, P8, DOI 10.1016/j.biocontrol.2008.06.004; Krugner R, 2009, J ECON ENTOMOL, V102, P960, DOI 10.1603/029.102.0315; Lauziere I, 2009, ANN ENTOMOL SOC AM, V102, P642, DOI 10.1603/008.102.0409; Luck J, 2001, POTENTIAL ESTABLISHM; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Mizell RF, 2008, ENVIRON ENTOMOL, V37, P1049, DOI 10.1603/0046-225X(2008)37[1049:BMFHVH]2.0.CO;2; Morse JG, 2005, CDFA PIERC DIS CONTR; Petit JN, 2008, BIOL INVASIONS, V10, P955, DOI 10.1007/s10530-007-9172-3; Pierce's Disease/Riparian Habitat Workgroup, 2000, INF MAN RIP VEG MAN; Pilkington L. J., 2005, California Agriculture, V59, P223, DOI 10.3733/ca.v059n04p223; R Development Core Team, 2012, R LANG ENV STAT COMP; Raven JA, 1983, ADV ECOLOGICAL RES; Setamou M, 2005, ANN ENTOMOL SOC AM, V98, P322, DOI 10.1603/0013-8746(2005)098[0322:BABOSH]2.0.CO;2; Son Y, 2010, ENVIRON ENTOMOL, V39, P1264, DOI 10.1603/EN09367; Tipping C, 2004, FLA ENTOMOL, V87, P372, DOI 10.1653/0015-4040(2004)087[0372:DAOISO]2.0.CO;2; Triapitsyn SV, 2000, FLA ENTOMOL, V83, P200, DOI 10.2307/3496158; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188	33	6	6	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90410	10.1371/journal.pone.0090410	http://dx.doi.org/10.1371/journal.pone.0090410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614821	Green Published, gold			2022-12-25	WOS:000332839300023
J	Silva, JA; Santana, ET; Manchini, MT; Antonio, EL; Bocalini, DS; Krieger, JE; Tucci, PJF; Serra, AJ				Silva, Jose Antonio, Jr.; Santana, Eduardo Tadeu; Manchini, Martha Trindade; Antonio, Ednei Luis; Bocalini, Danilo Sales; Krieger, Jose Eduardo; Ferreira Tucci, Paulo Jose; Serra, Andrey Jorge			Exercise Training Can Prevent Cardiac Hypertrophy Induced by Sympathetic Hyperactivity with Modulation of Kallikrein-Kinin Pathway and Angiogenesis	PLOS ONE			English	Article							TISSUE KALLIKREIN; NITRIC-OXIDE; BLOOD-PRESSURE; HUMAN HEART; ACTIVATION; RECEPTOR; SYSTEM; MUSCLE; ABNORMALITIES; PROGRESSION	Sympathetic hyperactivity induces adverse effects in myocardial. Recent studies have shown that exercise training induces cardioprotection against sympathetic overload; however, relevant mechanisms of this issue remain unclear. We analyzed whether exercise can prevent pathological hypertrophy induced by sympathetic hyperactivity with modulation of the kallikrein-kinin and angiogenesis pathways. Male Wistar rats were assigned to non-trained group that received vehicle; non-trained isoproterenol treated group (Iso, 0.3 mg kg(-1) day(-1)); and trained group (Iso+Exe) which was subjected to sympathetic hyperactivity with isoproterenol. The Iso rats showed hypertrophy and myocardial dysfunction with reduced force development and relaxation of muscle. The isoproterenol induced severe fibrosis, apoptosis and reduced myocardial capillary. Interestingly, exercise blunted hypertrophy, myocardial dysfunction, fibrosis, apoptosis and capillary decreases. The sympathetic hyperactivity was associated with high abundance of ANF mRNA and beta-MHC mRNA, which was significantly attenuated by exercise. The tissue kallikrein was augmented in the Iso+Exe group, and kinin B-1 receptor mRNA was increased in the Iso group. Moreover, exercise induced an increase of kinin B-2 receptor mRNA in myocardial. The myocardial content of eNOS, VEGF, VEGF receptor 2, pAkt and Bcl-2 were increased in the Iso+Exe group. Likewise, increased expression of pro-apoptotic Bad in the Iso rats was prevented by prior exercise. Our results represent the first demonstration that exercise can modulate kallikrein-kinin and angiogenesis pathways in the myocardial on sympathetic hyperactivity. These findings suggest that kallikrein-kinin and angiogenesis may have a key role in protecting the heart.	[Silva, Jose Antonio, Jr.; Santana, Eduardo Tadeu; Manchini, Martha Trindade; Bocalini, Danilo Sales; Serra, Andrey Jorge] Univ Nove Julho Uninove, Programa Posgrad Ciencias Reabilitacao, Sao Paulo, Brazil; [Antonio, Ednei Luis; Ferreira Tucci, Paulo Jose] Univ Fed Sao Paulo Unifesp, Sao Paulo, Brazil; [Krieger, Jose Eduardo] Univ Sao Paulo, Sao Paulo, Brazil; [Silva, Jose Antonio, Jr.; Serra, Andrey Jorge] Univ Nove Julho Uninove, Programa Posgrad Med, Sao Paulo, Brazil	Universidade Nove de Julho; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Nove de Julho	Serra, AJ (corresponding author), Univ Nove Julho Uninove, Programa Posgrad Ciencias Reabilitacao, Rua Vergueiro, Sao Paulo, Brazil.	andreyserra@gmail.com	Silva, Jose Antonio/AAA-8100-2019; Bocalini, Danilo/J-1997-2014; Serra, Andrey Jorge/E-7460-2015; Antonio, Ednei/AGG-9987-2022; Tucci, Paulo/D-1441-2015	Silva, Jose Antonio/0000-0001-6904-9185; Serra, Andrey Jorge/0000-0002-5407-8183; Antonio, Ednei/0000-0002-8254-5762; Krieger, Jose E/0000-0001-5464-1792; Tucci, Paulo/0000-0001-9793-670X; Manchini, Martha/0000-0001-5785-0899	Sao Paulo Research Foundation (FAPESP) [2009/54225-8]; National Council for Scientific and Technological [477458/2009-2, 479395/2012-8]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological	This work was supported by grant number 2009/54225-8, Sao Paulo Research Foundation (FAPESP) and National Council for Scientific and Technological (grant numbers 477458/2009-2; 479395/2012-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avgeris M, 2010, BIOL CHEM, V391, P505, DOI 10.1515/BC.2010.056; BALLIGAND JL, 1993, P NATL ACAD SCI USA, V90, P347, DOI 10.1073/pnas.90.1.347; Bocalini DS, 2009, INT HEART J, V50, P643, DOI 10.1536/ihj.50.643; Chao JL, 2008, HYPERTENSION, V52, P715, DOI 10.1161/HYPERTENSIONAHA.108.114587; Chao J, 2010, BIOL CHEM, V391, P345, DOI 10.1515/BC.2010.042; Cheng SM, 2013, INT J CARDIOL, V167, P478, DOI 10.1016/j.ijcard.2012.01.031; Concannon LG, 2012, PM&R, V4, P833, DOI 10.1016/j.pmrj.2012.08.007; Crimi E, 2009, NAT REV CARDIOL, V6, P292, DOI 10.1038/nrcardio.2009.8; Downs DS, 2012, RES Q EXERCISE SPORT, V83, P485; Emami N, 2007, CLIN CHIM ACTA, V381, P78, DOI 10.1016/j.cca.2007.02.023; Emanueli C, 2001, TRENDS PHARMACOL SCI, V22, P478, DOI 10.1016/S0165-6147(00)01761-2; Gallego M, 2001, PHARMACOL RES, V44, P311, DOI 10.1006/phrs.2001.0865; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; GERDES AM, 1994, CARDIOSCIENCE, V5, P203; Golbidi S, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/972807; Heather LC, 2009, J PHYSIOL PHARMACOL, V60, P31; Hein S, 2003, CIRCULATION, V107, P984, DOI 10.1161/01.CIR.0000051865.66123.B7; Huang CY, 2012, J APPL PHYSIOL, V112, P883, DOI 10.1152/japplphysiol.00605.2011; Kapakos G, 2010, CURR CARDIOL REV, V6, P247, DOI 10.2174/157340310793566055; Laufs U, 2005, EUR J CARDIOV PREV R, V12, P407, DOI 10.1097/01.hjr.0000174823.87269.2e; Lu FH, 2013, CELL PHYSIOL BIOCHEM, V31, P728, DOI 10.1159/000350091; Mahabeer R, 2000, PHARMACOL THERAPEUT, V88, P77, DOI 10.1016/S0163-7258(00)00080-2; Meneton P, 2001, P NATL ACAD SCI USA, V98, P2634, DOI 10.1073/pnas.051619598; Moreau ME, 2005, J PHARMACOL SCI, V99, P6, DOI 10.1254/jphs.SRJ05001X; Otani H, 2009, ANTIOXID REDOX SIGN, V11, P1913, DOI [10.1089/ars.2009.2453, 10.1089/ARS.2009.2453]; PACKER M, 1988, CIRCULATION, V77, P721, DOI 10.1161/01.CIR.77.4.721; Piepoli Massimo F, 2006, Curr Heart Fail Rep, V3, P33; Pontes FL, 2008, INT IMMUNOPHARMACOL, V8, P261, DOI 10.1016/j.intimp.2007.09.001; Rankin AJ, 2012, SCOT MED J, V57, P99, DOI 10.1258/smj.2011.011284; Rengo G, 2010, AM J PHYSIOL-HEART C, V298, pH2032, DOI 10.1152/ajpheart.00702.2009; Rundqvist B, 1997, CIRCULATION, V95, P169, DOI 10.1161/01.CIR.95.1.169; Ruzicka M, 2013, CLIN SCI, V124, P589, DOI 10.1042/CS20120437; Salimeh A, 2013, J PHYSIOL BIOCHEM, V69, P255, DOI 10.1007/s13105-012-0208-5; Serra AJ, 2008, EUR J HEART FAIL, V10, P534, DOI 10.1016/j.ejheart.2008.03.016; Serra AJ, 2010, J PHYSIOL-LONDON, V588, P2431, DOI 10.1113/jphysiol.2010.187310; Silva JA, 2000, FASEB J, V14, P1858; Stein B, 1996, AM J PHYSIOL-HEART C, V270, pH2021, DOI 10.1152/ajpheart.1996.270.6.H2021; Su JB, 2013, J RENIN ANG IN PRESS; VASSALLO DV, 1988, PHARMACOL RES, V20, P61, DOI 10.1016/S0031-6989(88)80607-6; Wu D, 2012, PLOS ONE, V7; Xu J, 2013, CLIN SCI, V124, P87, DOI 10.1042/CS20120341; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062373; Yin H, 2008, LIFE SCI, V82, P156, DOI 10.1016/j.lfs.2007.10.021; Zhang KR, 2007, APOPTOSIS, V12, P1579, DOI 10.1007/s10495-007-0090-8	44	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91017	10.1371/journal.pone.0091017	http://dx.doi.org/10.1371/journal.pone.0091017			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614810	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300064
J	Aitsi-Selmi, A; Bell, R; Shipley, MJ; Marmot, MG				Aitsi-Selmi, Amina; Bell, Ruth; Shipley, Martin J.; Marmot, Michael G.			Education Modifies the Association of Wealth with Obesity in Women in Middle-Income but Not Low-Income Countries: An Interaction Study Using Seven National Datasets, 2005-2010	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; HEALTH; CHINA; OVERWEIGHT; NUTRITION; TRENDS; RISK	Background: Education and wealth may have different associations with female obesity but this has not been investigated in detail outside high-income countries. This study examines the separate and inter-related associations of education and household wealth in relation to obesity in women in a representative sample of low- and middle-income countries (LMICs). Methods: The seven largest national surveys were selected from a list of Demographic and Health Surveys (DHS) ordered by decreasing sample size and resulted in a range of country income levels. These were nationally representative data of women aged 15-49 years collected in the period 2005-2010. The separate and joint effects, unadjusted and adjusted for age group, parity, and urban/rural residence using a multivariate logistic regression model are presented Results: In the four middle-income countries (Colombia, Peru, Jordan, and Egypt), an interaction was found between education and wealth on obesity (P-value for interaction <0.001). Among women with no/primary education the wealth effect was positive whereas in the group with higher education it was either absent or inverted (negative). In the poorer countries (India, Nigeria, Benin), there was no evidence of an interaction. Instead, the associations between each of education and wealth with obesity were independent and positive. There was a statistically significant difference between the average interaction estimates for the low-income and middle-income countries (P < 0.001). Conclusions: The findings suggest that education may protect against the obesogenic effects of increased household wealth as countries develop. Further research could examine the factors explaining the country differences in education effects.	[Aitsi-Selmi, Amina; Bell, Ruth; Shipley, Martin J.; Marmot, Michael G.] UCL, Dept Epidemiol & Publ Hlth, London, England	University of London; University College London	Aitsi-Selmi, A (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	a.aitsi-selmi@ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419	Wellcome Trust [WT088536MA]; British Heart Foundation; MRC; ESRC [ES/F02679X/1] Funding Source: UKRI; MRC [G0902037, G0701830, G0601647, G1000616] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Economic and Social Research Council [ES/F02679X/1] Funding Source: researchfish; Medical Research Council [G0601647, G1000616, G0902037, G0100222, G8802774, G19/35, G0701830] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust for funding through a clinical Research Training Fellowship [Grant no WT088536MA]. Martin Shipley is partly supported by the British Heart Foundation. Michael Marmot is supported by a MRC professorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitsi-Selmi A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-769; Aitsi-Selmi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039507; Alleyne G, 2013, LANCET; Austin AM, 2013, MATERN CHILD NUTR, V9, P167, DOI 10.1111/j.1740-8709.2011.00346.x; Bartley M., 2004, HLTH INEQUALITY INTR; Bobak M, 2000, J EPIDEMIOL COMMUN H, V54, P91, DOI 10.1136/jech.54.2.91; Brooks R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010587; Chandola T, 2006, J R STAT SOC A STAT, V169, P337, DOI 10.1111/j.1467-985X.2006.00411.x; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Cutler David M, 2010, J Health Econ, V29, P1, DOI 10.1016/j.jhealeco.2009.10.003; Cutler DM, 2006, ED HLTH EVALUATING T; Dahly DL, 2010, J NUTR, V140, P366, DOI 10.3945/jn.109.114207; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Du SF, 2004, SOC SCI MED, V59, P1505, DOI 10.1016/j.socscimed.2004.01.021; Eizenberg A, 2012, WORKING PAPER; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Harrell FE, 2001, REGRESSION MODELING; Hou XH, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-389; Howe LD, 2012, INT J EPIDEMIOL, V41, P871, DOI 10.1093/ije/dys037; James P, 2006, NUTR REV, V64, pS1, DOI 10.1301/nr.2006.may.S1-S11; Jones-Smith JC, 2012, INT J OBESITY, V36, P1114, DOI 10.1038/ijo.2011.179; Jones-Smith JC, 2011, AM J EPIDEMIOL, V173, P667, DOI 10.1093/aje/kwq428; Just DR, 2009, ANN BEHAV MED, V38, pS47, DOI 10.1007/s12160-009-9119-2; Labonte R, 2007, GLOBALIZATION HEALTH, V3, DOI 10.1186/1744-8603-3-7; Martorell R, 2000, EUR J CLIN NUTR, V54, P247, DOI 10.1038/sj.ejcn.1600931; McKinsey, 2012, WINN 30 TRILL DEC GO; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Mirowsky J., 2003, ED SOCIAL STATUS HLT; Monteiro C, 2004, INT J OBESITY, V28, P1181, DOI 10.1038/sj.ijo.0802716; Monteiro C. A., 2001, Journal of Nutrition, V131, P881; Neuman M, 2011, AM J CLIN NUTR, V94, P1348, DOI 10.3945/ajcn.111.018127; Poterico JA, 2012, OBESITY, V20, P2283, DOI 10.1038/oby.2011.288; Prentice AM, 2009, NESTLE NUTR WORKS SE, V63, P47, DOI 10.1159/000209972; Puoane T, 2002, OBES RES, V10, P1038, DOI 10.1038/oby.2002.141; Rutstein SO, 2004, DHS WEALTH INDEX, Vix; Saito M, 2003, J PHILOS EDUC, V37, P17, DOI 10.1111/1467-9752.3701002; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P153; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001235, 10.1371/journal.pmed.1001242]; Subramanian SV, 2013, INT J EPIDEMIOL, V42, P1410, DOI 10.1093/ije/dyt017; Subramanian SV, 2011, AM J CLIN NUTR, V93, P413, DOI 10.3945/ajcn.110.004820; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; USAID, 2012, SAMPL HOUS LIST MAN; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; Wolfe WS, 1997, INT J OBESITY, V21, P802, DOI 10.1038/sj.ijo.0800478; Xiao YY, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-355; Ziraba AK, 2009, BMC HEALTH SERV RES, V9, DOI [10.1186/1471-2458-9-465, 10.1186/1472-6963-9-46]	47	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90403	10.1371/journal.pone.0090403	http://dx.doi.org/10.1371/journal.pone.0090403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4IY	24608086	Green Submitted, gold, Green Published			2022-12-25	WOS:000332485800024
J	Khelwatty, SA; Essapen, S; Bagwan, I; Green, M; Seddon, AM; Modjtahedi, H				Khelwatty, Said Abdullah; Essapen, Sharadah; Bagwan, Izhar; Green, Margaret; Seddon, Alan Michael; Modjtahedi, Helmout			Co-Expression of HER Family Members in Patients with Dukes' C and D Colon Cancer and Their Impacts on Patient Prognosis and Survival	PLOS ONE			English	Article							FACTOR RECEPTOR EXPRESSION; COLORECTAL-CANCER; MONOCLONAL-ANTIBODY; EGFR EXPRESSION; MUTATIONAL STATUS; ERBB RECEPTORS; THERAPY; PANITUMUMAB; INHIBITOR; CETUXIMAB	The human epidermal growth factor receptor (EGFR) is an important therapeutic target in patients with metastatic colorectal cancer and anti-EGFR antibodies cetuximab and panitumumab have been approved for the treatment of such patients. Despite these advances, the duration of response in some patients can be limited. Since, EGFR is capable of forming heterodimers with the other members of the HER (Human epidermal receptor) family, it is important to investigate the co-expression and prognostic significance of all members of the HER family in colorectal cancer patients. The expression of the HER family members were determined in tumour specimens from 86 patients with Dukes' C and D (metastatic) colon cancer using immunohistochemistry. Sections were scored by the percentage of positive tumour cells and intensity of staining. Their associations with clinicopathological parameters, and overall survival and disease free survival were evaluated using univariate and multivariate analysis. Overall, 43%, 77%, 52% and 92% of the cases were EGFR, HER-2, HER-3 and HER-4 positive respectively. Interestingly, 35%, 24%, 43%, and 18% of the cases had co-expression of EGFR/HER-2, EGFR/HER-3, EGFR/HER-4 and all four members of the HER family respectively. Of these, only the expression of EGFR and co-expression of EGFR/HER-4 were associated with poorer disease-free survival in both univariate and multivariate analysis. Co-expression of all members of the HER family in colon cancer supports the need for further investigations on their predictive value for response to therapy with anti-EGFR mAbs and whether such sub-population of patients may benefit from therapy with the new generation of pan-HER inhibitors.	[Khelwatty, Said Abdullah; Essapen, Sharadah; Seddon, Alan Michael; Modjtahedi, Helmout] Kingston Univ London, Sch Life Sci, Kingston, England; [Essapen, Sharadah] Royal Surrey Cty Hosp, St Lukes Canc Ctr, Guildford, Surrey, England; [Bagwan, Izhar; Green, Margaret] Royal Surrey Cty Hosp, Dept Histopathol, Guildford, Surrey, England	Kingston University; Royal Surrey County Hospital; Royal Surrey County Hospital	Modjtahedi, H (corresponding author), Kingston Univ London, Sch Life Sci, Kingston, England.	H.Modjtahedi@Kingston.ac.uk		Modjtahedi, Helmout/0000-0002-5509-7415; Khelwatty, Said/0000-0002-9735-7641	BRIGHT cancer charity (UK)	BRIGHT cancer charity (UK)	This work is supported by a grant from BRIGHT cancer charity (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga CL, 2002, ONCOLOGIST, V7, P31; Baiocchi G, 2009, INT J COLORECTAL DIS, V24, P1059, DOI 10.1007/s00384-009-0702-6; Britten CD, 2004, MOL CANCER THER, V3, P1335; Chu E, 2012, CLIN COLORECTAL CANC, V11, P1, DOI 10.1016/j.clcc.2011.05.005; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Cunningham MP, 2006, CANCER RES, V66, P7708, DOI 10.1158/0008-5472.CAN-06-1000; Cunningham MP, 2006, INT J ONCOL, V28, P329; Dempke WCM, 2010, ANTICANCER RES, V30, P4673; Galizia G, 2006, ANN SURG ONCOL, V13, P823, DOI 10.1245/ASO.2006.05.052; Giusti RM, 2008, CLIN CANCER RES, V14, P1296, DOI 10.1158/1078-0432.CCR-07-1354; Goldstein NS, 2001, CANCER, V92, P1331, DOI 10.1002/1097-0142(20010901)92:5<1331::AID-CNCR1455>3.0.CO;2-M; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Hebbar M, 2006, ANTI-CANCER DRUG, V17, P855, DOI 10.1097/01.cad.0000217425.44584.9f; Hecht JR, 2010, CLIN CANCER RES, V16, P2205, DOI 10.1158/1078-0432.CCR-09-2017; Khelwatty SA, 2013, FRONT BIOSCI-LANDMRK, V18, P394, DOI 10.2741/4110; Khelwatty SA, 2011, INT J ONCOL, V39, P483, DOI 10.3892/ijo.2011.1054; Kluftinger A M, 1992, Surg Oncol, V1, P97, DOI 10.1016/0960-7404(92)90062-P; Konigsberg R, 2011, ONCOLOGY-BASEL, V81, P359, DOI 10.1159/000334919; Lee JC, 2002, EUR J CANCER, V38, P1065, DOI 10.1016/S0959-8049(02)00004-7; Leung SP, 2008, AM J SURG, V195, P604, DOI 10.1016/j.amjsurg.2007.12.032; Ljuslinder I, 2009, ANTICANCER RES, V29, P1489; Maurer CA, 1998, HUM PATHOL, V29, P771, DOI 10.1016/S0046-8177(98)90444-0; McIntyre E, 2010, BREAST CANCER RES TR, V122, P105, DOI 10.1007/s10549-009-0536-5; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Modjtahedi H, 2012, BRIT MED BULL, V104, P41, DOI 10.1093/bmb/lds032; Modjtahedi H, 2009, ANTI-CANCER DRUG, V20, P851, DOI 10.1097/CAD.0b013e3283330590; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Normanno N, 2003, ENDOCR-RELAT CANCER, V10, P1, DOI 10.1677/erc.0.0100001; Ooi A, 2004, MODERN PATHOL, V17, P895, DOI 10.1038/modpathol.3800137; Scartozzi M, 2004, J CLIN ONCOL, V22, P4772, DOI 10.1200/JCO.2004.00.117; Scartozzi M, 2011, ONCOLOGIST, V16, P53, DOI 10.1634/theoncologist.2010-0119; Shih T, 2006, CLIN THER, V28, P1779, DOI 10.1016/j.clinthera.2006.11.015; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siena S, 2009, JNCI-J NATL CANCER I, V101, P1308, DOI 10.1093/jnci/djp280; Spano JP, 2005, ANN ONCOL, V16, P102, DOI 10.1093/annonc/mdi006; Stintzing S, 2012, ANN ONCOL, V23, P1693, DOI 10.1093/annonc/mdr571; Takemura K, 1991, Nihon Shokakibyo Gakkai Zasshi, V88, P1177; Theodoropoulos GE, 2009, ANTICANCER RES, V29, P785; Wei Q, 2011, ONCOL REP, V25, P3, DOI 10.3892/or_00001035; Wong SF, 2005, CLIN THER, V27, P684, DOI 10.1016/j.clinthera.2005.06.003; Wu M, 2008, CLIN THER, V30, P14, DOI 10.1016/j.clinthera.2008.01.014	41	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91139	10.1371/journal.pone.0091139	http://dx.doi.org/10.1371/journal.pone.0091139			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609222	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000332485800102
J	Kim, JH; Lee, SM; Lee, JH; Jo, YR; Moon, MH; Shin, J; Kim, BJ; Hwang, KR; Lee, TS; Bai, KB; Jeon, HW				Kim, Jee Hyun; Lee, Seung Mi; Lee, Ji-Hyun; Jo, Yu Ri; Moon, Min Hoan; Shin, Jonghwan; Kim, Byoung Jae; Hwang, Kyu Ri; Lee, Taek Sang; Bai, Kwang Bum; Jeon, Hye Won			Successful Conservative Management of Ruptured Ovarian Cysts with Hemoperitoneum in Healthy Women	PLOS ONE			English	Article							RELATIVE BRADYCARDIA; CORPUS-LUTEUM	Study Objective: To determine the success rate of the "intended conservative management strategy" of ruptured ovarian cysts with hemoperitoneum and the risk factors for surgical interventions in healthy women of reproductive age. Methods: Patients who visited the emergency department with abdominal pain and were diagnosed with a ruptured ovarian cyst with hemoperitoneum between August 2008 and June 2013 were included in this retrospective study. The diagnosis of the ruptured ovarian cysts and hemoperitoneum was based on the clinical symptoms, physical examination and ultrasound and CT imaging. The rate of surgical interventions and the risk factors for surgical intervention were determined. Results: A total of 78 women were diagnosed with a ruptured ovarian cyst with hemoperitoneum. Most patients (80.8%, 63/ 78) were managed conservatively, and 19.2% of the patients (15/78) required a surgical intervention. In the multiple logistic regression analysis, the diastolic blood pressure (dBP) (odds ratio [OR] of 0.921 with 95% confidence interval [CI] of 0.855-0.993) and the depth of the total pelvic fluid collection in CT (DTFC_CT) (OR 1.599 with 95% CI 1.092-2.343) were the significant determining factors of surgical intervention after adjustment. The rate of surgical intervention was 6.5% vs. 15.8% vs. 77.8% in the patients with neither dBP <= 70 mmHg nor DTFC_CT >= 5.6 cm, those with only one of those features, and those with both, respectively. Conclusion: Most cases of ruptured ovarian cysts with hemoperitoneum can be managed conservatively. A low diastolic blood pressure and a large amount of hemoperitoneum suggest the need for surgical intervention.	[Kim, Jee Hyun; Lee, Ji-Hyun] Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, Songnam, South Korea; [Lee, Seung Mi; Kim, Byoung Jae; Hwang, Kyu Ri; Lee, Taek Sang; Bai, Kwang Bum; Jeon, Hye Won] Seoul Natl Univ, Seoul Metropolitan Govt, Dept Obstet & Gynecol, Boramae Med Ctr, Seoul, South Korea; [Jo, Yu Ri] Seoul Natl Univ Hosp, Dept Obstet & Gynecol, Seoul 110744, South Korea; [Moon, Min Hoan] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Diagnost Radiol, Seoul, South Korea; [Shin, Jonghwan] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Emergency Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Jeon, HW (corresponding author), Seoul Natl Univ, Seoul Metropolitan Govt, Dept Obstet & Gynecol, Boramae Med Ctr, Seoul, South Korea.	jshmom04@gmail.com	Lee, Jae Hyuk/W-5616-2018	Lee, Jae Hyuk/0000-0003-2429-4085				ADAMS S L, 1986, Journal of Emergency Medicine, V4, P383, DOI 10.1016/0736-4679(86)90216-7; Bottomley C, 2009, BEST PRACT RES CL OB, V23, P711, DOI 10.1016/j.bpobgyn.2009.02.001; BYDDER GM, 1980, J COMPUT ASSIST TOMO, V4, P145, DOI 10.1097/00004728-198004000-00002; Choi NJ, 2011, J COMPUT ASSIST TOMO, V35, P454, DOI 10.1097/RCT.0b013e31821f4bd2; Hertzberg BS, 1999, ABDOM IMAGING, V24, P304, DOI 10.1007/s002619900502; Ho WK, 2009, TAIWAN J OBSTET GYNE, V48, P108, DOI 10.1016/S1028-4559(09)60267-9; JANSEN RPS, 1978, AUST NZ J OBSTET GYN, V18, P206, DOI 10.1111/j.1479-828X.1978.tb00051.x; Lucey BC, 2005, CURR PROBL DIAGN RAD, V34, P182, DOI 10.1067/j.cpradiol.2005.06.001; Lucey BC, 2007, EMERG RADIOL, V14, P65, DOI [10.1007/s10140-007-0594-0, 10.1007/s10140-007-0600-6]; MacKenna A, 2000, HUM REPROD, V15, P2567, DOI 10.1093/humrep/15.12.2567; QUEENAN JT, 1980, FERTIL STERIL, V34, P99; RAZIEL A, 1993, EUR J OBSTET GYN R B, V50, P77, DOI 10.1016/0028-2243(93)90168-C; Somers MP, 2004, ANN EMERG MED, V43, P382, DOI 10.1016/j.annemergmed.2003.08.004; TANIGUCHI T, 1951, JAMA-J AM MED ASSOC, V147, P1420, DOI 10.1001/jama.1951.03670320020009; Thorson CM, 2013, AM SURGEON, V79, P398	15	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91171	10.1371/journal.pone.0091171	http://dx.doi.org/10.1371/journal.pone.0091171			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608424	gold, Green Submitted, Green Published			2022-12-25	WOS:000332485800110
J	Konecna, E; Safarova, D; Navratil, M; Hanacek, P; Coyne, C; Flavell, A; Vishnyakova, M; Ambrose, M; Redden, R; Smykal, P				Konecna, Eva; Safarova, Dana; Navratil, Milan; Hanacek, Pavel; Coyne, Clarice; Flavell, Andrew; Vishnyakova, Margarita; Ambrose, Mike; Redden, Robert; Smykal, Petr			Geographical Gradient of the eIF4E Alleles Conferring Resistance to Potyviruses in Pea (Pisum) Germplasm	PLOS ONE			English	Article							TRANSLATION INITIATION-FACTORS; GENETIC DIVERSITY; POPULATION-STRUCTURE; NATURAL VARIATION; VIRUSES; IDENTIFICATION; COEVOLUTION; CROP; RETROTRANSPOSON; SUSCEPTIBILITY	Background: The eukaryotic translation initiation factor 4E was shown to be involved in resistance against several potyviruses in plants, including pea. We combined our knowledge of pea germplasm diversity with that of the eIF4E gene to identify novel genetic diversity. Methodology/Principal findings: Germplasm of 2803 pea accessions was screened for eIF4E intron 3 length polymorphism, resulting in the detection of four eIF4E(A-B-C-S) variants, whose distribution was geographically structured. The eIF4E(A) variant conferring resistance to the P1 PSbMV pathotype was found in 53 accessions (1.9%), of which 15 were landraces from India, Afghanistan, Nepal, and 7 were from Ethiopia. A newly discovered variant, eIF4E(B), was present in 328 accessions (11.7%) from Ethiopia (29%), Afghanistan (23%), India (20%), Israel (25%) and China (39%). The eIF4E(C) variant was detected in 91 accessions (3.2% of total) from India (20%), Afghanistan (33%), the Iberian Peninsula (22%) and the Balkans (9.3%). The eIF4E(S) variant for susceptibility predominated as the wild type. Sequencing of 73 samples, identified 34 alleles at the whole gene, 26 at cDNA and 19 protein variants, respectively. Fifteen alleles were virologically tested and 9 alleles (eIF4E(A-1-2-3-4-5-6-7), eIF4E(B-1), eIF4E(C-2)) conferred resistance to the P1 PSbMV pathotype. Conclusions/Significance: This work identified novel eIF4E alleles within geographically structured pea germplasm and indicated their independent evolution from the susceptible eIF4E(S1) allele. Despite high variation present in wild Pisum accessions, none of them possessed resistance alleles, supporting a hypothesis of distinct mode of evolution of resistance in wild as opposed to crop species. The Highlands of Central Asia, the northern regions of the Indian subcontinent, Eastern Africa and China were identified as important centers of pea diversity that correspond with the diversity of the pathogen. The series of alleles identified in this study provides the basis to study the co-evolution of potyviruses and the pea host.	[Konecna, Eva; Hanacek, Pavel] Mendel Univ Brno, Dept Plant Biol, Brno, Czech Republic; [Safarova, Dana; Navratil, Milan] Palacky Univ, Dept Cell Biol & Genet, CR-77147 Olomouc, Czech Republic; [Konecna, Eva; Hanacek, Pavel] Mendel Univ Brno, CEITEC MENDELU, Brno, Czech Republic; [Coyne, Clarice] USDA, Western Reg Plant Intro Stn, Pullman, WA USA; [Flavell, Andrew] Univ Dundee, James Hutton Inst, Div Plant Sci, Invergowrie, Scotland; [Vishnyakova, Margarita] Vavilov Inst Plant Ind, St Petersburg, Russia; [Ambrose, Mike] John Innes Ctr, Norwich, Norfolk, England; [Redden, Robert] Australian Grains Genebank, Horsham, Vic, Australia; [Smykal, Petr] Palacky Univ, Dept Bot, CR-77147 Olomouc, Czech Republic	Mendel University in Brno; Palacky University Olomouc; Mendel University in Brno; United States Department of Agriculture (USDA); James Hutton Institute; University of Dundee; Vavilov All-Russian Institute of Plant Genetic Resources; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Palacky University Olomouc	Smykal, P (corresponding author), Palacky Univ, Dept Bot, CR-77147 Olomouc, Czech Republic.	petr.smykal@upol.cz	Hanacek, Pavel/E-6683-2012; SMÝKAL, Petr/I-3569-2019; Vishnyakova, Margarita Afanasyevna/S-4164-2016	Hanacek, Pavel/0000-0002-9807-1370; SMÝKAL, Petr/0000-0002-6117-8510; Vishnyakova, Margarita Afanasyevna/0000-0003-2808-7745	Ministry of Agriculture [IQ91A229]; USDA (United States Department of Agriculture) [5348-2100=017-00D]; BBSRC [BBS/E/J/000CA493] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000CA493] Funding Source: researchfish; ARS [ARS-0424494] Funding Source: Federal RePORTER	Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); USDA (United States Department of Agriculture)(United States Department of Agriculture (USDA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the Ministry of Agriculture IQ91A229 project. CC was supported by USDA (United States Department of Agriculture) project #5348-2100=017-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbo S, 2012, CRIT REV PLANT SCI, V31, P241, DOI 10.1080/07352689.2011.645428; ALCONERO R, 1985, ANN APPL BIOL, V106, P357, DOI 10.1111/j.1744-7348.1985.tb03125.x; Ali A, 2001, ARCH VIROL, V146, P1855, DOI 10.1007/s007050170038; Andrade M, 2009, J GEN PLANT PATHOL, V75, P241, DOI 10.1007/s10327-009-0163-3; Ashby JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015873; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bhullar NK, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-88; Bhullar NK, 2009, P NATL ACAD SCI USA, V106, P9519, DOI 10.1073/pnas.0904152106; Bruun-Rasmussen M, 2007, MOL PLANT MICROBE IN, V20, P1075, DOI 10.1094/MPMI-20-9-1075; Cavatorta JR, 2008, J MOL EVOL, V67, P551, DOI 10.1007/s00239-008-9172-7; Charron C, 2008, PLANT J, V54, P56, DOI 10.1111/j.1365-313X.2008.03407.x; Chimwamurombe PM, 2011, BIOLOGY AND BREEDING OF FOOD LEGUMES, P19, DOI 10.1079/9781845937669.0019; Cieslarova J, 2012, CZECH J GENET PLANT, V48, P61, DOI 10.17221/127/2011-CJGPB; De Candolle A., 1882, ORIGIN CULTIVATED PL; Fraile A, 2010, ADV VIRUS RES, V76, P1, DOI 10.1016/S0065-3527(10)76001-2; Gao Z, 2004, THEOR APPL GENET, V109, P488, DOI 10.1007/s00122-004-1652-6; Gibbs AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002523; HAGEDORN DJ, 1973, PHYTOPATHOLOGY, V63, P1130, DOI 10.1094/Phyto-63-1130; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hampton R. O., 1975, CMI AAB DESCRIPTIONS; HAMPTON RO, 1986, PISUM NEWSL, V18, P22; Hjulsager CK, 2006, VIROLOGY, V355, P52, DOI 10.1016/j.virol.2006.07.016; Hjulsager CK, 2002, MOL PLANT MICROBE IN, V15, P169, DOI 10.1094/MPMI.2002.15.2.169; Hofinger BJ, 2011, MOL ECOL, V20, P3653, DOI 10.1111/j.1365-294X.2011.05201.x; Ibiza VP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-631; Jeong HJ, 2012, MOL BREEDING, V29, P349, DOI 10.1007/s11032-011-9550-5; Jing R, 2012, THEOR APPL GENET, V125, P367, DOI 10.1007/s00122-012-1839-1; Jing RC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-44; JOHANSEN E, 1991, J GEN VIROL, V72, P2625, DOI 10.1099/0022-1317-72-11-2625; Johansen IE, 2001, J VIROL, V75, P6609, DOI 10.1128/JVI.75.14.6609-6614.2001; Johansen IE, 1996, J GEN VIROL, V77, P1329, DOI 10.1099/0022-1317-77-6-1329; Jones EI, 2009, AM NAT, V174, P780, DOI 10.1086/647971; Kang BC, 2005, PLANT J, V42, P392, DOI 10.1111/j.1365-313X.2005.02381.x; Kwon SJ, 2012, GENES GENOM, V34, P305, DOI 10.1007/s13258-011-0213-z; Latham LJ, 2001, AUST J AGR RES, V52, P771, DOI 10.1071/AR00165; Le Gall O, 2011, RECENT ADVANCES IN PLANT VIROLOGY, P177; Li L, 2013, GENET RESOUR CROP EV, V60, P1801, DOI 10.1007/s10722-013-9955-6; Lovisolo O, 2003, ADV VIRUS RES, V62, P325, DOI 10.1016/S0065-3527(03)62006-3; Maxted N, 2001, CURR PLANT SCI BIOT, V39, P181; MUSIL MILOS, 1966, BIOLOGIA [BRATISLAVA], V21, P133; Nicaise V, 2003, PLANT PHYSIOL, V132, P1272, DOI 10.1104/pp.102.017855; Nieto C, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-34; Olsen BS, 2001, ARCH VIROL, V146, P15, DOI 10.1007/s007050170187; Reeves PA, 2012, THEOR APPL GENET, V124, P1155, DOI 10.1007/s00122-011-1776-4; Rigola D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004761; Robaglia C, 2006, TRENDS PLANT SCI, V11, P40, DOI 10.1016/j.tplants.2005.11.004; Roossinck MJ, 2011, CURR OPIN VIROL, V1, P63, DOI 10.1016/j.coviro.2011.05.022; Rubio M, 2009, J GEN VIROL, V90, P2808, DOI 10.1099/vir.0.013151-0; Ruffel S, 2006, J GEN VIROL, V87, P2089, DOI 10.1099/vir.0.81817-0; Safarova D, 2008, ACTA VIROL, V52, P53; Sato M, 2005, FEBS LETT, V579, P1167, DOI 10.1016/j.febslet.2004.12.086; Smykal P, 2008, THEOR APPL GENET, V117, P413, DOI 10.1007/s00122-008-0785-4; Smykal P, 2013, ELSEV INSIGHT, P41, DOI 10.1016/B978-0-12-397935-3.00003-7; Smykal P, 2012, AGRONOMY-BASEL, V2, P74, DOI 10.3390/agronomy2020074; Smykal P, 2011, PLANT GENET RESOUR-C, V9, P4, DOI 10.1017/S147926211000033X; Smykal P, 2010, MOL BREEDING, V26, P425, DOI 10.1007/s11032-009-9383-7; Stein N, 2005, PLANT J, V42, P912, DOI 10.1111/j.1365-313X.2005.02424.x; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Vavilov N. I., 1949, ORIGIN VARIATION IMM, P13; Wang AM, 2012, MOL PLANT PATHOL, V13, P795, DOI 10.1111/j.1364-3703.2012.00791.x; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; Wylie SJ, 2011, ARCH VIROL, V156, P1287, DOI 10.1007/s00705-011-1002-3; Zohary D., 1993, DOMESTICATION PLANTS; Zong XX, 2009, THEOR APPL GENET, V118, P193, DOI 10.1007/s00122-008-0887-z	64	16	17	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90394	10.1371/journal.pone.0090394	http://dx.doi.org/10.1371/journal.pone.0090394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609094	gold, Green Published, Green Submitted			2022-12-25	WOS:000332485800023
J	Yan, XY; Ehnert, S; Culmes, M; Bachmann, A; Seeliger, C; Schyschka, L; Wang, ZY; Rahmanian-Schwarz, A; Stockle, U; De Sousa, PA; Pelisek, J; Nussler, AK				Yan, Xueying; Ehnert, Sabrina; Culmes, Mihaela; Bachmann, Anastasia; Seeliger, Claudine; Schyschka, Lilianna; Wang, Zhiyong; Rahmanian-Schwarz, Afshin; Stoeckle, Ulrich; De Sousa, Paul A.; Pelisek, Jaroslav; Nussler, Andreas K.			5-Azacytidine Improves the Osteogenic Differentiation Potential of Aged Human Adipose-Derived Mesenchymal Stem Cells by DNA Demethylation	PLOS ONE			English	Article							SELF-RENEWAL; OSTEOBLAST DIFFERENTIATION; CLINICAL-APPLICATIONS; LINEAGE; SOX2; MECHANISMS; PROLIFERATION; EXPRESSION; PATHWAYS; 5-HYDROXYMETHYLCYTOSINE	The therapeutic value of adipose-derived mesenchymal stem cells (Ad-MSCs) for bone regeneration is critically discussed. A possible reason for reduced osteogenic potential may be an age-related deterioration of the Ad-MSCs. In long term in vitro culture, epigenomic changes in DNA methylation are known to cause gene silencing, affecting stem cell growth as well as the differentiation potential. In this study, we observed an age-related decline in proliferation of primary human Ad-MSCs. Decreased Nanog, Oct4 and Lin28A and increased Sox2 gene-expression was accompanied by an impaired osteogenic differentiation potential of Ad-MSCs isolated from old donors (>60 a) as compared to Ad-MSCs isolated from younger donors (<45 a). 5-hydroxymethylcytosine (5 hmC) and 5-methylcytonsine (5 mC) distribution as well as TET gene expression were evaluated to assess the evidence of active DNA demethylation. We observed a decrease of 5 hmC in Ad-MSCs from older donors. Incubation of these cells with 5-Azacytidine induced proliferation and improved the osteogenic differentiation potential in these cells. The increase in AP activity and matrix mineralization was associated with an increased presence of 5 hmC as well as with an increased TET2 and TET3 gene expression. Our data show, for the first time, a decrease of DNA hydroxymethylation in Ad-MSCs which correlates with donor-age and that treatment with 5-Azacytidine provides an approach which could be used to rejuvenate Ad-MSCs from aged donors.	[Yan, Xueying; Ehnert, Sabrina; Bachmann, Anastasia; Stoeckle, Ulrich; Nussler, Andreas K.] Univ Tubingen, BG Trauma Ctr, Siegfried Weller Inst Trauma Res, Tubingen, Germany; [Culmes, Mihaela; Pelisek, Jaroslav] Tech Univ Munich, Klinikum Rechts Isar, Clin Vasc & Endovasc Surg, D-80290 Munich, Germany; [Seeliger, Claudine; Schyschka, Lilianna; Wang, Zhiyong] Tech Univ Munich, Klinikum Rechts Isar, Dept Trauma Surg, D-80290 Munich, Germany; [Rahmanian-Schwarz, Afshin] Univ Tubingen, BG Trauma Ctr, Clin Hand Plast Reconstruct & Vasc Surg, Tubingen, Germany; [De Sousa, Paul A.] Univ Edinburgh, Ctr Regenerat Med, Edinburgh, Midlothian, Scotland	Eberhard Karls University of Tubingen; Technical University of Munich; Technical University of Munich; Eberhard Karls University of Tubingen; University of Edinburgh	Nussler, AK (corresponding author), Univ Tubingen, BG Trauma Ctr, Siegfried Weller Inst Trauma Res, Tubingen, Germany.	andreas.nuessler@gmail.com	Nussler, Andreas/H-3557-2019; De Sousa, Paul A/H-7416-2013; Bachmann, Anastasia/F-8419-2014; Ehnert, Sabrina/AAE-8163-2019	Nussler, Andreas/0000-0002-6666-6791; De Sousa, Paul A/0000-0003-0745-2504; Ehnert, Sabrina/0000-0003-4347-1702; Seeliger, Claudine/0000-0002-7631-444X	Bayerische Forschungsstiftung; BG Trauma Center Tubingen; Medical Research Council [G0300484] Funding Source: researchfish; MRC [G0300484] Funding Source: UKRI	Bayerische Forschungsstiftung; BG Trauma Center Tubingen; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The present work was partially supported by the Bayerische Forschungsstiftung (www.forschungsstiftung.de) and by research funds of the BG Trauma Center Tubingen (www.bgu-tuebingen.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berdasco M, 2012, AGING CELL, V11, P181, DOI 10.1111/j.1474-9726.2012.00806.x; Casillas MA, 2003, MOL CELL BIOCHEM, V252, P33, DOI 10.1023/A:1025548623524; Chang YQ, 2009, NAT STRUCT MOL BIOL, V16, P312, DOI 10.1038/nsmb.1560; Cimmino L, 2011, CELL STEM CELL, V9, P193, DOI 10.1016/j.stem.2011.08.007; Ding DF, 2012, INT ORTHOP, V36, P1087, DOI 10.1007/s00264-011-1368-6; Ding JJ, 2012, CELL RES, V22, P155, DOI 10.1038/cr.2011.179; Ehnert S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014073; Feng C, 2012, CELL CYCLE, V11, P2486, DOI 10.4161/cc.20893; Granero-Molto F, 2009, STEM CELLS, V27, P1887, DOI 10.1002/stem.103; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kuo TK, 2008, GASTROENTEROLOGY, V134, P2111, DOI 10.1053/j.gastro.2008.03.015; Li ZL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020526; Liao Lian-Ming, 2005, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V13, P158; Liu L, 2011, J CELL BIOL, V193, P257, DOI 10.1083/jcb.201010131; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marcellini S, 2012, BIOESSAYS, V34, P953, DOI 10.1002/bies.201200061; Marsell R, 2011, INJURY, V42, P551, DOI 10.1016/j.injury.2011.03.031; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; McGee-Lawrence ME, 2011, GENE, V474, P1, DOI 10.1016/j.gene.2010.12.003; Meirelles LD, 2009, FRONT BIOSCI-LANDMRK, V14, P4281, DOI 10.2741/3528; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Park SB, 2012, CELL DEATH DIFFER, V19, P534, DOI 10.1038/cdd.2011.137; Polzer H, 2010, TISSUE ENG PART C-ME, V16, P1277, DOI [10.1089/ten.tec.2009.0745, 10.1089/ten.TEC.2009.0745]; Ruzov A, 2011, CELL RES, V21, P1332, DOI 10.1038/cr.2011.113; Seeliger C, 2013, CELL TRANSPLANT, V22, P119, DOI 10.3727/096368912X638946; Selvaraj V, 2010, TRENDS BIOTECHNOL, V28, P214, DOI 10.1016/j.tibtech.2010.01.002; Seo E, 2013, CELL REP, V3, P2075, DOI 10.1016/j.celrep.2013.05.029; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Smith JO, 2011, TISSUE ENG PART B-RE, V17, P307, DOI [10.1089/ten.teb.2011.0143, 10.1089/ten.TEB.2011.0143]; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Thompson RF, 2010, AGING CELL, V9, P506, DOI 10.1111/j.1474-9726.2010.00577.x; Tollervey J., 2012, EPIGENETICS, V7; Tsai CC, 2012, MOL CELL, V47, P169, DOI 10.1016/j.molcel.2012.06.020; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; Wang HT, 2012, AGING CELL, V11, P704, DOI 10.1111/j.1474-9726.2012.00838.x; Wang SH, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-19; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Yoon DS, 2011, CELL PROLIFERAT, V44, P428, DOI 10.1111/j.1365-2184.2011.00770.x; Yoshida CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032364	42	62	65	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90846	10.1371/journal.pone.0090846	http://dx.doi.org/10.1371/journal.pone.0090846			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603866	gold, Green Submitted, Green Published			2022-12-25	WOS:000332483600094
J	Yoder, SM; Dineen, SL; Wang, ZX; Thurmond, DC				Yoder, Stephanie M.; Dineen, Stacey L.; Wang, Zhanxiang; Thurmond, Debbie C.			YES, a Src Family Kinase, Is a Proximal Glucose-specific Activator of Cell Division Cycle Control Protein 42 ( Cdc42) in Pancreatic Islet beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Cdc42; Insulin Secretion; Pancreatic Islets; Src	STIMULATED INSULIN-SECRETION; GTP-BINDING PROTEINS; NUCLEOTIDE EXCHANGE FACTOR; TYROSINE KINASE; B-CELLS; RAT ISLETS; IN-VIVO; PHOSPHORYLATION; GROWTH; ACTIN	Background: Although Cdc42 signaling is a known requirement for insulin secretion to occur, how it is initiated remains unknown. Results: YES kinase is required for Cdc42 activation in human islets and cells. Conclusion: YES is a proximal, glucose-specific activator of Cdc42 and glucose-simulated insulin secretion. Significance: YES may provide a novel target for improvement of functional cell mass. Second-phase insulin secretion sustains insulin release in the face of hyperglycemia associated with insulin resistance, requiring the continued mobilization of insulin secretory granules to the plasma membrane. Cdc42, the small Rho family GTPase recognized as the proximal glucose-specific trigger to elicit second-phase insulin secretion, signals downstream to activate the p21-activated kinase (PAK1), which then signals to Raf-1/MEK/ERK to induce filamentous actin (F-actin) remodeling, to ultimately mobilize insulin granules to the plasma membrane. However, the steps required to initiate Cdc42 activation in a glucose-specific manner in cells have remained elusive. Toward this, we identified the involvement of the Src family kinases (SFKs), based upon the ability of SFK inhibitors to block glucose-stimulated Cdc42 and PAK1 activation events as well as the amplifying pathway of glucose-stimulated insulin release, in MIN6 cells. Indeed, subsequent studies performed in human islets revealed that SFK phosphorylation was induced only by glucose and within 1 min of stimulation before the activation of Cdc42 at 3 min. Furthermore, pervanadate treatment validated the phosphorylation event to be tyrosine-specific. Although RT-PCR showed cells to express five different SFK proteins, only two of these, YES and Fyn kinases, were found localized to the plasma membrane, and of these two, only YES kinase underwent glucose-stimulated tyrosine phosphorylation. Immunodetection and RNAi analyses further established YES kinase as a proximal glucose-specific signal in the Cdc42-signaling cascade. Identification of YES kinase provides new insight into the mechanisms underlying the sustainment of insulin secretion via granule mobilization/replenishment and F-actin remodeling.	[Yoder, Stephanie M.; Wang, Zhanxiang; Thurmond, Debbie C.] Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA; [Dineen, Stacey L.; Thurmond, Debbie C.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Thurmond, Debbie C.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Thurmond, DC (corresponding author), Herman B Wells Ctr Pediat Res, Dept Pediat, 635 Barnhill Dr,MS2031, Indianapolis, IN 46202 USA.	dthurmon@iu.edu			National Institutes of Health [F32 DK094488, CTSI-KL2 RR025760, DK067912, DK076614]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067912, R01DK076614, F32DK094488] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants F32 DK094488 (to S. M. Y.), CTSI-KL2 RR025760 (to Z. W.), and DK067912 and DK076614 (to D. C. T).	ALLAND L, 1994, J BIOL CHEM, V269, P16701; Amin R, 2002, J PHARMACOL EXP THER, V303, P82, DOI 10.1124/jpet.102.036160; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Bratanova-Tochkova TK, 2002, DIABETES, V51, pS83, DOI 10.2337/diabetes.51.2007.S83; Cao HM, 2004, EXP CELL RES, V294, P159, DOI 10.1016/j.yexcr.2003.11.010; Chen YC, 2013, ISLETS, V5, P22, DOI 10.4161/isl.24029; Cheng HY, 2007, AM J PHYSIOL-ENDOC M, V292, pE845, DOI 10.1152/ajpendo.00103.2006; Civelek VN, 1996, BIOCHEM J, V315, P1015, DOI 10.1042/bj3151015; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; Corkey BE, 2012, DIABETES, V61, P4, DOI 10.2337/db11-1483; Daniel S, 1999, DIABETES, V48, P1686, DOI 10.2337/diabetes.48.9.1686; Feng QY, 2006, NAT CELL BIOL, V8, P945, DOI 10.1038/ncb1453; Feng QY, 2010, J BIOL CHEM, V285, P18806, DOI 10.1074/jbc.M109.098079; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; HARDWICK JS, 1995, P NATL ACAD SCI USA, V92, P4527, DOI 10.1073/pnas.92.10.4527; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Huveneers S, 2007, CANCER RES, V67, P2693, DOI 10.1158/0008-5472.CAN-06-3654; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Jayaram B, 2011, BIOCHEM PHARMACOL, V81, P1016, DOI 10.1016/j.bcp.2011.01.006; Kalwat MA, 2013, BIOCHEM PHARMACOL, V85, P808, DOI 10.1016/j.bcp.2012.12.003; Kepner EM, 2011, AM J PHYSIOL-ENDOC M, V301, pE1072, DOI 10.1152/ajpendo.00312.2011; Kowluru A, 1996, BIOCHEM J, V313, P97, DOI 10.1042/bj3130097; Kowluru A, 1996, J CLIN INVEST, V98, P540, DOI 10.1172/JCI118822; Kuroiwa M, 2011, J CELL SCI, V124, P1726, DOI 10.1242/jcs.080291; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Lawrence JTR, 2003, P NATL ACAD SCI USA, V100, P13320, DOI 10.1073/pnas.2232129100; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; LI GD, 1993, BIOCHEM J, V289, P379, DOI 10.1042/bj2890379; Li SW, 1996, J BIOL CHEM, V271, P3863; Lim GE, 2009, ENDOCRINOLOGY, V150, P5249, DOI 10.1210/en.2009-0508; Liu BA, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-27; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; METZ SA, 1993, BIOCHEM J, V295, P31, DOI 10.1042/bj2950031; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mourad NI, 2010, AM J PHYSIOL-CELL PH, V299, pC389, DOI 10.1152/ajpcell.00138.2010; NAKAMURA K, 1993, ONCOGENE, V8, P3133; Nevins AK, 2003, AM J PHYSIOL-CELL PH, V285, pC698, DOI 10.1152/ajpcell.00093.2003; Nevins AK, 2006, J BIOL CHEM, V281, P18961, DOI 10.1074/jbc.M603604200; Newsholme P, 2009, DIABETOLOGIA, V52, P2489, DOI 10.1007/s00125-009-1536-z; Nie J, 2012, J BIOL CHEM, V287, P26435, DOI 10.1074/jbc.M112.378372; Nomura R, 1999, MOL BIOL CELL, V10, P975, DOI 10.1091/mbc.10.4.975; Ohara-Imaizumi M, 2002, J BIOL CHEM, V277, P3805, DOI 10.1074/jbc.C100712200; ORCI L, 1972, SCIENCE, V175, P1128, DOI 10.1126/science.175.4026.1128; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Rebelato E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024507; Rondas D, 2012, J BIOL CHEM, V287, P2423, DOI 10.1074/jbc.M111.279885; Rondas D, 2011, DIABETES, V60, P1146, DOI 10.2337/db10-0946; Rorsman P, 2000, NEWS PHYSIOL SCI, V15, P72; RORSMAN P, 1988, PFLUG ARCH EUR J PHY, V412, P597, DOI 10.1007/BF00583760; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; SATIN LS, 1985, PFLUG ARCH EUR J PHY, V404, P385, DOI 10.1007/BF00585354; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Singh NK, 2011, BLOOD, V118, P5701, DOI 10.1182/blood-2011-04-347468; Spurlin BA, 2003, DIABETES, V52, P1910, DOI 10.2337/diabetes.52.8.1910; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Sun XJ, 1996, J BIOL CHEM, V271, P10583, DOI 10.1074/jbc.271.18.10583; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Tu S, 2003, J BIOL CHEM, V278, P49293, DOI 10.1074/jbc.M307021200; Uenishi E, 2013, J BIOL CHEM, V288, P25851, DOI 10.1074/jbc.M113.464420; Veluthakal R, 2007, DIABETES, V56, P204, DOI 10.2337/db06-0668; Wang ZX, 2007, J BIOL CHEM, V282, P9536, DOI 10.1074/jbc.M610553200; Wang ZX, 2012, FEBS OPEN BIO, V2, P273, DOI 10.1016/j.fob.2012.09.001; Wang ZX, 2011, J BIOL CHEM, V286, P41359, DOI 10.1074/jbc.M111.291500; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Wasmeier C, 1999, BIOCHEM J, V341, P563, DOI 10.1042/0264-6021:3410563; Weaver JR, 2013, MOL CELL ENDOCRINOL, V369, P35, DOI 10.1016/j.mce.2013.01.011; Wiseman DA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.214031; Xi G, 2012, DIABETES, V61, P104, DOI 10.2337/db11-0990	74	23	23	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11476	11487		10.1074/jbc.M114.559328	http://dx.doi.org/10.1074/jbc.M114.559328			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24610809	hybrid, Green Published			2022-12-25	WOS:000334638500048
J	Airi, V; Gizzi, F; Falini, G; Levy, O; Dubinsky, Z; Goffredo, S				Airi, Valentina; Gizzi, Francesca; Falini, Giuseppe; Levy, Oren; Dubinsky, Zvy; Goffredo, Stefano			Reproductive Efficiency of a Mediterranean Endemic Zooxanthellate Coral Decreases with Increasing Temperature along a Wide Latitudinal Gradient	PLOS ONE			English	Article							BALANOPHYLLIA-EUROPAEA SCLERACTINIA; LEPTOPSAMMIA-PRUVOTI SCLERACTINIA; SEA-SURFACE TEMPERATURE; SEXUAL REPRODUCTION; MORPHOLOGICAL ASPECTS; THERMAL-STRESS; MORTALITY; GAMETOGENESIS; ANTHOZOA; GROWTH	Investments at the organismal level towards reproduction and growth are often used as indicators of health. Understanding how such energy allocation varies with environmental conditions may, therefore, aid in predicting possible responses to global climatic change in the near future. For example, variations in seawater temperature may alter the physiological functioning, behavior, reproductive output and demographic traits (e.g., productivity) of marine organisms, leading to shifts in the structure, spatial range, and abundance of populations. This study investigated variations in reproductive output associated with local seawater temperature along a wide latitudinal gradient on the western Italian coast, in the zooxanthellate Mediterranean coral, Balanophyllia europaea. Reproductive potential varied significantly among sites, where B. europaea individuals from the warmest site experienced loss of oocytes during gametogenesis. Most of the early oocytes from warmest sites did not reach maturity, possibly due to inhibition of metabolic processes at high temperatures, causing B. europaea to reabsorb the oocytes and utilize them as energy for other vital functions. In a progressively warming Mediterranean, the efficiency of the energy invested in reproduction could be considerably reduced in this species, thereby affecting vital processes. Given the projected increase in seawater temperature as a consequence of global climate change, the present study adds evidence to the threats posed by high temperatures to the survival of B. europaea in the next decades.	[Airi, Valentina; Gizzi, Francesca; Goffredo, Stefano] Alma Mater Studiorum Univ Bologna, Biol Sect, Dept Biol Geol & Environm Sci, Marine Sci Grp, Bologna, Italy; [Falini, Giuseppe] Alma Mater Studiorum Univ Bologna, Dept Chem G Ciamician, Bologna, Italy; [Levy, Oren; Dubinsky, Zvy] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	University of Bologna; University of Bologna; Bar Ilan University	Goffredo, S (corresponding author), Alma Mater Studiorum Univ Bologna, Biol Sect, Dept Biol Geol & Environm Sci, Marine Sci Grp, Bologna, Italy.	stefano.goffredo@marinesciencegroup.org	Gizzi, Francesca/Q-4866-2019; Gizzi, Francesca/K-5469-2015	Gizzi, Francesca/0000-0001-9447-8694; Gizzi, Francesca/0000-0001-9447-8694; goffredo, stefano/0000-0002-5022-9503; Airi, Valentina/0000-0002-6118-7441	European Research Council under the European Union/ERC [249930]	European Research Council under the European Union/ERC(European Research Council (ERC))	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 249930 - CoralWarm: Corals and global warming: the Mediterranean versus the Red Sea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Horani FA, 2005, SCI MAR, V69, P347, DOI 10.3989/scimar.2005.69n3347; Albright R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056468; Altman D.G., 1991, PRACTICAL STAT MED R, DOI [DOI 10.1002/SIM.4780101015, 10.1002/sim.4780101015]; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Barros V, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, pIX; Bauman AG, 2011, CORAL REEFS, V30, P405, DOI 10.1007/s00338-010-0711-5; Brierley AS, 2009, CURR BIOL, V19, pR602, DOI 10.1016/j.cub.2009.05.046; Caroselli E, 2011, ZOOLOGY, V114, P255, DOI 10.1016/j.zool.2011.04.003; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; Cupido R, 2012, MAR ECOL PROG SER, V469, P25, DOI 10.3354/meps09976; de Putron SJ, 2009, INVERTEBR BIOL, V128, P213, DOI 10.1111/j.1744-7410.2009.00170.x; Fadlallah Y.H., 1983, Coral Reefs, V2, P129, DOI 10.1007/BF00336720; Fantazzini P, 2013, ENVIRON SCI TECHNOL, V47, P12679, DOI 10.1021/es402521b; Fischer B, 2011, EVOLUTION, V65, P1221, DOI 10.1111/j.1558-5646.2010.01198.x; Gillooly JF, 2002, NATURE, V417, P70, DOI 10.1038/417070a; Goffredo S, 2008, CORAL REEFS, V27, P623, DOI 10.1007/s00338-008-0362-y; Goffredo S, 2006, MAR BIOL, V148, P923, DOI 10.1007/s00227-005-0137-8; Goffredo S, 2005, MAR BIOL, V147, P485, DOI 10.1007/s00227-005-1567-z; Goffredo S, 2004, MAR BIOL, V145, P1075, DOI 10.1007/s00227-004-1403-x; Goffredo S, 2004, CORAL REEFS, V23, P433, DOI 10.1007/s00338-004-0395-9; Goffredo S, 2002, MAR ECOL PROG SER, V229, P83, DOI 10.3354/meps229083; Goffredo S, 2007, MAR BIOL, V152, P351, DOI 10.1007/s00227-007-0695-z; Goffredo S, 2012, J MORPHOL, V273, P943, DOI 10.1002/jmor.20039; Goffredo S, 2011, B MAR SCI, V87, P589, DOI 10.5343/bms.2010.1068; Goffredo S, 2010, MAR BIOL RES, V6, P421, DOI 10.1080/17451000903428488; Goffredo S, 2009, LIMNOL OCEANOGR, V54, P930, DOI 10.4319/lo.2009.54.3.0930; Gori A, 2007, MAR BIOL, V151, P1571, DOI 10.1007/s00227-006-0595-7; Graham EM, 2008, CORAL REEFS, V27, P529, DOI 10.1007/s00338-008-0361-z; Harrison PL, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P59, DOI 10.1007/978-94-007-0114-4_6; Hayward A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016557; Henry LA, 2005, INT REV HYDROBIOL, V90, P125, DOI 10.1002/iroh.200410759; HOEGHGULDBERG O, 1995, AM ZOOL, V35, P415; Kersting DK, 2013, MAR ECOL PROG SER, V486, P165, DOI 10.3354/meps10356; Kipson S, 2012, MAR ECOL PROG SER, V470, P69, DOI 10.3354/meps09982; Korta M, 2010, FISH RES, V104, P56, DOI 10.1016/j.fishres.2010.01.010; Kruzic P, 2008, CORAL REEFS, V27, P337, DOI 10.1007/s00338-007-0334-7; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; Lesser MP, 2013, CORAL REEFS, V32, P25, DOI 10.1007/s00338-012-0993-x; Leuzinger S, 2003, OECOLOGIA, V136, P524, DOI 10.1007/s00442-003-1305-5; Leuzinger S, 2012, MAR BIOL, V159, P177, DOI 10.1007/s00227-011-1797-1; Linares C, 2008, CORAL REEFS, V27, P27, DOI 10.1007/s00338-007-0285-z; Llodra ER, 2002, ADV MAR BIOL, V43, P87; Lowerre-Barbieri SK, 2011, MAR COAST FISH, V3, P71, DOI 10.1080/19425120.2011.556932; Lueg JR, 2012, J MAR BIOL, V2012, DOI DOI 10.1155/2012/370247; Maltby L, 1999, ECOL APPL, V9, P431, DOI 10.1890/1051-0761(1999)009[0431:SSTIOO]2.0.CO;2; MCCLINTOCK JB, 1990, J EXP MAR BIOL ECOL, V139, P175, DOI 10.1016/0022-0981(90)90145-3; Michalek-Wagner K, 2001, CORAL REEFS, V19, P231, DOI 10.1007/s003380170003; Muscatine L., 1990, P75; Nakamura E, 2004, PHYCOL RES, V52, P38, DOI 10.1046/j.1322-0829.2003.00323.x; Negri AP, 2007, CORAL REEFS, V26, P759, DOI 10.1007/s00338-007-0258-2; Nespolo RF, 2009, EVOLUTION, V63, P2402, DOI 10.1111/j.1558-5646.2009.00706.x; Okubo N, 2007, MAR BIOL, V151, P353, DOI 10.1007/s00227-006-0490-2; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Parry ML, 2000, ASSESSMENT POTENTIAL; POTVIN C, 1993, ECOLOGY, V74, P1617, DOI 10.2307/1939920; Ribes M, 2007, INVERTEBR BIOL, V126, P307, DOI 10.1111/j.1744-7410.2007.00101.x; RICHMOND RH, 1990, MAR ECOL PROG SER, V60, P185, DOI 10.3354/meps060185; RINKEVICH B, 1989, MAR BIOL, V101, P259, DOI 10.1007/BF00391465; Sagarin RD, 2006, TRENDS ECOL EVOL, V21, P524, DOI 10.1016/j.tree.2006.06.008; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tamelander J, 2002, AMBIO, V31, P551, DOI 10.1639/0044-7447(2002)031[0551:CRFAMM]2.0.CO;2; Torrents O, 2011, MAR BIOL, V158, P1019, DOI 10.1007/s00227-011-1627-5; Weil E, 2009, DIS AQUAT ORGAN, V87, P45, DOI 10.3354/dao02103; Zibrowius H., 1980, MEM I OCEANOGR MONAC, V11, P1	64	20	20	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91792	10.1371/journal.pone.0091792	http://dx.doi.org/10.1371/journal.pone.0091792			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618568	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400131
J	Cornejo-Garcia, JA; Flores, C; Plaza-Seron, MC; Acosta-Herrera, M; Blanca-Lopez, N; Dona, I; Torres, MJ; Mayorga, C; Gueant-Rodriguez, RM; Ayuso, P; Fernandez, J; Laguna, JJ; Agundez, JAG; Garcia-Martin, E; Gueant, JL; Canto, G; Blanca, M				Antonio Cornejo-Garcia, Jose; Flores, Carlos; Plaza-Seron, Maria C.; Acosta-Herrera, Marialbert; Blanca-Lopez, Natalia; Dona, Inmaculada; Torres, Maria J.; Mayorga, Cristobalina; Gueant-Rodriguez, Rosa M.; Ayuso, Pedro; Fernandez, Javier; Laguna, Jose J.; Agundez, Jose A. G.; Garcia-Martin, Elena; Gueant, Jean-Louis; Canto, Gabriela; Blanca, Miguel			Variants of CEP68 Gene Are Associated with Acute Urticaria/Angioedema Induced by Multiple Non-Steroidal Anti-Inflammatory Drugs	PLOS ONE			English	Article							ASPIRIN-INTOLERANT ASTHMA; GENOME-WIDE ASSOCIATION; HYPERSENSITIVITY REACTIONS; CYSTEINYL-LEUKOTRIENES; POLYMORPHISMS; CHALLENGE; URTICARIA; PATTERNS; EICOSANOIDS; CENTROSOME	Non-steroidal anti-inflammatory drugs (NSAIDs) are the most consumed drugs worldwide because of their efficacy and utility in the treatment of pain and inflammatory diseases. However, they are also responsible for an important number of adverse effects including hypersensitivity reactions. The most important group of these reactions is triggered by non-immunological, pharmacological mechanisms catalogued under the denomination of cross-intolerance (CRI), with acute urticaria/angioedema induced by multiple NSAIDs (MNSAID-UA) the most frequently associated clinical entity. A recent genome-wide association study identified the gene encoding the centrosomal protein of 68 KDa (CEP68) as the major locus associated with aspirin intolerance susceptibility in asthmatics. In this study, we aimed to assess the role of this locus in susceptibility to CRI to NSAIDs by examining 53 common gene variants in a total of 635 patients that were classified as MNSAID-UA (n = 399), airway exacerbations (n = 110) or blended pattern (n = 126), and 425 controls. We found in the MNSAID-UA group a number of variants (17) associated (lowest p-value = 1.13 x 10(-6)), including the non-synonymous Gly74Ser variant (rs7572857) previously associated with aspirin intolerance susceptibility in asthmatics. Although not being significant in the context of multiple testing, eight of these variants were also associated with exacerbated respiratory disease or blended reactions. Our results suggest that CEP68 gene variants may play an important role in MNSAID-UA susceptibility and, despite the different regulatory mechanisms involved depending on the specific affected organ, in the development of hypersensitivity reactions to NSAIDs.	[Antonio Cornejo-Garcia, Jose; Plaza-Seron, Maria C.; Mayorga, Cristobalina; Ayuso, Pedro] IBIMA Malaga Univ Gen Hosp, Res Lab, Malaga, Spain; [Flores, Carlos; Acosta-Herrera, Marialbert] Inst Salud Carlos III, Ctr Invest Biomed Red CIBER Enfermedades Resp, Madrid, Spain; [Flores, Carlos; Acosta-Herrera, Marialbert] Hosp Univ NS de Candelaria, Res Unit, Tenerife, Spain; [Flores, Carlos] Univ La Laguna, Appl Genom Grp G2A, Genet Lab, Inst Univ Enfermedades Trop & Salud Publ Canarias, Tenerife, Spain; [Acosta-Herrera, Marialbert; Blanca, Miguel] Hosp Univ Dr Negrin, Res Unit, Las Palmas Gran Canaria, Spain; [Blanca-Lopez, Natalia] Infanta Leonor Hosp, Allergy Serv, Madrid, Spain; [Dona, Inmaculada; Torres, Maria J.; Mayorga, Cristobalina; Canto, Gabriela] Malaga Univ Gen Hosp, Unidad Gest Clin UGC Allergy Inst Invest Biomed I, Malaga, Spain; [Gueant-Rodriguez, Rosa M.; Gueant, Jean-Louis] Univ Nancy, Fac Med, INSERM, Nutr Genet & Exposit Risques Environm U954, Vandoeuvre Les Nancy, France; [Gueant-Rodriguez, Rosa M.; Gueant, Jean-Louis] Univ Hosp Ctr CHU Nancy, Vandoeuvre Les Nancy, France; [Fernandez, Javier] Alicante Hosp, Allergy Serv, Alicante, Spain; [Laguna, Jose J.] Cruz Roja Cent Hosp, Allergy Serv, Madrid, Spain; [Agundez, Jose A. G.] Univ Extremadura, Dept Pharmacol, Caceres, Spain; [Garcia-Martin, Elena] Univ Extremadura, Biochem Mol Biol & Genet Dept, Caceres, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Universidad de la Laguna; Hospital Universitario Infanta Leonor; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; CHU de Nancy; General University Hospital of Alicante; Universidad de Extremadura; Universidad de Extremadura	Blanca, M (corresponding author), Hosp Univ Dr Negrin, Res Unit, Las Palmas Gran Canaria, Spain.	mblancago@gmail.com	Fernandez, Javier/B-6425-2018; Mayorga, Cristobalina/D-7167-2018; Flores, Carlos/R-1159-2019; Agúndez, José A. G./A-5503-2008; Torres, Maria/GVU-3391-2022; Torres, María José/T-3518-2017; Mayorga, Lina/FBO-7730-2022; Cornejo-García, Jose Antonio/S-7726-2016; García-Martin, Elena/H-9828-2016; Martinez, Jose Julio Laguna/L-6891-2017	Fernandez, Javier/0000-0003-1065-7199; Mayorga, Cristobalina/0000-0001-8852-8077; Agúndez, José A. G./0000-0001-6895-9160; Torres, María José/0000-0001-5228-471X; Cornejo-García, Jose Antonio/0000-0003-3465-8735; García-Martin, Elena/0000-0002-8094-046X; Martinez, Jose Julio Laguna/0000-0001-5909-8979; Flores, Carlos/0000-0001-5352-069X; Ayuso Parejo, Pedro/0000-0002-9441-4022; Plaza-Seron, Maria del Carmen/0000-0003-4695-5075	Carlos III Institute of the Spanish Health Ministry network Red de Investigacion de Reacciones Adversas a Alergenos y Farmacos (RIRAAF) [RD12/0013/0001]; European Regional Development Funds; European Union; Health Government of Andalucia [PI-0279-2012]; Carlos III Institute [FI11/00074]; Canary Islands Government [EMER07/001];  [PI071220];  [PI10/01598];  [PS09/02419];  [PI11/00623]	Carlos III Institute of the Spanish Health Ministry network Red de Investigacion de Reacciones Adversas a Alergenos y Farmacos (RIRAAF); European Regional Development Funds(European Commission); European Union(European Commission); Health Government of Andalucia; Carlos III Institute(Instituto de Salud Carlos III); Canary Islands Government; ; ; ; 	This study was supported by grants from Carlos III Institute of the Spanish Health Ministry network Red de Investigacion de Reacciones Adversas a Alergenos y Farmacos (RIRAAF, RD12/0013/0001), PI071220, PI10/01598, PS09/02419, PI11/00623, which were co-financed by the European Regional Development Funds, "A way of making Europe'' from the European Union; and from the Health Government of Andalucia, PI-0279-2012. Dr. Cornejo-Garcia is a postdoctoral researcher of the Juan de la Cierva Program (Spanish Ministry of Science and Innovation). Dr. Flores was supported by a specific agreement Carlos III Institute and Canary Islands Government (EMER07/001). M. Acosta-Herrera was supported by a fellowship from Carlos III Institute (FI11/00074). Carlos III website: http://www.isciii.es. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agundez JAG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047571; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Antczak A, 2002, AM J RESP CRIT CARE, V166, P301, DOI 10.1164/rccm.2101021; Carlson CS, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001661; Chen Y, 2007, PROTEOMICS, V7, P2384, DOI 10.1002/pmic.200600968; Choi JH, 2004, HUM GENET, V114, P337, DOI 10.1007/s00439-004-1082-1; CHRISTIE PE, 1992, AM REV RESPIR DIS, V146, P1531, DOI 10.1164/ajrccm/146.6.1531; Conaghan PG, 2012, RHEUMATOL INT, V32, P1491, DOI 10.1007/s00296-011-2263-6; Cornejo-Garcia JA, 2012, CLIN EXP ALLERGY, V42, P1772, DOI 10.1111/j.1365-2222.2012.04078.x; Dona I, 2012, J INVEST ALLERG CLIN, V22, P363; Dona I, 2011, CLIN EXP ALLERGY, V41, P86, DOI 10.1111/j.1365-2222.2010.03651.x; Duroudier NP, 2009, ALLERGY, V64, P823, DOI 10.1111/j.1398-9995.2009.02015.x; Flores C, 2007, GENET EPIDEMIOL, V31, P296, DOI 10.1002/gepi.20210; Fosbol EL, 2008, PHARMACOEPIDEM DR S, V17, P822, DOI 10.1002/pds.1592; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gaber F, 2008, THORAX, V63, P1076, DOI 10.1136/thx.2008.101196; Garcia-Closas M, 1999, AM J EPIDEMIOL, V149, P689; Gomes E, 2004, CLIN EXP ALLERGY, V34, P1597, DOI 10.1111/j.1365-2222.2004.02070.x; Graser S, 2007, J CELL SCI, V120, P4321, DOI 10.1242/jcs.020248; Gray PA, 2002, BRIT J PHARMACOL, V137, P1031, DOI 10.1038/sj.bjp.0704927; Higashi N, 2010, J ALLERGY CLIN IMMUN, V125, P1084, DOI 10.1016/j.jaci.2009.12.977; Hirota N, 2012, FASEB J, V26, P1704, DOI 10.1096/fj.11-197061; Jinnai N, 2004, HUM MOL GENET, V13, P3203, DOI 10.1093/hmg/ddh332; Kim JY, 2013, ALLERGY ASTHMA IMMUN, V5, P34, DOI 10.4168/aair.2013.5.1.34; Kim JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013818; Kim SH, 2007, J CLIN IMMUNOL, V27, P613, DOI 10.1007/s10875-007-9115-x; Kim SH, 2010, CURR OPIN ALLERGY CL, V10, P280, DOI 10.1097/ACI.0b013e32833b1eb3; Kim SH, 2006, CLIN EXP ALLERGY, V36, P433, DOI 10.1111/j.1365-2222.2006.02457.x; Kim SH, 2005, J KOREAN MED SCI, V20, P926, DOI 10.3346/jkms.2005.20.6.926; Kowalski ML, 2011, ALLERGY, V66, P818, DOI 10.1111/j.1398-9995.2011.02557.x; Laidlaw TM, 2012, CLIN EXP ALLERGY, V42, P1313, DOI 10.1111/j.1365-2222.2012.03982.x; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Maheshwari R, 2004, J COLLOID INTERF SCI, V277, P79, DOI 10.1016/j.jcis.2004.04.023; Mastalerz L, 2008, THORAX, V63, P27, DOI 10.1136/thx.2007.080903; Mastalerz L, 2004, J ALLERGY CLIN IMMUN, V113, P771, DOI 10.1016/j.jaci.2003.12.323; McGovern T, 2010, AM J PHYSIOL-LUNG C, V299, pL808, DOI 10.1152/ajplung.00438.2009; Motola D, 2004, EUR J CLIN PHARMACOL, V60, P731, DOI 10.1007/s00228-004-0826-0; Park BL, 2013, HUM GENET, V132, P313, DOI 10.1007/s00439-012-1247-2; Park JS, 2005, PHARMACOGENET GENOM, V15, P483, DOI 10.1097/01.fpc.0000166456.84905.a0; Pino-Yanes M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018389; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Quiralte J, 2007, J INVEST ALLERG CLIN, V17, P182; Sanak M, 2000, AM J RESP CELL MOL, V23, P290, DOI 10.1165/ajrcmb.23.3.4051; Sanak M, 2004, CLIN EXP ALLERGY, V34, P1899, DOI 10.1111/j.1365-2222.2004.02123.x; Sanak M, 2011, J ALLERGY CLIN IMMUN, V127, P1141, DOI 10.1016/j.jaci.2010.12.1108; Setkowicz M, 2009, J ALLERGY CLIN IMMUN, V123, P174, DOI 10.1016/j.jaci.2008.09.005; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Swierczynska M, 2003, J ALLERGY CLIN IMMUN, V112, P995, DOI 10.1016/S0091-6749(03)02015-3; Szczeklik A, 2006, EUR J PHARMACOL, V533, P145, DOI 10.1016/j.ejphar.2005.12.053; SZCZEKLIK A, 1975, BRIT MED J, V1, P67, DOI 10.1136/bmj.1.5949.67; Szczeklik A, 1996, AM J RESP CRIT CARE, V154, P1608, DOI 10.1164/ajrccm.154.6.8970343; Weale ME, 2003, AM J HUM GENET, V73, P551, DOI 10.1086/378098; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zambonino MA, 2013, PEDIAT ALLERG IMM-UK, V24, P151, DOI 10.1111/pai.12039	57	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90966	10.1371/journal.pone.0090966	http://dx.doi.org/10.1371/journal.pone.0090966			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618698	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400039
J	Bouzid, MA; Hammouda, O; Matran, R; Robin, S; Fabre, C				Bouzid, Mohamed Amine; Hammouda, Omar; Matran, Regis; Robin, Sophie; Fabre, Claudine			Changes in Oxidative Stress Markers and Biological Markers of Muscle Injury with Aging at Rest and in Response to an Exhaustive Exercise	PLOS ONE			English	Article							ANTIOXIDANT STATUS; FREE-RADICALS; ECCENTRIC EXERCISE; YOUNG; BLOOD; OLD; LIPOPROTEINS; INFLAMMATION; BIOMARKERS; ENZYMES	Purpose: The aim of this study was to evaluate whether oxidative stress markers and biomarkers of muscle injury would be affected by aging at rest and in response to an incremental exhaustive exercise. Methods: Fifteen young (20.3 +/- 2.8 years) and fifteen older adults (65.1 +/- 3.5 years) performed an incremental cycle ergometer test to exhaustion. Before and after exercise, oxidative stress [superoxide dismutase (SOD), glutathione peroxidase (GPX), glutathione reductase (GR), ascorbic acid, alpha-Tocopherol, malondialdehyde (MDA)] and muscle injury [creatine kinase (CK), lactate deshydrogenase (LDH)] biomarkers were assessed. Results: At rest, there was no difference in oxidative stress markers and LDH level between the groups, however CK was significantly higher in the young group than the elderly group (p<0.05). During recovery, in comparison with resting values, a significant increase in SOD (1092 +/- 145.9 vs. 1243698 U/g Hb), GPX (67.4 +/- 12.7 vs. 79.2 +/- 15.6 U/g Hb) and GR (6.5 +/- 0.9 vs. 7.7 +/- 0.5 U/g Hb) activities were observed only in the young group (p<0.05). MDA has increased only in the older group (0.54 +/- 0.2 vs. 0.79 +/- 0.2 mu mol/l) (p<0.01). CK increased in both groups (young group: 122.5 +/- 22.2 vs. 161.9 +/- 18.7 UI/l; older group: 88.8 +/- 34.1 vs. 111.1 +/- 25.9 UI/l) (p<0.01), however LDH has increased only in the young group (400.5 +/- 22.2 vs. 485 +/- 18.7 UI/l) (p<0.01) without alteration in the older group (382.8 +/- 34.1 vs. 418.5 +/- 25.9 UI/l). Conclusions: These findings indicate that aging is associated with a decrease in antioxidant efficiency and an increase in oxidative stress damage. Furthermore, older adults would not more susceptible to exercise-induced muscle injury than young people.	[Bouzid, Mohamed Amine; Fabre, Claudine] Univ Lille Nord France, EA 4488, Fac Sci Sport & Educ Phys, Ronchin, France; [Hammouda, Omar] Natl Ctr Medecine & Sci Sports, Res Lab Sport Performance Optimisat, Tunis, Tunisia; [Matran, Regis; Robin, Sophie] CHRU Lille, Serv EFR, F-59037 Lille, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille	Hammouda, O (corresponding author), Natl Ctr Medecine & Sci Sports, Res Lab Sport Performance Optimisat, Tunis, Tunisia.	omarham007@yahoo.fr	HAMMOUDA, Omar/AGE-5171-2022	HAMMOUDA, Omar/0000-0002-5002-687X				Balkan J, 2002, INT J VITAM NUTR RES, V72, P315, DOI 10.1024/0300-9831.72.5.315; Bar-Shai M, 2008, FREE RADICAL BIO MED, V44, P202, DOI 10.1016/j.freeradbiomed.2007.03.019; Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005; Bejma J, 2000, ACTA PHYSIOL SCAND, V169, P343; Bloomer RJ, 2004, CAN J APPL PHYSIOL, V29, P245, DOI 10.1139/h04-017; Di Massimo C, 1999, CLIN HEMORHEOL MICRO, V20, P105; El Abed K, 2011, J STRENGTH COND RES, V25, P2400, DOI 10.1519/JSC.0b013e3181fc5c35; Fang YZ, 2002, NUTRITION, V18, P872, DOI 10.1016/S0899-9007(02)00916-4; Fantini AG, 1993, AM J PHYSIOL, V264, P1953; Farney TM, 2012, MED SCI SPORT EXER, V44, P1855, DOI 10.1249/MSS.0b013e3182592575; Figueiredo PA, 2009, J GERONTOL A-BIOL, V64, P21, DOI 10.1093/gerona/gln048; Fletcher GF, 2001, CIRCULATION, V104, P1694, DOI 10.1161/hc3901.095960; FrankiewiczJozko A, 1996, EUR J APPL PHYSIOL O, V74, P470; Gianni P, 2004, EXP GERONTOL, V39, P1391, DOI 10.1016/j.exger.2004.06.002; Hammouda O, 2011, CHRONOBIOL INT, V28, P958, DOI 10.3109/07420528.2011.613683; Hou JH, 1996, BIOCHEM J, V318, P1065, DOI 10.1042/bj3181065; JI LL, 1990, AM J PHYSIOL, V258, pR918, DOI 10.1152/ajpregu.1990.258.4.R918; KANTER MM, 1988, EUR J APPL PHYSIOL O, V57, P60, DOI 10.1007/BF00691239; Karaouzene N, 2011, NUTR METAB CARDIOVAS, V21, P792, DOI 10.1016/j.numecd.2010.02.007; Kasapoglu M, 2001, EXP GERONTOL, V36, P209, DOI 10.1016/S0531-5565(00)00198-4; Lavender AP, 2006, APPL PHYSIOL NUTR ME, V31, P218, DOI 10.1139/H05-028; Lavrovsky Y, 2000, EXP GERONTOL, V35, P521, DOI 10.1016/S0531-5565(00)00118-2; Lee HC, 2001, BIOGERONTOLOGY, V2, P231, DOI 10.1023/A:1013270512172; Meng SJ, 2010, INT J MOL SCI, V11, P1509, DOI 10.3390/ijms11041509; MEYDANI M, 1993, AM J PHYSIOL, V264, pR992, DOI 10.1152/ajpregu.1993.264.5.R992; Monemi M, 1998, J NEUROL SCI, V154, P35, DOI 10.1016/S0022-510X(97)00208-6; Mutlu-Turkoglu U, 2003, CLIN BIOCHEM, V36, P397, DOI 10.1016/S0009-9120(03)00035-3; Nikolaidis MG, 2007, MED SCI SPORT EXER, V39, P1080, DOI 10.1249/mss.0b013e31804ca10c; Ohishi S, 1997, CLIN EXP PHARMACOL P, V24, P326, DOI 10.1111/j.1440-1681.1997.tb01196.x; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Prasertsri P, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-13; Rousseau AS, 2006, J NUTR BIOCHEM, V17, P463, DOI 10.1016/j.jnutbio.2005.10.001; Sacheck JM, 2003, FREE RADICAL BIO MED, V34, P1575, DOI 10.1016/S0891-5849(03)00187-4; SCHAFER L, 1989, ANN NUTR METAB, V33, P315, DOI 10.1159/000177552; Schmuck A, 1996, EUR J CLIN NUTR, V50, P473; Shephard RJ, 2009, BRIT J SPORT MED, V43, P342, DOI 10.1136/bjsm.2007.044800; Siu PM, 2008, J APPL PHYSIOL, V105, P1695, DOI 10.1152/japplphysiol.90800.2008; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Toft AD, 2002, AM J PHYSIOL-CELL PH, V283, pC289, DOI 10.1152/ajpcell.00583.2001; Vina J, 2000, IUBMB LIFE, V50, P271, DOI 10.1080/15216540051080994; Wang CH, 2013, EXP BIOL MED, V238, P450, DOI 10.1177/1535370213493069; Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901; Williams CA, 2004, J ANIM SCI, V82, P588; You TJ, 2005, CAN J APPL PHYSIOL, V30, P677, DOI 10.1139/h05-148	44	63	64	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90420	10.1371/journal.pone.0090420	http://dx.doi.org/10.1371/journal.pone.0090420			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618679	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400017
J	Chen, J; Hou, RL; Zhang, X; Ye, Y; Wang, Y; Tian, J				Chen, Jian; Hou, Ruanling; Zhang, Xing; Ye, Yu; Wang, Yong; Tian, Jing			Calycosin Suppresses Breast Cancer Cell Growth via ER beta-Dependent Regulation of IGF-1R, p38 MAPK and PI3K/Akt Pathways	PLOS ONE			English	Article							FACTOR-I RECEPTOR; DOWN-REGULATION; CROSS-TALK; INSULIN; ESTROGEN; ALPHA; TARGET; VITRO; 17-BETA-ESTRADIOL; PHYTOESTROGENS	We previously reported that calycosin, a natural phytoestrogen structurally similar to estrogen, successfully triggered apoptosis of estrogen receptor (ER)-positive breast cancer cell line, MCF-7. To better understand the antitumor activities of calycosin against breast cancer, besides MCF-7 cells, another ER-positive cell line T-47D was analyzed here, with ER-negative cell lines (MDA-231, MDA-435) as control. Notably, calycosin led to inhibited cell proliferation and apoptosis only in ER-positive cells, particularly in MCF-7 cells, whereas no such effect was observed in ER-negative cells. Then we investigated whether regulation of ER beta, a subtype of ER, contributed to calycosin-induced apoptosis in breast cancer cells. The results showed that incubation of calycosin resulted in enhanced expression ER beta in MCF-7 and T-47D cells, rather than MDA-231 and MDA-435 cells. Moreover, with the upregulation of ER beta, successive changes in downstream signaling pathways were found, including inactivation of insulin-like growth factor 1 receptor (IGF-1R), then stimulation of p38 MAPK and suppression of the serine/threonine kinase (Akt), and finally poly(ADP-ribose) polymerase 1 (PARP-1) cleavage. However, the other two members of the mitogen-activated protein kinase (MAPK) family, extracellular signal-regulated kinase (ERK) 1/2 and c-Jun N-terminal kinase (JNK), were not consequently regulated by downregulated IGF-1R, indicating ERK 1/2 and JNK pathways were not necessary to allow proliferation inhibition by calycosin. Taken together, our results indicate that calycosin tends to inhibit growth and induce apoptosis in ER-positive breast cancer cells, which is mediated by ER beta-induced inhibition of IGF-1R, along with the selective regulation of MAPK and phosphatidylinositol 3-kinase (PI3K)/Akt pathways.	[Chen, Jian; Zhang, Xing] Guilin Med Univ, Sch Basic Med Sci, Guilin, Peoples R China; [Hou, Ruanling] Xinxiang Med Univ, Dept Physiol & Neurobiol, Xinxiang, Peoples R China; [Ye, Yu] Guangxi Med Univ, Affiliated Hosp 1, Dept Emergency, Nanning, Peoples R China; [Wang, Yong; Tian, Jing] Guilin Med Univ, Sch Basic Med Sci, Dept Physiol, Guilin, Peoples R China	Guilin Medical University; Xinxiang Medical University; Guangxi Medical University; Guilin Medical University	Tian, J (corresponding author), Guilin Med Univ, Sch Basic Med Sci, Dept Physiol, Guilin, Peoples R China.	glmcchenjian@163.com			National Natural Science Foundation of China [81260343]; Natural Science Foundation of Guangxi [2013GXNSFAA019143, 2013GXNSFBA019185]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangxi(National Natural Science Foundation of Guangxi Province)	This work was supported by National Natural Science Foundation of China (81260343) and Natural Science Foundation of Guangxi (2013GXNSFAA019143 and 2013GXNSFBA019185). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2005, J CELL PHYSIOL, V203, P193, DOI 10.1002/jcp.20219; Bartella V, 2012, CELL SIGNAL, V24, P1515, DOI 10.1016/j.cellsig.2012.03.012; Chen J, 2011, HORM METAB RES, V43, P681, DOI 10.1055/s-0031-1286306; Cotrim CZ, 2013, ONCOGENE, V32, P2390, DOI 10.1038/onc.2012.261; Fagan D, 2008, J MAMMARY GLAND BIOL, V13, P423, DOI 10.1007/s10911-008-9098-0; Friedlander TW, 2012, ONCOL REP, V27, P3, DOI 10.3892/or.2011.1487; Grober OMV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-36; Gupta S, 2009, J CELL MOL MED, V13, P1004, DOI 10.1111/j.1582-4934.2009.00697.x; Kang NH, 2013, FOOD CHEM TOXICOL, V59, P373, DOI 10.1016/j.fct.2013.06.029; Krolik M, 2012, ADV CLIN EXP MED, V21, P535; Langelier MF, 2013, CURR OPIN STRUC BIOL, V23, P134, DOI 10.1016/j.sbi.2013.01.003; Liang J, 2013, ANNU REV PHYSIOL, V75, P225, DOI 10.1146/annurev-physiol-030212-183708; Lin AHY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063199; Ma CX, 2013, BREAST CANCER RES TR, V139, P145, DOI 10.1007/s10549-013-2528-8; Ohtani M, 2009, BIOSCI TRENDS, V3, P131; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Renoir JM, 2013, BIOCHEM PHARMACOL, V85, P449, DOI 10.1016/j.bcp.2012.10.018; Renoir JM, 2012, STEROIDS, V77, P1249, DOI 10.1016/j.steroids.2012.07.019; Sabbatini P, 2009, CLIN CANCER RES, V15, P3058, DOI 10.1158/1078-0432.CCR-08-2530; Saxena R, 2013, STEROIDS, V78, P1071, DOI 10.1016/j.steroids.2013.07.004; Serrano ML, 2008, HORM METAB RES, V40, P661, DOI 10.1055/s-0028-1082080; Sukhanova MV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P736, DOI 10.1134/S0006297906070066; Tang HX, 2012, MED ONCOL, V29, P2640, DOI 10.1007/s12032-012-0198-8; Tian J, 2013, HORM METAB RES, V45, P593, DOI 10.1055/s-0033-1341510; Tiong CT, 2012, CARCINOGENESIS, V33, P1089, DOI 10.1093/carcin/bgs110; van der Veeken J, 2009, CURR CANCER DRUG TAR, V9, P748; van Duursen MBM, 2013, TOXICOL APPL PHARM, V269, P132, DOI 10.1016/j.taap.2013.03.014; Varewijck AJ, 2012, ENDOCR-RELAT CANCER, V19, pF63, DOI 10.1530/ERC-12-0026; Wallace JL, 2011, J MEMBRANE BIOL, V242, P53, DOI 10.1007/s00232-011-9376-4; Xu T, 2012, MOL BIOL REP, V39, P7743, DOI 10.1007/s11033-012-1611-2; Yakimchuk K, 2011, LEUKEMIA, V25, P1103, DOI 10.1038/leu.2011.68; Yu ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062642; Zhao Y, 2011, CANCER LETT, V313, P54, DOI 10.1016/j.canlet.2011.08.023	33	54	61	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91245	10.1371/journal.pone.0091245	http://dx.doi.org/10.1371/journal.pone.0091245			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618835	Green Submitted, Green Published, gold			2022-12-25	WOS:000332842400065
J	Fraisier, C; Koraka, P; Belghazi, M; Bakli, M; Granjeaud, S; Pophillat, M; Lim, SM; Osterhaus, A; Martina, B; Camoin, L; Almeras, L				Fraisier, Christophe; Koraka, Penelope; Belghazi, Maya; Bakli, Mahfoud; Granjeaud, Samuel; Pophillat, Matthieu; Lim, Stephanie M.; Osterhaus, Albert; Martina, Byron; Camoin, Luc; Almeras, Lionel			Kinetic Analysis of Mouse Brain Proteome Alterations Following Chikungunya Virus Infection before and after Appearance of Clinical Symptoms	PLOS ONE			English	Article							WEST-NILE-VIRUS; ALPHA-V-INTEGRINS; PLASMODIUM-FALCIPARUM; REUNION ISLAND; ACTIN CYTOSKELETON; ENDOCYTIC PATHWAY; ARP2/3 COMPLEX; NERVOUS-SYSTEM; SEVERE DISEASE; LATE ENDOSOMES	Recent outbreaks of Chikungunya virus (CHIKV) infection have been characterized by an increasing number of severe cases with atypical manifestations including neurological complications. In parallel, the risk map of CHIKV outbreaks has expanded because of improved vector competence. These features make CHIKV infection a major public health concern that requires a better understanding of the underlying physiopathological processes for the development of antiviral strategies to protect individuals from severe disease. To decipher the mechanisms of CHIKV infection in the nervous system, a kinetic analysis on the host proteome modifications in the brain of CHIKV-infected mice sampled before and after the onset of clinical symptoms was performed. The combination of 2D-DIGE and iTRAQ proteomic approaches, followed by mass spectrometry protein identification revealed 177 significantly differentially expressed proteins. This kinetic analysis revealed a dramatic down-regulation of proteins before the appearance of the clinical symptoms followed by the increased expression of most of these proteins in the acute symptomatic phase. Bioinformatic analyses of the protein datasets enabled the identification of the major biological processes that were altered during the time course of CHIKV infection, such as integrin signaling and cytoskeleton dynamics, endosome machinery and receptor recycling related to virus transport and synapse function, regulation of gene expression, and the ubiquitin-proteasome pathway. These results reveal the putative mechanisms associated with severe CHIKV infection-mediated neurological disease and highlight the potential markers or targets that can be used to develop diagnostic and/or antiviral tools.	[Fraisier, Christophe; Bakli, Mahfoud; Almeras, Lionel] Aix Marseille Univ, Unite Rech Malad Infect & Trop Emergentes, UM63, CNRS 7278,IRD 198,Inserm 1095, Marseille, France; [Koraka, Penelope; Lim, Stephanie M.; Osterhaus, Albert; Martina, Byron] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Belghazi, Maya] Aix Marseille Univ, CNRS, UMR 7286 CRN2M, Marseille, France; [Granjeaud, Samuel; Pophillat, Matthieu; Camoin, Luc] CRCM, Marseille Prote, INSERM, U1068, Marseille, France; [Granjeaud, Samuel; Pophillat, Matthieu; Camoin, Luc] Aix Marseille Univ, UM 105, Marseille, France; [Almeras, Lionel] IRBA, URBEP, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Erasmus University Rotterdam; Erasmus MC; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Almeras, L (corresponding author), Aix Marseille Univ, Unite Rech Malad Infect & Trop Emergentes, UM63, CNRS 7278,IRD 198,Inserm 1095, Marseille, France.	almeras.lionel@gmail.com	Camoin, Luc/AAB-3856-2019; Granjeaud, Samuel/AAE-6488-2022	Camoin, Luc/0000-0002-1230-4787; Granjeaud, Samuel/0000-0001-9245-1535; ALMERAS, Lionel/0000-0003-0490-5774; Martina, Byron/0000-0003-4980-4619; BAKLI, Mahfoud/0000-0002-1427-2985	European Community [261466]; Delegation Generale pour l'Armement (DGA) [ArthroSer 10Ca 401]	European Community(European Commission); Delegation Generale pour l'Armement (DGA)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007 - 2 013) under the project "VECTORIE'', EC grant agreement number 261466. This study was also supported by Delegation Generale pour l'Armement (DGA, ArthroSer 10Ca 401). This manuscript has been reviewed and corrected by American Journal Experts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abere B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034800; Abraham C, 2011, NEUROSCIENCE, V190, P75, DOI 10.1016/j.neuroscience.2011.05.069; Agola JO, 2011, CLIN GENET, V80, P305, DOI 10.1111/j.1399-0004.2011.01724.x; Alla SAO, 2011, BEST PRACT RES CL RH, V25, P337, DOI 10.1016/j.berh.2011.03.005; Allaire PD, 2013, J CELL SCI, V126, P722, DOI 10.1242/jcs.112375; Arpino C, 2009, REV MED VIROL, V19, P121, DOI 10.1002/rmv.606; Belizaire R, 2004, J COMP NEUROL, V470, P266, DOI 10.1002/cne.20008; Bernard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011479; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Bockaert J, 2010, ANNU REV PHARMACOL, V50, P89, DOI 10.1146/annurev.pharmtox.010909.105705; Briolant S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-141; Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X; Caminade C, 2012, J R SOC INTERFACE; Chen YS, 2013, CHIN J CANC; Chevallier J, 2009, FEBS LETT, V583, P1096, DOI 10.1016/j.febslet.2009.03.012; Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004; Chua CEL, 2010, FEBS LETT, V584, P1, DOI 10.1016/j.febslet.2009.11.051; Clague MJ, 1998, BIOCHEM J, V336, P271, DOI 10.1042/bj3360271; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Das T, 2010, PROG NEUROBIOL, V91, P121, DOI 10.1016/j.pneurobio.2009.12.006; Dhanwani R, 2011, PROTEOMICS, V11, P1936, DOI 10.1002/pmic.201000500; Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895; Dupuis-Maguiraga L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001446; Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167; Fontaine A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-187; Fontaine A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-276; Fraisier C, 2013, VIRUS RES IN PRESS; Fraisier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068318; Fuchs SY, 2012, GROWTH FACTORS, V30, P141, DOI 10.3109/08977194.2012.669382; Garmashova N, 2007, J VIROL, V81, P2472, DOI 10.1128/JVI.02073-06; Garmashova N, 2006, J VIROL, V80, P5686, DOI 10.1128/JVI.02739-05; Garrison AR, 2013, VIROLOGY; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Goodman SL, 2012, TRENDS PHARMACOL SCI, V33, P405, DOI 10.1016/j.tips.2012.04.002; Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x; Grande E, 2012, EXPERT REV ANTICANC, V12, P457, DOI [10.1586/era.12.26, 10.1586/ERA.12.26]; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Greenfield LJ, 2013, SEIZURE-EUR J EPILEP, V22, P589, DOI 10.1016/j.seizure.2013.04.015; Grieve Adam G, 2012, Int J Cell Biol, V2012, P852430, DOI 10.1155/2012/852430; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; Hoogenraad Casper C, 2010, Commun Integr Biol, V3, P433, DOI 10.4161/cib.3.5.12209; Jurado S, 2010, EMBO J, V29, P2827, DOI 10.1038/emboj.2010.160; Kalia M, 2013, J VIROL, V87, P148, DOI 10.1128/JVI.01399-12; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06; La Linn M, 2005, VIROLOGY, V336, P229, DOI 10.1016/j.virol.2005.03.015; Lee RCH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002050; Lei WL, 2012, CELL RES, V22, P954, DOI 10.1038/cr.2012.40; Li E, 2001, J VIROL, V75, P5405, DOI 10.1128/JVI.75.11.5405-5409.2001; Li G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011371; Liu BS, 2010, STROKE, V41, P1018, DOI 10.1161/STROKEAHA.110.579011; Mainou BA, 2012, J VIROL, V86, P8346, DOI 10.1128/JVI.00100-12; Martin KH, 2002, SCIENCE, V296, P1652, DOI 10.1126/science.296.5573.1652; Masliah E, 2004, J NEUROIMMUNOL, V157, P163, DOI 10.1016/j.jneuroim.2004.08.026; MATHIAS P, 1994, J VIROL, V68, P6811, DOI 10.1128/JVI.68.10.6811-6814.1994; Nakamura T, 1999, J BIOL CHEM, V274, P13322, DOI 10.1074/jbc.274.19.13322; Nakamura Y, 2011, EMBO J, V30, P719, DOI 10.1038/emboj.2010.357; NIMMANNITYA S, 1969, AM J TROP MED HYG, V18, P954, DOI 10.4269/ajtmh.1969.18.954; Pastorino B, 2009, MOL CELL PROTEOMICS, V8, P1623, DOI 10.1074/mcp.M800565-MCP200; Pattanakitsakul S, 2007, J PROTEOME RES, V6, P4592, DOI 10.1021/pr070366b; Queyriaux B, 2008, LANCET, V371, P723, DOI 10.1016/S0140-6736(08)60337-2; Renault P, 2007, AM J TROP MED HYG, V77, P727; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Robinson LJ, 1997, J CELL SCI, V110, P2079; ROBINSON M. C., 1955, TANGANYIKA TERRITORY IN 1952 53 I TRANS ROY SOC TROP MED AND HYG, V49, P28, DOI 10.1016/0035-9203(55)90080-8; Rocca DL, 2008, NAT CELL BIOL, V10, P259, DOI 10.1038/ncb1688; ROSS R. W., 1956, JOUR HYG, V54, P177; Schaffner Florence, 2013, Cancers (Basel), V5, P27, DOI 10.3390/cancers5010027; Schmidt K, 2013, J GEN VIROL; Scholte FEM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071047; Sheppard D, 2004, CURR OPIN CELL BIOL, V16, P552, DOI 10.1016/j.ceb.2004.06.017; Soumahoro MK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001197; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; Stewart PL, 2007, TRENDS MICROBIOL, V15, P500, DOI 10.1016/j.tim.2007.10.001; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574; Thio CLP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061444; THIRUVENGADAM KV, 1965, INDIAN J MED RES, V53, P729; Torrentino-Madamet M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-4; Tournebize P, 2009, REV NEUROL-FRANCE, V165, P48, DOI 10.1016/j.neurol.2008.06.009; van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244; Viswanathan K, 2010, CURR OPIN MICROBIOL, V13, P517, DOI 10.1016/j.mib.2010.05.012; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Werneke SW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002322; White LK, 2011, J VIROL, V85, P606, DOI 10.1128/JVI.00767-10; Wintachai P, 2012, J MED VIROL, V84, P1757, DOI 10.1002/jmv.23403; Yamashiro K, 2007, INT J BIOCHEM CELL B, V39, P910, DOI 10.1016/j.biocel.2007.01.015	87	29	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91397	10.1371/journal.pone.0091397	http://dx.doi.org/10.1371/journal.pone.0091397			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618821	gold, Green Published, Green Submitted			2022-12-25	WOS:000332842400086
J	Gressette, M; Verillaud, B; Jimenez-Pailhes, AS; Lelievre, H; Lo, KW; Ferrand, FR; Gattolliat, CH; Jacquet-Bescond, A; Kraus-Berthier, L; Depil, S; Busson, P				Gressette, Melanie; Verillaud, Benjamin; Jimenez-Pailhes, Anne-Sophie; Lelievre, Helene; Lo, Kwok-Wai; Ferrand, Francois-Regis; Gattolliat, Charles-Henry; Jacquet-Bescond, Anne; Kraus-Berthier, Laurence; Depil, Stephane; Busson, Pierre			Treatment of Nasopharyngeal Carcinoma Cells with the Histone-Deacetylase Inhibitor Abexinostat: Cooperative Effects with Cis-platin and Radiotherapy on Patient-Derived Xenografts	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; SUBEROYLANILIDE HYDROXAMIC ACID; PHASE-II; CONCURRENT CHEMORADIOTHERAPY; RANDOMIZED-TRIALS; INDUCED APOPTOSIS; GROWTH-FACTOR; P53 GENE; CHEMOTHERAPY; EXPRESSION	EBV-related nasopharyngeal carcinomas (NPCs) still raise serious therapeutic problems. The therapeutic potential of the histone-deacetylase (HDAC) inhibitor Abexinostat was investigated using 5 preclinical NPC models including 2 patient-derived xenografts (C15 and C17). The cytotoxicity of Abexinostat used either alone or in combination with cis-platin or irradiation was assessed in vitro by MTT and clonogenic assays using 2 EBV-negative (CNE1 and HONE1) and 3 EBV-positive NPC models (C15, C17 and C666-1). Subsequently, the 3 EBV-positive models were used under the form of xenografts to assess the impact of systemic treatments by Abexinostat or combinations of Abexinostat with cis-platin or irradiation. Several cell proteins known to be affected by HDAC inhibitors and the small viral non-coding RNA EBER1 were investigated in the treated tumors. Synergistic cytotoxic effects of Abexinostat combined with cis-platin or irradiation were demonstrated in vitro for each NPC model. When using xenografts, Abexinostat by itself (12.5 mg/kg, BID, 4 days a week for 3 weeks) had significant anti-tumor effects against C17. Cooperative effects with cis-platin (2 mg/kg, IP, at days 3, 10 and 17) and irradiation (1Gy) were observed for the C15 and C17 xenografts. Simultaneously two types of biological alterations were induced in the tumor tissue, especially in the C17 model: a depletion of the DNA-repair protein RAD51 and a stronger in situ detection of the small viral RNA EBER1. Overall, these results support implementation of phase I/II clinical trials of Abexinostat for the treatment of NPC. A depletion of RAD51 is likely to contribute to the cooperation of Abexinostat with DNA damaging agents. Reduction of RAD51 combined to enhanced detection of EBER 1 might be helpful for early assessment of tumor response.	[Gressette, Melanie; Verillaud, Benjamin; Jimenez-Pailhes, Anne-Sophie; Gattolliat, Charles-Henry; Busson, Pierre] Univ Paris 11, CNRS, UMR 8126, Villejuif, France; [Gressette, Melanie; Verillaud, Benjamin; Jimenez-Pailhes, Anne-Sophie; Gattolliat, Charles-Henry; Busson, Pierre] Gustave Roussy, Villejuif, France; [Lelievre, Helene; Jacquet-Bescond, Anne; Kraus-Berthier, Laurence; Depil, Stephane] Inst Rech Int Servier, Suresnes, France; [Lo, Kwok-Wai] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Ferrand, Francois-Regis] Hop Val de Grace, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Servier; Institut de Recherches Internationales Servier; Chinese University of Hong Kong; Val-de-Grace Hospital	Busson, P (corresponding author), Univ Paris 11, CNRS, UMR 8126, Villejuif, France.	pbusson@igr.fr	Verillaud, Benjamin/AAM-5105-2020	Busson, Pierre/0000-0003-1027-3400; Verillaud, Benjamin/0000-0003-0611-4570	Servier, a company developing Abexinostat; Institut Gustave Roussy; Institut National du Cancer [FOR - 2010-INCa_3113]; APHP-CNRS [RAFCNR11]	Servier, a company developing Abexinostat; Institut Gustave Roussy; Institut National du Cancer(Institut National du Cancer (INCA) France); APHP-CNRS(Centre National de la Recherche Scientifique (CNRS))	Research carried by Pierre Busson's group has been supported by a contract linking Servier, a company developing Abexinostat, and Institut Gustave Roussy. Benjamin Verillaud was the recipient of a fellowship from the Institut National du Cancer (FOR - 2010-INCa_3113) and from the APHP-CNRS (RAFCNR11). Helene Lelievre, Anne Jacquet-Bescond, Laurence Kraus-Berthier, and Stephane Depil are employed by Servier, and had a role in study design, data analysis, decision to publish, and preparation of the manuscript.	Adimoolam S, 2007, P NATL ACAD SCI USA, V104, P19482, DOI 10.1073/pnas.0707828104; Ali A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.260; Balluff B, 2011, AM J PATHOL, V179, P2720, DOI 10.1016/j.ajpath.2011.08.032; Baujat B, 2006, INT J RADIAT ONCOL, V64, P47, DOI 10.1016/j.ijrobp.2005.06.037; BERENBAUM MC, 1981, ADV CANCER RES, V35, P269, DOI 10.1016/S0065-230X(08)60912-4; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; BUSSON P, 1988, INT J CANCER, V42, P599, DOI 10.1002/ijc.2910420422; Chan ATC, 2005, J CLIN ONCOL, V23, P3568, DOI 10.1200/JCO.2005.02.147; Chan SYY, 2008, INT J CANCER, V122, P2169, DOI 10.1002/ijc.23374; Chen L, 2012, LANCET ONCOL, V13, P163, DOI 10.1016/S1470-2045(11)70320-5; Chen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079781; Chen XF, 2012, MOL CANCER RES, V10, P1052, DOI 10.1158/1541-7786.MCR-11-0587; Cheng Y, 2000, GENE CHROMOSOME CANC, V28, P82, DOI 10.1002/(SICI)1098-2264(200005)28:1<82::AID-GCC10>3.0.CO;2-8; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; Chua DTT, 2004, INT J RADIAT ONCOL, V59, P11, DOI 10.1016/j.ijrobp.2003.10.038; EFFERT P, 1992, J VIROL, V66, P3768, DOI 10.1128/JVI.66.6.3768-3775.1992; Feng BJ, 2013, ADV EXP MED BIOL, V778, P23; Fotheringham S, 2009, CANCER CELL, V15, P57, DOI 10.1016/j.ccr.2008.12.001; Friboulet L, 2008, NEOPLASIA, V10, P1183, DOI 10.1593/neo.08590; Gourzones C, 2013, ADV EXP MED BIOL, V778, P42; Hui EP, 2011, ANN ONCOL, V22, P1280, DOI 10.1093/annonc/mdq629; Hui EP, 2013, ADV EXP MED BIOL, V778, P149; Hui EP, 2002, CLIN CANCER RES, V8, P2595; Hui KF, 2012, INT J CANCER, V131, P1930, DOI 10.1002/ijc.27439; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; Jin Y, 2013, EUR J CANCER, V49, P1619, DOI 10.1016/j.ejca.2012.11.032; Kerr E, 2012, CELL DEATH DIFFER, V19, P1317, DOI 10.1038/cdd.2012.8; Klibi J, 2009, BLOOD, V113, P1957, DOI 10.1182/blood-2008-02-142596; Lee N, 2012, RNA, V18, P2073, DOI 10.1261/rna.034900.112; Lim WT, 2011, CLIN CANCER RES, V17, P5481, DOI 10.1158/1078-0432.CCR-10-3409; Pow EHN, 2006, INT J RADIAT ONCOL, V66, P981, DOI 10.1016/j.ijrobp.2006.06.013; Salvador MA, 2013, CLIN CANCER RES, V19, P6520, DOI 10.1158/1078-0432.CCR-13-0877; Sbih-Lammali F, 1999, CANCER RES, V59, P924; Su Sheng-Fa, 2011, Chin J Cancer, V30, P565, DOI 10.5732/cjc.010.10547; Takada K, 2012, SEMIN CANCER BIOL, V22, P162, DOI 10.1016/j.semcancer.2011.12.007; TOCZYSKI DP, 1994, P NATL ACAD SCI USA, V91, P3463, DOI 10.1073/pnas.91.8.3463; Weinrib L, 2001, CANCER GENE THER, V8, P352, DOI 10.1038/sj.cgt.7700319; Xiao X, 2007, INT J CANCER, V121, P2095, DOI 10.1002/ijc.22955; Zhang L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-558	39	31	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91325	10.1371/journal.pone.0091325	http://dx.doi.org/10.1371/journal.pone.0091325			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618637	gold, Green Published, Green Submitted			2022-12-25	WOS:000332842400075
J	Jia, JY; Jin, YX; Bian, T; Wu, DH; Yang, LJ; Terada, N; Wu, WH; Jin, SG				Jia, Jingyue; Jin, Yongxin; Bian, Ting; Wu, Donghai; Yang, Lijun; Terada, Naohiro; Wu, Weihui; Jin, Shouguang			Bacterial Delivery of TALEN Proteins for Human Genome Editing	PLOS ONE			English	Article							DNA-BINDING SPECIFICITY; DOUBLE-STRAND BREAKS; PSEUDOMONAS-AERUGINOSA; EFFECTOR NUCLEASES; III EFFECTORS; SECRETION; FIBROBLASTS; GENERATION; INJECTION; KNOCKOUT	Transcription Activator-Like Effector Nucleases (TALENs) are a novel class of sequence-specific nucleases that have recently gained prominence for its ease of production and high efficiency in genome editing. A TALEN pair recognizes specific DNA sequences and introduce double-strand break in the target site, triggering non-homologous end joining and homologous recombination. Current methods of TALEN delivery involves introduction of foreign genetic materials, such as plasmid DNA or mRNA, through transfection. Here, we show an alternative way of TALEN delivery, bacterial type III secretion system (T3SS) mediated direct injection of the TALEN proteins into human cells. Bacterially injected TALEN was shown to efficiently target host cell nucleus where it persists for almost 12 hours. Using a pair of TALENs targeting venus gene, such injected nuclear TALENs were shown functional in introducing DNA mutation in the target site. Interestingly, S-phase cells seem to show greater sensitivity to the TALEN mediated target gene modification. Accordingly, efficiency of such genome editing can easily be manipulated by the infection dose, number of repeated infections as well as enrichment of S phase cells. This work further extends the utility of T3SS in the delivery of functional proteins into mammalian cells to alter their characters for biomedical applications.	[Jia, Jingyue; Jin, Yongxin; Bian, Ting; Wu, Weihui; Jin, Shouguang] Nankai Univ, Dept Microbiol, Minist Educ, Key Lab, Tianjin 300071, Peoples R China; [Wu, Donghai] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China; [Wu, Donghai] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou, Guangdong, Peoples R China; [Yang, Lijun; Terada, Naohiro] Univ Florida, Dept Pathol, Gainesville, FL 32611 USA; [Jin, Shouguang] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA	Nankai University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Wu, WH (corresponding author), Nankai Univ, Dept Microbiol, Minist Educ, Key Lab, Tianjin 300071, Peoples R China.	wuweihui@nankai.edu.cn; sjin@ufl.edu	Jin, Shouguang/N-5548-2016	jia, jingyue/0000-0002-1522-9612	National Science Foundation of China [31170128]; National Basic Research Program of China (973 Program) [2012CB518700, 2010CB945500]; National Institutes of Health [RC1GM091238]; Bankhead-Coley Cancer Research Program [FLDH 09BW-12]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC1GM091238] Funding Source: NIH RePORTER	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bankhead-Coley Cancer Research Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Science Foundation of China (31170128), National Basic Research Program of China (973 Program, 2012CB518700 and 2010CB945500), National Institutes of Health (RC1GM091238) and Bankhead-Coley Cancer Research Program (FLDH 09BW-12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bichsel C, 2013, CELL REPROGRAM, V15, P117, DOI 10.1089/cell.2012.0058; Bichsel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016465; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Buttner D, 2004, MOL MICROBIOL, V54, P755, DOI 10.1111/j.1365-2958.2004.04302.x; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Grau J, 2013, BIOINFORMATICS, V29, P2931, DOI 10.1093/bioinformatics/btt501; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Khan M, 2013, BIOMATERIALS, V34, P5336, DOI 10.1016/j.biomaterials.2013.03.072; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mukherjee S, 2013, GENE, V525, P174, DOI 10.1016/j.gene.2013.03.098; Pastor A, 2005, FEMS MICROBIOL LETT, V253, P95, DOI 10.1016/j.femsle.2005.09.028; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; Wolff Jon A., 1992, Human Molecular Genetics, V1, P363, DOI 10.1093/hmg/1.6.363; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	26	23	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91547	10.1371/journal.pone.0091547	http://dx.doi.org/10.1371/journal.pone.0091547			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618838	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400103
J	Liu, D; Wu, AD; Cui, L; Hao, RD; Wang, Y; He, J; Guo, DY				Liu, Dan; Wu, An'dong; Cui, Lei; Hao, Ruidong; Wang, Yuan; He, Jing; Guo, Deyin			Hepatitis B Virus Polymerase Suppresses NF-kappa B Signaling by Inhibiting the Activity of IKKs via Interaction with Hsp90 beta	PLOS ONE			English	Article							X-PROTEIN; GENE-EXPRESSION; KINASE-ACTIVITY; ALPHA; TRANSCRIPTION; BINDING; ACTIVATION; PHOSPHORYLATION; INFECTION; SUBUNIT	Nuclear factor-kappa B (NF-kappa B) plays a central role in the regulation of diverse biological processes, including immune responses, development, cell growth, and cell survival. To establish persistent infection, many viruses have evolved strategies to evade the host's antiviral immune defenses. In the case of hepatitis B virus (HBV), which can cause chronic infection in the liver, immune evasion strategies used by the virus are not fully understood. It has recently been reported that the polymerase of HBV (Pol) inhibits interferon-beta (IFN-beta) activity by disrupting the interaction between IKK epsilon and the DDX3. In the current study, we found that HBV Pol suppressed NF-kB signaling, which can also contribute to IFN-beta production. HBV Pol did not alter the level of NF-kappa B expression, but it prevented NF-kappa B subunits involved in both the canonical and non-canonical NF-kappa B pathways from entering the nucleus. Further experiments demonstrated that HBV Pol preferentially suppressed the activity of the I kappa B kinase (IKK) complex by disrupting the association of IKK/NEMO with Cdc37/Hsp90, which is critical for the assembly of the IKK complex and recruitment of the IKK complex to the tumor necrosis factor type 1 receptor (TNF-R1). Furthermore, we found that HBV Pol inhibited the NF-kappa B-mediated transcription of target genes. Taken together, it is suggested that HBV Pol could counteract host innate immune responses by interfering with two distinct signaling pathways required for IFN-beta activation. Our studies therefore shed light on a potential therapeutic target for persistent infection with HBV.	[Guo, Deyin] Wuhan Univ, Natl Key Lab Virol, Wuhan 430072, Peoples R China; Wuhan Univ, Modern Virol Res Ctr, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Guo, DY (corresponding author), Wuhan Univ, Natl Key Lab Virol, Wuhan 430072, Peoples R China.	dguo@whu.edu.cn			China "973'' Basic Research Program [2010CB911800]; China NSFC [31221061]; Hubei Provincial Science & Technology Innovation Team [2012FFA043]; Hubei Province's Outstanding Medical Academic Leader Program	China "973'' Basic Research Program(National Basic Research Program of China); China NSFC(National Natural Science Foundation of China (NSFC)); Hubei Provincial Science & Technology Innovation Team; Hubei Province's Outstanding Medical Academic Leader Program	This study was supported by China "973'' Basic Research Program (#2010CB911800), China NSFC (grant 31221061) and Hubei Provincial Science & Technology Innovation Team grant (#2012FFA043). D.G. is also supported by Hubei Province's Outstanding Medical Academic Leader Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; BARTENSCHLAGER R, 1992, EMBO J, V11, P3413, DOI 10.1002/j.1460-2075.1992.tb05420.x; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Chen GQ, 2002, MOL CELL, V9, P401, DOI 10.1016/S1097-2765(02)00450-1; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Cho G, 2000, BIOCHEM BIOPH RES CO, V269, P191, DOI 10.1006/bbrc.2000.2240; Cho GA, 2000, BIOCHEM BIOPH RES CO, V274, P203, DOI 10.1006/bbrc.2000.3119; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Field N, 2003, J CELL SCI, V116, P3721, DOI 10.1242/jcs.00691; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Harling-McNabb L, 1999, INT IMMUNOL, V11, P1431, DOI 10.1093/intimm/11.9.1431; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hildt E, 1996, VIROLOGY, V225, P235, DOI 10.1006/viro.1996.0594; Hinz M, 2007, J BIOL CHEM, V282, P32311, DOI 10.1074/jbc.M705785200; Hosel M, 2009, HEPATOLOGY, V50, P1773, DOI 10.1002/hep.23226; Lara-Pezzi E, 1998, HEPATOLOGY, V28, P1013, DOI 10.1002/hep.510280416; Lee Y, 1998, CLIN CANCER RES, V4, P1711; Lewis J, 2000, J BIOL CHEM, V275, P10519, DOI 10.1074/jbc.275.14.10519; LUCITO R, 1992, J VIROL, V66, P983, DOI 10.1128/JVI.66.2.983-991.1992; MAHE Y, 1991, J BIOL CHEM, V266, P13759; Nam NH, 2006, MINI-REV MED CHEM, V6, P945, DOI 10.2174/138955706777934937; Neckers Len, 2003, Current Opinion in Oncology, V15, P419, DOI 10.1097/00001622-200311000-00003; Park SG, 2002, ARCH BIOCHEM BIOPHYS, V401, P99, DOI 10.1016/S0003-9861(02)00004-8; POLLACK JR, 1994, J VIROL, V68, P5579, DOI 10.1128/JVI.68.9.5579-5587.1994; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Rodriguez CI, 2002, J VIROL, V76, P3936, DOI 10.1128/JVI.76.8.3936-3942.2002; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Su F, 1996, J VIROL, V70, P4558, DOI 10.1128/JVI.70.7.4558-4566.1996; SUMMERS J, 1982, CELL, V29, P403, DOI 10.1016/0092-8674(82)90157-X; Tait SWG, 2000, J BIOL CHEM, V275, P34656, DOI 10.1074/jbc.M000320200; Wang H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000986; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Wu M, 2007, J GEN VIROL, V88, P3260, DOI 10.1099/vir.0.82959-0	43	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91658	10.1371/journal.pone.0091658	http://dx.doi.org/10.1371/journal.pone.0091658			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618592	gold, Green Published, Green Submitted			2022-12-25	WOS:000332842400113
J	Monsey, MS; Boyle, LM; Zhang, ML; Nguyen, CP; Kronman, HG; Ota, KT; Duman, RS; Taylor, JR; Schafe, GE				Monsey, Melissa S.; Boyle, Lara M.; Zhang, Melinda L.; Nguyen, Caroline P.; Kronman, Hope G.; Ota, Kristie T.; Duman, Ronald S.; Taylor, Jane R.; Schafe, Glenn E.			Chronic Corticosterone Exposure Persistently Elevates the Expression of Memory-Related Genes in the Lateral Amygdala and Enhances the Consolidation of a Pavlovian Fear Memory	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; EPIGENETIC MECHANISMS; CONTRASTING PATTERNS; CELL-PROLIFERATION; DORSAL HIPPOCAMPUS; PROTEIN ARC/ARG3.1; SPATIAL MEMORY; MAP KINASE; STRESS; BRAIN	Chronic exposure to stress has been widely implicated in the development of anxiety disorders, yet relatively little is known about the long-term effects of chronic stress on amygdala-dependent memory formation. Here, we examined the effects of a history of chronic exposure to the stress-associated adrenal steroid corticosterone (CORT) on the consolidation of a fear memory and the expression of memory-related immediate early genes (IEGs) in the lateral nucleus of the amygdala (LA). Rats received chronic exposure to CORT (50 mu g/ml) in their drinking water for 2 weeks and were then titrated off the CORT for an additional 6 days followed by a 2 week 'wash-out' period consisting of access to plain water. Rats were then either sacrificed to examine the expression of memory-related IEG expression in the LA or given auditory Pavlovian fear conditioning. We show that chronic exposure to CORT leads to a persistent elevation in the expression of the IEGs Arc/Arg3.1 and Egr-1 in the LA. Further, we show that rats with a history of chronic CORT exposure exhibit enhanced consolidation of a fear memory; short-term memory (STM) is not affected, while long-term memory (LTM) is significantly enhanced. Treatment with the selective serotonin reuptake inhibitor (SSRI) fluoxetine following the chronic CORT exposure period was observed to effectively reverse both the persistent CORT-related increases in memory-related IEG expression in the LA and the CORT-related enhancement in fear memory consolidation. Our findings suggest that chronic exposure to CORT can regulate memory-related IEG expression and fear memory consolidation processes in the LA in a long-lasting manner and that treatment with fluoxetine can reverse these effects.	[Monsey, Melissa S.; Boyle, Lara M.; Zhang, Melinda L.; Nguyen, Caroline P.; Kronman, Hope G.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Duman, Ronald S.; Taylor, Jane R.] Yale Univ, Interdept Neurosci Program, New Haven, CT USA; [Ota, Kristie T.; Duman, Ronald S.; Taylor, Jane R.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Schafe, Glenn E.] CUNY, Dept Psychol, New York, NY 10021 USA; [Schafe, Glenn E.] CUNY, Hunter Coll, Ctr Study Gene Struct & Funct, New York, NY 10021 USA; [Schafe, Glenn E.] CUNY, Grad Ctr, New York, NY 10021 USA	Yale University; Yale University; Yale University; City University of New York (CUNY) System; City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System	Schafe, GE (corresponding author), CUNY, Dept Psychol, New York, NY 10021 USA.	glenn.schafe@hunter.cuny.edu		Kronman, Hope/0000-0002-2828-723X	National Institutes of Health [MH 073949]; Yale University; Hunter Gene Center; American Psychological Association Dissertation Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale University; Hunter Gene Center; American Psychological Association Dissertation Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by National Institutes of Health Grant MH 073949 (to GES), Yale University and The Hunter Gene Center. MSM is supported by an American Psychological Association Dissertation Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBEL I, 1994, BRAIN RES, V657, P227, DOI 10.1016/0006-8993(94)90972-5; Barrett RM, 2008, LEARN MEMORY, V15, P460, DOI 10.1101/lm.917508; Barrientos RM, 2002, BEHAV BRAIN RES, V134, P299, DOI 10.1016/S0166-4328(02)00045-1; Birmaher B, 2003, J AM ACAD CHILD PSY, V42, P415, DOI 10.1097/01.CHI.0000037049.04952.9F; BODNOFF SR, 1995, J NEUROSCI, V15, P61; Brummelte S, 2010, NEUROSCIENCE, V168, P680, DOI 10.1016/j.neuroscience.2010.04.023; Burghardt NS, 2013, NEUROSCIENCE, V247, P253, DOI 10.1016/j.neuroscience.2013.05.050; Burghardt NS, 2013, BIOL PSYCHIAT, V73, P1078, DOI 10.1016/j.biopsych.2012.10.012; Burghardt NS, 2004, BIOL PSYCHIAT, V55, P1171, DOI 10.1016/j.biopsych.2004.02.029; Conrad CD, 1999, BEHAV NEUROSCI, V113, P902, DOI 10.1037/0735-7044.113.5.902; Conrad CD, 2004, NEUROBIOL LEARN MEM, V81, P185, DOI 10.1016/j.nlm.2004.01.002; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; DACHIR S, 1993, BEHAV NEURAL BIOL, V60, P103, DOI 10.1016/0163-1047(93)90173-F; Dagyte G, 2009, NEUROSCIENCE, V162, P904, DOI 10.1016/j.neuroscience.2009.05.053; Gourley SL, 2008, BIOL PSYCHIAT, V64, P884, DOI 10.1016/j.biopsych.2008.06.016; Gourley SL, 2008, BIOL PSYCHIAT, V63, P353, DOI 10.1016/j.biopsych.2007.07.016; Gourley SL, 2013, J NEUROSCI, V33, P3107, DOI 10.1523/JNEUROSCI.2138-12.2013; Gourley Shannon L, 2009, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0932s49; Gourley SL, 2009, NEUROPSYCHOPHARMACOL, V34, P707, DOI 10.1038/npp.2008.123; Gourley SL, 2008, ANN NY ACAD SCI, V1148, P509, DOI 10.1196/annals.1410.076; Johnson LR, 2005, NEUROSCIENCE, V136, P289, DOI 10.1016/j.neuroscience.2005.06.050; Kent JM, 1998, BIOL PSYCHIAT, V44, P812, DOI 10.1016/S0006-3223(98)00210-8; Lakshminarasimhan H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030481; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; LUINE V, 1994, BRAIN RES, V639, P167, DOI 10.1016/0006-8993(94)91778-7; Maddox SA, 2013, LEARN MEMORY, V20, P109, DOI 10.1101/lm.029157.112; Maddox SA, 2011, J NEUROSCI, V31, P7073, DOI 10.1523/JNEUROSCI.1120-11.2011; Maddox SA, 2011, LEARN MEMORY, V18, P24, DOI 10.1101/lm.1980211; Magarinos AM, 1998, BRAIN RES, V809, P314, DOI 10.1016/S0006-8993(98)00882-8; Malberg JE, 2003, NEUROPSYCHOPHARMACOL, V28, P1562, DOI 10.1038/sj.npp.1300234; Matus-Amat P, 2004, J NEUROSCI, V24, P2431, DOI 10.1523/JNEUROSCI.1598-03.2004; Mitra R, 2005, P NATL ACAD SCI USA, V102, P9371, DOI 10.1073/pnas.0504011102; Mitra R, 2008, P NATL ACAD SCI USA, V105, P5573, DOI 10.1073/pnas.0705615105; Monsey MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019958; Newport DJ, 2000, CURR OPIN NEUROBIOL, V10, P211, DOI 10.1016/S0959-4388(00)00080-5; Ou LC, 2006, NEUROPSYCHOPHARMACOL, V31, P287, DOI 10.1038/sj.npp.1300830; Ou LC, 2007, MOL PHARMACOL, V72, P350, DOI 10.1124/mol.107.034934; PAVLIDES C, 1993, HIPPOCAMPUS, V3, P183, DOI 10.1002/hipo.450030210; Pillai AG, 2012, NEUROPSYCHOPHARMACOL, V37, P2702, DOI 10.1038/npp.2012.135; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Ploski JE, 2008, J NEUROSCI, V28, P12383, DOI 10.1523/JNEUROSCI.1662-08.2008; Rattiner LM, 2004, LEARN MEMORY, V11, P727, DOI 10.1101/lm.83304; Rattiner LM, 2004, J NEUROSCI, V24, P4796, DOI 10.1523/JNEUROSCI.5654-03.2004; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Rudy JW, 2002, BEHAV NEUROSCI, V116, P530, DOI 10.1037//0735-7044.116.4.530; Schafe GE, 2000, J NEUROSCI, V20, P8177; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Vyas A, 2006, NEUROSCIENCE, V143, P387, DOI 10.1016/j.neuroscience.2006.08.003; Vyas A, 2004, BEHAV NEUROSCI, V118, P1450, DOI 10.1037/0735-7044.118.6.1450; Vyas A, 2004, NEUROSCIENCE, V128, P667, DOI 10.1016/j.neuroscience.2004.07.013; Vyas A, 2002, J NEUROSCI, V22, P6810; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; WOOLLEY CS, 1990, BRAIN RES, V531, P225, DOI 10.1016/0006-8993(90)90778-A; Xu JJ, 2011, NEUROSCIENCES, V16, P257; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941; Yehuda R, 2007, NEURON, V56, P19, DOI 10.1016/j.neuron.2007.09.006	63	24	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91530	10.1371/journal.pone.0091530	http://dx.doi.org/10.1371/journal.pone.0091530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618807	Green Published, gold			2022-12-25	WOS:000332842400101
J	Ren, JP; Liu, GL; Go, J; Kolli, D; Zhang, GP; Bao, XY				Ren, Junping; Liu, Guangliang; Go, Jonathan; Kolli, Deepthi; Zhang, Guanping; Bao, Xiaoyong			Human Metapneumovirus M2-2 Protein Inhibits Innate Immune Response in Monocyte-Derived Dendritic Cells	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; TOLL-LIKE RECEPTORS; INDUCIBLE GENE-I; YOUNG-CHILDREN; RIG-I; INFECTION; INTERFERON; INDUCTION; TRAFFICKING; RECOGNITION	Human metapneumovirus (hMPV) is a leading cause of lower respiratory infection in young children, the elderly and immunocompromised patients. Repeated hMPV infections occur throughout life. However, immune evasion mechanisms of hMPV infection are largely unknown. Recently, our group has demonstrated that hMPV M2-2 protein, an important virulence factor, contributes to immune evasion in airway epithelial cells by targeting the mitochondrial antiviral-signaling protein (MAVS). Whether M2-2 regulates the innate immunity in human dendritic cells (DC), an important family of immune cells controlling antigen presenting, is currently unknown. We found that human DC infected with a virus lacking M2-2 protein expression (rhMPV-Delta M2-2) produced higher levels of cytokines, chemokines and IFNs, compared to cells infected with wild-type virus (rhMPV-WT), suggesting that M2-2 protein inhibits innate immunity in human DC. In parallel, we found that myeloid differentiation primary response gene 88 (MyD88), an essential adaptor for Toll-like receptors (TLRs), plays a critical role in inducing immune response of human DC, as downregulation of MyD88 by siRNA blocked the induction of immune regulatory molecules by hMPV. Since M2-2 is a cytoplasmic protein, we investigated whether M2-2 interferes with MyD88-mediated antiviral signaling. We found that indeed M2-2 protein associated with MyD88 and inhibited MyD88-dependent gene transcription. In this study, we also identified the domains of M2-2 responsible for its immune inhibitory function in human DC. In summary, our results demonstrate that M2-2 contributes to hMPV immune evasion by inhibiting MyD88-dependent cellular responses in human DC.	[Ren, Junping; Liu, Guangliang; Go, Jonathan; Kolli, Deepthi; Bao, Xiaoyong] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Liu, Guangliang; Zhang, Guanping] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Otorhinolaryngol, Guangzhou 510275, Guangdong, Peoples R China; [Bao, Xiaoyong] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; Sun Yat Sen University; University of Texas System; University of Texas Medical Branch Galveston	Bao, XY (corresponding author), Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA.	xibao@utmb.edu			National Institutes of Health-National Institute of Allergy and Infectious Diseases [KAI074829A]; American Lung Association [RG232529N]; American Heart Association [12BGIA12060008]; Sun Yat-Sen University, Guangzhou, China; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Lung Association; American Heart Association(American Heart Association); Sun Yat-Sen University, Guangzhou, China; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by grants from the National Institutes of Health-National Institute of Allergy and Infectious Diseases KAI074829A, the American Lung Association RG232529N, and American Heart Association 12BGIA12060008 to X.B. G.L. was supported by a student scholarship from Sun Yat-Sen University, Guangzhou, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banos-Lara MD, 2013, J VIROL, V87, P1242, DOI 10.1128/JVI.01213-12; Bao XY, 2008, J VIROL, V82, P8224, DOI 10.1128/JVI.02584-07; Bao XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062568; Bao XY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000077; Boogaard I, 2007, IMMUNOLOGY, V122, P65, DOI 10.1111/j.1365-2567.2007.02613.x; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Chen S, 2007, J ENDOTOXIN RES, V13, P281, DOI 10.1177/0968051907085096; Davidson S, 2011, J IMMUNOL, V186, P5938, DOI 10.4049/jimmunol.1002635; de Graaff PAA, 2005, J IMMUNOL, V175, P5904, DOI 10.4049/jimmunol.175.9.5904; Edwards KM, 2013, NEW ENGL J MED, V368, P633, DOI 10.1056/NEJMoa1204630; Englund JA, 2006, ANN INTERN MED, V144, P344, DOI 10.7326/0003-4819-144-5-200603070-00010; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Goutagny N, 2010, J IMMUNOL, V184, P1168, DOI 10.4049/jimmunol.0902750; Guerrero-Plata A, 2006, AM J RESP CELL MOL, V34, P320, DOI 10.1165/rcmb.2005-0287OC; Guerrero-Plata A, 2005, J VIROL, V79, P10190, DOI 10.1128/JVI.79.16.10190-10199.2005; Hemmi H, 2003, J IMMUNOL, V170, P3059, DOI 10.4049/jimmunol.170.6.3059; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Jakubzick C, 2006, J IMMUNOL, V176, P3578, DOI 10.4049/jimmunol.176.6.3578; Jartti T, 2002, LANCET, V360, P1393, DOI 10.1016/S0140-6736(02)11391-2; Juarez E, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-2; Kawai T, 2005, ARTHRITIS RES THER, V7, P12, DOI 10.1186/ar1469; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawai T, 2006, J BIOCH TOKYO; Kolli D, 2011, J IMMUNOL, V187, P47, DOI 10.4049/jimmunol.1002589; Koyama S, 2008, CYTOKINE, V43, P336, DOI 10.1016/j.cyto.2008.07.009; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Liao S, 2008, J GEN VIROL, V89, P1978, DOI 10.1099/vir.0.2008/000778-0; Malmgaard L, 2004, J IMMUNOL, V173, P6890, DOI 10.4049/jimmunol.173.11.6890; Melchjorsen J, 2005, J VIROL, V79, P12944, DOI 10.1128/JVI.79.20.12944-12951.2005; Pulendran B, 2001, SCIENCE, V293, P253, DOI 10.1126/science.1062060; Ren J, 2013, VIRUS RES, DOI [10.1016/j.virusres.2013.06.014, DOI 10.1016/J.VIR-USRES.2013.06.014]; Ren JP, 2012, J VIROL, V86, P13049, DOI 10.1128/JVI.01248-12; Sato A, 2006, P NATL ACAD SCI USA, V103, P17343, DOI 10.1073/pnas.0605102103; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schreibelt G, 2010, CANCER IMMUNOL IMMUN, V59, P1573, DOI 10.1007/s00262-010-0833-1; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; van den Hoogen BG, 2007, CLIN INFECT DIS, V44, P1159, DOI 10.1086/513295; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; von Bernuth H, 2012, EUR J IMMUNOL, V42, P3126, DOI 10.1002/eji.201242683; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577	43	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91865	10.1371/journal.pone.0091865	http://dx.doi.org/10.1371/journal.pone.0091865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618691	Green Published, gold, Green Submitted			2022-12-25	WOS:000332842400137
J	Shen, HT; Cao, JS; Zhang, WJ; Zeng, XH; Wang, HR				Shen, Huitao; Cao, Jiansheng; Zhang, Wanjun; Zeng, Xinhua; Wang, Huaru			Winter Soil CO2 Flux from Different Mid-Latitude Sites from Middle Taihang Mountain in North China	PLOS ONE			English	Article							ECOSYSTEM RESPIRATION; WATER-CONTENT; TEMPERATURE; FOREST; PRECIPITATION; PLANTATION; DEPENDENCE; CLIMATE; LITTER; REGION	Winter soil respiration is a very important component of the annual soil carbon flux in some ecosystems. We hypothesized that, with all other factors being equal, shorter winter SR result in reduced contribution to annual soil C flux. In this study, the contribution of winter soil respiration to annual soil respiration was measured for three sites (grassland: dominated by Artemisia sacrorum, Bothriochloa ischaemum and Themeda japonica; shrubland: dominated by Vitex negundo var. heterophylla; plantation: dominated by Populus tomatosa) in a mountainous area of north China. Diurnal and intra-annual soil CO2 flux patterns were consistent among different sites, with the maximum soil respiration rates at 12:00 or 14:00, and in July or August. The lowest respiration rates were seen in February. Mean soil respiration rates ranged from 0.26 to 0.45 mu mol m(-2) s(-1) in the winter (December to February), and between 2.38 to 3.16 mu mol m(-2) s(-1) during the growing season (May-September). The winter soil carbon flux was 24.6 to 42.8 g C m(-2), which contributed 4.8 to 7.1% of the annual soil carbon flux. Based on exponential functions, soil temperature explained 73.8 to 91.8% of the within year variability in soil respiration rates. The Q(10) values of SR against ST at 10 cm ranged from 3.60 to 4.90 among different sites. In addition, the equation between soil respiration and soil temperature for the growing season was used to calculate the "modeled'' annual soil carbon flux based on the actual measured soil temperature. The "measured'' annual value was significantly higher than the "modeled'' annual value. Our results suggest that winter soil respiration plays a significant role in annual soil carbon balance, and should not be neglected when soil ecosystems are assessed as either sinks or sources of atmospheric CO2.	[Shen, Huitao; Cao, Jiansheng; Zhang, Wanjun; Zeng, Xinhua] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Agr Resources Res, Key Lab Agr Water Resources,Hebei Key Lab Agr Wat, Shijiazhuang, Hebei, Peoples R China; [Wang, Huaru] Yellow River Water Resources Protect Inst, Zhengzhou, Henan, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Yangtze River Water Resources Protection Bureau	Zhang, WJ (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Agr Resources Res, Key Lab Agr Water Resources,Hebei Key Lab Agr Wat, Shijiazhuang, Hebei, Peoples R China.	zhangwj@sjziam.ac.cn			Chinese Academy of Sciences [XDA05060600]; National Science and Technology Project in Rural Areas [2011BAD31B02]; CFERN & GENE Awards Funds on Ecological Paper	Chinese Academy of Sciences(Chinese Academy of Sciences); National Science and Technology Project in Rural Areas; CFERN & GENE Awards Funds on Ecological Paper	This work was supported by the "Strategic Priority Research Progam'' of Chinese Academy of Sciences (XDA05060600), the Twelfth Five-Year Plan of National Science and Technology Project in Rural Areas (2011BAD31B02), and CFERN & GENE Awards Funds on Ecological Paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, EOS T; Arevalo CBM, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001006; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Brooks PD, 2005, GLOBAL CHANGE BIOL, V11, P231, DOI 10.1111/j.1365-2486.2004.00877.x; Cao JS, 2013, HYDROL PROCESS, V27, P360, DOI 10.1002/hyp.9231; Chen QS, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003538; Cook FJ, 2008, SOIL BIOL BIOCHEM, V40, P1013, DOI 10.1016/j.soilbio.2007.12.012; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P230, DOI 10.1111/j.1365-2486.2005.01062.x; Dorrepaal E, 2009, NATURE, V460, P616, DOI 10.1038/nature08216; Du EZ, 2013, J PLANT ECOL, V6, P349, DOI 10.1093/jpe/rtt012; Elberling B, 2007, SOIL BIOL BIOCHEM, V39, P646, DOI 10.1016/j.soilbio.2006.09.017; Gaumont-Guay D, 2006, AGR FOREST METEOROL, V140, P220, DOI 10.1016/j.agrformet.2006.08.003; Grogan P, 2006, GLOBAL CHANGE BIOL, V12, P1479, DOI 10.1111/j.1365-2486.2006.01184.x; Han GX, 2012, ENVIRON MANAGE, V50, P39, DOI 10.1007/s00267-012-9869-7; Han SM, 2012, HYDROL PROCESS, V26, P1332, DOI 10.1002/hyp.8233; Jiang H, 2013, BIOGEOSCIENCES, V10, P3963, DOI 10.5194/bg-10-3963-2013; Kellman L, 2007, BIOGEOCHEMISTRY, V82, P101, DOI 10.1007/s10533-006-9056-0; Lellei-Kovacs E, 2011, EUR J SOIL BIOL, V47, P247, DOI 10.1016/j.ejsobi.2011.05.004; Li HJ, 2008, AGR FOREST METEOROL, V148, P490, DOI 10.1016/j.agrformet.2007.10.009; Li LJ, 2013, EUR J SOIL BIOL, V55, P83, DOI 10.1016/j.ejsobi.2012.12.009; Liu X.P., 2013, BIOGEOSCIENCES DISCU, V10, P11037; Luan JW, 2012, SOIL BIOL BIOCHEM, V44, P143, DOI 10.1016/j.soilbio.2011.08.012; Luo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042354; Mariko S, 2000, ECOL RES, V15, P363, DOI 10.1046/j.1440-1703.2000.00357.x; McDowell NG, 2000, TREE PHYSIOL, V20, P745; Michaelson GJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000920; Mo W, 2005, AGR FOREST METEOROL, V134, P81, DOI 10.1016/j.agrformet.2005.08.015; Monson RK, 2005, OECOLOGIA, V146, P130, DOI 10.1007/s00442-005-0169-2; Pavelka M, 2007, PLANT SOIL, V292, P171, DOI 10.1007/s11104-007-9213-9; Peng SS, 2009, SOIL BIOL BIOCHEM, V41, P1008, DOI 10.1016/j.soilbio.2008.10.023; Schindlbacher A, 2007, AGR FOREST METEOROL, V146, P205, DOI 10.1016/j.agrformet.2007.06.001; Shi XH, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004054; Song XZ, 2013, SCI TOTAL ENVIRON, V444, P363, DOI 10.1016/j.scitotenv.2012.12.006; Tang JW, 2008, AGR FOREST METEOROL, V148, P171, DOI 10.1016/j.agrformet.2007.08.008; Uchida M, 2005, AGR FOREST METEOROL, V134, P102, DOI 10.1016/j.agrformet.2005.11.003; Vargas R, 2008, NEW PHYTOL, V179, P460, DOI 10.1111/j.1469-8137.2008.02481.x; Wang T, 2011, BIOGEOSCIENCES, V8, P2009, DOI 10.5194/bg-8-2009-2011; Wang W, 2010, SOIL BIOL BIOCHEM, V42, P451, DOI 10.1016/j.soilbio.2009.11.028; Wu X, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003616; You WZ, 2013, TREES-STRUCT FUNCT, V27, P1417, DOI 10.1007/s00468-013-0889-6; Zhang LH, 2010, J ARID ENVIRON, V74, P1200, DOI 10.1016/j.jaridenv.2010.05.031; Zhou ZY, 2013, SOIL BIOL BIOCHEM, V57, P135, DOI 10.1016/j.soilbio.2012.08.010; Zimmermann M, 2009, SOIL BIOL BIOCHEM, V41, P1338, DOI 10.1016/j.soilbio.2009.02.023	43	6	7	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91589	10.1371/journal.pone.0091589	http://dx.doi.org/10.1371/journal.pone.0091589			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614868	Green Published, gold, Green Submitted			2022-12-25	WOS:000332839300142
J	Wang, XJ; Yu, H; Cai, ZH; Wang, ZF; Ma, BJ; Zhang, Y; Ye, Z				Wang, Xuejian; Yu, Hao; Cai, Zhenhua; Wang, Zhifeng; Ma, Baojun; Zhang, Yi; Ye, Zi			Anatomical Study on Meckel Cave with Endoscopic Endonasal, Endo-Maxillary Sinus, and Endo-Pterygoid Process Approaches	PLOS ONE			English	Article							INTERNAL CAROTID-ARTERY; PETROCLIVAL MENINGIOMAS; PTERYGOPALATINE FOSSA; TRIGEMINAL NEURINOMAS; SURGICAL-MANAGEMENT; SURGERY; REMOVAL; NEUROMA; NERVE	Objective: To study anatomical structures related to Meckel cave with endonasal endoscopic approach and to provide an anatomical basis for endoscopic surgery in Meckel cave. Methods: Meckel cave of 5 adult skulls (10 sides) were fixed with 10% formalin. The anatomical structures of Meckel cave and the related zones adjacent to Meckel cave were observed and measured with endoscopic endonasal approach. Results: Endoscopic endonasal, endo-maxillary sinus, and endo-pterygoid process approaches were successfully applied in observation of the anatomical structures of meckel cave and the rerated zones adjacent to Meckel cave and in measurement of distances between related anatomical structures for each case of samples. The relevant data were obtained. The distance between the front mouth of palatovaginal canal and vidian canal was 21.4 +/- 7 mm, the distance between opening of sphenoid sinus to the upper margin of the choana was 22.3 +/- 2.8 mm, the distance between the opening of vidian and foramen rotundum was 7.57 +/- 0.7 mm and the length of the pterygoid canal was 13.3 +/- 1.2 mm. Based on these data, the positions of the related important structures can be roughly located during surgical operation and various important structures in Meckel cave and its adjacent zones can be found out in a convenient and safe way. Conclusion: 1) It is feasible to use endonasal endoscopic approach to perform surgical operation in Meckel cave; 2) Use of endonasal endoscopic approach can protect and fully take the advantage of the vidian nerve to locate the position of foramina lacerum of the internal carotid artery during surgical operation; and 3) the observational and experimental data obtained with this approach can provide the rational basis for clinical operation procedures.	[Wang, Xuejian; Yu, Hao; Cai, Zhenhua; Wang, Zhifeng; Ma, Baojun; Zhang, Yi; Ye, Zi] Nantong Univ, Hosp 2, Dept Neurosurg, Nantong, Jiangsu, Peoples R China	Nantong University	Yu, H (corresponding author), Nantong Univ, Hosp 2, Dept Neurosurg, Nantong, Jiangsu, Peoples R China.	6841441@163.com.cn	Wang, Xuejian/K-4868-2019	Wang, Xuejian/0000-0003-0389-5674				Al-Mefty O, 2002, J NEUROSURG, V96, P453, DOI 10.3171/jns.2002.96.3.0453; Aziz KMA, 1999, NEUROSURGERY, V44, P1225; Bai ZQ, 2009, NEUROSCI BULL, V25, P376, DOI 10.1007/s12264-009-0605-0; Bambakidis NC, 2007, NEUROSURGERY, V61, P202, DOI [10.1227/01.NIEU.0000280119.36270.BA, 10.1227/01.neu.0000303218.61230.39]; BRICOLO AP, 1992, NEUROSURGERY, V31, P813, DOI 10.1227/00006123-199211000-00001; CRESPO JV, 1981, ACTA NEUROCHIR, V55, P321; Day JD, 1998, NEUROSURGERY, V42, P233, DOI 10.1097/00006123-199802000-00015; DelGaudio JM, 2003, ARCH OTOLARYNGOL, V129, P441, DOI 10.1001/archotol.129.4.441; Fries G, 1998, NEUROSURGERY, V42, P226, DOI 10.1097/00006123-199802000-00008; Gardner PA, 2010, NEUROSURGERY, V66, DOI 10.1227/NEU.0b013e3181faaa70; Goel A, 2003, NEUROSURGERY, V52, P783, DOI 10.1227/01.NEU.0000053365.05795.03; INOUE T, 1990, NEUROSURGERY, V26, P903, DOI 10.1227/00006123-199006000-00001; Jarrahy R, 2000, OTOLARYNG HEAD NECK, V123, P218, DOI 10.1067/mhn.2000.107451; Kassam AB, 2008, J NEUROSURG, V108, P177, DOI 10.3171/JNS/2008/108/01/0177; Kassam AB, 2009, NEUROSURGERY, V64, pS71, DOI 10.1227/01.NEU.0000335162.36862.54; King WA, 2001, NEUROSURGERY, V49, P108, DOI 10.1097/00006123-200107000-00017; Faleiro LCM, 2006, ARQ NEURO-PSIQUIAT, V64, P650, DOI 10.1590/S0004-282X2006000400025; MILLER CG, 1993, NEUROSURGERY, V33, P461; Muto J, 2010, NEUROSURGERY, V67, P291, DOI 10.1227/01.NEU.0000382967.84940.52; Nakamura M, 2010, EJSO-EUR J SURG ONC, V36, P208, DOI 10.1016/j.ejso.2009.07.004; Osawa S, 2009, NEUROSURGERY, V64, P385, DOI 10.1227/01.NEU.0000338945.54863.D9; Pichierri A, 2010, NEUROSURGERY, V67, P29, DOI 10.1227/01.NEU.0000383131.72001.9E; Pinheiro-Neto CD, 2012, LARYNGOSCOPE, V122, P6, DOI 10.1002/lary.21808; Sabanci PA, 2011, WORLD NEUROSURG, V76, P335, DOI 10.1016/j.wneu.2011.03.037; Samii M, 1997, NEUROSURGERY, V41, P767, DOI 10.1097/00006123-199710000-00003; Samii M, 2000, J NEUROSURG, V92, P235, DOI 10.3171/jns.2000.92.2.0235; Sekhar L N, 1991, Acta Neurochir Suppl (Wien), V53, P183; Seoane E, 1999, NEUROSURGERY, V44, P553, DOI 10.1097/00006123-199903000-00065; TAHA JM, 1995, J NEUROSURG, V82, P719, DOI 10.3171/jns.1995.82.5.0719; Vescan AD, 2007, LARYNGOSCOPE, V117, P1338, DOI 10.1097/MLG.0b013e31806146cd; Yoshida K, 1999, J NEUROSURG, V91, P202, DOI 10.3171/jns.1999.91.2.0202	31	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91444	10.1371/journal.pone.0091444	http://dx.doi.org/10.1371/journal.pone.0091444			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614159	gold, Green Published, Green Submitted			2022-12-25	WOS:000332839300127
J	Yamamoto, K; Yamamoto, H; Yoshida, K; Niwa, K; Nishi, Y; Mizuno, A; Kuwabara, M; Asano, T; Sakoda, K; Niinuma, H; Nakahara, F; Takeda, K; Shindoh, C; Komatsu, Y				Yamamoto, Kyoko; Yamamoto, Hiroyuki; Yoshida, Katsumi; Niwa, Koichiro; Nishi, Yutaro; Mizuno, Atsushi; Kuwabara, Masanari; Asano, Taku; Sakoda, Kunihiro; Niinuma, Hiroyuki; Nakahara, Fumiko; Takeda, Kyoko; Shindoh, Chiyohiko; Komatsu, Yasuhiro			The Total Urine Protein-to-Creatinine Ratio Can Predict the Presence of Microalbuminuria	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR MORTALITY; GENERAL-POPULATION; COST-EFFECTIVENESS; ALBUMINURIA; ASSOCIATION; PREVENTION	Background: The Kidney Disease: Improving Global Outcomes chronic kidney disease (CKD) guidelines recommend that CKD be classified based on the etiology, glomerular filtration rate (GFR) and degree of albuminuria. The present study aimed to establish a method that predicts the presence of microalbuminuria by measuring the total urine protein-to-creatinine ratio (TPCR) in patients with cardiovascular disease (CVD) risk factors. Methods and Results: We obtained urine samples from 1,033 patients who visited the cardiovascular clinic at St. Luke's International Hospital from February 2012 to August 2012. We measured the TPCR and the urine albumin-to-creatinine ratio (ACR) from random spot urine samples. We performed correlation, receiver operating characteristic (ROC) curve, sensitivity, and subgroup analyses. There was a strong positive correlation between the TPCR and ACR (R-2 = 0.861, p < 0.001). A ROC curve analysis for the TPCR revealed a sensitivity of 94.4%, a specificity of 86.1%, and an area under the curve of 0.903 for detecting microalbuminuria for a TPCR cut-off value of 84 mg/g of creatinine. The subgroup analysis indicated that the cut-off value could be used for patients with CVD risk factors. Conclusions: These results suggest that the TPCR with an appropriate cut-off value could be used to screen for the presence of microalbuminuria in patients with CVD risk factors. This simple, inexpensive measurement has broader applications, leading to earlier intervention and public benefit.	[Yamamoto, Kyoko; Shindoh, Chiyohiko] Tohoku Univ, Grad Sch Med, Dept Lab Med & Clin Sci, Sendai, Miyagi 980, Japan; [Yamamoto, Kyoko; Yamamoto, Hiroyuki; Komatsu, Yasuhiro] St Lukes Int Hosp, Div Nephrol, Dept Internal Med, Tokyo, Japan; [Yoshida, Katsumi] Tohoku Kosai Hosp, Hlth Med Ctr, Sendai, Miyagi, Japan; [Niwa, Koichiro; Nishi, Yutaro; Mizuno, Atsushi; Kuwabara, Masanari; Asano, Taku; Sakoda, Kunihiro; Niinuma, Hiroyuki] St Lukes Int Hosp, Dept Cardiol, Cardiovasc Ctr, Tokyo, Japan; [Nakahara, Fumiko; Takeda, Kyoko] St Lukes Int Hosp, Clin Lab Dept, Tokyo, Japan	Tohoku University; St. Luke's International Hospital; St. Luke's International Hospital; St. Luke's International Hospital	Yamamoto, H (corresponding author), St Lukes Int Hosp, Div Nephrol, Dept Internal Med, Tokyo, Japan.	yama-h@umin.ac.jp; komayasu@luke.or.jp	Kuwabara, Masanari/O-9844-2017; Asano, Taku/AAU-5875-2021; Komatsu, Yasuhiro/AAW-1969-2020	Kuwabara, Masanari/0000-0002-6601-4347; Yamamoto, Hiroyuki/0000-0003-3337-7595	St. Luke's Life Science Institute	St. Luke's Life Science Institute(St. Luke's Life Science Institute (SLLSI))	This study was supported, in part, by a grant from St. Luke's Life Science Institute. No additional external funding received for this study. http://sllsi.luke.or.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhafiz AH, 2011, NEPHRON EXP NEPHROL, V119, pE6, DOI 10.1159/000328015; Atkins RC, 2003, NEPHROL DIAL TRANSPL, V18, P2170, DOI 10.1093/ndt/gfg314; Atthobari J, 2006, CLIN THER, V28, P432, DOI 10.1016/j.clinthera.2006.03.012; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Boersma C, 2010, CLIN THER, V32, P1103, DOI 10.1016/j.clinthera.2010.06.013; Brenner BM, 2008, BRENNER RECTORS KIDN; Brosius FC, 2006, CIRCULATION, V114, P1083, DOI 10.1161/CIRCULATIONAHA.106.177321; de Jong PE, 2006, J AM SOC NEPHROL, V17, P2120, DOI 10.1681/ASN.2006010097; Estacio RO, 2012, AM J CARDIOL, V109, P1743, DOI 10.1016/j.amjcard.2012.02.020; *KIDN DIS IMP GLOB, KDIGO 2012 CLIN PRAC; Lamb EJ, 2009, ANN CLIN BIOCHEM, V46, P205, DOI 10.1258/acb.2009.009007; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Methven S, 2010, NEPHROL DIAL TRANSPL, V25, P2991, DOI 10.1093/ndt/gfq140; *NAT KIDN FDN, 2007, AM J KIDNEY DIS S, V49, pS1, DOI DOI 10.1053/J.; Panek R, 2011, NEPHROL DIAL TRANSPL, V26, P1385, DOI 10.1093/ndt/gfq503; SHIHABI ZK, 1991, CLIN CHEM, V37, P621; Smith ER, 2012, NEPHROL DIAL TRANSPL, V27, P1534, DOI 10.1093/ndt/gfr708; Weir MR, 2007, CLIN J AM SOC NEPHRO, V2, P581, DOI 10.2215/CJN.03190906; WHO (World Health Organization), 1996, BIOL MON CHEM EXP WO; Yamamoto K, 2011, TOHOKU J EXP MED, V225, P195, DOI 10.1620/tjem.225.195	22	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91067	10.1371/journal.pone.0091067	http://dx.doi.org/10.1371/journal.pone.0091067			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614247	gold, Green Submitted, Green Published			2022-12-25	WOS:000332839300071
J	Freese, C; Reinhardt, S; Hefner, G; Unger, RE; Kirkpatrick, CJ; Endres, K				Freese, Christian; Reinhardt, Sven; Hefner, Gudrun; Unger, Ronald E.; Kirkpatrick, C. James; Endres, Kristina			A Novel Blood-Brain Barrier Co-Culture System for Drug Targeting of Alzheimer's Disease: Establishment by Using Acitretin as a Model Drug	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; IN-VITRO MODEL; MICROVASCULAR ENDOTHELIAL-CELLS; PAIRED HELICAL FILAMENTS; SECRETASE CLEAVAGE; PRIMARY CULTURES; BETA-SECRETASE; P-GLYCOPROTEIN; RETINOIC ACID; UP-REGULATION	In the pathogenesis of Alzheimer's disease (AD) the homeostasis of amyloid precursor protein (APP) processing in the brain is impaired. The expression of the competing proteases ADAM10 (a disintegrin and metalloproteinase 10) and BACE-1 (beta site APP cleaving enzyme 1) is shifted in favor of the A-beta generating enzyme BACE-1. Acitretin-a synthetic retinoid-e. g., has been shown to increase ADAM10 gene expression, resulting in a decreased level of A-beta peptides within the brain of AD model mice and thus is of possible value for AD therapy. A striking challenge in evaluating novel therapeutically applicable drugs is the analysis of their potential to overcome the blood-brain barrier (BBB) for central nervous system targeting. In this study, we established a novel cell-based bio-assay model to test ADAM10-inducing drugs for their ability to cross the BBB. We therefore used primary porcine brain endothelial cells (PBECs) and human neuroblastoma cells (SH-SY5Y) transfected with an ADAM10-promoter luciferase reporter vector in an indirect co-culture system. Acitretin served as a model substance that crosses the BBB and induces ADAM10 expression. We ensured that ADAM10-dependent constitutive APP metabolism in the neuronal cells was unaffected under co-cultivation conditions. Barrier properties established by PBECs were augmented by co-cultivation with SH-SY5Y cells and they remained stable during the treatment with acitretin as demonstrated by electrical resistance measurement and permeability-coefficient determination. As a consequence of transcellular acitretin transport measured by HPLC, the activity of the ADAM10-promoter reporter gene was significantly increased in co-cultured neuronal cells as compared to vehicle-treated controls. In the present study, we provide a new bio-assay system relevant for the study of drug targeting of AD. This bio-assay can easily be adapted to analyze other Alzheimer- or CNS disease-relevant targets in neuronal cells, as their therapeutical potential also depends on the ability to penetrate the BBB.	[Freese, Christian; Unger, Ronald E.; Kirkpatrick, C. James] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Pathol, REPAIR Lab, D-55122 Mainz, Germany; [Freese, Christian; Unger, Ronald E.; Kirkpatrick, C. James] European Inst Excellence Tissue Engn & Regenerat, Mainz, Germany; [Reinhardt, Sven; Hefner, Gudrun; Endres, Kristina] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Psychiat & Psychotherapy, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Freese, C (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Pathol, REPAIR Lab, D-55122 Mainz, Germany.	freesec@uni-mainz.de	Endres, Kristina/K-4960-2015; Freese, Christian/Q-5540-2016	Freese, Christian/0000-0001-8411-1573; Kirkpatrick, Charles James/0000-0002-0088-418X	Federal Ministry of Education and Research (BMBF) [FKZ01GS08130]	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by Federal Ministry of Education and Research (BMBF) grant (FKZ01GS08130; www.bmbf.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Armstrong JL, 2005, BIOCHEM PHARMACOL, V69, P1299, DOI 10.1016/j.bcp.2005.02.003; Bowman Gene L, 2008, Aging health, V4, P47, DOI 10.2217/1745509X.4.1.47; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Carl SM, 2010, MOL PHARM; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; Culot M, 2008, TOXICOL IN VITRO, V22, P799, DOI 10.1016/j.tiv.2007.12.016; Cury PR, 2007, J PERIODONTOL, V78, P1309, DOI 10.1902/jop.2007.060225; Dauchy S, 2009, BIOCHEM PHARMACOL, V77, P897, DOI 10.1016/j.bcp.2008.11.001; DEHOUCK MP, 1990, J NEUROCHEM, V54, P1798, DOI 10.1111/j.1471-4159.1990.tb01236.x; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; EISENHARDT EU, 1994, DRUG METAB DISPOS, V22, P26; Endres K, 2010, FEBS J, V277, P1585, DOI 10.1111/j.1742-4658.2010.07566.x; Forster C, 2008, J PHYSIOL-LONDON, V586, P1937, DOI 10.1113/jphysiol.2007.146852; Franke H, 1999, BRAIN RES, V818, P65, DOI 10.1016/S0006-8993(98)01282-7; Franke H, 2000, BRAIN RES PROTOC, V5, P248, DOI 10.1016/S1385-299X(00)00020-9; Fricker G, 2002, BRIT J PHARMACOL, V135, P1308, DOI 10.1038/sj.bjp.0704557; Gaillard PJ, 2001, EUR J PHARM SCI, V12, P215, DOI 10.1016/S0928-0987(00)00123-8; Gumbleton M, 2001, J PHARM SCI-US, V90, P1681, DOI 10.1002/jps.1119; Hatherell K, 2011, J NEUROSCI METH, V199, P223, DOI 10.1016/j.jneumeth.2011.05.012; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hendrie HC, 1998, AM J GERIAT PSYCHIAT, V6, pS3, DOI 10.1097/00019442-199821001-00002; Hermanns MI, 2009, J ROYAL SOC INTERFAC; Holthoewer D, 2012, NEURODEGENER DIS, V10, P224, DOI 10.1159/000334300; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Igarashi Y, 1999, BIOCHEM BIOPH RES CO, V261, P108, DOI 10.1006/bbrc.1999.0992; Iqbal K, 2008, J CELL MOL MED, V12, P38, DOI 10.1111/j.1582-4934.2008.00225.x; Ishida A, 1997, NEUROREPORT, V8, P2133, DOI 10.1097/00001756-199707070-00009; ISHIGURO K, 1993, FEBS LETT, V325, P167, DOI 10.1016/0014-5793(93)81066-9; ISHIGURO K, 1992, J BIOL CHEM, V267, P10897; Joshi YB, 2012, J ALZHEIMERS DIS, V31, P167, DOI 10.3233/JAD-2012-120328; Karch A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084405; Kasper J, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-6; Kelleher RJ, 2013, AM J CARDIOVASC DIS, V3, P197; Kido Y, 2004, DRUG METABOLISM PHAR, V17, P34; Kuperstein F, 2002, EUR J NEUROSCI, V16, P44, DOI 10.1046/j.1460-9568.2002.02056.x; Lai CH, 2005, BRAIN RES REV, V50, P258, DOI 10.1016/j.brainresrev.2005.07.004; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Loscher W, 2005, PROG NEUROBIOL, V76, P22, DOI 10.1016/j.pneurobio.2005.04.006; Ly PTT, 2013, J CLIN INVEST, V123, P224, DOI 10.1172/JCI64516; Maruszak A, 2011, PROG NEURO-PSYCHOPH, V35, P320, DOI 10.1016/j.pnpbp.2010.07.004; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Messing L, 2013, NEUROBIOL AGING, V34, P1343, DOI 10.1016/j.neurobiolaging.2012.10.024; Nakagawa S, 2007, CELL MOL NEUROBIOL, V27, P687, DOI 10.1007/s10571-007-9195-4; Patabendige A, 2013, BRAIN RES, V1521, P1, DOI 10.1016/j.brainres.2012.06.057; Perry G, 1999, NEUROREPORT, V10, P2411, DOI 10.1097/00001756-199908020-00035; Poller B, 2010, CELL MOL NEUROBIOL, V30, P63, DOI 10.1007/s10571-009-9431-1; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Sathya M, 2012, CLIN CHIM ACTA, V414, P171, DOI 10.1016/j.cca.2012.08.013; Schiera G, 2003, J CELL MOL MED, V7, P165, DOI 10.1111/j.1582-4934.2003.tb00215.x; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/BSE0500161, 10.1042/bse0500161]; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Tippmann F, 2009, FASEB J, V23, P1643, DOI 10.1096/fj.08-121392; TONTSCH U, 1991, BRAIN RES, V539, P247, DOI 10.1016/0006-8993(91)91628-E; Unger RE, 2002, IN VITRO CELL DEV-AN, V38, P273; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vos SJB, 2013, LANCET NEUROL, V12, P957, DOI 10.1016/S1474-4422(13)70194-7; Wan XZ, 2012, J NEUROSCI, V32, P3910, DOI 10.1523/JNEUROSCI.3916-11.2012; Weidenfeller C, 2007, J NEUROCHEM, V101, P555, DOI 10.1111/j.1471-4159.2006.04394.x; Weksler B, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-16; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Wolfe MS, 2012, ADV PHARMACOL, V64, P127, DOI 10.1016/B978-0-12-394816-8.00004-0; Yamagata K, 2003, NEUROSCIENCE, V116, P649, DOI 10.1016/S0306-4522(02)00715-7; Zhang Y, 2006, DRUG METAB DISPOS, V34, P1935, DOI 10.1124/dmd.105.006437; Zipser BD, 2007, NEUROBIOL AGING, V28, P977, DOI 10.1016/j.neurobiolaging.2006.05.016; Zozulya A, 2008, BRAIN RES, V1189, P1, DOI 10.1016/j.brainres.2007.10.099	70	32	33	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91003	10.1371/journal.pone.0091003	http://dx.doi.org/10.1371/journal.pone.0091003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608847	Green Published, Green Submitted, gold			2022-12-25	WOS:000332485800077
J	Kessels, MY; Huitema, LFA; Boeren, S; Kranenbarg, S; Schulte-Merker, S; van Leeuwen, JL; de Vries, SC				Kessels, Maurijn Y.; Huitema, Leonie F. A.; Boeren, Sjef; Kranenbarg, Sander; Schulte-Merker, Stefan; van Leeuwen, Johan L.; de Vries, Sacco C.			Proteomics Analysis of the Zebrafish Skeletal Extracellular Matrix	PLOS ONE			English	Article							GENE-EXPRESSION; BONE-DEVELOPMENT; SERINE-PROTEASE; SAMPLE PREPARATION; CARTILAGE; COLLAGEN; REVEALS; GROWTH; DIFFERENTIATION; MINERALIZATION	The extracellular matrix of the immature and mature skeleton is key to the development and function of the skeletal system. Notwithstanding its importance, it has been technically challenging to obtain a comprehensive picture of the changes in skeletal composition throughout the development of bone and cartilage. In this study, we analyzed the extracellular protein composition of the zebrafish skeleton using a mass spectrometry-based approach, resulting in the identification of 262 extracellular proteins, including most of the bone and cartilage specific proteins previously reported in mammalian species. By comparing these extracellular proteins at larval, juvenile, and adult developmental stages, 123 proteins were found that differed significantly in abundance during development. Proteins with a reported function in bone formation increased in abundance during zebrafish development, while analysis of the cartilage matrix revealed major compositional changes during development. The protein list includes ligands and inhibitors of various signaling pathways implicated in skeletogenesis such as the Int/Wingless as well as the insulin-like growth factor signaling pathways. This first proteomic analysis of zebrafish skeletal development reveals that the zebrafish skeleton is comparable with the skeleton of other vertebrate species including mammals. In addition, our study reveals 6 novel proteins that have never been related to vertebrate skeletogenesis and shows a surprisingly large number of differences in the cartilage and bone proteome between the head, axis and caudal fin regions. Our study provides the first systematic assessment of bone and cartilage protein composition in an entire vertebrate at different stages of development.	[Kessels, Maurijn Y.; Boeren, Sjef; de Vries, Sacco C.] Wageningen Univ, Biochem Lab, NL-6700 AP Wageningen, Netherlands; [Kessels, Maurijn Y.; Kranenbarg, Sander; Schulte-Merker, Stefan; van Leeuwen, Johan L.] Wageningen Univ, Expt Zool Grp, NL-6700 AP Wageningen, Netherlands; [Huitema, Leonie F. A.; Schulte-Merker, Stefan] Hubrecht Inst KNAW, Utrecht, Netherlands; [Huitema, Leonie F. A.; Schulte-Merker, Stefan] Univ Med Ctr Utrecht, Utrecht, Netherlands	Wageningen University & Research; Wageningen University & Research; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	de Vries, SC (corresponding author), Wageningen Univ, Biochem Lab, NL-6700 AP Wageningen, Netherlands.	Sacco.devries@wur.nl	van Leeuwen, Johan L/B-7897-2011; van Leeuwen, Johan/N-3437-2019	van Leeuwen, Johan/0000-0002-4433-880X	Research School VLAG, Wageningen University [6161100538]	Research School VLAG, Wageningen University	This work was supported by Grant no. 6161100538 Research School VLAG, Wageningen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens CH, 2010, NAT REV MOL CELL BIO, V11, P789, DOI 10.1038/nrm2973; Alves RDAM, 2011, J PROTEOME RES, V10, P4725, DOI 10.1021/pr200522n; Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; Andress DL, 2001, AM J PHYSIOL-ENDOC M, V281, pE283, DOI 10.1152/ajpendo.2001.281.2.E283; ASHTON BA, 1976, CALC TISS RES, V22, P27; Balooch G, 2005, P NATL ACAD SCI USA, V102, P18813, DOI 10.1073/pnas.0507417102; Bernardo BC, 2011, J BIOL CHEM, V286, P37758, DOI 10.1074/jbc.M111.248039; Bhatia VN, 2009, ANAL CHEM, V81, P9819, DOI 10.1021/ac901335x; Bikle Daniel D, 2012, Curr Mol Pharmacol, V5, P135; Bird NC, 2003, DEV DYNAM, V228, P337, DOI 10.1002/dvdy.10387; Brellier F, 2012, INT J BIOL SCI, V8, P187, DOI 10.7150/ijbs.8.187; Cerda J, 2002, DEV DYNAM, V224, P200, DOI 10.1002/dvdy.10101; Chatani M, 2011, DEV BIOL, V360, P96, DOI 10.1016/j.ydbio.2011.09.013; Deshpande AS, 2008, CRYST GROWTH DES, V8, P3084, DOI 10.1021/cg800252f; Enomoto-Iwamoto M, 2002, DEV BIOL, V251, P142, DOI 10.1006/dbio.2002.0802; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200; Flores MV, 2004, GENE EXPR PATTERNS, V4, P573, DOI 10.1016/j.modgep.2004.01.016; Fox AJS, 2009, SPORTS HEALTH, V1, P461, DOI 10.1177/1941738109350438; Graham JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074094; Hegde PS, 2003, CURR OPIN BIOTECH, V14, P647, DOI 10.1016/j.copbio.2003.10.006; Hou J, 2005, J CELL BIOCHEM, V94, P470, DOI 10.1002/jcb.20328; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Huitema LFA, 2012, P NATL ACAD SCI USA, V109, P21372, DOI 10.1073/pnas.1214231110; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; James CG, 2005, MOL BIOL CELL, V16, P5316, DOI 10.1091/mbc.E05-01-0084; Jiang XG, 2007, J PROTEOME RES, V6, P2287, DOI 10.1021/pr070056t; Karve Tejaswita M, 2011, J Amino Acids, V2011, P207691, DOI 10.4061/2011/207691; Kim T, 2009, J BIOL CHEM, V284, P15308, DOI 10.1074/jbc.M807722200; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kvist AJ, 2008, MATRIX BIOL, V27, P22, DOI 10.1016/j.matbio.2007.07.007; Lammi MJ, 2006, ELECTROPHORESIS, V27, P2687, DOI 10.1002/elps.200600004; LeClair EE, 2009, DEV DYNAM, V238, P2550, DOI 10.1002/dvdy.22086; Lee C, 2009, FRONT BIOSCI-LANDMRK, V14, P2911, DOI 10.2741/3422; Li N, 2009, DEV DYNAM, V238, P459, DOI 10.1002/dvdy.21838; Lu C, 2013, BONE, V53, P566, DOI 10.1016/j.bone.2012.12.016; Mackay E, 2013, BONEKEY IN PRESS; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Manza LL, 2005, PROTEOMICS, V5, P1742, DOI 10.1002/pmic.200401063; Mohan S., 1995, Progress in Growth Factor Research, V6, P465, DOI 10.1016/0955-2235(95)00027-5; Nagayama M, 2008, J DENT RES, V87, P244, DOI 10.1177/154405910808700309; Nakamura H, 2004, BONE, V34, P48, DOI 10.1016/j.bone.2003.09.001; Nishino J, 2004, EMBO J, V23, P1998, DOI 10.1038/sj.emboj.7600202; Nunez C, 2006, J BACTERIOL, V188, P2792, DOI 10.1128/JB.188.8.2792-2800.2006; Nusse R, 2012, EMBO J, V31, P2670, DOI 10.1038/emboj.2012.146; Onnerfjord P, 2012, J BIOL CHEM, V287, P18913, DOI 10.1074/jbc.M111.298968; Peruzzi B, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1651; Quondamatteo F, 2002, HISTOCHEM J, V34, P369, DOI 10.1023/A:1023675619251; Rotllant J, 2008, MATRIX BIOL, V27, P561, DOI 10.1016/j.matbio.2008.03.001; Rozen S, 2000, Methods Mol Biol, V132, P365; Schreiweis MA, 2007, J CELL BIOCHEM, V101, P466, DOI 10.1002/jcb.21196; Schulte-Merker S., 2002, ZEBRAFISH PRACTICAL, V261, P39; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Singh SK, 2011, J SEP SCI, V34, P225, DOI 10.1002/jssc.201000626; Sintuu C, 2008, J ORTHOP RES, V26, P753, DOI 10.1002/jor.20580; Smith A, 2008, DEV DYNAM, V237, P417, DOI 10.1002/dvdy.21417; Spoorendonk KM, 2010, J APPL ICHTHYOL, V26, P219, DOI 10.1111/j.1439-0426.2010.01409.x; Spoorendonk KM, 2008, DEVELOPMENT, V135, P3765, DOI 10.1242/dev.024034; Sprague J, 2003, NUCLEIC ACIDS RES, V31, P241, DOI 10.1093/nar/gkg027; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Tahimic Candice G T, 2013, Front Endocrinol (Lausanne), V4, P6, DOI 10.3389/fendo.2013.00006; TAKAHASHI S, 1994, J BIOL CHEM, V269, P28696; Tiaden AN, 2012, STEM CELLS, V30, P2271, DOI 10.1002/stem.1190; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; Tocharus J, 2004, DEV GROWTH DIFFER, V46, P257; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; TRIFFITT JT, 1976, NATURE, V262, P226, DOI 10.1038/262226a0; Tsuchiya A, 2005, BONE, V37, P323, DOI 10.1016/j.bone.2005.03.015; van Gool SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044561; Viguet-Carrin S, 2006, OSTEOPOROSIS INT, V17, P319, DOI 10.1007/s00198-005-2035-9; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Wilson R, 2012, MOL CELLULAR PROTEOM, V11; Wisniewski JR, 2009, NAT METHODS, V6, P785, DOI 10.1038/nmeth1109-785b; Yamada Y, 2003, J HUM GENET, V48, P469, DOI 10.1007/s10038-003-0063-x; Zhang H, 2003, OSTEOARTHR CARTILAGE, V11, P309, DOI 10.1016/S1063-4584(03)00032-3; Zhu WH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/840518	76	31	31	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90568	10.1371/journal.pone.0090568	http://dx.doi.org/10.1371/journal.pone.0090568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608635	Green Published, gold, Green Submitted			2022-12-25	WOS:000332485800034
J	Lei, ST; Zeng, B; Yuan, Z; Su, XL				Lei, Shutong; Zeng, Bo; Yuan, Zhi; Su, Xiaolei			Changes in Carbohydrate Content and Membrane Stability of Two Ecotypes of Calamagrostis arundinacea Growing at Different Elevations in the Drawdown Zone of the Three Gorges Reservoir	PLOS ONE			English	Article							LONG-TERM SUBMERGENCE; TOLERANCE; RECOVERY; GROWTH; PHOTOSYNTHESIS; RESPONSES; SURVIVAL; PLANTS; RICE	Background: The Three Gorges project has caused many ecosystem problems. Ecological restoration using readily-available plants is an effective way of mitigating environmental impacts. Two perennial submergence-tolerant ecotypes of Calamagrostis arundinacea were planted in an experimental field in the drawdown zone. Responses of the two plant ecotypes to flooding stress in the drawdown zone were unknown. Methodology/Principal Findings: Carbohydrate content and membrane stability, two key factors for survival of plants under flooding stress, of two ecotypes (designated "dwarf" and "green") of C. arundinacea growing at different elevations of the drawdown zone were investigated. Live stems (LS) and dead stems (DS) of the two plant ecotypes at eight elevations (175, 170, 162, 160, 158, 155, 152 m and 149 m) were sampled. Contents of soluble sugar, starch and malondialdehyde (MDA), as well as plasma membrane permeability of live stems were measured. The lowest elevations for survival of dwarf and green C. arundinacea were 160 m and 158 m, respectively. Soluble sugar content of live stems of both ecotypes decreased with elevation, with amounts from an elevation of 170 m being lower than from an elevation of 175 m. MDA content and plasma membrane permeability in live stems of green C. arundinacea did not increase with the decrease in elevation, while these measures in dwarf C. arundinacea from an elevation of 162 m were significantly higher than from an elevation of 175 m. Conclusions: Carbohydrate content, especially soluble sugar content, in both ecotypes was more sensitive to flooding stress than membrane stability. Green C. arundinacea had a higher tolerance to submergence than dwarf C. arundinacea, and thus green C. arundinacea can be planted at lower elevations than dwarf C. arundinacea.	[Lei, Shutong] Linyi Univ, Managing Off Natl Assets & Lab Equipments, Linyi, Peoples R China; [Lei, Shutong; Zeng, Bo; Yuan, Zhi; Su, Xiaolei] Southwest Univ, Chongqing Key Lab Plant Ecol & Resources Three Go, Key Lab Ecoenviron Three Gorges Reservoir Reg, Minist Educ, Chongqing, Peoples R China	Linyi University; Southwest University - China	Zeng, B (corresponding author), Southwest Univ, Chongqing Key Lab Plant Ecol & Resources Three Go, Key Lab Ecoenviron Three Gorges Reservoir Reg, Minist Educ, Chongqing, Peoples R China.	bzeng@swu.edu.cn			National Natural Science Foundation of China [31070474, 31370443]; National Basic Research Program of China [2012CB723205]; Research Grant for Disciplines Conferring Doctorate in China [20100182110022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Research Grant for Disciplines Conferring Doctorate in China	This research was supported by grants of National Natural Science Foundation of China Nos. 31070474, 31370443 (http://159.226.244.22/portal/Proj_List.asp), National Basic Research Program of China No. 2012CB723205 (http://www.973.gov.cn/AreaMana.aspx), and Research Grant for Disciplines Conferring Doctorate in China (20100182110022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[罗芳丽 LUO FangLi], 2006, [生态学报, Acta Ecologica Sinica], V26, P3602; Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; Fukao T, 2004, TRENDS PLANT SCI, V9, P449, DOI 10.1016/j.tplants.2004.07.005; HEATH RL, 1965, BIOCHEM BIOPH RES CO, V19, P716, DOI 10.1016/0006-291X(65)90316-5; Hong Ming, 2011, Yingyong Shengtai Xuebao, V22, P2829; Jackson MB, 2009, ANN BOT-LONDON, V103, P137, DOI 10.1093/aob/mcn242; Jie SL, 2012, ACTA ECOL SIN, V32, P723; Lei S, 2012, ACTA ECOL SINICA, V32, P227, DOI DOI 10.1016/J.CHNAES.2012.06.001; Lei ST, 2009, J CHONGQING NORM U N, V26, P30; Li Y., 2008, ACTA ECOL SINICA, V28, P1924; Luo FL, 2011, ANN BOT-LONDON, V107, P49, DOI 10.1093/aob/mcq212; Luo FL, 2009, ANN BOT-LONDON, V104, P1435, DOI 10.1093/aob/mcp257; Pan RC, 2003, PLANT PHYSL; Pena-Fronteras JT, 2009, ANN BOT-LONDON, V103, P295, DOI 10.1093/aob/mcn085; Perata P, 2011, NEW PHYTOL, V190, P269, DOI 10.1111/j.1469-8137.2011.03702.x; Ram PC, 2002, FIELD CROP RES, V76, P131, DOI 10.1016/S0378-4290(02)00035-7; Shen Jian-Hong, 2011, Chinese Journal of Plant Ecology, V35, P237, DOI 10.3724/SP.J.1258.2011.00237; [苏晓磊 Su Xiaolei], 2010, [生态学报, Acta Ecologica Sinica], V30, P2585; Tan S D, 2008, RESOUR ENV YANGTZE B, V17, P101; Tan SD, 2010, ACTA PHYSIOL PLANT, V32, P133, DOI 10.1007/s11738-009-0388-y; Visser EJW, 2003, ANN BOT-LONDON, V91, P107, DOI 10.1093/aob/mcg014; Wang Hai-Feng, 2008, Zhiwu Shengtai Xuebao, V32, P977, DOI 10.3773/j.issn.1005-264x.2008.05.001; [王海锋 WANG HaiFeng], 2008, [生态学报, Acta Ecologica Sinica], V28, P2571; Zhang JianJun, 2012, Scientia Silvae Sinicae, V48, P154; [张艳红 ZHANG Yanhong], 2006, [西南师范大学学报. 自然科学版, Journal of Southwest China Normal University. Natural Science], V31, P153; Zhang ZL, 2003, EXPT GUIDE PLANT PHS; [周永娟 Zhou Yongjuan], 2010, [生态学报, Acta Ecologica Sinica], V30, P6726	27	12	12	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91394	10.1371/journal.pone.0091394	http://dx.doi.org/10.1371/journal.pone.0091394			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608821	Green Published, Green Submitted, gold			2022-12-25	WOS:000332485800133
J	Sadhu, S; Manukonda, AR; Yeruva, AR; Patel, SK; Saggurti, N				Sadhu, Santhosh; Manukonda, Archana Rao; Yeruva, Anthony Reddy; Patel, Sangram Kishor; Saggurti, Niranjan			Role of a Community-to-Community Learning Strategy in the Institutionalization of Community Mobilization among Female Sex Workers in India	PLOS ONE			English	Article							ANDHRA-PRADESH; CONDOM USE; HEALTH	Introduction: The institutionalization of community mobilization is not well understood in literature. This paper aims to understand the role of the community-to-community learning strategy in the institutionalization of community mobilization among sex workers communities across eight districts of Andhra Pradesh, India. Materials and Methods: Data collected during baseline (March, 2010) and endline (June, 2012) under an HIV prevention project (SAKSHAM project) was used to investigate the strength (as score) of community mobilization based on two learning strategies: non-government organization (NGO)-to-community-based organization (CBO) strategy, and community-to-CBO strategy. The strength of community mobilization was assessed based on different parameters. The change in scores were computed as a percentage of the improvement to the total potential improvement from baseline to endline on specific indicators and overall. Results: Most of the CBOs considered in the pre-post assessment had been registered during 2004-2008. At baseline, the community ownership and preparedness index scores for the eight CBOs under the community-to-CBO strategy ranged between 21.5 and 27.7 while the scores for the three CBOs under the NGO-to-CBO strategy ranged between 16.3 and 21.5. By endline, the strength of community mobilization among CBOs under the community-to-CBO strategy increased 18 points (equivalent to 23% potential improvement) whereas the strength of community mobilization among CBOs under the NGO-to-CBO strategy increased only 10 points (equivalent to 13% potential improvement). The average percentage difference in improvement between the strategies was 10% (p = 0.102). Further analyses indicate that a greater improvement in community-to-CBO learning strategy was noted around managerial capacities and engagement with stakeholders than other parameters. Conclusion: The community -to- CBO learning strategy presents promising results for HIV prevention with regard to institutionalization of community mobilization among sex workers communities. Findings support the scaling-up of community mobilization initiatives within HIV prevention interventions using well trained community members in India and elsewhere.	[Sadhu, Santhosh; Manukonda, Archana Rao; Yeruva, Anthony Reddy] CARE India, Hyderabad, Andhra Pradesh, India; [Patel, Sangram Kishor; Saggurti, Niranjan] Populat Council, HIV & AIDS Program, New Delhi, India		Sadhu, S (corresponding author), CARE India, Hyderabad, Andhra Pradesh, India.	santhoshsadhu@gmail.com		Saggurti, Niranjan/0000-0002-5267-8425	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The study was funded by Bill & Melinda Gates Foundation to CARE-India as part of Avahan, its India AIDS Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This paper was written as part of a mentorship program to the first author, under the Knowledge Network Project of the Population Council, which is a grantee of the Bill & Melinda Gates Foundation through Avahan, its India AIDS Initiative. The views expressed herein are those of the authors and do not necessarily reflect the official policy or position of the Bill & Melinda Gates Foundation and Avahan.	Blankenship KA, 2008, AIDS, V22, pS109, DOI 10.1097/01.aids.0000343769.92949.dd; BRACHT N, 1994, HEALTH EDUC RES, V9, P243, DOI 10.1093/her/9.2.243; CARE India, 2010, LEARN SIT ASS TARG I; CARE India, 2012, COMM COMM LEARN NEW; Chambers R., 1997, WHOSE REALITY COUNTS; Chattopadhyay A, 2004, AIDS PATIENT CARE ST, V18, P159, DOI 10.1089/108729104322994847; Gaikwad SS, 2012, J EPIDEMIOL COMMUN H, V66, pII69, DOI 10.1136/jech-2011-200514; Galavotti C, 2012, J EPIDEMIOL COMMUN H, V66, pII9, DOI 10.1136/jech-2011-200465; Jana S, 2004, AIDS EDUC PREV, V16, P405, DOI 10.1521/aeap.16.5.405.48734; Kothari Cooke, 2001, PARTICIPATION NEW TY; Michau, 2007, GENDER DEV, V15, P95; Mintrom M, 1997, AM J POLIT SCI, V41, P738, DOI 10.2307/2111674; Narayanan P, 2012, J EPIDEMIOL COMMUN H, V66, pII34, DOI 10.1136/jech-2012-201065; Nyonator FK, 2005, HEALTH POLICY PLANN, V20, P25, DOI 10.1093/heapol/czi003; Pinto RM, 2008, WOMEN HEALTH, V47, P83, DOI 10.1300/J013v47n01_05; Praxis, 2009, MEAS COMM MOB PROC M; Saggurti N, 2013, AIDS CARE, V25, pS55, DOI 10.1080/09540121.2012.749334; Sarkar S, 2010, SEX TRANSM INFECT, V86, pI2, DOI 10.1136/sti.2009.039289; Thomas T, 2012, J EPIDEMIOL COMMUN H, V66, pII26, DOI 10.1136/jech-2011-200590; Tripathy P, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-182; UNFPA UNAIDS APNSW, 2012, HIV SEX WORK COLL IN; World Bank, 2012, IND COMM EMP KEY TUR; World Bank, 2007, COMM LED TOT SAN RUR	23	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90592	10.1371/journal.pone.0090592	http://dx.doi.org/10.1371/journal.pone.0090592			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4IY	24608680	Green Published, gold, Green Submitted			2022-12-25	WOS:000332485800035
J	Bian, LJ; Ji, X				Bian, Liujiao; Ji, Xu			Distribution, Transition and Thermodynamic Stability of Protein Conformations in the Denaturant-Induced Unfolding of Proteins	PLOS ONE			English	Article							MOLTEN GLOBULE; GUANIDINIUM CHLORIDE; ALPHA-LACTALBUMIN; CYTOCHROME-C; FOLDING PATHWAYS; LOW-TEMPERATURE; COMPACT STATE; INTERMEDIATE; BINDING; UREA	Background: Extensive and intensive studies on the unfolding of proteins require appropriate theoretical model and parameter to clearly illustrate the feature and characteristic of the unfolding system. Over the past several decades, four approaches have been proposed to describe the interaction between proteins and denaturants, but some ambiguity and deviations usually occur in the explanation of the experimental data. Methodology/Principal Findings: In this work, a theoretical model was presented to show the dependency of the residual activity ratio of the proteins on the molar denaturant concentration. Through the characteristic unfolding parameters k(i) and Delta m(i) in this model, the distribution, transition and thermodynamic stability of protein conformations during the unfolding process can be quantitatively described. This model was tested with the two-state unfolding of bovine heart cytochrome c and the three-state unfolding of hen egg white lysozyme induced by both guanidine hydrochloride and urea, the four-state unfolding of bovine carbonic anhydrase b induced by guanidine hydrochloride and the unfolding of some other proteins induced by denaturants. The results illustrated that this model could be used accurately to reveal the distribution and transition of protein conformations in the presence of different concentrations of denaturants and to evaluate the unfolding tendency and thermodynamic stability of different conformations. In most denaturant-induced unfolding of proteins, the unfolding became increasingly hard in next transition step and the proteins became more unstable as they attained next successive stable conformation. Conclusions/Significance: This work presents a useful method for people to study the unfolding of proteins and may be used to describe the unfolding and refolding of other biopolymers induced by denaturants, inducers, etc.	[Bian, Liujiao; Ji, Xu] NW Univ Xian, Coll Life Sci, Xian 710069, Shaanxi, Peoples R China	Northwest University Xi'an	Bian, LJ (corresponding author), NW Univ Xian, Coll Life Sci, Xian 710069, Shaanxi, Peoples R China.	bianliujiao@sohu.com			National Natural Science Foundation of China [21075097]; Key Program for Science and Technology Innovative Research Team of Shaanxi Province [2013KCT-24]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program for Science and Technology Innovative Research Team of Shaanxi Province	This work was supported by a grant from National Natural Science Foundation of China (Grant 21075097) and Key Program for Science and Technology Innovative Research Team of Shaanxi Province (No. 2013KCT-24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO DOV, 1991, BIOCHEMISTRY-US, V30, P5974, DOI 10.1021/bi00238a023; Bhuyan AK, 2001, J MOL BIOL, V312, P1135, DOI 10.1006/jmbi.2001.4993; Bian LJ, 2011, CHINESE J CHEM, V29, P813, DOI 10.1002/cjoc.201190163; Blancas-Mejia LM, 2009, J MOL BIOL, V386, P1153, DOI 10.1016/j.jmb.2008.12.069; Bose HS, 1999, P NATL ACAD SCI USA, V96, P7250, DOI 10.1073/pnas.96.13.7250; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWNELL PF, 1991, AUST J PLANT PHYSIOL, V18, P589, DOI 10.1071/PP9910589; Chimon S, 2005, J AM CHEM SOC, V127, P13472, DOI 10.1021/ja054039l; D'Onofrio M, 2009, ARCH BIOCHEM BIOPHYS, V481, P21, DOI 10.1016/j.abb.2008.10.017; Darley-Usmar V. M., 1987, MITOCHONDRIA PRACTIC; DeKoster GT, 1997, BIOPHYS CHEM, V64, P59, DOI 10.1016/S0301-4622(96)02219-3; DOLGIKH DA, 1981, FEBS LETT, V136, P311, DOI 10.1016/0014-5793(81)80642-4; DOLGIKH DA, 1985, EUR BIOPHYS J BIOPHY, V13, P109, DOI 10.1007/BF00256531; Domingues MM, 2009, BIOPHYS J, V96, P987, DOI 10.1016/j.bpj.2008.10.044; ELIEZER D, 1993, BIOPHYS J, V65, P912, DOI 10.1016/S0006-3495(93)81124-X; Fang Y, 2003, ACTA CHIM SINICA, V61, P803; Fedor MJ, 2008, J BIOL CHEM, V283, P1209, DOI 10.1074/jbc.R700046200; FINK AL, 1994, BIOCHEMISTRY-US, V33, P12504, DOI 10.1021/bi00207a018; Gorovits BM, 1998, BBA-PROTEIN STRUCT M, V1382, P120, DOI 10.1016/S0167-4838(97)00158-1; GOTO Y, 1990, P NATL ACAD SCI USA, V87, P573, DOI 10.1073/pnas.87.2.573; Grimsrud PA, 2008, J BIOL CHEM, V283, P21837, DOI 10.1074/jbc.R700019200; Hammes GG, 2008, J BIOL CHEM, V283, P22337, DOI 10.1074/jbc.X800005200; Harder ME, 2009, BIOPHYS CHEM, V141, P1, DOI 10.1016/j.bpc.2008.12.001; HINDS DA, 1995, TRENDS BIOTECHNOL, V13, P23, DOI 10.1016/S0167-7799(00)88897-6; Kataoka M, 1997, PROTEIN SCI, V6, P422; Kurganov BI, 2002, BIOCHEMISTRY-MOSCOW+, V67, P409, DOI 10.1023/A:1015277805345; Kuznetsova IM, 2002, BBA-PROTEIN STRUCT M, V1596, P138, DOI 10.1016/S0167-4838(02)00212-1; Muralidhar D, 2005, J BIOL CHEM, V280, P15569, DOI 10.1074/jbc.M414243200; Pace C N, 1986, Methods Enzymol, V131, P266; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Rozema D, 1996, BIOCHEMISTRY-US, V35, P15760, DOI 10.1021/bi961638j; SCHELLMAN JA, 1975, BIOPOLYMERS, V14, P999, DOI 10.1002/bip.1975.360140509; SCHELLMAN JA, 1994, BIOPOLYMERS, V34, P1015, DOI 10.1002/bip.360340805; Schellman JA, 1996, BIOPHYS CHEM, V59, P259, DOI 10.1016/0301-4622(95)00130-1; SCHELLMAN JA, 1993, BIOPHYS CHEM, V45, P273, DOI 10.1016/0301-4622(93)80008-7; STANIFORTH RA, 1993, BIOCHEMISTRY-US, V32, P3842, DOI 10.1021/bi00066a003; Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7; Uverskii VN, 1998, BIOFIZIKA+, V43, P416; Uversky VN, 1998, J MOL BIOL, V278, P879, DOI 10.1006/jmbi.1998.1741; UVERSKY VN, 1994, BIOCHEMISTRY-US, V33, P2782, DOI 10.1021/bi00176a006; Uversky VN, 1996, J MOL BIOL, V255, P215, DOI 10.1006/jmbi.1996.0018; Uversky VN, 1997, PROTEIN PEPTIDE LETT, V4, P355; Uversky VN, 1997, FOLD DES, V2, P163, DOI 10.1016/S1359-0278(97)00023-0; Welker E, 2004, J AM CHEM SOC, V126, P3720, DOI 10.1021/ja031658q; WU LC, 1993, BIOCHEMISTRY-US, V32, P10271, DOI 10.1021/bi00089a050	45	5	5	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91129	10.1371/journal.pone.0091129	http://dx.doi.org/10.1371/journal.pone.0091129			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603868	Green Published, Green Submitted, gold			2022-12-25	WOS:000332483600133
J	Blivet, S; Cobarzan, D; Beauchet, A; El Hajjam, M; Lacombe, P; Chinet, T				Blivet, Sandra; Cobarzan, Daniel; Beauchet, Alain; El Hajjam, Mostafa; Lacombe, Pascal; Chinet, Thierry			Impact of Pulmonary Arteriovenous Malformations on Respiratory-Related Quality of Life in Patients with Hereditary Haemorrhagic Telangiectasia	PLOS ONE			English	Article							HEALTH-STATUS; QUESTIONNAIRE; EMBOLIZATION; EPISTAXIS; DISEASE; HHT	Fifteen to fifty percent of patients with hereditary haemorrhagic telangiectasia have pulmonary arteriovenous malformations. The objective of this study was to measure the effect of the presence of pulmonary arteriovenous malformations and of their embolisation on respiratory-related quality of life (QoL). We prospectively recruited patients with a diagnosis of hereditary haemorrhagic telangiectasia based on the Curacao criteria and/or the identification of a pathogenic mutation. Respiratory-related quality of life was measured using the Saint George's Respiratory Questionnaire (SGRQ). Patients who underwent embolisation of pulmonary arteriovenous malformations completed the questionnaire before and 6-12 mo after the procedure. The 56 participants were divided into three groups: no pulmonary arteriovenous malformation (group A, n = 10), small pulmonary arteriovenous malformations not accessible to embolotherapy (group B, n = 19), and large pulmonary arteriovenous malformations accessible to embolotherapy (group C, n = 27). The SGRQ score was significantly higher in group C compared to the other groups, indicating a worse respiratory-specific QoL. There was no significant difference between groups A and B. Among the 17 patients who underwent an embolisation, the SGRQ score decreased significantly after the procedure, to a value similar to that in patients without pulmonary arteriovenous malformation. Our results indicate that the presence of large but not small pulmonary arteriovenous malformations negatively affects the respiratory-related quality of life and that embolisation of pulmonary arteriovenous malformations normalizes the respiratory-related quality of life.	[Blivet, Sandra; Cobarzan, Daniel; El Hajjam, Mostafa; Lacombe, Pascal; Chinet, Thierry] Univ Versailles St Quentin En Yvelines, Hop Ambroise Pare, AP HP, Boulogne, France; [Beauchet, Alain] Univ Versailles St Quentin En Yvelines, Hop Ambroise Pare, AP HP, Dept Sante Publ, Boulogne, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay	Chinet, T (corresponding author), Univ Versailles St Quentin En Yvelines, Hop Ambroise Pare, AP HP, Boulogne, France.	Thierry.Chinet@Apr.Aphp.Fr			French HHT patient association, AMRO-France HHT (Association Maladie Rendu-Osler)	French HHT patient association, AMRO-France HHT (Association Maladie Rendu-Osler)	This work received financial support from the French HHT patient association, AMRO-France HHT (Association Maladie Rendu-Osler). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abdalla SA, 2006, J MED GENET, V43, P97, DOI 10.1136/jmg.2005.030833; Al-Shair K, 2013, CHEST, V144, P623, DOI 10.1378/chest.12-0014; Bouchet C, 1996, REV MAL RESPIR, V13, P43; de Gussem EM, 2009, RHINOLOGY, V47, P85; Faughnan ME, 2011, J MED GENET, V48, P73, DOI 10.1136/jmg.2009.069013; Faughnan ME, 2009, EUR RESPIR J, V33, P1186, DOI 10.1183/09031936.00061308; Geirdal AO, 2012, AM J MED GENET A, V158A, P1269, DOI 10.1002/ajmg.a.35309; Geisthoff UW, 2007, OTOLARYNG HEAD NECK, V136, P726, DOI 10.1016/j.otohns.2006.12.019; Gossage JR, 1998, AM J RESP CRIT CARE, V158, P643, DOI 10.1164/ajrccm.158.2.9711041; Gupta S, 2009, CHEST, V136, P849, DOI 10.1378/chest.09-0334; GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Jones PW, 2002, EUR RESPIR J, V19, P398, DOI 10.1183/09031936.02.00063702; Karapantzos I, 2005, EUR ARCH OTO-RHINO-L, V262, P830, DOI 10.1007/s00405-004-0911-0; Lacombe P, 2009, CHEST, V135, P1031, DOI 10.1378/chest.08-1794; Lennox PA, 2005, AM J RHINOL, V19, P71, DOI 10.1177/194589240501900112; Moussouttas M, 2000, NEUROLOGY, V55, P959, DOI 10.1212/WNL.55.7.959; Nishiyama O, 2005, RESP MED, V99, P408, DOI 10.1016/j.rmed.2004.09.005; Pasculli G, 2004, QUAL LIFE RES, V13, P1715, DOI 10.1007/s11136-004-7865-y; Pfister M, 2009, ACTA OTO-LARYNGOL, V129, P862, DOI 10.1080/00016480802468138; Rubenfire M, 2009, CHEST, V136, P597, DOI 10.1378/chest.08-1260; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; Trerotola SO, 2010, AM J ROENTGENOL, V195, P837, DOI 10.2214/AJR.10.5230; Velthuis S, 2013, CHEST, V144, P542, DOI 10.1378/chest.12-1599	24	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90937	10.1371/journal.pone.0090937	http://dx.doi.org/10.1371/journal.pone.0090937			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603803	Green Submitted, Green Published, gold			2022-12-25	WOS:000332483600110
J	Keijsers, JGS; Poortinga, A; Riksen, MJPM; Maroulis, J				Keijsers, Joep G. S.; Poortinga, Ate; Riksen, Michel J. P. M.; Maroulis, Jerry			Spatio-Temporal Variability in Accretion and Erosion of Coastal Foredunes in the Netherlands: Regional Climate and Local Topography	PLOS ONE			English	Article							AEOLIAN SAND TRANSPORT; SEDIMENT TRANSPORT; DUNE EROSION; BEACH; FETCH; SHOREFACE; MORPHODYNAMICS; DYNAMICS; STORMS; RATES	Depending on the amount of aeolian sediment input and dune erosion, dune size and morphology change over time. Since coastal foredunes play an important role in the Dutch coastal defence, it is important to have good insight in the main factors that control these changes. In this paper the temporal variations in foredune erosion and accretion were studied in relation to proxies for aeolian transport potential and storminess using yearly elevation measurements from 1965 to 2012 for six sections of the Dutch coast. Longshore differences in the relative impacts of erosion and accretion were examined in relation to local beach width. The results show that temporal variability in foredune accretion and erosion is highest in narrow beach sections. Here, dune erosion alternates with accretion, with variability displaying strong correlations with yearly values of storminess (maximum sea levels). In wider beach sections, dune erosion is less frequent, with lower temporal variability and stronger correlations with time series of transport potential. In erosion dominated years, eroded volumes decrease from narrow to wider beaches. When accretion dominates, dune-volume changes are relatively constant alongshore. Dune erosion is therefore suggested to control spatial variability in dune-volume changes. On a scale of decades, the volume of foredunes tends to increase more on wider beaches. However, where widths exceed 200 to 300 m, this trend is no longer observed.	[Keijsers, Joep G. S.; Poortinga, Ate; Riksen, Michel J. P. M.; Maroulis, Jerry] Wageningen Univ, Soil Phys & Land Management Grp, NL-6700 AP Wageningen, Netherlands; [Maroulis, Jerry] Univ Sunshine Coast, Sch Sci Educ & Engn, Sippy Downs, Qld 4556, Australia	Wageningen University & Research; University of the Sunshine Coast	Keijsers, JGS (corresponding author), Wageningen Univ, Soil Phys & Land Management Grp, NL-6700 AP Wageningen, Netherlands.	joep.keijsers@wur.nl	Maroulis, Jerry/H-8799-2019; Riksen, Michel/B-3851-2014	Maroulis, Jerry/0000-0002-6039-8693; Riksen, Michel/0000-0002-3695-4362; Poortinga, Ate/0000-0001-9647-2317	Ministry of Infrastructure and the Environment	Ministry of Infrastructure and the Environment	This study was carried out in the framework of the Dutch National Research Programme Knowledge for Climate (www.knowledgeforclimate.org). This research programme is co-financed by the Ministry of Infrastructure and the Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard T, 2004, GEOMORPHOLOGY, V60, P205, DOI 10.1016/j.geomorph.2003.08.002; Aagaard T., 2004, GEOGR TIDSSKR-DEN, V104, P5, DOI [10.1080/00167223.2004.10649499, DOI 10.1080/00167223.2004.10649499]; Adriani MJ, 1974, SAND STABILIZATION D, P68; Anthony EJ, 2006, GEOMORPHOLOGY, V81, P316, DOI 10.1016/j.geomorph.2006.04.022; Anthony EJ, 2013, GEOMORPHOLOGY, V199, P8, DOI 10.1016/j.geomorph.2012.06.007; Anthony EJ, 2009, GEOMORPHOLOGY, V105, P95, DOI 10.1016/j.geomorph.2007.12.013; Arens SM, 1996, GEOMORPHOLOGY, V17, P3, DOI 10.1016/0169-555X(95)00089-N; ARENS SM, 1994, J COASTAL RES, V10, P189; Bagnold R.A., 1954, PHYS BLOWN SAND DESE; Bakker MAJ, 2012, J COAST RES; Bakker WT, 1968, SHORE BEACH, V36, P4; Bauer BO, 2003, GEOMORPHOLOGY, V49, P89, DOI 10.1016/S0169-555X(02)00165-4; Bochev-van der Burgh LM, 2011, COAST ENG, V58, P927, DOI 10.1016/j.coastaleng.2011.05.013; Bollweg AE, 1997, EXTRACTIE STRANDPROT; Burroughs SM, 2008, J COASTAL RES, V24, P104, DOI 10.2112/05-0583.1; CHAPMAN DM, 1990, EARTH SURF PROCESSES, V15, P751, DOI 10.1002/esp.3290150808; Cheung KF, 2007, J COASTAL RES, V23, P106, DOI 10.2112/04-0403.1; Cooper JAG, 2004, MAR GEOL, V210, P261, DOI 10.1016/j.margeo.2004.05.012; da Silva GM, 2012, MAR GEOL, V323, P29, DOI 10.1016/j.margeo.2012.07.015; Davidson-Arnott RGD, 1990, SEASONAL PATTERNS CO, P177; Davidson-Arnott RGD, 2008, EARTH SURF PROC LAND, V33, P55, DOI 10.1002/esp.1527; DavidsonArnott RGD, 1996, J COASTAL RES, V12, P654; Davis R. B.  III, 1987, Proceedings of the Thirteenth Annual Northeast Bioengineering Conference (Cat. No.87CH2436-4), P131; De Graaf HJC, 2003, INWINNING DROGE JARK, P43; de Vries S, 2012, COAST ENG, V67, P41, DOI 10.1016/j.coastaleng.2012.04.002; Delgado-Fernandez I, 2011, GEOMORPHOLOGY, V126, P217, DOI 10.1016/j.geomorph.2010.11.005; Delgado-Fernandez I, 2010, AEOLIAN RES, V2, P61, DOI 10.1016/j.aeolia.2010.04.001; Fryberger S., 1979, STUDY GLOBAL SAND SE; Gares PA, 1996, J COASTAL RES, V12, P673; Gillette DA, 1996, EARTH SURF PROCESSES, V21, P641, DOI 10.1002/(SICI)1096-9837(199607)21:7&lt;641::AID-ESP662&gt;3.0.CO;2-9; Guillen J, 1999, EARTH SURF PROC LAND, V24, P517, DOI 10.1002/(SICI)1096-9837(199906)24:6<517::AID-ESP974>3.0.CO;2-A; Hesp P, 2002, GEOMORPHOLOGY, V48, P245, DOI 10.1016/S0169-555X(02)00184-8; Houser C., 2013, TREATISE GEOMORPHOLO, P267; Houser C, 2008, GEOMORPHOLOGY, V100, P223, DOI 10.1016/j.geomorph.2007.12.007; Jackson DWT, 1999, SEDIMENTOLOGY, V46, P517; Jackson NL, 1998, GEOMORPHOLOGY, V22, P151, DOI 10.1016/S0169-555X(97)00065-2; Komar P. D., 1976, SHORE BEACH, V44, P9; KRIEBEL DL, 1985, COAST ENG, V9, P221, DOI 10.1016/0378-3839(85)90009-2; KROON A, 1990, J COASTAL RES, V6, P367; Ministerie van Verkeer en Waterstaat, 1990, KUSTN KUSTV 1990, P65; NICKLING WG, 1984, SEDIMENTOLOGY, V31, P111, DOI 10.1111/j.1365-3091.1984.tb00726.x; NORDSTROM KF, 1992, SEDIMENTOLOGY, V39, P769, DOI 10.1111/j.1365-3091.1992.tb02152.x; Ollerhead J, 2013, EARTH SURF PROC LAND, V38, P284, DOI 10.1002/esp.3327; Oost AP, 2012, OCEAN COAST MANAGE, V68, P18, DOI 10.1016/j.ocecoaman.2012.07.010; Oosterwijk HJM, 1987, AANSLUITING HOOGTE D, P23; Pye K, 2008, GEOMORPHOLOGY, V102, P652, DOI 10.1016/j.geomorph.2008.06.011; Quartel S, 2008, MAR GEOL, V250, P19, DOI 10.1016/j.margeo.2007.11.003; Rijkswaterstaat, 1973, STORMVL 2 3 APR 1973, P10; Rijkswaterstaat, 1990, VERSL CROC STORMVL 2, P67; Ruessink BG, 2002, EARTH SURF PROC LAND, V27, P1043, DOI 10.1002/esp.391; Sallenger AH, 2003, J COASTAL RES, V19, P125; Sallenger AH, 2000, J COASTAL RES, V16, P890; Saye SE, 2005, GEOMORPHOLOGY, V72, P128, DOI 10.1016/j.geomorph.2005.05.007; SHERMAN DJ, 1993, PROG PHYS GEOG, V17, P413, DOI 10.1177/030913339301700402; Stockdon HF, 2006, COAST ENG, V53, P573, DOI 10.1016/j.coastaleng.2005.12.005; van der Wal D, 1998, J ARID ENVIRON, V39, P533, DOI 10.1006/jare.1997.0364; van der Wal D, 2004, J COASTAL RES, V20, P317, DOI 10.2112/1551-5036(2004)20[317:BIINAA]2.0.CO;2; VANDEGRAAFF J, 1986, COAST ENG, V9, P479, DOI 10.1016/0378-3839(86)90009-8; VELLINGA P, 1982, COAST ENG, V6, P361, DOI 10.1016/0378-3839(82)90007-2; VERHAGEN HJ, 1989, COAST ENG, V13, P129, DOI 10.1016/0378-3839(89)90020-3; Vousdoukas MI, 2012, EARTH SURF PROC LAND, V37, P583, DOI 10.1002/esp.2264; Wijnberg K.M., 2012, JUB C P, P35	62	64	64	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91115	10.1371/journal.pone.0091115	http://dx.doi.org/10.1371/journal.pone.0091115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603812	Green Published, gold, Green Submitted			2022-12-25	WOS:000332483600131
J	Sanchez-Dominguez, CN; Reyes-Lopez, MA; Bustamante, A; Cerda-Flores, RM; Villalobos-Torres, MD; Gallardo-Blanco, HL; Rojas-Martinez, A; Martinez-Rodriguez, HG; Barrera-Saldana, HA; Ortiz-Lopez, R				Sanchez-Dominguez, Celia N.; Reyes-Lopez, Miguel A.; Bustamante, Adriana; Cerda-Flores, Ricardo M.; Villalobos-Torres, Maria del C.; Gallardo-Blanco, Hugo L.; Rojas-Martinez, Augusto; Martinez-Rodriguez, Herminia G.; Barrera-Saldana, Hugo A.; Ortiz-Lopez, Rocio			The Tumor Necrosis Factor alpha (-308 A/G) Polymorphism Is Associated with Cystic Fibrosis in Mexican Patients	PLOS ONE			English	Article							MANNOSE-BINDING-LECTIN; ALPHA-1-ANTITRYPSIN DEFICIENCY ALLELES; SYNCYTIAL VIRUS BRONCHIOLITIS; AIRWAY EPITHELIAL-CELLS; LUNG-DISEASE; TNF-ALPHA; ANTITRYPSIN DEFICIENCY; PROMOTER POLYMORPHISM; RHEUMATOID-ARTHRITIS; GENE POLYMORPHISMS	Environmental and genetic factors may modify or contribute to the phenotypic differences observed in multigenic and monogenic diseases, such as cystic fibrosis (CF). An analysis of modifier genes can be helpful for estimating patient prognosis and directing preventive care. The aim of this study is to determine the association between seven genetic variants of four modifier genes and CF by comparing their corresponding allelic and genotypic frequencies in CF patients (n = 81) and control subjects (n = 104). Genetic variants of MBL2 exon 1 (A, B, C and D), the IL-8 promoter (2251 A/T), the TNF alpha promoter (TNF1/TNF2), and SERPINA1 (PI*Z and PI*S) were tested in CF patients and control subjects from northeastern Mexico by PCR-RFLP. Results: The TNF2 allele (P=0.012, OR 3.43, 95% CI 1.25-9.38) was significantly associated with CF under the dominant and additive models but was not associated with CF under the recessive model. This association remained statistically significant after adjusting for multiple tests using the Bonferroni correction (P=0.0482). The other tested variants and genotypes did not show any association with the disease. Conclusion: An analysis of seven genetic variants of four modifier genes showed that one variant, the TNF2 allele, appears to be significantly associated with CF in Mexican patients.	[Sanchez-Dominguez, Celia N.; Villalobos-Torres, Maria del C.; Rojas-Martinez, Augusto; Martinez-Rodriguez, Herminia G.; Barrera-Saldana, Hugo A.; Ortiz-Lopez, Rocio] Univ Autonoma Nuevo Leon, Fac Med, Dept Bioquim & Med Mol, Monterrey, Nuevo Leon, Mexico; [Reyes-Lopez, Miguel A.] Inst Politecn Nacl, Ctr Biotecnol Genom, Lab Med Conservac, Reynosa, Tamaulipas, Mexico; [Bustamante, Adriana] Univ Autonoma Nuevo Leon, Fac Med, Clin Fibrosis Quist, Ctr Prevenc & Rehabil Enfermedades Pulm Cron CEPR, Monterrey, Nuevo Leon, Mexico; [Bustamante, Adriana] Hosp Univ Dr Jose Eleuterio Gonzalez, Monterrey, Nuevo Leon, Mexico; [Cerda-Flores, Ricardo M.] Univ Autonoma Nuevo Leon, Fac Enfermeria, Monterrey, Nuevo Leon, Mexico; [Gallardo-Blanco, Hugo L.] Univ Autonoma Nuevo Leon, Fac Med, Dept Genet, Monterrey, Nuevo Leon, Mexico; [Rojas-Martinez, Augusto; Ortiz-Lopez, Rocio] Univ Autonoma Nuevo Leon, Ctr Invest & Desarrollo Ciencias Salud, Monterrey, Nuevo Leon, Mexico	Universidad Autonoma de Nuevo Leon; Instituto Politecnico Nacional - Mexico; Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon	Ortiz-Lopez, R (corresponding author), Univ Autonoma Nuevo Leon, Fac Med, Dept Bioquim & Med Mol, Monterrey, Nuevo Leon, Mexico.	rortizlopez@gmail.com	Ortiz-Lopez, Rocio/F-7020-2014; ROJAS-MARTINEZ, AUGUSTO/Z-3585-2019; ROJAS-MARTINEZ, AUGUSTO/D-1710-2011; Gallardo Blanco, Hugo Leonid/GLU-6868-2022; Ortiz-Lopez, Rocio/N-4827-2018; Sanchez-Dominguez, Celia Nohemi/AAJ-8561-2020; Bustamante, Adriana Ester/AAR-2816-2021; Blanco, Hugo L Gallardo/L-4326-2013; Reyes-Lopez, Miguel Angel/D-9308-2011	Ortiz-Lopez, Rocio/0000-0002-7783-026X; ROJAS-MARTINEZ, AUGUSTO/0000-0003-3765-6778; Ortiz-Lopez, Rocio/0000-0002-7783-026X; Sanchez-Dominguez, Celia Nohemi/0000-0002-3444-9565; Bustamante, Adriana Ester/0000-0002-8245-6671; Blanco, Hugo L Gallardo/0000-0002-7816-4967; Reyes-Lopez, Miguel Angel/0000-0001-9939-3032; Barrera Saldana, Hugo A./0000-0003-1587-4571	Consejo Nacional de Ciencia y Tecnologia CONACyT [62291, 48497]; UANL's PAICyT [1648-07]; Fondo Mixto de Fomento a la Investigacion Cientifica y Tecnologica CONACYT - Gobierno del Estado de Tamaulipas [73578]; SIP-IPN [20080682]; CONACyT; PIFI-IPN; Universia Santander for CNSD	Consejo Nacional de Ciencia y Tecnologia CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UANL's PAICyT; Fondo Mixto de Fomento a la Investigacion Cientifica y Tecnologica CONACYT - Gobierno del Estado de Tamaulipas; SIP-IPN; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PIFI-IPN; Universia Santander for CNSD	This work was supported by grants from the Consejo Nacional de Ciencia y Tecnologia CONACyT (62291 and 48497) and UANL's PAICyT (1648-07) for ROL, Fondo Mixto de Fomento a la Investigacion Cientifica y Tecnologica CONACYT - Gobierno del Estado de Tamaulipas (73578) and SIP-IPN (20080682) for MARL. The authors gratefully acknowledge scholarships from CONACyT, PIFI-IPN and Universia Santander for CNSD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alino-Pellicer SF, 2003, FEDERACION ESPANOLA; Alonso MJ, 2007, ANN HUM GENET, V71, P194, DOI 10.1111/j.1469-1809.2006.00310.x; Arinir U, 2005, ELECTROPHORESIS, V26, P2888, DOI 10.1002/elps.200500095; Buranawuti K, 2007, J MED GENET, V44, P209, DOI 10.1136/jmg.2006.046318; Castro-Giner F, 2009, EUR RESPIR J, V33, P1003, DOI 10.1183/09031936.00140608; Chavez-Saldana M, 2010, REV INVEST CLIN, V62, P546; Chen YP, 2006, CHINESE MED J-PEKING, V119, P719, DOI 10.1097/00029330-200605010-00003; Collaco JM, 2008, CURR OPIN PULM MED, V14, P559, DOI 10.1097/MCP.0b013e3283121cdc; Correa PA, 2005, J RHEUMATOL, V32, P219; Correa Paula A, 2004, Biomed., V24, P43; Cowan MJ, 2000, ANN NY ACAD SCI, V923, P193; Davies JC, 2004, EUR RESPIR J, V24, P798, DOI 10.1183/09031936.04.00055404; de Araujo FG, 2005, BRAZ J MED BIOL RES, V38, P11, DOI 10.1590/S0100-879X2005000100003; Eisen DP, 2010, J INNATE IMMUN, V2, P114, DOI 10.1159/000228159; Frangolias DD, 2003, AM J RESP CELL MOL, V29, P390, DOI 10.1165/rcmb.2002-0271OC; Gambari R, 2012, INT IMMUNOPHARMACOL, V13, P308, DOI 10.1016/j.intimp.2012.04.010; Garred P, 2006, GENES IMMUN, V7, P85, DOI 10.1038/sj.gene.6364283; Garred P, 2002, PEDIATR PULM, V33, P201, DOI 10.1002/ppul.10064; Flores-Ramos LG, 2013, GENET MOL RES, V12, P5680, DOI 10.4238/2013.November.18.17; GREBE TA, 1994, AM J HUM GENET, V54, P443; Haerynck F, 2012, HUM IMMUNOL, V73, P1175, DOI 10.1016/j.humimm.2012.08.010; Hajeer AH, 2000, MICROSC RES TECHNIQ, V50, P216, DOI 10.1002/1097-0029(20000801)50:3<216::AID-JEMT5>3.0.CO;2-Q; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; Heinzmann A, 2004, J ALLERGY CLIN IMMUN, V114, P671, DOI 10.1016/j.jaci.2004.06.038; Hillian AD, 2008, GENES IMMUN, V9, P501, DOI 10.1038/gene.2008.42; Hull J, 2000, THORAX, V55, P1023, DOI 10.1136/thorax.55.12.1023; Hull J, 1998, THORAX, V53, P1018, DOI 10.1136/thx.53.12.1018; Jimenez-Morales S, 2009, HUM IMMUNOL, V70, P251, DOI 10.1016/j.humimm.2009.01.027; Kilpatrick DC, 2003, BIOCHEM SOC T, V31, P745, DOI 10.1042/BST0310745; Kim J, 2007, CURR ALLERGY ASTHM R, V7, P151, DOI 10.1007/s11882-007-0013-3; Kok KF, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-22; Lee WP, 2005, CLIN CANCER RES, V11, P6431, DOI 10.1158/1078-0432.CCR-05-0942; Lora JM, 2005, J BIOL CHEM, V280, P36510, DOI 10.1074/jbc.M507977200; Madsen HO, 1998, J IMMUNOL, V161, P3169; Mahadeva R, 1998, THORAX, V53, P1022, DOI 10.1136/thx.53.12.1022; Mahadeva R, 1998, EUR RESPIR J, V11, P873, DOI 10.1183/09031936.98.11040873; Meyer P, 2002, CLIN GENET, V62, P325, DOI 10.1034/j.1399-0004.2002.620413.x; Miravitlles M, 2003, CHEST, V124, P404, DOI 10.1378/chest.124.1.404; Mizunoe S, 2012, J PHARMACOL SCI, V118, P512, DOI 10.1254/jphs.11240FP; Muhlebach MS, 2006, CLIN EXP IMMUNOL, V145, P302, DOI 10.1111/j.1365-2249.2006.03151.x; Nagy A, 2003, J ALLERGY CLIN IMMUN, V112, P729, DOI 10.1016/S0091-6749(03)02010-4; Sanchez-Dominguez CN, 2008, ALLERGY ASTHMA PROC, V29, P406, DOI 10.2500/aap.2008.29.3125; Orozco L, 2000, HUM GENET, V106, P360, DOI 10.1007/s004390051051; Parra-Rojas I, 2006, HEREDITAS, V143, P167, DOI 10.1111/j.2006.0018-0661.01936.x; Puthothu Beena, 2006, Clin Mol Allergy, V4, P2; Rodriguez-Carreon AA, 2005, J AUTOIMMUN, V24, P63, DOI 10.1016/j.jaut.2004.11.002; Rowntree RK, 2003, ANN HUM GENET, V67, P471, DOI 10.1046/j.1469-1809.2003.00028.x; Sandford AJ, 1999, AM J RESP CRIT CARE, V159, P1624, DOI 10.1164/ajrccm.159.5.9711004; Schrijver I, 2005, J MOL DIAGN, V7, P289, DOI 10.1016/S1525-1578(10)60557-0; Shmarina G, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-19; Sugarman EA, 2004, GENET MED, V6, P392, DOI 10.1097/01.GIM.0000139503.22088.66; Summerfield JA, 2003, BIOCHEM SOC T, V31, P770, DOI 10.1042/bst0310770; Tin SK, 2005, J IMMUNOL METHODS, V303, P148, DOI 10.1016/j.jim.2005.06.001; Turner MW, 1996, IMMUNOL TODAY, V17, P532, DOI 10.1016/0167-5699(96)10062-1; Uguz A, 2005, PEDIAT ALLERG IMM-UK, V16, P231, DOI 10.1111/j.1399-3038.2005.00258.x; Vargas-Alarcon G, 2006, HUM IMMUNOL, V67, P826, DOI 10.1016/j.humimm.2006.07.009; Vargas-Alarcon G, 2012, GENET TEST MOL BIOMA, V16, P1246, DOI 10.1089/gtmb.2012.0100; Velazquez A, 2000, REV MEX PEDIAT, V67, P206; VillalobosTorres C, 1997, AM J MED GENET, V69, P380; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; Wu H, 2007, ENVIRON HEALTH PERSP, V115, P616, DOI 10.1289/ehp.9740; Yarden J, 2004, J MED GENET, V41, P629, DOI 10.1136/jmg.2003.017947	62	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90945	10.1371/journal.pone.0090945	http://dx.doi.org/10.1371/journal.pone.0090945			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603877	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000332483600113
J	Torring, PM; Larsen, MJ; Kjeldsen, AD; Ousager, LB; Tan, QH; Brusgaard, K				Torring, Pernille M.; Larsen, Martin Jakob; Kjeldsen, Anette D.; Ousager, Lilian Bomme; Tan, Qihua; Brusgaard, Klaus			Long Non-Coding RNA Expression Profiles in Hereditary Haemorrhagic Telangiectasia	PLOS ONE			English	Article							PREVALENCE; MUTATIONS; ENDOGLIN	Hereditary Haemorrhagic Telangiectasia (HHT) is an autosomal dominantly inherited vascular disease characterized by the presence of mucocutaneous telangiectasia and arteriovenous malformations in visceral organs. HHT is predominantly caused by mutations in ENG and ACVRL1, which both belong to the TGF-beta signalling pathway. The exact mechanism of how haploinsufficiency of ENG and ACVRL1 leads to HHT manifestations remains to be identified. As long non-coding RNAs (lncRNAs) are increasingly recognized as key regulators of gene expression and constitute a sizable fraction of the human transcriptome, we wanted to assess whether lncRNAs play a role in the molecular pathogenesis of HHT manifestations. By microarray technology, we profiled lncRNA transcripts from HHT nasal telangiectasial and non-telangiectasial tissue using a paired design. The microarray probes were annotated using the GENCODE v. 16 dataset, identifying 4,810 probes mapping to 2,811 lncRNAs. Comparing HHT telangiectasial tissue with HHT non-telangiectasial tissue, we identified 42 lncRNAs that are differentially expressed (q<0.001). Using GREAT, a tool that assumes cis-regulation, we showed that differently expressed lncRNAs are enriched for genomic loci involved in key pathways concerning HHT. Our study identified lncRNAs that are aberrantly expressed in HHT telangiectasia and indicates that lncRNAs may contribute to regulate protein-coding loci in HHT. These results suggest that the lncRNA component of the transcriptome deserves more attention in HHT. A deeper understanding of lncRNAs and their role in telangiectasia formation possesses potential for discovering therapeutic targets in HHT.	[Torring, Pernille M.; Larsen, Martin Jakob; Ousager, Lilian Bomme; Tan, Qihua; Brusgaard, Klaus] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Kjeldsen, Anette D.] Odense Univ Hosp, Dept Otorhinolaryngol, DK-5000 Odense, Denmark; [Torring, Pernille M.; Larsen, Martin Jakob; Kjeldsen, Anette D.; Ousager, Lilian Bomme; Brusgaard, Klaus] Univ Southern Denmark, Inst Clin Res, Odense, Denmark; [Tan, Qihua] Univ Southern Denmark, Inst Publ Hlth, Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark	Torring, PM (corresponding author), Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark.	pernille.toerring@rsyd.dk	Ousager, Lilian Bomme/F-7119-2015; Tan, Qihua/F-1349-2015; Tan, Qihua/AAG-2582-2019; Larsen, Martin Jakob/L-5794-2019; Brusgaard, Klaus/AGE-8988-2022	Tan, Qihua/0000-0003-3194-0030; Tan, Qihua/0000-0003-3194-0030; Ousager, Lilian Bomme/0000-0001-9936-2201; Brusgaard, Klaus/0000-0002-2096-4988; Larsen, Martin Jakob/0000-0003-4107-8771; Kjeldsen, Anette Drohse/0000-0003-0593-6302	Region of Southern Denmark, Overlaegeradets (OUH); Hans Skouby Fond; Torben og Alice Frimodts Fond; Fonden til laegevidenskabens fremme; Tomrermester Alfred Andersen og Hustrus Fond; AJ Andersen og Hustrus Fond; Aase og Ejnar Danielsens Fond; Syddansk Universitets Forskningsfond	Region of Southern Denmark, Overlaegeradets (OUH); Hans Skouby Fond; Torben og Alice Frimodts Fond; Fonden til laegevidenskabens fremme; Tomrermester Alfred Andersen og Hustrus Fond; AJ Andersen og Hustrus Fond; Aase og Ejnar Danielsens Fond; Syddansk Universitets Forskningsfond	This work was supported by the Region of Southern Denmark, Overlaegeradets (OUH), Hans Skouby Fond, Torben og Alice Frimodts Fond, Fonden til laegevidenskabens fremme, Tomrermester Alfred Andersen og Hustrus Fond, AJ Andersen og Hustrus Fond, Aase og Ejnar Danielsens Fond and Syddansk Universitets Forskningsfond. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Attisano L, 2000, CURR OPIN CELL BIOL, V12, P235, DOI 10.1016/S0955-0674(99)00081-2; Brusgaard K, 2004, CLIN GENET, V66, P556, DOI 10.1111/j.1399-0004.2004.00341.x; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Eerola I, 2003, AM J HUM GENET, V73, P1240, DOI 10.1086/379793; Faughnan ME, 2011, J MED GENET, V48, P73, DOI 10.1136/jmg.2009.069013; Fernandez-Lopez A, 2007, HUM MOL GENET, V16, P1515, DOI 10.1093/hmg/ddm069; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Kjeldsen AD, 2014, ACTA NEUROL SCAND, V129, P192, DOI 10.1111/ane.12167; Kjeldsen AD, 2000, J INTERN MED, V248, P255, DOI 10.1046/j.1365-2796.2000.00725.x; Kjeldsen AD, 1999, J INTERN MED, V245, P31, DOI 10.1046/j.1365-2796.1999.00398.x; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lesca G, 2004, HUM MUTAT, V23, P289, DOI 10.1002/humu.20017; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Ponting CP, 2010, HUM MOL GENET, V19, pR162, DOI 10.1093/hmg/ddq362; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Schulte Claudia, 2005, Hum Mutat, V25, P595, DOI 10.1002/humu.9345; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; Thomas B, 2007, EUR J CLIN INVEST, V37, P580, DOI 10.1111/j.1365-2362.2007.01824.x; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Torring PM, 2014, CLIN GENET, V86, P123, DOI 10.1111/cge.12269	23	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90272	10.1371/journal.pone.0090272	http://dx.doi.org/10.1371/journal.pone.0090272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603890	Green Submitted, gold, Green Published			2022-12-25	WOS:000332483600037
J	Guzzetta, G; Faustini, L; Panatto, D; Gasparini, R; Manfredi, P				Guzzetta, Giorgio; Faustini, Luca; Panatto, Donatella; Gasparini, Roberto; Manfredi, Piero			The Impact of HPV Female Immunization in Italy: Model Based Predictions	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; CERVICAL-CANCER; PARTICLE VACCINE; NATURAL-HISTORY; SEXUAL-ACTIVITY; PREVALENCE; RISK; EPIDEMIOLOGY; TRANSMISSION; POPULATION	The Human Papillomavirus (HPV) is a sexually transmitted virus that causes cervical cancer. Since 2008 a vaccination program targeting 12-year-old girls has been initiated in Italy, backing up the cervical screening program already active since 1996. We propose a mathematical model of HPV transmission dynamics with the aim of evaluating the impact of these prevention strategies. The model considers heterosexual transmission of HPV types 16 and 18, structured by sex, age and sexual activity level, where transition to sexual activity is explicitly modeled from recent survey data. The epidemiological structure is a hybrid SIS/SIR, where a fraction of individuals recovering from infection develops permanent immunity against reinfection. Infections may progress to cervical lesions and cancer and heal spontaneously or upon treatment. Women undergoing hysterectomy (either after treatment of HPV lesions or by other causes) also transmit HPV infection. The model fits well both the age-specific prevalence of HPV infections and the incidence of cervical cancers in Italy, and accurately reproduces the decreasing trend in cancer incidence due to the introduction of the screening program. The model predicts that if the screening coverage is maintained at current levels, even in the absence of vaccination, such trend will continue in the next few decades, eventually plateauing at 25% below the current level. The additional initiation of routine vaccination targeting 12-year-old girls will further reduce cervical cancer incidence by two thirds at equilibrium, under realistic assumptions of 70% coverage and a duration of protective immunity of 50 years. If catch-up immunization of 25-year-old women at first cervical screening is also introduced, about 3,000 cervical cancer cases overall can be averted, corresponding to 9.6% of all cases expected in the scenario without catch-up. We conclude that HPV vaccination in addition to cervical screening will significantly reduce the burden of cervical cancer in Italy.	[Guzzetta, Giorgio] Trento Rise, Trento, Italy; [Guzzetta, Giorgio] Fdn Bruno Kessler, Trento, Italy; [Faustini, Luca] Istat Toscana, Florence, Italy; [Panatto, Donatella; Gasparini, Roberto] Univ Genoa, Dipartimento Sci Salute, Genoa, Italy; [Manfredi, Piero] Univ Pisa, Dipartimento Econ Management, Pisa, Italy	Fondazione Bruno Kessler; University of Genoa; University of Pisa	Guzzetta, G (corresponding author), Trento Rise, Trento, Italy.	g.guzzetta@trentorise.eu	Bragazzi, Nicola Luigi/G-1672-2011	Bragazzi, Nicola Luigi/0000-0001-8409-868X; Guzzetta, Giorgio/0000-0002-9296-9470; Panatto, Donatella/0000-0002-2677-0551; Gasparini, Roberto/0000-0002-1012-6913	Italian Ministry of Research [2009ZPM4X4]	Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR))	The study was funded by the Italian Ministry of Research under project grant 2009ZPM4X4 titled "I vaccini tra nuove tecnologie e nuove applicazioni. Valutazione dell'impatto dei vaccini recentemente introdotti nei piani di prevenzione regionali e prospettive future.'', awarded to RG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accetta G, 2010, J MED SCREEN, V00, P1; AIRTUM (Italian Association of Cancer Registries), IT PROJ; Barnabas RV, 2006, PLOS MED, V3, P624, DOI 10.1371/journal.pmed.0030138; Baussano I, 2011, VACCINE, V29, P1270, DOI 10.1016/j.vaccine.2010.11.082; Baussano I, 2010, EPIDEMICS-NETH, V2, P21, DOI 10.1016/j.epidem.2010.02.002; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Burchell AN, 2006, VACCINE, V24, P52, DOI 10.1016/j.vaccine.2006.05.031; Capri S, 2011, GYNECOL ONCOL, V121, P514, DOI 10.1016/j.ygyno.2011.01.029; Carozzi FM, 2010, CANCER EPIDEM BIOMAR, V19, P2389, DOI 10.1158/1055-9965.EPI-10-0131; Castellsague X, 2008, GYNECOL ONCOL, V110, pS4, DOI 10.1016/j.ygyno.2008.07.045; Castle PE, 2004, J INFECT DIS, V190, P458, DOI 10.1086/421916; Choi YH, 2010, VACCINE, V28, P4091, DOI 10.1016/j.vaccine.2009.09.125; Dalla Zuanna G, 2010, COMPORTAMENTO SESSUA; David MP, 2009, GYNECOL ONCOL, V115, pS1, DOI 10.1016/j.ygyno.2009.01.011; Dona MG, 2012, J CLIN VIROL, V54, P185, DOI 10.1016/j.jcv.2012.02.014; Durham DP, 2012, J INFECT DIS, V206, P1291, DOI 10.1093/infdis/jis494; Elbasha EH, 2008, B MATH BIOL, V70, P2126, DOI 10.1007/s11538-008-9338-x; Fraser C, 2007, VACCINE, V25, P4324, DOI 10.1016/j.vaccine.2007.02.069; GARNETT GP, 1993, PHILOS T R SOC B, V342, P137, DOI 10.1098/rstb.1993.0143; Giambi C., 2012, STATO AVANZAMENTO CA; Giambi C, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-74; Gravitt PE, 2011, J CLIN INVEST, V121, P4593, DOI 10.1172/JCI57149; Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485; Harper DM, 2009, EXPERT REV VACCINES, V8, P1663, DOI [10.1586/erv.09.123, 10.1586/ERV.09.123]; HERNES G, 1972, AM SOCIOL REV, V37, P173, DOI 10.2307/2094025; Hethcote H., 1996, MODELING HETEROGENEO; Hildesheim A, 2007, JAMA-J AM MED ASSOC, V298, P743, DOI 10.1001/jama.298.7.743; Ho GYF, 2002, J INFECT DIS, V186, P737, DOI 10.1086/342972; International Agency for Research on Cancer, 2011, IARC MON EV CARC R B, V100B, P261; JACQUEZ JA, 1988, MATH BIOSCI, V92, P119, DOI 10.1016/0025-5564(88)90031-4; Kjellgren O, 1995, ACTA ONCOL, V34, P1017, DOI 10.3109/02841869509127228; Koulova A, 2008, VACCINE, V26, P6529, DOI 10.1016/j.vaccine.2008.08.067; La Torre G, 2010, VACCINE, V28, P3379, DOI 10.1016/j.vaccine.2010.02.080; Longworth MS, 2004, MICROBIOL MOL BIOL R, V68, P362, DOI 10.1128/MMBR.68.2.362-372.2004; LYNGE E, 1989, WORLD J SURG, V13, P71, DOI 10.1007/BF01671157; Malik ZA, 2009, VIRAL IMMUNOL, V22, P445, DOI 10.1089/vim.2009.0055; Mariani L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-259; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Marra F, 2009, PHARMACOECONOMICS, V27, P127, DOI 10.2165/00019053-200927020-00004; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Materia E, 2002, J EPIDEMIOL COMMUN H, V56, P461, DOI 10.1136/jech.56.6.461; Mennini FS, 2009, GYNECOL ONCOL, V112, P370, DOI 10.1016/j.ygyno.2008.09.031; Moscicki AB, 2006, VACCINE, V24, P42, DOI 10.1016/j.vaccine.2006.06.018; National Observatory on Screening, YEARL REP; Panatto D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-623; Park H, 1998, STAT PROBABIL LETT, V40, P227, DOI 10.1016/S0167-7152(98)00088-1; Raybould R, 2011, OPEN CLIN CANC J, V5, P1; Rodriguez AC, 2008, JNCI-J NATL CANCER I, V100, P513, DOI 10.1093/jnci/djn044; Ronco G, 2008, J NATL CANCER I, V100, P492, DOI 10.1093/jnci/djn065; Rossi PG, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-26; Rossi PG, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-214; Rowhani-Rahbar A, 2012, J CLIN VIROL, V53, P239, DOI 10.1016/j.jcv.2011.12.009; Safaeian M, 2010, JNCI-J NATL CANCER I, V102, P1653, DOI 10.1093/jnci/djq384; Schiller JT, 2012, VACCINE, V30, pF123, DOI 10.1016/j.vaccine.2012.04.108; Smith JS, 2008, J ADOLESCENT HEALTH, V43, pS5, DOI 10.1016/j.jadohealth.2008.07.009; Stang A, 2013, EUR J PUBLIC HEALTH, V23, P879, DOI 10.1093/eurpub/cks080; Stanley M, 2010, GYNECOL ONCOL, V117, pS5, DOI [10.1016/j.ygyno.2010.01.024, 10.1016/j.ygyno.2010.04.002]; Trottier H, 2010, CANCER RES, V70, P8569, DOI 10.1158/0008-5472.CAN-10-0621; Vaccarella S, 2013, EUR J CANCER, V49, P3262, DOI 10.1016/j.ejca.2013.04.024; Van de Velde N, 2012, JNCI-J NATL CANCER I, V104, P1712, DOI 10.1093/jnci/djs395; Van de Velde N, 2010, VACCINE, V28, P5473, DOI 10.1016/j.vaccine.2010.05.056; Villa LL, 2006, BRIT J CANCER, V95, P1459, DOI 10.1038/sj.bjc.6603469; Viscidi RP, 2004, CANCER EPIDEM BIOMAR, V13, P324, DOI 10.1158/1055-9965.EPI-03-0166	63	8	8	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91698	10.1371/journal.pone.0091698	http://dx.doi.org/10.1371/journal.pone.0091698			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618824	Green Submitted, Green Published, gold			2022-12-25	WOS:000332842400122
J	Montalvo, NF; Davis, J; Vicente, J; Pittiglio, R; Ravel, J; Hill, RT				Montalvo, Naomi F.; Davis, Jeanette; Vicente, Jan; Pittiglio, Raquel; Ravel, Jacques; Hill, Russell T.			Integration of Culture-Based and Molecular Analysis of a Complex Sponge-Associated Bacterial Community	PLOS ONE			English	Article							MARINE SPONGES; MICROTHRIX-PARVICELLA; MICROMONOSPORA SP; SEQUENCE DATA; DIVERSITY; PCR; MICROORGANISMS; SYMBIONTS; GENES; SOIL	The bacterial communities of sponges have been studied using molecular techniques as well as culture-based techniques, but the communities described by these two methods are remarkably distinct. Culture-based methods describe communities dominated by Proteobacteria, and Actinomycetes while molecular methods describe communities dominated by predominantly uncultivated groups such as the Chloroflexi, Acidobacteria, and Acidimicrobidae. In this study, we used a wide range of culture media to increase the diversity of cultivable bacteria from the closely related giant barrel sponges, Xestospongia muta collected from the Florida Keys, Atlantic Ocean and Xestospongia testudinaria, collected from Indonesia, Pacific Ocean. Over 400 pure cultures were isolated and identified from X. muta and X. testudinaria and over 90 bacterial species were represented. Over 16,000 pyrosequences were analyzed and assigned to 976 OTUs. We employed both cultured-based methods and pyrosequencing to look for patterns of overlap between the culturable and molecular communities. Only one OTU was found in both the molecular and culturable communities, revealing limitations inherent in both approaches.	[Montalvo, Naomi F.; Davis, Jeanette; Vicente, Jan; Pittiglio, Raquel; Hill, Russell T.] Univ Maryland, Inst Marine & Environm Technol, Ctr Environm Sci, Baltimore, MD 21201 USA; [Ravel, Jacques] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology; University System of Maryland; University of Maryland Baltimore	Hill, RT (corresponding author), Univ Maryland, Inst Marine & Environm Technol, Ctr Environm Sci, Baltimore, MD 21201 USA.	hill@umces.edu	Ravel, Jacques/D-2530-2009; Hill, Russell/AAF-4190-2019	Hill, Russell/0000-0002-9832-1851; Ravel, Jacques/0000-0002-0851-2233	National Science Foundation Microbial Observatories Program [MCB-0238515]; Microbial Interactions and Processes Program [MCB-0703467]; BIO/IOS Program [IOS-0919728]; ASM Robert D. Watkins Fellowship Program; NOAA Living Marine Resources Cooperative Science Center (LMRCSC) (NOAA Award) [NA11SEC4810002]	National Science Foundation Microbial Observatories Program(National Science Foundation (NSF)); Microbial Interactions and Processes Program; BIO/IOS Program; ASM Robert D. Watkins Fellowship Program; NOAA Living Marine Resources Cooperative Science Center (LMRCSC) (NOAA Award)	This study was supported by grants from the National Science Foundation Microbial Observatories Program (MCB-0238515), the Microbial Interactions and Processes Program (MCB-0703467) and BIO/IOS Program (IOS-0919728). NM was supported by the ASM Robert D. Watkins Fellowship Program. NM, JD and JV were supported by the NOAA Living Marine Resources Cooperative Science Center (LMRCSC) (NOAA Award No. NA11SEC4810002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourne D, 2008, ISME J, V2, P350, DOI 10.1038/ismej.2007.112; Cassler M, 2008, MICROB ECOL, V55, P384, DOI 10.1007/s00248-007-9283-5; Devi P, 2010, MAR DRUGS, V8, P1203, DOI 10.3390/md8041203; Enticknap JJ, 2006, APPL ENVIRON MICROB, V72, P3724, DOI 10.1128/AEM.72.5.3724-3732.2006; Esteves AIS, 2013, FEMS MICROBIOL ECOL, V85, P519, DOI 10.1111/1574-6941.12140; GIOVANNONI SJ, 2000, MICROBIAL ECOLOGY OC, P47; GRIMES DJ, 1986, MICROBIOL SCI, V3, P324; Gurgui C, 2010, METHODS MOL BIOL, V668, P247, DOI 10.1007/978-1-60761-823-2_17; Gutierrez-Lugo MT, 2005, NAT PROD RES, V19, P645, DOI 10.1080/14786410412331272040; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Hansson L, 2009, MAR ECOL PROG SER, V397, P89, DOI 10.3354/meps08429; Hoffmann F, 2009, ENVIRON MICROBIOL, V11, P2228, DOI 10.1111/j.1462-2920.2009.01944.x; Hoffmann M, 2010, ISME J, V4, P1608, DOI 10.1038/ismej.2010.85; Janssen PH, 1997, APPL ENVIRON MICROB, V63, P1382, DOI 10.1128/AEM.63.4.1382-1388.1997; KOCIANOVA E, 1994, J APPL BACTERIOL, V76, P301, DOI 10.1111/j.1365-2672.1994.tb01632.x; Lafi FF, 2005, MICROB ECOL, V50, P213, DOI 10.1007/s00248-004-0202-8; Lee OO, 2011, ISME J, V5, P650, DOI 10.1038/ismej.2010.165; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Lui M, 2012, ISME J, V6, P1515; Mohamed NM, 2008, ENVIRON MICROBIOL, V10, P2910, DOI 10.1111/j.1462-2920.2008.01704.x; Mohamed NM, 2008, ENVIRON MICROBIOL, V10, P75, DOI 10.1111/j.1462-2920.2007.01431.x; Mohamed NM, 2010, ISME J, V4, P38, DOI 10.1038/ismej.2009.84; Montalvo NF, 2011, APPL ENVIRON MICROB, V77, P7207, DOI 10.1128/AEM.05285-11; Montalvo NF, 2005, ANTON LEEUW INT J G, V87, P29, DOI 10.1007/s10482-004-6536-x; Piel J, 2009, NAT PROD REP, V26, P338, DOI 10.1039/b703499g; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Raina JB, 2009, APPL ENVIRON MICROB, V75, P3492, DOI 10.1128/AEM.02567-08; RAVEL J, 2010, P NATL ACAD SCI US; REASONER DJ, 1985, APPL ENVIRON MICROB, V49, P1; Sait M, 2002, ENVIRON MICROBIOL, V4, P654, DOI 10.1046/j.1462-2920.2002.00352.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Sfanos K, 2005, SYST APPL MICROBIOL, V28, P242, DOI 10.1016/j.syapm.2004.12.002; Shade A, 2012, ENVIRON MICROBIOL, V14, P2247, DOI 10.1111/j.1462-2920.2012.02817.x; Siegl A, 2011, ISME J, V5, P61, DOI 10.1038/ismej.2010.95; Simpson TL, 1984, CELL BIOL SPONGES, P662; Sipkema D, 2011, APPL ENVIRON MICROB, V77, P2130, DOI 10.1128/AEM.01203-10; Sipos R, 2007, FEMS MICROBIOL ECOL, V60, P341, DOI 10.1111/j.1574-6941.2007.00283.x; SLIJKHUIS H, 1983, APPL ENVIRON MICROB, V46, P832, DOI 10.1128/AEM.46.4.832-839.1983; Sousa TD, 2012, J NAT PROD, V75, P489, DOI 10.1021/np200795p; STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Taylor MW, 2011, MAR BIOTECHNOL, V13, P1057, DOI 10.1007/s10126-011-9397-0; Thiel V, 2007, MICROB ECOL, V54, P101, DOI 10.1007/s00248-006-9177-y; Thomas T, 2010, ISME J, V4, P1557, DOI 10.1038/ismej.2010.74; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Webster NS, 2001, MAR BIOL, V138, P843, DOI 10.1007/s002270000503; White JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038204; Wicke C, 2000, J NAT PROD, V63, P621, DOI 10.1021/np990313b; WILKINSON CR, 1981, MICROBIAL ECOL, V7, P13, DOI 10.1007/BF02010474; Zan JD, 2012, MOL MICROBIOL, V85, P916, DOI 10.1111/j.1365-2958.2012.08149.x; Zan JD, 2011, ISME J, V5, P1505, DOI 10.1038/ismej.2011.31	54	40	40	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90517	10.1371/journal.pone.0090517	http://dx.doi.org/10.1371/journal.pone.0090517			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618773	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400020
J	Parikh, I; Fardo, DW; Estus, S				Parikh, Ishita; Fardo, David W.; Estus, Steven			Genetics of PICALM Expression and Alzheimer's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; IDENTIFIES VARIANTS; COMMON VARIANTS; CLATHRIN; PROTEIN; CD33; CLU; CD2AP; EPHA1; CALM	Novel Alzheimer's disease (AD) risk factors have been identified by genome-wide association studies. Elucidating the mechanism underlying these factors is critical to the validation process and, by identifying rate-limiting steps in AD risk, may yield novel therapeutic targets. Here, we evaluated the association between the AD-associated polymorphism rs3851179 near PICALM, which encodes a clathrin-coated pit accessory protein. Immunostaining established that PICALM is expressed predominately in microvessels in human brain. Consistent with this finding, PICALM mRNA expression correlated with expression of the endothelial genes vWF and CD31. Additionally, we found that PICALM expression was modestly increased with the rs3851179A AD-protective allele. Analysis of PICALM isoforms found several isoforms lacking exons encoding elements previously identified as critical to PICALM function. Increased expression of the common isoform lacking exon 13 was also associated with the rs3851179A protective allele; this association was not apparent when this isoform was compared with total PICALM expression, indicating that the SNP is associated with total PICALM expression and not this isoform per se. Interestingly, PICALM lacking exons 2-4 was not associated with rs3851179 but was associated with rs592297, which is located in exon 5. Thus, our primary findings are that multiple PICALM isoforms are expressed in the human brain, that PICALM is robustly expressed in microvessels, and that expression of total PICALM is modestly correlated with the AD-associated SNP rs3851179. We interpret these results as suggesting that increased PICALM expression in the microvasculature may reduce AD risk.	[Parikh, Ishita; Estus, Steven] Univ Kentucky, Dept Physiol, Sanders Brown Ctr Aging, Lexington, KY 40506 USA; [Fardo, David W.] Univ Kentucky, Sanders Brown Ctr Aging, Dept Biostat, Lexington, KY USA	University of Kentucky; University of Kentucky	Estus, S (corresponding author), Univ Kentucky, Dept Physiol, Sanders Brown Ctr Aging, Lexington, KY 40506 USA.	steve.estus@uky.edu		Parikh, Ishita/0000-0001-9335-733X; Fardo, David/0000-0002-7207-4696	National Institute on Aging [P01-AG030128, K25-AG043546]; NATIONAL INSTITUTE ON AGING [P01AG030128, R01AG045775, K25AG043546, P30AG028383] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors acknowledge the National Institute on Aging for funding (P01-AG030128 (Estus) and K25-AG043546 (Fardo)), the University of Kentucky Alzheimer's Center for tissue (P30-AG028383) and James Simpson for technical assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M, 2012, NEUROLOGY, V79, P221, DOI 10.1212/WNL.0b013e3182605801; Ando K, 2013, ACTA NEUROPATHOL, V125, P861, DOI 10.1007/s00401-013-1111-z; Avramopoulos D, 2009, GENOME MED, V1, DOI 10.1186/gm34; Baig S, 2010, J NEUROPATH EXP NEUR, V69, P1071, DOI 10.1097/NEN.0b013e3181f52e01; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Harel A, 2011, NEUROMOL MED, V13, P88, DOI 10.1007/s12017-010-8142-6; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Jackson DE, 2003, FEBS LETT, V540, P7, DOI 10.1016/S0014-5793(03)00224-2; Jun G, 2010, ARCH NEUROL-CHICAGO, V67, P1473, DOI 10.1001/archneurol.2010.201; Karch CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050976; Lambert JC, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.11.022; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Ling IF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033923; Malik M, 2013, J NEUROSCI, V33, P13320, DOI 10.1523/JNEUROSCI.1224-13.2013; Meyerholz A, 2005, TRAFFIC, V6, P1225, DOI 10.1111/j.1600-0854.2005.00355.x; Morgan K, 2011, NEUROPATH APPL NEURO, V37, P353, DOI 10.1111/j.1365-2990.2011.01181.x; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Ramanan V, 2011, INTEGR BIOL-UK, V3, P803, DOI 10.1039/c1ib00036e; Rosenbloom KR, 2012, NUCL ACIDS RES; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Sagare AP, 2012, COLD SPRING HARB PER, V2; Schnetz-Boutaud NC, 2012, ANN HUM GENET, V76, P448, DOI 10.1111/j.1469-1809.2012.00727.x; Scotland PB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044252; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; Xiao QL, 2012, J BIOL CHEM, V287, P21279, DOI 10.1074/jbc.M111.338376	31	48	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91242	10.1371/journal.pone.0091242	http://dx.doi.org/10.1371/journal.pone.0091242			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618820	gold, Green Published, Green Submitted			2022-12-25	WOS:000332842400063
J	Shimizu, E; Glaspy, K; Witt, MD; Poon, K; Black, S; Schwartz, S; Bholat, T; Diaz, N; Kuo, A; Spellberg, B				Shimizu, Eri; Glaspy, Kathleen; Witt, Mallory D.; Poon, Kimble; Black, Susan; Schwartz, Shelley; Bholat, Tasneem; Diaz, Norma; Kuo, Allen; Spellberg, Brad			Readmissions at a Public Safety Net Hospital	PLOS ONE			English	Article							POTENTIALLY PREVENTABLE READMISSIONS; HEALTH LITERACY; MEDICARE BENEFICIARIES; INPATIENT CARE; DISCHARGE; QUALITY; PROGRAM; REHOSPITALIZATION; ASSOCIATION; EVENTS	Objective: We aimed to determine factors related to avoidability of 30-day readmissions at our public, safety net hospital in the United States (US). Methods: We prospectively reviewed medical records of adult internal medicine patients with scheduled and unscheduled 30-day readmissions. We also interviewed patients if they were available. An independent panel used pre-specified, objective criteria to adjudicate potential avoidability. Results: Of 153 readmissions evaluated, 68% were unscheduled. Among these, 67% were unavoidable, primarily due to disease progression and development of new diagnoses. Scheduled readmissions accounted for 32% of readmissions and most (69%) were clinically appropriate and unavoidable. The scheduled but avoidable readmissions (31%) were attributed largely to limited resources in our healthcare system. Conclusions: Most readmissions at our public, safety net hospital were unavoidable, even among our unscheduled readmissions. Surprisingly, one-third of our overall readmissions were scheduled, the majority reflecting appropriate management strategies designed to reduce unnecessary hospital days. The scheduled but avoidable readmissions were due to constrained access to non-emergent, expensive procedures that are typically not reimbursed given our system's payor mix, a problem which likely plague other safety net systems. These findings suggest that readmissions do not necessarily reflect inadequate medical care, may reflect resource constraints that are unlikely to be addressable in systems caring for a large burden of uninsured patients, and merit individualized review.	[Shimizu, Eri; Glaspy, Kathleen; Schwartz, Shelley; Bholat, Tasneem; Kuo, Allen; Spellberg, Brad] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Div Gen Internal Med, Torrance, CA 90509 USA; [Shimizu, Eri] Hawaii Permanente Med Grp, Dept Med, Wailuku, HI USA; [Shimizu, Eri; Poon, Kimble] Maui Mem Med Ctr, Dept Med, Wailuku, HI USA; [Glaspy, Kathleen; Witt, Mallory D.; Spellberg, Brad] Univ Calif Los Angeles, David Geffen Sch Med, Torrance, CA USA; [Witt, Mallory D.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Div HIV Med, Torrance, CA 90509 USA; [Black, Susan; Diaz, Norma] Harbor UCLA Med Ctr, Dept Qual, Torrance, CA 90509 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Permanente Medical Groups; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Shimizu, E (corresponding author), Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Div Gen Internal Med, Torrance, CA 90509 USA.	eshimizu37@gmail.com						[Anonymous], 2007, MED PAYM ADV COMM RE, P107; Arbaje AI, 2008, GERONTOLOGIST, V48, P495, DOI 10.1093/geront/48.4.495; ASHTON CM, 1995, ANN INTERN MED, V122, P415, DOI 10.7326/0003-4819-122-6-199503150-00003; ASHTON CM, 1994, MED CARE, V32, P755, DOI 10.1097/00005650-199408000-00001; Ashton CM, 1997, MED CARE, V35, P1044, DOI 10.1097/00005650-199710000-00006; Berenson Julia, 2012, Issue Brief (Commonw Fund), V34, P1; Calvillo-King L, 2013, J GEN INTERN MED, V28, P269, DOI 10.1007/s11606-012-2235-x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chew LD, 2004, FAM MED, V36, P588; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Dudas V, 2001, AM J MED, V111, P26, DOI 10.1016/S0002-9343(01)00966-4; Forster AJ, 2005, J GEN INTERN MED, V20, P317, DOI 10.1111/j.1525-1497.2005.30390.x; Forster AJ, 2004, CAN MED ASSOC J, V170, P345; Goldfield NI, 2008, HEALTH CARE FINANC R, V30, P75; Horwitz LI, 2013, JAMA INTERN MED, V173, P1715, DOI 10.1001/jamainternmed.2013.9318; Hughes M R, 2000, Top Health Inf Manage, V20, P65; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jiang HJ, 2005, AM J PUBLIC HEALTH, V95, P1561, DOI 10.2105/AJPH.2004.044222; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P342, DOI 10.1001/jama.2012.94856; Joynt KE, 2012, NEW ENGL J MED, V366, P1366, DOI 10.1056/NEJMp1201598; Joynt KE, 2011, JAMA-J AM MED ASSOC, V305, P675, DOI 10.1001/jama.2011.123; Makaryus AN, 2005, MAYO CLIN PROC, V80, P991, DOI 10.4065/80.8.991; Maniaci MJ, 2008, MAYO CLIN PROC, V83, P554, DOI 10.4065/83.5.554; Mitchell SE, 2012, J HEALTH COMMUN, V17, P325, DOI 10.1080/10810730.2012.715233; Oddone EZ, 1996, J GEN INTERN MED, V11, P597, DOI 10.1007/BF02599027; Rodriguez F, 2011, AM HEART J, V162, P254, DOI 10.1016/j.ahj.2011.05.009; Strunin L, 2007, J HOSP MED, V2, P297, DOI 10.1002/jhm.206; van Walraven C, 2011, CAN MED ASSOC J, V183, pE391, DOI 10.1503/cmaj.101860; Weissman JS, 1999, MED CARE, V37, P490, DOI 10.1097/00005650-199905000-00008; WEISSMAN JS, 1994, INQUIRY-J HEALTH CAR, V31, P163	31	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91244	10.1371/journal.pone.0091244	http://dx.doi.org/10.1371/journal.pone.0091244			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618829	gold, Green Submitted, Green Published			2022-12-25	WOS:000332842400064
J	Tsai, JR; Liu, PL; Chen, YH; Chou, SH; Yang, MC; Cheng, YJ; Hwang, JJ; Yin, WH; Chong, IW				Tsai, Jong-Rung; Liu, Po-Len; Chen, Yung-Hsiang; Chou, Shah-Hwa; Yang, Ming-Chan; Cheng, Yu-Jen; Hwang, Jhi-Jhu; Yin, Wei-Hsian; Chong, Inn-Wen			Ginkgo biloba Extract Decreases Non-Small Cell Lung Cancer Cell Migration by Downregulating Metastasis-Associated Factor Heat-Shock Protein 27	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; ESTROGEN-RECEPTOR; STRESS-PROTEINS; EXPRESSION; HSP27; ACTIVATION; CHEMOTHERAPY; APOPTOSIS; SURVIVAL; ADENOCARCINOMA	Heat-shock proteins (HSPs) are molecular chaperones that protect proteins from damage. HSP27 expression is associated with cancer transformation and invasion. Ginkgo biloba extract (EGb761), the most widely sold herbal supplement, has antiangiogenic effects and induces tumor apoptosis. Data regarding the effect of EGb761 on HSP expression is limited, particularly in cancer. HSP27 expression in paired tumors and normal lung tissues of 64 patients with non-small cell lung cancer (NSCLC) were detected by real-time PCR, western blotting, and immunohistochemistry. NSCLC cell lines (A549/H441) were used to examine the migratory abilities in vitro. NSCLC tissue showed higher HSP27 expression than normal lung tissue. Kaplan-Meier survival analysis showed that NSCLC patients with low HSP27 expression ratio (<1) had significantly longer survival time than those with a high expression ratio (>1) (p = 0.04). EGb761 inhibited HSP27 expression and migratory ability of A549/H441 cells, which is the same as HSP27-siRNA transfection effect. Moreover, EGb761 treatment activated the AKT and p38 pathways and did not affect the expression of PI3K, ERK, and JNK pathways. HSP27 is a poor prognostic indicator of NSCLC. EGb761 can decrease the migration ability of A549/H441 by inhibiting HSP27 expression most likely through AKT and p38 MAPK pathways activation.	[Tsai, Jong-Rung; Liu, Po-Len; Chou, Shah-Hwa; Hwang, Jhi-Jhu; Chong, Inn-Wen] Kaohsiung Med Univ, Coll Med, Dept Resp Therapy, Kaohsiung, Taiwan; [Tsai, Jong-Rung; Hwang, Jhi-Jhu; Chong, Inn-Wen] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Yung-Hsiang] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan; [Chou, Shah-Hwa] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Chest Surg, Dept Surg, Kaohsiung, Taiwan; [Yang, Ming-Chan] Yuans Gen Hosp, Dept Surg, Kaohsiung, Taiwan; [Cheng, Yu-Jen] I Shou Univ, E Da Hosp, Dept Surg, Dept Hlth Management,Div Thorac Surg, Kaohsiung, Taiwan; [Yin, Wei-Hsian] Natl Yang Ming Univ, Fac Med, Cheng Hsin Gen Hosp, Div Cardiol, Taipei 112, Taiwan; [Yin, Wei-Hsian] Natl Yang Ming Univ, Sch Med, Cardiovasc Res Ctr, Taipei 112, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; China Medical University Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital; E-Da Hospital; I Shou University; Cheng Hsin General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chong, IW (corresponding author), Kaohsiung Med Univ, Coll Med, Dept Resp Therapy, Kaohsiung, Taiwan.	chong@kmu.edu.tw	Chen, Yung-Hsiang/K-6766-2015	Chen, Yung-Hsiang/0000-0002-8756-5113; Tsai, Jong rung/0000-0002-3222-0409	Kaohsiung Medical University [KMU-Q098022]; National Science Council, Taiwan [NSC102-2314-B-037-067]	Kaohsiung Medical University; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported in part by grant KMU-Q098022 from the Kaohsiung Medical University, and grant NSC102-2314-B-037-067 from National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrian S, 2002, CELL STRESS CHAPERON, V7, P177, DOI 10.1379/1466-1268(2002)007<0177:OOHATM>2.0.CO;2; Arts HJG, 1999, INT J CANCER, V84, P234, DOI 10.1002/(SICI)1097-0215(19990621)84:3<234::AID-IJC6>3.0.CO;2-9; Atkins D, 2005, CONTRIB NEPHROL, V148, P35, DOI 10.1159/000086042; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bausero MA, 2004, TUMOR BIOL, V25, P243, DOI 10.1159/000081387; Berrieman HK, 2006, ONCOL REP, V15, P283; Bubendorf L, 1999, J NATL CANCER I, V91, P1758, DOI 10.1093/jnci/91.20.1758; Chao JCJ, 2004, WORLD J GASTROENTERO, V10, P37; Chen XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059314; Chen XH, 2011, CELL PHYSIOL BIOCHEM, V27, P227, DOI 10.1159/000327948; CHRETIEN P, 1988, J CELL PHYSIOL, V137, P157, DOI 10.1002/jcp.1041370119; CIOCCA DR, 1989, CANCER RES, V49, P4298; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Conroy SE, 1998, BRIT J CANCER, V77, P1875, DOI 10.1038/bjc.1998.312; Cornford PA, 2000, CANCER RES, V60, P7099; DeFeudis FV, 2003, FUND CLIN PHARMACOL, V17, P405, DOI 10.1046/j.1472-8206.2003.00156.x; Dorion S, 2002, CELL STRESS CHAPERON, V7, P200, DOI 10.1379/1466-1268(2002)007<0200:AOTMAP>2.0.CO;2; Erkizan O, 2004, UROLOGY, V64, P474, DOI 10.1016/j.urology.2004.04.017; Eskenazi AE, 1998, CLIN EXP METASTAS, V16, P283, DOI 10.1023/A:1006553127695; Fukaya H, 1999, Nihon Jibiinkoka Gakkai Kaiho, V102, P907; Gandour-Edwards R, 1998, OTOLARYNG HEAD NECK, V118, P610, DOI 10.1016/S0194-5998(98)70229-3; Ghosh A, 2013, EXP MOL PATHOL, V94, P103, DOI 10.1016/j.yexmp.2012.09.001; Grabinski N, 2011, CELL SIGNAL; Guo YL, 1998, J BIOL CHEM, V273, P4027, DOI 10.1074/jbc.273.7.4027; Hadchity E, 2009, MOL THER, V17, P1387, DOI 10.1038/mt.2009.90; Hauns B, 1999, ARZNEIMITTEL-FORSCH, V49, P1030; HIGHTOWER LE, 1991, CELL, V66, P191, DOI 10.1016/0092-8674(91)90611-2; Hsu HS, 2011, CANCER; KANITAKIS J, 1989, J CUTAN PATHOL, V16, P272, DOI 10.1111/j.1600-0560.1989.tb00051.x; Kapranos N, 2002, J CANCER RES CLIN, V128, P426, DOI 10.1007/s00432-002-0357-y; Kim KS, 2005, ORAL ONCOL, V41, P383, DOI 10.1016/j.oraloncology.2004.09.013; King KL, 2000, CANCER, V88, P2464, DOI 10.1002/1097-0142(20000601)88:11<2464::AID-CNCR6>3.0.CO;2-W; Lemieux P., 1997, BIOL DELAY SYSTEMS L, V17, P113; Malusecka E, 2008, ANTICANCER RES, V28, P501; Mansi L, 2011, B CANC; Moon A, 2010, PATHOLOGY, V42, P421, DOI 10.3109/00313025.2010.493866; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Nano M, 2000, Chir Ital, V52, P313; Oken BS, 1998, ARCH NEUROL-CHICAGO, V55, P1409, DOI 10.1001/archneur.55.11.1409; Onen A, 1999, ACTA GASTRO-ENT BELG, V62, P386; Pietri S, 1997, CARDIOVASC DRUG THER, V11, P121, DOI 10.1023/A:1007728729844; PUY LA, 1989, CANCER, V64, P1067, DOI 10.1002/1097-0142(19890901)64:5<1067::AID-CNCR2820640518>3.0.CO;2-H; Rozsas A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077459; Sarhadi V, 2006, J PATHOL, V209, P206, DOI 10.1002/path.1960; Soldes OS, 1999, BRIT J CANCER, V79, P595, DOI 10.1038/sj.bjc.6690094; Storm FK, 1996, ANN SURG ONCOL, V3, P570, DOI 10.1007/BF02306091; Takeno S, 2001, DIS ESOPHAGUS, V14, P149, DOI 10.1046/j.1442-2050.2001.00174.x; Takeno S, 2001, ANN SURG ONCOL, V8, P215, DOI 10.1245/aso.2001.8.3.215; Tang SQ, 1997, J BIOL CHEM, V272, P28704, DOI 10.1074/jbc.272.45.28704; Tian T, 2007, CANCER SCI, V98, P1265, DOI 10.1111/j.1349-7006.2007.00514.x; Tsuruta M, 2008, ONCOL REP, V20, P1165, DOI 10.3892/or_00000125; Wang GD, 2004, ONCOL REP, V12, P955; Wang W, 2011, TUMOR BIOL, V32, P1199, DOI 10.1007/s13277-011-0223-0; WEISS A, 1984, J IMMUNOL, V133, P123; Wikman H, 2002, ONCOGENE, V21, P5804, DOI 10.1038/sj.onc.1205726; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yao HX, 2009, LUNG CANCER, V65, P41, DOI 10.1016/j.lungcan.2008.10.024; Zhang Y, 2007, CLIN CANCER RES, V13, P2855, DOI 10.1158/1078-0432.CCR-06-2090; Zimmermann M, 2012, CLIN CHIM ACTA, V413, P1115, DOI 10.1016/j.cca.2012.03.008	59	24	31	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91331	10.1371/journal.pone.0091331	http://dx.doi.org/10.1371/journal.pone.0091331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618684	Green Published, gold, Green Submitted			2022-12-25	WOS:000332842400078
J	Berg, M; Michalowski, A; Palzer, S; Rupp, S; Sohn, K				Berg, Michael; Michalowski, Annette; Palzer, Silke; Rupp, Steffen; Sohn, Kai			An In Vivo Photo-Cross-Linking Approach Reveals a Homodimerization Domain of Aha1 in S. cerevisiae	PLOS ONE			English	Article							EXPANDED GENETIC-CODE; ESCHERICHIA-COLI; AMINO-ACID; SACCHAROMYCES-CEREVISIAE; COCHAPERONE AHA1; YEAST PROTEOME; PROTEINS; HSP90; CELLS; SITE	Protein-protein interactions play an essential role in almost any biological processes. Therefore, there is a particular need for methods which describe the interactions of a defined target protein in its physiological context. Here we report a method to photo-cross-link interacting proteins in S. cerevisiae by using the non-canonical amino acid p-azido-L-phenylalanine (pAzpa). Based on the expanded genetic code the photoreactive non-canonical amino acid pAzpa was site-specifically incorporated at eight positions into a domain of Aha1 that was previously described to bind Hsp90 in vitro to function as a cochaperone of Hsp90 and activates its ATPase activity. In vivo photo-cross-linking to the cognate binding partner of Aha1 was carried out by irradiation of mutant strains with UV light (365 nm) to induce covalent intermolecular bonds. Surprisingly, an interaction between Aha1 and Hsp90 was not detected, although, we could confirm binding of suppressed pAzpa containing Aha1 to Hsp90 by native co-immunoprecipitation. However, a homodimer consisting of two covalently crosslinked Aha1 monomers was identified by mass spectrometry. This homodimer could also be confirmed using p-benzoyl-L-phenylalanine, another photoreactive non-canonical amino acid. Crosslinking was highly specific as it was dependent on irradiation using UV light, the exact position of the non-canonical amino acid in the protein sequence as well as on the addition of the non-canonical amino acid to the growth medium. Therefore it seems possible that an interaction of Aha1 with Hsp90 takes place at different positions than previously described in vitro highlighting the importance of in vivo techniques to study protein-protein interactions. Accordingly, the expanded genetic code can easily be applied to other S. cerevisiae proteins to study their interaction under physiological relevant conditions in vivo.	[Berg, Michael; Rupp, Steffen; Sohn, Kai] Fraunhofer IGB, Stuttgart, Germany; [Michalowski, Annette] Univ Stuttgart, IBVT, D-70174 Stuttgart, Germany; [Palzer, Silke] Univ Stuttgart, IGVP, D-70174 Stuttgart, Germany	University of Stuttgart; University of Stuttgart	Sohn, K (corresponding author), Fraunhofer IGB, Stuttgart, Germany.	kai.sohn@igb.fraunhofer.de			Fraunhofer grant "MEF Genoprot"	Fraunhofer grant "MEF Genoprot"	This work was supported by a Fraunhofer grant "MEF Genoprot". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agard NJ, 2006, ACS CHEM BIOL, V1, P644, DOI 10.1021/cb6003228; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Chen S, 2007, J MOL BIOL, V371, P112, DOI 10.1016/j.jmb.2007.05.017; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Chin JW, 2002, J AM CHEM SOC, V124, P9026, DOI 10.1021/ja027007w; Cho H, 2011, P NATL ACAD SCI USA, V108, P9060, DOI 10.1073/pnas.1100387108; Das S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.182931; Dennehey BK, 2013, MOL CELL BIOL, V33, P605, DOI 10.1128/MCB.01053-12; Dorman G, 2000, TRENDS BIOTECHNOL, V18, P64, DOI 10.1016/S0167-7799(99)01402-X; Forne I, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012088; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Grunbeck A, 2011, BIOCHEMISTRY-US, V50, P3411, DOI 10.1021/bi200214r; Hino N, 2005, NAT METHODS, V2, P201, DOI 10.1038/NMETH739; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Krishnamurthy M, 2011, ACS CHEM BIOL, V6, P1321, DOI 10.1021/cb200308e; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemke EA, 2007, NAT CHEM BIOL, V3, P769, DOI 10.1038/nchembio.2007.44; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Majmudar CY, 2009, J AM CHEM SOC, V131, P14240, DOI 10.1021/ja904378z; Meyer P, 2004, EMBO J, V23, P1402, DOI 10.1038/sj.emboj.7600141; Millson SH, 2005, EUKARYOT CELL, V4, P849, DOI 10.1128/EC.4.5.849-860.2005; Mollapour M, 2010, MOL CELL, V37, P333, DOI 10.1016/j.molcel.2010.01.005; Mori H, 2006, P NATL ACAD SCI USA, V103, P16159, DOI 10.1073/pnas.0606390103; Nehring S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031992; Palzer S, 2013, EUKARYOT CELL; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Peters FB, 2009, CHEM BIOL, V16, P148, DOI 10.1016/j.chembiol.2009.01.013; Pham ND, 2012, CURR OPIN CHEM BIOL; Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006; Seok WK, 2004, INORG CHEM, V43, P5205, DOI 10.1021/ic0302985; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Takimoto JK, 2009, MOL BIOSYST, V5, P931, DOI 10.1039/b904228h; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wittelsberger A, 2008, CHEM BIOL DRUG DES, V71, P380, DOI 10.1111/j.1747-0285.2008.00646.x; Wu JW, 1999, ACTA BIOCHIM POL, V46, P591, DOI 10.18388/abp.1999_4131; Xie JM, 2006, NAT REV MOL CELL BIO, V7, P775, DOI 10.1038/nrm2005; Young TS, 2009, BIOCHEMISTRY-US, V48, P2643, DOI 10.1021/bi802178k	45	12	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e89436	10.1371/journal.pone.0089436	http://dx.doi.org/10.1371/journal.pone.0089436			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614167	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300011
J	do Amaral, DN; Cavalcanti, BC; Bezerra, DP; Ferreira, PMP; Castro, RD; Sabino, JR; Machado, CML; Chammas, R; Pessoa, C; Sant'Anna, CMR; Barreiro, EJ; Lima, LM				do Amaral, Daniel Nascimento; Cavalcanti, Bruno C.; Bezerra, Daniel P.; Ferreira, Paulo Michel P.; Castro, Rosane de Paula; Sabino, Jose Ricardo; Longo Machado, Camila Maria; Chammas, Roger; Pessoa, Claudia; Sant'Anna, Carlos M. R.; Barreiro, Eliezer J.; Lima, Lidia Moreira			Docking, Synthesis and Antiproliferative Activity of N-Acylhydrazone Derivatives Designed as Combretastatin A4 Analogues	PLOS ONE			English	Article							HOLLOW-FIBER ASSAY; BETA-TUBULIN; TARGET; GROWTH; SERIES; TUMOR; MODEL	Cancer is the second most common cause of death in the USA. Among the known classes of anticancer agents, the microtubule-targeted antimitotic drugs are considered to be one of the most important. They are usually classified into microtubule-destabilizing (e. g., Vinca alkaloids) and microtubule-stabilizing (e. g., paclitaxel) agents. Combretastatin A4 (CA-4), which is a natural stilbene isolated from Combretum caffrum, is a microtubule-destabilizing agent that binds to the colchicine domain on beta-tubulin and exhibits a lower toxicity profile than paclitaxel or the Vinca alkaloids. In this paper, we describe the docking study, synthesis, antiproliferative activity and selectivity index of the N-acylhydrazone derivatives (5a-r) designed as CA-4 analogues. The essential structural requirements for molecular recognition by the colchicine binding site of beta-tubulin were recognized, and several compounds with moderate to high antiproliferative potency (IC50 values <= 18 mu M and >= 4 nM) were identified. Among these active compounds, LASSBio-1586 (5b) emerged as a simple antitumor drug candidate, which is capable of inhibiting microtubule polymerization and possesses a broad in vitro and in vivo antiproliferative profile, as well as a better selectivity index than the prototype CA-4, indicating improved selective cytotoxicity toward cancer cells.	[do Amaral, Daniel Nascimento; Barreiro, Eliezer J.; Lima, Lidia Moreira] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Farmacos & Medicamento, Lab Avaliacao & Sintese Subst Bioat LASSBio, Rio De Janeiro, Brazil; [do Amaral, Daniel Nascimento; Barreiro, Eliezer J.; Lima, Lidia Moreira] Univ Fed Rio de Janeiro, Inst Quim, Programa Posgrad Quim, Rio De Janeiro, Brazil; [Cavalcanti, Bruno C.; Bezerra, Daniel P.; Pessoa, Claudia] Univ Fed Ceara, Fac Med, Dept Fisiol & Farmacol, Fortaleza, Ceara, Brazil; [Ferreira, Paulo Michel P.] Univ Fed Piaui, Dept Ciencias Biol, Picos, Brazil; [Castro, Rosane de Paula; Sabino, Jose Ricardo] Univ Fed Goias, Inst Fis, Goiania, Go, Brazil; [Longo Machado, Camila Maria; Chammas, Roger] Univ Sao Paulo, Fac Med, Dept Radiol, Sao Paulo, Brazil; [Sant'Anna, Carlos M. R.] Univ Fed Rural Rio de Janeiro, Dept Quim, Seropedica, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Ceara; Universidade Federal do Piaui; Universidade Federal de Goias; Universidade de Sao Paulo; Universidade Federal Rural do Rio de Janeiro (UFRRJ)	Lima, LM (corresponding author), Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Farmacos & Medicamento, Lab Avaliacao & Sintese Subst Bioat LASSBio, Rio De Janeiro, Brazil.	lidia@lassbio.icb.ufrj.br	SABINO, JOSE RICARDO/AAB-5846-2021; Bezerra, Daniel P/K-7889-2017; Amaral, Daniel/V-5658-2019; Fapesp, Biota/F-8655-2017; Lima, Lidia M/D-9587-2015; Chammas, Roger/A-8004-2011; Ferreira, Paulo Michel Pinheiro/J-6783-2012; Sant'Anna, Carlos Mauricio Rabello de/G-3879-2012; Machado, Camila/C-4077-2012; Barreiro, Eliezer J/B-1131-2011; Coêlho Cavalcanti, Bruno/F-1555-2015	Bezerra, Daniel P/0000-0002-6774-2063; Amaral, Daniel/0000-0002-6800-0248; Fapesp, Biota/0000-0002-9887-8449; Lima, Lidia M/0000-0002-8625-6351; Chammas, Roger/0000-0003-0342-8726; Ferreira, Paulo Michel Pinheiro/0000-0001-6862-6497; Sant'Anna, Carlos Mauricio Rabello de/0000-0003-1989-5038; Barreiro, Eliezer J/0000-0003-1759-0038; 	CNPq; FAPERJ; INCT-INOFAR [573.564/2008-6, E-26/170.020/2008]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); INCT-INOFAR	This work was supported by CNPq (BR), FAPERJ (BR) and INCT-INOFAR (BR, 573.564/2008-6 and E-26/170.020/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MM, 2010, J COMB CHEM, V12, P245, DOI 10.1021/cc9001444; Bai RL, 2000, J BIOL CHEM, V275, P40443, DOI 10.1074/jbc.M005299200; Baxter CA, 1998, PROTEINS, V33, P367, DOI 10.1002/(SICI)1097-0134(19981115)33:3<367::AID-PROT6>3.3.CO;2-N; BONNE D, 1985, J BIOL CHEM, V260, P2819; Borchhardt DM, 2010, J BRAZIL CHEM SOC, V21, P142, DOI 10.1590/S0103-50532010000100021; Cao XF, 2011, J CHIN CHEM SOC-TAIP, V58, P35, DOI 10.1002/jccs.201190055; Combes S, 2011, J MED CHEM, V54, P3153, DOI 10.1021/jm901826e; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Dorleans A, 2009, P NATL ACAD SCI USA, V106, P13775, DOI 10.1073/pnas.0904223106; Ducki S, 1998, BIOORG MED CHEM LETT, V8, P1051, DOI 10.1016/S0960-894X(98)00162-0; Ducki S, 2009, BIOORGAN MED CHEM, V17, P7698, DOI 10.1016/j.bmc.2009.09.039; Ducki S, 2009, BIOORGAN MED CHEM, V17, P7711, DOI 10.1016/j.bmc.2009.09.044; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Farrugia L.J., 1997, J APPL CRYSTALLOGR, V30, P565, DOI [10.1107/S0021889897003117, DOI 10.1107/S0021889897003117]; Farrugia L.J., 1999, J APPL CRYSTALLOGR, V32, P837, DOI [DOI 10.1107/S0021889812029111, 10.1107/S0021889899006020, DOI 10.1107/S0021889899006020, 10.1107/S0021889812029111]; Furst R, 2009, BIOORG MED CHEM LETT, V19, P6948, DOI 10.1016/j.bmcl.2009.10.064; Hall LM, 2000, ANTICANCER RES, V20, P903; HOLLINGSHEAD MG, 1995, LIFE SCI, V57, P131, DOI 10.1016/0024-3205(95)00254-4; HORWITZ JP, 1954, J ORG CHEM, V19, P194, DOI 10.1021/jo01367a007; Jin LH, 2006, BIOORG MED CHEM LETT, V16, P5036, DOI 10.1016/j.bmcl.2006.07.048; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kummerle AE, 2009, EUR J MED CHEM, V44, P4004, DOI 10.1016/j.ejmech.2009.04.044; Lee L, 2010, J MED CHEM, V53, P325, DOI 10.1021/jm901268n; Lima PC, 2000, EUR J MED CHEM, V35, P187, DOI 10.1016/S0223-5234(00)00120-3; MACK CH, 1969, J CHEM ENG DATA, V14, P258, DOI 10.1021/je60041a042; MAZZONE G, 1978, FARMACO-ED SCI, V33, P963; Mazzone G, 1991, B SEDUTE ACAD GIONIA, V8, P689; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; Prise VE, 2002, INT J ONCOL, V21, P717; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Sadar MD, 2002, MOL CANCER THER, V1, P629; Schneider P, 2009, PHYTOCHEM LETT, V2, P85, DOI 10.1016/j.phytol.2008.12.004; Shan Y, 2011, CURR MED CHEM, V18, P523, DOI 10.2174/092986711794480221; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Singh P, 2008, IUBMB LIFE, V60, P368, DOI 10.1002/iub.42; Snyder JP, 2001, P NATL ACAD SCI USA, V98, P5312, DOI 10.1073/pnas.051309398; Suggitt M, 2004, CLIN CANCER RES, V10, P6677, DOI 10.1158/1078-0432.CCR-04-0855; Tron GC, 2006, J MED CHEM, V49, P3033, DOI 10.1021/jm0512903; Wermuth GC, 2008, PRACTICE MED CHEM, P448; Workman P, 1998, BRIT J CANCER, V77, P1; Yogeeswari P, 2005, J MED CHEM, V48, P6202, DOI 10.1021/jm050283b	43	38	38	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e85380	10.1371/journal.pone.0085380	http://dx.doi.org/10.1371/journal.pone.0085380			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614859	Green Published, gold			2022-12-25	WOS:000332839300002
J	Helin-Salmivaara, A; Lavikainen, P; Aarnio, E; Huupponen, R; Korhonen, MJ				Helin-Salmivaara, Arja; Lavikainen, Piia; Aarnio, Emma; Huupponen, Risto; Korhonen, Maarit Jaana			Sequential Cohort Design Applying Propensity Score Matching to Analyze the Comparative Effectiveness of Atorvastatin and Simvastatin in Preventing Cardiovascular Events	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; HOSPITAL DISCHARGE REGISTER; OUTCOMES; THERAPY; STATINS; DISEASE; STROKE	Background: Sequential cohort design (SCD) applying matching for propensity scores (PS) in accrual periods has been proposed to mitigate bias caused by channeling when calendar time is a proxy for strong confounders. We studied the channeling of patients according to atorvastatin and simvastatin initiation in Finland, starting from the market introduction of atorvastatin in 1998, and explored the SCD PS approach to analyzing the comparative effectiveness of atorvastatin versus simvastatin in the prevention of cardiovascular events (CVE). Methods: Initiators of atorvastatin or simvastatin use in the 45-75-year age range in 1998-2006 were characterized by their propensity of receiving atorvastatin over simvastatin, as estimated for 17 six-month periods. Atorvastatin (10 mg) and simvastatin (20 mg) initiators were matched 1: 1 on the PS, as estimated for the whole cohort and within each period. Cox regression models were fitted conventionally, and also for the PS matched cohort and the periodically PS matched cohort, to estimate the hazard ratios (HR) for CVEs. Findings: Atorvastatin (10 mg) was associated with a 11%-12% lower incidence of CVE in comparison with simvastatin (20 mg). The HR estimates were the same for a conventional Cox model (0.88, 95% confidence interval 0.85-0.91), for the analysis in which the PS was used to match across all periods and the Cox model was adjusted for strong confounders (0.89, 0.85-0.92), and for the analysis in which PS matching was applied within sequential periods (0.88, 0.84-0.92). The HR from a traditional PS matched analysis was 0.80 (0.77-0.83). Conclusions: The SCD PS approach produced effect estimates similar to those obtained in matching for PS within the whole cohort and adjusting the outcome model for strong confounders, but at the cost of efficiency. A traditional PS matched analysis without further adjustment in the outcome model produced estimates further away from unity.	[Helin-Salmivaara, Arja; Lavikainen, Piia; Huupponen, Risto; Korhonen, Maarit Jaana] Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland; [Helin-Salmivaara, Arja] Hosp Dist Helsinki, Unit Primary Hlth Care, Helsinki, Finland; [Helin-Salmivaara, Arja] Uusimaa, Helsinki, Finland; [Aarnio, Emma; Huupponen, Risto] Turku Univ Hosp, Tykslab, Dept Clin Pharmacol, FIN-20520 Turku, Finland; [Aarnio, Emma] Univ Eastern Finland, Sch Pharm, Kuopio, Finland; [Korhonen, Maarit Jaana] Univ Turku, Dept Publ Hlth, Turku, Finland	University of Turku; University of Turku; University of Eastern Finland; University of Turku	Helin-Salmivaara, A (corresponding author), Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland.	arja.helin-salmivaara@utu.fi		Lavikainen, Piia/0000-0003-3560-8860; Aarnio, Emma/0000-0002-6555-7833; Korhonen, Maarit/0000-0002-2953-4757	Academy of Finland [138255]	Academy of Finland(Academy of Finland)	This study was funded by the Academy of Finland (www.aka.fi, decision number 138255). The Academy of Finland had no role in the design, analyses, interpretation of data, writing the report, or in the decision to submit the manuscript.	Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Dilokthornsakul P, 2012, 28 INT C PHARM THER; Dusetzina SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063973; European Medicines Agency, CER; Foody JM, 2008, CLIN THER, V30, P195, DOI 10.1016/j.clinthera.2008.01.003; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Gagne JJ, 2012, EPIDEMIOLOGY, V23, P238, DOI 10.1097/EDE.0b013e3182459d7d; Halava H, 2009, EUR J CLIN PHARMACOL, V65, P927, DOI 10.1007/s00228-009-0664-1; Jacobson TA, 2008, MAYO CLIN PROC, V83, P1316, DOI 10.1016/S0025-6196(11)60779-9; Korhonen MJ, 2009, EUR J CLIN PHARMACOL, V65, P1167, DOI 10.1007/s00228-009-0701-0; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Mack CD, 2013, PHARMACOEPIDEM DR S, V22, P810, DOI 10.1002/pds.3386; Martikainen JE, 2010, MED CARE, V48, P761, DOI 10.1097/MLR.0b013e3181e41bcb; Pajunen P, 2005, EUR J CARDIOV PREV R, V12, P132, DOI 10.1097/00149831-200504000-00007; Parsons LS, USING SAS SOFTWARE P; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; Rassen JA, 2012, PHARMACOEPIDEM DR S, V21, P697, DOI 10.1002/pds.2256; Schneeweiss S, 2011, CLIN PHARMACOL THER, V90, P777, DOI 10.1038/clpt.2011.235; Seeger JD, 2005, PHARMACOEPIDEM DR S, V14, P465, DOI 10.1002/pds.1062; Simpson RJ, 2009, MAYO CLIN PROC, V84, P1065, DOI 10.4065/mcp.2009.0298; Tolonen H, 2007, EUR J CARDIOV PREV R, V14, P380, DOI 10.1097/01.hjr.0000239466.26132.f2; Wahl PM, 2012, DRUG SAFETY, V35, P407, DOI 10.2165/11594770-000000000-00000; Weng TC, 2010, J CLIN PHARM THER, V35, P139, DOI 10.1111/j.1365-2710.2009.01085.x; WHO, ATC DDD SYST; Wilke RA, 2008, BASIC CLIN PHARMACOL, V103, P354, DOI 10.1111/j.1742-7843.2008.00291.x	25	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90325	10.1371/journal.pone.0090325	http://dx.doi.org/10.1371/journal.pone.0090325			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614626	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300020
J	Sood, R; Flint-Ashtamker, G; Borenstein, D; Barki-Harrington, L				Sood, Rapita; Flint-Ashtamker, Galit; Borenstein, Dafna; Barki-Harrington, Liza			Upregulation of Prostaglandin Receptor EP1 Expression Involves Its Association with Cyclooxygenase-2	PLOS ONE			English	Article							PROSTANOID RECEPTORS; PROTEIN-DEGRADATION; ENDOTHELIAL-CELLS; ARACHIDONIC-ACID; E-2 RECEPTORS; LOCALIZATION; SUBTYPE; PATHWAY; DRUGS; CDNA	While many signals cause upregulation of the pro-inflammatory enzyme cyclooxygenase -2 (COX-2), much less is known about mechanisms that actively downregulate its expression. We have recently shown that the prostaglandin EP1 receptor reduces the expression of COX-2 in a pathway that facilitates its ubiquitination and degradation via the 26S proteasome. Here we show that an elevation of COX-2 intracellular levels causes an increase in the endogenous expression of prostaglandin EP1. The increase in EP1 levels does not occur at the transcriptional level, but is rather associated with complex formation between the receptor and COX-2, which occurs both in vitro and in mammalian tissues. The EP1-COX-2 complex is disrupted following binding of arachidonic acid to COX-2 and accompanied by a parallel reduction in EP1 levels. We propose that a transient interaction between COX-2 and EP1 constitutes a feedback loop whereby an increase in COX-2 expression elevates EP1, which ultimately acts to downregulate COX-2 by expediting its proteasomal degradation. Such a post translational mechanism may serve to control both the ligand-generating system of COX-2 and its reception system.	[Sood, Rapita; Flint-Ashtamker, Galit; Borenstein, Dafna; Barki-Harrington, Liza] Univ Haifa, Dept Human Biol, Fac Nat Sci, IL-31999 Haifa, Israel	University of Haifa	Barki-Harrington, L (corresponding author), Univ Haifa, Dept Human Biol, Fac Nat Sci, IL-31999 Haifa, Israel.	lbarki@psy.haifa.ac.il			United States-Israel Binational Scientific Foundation [2009246]	United States-Israel Binational Scientific Foundation	This study was funded by the United States-Israel Binational Scientific Foundation, project number 2009246. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya M, 1998, P NATL ACAD SCI USA, V95, P15792, DOI 10.1073/pnas.95.26.15792; Bhattacharya M, 1999, J BIOL CHEM, V274, P15719, DOI 10.1074/jbc.274.22.15719; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; Chen SF, 2013, J BIOL CHEM, V288, P33462, DOI 10.1074/jbc.M113.521799; Chen SF, 2010, J CELL BIOCHEM, V109, P356, DOI 10.1002/jcb.22407; Dannenberg AJ, 2001, LANCET ONCOL, V2, P544, DOI 10.1016/S1470-2045(01)00488-0; Dannenberg AJ, 2003, CANCER CELL, V4, P431, DOI 10.1016/S1535-6108(03)00310-6; Fujino H, 2003, J BIOL CHEM, V278, P12151, DOI 10.1074/jbc.M212665200; Gobeil F, 2002, CIRC RES, V90, P682, DOI 10.1161/01.RES.0000013303.17964.7A; Haddad A, 2012, J BIOL CHEM, V287, P17214, DOI 10.1074/jbc.M111.304220; HAIMOVITZFRIEDMAN A, 1991, CANCER RES, V51, P2552; Han C, 2006, J BIOL CHEM, V281, P24831, DOI 10.1074/jbc.M602201200; HARKER LA, 1986, CIRCULATION, V73, P206, DOI 10.1161/01.CIR.73.2.206; Ichikawa A, 1996, J LIPID MEDIAT CELL, V14, P83, DOI 10.1016/0929-7855(96)00512-3; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; KATOH H, 1995, BBA-GEN SUBJECTS, V1244, P41, DOI 10.1016/0304-4165(94)00182-W; RIDKER PM, 1991, ANN INTERN MED, V114, P835, DOI 10.7326/0003-4819-114-10-835; Rouzer CA, 2003, CHEM REV, V103, P2239, DOI 10.1021/cr000068x; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Rowlinson SW, 1999, J BIOL CHEM, V274, P23305, DOI 10.1074/jbc.274.33.23305; Sharma NP, 2010, MOL PHARMACOL, V77, P979, DOI 10.1124/mol.109.063115; Smith T, 2000, J BIOL CHEM, V275, P40407, DOI 10.1074/jbc.M005563200; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172/JCI13271; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; WATABE A, 1993, J BIOL CHEM, V268, P20175; Zhang L, 2007, MOL CELL BIOCHEM, V305, P19, DOI 10.1007/s11010-007-9523-5; Zidar N, 2008, J CELL MOL MED	28	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91018	10.1371/journal.pone.0091018	http://dx.doi.org/10.1371/journal.pone.0091018			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614038	Green Submitted, gold, Green Published			2022-12-25	WOS:000332839300065
J	Tajiri, N; Quach, DM; Kaneko, Y; Wu, S; Lee, D; Lam, T; Hayama, KL; Hazel, TG; Johe, K; Wu, MC; Borlongan, CV				Tajiri, Naoki; Quach, David M.; Kaneko, Yuji; Wu, Stephanie; Lee, David; Lam, Tina; Hayama, Ken L.; Hazel, Thomas G.; Johe, Karl; Wu, Michael C.; Borlongan, Cesar V.			Behavioral and Histopathological Assessment of Adult Ischemic Rat Brains after Intracerebral Transplantation of NSI-566RSC Cell Lines	PLOS ONE			English	Article							NEURAL STEM-CELLS; SPINAL-CORD; FUNCTIONAL RECOVERY; STROKE THERAPY; CYCLOSPORINE-A; GRAFTS; DISEASE; NEUROPROTECTION; TRANSLATION; DISORDERS	Stroke is a major cause of death and disability, with very limited treatment option. Cell-based therapies have emerged as potential treatments for stroke. Indeed, studies have shown that transplantation of neural stem cells (NSCs) exerts functional benefits in stroke models. However, graft survival and integration with the host remain pressing concerns with cell-based treatments. The current study set out to investigate those very issues using a human NSC line, NSI-566RSC, in a rat model of ischemic stroke induced by transient occlusion of the middle cerebral artery. Seven days after stroke surgery, those animals that showed significant motor and neurological impairments were randomly assigned to receive NSI-566RSC intracerebral transplants at two sites within the striatum at three different doses: group A (0 cells/mu l), group B (5,000 cells/mu l), group C (10,000 cells/mu l), and group D (20,000 cells/mu l). Weekly behavioral tests, starting at seven days and continued up to 8 weeks after transplantation, revealed dose-dependent recovery from both motor and neurological deficits in transplanted stroke animals. Eight weeks after cell transplantation, immunohistochemical investigations via hematoxylin and eosin staining revealed infarct size was similar across all groups. To identify the cell graft, and estimate volume, immunohistochemistry was performed using two human-specific antibodies: one to detect all human nuclei (HuNu), and another to detect human neuron-specific enolase (hNSE). Surviving cell grafts were confirmed in 10/10 animals of group B, 9/10 group C, and 9/10 in group D. hNSE and HuNu staining revealed similar graft volume estimates in transplanted stroke animals. hNSE-immunoreactive fibers were also present within the corpus callosum, coursing in parallel with host tracts, suggesting a propensity to follow established neuroanatomical features. Despite absence of reduction in infarct volume, NSI-566RSC transplantation produced behavioral improvements possibly via robust engraftment and neuronal differentiation, supporting the use of this NSC line for stroke therapy.	[Tajiri, Naoki; Kaneko, Yuji; Borlongan, Cesar V.] Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33612 USA; [Quach, David M.; Wu, Stephanie; Lee, David; Lam, Tina; Hayama, Ken L.; Hazel, Thomas G.; Johe, Karl] Neuralstem Inc, Rockville, MD USA; [Wu, Michael C.] Neurodigitech LLC, San Diego, CA USA	State University System of Florida; University of South Florida	Borlongan, CV (corresponding author), Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33612 USA.	cborlong@health.usf.edu	Tajiri, Naoki/K-1230-2012; Borlongan, Cesar/I-5696-2012; Wu, Michael/AAP-2829-2021	Tajiri, Naoki/0000-0003-2189-662X; Borlongan, Cesar/0000-0002-2966-9782; 	Neuralstem Inc; National Institutes of Health; National Institute of Neurological Disorders and Stroke [1R01NS071956-01]; James and Esther King Foundation for Biomedical Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071956] Funding Source: NIH RePORTER	Neuralstem Inc; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); James and Esther King Foundation for Biomedical Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	CVB received research support from Neuralstem Inc for this study. DMQ, SW, DL, TL, KLH, TGH and KJ are employed by the funder of this study, Neuralstem Inc. CVB is supported by National Institutes of Health, National Institute of Neurological Disorders and Stroke 1R01NS071956-01 and James and Esther King Foundation for Biomedical Research Program. The funder provided support in the form of salaries for authors DMQ, SW, DL, TL, KLH, TGH and KJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Borlongan CV, 2011, LEUKEMIA, V25, P1674, DOI 10.1038/leu.2011.167; Borlongan CV, 2008, REGEN MED, V3, P249, DOI 10.2217/17460751.3.3.249; Borlongan CV, 2011, PROG NEUROBIOL, V95, P213, DOI 10.1016/j.pneurobio.2011.08.005; Borlongan CV, 2010, STEM CELLS DEV, V19, P439, DOI 10.1089/scd.2009.0340; Borlongan CV, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-31; Borlongan CV, 2009, STROKE, V40, pS146, DOI 10.1161/STROKEAHA.108.533091; Borlongan CV, 2005, LIFE SCI, V76, P1503, DOI 10.1016/j.lfs.2004.09.022; Borlongan CV, 1998, EXP NEUROL, V149, P310, DOI 10.1006/exnr.1997.6730; Chen JL, 2013, CELL TRANSPLANT, V22, P871, DOI 10.3727/096368911X637380; Chopp M, 2009, CELL TRANSPLANT, V18, P691, DOI 10.3727/096368909X470883; Cizkova D, 2007, NEUROSCIENCE, V147, P546, DOI 10.1016/j.neuroscience.2007.02.065; Dailey T., 2013, CELL BASED THERAPIES, P29; Fisher M, 2013, ANN NEUROL, V73, P4, DOI 10.1002/ana.23744; Garbuzova-Davis S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063553; Glass JD, 2012, STEM CELLS, V30, P1144, DOI 10.1002/stem.1079; Guo XF, 2010, J TISSUE ENG REGEN M, V4, P181, DOI 10.1002/term.223; Guzman R, 2008, STROKE, V39, P1300, DOI 10.1161/STROKEAHA.107.500470; Hefferan MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042614; Hess DC, 2008, CELL PROLIFERAT, V41, P94, DOI 10.1111/j.1365-2184.2008.00486.x; Hess David C, 2008, Expert Rev Neurother, V8, P1193, DOI 10.1586/14737175.8.8.1193; Kaneko Y, 2013, CNS NEUROL DISORD-DR, V12, P405, DOI 10.2174/1871527311312030013; Kaneko Y, 2012, CURR PHARM DESIGN, V18, P3731, DOI 10.2174/138161212802002733; Lunn JS, 2010, STEM CELLS DEV, V19, P1983, DOI 10.1089/scd.2010.0003; Matsukawa N, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-126; Mays R. W., 2010, J EXP STROKE TRANSL, V3, P34; Nelson PT, 2002, AM J PATHOL, V160, P1201, DOI 10.1016/S0002-9440(10)62546-1; Rodrigues MCO, 2012, NEUROSCI BIOBEHAV R, V36, P177, DOI 10.1016/j.neubiorev.2011.05.010; Osman MM, 2011, NEUROPEPTIDES, V45, P359, DOI 10.1016/j.npep.2011.04.002; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pollock K, 2006, EXP NEUROL, V199, P143, DOI 10.1016/j.expneurol.2005.12.011; Raore B, 2011, SPINE, V36, pE164, DOI 10.1097/BRS.0b013e3181d77a47; Sanberg PR, 2012, PROG BRAIN RES, V201, P99, DOI 10.1016/B978-0-444-59544-7.00006-8; Sanberg PR, 2012, BRIT MED BULL, V101, P163, DOI 10.1093/bmb/lds001; Saver JL, 2013, JAMA-J AM MED ASSOC, V309, P2480, DOI 10.1001/jama.2013.6959; Savitz SI, 2013, STROKE, V44, pS107, DOI 10.1161/STROKEAHA.112.679605; Sinden JD, 2012, PROG BRAIN RES, V201, P119, DOI 10.1016/B978-0-444-59544-7.00007-X; Sinden JD, 2012, INT J STROKE, V7, P426, DOI 10.1111/j.1747-4949.2012.00840.x; Stroemer P, 2009, NEUROREHAB NEURAL RE, V23, P895, DOI 10.1177/1545968309335978; Tajiri N, 2013, TRANSL STROKE RES, V4, P308, DOI 10.1007/s12975-012-0241-2; Tajiri N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043779; Tanny SPT, 2013, STROKE, V44, P2269, DOI 10.1161/STROKEAHA.113.001295; Teng YD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004579; Teng YD, 2011, CURR NEUROPHARMACOL, V9, P574, DOI 10.2174/157015911798376299; Usvald D, 2010, CELL TRANSPLANT, V19, P1103, DOI 10.3727/096368910X503406; van Gorp S, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt209; Wechsler L, 2009, STROKE, V40, P510, DOI 10.1161/STROKEAHA.108.526863; Xu LY, 2006, TRANSPLANTATION, V82, P865, DOI 10.1097/01.tp.0000235532.00920.7a; Xu LY, 2011, NEUROSCI LETT, V494, P222, DOI 10.1016/j.neulet.2011.03.017; Xu LY, 2009, J COMP NEUROL, V514, P297, DOI 10.1002/cne.22022; Yan J, 2007, PLOS MED, V4, P318, DOI 10.1371/journal.pmed.0040039; Yan J, 2006, STEM CELLS, V24, P1976, DOI 10.1634/stemcells.2005-0518; Yang B, 2012, STEM CELLS DEV, V21, P3332, DOI 10.1089/scd.2012.0037; Yasuhara T, 2009, STEM CELLS DEV, V18, P1501, DOI 10.1089/scd.2009.0011	53	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91408	10.1371/journal.pone.0091408	http://dx.doi.org/10.1371/journal.pone.0091408			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614895	Green Submitted, Green Published, gold			2022-12-25	WOS:000332839300123
J	Wang, JZ; Zhang, YW; Xu, K; Mao, XB; Xue, LJ; Liu, XB; Yu, HJ; Chen, LB; Chu, XY				Wang, Jingzi; Zhang, Youwei; Xu, Kai; Mao, Xiaobei; Xue, Lijun; Liu, Xiaobei; Yu, Hongjun; Chen, Longbang; Chu, Xiaoyuan			Genome-Wide Screen of DNA Methylation Changes Induced by Low Dose X-Ray Radiation in Mice	PLOS ONE			English	Article							CHROMOSOMAL INSTABILITY; EXCISION-REPAIR; CELLS; DAMAGE; GENE; HYPOMETHYLATION; CARCINOGENESIS; IRRADIATION; PATTERNS; EXPOSURE	Epigenetic mechanisms play a key role in non-targeted effects of radiation. The purpose of this study was to investigate global hypomethylation and promoter hypermethylation of particular genes induced by low dose radiation (LDR). Thirty male BALB/c mice were divided into 3 groups: control, acutely exposed (0.5Gy X-rays), and chronic exposure for 10 days (0.05Gy/d610d). High-performance liquid chromatography (HPLC) and MeDIP-quantitative polymerase chain reaction (qPCR) were used to study methylation profiles. DNMT1 and MBD2 expression was determined by qPCR and western blot assays. Methylation and expression of Rad23b and Ddit3 were determined by bisulfate sequencing primers (BSP) and qPCR, respectively. The results show that LDR induced genomic hypomethylation in blood 2 h postirraditaion, but was not retained at 1-month. DNMT1 and MBD2 were downregulated in a tissue-specific manner but did not persist. Specific hypermethylation was observed for 811 regions in the group receiving chronic exposure, which covered almost all key biological processes as indicated by GO and KEGG pathway analysis. Eight hypermethylated genes (Rad23b, Tdg, Ccnd1, Ddit3, Llgl1, Rasl11a, Tbx2, Scl6a15) were verified by MeDIP-qPCR. Among them, Rad23b and Ddit3 gene displayed tissue-specific methylation and downregulation, which persisted for 1-month postirradiation. Thus, LDR induced global hypomethylation and tissue-specific promoter hypermethylation of particular genes. Promoter hypermethylation, rather than global hypomethylation, was relatively stable. Dysregulation of methylation might be correlated with down-regulation of DNMT1 and MBD2, but much better understanding the molecular mechanisms involved in this process will require further study.	[Wang, Jingzi; Zhang, Youwei; Xu, Kai; Mao, Xiaobei; Xue, Lijun; Liu, Xiaobei; Yu, Hongjun; Chen, Longbang; Chu, Xiaoyuan] Southern Med Univ, Nanjing Clin Sch, Jinling Hosp, Dept Med Oncol, Nanjing, Jiangsu, Peoples R China; [Zhang, Youwei] Yangzhou Univ, Clin Sch 2, Yangzhou Peoples Hosp 1, Dept Med Oncol, Yangzhou, Peoples R China	Southern Medical University - China; Yangzhou University	Chu, XY (corresponding author), Southern Med Univ, Nanjing Clin Sch, Jinling Hosp, Dept Med Oncol, Nanjing, Jiangsu, Peoples R China.	chuxiaoyuan6906@gmail.com		Liu, Zhi-Hong/0000-0001-6093-0726	National Natural Science Foundation of China [81272394]; Medical and Health Research Fund of Nanjing Military, PLA [11MA092]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical and Health Research Fund of Nanjing Military, PLA	This work was supported by the National Natural Science Foundation of China (No. 81272394) and Medical and Health Research Fund of Nanjing Military, PLA (No. 11MA092). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong CA, 2012, EPIGENETICS-US, V7, P892, DOI 10.4161/epi.21094; Aypar U, 2011, INT J RADIAT BIOL, V87, P179, DOI 10.3109/09553002.2010.522686; Aypar U, 2011, MUTAT RES-FUND MOL M, V707, P24, DOI 10.1016/j.mrfmmm.2010.12.003; Bernal AJ, 2013, FASEB J, V27, P665, DOI 10.1096/fj.12-220350; Duthie SJ, 2000, NUTR CANCER, V37, P245, DOI 10.1207/S15327914NC372_18; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Friso S, 2002, ANAL CHEM, V74, P4526, DOI 10.1021/ac020050h; Huang L, 2003, ONCOGENE, V22, P5848, DOI 10.1038/sj.onc.1206697; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; KALINICH JF, 1989, RADIAT RES, V117, P185, DOI 10.2307/3577319; Kang KA, 2012, TUMOR BIOL, V33, P403, DOI 10.1007/s13277-012-0322-6; Karotki AV, 2012, CELL MOL LIFE SCI, V69, P3351, DOI 10.1007/s00018-012-1148-5; Kaup S, 2006, MUTAT RES-FUND MOL M, V597, P87, DOI 10.1016/j.mrfmmm.2005.06.032; Koga Y, 2009, GENOME RES, V19, P1462, DOI 10.1101/gr.091447.109; Kovalchuk O, 2004, MUTAT RES-FUND MOL M, V548, P75, DOI 10.1016/j.mrfmmm.2003.12.016; Kuhmann C, 2011, RADIOTHER ONCOL, V101, P116, DOI 10.1016/j.radonc.2011.05.048; Limoli CL, 1997, CANCER RES, V57, P5557; Lin J, 2010, LEUKEMIA RES, V34, P991, DOI 10.1016/j.leukres.2010.01.003; Nandakumar V, 2011, CARCINOGENESIS, V32, P597, DOI 10.1093/carcin/bgq282; Panayiotidis MI, 2004, ANTIOXID REDOX SIGN, V6, P129, DOI 10.1089/152308604771978435; Pengt B, 2005, J BIOL CHEM, V280, P4182, DOI 10.1074/jbc.M412566200; Pogribny I, 2004, BIOCHEM BIOPH RES CO, V320, P1253, DOI 10.1016/j.bbrc.2004.06.081; Pogrlbny I, 2005, MOL CANCER RES, V3, P553, DOI 10.1158/1541-7786.MCR-05-0074; Ponnaluri VKC, 2013, BIOCHEM BIOPH RES CO, V436, P115, DOI 10.1016/j.bbrc.2013.05.077; Snyder AR, 2005, DNA REPAIR, V4, P958, DOI 10.1016/j.dnarep.2005.04.003; Suzuki K, 2012, JPN J CLIN ONCOL, V42, P563, DOI 10.1093/jjco/hys078; Tawa R, 1998, J RADIAT RES, V39, P271, DOI 10.1269/jrr.39.271; THU KL, 2009, JOVE-J VIS EXP, V23, P935; Wang YL, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-54; Weber M, 2007, CURR OPIN CELL BIOL, V19, P273, DOI 10.1016/j.ceb.2007.04.011	30	23	32	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90804	10.1371/journal.pone.0090804	http://dx.doi.org/10.1371/journal.pone.0090804			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614869	Green Submitted, Green Published, gold			2022-12-25	WOS:000332839300043
J	Duvvuri, VR; Duvvuri, B; Alice, C; Wu, GE; Gubbay, JB; Wu, JH				Duvvuri, Venkata R.; Duvvuri, Bhargavi; Alice, Christilda; Wu, Gillian E.; Gubbay, Jonathan B.; Wu, Jianhong			Preexisting CD4+T-Cell Immunity in Human Population to Avian Influenza H7N9 Virus: Whole Proteome-Wide Immunoinformatics Analyses	PLOS ONE			English	Article							T-CELL RESPONSE; EPITOPE-BASED DIAGNOSTICS; A H7N9; SEASONAL INFLUENZA; VACCINE TARGETS; HUMAN INFECTION; ORIGIN; CHINA; PROTECTION; IMMUNOGENICITY	In 2013, a novel avian influenza H7N9 virus was identified in human in China. The antigenically distinct H7N9 surface glycoproteins raised concerns about lack of cross-protective neutralizing antibodies. Epitope-specific preexisting T-cell immunity was one of the protective mechanisms in pandemic 2009 H1N1 even in the absence of cross-protective antibodies. Hence, the assessment of preexisting CD4+ T-cell immunity to conserved epitopes shared between H7N9 and human influenza A viruses (IAV) is critical. A comparative whole proteome-wide immunoinformatics analysis was performed to predict the CD4+ T-cell epitopes that are commonly conserved within the proteome of H7N9 in reference to IAV subtypes (H1N1, H2N2, and H3N2). The CD4+ T-cell epitopes that are commonly conserved (similar to 556) were further screened against the Immune Epitope Database (IEDB) to validate their immunogenic potential. This analysis revealed that 45.5% (253 of 556) epitopes are experimentally proven to induce CD4+ T-cell memory responses. In addition, we also found that 23.3% of CD4+ T-cell epitopes have >= 90% of sequence homology with experimentally defined CD8+ T-cell epitopes. We also conducted the population coverage analysis across different ethnicities using commonly conserved CD4+ T-cell epitopes and corresponding HLA-DRB1 alleles. Interestingly, the indigenous populations from Canada, United States, Mexico and Australia exhibited low coverage (28.65% to 45.62%) when compared with other ethnicities (57.77% to 94.84%). In summary, the present analysis demonstrate an evidence on the likely presence of preexisting T-cell immunity in human population and also shed light to understand the potential risk of H7N9 virus among indigenous populations, given their high susceptibility during previous pandemic influenza events. This information is crucial for public health policy, in targeting priority groups for immunization programs.	[Duvvuri, Venkata R.; Duvvuri, Bhargavi; Alice, Christilda; Wu, Jianhong] York Inst Hlth Res, Ctr Dis Modelling, Toronto, ON, Canada; [Gubbay, Jonathan B.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Wu, Gillian E.; Wu, Jianhong] York Univ, Toronto, ON M3J 2R7, Canada; [Gubbay, Jonathan B.] Publ Hlth Ontario, Toronto, ON, Canada; [Gubbay, Jonathan B.] Univ Toronto, Toronto, ON, Canada; [Gubbay, Jonathan B.] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada	York University - Canada; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); York University - Canada; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Duvvuri, VR (corresponding author), York Inst Hlth Res, Ctr Dis Modelling, Toronto, ON, Canada.	venkata.r.duvvuri@gmail.com	Duvvuri, Bhargavi/H-3443-2019; Wu, Jian/AAU-5221-2020; wu, ge/ABE-3285-2020; Duvvuri, Venkata R/H-2728-2019; Gubbay, Jonathan/Q-8580-2019; Wu, Jian/AAU-5221-2020	Duvvuri, Bhargavi/0000-0002-8717-0584; Wu, Jian/0000-0001-9933-7364; Duvvuri, Venkata R/0000-0001-7356-338X; Gubbay, Jonathan/0000-0003-0026-3786; Wu, Jian/0000-0002-3394-1507	Canada Research Chairs program; Natural Sciences and Engineering Research Council of Canada; International Development Research Centre	Canada Research Chairs program(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); International Development Research Centre	This work was supported by the Canada Research Chairs program, The Natural Sciences and Engineering Research Council of Canada and International Development Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlers JD, 1997, P NATL ACAD SCI USA, V94, P10856, DOI 10.1073/pnas.94.20.10856; Assarsson E, 2008, J VIROL, V82, P12241, DOI 10.1128/JVI.01563-08; Ayyoub M, 2005, CLIN IMMUNOL, V114, P70, DOI 10.1016/j.clim.2004.08.014; Boggild AK, 2011, CAN J PUBLIC HEALTH, V102, P345, DOI 10.1007/BF03404174; Brooks EG, 2012, J FORENSIC SCI, V57, P1512, DOI 10.1111/j.1556-4029.2012.02163.x; Bui HH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-361; Bui HH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-153; CARRENO BM, 1992, J IMMUNOL, V148, P894; Cheng VCC, 2012, CLIN MICROBIOL REV, V25, P223, DOI 10.1128/CMR.05012-11; De Groot AS, 2013, HUM VACC IMMUNOTHER, V9, P950, DOI 10.4161/hv.24939; De Groot AS, 2009, VACCINE, V27, P5740, DOI 10.1016/j.vaccine.2009.07.040; Dennis KM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3693; Duvvuri VR, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-204; Duvvuri VR, 2012, VACCINE, V30, P6054, DOI 10.1016/j.vaccine.2012.07.054; Duvvuri VRSK, 2010, INFLUENZA OTHER RESP, V4, P249, DOI 10.1111/j.1750-2659.2010.00161.x; Galli G, 2009, P NATL ACAD SCI USA, V106, P3877, DOI 10.1073/pnas.0813390106; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Heiny AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001190; Hertz T, 2013, P NATL ACAD SCI USA, V110, P13492, DOI 10.1073/pnas.1221555110; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Karosiene E, 2013, IMMUNOGENETICS, V65, P711, DOI 10.1007/s00251-013-0720-y; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Khan AM, 2006, CELL IMMUNOL, V244, P141, DOI 10.1016/j.cellimm.2007.02.005; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; La Ruche G, 2009, EUROSURVEILLANCE, V14, P51; Li Q., 2013, N ENGL J ME IN PRESS; Lin HH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S22; Lindstrom S, 2012, EMERG INFECT DIS, V18, P834, DOI 10.3201/eid1805.111922; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Lv HK, 2013, EMERG INFECT DIS, V19, P1885, DOI 10.3201/eid1911.130717; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Qi X, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4752; Quinones-Parra S, 2014, P NATL ACAD SCI US; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Richards KA, 2010, J IMMUNOL, V185, P4998, DOI 10.4049/jimmunol.1001395; Roti M, 2008, J IMMUNOL, V180, P1758, DOI 10.4049/jimmunol.180.3.1758; Schaffer A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-869; Trauer JM, 2013, EMERG INFECT DIS, V19, P92, DOI 10.3201/eid1901.111643; TUITE AR, 2009, CMAJ, V182, P131, DOI DOI 10.1503/CMAJ.091807; Uyeki TM, 2013, NEW ENGL J MED, V368, P1862, DOI 10.1056/NEJMp1304661; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Webby RJ, 2003, P NATL ACAD SCI USA, V100, P7235, DOI 10.1073/pnas.1232449100; Weinfurter JT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002381; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; World Health Organization, BACKGR SUMM HUM INF; Yang SG, 2014, J INFECT DIS, V209, P265, DOI 10.1093/infdis/jit430; Zarychanski R, 2010, CAN MED ASSOC J, V182, P257, DOI 10.1503/cmaj.091884; Zhu YF, 2013, LANCET, V381, P2134, DOI 10.1016/S0140-6736(13)61135-6; Zwaveling S, 2002, J IMMUNOL, V169, P350, DOI 10.4049/jimmunol.169.1.350	51	10	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91273	10.1371/journal.pone.0091273	http://dx.doi.org/10.1371/journal.pone.0091273			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609014	Green Published, gold, Green Submitted			2022-12-25	WOS:000332485800120
J	McCutcheon, S; Langeveld, JPM; Tan, BC; Gill, AC; de Wolf, C; Martin, S; Gonzalez, L; Alibhai, J; Blanco, ARA; Campbell, L; Hunter, N; Houston, EF				McCutcheon, Sandra; Langeveld, Jan P. M.; Tan, Boon Chin; Gill, Andrew C.; de Wolf, Christopher; Martin, Stuart; Gonzalez, Lorenzo; Alibhai, James; Blanco, A. Richard Alejo; Campbell, Lauren; Hunter, Nora; Houston, E. Fiona			Prion Protein-Specific Antibodies that Detect Multiple TSE Agents with High Sensitivity	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; PRP MONOCLONAL-ANTIBODIES; CELLULAR PRION; IMMUNOFLUOROMETRIC ASSAY; DIFFERENTIAL-DIAGNOSIS; PENTOSAN POLYSULFATE; SHEEP BRAIN; SCRAPIE; DISEASE; EPITOPES	This paper describes the generation, characterisation and potential applications of a panel of novel anti-prion protein monoclonal antibodies (mAbs). The mAbs were generated by immunising PRNP null mice, using a variety of regimes, with a truncated form of recombinant ovine prion protein spanning residues 94-233. Epitopes of specific antibodies were mapped using solid-phase Pepscan analysis and clustered to four distinct regions within the PrP molecule. We have demonstrated the utility of these antibodies by use of Western blotting and immunohistochemistry in tissues from a range of different species affected by transmissible spongiform encephalopathy (TSE). In comparative tests against extensively-used and widely-published, commercially available antibodies, similar or improved results can be obtained using these new mAbs, specifically in terms of sensitivity of detection. Since many of these antibodies recognise native PrP C, they could also be applied to a broad range of immunoassays such as flow cytometry, DELFIA analysis or immunoprecipitation. We are using these reagents to increase our understanding of TSE pathogenesis and for use in potential diagnostic screening assays.	[McCutcheon, Sandra; Tan, Boon Chin; Gill, Andrew C.; de Wolf, Christopher; Alibhai, James; Blanco, A. Richard Alejo; Campbell, Lauren; Hunter, Nora; Houston, E. Fiona] Roslin Inst, Div Neurobiol, Edinburgh, Midlothian, Scotland; [McCutcheon, Sandra; Tan, Boon Chin; Gill, Andrew C.; de Wolf, Christopher; Alibhai, James; Blanco, A. Richard Alejo; Campbell, Lauren; Hunter, Nora; Houston, E. Fiona] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland; [Langeveld, Jan P. M.] Cent Vet Inst Wageningen UR, Lelystad, Netherlands; [Martin, Stuart; Gonzalez, Lorenzo] Anim Hlth & Vet Labs Agcy, Lasswade Lab, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Wageningen University & Research	McCutcheon, S (corresponding author), Roslin Inst, Div Neurobiol, Edinburgh, Midlothian, Scotland.	sandra.mccutcheon@roslin.ed.ac.uk	Gill, ANdrew/GRO-1248-2022; González, Lorenzo/A-5325-2010; Gill, Andrew C/A-5219-2009	González, Lorenzo/0000-0003-4199-4526; Gill, Andrew C/0000-0001-5201-9473; Tan, Kyle BC/0000-0001-5901-2418	BBSRC [201/BS3 09722]; British Council; NWO for (UK-Netherlands Partnership Program) [PPS 801]; BBSRC [BBS/E/D/20251968, BBS/E/A/00001658, BBS/E/D/20251967] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/A/00001658, BBS/E/D/20251967, 1026989, BBS/E/D/20251968] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Council(The British Council in India); NWO for (UK-Netherlands Partnership Program); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by grants from BBSRC (201/BS3 09722), British Council and the NWO for (UK-Netherlands Partnership Program, PPS 801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrievskaia O, 2006, CLIN VACCINE IMMUNOL, V13, P98, DOI 10.1128/CVI.13.1.98-105.2006; Baron T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000137; BARRY RA, 1986, J INFECT DIS, V154, P518, DOI 10.1093/infdis/154.3.518; Benestad SL, 2003, VET REC, V153, P202, DOI 10.1136/vr.153.7.202; Beringue V, 2003, BRAIN, V126, P2065, DOI 10.1093/brain/awg205; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Biacabe AG, 2007, PRION, V1, P61, DOI 10.4161/pri.1.1.3828; Brown KL, 2013, J GEN VIROLOGY; Campbell L, 2013, BBA-MOL BASIS DIS, V1832, P826, DOI 10.1016/j.bbadis.2013.02.020; Dawson M, 1998, VET REC, V142, P623; de Marco MF, 2010, J PATHOL, V222, P380, DOI 10.1002/path.2767; Esiri MM, 2000, NEUROPATH APPL NEURO, V26, P273, DOI 10.1046/j.1365-2990.2000.00239.x; Farquhar C, 1999, LANCET, V353, P117, DOI 10.1016/S0140-6736(98)05395-1; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; GEYSEN HM, 1984, P NATL ACAD SCI-BIOL, V81, P3998, DOI 10.1073/pnas.81.13.3998; Gill AC, 2011, CAB REV, V6; GOLDMANN W, 1994, J GEN VIROL, V75, P989, DOI 10.1099/0022-1317-75-5-989; Gonzalez L, 2005, J GEN VIROL, V86, P827, DOI 10.1099/vir.0.80299-0; Gonzalez L, 2002, J COMP PATHOL, V126, P17, DOI 10.1053/jcpa.2001.0516; Gretzschel A, 2006, J GEN VIROL, V87, P3715, DOI 10.1099/vir.0.81816-0; GROSCHUP MH, 1993, J GEN VIROL, V74, P1451, DOI 10.1099/0022-1317-74-7-1451; Halliday S, 2005, J GEN VIROL, V86, P1571, DOI 10.1099/vir.0.80561-0; Harlow E, 1988, LAB MANUAL, P310; Harmeyer S, 1998, J GEN VIROL, V79, P937, DOI 10.1099/0022-1317-79-4-937; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Holada K, 2007, TRANSFUSION, V47, P2223, DOI 10.1111/j.1537-2995.2007.01451.x; Holznagel E, 2010, TRANSFUSION, V50, P452, DOI 10.1111/j.1537-2995.2009.02437.x; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; Horiuchi M, 2009, VIROLOGY, V394, P200, DOI 10.1016/j.virol.2009.08.025; Hunter N, 1997, TRENDS MICROBIOL, V5, P331, DOI 10.1016/S0966-842X(97)01081-0; Jacobs JG, 2011, J VIROL, V85, P12537, DOI 10.1128/JVI.00448-11; Jacobs JG, 2011, J GEN VIROL, V92, P222, DOI 10.1099/vir.0.026153-0; Jeffrey M, 2006, J COMP PATHOL, V134, P17, DOI 10.1016/j.jcpa.2005.06.005; Jeffrey M, 2003, J GEN VIROL, V84, P1033, DOI 10.1099/vir.0.18825-0; Jeffrey M, 2001, J COMP PATHOL, V125, P271, DOI 10.1053/jcpa.2001.0499; Kanyo ZF, 1999, J MOL BIOL, V293, P855, DOI 10.1006/jmbi.1999.3193; Kascsak R, 2010, J BIOL CHEM, V285, pLE5, DOI 10.1074/jbc.L109.088831; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kirby L, 2003, J GEN VIROL, V84, P1013, DOI 10.1099/vir.0.18903-0; Kirby L, 2010, BIOCHEMISTRY-US, V49, P1448, DOI 10.1021/bi901855z; Klohn PC, 2012, SCIENCE, V335, P52, DOI 10.1126/science.1215579; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; Kovacs GG, 2002, BRAIN PATHOL, V12, P1; Krasemann S, 1996, J IMMUNOL METHODS, V199, P109, DOI 10.1016/S0022-1759(96)00165-2; Langeveld Jan P M, 2006, BMC Vet Res, V2, P19, DOI 10.1186/1746-6148-2-19; Lee CA, 1998, THROMB HAEMOSTASIS, V80, P909; Lee IY, 1998, GENOME RES, V8, P1022, DOI 10.1101/gr.8.10.1022; Lezmi S, 2004, J VIROL, V78, P3654, DOI 10.1128/JVI.78.7.3654-3662.2004; Li L, 2009, PROTEIN ENG DES SEL, V22, P523, DOI 10.1093/protein/gzp038; Madampage CA, 2013, PRION, V7; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; McCutcheon S, 2005, J IMMUNOL METHODS, V298, P119, DOI 10.1016/j.jim.2005.01.012; McCutcheon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023169; Moroncini G, 2004, P NATL ACAD SCI USA, V101, P10404, DOI 10.1073/pnas.0403522101; Nakamura N, 2003, HYBRIDOMA HYBRIDOM, V22, P263, DOI 10.1089/153685903322328992; Orru CD, 2011, MBIO, V2, DOI 10.1128/mBio.00078-11; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pan T, 2004, J NEUROCHEM, V90, P1205, DOI 10.1111/j.1471-4159.2004.02582.x; Panigaj M, 2011, TRANSFUSION, V51, P1012, DOI 10.1111/j.1537-2995.2010.02924.x; Paramithiotis E, 2003, NAT MED, V9, P893, DOI 10.1038/nm883; PICCARDO P, 1995, J NEUROPATH EXP NEUR, V54, P790, DOI 10.1097/00005072-199511000-00006; Pirisinu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066405; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; Privat N, 2008, MODERN PATHOL, V21, P140, DOI 10.1038/modpathol.3800994; Rhie A, 2003, J BIOL CHEM, V278, P39697, DOI 10.1074/jbc.M305297200; Rodriguez-Martinez AB, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-99; Roettger Y, 2013, NAT REV NEUROL, V9, P98, DOI 10.1038/nrneurol.2012.258; Rubenstein R, 1999, J NEUROVIROL, V5, P401, DOI 10.3109/13550289909029481; Seuberlich T, 2012, EMERG INFECT DIS, V18, P158, DOI 10.3201/eid1801.111225; Shimizu Y, 2010, MICROBIOL IMMUNOL, V54, P112, DOI 10.1111/j.1348-0421.2009.00190.x; Silva CJ, 2012, PRION, V6, P163, DOI 10.4161/pri.18795; Slootstra JW, 1996, MOL DIVERS, V1, P87, DOI 10.1007/BF01721323; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Stack MJ, 2002, ACTA NEUROPATHOL, V104, P279, DOI 10.1007/s00401-002-0556-2; Stanker LH, 2012, HYBRIDOMA, V31, P314, DOI 10.1089/hyb.2012.0022; Tan BC, 2012, J GEN VIROL, V93, P2749, DOI 10.1099/vir.0.039008-0; Tang Y, 2012, J IMMUNOL METHODS, V380, P30, DOI 10.1016/j.jim.2012.03.004; Tang Y, 2010, J IMMUNOL METHODS, V356, P29, DOI 10.1016/j.jim.2010.03.002; Thackray AM, 2006, BIOCHEM J, V400, P349, DOI 10.1042/BJ20060746; Thackray AM, 2005, BIOCHEM J, V390, P563, DOI 10.1042/BJ20050571; Thuring CMA, 2004, J CLIN MICROBIOL, V42, P972, DOI 10.1128/JCM.42.3.972-980.2004; Thuring CMA, 2005, J COMP PATHOL, V132, P59, DOI 10.1016/j.jcpa.2004.06.004; Todd NV, 2005, J INFECTION, V50, P394, DOI 10.1016/j.jinf.2004.07.015; Tveit H, 2005, BIOCHEM BIOPH RES CO, V337, P232, DOI 10.1016/j.bbrc.2005.09.031; vanKeulen LJM, 1996, J CLIN MICROBIOL, V34, P1228, DOI 10.1128/JCM.34.5.1228-1231.1996; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Whyte SM, 2003, BIOCHEM J, V373, P485, DOI 10.1042/BJ20021911; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Wisniewski T, 2010, EXPERT REV VACCINES, V9, P1441, DOI [10.1586/erv.10.131, 10.1586/ERV.10.131]; YOKOYAMA T, 1995, CLIN DIAGN LAB IMMUN, V2, P172, DOI 10.1128/CDLI.2.2.172-176.1995; Yuan FF, 2005, IMMUNOL CELL BIOL, V83, P632, DOI 10.1111/j.1440-1711.2005.01384.x; Zanusso G, 1998, P NATL ACAD SCI USA, V95, P8812, DOI 10.1073/pnas.95.15.8812	93	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91143	10.1371/journal.pone.0091143	http://dx.doi.org/10.1371/journal.pone.0091143			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608105	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000332485800103
J	Tsang, VWK; Young, D; During, MJ; Birch, NP				Tsang, Vicky W. K.; Young, Deborah; During, Matthew J.; Birch, Nigel P.			AAV-Mediated Overexpression of Neuroserpin in the Hippocampus Decreases PSD-95 Expression but Does Not Affect Hippocampal-Dependent Learning and Memory	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; SERINE-PROTEASE INHIBITOR; CENTRAL-NERVOUS-SYSTEM; LONG-TERM POTENTIATION; TRANSGENIC MICE; SYNAPTIC PLASTICITY; RECEPTOR SUBUNIT; GENE-EXPRESSION; NMDA RECEPTOR; RAT-BRAIN	Neuroserpin is a serine protease inhibitor, or serpin, that is expressed in the nervous system and inhibits the protease tissue plasminogen activator (tPA). Neuroserpin has been suggested to play a role in learning and memory but direct evidence for such a role is lacking. Here we have used an adeno-associated virus (AAV) vector expression system to investigate the effect of neuroserpin on hippocampal-dependent learning and memory in the young adult rat. A FLAG-tagged neuroserpin construct was initially characterized by in vitro transcription/translation and transfection into HEK293 cells and shown to interact with tPA and be targeted to the secretory pathway. Targeted injection of a chimeric AAV1/2 vector expressing FLAG-neuroserpin resulted in localized overexpression in the dorsal hippocampus. Neuroserpin overexpression led to the appearance of an unstable neuroserpin: tPA complex in zymographic assays consistent with interaction with endogenous tPA in vivo. Rats overexpressing neuroserpin also showed a significant decrease in the levels of postsynaptic density protein 95, a major postsynaptic scaffolding protein. Three weeks after injection, a range of behavioural tests was performed to measure spatial and associative learning and memory, as well as innate and acquired fear. These tests provided no evidence of a role for neuroserpin in hippocampal-dependent learning and memory. In summary this study does not support a role for neuroserpin in hippocampal-dependent learning and memory in young adult rats but does suggest an involvement of neuroserpin in hippocampal synaptic plasticity.	[Tsang, Vicky W. K.; Birch, Nigel P.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Young, Deborah; During, Matthew J.] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Young, Deborah] Univ Auckland, Dept Pharmacol & Clin Pharmacol, Auckland 1, New Zealand; [Tsang, Vicky W. K.; Young, Deborah; During, Matthew J.; Birch, Nigel P.] Univ Auckland, Ctr Brain Res, Auckland 1, New Zealand; [During, Matthew J.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	University of Auckland; University of Auckland; University of Auckland; University of Auckland; Ohio State University	Tsang, VWK (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.	v.tsang@auckland.ac.nz	During, Matthew/AAC-1388-2020; Birch, Nigel/H-2498-2011	Birch, Nigel/0000-0002-8417-3587; Young, Deborah/0000-0003-1085-2824	Royal Society of New Zealand Marsden Grant; University of Auckland Doctoral Scholarship	Royal Society of New Zealand Marsden Grant(Royal Society of New ZealandMarsden Fund (NZ)); University of Auckland Doctoral Scholarship	This research was funded by a Royal Society of New Zealand Marsden Grant. V. W. K. T. was supported by a University of Auckland Doctoral Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker-Carlson K, 2002, J BIOL CHEM, V277, P46852, DOI 10.1074/jbc.M207740200; Berger P, 1999, MOL CELL NEUROSCI, V14, P455, DOI 10.1006/mcne.1999.0804; Bolivar VJ, 2003, BEHAV NEUROSCI, V117, P1233, DOI 10.1037/0735-7044.117.6.1233; Borges VM, 2010, J NEUROSCI RES, V88, P2610, DOI 10.1002/jnr.22428; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Calabresi P, 2000, EUR J NEUROSCI, V12, P1002, DOI 10.1046/j.1460-9568.2000.00991.x; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Carreton O, 2012, EXP NEUROL, V237, P335, DOI 10.1016/j.expneurol.2012.06.033; Chen XB, 2005, P NATL ACAD SCI USA, V102, P11551, DOI 10.1073/pnas.0505359102; Cinelli P, 2001, MOL CELL NEUROSCI, V18, P443, DOI 10.1006/mcne.2001.1028; Conde CA, 1999, PHARMACOL BIOCHEM BE, V63, P63, DOI 10.1016/S0091-3057(98)00251-2; De Roo M, 2008, CEREB CORTEX, V18, P151, DOI 10.1093/cercor/bhm041; Dobo J, 2004, J BIOL CHEM, V279, P9264, DOI 10.1074/jbc.M311731200; During Matthew J, 2003, Methods Mol Med, V76, P221; El-Hussein AE, 2000, SCIENCE, V290, P1364; Fassio A, 2011, SEMIN CELL DEV BIOL, V22, P408, DOI 10.1016/j.semcdb.2011.07.005; Feyissa AM, 2009, PROG NEURO-PSYCHOPH, V33, P70, DOI 10.1016/j.pnpbp.2008.10.005; Frey U, 1996, J NEUROSCI, V16, P2057; Hall C, 1932, U CALIFORNIA PUBLICA; Hall RA, 1997, J BIOL CHEM, V272, P4135, DOI 10.1074/jbc.272.7.4135; Hastings GA, 1997, J BIOL CHEM, V272, P33062, DOI 10.1074/jbc.272.52.33062; Hauck B, 2003, MOL THER, V7, P419, DOI 10.1016/S1525-0016(03)00012-1; Hill RM, 2000, BIOCHEM J, V345, P595, DOI 10.1042/0264-6021:3450595; Huang YY, 1996, P NATL ACAD SCI USA, V93, P8699, DOI 10.1073/pnas.93.16.8699; Huh KH, 1999, J BIOL CHEM, V274, P151, DOI 10.1074/jbc.274.1.151; Ishigami S, 2007, BIOCHEM J, V402, P25, DOI 10.1042/BJ20061170; KAPLITT MG, 1994, NAT GENET, V8, P148, DOI 10.1038/ng1094-148; Karolewicz B, 2009, INT J NEUROPSYCHOPH, V12, P143, DOI 10.1017/S1461145708008985; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Kiyota T, 2011, GENE THER, V19; Klugmann M, 2005, MOL CELL NEUROSCI, V28, P347, DOI 10.1016/j.mcn.2004.10.002; Krueger SR, 1997, J NEUROSCI, V17, P8984; Lee TW, 2008, J NEUROSCI RES, V86, P1243, DOI 10.1002/jnr.21592; Li SF, 2006, BRAIN RES, V1122, P1, DOI 10.1016/j.brainres.2006.09.042; Madani R, 2003, MOL CELL NEUROSCI, V23, P473, DOI 10.1016/S1044-7431(03)00077-0; Madani R, 1999, EMBO J, V18, P3007, DOI 10.1093/emboj/18.11.3007; Makarova A, 2003, J BIOL CHEM, V278, P50250, DOI 10.1074/jbc.M309150200; Martin AM, 2008, J BIOL CHEM, V283, P12004, DOI 10.1074/jbc.M707607200; Mastakov MY, 2001, MOL THER, V3, P225, DOI 10.1006/mthe.2001.0246; Mataga N, 2002, P NATL ACAD SCI USA, V99, P7717, DOI 10.1073/pnas.102088899; MEIRI N, 1994, P NATL ACAD SCI USA, V91, P3196, DOI 10.1073/pnas.91.8.3196; Miranda E, 2004, J BIOL CHEM, V279, P28283, DOI 10.1074/jbc.M313166200; Miranda E, 2006, CELL MOL LIFE SCI, V63, P709, DOI 10.1007/s00018-005-5077-4; Miranda E, 2008, HUM MOL GENET, V17, P1527, DOI 10.1093/hmg/ddn041; Mouravlev A, 2006, P NATL ACAD SCI USA, V103, P4705, DOI 10.1073/pnas.0506137103; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Olson ST, 2011, PROG MOL BIOL TRANSL, V99, P185, DOI 10.1016/S1877-1173(11)99005-X; Osterwalder T, 1998, J BIOL CHEM, V273, P2312, DOI 10.1074/jbc.273.4.2312; Osterwalder T, 1996, EMBO J, V15, P2944, DOI 10.1002/j.1460-2075.1996.tb00657.x; Pawlak R, 2002, NEUROSCIENCE, V113, P995, DOI 10.1016/S0306-4522(02)00166-5; Ricagno S, 2009, J MOL BIOL, V388, P109, DOI 10.1016/j.jmb.2009.02.056; Teesalu T, 2004, THROMB HAEMOSTASIS, V92, P358; Toro C, 2005, SCHIZOPHR RES, V80, P323, DOI 10.1016/j.schres.2005.07.003; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; VASSALLI JD, 1984, J EXP MED, V159, P1653, DOI 10.1084/jem.159.6.1653; Wang DV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018739; Wannier-Morino P, 2003, EUR J NEUROSCI, V17, P1853, DOI 10.1046/j.1460-9568.2003.02628.x; Watson Paxinos, 1986, RAT BRAIN STEREOTAXI; Woods GF, 2011, J NEUROSCI, V31, P12129, DOI 10.1523/JNEUROSCI.6662-10.2011; Xu R, 2001, GENE THER, V8, P1323, DOI 10.1038/sj.gt.3301529; Xu WF, 2011, CURR OPIN NEUROBIOL, V21, P306, DOI 10.1016/j.conb.2011.03.001; Zhou AW, 2001, J BIOL CHEM, V276, P27541, DOI 10.1074/jbc.M102594200	63	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91050	10.1371/journal.pone.0091050	http://dx.doi.org/10.1371/journal.pone.0091050			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608243	Green Submitted, Green Published, gold			2022-12-25	WOS:000332485800088
J	Wills, ES; Jonkers, DMAE; Savelkoul, PH; Masclee, AA; Pierik, MJ; Penders, J				Wills, Edgar S.; Jonkers, Daisy M. A. E.; Savelkoul, Paul H.; Masclee, Ad A.; Pierik, Marieke J.; Penders, John			Fecal Microbial Composition of Ulcerative Colitis and Crohn's Disease Patients in Remission and Subsequent Exacerbation	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; COLONIC-MUCOSA; DIVERSITY; IBD; 6-MERCAPTOPURINE; AZATHIOPRINE; MICROFLORA; FLORA	Background: Limited studies have examined the intestinal microbiota composition in relation to changes in disease course of IBD over time. We aimed to study prospectively the fecal microbiota in IBD patients developing an exacerbation during follow-up. Design: Fecal samples from 10 Crohn's disease (CD) and 9 ulcerative colitis (UC) patients during remission and subsequent exacerbation were included. Active disease was determined by colonoscopy and/or fecal calprotectine levels. Exclusion criteria were pregnancy, antibiotic use, enema use and/or medication changes between consecutive samples. The microbial composition was assessed by 16S rDNA pyrosequencing. Results: After quality control, 6,194-11,030 sequences per sample were available for analysis. Patient-specific shifts in bacterial composition and diversity were observed during exacerbation compared to remission, but overarching shifts within UC or CD were not observed. Changes in the bacterial community composition between remission and exacerbation as assessed by Bray-Curtis dissimilarity, were significantly larger in CD versus UC patients (0.59 vs. 0.42, respectively; p = 0.025). Thiopurine use was found to be a significant cause of clustering as shown by Principal Coordinate Analysis and was associated with decreases in bacterial richness (Choa1 501.2 vs. 847.6 in non-users; p<0.001) and diversity (Shannon index: 5.13 vs. 6.78, respectively; p<0.01). Conclusion: Shifts in microbial composition in IBD patients with changing disease activity over time seem to be patient-specific, and are more pronounced in CD than in UC patients. Furthermore, thiopurine use was found to be associated with the microbial composition and diversity, and should be considered when studying the intestinal microbiota in relation to disease course.	[Wills, Edgar S.; Jonkers, Daisy M. A. E.; Masclee, Ad A.; Pierik, Marieke J.] Maastricht Univ, Med Ctr, Div Gastroenterol & Hepatol, Sch Nutr Toxicol & Metab NUTRIM, Maastricht, Netherlands; [Wills, Edgar S.; Savelkoul, Paul H.; Penders, John] Maastricht Univ, Med Ctr, Dept Med Microbiol, Sch Nutr Toxicol & Metab NUTRIM, Maastricht, Netherlands; [Penders, John] Maastricht Univ, Dept Epidemiol, Sch Publ Hlth & Primary Care Caphri, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University	Penders, J (corresponding author), Maastricht Univ, Med Ctr, Dept Med Microbiol, Sch Nutr Toxicol & Metab NUTRIM, Maastricht, Netherlands.	j.penders@mumc.nl	Penders, John/A-1280-2011	Penders, John/0000-0001-9146-5919	Academic Foundation of Maastricht University Medical Center+; IBD Research Foundation	Academic Foundation of Maastricht University Medical Center+; IBD Research Foundation	This study was financially supported by grants form the Academic Foundation of Maastricht University Medical Center+ and by the IBD Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	af Bjorkesten CG, 2012, SCAND J GASTROENTERO, V47, P528, DOI 10.3109/00365521.2012.660542; Andoh A, 2011, J GASTROENTEROL, V46, P479, DOI 10.1007/s00535-010-0368-4; Bibiloni R, 2006, J MED MICROBIOL, V55, P1141, DOI 10.1099/jmm.0.46498-0; Blumenstein I, 2008, INFLAMM BOWEL DIS, V14, P53, DOI 10.1002/ibd.20257; Buchanan J, 2011, J CROHNS COLITIS, V5, P301, DOI 10.1016/j.crohns.2011.02.005; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06; Greenstein RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000161; Kaser A, 2010, DIGEST DIS, V28, P395, DOI 10.1159/000320393; Kotlowski R, 2007, GUT, V56, P669, DOI 10.1136/gut.2006.099796; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Lladser ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021105; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Martinez-Medina M, 2006, INFLAMM BOWEL DIS, V12, P1136, DOI 10.1097/01.mib.0000235828.09305.0c; Masclee GMC, 2013, INFLAMM BOWEL DIS, V19, P124, DOI 10.1002/ibd.22976; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Mylonaki M, 2005, INFLAMM BOWEL DIS, V11, P481, DOI 10.1097/01.MIB.0000159663.62651.4f; Nagalingam NA, 2011, INFLAMM BOWEL DIS; Nam YD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022109; Ohkusa T, 2002, J GASTROEN HEPATOL, V17, P849, DOI 10.1046/j.1440-1746.2002.02834.x; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Patrick Sheila, 2012, Mob Genet Elements, V2, P149; Prindiville TP, 2000, EMERG INFECT DIS, V6, P171, DOI 10.3201/eid0602.000210; Rajilic-Stojanovic M, 2013, INFLAMM BOWEL DIS, V19, P481, DOI 10.1097/MIB.0b013e31827fec6d; Regueiro M, 2011, INFLAMM BOWEL DIS, V17, P118, DOI 10.1002/ibd.21355; Rehman A, 2010, J MED MICROBIOL, V59, P1114, DOI 10.1099/jmm.0.021170-0; Robizadeh S, 2007, INFLAMM BOWEL DIS, V13, P1475, DOI 10.1002/ibd.20265; Sandborn WJ, 2001, GUT, V48, P591, DOI 10.1136/gut.48.5.591; Scharl M, 2012, CURR OPIN GASTROEN, V28, P301, DOI 10.1097/MOG.0b013e328353e61e; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Sepehri S, 2007, INFLAMM BOWEL DIS, V13, P675, DOI 10.1002/ibd.20101; Shin SJ, 2008, ANTIMICROB AGENTS CH, V52, P418, DOI 10.1128/AAC.00678-07; Sokol H, 2006, INFLAMM BOWEL DIS, V12, P106, DOI 10.1097/01.MIB.0000200323.38139.c6; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sokol H, 2008, INFLAMM BOWEL DIS, V14, P858, DOI 10.1002/ibd.20392; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Swidsinski A, 2008, INFLAMM BOWEL DIS, V14, P147, DOI 10.1002/ibd.20330; Takaishi H, 2008, INT J MED MICROBIOL, V298, P463, DOI 10.1016/j.ijmm.2007.07.016; Talley NJ, 2011, AM J GASTROENTEROL, V106, pS2, DOI 10.1038/ajg.2011.58; van den Bogert B, 2011, APPL ENVIRON MICROB, V77, P2071, DOI 10.1128/AEM.02477-10; van der Valk ME, 2014, GUT; Vaughn BP, 2014, CURR TREAT OPTIONS G; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Young VB, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00144	52	86	89	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90981	10.1371/journal.pone.0090981	http://dx.doi.org/10.1371/journal.pone.0090981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608638	gold, Green Submitted, Green Published			2022-12-25	WOS:000332485800073
J	Janoir, C; Cohen, R; Levy, C; Bingen, E; Lepoutre, A; Gutmann, L; Varon, E				Janoir, Claire; Cohen, Robert; Levy, Corinne; Bingen, Edouard; Lepoutre, Agnes; Gutmann, Laurent; Varon, Emmanuelle		Observ Regionaux Pneumocoque ORP	Clonal Expansion of the Macrolide Resistant ST386 within Pneumococcal Serotype 6C in France	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE SEROTYPE; ACUTE OTITIS-MEDIA; CONJUGATE VACCINE; INVASIVE DISEASE; NASOPHARYNGEAL CARRIAGE; 6D; 6A; IDENTIFICATION; 13-VALENT; PCR	In France, the use of the 7-valent pneumococcal conjugate vaccine (PCV7) lead to an overall significant decrease in PCV7 invasive pneumococcal disease (IPD) incidence. However, the decrease in vaccine serotype prevalence was partially counterbalanced by the serotype replacement phenomenon. In this study, we analyzed the role of the newly described serotype 6C as one of the replacement serotypes. This work was conducted on a large time scale from the early PCV7 era (2002-2003) to the PCV13 era (2010-2011), both on IPD strains recovered from the whole population and nasopharyngeal colonizing strains isolated in infant less than two years, who are known to be the main reservoir for pneumococci. Serotype 6C took advantage over 6A and 6B serotypes, which both decreased over time. A continuous and significant increase in 6C IPD was observed in adults along the study period; in contrast, in children less than two years, only an increase in 6C nasopharyngeal carriage was found, the prevalence of serotype 6C in IPD remaining very low over time. Among 101 6C invasive and colonizing strains studied by MLST, 24 STs were found to be related to three major clonal complexes, CC395, CC176, and CC315. STs related to CC176 tend to disappear after 2009 and were essentially replaced by ST386 (CC315), which dramatically increased over time. This clonal expansion may be explained by the erythromycin and tetracycline resistances associated with this clone. Finally, the decrease observed in nasopharyngeal 6C carriage since 2010, likely related to the PCV13 introduction in the French immunization schedule, is expected to lead to a decrease in 6C IPD in adults thereafter.	[Janoir, Claire; Gutmann, Laurent; Varon, Emmanuelle] Hop Europeen Georges Pompidou, AP HP, CNRP, Paris, France; [Janoir, Claire] Fac Pharm EA4043, Dept Microbiol, Chatenay Malabry, France; [Cohen, Robert] Ctr Hosp Intercommunal, Dept Microbiol, Creteil, France; [Cohen, Robert; Levy, Corinne] Ctr Hosp Intercommunal, Ctr Rech Clin, Creteil, France; [Cohen, Robert; Levy, Corinne] Assoc Clin Therapeut Infantile Val de Marne ACTIV, St Maur Des Fosses, France; [Cohen, Robert; Levy, Corinne; Bingen, Edouard] GPIP, Paris, France; [Bingen, Edouard] Univ Paris 07, Hop Robert Debre, AP HP, Dept Microbiol, Paris, France; [Lepoutre, Agnes] Inst Veille Sanit, Dept Malad Infect, St Maurice, France; [Gutmann, Laurent; Varon, Emmanuelle] Hop Europeen Georges Pompidou, AP HP, Microbiol Lab, Paris, France; [Gutmann, Laurent] INSERM, U872, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Institute of Public Health Surveillance; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Varon, E (corresponding author), Hop Europeen Georges Pompidou, AP HP, CNRP, Paris, France.	emmanuelle.varon@egp.aphp.fr	Cohen, Robert/AAM-4426-2021; LEVY, Corinne/AAM-3541-2021	Cohen, Robert/0000-0001-6151-0686; LEVY, Corinne/0000-0002-1927-6360; KEMPF, Marie/0000-0002-2943-7500	Public Health Service grant from InVS; Pfizer	Public Health Service grant from InVS; Pfizer(Pfizer)	This work was supported by Public Health Service grant from InVS. Financial support was given by Pfizer for part of the carriage study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens N, 2011, J ANTIMICROB CHEMOTH, V66, P3, DOI 10.1093/jac/dkr453; Bratcher PE, 2011, MICROBIOL-SGM, V157, P189, DOI 10.1099/mic.0.043901-0; Bratcher PE, 2010, MICROBIOL-SGM, V156, P555, DOI 10.1099/mic.0.034116-0; Cai P, 2012, CARBOHYD RES, V351, P98, DOI 10.1016/j.carres.2012.01.017; Campos LC, 2009, DIAGN MICR INFEC DIS, V65, P112, DOI 10.1016/j.diagmicrobio.2009.06.020; Carvalho MD, 2009, J CLIN MICROBIOL, V47, P554, DOI 10.1128/JCM.01919-08; Catalayud L, 2010, J CLIN MICROBIOL, V48, P1310; Cohen R, 2010, VACCINE, V28, P6114, DOI 10.1016/j.vaccine.2009.05.037; Cohen R, 2012, PEDIATR INFECT DIS J, V31, P297, DOI 10.1097/INF.0b013e318247ef84; Cooper D, 2011, VACCINE, V29, P7207, DOI 10.1016/j.vaccine.2011.06.056; Dagan R, 2013, CLIN INFECT DIS, V57, P952, DOI 10.1093/cid/cit428; Elberse K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025018; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Gertz RE, 2010, J INFECT DIS, V201, P770, DOI 10.1086/650496; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Jacobs MR, 2010, J CLIN MICROBIOL, V48, P1456, DOI 10.1128/JCM.01907-09; Jacobs MR, 2009, J CLIN MICROBIOL, V47, P64, DOI 10.1128/JCM.01524-08; Jean-Verdier B, 2011, MED ENFANCE, V31, P187; Jin P, 2009, J INFECT DIS, V200, P1375, DOI 10.1086/606118; Jin P, 2009, J CLIN MICROBIOL, V47, P2470, DOI 10.1128/JCM.00484-09; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Lambertsen L, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-282; LEPOUTRE A, 2008, EURO SURVEILL, V13; Loman NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064731; Mavroidi A, 2004, J BACTERIOL, V186, P8181, DOI 10.1128/JB.186.24.8181-8192.2004; Millar EV, 2010, CLIN INFECT DIS, V51, P1258, DOI 10.1086/657070; Moschioni M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061003; Nahm MH, 2009, J INFECT DIS, V199, P320, DOI 10.1086/596064; Nunes S, 2009, J CLIN MICROBIOL, V47, P472, DOI 10.1128/JCM.01984-08; Oftadeh S, 2010, J CLIN MICROBIOL, V48, P3378, DOI 10.1128/JCM.00675-10; Park IH, 2008, J INFECT DIS, V198, P1818, DOI 10.1086/593339; Park IH, 2007, INFECT IMMUN, V75, P4482, DOI 10.1128/IAI.00510-07; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Rolo D, 2011, J ANTIMICROB CHEMOTH, V66, P1712, DOI 10.1093/jac/dkr193; Rolo D, 2011, J CLIN MICROBIOL, V49, P2328, DOI 10.1128/JCM.02545-10; Song JH, 2011, J CLIN MICROBIOL, V49, P1758, DOI 10.1128/JCM.02628-10; Tocheva AS, 2010, EMERG INFECT DIS, V16, P154, DOI 10.3201/eid1601.090650; Varon E, CTR NATL REFERENCE P; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2; World Health Organization, 2007, WKLY EPIDEMIOL REC, V82, P93; Yildirim I, 2010, VACCINE, V29, P283, DOI 10.1016/j.vaccine.2010.10.032	41	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90935	10.1371/journal.pone.0090935	http://dx.doi.org/10.1371/journal.pone.0090935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603763	Green Submitted, Green Published, gold			2022-12-25	WOS:000332483600109
J	Utami, KH; Hillmer, AM; Aksoy, I; Chew, EGY; Teo, ASM; Zhang, ZS; Lee, CWH; Chen, PJ; Seng, CC; Ariyaratne, PN; Rouam, SL; Soo, LS; Yousoof, S; Prokudin, I; Peters, G; Collins, F; Wilson, M; Kakakios, A; Haddad, G; Menuet, A; Perche, O; Tay, SKH; Sung, KWK; Ruan, XA; Ruan, YJ; Liu, ET; Briault, S; Jamieson, RV; Davila, S; Cacheux, V				Utami, Kagistia H.; Hillmer, Axel M.; Aksoy, Irene; Chew, Elaine G. Y.; Teo, Audrey S. M.; Zhang, Zhenshui; Lee, Charlie W. H.; Chen, Pauline J.; Seng, Chan Chee; Ariyaratne, Pramila N.; Rouam, Sigrid L.; Soo, Lim Seong; Yousoof, Saira; Prokudin, Ivan; Peters, Gregory; Collins, Felicity; Wilson, Meredith; Kakakios, Alyson; Haddad, Georges; Menuet, Arnaud; Perche, Olivier; Tay, Stacey Kiat Hong; Sung, Ken W. K.; Ruan, Xiaoan; Ruan, Yijun; Liu, Edison T.; Briault, Sylvain; Jamieson, Robyn V.; Davila, Sonia; Cacheux, Valere			Detection of Chromosomal Breakpoints in Patients with Developmental Delay and Speech Disorders	PLOS ONE			English	Article							LINKED LYMPHOPROLIFERATIVE SYNDROME; COPY NUMBER VARIATION; HUMAN GENOME; TRANSLOCATION BREAKPOINT; INSITU HYBRIDIZATION; STRUCTURAL VARIATION; MENTAL-RETARDATION; REARRANGEMENTS; GENE; SCHIZOPHRENIA	Delineating candidate genes at the chromosomal breakpoint regions in the apparently balanced chromosome rearrangements (ABCR) has been shown to be more effective with the emergence of next-generation sequencing (NGS) technologies. We employed a large-insert (7-11 kb) paired-end tag sequencing technology (DNA-PET) to systematically analyze genome of four patients harbouring cytogenetically defined ABCR with neurodevelopmental symptoms, including developmental delay (DD) and speech disorders. We characterized structural variants (SVs) specific to each individual, including those matching the chromosomal breakpoints. Refinement of these regions by Sanger sequencing resulted in the identification of five disrupted genes in three individuals: guanine nucleotide binding protein, q polypeptide (GNAQ), RNA-binding protein, fox-1 homolog (RBFOX3), unc-5 homolog D (C. elegans) (UNC5D), transmembrane protein 47 (TMEM47), and X-linked inhibitor of apoptosis (XIAP). Among them, XIAP is the causative gene for the immunodeficiency phenotype seen in the patient. The remaining genes displayed specific expression in the fetal brain and have known biologically relevant functions in brain development, suggesting putative candidate genes for neurodevelopmental phenotypes. This study demonstrates the application of NGS technologies in mapping individual gene disruptions in ABCR as a resource for deciphering candidate genes in human neurodevelopmental disorders (NDDs).	[Utami, Kagistia H.; Hillmer, Axel M.; Aksoy, Irene; Chew, Elaine G. Y.; Teo, Audrey S. M.; Zhang, Zhenshui; Lee, Charlie W. H.; Chen, Pauline J.; Seng, Chan Chee; Ariyaratne, Pramila N.; Rouam, Sigrid L.; Soo, Lim Seong; Sung, Ken W. K.; Ruan, Xiaoan; Ruan, Yijun; Liu, Edison T.; Davila, Sonia; Cacheux, Valere] Genome Inst Singapore, Singapore, Singapore; [Yousoof, Saira; Prokudin, Ivan; Jamieson, Robyn V.] Childrens Hosp Westmead, Childrens Med Res Inst, Sydney, NSW, Australia; [Yousoof, Saira; Prokudin, Ivan; Jamieson, Robyn V.] Save Sight Inst, Sydney, NSW, Australia; [Yousoof, Saira; Prokudin, Ivan] Univ Sydney, Sydney Med Sch, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia; [Yousoof, Saira; Prokudin, Ivan] Univ Sydney, Sydney Med Sch, Discipline Genet Med, Sydney, NSW 2006, Australia; [Peters, Gregory] Childrens Hosp Westmead, Dept Cytogenet, Sydney, NSW, Australia; [Collins, Felicity; Wilson, Meredith] Childrens Hosp Westmead, Dept Clin Genet, Sydney, NSW, Australia; [Kakakios, Alyson] Childrens Hosp Westmead, Dept Immunol, Sydney, NSW, Australia; [Haddad, Georges] Ctr Hosp, Unite Genet, Blois, France; [Menuet, Arnaud; Perche, Olivier; Briault, Sylvain] Ctr Hosp Reg Orleans, Serv Genet INEM CNRS Univ UMR7355, Orleans, France; [Utami, Kagistia H.; Tay, Stacey Kiat Hong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore 117595, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Children's Medical Research Institute - Australia; University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of Sydney; Centre Hospitalier Regional d'Orleans; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); National University of Singapore	Cacheux, V (corresponding author), Genome Inst Singapore, Singapore, Singapore.	valerecacheux@gmail.com	Utami, Kagistia Hana/AAS-2710-2021; Jamieson, Robyn/M-5161-2019; Aksoy, Irene/O-2238-2013; Hillmer, Axel M/B-7485-2015; Hillmer, Axel M/N-2927-2014; Tay, Stacey/E-7029-2015	Jamieson, Robyn/0000-0002-7285-0253; Aksoy, Irene/0000-0003-4353-5876; Hillmer, Axel M/0000-0002-3381-7266; Hillmer, Axel M/0000-0002-3381-7266; Tay, Stacey/0000-0002-3077-4184; Sung, Wing-Kin/0000-0001-7806-7086; Chew, Elaine/0000-0001-9763-703X; Perche, Olivier/0000-0002-6513-5534	Biomedical Medical Research Council (BMRC) of the Agency for Science, Technology and Research (A*STAR), Singapore; National Health and Medical Research Australia (NHMRC); Singapore International Graduate Award (SINGA) fellowship; Genome Institute of Singapore internal research funds from the BMRC	Biomedical Medical Research Council (BMRC) of the Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); National Health and Medical Research Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Singapore International Graduate Award (SINGA) fellowship; Genome Institute of Singapore internal research funds from the BMRC	This study is supported by grants from Biomedical Medical Research Council (BMRC) of the Agency for Science, Technology and Research (A*STAR), Singapore. Support is also acknowledged from the National Health and Medical Research Australia (NHMRC). KHU is funded by Singapore International Graduate Award (SINGA) fellowship. Additional support was also provided by the Genome Institute of Singapore internal research funds from the BMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MM, 2012, J PHYS CHEM A, V116, P11034, DOI 10.1021/jp3090233; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ben-Zur T, 2000, DEV BIOL, V217, P107, DOI 10.1006/dbio.1999.9532; Ben-Zur T, 1999, GENOMICS, V58, P102, DOI 10.1006/geno.1999.5798; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; Chen W, 2010, EUR J HUM GENET, V18, P539, DOI 10.1038/ejhg.2009.211; CHERIF D, 1990, NOUV REV FR HEMATOL, V32, P459; Chiang C, 2012, NAT GENET, V44, P390, DOI 10.1038/ng.2202; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Corpas M, 2012, CURR PROTOC HUM GENE; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fantes JA, 2008, AM J HUM GENET, V82, P916, DOI 10.1016/j.ajhg.2008.02.007; Girirajan S, 2012, NEW ENGL J MED, V367, P1321, DOI 10.1056/NEJMoa1200395; Hillmer AM, 2011, GENOME RES, V21, P665, DOI 10.1101/gr.113555.110; Hochstenbach R, 2009, EUR J MED GENET, V52, P161, DOI 10.1016/j.ejmg.2009.03.015; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Inaki K, 2011, GENOME RES, V21, P676, DOI 10.1101/gr.113225.110; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kloosterman WP, 2012, CELL REP, V1, P648, DOI 10.1016/j.celrep.2012.05.009; Kloosterman WP, 2011, HUM MOL GENET, V20, P1916, DOI 10.1093/hmg/ddr073; Kloosterman WP, 2013, CURR OPIN CELL BIOL; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Le Scouarnec S, 2012, HEREDITY, V108, P75, DOI 10.1038/hdy.2011.100; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; MACGREGOR DJ, 1989, J MED GENET, V26, P590, DOI 10.1136/jmg.26.9.590; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Millar JK, 2001, MOL PSYCHIATR, V6, P173, DOI 10.1038/sj.mp.4000784; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; MUIR WJ, 1995, CYTOGENET CELL GENET, V70, P35, DOI 10.1159/000133986; Nagarajan N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r115; Ng KP, 2012, NAT MED; Offermanns S, 1997, P NATL ACAD SCI USA, V94, P14089, DOI 10.1073/pnas.94.25.14089; Rauch A, 2004, J MED GENET, V41, P916, DOI 10.1136/jmg.2004.022855; Rauch A, 2006, AM J MED GENET A, V140A, P2063, DOI 10.1002/ajmg.a.31416; RAY PN, 1985, NATURE, V318, P672, DOI 10.1038/318672a0; Rigaud S, 2006, NATURE, V444, P110, DOI 10.1038/nature05257; Rigaud S, 2007, M S-MED SCI, V23, P235, DOI 10.1051/medsci/2007233235; Savage MS, 2011, CURR OPIN OBSTET GYN, V23, P103, DOI 10.1097/GCO.0b013e32834457c7; Schluth-Bolard C, 2013, J MED GENET, V50, P144, DOI 10.1136/jmedgenet-2012-101351; Shaffer LG, 2005, GENET MED, V7, P650, DOI 10.1097/01.gim.0000186545.83160.1e; Swaminathan GJ, 2012, HUM MOL GENET, V21, pR37, DOI 10.1093/hmg/dds362; Takemoto M, 2011, CEREB CORTEX, V21, P1925, DOI 10.1093/cercor/bhq265; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Talkowski ME, 2011, AM J HUM GENET, V88, P469, DOI 10.1016/j.ajhg.2011.03.013; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; van Heesch S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-257; Vandeweyer G, 2009, HUM GENET, V126, P133, DOI 10.1007/s00439-009-0661-6; VERGA V, 1991, AM J HUM GENET, V48, P1133; Wang JC, 2010, AM J MED GENET A, V152A, P209, DOI 10.1002/ajmg.a.33161; WARBURTON D, 1991, AM J HUM GENET, V49, P995; Yao F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046152; Zhu YY, 2013, J CLIN INVEST, V123, P2935, DOI 10.1172/JCI65988	59	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90852	10.1371/journal.pone.0090852	http://dx.doi.org/10.1371/journal.pone.0090852			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603971	gold, Green Published, Green Submitted			2022-12-25	WOS:000332483600099
J	Manna, P; Gungor, N; McVie, R; Jain, SK				Manna, Prasenjit; Gungor, Neslihan; McVie, Robert; Jain, Sushil K.			Decreased Cystathionine-gamma- lyase ( CSE) Activity in Livers of Type 1 Diabetic Rats and Peripheral Blood Mononuclear Cells ( PBMC) of Type 1 Diabetic Patients	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acetoacetate; Diabetes; Glucose; Hydrogen Sulfide; Ketone Bodies	ENDOPLASMIC-RETICULUM STRESS; ACTIVATED PROTEIN-KINASE; CULTURED U937 MONOCYTES; VITAMIN-D DEFICIENCY; ACID-LABILE SULFUR; HYDROGEN-SULFIDE; HIGH-GLUCOSE; OXIDATIVE STRESS; LIPID-PEROXIDATION; KETONE-BODIES	Background: Mechanism of impaired H2S signaling in diabetes is not clear. Results: Livers from type 1 diabetic (T1D) rats and PBMC isolated from T1D patients have lower cystathionine--lyase activity. High glucose and/or high ketone treatment also decreased cystathionine--lyase activity in U937 monocytes and PBMC of healthy subjects. Conclusion: Uncontrolled glycemia and ketosis down-regulate cystathionine--lyase activity in T1D. Significance: Impaired cystathionine--lyase can dysregulate H2S signaling in diabetes. The liver plays a major role in the formation of H2S, a novel signaling molecule. Diabetes is associated with lower blood levels of H2S. This study investigated the activities of cystathionine--lyase (CSE, the enzyme that catalyzes H2S formation) in livers of type 1 diabetic (T1D) animals and in peripheral blood mononuclear cells (PBMC) isolated from T1D patients. T1D is associated with both hyperketonemia (acetoacetate and -hydroxybutyrate) and hyperglycemia. This study also examined the role of hyperglycemia and hyperketonemia per se in decreased CSE activity using U937 monocytes and PBMC isolated from healthy subjects. Livers from streptozotocin-treated T1D rats demonstrated a significantly higher reactive oxygen species production, lower CSE protein expression and activity, and lower H2S formation compared with those of controls. Studies with T1D patients showed a decrease in CSE protein expression and activity in PBMC compared with those of age-matched normal subjects. Cell culture studies demonstrated that high glucose (25 mm) and/or acetoacetate (4 mm) increased reactive oxygen species, decreased CSE mRNA expression, protein expression, and enzymatic activity, and reduced H2S levels; however, -hydroxybutyrate treatment had no effect. A similar effect, which was also observed in PBMC treated with high glucose alone or along with acetoacetate, was prevented by vitamin D supplementation. Studies with CSE siRNA provide evidence for a relationship between impaired CSE expression and reduced H2S levels. This study demonstrates for the first time that both hyperglycemia and hyperketonemia mediate a reduction in CSE expression and activity, which can contribute to the impaired H2S signaling associated with diabetes.	[Manna, Prasenjit; Gungor, Neslihan; McVie, Robert; Jain, Sushil K.] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, Shreveport, LA 71103 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Jain, SK (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, 1501 Kings Hwy, Shreveport, LA 71103 USA.	sjain@lsuhsc.edu		Jain, Sushil/0000-0002-9574-0436; Manna, Prasenjit/0000-0003-1952-6531	National Institutes of Health grant (NIDDK); Office of Dietary Supplements of the National Institutes of Health [RO1 DK072433]; Malcolm Feist Endowed Chair in Diabetes; Malcolm Feist Cardiovascular Research Endowment, LSU Health Sciences Center, Shreveport; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072433] Funding Source: NIH RePORTER	National Institutes of Health grant (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Office of Dietary Supplements of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Malcolm Feist Endowed Chair in Diabetes; Malcolm Feist Cardiovascular Research Endowment, LSU Health Sciences Center, Shreveport; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by a National Institutes of Health grant (NIDDK) and Office of Dietary Supplements of the National Institutes of Health Grant RO1 DK072433. This work was also supported by the Malcolm Feist Endowed Chair in Diabetes and by a fellowship from the Malcolm Feist Cardiovascular Research Endowment, LSU Health Sciences Center, Shreveport.	Abdelmegeed MA, 2004, J PHARMACOL EXP THER, V310, P728, DOI 10.1124/jpet.104.066522; Aljabri KS, 2010, ANN SAUDI MED, V30, P454, DOI 10.4103/0256-4947.72265; ARTUCH R, 1995, EUR J CLIN CHEM CLIN, V33, P529; Biermann J, 2011, MOL VIS, V17, P1275; Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x; Brancaleone V, 2008, BRIT J PHARMACOL, V155, P673, DOI 10.1038/bjp.2008.296; BRAND FN, 1989, DIABETES, V38, P504, DOI 10.2337/diabetes.38.4.504; CANDILOROS H, 1995, DIABETES CARE, V18, P549, DOI 10.2337/diacare.18.4.549; Chang L, 2008, AMINO ACIDS, V34, P573, DOI 10.1007/s00726-007-0011-8; DENHOLM EM, 1991, J IMMUNOL METHODS, V144, P247, DOI 10.1016/0022-1759(91)90092-T; Devrajani B., 2012, WORLD APPL SCI J, V16, P1269; El-Seweidy MM, 2011, ARCH BIOCHEM BIOPHYS, V506, P48, DOI 10.1016/j.abb.2010.10.014; Elsey DJ, 2010, CELL BIOCHEM FUNCT, V28, P95, DOI 10.1002/cbf.1618; Grant WB, 2010, J AM MED DIR ASSOC, V11, P617, DOI 10.1016/j.jamda.2010.03.013; HARRISON JE, 1981, BIOCHEM MED METAB B, V26, P339, DOI 10.1016/0006-2944(81)90010-7; Hoogeveen EK, 1998, ARTERIOSCL THROM VAS, V18, P133, DOI 10.1161/01.ATV.18.1.133; HULTBERG B, 1991, SCAND J CLIN LAB INV, V51, P277, DOI 10.3109/00365519109091615; Jacobs RL, 1998, DIABETES, V47, P1967, DOI 10.2337/diabetes.47.12.1967; Jain SK, 1999, DIABETES CARE, V22, P1171, DOI 10.2337/diacare.22.7.1171; Jain SK, 1999, DIABETES, V48, P1850, DOI 10.2337/diabetes.48.9.1850; Jain SK, 1998, FREE RADICAL BIO MED, V25, P1083, DOI 10.1016/S0891-5849(98)00140-3; Jain SK, 2002, DIABETES, V51, P2287, DOI 10.2337/diabetes.51.7.2287; Jain SK, 2003, DIABETES CARE, V26, P2139, DOI 10.2337/diacare.26.7.2139; Jain SK, 2007, ANTIOXID REDOX SIGN, V9, P1581, DOI 10.1089/ars.2007.1577; Jain SK, 2013, BIOCHEM BIOPH RES CO, V437, P7, DOI 10.1016/j.bbrc.2013.06.004; Jain SK, 2013, ANTIOXID REDOX SIGN, V18, P1154, DOI 10.1089/ars.2012.4843; Jain SK, 2010, ANTIOXID REDOX SIGN, V12, P1333, DOI 10.1089/ars.2009.2956; Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Kaneko Y, 2006, DIABETES, V55, P1391, DOI 10.2337/db05-1082; Kaneko Y, 2009, FEBS LETT, V583, P377, DOI 10.1016/j.febslet.2008.12.026; Kmiec Z, 2001, ADV ANAT EMBRYOL CEL, V161, P1; KOCH DD, 1987, CLIN CHEM, V33, P1761; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; Lee HJ, 2012, J BIOL CHEM, V287, P4451, DOI 10.1074/jbc.M111.278325; Lefer DJ, 2007, P NATL ACAD SCI USA, V104, P17907, DOI 10.1073/pnas.0709010104; Liu YH, 2012, ANTIOXID REDOX SIGN, V17, P141, DOI 10.1089/ars.2011.4005; Manna P, 2013, J CELL BIOCHEM, V114, P2334, DOI 10.1002/jcb.24578; Manna P, 2012, CELL PHYSIOL BIOCHEM, V30, P1363, DOI 10.1159/000343325; Manna P, 2012, J BIOL CHEM, V287, P42324, DOI 10.1074/jbc.M112.407833; Manna P, 2011, J BIOL CHEM, V286, P39848, DOI 10.1074/jbc.M111.270884; MUDD SH, 1985, AM J HUM GENET, V37, P1; Newton CA, 2004, ARCH INTERN MED, V164, P1925, DOI 10.1001/archinte.164.17.1925; Nicholson CK, 2010, PHARMACOL RES, V62, P289, DOI 10.1016/j.phrs.2010.06.002; Norris EJ, 2011, SHOCK, V36, P242, DOI 10.1097/SHK.0b013e3182252ee7; OGASAWARA Y, 1994, BIOL PHARM BULL, V17, P1535; Pan LL, 2012, ANTIOXID REDOX SIGN, V17, P106, DOI 10.1089/ars.2011.4349; Pan LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019766; Parker GA, 2005, TOXICOL PATHOL, V33, P52, DOI 10.1080/01926230590522365; Qu K, 2008, NEUROCHEM INT, V52, P155, DOI 10.1016/j.neuint.2007.05.016; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; ROBILLON JF, 1994, DIABETES METAB, V20, P494; Roe TF, 1996, J DIABETES COMPLICAT, V10, P100, DOI 10.1016/1056-8727(94)00058-1; Rosen CJ, 2012, ENDOCR REV, V33, P456, DOI 10.1210/er.2012-1000; Rubinstein R, 2008, CLIN EXP IMMUNOL, V154, P235, DOI 10.1111/j.1365-2249.2008.03742.x; Schwalfenberg G, 2008, CAN FAM PHYSICIAN, V54, P864; Shibuya N, 2009, J BIOCHEM, V146, P623, DOI 10.1093/jb/mvp111; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; STEPHENS JM, 1971, DIABETES, V20, P485, DOI 10.2337/diab.20.7.485; Suzuki K, 2011, P NATL ACAD SCI USA, V108, P13829, DOI 10.1073/pnas.1105121108; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Szabo C, 2013, P NATL ACAD SCI USA, V110, P12474, DOI 10.1073/pnas.1306241110; Szabo C, 2012, ANTIOXID REDOX SIGN, V17, P68, DOI 10.1089/ars.2011.4451; Tang XQ, 2011, J MOL NEUROSCI, V45, P60, DOI 10.1007/s12031-010-9477-z; Taniguchi S, 2011, BRIT J PHARMACOL, V162, P1171, DOI 10.1111/j.1476-5381.2010.01119.x; Ubuka T, 2001, J CHROMATOGR B, V757, P31, DOI 10.1016/S0378-4347(01)00046-9; Umpierrez Guillermo E, 2003, Treat Endocrinol, V2, P95, DOI 10.2165/00024677-200302020-00003; Wang KQ, 2013, CIRCULATION, V127, P2514, DOI 10.1161/CIRCULATIONAHA.113.001631; Wang YF, 2006, BIOCHEM BIOPH RES CO, V345, P851, DOI 10.1016/j.bbrc.2006.04.162; Wang YF, 2009, ARTERIOSCL THROM VAS, V29, P173, DOI 10.1161/ATVBAHA.108.179333; WESTLEY AM, 1991, ANAL BIOCHEM, V195, P63, DOI 10.1016/0003-2697(91)90295-5; White NH, 2003, REV ENDOCR METAB DIS, V4, P343, DOI 10.1023/A:1027350028584; White NH, 2000, ENDOCRIN METAB CLIN, V29, P657, DOI 10.1016/S0889-8529(05)70158-4; Whiteman M, 2010, DIABETOLOGIA, V53, P1722, DOI 10.1007/s00125-010-1761-5; Wilinski B, 2012, FOLIA BIOL-KRAKOW, V60, P243, DOI 10.3409/fb60_3-4.243-247; Wu LY, 2009, LAB INVEST, V89, P59, DOI 10.1038/labinvest.2008.109; Xue R, 2013, ANTIOXID REDOX SIGN, V19, P5, DOI 10.1089/ars.2012.5024; Yamamoto J, 2013, CLIN EXP NEPHROL, V17, P32, DOI 10.1007/s10157-012-0670-y; Yan H, 2004, BIOCHEM BIOPH RES CO, V313, P22, DOI 10.1016/j.bbrc.2003.11.081; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yang GD, 2007, J BIOL CHEM, V282, P16567, DOI 10.1074/jbc.M700605200; Yang GD, 2011, AM J PATHOL, V179, P869, DOI 10.1016/j.ajpath.2011.04.028; Yokoo H, 2003, J PHARMACOL EXP THER, V304, P994, DOI 10.1124/jpet.102.044115; Yuan P, 2011, NEPHROL DIAL TRANSPL, V26, P2119, DOI 10.1093/ndt/gfq749; Yusuf M, 2005, BIOCHEM BIOPH RES CO, V333, P1146, DOI 10.1016/j.bbrc.2005.06.021; Zhang QQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074422; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008; ZUCKERFR.D, 1974, J IMMUNOL, V112, P234	88	53	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11767	11778		10.1074/jbc.M113.524645	http://dx.doi.org/10.1074/jbc.M113.524645			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24610811	Green Published, hybrid			2022-12-25	WOS:000335010600018
J	Morcillo, F; Gonzalez-Munoz, MT; Reitz, T; Romero-Gonzalez, ME; Arias, JM; Merroun, ML				Morcillo, Fernando; Gonzalez-Munoz, Maria T.; Reitz, Thomas; Romero-Gonzalez, Maria E.; Arias, Jose M.; Merroun, Mohamed L.			Biosorption and Biomineralization of U(VI) by the Marine Bacterium Idiomarina loihiensis MAH1: Effect of Background Electrolyte and pH	PLOS ONE			English	Article							LASER-INDUCED FLUORESCENCE; 3 ECO-TYPES; COMPLEX-FORMATION; URANIUM; SPECTROSCOPY; PRECIPITATION; ADSORPTION; MINERALS; SEAWATER; STRAINS	The main goal of this study is to compare the effects of pH, uranium concentration, and background electrolyte (seawater and NaClO4 solution) on the speciation of uranium(VI) associated with the marine bacterium Idiomarina loihiensis MAH1. This was done at the molecular level using a multidisciplinary approach combining X-ray Absorption Spectroscopy (XAS), Time-Resolved Laser-Induced Fluorescence Spectroscopy (TRLFS), and High Resolution Transmission Electron Microscopy (HRTEM). We showed that the U(VI)/bacterium interaction mechanism is highly dependent upon pH but also the nature of the used background electrolyte played a role. At neutral conditions and a U concentration ranging from 5-10(-4) to 10(-5) M (environmentally relevant concentrations), XAS analysis revealed that uranyl phosphate mineral phases, structurally resembling meta-autunite [Ca(UO2)(2)(PO4)(2) 2-6H(2)O] are precipitated at the cell surfaces of the strain MAH1. The formation of this mineral phase is independent of the background solution but U(VI) luminescence lifetime analyses demonstrated that the U(VI) speciation in seawater samples is more intricate, i. e., different complexes were formed under natural conditions. At acidic conditions, pH 2, 3 and 4.3 ([U] = 5 . 10(-4) M, background electrolyte = 0.1 M NaClO4), the removal of U from solution was due to biosorption to Extracellular Polysaccharides (EPS) and cell wall components as evident from TEM analysis. The LIII-edge XAS and TRLFS studies showed that the biosorption process observed is dependent of pH. The bacterial cell forms a complex with U through organic phosphate groups at pH 2 and via phosphate and carboxyl groups at pH 3 and 4.3, respectively. The differences in the complexes formed between uranium and bacteria on seawater compared to NaClO4 solution demonstrates that the actinide/microbe interactions are influenced by the three studied factors, i.e., the pH, the uranium concentration and the chemical composition of the solution.	[Morcillo, Fernando; Gonzalez-Munoz, Maria T.; Arias, Jose M.; Merroun, Mohamed L.] Univ Granada, Dept Microbiol, Granada, Spain; [Reitz, Thomas] Helmholtz Zentrum Dresden Rossendorf, Inst Resource Ecol, Dresden, Germany; [Romero-Gonzalez, Maria E.] Univ Sheffield, Struct & Civil Engn Dept, Sheffield, S Yorkshire, England	University of Granada; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); University of Sheffield	Merroun, ML (corresponding author), Univ Granada, Dept Microbiol, Granada, Spain.	merroun@ugr.es	Reitz, Thomas/AFP-6355-2022; Merroun, Mohamed/L-4514-2014; González-Muñoz, Maria Teresa/N-1160-2014	Merroun, Mohamed/0000-0003-4553-5976; González-Muñoz, Maria Teresa/0000-0001-5170-4604; Romero-Gonzalez, Maria/0000-0001-5808-5383	Ministerio de Ciencia e Innovacion [CGL2009-09760, CGL2012-36505]; Junta de Andalucia, Spain [RNM 3943]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Andalucia, Spain(Junta de AndaluciaEuropean Commission)	This work was funded by the grants CGL2009-09760 and CGL2012-36505 (Ministerio de Ciencia e Innovacion), and RNM 3943 (Junta de Andalucia), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amayri S, 2005, J SOLID STATE CHEM, V178, P567, DOI 10.1016/j.jssc.2004.07.050; Ankudinov AL, 1998, PHYS REV B, V58, P7565, DOI 10.1103/PhysRevB.58.7565; Appukuttan D, 2011, J BIOTECHNOL, V154, P285, DOI 10.1016/j.jbiotec.2011.05.002; Baik MH, 2004, RADIOCHIM ACTA, V92, P663, DOI 10.1524/ract.92.9.663.54980; Barkleit A, 2008, DALTON T, P2879, DOI 10.1039/b715669c; Barkleit A, 2009, DALTON T, P5379, DOI 10.1039/b818702a; Barnett MO, 2002, ENVIRON SCI TECHNOL, V36, P937, DOI 10.1021/es010846i; Bernhard G, 2001, RADIOCHIM ACTA, V89, P511, DOI 10.1524/ract.2001.89.8.511; Bleise A, 2003, J ENVIRON RADIOACTIV, V64, P93, DOI 10.1016/S0265-931X(02)00041-3; Bonhoure I, 2007, RADIOCHIM ACTA, V95, P165, DOI 10.1524/ract.2007.95.3.165; Bowler C, 2009, NATURE, V459, P180, DOI 10.1038/nature08056; Brendler V, 1996, RADIOCHIM ACTA, V74, P75; DeLong EF, 2005, NATURE, V437, P336, DOI 10.1038/nature04157; Denecke MA, 1998, J ALLOY COMPD, V271, P123, DOI 10.1016/S0925-8388(98)00038-3; ELIET V, 1995, J CHEM SOC FARADAY T, V91, P2275, DOI 10.1039/ft9959102275; Fein JB, 1997, GEOCHIM COSMOCHIM AC, V61, P3319, DOI 10.1016/S0016-7037(97)00166-X; Geipel G, 2000, RADIOCHIM ACTA, V88, P757, DOI 10.1524/ract.2000.88.9-11.757; Geipel G, 1996, RADIOCHIM ACTA, V75, P199; Geissler A, 2009, GEOBIOLOGY, V7, P282, DOI 10.1111/j.1472-4669.2009.00199.x; George G.N., 1995, EXAFSPAK SUITE COMPU; Gilat E, 1975, P IAEA 30 JUN 4 JUL; Gonzalez-Munoz MT, 2012, GEOLOGY, V40, P675, DOI 10.1130/G33006.1; Gunther A, 2011, RADIOCHIM ACTA, V99, P535, DOI 10.1524/ract.2011.1847; Gustafsson JP, 2009, APPL GEOCHEM, V24, P454, DOI 10.1016/j.apgeochem.2008.12.032; Henderson GM, 2003, REV MINERAL GEOCHEM, V52, P493, DOI 10.2113/0520493; Hudson EA, 1996, PHYS REV B, V54, P156, DOI 10.1103/PhysRevB.54.156; Iyer A, 2005, MAR POLLUT BULL, V50, P340, DOI 10.1016/j.marpolbul.2004.11.012; Kelly SD, 2002, GEOCHIM COSMOCHIM AC, V66, P3855, DOI 10.1016/S0016-7037(02)00947-X; Koban A, 2004, RADIOCHIM ACTA, V92, P903, DOI 10.1524/ract.92.12.903.55114; Konstantinou M., 2004, MEDITERR MAR SCI, V5, P55, DOI [10.12681/mms.210, DOI 10.12681/MMS.210]; Krawczyk-Barsch E, 2012, GEOCHIM COSMOCHIM AC, V96, P94, DOI 10.1016/j.gca.2012.08.012; Macaskie LE, 2000, MICROBIOL-SGM, V146, P1855, DOI 10.1099/00221287-146-8-1855; MAKAROV ES, 1960, DOKL AKAD NAUK SSSR+, V132, P673; Matz W, 1999, J SYNCHROTRON RADIAT, V6, P1076, DOI 10.1107/S0909049599010663; Merroun M, 2006, RADIOCHIM ACTA, V94, P723, DOI 10.1524/ract.2006.94.9.723; Merroun M, 2003, RADIOCHIM ACTA, V91, P583, DOI 10.1524/ract.91.10.583.22477; Merroun M, 2002, BIOCHEM SOC T, V30, P669, DOI 10.1042/BST0300669; Merroun ML, 2005, APPL ENVIRON MICROB, V71, P5532, DOI 10.1128/AEM.71.9.5532-5543.2005; Merroun ML, 2003, BIOMETALS, V16, P331, DOI 10.1023/A:1020612600726; Merroun ML, 2011, J HAZARD MATER, V197, P1, DOI 10.1016/j.jhazmat.2011.09.049; Merroun ML, 2008, J CONTAM HYDROL, V102, P285, DOI 10.1016/j.jconhyd.2008.09.019; Morcillo De Amuedo F, 2010, THESIS U GRANADA SPA; Moulin C, 1998, APPL SPECTROSC, V52, P528, DOI 10.1366/0003702981944076; Nedelkova M, 2007, FEMS MICROBIOL ECOL, V59, P694, DOI 10.1111/j.1574-6941.2006.00261.x; OECD Uranium, 2009, OECD NEA PUBL; Panak PJ, 2000, RADIOCHIM ACTA, V88, P71, DOI 10.1524/ract.2000.88.2.071; Reitz T, 2011, RADIOCHIM ACTA, V99, P543, DOI 10.1524/ract.2011.1848; Reitz T, 2010, RADIOCHIM ACTA, V98, P249, DOI 10.1524/ract.2010.1716; Sakamoto N, 2008, BIOINORG CHEM APPL, V2008, DOI 10.1155/2008/706240; Siokou-Frangou I, 2010, BIOGEOSCIENCES, V7, P1543, DOI 10.5194/bg-7-1543-2010; Takata H, 2011, J RADIOANAL NUCL CH, V287, P795, DOI 10.1007/s10967-010-0827-7; Gonzalez-Munoz MT, 2008, CHEMOSPHERE, V72, P465, DOI 10.1016/j.chemosphere.2008.02.010; Vogel M, 2010, SCI TOTAL ENVIRON, V409, P384, DOI 10.1016/j.scitotenv.2010.10.011; YONG P, 1995, B ENVIRON CONTAM TOX, V54, P892, DOI 10.1007/BF00197975	54	34	36	1	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91305	10.1371/journal.pone.0091305	http://dx.doi.org/10.1371/journal.pone.0091305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618567	Green Submitted, Green Published, gold			2022-12-25	WOS:000332842400071
J	Toth, E; Huszar, K; Bencsura, P; Kulcsar, PI; Vodicska, B; Nyeste, A; Welker, Z; Toth, S; Welker, E				Toth, Eszter; Huszar, Krisztina; Bencsura, Petra; Kulcsar, Peter Istvan; Vodicska, Barbara; Nyeste, Antal; Welker, Zsombor; Toth, Szilvia; Welker, Ervin			Restriction Enzyme Body Doubles and PCR Cloning: On the General Use of Type IIS Restriction Enzymes for Cloning	PLOS ONE			English	Article							LIGATION-INDEPENDENT CLONING; ONE-STEP; ONE-POT; DNA; SITES; ENDONUCLEASES; MUTAGENESIS; DELETIONS; CLEAVAGE; VECTORS	The procedure described here allows the cloning of PCR fragments containing a recognition site of the restriction endonuclease ( Type IIP) used for cloning in the sequence of the insert. A Type IIS endonuclease - a Body Double of the Type IIP enzyme - is used to generate the same protruding palindrome. Thus, the insert can be cloned to the Type IIP site of the vector without digesting the PCR product with the same Type IIP enzyme. We achieve this by incorporating the recognition site of a Type IIS restriction enzyme that cleaves the DNA outside of its recognition site in the PCR primer in such a way that the cutting positions straddle the desired overhang sequence. Digestion of the PCR product by the Body Double generates the required overhang. Hitherto the use of Type IIS restriction enzymes in cloning reactions has only been used for special applications, the approach presented here makes Type IIS enzymes as useful as Type IIP enzymes for general cloning purposes. To assist in finding Body Double enzymes, we summarised the available Type IIS enzymes which are potentially useful for Body Double cloning and created an online program ( http://group.szbk.u-szeged.hu/welkergr/body_double/index.html) for the selection of suitable Body Double enzymes and the design of the appropriate primers.	[Toth, Eszter; Kulcsar, Peter Istvan; Vodicska, Barbara; Nyeste, Antal; Welker, Ervin] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Huszar, Krisztina; Bencsura, Petra; Welker, Zsombor; Toth, Szilvia; Welker, Ervin] Hungarian Acad Sci, Inst Mol Pharmacol, Res Ctr Nat Sci, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Welker, E (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary.	welker@brc.hu	Vodicska, Barbara/AGY-8745-2022; Kulcsár, Péter István/AAD-8175-2021; Welker, Ervin/AAC-6493-2022	Kulcsár, Péter István/0000-0002-7783-5108; Vodicska, Barbara/0000-0003-1191-234X	Hungarian Scientific Research Fund [K-82090]; Hungarian National Development Agency [TAMOP-4.2.2.A-11/1/2012-0052]; National Excellence Program - "Elaborating and operating an inland student and researcher personal support system convergence program'' [TAMOP 4.2.4. A/2-11-1-2012-0001, TAMOP 4.2.4. A/1-11-1-2012-0001]; European Union; European Social Fund	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian National Development Agency; National Excellence Program - "Elaborating and operating an inland student and researcher personal support system convergence program''; European Union(European Commission); European Social Fund(European Social Fund (ESF))	This work was supported by the Hungarian Scientific Research Fund [K-82090]; the Hungarian National Development Agency [TAMOP-4.2.2.A-11/1/2012-0052]; and the National Excellence Program - "Elaborating and operating an inland student and researcher personal support system convergence program'' [TAMOP 4.2.4.A/2-11-1-2012-0001 to Eszter Toth and TAMOP 4.2.4. A/1-11-1-2012-0001 to Barbara Vodicska]. The project was subsidized by the European Union and co-financed by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; BECK R, 1994, NUCLEIC ACIDS RES, V22, P886, DOI 10.1093/nar/22.5.886; BERGER SL, 1993, ANAL BIOCHEM, V214, P571, DOI 10.1006/abio.1993.1540; Berlin Y A, 1999, Curr Issues Mol Biol, V1, P21; Boncompain G, 2012, NAT METHODS, V9, P493, DOI [10.1038/NMETH.1928, 10.1038/nmeth.1928]; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Fromme Tobias, 2007, J Biol Eng, V1, P7, DOI 10.1186/1754-1611-1-7; GAYLE RB, 1987, GENE, V54, P221, DOI 10.1016/0378-1119(87)90490-2; GILMARTIN PM, 1989, NUCLEIC ACIDS RES, V17, P4901, DOI 10.1093/nar/17.12.4901; HASAN N, 1989, GENE, V82, P305, DOI 10.1016/0378-1119(89)90055-3; HASAN N, 1986, GENE, V50, P55, DOI 10.1016/0378-1119(86)90309-4; HAYDEN MA, 1988, DNA-J MOLEC CELL BIO, V7, P571, DOI 10.1089/dna.1.1988.7.571; Ivics Z, 2007, MOL THER, V15, P1137, DOI 10.1038/sj.mt.6300169; Kuzuya A, 2012, MOLECULES, V17, P328, DOI 10.3390/molecules17010328; LEBEDENKO EN, 1991, NUCLEIC ACIDS RES, V19, P6757, DOI 10.1093/nar/19.24.6757; Lu Q, 2005, TRENDS BIOTECHNOL, V23, P199, DOI 10.1016/j.tibtech.2005.02.008; MORMENEO S, 1987, GENE, V61, P21, DOI 10.1016/0378-1119(87)90361-1; Padgett KA, 1996, GENE, V168, P31, DOI 10.1016/0378-1119(95)00731-8; Pingoud A, 2005, CELL MOL LIFE SCI, V62, P685, DOI 10.1007/s00018-004-4513-1; PODHAJSKA AJ, 1985, GENE, V40, P175, DOI 10.1016/0378-1119(85)90040-X; Prabhakara R, 2013, INFECT IMMUN, V81, P1306, DOI 10.1128/IAI.01304-12; Rebatchouk D, 1996, P NATL ACAD SCI USA, V93, P10891, DOI 10.1073/pnas.93.20.10891; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; SCARPULLA RC, 1982, ANAL BIOCHEM, V121, P356, DOI 10.1016/0003-2697(82)90493-6; STEMMER WPC, 1992, BIOTECHNIQUES, V13, P214; SZYBALSKI W, 1991, GENE, V100, P13, DOI 10.1016/0378-1119(91)90345-C; SZYBALSKI W, 1985, GENE, V40, P169, DOI 10.1016/0378-1119(85)90039-3; Tillett D, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e26; Toth E, 2013, BBA-MOL CELL RES, V1833, P1199, DOI 10.1016/j.bbamcr.2013.01.020; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019722; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016765; Welker E, 2000, BIOCHEM BIOPH RES CO, V271, P534, DOI 10.1006/bbrc.2000.2668	33	7	8	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90896	10.1371/journal.pone.0090896	http://dx.doi.org/10.1371/journal.pone.0090896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618593	Green Submitted, Green Published, gold			2022-12-25	WOS:000332842400034
J	Zhang, HJ; Jiang, XJ; Xiao, WF; Lu, LP				Zhang, Hangjun; Jiang, Xiaojun; Xiao, Wenfeng; Lu, Liping			Proteomic Strategy for the Analysis of the Polychlorobiphenyl-Degrading Cyanobacterium Anabaena PD-1 Exposed to Aroclor 1254	PLOS ONE			English	Article							POLYCHLORINATED-BIPHENYLS; PSEUDOMONAS-PUTIDA; STRESS-RESPONSE; DEGRADATION; PROTEINS; BIODEGRADATION; BIOREMEDIATION; DIOXYGENASES; METABOLITES; POLLUTANTS	The cyanobacterium Anabaena PD-1, which was originally isolated from polychlorobiphenyl (PCB)-contaminated paddy soils, has capabilities for dechlorinatin and for degrading the commercial PCB mixture Aroclor 1254. In this study, 25 upregulated proteins were identified using 2D electrophoresis (2-DE) coupled with matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS). These proteins were involved in (i) PCB degradation (i.e., 3-chlorobenzoate-3,4-dioxygenase); (ii) transport processes [e. g., ATP-binding cassette (ABC) transporter substrate-binding protein, amino acid ABC transporter substrate-binding protein, peptide ABC transporter substrate-binding protein, putrescine-binding protein, periplasmic solute-binding protein, branched-chain amino acid uptake periplasmic solutebinding protein, periplasmic phosphate-binding protein, phosphonate ABC transporter substrate-binding protein, and xylose ABC transporter substrate-binding protein]; (iii) energetic metabolism (e. g., methanol/ethanol family pyrroloquinoline quinone (PQQ)-dependent dehydrogenase, malate-CoA ligase subunit beta, enolase, ATP synthase beta subunit, FOF1 ATP synthase subunit beta, ATP synthase a subunit, and IMP cyclohydrolase); (iv) electron transport (cytochrome b(6)f complex FeS protein); (v) general stress response (e. g., molecular chaperone DnaK, elongation factor G, and translation elongation factor thermostable); (vi) carbon metabolism (methanol dehydrogenase and malate-CoA ligase subunit beta); and (vii) nitrogen reductase (nitrous oxide reductase). The results of real-time polymerase chain reaction showed that the genes encoding for dioxygenase, ABC transporters, transmembrane proteins, electron transporter, and energetic metabolism proteins were significantly upregulated during PCB degradation. These genes upregulated by 1.26- to 8.98-fold. These findings reveal the resistance and adaptation of cyanobacterium to the presence of PCBs, shedding light on the complexity of PCB catabolism by Anabaena PD-1.	[Zhang, Hangjun; Jiang, Xiaojun; Xiao, Wenfeng; Lu, Liping] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China	Hangzhou Normal University	Zhang, HJ (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China.	zhanghangjun@gmail.com		zhang, hangjun/0000-0002-3281-6093	Natural Science Foundation of China [21077030]; Program for Excellent Young Teachers in Hangzhou Normal University [JTAS 2011-01-012]; Program for talents in Hangzhou City; Undergraduates innovation ability promotion project in Hangzhou Normal University [CX2013078]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Excellent Young Teachers in Hangzhou Normal University; Program for talents in Hangzhou City; Undergraduates innovation ability promotion project in Hangzhou Normal University	This work was supported by the Natural Science Foundation of China (21077030), the Program for Excellent Young Teachers in Hangzhou Normal University (JTAS 2011-01-012), the Program for talents in Hangzhou City, and the Undergraduates innovation ability promotion project in Hangzhou Normal University (CX2013078). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agullo L, 2007, FEMS MICROBIOL LETT, V267, P167, DOI 10.1111/j.1574-6968.2006.00554.x; Alba BM, 2004, MOL MICROBIOL, V52, P613, DOI 10.1111/j.1365-2958.2003.03982.x; Balk J, 2005, TRENDS PLANT SCI, V10, P324, DOI 10.1016/j.tplants.2005.05.002; Baniulis D, 2009, J BIOL CHEM, V284, P9861, DOI 10.1074/jbc.M809196200; Barriault D, 2001, CAN J MICROBIOL, V47, P1025, DOI 10.1139/cjm-47-11-1025; Ben Hassine S, 2012, CHEMOSPHERE, V89, P369, DOI 10.1016/j.chemosphere.2012.05.035; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breugelmans P, 2010, RES MICROBIOL, V161, P208, DOI 10.1016/j.resmic.2010.01.010; Cao B, 2008, BIOTECHNOL BIOENG, V101, P1297, DOI 10.1002/bit.21997; Cao B, 2009, J CHEM TECHNOL BIOT, V84, P1178, DOI 10.1002/jctb.2155; Colbert CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052550; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Cvancarova M, 2012, CHEMOSPHERE, V88, P1317, DOI 10.1016/j.chemosphere.2012.03.107; Dominguez-Cuevas P, 2006, J BIOL CHEM, V281, P11981, DOI 10.1074/jbc.M509848200; Eixarch H, 2010, PROCESS BIOCHEM, V45, P794, DOI 10.1016/j.procbio.2009.12.015; Endo R, 2007, J BACTERIOL, V189, P3712, DOI 10.1128/JB.01883-06; Fanous A, 2007, CHEMOSPHERE, V69, P25, DOI 10.1016/j.chemosphere.2007.04.075; Field JA, 2008, ENVIRON POLLUT, V155, P1, DOI 10.1016/j.envpol.2007.10.016; Furukawa K, 2000, CURR OPIN BIOTECH, V11, P244, DOI 10.1016/S0958-1669(00)00091-4; Gibson DT, 2000, CURR OPIN BIOTECH, V11, P236, DOI 10.1016/S0958-1669(00)00090-2; Giuffrida MG, 2001, ELECTROPHORESIS, V22, P1705, DOI 10.1002/1522-2683(200105)22:9<1705::AID-ELPS1705>3.0.CO;2-0; Hong CY, 2012, J ENVIRON SCI HEAL A, V47, P1878, DOI 10.1080/03601234.2012.676432; Huang F, 2006, PROTEOMICS, V6, P910, DOI 10.1002/pmic.200500114; Jones KC, 1999, ENVIRON POLLUT, V100, P209, DOI 10.1016/S0269-7491(99)00098-6; Kaneko T, 2001, DNA RES, V8, P205, DOI 10.1093/dnares/8.5.205; Kim SJ, 2009, CURR OPIN MICROBIOL, V12, P301, DOI 10.1016/j.mib.2009.03.006; Kumamaru T, 1998, NAT BIOTECHNOL, V16, P663, DOI 10.1038/nbt0798-663; Kurian D, 2006, PROTEOMICS, V6, P3614, DOI 10.1002/pmic.200600033; Lambo AJ, 2007, J APPL MICROBIOL, V102, P1318, DOI 10.1111/j.1365-2672.2006.03268.x; Li ZM, 2009, SOIL BIOL BIOCHEM, V41, P984, DOI 10.1016/j.soilbio.2008.10.026; Liu Y, 2013, J ENVIRON SCI, V25, P1662, DOI 10.1016/S1001-0742(12)60182-X; Lund PA, 2001, ADV MICROB PHYSIOL, V44, P93, DOI 10.1016/S0065-2911(01)44012-4; NAKATSU CH, 1995, MICROBIOL-UK, V141, P485, DOI 10.1099/13500872-141-2-485; Nam JW, 2001, BIOSCI BIOTECH BIOCH, V65, P254, DOI 10.1271/bbb.65.254; Ohtsubo Y, 2004, APPL MICROBIOL BIOT, V65, P250, DOI 10.1007/s00253-004-1654-y; Pandey S, 2012, J PROTEOMICS, V75, P921, DOI 10.1016/j.jprot.2011.10.011; Papazi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061682; Papazi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049037; Park SH, 2001, CURR MICROBIOL, V43, P176, DOI 10.1007/s002840010283; Perez-Pantoja D., 2009, HDB HYDROCARBON LIPI, P1356; Ren NQ, 2007, ENVIRON SCI TECHNOL, V41, P3871, DOI 10.1021/es063004y; RIESKE JS, 1964, BIOCHEM BIOPH RES CO, V15, P338, DOI 10.1016/0006-291X(64)90171-8; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Robinson GK, 1998, BIOCHEM SOC T, V26, P686, DOI 10.1042/bst0260686; Rodrigues JLM, 2006, APPL ENVIRON MICROB, V72, P2476, DOI 10.1128/AEM.72.4.2476-2482.2006; Samanta SK, 2002, TRENDS BIOTECHNOL, V20, P243, DOI 10.1016/S0167-7799(02)01943-1; Santos PM, 2004, PROTEOMICS, V4, P2640, DOI 10.1002/pmic.200300793; Schultze M, 2009, BBA-BIOENERGETICS, V1787, P1479, DOI 10.1016/j.bbabio.2009.06.010; Segura A, 1999, ENVIRON MICROBIOL, V1, P191, DOI 10.1046/j.1462-2920.1999.00033.x; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Singer AC, 2000, APPL MICROBIOL BIOT, V54, P838, DOI 10.1007/s002530000472; Subashchandrabose SR, 2013, ENVIRON INT, V51, P59, DOI 10.1016/j.envint.2012.10.007; Tsuji N, 2003, BIOTECHNOL LETT, V25, P241, DOI 10.1023/A:1022333406348; Tu C, 2011, J HAZARD MATER, V186, P1438, DOI 10.1016/j.jhazmat.2010.12.008; Waid John S., 1986, PCBS ENV; Yun SH, 2011, J PROTEOMICS, V74, P620, DOI 10.1016/j.jprot.2011.01.020; Zhang HJ, 2012, J APPL PHYCOL, V24, P221, DOI 10.1007/s10811-011-9670-7; Zhang Y, 2009, BIODEGRADATION, V20, P55, DOI 10.1007/s10532-008-9199-x	58	9	9	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91162	10.1371/journal.pone.0091162	http://dx.doi.org/10.1371/journal.pone.0091162			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618583	gold, Green Submitted, Green Published			2022-12-25	WOS:000332842400053
J	Candido, ED; Fernandes, GD; de Alencar, SA; Cardoso, MHES; de Freitas Lima, SM; Miranda, VD; Porto, WF; Nolasco, DO; de Oliveira, NG; Barbosa, AEAD; Pogue, RE; Rezende, TMB; Dias, SC; Franco, OL				Candido, Elizabete de Souza; Fernandes, Gabriel da Rocha; de Alencar, Sergio Amorim; Cardoso, Marlon Henrique e Silva; de Freitas Lima, Stella Maris; Miranda, Vivian de Jesus; Porto, William Farias; Nolasco, Diego Oliveira; de Oliveira, Nelson Gomes; Anjos de Deus Barbosa, Aulus Estevao; Pogue, Robert Edward; Rezende, Taia Maria Berto; Dias, Simoni Campos; Franco, Octavio Luiz			Shedding Some Light over the Floral Metabolism by Arum Lily (Zantedeschia aethiopica) Spathe De Novo Transcriptome Assembly	PLOS ONE			English	Article							LIPID TRANSFER PROTEINS; LYSM RECEPTOR KINASE; PSEUDOMONAS-SYRINGAE; ANTIMICROBIAL PEPTIDES; DISEASE RESISTANCE; ARABIDOPSIS TCH4; BASAL DEFENSE; PLANT; GENE; AUXIN	Zantedeschia aethiopica is an evergreen perennial plant cultivated worldwide and commonly used for ornamental and medicinal purposes including the treatment of bacterial infections. However, the current understanding of molecular and physiological mechanisms in this plant is limited, in comparison to other non-model plants. In order to improve understanding of the biology of this botanical species, RNA-Seq technology was used for transcriptome assembly and characterization. Following Z. aethiopica spathe tissue RNA extraction, high-throughput RNA sequencing was performed with the aim of obtaining both abundant and rare transcript data. Functional profiling based on KEGG Orthology (KO) analysis highlighted contigs that were involved predominantly in genetic information (37%) and metabolism (34%) processes. Predicted proteins involved in the plant circadian system, hormone signal transduction, secondary metabolism and basal immunity are described here. In silico screening of the transcriptome data set for antimicrobial peptide (AMP) - encoding sequences was also carried out and three lipid transfer proteins (LTP) were identified as potential AMPs involved in plant defense. Spathe predicted protein maps were drawn, and suggested that major plant efforts are expended in guaranteeing the maintenance of cell homeostasis, characterized by high investment in carbohydrate, amino acid and energy metabolism as well as in genetic information.	[Candido, Elizabete de Souza; Fernandes, Gabriel da Rocha; de Alencar, Sergio Amorim; de Freitas Lima, Stella Maris; Miranda, Vivian de Jesus; Porto, William Farias; Nolasco, Diego Oliveira; Anjos de Deus Barbosa, Aulus Estevao; Pogue, Robert Edward; Rezende, Taia Maria Berto; Dias, Simoni Campos; Franco, Octavio Luiz] Univ Catolica Brasilia, Programa Pos Graduacao Cienc Genom & Biotecnol, Brasilia, DF, Brazil; [Candido, Elizabete de Souza; Cardoso, Marlon Henrique e Silva; de Freitas Lima, Stella Maris; Miranda, Vivian de Jesus; Porto, William Farias; de Oliveira, Nelson Gomes; Anjos de Deus Barbosa, Aulus Estevao; Rezende, Taia Maria Berto; Dias, Simoni Campos; Franco, Octavio Luiz] Univ Catolica Brasilia, Ctr Anal Proteom & Bioquim, Brasilia, DF, Brazil; [de Oliveira, Nelson Gomes] Univ Brasilia, Programa Pos Graduacao Biol Anim, Brasilia, DF, Brazil; [Nolasco, Diego Oliveira] Univ Catolica Brasilia, Curso Fis, Brasilia, DF, Brazil; [Rezende, Taia Maria Berto] Univ Catolica Brasilia, Curso Odontol, Brasilia, DF, Brazil	Universidade Catolica de Brasilia; Universidade Catolica de Brasilia; Universidade de Brasilia; Universidade Catolica de Brasilia; Universidade Catolica de Brasilia	Franco, OL (corresponding author), Univ Catolica Brasilia, Programa Pos Graduacao Cienc Genom & Biotecnol, Brasilia, DF, Brazil.	ocfranco@gmail.com	Cardoso, Marlon/O-9734-2019; Cardoso, Marlon H/N-6972-2017; da Rocha Fernandes, Gabriel/A-5383-2010; de Alencar, Sérgio A/G-9545-2012; Oliveira-Júnior, Nelson/M-5794-2014; Nolasco, Diego O/O-6743-2014; Pogue, Robert/C-3860-2016; de Freitas Lima, Stella Maris/A-4501-2014; Nolasco, Diego O./D-1241-2017; Franco, Octavio L/T-3020-2017; Rezende, Taia M B/D-3732-2015; Cândido, Elizabete/F-3347-2019	Cardoso, Marlon/0000-0001-6676-5362; Cardoso, Marlon H/0000-0001-6676-5362; da Rocha Fernandes, Gabriel/0000-0002-4897-8521; de Alencar, Sérgio A/0000-0001-8236-6468; Oliveira-Júnior, Nelson/0000-0001-9437-6778; Nolasco, Diego O/0000-0001-7931-5475; Pogue, Robert/0000-0002-8789-3512; de Freitas Lima, Stella Maris/0000-0003-1359-8761; Nolasco, Diego O./0000-0001-7931-5475; Rezende, Taia M B/0000-0002-4148-0659; Cândido, Elizabete/0000-0002-3126-029X; Barbosa, Aulus/0000-0003-2332-5337; Miranda, Vivian/0000-0002-2739-6100; Franco, Octavio/0000-0001-9546-0525	Center for Scientific Computing (NCC/GridUNESP) of the Sao Paulo State University (UNESP)	Center for Scientific Computing (NCC/GridUNESP) of the Sao Paulo State University (UNESP)	This research was granted by CNPq, CAPES, FAPDF and UCB. The authors are thankful to the support provided by the Center for Scientific Computing (NCC/GridUNESP) of the Sao Paulo State University (UNESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAIJ C, 1972, BIOCHIM BIOPHYS ACTA, V269, P192, DOI 10.1016/0005-2787(72)90426-1; Ahmed AS, 2012, J ETHNOPHARMACOL, V143, P826, DOI 10.1016/j.jep.2012.08.004; Albrecht C, 2012, P NATL ACAD SCI USA, V109, P303, DOI 10.1073/pnas.1109921108; ANESINI C, 1993, J ETHNOPHARMACOL, V39, P119, DOI 10.1016/0378-8741(93)90027-3; Annadurai RS, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-663; Arondel V, 2000, PLANT SCI, V157, P1, DOI 10.1016/S0168-9452(00)00232-6; Avato P, 1997, PLANTA MED, V63, P503, DOI 10.1055/s-2006-957751; Belkhadir Y, 2006, SCIENCE, V314, P1410, DOI 10.1126/science.1134040; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Bhuvaneshwari L, 2007, ANC SCI LIFE, V26, P24; Burgess A, 2011, IMMUNOL CELL BIOL, V89, P661, DOI 10.1038/icb.2011.30; Chen CM, 2011, PLANT SCI, V181, P439, DOI 10.1016/j.plantsci.2011.07.003; Chou ML, 2013, PLANTA; Cunningham AB., 1996, ZULU MED PLANTS INVE; Curir P, 2003, PHYTOCHEM ANALYSIS, V14, P8, DOI 10.1002/pca.672; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Torres M, 2006, PLANT J, V47, P368, DOI 10.1111/j.1365-313X.2006.02798.x; Dhankhar Sandeep, 2012, Recent Pat Antiinfect Drug Discov, V7, P242; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fu J, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00074; Fu J, 2011, PLANT PHYSIOL, V155, P589, DOI 10.1104/pp.110.163774; Garg R, 2011, PLANT PHYSIOL, V156, P1661, DOI 10.1104/pp.111.178616; Ge XC, 2003, J BIOCHEM MOL BIOL, V36, P603; Giang KTN, 2011, J BIOL CHEM, V286, P24275, DOI 10.1074/jbc.M111.229922; Gimenez-Ibanez S, 2009, PLANT SIGNAL BEHAV, V4, P539, DOI 10.4161/psb.4.6.8697; Gimenez-Ibanez S, 2009, CURR BIOL, V19, P423, DOI 10.1016/j.cub.2009.01.054; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hann DR, 2007, PLANT J, V49, P607, DOI 10.1111/j.1365-313X.2006.02981.x; Hanson AD, 2002, CURR OPIN PLANT BIOL, V5, P244, DOI 10.1016/S1369-5266(02)00249-2; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hirano K, 2008, TRENDS PLANT SCI, V13, P192, DOI 10.1016/j.tplants.2008.02.005; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Iliev EA, 2002, PLANT PHYSIOL, V130, P770, DOI 10.1104/pp.008680; Ishihama N, 2012, CURR OPIN PLANT BIOL, V15, P431, DOI 10.1016/j.pbi.2012.02.003; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karlova Rumyana, 2006, Sci STKE, V2006, ppe36, DOI 10.1126/stke.3542006pe36; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee J, 2012, PLANTA; Leyser O, 2006, CURR BIOL, V16, pR424, DOI 10.1016/j.cub.2006.05.014; Li XY, 2005, P NATL ACAD SCI USA, V102, P12990, DOI 10.1073/pnas.0502425102; Lin L, 2009, MOL BIOL REP, V36, P437, DOI 10.1007/s11033-007-9198-8; Liu YB, 2010, PLANT PHYSIOL BIOCH, V48, P836, DOI 10.1016/j.plaphy.2010.07.001; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; LULIN H, 2012, PLOS ONE, V0007; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Meyer E, 2012, PLANT J, V70, P879, DOI 10.1111/j.1365-313X.2012.04938.x; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mohammed MJ, 2009, PHYTOMEDICINE, V16, P632, DOI 10.1016/j.phymed.2008.12.026; MOLINA A, 1993, FEBS LETT, V316, P119, DOI 10.1016/0014-5793(93)81198-9; Munoz-Merida A., 2013, DNA RES; NCCLS, 2003, M7A6 NCCLS; Oh MH, 2010, P NATL ACAD SCI USA, V107, P17827, DOI 10.1073/pnas.0915064107; Oh Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057868; Ohta M, 2000, PLANT J, V22, P29, DOI 10.1046/j.1365-313x.2000.00709.x; Park J, 2013, PLANT CELL; Park JE, 2007, J BIOL CHEM, V282, P10036, DOI 10.1074/jbc.M610524200; Pauwels L, 2011, PLANT CELL, V23, P3089, DOI 10.1105/tpc.111.089300; Pieterse C. M. J., 2001, AgBiotechNet, V3, P1; Pirrello J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-190; Porto WF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051444; Porto WF, 2012, PEPTIDES, V38, P127, DOI 10.1016/j.peptides.2012.07.025; Porto WF, 2010, LECT N BIOINFORMAT, V6268, P59, DOI 10.1007/978-3-642-15060-9_6; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Rahnamaeian M, 2011, PLANT SIGNAL BEHAV, V6, P1325, DOI 10.4161/psb.6.9.16319; Roenneberg T, 1999, J BIOL RHYTHM, V14, P449, DOI 10.1177/074873099129001019; Roy A, 2012, NUCLEIC ACIDS RES, V40, pW471, DOI 10.1093/nar/gks372; SEGURA A, 1993, FEBS LETT, V332, P243, DOI 10.1016/0014-5793(93)80641-7; Setzer M. C., 2006, Biologically active natural products for the 21st century, P21; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; Stotz HU, 2009, PLANT MOL BIOL, V71, P131, DOI 10.1007/s11103-009-9512-z; Takai R, 2008, MOL PLANT MICROBE IN, V21, P1635, DOI 10.1094/MPMI-21-12-1635; Takechi K, 1999, PLANT CELL PHYSIOL, V40, P1287, DOI 10.1093/oxfordjournals.pcp.a029517; Tavares LS, 2008, PEPTIDES, V29, P1842, DOI 10.1016/j.peptides.2008.06.003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ueguchi-Tanaka M, 2007, ANNU REV PLANT BIOL, V58, P183, DOI 10.1146/annurev.arplant.58.032806.103830; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Verma AK, 2010, INDIAN J PHARM SCI, V72, P655, DOI 10.4103/0250-474X.78541; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Wang GF, 2011, PLANT PHYSIOL, V156, P1508, DOI 10.1104/pp.111.176776; Wei ZZ, 2012, AM J BOT, V99, pE493, DOI 10.3732/ajb.1200228; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; XU W, 1995, PLANT CELL, V7, P1555, DOI 10.1105/tpc.7.10.1555; Yan XH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-26; Yang CQ, 2012, J INTEGR PLANT BIOL, V54, P703, DOI 10.1111/j.1744-7909.2012.01161.x; Yi O, 2007, INT J FOOD SCI NUTR, V58, P178, DOI 10.1080/09637480601121318; Zeng JG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053409, 10.1371/journal.pone.0082091]; Zhai RR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-19; Zhang SW, 2009, PLANT PHYSIOL, V151, P1889, DOI 10.1104/pp.109.146803; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042082; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang ZQ, 2007, PLANT PHYSIOL, V145, P450, DOI 10.1104/pp.107.106021; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2008, CURR OPIN IMMUNOL, V20, P10, DOI 10.1016/j.coi.2007.11.003; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	108	10	12	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90487	10.1371/journal.pone.0090487	http://dx.doi.org/10.1371/journal.pone.0090487			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614014	Green Published, gold, Green Submitted			2022-12-25	WOS:000332839300026
J	Criscuoli, I; Alberti, G; Baronti, S; Favilli, F; Martinez, C; Calzolari, C; Pusceddu, E; Rumpel, C; Viola, R; Miglietta, F				Criscuoli, Irene; Alberti, Giorgio; Baronti, Silvia; Favilli, Filippo; Martinez, Cristina; Calzolari, Costanza; Pusceddu, Emanuela; Rumpel, Cornelia; Viola, Roberto; Miglietta, Franco			Carbon Sequestration and Fertility after Centennial Time Scale Incorporation of Charcoal into Soil	PLOS ONE			English	Article							CHEMICAL-PROPERTIES; ORGANIC-CARBON; BLACK CARBON; LAND-USE; BIOCHAR; PHOSPHORUS; FRACTIONATION; PROPAGATION; TERRAMARA; ISOTOPES	The addition of pyrogenic carbon (C) in the soil is considered a potential strategy to achieve direct C sequestration and potential reduction of non-CO2 greenhouse gas emissions. In this paper, we investigated the long term effects of charcoal addition on C sequestration and soil physico-chemical properties by studying a series of abandoned charcoal hearths in the Eastern Alps of Italy established in the XIX century. This natural setting can be seen as an analogue of a deliberate experiment with replications. Carbon sequestration was assessed indirectly by comparing the amount of pyrogenic C present in the hearths (23.3+/-4.7 kg C m(-2)) with the estimated amount of charcoal that was left on the soil after the carbonization (29.3+/-5.1 kg C m(-2)). After taking into account uncertainty associated with parameters' estimation, we were able to conclude that 80+/-21% of the C originally added to the soil via charcoal can still be found there and that charcoal has an overall Mean Residence Time of 650+/-139 years, thus supporting the view that charcoal incorporation is an effective way to sequester atmospheric CO2. We also observed an overall change in the physical properties (hydrophobicity and bulk density) of charcoal hearth soils and an accumulation of nutrients compared to the adjacent soil without charcoal. We caution, however, that our site-specific results should not be generalized without further study.	[Criscuoli, Irene; Martinez, Cristina; Miglietta, Franco] Fdn E Mach, FoxLab, San Michele All Adige, Trento, Italy; [Alberti, Giorgio] European Forest Inst, MountFor Project Ctr, San Michele All Adige, Trento, Italy; [Alberti, Giorgio] Univ Udine, Dept Agr & Environm Sci, I-33100 Udine, Italy; [Baronti, Silvia; Martinez, Cristina; Pusceddu, Emanuela; Miglietta, Franco] CNR, Inst Biometeorol, Florence, Italy; [Favilli, Filippo] European Acad Bolzano, Bolzano, Italy; [Calzolari, Costanza] CNR, Inst Res Hydrogeol Protect, Sesto Fiorentino, FI, Italy; [Criscuoli, Irene; Rumpel, Cornelia] CNRS INRA ENS Paris 6, Biogeochim & Ecol Milieux Continentaux, Thiverval Grignon, France; [Viola, Roberto] Fdn E Mach, Ctr Res & Innovat, San Michele All Adige, Trento, Italy	Fondazione Edmund Mach; University of Udine; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biometeorologia (IBIMET-CNR); European Academy of Bozen-Bolzano; Consiglio Nazionale delle Ricerche (CNR); INRAE; UDICE-French Research Universities; Sorbonne Universite; Fondazione Edmund Mach	Criscuoli, I (corresponding author), Fdn E Mach, FoxLab, San Michele All Adige, Trento, Italy.	irene.criscuoli@fmach.it	Baronti, Silvia/AAD-5339-2019; Calzolari, Maria/AAV-9538-2020; Pusceddu, Emanuela/P-1620-2018; Favilli, Filippo/AAA-8738-2022; Baronti, Silvia/D-2828-2011; Rumpel, Cornelia/A-2001-2015; Martinez, Cristina/F-3251-2017; Baronti, Silvia/AAX-7952-2020; Miglietta, Franco/B-6137-2008; Viola, Roberto/F-3657-2014	Baronti, Silvia/0000-0002-0986-0723; Calzolari, Maria/0000-0002-2126-9290; Pusceddu, Emanuela/0000-0002-1325-6932; Favilli, Filippo/0000-0001-8101-0689; Baronti, Silvia/0000-0002-0986-0723; Rumpel, Cornelia/0000-0003-2131-9451; Martinez, Cristina/0000-0003-1592-9149; Miglietta, Franco/0000-0003-1474-8143; Viola, Roberto/0000-0002-8202-8503; Alberti, Giorgio/0000-0003-2422-3009	European Commission [FP7-ENV-478 2010ID-265179]; Regione Toscana, Italy; Fondazione Edmund Mach, Trento	European Commission(European CommissionEuropean Commission Joint Research Centre); Regione Toscana, Italy(Regione Toscana); Fondazione Edmund Mach, Trento	This study was financially supported by the European Commission through the EuroChar project (FP7-ENV-478 2010ID-265179) and AgroPyroGas funded by Regione Toscana, Italy. I. C. was supported by a Ph.D. grant from Fondazione Edmund Mach, Trento. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ASACSSA SSSA INT ANN; BACKMEROFF C. E., 2013, MIN CULT LANDSC 8 IN, P218; Badeck FW, 2005, RAPID COMMUN MASS SP, V19, P1381, DOI 10.1002/rcm.1912; Ball DF, 1964, LOSS ON IGNITION EST, V15; Basso Andres S., 2013, GCB Bioenergy, V5, P132, DOI 10.1111/gcbb.12026; BERGAMETTI G, 1992, J ATMOS CHEM, V14, P501, DOI 10.1007/BF00115254; Bird MI, 2012, ORG GEOCHEM, V42, P1529, DOI 10.1016/j.orggeochem.2010.09.005; Carcaillet C, 2001, HOLOCENE, V11, P231, DOI 10.1191/095968301674071040; Cheng CH, 2008, GEOCHIM COSMOCHIM AC, V72, P1598, DOI 10.1016/j.gca.2008.01.010; Cremaschi M, 2006, QUATERN INT, V151, P87, DOI 10.1016/j.quaint.2006.01.020; Del Galdo I, 2003, GLOBAL CHANGE BIOL, V9, P1204, DOI 10.1046/j.1365-2486.2003.00657.x; Di Piazza A., 2012, ANALISI SERIE GIORNA; Eckmeier E, 2007, BIOGEOSCIENCES, V4, P377, DOI 10.5194/bg-4-377-2007; Favilli F, 2010, HOLOCENE, V20, P67, DOI 10.1177/0959683609348850; Flueck Werner T., 2009, Sustainability, V1, P104, DOI 10.3390/su1020104; Food and Agriculture Organization of the United Nation (FAO), 1987, SIMPL TECHN CHARC MA; FRIEDLI H, 1986, NATURE, V324, P237, DOI 10.1038/324237a0; Genesio L, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014025; Glaser B, 2001, NATURWISSENSCHAFTEN, V88, P37, DOI 10.1007/s001140000193; Glaser B, 2002, BIOL FERT SOILS, V35, P219, DOI 10.1007/s00374-002-0466-4; Graber ER, 2010, PLANT SOIL, V337, P481, DOI 10.1007/s11104-010-0544-6; Gurwick NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075932; Hesketh N, 2000, J ENVIRON QUAL, V29, P105, DOI 10.2134/jeq2000.00472425002900010013x; Jaffe R, 2013, SCIENCE, V340, P345, DOI 10.1126/science.1231476; Joseph SD, 2007, BIOCHAR CARBON SEQUE, P130; Kaal J, 2008, J ARCHAEOL SCI, V35, P2133, DOI 10.1016/j.jas.2008.01.013; Keeling CD, 2011, CONCENTRATION ISOTOP; Kinney TJ, 2012, BIOMASS BIOENERG, V41, P34, DOI 10.1016/j.biombioe.2012.01.033; Knicker H, 2011, QUATERN INT, V243, P251, DOI 10.1016/j.quaint.2011.02.037; Laird DA, 2008, CHARCOAL VISION WIN, DOI [10.2134/agronj2007.0161, DOI 10.2134/AGR0NJ2007.0161]; Lane PNJ, 2004, HYDROL PROCESS, V18, P879, DOI 10.1002/hyp.1316; Lehmann J., 2006, Mitigation and Adaptation Strategies for Global Change, V11, P403, DOI 10.1007/s11027-005-9006-5; Lehmann J, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002435; Lehmann J, 2011, SOIL BIOL BIOCHEM, V43, P1812, DOI 10.1016/j.soilbio.2011.04.022; LETEY J., 1969, Water-repellent soils. Proceedings of the symposium on water-repellent soils held at the University of California, Riverside, May 6-10, 1968., P43; Lo E, 2005, ECOL MONOGR, V75, P451, DOI 10.1890/05-0030; Mahowald N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2008GB003240; Mantovani P, 2006, RICORDI CARBONER BON; Masiello CA, 2004, MAR CHEM, V92, P201, DOI 10.1016/j.marchem.2004.06.043; Mencuccini M, 2005, ECOL LETT, V8, P1183, DOI 10.1111/j.1461-0248.2005.00819.x; Mercuri AM, 2006, VEG HIST ARCHAEOBOT, V16, P43, DOI 10.1007/s00334-006-0034-1; Naisse C, 2013, ORG GEOCHEM, V60, P40, DOI 10.1016/j.orggeochem.2013.04.011; Oguntunde PG, 2004, BIOL FERT SOILS, V39, P295, DOI 10.1007/s00374-003-0707-1; Oguntunde PG, 2008, J PLANT NUTR SOIL SC, V171, P591, DOI 10.1002/jpln.200625185; Peng X, 2011, SOIL TILL RES, V112, P159, DOI 10.1016/j.still.2011.01.002; Poda A, 1963, TAVOLE STEREOMETRICH, P780; Pusceddu E, 2013, J PHYS CONF SER, V470, DOI 10.1088/1742-6596/470/1/012003; Quilliam RS, 2013, SOIL BIOL BIOCHEM, V65, P287, DOI 10.1016/j.soilbio.2013.06.004; Reynolds WD, 2009, GEODERMA, V152, P252, DOI 10.1016/j.geoderma.2009.06.009; Rizzi G, 2010, SENTIERO VAL SOLE SF; Saurer M, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000689; Schenkel Y, 1998, BIOMASS BIOENERG, V14, P505, DOI 10.1016/S0961-9534(97)10033-2; Schmidt MWI, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001939; Schutz M, 2006, ECOSYSTEMS, V9, P624, DOI 10.1007/s10021-006-0091-4; SCOTT DF, 1990, J HYDROL, V121, P239, DOI 10.1016/0022-1694(90)90234-O; Singh N, 2012, BIOGEOSCIENCES, V9, P2847, DOI 10.5194/bg-9-2847-2012; SMITH NJH, 1980, ANN ASSOC AM GEOGR, V70, P553, DOI 10.1111/j.1467-8306.1980.tb01332.x; Smith R.T, 1975, TECHNIQUES PEDOLOGY; Sonna R, STUDI RICERCHE, P1; Tait D., 2000, J LIMNOL, V59, DOI [10.4081/jlimnol.2000.61, DOI 10.4081/JLIMNOL.2000.61]; Tonolli S, 2011, EUR J FOREST RES, V130, P569, DOI 10.1007/s10342-010-0445-5; USEPA Method 3052, 1996, 3052 USEPA; Vendrell P, 1990, COMMUNICATIONS SOIL, V21; Willis RB, 1993, COMMUNICATIONS SOIL, V24; Woolf D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1053; Yanai Y, 2007, SOIL SCI PLANT NUTR, V53, P181, DOI 10.1111/j.1747-0765.2007.00123.x; Zimmermann M, 2012, GLOBAL CHANGE BIOL, V18, P3306, DOI 10.1111/j.1365-2486.2012.02796.x	68	47	47	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91114	10.1371/journal.pone.0091114	http://dx.doi.org/10.1371/journal.pone.0091114			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614647	Green Published, gold, Green Submitted			2022-12-25	WOS:000332839300078
J	Hwang, KK; Trama, AM; Kozink, DM; Chen, X; Wiehe, K; Cooper, AJ; Xia, SM; Wang, MY; Marshall, DJ; Whitesides, J; Alam, M; Tomaras, GD; Allen, SL; Rai, KR; McKeating, J; Catera, R; Yan, XJ; Chu, CC; Kelsoe, G; Liao, HX; Chiorazzi, N; Haynes, BF				Hwang, Kwan-Ki; Trama, Ashley M.; Kozink, Daniel M.; Chen, Xi; Wiehe, Kevin; Cooper, Abby J.; Xia, Shi-Mao; Wang, Minyue; Marshall, Dawn J.; Whitesides, John; Alam, Munir; Tomaras, Georgia D.; Allen, Steven L.; Rai, Kanti R.; McKeating, Jane; Catera, Rosa; Yan, Xiao-Jie; Chu, Charles C.; Kelsoe, Garnett; Liao, Hua-Xin; Chiorazzi, Nicholas; Haynes, Barton F.			IGHV1-69 B Cell Chronic Lymphocytic Leukemia Antibodies Cross-React with HIV-1 and Hepatitis C Virus Antigens as Well as Intestinal Commensal Bacteria	PLOS ONE			English	Article							HIGH-FREQUENCY; PREFERENTIAL USE; INFLUENZA-VIRUS; GENE; NEUTRALIZATION; SUBSETS; EXPRESSION; LYMPHOMAS; IDIOTYPES; SELECTION	IGHV1-B-cell chronic lymphocytic leukemia (B-CLL) patients expressing unmutated immunoglobulin heavy variable regions (IGHVs) use the IGHV1-69 B cell receptor (BCR) in 25% of cases. Since HIV-1 envelope gp41 antibodies also frequently use IGHV1-69 gene segments, we hypothesized that IGHV1-69 B-CLL precursors may contribute to the gp41 B cell response during HIV-1 infection. To test this hypothesis, we rescued 5 IGHV1-69 unmutated antibodies as heterohybridoma IgM paraproteins and as recombinant IgG(1) antibodies from B-CLL patients, determined their antigenic specificities and analyzed BCR sequences. IGHV1-69 B-CLL antibodies were enriched for reactivity with HIV-1 envelope gp41, influenza, hepatitis C virus E2 protein and intestinal commensal bacteria. These IGHV1-69 B-CLL antibodies preferentially used IGHD3 and IGHJ6 gene segments and had long heavy chain complementary determining region 3s (HCDR3s) (>= 21 aa). IGHV1-69 B-CLL BCRs exhibited a phenylalanine at position 54 (F-54) of the HCDR2 as do rare HIV-1 gp41 and influenza hemagglutinin stem neutralizing antibodies, while IGHV1-69 gp41 antibodies induced by HIV-1 infection predominantly used leucine (L-54) allelic variants. These results demonstrate that the B-CLL cell population is an expansion of members of the innate polyreactive B cell repertoire with reactivity to a number of infectious agent antigens including intestinal commensal bacteria. The B-CLL IGHV1-69 B cell usage of F-54 allelic variants strongly suggests that IGHV1-69 B-CLL gp41 antibodies derive from a restricted B cell pool that also produces rare HIV-1 gp41 and influenza hemagglutinin stem antibodies.	[Hwang, Kwan-Ki; Trama, Ashley M.; Kozink, Daniel M.; Chen, Xi; Wiehe, Kevin; Cooper, Abby J.; Xia, Shi-Mao; Wang, Minyue; Marshall, Dawn J.; Whitesides, John; Alam, Munir; Tomaras, Georgia D.; Liao, Hua-Xin; Haynes, Barton F.] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC 27708 USA; [McKeating, Jane] Univ Birmingham, Sch Immun & Infect, Inst Biomed Res, Birmingham, W Midlands, England; [Allen, Steven L.; Rai, Kanti R.; Catera, Rosa; Yan, Xiao-Jie; Chu, Charles C.; Chiorazzi, Nicholas] Feinstein Inst Med Res, Karches Ctr Chron Lymphocyt Leukemia Res, Manhasset, NY USA; [Kelsoe, Garnett] Duke Univ, Sch Med, Dept Immunol, Durham, NC USA	Duke University; University of Birmingham; Northwell Health; Duke University	Haynes, BF (corresponding author), Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC 27708 USA.	hayne002@mc.duke.edu	Allen, Steven/N-6088-2019; Tomaras, Georgia/J-5041-2016	Allen, Steven/0000-0002-3482-3182; McKeating, Jane/0000-0002-7229-5886	National Institute of Allergy and Infectious Diseases of the National Institutes of Health; Center for HIV/AIDS Vaccine Immunology [U19-AI067854]; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery [UM1-AI100645-01]; National Cancer Institute of the National Institutes of Health [CA81554]; Nash Family Foundation; Karches Foundation; NATIONAL CANCER INSTITUTE [R01CA081554, P30CA014236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100645, U19AI067854] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for HIV/AIDS Vaccine Immunology; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Nash Family Foundation; Karches Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, by the Center for HIV/AIDS Vaccine Immunology, grant number U19-AI067854 and by the Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, grant number UM1-AI100645-01. This work was also supported by an R01 grant from the National Cancer Institute of the National Institutes of Health, grant number CA81554 and by philanthropic grants from the Nash Family Foundation and the Karches Foundation to KRR and NC. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Baumgarth N, 1999, P NATL ACAD SCI USA, V96, P2250, DOI 10.1073/pnas.96.5.2250; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Bomsel M, 1998, IMMUNITY, V9, P277, DOI 10.1016/S1074-7613(00)80610-X; Carbonari M, 2005, J IMMUNOL, V174, P6532, DOI 10.4049/jimmunol.174.10.6532; Catera R, 2008, MOL MED, V14, P665, DOI 10.2119/2008-00102.Catera; Chan CH, 2001, BLOOD, V97, P1023, DOI 10.1182/blood.V97.4.1023; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Chiorazzi N, 2011, BLOOD, V117, P1781, DOI 10.1182/blood-2010-07-155663; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Darzentas N, 2010, LEUKEMIA, V24, P125, DOI 10.1038/leu.2009.186; Davies J, 1996, IMMUNOTECHNOLOGY, V2, P169, DOI 10.1016/S1380-2933(96)00045-0; Dennison SM, 2011, J VIROL, V85, P1340, DOI 10.1128/JVI.01680-10; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fais F, 1998, J CLIN INVEST, V102, P1515, DOI 10.1172/JCI3009; Ghiotto F, 2006, MOL MED, V12, P300, DOI 10.2119/2006-00080.Ghiotto; Gorny MK, 2009, MOL IMMUNOL, V46, P917, DOI 10.1016/j.molimm.2008.09.005; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Gustchina E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001182; Herve M, 2005, J CLIN INVEST, V115, P1636, DOI 10.1172/JCI24387; Hwang KK, 2012, BLOOD, V119, pE35, DOI 10.1182/blood-2011-08-371203; Kawatsu K, 2008, J CLIN MICROBIOL, V46, P1226, DOI 10.1128/JCM.02170-07; KIPPS TJ, 1990, J EXP MED, V171, P189, DOI 10.1084/jem.171.1.189; KIPPS TJ, 1991, J CLIN INVEST, V87, P2087, DOI 10.1172/JCI115239; KIPPS TJ, 1988, BLOOD, V72, P422; KIPPS TJ, 1989, P NATL ACAD SCI USA, V86, P5913, DOI 10.1073/pnas.86.15.5913; Liao HX, 2006, VIROLOGY, V353, P268, DOI 10.1016/j.virol.2006.04.043; Liao HX, 2011, J EXP MED, V208, P2237, DOI 10.1084/jem.20110363; Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014; Logvinoff C, 2004, P NATL ACAD SCI USA, V101, P10149, DOI 10.1073/pnas.0403519101; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; Ma BJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002200; Messmer BT, 2004, J EXP MED, V200, P519, DOI 10.1084/jem.20040544; Morris L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023532; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Murray F, 2008, BLOOD, V111, P1524, DOI 10.1182/blood-2007-07-099564; Myhrinder AL, 2008, BLOOD, V111, P3838, DOI 10.1182/blood-2007-11-125450; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Sabin C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001195; Sasso EH, 1996, J CLIN INVEST, V97, P2074, DOI 10.1172/JCI118644; SASSO EH, 1993, J CLIN INVEST, V91, P2358, DOI 10.1172/JCI116468; Schelonka RL, 2008, J IMMUNOL, V181, P8409, DOI 10.4049/jimmunol.181.12.8409; SCHROEDER HW, 1987, SCIENCE, V238, P791, DOI 10.1126/science.3118465; Seifert M, 2012, J EXP MED, V209, P2183, DOI 10.1084/jem.20120833; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Tobin G, 2004, BLOOD, V104, P2879, DOI 10.1182/blood-2004-01-0132; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Widhopf GF, 2004, BLOOD, V104, P2499, DOI 10.1182/blood-2004-03-0818; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352	51	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90725	10.1371/journal.pone.0090725	http://dx.doi.org/10.1371/journal.pone.0090725			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614505	Green Published, gold, Green Submitted			2022-12-25	WOS:000332839300035
J	Wielders, CCH; Wuister, AMH; de Visser, VL; de Jager-Leclercq, MG; Groot, CAR; Dijkstra, F; van Gageldonk-Lafeber, AB; van Leuken, JPG; Wever, PC; van der Hoek, W; Schneeberger, PM				Wielders, Cornelia C. H.; Wuister, Annemarie M. H.; de Visser, Veerle L.; de Jager-Leclercq, Monique G.; Groot, Cornelis A. R.; Dijkstra, Frederika; van Gageldonk-Lafeber, Arianne B.; van Leuken, Jeroen P. G.; Wever, Peter C.; van der Hoek, Wim; Schneeberger, Peter M.			Characteristics of Hospitalized Acute Q Fever Patients during a Large Epidemic, The Netherlands	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; OUTBREAK; MORTALITY; HYPONATREMIA; ASSOCIATION; MANAGEMENT; IDENTIFY; FEATURES	Background: From 2007 to 2009, the Netherlands experienced a major Q fever epidemic, with higher hospitalization rates than the 2-5% reported in the literature for acute Q fever pneumonia and hepatitis. We describe epidemiological and clinical features of hospitalized acute Q fever patients and compared patients presenting with Q fever pneumonia with patients admitted for other forms of community-acquired pneumonia (CAP). We also examined whether proximity to infected ruminant farms was a risk factor for hospitalization. Methods: A retrospective cohort study was conducted for all patients diagnosed and hospitalized with acute Q fever between 2007 and 2009 in one general hospital situated in the high incidence area in the south of the Netherlands. Pneumonia severity scores (PSI and CURB-65) of acute Q fever pneumonia patients (defined as infiltrate on a chest x-ray) were compared with data from CAP patients. Hepatitis was defined as a. twofold the reference value for alanine aminotransferase and for bilirubin. Results: Among the 183 hospitalized acute Q fever patients, 86.0% had pneumonia. Elevated liver enzymes (alanine aminotransferase) were found in 32.3% of patients, although hepatitis was not observed in any of them. The most frequent clinical signs upon presentation were fever, cough and dyspnoea. The median duration of admission was five days. Acute Q fever pneumonia patients were younger, had less co-morbidity, and lower PSI and CURB-65 scores than other CAP patients. Anecdotal information from attending physicians suggests that some patients were admitted because of severe subjective dyspnoea, which was not included in the scoring systems. Proximity to an infected ruminant farm was not associated with hospitalization. Conclusion: Hospitalized Dutch acute Q fever patients mostly presented with fever and pneumonia. Patients with acute Q fever pneumonia were hospitalized despite low PSI and CURB-65 scores, presumably because subjective dyspnoea was not included in the scoring systems.	[Wielders, Cornelia C. H.; Wever, Peter C.; Schneeberger, Peter M.] Jeroen Bosch Hosp, Dept Med Microbiol & Infect Control, Shertogenbosch, Netherlands; [Wielders, Cornelia C. H.; Wuister, Annemarie M. H.; Dijkstra, Frederika; van Gageldonk-Lafeber, Arianne B.; van Leuken, Jeroen P. G.; van der Hoek, Wim; Schneeberger, Peter M.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [Wuister, Annemarie M. H.; de Jager-Leclercq, Monique G.] Bernhoven Hosp, Dept Internal Med, Uden, Netherlands; [de Visser, Veerle L.] Jeroen Bosch Hosp, Dept Pulm Dis, Shertogenbosch, Netherlands; [Groot, Cornelis A. R.] Bernhoven Hosp, Dept Pulm Dis, Uden, Netherlands; [van Leuken, Jeroen P. G.] Univ Utrecht, Fac Vet Sci, Inst Risk Assessment Sci, Utrecht, Netherlands	Jeroen Bosch Ziekenhuis; Netherlands National Institute for Public Health & the Environment; Jeroen Bosch Ziekenhuis; Utrecht University	Wielders, CCH (corresponding author), Jeroen Bosch Hosp, Dept Med Microbiol & Infect Control, Shertogenbosch, Netherlands.	l.wielders@jbz.nl	Wielders, Cornelia CH/I-1970-2019; Dijkstra, Frederika/ABF-3865-2021	Wielders, Cornelia CH/0000-0002-2413-9088; Dijkstra, Frederika/0000-0003-0012-740X	Netherlands Organisation for Health Research and Development (ZonMw) [205520006]	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This work was supported by the Netherlands Organisation for Health Research and Development (ZonMw)(http://www.zonmw.nl/), grant number 205520006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; BERNARD E, 1994, EUR J CLIN MICROBIOL, V13, P658, DOI 10.1007/BF01973993; Bernit E, 2002, ARCH INTERN MED, V162, P693, DOI 10.1001/archinte.162.6.693; Caron F, 1998, CHEST, V114, P808, DOI 10.1378/chest.114.3.808; Comprehensive Cancer Centre the Netherlands, 2011, NETH CANC REG COMPR; Cunha BA, 2000, CLIN MICROBIOL INFEC, V6, P633, DOI 10.1046/j.1469-0691.2000.0194f.x; de Alarcon A, 2003, J INFECTION, V47, P110, DOI 10.1016/S0163-4453(03)00013-6; de Wit NCJ, 2009, CLIN CHEM LAB MED, V47, P1407, DOI 10.1515/CCLM.2009.307; Dijkstra F, 2011, EPIDEMIOL INFECT, V139, P1332, DOI 10.1017/S0950268810002621; Dijkstra F, 2012, FEMS IMMUNOL MED MIC, V64, P3, DOI 10.1111/j.1574-695X.2011.00876.x; DUPONT HT, 1992, AM J MED, V93, P427, DOI 10.1016/0002-9343(92)90173-9; Ergas D, 2006, ISR MED ASSOC J, V8, P337; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Fournier PE, 1998, J CLIN MICROBIOL, V36, P1823, DOI 10.1128/JCM.36.7.1823-1834.1998; Gilsdorf A, 2008, EPIDEMIOL INFECT, V136, P1084, DOI 10.1017/S0950268807009533; Gommer AM, 2011, BETTER HLTH DUTCH 20; Kampschreur LM, 2010, NETH J MED, V68, P408; Kampschreur LM, 2012, EMERG INFECT DIS, V18, P563, DOI 10.3201/eid1804.111478; Karagiannis I, 2009, EPIDEMIOL INFECT, V137, P1283, DOI 10.1017/S0950268808001908; Lai CH, 2008, SCAND J INFECT DIS, V40, P105, DOI 10.1080/00365540701558722; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Marrie TJ, 1996, J INFECT DIS, V173, P484, DOI 10.1093/infdis/173.2.484; MARRIE TJ, 1990, CAN VET J, V31, P555; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Medic S, 2012, EUROSURVEILLANCE, V17, P2; Nair V, 2007, AM J NEPHROL, V27, P184, DOI 10.1159/000100866; Oyston PCF, 2011, J MED MICROBIOL, V60, P9, DOI 10.1099/jmm.0.024778-0; Parker NR, 2006, LANCET, V367, P679, DOI 10.1016/S0140-6736(06)68266-4; Porten K, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-147; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Raoult D, 2000, MEDICINE, V79, P109, DOI 10.1097/00005792-200003000-00005; Schimmer B, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-69; SMITH DL, 1993, RESP MED, V87, P509, DOI 10.1016/0954-6111(93)90006-L; Snijders BEP, 2013, PRIM CARE RESP J, V22, P400, DOI 10.4104/pcrj.2013.00085; SOBRADILLO V, 1989, EUR RESPIR J, V2, P263; Statistics Netherlands, 2013, HLTH LIF MED CONT RE; TIGERTT WD, 1961, BACTERIOL REV, V25, P285, DOI 10.1128/MMBR.25.3.285-293.1961; Van den Brom R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054021; van der Hoek W, 2010, EURO SURVEILL, P15; van der Hoek W, 2012, ADV EXP MED BIOL, V984, P329, DOI 10.1007/978-94-007-4315-1_17; van Gageldonk-Lafeber AB, 2013, NETH J MED, V71, P418; Vardi M, 2011, EUR J CLIN MICROBIOL, V30, P1527, DOI 10.1007/s10096-011-1255-5; Waikar SS, 2009, AM J MED, V122, P857, DOI 10.1016/j.amjmed.2009.01.027; Wald R, 2010, ARCH INTERN MED, V170, P294, DOI 10.1001/archinternmed.2009.513; Wegdam-Blans MCA, 2012, J INFECTION, V64, P247, DOI 10.1016/j.jinf.2011.12.014; Wielders CCH, 2013, J CLIN MICROBIOL, V51, P3192, DOI 10.1128/JCM.00993-13; Wielders CCH, 2013, EUR J CLIN INVEST, V43, P616, DOI 10.1111/eci.12073; Wiersinga WJ, 2012, NETH J MED, V70, P90; Zilberberg Marya D, 2008, BMC Pulm Med, V8, P16, DOI 10.1186/1471-2466-8-16	49	24	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91764	10.1371/journal.pone.0091764	http://dx.doi.org/10.1371/journal.pone.0091764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614585	gold, Green Published, Green Submitted			2022-12-25	WOS:000332839300155
J	Hassan, LEA; Ahamed, MBK; Majid, ASA; Iqbal, MA; Al Suede, FSR; Haque, RA; Ismail, Z; Ein, OC; Majid, AMSA				Hassan, Loiy Elsir Ahmed; Ahamed, Mohamed B. Khadeer; Majid, Aman Shah Abdul; Iqbal, Muhammad Adnan; Al Suede, Fouad Saleih R.; Haque, Rosenani A.; Ismail, Zhari; Ein, Oon Chern; Majid, Amin Malik Shah Abdul			Crystal Structure Elucidation and Anticancer Studies of (-)-Pseudosemiglabrin: A Flavanone Isolated from the Aerial Parts of Tephrosia apollinea	PLOS ONE			English	Article							BIS-BENZIMIDAZOLIUM SALTS; CANCER CHEMOPREVENTION; PHYSICAL-PROPERTIES; CARBENE COMPLEXES; NATURAL-PRODUCTS; CELL-LINES; APOPTOSIS; DERIVATIVES; AGENTS; ESTER	Tephrosia apollinea is a perennial shrublet widely distributed in Africa and is known to have medicinal properties. The current study describes the bio-assay (cytotoxicity) guided isolation of (-)-pseudosemiglabrin from the aerial parts of T. apollinea. The structural and stereochemical features have been described using spectral and x-ray crystallographic techniques. The cytotoxicity of isolated compound was evaluated against nine cancer cell lines. In addition, human fibroblast was used as a model cell line for normal cells. The results showed that (-)-pseudosemiglabrin exhibited dose-dependent antiproliferative effect on most of the tested cancer cell lines. Selectively, the compound showed significant inhibitory effect on the proliferation of leukemia, prostate and breast cancer cell lines. Further studies revealed that, the compound exhibited proapoptotic phenomenon of cytotoxicity. Interestingly, the compound did not display toxicity against the normal human fibroblast. It can be concluded that (-)-pseudosemiglabrin is worthy for further investigation as a potential chemotherapeutic agent.	[Hassan, Loiy Elsir Ahmed; Ahamed, Mohamed B. Khadeer; Al Suede, Fouad Saleih R.; Ismail, Zhari; Majid, Amin Malik Shah Abdul] Univ Sains Malaysia, Sch Pharmaceut Sci, EMAN Res & Testing Lab, George Town, Malaysia; [Majid, Aman Shah Abdul] Univ Sains Malaysia, Adv Med & Dent Inst IPPT, George Town, Malaysia; [Iqbal, Muhammad Adnan; Haque, Rosenani A.] Univ Sains Malaysia, Sch Chem Sci, George Town, Malaysia; [Ein, Oon Chern] Univ Sains Malaysia, Inst Res Mol Med INFORMM, George Town, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia; Universiti Sains Malaysia; Universiti Sains Malaysia	Majid, AMSA (corresponding author), Univ Sains Malaysia, Sch Pharmaceut Sci, EMAN Res & Testing Lab, George Town, Malaysia.	aminmalikshah@gmail.com	Basheer, Mohamed Khadeer Ahamed/P-1681-2014; Majid, Aman Shah Abdul/I-3809-2012; Oon, Chern E/B-3684-2013; Iqbal, Muhammad Adnan/Q-5408-2016; Alsuede, Fouad Saleih Resq/AAE-6203-2021; Haque, Rosenani/J-2461-2017	Basheer, Mohamed Khadeer Ahamed/0000-0001-9616-1770; Majid, Aman Shah Abdul/0000-0001-9679-122X; Oon, Chern E/0000-0002-4685-6408; Iqbal, Muhammad Adnan/0000-0001-6241-7547; Abdul Majid, Amin Malik Shah/0000-0001-7499-2258; A. Haque, Rosenani/0000-0002-5232-1469	TWAS-USM [3240240313]; USM [304/PKIMIA/6311123]	TWAS-USM; USM(Universiti Sains Malaysia)	The authors wish to acknowledge TWAS-USM (FR number: 3240240313) for the fellowship to LEAH and financial support for this research. RAH is thankful to USM for the research grant No 304/PKIMIA/6311123. The authors state that the funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE H, 1995, MACROMOLECULES, V28, P844, DOI 10.1021/ma00108a007; Abou-Douh AM, 2005, Z NATURFORSCH B, V60, P458; Ahamed MBK, 2012, NUTR CANCER, V64, P89, DOI 10.1080/01635581.2012.630160; Al-Salahi OSA, 2013, MICROVASC RES, V90, P30, DOI 10.1016/j.mvr.2013.07.007; Anadu NO, 2006, J MED CHEM, V49, P3897, DOI 10.1021/jm0602817; Aytemir MD, 2003, TURK J CHEM, V27, P445; BIBBY MC, 1987, BRIT J CANCER, V55, P159, DOI 10.1038/bjc.1987.32; Bold RJ, 1997, SURG ONCOL, V6, P133, DOI 10.1016/S0960-7404(97)00015-7; Brinkmann M, 2000, J AM CHEM SOC, V122, P5147, DOI 10.1021/ja993608k; Castedo M, 2002, J IMMUNOL METHODS, V265, P39, DOI 10.1016/S0022-1759(02)00069-8; Chen YJ, 2001, ANTI-CANCER DRUG, V12, P143, DOI 10.1097/00001813-200102000-00008; Daouda B, 2013, ACTA CRYSTALLOGR E, V69, pO662, DOI 10.1107/S1600536813008702; Du ZY, 2013, ACTA CRYSTALLOGR E, V69, pO624, DOI 10.1107/S1600536813008015; Gulecha V, 2011, ASIAN PAC J TROP MED, V4, P526, DOI 10.1016/S1995-7645(11)60139-9; Haque R., 2013, MED CHEM RES, DOI 10. 1007/s00044-012-0461-8; Haque RA, 2013, APPL ORGANOMET CHEM, V27, P214, DOI 10.1002/aoc.2953; Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004; Hong WK, 1997, SCIENCE, V278, P1073, DOI 10.1126/science.278.5340.1073; Iqbal MA, 2013, MED CHEM RES, V22, P2455, DOI 10.1007/s00044-012-0240-6; Jayashree BS, 2012, MED CHEM RES, V21, P1991, DOI 10.1007/s00044-011-9725-y; Kajimoto S, 2002, INT J CANCER, V99, P879, DOI 10.1002/ijc.10414; Kalai T, 2004, ARKIVOC, P266, DOI 10.3998/ark.5550190.0005.721; Kelloff GJ, 1999, ANN NY ACAD SCI, V889, P1, DOI 10.1111/j.1749-6632.1999.tb08718.x; Khoo BY, 2010, INT J MOL SCI, V11, P2188, DOI 10.3390/ijms11052188; Kosmider B, 2004, DRUG DEVELOP RES, V63, P200, DOI 10.1002/ddr.10421; Lahtinen M, 2013, ACTA CRYSTALLOGR E, V69, pO681, DOI 10.1107/S1600536813008957; Lehmler HJ, 2013, ACTA CRYSTALLOGR E, V69, pO650, DOI 10.1107/S160053681300826X; Li X, 2006, PHARMAZIE, V61, P474; Li ZJ, 1997, J PHARM SCI, V86, P1073, DOI 10.1021/js970195h; Lim HK, 2009, FOOD CHEM, V114, P1245, DOI 10.1016/j.foodchem.2008.10.088; Lindholm P, 2002, J BIOMOL SCREEN, V7, P333, DOI 10.1177/108705710200700405; Mann J, 2002, NAT REV CANCER, V2, P143, DOI 10.1038/nrc723; MANOHARAN R, 1993, ATHEROSCLEROSIS, V103, P181, DOI 10.1016/0021-9150(93)90261-R; Matysik G, 2005, CHROMATOGRAPHIA, V61, P89, DOI 10.1365/s10337-004-0443-1; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Musharraf SG, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-77; Nassar ZD, 2012, ONCOL REP, V27, P727, DOI 10.3892/or.2011.1569; Nobili S, 2009, PHARMACOL RES, V59, P365, DOI 10.1016/j.phrs.2009.01.017; Qian Y, 2010, BIOORGAN MED CHEM, V18, P4991, DOI 10.1016/j.bmc.2010.06.003; REILLY M, 1995, TETRAHEDRON LETT, V36, P217, DOI 10.1016/0040-4039(94)02226-2; Ren WY, 2003, MED RES REV, V23, P519, DOI 10.1002/med.10033; Seidel N, 2013, ACTA CRYSTALLOGR E, V69, pO1732, DOI 10.1107/S1600536813028857; Skommer J, 2007, LEUKEMIA RES, V31, P277, DOI 10.1016/j.leukres.2006.06.027; Song XQ, 2005, MOL PHARMACEUT, V2, P157, DOI 10.1021/mp049888e; Sun SY, 2004, JNCI-J NATL CANCER I, V96, P662, DOI 10.1093/jnci/djh123; Touqeer S, 2013, REV PHYTOCHEMISTRY P; Vatkar B. S., 2010, International Journal of ChemTech Research, V2, P504; WATERMAN PG, 1980, PHYTOCHEMISTRY, V19, P909, DOI 10.1016/0031-9422(80)85137-5; Wattenberg LW, 1995, ANN NY ACAD SCI, V768, P73, DOI 10.1111/j.1749-6632.1995.tb12111.x; Xue F, 2009, J SUN YAT SEN U MED, V4, P015; Zhang H, 2013, ACTA CRYSTALLOGR E, V69, pO678, DOI 10.1107/S1600536813008829	51	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90806	10.1371/journal.pone.0090806	http://dx.doi.org/10.1371/journal.pone.0090806			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608571	gold, Green Published, Green Submitted			2022-12-25	WOS:000332485800052
J	Oh, TJ; Hyun, SH; Lee, SG; Chun, YJ; Sung, GH; Choi, HK				Oh, Taek-Joo; Hyun, Sun-Hee; Lee, Seul-Gi; Chun, Young-Jin; Sung, Gi-Ho; Choi, Hyung-Kyoon			NMR and GC-MS Based Metabolic Profiling and Free-Radical Scavenging Activities of Cordyceps pruinosa Mycelia Cultivated under Different Media and Light Conditions	PLOS ONE			English	Article							CULTURED MYCELIA; FRUITING BODY; ANTIOXIDANT ACTIVITIES; EDIBLE MUSHROOMS; IN-VITRO; MILITARIS; ASPERGILLUS; SPORULATION; FUNGI; POLYSACCHARIDE	Variation of metabolic profiles in Cordyceps pruinosa mycelia cultivated under various media and light conditions was investigated using 1 H nuclear magnetic resonance (NMR) analysis and gas chromatography mass spectrometry (GC-MS) with multivariate statistical analysis. A total of 71 metabolites were identified (5 alcohols, 21 amino acids, 15 organic acids, 4 purines, 3 pyrimidines, 7 sugars, 11 fatty acids, and 5 other metabolites) by NMR and GC-MS analysis. The mycelia grown in nitrogen media and under dark conditions showed the lowest growth and ergosterol levels, essential to a functional fungal cell membrane; these mycelia, however, had the highest levels of putrescine, which is involved in abiotic stress tolerance. In contrast, mycelia cultivated in sabouraud dextrose agar with yeast extract (SDAY) media and under light conditions contained relatively higher levels of fatty acids, including valeric acid, stearic acid, lignoceric acid, myristic acid, oleic acid, palmitoleic acid, hepadecenoic acid, and linoleic acid. These mycelia also had the highest phenolic content and antioxidant activity, and did not exhibit growth retardation due to enhanced asexual development caused by higher levels of linoleic acid. Therefore, we suggested that a light-enriched environment with SDAY media was more optimal than dark condition for cultivation of C. pruinosa mycelia as biopharmaceutical or nutraceutical resources.	[Oh, Taek-Joo; Hyun, Sun-Hee; Lee, Seul-Gi; Chun, Young-Jin; Choi, Hyung-Kyoon] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea; [Sung, Gi-Ho] RDA, Natl Inst Hort & Herbal Sci, Dept Herbal Crop Res, Mushroom Res Div, Eumseong, South Korea	Chung Ang University; National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea	Sung, GH (corresponding author), RDA, Natl Inst Hort & Herbal Sci, Dept Herbal Crop Res, Mushroom Res Div, Eumseong, South Korea.	sung97330@gmail.com; hykychoi@cau.ac.kr			Next-Generation Biogreen 21 Program, Rural Development Administration [PJ008154]; Mid-career Researcher Program through NRF [NRF-2012R1A2A2A02011748]; MSIP, Republic of Korea	Next-Generation Biogreen 21 Program, Rural Development Administration; Mid-career Researcher Program through NRF; MSIP, Republic of Korea	This work was supported by a grant from the Next-Generation Biogreen 21 Program (No. PJ008154), Rural Development Administration, and by Mid-career Researcher Program (NRF-2012R1A2A2A02011748) through NRF grant funded by the MSIP, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calvo AM, 2001, J BIOL CHEM, V276, P25766, DOI 10.1074/jbc.M100732200; Calvo AM, 1999, APPL ENVIRON MICROB, V65, P3668; Chen SY, 2012, LWT-FOOD SCI TECHNOL, V47, P274, DOI 10.1016/j.lwt.2012.01.019; Dadakova E, 2009, EUR FOOD RES TECHNOL, V230, P163, DOI 10.1007/s00217-009-1148-3; de Oliveira AC, 2009, FOOD CHEM, V115, P469, DOI 10.1016/j.foodchem.2008.12.045; Dong CH, 2008, LWT-FOOD SCI TECHNOL, V41, P669, DOI 10.1016/j.lwt.2007.05.002; Dong JZ, 2012, APPL BIOCHEM BIOTECH, V166, P2030, DOI 10.1007/s12010-012-9628-5; Dyer PS, 2012, FEMS MICROBIOL REV, V36, P165, DOI 10.1111/j.1574-6976.2011.00308.x; Fan DD, 2012, BIOCHEM ENG J, V60, P30, DOI 10.1016/j.bej.2011.09.014; FURUYA T, 1983, PHYTOCHEMISTRY, V22, P2509, DOI 10.1016/0031-9422(83)80150-2; Gill SS, 2010, PLANT SIGNAL BEHAV, V5, P26, DOI 10.4161/psb.5.1.10291; GOLDSTEIN A, 1962, J GEN MICROBIOL, V28, P689; Hao Y, 1999, JUN WU XUE BAO, V18, P307; HILL EP, 1976, J GEN MICROBIOL, V95, P39, DOI 10.1099/00221287-95-1-39; Huang J, 1998, J FUJIAN TEACH U NAT, V14, P82; Johnson L, 2008, MYCOL RES, V112, P170, DOI 10.1016/j.mycres.2007.11.012; Kalogeropoulos N, 2013, FOOD CHEM TOXICOL, V55, P378, DOI 10.1016/j.fct.2013.01.010; Kim HG, 2010, J ETHNOPHARMACOL, V128, P342, DOI 10.1016/j.jep.2010.01.049; Kim KM, 2003, TOXICOL APPL PHARM, V190, P1, DOI 10.1016/S0041-008X(03)00152-2; Kim MY, 2008, J AGR FOOD CHEM, V56, P7265, DOI 10.1021/jf8008553; Kim Soo-Young, 2010, Mycobiology, V38, P133, DOI 10.4489/MYCO.2010.38.2.133; Lee Je-O, 2007, Mycobiology, V35, P230, DOI 10.4489/MYCO.2007.35.4.230; Liang ZQ, 1991, MYCOSYSTEMA, V10, P104; Liu J., 2001, THE J, V17, P189; Liu ZY, 2002, MYCOL RES, V106, P1100, DOI 10.1017/S0953756202006378; Ou ZQ, 2013, J PHARM PHARMACOL, V65, P271, DOI 10.1111/j.2042-7158.2012.01591.x; Palacios I, 2011, FOOD CHEM, V128, P674, DOI 10.1016/j.foodchem.2011.03.085; Park HS, 2012, CURR OPIN MICROBIOL, V15, P669, DOI 10.1016/j.mib.2012.09.006; Prathumpai W, 2007, APPL BIOCHEM BIOTECH, V136, P223, DOI 10.1007/BF03259856; Ramadan Z, 2006, TALANTA, V68, P1683, DOI 10.1016/j.talanta.2005.08.042; Shrestha Bhushan, 2006, Mycobiology, V34, P83, DOI 10.4489/MYCO.2006.34.2.083; Styczynski MP, 2007, ANAL CHEM, V79, P966, DOI 10.1021/ac0614846; Sung Jae-Mo, 2006, Mycobiology, V34, P131, DOI 10.4489/MYCO.2006.34.3.131; Vanegas JM, 2012, BIOPHYS J, V102, P507, DOI 10.1016/j.bpj.2011.12.038; Won SY, 2005, J ETHNOPHARMACOL, V96, P555, DOI 10.1016/j.jep.2004.10.009; Xiao JH, 2004, PROCESS BIOCHEM, V39, P2241, DOI 10.1016/j.procbio.2003.11.026	36	17	18	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90823	10.1371/journal.pone.0090823	http://dx.doi.org/10.1371/journal.pone.0090823			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608751	Green Published, gold, Green Submitted			2022-12-25	WOS:000332485800055
J	Wu, H; Ji, HK				Wu, Hao; Ji, Hongkai			PolyaPeak: Detecting Transcription Factor Binding Sites from ChIP-seq Using Peak Shape Information	PLOS ONE			English	Article							GENOME; IDENTIFICATION; PROFILES	ChIP-seq is a powerful technology for detecting genomic regions where a protein of interest interacts with DNA. ChIP-seq data for mapping transcription factor binding sites (TFBSs) have a characteristic pattern: around each binding site, sequence reads aligned to the forward and reverse strands of the reference genome form two separate peaks shifted away from each other, and the true binding site is located in between these two peaks. While it has been shown previously that the accuracy and resolution of binding site detection can be improved by modeling the pattern, efficient methods are unavailable to fully utilize that information in TFBS detection procedure. We present PolyaPeak, a new method to improve TFBS detection by incorporating the peak shape information. PolyaPeak describes peak shapes using a flexible Polya model. The shapes are automatically learnt from the data using Minorization-Maximization (MM) algorithm, then integrated with the read count information via a hierarchical model to distinguish true binding sites from background noises. Extensive real data analyses show that PolyaPeak is capable of robustly improving TFBS detection compared with existing methods. An R package is freely available.	[Wu, Hao] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Ji, Hongkai] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA	Emory University; Johns Hopkins University	Wu, H (corresponding author), Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA.	hao.wu@emory.edu; hji@jhsph.edu	Wu, Hao/H-3899-2017	Wu, Hao/0000-0003-1269-7354	National Institute of Health [R01HG006282]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006282] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Research by HJ is supported by the National Institute of Health grant: R01HG006282. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chen L, 2011, BIOINFORMATICS, V27, P1447, DOI 10.1093/bioinformatics/btr156; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Guo YC, 2010, BIOINFORMATICS, V26, P3028, DOI 10.1093/bioinformatics/btq590; Hower V, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-15; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kuan PF, 2011, J AM STAT ASSOC, V106, P891, DOI 10.1198/jasa.2011.ap09706; Laajala TD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-618; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Qin ZHS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-369; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Rye MB, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1187; Spyrou C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-299; Thomas DJ, 2007, NUCLEIC ACIDS RES, V35, pD663, DOI 10.1093/nar/gkl1017; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Wilbanks EG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011471; ZHANG X, 2010, BIOMETRICS; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou H, 2010, J COMPUT GRAPH STAT, V19, P645, DOI 10.1198/jcgs.2010.09014	23	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e89694	10.1371/journal.pone.0089694	http://dx.doi.org/10.1371/journal.pone.0089694			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608116	Green Published, Green Submitted, gold			2022-12-25	WOS:000332485800006
J	Vianello, S; Consolaro, F; Bich, C; Cancela, JM; Roulot, M; Lanchec, E; Touboul, D; Brunelle, A; Israel, M; Benoit, E; de la Porte, S				Vianello, Sara; Consolaro, Francesca; Bich, Claudia; Cancela, Jose-Manuel; Roulot, Morgane; Lanchec, Erwan; Touboul, David; Brunelle, Alain; Israel, Maurice; Benoit, Evelyne; de la Porte, Sabine			Low doses of arginine butyrate derivatives improve dystrophic phenotype and restore membrane integrity in DMD models	FASEB JOURNAL			English	Article						mdx; mass spectrometry imaging; neuromuscular excitability; calcium homeostasis	DUCHENNE MUSCULAR-DYSTROPHY; ION MASS-SPECTROMETRY; MDX MOUSE MODEL; BETA-HEMOGLOBINOPATHIES; DECREASES INFLAMMATION; SKELETAL MYOTUBES; GENE-EXPRESSION; MUSCLE; CALCIUM; MICE	A new approach to treating Duchenne muscular dystrophy was investigated by using the ester or amide covalent association of arginine [nitric oxide (NO) pathway] and butyrate [histone deacetylase (HDAC) inhibition] in mdx mice and patient myotubes. Two prodrugs were synthesized, and the beneficial effects on dystrophic phenotype were studied. Nerve excitability abnormalities detected in saline-treated mice were almost totally rescued in animals treated at low doses (50-100 mg/kg/d). Force and fatigue resistance were improved approximate to 60% and 3.5-fold, respectively, and the percentage of necrosis in heart sections was reduced approximate to 90% in the treated mice. A decrease of >50% in serum creatine kinase indicated an overall improvement in the muscles. Restoration of membrane integrity was studied directly by measuring the reduction (approximate to 74%) of Evans blue incorporation in the limb muscles of the treated animals, the increase in utrophin level, and the normalization of lipid composition of the heart. In cultures of human myotubes (primary cells and cell line), both prodrugs and HDAC inhibitors increased by 2- to 4-fold the utrophin level, which was correctly localized at the membrane. beta-Dystroglycan and embryonic myosin protein levels were also increased. Finally, a 50% reduction in the number of spontaneous Ca2+ spikes was observed after treatment with NO synthase substrate and HDAC inhibitors. Overall, the beneficial effects were obtained with doses 10 (in vivo) and 5 (in vitro) times lower than those of the salt formulation. Altogether, these data constitute proof of principle of the beneficial effects of low doses of arginine butyrate derivatives on muscular dystrophy, enhancing the NO pathway and inhibiting HDAC.	[Vianello, Sara; Consolaro, Francesca; Roulot, Morgane; Israel, Maurice; Benoit, Evelyne; de la Porte, Sabine] CNRS, Inst Neurobiol Alfred Fessard, FRC 2118, UPR 3294, F-91198 Gif Sur Yvette, France; [Bich, Claudia; Lanchec, Erwan; Touboul, David] CNRS, Ctr Rech Gif, Inst Chim Subst Nat, UPR 2301, F-91198 Gif Sur Yvette, France; [Cancela, Jose-Manuel; Lanchec, Erwan] Univ Paris 11, CNRS, Ctr Neurosci Paris Sud, UMR 8195, Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet	de la Porte, S (corresponding author), CNRS, Inst Neurobiol Alfred Fessard, UPR 3294, Ave Terrasse,Bat 32-33, F-91198 Gif Sur Yvette, France.	sabine.delaporte@inaf.cnrs-gif.fr	de la Porte, Sabine/N-5275-2018; de la PORTE, Sabine/AAE-4208-2022; Brunelle, Alain/L-3889-2013	de la PORTE, Sabine/0000-0002-7725-8646; Brunelle, Alain/0000-0001-6526-6481; Bich, Claudia/0000-0002-8243-4018; Cancela, Jose-Manuel/0000-0002-6234-1500; Touboul, David/0000-0003-2751-774X; BENOIT, Evelyne/0000-0001-5501-0888	Eusopean Community (EC) [QLRI-CT-2002-02769]	Eusopean Community (EC)	The authors thank Dr. D. Boerio for having introduced the techniques of recording neuromuscular excitability to their laboratory; Kamel Mamchaoui (Hopital Pitie-Salpetriere, Paris, France) for technical help with the cell line cultures; the French Banque de Tissus pour la Recherche (BTR; Institut de Myologie, Paris, France) for providing human muscles; and Drs. Vincent Mouly (Hopital Pitie-Salpetriere, Paris, France) and Francesco Muntoni (Centre for Neuromuscular Disease, London, UK) for providing the human cell lines. The BTR is a partner of the EuroBioBank network funded by the Eusopean Community (EC) under the Fifth Framework Program (QLRI-CT-2002-02769). The authors declare no conflicts of interest.	Altamirano F, 2012, J BIOL CHEM, V287, P20876, DOI 10.1074/jbc.M112.344929; Banks GB, 2009, MOL CELL NEUROSCI, V40, P433, DOI 10.1016/j.mcn.2008.12.011; Benabdellah F, 2009, NEUROBIOL DIS, V36, P252, DOI 10.1016/j.nbd.2009.07.013; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Boerio D, 2009, J PERIPHER NERV SYST, V14, P45, DOI 10.1111/j.1529-8027.2009.00205.x; Bostock H, 1998, MUSCLE NERVE, V21, P137, DOI 10.1002/(SICI)1097-4598(199802)21:2<137::AID-MUS1>3.0.CO;2-C; Consalvi S, 2013, MOL MED, V19, P79, DOI 10.2119/molmed.2013.00011; Constantin B, 2006, J MUSCLE RES CELL M, V27, P375, DOI 10.1007/s10974-006-9085-2; Fairclough RJ, 2011, EXP PHYSIOL, V96, P1101, DOI 10.1113/expphysiol.2010.053025; Finkel RS, 2010, J CHILD NEUROL, V25, P1158, DOI 10.1177/0883073810371129; Fisher R, 2001, NEUROMUSCULAR DISORD, V11, P713, DOI 10.1016/S0960-8966(01)00220-6; Gordon BS, 2013, CLIN NUTR, V32, P104, DOI 10.1016/j.clnu.2012.06.003; Goyenvalle A, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-8; Gurpur PB, 2009, AM J PATHOL, V174, P999, DOI 10.2353/ajpath.2009.080537; Hnia K, 2008, AM J PATHOL, V172, P1509, DOI 10.2353/ajpath.2008.071009; Hori YS, 2011, J PHARMACOL EXP THER, V338, P784, DOI 10.1124/jpet.111.183210; Kikuchi K, 2012, ANNU REV CELL DEV BI, V28, P719, DOI 10.1146/annurev-cellbio-101011-155739; Marchand E, 2004, EXP CELL RES, V297, P363, DOI 10.1016/j.yexcr.2004.02.032; Marques MJ, 2007, ANAT REC, V290, P181, DOI 10.1002/ar.20421; Meregalli M, 2010, BIODRUGS, V24, P237, DOI 10.2165/11534300-000000000-00000; Minetti GC, 2006, NAT MED, V12, P1147, DOI 10.1038/nm1479; Ozawa E, 1999, MOL CELL BIOCHEM, V190, P143, DOI 10.1023/A:1006974613418; PERRINE SP, 1993, EXPERIENTIA, V49, P133, DOI 10.1007/BF01989417; Perrine SP, 2008, PEDIATR ANN, V37, P339, DOI 10.3928/00904481-20080501-10; Perrine SR, 2007, BLOOD, V109, P2571, DOI 10.1182/blood-2006-01-024703; Pichavant C, 2011, MOL THER, V19, P830, DOI 10.1038/mt.2011.59; Quinlan JG, 2004, NEUROMUSCULAR DISORD, V14, P491, DOI 10.1016/j.nmd.2004.04.007; Simplicio AL, 2008, MOLECULES, V13, P519, DOI 10.3390/molecules13030519; Spurney CF, 2008, NEUROMUSCULAR DISORD, V18, P371, DOI 10.1016/j.nmd.2008.03.008; Tahallah N, 2008, J LIPID RES, V49, P438, DOI 10.1194/jlr.M700421-JLR200; Touboul D, 2005, J LIPID RES, V46, P1388, DOI 10.1194/jlr.M500058-JLR200; Touboul D, 2004, EUR J MASS SPECTROM, V10, P657, DOI 10.1255/ejms.671; Vianello S, 2013, FASEB J, V27, P2256, DOI 10.1096/fj.12-215723; Weinberg RS, 2005, BLOOD, V105, P1807, DOI 10.1182/blood-2004-02-0454; Whitehead NP, 2006, CLIN EXP PHARMACOL P, V33, P657, DOI 10.1111/j.1440-1681.2006.04394.x; Yiu EM, 2008, NEUROL INDIA, V56, P236	36	10	10	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2014	28	6					2603	2619		10.1096/fj.13-244798	http://dx.doi.org/10.1096/fj.13-244798			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AM5GA	24604079				2022-12-25	WOS:000339883600019
J	Lu, WZ; Yang, SC; Chen, LZ; Wang, WQ; Du, XN; Wang, CM; Ma, Y; Lin, GX; Lin, GH				Lu, Weizhi; Yang, Shengchang; Chen, Luzhen; Wang, Wenqing; Du, Xiaona; Wang, Canmou; Ma, Yan; Lin, Guangxuan; Lin, Guanghui			Changes in Carbon Pool and Stand Structure of a Native Subtropical Mangrove Forest after Inter-Planting with Exotic Species Sonneratia apetala	PLOS ONE			English	Article							INVASION; SEQUESTRATION; CONSERVATION; PLANTATIONS; RESTORATION; LITTERFALL; WORLD	In this study, we compared stand structure, biomass and soil carbon pools, and litterfall production between a mixed mangrove forest consisting of Aegiceras corniculatum inter-planted with the exotic Sonneratia apetala and a native monospecific forest dominated by A. corniculatum in the intertidal area of Zhanjiang, Guangdong Province, southeast China. The goal of this study was to test the hypothesis that inter-planting fast growing exotic mangrove S. apetala into subtropical native mangrove forests will significantly increase C sequestration. Although the tree heights and basal diameters of S. apetala were significantly higher than those of A. corniculatum, the density of the 12-year-old S. apetala trees in the mixed forest was much smaller than that of A. corniculatum in the monospecific forest. In contrast to several previous studies on S. apetala forests planted directly on mangrove-free mudflats, the mixed mangrove forest showed no significant difference in either standing biomass or soil carbon pools from the native monospecific mangrove forest (p = 0.294 and 0.073, respectively) twelve years after inter-planting with S. apetala. Moreover, carbon cycling was likely speeded up after inter-planting S. apetala due to higher litterfall input and lower C/N ratio. Thus, inter-planting fast-growing S. apetala into native mangrove forest is not an effective way to increase carbon sequestration in this subtropical mangrove forest. Given that exotic plant species may exert negative impact on native mangrove species and related epifauna, this fast-growing mangrove species is not suitable for mangrove plantation projects aiming mainly at enhancing carbon sequestration.	[Lu, Weizhi; Yang, Shengchang; Chen, Luzhen; Wang, Wenqing; Du, Xiaona; Wang, Canmou; Ma, Yan] Xiamen Univ, Sch Life Sci, Minist Educ Coastal & Wetland Ecosyst, Key Lab, Xiamen, Fujian, Peoples R China; [Lu, Weizhi; Lin, Guanghui] Tsinghua Univ, Grad Sch Shenzhen, Div Marine Sci & Technol, Shenzhen 518057, Guangdong, Peoples R China; [Lin, Guangxuan] Adm Bur Zhanjiang Natl Mangrove Nat Reserve, Zhanjiang, Guangdong, Peoples R China; [Lin, Guanghui] Tsinghua Univ, Ctr Earth Syst Sci, Key Lab Earth Syst Modeling, Minist Educ, Beijing 100084, Peoples R China	Xiamen University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Tsinghua University	Lin, GH (corresponding author), Tsinghua Univ, Grad Sch Shenzhen, Div Marine Sci & Technol, Shenzhen 518057, Guangdong, Peoples R China.	lingh@mail.tsinghua.edu.cn			National Natural Science Foundation of China [30930017]; Ministry of Science and Techology, China [2013CB556601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Techology, China	This study was supported financially by National Natural Science Foundation of China (30930017) and by National Key Basic Research Program (or 973 program) of Ministry of Science and Techology, China (2013CB556601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alongi DM, 2012, CARBON MANAG, V3, P313, DOI [10.4155/cmt.12.20, 10.4155/CMT.12.20]; Alongi DM, 2011, ENVIRON SCI POLICY, V14, P462, DOI 10.1016/j.envsci.2011.02.004; Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; Barbier EB, 2006, FRONT ECOL ENVIRON, V4, P124, DOI 10.1890/1540-9295(2006)004[0124:NBTNDR]2.0.CO;2; Bosire JO, 2008, AQUAT BOT, V89, P251, DOI 10.1016/j.aquabot.2008.03.010; Bouillon S, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003052; Cai Li-zhe, 2012, Yingyong Shengtai Xuebao, V23, P965; Chang SE, 2006, EARTHQ SPECTRA, V22, pS863, DOI 10.1193/1.2201971; Chen LZ, 2012, FOREST ECOL MANAG, V284, P222, DOI 10.1016/j.foreco.2012.06.058; Chen LZ, 2009, J PLANT ECOL, V2, P45, DOI 10.1093/jpe/rtp009; CLARKE PJ, 1994, AUST J BOT, V42, P37, DOI 10.1071/BT9940037; Craft C, 2003, ECOL APPL, V13, P1417, DOI 10.1890/02-5086; Dassonville N, 2007, ECOSCIENCE, V14, P230, DOI 10.2980/1195-6860(2007)14[230:IBFJIT]2.0.CO;2; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Finzi AC, 2006, ECOLOGY, V87, P15, DOI 10.1890/04-1748; Giri C, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI 10.1111/j.1466-8238.2010.00584.x; Gong P, 2010, SCI CHINA EARTH SCI, V53, P1036, DOI 10.1007/s11430-010-4002-3; Han WeiDong, 2001, Journal of Forestry Research, V12, P229, DOI 10.1007/BF02856712; Irving AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018311; Larson DL, 2001, ECOL APPL, V11, P128, DOI 10.1890/1051-0761(2001)011[0128:APIIMG]2.0.CO;2; Li DJ, 2012, NEW PHYTOL, V195, P172, DOI 10.1111/j.1469-8137.2012.04150.x; Liao W.B., 1990, J FOREST RES, P47; Lin P, 1990, J XIAMEN U NATURAL S, V29, P209; Lin P, 1985, J XIAMEN U NATURAL S, V24, P508; Lin P, 1990, ACTA PHYTOECOLOGICA, V14, P69; Lindsay EA, 2005, J APPL ECOL, V42, P556, DOI 10.1111/j.1365-2664.2005.01036.x; Lu C.Y., 1988, J XIAMEN UNIV-NAT SC, V27, P459; Luo YQ, 2006, ECOLOGY, V87, P3, DOI 10.1890/05-0923; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Metz ORDB, 2007, CLIMATE CHANGE 2007; Miao S.Y., 1998, GUIHAIA, V18, P16; Moriya H, 1986, BIOL SYSTEM MANGROVE, P123; Ordonez A, 2010, FUNCT ECOL, V24, P1353, DOI 10.1111/j.1365-2435.2010.01739.x; Ren H, 2008, ECOL RES, V23, P401, DOI 10.1007/s11284-007-0393-9; Ren H, 2010, PLANT SOIL, V327, P279, DOI 10.1007/s11104-009-0053-7; Ren H, 2009, ECOL ENG, V35, P1243, DOI 10.1016/j.ecoleng.2009.05.008; Sathirathai S, 2001, CONTEMP ECON POLICY, V19, P109, DOI 10.1093/cep/19.2.109; Walters BB, 2008, AQUAT BOT, V89, P220, DOI 10.1016/j.aquabot.2008.02.009; Yee S, 2010, REDD BLUE CARBON CAR; ZAN QJ, 2001, J WUHAN BOT RES, V15, P391; [张乔民 Zhang Qiaomin], 2003, [生态学报, Acta Ecologica Sinica], V23, P1977; ZHENG FZ, 2000, J XIAMEN U, V39, P693	44	27	28	10	142	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91238	10.1371/journal.pone.0091238	http://dx.doi.org/10.1371/journal.pone.0091238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618793	Green Submitted, Green Published, gold			2022-12-25	WOS:000332842400062
J	Purves-Tyson, TD; Owens, SJ; Double, KL; Desai, R; Handelsman, DJ; Weickert, CS				Purves-Tyson, Tertia D.; Owens, Samantha J.; Double, Kay L.; Desai, Reena; Handelsman, David J.; Weickert, Cynthia Shannon			Testosterone Induces Molecular Changes in Dopamine Signaling Pathway Molecules in the Adolescent Male Rat Nigrostriatal Pathway	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; MALE SPRAGUE-DAWLEY; SUBSTANTIA-NIGRA; SEX-DIFFERENCES; BRAIN-FUNCTION; MESSENGER-RNA; SCHIZOPHRENIA; ANDROGEN; NEURONS; TRANSPORTER	Adolescent males have an increased risk of developing schizophrenia, implicating testosterone in the precipitation of dopamine-related psychopathology. Evidence from adult rodent brain indicates that testosterone can modulate nigrostriatal dopamine. However, studies are required to understand the role testosterone plays in maturation of dopamine pathways during adolescence and to elucidate the molecular mechanism(s) by which testosterone exerts its effects. We hypothesized that molecular indices of dopamine neurotransmission [synthesis (tyrosine hydroxylase), breakdown (catechol-O-methyl transferase; monoamine oxygenase), transport [vesicular monoamine transporter (VMAT), dopamine transporter (DAT)] and receptors (DRD1-D5)] would be changed by testosterone or its metabolites, dihydrotestosterone and 17 beta-estradiol, in the nigrostriatal pathway of adolescent male rats. We found that testosterone and dihydrotestosterone increased DAT and VMAT mRNAs in the substantia nigra and that testosterone increased DAT protein at the region of the cell bodies, but not in target regions in the striatum. Dopamine receptor D2 mRNA was increased and D3 mRNA was decreased in substantia nigra and/or striatum by androgens. These data suggest that increased testosterone at adolescence may change dopamine responsivity of the nigrostriatal pathway by modulating, at a molecular level, the capacity of neurons to transport and respond to dopamine. Further, dopamine turnover was increased in the dorsal striatum following gonadectomy and this was prevented by testosterone replacement. Gene expression changes in the dopaminergic cell body region may serve to modulate both dendritic dopamine feedback inhibition and reuptake in the dopaminergic somatodendritic field as well as dopamine release and re-uptake dynamics at the presynaptic terminals in the striatum. These testosterone-induced changes of molecular indices of dopamine neurotransmission in males are primarily androgen receptor-driven events as estradiol had minimal effect. We conclude that nigrostriatal responsivity to dopamine may be modulated by testosterone acting via androgen receptors to alter gene expression of molecules involved in dopamine signaling during adolescence.	[Purves-Tyson, Tertia D.; Owens, Samantha J.; Weickert, Cynthia Shannon] Schizophrenia Res Inst, Sydney, NSW, Australia; [Purves-Tyson, Tertia D.; Owens, Samantha J.; Weickert, Cynthia Shannon] Neurosci Res Australia, Schizophrenia Res Lab, Sydney, NSW, Australia; [Double, Kay L.] Univ Sydney, Sydney Med Sch, Sch Med Sci, Discipline Biomed Sci, Sydney, NSW 2006, Australia; [Purves-Tyson, Tertia D.; Owens, Samantha J.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Desai, Reena; Handelsman, David J.] Univ Sydney, Concord Hosp, ANZAC Res Inst, Concord, NSW, Australia; [Weickert, Cynthia Shannon] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia	Neuroscience Research Australia; University of Sydney; University of New South Wales Sydney; Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; University of New South Wales Sydney	Weickert, CS (corresponding author), Schizophrenia Res Inst, Sydney, NSW, Australia.	c.weickert@neura.edu.au	Purves-Tyson, Tertia D/C-9799-2011; Research Institute, ANZAC/CAE-9030-2022; Double, Kay/AAX-7902-2021; Ekanayake, Kanchana/P-8817-2016; Handelsman, David/AAR-9580-2021	Purves-Tyson, Tertia D/0000-0003-2401-4266; Double, Kay/0000-0001-8712-7781; Handelsman, David/0000-0002-4200-7476; Shannon Weickert, Cynthia/0000-0002-4560-0259	Schizophrenia Research Institute; NSW Ministry of Health; Macquarie Group Foundation; University of New South Wales; Neuroscience Research Australia; NHMRC [1020981]; NHMRC (Australia) [1021970, 401101]	Schizophrenia Research Institute; NSW Ministry of Health; Macquarie Group Foundation; University of New South Wales; Neuroscience Research Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	CSW and the Schizophrenia Research Laboratory are supported by the Schizophrenia Research Institute (utilizing infrastructure funding from the NSW Ministry of Health and the Macquarie Group Foundation), the University of New South Wales, and Neuroscience Research Australia. This study was supported by an NH&MRC Project Grant to CSW and KLD (#1020981). CSW is the recipient of a NH&MRC (Australia) Research Fellowship (#1021970). KLD is the recipient of a NH&MRC (Australia) Senior Research Fellowship (#401101). (http://www.nhmrc.gov.au/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 2000, P NATL ACAD SCI USA, V97, P8104, DOI 10.1073/pnas.97.14.8104; ABREU P, 1988, NEUROSCI LETT, V95, P213, DOI 10.1016/0304-3940(88)90659-3; Akil M, 2003, J NEUROSCI, V23, P2008; ALBURGES ME, 1993, BIOMED CHROMATOGR, V7, P306, DOI 10.1002/bmc.1130070605; Aleman A, 2003, ARCH GEN PSYCHIAT, V60, P565, DOI 10.1001/archpsyc.60.6.565; Allan CM, 2010, ENDOCRINOLOGY, V151, P2800, DOI 10.1210/en.2009-1477; Aubele T, 2011, CEREB CORTEX, V21, P222, DOI 10.1093/cercor/bhq083; Bai YY, 2011, ENDOCRINOLOGY, V152, P1562, DOI 10.1210/en.2010-1042; BEATTY WW, 1982, PHARMACOL BIOCHEM BE, V16, P565, DOI 10.1016/0091-3057(82)90416-6; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Beckstead MJ, 2004, NEURON, V42, P939, DOI 10.1016/j.neuron.2004.05.019; Birgner C, 2008, BRAIN RES, V1219, P103, DOI 10.1016/j.brainres.2008.05.014; Blystone CR, 2007, TOXICOL SCI, V97, P65, DOI 10.1093/toxsci/kfm004; CELOTTI F, 1992, FRONT NEUROENDOCRIN, V13, P163; Ciliax BJ, 1999, J COMP NEUROL, V409, P38, DOI 10.1002/(SICI)1096-9861(19990621)409:1<38::AID-CNE4>3.0.CO;2-1; DLUZEN DE, 1989, J NEUROENDOCRINOL, V1, P285, DOI 10.1111/j.1365-2826.1989.tb00117.x; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Glatt SJ, 2006, AM J MED GENET B, V141B, P149, DOI 10.1002/ajmg.b.30273; Glatt SJ, 2003, MOL PSYCHIATR, V8, P911, DOI 10.1038/sj.mp.4001321; Handa RJ, 2008, HORM BEHAV, V53, P741, DOI 10.1016/j.yhbeh.2007.09.012; Harwood DT, 2009, CLIN CHIM ACTA, V409, P78, DOI 10.1016/j.cca.2009.09.003; Hermans EJ, 2010, NEUROIMAGE, V52, P277, DOI 10.1016/j.neuroimage.2010.04.019; Hersch SM, 1997, J COMP NEUROL, V388, P211; Howes OD, 2012, ARCH GEN PSYCHIAT, V69, P776, DOI 10.1001/archgenpsychiatry.2012.169; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Huck S.W., 2009, STAT MISCONCEPTIONS; Johnson ML, 2010, J NEUROENDOCRINOL, V22, P238, DOI 10.1111/j.1365-2826.2010.01965.x; Kegeles LS, 2010, ARCH GEN PSYCHIAT, V67, P231, DOI 10.1001/archgenpsychiatry.2010.10; Kindlundh AMS, 2004, NEUROSCI LETT, V356, P131, DOI 10.1016/j.neulet.2003.11.040; KONTUR P, 1984, J NEUROSCI METH, V11, P5, DOI 10.1016/0165-0270(84)90003-7; KORENBROT CC, 1977, BIOL REPROD, V17, P298, DOI 10.1095/biolreprod17.2.298; Kritzer MF, 2008, J NEUROSCI, V28, P9525, DOI 10.1523/JNEUROSCI.2637-08.2008; LACEY MG, 1987, J PHYSIOL-LONDON, V392, P397, DOI 10.1113/jphysiol.1987.sp016787; Laruelle M, 1999, BIOL PSYCHIAT, V46, P56, DOI 10.1016/S0006-3223(99)00067-0; Leung A, 2000, ACTA PSYCHIAT SCAND, V101, P3; Lewis EM, 2002, DRUG CHEM TOXICOL, V25, P437, DOI 10.1081/DCT-120014794; Markham JA, 2012, REV ENDOCR METAB DIS, V13, P187, DOI 10.1007/s11154-011-9184-2; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; McGrath J, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-13; McNamara KM, 2010, J STEROID BIOCHEM, V121, P611, DOI 10.1016/j.jsbmb.2010.02.001; Meyers B, 2010, NEUROSCIENCE, V165, P850, DOI 10.1016/j.neuroscience.2009.11.013; Morris RW, 2010, PSYCHONEUROENDOCRINO, V35, P896, DOI 10.1016/j.psyneuen.2009.12.002; Nirenberg MJ, 1996, J NEUROSCI, V16, P436; Nirenberg MJ, 1996, J NEUROSCI, V16, P4135; Noriega NC, 2009, TOXICOL SCI, V111, P163, DOI 10.1093/toxsci/kfp129; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Perez SE, 2003, DEV BRAIN RES, V145, P117, DOI 10.1016/S0165-3806(03)00223-2; Purves-Tyson TD, 2007, NEUROSCIENCE, V148, P92, DOI 10.1016/j.neuroscience.2007.05.043; Purves-Tyson TD, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-95; Ravizza T, 2003, NEUROSCI LETT, V338, P57, DOI 10.1016/S0304-3940(02)01317-4; SAKSENA SK, 1979, EXP AGING RES, V5, P179, DOI 10.1080/03610737908257197; Seeman P, 2006, EXPERT OPIN THER TAR, V10, P515, DOI 10.1517/14728222.10.4.515; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Silva MAD, 2009, EUR NEUROPSYCHOPHARM, V19, P53, DOI 10.1016/j.euroneuro.2008.08.003; Simons CJ, 2012, SCHIZOPHR B; SINGH J, 1995, ENDOCRINOLOGY, V136, P5311, DOI 10.1210/en.136.12.5311; Thiblin I, 1999, BRIT J PHARMACOL, V126, P1301, DOI 10.1038/sj.bjp.0702412; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walker DM, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102798; Walker QD, 2001, NEUROPSYCHOPHARMACOL, V25, P118, DOI 10.1016/S0893-133X(00)00248-7; Weickert CS, 2008, HUM MOL GENET, V17, P2293, DOI 10.1093/hmg/ddn130; Weickert CS, 2010, AUST NZ J PSYCHIAT, V44, P59, DOI 10.3109/00048670903393662; Wood RI, 2008, FRONT NEUROENDOCRIN, V29, P490, DOI 10.1016/j.yfrne.2007.12.002	63	55	59	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91151	10.1371/journal.pone.0091151	http://dx.doi.org/10.1371/journal.pone.0091151			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618531	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400051
J	Yoshimura, H; Iwasaki, S; Nishio, S; Kumakawa, K; Tono, T; Kobayashi, Y; Sato, H; Nagai, K; Ishikawa, K; Ikezono, T; Naito, Y; Fukushima, K; Oshikawa, C; Kimitsuki, T; Nakanishi, H; Usami, S				Yoshimura, Hidekane; Iwasaki, Satoshi; Nishio, Shin-ya; Kumakawa, Kozo; Tono, Tetsuya; Kobayashi, Yumiko; Sato, Hiroaki; Nagai, Kyoko; Ishikawa, Kotaro; Ikezono, Tetsuo; Naito, Yasushi; Fukushima, Kunihiro; Oshikawa, Chie; Kimitsuki, Takashi; Nakanishi, Hiroshi; Usami, Shin-ichi			Massively Parallel DNA Sequencing Facilitates Diagnosis of Patients with Usher Syndrome Type 1	PLOS ONE			English	Article							SYNDROME TYPE-I; GENE; MUTATIONS; JAPANESE; VARIANTS; PCDH15; LOCUS; MAPS	Usher syndrome is an autosomal recessive disorder manifesting hearing loss, retinitis pigmentosa and vestibular dysfunction, and having three clinical subtypes. Usher syndrome type 1 is the most severe subtype due to its profound hearing loss, lack of vestibular responses, and retinitis pigmentosa that appears in prepuberty. Six of the corresponding genes have been identified, making early diagnosis through DNA testing possible, with many immediate and several long-term advantages for patients and their families. However, the conventional genetic techniques, such as direct sequence analysis, are both time-consuming and expensive. Targeted exon sequencing of selected genes using the massively parallel DNA sequencing technology will potentially enable us to systematically tackle previously intractable monogenic disorders and improve molecular diagnosis. Using this technique combined with direct sequence analysis, we screened 17 unrelated Usher syndrome type 1 patients and detected probable pathogenic variants in the 16 of them (94.1%) who carried at least one mutation. Seven patients had the MYO7A mutation (41.2%), which is the most common type in Japanese. Most of the mutations were detected by only the massively parallel DNA sequencing. We report here four patients, who had probable pathogenic mutations in two different Usher syndrome type 1 genes, and one case of MYO7A/PCDH15 digenic inheritance. This is the first report of Usher syndrome mutation analysis using massively parallel DNA sequencing and the frequency of Usher syndrome type 1 genes in Japanese. Mutation screening using this technique has the power to quickly identify mutations of many causative genes while maintaining cost-benefit performance. In addition, the simultaneous mutation analysis of large numbers of genes is useful for detecting mutations in different genes that are possibly disease modifiers or of digenic inheritance.	[Yoshimura, Hidekane; Nishio, Shin-ya; Usami, Shin-ichi] Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 390, Japan; [Iwasaki, Satoshi] Shinshu Univ, Sch Med, Dept Hearing Implant Sci, Matsumoto, Nagano 390, Japan; [Iwasaki, Satoshi] Int Univ Hlth & Welf, Mita Hosp, Dept Otorhinolaryngol, Minato Ku, Tokyo, Japan; [Kumakawa, Kozo] Toranomon Gen Hosp, Okinaka Mem Inst Med Res, Dept Otolaryngol, Minato Ku, Tokyo, Japan; [Tono, Tetsuya] Miyazaki Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Miyazaki, Japan; [Kobayashi, Yumiko; Sato, Hiroaki] Iwate Med Univ, Dept Otolaryngol Head & Neck Surg, Morioka, Iwate 020, Japan; [Nagai, Kyoko] Gunma Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Maebashi, Gunma 371, Japan; [Ishikawa, Kotaro] Natl Rehabil Ctr Persons Disabil, Dept Otolaryngol, Tokorozawa, Saitama, Japan; [Ikezono, Tetsuo] Saitama Med Univ, Dept Otolaryngol, Moroyama, Saitama, Japan; [Naito, Yasushi] Gen Hosp, Kobe City Med Ctr, Dept Otolaryngol, Kobe, Hyougo, Japan; [Fukushima, Kunihiro] Okayama Univ, Postgrad Sch Med Dent & Pharmaceut Sci, Dept Otorhinolaryngol Head & Neck Surg, Okayama 7008530, Japan; [Oshikawa, Chie] Kyushu Univ, Grad Sch Med Sci, Dept Otorhinolaryngol, Fukuoka 812, Japan; [Kimitsuki, Takashi] Kyushu Cent Hosp, Dept Otorhinolaryngol, Fukuoka, Japan; [Nakanishi, Hiroshi] Hamamatsu Univ Sch Med, Dept Otorhinolaryngol, Hamamatsu, Shizuoka 4313192, Japan	Shinshu University; Shinshu University; International University of Health & Welfare; Toranomon Hospital; University of Miyazaki; Iwate Medical University; Gunma University; Saitama Medical University; Kobe City Medical Center General Hospital; Okayama University; Kyushu University; Hamamatsu University School of Medicine	Usami, S (corresponding author), Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 390, Japan.	usami@shinshu-u.ac.jp		Nishio, Shin-ya/0000-0001-6640-2297	Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Science and Culture of Japan	Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labour and Welfare of Japan (S. U.), and by a Grant-in-Aid for Scientific Research from the (then) Ministry of Education, Science and Culture of Japan (http://www.mext.go.jp/english/) (S. U.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Aller E, 2010, MOL VIS, V16, P495; Ben-Yosef T, 2003, NEW ENGL J MED, V348, P1664, DOI 10.1056/NEJMoa021502; Bonnet C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-21; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Chang X, 2012, J MED GENET, V49, P433, DOI 10.1136/jmedgenet-2012-100918; Ebermann I, 2010, J CLIN INVEST, V120, P1812, DOI 10.1172/JCI39715; Eudy JD, 1998, GENOMICS, V50, P382, DOI 10.1006/geno.1998.5345; Jaworek TJ, 2012, J HUM GENET, V57, P633, DOI 10.1038/jhg.2012.79; Joensuu T, 2001, AM J HUM GENET, V69, P673, DOI 10.1086/323610; Kimberling WJ, 2010, GENET MED, V12, P512, DOI 10.1097/GIM.0b013e3181e5afb8; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Miyagawa M, 2013, PLOS ONE; Mustapha M, 2002, HUM GENET, V110, P348, DOI 10.1007/s00439-002-0690-x; Nakanishi H, 2011, J HUM GENET, V56, P484, DOI 10.1038/jhg.2011.45; Nakanishi H, 2010, J HUM GENET, V55, P796, DOI 10.1038/jhg.2010.115; Ouyang XM, 2005, HUM GENET, V116, P292, DOI 10.1007/s00439-004-1227-2; Riazuddin S, 2012, NAT GENET, V44, P1265, DOI 10.1038/ng.2426; Senften M, 2006, J NEUROSCI, V26, P2060, DOI 10.1523/JNEUROSCI.4251-05.2006; Stabej PL, 2012, J MED GENET, V49, P27, DOI 10.1136/jmedgenet-2011-100468; Usami SI, 2008, ACTA OTO-LARYNGOL, V128, P446, DOI 10.1080/00016480701785046; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Weston MD, 2004, AM J HUM GENET, V74, P357, DOI 10.1086/381685; Yan D, 2010, J HUM GENET, V55, P327, DOI 10.1038/jhg.2010.29	26	30	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90688	10.1371/journal.pone.0090688	http://dx.doi.org/10.1371/journal.pone.0090688			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618850	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400025
J	Kashyap, RS; Nayak, AR; Gaherwar, HM; Husain, AA; Shekhawat, SD; Jain, RK; Panchbhai, MS; Raje, DV; Purohit, HJ; Taori, GM; Daginawala, HF				Kashyap, Rajpal S.; Nayak, Amit R.; Gaherwar, Hari M.; Husain, Aliabbas A.; Shekhawat, Seema D.; Jain, Ruchika K.; Panchbhai, Milind S.; Raje, Dhananjay V.; Purohit, Hemant J.; Taori, Girdhar M.; Daginawala, Hatim F.			Latent TB Infection Diagnosis in Population Exposed to TB Subjects in Close and Poor Ventilated High TB Endemic Zone in India	PLOS ONE			English	Article							BLOOD INTERFERON-GAMMA; MYCOBACTERIUM-TUBERCULOSIS INFECTION; HEALTH-CARE WORKERS; SKIN-TEST; RELEASE ASSAYS; LARGE-SCALE; MALNUTRITION; TRANSMISSION; RISK	Background: The present study was designed to investigate the utility of Quantiferon TB gold (QFT-G) and Tuberculin skin test (TST) for diagnosis of latent TB infection (LTBI) in high crowding TB endemic zone of Nagpur, India and their comparison with associated risk factors. Methods: Out of 342 eligible participants, QFT-G and TST were performed in 162 participants. Results: The prevalence of LTBI observed according to QFT-G and TST was 48% and 42% respectively, with an agreement of 52.47%. QFT-G positivity was associated with age while TST positivity was associated with body mass index (BMI). Duration of exposure emerged as a key risk factor significantly associated with both the tests. Conclusion: The prevalence of LTBI was quite high in the studied zone as detected by both the evaluated tests and thus, the combination of both the tests will be best predictive for LTBI in such high TB endemic regions.	[Kashyap, Rajpal S.; Nayak, Amit R.; Gaherwar, Hari M.; Husain, Aliabbas A.; Shekhawat, Seema D.; Jain, Ruchika K.; Panchbhai, Milind S.; Taori, Girdhar M.; Daginawala, Hatim F.] Cent India Inst Med Sci, Biochem Res Lab, Nagpur, Maharashtra, India; [Raje, Dhananjay V.] MDS Bioanalyt Pvt Ltd, Nagpur, Maharashtra, India; [Purohit, Hemant J.] Natl Environm Engn Res Inst, Environm Genom Unit, Nagpur 440020, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Environmental Engineering Research Institute (NEERI)	Kashyap, RS (corresponding author), Cent India Inst Med Sci, Biochem Res Lab, Nagpur, Maharashtra, India.	raj_ciims@rediffmail.com	Panchabhai, Dr. Milind(MishtiZ) Sadashiv/AIB-4720-2022; Kashyap, Rajpal/AAP-8461-2020		Central India Institute of Medical Sciences	Central India Institute of Medical Sciences	Authors would like to thank Central India Institute of Medical Sciences for funding this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batra S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040880; Connell TG, 2006, THORAX, V61, P616, DOI 10.1136/thx.2005.048033; Davidow AL, 2008, INT J TUBERC LUNG D, V12, P152; FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28; Fietta A, 2003, AM J INFECT CONTROL, V31, P347, DOI 10.1016/S0196-6553(02)48240-5; GRZYBOWSKI S, 1975, Bulletin of the International Union Against Tuberculosis, V50, P90; Harada N, 2006, INFECT CONT HOSP EP, V27, P442, DOI 10.1086/504358; Hesseling AC, 2009, THORAX, V64, P840, DOI 10.1136/thx.2007.085340; Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362; Kang YA, 2005, JAMA-J AM MED ASSOC, V293, P2756, DOI 10.1001/jama.293.22.2756; Kashyap RS, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-74; Kashyap RS, 2005, CLIN DIAGN LAB IMMUN, V12, P752, DOI 10.1128/CDLI.12.6.752-758.2005; Lienhardt C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010508; Lucas M, 2010, THORAX, V65, P442, DOI 10.1136/thx.2009.127555; Mahomed H, 2006, INT J TUBERC LUNG D, V10, P310; Mori T, 2004, AM J RESP CRIT CARE, V170, P59, DOI 10.1164/rccm.200402-179OC; Mutsvangwa J, 2010, THORAX, V65, P315, DOI 10.1136/thx.2009.124891; Nakaoka H, 2006, EMERG INFECT DIS, V12, P1383, DOI 10.3201/eid1209.051606; Nienhaus A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002665; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Panchbhai M. S., 2011, International Journal of Biology, V3, P122; Pelly TF, 2005, INT J TUBERC LUNG D, V9, P977; ROUILLON A, 1976, TUBERCLE, V57, P275, DOI 10.1016/S0041-3879(76)80006-2; SHAW JB, 1954, AM REV TUBERC PULM, V69, P724; Singh D, 2001, AM J RESP CRIT CARE, V164, P962, DOI 10.1164/ajrccm.164.6.2102076; Van Lettow M, 2004, INT J TUBERC LUNG D, V8, P211; Zwerling A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043014; Zwerling A, 2012, THORAX, V67, P62, DOI 10.1136/thx.2010.143180	28	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e89524	10.1371/journal.pone.0089524	http://dx.doi.org/10.1371/journal.pone.0089524			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614179	gold, Green Submitted, Green Published			2022-12-25	WOS:000332839300012
J	Li, ZH; Li, W; Shi, JL; Tang, MK				Li, Ze-Hui; Li, Wei; Shi, Jin-Li; Tang, Min-Ke			Nardosinone Improves the Proliferation, Migration and Selective Differentiation of Mouse Embryonic Neural Stem Cells	PLOS ONE			English	Article							PROGENITOR PROLIFERATION; PROTEIN; SURVIVAL; ASSAY	In this study, we investigated the impact of Nardosinone, a bioactive component in Nardostachys root, on the proliferation and differentiation of neural stem cells. The neural stem cells were isolated from cerebrums of embryonic day 14 CD1 mice. The proliferation of cells was monitored using the cell counting kit-8 assay, bromodeoxyuridine incorporation and cell cycle analysis. Cell migration and differentiation were investigated with the neurosphere assay and cell specific markers, respectively. The results showed that Nardosinone promotes cells proliferation and increases cells migration distance in a dose-dependent manner. Nardosinone also induces the selective differentiation of neural stem cells to neurons and oligodendrocytes, as indicated by the expression of microtubule-associated protein-2 and myelin basic protein, respectively. Nardosinone also increases the expression of phospho-extracellular signal-regulated kinase and phospho-cAMP response element binding protein during proliferation and differentiation. In conclusion, this study reveals the regulatory effects of Nardosinone on neural stem cells, which may have significant implications for the treatment of brain injury and neurodegenerative diseases.	[Li, Ze-Hui] Univ Toledo, Coll Med, Dept Biomed Sci, Toledo, OH 43606 USA; [Li, Ze-Hui; Li, Wei; Shi, Jin-Li; Tang, Min-Ke] Beijing Univ Chinese Med, Dept Pharmacol, Beijing, Peoples R China	University System of Ohio; University of Toledo; Beijing University of Chinese Medicine	Tang, MK (corresponding author), Beijing Univ Chinese Med, Dept Pharmacol, Beijing, Peoples R China.	tangmk@bucm.edu.cn			Program for New Century Excellent Talents of the Ministry of Education of China; National Natural Science Foundation of China [30772763]	Program for New Century Excellent Talents of the Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Program for New Century Excellent Talents of the Ministry of Education of China (2010) and the National Natural Science Foundation of China (30772763). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boscia F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006486; Dworkin S, 2009, STEM CELLS, V27, P1347, DOI 10.1002/stem.56; Gampe K, 2011, BRAIN RES, V1376, P31, DOI 10.1016/j.brainres.2010.11.040; Herold S, 2011, MOL CELL NEUROSCI, V46, P79, DOI 10.1016/j.mcn.2010.08.008; Ishido M, 2010, J HEALTH SCI, V56, P175, DOI 10.1248/jhs.56.175; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Ladiwala U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038613; Li P, 2003, J PHARMACOL SCI, V93, P122, DOI 10.1254/jphs.93.122; Li Wei, 2013, Yaoxue Xuebao, V48, P1422; Liu SS, 1963, TRADITIONAL CHINESE, P155; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Metkar Bharat, 1999, Indian Journal of Natural Products, V15, P10; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506; Pucilowska J, 2012, J NEUROSCI, V32, P8663, DOI 10.1523/JNEUROSCI.1107-12.2012; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Samuels IS, 2008, J NEUROSCI, V28, P6983, DOI 10.1523/JNEUROSCI.0679-08.2008; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174	18	15	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91260	10.1371/journal.pone.0091260	http://dx.doi.org/10.1371/journal.pone.0091260			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614893	Green Submitted, gold, Green Published			2022-12-25	WOS:000332839300103
J	Lopez-Lopez, E; Gutierrez-Camino, A; Pinan, MA; Sanchez-Toledo, J; Uriz, JJ; Ballesteros, J; Garcia-Miguel, P; Navajas, A; Garcia-Orad, A				Lopez-Lopez, Elixabet; Gutierrez-Camino, Angela; Angeles Pinan, Maria; Sanchez-Toledo, Jose; Javier Uriz, Jose; Ballesteros, Javier; Garcia-Miguel, Purificacion; Navajas, Aurora; Garcia-Orad, Africa			Pharmacogenetics of MicroRNAs and MicroRNAs Biogenesis Machinery in Pediatric Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; LINKING POLYMORPHISMS; POLYMIRTS DATABASE; DRUG-RESISTANCE; COMPLEX TRAITS; TARGET SITES; CANCER; METHOTREXATE; CHILDHOOD; TOXICITY	Despite the clinical success of acute lymphoblastic leukemia (ALL) therapy, toxicity is frequent. Therefore, it would be useful to identify predictors of adverse effects. In the last years, several studies have investigated the relationship between genetic variation and treatment-related toxicity. However, most of these studies are focused in coding regions. Nowadays, it is known that regions that do not codify proteins, such as microRNAs (miRNAs), may have an important regulatory function. MiRNAs can regulate the expression of genes affecting drug response. In fact, the expression of some of those miRNAs has been associated with drug response. Genetic variations affecting miRNAs can modify their function, which may lead to drug sensitivity. The aim of this study was to detect new toxicity markers in pediatric B-ALL, studying miRNA-related polymorphisms, which can affect miRNA levels and function. We analyzed 118 SNPs in pre-miRNAs and miRNA processing genes in association with toxicity in 152 pediatric B-ALL patients all treated with the same protocol (LAL/SHOP). Among the results found, we detected for the first time an association between rs639174 in DROSHA and vomits that remained statistically significant after FDR correction. DROSHA had been associated with alterations in miRNAs expression, which could affect genes involved in drug transport. This suggests that miRNA-related SNPs could be a useful tool for toxicity prediction in pediatric B-ALL.	[Lopez-Lopez, Elixabet; Gutierrez-Camino, Angela; Garcia-Orad, Africa] Univ Basque Country UPV EHU, Fac Med & Odontol, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain; [Angeles Pinan, Maria] Univ Hosp Cruces, Serv Hematol & Hemotherapy, Bilbao, Spain; [Sanchez-Toledo, Jose] VHIR, Univ Hosp Vall dHebron, Serv Pediat Oncol & Hematol, Barcelona, Spain; [Javier Uriz, Jose] Univ Hosp Donostia, Unit Pediat Oncohematol, San Sebastian, Spain; [Ballesteros, Javier] Univ Basque Country UPV EHU, Fac Med & Odontol, Dept Neurosci, Leioa, Spain; [Garcia-Miguel, Purificacion] Univ Hosp La Paz, Serv Pediat Oncohematol, Madrid, Spain; [Navajas, Aurora] Univ Hosp Cruces, Unit Pediat Hematol Oncol, Bilbao, Spain	University of Basque Country; Hospital Universitario Cruces; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); University Hospital Donostia; University of Basque Country; Hospital Universitario La Paz; Hospital Universitario Cruces	Garcia-Orad, A (corresponding author), Univ Basque Country UPV EHU, Fac Med & Odontol, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain.	africa.garciaorad@ehu.es	Gutierrez-Camino, Angela/AAM-2032-2020; Ballesteros, Javier/O-8267-2015; López-López, Elixabet/T-4607-2019	Gutierrez-Camino, Angela/0000-0002-8679-6868; Ballesteros, Javier/0000-0002-6713-1916; Garcia.Orad, Africa/0000-0002-5575-3080; Lopez-Lopez, Elixabet/0000-0002-5309-3031	Spanish Thematic Network for Cooperative Investigation in Cancer RTICC [RD/06/0020/0048]; Basque Government [GIC10/71, SAI11/75]; University of the Basque Country UPV/EHU [UFI11/35, GIU10/24]; Investigation Vice-rector's office of the University of the Basque Country UPV/EHU	Spanish Thematic Network for Cooperative Investigation in Cancer RTICC; Basque Government(Basque Government); University of the Basque Country UPV/EHU; Investigation Vice-rector's office of the University of the Basque Country UPV/EHU	This project was supported by the Spanish Thematic Network for Cooperative Investigation in Cancer RTICC (RD/06/0020/0048), Basque Government (GIC10/71, SAI11/75), and University of the Basque Country UPV/EHU (UFI11/35 and GIU10/24). ELL was supported by a predoctoral grant from the Basque Government and by a "Fellowship for recent doctors until their integration in postdoctoral programs" by the Investigation Vice-rector's office of the University of the Basque Country UPV/EHU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Han BW, 2011, HUM MOL GENET, V20, P4903, DOI 10.1093/hmg/ddr428; Hiard S, 2010, NUCLEIC ACIDS RES, V38, pD640, DOI 10.1093/nar/gkp926; Hochberg Y, 1995, J ROYAL STAT SOC B; Huang L, 2008, LEUKEMIA, V22, P1798, DOI 10.1038/leu.2008.66; Johnston WT, 2010, CANCER EPIDEMIOL, V34, P659, DOI 10.1016/j.canep.2010.06.020; Kishi S, 2007, BLOOD, V109, P4151, DOI 10.1182/blood-2006-10-054528; Kotnik BF, 2011, EUR J CLIN PHARMACOL, V67, P993, DOI 10.1007/s00228-011-1046-z; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liu SG, 2011, LEUKEMIA LYMPHOMA, V52, P1030, DOI 10.3109/10428194.2011.563883; Lopez-Lopez Elixabet, 2013, Pharmacogenet Genomics, V23, P53, DOI 10.1097/FPC.0b013e32835c3b24; Lopez-Lopez E, 2011, PEDIATR BLOOD CANCER, V57, P612, DOI 10.1002/pbc.23074; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; Mishra PJ, 2009, PHARMACOGENOMICS, V10, P399, DOI 10.2217/14622416.10.3.399; Munker R, 2011, CLIN SCI, V121, P141, DOI 10.1042/CS20110005; Phua SLC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025689; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Pui CH, 2012, BLOOD, V120, P1165, DOI 10.1182/blood-2012-05-378943; Rosalina WRW, 2012, J CLIN PHARM THER, V37, P237, DOI 10.1111/j.1365-2710.2011.01272.x; Rotunno M, 2010, BRIT J CANCER, V103, P1870, DOI 10.1038/sj.bjc.6605976; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Schotte D, 2011, HAEMATOL-HEMATOL J, V96, P703, DOI 10.3324/haematol.2010.026138; Slaby O, 2012, J CELL MOL MED, V16, P8, DOI 10.1111/j.1582-4934.2011.01359.x; Trevin LR, 2009, J CLIN ONCOL, V27, P5972, DOI 10.1200/JCO.2008.20.4156; Yokoi T, 2013, ANNU REV PHARMACOL, V53, P377, DOI 10.1146/annurev-pharmtox-011112-140250; Zhang XF, 2010, CARCINOGENESIS, V31, P2118, DOI 10.1093/carcin/bgq177; Ziebarth JD, 2012, NUCLEIC ACIDS RES, V40, pD216, DOI 10.1093/nar/gkr1026	29	30	32	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91261	10.1371/journal.pone.0091261	http://dx.doi.org/10.1371/journal.pone.0091261			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614921	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300104
J	Nguyen, MT; Koo, BK; Vu, TTT; Song, JA; Chong, SH; Jeong, B; Ryu, HB; Moh, SH; Choe, H				Minh Tan Nguyen; Koo, Bon-Kyung; Thu Trang Thi Vu; Song, Jung-A; Chong, Seon-Ha; Jeong, Boram; Ryu, Han-Bong; Moh, Sang-Hyun; Choe, Han			Prokaryotic Soluble Overexpression and Purification of Bioactive Human Growth Hormone by Fusion to Thioredoxin, Maltose Binding Protein, and Protein Disulfide Isomerase	PLOS ONE			English	Article							ESCHERICHIA-COLI; EXPRESSION SYSTEM; DNA CLONING; SOLUBILIZATION; REDUCTION; RETENTION; PROLACTIN; DOMAINS; SCALE	Human growth hormone (hGH) is synthesized by somatotroph cells of the anterior pituitary gland and induces cell proliferation and growth. This protein has been approved for the treatment of various conditions, including hGH deficiency, chronic renal failure, and Turner syndrome. Efficient production of hGH in Escherichia coli (E. coli) has proven difficult because the E. coli-expressed hormone tends to aggregate and form inclusion bodies, resulting in poor solubility. In this study, seven N-terminal fusion partners, hexahistidine (His6), thioredoxin (Trx), glutathione S-transferase (GST), maltose-binding protein (MBP), N-utilization substance protein A (NusA), protein disulfide bond isomerase (PDI), and the b'a' domain of PDI (PDIb'a'), were tested for soluble overexpression of codon-optimized hGH in E. coli. We found that MBP and hPDI tags significantly increased the solubility of the hormone. In addition, lowering the expression temperature to 18 degrees C also dramatically increased the solubility of all the fusion proteins. We purified hGH from MBP-, PDIb'a'-, or Trx-tagged hGH expressed at 18 degrees C in E. coli using simple chromatographic techniques and compared the final purity, yield, and activity of hGH to assess the impact of each partner protein. Purified hGH was highly pure on silver-stained gel and contained very low levels of endotoxin. On average, similar to 37 mg, similar to 12 mg, and similar to 7 mg of hGH were obtained from 500 mL-cell cultures of Trx-hGH, MBP-hGH, and PDIb'a'-hGH, respectively. Subsequently, hGH was analyzed using mass spectroscopy to confirm the presence of two intra-molecular disulfide bonds. The bioactivity of purified hGHs was demonstrated using Nb2-11 cell.	[Minh Tan Nguyen; Koo, Bon-Kyung; Thu Trang Thi Vu; Song, Jung-A; Chong, Seon-Ha; Jeong, Boram; Ryu, Han-Bong; Choe, Han] Univ Ulsan, Coll Med, Dept Physiol, Seoul, South Korea; [Minh Tan Nguyen; Koo, Bon-Kyung; Thu Trang Thi Vu; Song, Jung-A; Chong, Seon-Ha; Jeong, Boram; Ryu, Han-Bong; Choe, Han] Univ Ulsan, Coll Med, Biomed Inst Technol, Seoul, South Korea; [Moh, Sang-Hyun] BioFD & C Co Ltd, Inchon, South Korea	University of Ulsan; University of Ulsan	Choe, H (corresponding author), Univ Ulsan, Coll Med, Dept Physiol, Seoul, South Korea.	hchoe@ulsan.ac.kr	Nguyen, Minh Tan/AAH-7865-2019	choe, han/0000-0003-4604-647X	MRC [2008-0062286]; Priority Research Center Program of National Research Foundation [2009-0094054]; Ministry of Education, Science and Technology of Korea	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Priority Research Center Program of National Research Foundation; Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by MRC grant (2008-0062286) and Priority Research Center Program (2009-0094054) of National Research Foundation funded by the Ministry of Education, Science and Technology of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte-Deshpande A, 2009, BIOTECHNOL APPL BIOC, V54, P197, DOI 10.1042/BA20090179; Ayyar Vageesh S, 2011, Indian J Endocrinol Metab, V15 Suppl 3, pS162, DOI 10.4103/2230-8210.84852; Bach H, 2001, J MOL BIOL, V312, P79, DOI 10.1006/jmbi.2001.4914; Baldwin RL, 1996, BIOPHYS J, V71, P2056, DOI 10.1016/S0006-3495(96)79404-3; Baumann GP, 2009, GROWTH HORM IGF RES, V19, P333, DOI 10.1016/j.ghir.2009.04.011; BECKER GW, 1986, FEBS LETT, V204, P145, DOI 10.1016/0014-5793(86)81403-X; Besson A, 2005, J CLIN ENDOCR METAB, V90, P2493, DOI 10.1210/jc.2004-1838; Bolar K, 2008, J CLIN ENDOCR METAB, V93, P344, DOI 10.1210/jc.2007-1723; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Calik P, 2008, BIOTECHNOL PROGR, V24, P221, DOI 10.1021/bp070294t; Catzel D, 2003, PROTEIN EXPRES PURIF, V32, P126, DOI 10.1016/j.pep.2003.07.002; CONNORS MH, 1973, J CLIN ENDOCR METAB, V37, P499, DOI 10.1210/jcem-37-4-499; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; De Palo EF, 2006, CLIN CHIM ACTA, V364, P67, DOI 10.1016/j.cca.2005.06.009; DIXON JS, 1966, SCIENCE, V154, P785, DOI 10.1126/science.154.3750.785; Fahnert B, 2004, ADV BIOCHEM ENG BIOT, V89, P93; Franklin SL, 2009, ENDOCRIN METAB CLIN, V38, P587, DOI 10.1016/j.ecl.2009.06.006; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Gu YP, 2001, MOL CELL BIOCHEM, V223, P35, DOI 10.1023/A:1017941625858; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Jeay S, 2002, MOL CELL ENDOCRINOL, V188, P1, DOI 10.1016/S0303-7207(02)00014-X; Jung AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083781; Junnila RK, 2013, ENDOKRYNOL POL, V64, P300, DOI 10.5603/EP.2013.0009; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kasimova MR, 2002, J MOL BIOL, V318, P679, DOI 10.1016/S0022-2836(02)00137-7; Kim MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056168; Koo TY, 2007, J MICROBIOL BIOTECHN, V17, P579; Kopchick JJ, 2003, HORM RES, V60, P103, DOI 10.1159/000074510; Lan HL, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/306462; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; MARTIAL JA, 1979, SCIENCE, V205, P602, DOI 10.1126/science.377496; NILSSON A, 1994, EUR J CLIN NUTR, V48, pS150; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Park C, 2007, J MOL BIOL, V368, P1426, DOI 10.1016/j.jmb.2007.02.091; Patra AK, 2000, PROTEIN EXPRES PURIF, V18, P182, DOI 10.1006/prep.1999.1179; Shin NK, 1998, J BIOTECHNOL, V62, P143, DOI 10.1016/S0168-1656(98)00054-6; Singh SM, 2009, PROTEIN EXPRES PURIF, V68, P54, DOI 10.1016/j.pep.2009.05.014; Sockolosky JT, 2013, PROTEIN EXPRES PURIF, V87, P129, DOI 10.1016/j.pep.2012.11.002; Solomon G, 2006, GROWTH HORM IGF RES, V16, P297, DOI 10.1016/j.ghir.2006.07.002; Song JA, 2013, APPL BIOCHEM BIOTECH, V170, P67, DOI 10.1007/s12010-013-0140-3; Sonoda H, 2008, BIOSCI BIOTECH BIOCH, V72, P2675, DOI 10.1271/bbb.80332; TANAKA T, 1980, J CLIN ENDOCR METAB, V51, P1058, DOI 10.1210/jcem-51-5-1058; Tritos NA, 1998, AM J MED, V105, P44, DOI 10.1016/S0002-9343(98)00135-1; WALSH RJ, 1990, BRAIN RES, V530, P1, DOI 10.1016/0006-8993(90)90651-Q; Wang S, 2013, APPL MICROBIOL BIOT, V97, P2885, DOI 10.1007/s00253-012-4553-7; WATAHIKI M, 1989, J BIOL CHEM, V264, P312; Waugh DS, 2011, PROTEIN EXPRES PURIF, V80, P283, DOI 10.1016/j.pep.2011.08.005; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Xu J, 2009, VITAM HORM, V80, P125, DOI 10.1016/S0083-6729(08)00606-7; YARASHESKI KE, 1992, AM J PHYSIOL, V262, pE261, DOI 10.1152/ajpendo.1992.262.3.E261	54	49	56	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e89038	10.1371/journal.pone.0089038	http://dx.doi.org/10.1371/journal.pone.0089038			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614134	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300010
J	Selokar, NL; Saini, M; Palta, P; Chauhan, MS; Manik, R; Singla, SK				Selokar, Naresh L.; Saini, Monika; Palta, Prabhat; Chauhan, Manmohan S.; Manik, Radheysham; Singla, Suresh K.			Hope for Restoration of Dead Valuable Bulls through Cloning Using Donor Somatic Cells Isolated from Cryopreserved Semen	PLOS ONE			English	Article							EPITHELIAL-CELLS; NUCLEAR TRANSFER; CLONED EMBRYOS; METHYLATION; PROLIFERATION; CULTURE; TIME	Somatic cells were isolated from cryopreserved semen of 4 buffalo bulls, 3 of which had died over 10 years earlier, and were established in culture. The cells expressed cytokeratin-18, keratin and vimentin indicating that they were of epithelial origin. The cells were used as nuclear donors for hand-made cloning for producing buffalo embryos. The blastocyst rate and quality, as indicated by apoptotic index, were comparable among embryos produced using cells obtained from fresh or frozen-thawed semen or those obtained from conventional cell sources such as skin. Examination of the epigenetic status revealed that the global level of H3K27me3 but not that of H3K9/14ac and H4K5ac differed significantly (P<0.05) among cloned embryos from different bulls. The relative mRNA abundance of HDAC1, DNMT1, P53 and CASPASE 3 but not that of DNMT3a differed in cells and in cloned embryos. Following transfer of 24 cloned embryos produced from fresh semen-derived cells to 12 recipients, one calf weighing 55 kg, which is now 6 months of age and is normal, was born through normal parturition. Following transfer of 20 embryos produced from frozen-thawed semen-derived cells to 10 recipients, 2 became pregnant, one of which aborted in the first trimester; the calf born was severely underweight (17 kg), and died 12 h after birth. The ability of cells derived from fresh and frozen-thawed semen to produce live offspring confirms the ability of these cells to be reprogrammed. Our findings pave the way for restoration of highly precious progeny-tested bulls, which has immense economic importance, and can also be used for restoration of endangered species.	[Selokar, Naresh L.; Saini, Monika; Palta, Prabhat; Chauhan, Manmohan S.; Manik, Radheysham; Singla, Suresh K.] Natl Dairy Res Inst, Anim Biotechnol Ctr, Karnal, India; [Selokar, Naresh L.] Cent Inst Res Buffaloes, Dept Anim Physiol & Reprod, Cellular Reprogramming Lab, Hisar, Haryana, India	Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Central Institute for Research on Buffaloes	Singla, SK (corresponding author), Natl Dairy Res Inst, Anim Biotechnol Ctr, Karnal, India.	singlasuresh@yahoo.com	Selokar, Naresh/D-6526-2015; Saini, Monika/R-6753-2019	Selokar, Naresh/0000-0003-3687-3914; Saini, Monika/0000-0003-1357-3679	National Agriculture Innovative Project (NAIP) [C 2-1-(5)/2007, C-2067, 075]; CSIR-SRF	National Agriculture Innovative Project (NAIP); CSIR-SRF(Council of Scientific & Industrial Research (CSIR) - India)	The present work was funded by National Agriculture Innovative Project (NAIP) grant to SKS (C 2-1-(5)/2007) and MSC (C-2067 and 075. NLS and MS are recipients of CSIR-SRF fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.naip.icar.org.in	Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Iuso D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051317; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; Kim MK, 2007, CLONING STEM CELLS, V9, P130, DOI 10.1089/clo.2006.0034; Leland GD, 2002, CULTURE EPITHELIAL C, Vsecond, P277; Liu J, 2010, THERIOGENOLOGY, V74, P1629, DOI 10.1016/j.theriogenology.2010.06.035; Liu J, 2009, ANIM REPROD SCI, V115, P49, DOI 10.1016/j.anireprosci.2008.11.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loi P, 2001, NAT BIOTECHNOL, V19, P962, DOI 10.1038/nbt1001-962; Nel-Themaat L, 2007, REPROD FERT DEVELOP, V19, P576, DOI 10.1071/RD06153; Nel-Themaat L, 2008, CLONING STEM CELLS, V10, P143, DOI 10.1089/clo.2007.0067; Rybouchkin A, 2006, BIOL REPROD, V74, P1083, DOI 10.1095/biolreprod.105.047456; Santos F, 2003, CURR BIOL, V13, P1116, DOI 10.1016/S0960-9822(03)00419-6; Selokar NL, 2012, THERIOGENOLOGY, V78, P930, DOI 10.1016/j.theriogenology.2012.03.018; Selokar NL, 2012, CELL REPROGRAM, V14, P146, DOI 10.1089/cell.2011.0076; Sirisha K, 2013, REPROD DOMEST ANIM, V48, P538, DOI 10.1111/rda.12122; Vajta G, 1998, MOL REPROD DEV, V51, P53, DOI 10.1002/(SICI)1098-2795(199809)51:1&lt;53::AID-MRD6&gt;3.0.CO;2-V; Vajta G, 2001, Cloning, V3, P89, DOI 10.1089/15204550152475590; Williams JB, 2006, METH MOL B, V348, P169; Yanxin LX, 2006, MOL REPROD DEV, V73, P189, DOI 10.1002/mrd.20405	21	45	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90755	10.1371/journal.pone.0090755	http://dx.doi.org/10.1371/journal.pone.0090755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614586	Green Submitted, Green Published, gold			2022-12-25	WOS:000332839300037
J	Wang, T; Zeng, X; Li, WY; Zhu, HJ; Wang, G; Liu, X; Lv, YG; Wu, JH; Zhuang, XH; Zhang, JL; Zhao, Y; Huang, HD; Fan, J; Yao, Q; He, CY; Zhang, XQ; Huang, C; Chen, JH; Wang, L				Wang, Ting; Zeng, Xi; Li, Weiyang; Zhu, Haijun; Wang, Guan; Liu, Xiao; Lv, Yonggang; Wu, Jinghua; Zhuang, Xuehan; Zhang, Juliang; Zhao, Yi; Huang, Haodong; Fan, Jing; Yao, Qing; He, Chenyang; Zhang, Xiuqing; Huang, Chen; Chen, Jianghao; Wang, Ling			Detection and Analysis of Human Papillomavirus (HPV) DNA in Breast Cancer Patients by an Effective Method of HPV Capture	PLOS ONE			English	Article							VARIANT LINEAGES; TISSUE SAMPLES; NO EVIDENCE; ASSOCIATION; PROTEIN; PERSISTENCE; CARCINOMAS; EVOLUTION; INFECTION; SEQUENCES	Despite an increase in the number of molecular epidemiological studies conducted in recent years to evaluate the association between human papillomavirus (HPV) and the risk of breast carcinoma, these studies remain inconclusive. Here we aim to detect HPV DNA in various tissues from patients with breast carcinoma using the method of HPV capture combined with massive paralleled sequencing (MPS). To validate the confidence of our methods, 15 cervical cancer samples were tested by PCR and the new method. Results showed that there was 100% consistence between the two methods. DNA from peripheral blood, tumor tissue, adjacent lymph nodes and adjacent normal tissue were collected from seven malignant breast cancer patients, and HPV type 16(HPV16) was detected in 1/7, 1/7, 1/7and 1/7 of patients respectively. Peripheral blood, tumor tissue and adjacent normal tissue were also collected from two patients with benign breast tumor, and 1/2, 2/2 and 2/2 was detected to have HPV16 DNA respectively. MPS metrics including mapping ratio, coverage, depth and SNVs were provided to characterize HPV in samples. The average coverage was 69% and 61.2% for malignant and benign samples respectively. 126 SNVs were identified in all 9 samples. The maximum number of SNVs was located in the gene of E2 and E4 among all samples. Our study not only provided an efficient method to capture HPV DNA, but detected the SNVS, coverage, SNV type and depth. The finding has provided further clue of association between HPV16 and breast cancer.	[Wang, Ting; Zhu, Haijun; Lv, Yonggang; Zhang, Juliang; Fan, Jing; Yao, Qing; He, Chenyang; Chen, Jianghao; Wang, Ling] Fourth Mil Med Univ, Xijing Hosp, Dept Vasc & Endocrine Surg, Xian 710032, Peoples R China; [Zeng, Xi; Li, Weiyang; Wang, Guan; Liu, Xiao; Wu, Jinghua; Zhuang, Xuehan; Zhao, Yi; Huang, Haodong; Zhang, Xiuqing] BGI Shenzhen, Shenzhen, Peoples R China; [Huang, Chen] Fourth Mil Med Univ, Xijing Hosp, Dept Nephrol, Xian 710032, Peoples R China; [Li, Weiyang; Zhao, Yi; Huang, Haodong] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Chinah, Peoples R China; [Zeng, Xi] Chinese Univ Hong Kong, CUHK BGI Innovat Inst Transom, Div Genom & Bioinformat, Hong Kong, Hong Kong, Peoples R China; [Liu, Xiao] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Air Force Military Medical University; Beijing Genomics Institute (BGI); Air Force Military Medical University; South China University of Technology; Chinese University of Hong Kong; University of Copenhagen	Huang, C (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Nephrol, Xian 710032, Peoples R China.	huangchen@fmmu.edu.cn; jhchen@fmmu.edu.cn; vascular@fmmu.edu	Liu, Xiao/P-2732-2015; Li, Weiyang/GRO-0563-2022	Liu, Xiao/0000-0002-8073-0534; 	National Natural Science Fund [81272899, 81172510]; Discipline booster plan of Xi Jing Hospital [XJZT12Z07]; Chinese 863 program [2012AA02A201]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Discipline booster plan of Xi Jing Hospital; Chinese 863 program(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Fund (81272899 & 81172510) and Discipline booster plan of Xi Jing Hospital (XJZT12Z07). The study is also sponsored by Chinese 863 program (no. 2012AA02A201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Nuno E, 2004, ANTICANCER RES, V24, P1319; Antonsson A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039842; ARMSTRONG B, 1975, INT J CANCER, V15, P617, DOI 10.1002/ijc.2910150411; Blakaj DM, FRONT BIOSCI, V14, P900; Buck CB, 2008, J VIROL, V82, P5190, DOI 10.1128/JVI.02726-07; Campeau PM, 2008, HUM GENET, V124, P31, DOI 10.1007/s00439-008-0529-1; Chen AC, J MED VIROL, V81, P1792; Damin APS, 2004, BREAST CANCER RES TR, V84, P131, DOI 10.1023/B:BREA.0000018411.89667.0d; de Cremoux P, BREAST CANC RES TREA, V109, P55; de Villiers EM, 2005, BREAST CANCER RES, V7, pR1, DOI 10.1186/bcr940; DILONARDO A, 1992, BREAST CANCER RES TR, V21, P95, DOI 10.1007/BF01836955; Gheit T, 2011, CANCER EPIDEM BIOMAR, V20, P1315, DOI 10.1158/1055-9965.EPI-10-1187; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Gumus M, 2006, J EXP CLIN CANC RES, V25, P515; KIMURA M, 1977, NATURE, V267, P275, DOI 10.1038/267275a0; Kroupis C, 2006, CLIN BIOCHEM, V39, P727, DOI 10.1016/j.clinbiochem.2006.03.005; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li WY, 2013, GENOMICS, V102, P338, DOI 10.1016/j.ygeno.2013.07.002; Lindel K, 2007, BREAST, V16, P172, DOI 10.1016/j.breast.2006.09.001; Liu Xin, 2005, Di Yi Jun Yi Da Xue Xue Bao, V25, P1272; Masterson PJ, 1998, J VIROL, V72, P7407, DOI 10.1128/JVI.72.9.7407-7419.1998; MIYATA T, 1979, J MOL EVOL, V12, P219, DOI 10.1007/BF01732340; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Schiffman M, 2010, CANCER RES, V70, P3159, DOI 10.1158/0008-5472.CAN-09-4179; Shang QL, 2011, J CLIN MICROBIOL, V49, P2656, DOI 10.1128/JCM.02203-10; Silva RG, 2011, BREAST CANCER RES TR, V125, P261, DOI 10.1007/s10549-010-1129-z; Smith B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021375; Sun M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036577; Wang T, 2012, MED ONCOL, V29, P48, DOI 10.1007/s12032-010-9812-9; Widschwendter A, 2004, J CLIN VIROL, V31, P292, DOI 10.1016/j.jcv.2004.06.009; WREDE D, 1992, BRIT J CANCER, V65, P891, DOI 10.1038/bjc.1992.186; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	34	14	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90343	10.1371/journal.pone.0090343	http://dx.doi.org/10.1371/journal.pone.0090343			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614680	gold, Green Submitted, Green Published			2022-12-25	WOS:000332839300021
J	Link, J; Ryner, ML; Fink, K; Hermanrud, C; Lima, I; Brynedal, B; Kockum, I; Hillert, J; Fogdell-Hahn, A				Link, Jenny; Ryner, Malin Lundkvist; Fink, Katharina; Hermanrud, Christina; Lima, Izaura; Brynedal, Boel; Kockum, Ingrid; Hillert, Jan; Fogdell-Hahn, Anna			Human Leukocyte Antigen Genes and Interferon Beta Preparations Influence Risk of Developing Neutralizing Anti-Drug Antibodies in Multiple Sclerosis	PLOS ONE			English	Article							BINDING; IMMUNOGENICITY; QUANTITATION; HAPLOTYPE; TITER	A significant proportion of patients with multiple sclerosis who receive interferon beta (IFN beta) therapy develop neutralizing antibodies (NAbs) that reduce drug efficacy. To investigate if HLA class I and II alleles are associated with development of NAbs against IFN beta we analyzed whether NAb status and development of NAb titers high enough to be biologically relevant (>150 tenfold reduction units/ml) correlated with the HLA allele group carriage in a cohort of 903 Swedish patients with multiple sclerosis treated with either intramuscular IFN beta-1a, subcutaneous IFN beta-1a or subcutaneous IFN beta-1b. Carriage of HLA-DRB1*15 was associated with increased risk of developing NAbs and high NAb titers. After stratification based on type of IFNb preparation, HLA-DRB1*15 carriage was observed to increase the risk of developing NAbs as well as high NAb titers against both subcutaneous and intramuscular IFN beta-1a. Furthermore, in patients receiving subcutaneous IFN beta-1a carriage of HLA-DQA1*05 decreased the risk for high NAb titers. In IFN beta-1b treated patients, HLA-DRB1* 04 increased the risk of developing high NAb titers, and in a subgroup analysis of DRB1*04 alleles the risk for NAbs was increased in DRB1*04:01 carriers. In conclusion, there is a preparation-specific genetically determined risk to develop NAbs against IFN beta high enough to be clinically relevant in treatment decisions for patients with multiple sclerosis if confirmed in future studies. However, choice of IFN beta preparation still remains the single most significant determinant for the risk of developing NAbs.	[Link, Jenny; Ryner, Malin Lundkvist; Fink, Katharina; Hermanrud, Christina; Lima, Izaura; Kockum, Ingrid; Hillert, Jan; Fogdell-Hahn, Anna] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Brynedal, Boel] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Ryner, ML (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	malin.ryner@ki.se	; Kockum, Ingrid/O-8781-2018	Lima Bomfim, Izaura/0000-0003-0890-3872; Link, Jenny/0000-0002-6134-9404; Kockum, Ingrid/0000-0002-0867-4726; Fogdell-Hahn, Anna/0000-0002-0311-9184; Brynedal, Boel/0000-0002-7872-2981	Swedish Association for Persons with Neurological Disabilities, Swedish Research Council; Bibbi and Nils Jensens Foundation; European Commission; Innovative Medicines Initiative Joint Undertaking [115303]; European Union's Seventh Framework Program; EFPIA	Swedish Association for Persons with Neurological Disabilities, Swedish Research Council; Bibbi and Nils Jensens Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Innovative Medicines Initiative Joint Undertaking; European Union's Seventh Framework Program; EFPIA	This study was supported by an unrestricted research grant from BiogenIdec and research grants from the Swedish Association for Persons with Neurological Disabilities, Swedish Research Council, Bibbi and Nils Jensens Foundation and the European Commission and the Innovative Medicines Initiative Joint Undertaking under grant agreement no [115303], resources of which are composed of financial contribution from the European Union's Seventh Framework Program (FP7/2007-2013) and EFPIA companies' in kind contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlers JD, 2010, TRENDS MOL MED, V16, P478, DOI 10.1016/j.molmed.2010.07.007; Barbosa MDFS, 2006, CLIN IMMUNOL, V118, P42, DOI 10.1016/j.clim.2005.08.017; Barnard JG, 2013, J PHARM SCI-US, V102, P915, DOI 10.1002/jps.23415; Bertolotto A, 2007, J IMMUNOL METHODS, V321, P19, DOI 10.1016/j.jim.2006.12.012; Bertolotto A, 2004, J NEUROL, V251, P15, DOI 10.1007/s00415-004-1204-7; Bozhinov A, 2012, J ALLERGY CLIN IMMUN, V129, P855, DOI 10.1016/j.jaci.2011.10.035; Buck D, 2011, ARCH NEUROL-CHICAGO, V68, P480, DOI 10.1001/archneurol.2011.65; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Dengjel J, 2005, J MASS SPECTROM, V40, P100, DOI 10.1002/jms.780; Dilthey A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002877; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Engelhard VH, 2006, CURR OPIN IMMUNOL, V18, P92, DOI 10.1016/j.coi.2005.11.015; Farrell RA, 2011, MULT SCLER J, V17, P1333, DOI 10.1177/1352458511412654; Francis G, 2001, NEUROLOGY, V56, P1628; Grossberg SE, 2011, J INTERF CYTOK RES, V31, P337, DOI 10.1089/jir.2010.0038; Hegen H, 2012, MULT SCLER J, V18, P610, DOI 10.1177/1352458511426738; Hesse D, 2009, NEUROLOGY, V73, P372, DOI 10.1212/WNL.0b013e3181b04c98; Hoffmann S, 2008, AM J HUM GENET, V83, P219, DOI 10.1016/j.ajhg.2008.07.006; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Jensen PEH, 2012, EUR J NEUROL, V19, P1311, DOI 10.1111/j.1468-1331.2012.03721.x; Jungedal R, 2012, MULT SCLER J, V18, P1775, DOI 10.1177/1352458512446036; Kappos L, 2005, NEUROLOGY, V65, P40, DOI 10.1212/01.wnl.0000171747.59767.5c; KAWADE Y, 1986, METHOD ENZYMOL, V119, P558; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; Paolicelli D, 2013, J NEUROL, V260, P1562, DOI 10.1007/s00415-012-6829-3; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ross C, 2000, ANN NEUROL, V48, P706, DOI 10.1002/1531-8249(200011)48:5<706::AID-ANA3>3.3.CO;2-M; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schlesselman JJ, 1982, CASE CONTROL STUDIES; Sominanda A, 2008, J NEUROL NEUROSUR PS, V79, P57, DOI 10.1136/jnnp.2007.122549; Sominanda A, 2007, MULT SCLER, V13, P208, DOI 10.1177/1352458506070762; Sorensen PS, 2003, LANCET, V362, P1184, DOI 10.1016/S0140-6736(03)14541-2; Stickler M, 2004, GENES IMMUN, V5, P1, DOI 10.1038/sj.gene.6364027; Weber F, 2012, PHARMACOGENOMICS J, V12, P238, DOI 10.1038/tpj.2011.14	39	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90479	10.1371/journal.pone.0090479	http://dx.doi.org/10.1371/journal.pone.0090479			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608124	Green Submitted, Green Published, gold			2022-12-25	WOS:000332485800027
J	Surendran, S; Girijamma, A; Nair, R; Ramegowda, KS; Nair, DH; Thulaseedharan, JV; Lakkappa, RB; Kamalapurkar, G; Kartha, CC				Surendran, Sumi; Girijamma, Athira; Nair, Radhakrishnan; Ramegowda, Kalpana S.; Nair, Divya H.; Thulaseedharan, Jissa V.; Lakkappa, Ravikumar B.; Kamalapurkar, Giridhar; Kartha, Chandrasekharan C.			Forkhead box C2 Promoter Variant c.-512C > T Is Associated with Increased Susceptibility to Chronic Venous Diseases	PLOS ONE			English	Article							VARICOSE-VEINS; LYMPHEDEMA-DISTICHIASIS; TRANSCRIPTION FACTORS; IN-VITRO; FOXC2; EXPRESSION; MUTATIONS; FAILURE; LINKAGE; REGION	Chronic venous disease (CVD) is one of the most prevalent yet underrated disorders worldwide. High heritability estimates of CVD indicate prominent genetic components in its etiology and pathology. Mutations in human forkhead box C2 (Fox(2) gene are strongly associated with valve failure in saphenous and deep veins of lower extremities. We explored the association of genetic variants of FoxC2 as well as FoxC2 mRNA and protein expression levels with CVD of lower limbs. We systematically sequenced the single coding exon, 5' and 3' flanking regions of FoxC2 gene in 754 study subjects which includes 382 patients with CVD and 372 healthy subjects. Four novel and three reported polymorphisms were identified in our cohort. Three variants in 5' flanking region and one in 3' flanking region of FoxC2 gene were significantly associated with CVD risk. FoxC2 mRNA in vein tissues from 22 patients was 4 +/- 1.42 fold increased compared to saphenous veins from 20 normal subjects (p<0.01). FoxC2 protein was also significantly upregulated in varicose veins compared to control samples. The c.-512C>T (rs34221227: C>T) variant which is located in the FoxC2 putative promoter region was further analyzed. Functional analysis of c.-512C>T revealed increased mRNA and protein expression in patients with homozygous TT genotype compared to heterozygous CT and wild CC genotypes. Luciferase assay indicated higher transcriptional activity of mutant compared to wild genotype of this variant. These findings suggested that c.-512C>T variant of FoxC2 was strongly associated with susceptibility to CVD and also that this variant resulted in FoxC2 overexpression. To obtain a mechanistic insight into the role of upregulated FoxC2 in varicosities, we overexpressed FoxC2 in venous endothelial cells and observed elevated expression of arterial markers 0114 and Hey2 and downregulation of venous marker COUP-TFIL Our study indicates altered FoxC2-Notch signaling in saphenous vein wall remodeling in patients with varicose veins.	[Surendran, Sumi; Girijamma, Athira; Kartha, Chandrasekharan C.] Rajiv Gandhi Ctr Biotechnol, Thiruvananthapuram, Kerala, India; [Nair, Radhakrishnan] St Thomas Inst Res Venous Dis, Changanassery, Kerala, India; [Ramegowda, Kalpana S.; Kamalapurkar, Giridhar] Sri Jayadeva Inst Cardiovasc Sci & Res, Bangalore, Karnataka, India; [Nair, Divya H.; Thulaseedharan, Jissa V.] Sree Chitra Tirunal Inst Med Sci & Technol, Achutha Menon Ctr Hlth Sci Studies, Thiruvananthapuram, Kerala, India; [Lakkappa, Ravikumar B.] Kempegowda Inst Med Sci, Bangalore, Karnataka, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST); Kempegowda Institute of Medical Sciences (KIMS)	Kartha, CC (corresponding author), Rajiv Gandhi Ctr Biotechnol, Thiruvananthapuram, Kerala, India.	cckartha@rgcb.res.in		Kartha, CC/0000-0002-6782-4456; S, Sumi/0000-0002-1162-0219	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by intramural funds from the authors' institute without any aid from external funding agencies. Sumi S was supported by a post-doctoral fellowship from Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bihari I, 2012, PHLEBOLOGY, V27, P77, DOI 10.1258/phleb.2011.010063; Brice G, 2002, J MED GENET, V39, P478, DOI 10.1136/jmg.39.7.478; CORNUTHENARD A, 1994, J DERMATOL SURG ONC, V20, P318, DOI 10.1111/j.1524-4725.1994.tb01631.x; Diez H, 2007, EXP CELL RES, V313, P1, DOI 10.1016/j.yexcr.2006.09.009; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Eklof B, 2004, J VASC SURG, V40, P1248, DOI 10.1016/j.jvs.2004.09.027; Fiebig A, 2010, HUM GENET, V127, P669, DOI 10.1007/s00439-010-0812-9; Hayashi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002401; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kume T, 2009, ADV EXP MED BIOL, V665, P63; Labropoulos N, 2005, J VASC SURG, V41, P291, DOI 10.1016/j.jvs.2004.11.014; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Mellor RH, 2007, CIRCULATION, V115, P1912, DOI 10.1161/CIRCULATIONAHA.106.675348; Ng MYM, 2005, J MED GENET, V42, P235, DOI 10.1136/jmg.2004.024075; Petrova TV, 2004, NAT MED, V10, P974, DOI 10.1038/nm1094; PORTER JM, 1995, J VASC SURG, V21, P635, DOI 10.1016/S0741-5214(95)70195-8; Ramachandran S, 2012, PROTEOMICS, V12, P2808, DOI 10.1002/pmic.201100586; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Ridderstrale M, 2002, DIABETES, V51, P3554, DOI 10.2337/diabetes.51.12.3554; Robertson L, 2008, PHLEBOLOGY, V23, P103, DOI 10.1258/phleb.2007.007061; Sakata Y, 2004, ARTERIOSCL THROM VAS, V24, P2069, DOI 10.1161/01.ATV.0000143936.77094.a4; Seo S, 2006, DEV BIOL, V294, P458, DOI 10.1016/j.ydbio.2006.03.035; SISTO T, 1995, EUR J SURG, V161, P405; van Steensel MAM, 2009, HUM MUTAT, V30, pE1002, DOI 10.1002/humu.21127; Wu X, 2011, LYMPHOLOGY, V44, P35	26	15	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90682	10.1371/journal.pone.0090682	http://dx.doi.org/10.1371/journal.pone.0090682			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608096	gold, Green Published, Green Submitted			2022-12-25	WOS:000332485800044
J	Bao, GB; Schild, D				Bao, Guobin; Schild, Detlev			Fast and Accurate Fitting and Filtering of Noisy Exponentials in Legendre Space	PLOS ONE			English	Article								The parameters of experimentally obtained exponentials are usually found by least-squares fitting methods. Essentially, this is done by minimizing the mean squares sum of the differences between the data, most often a function of time, and a parameter-defined model function. Here we delineate a novel method where the noisy data are represented and analyzed in the space of Legendre polynomials. This is advantageous in several respects. First, parameter retrieval in the Legendre domain is typically two orders of magnitude faster than direct fitting in the time domain. Second, data fitting in a low-dimensional Legendre space yields estimates for amplitudes and time constants which are, on the average, more precise compared to least-squares-fitting with equal weights in the time domain. Third, the Legendre analysis of two exponentials gives satisfactory estimates in parameter ranges where least-squares-fitting in the time domain typically fails. Finally, filtering exponentials in the domain of Legendre polynomials leads to marked noise removal without the phase shift characteristic for conventional lowpass filters.	[Bao, Guobin; Schild, Detlev] Univ Gottingen, Dept Neurophysiol & Cellular Biophys, D-37073 Gottingen, Germany; [Bao, Guobin; Schild, Detlev] DFG Cluster Excellence 171, Gottingen, Germany	University of Gottingen	Schild, D (corresponding author), Univ Gottingen, Dept Neurophysiol & Cellular Biophys, D-37073 Gottingen, Germany.	dschild@gwdg.de			Cluster of Excellence; DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain	Cluster of Excellence; DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain(German Research Foundation (DFG))	This work was funded by the Cluster of Excellence and DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz M., 1965, HDB MATH FUNCTIONS; Bazzicalupi C, 2010, DALTON T, V39, P9838, DOI 10.1039/c0dt00552e; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Courant R., 2008, METHODS MATH PHYS; Halmer D, 2004, REV SCI INSTRUM, V75, P2187, DOI 10.1063/1.1711189; Jerri A., 1992, INTEGRAL DISCRETE TR; Legendre A.M., 1806, NOUVELLES METHODES D; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI [10.1090/qam/10666, DOI 10.1090/QAM/10666]; Marquardt D., 1963, INT J COMPUT VISION, V11, P431, DOI DOI 10.1137/0111030; MendezPerez JMR, 1997, MATH NACHR, V188, P219, DOI 10.1002/mana.19971880113; Papoulis A., 2001, PROBABILITY RANDOM V, V4th ed.; Tranter J, 1950, Q J MATH OXFORD, V2, P1	13	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90500	10.1371/journal.pone.0090500	http://dx.doi.org/10.1371/journal.pone.0090500			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603904	gold, Green Published, Green Submitted			2022-12-25	WOS:000332483600058
J	Jung, WJ; Lee, JW; Yoo, JC				Jung, Won-Ju; Lee, Jin-Won; Yoo, Jeong-Chil			"cu-coo'': Can You Recognize My Stepparents? - A Study of Host-Specific Male Call Divergence in the Common Cuckoo	PLOS ONE			English	Article							CUCULUS-CANORUS; EGG APPEARANCE; RACES; EVOLUTION; DISCRIMINATION; COEVOLUTION; VARIANCE; SONG	The presence of multiple host-specific races in the common cuckoo Cuculus canorus has long been recognized as an evolutionary enigma but how this genetic divergence could be maintained is still equivocal. Some recent studies supported biparental genetic contribution in maintaining the host-races, implying the necessity that they should recognize and mate assortatively with those who belong to the same host-race. One potential mechanism to accomplish this is that males may produce distinctive calls according to host-specific lineages. In order to test this hypothesis, we carried out a comparative study for male cuckoo calls recorded from three distant populations, where two populations share a same host species while the other parasitizes a different host species. Populations with similar habitat structures, maintaining comparable distance interval (ca. 150 km) between neighboring ones, were selected so as to minimize any other causes of vocal differentiation except the pattern of host use. By comparing the vocal characteristics of male cuckoos at the level of individual as well as population, we found that individual males indeed produced different calls in terms of spectral and temporal features. However, these differences disappeared when we compared the calls at the population level according to host species and geographic location. In conclusion, it seems unlikely for the cuckoos to identify the stepparent of male cuckoos based solely on the vocal characteristics, although they may be able to use this cue for individual recognition. Future studies including detailed morphological and genetic comparisons will be worthwhile to further elucidate this issue.	[Lee, Jin-Won] Kyung Hee Univ, Korea Inst Ornithol, Seoul, South Korea; Kyung Hee Univ, Dept Biol, Seoul, South Korea	Kyung Hee University; Kyung Hee University	Lee, JW (corresponding author), Kyung Hee Univ, Korea Inst Ornithol, Seoul, South Korea.	jwlee99@khu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [NRF-2012R1A6A3A04040003]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF; www.nrf.re.kr) funded by the Ministry of Education, Science and Technology (NRF-2012R1A6A3A04040003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubin T, 2002, ADV STUD BEHAV, V31, P243, DOI 10.1016/S0065-3454(02)80010-9; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Berlin S, 2004, P NATL ACAD SCI USA, V101, P15967, DOI 10.1073/pnas.0405126101; BROOKE MD, 1988, NATURE, V335, P630; Chance EP., 1940, TRUTH CUCKOO; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Davies NB, 2006, P ROY SOC B-BIOL SCI, V273, P693, DOI 10.1098/rspb.2005.3324; Davies NB, 1998, OX ORN SER, V9, P59; DAVIES NB, 1989, J ANIM ECOL, V58, P207, DOI 10.2307/4995; DAVIES NB, 1989, J ANIM ECOL, V58, P225, DOI 10.2307/4996; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; DHONDT AA, 1992, TRENDS ECOL EVOL, V7, P178, DOI 10.1016/0169-5347(92)90068-M; Dooling RJ, 2000, SPR HDB AUD, V13, P308; Falls JB., 1982, ACOUSTIC COMMUNICATI, P237; Fisher J., 1954, P71; Fossoy F, 2011, P ROY SOC B-BIOL SCI, V278, P1639, DOI 10.1098/rspb.2010.2090; Fuisz TI, 2007, P ROY SOC B-BIOL SCI, V274, P2093, DOI 10.1098/rspb.2007.0487; Gibbs HL, 2000, NATURE, V407, P183, DOI 10.1038/35025058; Honza M, 2002, ANIM BEHAV, V64, P861, DOI 10.1006/anbe.2002.1969; Kang CW, 2009, FIELDGUIDE BOOK BIRD; KROODSMA DE, 1991, ANIM BEHAV, V42, P477, DOI 10.1016/S0003-3472(05)80047-8; Kruger O, 2013, J EVOLUTION BIOL, V26, P2447, DOI 10.1111/jeb.12238; Lambrechts Marcel M., 1995, Current Ornithology, V12, P115; Lee Jin-Won, 2004, Korean Journal of Biological Sciences, V8, P77; Marchetti K, 1998, SCIENCE, V282, P471, DOI 10.1126/science.282.5388.471; MASATAKA N, 1985, DEV PSYCHOBIOL, V18, P107, DOI 10.1002/dev.420180203; Moksnes A, 2008, J AVIAN BIOL, V39, P238, DOI 10.1111/j.2008.0908-8857.04158.x; Mulard H, 2009, BIOL J LINN SOC, V97, P289, DOI 10.1111/j.1095-8312.2009.01198.x; NAKAMURA H, 1990, Japanese Journal of Ornithology, V39, P1, DOI 10.3838/jjo.39.1; Nakamura Hiroshi, 1997, Japanese Journal of Ornithology, V46, P23, DOI 10.3838/jjo.46.23; Nakamura Hiroshi, 2005, Ornithological Science, V4, P31, DOI 10.2326/osj.4.31; Payne RB, 2005, THE CUCKOOS; Peake TM, 1999, ETHOL ECOL EVOL, V11, P123, DOI 10.1080/08927014.1999.9522831; Podos J, 2007, ADV STUD BEHAV, V37, P403, DOI 10.1016/S0065-3454(07)37009-5; Punnett RC, 1933, NATURE, V132, P892, DOI 10.1038/132892b0; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reby D, 1998, J ZOOL, V245, P79, DOI 10.1017/S0952836998005093; Robson C, 2007, HDB BIRDS WORLD, V12, P292; ROTHSTEIN SI, 1990, ANNU REV ECOL SYST, V21, P481, DOI 10.1146/annurev.es.21.110190.002405; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; SEEL DC, 1977, IBIS, V119, P309, DOI 10.1111/j.1474-919X.1977.tb08250.x; SHY E, 1985, Amphibia-Reptilia, V6, P343, DOI 10.1163/156853885X00335; Stoddard MC, 2013, ANIM BEHAV, V85, P693, DOI 10.1016/j.anbehav.2013.01.005; Stoddard MC, 2011, EVOLUTION, V65, P2004, DOI 10.1111/j.1558-5646.2011.01262.x; Stokke BG, 2002, EVOLUTION, V56, P199; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Vogl W, 2002, ANIM BEHAV, V64, P843, DOI 10.1006/anbe.2003.1967; Wyllie I., 1981, CUCKOO	48	18	21	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90468	10.1371/journal.pone.0090468	http://dx.doi.org/10.1371/journal.pone.0090468			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603770	Green Published, Green Submitted, gold			2022-12-25	WOS:000332483600054
J	Suzuki, N; Fujimoto, Z; Kim, YM; Momma, M; Kishine, N; Suzuki, R; Suzuki, S; Kitamura, S; Kobayashi, M; Kimura, A; Funane, K				Suzuki, Nobuhiro; Fujimoto, Zui; Kim, Young-Min; Momma, Mitsuru; Kishine, Naomi; Suzuki, Ryuichiro; Suzuki, Shiho; Kitamura, Shinichi; Kobayashi, Mikihiko; Kimura, Atsuo; Funane, Kazumi			Structural Elucidation of the Cyclization Mechanism of alpha-1,6-Glucan by Bacillus circulans T-3040 Cycloisomaltooligosaccharide Glucanotransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate-binding Protein; Carbohydrate Structure; Crystal Structure; Enzyme Catalysis; Enzyme Structure; Glycoside Hydrolases; X-ray Crystallography; Cycloisomaltooligosaccharide Glucanotransferase; Dextran	CARBOHYDRATE-BINDING MODULE; CATALYTIC AMINO-ACIDS; HYDROLASE FAMILY 66; CYCLODEXTRIN GLYCOSYLTRANSFERASE; ALPHA-AMYLASE; CYCLIC ISOMALTOOLIGOSACCHARIDES; STREPTOCOCCUS-MUTANS; ENZYMATIC PRODUCTION; PRODUCT SPECIFICITY; GAMMA-CYCLODEXTRIN	Background: Cycloisomaltooligosaccharide glucanotransferase catalyzes an intramolecular transglucosylation reaction and produces cycloisomaltooligosaccharides from dextran. Results: The crystal structure of Bacillus circulans T-3040 cycloisomaltooligosaccharide glucanotransferase was determined. Conclusion: The enzyme structures complexed with isomaltooligosaccharides and cycloisomaltooctaose revealed the molecular mechanism of action. Significance: CBM35 functions in the product size determination and substrate recruitment. Bacillus circulans T-3040 cycloisomaltooligosaccharide glucanotransferase belongs to the glycoside hydrolase family 66 and catalyzes an intramolecular transglucosylation reaction that produces cycloisomaltooligosaccharides from dextran. The crystal structure of the core fragment from Ser-39 to Met-738 of B. circulans T-3040 cycloisomaltooligosaccharide glucanotransferase, devoid of its N-terminal signal peptide and C-terminal nonconserved regions, was determined. The structural model contained one catalytic (/)(8)-barrel domain and three -domains. Domain N with an immunoglobulin-like -sandwich fold was attached to the N terminus; domain C with a Greek key -sandwich fold was located at the C terminus, and a carbohydrate-binding module family 35 (CBM35) -jellyroll domain B was inserted between the 7th -strand and the 7th -helix of the catalytic domain A. The structures of the inactive catalytic nucleophile mutant enzyme complexed with isomaltohexaose, isomaltoheptaose, isomaltooctaose, and cycloisomaltooctaose revealed that the ligands bound in the catalytic cleft and the sugar-binding site of CBM35. Of these, isomaltooctaose bound in the catalytic site extended to the second sugar-binding site of CBM35, which acted as subsite -8, representing the enzymesubstrate complex when the enzyme produces cycloisomaltooctaose. The isomaltoheptaose and cycloisomaltooctaose bound in the catalytic cleft with a circular structure around Met-310, representing the enzymeproduct complex. These structures collectively indicated that CBM35 functions in determining the size of the product, causing the predominant production of cycloisomaltooctaose by the enzyme. The canonical sugar-binding site of CBM35 bound the mid-part of isomaltooligosaccharides, indicating that the original function involved substrate binding required for efficient catalysis.	[Suzuki, Nobuhiro; Fujimoto, Zui; Kim, Young-Min; Momma, Mitsuru; Kishine, Naomi; Kobayashi, Mikihiko] Natl Inst Agrobiol Sci, Biomol Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Kim, Young-Min; Kimura, Atsuo] Hokkaido Univ, Div Appl Biosci, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan; [Suzuki, Ryuichiro; Kobayashi, Mikihiko; Funane, Kazumi] Natl Agr & Food Res Org, Appl Microbiol Div, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan; [Suzuki, Shiho; Kitamura, Shinichi] Osaka Prefecture Univ, Coll Life Environm & Adv Sci, Sakai, Osaka 5998531, Japan; [Kobayashi, Mikihiko] Jissen Womens Univ, Dept Food & Hlth Sci, Hino, Tokyo 1918510, Japan	National Institute of Agrobiological Sciences - Japan; Hokkaido University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; Osaka Metropolitan University	Fujimoto, Z (corresponding author), Natl Inst Agrobiol Sci, Biomol Res Unit, Tsukuba, Ibaraki 3058602, Japan.	zui@affrc.go.jp; funane@affrc.go.jp	Suzuki, Nobuhiro/M-7238-2015; Suzuki, Shiho/B-2797-2016; Kitamura, Shinichi/F-4290-2011	Suzuki, Nobuhiro/0000-0001-8420-5852; Fujimoto, Zui/0000-0002-3551-6854; Kitamura, Shinichi/0000-0001-7115-6561	Program for Promotion of Basic and Applied Research for Innovations in the Bio-oriented Industry (BRAIN, Japan); scientific technique research promotion program for agriculture, forestry, fisheries and food industry (Japan)	Program for Promotion of Basic and Applied Research for Innovations in the Bio-oriented Industry (BRAIN, Japan); scientific technique research promotion program for agriculture, forestry, fisheries and food industry (Japan)	This work was supported in part by the Program for Promotion of Basic and Applied Research for Innovations in the Bio-oriented Industry (BRAIN, Japan) and by the scientific technique research promotion program for agriculture, forestry, fisheries and food industry (Japan).	Aoki H, 1997, BIOCHEM J, V323, P859, DOI 10.1042/bj3230859; Astray G, 2009, FOOD HYDROCOLLOID, V23, P1631, DOI 10.1016/j.foodhyd.2009.01.001; Barends TRM, 2007, J BIOL CHEM, V282, P17242, DOI 10.1074/jbc.M701444200; Beier L, 2000, PROTEIN ENG, V13, P509, DOI 10.1093/protein/13.7.509; Biwer A, 2002, APPL MICROBIOL BIOT, V59, P609, DOI 10.1007/s00253-002-1057-x; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Funane K, 2007, J BIOTECHNOL, V130, P188, DOI 10.1016/j.jbiotec.2007.03.009; Funane K, 2011, BBA-PROTEINS PROTEOM, V1814, P428, DOI 10.1016/j.bbapap.2010.12.009; Funane K, 2008, BIOSCI BIOTECH BIOCH, V72, P3277, DOI 10.1271/bbb.80384; Henshaw JL, 2004, J BIOL CHEM, V279, P21552, DOI 10.1074/jbc.M401620200; Igarashi T, 2002, ORAL MICROBIOL IMMUN, V17, P193, DOI 10.1034/j.1399-302X.2002.170310.x; Imamura H, 2003, J BIOL CHEM, V278, P19378, DOI 10.1074/jbc.M213134200; Imamura K, 2005, ACTA CRYSTALLOGR F, V61, P109, DOI 10.1107/S1744309104030829; Jung JH, 2011, PROTEINS, V79, P633, DOI 10.1002/prot.22911; Kim YM, 2012, FEBS J, V279, P3185, DOI 10.1111/j.1742-4658.2012.08698.x; Kim YM, 2012, J BIOL CHEM, V287, P19927, DOI 10.1074/jbc.M111.339036; Kim YM, 2010, APPL MICROBIOL BIOT, V85, P581, DOI 10.1007/s00253-009-2121-6; KOBAYASHI M, 1995, BIOSCI BIOTECH BIOCH, V59, P1861, DOI 10.1271/bbb.59.1861; LAWSON CL, 1994, J MOL BIOL, V236, P590, DOI 10.1006/jmbi.1994.1168; Leemhuis H, 2003, BIOCHEMISTRY-US, V42, P7518, DOI 10.1021/bi034439q; Leemhuis H, 2010, APPL MICROBIOL BIOT, V85, P823, DOI 10.1007/s00253-009-2221-3; Li ZF, 2007, APPL MICROBIOL BIOT, V77, P245, DOI 10.1007/s00253-007-1166-7; Loftsson T, 2007, J PHARM PHARMACOL, V59, P629, DOI 10.1211/jpp.59.5.0002; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NAKAJIMA R, 1986, APPL MICROBIOL BIOT, V23, P355; Nielsen MM, 2009, BIOCHEMISTRY-US, V48, P7686, DOI 10.1021/bi900795a; OGUMA T, 1993, BIOSCI BIOTECH BIOCH, V57, P1225, DOI 10.1271/bbb.57.1225; Oguma T., 1995, Journal of Applied Glycoscience, V42, P415; OGUMA T, 1994, FEBS LETT, V345, P135, DOI 10.1016/0014-5793(94)00418-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Penninga D, 1996, J BIOL CHEM, V271, P32777, DOI 10.1074/jbc.271.51.32777; PENNINGA D, 1995, BIOCHEMISTRY-US, V34, P3368, DOI 10.1021/bi00010a028; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pires VMR, 2004, J BIOL CHEM, V279, P21560, DOI 10.1074/jbc.M401599200; Przylas I, 2000, J MOL BIOL, V296, P873, DOI 10.1006/jmbi.1999.3503; Qi QS, 2005, APPL MICROBIOL BIOT, V66, P475, DOI 10.1007/s00253-004-1781-5; Robyt JF, 2008, CARBOHYD RES, V343, P3039, DOI 10.1016/j.carres.2008.09.012; Suzuki M., 1999, Journal of Applied Glycoscience, V46, P469; Suzuki N, 2013, ACTA CRYSTALLOGR F, V69, P946, DOI 10.1107/S174430911301991X; Suzuki N, 2012, J BIOL CHEM, V287, P19916, DOI 10.1074/jbc.M112.342444; Suzuki R, 2012, BBA-PROTEINS PROTEOM, V1824, P919, DOI 10.1016/j.bbapap.2012.04.001; Suzuki S, 2014, CARBOHYD POLYM, V99, P432, DOI 10.1016/j.carbpol.2013.07.089; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Tilden EB, 1939, J AM CHEM SOC, V61, P2900, DOI DOI 10.1021/JA01265A091; Tunnicliffe RB, 2005, J MOL BIOL, V347, P287, DOI 10.1016/j.jmb.2005.01.038; Uitdehaag JCM, 1999, J BIOL CHEM, V274, P34868, DOI 10.1074/jbc.274.49.34868; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van der Veen BA, 2000, BBA-PROTEIN STRUCT M, V1543, P336, DOI 10.1016/S0167-4838(00)00233-8; Wind RD, 1998, EUR J BIOCHEM, V253, P598, DOI 10.1046/j.1432-1327.1998.2530598.x; Yamamoto T, 2006, BIOSCI BIOTECH BIOCH, V70, P1947, DOI 10.1271/bbb.60105	55	26	26	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					12040	12051		10.1074/jbc.M114.547992	http://dx.doi.org/10.1074/jbc.M114.547992			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24616103	Green Published, hybrid			2022-12-25	WOS:000335010600042
J	Oleson, BJ; Broniowska, KA; Schreiber, KH; Tarakanova, VL; Corbett, JA				Oleson, Bryndon J.; Broniowska, Katarzyna A.; Schreiber, Katherine H.; Tarakanova, Vera L.; Corbett, John A.			Nitric Oxide Induces Ataxia Telangiectasia Mutated ( ATM) Protein-dependent gamma H2AX Protein Formation in Pancreatic beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Cell; Cytokine; DNA Repair; Nitric Oxide; ATM; H2AX	DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; REQUIRES GENE-TRANSCRIPTION; PHOSPHORYLATES HISTONE H2AX; INSULIN-SECRETION; RAT ISLETS; INTERFERON-GAMMA; LANGERHANS; INHIBITION; KINASE	Background: The mechanisms that control cell fate following cytokine- and nitric oxide-induced damage remain unknown. Results: Cytokine-induced nitric oxide activates ATM and ATM-dependent caspase activation in cells. Conclusion: ATM regulates the induction of apoptosis in cytokine-treated cells. Significance: These studies define a role for DNA damage and ATM activation in nitric oxide-induced cell apoptosis. In this study, the effects of cytokines on the activation of the DNA double strand break repair factors histone H2AX (H2AX) and ataxia telangiectasia mutated (ATM) were examined in pancreatic cells. We show that cytokines stimulate H2AX phosphorylation (H2AX formation) in rat islets and insulinoma cells in a nitric oxide- and ATM-dependent manner. In contrast to the well documented role of ATM in DNA repair, ATM does not appear to participate in the repair of nitric oxide-induced DNA damage. Instead, nitric oxide-induced H2AX formation correlates temporally with the onset of irreversible DNA damage and the induction of apoptosis. Furthermore, inhibition of ATM attenuates cytokine-induced caspase activation. These findings show that the formation of DNA double strand breaks correlates with ATM activation, irreversible DNA damage, and ATM-dependent induction of apoptosis in cytokine-treated cells.	[Oleson, Bryndon J.; Broniowska, Katarzyna A.; Corbett, John A.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Tarakanova, Vera L.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [Schreiber, Katherine H.] St Louis Univ, Edward A Doisy Dept Biochem & Mol Biol, Sch Med, St Louis, MO 63104 USA	Medical College of Wisconsin; Medical College of Wisconsin; Saint Louis University	Corbett, JA (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 W Watertown Plank Rd, Milwaukee, WI 53226 USA.	jcorbett@mcw.edu		Broniowska, Katarzyna/0000-0002-8000-9093	National Institutes of Health [DK52194, AI-44458]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052194] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK52194 and AI-44458 (to J. A. C.).	Bhatti S, 2011, CELL MOL LIFE SCI, V68, P2977, DOI 10.1007/s00018-011-0683-9; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Burney S, 1999, MUTAT RES-FUND MOL M, V424, P37, DOI 10.1016/S0027-5107(99)00006-8; CETKOVICCVRLJE M, 1994, CYTOKINE, V6, P399, DOI 10.1016/1043-4666(94)90064-7; Chambers KT, 2008, DIABETES, V57, P124, DOI 10.2337/db07-0944; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; COMENS PG, 1987, DIABETES, V36, P963, DOI 10.2337/diabetes.36.8.963; CORBETT JA, 1992, BIOCHEM J, V287, P229, DOI 10.1042/bj2870229; CORBETT JA, 1991, J BIOL CHEM, V266, P21351; CORBETT JA, 1992, J CLIN INVEST, V90, P2384, DOI 10.1172/JCI116129; CORBETT JA, 1994, BIOCHEM J, V299, P719, DOI 10.1042/bj2990719; de Feraudy S, 2010, P NATL ACAD SCI USA, V107, P6870, DOI 10.1073/pnas.1002175107; DELANEY CA, 1993, FEBS LETT, V333, P291, DOI 10.1016/0014-5793(93)80673-I; FEHSEL K, 1993, DIABETES, V42, P496, DOI 10.2337/diabetes.42.3.496; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Heitmeier MR, 1997, J BIOL CHEM, V272, P13697, DOI 10.1074/jbc.272.21.13697; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; HUGHES JH, 1990, J CLIN INVEST, V86, P856, DOI 10.1172/JCI114785; Hughes KJ, 2011, J BIOL CHEM, V286, P8338, DOI 10.1074/jbc.M110.204768; Hughes KJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE1187, DOI 10.1152/ajpendo.00214.2009; Hughes KJ, 2009, J BIOL CHEM, V284, P27402, DOI 10.1074/jbc.M109.046912; Jang ER, 2010, EXP MOL MED, V42, P195, DOI 10.3858/emm.2010.42.3.020; Kelly Colleen B, 2003, Methods Mol Med, V83, P3; LACY PE, 1994, MT SINAI J MED, V61, P170; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Li S, 2000, NATURE, V406, P210, DOI 10.1038/35018134; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; Maekawa T, 2008, ONCOGENE, V27, P1045, DOI 10.1038/sj.onc.1210727; MANDRUPPOULSEN T, 1985, ALLERGY, V40, P424, DOI 10.1111/j.1398-9995.1985.tb02681.x; MANDRUPPOULSEN T, 1986, DIABETOLOGIA, V29, P63, DOI 10.1007/BF02427283; MCDANIEL ML, 1983, METHOD ENZYMOL, V98, P182; McDaniel ML, 1996, P SOC EXP BIOL MED, V211, P24; Meares GP, 2013, AM J PHYSIOL-ENDOC M, V304, pE614, DOI 10.1152/ajpendo.00424.2012; Meares GP, 2010, J BIOL CHEM, V285, P3191, DOI 10.1074/jbc.M109.047365; Mukherjee B, 2006, DNA REPAIR, V5, P575, DOI 10.1016/j.dnarep.2006.01.011; Murata M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/623019; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Padgett LE, 2013, ANN NY ACAD SCI, V1281, P16, DOI 10.1111/j.1749-6632.2012.06826.x; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pinto DMS, 2010, SUBCELL BIOCHEM, V50, P55, DOI 10.1007/978-90-481-3471-7_4; Pommier Y, 2003, MUTAT RES-FUND MOL M, V532, P173, DOI 10.1016/j.mrfmmm.2003.08.016; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007; Rosales AL, 2004, FREE RADICAL RES, V38, P665, DOI 10.1080/10715760410001697609; Scarim AL, 2003, ENDOCRINOLOGY, V144, P3415, DOI 10.1210/en.2002-0112; Scarim AL, 1997, ENDOCRINOLOGY, V138, P5301, DOI 10.1210/en.138.12.5301; Scarim AL, 2001, AM J PATHOL, V159, P273, DOI 10.1016/S0002-9440(10)61693-8; Schroder Heinz C, 2006, Methods Mol Biol, V314, P287; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Solier S, 2009, MOL CELL BIOL, V29, P68, DOI 10.1128/MCB.00581-08; SOUTHERN C, 1990, FEBS LETT, V276, P42, DOI 10.1016/0014-5793(90)80502-A; TICE RR, 1991, ADV EXP MED BIOL, V283, P157; Ullmann K, 2008, ARCH TOXICOL, V82, P861, DOI 10.1007/s00204-008-0356-0; Wang ZQ, 2009, J CELL PHYSIOL, V221, P213, DOI 10.1002/jcp.21844; WELSH N, 1991, ENDOCRINOLOGY, V129, P3167, DOI 10.1210/endo-129-6-3167; WINK DA, 1991, SCIENCE, V254, P1001, DOI 10.1126/science.1948068; Wollheim CB, 2002, DIABETES, V51, pS37, DOI 10.2337/diabetes.51.2007.S37; Yang YC, 2013, ANTIOXID REDOX SIGN, V18, P1129, DOI 10.1089/ars.2012.4620	60	24	24	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11454	11464		10.1074/jbc.M113.531228	http://dx.doi.org/10.1074/jbc.M113.531228			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24610783	hybrid, Green Published			2022-12-25	WOS:000334638500046
J	Rungrassamee, W; Klanchui, A; Maibunkaew, S; Chaiyapechara, S; Jiravanichpaisal, P; Karoonuthaisiri, N				Rungrassamee, Wanilada; Klanchui, Amornpan; Maibunkaew, Sawarot; Chaiyapechara, Sage; Jiravanichpaisal, Pikul; Karoonuthaisiri, Nitsara			Characterization of Intestinal Bacteria in Wild and Domesticated Adult Black Tiger Shrimp (Penaeus monodon)	PLOS ONE			English	Article							SP-NOV.; GUT MICROBIOTA; DIGESTIVE-TRACT; GEN. NOV.; LITOPENAEUS-VANNAMEI; MOLECULAR ANALYSIS; MARINE BACTERIUM; WHITE SHRIMP; DEEP-SEA; DIVERSITY	The black tiger shrimp (Penaeus monodon) is a marine crustacean of economic importance in the world market. To ensure sustainability of the shrimp industry, production capacity and disease outbreak prevention must be improved. Understanding healthy microbial balance inside the shrimp intestine can provide an initial step toward better farming practice and probiotic applications. In this study, we employed a barcode pyrosequencing analysis of V3-4 regions of 16S rRNA genes to examine intestinal bacteria communities in wild-caught and domesticated P. monodon broodstock. Shrimp faeces were removed from intestines prior to further analysis in attempt to identify mucosal bacterial population. Five phyla, Actinobacteria, Fusobacteria, Proteobacteria, Firmicutes and Bacteroidetes, were found in all shrimp from both wild and domesticated environments. The operational taxonomic unit (OTU) was assigned at 97% sequence identity, and our pyrosequencing results identified 18 OTUs commonly found in both groups. Sequences of the shared OTUs were similar to bacteria in three phyla, namely i) Proteobacteria (Vibrio, Photobacterium, Novosphingobium, Pseudomonas, Sphingomonas and Undibacterium), ii) Firmicutes (Fusibacter), and iii) Bacteroidetes (Cloacibacterium). The shared bacterial members in P. monodon from two different habitats provide evidence that the internal environments within the host shrimp also exerts selective pressure on bacterial members. Intestinal bacterial profiles were compared using denaturing gradient gel electrophoresis (DGGE). The sequences from DGGE bands were similar to those of Vibrio and Photobacterium in all shrimp, consistent with pyrosequencing results. This work provides the first comprehensive report on bacterial populations in the intestine of adult black tiger shrimp and reveals some similar bacterial members between the intestine of wild-caught and domesticated shrimp.	[Rungrassamee, Wanilada; Klanchui, Amornpan; Maibunkaew, Sawarot; Karoonuthaisiri, Nitsara] Natl Ctr Genet Engn & Biotechnol BIOTEC, Microarray Lab, Khlong Luang, Pathum Thani, Thailand; [Chaiyapechara, Sage; Jiravanichpaisal, Pikul] Natl Ctr Genet Engn & Biotechnol BIOTEC, Aquat Mol Genet & Biotechnol Lab, Khlong Luang, Pathum Thani, Thailand	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Karoonuthaisiri, N (corresponding author), Natl Ctr Genet Engn & Biotechnol BIOTEC, Microarray Lab, Khlong Luang, Pathum Thani, Thailand.	nitsara.kar@biotec.or.th	Rungrassamee, Wanilada/E-1718-2011	Rungrassamee, Wanilada/0000-0002-5802-4342; Chaiyapechara, Sage/0000-0002-6836-2759	Thailand Research Fund [DBG5380030]; National Center for Genetic Engineering and Biotechnology (BIOTEC) [P-10-10722]	Thailand Research Fund(Thailand Research Fund (TRF)); National Center for Genetic Engineering and Biotechnology (BIOTEC)	The project received funding support from the Thailand Research Fund (grant number DBG5380030) and the National Center for Genetic Engineering and Biotechnology (BIOTEC, grant number P-10-10722). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Hania W, 2012, INT J SYST EVOL MICR, V62, P1365, DOI 10.1099/ijs.0.034603-0; Blaut M, 2007, J NUTR, V137, p751S, DOI 10.1093/jn/137.3.751S; Briggs M, 2005, FAO FISHERIES TECHNI; Browdy CL, 1998, AQUACULTURE, V164, P3, DOI 10.1016/S0044-8486(98)00174-4; Brune A, 2000, CURR OPIN MICROBIOL, V3, P263, DOI 10.1016/S1369-5274(00)00087-4; Cai L., 2013, PLOS ONE, V8; Chaiyapechara S, 2012, MICROB ECOL, V63, P938, DOI 10.1007/s00248-011-9936-2; Cleary DFR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029380; Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06; Desriac F, 2010, MAR DRUGS, V8, P1153, DOI 10.3390/md8041153; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dhanasiri AKS, 2011, MICROB ECOL, V61, P20, DOI 10.1007/s00248-010-9673-y; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fraune S, 2007, P NATL ACAD SCI USA, V104, P13146, DOI 10.1073/pnas.0703375104; Fujimura KE, 2010, EXPERT REV ANTI-INFE, V8, P435, DOI [10.1586/eri.10.14, 10.1586/ERI.10.14]; Gaggia F, 2010, INT J FOOD MICROBIOL, V141, pS15, DOI 10.1016/j.ijfoodmicro.2010.02.031; Ghyselinck J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071360; Gillilland MG, 2012, APPL ENVIRON MICROB, V78, P2359, DOI 10.1128/AEM.05239-11; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Holben WE, 2002, MICROB ECOL, V44, P175, DOI 10.1007/s00248-002-1011-6; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Islam KBMS, 2011, GASTROENTEROLOGY, V141, P1773, DOI 10.1053/j.gastro.2011.07.046; Jarchum I, 2011, CURR OPIN IMMUNOL, V23, P353, DOI 10.1016/j.coi.2011.03.001; Johnson CN, 2008, J WORLD AQUACULT SOC, V39, P251, DOI 10.1111/j.1749-7345.2008.00155.x; Khan ST, 2007, INT J SYST EVOL MICR, V57, P265, DOI 10.1099/ijs.0.64628-0; Kongnum K, 2012, FISH SHELLFISH IMMUN, V32, P170, DOI 10.1016/j.fsi.2011.11.008; KRAXBERGERBEATTY T, 1990, J FISH DIS, V13, P557, DOI 10.1111/j.1365-2761.1990.tb00819.x; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lebel L, 2010, ENVIRON SCI POLICY, V13, P291, DOI 10.1016/j.envsci.2010.03.005; Lee HI, 2010, ANAEROBE, V16, P522, DOI 10.1016/j.anaerobe.2010.07.002; Lee K, 2007, INT J SYST EVOL MICR, V57, P1653, DOI 10.1099/ijs.0.64960-0; Lee YS, 2009, INT J SYST EVOL MICR, V59, P1609, DOI 10.1099/ijs.0.006866-0; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Liu HD, 2011, AQUACULTURE, V317, P32, DOI 10.1016/j.aquaculture.2011.04.008; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MARTE CL, 1980, CRUSTACEANA, V38, P225, DOI 10.1163/156854080X00139; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Meziti A, 2012, SYST APPL MICROBIOL, V35, P473, DOI 10.1016/j.syapm.2012.07.004; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Navarrete P, 2009, MICROB ECOL, V57, P550, DOI 10.1007/s00248-008-9448-x; ORTIGOSA M, 1994, SYST APPL MICROBIOL, V17, P216, DOI 10.1016/S0723-2020(11)80011-1; OSULLIVAN J, 1990, J ANTIBIOT, V43, P913, DOI 10.7164/antibiotics.43.913; Oxley APA, 2002, J APPL MICROBIOL, V93, P214, DOI 10.1046/j.1365-2672.2002.01673.x; Ravot G, 1999, INT J SYST BACTERIOL, V49, P1141, DOI 10.1099/00207713-49-3-1141; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Rengpipat S, 1998, AQUACULTURE, V167, P301, DOI 10.1016/S0044-8486(98)00305-6; Rengpipat S, 2003, DIS AQUAT ORGAN, V55, P169, DOI 10.3354/dao055169; Ringo E, 1998, AQUACULTURE, V160, P177, DOI 10.1016/S0044-8486(97)00299-8; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Ronaghi M, 2001, GENOME RES, V11, P3, DOI 10.1101/gr.11.1.3; Rosenberry B., 2001, WORLD SHRIMP FARMING, V14, P5; Rungrassamee W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060802; Schloss PD, 2008, ISME J, V2, P265, DOI 10.1038/ismej.2008.5; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schluter J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001424; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Soonthornchai W, 2010, DEV COMP IMMUNOL, V34, P19, DOI 10.1016/j.dci.2009.07.007; Sullam KE, 2012, MOL ECOL, V21, P3363, DOI 10.1111/j.1365-294X.2012.05552.x; Tan TF, 2009, INT J SYST EVOL MICR, V59, P1143, DOI 10.1099/ijs.0.000901-0; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; Vaseeharan B, 2003, MICROBIOL RES, V158, P299, DOI 10.1078/0944-5013-00208; Verschuere L, 2000, MICROBIOL MOL BIOL R, V64, P655, DOI 10.1128/MMBR.64.4.655-671.2000; Wang BJ, 2009, INT J SYST EVOL MICR, V59, P1116, DOI 10.1099/ijs.0.002477-0; Wang CS, 2009, INT J SYST EVOL MICR, V59, P545, DOI 10.1099/ijs.0.004531-0; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y, 2010, INT J SYST EVOL MICR, V60, P2517, DOI 10.1099/ijs.0.016915-0; Waqairatu SS, 2012, ECOL EVOL, V2, P2057, DOI 10.1002/ece3.316; Wilson KH, 2006, ANAEROBE, V12, P249, DOI 10.1016/j.anaerobe.2006.09.002; Wongwilaiwalin S, 2010, ENZYME MICROB TECH, V47, P283, DOI 10.1016/j.enzmictec.2010.07.013; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; Yoon JH, 2007, INT J SYST EVOL MICR, V57, P856, DOI 10.1099/ijs.0.64779-0; Zou Z, 2008, INSECT BIOCHEM MOLEC, V38, P677, DOI 10.1016/j.ibmb.2008.03.009	81	178	202	6	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91853	10.1371/journal.pone.0091853	http://dx.doi.org/10.1371/journal.pone.0091853			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618668	gold, Green Submitted, Green Published			2022-12-25	WOS:000332842400135
J	Subhi, Y; Henningsen, GO; Larsen, CT; Sorensen, MS; Sorensen, TL				Subhi, Yousif; Henningsen, Gitte O.; Larsen, Charlotte T.; Sorensen, Mette S.; Sorensen, Torben L.			Foveal Morphology Affects Self-Perceived Visual Function and Treatment Response in Neovascular Age-Related Macular Degeneration: A Cohort Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; VISION-RELATED FUNCTION; QUESTIONNAIRE NEI-VFQ; RANIBIZUMAB TREATMENT; PHOTORECEPTOR INTEGRITY; SUBGROUP ANALYSIS; CLINICAL-TRIAL; ACUITY; PREDICTORS; EYES	Objectives: To investigate the relationship between foveal morphology and self-perceived visual function in patients with neovascular age-related macular degeneration (AMD) and whether foveal characteristics are associated with Ranibizumab treatment response on the self-perceived visual function. Methods: This prospective cohort study included patients with newly diagnosed neovascular AMD found eligible for treatment with Ranibizumab. Foveal morphology of both eyes was assessed using spectral-domain optical coherence tomography and all patients were interviewed using the 39-item National Eye Institute Visual Function Questionnaire (VFQ). Patients were re-interviewed 3 and 12 months after initiation of treatment with Ranibizumab. We evaluated foveal morphology at baseline in relation to VFQ scores at baseline and clinically meaningful changes in VFQ after 3 and 12 months. Results: VFQ scores correlated with central foveal thickness, central foveal thickness of neuroretina (CFN), foveal RPE elevation, foveal integrity of the photoreceptor inner segment/outer segment junction (IS/OS), and external limiting membrane. In a multiple linear regression model, only best-corrected visual acuity of the better eye (p<0.001) and the IS/OS status in the better eye (p = 0.012) remained significant (Adjusted R-2 = 0.418). Lower baseline VFQ and a baseline CFN within 170-270 mu m in the better eye were both associated with a clinically meaningful increase in the VFQ scores after 3 and 12 months. An absent foveal IS/OS band in the better eye was associated with a clinically meaningful decrease in the VFQ scores at 12 months. Conclusions: Foveal morphology in the better eye influences the self-perceived visual function in patients with neovascular AMD and possesses a predictive value for change in the self-perceived visual function at 3 and 12 months after initiation of treatment. These findings may help clinicians provide patients more individualized information of their disease and treatment prognosis from a patient-perceived point-of-view.	[Subhi, Yousif; Henningsen, Gitte O.; Larsen, Charlotte T.; Sorensen, Mette S.; Sorensen, Torben L.] Copenhagen Univ Hosp Roskilde, Dept Ophthalmol, Clin Eye Res Unit, Roskilde, Denmark; [Subhi, Yousif; Sorensen, Torben L.] Univ Copenhagen, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Sorensen, TL (corresponding author), Copenhagen Univ Hosp Roskilde, Dept Ophthalmol, Clin Eye Res Unit, Roskilde, Denmark.	torbenls@dadlnet.dk	Subhi, Yousif/ABG-6330-2020; Sørensen, Torben Lykke L/N-1417-2014	Subhi, Yousif/0000-0001-6620-5365; Sørensen, Torben Lykke L/0000-0002-6790-0199	Region Zealand Research Foundation	Region Zealand Research Foundation	This work is supported by the Region Zealand Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi-Kurashige Y, 2012, GRAEF ARCH CLIN EXP, V250, P1129, DOI 10.1007/s00417-012-1928-5; Bauer P, 2008, KLIN MONATSBL AUGENH, V225, P376, DOI 10.1055/s-2008-1027264; Boyer DS, 2007, OPHTHALMOLOGY, V114, P246, DOI 10.1016/j.ophtha.2006.10.045; Bressler NM, 2010, OPHTHALMOLOGY, V117, P747, DOI 10.1016/j.ophtha.2009.09.002; Brundage M, 2011, QUAL LIFE RES, V20, P653, DOI 10.1007/s11136-010-9793-3; Chang TS, 2007, ARCH OPHTHALMOL-CHIC, V125, P1460, DOI 10.1001/archopht.125.11.1460; Chhablani J, 2013, INT J OPHTHALMOL-CHI, V6, P62, DOI 10.3980/j.issn.2222-3959.2013.01.13; Clemons TE, 2003, ARCH OPHTHALMOL-CHIC, V121, P211; Falk MK, 2013, AM J OPHTHALMOL, V155, P89, DOI 10.1016/j.ajo.2012.06.031; Finger RP, 2013, ACTA OPHTHALMOL, V91, P540, DOI 10.1111/j.1755-3768.2012.02493.x; Gomi F, 2008, CURR OPIN OPHTHALMOL, V19, P208, DOI 10.1097/ICU.0b013e3282fb7c33; Hayashi H, 2009, AM J OPHTHALMOL, V148, P83, DOI 10.1016/j.ajo.2009.01.017; Kaiser PK, 2007, AM J OPHTHALMOL, V144, P850, DOI 10.1016/j.ajo.2007.08.012; Kurashige Y, 2012, RETINA-J RET VIT DIS, V32, P792, DOI 10.1097/IAE.0b013e3182278b98; Leys A, 2008, EYE, V22, P792, DOI 10.1038/sj.eye.6702900; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Mangione CM, 1998, ARCH OPHTHALMOL-CHIC, V116, P1496, DOI 10.1001/archopht.116.11.1496; Marella M, 2010, INVEST OPHTH VIS SCI, V51, P2878, DOI 10.1167/iovs.09-4494; Margolis MK, 2002, PHARMACOECONOMICS, V20, P791, DOI 10.2165/00019053-200220120-00001; Marques IR, 2013, OPHTHALMOLOGICA, V229, P158, DOI 10.1159/000343709; Miskala PH, 2007, OPHTHAL EPIDEMIOL, V14, P205, DOI 10.1080/09286580701502970; Oishi A, 2010, AM J OPHTHALMOL, V150, P27, DOI 10.1016/j.ajo.2010.02.012; Orr P, 2011, INVEST OPHTH VIS SCI, V52, P3354, DOI 10.1167/iovs.10-5645; Pappuru RR, 2011, INVEST OPHTH VIS SCI, V52, P6743, DOI 10.1167/iovs.10-6723; Pesudovs K, 2010, J CATARACT REFR SURG, V36, P718, DOI 10.1016/j.jcrs.2009.11.019; Rein DB, 2009, ARCH OPHTHALMOL-CHIC, V127, P533, DOI 10.1001/archophthalmol.2009.58; Revicki DA, 2010, INVEST OPHTH VIS SCI, V51, P712, DOI 10.1167/iovs.09-3766; Richter-Mueksch S, 2006, GRAEF ARCH CLIN EXP, V244, P154, DOI 10.1007/s00417-005-0063-y; Rubin GS, 2000, INVEST OPHTH VIS SCI, V41, P3327; Sabour-Pickett S, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/268438; Shin HJ, 2012, GRAEF ARCH CLIN EXP, V250, P61, DOI 10.1007/s00417-011-1774-x; Shin HJ, 2011, RETINA-J RET VIT DIS, V31, P1627, DOI 10.1097/IAE.0b013e31820d3d01; Sorensen MS, 2011, DAN MED BULL, V58; Sorensen TL, 2011, ACTA OPHTHALMOL, V89, pE97, DOI 10.1111/j.1755-3768.2010.01899.x; Suner IJ, 2009, INVEST OPHTH VIS SCI, V50, P3629, DOI 10.1167/iovs.08-3225; Tuulonen A, 2009, ACTA OPHTHALMOL, V87, P820, DOI 10.1111/j.1755-3768.2009.01532.x; Watanabe K, 2013, JAMA OPHTHALMOL, V131, P172, DOI 10.1001/jamaophthalmol.2013.686; Wiliams RA, 1998, ARCH OPHTHALMOL-CHIC, V116, P514; Ying GS, 2013, OPHTHALMOLOGY, V120, P122, DOI 10.1016/j.ophtha.2012.07.042	39	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91227	10.1371/journal.pone.0091227	http://dx.doi.org/10.1371/journal.pone.0091227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618706	Green Published, gold, Green Submitted			2022-12-25	WOS:000332842400059
J	Berthet, P; Lansner, A				Berthet, Pierre; Lansner, Anders			Optogenetic Stimulation in a Computational Model of the Basal Ganglia Biases Action Selection and Reward Prediction Error	PLOS ONE			English	Article							DOPAMINE NEURONS; CORTICOSTRIATAL SYNAPSES; DEPENDENT PLASTICITY; SYNAPTIC PLASTICITY; STRIATAL NEURONS; CORTEX; RAT; ORGANIZATION; VALUES; ROLES	Optogenetic stimulation of specific types of medium spiny neurons (MSNs) in the striatum has been shown to bias the selection of mice in a two choices task. This shift is dependent on the localisation and on the intensity of the stimulation but also on the recent reward history. We have implemented a way to simulate this increased activity produced by the optical flash in our computational model of the basal ganglia (BG). This abstract model features the direct and indirect pathways commonly described in biology, and a reward prediction pathway (RP). The framework is similar to Actor-Critic methods and to the ventral/ dorsal distinction in the striatum. We thus investigated the impact on the selection caused by an added stimulation in each of the three pathways. We were able to reproduce in our model the bias in action selection observed in mice. Our results also showed that biasing the reward prediction is sufficient to create a modification in the action selection. However, we had to increase the percentage of trials with stimulation relative to that in experiments in order to impact the selection. We found that increasing only the reward prediction had a different effect if the stimulation in RP was action dependent (only for a specific action) or not. We further looked at the evolution of the change in the weights depending on the stage of learning within a block. A bias in RP impacts the plasticity differently depending on that stage but also on the outcome. It remains to experimentally test how the dopaminergic neurons are affected by specific stimulations of neurons in the striatum and to relate data to predictions of our model.	[Berthet, Pierre; Lansner, Anders] Stockholm Univ, S-10691 Stockholm, Sweden; [Berthet, Pierre; Lansner, Anders] KTH Royal Inst Technol, Sch Comp Sci & Commun, Dept Computat Biol, Stockholm, Sweden; [Berthet, Pierre; Lansner, Anders] Karolinska Inst, Stockholm Brain Inst, Stockholm, Sweden	Stockholm University; Royal Institute of Technology; Karolinska Institutet	Berthet, P (corresponding author), Stockholm Univ, S-10691 Stockholm, Sweden.	berthet@kth.se	Lansner, Anders/E-4824-2016	Lansner, Anders/0000-0002-2358-7815; berthet, pierre/0000-0002-6878-6842	European Union [237955, 269921]; Swedish Research Council	European Union(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission)	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007 2013) under grant agreement no. 237955 (https://facets.kip.uni-heidelberg.de/ITN/, FACETS-ITN) and no. 269921 (http://brainscales.kip.uni-heidelberg.de/, BrainScaleS), and from the Swedish Research Council (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamantidis AR, 2011, J NEUROSCI, V31, P10829, DOI 10.1523/JNEUROSCI.2246-11.2011; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Ball KT, 2011, BEHAV BRAIN RES, V222, P390, DOI 10.1016/j.bbr.2011.03.064; Berthet P, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00065; Bromberg-Martin ES, 2010, J NEUROPHYSIOL, V104, P1068, DOI 10.1152/jn.00158.2010; Buesing L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002211; Charlesworth JD, 2012, NATURE, V486, P251, DOI 10.1038/nature11078; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Cohen MX, 2009, BEHAV BRAIN RES, V199, P141, DOI 10.1016/j.bbr.2008.09.029; Crittenden JR, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00059; Daw ND, 2006, CURR OPIN NEUROBIOL, V16, P199, DOI 10.1016/j.conb.2006.03.006; Deneve S, 2008, NEURAL COMPUT, V20, P91, DOI 10.1162/neco.2008.20.1.91; Doya K, 2002, NEURAL COMPUT, V14, P1347, DOI 10.1162/089976602753712972; Doya K., 2007, BAYESIAN BRAIN; Fujiyama F, 2011, EUR J NEUROSCI, V33, P668, DOI 10.1111/j.1460-9568.2010.07564.x; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Houk J. C., 1995, MODEL BASAL GANGLIA; Hwang EJ, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00121; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Kim H, 2009, J NEUROSCI, V29, P14701, DOI 10.1523/JNEUROSCI.2728-09.2009; Kravitz A V, 2012, NAT NEUROSCI, P1; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kreitzer AC, 2011, NEUROSCIENCE, V198, P19, DOI 10.1016/j.neuroscience.2011.08.018; Kress GJ, 2013, NAT NEUROSCI, V16, P665, DOI 10.1038/nn.3397; Lau B, 2007, J NEUROSCI, V27, P14502, DOI 10.1523/JNEUROSCI.3060-07.2007; Lenz JD, 2013, BEHAV BRAIN RES, P1; Lerner TN, 2011, CURR OPIN NEUROBIOL, V21, P322, DOI 10.1016/j.conb.2011.01.005; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; MCGEORGE AJ, 1989, NEUROSCIENCE, V29, P503, DOI 10.1016/0306-4522(89)90128-0; McHaffie JG, 2005, TRENDS NEUROSCI, V28, P401, DOI 10.1016/j.tins.2005.06.006; Mengual E, 1999, J CHEM NEUROANAT, V16, P187; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Nambu A, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00026; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Ostendorf F, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00010; Oyama K, 2010, J NEUROSCI, V30, P11447, DOI 10.1523/JNEUROSCI.1719-10.2010; Pawlak V., 2010, FRONT SYNAPTIC NEURO, V2, P146, DOI DOI 10.3389/FNSYN.2010.00146; Pawlak V, 2008, J NEUROSCI, V28, P2435, DOI 10.1523/JNEUROSCI.4402-07.2008; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; Reynolds JNJ, 2000, NEUROSCIENCE, V99, P199, DOI 10.1016/S0306-4522(00)00273-6; Reynolds JNJ, 2002, NEURAL NETWORKS, V15, P507, DOI 10.1016/S0893-6080(02)00045-X; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Sandberg A, 2002, NETWORK-COMP NEURAL, V13, P179, DOI 10.1088/0954-898X/13/2/302; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Sheth SA, 2011, J NEUROSCI, V31, P4878, DOI 10.1523/JNEUROSCI.3658-10.2011; Smith Y, 1998, NEUROSCIENCE, V86, P353; Steinberg EE, 2013, NAT NEUROSCI, V16, P966, DOI 10.1038/nn.3413; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Szydlowski SN, 2013, J NEUROSCI, V33, P1678, DOI 10.1523/JNEUROSCI.3572-12.2013; Tai LH, 2012, NAT NEUROSCI, V15, P1281, DOI 10.1038/nn.3188; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; Wang AY, 2013, NAT NEUROSCI, V16, P639, DOI 10.1038/nn.3377; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Wickens JR, 1996, NEUROSCIENCE, V70, P1, DOI 10.1016/0306-4522(95)00436-M; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852	63	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90578	10.1371/journal.pone.0090578	http://dx.doi.org/10.1371/journal.pone.0090578			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614169	Green Published, gold, Green Submitted			2022-12-25	WOS:000332839300030
J	Brink, AATP; von Wintersdorff, CJH; van der Donk, CFM; Peeters, AMMW; Beisser, PS; Stobberingh, EE; Wolffs, PFG				Brink, Antoinette A. T. P.; von Wintersdorff, Christian J. H.; van der Donk, Christina F. M.; Peeters, Anne M. M. W.; Beisser, Patrick S.; Stobberingh, Ellen E.; Wolffs, Petra F. G.			Development and Validation of a Single-Tube Multiple-Locus Variable Number Tandem Repeat Analysis for Klebsiella pneumoniae	PLOS ONE			English	Article							BETA-LACTAMASE; STRAIN; ENZYME	Genotyping of Klebsiella pneumoniae is indispensable for management of nosocomial infections, monitoring of emerging strains -including extended-spectrum beta-lactamase (ESBL) producers-, and general epidemiology. Such objectives require a high-resolution genotyping method with a fixed scheme that allows (1) long-term retrospective and prospective assessment, (2) objective result readout and (3) library storage for database development and exchangeable results. We have developed a multiple-locus variable number tandem repeat analysis (MLVA) using a single-tube fluorescently primed multiplex PCR for 8 Variable Number Tandem Repeats (VNTRs) and automated fragment size analysis. The type allocation scheme was optimized using 224 K. pneumoniae clinical isolates, which yielded 101 MLVA types. The method was compared to the gold standard multilocus sequence typing (MLST) using a subset of these clinical isolates (n = 95) and found to be highly concordant, with at least as high a resolution but with considerably less hands-on time. Our results position this MLVA scheme as an appropriate, high-throughput and relatively low-cost tool for K. pneumoniae epidemiology.	[Brink, Antoinette A. T. P.; von Wintersdorff, Christian J. H.; van der Donk, Christina F. M.; Peeters, Anne M. M. W.; Beisser, Patrick S.; Stobberingh, Ellen E.; Wolffs, Petra F. G.] Maastricht Univ, Med Ctr, Dept Med Microbiol, Maastricht, Netherlands; [Stobberingh, Ellen E.; Wolffs, Petra F. G.] Univ Maastricht, Sch Publ Hlth & Primary Care, Maastricht, Netherlands	Maastricht University; Maastricht University	Wolffs, PFG (corresponding author), Maastricht Univ, Med Ctr, Dept Med Microbiol, Maastricht, Netherlands.	p.wolffs@mumc.nl		von Wintersdorff, Christian/0000-0003-4409-4611; Wolffs, Petra/0000-0002-5326-3985				ARLET G, 1994, J CLIN MICROBIOL, V32, P2553, DOI 10.1128/JCM.32.10.2553-2558.1994; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Chaves J, 2001, ANTIMICROB AGENTS CH, V45, P2856, DOI 10.1128/AAC.45.10.2856-2861.2001; COWAN ST, 1960, J GEN MICROBIOL, V23, P601, DOI 10.1099/00221287-23-3-601; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Drieux L, 2008, CLIN MICROBIOL INFEC, V14, P90, DOI 10.1111/j.1469-0691.2007.01846.x; Fehlberg LCC, 2012, BRAZ J INFECT DIS, V16, P577, DOI 10.1016/j.bjid.2012.07.001; Fouts DE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000141; Gadberry MD, 2005, BIOINFORMATICS, V21, P1263, DOI 10.1093/bioinformatics/bti134; Krenke BE, 2002, J FORENSIC SCI, V47, P773; Lindstedt BA, 2003, J CLIN MICROBIOL, V41, P1469, DOI 10.1128/JCM.41.4.1469-1479.2003; Lobersli I, 2012, J MICROBIOL METH, V88, P134, DOI 10.1016/j.mimet.2011.11.003; McClelland M, 2006, KLEBSIELLA PNEUMONIA; Pallecchi L, 2004, ANTIMICROB AGENTS CH, V48, P4556, DOI 10.1128/AAC.48.12.4556-4561.2004; Pitout JDD, 2007, CLIN MICROBIOL INFEC, V13, P291, DOI 10.1111/j.1469-0691.2006.01645.x; Potron A, 2011, CLIN MICROBIOL INFEC, V17, pE24, DOI 10.1111/j.1469-0691.2011.03669.x; Rasheed JK, 2000, ANTIMICROB AGENTS CH, V44, P2382, DOI 10.1128/AAC.44.9.2382-2388.2000; Schouls LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005082; Turton JF, 2010, J MED MICROBIOL, V59, P541, DOI 10.1099/jmm.0.015198-0; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; van Belkum A, 2007, FEMS IMMUNOL MED MIC, V49, P22, DOI 10.1111/j.1574-695X.2006.00173.x; Wu KM, 2009, J BACTERIOL, V191, P4492, DOI 10.1128/JB.00315-09	23	9	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91209	10.1371/journal.pone.0091209	http://dx.doi.org/10.1371/journal.pone.0091209			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614534	Green Submitted, Green Published, gold			2022-12-25	WOS:000332839300095
J	Schouten, HJ; Koek, HL; Kruisman-Ebbers, M; Geersing, GJ; Oudega, R; Kars, MC; Moons, KGM; van Delden, JJM				Schouten, Henrike J.; Koek, Huiberdina L.; Kruisman-Ebbers, Marije; Geersing, Geert-Jan; Oudega, Ruud; Kars, Marijke C.; Moons, Karel G. M.; van Delden, Johannes J. M.			Decisions to Withhold Diagnostic Investigations in Nursing Home Patients with a Clinical Suspicion of Venous Thromboembolism	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; PULMONARY-EMBOLISM; ELDERLY-PATIENTS; CARE; HOSPITALIZATION; ANTICOAGULANT; TRANSITIONS; RESIDENTS; PHYSICIAN; ACCURACY	Background: This study aimed to gather insights in physicians' considerations for decisions to either refer for-or to withhold additional diagnostic investigations in nursing home patients with a suspicion of venous thromboembolism. Methods: Our study was nested in an observational study on diagnostic strategies for suspected venous thromboembolism in nursing home patients. Patient characteristics, bleeding-complications and mortality were related to the decision to withhold investigations. For a better understanding of the physicians' decisions, 21 individual face-to-face in-depth interviews were performed and analysed using the grounded theory approach. Results: Referal for additional diagnostic investigations was forgone in 126/322 (39.1%) patients with an indication for diagnostic work-up. 'Blind' anticoagulant treatment was initiated in 95 (75.4%) of these patients. The 3month mortality rates were higher for patients in whom investigations were withheld than in the referred patients, irrespective of anticoagulant treatment (odds ratio 2.45; 95% confidence interval 1.40 to 4.29) but when adjusted for the probability of being referred (i.e. the propensity score), there was no relation of non-diagnosis decisions to mortality (odds ratio 1.75; 0.98 to 3.11). In their decisions to forgo diagnostic investigations, physicians incorporated the estimated relative impact of the potential disease; the potential net-benefits of diagnostic investigations and whether performing investigations agreed with established management goals in advance care planning. Conclusion: Referral for additional diagnostic investigations is withheld in almost 40% of Dutch nursing home patients with suspected venous thromboembolism and an indication for diagnostic work-up. We propose that, given the complexity of these decisions and the uncertainty regarding their indirect effects on patient outcome, more attention should be focused on the decision to either use or withhold additional diagnostic tests.	[Schouten, Henrike J.; Kruisman-Ebbers, Marije; Geersing, Geert-Jan; Oudega, Ruud; Kars, Marijke C.; Moons, Karel G. M.; van Delden, Johannes J. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Schouten, Henrike J.; Koek, Huiberdina L.] Univ Med Ctr Utrecht, Dept Geriatr, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Schouten, HJ (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	h.j.schouten@umcutrecht.nl	Geersing, Geert-Jan/AAY-1119-2021; Kars, Marijke C/M-4301-2015		Netherlands Organization for Scientific Research (ZonMw) [17088-2502]	Netherlands Organization for Scientific Research (ZonMw)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development)	Financial support was provided by the Netherlands Organization for Scientific Research (ZonMw project number 17088-2502). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, CODE CONDUCT MED RES; AVVV NVVA Sting, 2006, BEGR ZORGV BETR BESL; BARRITT DW, 1960, LANCET, V1, P1309; Boeije H., 2009, ANAL QUALITATIVE RES; Boockvar K, 2004, ARCH INTERN MED, V164, P545, DOI 10.1001/archinte.164.5.545; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; de Casterle BD, 2012, INT J NURS STUD, V49, P360, DOI 10.1016/j.ijnurstu.2011.09.012; Di Nisio M, 2007, J THROMB HAEMOST, V5, P296, DOI 10.1111/j.1538-7836.2007.02328.x; Ferrante di Ruffano L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e686; Fried TR, 1997, J AM GERIATR SOC, V45, P265, DOI 10.1111/j.1532-5415.1997.tb00938.x; Gill TM, 2011, J GERONTOL A-BIOL, V66, P1238, DOI 10.1093/gerona/glr142; GILLICK MR, 1982, SOC SCI MED, V16, P1033, DOI 10.1016/0277-9536(82)90175-7; Givens JL, 2012, J AM GERIATR SOC, V60, P905, DOI 10.1111/j.1532-5415.2012.03919.x; Glaser B, 1978, DISCOV GROUNDED THEO; Goldfeld KS, 2013, J PAIN SYMPTOM MANAG, V10; Goodacre S, 2005, ANN INTERN MED, V143, P129, DOI 10.7326/0003-4819-143-2-200507190-00012; Gozalo P, 2011, NEW ENGL J MED, V365, P1212, DOI 10.1056/NEJMsa1100347; Hamaker ME, 2012, J AM MED DIR ASSOC, V13, P464, DOI 10.1016/j.jamda.2012.01.002; Helton MR, 2006, ANN FAM MED, V4, P221, DOI 10.1370/afm.536; Hylek EM, 2007, CIRCULATION, V115, P2689, DOI 10.1161/CIRCULATIONAHA.106.653048; Khreizat HS, 2012, DRUG AGING, V29, P307, DOI 10.2165/11599060-000000000-00000; Koopmans RTCM, 2010, J AM GERIATR SOC, V58, P1807, DOI 10.1111/j.1532-5415.2010.03043.x; Ling J, 2000, EUR J CANCER, V36, P621, DOI 10.1016/S0959-8049(99)00330-5; Lingard L, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.39602.690162.47; Masotti L, 2008, VASC HEALTH RISK MAN, V4, P629, DOI 10.2147/VHRM.S2605; Mitchell AM, 2012, ACAD EMERG MED, V19, P618, DOI 10.1111/j.1553-2712.2012.01374.x; Oudega R, 2005, THROMB HAEMOSTASIS, V94, P200, DOI 10.1160/TH04-12-0829; Oudega R, 2005, FAM PRACT, V22, P86, DOI 10.1093/fampra/cmh718; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Prasad V, 2012, ARCH INTERN MED, V172, P955, DOI 10.1001/archinternmed.2012.195; Righini M, 2005, J AM GERIATR SOC, V53, P1039, DOI 10.1111/j.1532-5415.2005.53309.x; Schouten HJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2492; Schouten HJ, 2012, J AM MED DIR ASSOC, V13, P682, DOI 10.1016/j.jamda.2012.05.010; Schulman S, 2008, CHEST, V133, p257S, DOI 10.1378/chest.08-0674; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Wells PS, 2007, J THROMB HAEMOST, V5, P41, DOI 10.1111/j.1538-7836.2007.02493.x; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66; Wiener RS, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3368	39	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90395	10.1371/journal.pone.0090395	http://dx.doi.org/10.1371/journal.pone.0090395			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9FH	24614754	gold, Green Submitted, Green Published			2022-12-25	WOS:000332839300022
J	Ueno, T; Funatsu, T				Ueno, Taro; Funatsu, Takashi			Label-Free Quantification of MicroRNAs Using Ligase-Assisted Sandwich Hybridization on a DNA Microarray	PLOS ONE			English	Article							RNA; EXPRESSION; LIGATION; CANCER; PROBES; ACID; PCR	MicroRNAs (miRNAs) can be used as biomarkers for cancer and other human diseases; therefore, high-throughput and reliable miRNA-quantification methods are required to exploit these markers for diagnostic testing. In this report, we describe the construction of a platform for miRNA-quantification using ligase-assisted sandwich hybridization (LASH) without miRNA-labeling. T4 DNA ligase was used to compensate for the low affinity between miRNAs and two short complementary DNA probes, and it improved the hybridization yield,50,000 times. The LASH assay enabled synthesized miR-143 to be quantified at concentrations ranging from 30 fM to 30 pM. The LASH assay could also quantify endogenous miR-143 released from cultured cells as well as some miRNAs in total RNAs derived from blood. Furthermore, multi-color detection enabled us to distinguish between the highly homologous miR-141 and miR-200a. This simple label-free quantification technique is an easy-to-use approach that can be applied to disease diagnosis.	[Ueno, Taro; Funatsu, Takashi] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan	University of Tokyo	Funatsu, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan.	funatsu@mail.ecc.u-tokyo.ac.jp	Funatsu, Takashi/Q-1404-2015	Funatsu, Takashi/0000-0002-9656-8308	Japan Society for the Promotion of Science (JSPS)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) from the Japan Society for the Promotion of Science (JSPS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arata H, 2012, ANALYST, V137, P3234, DOI 10.1039/c2an16154k; Asslaber D, 2010, J NUCL ACIDS, V1, pe14; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Driskell JD, 2010, CHEM COMMUN, V46, P3298, DOI 10.1039/c002059a; Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798; Duan DM, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr774; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Feuillie C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017847; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hunt EA, 2009, ANAL BIOCHEM, V387, P1, DOI 10.1016/j.ab.2009.01.011; Husale S, 2009, NATURE, V462, P1075, DOI 10.1038/nature08626; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lee JM, 2010, ANGEW CHEM INT EDIT, V49, P8662, DOI 10.1002/anie.201004000; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li J, 2009, ANAL CHEM, V81, P5446, DOI 10.1021/ac900598d; Maroney PA, 2008, NAT PROTOC, V3, P279, DOI 10.1038/nprot.2007.530; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nielsen UB, 2004, J IMMUNOL METHODS, V290, P107, DOI 10.1016/j.jim.2004.04.012; Poehlmann C, 2010, ANAL CHEM, V82, P4434, DOI 10.1021/ac100186p; Rant U, 2007, P NATL ACAD SCI USA, V104, P17364, DOI 10.1073/pnas.0703974104; Repsilber D, 2005, METHOD INFORM MED, V44, P400; Roy S, 2011, LAB CHIP, V11, P1886, DOI 10.1039/c0lc00638f; Sipova H, 2010, ANAL CHEM, V82, P10110, DOI 10.1021/ac102131s; Su X, 2007, ANAL CHEM, V79, P7192, DOI 10.1021/ac0709403; Wach S, 2012, INT J CANCER, V130, P611, DOI 10.1002/ijc.26064; Yang WJ, 2008, ANAL BIOCHEM, V376, P183, DOI 10.1016/j.ab.2008.02.003; Yeh HC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl787; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	31	22	25	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90920	10.1371/journal.pone.0090920	http://dx.doi.org/10.1371/journal.pone.0090920			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614340	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300055
J	Szymanska, S; Lordal, M; Rathnayake, N; Gustafsson, A; Johannsen, A				Szymanska, Sara; Lordal, Mikael; Rathnayake, Nilminie; Gustafsson, Anders; Johannsen, Annsofi			Dental Caries, Prevalence and Risk Factors in Patients with Crohn's Disease	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; HEALTH; TASTE	Objective: The present study tested the hypothesis that patients with Crohn's disease (CD) have a higher prevalence and risk for caries compared to people without CD. Material and Methods: Patients with CD were divided into groups; 71 patients (50.7 +/- 13.9 years) who had gone through resective intestinal surgery and 79 patients (42.0 +/- 14.4 years) who had not. The patients were compared to 75 controls (48.6 +/- 13.4 years) regarding DMF-T and DMF-S, Lactobacilli (LB), Streptococcus mutans (SM), salivary flow and dental plaque. Statistical methods including ANOVA or Chi-square test for calculation of demographic differences between groups, analysis of covariance (ANCOVA) to compare the clinical variable and Post hoc analyses were done with Fischers Least Significant Difference test or Chi-square. Non-parametric Spearman's correlation matrix coefficient was estimated between clinical variables and disease duration. Results: CD patients who had been subjected to resective surgery had a higher DMF-S score (50.7 versus 36.5; p = 0.01) compared to the control group after adjusting for age, gender and smoking. These patients had higher counts of SM (1.5 versus 0.9; p = 0.04) and LB (10000.0 versus 1000.0; p = 0.01), and more dental plaque (53.7 versus 22.6; p = 0.001). CD patients reported a more frequent consumption of sweetened drinks between meals compared to controls (p = 0.001). Conclusions: The present study shows that patients with CD who had undergone resective surgery had a higher DMFs score, and higher salivary counts of Lactobacilli and Streptococcus mutans compared to the control group.	[Szymanska, Sara; Rathnayake, Nilminie; Gustafsson, Anders; Johannsen, Annsofi] Karolinska Inst, Dept Dent Med, Div Periodontol, Huddinge, Sweden; [Lordal, Mikael] Karolinska Inst, Dept Med, Div Gastroenterol & Hepathol, Huddinge, Sweden; [Lordal, Mikael] Sophiahemmet, Stockholm Gastro Ctr, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Johannsen, A (corresponding author), Karolinska Inst, Dept Dent Med, Div Periodontol, Huddinge, Sweden.	annsofi.johannsen@ki.se			Swedish Association of People with Stomach and Bowel Diseases; Swedish Patent Revenue Research Found; Praktikertjanst AB, Sweden; Swedish Society of Gastroenterology; Sophiahemmet Research Funds	Swedish Association of People with Stomach and Bowel Diseases; Swedish Patent Revenue Research Found; Praktikertjanst AB, Sweden; Swedish Society of Gastroenterology; Sophiahemmet Research Funds	This study was supported by the Swedish Association of People with Stomach and Bowel Diseases, Swedish Patent Revenue Research Found, Praktikertjanst AB, Sweden, Swedish Society of Gastroenterology and Sophiahemmet Research Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEVENIUS J, 1988, ORAL SURG ORAL MED O, V65, P304, DOI 10.1016/0030-4220(88)90114-4; Brito F, 2008, J CLIN PERIODONTOL, V35, P555, DOI 10.1111/j.1600-051X.2008.01231.x; Cho JH, 2011, GASTROENTEROLOGY, V140, P1704, DOI 10.1053/j.gastro.2011.02.046; Crohn BB, 1932, J AMER MED ASSOC, V99, P1323, DOI 10.1001/jama.1932.02740680019005; Fatahzadeh M, 2009, ORAL SURG ORAL MED O, V108, pE1, DOI 10.1016/j.tripleo.2009.07.035; Ferrante M, 2012, CURR DRUG TARGETS, V13, P1294, DOI 10.2174/138945012802429679; Gibson PR, 2005, ALIMENT PHARM THER, V21, P1399, DOI 10.1111/j.1365-2036.2005.02506.x; Grossner-Schreiber B, 2006, J CLIN PERIODONTOL, V33, P478, DOI 10.1111/j.1600-051X.2006.00942.x; Habashneh RA, 2012, J PERIODONTAL RES, V47, P293, DOI 10.1111/j.1600-0765.2011.01431.x; Head Kathleen, 2004, Altern Med Rev, V9, P360; Kappelman MD, 2007, CLIN GASTROENTEROL H, V5, P1424, DOI 10.1016/j.cgh.2007.07.012; Katz JA, 2007, J DIGEST DIS, V8, P65, DOI 10.1111/j.1443-9573.2007.00287.x; Keefer L, 2011, BEHAV RES THER, V49, P145, DOI 10.1016/j.brat.2010.12.005; LENNARDJONES JE, 1984, POSTGRAD MED J, V60, P797, DOI 10.1136/pgmj.60.709.797; PENNY WJ, 1983, GUT, V24, P288, DOI 10.1136/gut.24.4.288; Reif S, 1997, GUT, V40, P754, DOI 10.1136/gut.40.6.754; Rikardsson S, 2009, ORAL HLTH PREV DENT, V7, P277; ROONEY TP, 1984, ORAL SURG ORAL MED O, V57, P623, DOI 10.1016/0030-4220(84)90284-6; Schutz T, 2003, DIGEST DIS, V21, P252, DOI 10.1159/000073343; Selwitz RH, 2007, LANCET, V369, P51, DOI 10.1016/S0140-6736(07)60031-2; Singhal S, 2011, DIGEST DIS SCI, V56, P170, DOI 10.1007/s10620-010-1263-9; SOLOMONS NW, 1977, DIGESTION, V16, P87, DOI 10.1159/000198059; Stange EF, 2006, GUT, V55, DOI 10.1136/gut.2005.081950a; SUNDH B, 1993, ORAL SURG ORAL MED O, V76, P564, DOI 10.1016/0030-4220(93)90063-A; Takahashi N, 2011, J DENT RES, V90, P294, DOI 10.1177/0022034510379602; Touger-Decker R, 2003, AM J CLIN NUTR, V78, p881S, DOI 10.1093/ajcn/78.4.881S; TRAGNONE A, 1995, EUR J GASTROEN HEPAT, V7, P47; Vind I, 2006, AM J GASTROENTEROL, V101, P1274, DOI 10.1111/j.1572-0241.2006.00552.x; World Health Organization, 1997, WHO OR HLTH SURV BAS, V4th	29	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91059	10.1371/journal.pone.0091059	http://dx.doi.org/10.1371/journal.pone.0091059			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608416	gold, Green Published, Green Submitted			2022-12-25	WOS:000332485800090
J	Chen, YN; Mao, Y; Liu, HL; Yu, FX; Li, SX; Yin, TM				Chen, Yingnan; Mao, Yan; Liu, Hailin; Yu, Faxin; Li, Shuxian; Yin, Tongming			Transcriptome Analysis of Differentially Expressed Genes Relevant to Variegation in Peach Flowers	PLOS ONE			English	Article							CHALCONE SYNTHASE GENE; TRANSPOSABLE ELEMENT; FLAVONOID BIOSYNTHESIS; COLOR; JAPANESE; PETUNIA; GENOME; BIOCHEMISTRY; ANNOTATION; SUPPRESSION	Background: Variegation in flower color is commonly observed in many plant species and also occurs on ornamental peaches (Prunus persica f. versicolor [Sieb.] Voss). Variegated plants are highly valuable in the floricultural market. To gain a global perspective on genes differentially expressed in variegated peach flowers, we performed large-scale transcriptome sequencing of white and red petals separately collected from a variegated peach tree. Results: A total of 1,556,597 high-quality reads were obtained, with an average read length of 445 bp. The ESTs were assembled into 16,530 contigs and 42,050 singletons. The resulting unigenes covered about 60% of total predicted genes in the peach genome. These unigenes were further subjected to functional annotation and biochemical pathway analysis. Digital expression analysis identified a total of 514 genes differentially expressed between red and white flower petals. Since peach flower coloration is determined by the expression and regulation of structural genes relevant to flavonoid biosynthesis, a detailed examination detected four key structural genes, including C4H, CHS, CHI and F3H, expressed at a significantly higher level in red than in white petal. Except for the structural genes, we also detected 11 differentially expressed regulatory genes relating to flavonoid biosynthesis. Using the differentially expressed structural genes as the test objects, we validated the digital expression results by using quantitative real-time PCR, and the differential expression of C4H, CHS and F3H were confirmed. Conclusion: In this study, we generated a large EST collection from flower petals of a variegated peach. By digital expression analysis, we identified an informative list of candidate genes associated with variegation in peach flowers, which offered a unique opportunity to uncover the genetic mechanisms underlying flower color variegation.	[Chen, Yingnan; Mao, Yan; Liu, Hailin; Li, Shuxian; Yin, Tongming] Nanjing Forestry Univ, Southern Modern Forestry Collaborat Innovat Ctr, Nanjing, Jiangsu, Peoples R China; [Yu, Faxin] Jiangxi Acad Sci, Inst Biol & Resources, Nanchang, Jiangxi, Peoples R China	Nanjing Forestry University	Yin, TM (corresponding author), Nanjing Forestry Univ, Southern Modern Forestry Collaborat Innovat Ctr, Nanjing, Jiangsu, Peoples R China.	tmyin@njfu.com.cn			Natural Science Foundation of China [31270711, 31125008]; Jiangsu Natural Science Foundation for Youth [BK20130968]; Program for Innovative Research Team in Universities of Jiangsu Province; Educational Department of China; Priority Academic Program Development of Jiangsu Higher Education Institutions	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation for Youth; Program for Innovative Research Team in Universities of Jiangsu Province; Educational Department of China; Priority Academic Program Development of Jiangsu Higher Education Institutions	Funding for this research was provided by the Natural Science Foundation of China (31270711 and 31125008), the Jiangsu Natural Science Foundation for Youth (BK20130968), and the Program for Innovative Research Team in Universities of Jiangsu Province and the Educational Department of China. It was also funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aoki-Kinoshita Kiyoko F., 2007, V396, P71; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Broun P, 2005, CURR OPIN PLANT BIOL, V8, P272, DOI 10.1016/j.pbi.2005.03.006; Bruce W, 2000, PLANT CELL, V12, P65, DOI 10.1105/tpc.12.1.65; CHAPARRO JX, 1995, J HERED, V86, P186, DOI 10.1093/oxfordjournals.jhered.a111560; Davies KM, 2012, FUNCT PLANT BIOL, V39, P619, DOI 10.1071/FP12195; Davies Kevin M., 2009, P49, DOI 10.1007/978-0-387-77335-3_3; Dixon RA, 1996, GENE, V179, P61, DOI 10.1016/S0378-1119(96)00327-7; Dubois A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-638; FORKMANN G, 1986, Z NATURFORSCH C, V41, P179; GOTO T, 1991, ANGEW CHEM INT EDIT, V30, P17, DOI 10.1002/anie.199100171; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; GUTTERSON N, 1995, HORTSCIENCE, V30, P964, DOI 10.21273/HORTSCI.30.5.964; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; HOSHINO A, 1995, MOL GEN GENET, V247, P114, DOI 10.1007/BF00425828; Huang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038653; Iida S, 1999, ANN NY ACAD SCI, V870, P265, DOI 10.1111/j.1749-6632.1999.tb08887.x; Iida S, 2004, ONCOGENE, V23, P5266, DOI 10.1038/sj.onc.1207623; INAGAKI Y, 1994, PLANT CELL, V6, P375, DOI 10.1105/tpc.6.3.375; KEVAN PG, 1983, ANNU REV ENTOMOL, V28, P407, DOI 10.1146/annurev.en.28.010183.002203; Liu D, 2001, PLANT CELL PHYSIOL, V42, P419, DOI 10.1093/pcp/pce053; Liu JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060181; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahomed W, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-167; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Mol J, 1998, TRENDS PLANT SCI, V3, P212, DOI 10.1016/S1360-1385(98)01242-4; Morita Y, 2006, PLANT CELL PHYSIOL, V47, P457, DOI 10.1093/pcp/pcj012; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Morohashi K, 2012, PLANT CELL, V24, P2745, DOI 10.1105/tpc.112.098004; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Quattrocchio F, 1999, PLANT CELL, V11, P1433, DOI 10.1105/tpc.11.8.1433; Quinlan RJ, 2008, CURR TOP DEV BIOL, V84, P249, DOI 10.1016/S0070-2153(08)00605-4; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; RONCHI A, 1995, EMBO J, V14, P5318, DOI 10.1002/j.1460-2075.1995.tb00216.x; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schwinn K, 2006, PLANT CELL, V18, P831, DOI 10.1105/tpc.105.039255; Stekel DJ, 2000, GENOME RES, V10, P2055, DOI 10.1101/gr.GR-1325RR; Suzuki S, 2007, PLANT CELL REP, V26, P951, DOI 10.1007/s00299-006-0302-7; To KinYing, 2006, Floriculture, ornamental and plant biotechnology, P300; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; van Houwelingen A, 1998, PLANT J, V13, P39, DOI 10.1046/j.1365-313X.1998.00005.x; VANDERKROL AR, 1988, NATURE, V333, P866, DOI 10.1038/333866a0; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Wang L, 2013, PLANT MOL BIOL, V83, P365, DOI 10.1007/s11103-013-0093-5; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Wu B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-15; Yabuya T, 2001, PLANT SCI, V160, P499, DOI 10.1016/S0168-9452(00)00417-9; Yoshida K, 2000, PHYTOCHEMISTRY, V54, P85, DOI 10.1016/S0031-9422(00)00049-2; Zhang X, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r165; Zhang ZP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018379; Zhu ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034335; Zuker A, 2002, MOL BREEDING, V9, P33, DOI 10.1023/A:1019204531262	60	48	53	5	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90842	10.1371/journal.pone.0090842	http://dx.doi.org/10.1371/journal.pone.0090842			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603808	Green Published, gold, Green Submitted			2022-12-25	WOS:000332483600092
J	Vadivel, A; Alphonse, RS; Ionescu, L; Machado, DS; O'Reilly, M; Eaton, F; Haromy, A; Michelakis, ED; Thebaud, B				Vadivel, Arul; Alphonse, Rajesh S.; Ionescu, Lavinia; Machado, Desiree S.; O'Reilly, Megan; Eaton, Farah; Haromy, Al; Michelakis, Evangelos D.; Thebaud, Bernard			Exogenous Hydrogen Sulfide (H2S) Protects Alveolar Growth in Experimental O-2-Induced Neonatal Lung Injury	PLOS ONE			English	Article							INHALED NITRIC-OXIDE; BRONCHOPULMONARY DYSPLASIA; PULMONARY-HYPERTENSION; INCREASES SURVIVAL; PRETERM INFANTS; SMOOTH-MUSCLE; HYPEROXIA; DISEASE; DAMAGE; CELLS	Background: Bronchopulmonary dysplasia (BPD), the chronic lung disease of prematurity, remains a major health problem. BPD is characterized by impaired alveolar development and complicated by pulmonary hypertension (PHT). Currently there is no specific treatment for BPD. Hydrogen sulfide (H2S), carbon monoxide and nitric oxide (NO), belong to a class of endogenously synthesized gaseous molecules referred to as gasotransmitters. While inhaled NO is already used for the treatment of neonatal PHT and currently tested for the prevention of BPD, H2S has until recently been regarded exclusively as a toxic gas. Recent evidence suggests that endogenous H2S exerts beneficial biological effects, including cytoprotection and vasodilatation. We hypothesized that H2S preserves normal alveolar development and prevents PHT in experimental BPD. Methods: We took advantage of a recently described slow-releasing H2S donor, GYY4137 (morpholin-4-ium-4-methoxyphenyl(morpholino) phosphinodithioate) to study its lung protective potential in vitro and in vivo. Results: In vitro, GYY4137 promoted capillary-like network formation, viability and reduced reactive oxygen species in hyperoxia-exposed human pulmonary artery endothelial cells. GYY4137 also protected mitochondrial function in alveolar epithelial cells. In vivo, GYY4137 preserved and restored normal alveolar growth in rat pups exposed from birth for 2 weeks to hyperoxia. GYY4137 also attenuated PHT as determined by improved pulmonary arterial acceleration time on echo-Doppler, pulmonary artery remodeling and right ventricular hypertrophy. GYY4137 also prevented pulmonary artery smooth muscle cell proliferation. Conclusions: H2S protects from impaired alveolar growth and PHT in experimental O-2-induced lung injury. H2S warrants further investigation as a new therapeutic target for alveolar damage and PHT.	[Vadivel, Arul; Thebaud, Bernard] Univ Ottawa, Sprott Ctr Stem Cell Res, Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON, Canada; [Vadivel, Arul; Thebaud, Bernard] Univ Ottawa, Childrens Hosp Eastern Ontario, Ottawa, ON, Canada; [Alphonse, Rajesh S.; Ionescu, Lavinia; Machado, Desiree S.; O'Reilly, Megan; Eaton, Farah; Haromy, Al; Michelakis, Evangelos D.] Univ Alberta, Sch Human Dev, Dept Pediat, Women & Childrens Hlth Res Inst,Cardiovasc Res Ct, Edmonton, AB, Canada; [Alphonse, Rajesh S.; Ionescu, Lavinia; Machado, Desiree S.; O'Reilly, Megan; Eaton, Farah; Haromy, Al; Michelakis, Evangelos D.] Univ Alberta, Pulm Res Grp, Edmonton, AB, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Children's Hospital of Eastern Ontario; University of Alberta; University of Alberta	Thebaud, B (corresponding author), Univ Ottawa, Sprott Ctr Stem Cell Res, Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON, Canada.	bthebaud@ohri.ca			Canadian Institutes of Health Research (CIHR); Maternal Fetal Neonatal Health Training Program (MFN); CIHR-IHDCYH; Alberta Innovates Health Solutions (AIHS); CIHR; AIHS; Canada Foundation for Innovation (CFI); Canada Research Chairs Program; Stollery Children's Hospital Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Maternal Fetal Neonatal Health Training Program (MFN); CIHR-IHDCYH(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions (AIHS); CIHR(Canadian Institutes of Health Research (CIHR)); AIHS; Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Canada Research Chairs Program(Canada Research Chairs); Stollery Children's Hospital Foundation	This work was supported by the Canadian Institutes of Health Research (CIHR). AV and LI were supported by a stipend from the Maternal Fetal Neonatal Health Training Program (MFN) sponsored by CIHR-IHDCYH. RAS was supported by a stipend from Alberta Innovates Health Solutions (AIHS). BT and EDM were supported by CIHR, AIHS, Canada Foundation for Innovation (CFI), and the Canada Research Chairs Program. BT was also supported by the Stollery Children's Hospital Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphonse RS, 2011, AM J RESP CELL MOL, V44, P146, DOI 10.1165/rcmb.2009-0182OC; Archer SL, 2004, CIRC RES, V95, P308, DOI 10.1161/01.RES.0000137173.42723.fb; Balasubramaniam V, 2006, AM J PHYSIOL-LUNG C, V291, pL119, DOI 10.1152/ajplung.00395.2005; Berkelhamer SK, 2013, SEMIN PERINATOL, V37, P124, DOI 10.1053/j.semperi.2013.01.009; Bland RD, 2005, AM J RESP CRIT CARE, V172, P899, DOI 10.1164/rccm.200503-384OC; Cai WJ, 2007, CARDIOVASC RES, V76, P29, DOI 10.1016/j.cardiores.2007.05.026; Chen YH, 2012, RESP PHYSIOL NEUROBI, V184, P130, DOI 10.1016/j.resp.2012.03.009; Cho HY, 2012, ANTIOXID REDOX SIGN, V17, P1066, DOI 10.1089/ars.2011.4288; Esteve JM, 1999, FASEB J, V13, P1055, DOI 10.1096/fasebj.13.9.1055; Faller S, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-26; Faller S, 2010, ANESTHESIOLOGY, V113, P104, DOI 10.1097/ALN.0b013e3181de7107; Francis RC, 2011, ANESTHESIOLOGY, V115, P1012, DOI 10.1097/ALN.0b013e31823306cf; FREEMAN BA, 1981, J BIOL CHEM, V256, P986; Iams JD, 2008, LANCET, V371, P164, DOI 10.1016/S0140-6736(08)60108-7; Jankov RP, 2006, PEDIATR RES, V60, P245, DOI 10.1203/01.pdr.0000233056.37254.0b; Kinsella JP, 2006, LANCET, V367, P1421, DOI 10.1016/S0140-6736(06)68615-7; Kotecha SJ, 2013, THORAX, V68, P760, DOI 10.1136/thoraxjnl-2012-203079; Ladha F, 2005, AM J RESP CRIT CARE, V172, P750, DOI 10.1164/rccm.200503-510OC; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; McCurnin DC, 2005, AM J PHYSIOL-LUNG C, V288, pL450, DOI 10.1152/ajplung.00347.2004; McGrath-Morrow S, 2009, AM J PHYSIOL-LUNG C, V296, pL565, DOI 10.1152/ajplung.90487.2008; Meng QH, 2007, AM J PATHOL, V170, P1406, DOI 10.2353/ajpath.2007.060939; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Mourani PM, 2013, CURR OPIN PEDIATR, V25, P329, DOI 10.1097/MOP.0b013e328360a3f6; Muellner MK, 2009, BIOCHEM J, V420, P277, DOI 10.1042/BJ20082421; Pierro M, 2013, THORAX, V68, P475, DOI 10.1136/thoraxjnl-2012-202323; Rajendrasozhan S, 2008, AM J RESP CRIT CARE, V177, P861, DOI 10.1164/rccm.200708-1269OC; Shah PS, 2012, J PERINATOL, V32, P132, DOI 10.1038/jp.2011.68; Singleton PA, 2009, CIRC RES, V104, P978, DOI 10.1161/CIRCRESAHA.108.193367; Soll RF, 2012, NEONATOLOGY, V102, P251, DOI 10.1159/000338552; Sutendra G., 2010, SCI TRANSL MED, V2; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Tang XQ, 2008, CLIN EXP PHARMACOL P, V35, P180, DOI 10.1111/j.1440-1681.2007.04799.x; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; Vadivel A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067225; van Haaften T, 2009, AM J RESP CRIT CARE, V180, P1131, DOI 10.1164/rccm.200902-0179OC; Wang T, 2012, AM J RESP CELL MOL, V47, P491, DOI 10.1165/rcmb.2011-0248OC; Zheng ZZ, 2007, INT J BIOCHEM CELL B, V39, P340, DOI 10.1016/j.biocel.2006.09.001	38	40	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90965	10.1371/journal.pone.0090965	http://dx.doi.org/10.1371/journal.pone.0090965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603989	gold, Green Published, Green Submitted			2022-12-25	WOS:000332483600117
J	Ho, HN; Van Doorn, GH; Kawabe, T; Watanabe, J; Spence, C				Ho, Hsin-Ni; Van Doorn, George H.; Kawabe, Takahiro; Watanabe, Junji; Spence, Charles			Colour-Temperature Correspondences: When Reactions to Thermal Stimuli Are Influenced by Colour	PLOS ONE			English	Article							APPARENT WARMTH; IMPLICIT; COOL; HUE	In our daily lives, information concerning temperature is often provided by means of colour cues, with red typically being associated with warm/hot, and blue with cold. While such correspondences have been known about for many years, they have primarily been studied using subjective report measures. Here we examined this correspondence using two more objective response measures. First, we used the Implicit Association Test (IAT), a test designed to assess the strength of automatic associations between different concepts in a given individual. Second, we used a priming task that involved speeded target discrimination in order to assess whether priming colour or thermal information could invoke the crossmodal association. The results of the IAT confirmed that the association exists at the level of response selection, thus indicating that a participant's responses to colour or thermal stimuli are influenced by the colour-temperature correspondence. The results of the priming experiment revealed that priming a colour affected thermal discrimination reaction times (RTs), but thermal cues did not influence colour discrimination responses. These results may therefore provide important clues as to the level of processing at which such colour-temperature correspondences are represented.	[Ho, Hsin-Ni; Kawabe, Takahiro; Watanabe, Junji] NTT Corp, NTT Commun Sci Labs, Atsugi, Kanagawa, Japan; [Van Doorn, George H.] Federat Univ, Sch Appl Media & Social Sci, Churchill, Vic, Australia; [Spence, Charles] Univ Oxford, Dept Expt Psychol, Crossmodal Res Lab, Oxford OX1 3UD, England	Nippon Telegraph & Telephone Corporation; Federation University Australia; University of Oxford	Ho, HN (corresponding author), NTT Corp, NTT Commun Sci Labs, Atsugi, Kanagawa, Japan.	ho.hsinni@lab.ntt.co.jp	Ho, Hsin-Ni/AAV-5590-2021	Ho, Hsin-Ni/0000-0002-9940-9089; Van Doorn, George/0000-0001-7311-7099				Ballesteros S, 2008, EXP BRAIN RES, V189, P473, DOI 10.1007/s00221-008-1441-6; BENNETT CA, 1972, HUM FACTORS, V14, P149, DOI 10.1177/001872087201400204; BERRY PC, 1961, J APPL PSYCHOL, V45, P248, DOI 10.1037/h0040221; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Changizi MA, 2006, BIOL LETT-UK, V2, P217, DOI 10.1098/rsbl.2006.0440; Deroy O, 2013, PSYCHON B REV, V20, P643, DOI 10.3758/s13423-013-0387-2; Ernst MO, 2007, J VISION, V7, DOI 10.1167/7.5.7; Evans KK, 2010, J VISION, V10, DOI 10.1167/10.1.6; Fenko A, 2010, MATER DESIGN, V31, P1325, DOI 10.1016/j.matdes.2009.09.008; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Hardin CL, 2000, J CONSCIOUSNESS STUD, V7, P113; KEARNEY GE, 1966, AUST J PSYCHOL, V18, P271, DOI 10.1080/00049536608255549; Kim SH, 1998, BIOL RHYTHM RES, V29, P151, DOI 10.1076/brhm.29.2.151.1449; Kumakura E, 2013, OPAM 21 ANN M TOR CA; Liu B, 2012, NEUROSCIENCE, V223, P21, DOI 10.1016/j.neuroscience.2012.06.009; Marks L. E., 2004, HDB MULTISENSORY PRO, P85; Marks LE, 2000, VARIETIES OF ANOMALOUS EXPERIENCE: EXAMINING THE SCIENTIFIC EVIDENCE, P121, DOI 10.1037/10371-004; Michael GA, 2008, NEUROSCI LETT, V436, P141, DOI 10.1016/j.neulet.2008.03.007; Michael GA, 2010, BEHAV BRAIN RES, V207, P418, DOI 10.1016/j.bbr.2009.10.027; MORGAN GA, 1975, AM J PSYCHOL, V88, P125, DOI 10.2307/1421671; Neely J. H., 1991, BASIC PROCESSES READ, P264, DOI DOI 10.1016/J.BRAINRES.2007.05.058; Parise CV, 2012, EXP BRAIN RES, V220, P319, DOI 10.1007/s00221-012-3140-6; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Piqueras-Fiszman B, 2012, FOOD QUAL PREFER, V25, P148, DOI 10.1016/j.foodqual.2012.02.010; Rossell SL, 2004, EMOTION, V4, P354, DOI 10.1037/1528-3542.4.4.354; Spence C, 2011, ATTEN PERCEPT PSYCHO, V73, P971, DOI 10.3758/s13414-010-0073-7; Stone NJ, 2001, J ENVIRON PSYCHOL, V21, P179, DOI 10.1006/jevp.2000.0193; Taft C, 1992, CROSS NATL COMP COLO; Tinker MA, 1938, AM J PSYCHOL, V51, P532, DOI 10.2307/1416154; Tomaselli KG., 2001, CULTURAL STUDIES CRI, V1, P283; Walker P, 2012, PERCEPTION, V41, P620, DOI 10.1068/p7195; Ward J, 2006, CORTEX, V42, P264, DOI 10.1016/S0010-9452(08)70352-6; Williams LE, 2008, SCIENCE, V322, P606, DOI 10.1126/science.1162548; WRIGHT B, 1962, AM J PSYCHOL, V75, P232, DOI 10.2307/1419606	34	53	53	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91854	10.1371/journal.pone.0091854	http://dx.doi.org/10.1371/journal.pone.0091854			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9GM	24618675	Green Published, gold, Green Submitted			2022-12-25	WOS:000332842400136
J	Xie, P; Guo, F; Ma, YY; Zhu, HL; Wang, FD; Xue, BZ; Shi, H; Yang, J; Yu, LQ				Xie, Ping; Guo, Feng; Ma, Yinyan; Zhu, Hongling; Wang, Freddy; Xue, Bingzhong; Shi, Hang; Yang, Jian; Yu, Liqing			Intestinal Cgi-58 Deficiency Reduces Postprandial Lipid Absorption	PLOS ONE			English	Article							CHANARIN-DORFMAN-SYNDROME; PICK C1-LIKE 1; STORAGE DISEASE; FAT-ABSORPTION; HEPATIC STEATOSIS; TRIGLYCERIDE; MICE; CHOLESTEROL; DROPLETS; LIVER	Comparative Gene Identification-58 (CGI-58), a lipid droplet (LD)-associated protein, promotes intracellular triglyceride (TG) hydrolysis in vitro. Mutations in human CGI-58 cause TG accumulation in numerous tissues including intestine. Enterocytes are thought not to store TG-rich LDs, but a fatty meal does induce temporary cytosolic accumulation of LDs. Accumulated LDs are eventually cleared out, implying existence of TG hydrolytic machinery in enterocytes. However, identities of proteins responsible for LD-TG hydrolysis remain unknown. Here we report that intestine-specific inactivation of CGI-58 in mice significantly reduces postprandial plasma TG concentrations and intestinal TG hydrolase activity, which is associated with a 4-fold increase in intestinal TG content and large cytosolic LD accumulation in absorptive enterocytes during the fasting state. Intestine-specific CGI-58 knockout mice also display mild yet significant decreases in intestinal fatty acid absorption and oxidation. Surprisingly, inactivation of CGI-58 in intestine significantly raises plasma and intestinal cholesterol, and reduces hepatic cholesterol, without altering intestinal cholesterol absorption and fecal neutral sterol excretion. In conclusion, intestinal CGI-58 is required for efficient postprandial lipoprotein-TG secretion and for maintaining hepatic and plasma lipid homeostasis. Our animal model will serve as a valuable tool to further define how intestinal fat metabolism influences the pathogenesis of metabolic disorders, such as obesity and type 2 diabetes.	[Xie, Ping; Guo, Feng; Ma, Yinyan; Wang, Freddy; Yu, Liqing] Wake Forest Univ Hlth Sci, Dept Biochem, Winston Salem, NC 27109 USA; [Xie, Ping] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Xie, Ping] Peking Union Med Coll, Beijing 100021, Peoples R China; [Ma, Yinyan; Zhu, Hongling; Yu, Liqing] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Xue, Bingzhong; Shi, Hang] Georgia State Univ, Dept Biol, Atlanta, GA USA; [Yang, Jian] Univ S Alabama, Coll Med, Dept Physiol, Mobile, GA USA	Wake Forest University; Wake Forest University School of Medicine; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University System of Maryland; University of Maryland College Park; University System of Georgia; Georgia State University	Yu, LQ (corresponding author), Wake Forest Univ Hlth Sci, Dept Biochem, Winston Salem, NC 27109 USA.	Lyu123@Umd.Edu		Zhu, Hongling/0000-0003-0612-009X	National Institute of Diabetes and Digestive and Kidney Diseases [R01DK085176, R01DK084172]; National Heart, Lung and Blood Institute [R01HL107500]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085176, R01DK084172] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by Award Numbers R01DK085176 (LY) and R01DK084172 (HS) from the National Institute of Diabetes and Digestive and Kidney Diseases, and R01HL107500 (BX) from the National Heart, Lung and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown JM, 2007, J LIPID RES, V48, P2295, DOI 10.1194/jlr.M700279-JLR200; Brown JM, 2010, J LIPID RES, V51, P3306, DOI 10.1194/jlr.M010256; Bruno C, 2008, BIOCHEM BIOPH RES CO, V369, P1125, DOI 10.1016/j.bbrc.2008.03.010; Cartwright IJ, 2000, J LIPID RES, V41, P1728; CHANARIN I, 1975, BRIT MED J, V1, P553, DOI 10.1136/bmj.1.5957.553; DORFMAN ML, 1974, ARCH DERMATOL, V110, P261, DOI 10.1001/archderm.110.2.261; FILER LJ, 1969, J NUTR, V99, P293, DOI 10.1093/jn/99.3.293; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; Friedman EJ, 2011, J BIOL CHEM, V286, P30107, DOI 10.1074/jbc.M111.227256; Guo F, 2013, J LIPID RES, V54, P2109, DOI 10.1194/jlr.M035519; Igal RA, 1997, J PEDIATR GASTR NUTR, V25, P541, DOI 10.1097/00005176-199711000-00011; Jandacek RJ, 2004, GASTROENTEROLOGY, V127, P139, DOI 10.1053/j.gastro.2004.04.007; Jia L, 2010, J LIPID RES, V51, P3135, DOI 10.1194/jlr.M006353; Jia L, 2010, J LIPID RES, V51, P3024, DOI 10.1194/jlr.M008599; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lefevre C, 2001, AM J HUM GENET, V69, P1002, DOI 10.1086/324121; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Lu X, 2010, CELL CYCLE, V9, P2719, DOI 10.4161/cc.9.14.12181; MIRANDA A, 1979, MUSCLE NERVE, V2, P1, DOI 10.1002/mus.880020102; Petit V, 2007, J LIPID RES, V48, P278, DOI 10.1194/jlr.M600283-JLR200; Radner FPW, 2010, J BIOL CHEM, V285, P7300, DOI 10.1074/jbc.M109.081877; Robertson MD, 2003, GUT, V52, P834, DOI 10.1136/gut.52.6.834; Schweiger M, 2009, AM J PHYSIOL-ENDOC M, V297, pE289, DOI 10.1152/ajpendo.00099.2009; Simon GM, 2006, J BIOL CHEM, V281, P26465, DOI 10.1074/jbc.M604660200; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Tang WQ, 2008, ARTERIOSCL THROM VAS, V28, P448, DOI 10.1161/ATVBAHA.107.160465; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Turley SD, 2003, CURR OPIN LIPIDOL, V14, P233, DOI 10.1097/00041433-200306000-00002; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Zhu JB, 2009, J LIPID RES, V50, P1080, DOI 10.1194/jlr.M800555-JLR200	31	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91652	10.1371/journal.pone.0091652	http://dx.doi.org/10.1371/journal.pone.0091652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618586	Green Submitted, Green Published, gold			2022-12-25	WOS:000332842400112
J	Cai, XL; Han, XY; Zhang, SM; Luo, YY; Chen, YL; Ji, LN				Cai, Xiaoling; Han, Xueyao; Zhang, Simin; Luo, Yingying; Chen, Yingli; Ji, Linong			Age at Diagnosis and C-Peptide Level Are Associated with Diabetic Retinopathy in Chinese	PLOS ONE			English	Article							BETA-CELL FUNCTION; SUBCLINICAL HYPOTHYROIDISM; RISK-FACTORS; EARLY-ONSET; FOLLOW-UP; PREVALENCE; COMPLICATIONS; COHORT; EPIDEMIOLOGY; POPULATION	Objective: To find the associations between diabetic retinopathy and age at diagnosis, C-peptide level and thyroid-stimulating hormone (TSH) level in Chinese type 2 diabetes mellitus. Methods: 3100 hospitalized type 2 diabetic patients in Peking University People's Hospital were included in this retrospective study. Their medical history and the laboratory data were collected. All the patients received examination of diabetic retinopathy (DR) by professional ophthalmologist. Results: Comparisons among patients with NDR, NPDR and PDR showed that with the progression of diabetic retinopathy, patients turned to have older age but younger age at diagnosis of diabetes, and have higher SBP, longer duration of diabetes, higher mean HbA1c but lower fasting and 2 hours postprandial C-peptide level. Moreover, with the progression of diabetic retinopathy, patients turned to have higher prevalence of primary hypertension, higher prevalence of peripheral vascular sclerosis, higher proportion with insulin treatment. TSH level was comparable among the three groups of patients. Association analysis showed that after adjusting for age, sex, duration of diabetes, body mass index, HbA1c, blood pressure and albuminurea creatinine ratio and insulin treatment, age at diagnosis (OR 0.888, 95% CI 0.870-0.907, p = 0.00) and postprandial C-peptide (OR 0.920, 95% CI 0.859-0.937, p = 0.00) are the independent associated factors of DR in Chinese type 2 diabetes. Conclusions: According to the results, postprandial C-peptide level and age at diabetes may be two independent associated factors with DR in Chinese type 2 diabetes. The lower level of postprandial C-peptide, the younger age at diagnosis, may indicate the higher prevalence of DR.	[Cai, Xiaoling; Han, Xueyao; Zhang, Simin; Luo, Yingying; Chen, Yingli; Ji, Linong] Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, Beijing 100871, Peoples R China	Peking University	Ji, LN (corresponding author), Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, Beijing 100871, Peoples R China.	prof_jilinong@aliyun.com	Linong, Ji/AAB-6543-2020	Cai, Xiaoling/0000-0002-7881-0543				Bo S, 2012, EUR J ENDOCRINOL, V167, P173, DOI 10.1530/EJE-12-0085; Cai XL, 2006, CHINESE MED J-PEKING, V119, P822, DOI 10.1097/00029330-200605020-00005; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chen HS, 2007, DIABETIC MED, V24, P1336, DOI 10.1111/j.1464-5491.2007.02270.x; Chuang LM, 2006, DIABETES RES CLIN PR, V71, P146, DOI 10.1016/j.diabres.2005.05.007; Fukui T, 2013, ENDOCR J, V60, P715, DOI 10.1507/endocrj.EJ12-0357; Gottsater A, 1999, DIABETIC MED, V16, P49, DOI 10.1046/j.1464-5491.1999.00001.x; Kim BY, 2011, ENDOCR J, V58, P1065, DOI 10.1507/endocrj.EJ11-0199; Kim BY, 2012, ACTA DIABETOL, V49, P9, DOI 10.1007/s00592-010-0249-6; Kim JH, 2011, J KOREAN MED SCI, V26, P1068, DOI 10.3346/jkms.2011.26.8.1068; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; KLEIN R, 1995, DIABETES, V44, P796, DOI 10.2337/diabetes.44.7.796; Kostev K, 2013, DIABETOLOGIA, V56, P109, DOI 10.1007/s00125-012-2742-7; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045264; Mosier M A, 1984, Diabetes Res, V1, P151; Nakanishi K, 2008, J CLIN ENDOCR METAB, V93, P4759, DOI 10.1210/jc.2008-1209; Ramis JN, 2012, DIABETES RES CLIN PR, V97, pE45, DOI 10.1016/j.diabres.2012.05.015; Porta M, 2002, DIABETOLOGIA, V45, P1617, DOI 10.1007/s00125-002-0990-7; Rema M, 2005, INVEST OPHTH VIS SCI, V46, P2328, DOI 10.1167/iovs.05-0019; Sivaprasad S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032182; Song SH, 2011, DIABETES RES CLIN PR, V94, P207, DOI 10.1016/j.diabres.2011.07.030; Steffes MW, 2003, DIABETES CARE, V26, P832, DOI 10.2337/diacare.26.3.832; Tapp RJ, 2003, DIABETES CARE, V26, P1731, DOI 10.2337/diacare.26.6.1731; Thomas RL, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e874; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Yang JK, 2010, DIABETES CARE, V33, P1018, DOI 10.2337/dc09-1784; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Yokoyama H, 1997, DIABETES CARE, V20, P844, DOI 10.2337/diacare.20.5.844; Yoon HJ, 2012, DIABETES METAB J, V36, P379, DOI 10.4093/dmj.2012.36.5.379; Zheng WW, 2011, DIABETES RES CLIN PR, V92, P244, DOI 10.1016/j.diabres.2011.02.007	32	15	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91174	10.1371/journal.pone.0091174	http://dx.doi.org/10.1371/journal.pone.0091174			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614131	Green Published, gold, Green Submitted			2022-12-25	WOS:000332839300088
J	Deng, B; Xu, H; Zhang, J; Wang, J; Han, LC; Li, LY; Wu, GL; Hou, YN; Guo, GZ; Wang, Q; Sang, HF; Xu, LX				Deng, Bin; Xu, Hao; Zhang, Jin; Wang, Jin; Han, Li-Chun; Li, Li-Ya; Wu, Guang-Li; Hou, Yan-Ning; Guo, Guo-Zhen; Wang, Qiang; Sang, Han-Fei; Xu, Li-Xian			Neuroprotective Effects of Sevoflurane against Electromagnetic Pulse-Induced Brain Injury through Inhibition of Neuronal Oxidative Stress and Apoptosis	PLOS ONE			English	Article							MOBILE PHONE RADIATION; FOCAL CEREBRAL-ISCHEMIA; FLUORO-JADE-C; FREE-RADICALS; MITOCHONDRIAL-FUNCTION; REPERFUSION INJURY; EXPOSURE; RATS; EXPRESSION; PROTEIN	Electromagnetic pulse (EMP) causes central nervous system damage and neurobehavioral disorders, and sevoflurane protects the brain from ischemic injury. We investigated the effects of sevoflurane on EMP-induced brain injury. Rats were exposed to EMP and immediately treated with sevoflurane. The protective effects of sevoflurane were assessed by Nissl staining, Fluoro-Jade C staining and electron microscopy. The neurobehavioral effects were assessed using the open-field test and the Morris water maze. Finally, primary cerebral cortical neurons were exposed to EMP and incubated with different concentration of sevoflurane. The cellular viability, lactate dehydrogenase (LDH) release, superoxide dismutase (SOD) activity and malondialdehyde (MDA) level were assayed. TUNEL staining was performed, and the expression of apoptotic markers was determined. The cerebral cortexes of EMP-exposed rats presented neuronal abnormalities. Sevoflurane alleviated these effects, as well as the learning and memory deficits caused by EMP exposure. In vitro, cell viability was reduced and LDH release was increased after EMP exposure; treatment with sevoflurane ameliorated these effects. Additionally, sevoflurane increased SOD activity, decreased MDA levels and alleviated neuronal apoptosis by regulating the expression of cleaved caspase-3, Bax and Bcl-2. These findings demonstrate that Sevoflurane conferred neuroprotective effects against EMP radiation-induced brain damage by inhibiting neuronal oxidative stress and apoptosis.	[Deng, Bin; Zhang, Jin; Xu, Li-Xian] Fourth Mil Med Univ, State Key Lab Mil Stomatol, Dept Anesthesiol, Sch Stomatol, Xian 710032, Peoples R China; [Xu, Hao] Fourth Mil Med Univ, Dept Anat Histol & Embryol, KK Leung Brain Res Ctr, Xian 710032, Peoples R China; [Hou, Yan-Ning; Sang, Han-Fei] Peoples Liberat Army, Bethune Int Peace Hosp, Dept Clin Pharmacol, Shijiazhuang, Peoples R China; [Wang, Jin; Guo, Guo-Zhen] Fourth Mil Med Univ, Dept Radiat Med, Fac Prevent Med, Xian 710032, Peoples R China; [Han, Li-Chun] Shannxi Tumor Hosp, Dept Anesthesiol, Xian, Peoples R China; [Li, Li-Ya; Wang, Qiang] Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian 710032, Peoples R China; [Wu, Guang-Li] Peoples Liberat Army, Dept Nephrol, Bethune Int Peace Hosp, Shijiazhuang, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Wang, Q (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian 710032, Peoples R China.	wangqiang@fmmu.edu.cn; hfsang@fmmu.edu.cn; xlx116@fmmu.edu.cn			National Natural Science Foundation of China [30371763, 81071060, 81070997, 31100785, 81171237]; Natural Science Foundation of Shaanxi Province [2006C254, 2011KJXX67, 2013JM4040, 2012KTCG01-02, 2013KTZB03-03]; Fourth Military Medical University Foundation [2013-D03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province); Fourth Military Medical University Foundation	This work was supported by the National Natural Science Foundation of China (Grants No. 30371763, No. 81071060, No. 81070997, No. 31100785 and No. 81171237), the Natural Science Foundation of Shaanxi Province (Grants No. 2006C254, No. 2011KJXX67 and No. 2013JM4040, 2012KTCG01-02,2013KTZB03-03), and the Fourth Military Medical University Foundation (Grant No. 2013-D03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedirli N, 2012, J NEUROSURG ANESTH, V24, P336, DOI 10.1097/ANA.0b013e318266791e; Bian GL, 2007, BRAIN RES, V1150, P55, DOI 10.1016/j.brainres.2007.02.078; Blancas S, 2011, NEUROCHEM INT, V58, P934, DOI 10.1016/j.neuint.2011.03.017; Blettner M, 2000, ACTA ONCOL, V39, P927; Borah A, 2013, CNS NEUROSCI THER, V19, P847, DOI 10.1111/cns.12175; Bundgaard H, 1998, ACTA ANAESTH SCAND, V42, P621, DOI 10.1111/j.1399-6576.1998.tb05292.x; Challis LJ, 2005, BIOELECTROMAGNETICS, pS98, DOI 10.1002/bem.20119; Chavdoula ED, 2010, MUTAT RES-GEN TOX EN, V700, P51, DOI 10.1016/j.mrgentox.2010.05.008; Chen YB, 2011, INT J RADIAT BIOL, V87, P1147, DOI 10.3109/09553002.2011.584937; Cheng G, 2009, NEUROSCI LETT, V451, P105, DOI 10.1016/j.neulet.2008.12.045; Codaccioni JL, 2009, ANESTHESIOLOGY, V110, P1271, DOI 10.1097/ALN.0b013e3181a1fe68; Deng B, 2013, BIOMATERIALS, V34, P8786, DOI 10.1016/j.biomaterials.2013.07.076; Ding GR, 2010, TOXICOL LETT, V196, P154, DOI 10.1016/j.toxlet.2010.04.011; Ding GR, 2009, BIOMED ENVIRON SCI, V22, P265, DOI 10.1016/S0895-3988(09)60055-6; Dragicevic N, 2011, NEUROSCIENCE, V185, P135, DOI 10.1016/j.neuroscience.2011.04.012; Funk RHW, 2009, PROG HISTOCHEM CYTO, V43, P177, DOI 10.1016/j.proghi.2008.07.001; Grafstrom G, 2008, BRAIN RES BULL, V77, P257, DOI 10.1016/j.brainresbull.2008.08.004; Grigoriev Yu G., 2011, Radiatsionnaya Biologiya Radioekologiya, V51, P721; Head BP, 2007, CURR OPIN ANESTHESIO, V20, P395, DOI 10.1097/ACO.0b013e3282efa69d; Hug K, 2006, SOZ PRAVENTIV MED, V51, P210, DOI 10.1007/s00038-006-5096-4; Irmak MK, 2000, CELL BIOCHEM FUNCT, V20, P279; Istaphanous GK, 2011, ANESTHESIOLOGY, V114, P578, DOI 10.1097/ALN.0b013e3182084a70; Jeon YT, 2013, J NEUROSURG ANESTH, V25, P43, DOI 10.1097/ANA.0b013e31826ca3bc; Jiang DP, 2013, ARCH MED RES, V44, P178, DOI 10.1016/j.arcmed.2013.03.005; Liu HG, 2012, MOL BIOL REP, V39, P10505, DOI 10.1007/s11033-012-1935-y; Lorsomradee S, 2006, J CARDIOTHOR VASC AN, V20, P684, DOI 10.1053/j.jvca.2006.02.035; Muehsam D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061752; Ozgur E, 2010, INT J RADIAT BIOL, V86, P935, DOI 10.3109/09553002.2010.496029; Pape M, 2006, ANESTH ANALG, V103, P173, DOI 10.1213/01.ane.0000222634.51192.a4; Qiu LB, 2010, TOXICOLOGY, V273, P29, DOI 10.1016/j.tox.2010.04.013; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Somosy Z, 2000, MICRON, V31, P165, DOI 10.1016/S0968-4328(99)00083-9; Trosic I, 2011, COLLEGIUM ANTROPOL, V35, P1259; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wang JK, 2010, BRAIN RES, V1357, P142, DOI 10.1016/j.brainres.2010.08.009; Wang Q, 2011, J SURG RES, V169, P292, DOI 10.1016/j.jss.2009.11.707; Wang Q, 2009, CELL MOL NEUROBIOL, V29, P97, DOI 10.1007/s10571-008-9301-2; Wang R, 2011, BRAIN RES, V1372, P127, DOI 10.1016/j.brainres.2010.11.059; Wilson JX, 2002, J NEUROSURG ANESTH, V14, P66, DOI 10.1097/00008506-200201000-00014; Yang Y, 2012, NEUROSCI LETT, V516, P15, DOI 10.1016/j.neulet.2012.03.022; Ye RD, 2012, CRIT CARE MED, V40, P2685, DOI 10.1097/CCM.0b013e318258fb90; Zeng Y, 2012, BRAIN RES, V1452, P140, DOI 10.1016/j.brainres.2012.02.063; Zhang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063472; Zhang Y, 2012, MOLECULES, V17, P341, DOI 10.3390/molecules17010341; Zhou JX, 2013, BIOMED ENVIRON SCI, V26, P128, DOI 10.3967/0895-3988.2013.02.007	45	18	27	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91019	10.1371/journal.pone.0091019	http://dx.doi.org/10.1371/journal.pone.0091019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614080	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300066
J	Dupuy, AK; David, MS; Li, L; Heider, TN; Peterson, JD; Montano, EA; Dongari-Bagtzoglou, A; Diaz, PI; Strausbaugh, LD				Dupuy, Amanda K.; David, Marika S.; Li, Lu; Heider, Thomas N.; Peterson, Jason D.; Montano, Elizabeth A.; Dongari-Bagtzoglou, Anna; Diaz, Patricia I.; Strausbaugh, Linda D.			Redefining the Human Oral Mycobiome with Improved Practices in Amplicon-based Taxonomy: Discovery of Malassezia as a Prominent Commensal	PLOS ONE			English	Article							FUNGAL; DIVERSITY; COLONIZATION; BIODIVERSITY; NOMENCLATURE; MAGNITUDE; IMPACTS; GALAXY; PLANT	Fungi are a large, complex group, increasingly recognized as emerging threats. Their roles as modifiers of health mandate accurate portrayals of fungal communities in humans. As an entry point into the airways and gastrointestinal tract, fungi in the mouth are relevant to several biocompartments. We have revised current practices in sequence-based taxonomy assignments and employed the improvements to address the question of the fungal genera present in the healthy human mouth. The human oral mycobiome was surveyed using massively parallel, high throughput sequencing of internal transcribed spacer 1 (ITS1) amplicons from saliva following robust extraction methods. Taxonomy was assigned by comparison to a curated reference dataset, followed by filtering with an empirically determined BLAST E-value match statistic (10(-42)). Nomenclature corrections further refined results by conjoining redundant names for a single fungal genus. Following these curation steps, about two-thirds of the initially identified genera were eliminated. In comparison with the one similar metagenomic study and several earlier culture-based ones, our findings change the current conception of the oral mycobiome, especially with the discovery of the high prevalence and abundance of the genus Malassezia. Previously identified as an important pathogen of the skin, and recently reported as the predominant fungal genus at the nostril and backs of the head and ear, this is the first account of Malassezia in the human mouth. Findings from this study were in good agreement with others on the existence of many consensus members of the core mycobiome, and on unique patterns for individual subjects. This research offered a cautionary note about unconditional acceptance of lengthy lists of community members produced by automated assignments, provided a roadmap for enhancing the likely biological relevance of sequence-based fungal surveys, and built the foundation for understanding the role of fungi in health and disease of the oral cavity.	[Dupuy, Amanda K.; David, Marika S.; Li, Lu; Heider, Thomas N.; Peterson, Jason D.; Montano, Elizabeth A.; Strausbaugh, Linda D.] Univ Connecticut, Ctr Appl Genet & Technol, Storrs, CT 06269 USA; [Dupuy, Amanda K.; David, Marika S.; Li, Lu; Heider, Thomas N.; Peterson, Jason D.; Montano, Elizabeth A.; Strausbaugh, Linda D.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA; [Dongari-Bagtzoglou, Anna; Diaz, Patricia I.] Univ Connecticut, Ctr Hlth, Div Periodontol, Dept Oral Hlth & Diagnost Sci,Sch Dent Med, Farmington, CT USA	University of Connecticut; University of Connecticut; University of Connecticut	Strausbaugh, LD (corresponding author), Univ Connecticut, Ctr Appl Genet & Technol, Storrs, CT 06269 USA.	Linda.Strausbaugh@uconn.edu			NIH [RO1 DE021578]; NSF MRI [0821466]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021578] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF MRI(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	NIH RO1 DE021578, The Oral Microbiome during Cancer Chemotherapy and Its Role in Oral Mucositis; and NSF MRI 0821466, MRI: Acquisition of a Genome Sequencer for Research and Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107; Ashbee HR, 2002, CLIN MICROBIOL REV, V15, P21, DOI 10.1128/CMR.15.1.21-57.2002; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Braun U, 2012, IMA FUNGUS, V3, P81, DOI 10.5598/imafungus.2012.03.01.08; Brown GD, 2012, SCIENCE, V336, P647, DOI 10.1126/science.1222236; Buzina W, 2005, J CLIN MICROBIOL, V43, P2009, DOI 10.1128/JCM.43.4.2009-2011.2005; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang HJ, 1998, NEW ENGL J MED, V338, P706, DOI 10.1056/NEJM199803123381102; Delhaes L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036313; Diaz PI, 2012, MOL ORAL MICROBIOL, V27, P182, DOI 10.1111/j.2041-1014.2012.00642.x; Diaz PI, 2013, CLIN VACCINE IMMUNOL, V20, P920, DOI 10.1128/CVI.00734-12; Diaz PI, 2012, FRONT ORAL BIOL, V15, P17, DOI 10.1159/000329669; Everett JE, 2003, TRANSPL P, V35, P1387, DOI 10.1016/S0041-1345(03)00440-8; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hamad I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040888; Hawksworth DL, 2012, MYCOSPHERE, V3, P143, DOI [10.5943/mycosphere/3/2/4, 10.5598/imafungus.2012.03.01.03]; Hawksworth DL, 2011, IMA FUNGUS, V2, P155, DOI 10.5598/imafungus.2011.02.02.06; Hawksworth DL, 2011, IMA FUNGUS, V2, P105, DOI 10.5598/imafungus.2011.02.01.14; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; HAWKSWORTH DL, 1991, MYCOL RES, V95, P641, DOI 10.1016/S0953-7562(09)80810-1; HCv Woerden, 2013, BMC INFECT DIS, V13, P1471; Hubka V, 2013, MYCOLOGIA; IOM (Institute of Medicine), 2011, FUNG DIS EM THREAT H; Kalkanci A, 2006, MED MYCOL, V44, P531, DOI 10.1080/13693780500340510; LaTuga MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027858; Lee CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044224; Nagano Y, 2010, MED MYCOL, V48, P166, DOI 10.3109/13693780903127506; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Nonnenmann MW, 2012, J ENVIRON MONITOR, V14, P2038, DOI 10.1039/c2em30229b; Park HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032847, 10.1371/journal.pone.0039921]; Saunders CW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002701; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Shelton BG, 2002, APPL ENVIRON MICROB, V68, P1743, DOI 10.1128/AEM.68.4.1743-1753.2002; Suh SO, 2006, MYCOLOGIA, V98, P1006, DOI 10.3852/mycologia.98.6.1006; Taylor D, 2011, BIOINFORMATICS PIPEL; Taylor JW, 2011, IMA FUNGUS, V2, P113, DOI 10.5598/imafungus.2011.02.02.01; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; White T., 1990, PCR PROTOCOLS GUIDE, P315; Yoshikawa T, 2008, INT J ORAL MED SCI, V7, P72	45	150	154	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90899	10.1371/journal.pone.0090899	http://dx.doi.org/10.1371/journal.pone.0090899			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614173	gold, Green Submitted, Green Published			2022-12-25	WOS:000332839300051
J	McCracken, A; Locke, J				McCracken, Allen; Locke, John			Mutations in CG8878, a Novel Putative Protein Kinase, Enhance P Element Dependent Silencing (PDS) and Position Effect Variegation (PEV) in Drosophila melanogaster	PLOS ONE			English	Article							ARCHITECTURE; ASSOCIATION; CHROMOSOME; HOMOLOG; NHK-1; GENE; PIWI	Genes in multicellular organisms are expressed as part of a developmental program that is largely dependent on self-perpetuating higher-order chromatin states. The mechanism of establishing and maintaining these epigenetic events is well studied in Drosophila. The first known example of an epigenetic effect was that of (PEV) in Drosophila, which has been shown to be due to gene silencing via heterochromatin formation. We are investigating a process similar to Position Effect Variegation (PEV) using a mini-w transgene, called Pci, inserted in the upstream regulatory region of ci. The mini-white(+) transgene in Pci is expressed throughout the adult eye; however, when other P or KP elements are present, a variegated eye phenotype results indicating random w(+) silencing during development. This P element dependent silencing (PDS) can be modified by the haplo-suppressors/triplo-enhancers, Su(var)205 and Su(var)3-7, indicating that these heterochromatic modifiers also act dose dependently in PDS. Here we use a spontaneous derivative mutation of Pci called Pci(E1) (E1) that variegates like PDS in the absence of P elements, presumably due to an adjacent gypsy element insertion, to screen for second-site modifier mutations that enhance variable silencing of white(+) in E1. We isolated 7 mutations in CG8878, an essential gene, that enhance the E1 variegated phenotype. CG8878, a previously uncharacterized gene, potentially encodes a serine/threonine kinase whose closest Drosophila paralogue, ballchen (nhk-1), phosphorylates histones. These mutant alleles enhance both PDS at E1 and Position Effect Variegation (PEV) at w(m4), indicating a previously unknown common silencing mechanism between the two.	[McCracken, Allen; Locke, John] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Locke, J (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	john.locke@ualberta.ca			Natural Sciences and Engineering Research Council (NESRC) of Canada	Natural Sciences and Engineering Research Council (NESRC) of Canada	This work was supported by funding from a Discovery Grant from the Natural Sciences and Engineering Research Council (NESRC) of Canada (http://www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara H, 2004, GENE DEV, V18, P877, DOI 10.1101/gad.1184604; Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; Belyaeva ES, 1997, CHROMOSOMA, V106, P124, DOI 10.1007/s004120050232; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Brodie R, 2004, BIOINFORMATICS, V20, P279, DOI 10.1093/bioinformatics/btg406; Bushey D, 2004, GENETICS, V168, P1395, DOI 10.1534/genetics.104.026914; Chetverina D, 2008, NUCLEIC ACIDS RES, V36, P929, DOI 10.1093/nar/gkm992; Csink AK, 1996, NATURE, V381, P529, DOI 10.1038/381529a0; Dernburg AF, 1996, CELL, V85, P745, DOI 10.1016/S0092-8674(00)81240-4; EATON S, 1990, GENE DEV, V4, P1068, DOI 10.1101/gad.4.6.1068; Ephrussi B, 1944, GENETICS, V29, P148; Gelbart WM, 2011, FLYBASE ANAL; Hahn MW, 2007, PLOS GENET, V3, P2135, DOI 10.1371/journal.pgen.0030197; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Ivanovska I, 2005, GENE DEV, V19, P2571, DOI 10.1101/gad.1348905; Lancaster OM, 2007, J CELL BIOL, V179, P817, DOI 10.1083/jcb.200706067; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Qi HY, 2009, DEV DYNAM, V238, P3248, DOI 10.1002/dvdy.22150; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Sameny A, 2011, GENOME, V54, P752, DOI [10.1139/G11-023, 10.1139/g11-023]; Shin J, 2011, J BIOL CHEM, V286, P22131, DOI 10.1074/jbc.M110.200162; Sun FL, 2000, P NATL ACAD SCI USA, V97, P5340, DOI 10.1073/pnas.090530797; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Wang YL, 2000, TRENDS BIOCHEM SCI, V25, P300, DOI 10.1016/S0968-0004(00)01561-9; Zhang WG, 2006, DEVELOPMENT, V133, P229, DOI 10.1242/dev.02199	26	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e71695	10.1371/journal.pone.0071695	http://dx.doi.org/10.1371/journal.pone.0071695			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614804	Green Published, gold, Green Submitted			2022-12-25	WOS:000332839300001
J	Tala; Sun, XO; Chen, J; Zhang, LL; Liu, NN; Zhou, J; Li, DW; Liu, M				Tala; Sun, Xiaoou; Chen, Jie; Zhang, Linlin; Liu, Ningning; Zhou, Jun; Li, Dengwen; Liu, Min			Microtubule Stabilization by Mdp3 Is Partially Attributed to Its Modulation of HDAC6 in Addition to Its Association with Tubulin and Microtubules	PLOS ONE			English	Article							DEACETYLASE HDAC6; ACETYLATION; CYTOSKELETON; PROTEINS	Microtubule-mediated cellular events such as intracellular transport and the maintenance of cell polarity are highly dependent upon microtubule stability, which is controlled by a repertoire of microtubule-associated proteins (MAPs) in the cell. MAP7 domain-containing protein 3 (Mdp3) has recently been identified as a critical regulator of microtubule stability. However, it remains elusive how Mdp3 carries out this function. In this study, by examination of tubulin partitioning between the polymer and soluble dimer forms, we found that Mdp3 could protect microtubules from cold-or nocodazole-induced depolymerization. Immunoblotting and immunofluorescence microscopy showed that knockdown of Mdp3 expression significantly reduced the level of tubulin acetylation. In vitro tubulin polymerization assays revealed that the amino-terminal region of Mdp3 was necessary for its ability to stabilize microtubules. Immunoprecipitation and pulldown experiments showed that the amino-terminal region mediated the interaction of Mdp3 with histone deacetylase 6 (HDAC6), in addition to its association with tubulin and microtubules. Immunofluorescence microscopy further demonstrated that endogenous Mdp3 and HDAC6 colocalized in the cytoplasm. Moreover, depletion of Mdp3 dramatically increased the activity of HDAC6 toward tubulin deacetylation. These findings suggest that Mdp3 controls microtubule stability through its binding to tubulin and microtubules as well as its regulation of HDAC6 activity.	[Tala; Sun, Xiaoou; Chen, Jie; Zhang, Linlin; Liu, Ningning; Zhou, Jun; Li, Dengwen] Nankai Univ, Dept Genet & Cell Biol, Coll Life Sci, Tianjin 300071, Peoples R China; [Liu, Min] Tianjin Med Univ, Dept Biochem, Sch Basic Med Sci, Tianjin, Peoples R China	Nankai University; Tianjin Medical University	Liu, M (corresponding author), Tianjin Med Univ, Dept Biochem, Sch Basic Med Sci, Tianjin, Peoples R China.	minliu@tijmu.edu.cn	Zhou, Jun/D-4654-2017; Zhang, Linlin/J-6639-2019	Zhou, Jun/0000-0001-7858-8260; Zhang, Linlin/0000-0003-3240-1215	National Natural Science Foundation of China [31171334, 31170820, 31271437, 31371382]; Tianjin Natural Science Foundation [13JCZDJC30300]; 111 project of the Ministry of Education of China [B08011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Natural Science Foundation(Natural Science Foundation of Tianjin); 111 project of the Ministry of Education of China(Ministry of Education, China - 111 Project)	This work was supported by grants from the National Natural Science Foundation of China (31171334, 31170820, 31271437, and 31371382), the Tianjin Natural Science Foundation (13JCZDJC30300), and the 111 project of the Ministry of Education of China (B08011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Aldana-Masangkay GI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/875824; Amos LA, 2005, ADV PROTEIN CHEM, V71, P257, DOI 10.1016/S0065-3233(04)71007-4; Boyault C, 2007, ONCOGENE, V26, P5468, DOI 10.1038/sj.onc.1210614; Cassimeris L, 2001, INT REV CYTOL, V210, P163; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Delacourte A, 1997, INT REV CYTOL, V171, P167; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Gundersen GG, 2004, CURR OPIN CELL BIOL, V16, P106, DOI 10.1016/j.ceb.2003.11.010; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Joshi HC, 1998, CURR OPIN CELL BIOL, V10, P35, DOI 10.1016/S0955-0674(98)80084-7; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Lee YS, 2008, CANCER RES, V68, P7561, DOI 10.1158/0008-5472.CAN-08-0188; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Perdiz D, 2011, CELL SIGNAL, V23, P763, DOI 10.1016/j.cellsig.2010.10.014; Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200; SCHOENFELD TA, 1994, INT REV CYTOL, V151, P67, DOI 10.1016/S0074-7696(08)62631-5; Simoes-Pires C, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-7; Sun XO, 2011, CELL CYCLE, V10, P3929, DOI 10.4161/cc.10.22.18106; VALE RD, 1987, ANNU REV CELL BIOL, V3, P347, DOI 10.1146/annurev.cb.03.110187.002023; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115	26	4	5	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90932	10.1371/journal.pone.0090932	http://dx.doi.org/10.1371/journal.pone.0090932			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614595	Green Published, gold, Green Submitted			2022-12-25	WOS:000332839300059
J	Higuchi, T; Fujimura, H; Yuyama, I; Harii, S; Agostini, S; Oomori, T				Higuchi, Tomihiko; Fujimura, Hiroyuki; Yuyama, Ikuko; Harii, Saki; Agostini, Sylvain; Oomori, Tamotsu			Biotic Control of Skeletal Growth by Scleractinian Corals in Aragonite-Calcite Seas	PLOS ONE			English	Article							TEMPERATURE; MINERALOGY; EVOLUTION; DRIVEN	Modern scleractinian coral skeletons are commonly composed of aragonite, the orthorhombic form of CaCO3. Under certain conditions, modern corals produce calcite as a secondary precipitate to fill pore space. However, coral construction of primary skeletons from calcite has yet to be demonstrated. We report a calcitic primary skeleton produced by the modern scleractinian coral Acropora tenuis. When uncalcified juveniles were incubated from the larval stage in seawater with low mMg/Ca levels, the juveniles constructed calcitic crystals in parts of the primary skeleton such as the septa; the deposits were observable under Raman microscopy. Using scanning electron microscopy, we observed different crystal morphologies of aragonite and calcite in a single juvenile skeleton. Quantitative analysis using X-ray diffraction showed that the majority of the skeleton was composed of aragonite even though we had exposed the juveniles to manipulated seawater before their initial crystal nucleation and growth processes. Our results indicate that the modern scleractinian coral Acropora mainly produces aragonite skeletons in both aragonite and calcite seas, but also has the ability to use calcite for part of its skeletal growth when incubated in calcite seas.	[Higuchi, Tomihiko; Yuyama, Ikuko] Shizuoka Univ, Grad Sch Sci & Technol, Suruga Ku, Shizuoka, Japan; [Fujimura, Hiroyuki; Oomori, Tamotsu] Univ Ryukyus, Dept Chem Biol & Marine Sci, Nishihara, Okinawa 90301, Japan; [Harii, Saki] Univ Ryukyus, Trop Biosphere Res Ctr, Sesoko Stn, Motobu, Okinawa, Japan; [Agostini, Sylvain] Univ Tsukuba, Shimoda Marine Res Ctr, Shimoda, Shizuoka, Japan	Shizuoka University; University of the Ryukyus; University of the Ryukyus; University of Tsukuba	Higuchi, T (corresponding author), Shizuoka Univ, Grad Sch Sci & Technol, Suruga Ku, Shizuoka, Japan.	dthiguc@ipc.shizuoka.ac.jp; fujimura@sci.u-ryukyu.ac.jp	Higuchi, Tomihiko/AAW-6006-2020; Higuchi, Tomihiko/D-7118-2019; Harii, Saki/AHC-2263-2022	Higuchi, Tomihiko/0000-0001-7324-5752; Higuchi, Tomihiko/0000-0001-7324-5752; Harii, Saki/0000-0003-0440-7169; Agostini, Sylvain/0000-0001-9040-9296	Sasagawa Scientific Research Grant from The Japan Science Society [24-704 M]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [20121003, 20310014]; Grants-in-Aid for Scientific Research [14J40135] Funding Source: KAKEN	Sasagawa Scientific Research Grant from The Japan Science Society; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Sasagawa Scientific Research Grant from The Japan Science Society (No. 24-704 M), Grant-in-Aid for Scientific Research on Innovative Areas "Coral reef science for symbiosis and coexistence of human and ecosystem under combined stresses" (No. 20121003) and "Response and possible drastic change of coral reef ecosystem in response to global warming and ocean acidification" (No. 20310014) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison N, 2007, GEOCHIM COSMOCHIM AC, V71, P4693, DOI 10.1016/j.gca.2007.07.026; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Berner RA, 2006, GEOCHIM COSMOCHIM AC, V70, P5653, DOI 10.1016/j.gca.2005.11.032; Clode PL, 2011, CORAL REEFS, V30, P1, DOI 10.1007/s00338-010-0673-7; Cohen AL, 2003, REV MINERAL GEOCHEM, V54, P151, DOI 10.2113/0540151; Cowan J. A., 1993, INORGANIC BIOCH INTR; Cuif JP, 1999, COMP BIOCHEM PHYS A, V123, P269, DOI 10.1016/S1095-6433(99)00059-8; Drake JL, 2013, P NATL ACAD SCI USA, V110, P3788, DOI 10.1073/pnas.1301419110; Dubinsky Z, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P1, DOI 10.1007/978-94-007-0114-4; Fine M, 2007, SCIENCE, V315, P1811, DOI 10.1126/science.1137094; Fukuda I, 2003, BIOCHEM BIOPH RES CO, V304, P11, DOI 10.1016/S0006-291X(03)00527-8; Goffredo S, 2012, GEOCHIM COSMOCHIM AC, V85, P187, DOI 10.1016/j.gca.2012.02.014; Goffredo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022338; GOLDSMITH JR, 1961, AM MINERAL, V46, P453; HOUCK JE, 1975, SCIENCE, V189, P997, DOI 10.1126/science.189.4207.997; Iwao K, 2002, CORAL REEFS, V21, P127, DOI 10.1007/s00338-002-0219-8; Kiessling W, 2008, NAT GEOSCI, V1, P527, DOI 10.1038/ngeo251; Medina M, 2006, P NATL ACAD SCI USA, V103, P9096, DOI 10.1073/pnas.0602444103; Nothdurft LD, 2007, GEOCHIM COSMOCHIM AC, V71, P5423, DOI 10.1016/j.gca.2007.09.025; OHDE S, 1978, GEOCHEM J, V12, P115, DOI 10.2343/geochemj.12.115; OOMORI T, 1987, MAR CHEM, V20, P327, DOI 10.1016/0304-4203(87)90066-1; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Rahman MA, 2009, CONNECT TISSUE RES, V50, P285, DOI 10.3109/03008200802714933; Ries JB, 2010, BIOGEOSCIENCES, V7, P2795, DOI 10.5194/bg-7-2795-2010; Ries JB, 2006, GEOLOGY, V34, P525, DOI 10.1130/G22600.1; SANDBERG PA, 1983, NATURE, V305, P19, DOI 10.1038/305019a0; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Stanley GD, 2003, EARTH-SCI REV, V60, P195, DOI 10.1016/S0012-8252(02)00104-6; Stanley GD, 2001, SCIENCE, V291, P1913, DOI 10.1126/science.1056632; Stanley SM, 2006, PALAEOGEOGR PALAEOCL, V232, P214, DOI 10.1016/j.palaeo.2005.12.010; Stanley SM, 1998, PALAEOGEOGR PALAEOCL, V144, P3, DOI 10.1016/S0031-0182(98)00109-6; Stolarski J, 2007, SCIENCE, V318, P92, DOI 10.1126/science.1149237; Suwa R, 2010, FISHERIES SCI, V76, P93, DOI 10.1007/s12562-009-0189-7; Yamamoto S, 2012, BIOGEOSCIENCES, V9, P1441, DOI 10.5194/bg-9-1441-2012; Yuyama I, 2012, MAR ENVIRON RES, V76, P41, DOI 10.1016/j.marenvres.2011.09.004	35	14	16	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91021	10.1371/journal.pone.0091021	http://dx.doi.org/10.1371/journal.pone.0091021			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609012	Green Submitted, Green Published, gold			2022-12-25	WOS:000332485800081
J	Wang, PL; Bao, Y; Yee, MC; Barrett, SP; Hogan, GJ; Olsen, MN; Dinneny, JR; Brown, PO; Salzman, J				Wang, Peter L.; Bao, Yun; Yee, Muh-Ching; Barrett, Steven P.; Hogan, Gregory J.; Olsen, Mari N.; Dinneny, Jose R.; Brown, Patrick O.; Salzman, Julia			Circular RNA Is Expressed across the Eukaryotic Tree of Life	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; SCHIZOSACCHAROMYCES-POMBE; INTRON DEFINITION; EXON DEFINITION; MESSENGER-RNA; FISSION YEAST; GENE; TRANSCRIPTS; CIRCLES; REPEATS	An unexpectedly large fraction of genes in metazoans (human, mouse, zebrafish, worm, fruit fly) express high levels of circularized RNAs containing canonical exons. Here we report that circular RNA isoforms are found in diverse species whose most recent common ancestor existed more than one billion years ago: fungi (Schizosaccharomyces pombe and Saccharomyces cerevisiae), a plant (Arabidopsis thaliana), and protists (Plasmodium falciparum and Dictyostelium discoideum). For all species studied to date, including those in this report, only a small fraction of the theoretically possible circular RNA isoforms from a given gene are actually observed. Unlike metazoans, Arabidopsis, D. discoideum, P. falciparum, S. cerevisiae, and S. pombe have very short introns (similar to 100 nucleotides or shorter), yet they still produce circular RNAs. A minority of genes in S. pombe and P. falciparum have documented examples of canonical alternative splicing, making it unlikely that all circular RNAs are by-products of alternative splicing or 'piggyback' on signals used in alternative RNA processing. In S. pombe, the relative abundance of circular to linear transcript isoforms changed in a gene-specific pattern during nitrogen starvation. Circular RNA may be an ancient, conserved feature of eukaryotic gene expression programs.	[Wang, Peter L.; Barrett, Steven P.; Hogan, Gregory J.; Olsen, Mari N.; Brown, Patrick O.; Salzman, Julia] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Wang, Peter L.; Salzman, Julia] Stanford Univ, Stanford Canc Inst, Sch Med, Stanford, CA 94305 USA; [Bao, Yun; Yee, Muh-Ching; Dinneny, Jose R.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Bao, Yun; Yee, Muh-Ching; Dinneny, Jose R.] Natl Univ Singapore, Temasek Lifesci Lab, Singapore 117548, Singapore; [Bao, Yun; Yee, Muh-Ching; Dinneny, Jose R.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Olsen, Mari N.; Brown, Patrick O.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford Cancer Institute; Stanford University; Carnegie Institution for Science; National University of Singapore; National University of Singapore; Howard Hughes Medical Institute; Stanford University	Salzman, J (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	julia.salzman@stanford.edu	wang, peter/AAD-5851-2020	Dinneny, Jose/0000-0002-3998-724X	Howard Hughes Medical Institute; Canary Foundation; NIH NCI [1K99CA168987-01]; NATIONAL CANCER INSTITUTE [R00CA168987, K99CA168987] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canary Foundation; NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported mainly by the Howard Hughes Medical Institute. POB is an investigator for the Howard Hughes Medical Institute. PLW was supported by a grant from the Canary Foundation. JS was supported by NIH NCI 1K99CA168987-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awan AR, 2013, P NATL ACAD SCI USA, V110, P12762, DOI 10.1073/pnas.1218353110; Bailleul B, 1996, NUCLEIC ACIDS RES, V24, P1015, DOI 10.1093/nar/24.6.1015; Baum J, 2009, NUCLEIC ACIDS RES, V37, P3788, DOI 10.1093/nar/gkp239; Burd CE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001233; Caldas C, 1998, GENE, V208, P167, DOI 10.1016/S0378-1119(97)00640-9; COCQUERELLE C, 1993, FASEB J, V7, P155, DOI 10.1096/fasebj.7.1.7678559; Collart M A, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1312s23; Csuros M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002150; De Conti L, 2013, WIRES RNA, V4, P49, DOI 10.1002/wrna.1140; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Dubin RA, 1995, GENE, V167, P245, DOI 10.1016/0378-1119(95)00639-7; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hansen TB, 2011, EMBO J, V30, P4414, DOI 10.1038/emboj.2011.359; Hossain MA, 2011, NUCLEIC ACIDS RES, V39, P8612, DOI 10.1093/nar/gkr497; Houseley JM, 2006, J HERED, V97, P253, DOI 10.1093/jhered/esj037; HSU MT, 1979, NATURE, V280, P339, DOI 10.1038/280339a0; Irimia M, 2013, TRENDS GENET, V29, P521, DOI 10.1016/j.tig.2013.05.008; Irimia M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000148; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Lamm AT, 2011, GENOME RES, V21, P265, DOI 10.1101/gr.108845.110; Li YT, 2011, MOL PLANT, V4, P171, DOI 10.1093/mp/ssq052; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Moldon A, 2008, NATURE, V455, P997, DOI 10.1038/nature07325; Nam K, 1997, MOL CELL BIOL, V17, P809, DOI 10.1128/MCB.17.2.809; NIGRO JM, 1991, CELL, V64, P607, DOI 10.1016/0092-8674(91)90244-S; Ram O, 2007, TRENDS GENET, V23, P5, DOI 10.1016/j.tig.2006.10.002; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; Romfo CM, 2000, MOL CELL BIOL, V20, P7955, DOI 10.1128/MCB.20.21.7955-7970.2000; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Shao XA, 2006, BIOINFORMATICS, V22, P692, DOI 10.1093/bioinformatics/bti795; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Singh PK, 2012, BBA-GENE REGUL MECH, V1819, P1186, DOI 10.1016/j.bbagrm.2012.08.014; Sorber K, 2011, NUCLEIC ACIDS RES, V39, P3820, DOI 10.1093/nar/gkq1223; Vincent HA, 2006, J BIOL CHEM, V281, P29769, DOI 10.1074/jbc.M606744200; Yanagida M, 2009, TRENDS CELL BIOL, V19, P705, DOI 10.1016/j.tcb.2009.09.006; Zaphiropoulos PG, 1996, P NATL ACAD SCI USA, V93, P6536, DOI 10.1073/pnas.93.13.6536; Zhang XH, 2011, EUKARYOT CELL, V10, P1422, DOI 10.1128/EC.05193-11	40	561	599	7	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90859	10.1371/journal.pone.0090859	http://dx.doi.org/10.1371/journal.pone.0090859			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609083	Green Published, gold, Green Submitted			2022-12-25	WOS:000332485800061
J	Castello, NA; Nguyen, MH; Tran, JD; Cheng, D; Green, KN; LaFerla, FM				Castello, Nicholas A.; Nguyen, Michael H.; Tran, Jenny D.; Cheng, David; Green, Kim N.; LaFerla, Frank M.			7,8-Dihydroxyflavone, a Small Molecule TrkB Agonist, Improves Spatial Memory and Increases Thin Spine Density in a Mouse Model of Alzheimer Disease-Like Neuronal Loss	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; DENDRITIC SPINES; ENTORHINAL CORTEX; BRAIN; BDNF; CA1; DEFICITS; HIPPOCAMPUS; PLASTICITY; MICE	Augmenting BDNF/TrkB signaling has been demonstrated to be a promising strategy for reversing cognitive deficits in preclinical models of Alzheimer disease (AD). Although these studies highlight the potential of targeting BDNF/TrkB signaling, this strategy has not yet been tested in a model that develops the disease features that are most closely associated with cognitive decline in AD: severe synaptic and neuronal loss. In the present study, we investigated the impact of 7,8-dihydroxyflavone (DHF), a TrkB agonist, in CaM/Tet-DTA mice, an inducible model of severe neuronal loss in the hippocampus and cortex. Systemic 7,8-DHF treatment significantly improved spatial memory in lesioned mice, as measured by water maze. Analysis of GFP-labeled neurons in CaM/Tet-DTA mice revealed that 7,8-DHF induced a significant and selective increase in the density of thin spines in CA1 of lesioned mice, without affecting mushroom or stubby spines. These findings suggest chronic upregulation of TrkB signaling with 7,8-DHF may be an effective and practical strategy for improving function in AD, even after substantial neuronal loss has occurred.	[Castello, Nicholas A.; Nguyen, Michael H.; Tran, Jenny D.; Cheng, David; Green, Kim N.; LaFerla, Frank M.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92697 USA; [Castello, Nicholas A.; Nguyen, Michael H.; Tran, Jenny D.; Cheng, David; Green, Kim N.; LaFerla, Frank M.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine	LaFerla, FM (corresponding author), Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92697 USA.	laferla@uci.edu			American Health Assistance Foundation (FML) [NIH F31AG034061]; NATIONAL INSTITUTE ON AGING [F31AG034061] Funding Source: NIH RePORTER	American Health Assistance Foundation (FML); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by a grant from the American Health Assistance Foundation (FML) and NIH F31AG034061 (NAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aungst S, 2013, J NEUROPHYSIOL, V109, P813, DOI 10.1152/jn.00869.2012; Bartoletti A, 2002, J NEUROSCI, V22, P10072; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Bobinski M, 1998, BRAIN RES, V805, P267, DOI 10.1016/S0006-8993(98)00759-8; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Brown CE, 2008, STROKE, V39, P1286, DOI 10.1161/STROKEAHA.107.498238; Brown CE, 2007, J NEUROSCI, V27, P4101, DOI 10.1523/JNEUROSCI.4295-06.2007; Chakravarthy S, 2006, P NATL ACAD SCI USA, V103, P1071, DOI 10.1073/pnas.0506305103; COTMAN CW, 1973, P NATL ACAD SCI USA, V70, P3473, DOI 10.1073/pnas.70.12.3473; Devi L, 2012, NEUROPSYCHOPHARMACOL, V37, P434, DOI 10.1038/npp.2011.191; Dinocourt C, 2006, EUR J NEUROSCI, V24, P1857, DOI 10.1111/j.1460-9568.2006.05067.x; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; FUKUTANI Y, 1995, NEUROSCI LETT, V200, P57, DOI 10.1016/0304-3940(95)12083-G; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Gorski JA, 2003, J NEUROSCI, V23, P6856; HAMORI J, 1990, J EXP BIOL, V153, P251; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Iwasaki Y, 2012, J NEUROSCI RES, V90, P981, DOI 10.1002/jnr.22830; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; Lin AJ, 2013, LASERS SURG MED; Massa SM, 2010, J CLIN INVEST, V120, P1774, DOI 10.1172/JCI41356; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Monville C, 2006, J NEUROSCI METH, V158, P219, DOI 10.1016/j.jneumeth.2006.06.001; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; NEARY D, 1986, J NEUROL NEUROSUR PS, V49, P229, DOI 10.1136/jnnp.49.3.229; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Posmantur RM, 1996, J NEUROPATH EXP NEUR, V55, P68, DOI 10.1097/00005072-199601000-00007; Price JL, 2001, ARCH NEUROL-CHICAGO, V58, P1395, DOI 10.1001/archneur.58.9.1395; Radecki DT, 2005, HIPPOCAMPUS, V15, P246, DOI 10.1002/hipo.20048; Sadan O, 2009, STEM CELLS DEV, V18, P1179, DOI 10.1089/scd.2008.0411; Sasaki M, 2009, J NEUROSCI, V29, P14932, DOI 10.1523/JNEUROSCI.2769-09.2009; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; SCHEFF SW, 1977, BEHAV BIOL, V21, P286, DOI 10.1016/S0091-6773(77)90374-1; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tyler WJ, 2003, J PHYSIOL-LONDON, V553, P497, DOI 10.1113/jphysiol.2003.052639; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8; Xie YX, 2010, J NEUROSCI, V30, P14708, DOI 10.1523/JNEUROSCI.1637-10.2010; Yacoubian TA, 2000, NAT NEUROSCI, V3, P342, DOI 10.1038/73911; Yamasaki TR, 2007, J NEUROSCI, V27, P11925, DOI 10.1523/JNEUROSCI.1627-07.2007; Yeung ST, 2014, NEUROSCIENCE, V259, P214, DOI 10.1016/j.neuroscience.2013.11.054; Zeng Y, 2012, J ALZHEIMERS DIS, V31, P765, DOI 10.3233/JAD-2012-120886; Zhang Z, 2013, NEUROPSYCHOPHARMACOL	50	83	89	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91453	10.1371/journal.pone.0091453	http://dx.doi.org/10.1371/journal.pone.0091453			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614170	Green Published, gold			2022-12-25	WOS:000332839300128
J	Ehrlich, ES; Chmura, JC; Smith, JC; Kalu, NN; Hayward, GS				Ehrlich, Elana S.; Chmura, Jennifer C.; Smith, John C.; Kalu, Nene N.; Hayward, Gary S.			KSHV RTA Abolishes NFkB Responsive Gene Expression during Lytic Reactivation by Targeting vFLIP for Degradation via the Proteasome	PLOS ONE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; KAPPA-B ACTIVATION; E3 LIGASE; PROMOTES DEGRADATION; NUCLEAR ANTIGEN; LYMPHOMA-CELLS; KINASE COMPLEX; PROTEIN; REPLICATION; PATHWAY	Kaposi's sarcoma herpesvirus (KSHV) is a gamma-2 herpesvirus present in all cases of Kaposi's sarcoma, primary effusion lymphoma (PEL), and some cases of multicentric Castleman's disease. Viral FLICE inhibitory protein (vFLIP) is a latently expressed gene that has been shown to be essential for survival of latently infected PEL cells by activating the NFkB pathway. Inhibitors of either vFLIP expression or the NF kappa B pathway result in enhanced lytic reactivation and apoptosis. We have observed a decrease in vFLIP protein levels and of NF kappa B activation in the presence of the KSHV lytic switch protein RTA. Whereas vFLIP alone induced expression of the NF kappa B responsive genes ICAM1 and TNF alpha, inclusion of RTA decreased vFLIP induced ICAM1 and TNF alpha expression in both co-transfected 293T cells and in doxycycline induced TREx BCBL1 cells. RTA expression resulted in proteasome dependent destabilization of vFLIP. Neither RTA ubiquitin E3 ligase domain mutants nor a dominant-negative RAUL mutant abrogated this effect, while RTA truncation mutants did, suggesting that RTA recruits a novel cellular ubiquitin E3 ligase to target vFLIP for proteasomal degradation, allowing for inhibition of NF B responsive gene expression early during lytic reactivation.	[Ehrlich, Elana S.; Kalu, Nene N.; Hayward, Gary S.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Viral Oncol Program, Baltimore, MD USA; [Ehrlich, Elana S.; Chmura, Jennifer C.; Smith, John C.] Towson Univ, Dept Biol Sci, Towson, MD 21252 USA	Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; Towson University	Ehrlich, ES (corresponding author), Towson Univ, Dept Biol Sci, Towson, MD 21252 USA.	eehrlich@towson.edu; ghayward@jhmi.edu			Anti-Cancer Drug Development (ACDD) Training Program [T32 CA009243-35]; National Institutes of Health NCI [R01 CA073585-15]; NATIONAL CANCER INSTITUTE [T32CA009243, R01CA073585] Funding Source: NIH RePORTER	Anti-Cancer Drug Development (ACDD) Training Program; National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by a Post-Doctoral stipend to Elana Ehrlich from the Anti-Cancer Drug Development (ACDD) Training Program Grant T32 CA009243-35 and by National Institutes of Health NCI Research Grant R01 CA073585-15 to GSH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JB, 2003, ONCOGENE, V22, P3371, DOI 10.1038/sj.onc.1206407; Ballestas ME, 1999, SCIENCE, V284, P641, DOI 10.1126/science.284.5414.641; Brown HJ, 2003, J VIROL, V77, P8532, DOI 10.1128/JVI.77.15.8532-8540.2003; Chaudhary PM, 1999, ONCOGENE, V18, P5738, DOI 10.1038/sj.onc.1202976; Cotter MA, 1999, VIROLOGY, V264, P254, DOI 10.1006/viro.1999.9999; Field N, 2003, J CELL SCI, V116, P3721, DOI 10.1242/jcs.00691; Gould F, 2009, J VIROL, V83, P6727, DOI 10.1128/JVI.00351-09; Grossmann C, 2008, VIROLOGY, V375, P94, DOI 10.1016/j.virol.2007.12.044; Guasparri I, 2004, J EXP MED, V199, P993, DOI 10.1084/jem.20031467; Krishnan HH, 2004, J VIROL, V78, P3601, DOI 10.1128/JVI.78.7.3601-3620.2004; Liu L, 2002, J BIOL CHEM, V277, P13745, DOI 10.1074/jbc.M110480200; Matta H, 2004, P NATL ACAD SCI USA, V101, P9399, DOI 10.1073/pnas.0308016101; Matta H, 2007, J BIOL CHEM, V282, P24858, DOI 10.1074/jbc.M700118200; Nakamura H, 2003, J VIROL, V77, P4205, DOI 10.1128/JVI.77.7.4205-4220.2003; Punj V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037498; Punj V, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-50; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Sgarbanti M, 2004, ONCOGENE, V23, P5770, DOI 10.1038/sj.onc.1207707; Sun Q, 2003, BLOOD, V101, P1956, DOI 10.1182/blood-2002-07-2072; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Sun R, 1999, J VIROL, V73, P2232, DOI 10.1128/JVI.73.3.2232-2242.1999; Wang SE, 2003, J VIROL, V77, P600, DOI 10.1128/JVI.77.1.600-623.2003; Yang ZL, 2008, J VIROL, V82, P3590, DOI 10.1128/JVI.02229-07; Ye FC, 2008, J VIROL, V82, P4235, DOI 10.1128/JVI.02370-07; You JX, 2003, J BIOL CHEM, V278, P23369, DOI 10.1074/jbc.M212887200; Yu YX, 2010, IMMUNITY, V33, P863, DOI 10.1016/j.immuni.2010.11.027; Yu YX, 2005, IMMUNITY, V22, P59, DOI 10.1016/j.immuni.2004.11.011	27	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91359	10.1371/journal.pone.0091359	http://dx.doi.org/10.1371/journal.pone.0091359			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614587	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300116
J	Nakasugi, K; Crowhurst, R; Bally, J; Waterhouse, P				Nakasugi, Kenlee; Crowhurst, Ross; Bally, Julia; Waterhouse, Peter			Combining Transcriptome Assemblies from Multiple De Novo Assemblers in the Allo-Tetraploid Plant Nicotiana benthamiana	PLOS ONE			English	Article							RNA-SEQ DATA; READ ALIGNMENT; PROTEIN; WHEAT; GENES; ARABIDOPSIS; UNIPROT; SPACE	Background: Nicotiana benthamiana is an allo-tetraploid plant, which can be challenging for de novo transcriptome assemblies due to homeologous and duplicated gene copies. Transcripts generated from such genes can be distinct yet highly similar in sequence, with markedly differing expression levels. This can lead to unassembled, partially assembled or mis-assembled contigs. Due to the different properties of de novo assemblers, no one assembler with any one given parameter space can re-assemble all possible transcripts from a transcriptome. Results: In an effort to maximise the diversity and completeness of de novo assembled transcripts, we utilised four de novo transcriptome assemblers, TransAbyss, Trinity, SOAPdenovo-Trans, and Oases, using a range of k-mer sizes and different input RNA-seq read counts. We complemented the parameter space biologically by using RNA from 10 plant tissues. We then combined the output of all assemblies into a large super-set of sequences. Using a method from the EvidentialGene pipeline, the combined assembly was reduced from 9.9 million de novo assembled transcripts to about 235,000 of which about 50,000 were classified as primary. Metrics such as average bit-scores, feature response curves and the ability to distinguish paralogous or homeologous transcripts, indicated that the EvidentialGene processed assembly was of high quality. Of 35 RNA silencing gene transcripts, 34 were identified as assembled to full length, whereas in a previous assembly using only one assembler, 9 of these were partially assembled. Conclusions: To achieve a high quality transcriptome, it is advantageous to implement and combine the output from as many different de novo assemblers as possible. We have in essence taking the 'best' output from each assembler while minimising sequence redundancy. We have also shown that simultaneous assessment of a variety of metrics, not just focused on contig length, is necessary to gauge the quality of assemblies.	[Nakasugi, Kenlee; Bally, Julia; Waterhouse, Peter] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Crowhurst, Ross] Mt Albert Res Ctr, Auckland, New Zealand; [Waterhouse, Peter] Queensland Univ Technol, Ctr Trop Crops & Biocommod, Brisbane, Qld 4001, Australia	University of Sydney; New Zealand Institute for Plant & Food Research Ltd; Queensland University of Technology (QUT)	Nakasugi, K (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	kenlee.nakasugi@sydney.edu.au; peter.waterhouse@qut.edu.au	Crowhurst, Ross N/N-8892-2017	Crowhurst, Ross N/0000-0003-0608-2134; Bally, Julia/0000-0003-0692-280X; Waterhouse, Peter/0000-0002-2812-3753	ARC Federation Fellowship [FF0776510]	ARC Federation Fellowship(Australian Research Council)	PMW is funded by the ARC Federation Fellowship FF0776510. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Bombarely A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-406; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Duan JL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-392; Gilbert D., 2013, P 7 ANN ARTHR GEN S; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gruenheit N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-92; Haznedaroglu BZ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-170; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Izawa T, 2002, GENE DEV, V16, P2006, DOI 10.1101/gad.999202; Jones L, 2006, PLANT PHYSIOL, V141, P598, DOI 10.1104/pp.105.076109; Krasileva KV, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r66; Krzywinski MI, 2009, GENOME RES; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li CX, 2008, PLANT J, V55, P543, DOI 10.1111/j.1365-313X.2008.03526.x; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Nakasugi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059534; Oono Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-77; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; R Core Team, 2012, R LANG ENV STAT COMP; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Ranwez V, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S15-S15; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Schreiber AW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-492; Schulz M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-18; Sierro N, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r60; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Vezzi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052210; Vezzi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031002; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xie Y, 2013, ARXIV13056760; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; Yang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-328; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2	46	103	103	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91776	10.1371/journal.pone.0091776	http://dx.doi.org/10.1371/journal.pone.0091776			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614631	Green Published, gold			2022-12-25	WOS:000332839300157
J	Peddayelachagiri, BV; Paul, S; Makam, SS; Urs, RM; Kingston, JJ; Tuteja, U; Sripathy, MH; Batra, HV				Peddayelachagiri, Bhavani V.; Paul, Soumya; Makam, Shivakiran S.; Urs, Radhika M.; Kingston, Joseph J.; Tuteja, Urmil; Sripathy, Murali H.; Batra, Harsh V.			Functional Characterization and Evaluation of In Vitro Protective Efficacy of Murine Monoclonal Antibodies BURK24 and BURK37 against Burkholderia pseudomallei	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; PSEUDOMONAS-AERUGINOSA; CAPSULAR POLYSACCHARIDE; ESCHERICHIA-COLI; SERUM RESISTANCE; STAPHYLOCOCCUS-EPIDERMIDIS; ANTIBIOTIC SUSCEPTIBILITY; INTRACELLULAR SURVIVAL; NEISSERIA-GONORRHOEAE; FACTOR-H	Burkholderia pseudomallei, the causative agent of melioidosis has been recognized by CDC as a category B select agent. Although substantial efforts have been made for development of vaccine molecules against the pathogen, significant hurdles still remain. With no licensed vaccines available and high relapse rate of the disease, there is a pressing need for development of alternate protection strategies. Antibody-mediated passive protection is promising in this regard and our primary interest was to unravel this frontier of specific mAbs against Burkholderia pseudomallei infections, as functional characterization of antibodies is a pre-requisite to demonstrate them as protective molecules. To achieve this, we designed our study on in vitro-based approach and assessed two mAbs, namely BURK24 and BURK37, reactive with outer membrane proteins and lipopolysaccharide of the pathogen respectively, for their ability to manifest inhibitory effects on the pathogenesis mechanisms of B. pseudomallei including biofilm formation, invasion and induction of apoptosis. The experiments were performed using B. pseudomallei standard strain NCTC 10274 and a clinical isolate, B. pseudomallei 621 recovered from a septicemia patient with diabetic ailment. The growth kinetic studies of the pathogen in presence of various concentrations of each individual mAb revealed their anti-bacterial properties. Minimal inhibitory concentration and minimal bactericidal concentration of both the mAbs were determined by using standards of Clinical and Laboratory Standards Institute (CLSI) and experiments were performed using individual mAbs at their respective bacteriostatic concentration. As an outcome, both mAbs exhibited significant anti-Burkholderia pseudomallei properties. They limited the formation of biofilm by the bacterium and completely crippled its invasion into human alveolar adenocarcinoma epithelial cells. Also, the mAbs were appreciably successful in preventing the bacterium to induce apoptosis in A549 cells. The present study design revealed the protection attributes possessed by BURK24 and BURK37 that has to be further substantiated by additional in vivo studies.	[Peddayelachagiri, Bhavani V.; Paul, Soumya; Makam, Shivakiran S.; Urs, Radhika M.; Kingston, Joseph J.; Sripathy, Murali H.; Batra, Harsh V.] Def Food Res Lab, Div Microbiol, Mysore 570011, Karnataka, India; [Tuteja, Urmil] Def Res & Dev Estab, Div Microbiol, Gwalior 474002, Madhya Pradesh, India	Defence Research & Development Organisation (DRDO); Defence Food Research Laboratory (DFRL); Defence Research & Development Organisation (DRDO); Defence Research & Development Establishment (DRDE)	Batra, HV (corresponding author), Def Food Res Lab, Div Microbiol, Mysore 570011, Karnataka, India.	drharshvardhanbatra@gmail.com	S, Shivakiran M/D-7211-2015	S, Shivakiran M/0000-0003-3844-9770	Department of Science and Technology (DST), India; Council of Scientific and Industrial Research (CSIR), India	Department of Science and Technology (DST), India(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	The first author is thankful to Department of Science and Technology (DST), India for support through INSPIRE program. The third author is thankful to Council of Scientific and Industrial Research (CSIR), India for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2000, MICROBIOL IMMUNOL, V44, P629, DOI 10.1111/j.1348-0421.2000.tb02543.x; Allwood EM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00170; Anuntagool N, 2006, AM J TROP MED HYG, V74, P348, DOI 10.4269/ajtmh.2006.74.348; AuCoin DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035386; Behera B, 2012, ASIAN PAC J TROP MED, V5, P329, DOI 10.1016/S1995-7645(12)60050-9; Bogino PC, 2013, INT J MOL SCI, V14, P15838, DOI 10.3390/ijms140815838; Bottex C, 2005, IMMUNOPHARM IMMUNOT, V27, P565, DOI 10.1080/08923970500493995; Brekke OH, 2003, NAT REV DRUG DISCOV, V2, P52, DOI 10.1038/nrd984; Brook MD, 1997, J APPL MICROBIOL, V82, P589, DOI 10.1111/j.1365-2672.1997.tb02867.x; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CHAOWAGUL W, 1993, J INFECT DIS, V168, P1181, DOI 10.1093/infdis/168.5.1181; Chetchotisakd P, 2014, LANCET, V383, P807, DOI 10.1016/S0140-6736(13)61951-0; Clinical and Laboratory Standards Institute, 1999, METHODS DETERMINING; CROSA JH, 1981, INFECT IMMUN, V31, P223, DOI 10.1128/IAI.31.1.223-227.1981; Currie BJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000900; DANCE DAB, 1989, J ANTIMICROB CHEMOTH, V24, P295, DOI 10.1093/jac/24.3.295; DIPADOVA FE, 1993, INFECT IMMUN, V61, P3863, DOI 10.1128/IAI.61.9.3863-3872.1993; Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002; FINKE M, 1991, INFECT IMMUN, V59, P1251, DOI 10.1128/IAI.59.4.1251-1254.1991; FULOP MJ, 1991, J CLIN MICROBIOL, V29, P1407, DOI 10.1128/JCM.29.7.1407-1412.1991; Griep RA, 1998, PHYTOPATHOLOGY, V88, P795, DOI 10.1094/PHYTO.1998.88.8.795; HEESEMANN J, 1987, FEMS MICROBIOL LETT, V40, P37, DOI 10.1016/0378-1097(87)90512-X; Hellwage J, 2001, J BIOL CHEM, V276, P8427, DOI 10.1074/jbc.M007994200; Jenney AWJ, 2001, INT J ANTIMICROB AG, V17, P109, DOI 10.1016/S0924-8579(00)00334-4; Jones AL, 1996, INFECT IMMUN, V64, P782, DOI 10.1128/IAI.64.3.782-790.1996; Jones SM, 2002, J MED MICROBIOL, V51, P1055, DOI 10.1099/0022-1317-51-12-1055; Kespichayawattana W, 2000, INFECT IMMUN, V68, P5377, DOI 10.1128/IAI.68.9.5377-5384.2000; Kim K, 2010, APPL ENVIRON MICROB, V76, P5188, DOI 10.1128/AEM.02498-09; Knobloch JKM, 2002, J ANTIMICROB CHEMOTH, V49, P683, DOI 10.1093/jac/49.4.683; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Koh SF, 2013, TROP BIOMED, V30, P428; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kulkarni RD, 2010, INDIAN J MED RES, V131, P584; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVITZ SM, 1991, J INFECT DIS, V163, P1108, DOI 10.1093/infdis/163.5.1108; Lin J, 2002, MICROBES INFECT, V4, P325, DOI 10.1016/S1286-4579(02)01545-9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MASUDA N, 1995, ANTIMICROB AGENTS CH, V39, P645, DOI 10.1128/AAC.39.3.645; Mitov I, 2003, FEMS MICROBIOL LETT, V225, P299, DOI 10.1016/S0378-1097(03)00533-0; MORELLO JA, 1989, J INFECT DIS, V160, P1012, DOI 10.1093/infdis/160.6.1012; Nelson M, 2004, J MED MICROBIOL, V53, P1177, DOI 10.1099/jmm.0.45766-0; Phewkliang A, 2010, SE ASIAN J TROP MED, V41, P1164; Pibalpakdee P, 2012, INT J ANTIMICROB AG, V39, P356, DOI 10.1016/j.ijantimicag.2011.12.010; POLLACK M, 1995, INFECT IMMUN, V63, P4481, DOI 10.1128/IAI.63.11.4481-4488.1995; Ram S, 1998, J EXP MED, V188, P671, DOI 10.1084/jem.188.4.671; Sawasdidoln C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009196; Shahin Susan, 2004, DSTOTR1584; Silva EB, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00010; Sun DQ, 2005, CLIN DIAGN LAB IMMUN, V12, P93, DOI 10.1128/CDLI.12.1.93-100.2005; Suparak S, 2005, J BACTERIOL, V187, P6556, DOI 10.1128/JB.187.18.6556-6560.2005; ter Meulen J, 2007, EXPERT OPIN EMERG DR, V12, P525, DOI 10.1517/14728214.12.4.525; Thibault FM, 2004, J ANTIMICROB CHEMOTH, V54, P1134, DOI 10.1093/jac/dkh471; Toropainen M, 2006, INFECT IMMUN, V74, P2803, DOI 10.1128/IAI.74.5.2803-2808.2006; Wayne P.A., 2006, CLSI NCCLS M7 A7, V7th; WEISER JN, 1991, INFECT IMMUN, V59, P2252, DOI 10.1128/IAI.59.7.2252-2258.1991; Westerman RB, 1997, J CLIN MICROBIOL, V35, P679, DOI 10.1128/JCM.35.3.679-684.1997; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0	57	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90930	10.1371/journal.pone.0090930	http://dx.doi.org/10.1371/journal.pone.0090930			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614539	Green Submitted, Green Published, gold			2022-12-25	WOS:000332839300058
J	Garbe, J; Sjogren, J; Cosgrave, EFJ; Struwe, WB; Bober, M; Olin, AI; Rudd, PM; Collin, M				Garbe, Julia; Sjogren, Jonathan; Cosgrave, Eoin F. J.; Struwe, Weston B.; Bober, Marta; Olin, Anders I.; Rudd, Pauline M.; Collin, Mattias			EndoE from Enterococcus faecalis Hydrolyzes the Glycans of the Biofilm Inhibiting Protein Lactoferrin and Mediates Growth	PLOS ONE			English	Article							BETA-N-ACETYLGLUCOSAMINIDASE; BACTERIAL MOONLIGHTING PROTEINS; URINARY-TRACT-INFECTION; STREPTOCOCCUS-PYOGENES; ALPHA-ENOLASE; HOST-DEFENSE; IRON; PATHOGENESIS; VIRULENCE; SURFACE	Glycosidases are widespread among bacteria. The opportunistic human pathogen Enterococcus faecalis encodes several putative glycosidases but little is known about their functions. The identified endo-beta-N-acetylglucosaminidase EndoE has activity on the N-linked glycans of the human immunoglobulin G (IgG). In this report we identified the human glycoprotein lactoferrin (hLF) as a new substrate for EndoE. Hydrolysis of the N-glycans from hLF was investigated using lectin blot, UHPLC and mass spectrometry, showing that EndoE releases major glycoforms from this protein. hLF was shown to inhibit biofilm formation of E. faecalis in vitro. Glycans of hLF influence the binding to E. faecalis, and EndoE-hydrolyzed hLF inhibits biofilm formation to lesser extent than intact hLF indicating that EndoE prevents the inhibition of biofilm. In addition, hLF binds to a surface-associated enolase of E. faecalis. Culture experiments showed that the activity of EndoE enables E. faecalis to use the glycans derived from lactoferrin as a carbon source indicating that they could be used as nutrients in vivo when no other preferred carbon source is available. This report adds important information about the enzymatic activity of EndoE from the commensal and opportunist E. faecalis. The activity on the human glycoprotein hLF, and the functional consequences with reduced inhibition of biofilm formation highlights both innate immunity functions of hLF and a bacterial mechanism to evade this innate immunity function. Taken together, our results underline the importance of glycans in the interplay between bacteria and the human host, with possible implications for both commensalism and opportunism.	[Garbe, Julia; Sjogren, Jonathan; Bober, Marta; Olin, Anders I.; Collin, Mattias] Lund Univ, Dept Clin Sci, Div Infect Med, Lund, Sweden; [Cosgrave, Eoin F. J.; Struwe, Weston B.; Rudd, Pauline M.] NIBRT, Dublin Oxford Glycobiol Grp, Blackrock, Dublin, Ireland	Lund University	Garbe, J (corresponding author), Lund Univ, Dept Clin Sci, Div Infect Med, Lund, Sweden.	julia.garbe@med.lu.se	Struwe, Weston/D-6180-2018; Collin, Mattias/C-6398-2009	Struwe, Weston/0000-0003-0594-226X; Collin, Mattias/0000-0002-6166-7410; Sjogren, Jonathan/0000-0003-1371-9623	Swedish governmental funding for clinical research (ALF); Swedish Research Council [2010-57X-20240]; Foundation of Wiberg; Foundation of Kock; Foundation of Bergvall; Foundation of Osterlund; Foundation of Hedberg; Foundation of Hedlund; Foundation of Groschinsky; Foundation of Soderberg; Swedish Society for Medicine; Royal Physiographic Society; King Gustaf V's Memorial Fund; Medical Faculty at Lund University; Hansa Medical AB	Swedish governmental funding for clinical research (ALF); Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundation of Wiberg; Foundation of Kock; Foundation of Bergvall; Foundation of Osterlund; Foundation of Hedberg; Foundation of Hedlund; Foundation of Groschinsky; Foundation of Soderberg; Swedish Society for Medicine; Royal Physiographic Society; King Gustaf V's Memorial Fund; Medical Faculty at Lund University; Hansa Medical AB	MC is supported by Swedish governmental funding for clinical research (ALF), grants from the Swedish Research Council (2010-57X-20240; http://www.vr.se/), the Foundations of Wiberg (http://www.ake-wiberg.com/), Kock (http://www.kockskastiftelsen.se/), Bergvall (http://www.magnbergvallsstiftelse.nu/), Osterlund (http://www.alfredosterlundsstiftelse.se/), Hedberg (http://www.hedbergsstiftelse.se/), Hedlund (http://www.hedlundsstiftelse.se/), Groschinsky (http://www.groschinsky.org/), Soderberg (http://www.torstensoderbergsstiftelse.se/), the Swedish Society for Medicine (http://www.ssmf.se/), the Royal Physiographic Society (http://www.fysiografen.se/), King Gustaf V's Memorial Fund, the Medical Faculty at Lund University (http://www.med.lu.se/english/about_the_faculty), and Hansa Medical AB (http://www.hansamedical.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allhorn M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001413; Allhorn M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-3; ALUGUPALLI KR, 1995, APMIS, V103, P154, DOI 10.1111/j.1699-0463.1995.tb01091.x; Andres MT, 2010, ANTIMICROB AGENTS CH, V54, P4335, DOI 10.1128/AAC.01620-09; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Berlutti F, 2004, BIOMETALS, V17, P271; BROCK JH, 1980, ARCH DIS CHILD, V55, P417, DOI 10.1136/adc.55.6.417; Byers HL, 1999, GLYCOBIOLOGY, V9, P469, DOI 10.1093/glycob/9.5.469; CLARKE VA, 1995, J BIOL CHEM, V270, P8805, DOI 10.1074/jbc.270.15.8805; Collin M, 2004, J BIOL CHEM, V279, P22558, DOI 10.1074/jbc.M402156200; Collin M, 2002, INFECT IMMUN, V70, P6646, DOI 10.1128/IAI.70.12.6646-6651.2002; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; ELLISON RT, 1988, INFECT IMMUN, V56, P2774, DOI 10.1128/IAI.56.11.2774-2781.1988; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; Foley I, 1997, J ANTIMICROB CHEMOTH, V40, P667, DOI 10.1093/jac/40.5.667; Frederiksen RF, 2013, MICROBIOL-SGM, V159, P833, DOI 10.1099/mic.0.051839-0; Garbe J, 2012, J INNATE IMMUN, V4, P121, DOI 10.1159/000334775; Ge JP, 2004, INFECT IMMUN, V72, P6748, DOI 10.1128/IAI.72.11.6748-6752.2004; Gonzalez-Chavez SA, 2009, INT J ANTIMICROB AG, V33, DOI 10.1016/j.ijantimicag.2008.07.020; Guile GR, 1996, ANAL BIOCHEM, V240, P210, DOI 10.1006/abio.1996.0351; GUZMAN CA, 1989, INFECT IMMUN, V57, P1834; HALL LMC, 1992, J CLIN MICROBIOL, V30, P1953, DOI 10.1128/JCM.30.8.1953-1957.1992; Harvey DJ, 2009, PROTEOMICS, V9, P3796, DOI 10.1002/pmic.200900096; Henderson B, 2013, CURR TOP MICROBIOL, V358, P155, DOI 10.1007/82_2011_188; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; Joyanes Providencia, 1999, Clin Microbiol Infect, V5, P382, DOI 10.1111/j.1469-0691.1999.tb00160.x; King SJ, 2010, MOL ORAL MICROBIOL, V25, P15, DOI 10.1111/j.2041-1014.2009.00564.x; Lambert LA, 2005, COMP BIOCHEM PHYS B, V142, P129, DOI 10.1016/j.cbpb.2005.07.007; Legrand D, 2004, BIOMETALS, V17, P225, DOI 10.1023/B:BIOM.0000027696.48707.42; Legrand D, 2008, ADV EXP MED BIOL, V606, P163, DOI 10.1007/978-0-387-74087-4_6; Leitch EC, 1999, J MED MICROBIOL, V48, P867, DOI 10.1099/00222615-48-9-867; MASSON PL, 1971, COMP BIOCHEM PHYSIOL, V39, P119, DOI 10.1016/0305-0491(71)90258-6; Mohamed JA, 2004, INFECT IMMUN, V72, P3658, DOI 10.1128/IAI.72.6.3658-3663.2004; Mohamed JA, 2007, J MED MICROBIOL, V56, P1581, DOI 10.1099/jmm.0.47331-0; MURRAY BE, 1993, J BACTERIOL, V175, P5216, DOI 10.1128/JB.175.16.5216-5223.1993; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Renzi F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002118; RICE LB, 1991, REV INFECT DIS, V13, P1; Roberts G, 2001, J MED MICROBIOL, V50, P620, DOI 10.1099/0022-1317-50-7-620; Roberts G, 2000, J BACTERIOL, V182, P882, DOI 10.1128/JB.182.4.882-890.2000; Rooijakkers SHM, 2010, J BIOL CHEM, V285, P27609, DOI 10.1074/jbc.M110.154930; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Sava IG, 2010, CLIN MICROBIOL INFEC, V16, P533, DOI 10.1111/j.1469-0691.2010.03213.x; Shankar N, 2001, INFECT IMMUN, V69, P4366, DOI 10.1128/IAI.69.7.4366-4372.2001; Singh P, 2005, NATURE, V417, P552; Sjogren J, 2013, BIOCHEM J, V455, P107, DOI 10.1042/BJ20130126; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Valenti P, 2005, CELL MOL LIFE SCI, V62, P2576, DOI 10.1007/s00018-005-5372-0; VANBERKEL PHC, 1995, BIOCHEM J, V312, P107, DOI 10.1042/bj3120107; Wakabayashi H, 2009, ANTIMICROB AGENTS CH, V53, P3308, DOI 10.1128/AAC.01688-08; Ward PP, 2004, BIOMETALS, V17, P203, DOI 10.1023/B:BIOM.0000027693.60932.26; WILLIAMS P, 1992, MED MICROBIOL IMMUN, V181, P301; Yu TA, 2011, GLYCOBIOLOGY, V21, P206, DOI 10.1093/glycob/cwq151	57	23	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91035	10.1371/journal.pone.0091035	http://dx.doi.org/10.1371/journal.pone.0091035			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608122	Green Published, Green Submitted, gold			2022-12-25	WOS:000332485800085
J	Haile, D; Belachew, T; Birhanu, G; Setegn, T; Biadgilign, S				Haile, Demewoz; Belachew, Tefera; Birhanu, Getenesh; Setegn, Tesfaye; Biadgilign, Sibhatu			Predictors of Breastfeeding Cessation among HIV Infected Mothers in Southern Ethiopia: A Survival Analysis	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; UNINFECTED CHILDREN; DURATION; BOTSWANA; BORN	Background: Mother-to-child transmission (MTCT) of Human immunodeficiency virus (HIV) through breastfeeding remains the most significant route infection among children. Although the current guideline is recommending continued breastfeeding for HIV exposed infants, significant proportion of infants have been subjected to early weaning to prevent HIV transmission. However the predictors of breastfeeding cessation among HIV positive mothers were not documented in Ethiopia. Therefore the objective of this study was to determine the predictors of breastfeeding cessation among HIV-infected women in Southern Ethiopia. Methods: A facility based cross sectional study was conducted in Southern Ethiopia. The samples were selected by cluster sampling technique. The Kaplan-Meier curve was used to describe the survival time of breastfeeding and a step-wise multivariable Cox-proportional hazards regression model were used to identify the predictors of breastfeeding cessation. Both crude and adjusted hazard ratio were determined and p < 0.05 was considered as statistically significant. Result: The mean duration of breastfeeding among HIV positive mothers was 13.79 [95% CI: (12.97-14.59)] months. The Kaplan-Meier estimate showed that proportions of women who were breastfeeding at 6, 9, 12 and 17 months were 89.3%, 75.3%, 66% and 17%, respectively. Those mothers having a monthly income of <= 500 ETB [AHR = 0.16, 95% CI :(0.03-0.76)], having a family size of three and below [AHR = 0.12, 95% CI: (0.02-0.68), four and above [AHR = 0.07, 95% CI: (0.01-0.35)] and bottle feeding [AHR = 3.95, 95% CI: (1.64-9.51)] were also independent factors associated with breastfeeding cessation. Conclusion: Above one third of HIV positive mothers stopped breastfeeding before 12 months. Monthly income, bottle feeding and family size were the independent predictors of breastfeeding cessations. Strengthening the current counseling and promotion modality on avoidance of bottle feeding and continued breastfeeding is recommended for improved HIV free survival.	[Haile, Demewoz] Madawalabu Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Bale Goba, Ethiopia; [Belachew, Tefera] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Populat & Family Hlth, Jimma, Ethiopia; [Birhanu, Getenesh] Hawassa Univ, Sch Food Sci & Nutr, Dept Appl Human Nutr, Hawassa, Ethiopia; [Setegn, Tesfaye] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Bahir Dar, Ethiopia; [Biadgilign, Sibhatu] Independent Publ Hlth Consultants, Addis Ababa, Ethiopia	Jimma University; Hawassa University; Bahir Dar University	Haile, D (corresponding author), Madawalabu Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Bale Goba, Ethiopia.	demewozhaile@yahoo.com	Belachew, Tefera/AAO-5877-2020; Mengistu, Tesfaye S./AAI-4027-2021; Mengistu, Tesfaye Setegn/AFQ-0237-2022	Mengistu, Tesfaye S./0000-0001-8276-5143; Haile, Demewoz/0000-0003-0047-4276; Biadgilign, Sibhatu/0000-0002-7582-5977	HENNA (Higher Education Network for Applied Human Nutrition between Eastern Africa and Europe) project	HENNA (Higher Education Network for Applied Human Nutrition between Eastern Africa and Europe) project	Funding provided by HENNA (Higher Education Network for Applied Human Nutrition between Eastern Africa and Europe) (http://hennaproject.org) project funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agboado G, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-3; Arpadi S, 2009, AM J CLIN NUTR, V90, P344, DOI 10.3945/ajcn.2009.27745; Berra S, 2003, ACTA PAEDIATR, V92, P952, DOI 10.1080/08035250310004216; Chaves RG, 2007, J PEDIAT-BRAZIL, V83, P241, DOI 10.2223/JPED.1610; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834; Creek TL, 2010, JAIDS-J ACQ IMM DEF, V53, P14, DOI 10.1097/QAI.0b013e3181bdf676; Doherty T, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-105; Ethiopia CCSA, 2007, SUMM STAT REP 2007 P; Fadnes LT, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-124; Ghuman MR, 2009, S AFR J CLIN NUTR, V22, P74, DOI 10.1080/16070658.2009.11734222; *HAPCO FMOH, 2007, GUID PREV MOTH TO CH; Hornell A, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e38; Kagaayi J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003877; Kuhn L, 2008, NEW ENGL J MED, V359, P130, DOI 10.1056/NEJMoa073788; Morgan MC, 2010, AIDS CARE, V22, P866, DOI 10.1080/09540120903483000; Onyango-Makumbi C, 2010, J ACQUIR IMMUNE DEFI, V53; Petraro P, 2011, MATERN CHILD NUTR, V7, P273, DOI 10.1111/j.1740-8709.2009.00236.x; Taha TE, 2011, CLIN INFECT DIS, V53, P388, DOI 10.1093/cid/cir413; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; WHO U, 2008, IND ASS INF YOUNG CH; WHO/UNAIDS/UNICEF, 2009, UN ACC SCAL HIV PRIO; Young SL, 2011, ADV NUTR, V2, P225, DOI 10.3945/an.110.000224	23	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90067	10.1371/journal.pone.0090067	http://dx.doi.org/10.1371/journal.pone.0090067			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608772	Green Published, Green Submitted, gold			2022-12-25	WOS:000332485800016
J	Konitsiotis, AD; Chang, SC; Jovanovic, B; Ciepla, P; Masumoto, N; Palmer, CP; Tate, EW; Couchman, JR; Magee, AI				Konitsiotis, Antonios D.; Chang, Shu-Chun; Jovanovic, Biljana; Ciepla, Paulina; Masumoto, Naoko; Palmer, Christopher P.; Tate, Edward W.; Couchman, John R.; Magee, Anthony I.			Attenuation of Hedgehog Acyltransferase-Catalyzed Sonic Hedgehog Palmitoylation Causes Reduced Signaling, Proliferation and Invasiveness of Human Carcinoma Cells	PLOS ONE			English	Article							LIPID MODIFICATIONS; PATHWAY; INHIBITION; REQUIREMENT; DIFFERENTIATION; ACTIVATION; INDUCTION; DESERT; GROWTH; MODEL	Overexpression of Hedgehog family proteins contributes to the aetiology of many cancers. To be highly active, Hedgehog proteins must be palmitoylated at their N-terminus by the MBOAT family multispanning membrane enzyme Hedgehog acyltransferase (Hhat). In a pancreatic ductal adenocarcinoma (PDAC) cell line PANC-1 and transfected HEK293a cells Hhat localized to the endoplasmic reticulum. siRNA knockdown showed that Hhat is required for Sonic hedgehog (Shh) palmitoylation, for its assembly into high molecular weight extracellular complexes and for functional activity. Hhat knockdown inhibited Hh autocrine and juxtacrine signaling, and inhibited PDAC cell growth and invasiveness in vitro. In addition, Hhat knockdown in a HEK293a cell line constitutively expressing Shh and A549 human non-small cell lung cancer cells inhibited their ability to signal in a juxtacrine/paracrine fashion to the reporter cell lines C3H10T1/2 and Shh-Light2. Our data identify Hhat as a key player in Hh-dependent signaling and tumour cell transformed behaviour.	[Konitsiotis, Antonios D.; Chang, Shu-Chun; Jovanovic, Biljana; Magee, Anthony I.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Mol Med Sect, London, England; [Ciepla, Paulina; Masumoto, Naoko; Tate, Edward W.] Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AY, England; [Ciepla, Paulina; Masumoto, Naoko; Tate, Edward W.; Magee, Anthony I.] Univ London Imperial Coll Sci Technol & Med, Inst Chem Biol, London SW7 2AY, England; [Palmer, Christopher P.] London Metropolitan Univ, Inst Hlth Res & Policy, London, England; [Couchman, John R.] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark	Imperial College London; Imperial College London; Imperial College London; London Metropolitan University; University of Copenhagen	Magee, AI (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Mol Med Sect, London, England.	t.magee@imperial.ac.uk	Magee, Anthony/V-8345-2019; Masumoto, Naoko/AAH-6687-2021	Tate, Edward/0000-0003-2213-5814; Masumoto, Naoko/0000-0002-1609-5185; Ciepla, Paulina/0000-0002-5139-9635	UK Medical Research Council [G0700771]; Pancreatic Cancer Research Fund; National Heart & Lung Institute Foundation; Imperial College London Institute of Chemical Biology EPSRC Doctoral Training Centre [EP/F500416/1]; Danish National Research Foundation; Fabrikant Vilhelm Pedersen og Hustrus Legat; Novo Nordisk Fonden; Lundbeck Fonden; Danish Cancer Society [DP08019]; BBSRC [BB/D02014X/1]; Biotechnology and Biological Sciences Research Council [978583, BB/D02014X/1] Funding Source: researchfish; Cancer Research UK [16402] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Pancreatic Cancer Research Fund; National Heart & Lung Institute Foundation; Imperial College London Institute of Chemical Biology EPSRC Doctoral Training Centre(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Danish National Research Foundation(Danmarks Grundforskningsfond); Fabrikant Vilhelm Pedersen og Hustrus Legat; Novo Nordisk Fonden(Novo Nordisk Foundation); Lundbeck Fonden(Lundbeckfonden); Danish Cancer Society(Danish Cancer Society); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	This work was supported by UK Medical Research Council (www.mrc.ac.uk) grant #G0700771 to AIM and a grant from the Pancreatic Cancer Research Fund (www.pcrf.org.uk) grant to AIM and EWT. BJ was funded by a PhD studentship from the National Heart & Lung Institute Foundation (www.nhlif.info). PC and NM were funded by PhD studentships from the Imperial College London Institute of Chemical Biology EPSRC Doctoral Training Centre (grant EP/F500416/1; www.epsrc.ac.uk). JRC was supported by The Danish National Research Foundation (http://dg.dk/en/), Fabrikant Vilhelm Pedersen og Hustrus Legat (www.vplegat.dk), Novo Nordisk Fonden (www.novonordiskfonden.dk), Lundbeck Fonden (www.lundbeckfoundation.com) and was co-PI of Project DP08019 from the Danish Cancer Society (www.cancer.dk). EWT thanks BBSRC (www.bbsrc.ac.uk) for the award of a David Phillips Fellowship (grant BB/D02014X/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphe C, 2004, DEVELOPMENT, V131, P5009, DOI 10.1242/dev.01367; Barnett BP, 2010, SCIENCE, V330, P1689, DOI 10.1126/science.1196154; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; Buglino JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011195; Callejo A, 2006, DEVELOPMENT, V133, P471, DOI 10.1242/dev.02217; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chang SC, 2011, J BIOL CHEM, V286, P44391, DOI 10.1074/jbc.M111.285361; Chang SC, 2009, MOL MEMBR BIOL, V26, P104, DOI 10.1080/09687680802706432; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Chi SM, 2006, CANCER LETT, V244, P53, DOI 10.1016/j.canlet.2005.11.036; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Dierker T, 2009, J BIOL CHEM, V284, P8013, DOI 10.1074/jbc.M806838200; Farzan SF, 2008, AM J PHYSIOL-GASTR L, V294, pG844, DOI 10.1152/ajpgi.00564.2007; Fokin VV, 2007, ACS CHEM BIOL, V2, P775, DOI 10.1021/cb700254v; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Hatsell S, 2007, J MAMMARY GLAND BIOL, V12, P163, DOI 10.1007/s10911-007-9048-2; Heal WP, 2008, ORG BIOMOL CHEM, V6, P2308, DOI 10.1039/b803258k; Heal WP, 2011, CHEM COMMUN, V47, P4081, DOI 10.1039/c0cc04710d; Jacob L, 2007, SCIENCE, V318, P66, DOI 10.1126/science.1147314; Katano M, 2005, CANCER LETT, V227, P99, DOI 10.1016/j.canlet.2004.11.030; Kohtz JD, 2001, DEVELOPMENT, V128, P2351; Lee JD, 2001, CURR BIOL, V11, P1147, DOI 10.1016/S0960-9822(01)00323-2; Lehnert L, 1999, ANN NY ACAD SCI, V880, P83, DOI 10.1111/j.1749-6632.1999.tb09512.x; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; Micchelli CA, 2002, DEVELOPMENT, V129, P843; Nakajima A, 2008, CANCER SCI, V99, P1892, DOI 10.1111/j.1349-7006.2008.00904.x; Nakamura T, 1997, BIOCHEM BIOPH RES CO, V237, P465, DOI 10.1006/bbrc.1997.7156; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Ohlig S, 2012, J BIOL CHEM, V287, P43708, DOI 10.1074/jbc.M112.356667; Ohlig S, 2011, DEV CELL, V20, P764, DOI 10.1016/j.devcel.2011.05.010; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Pathi S, 2001, MECH DEVELOP, V106, P107, DOI 10.1016/S0925-4773(01)00427-0; Petrova E, 2013, NAT CHEM BIOL, V9, P247, DOI [10.1038/NCHEMBIO.1184, 10.1038/nchembio.1184]; Proffitt KD, 2013, CANCER RES, V73, P502, DOI 10.1158/0008-5472.CAN-12-2258; Rodriguez-Blanco J, 2013, ONCOGENE, V32, P2335, DOI 10.1038/onc.2012.243; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Sirivatanauksorn V, 2001, INT J CANCER, V91, P350, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1049>3.3.CO;2-3; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Tian H, 2009, P NATL ACAD SCI USA, V106, P4254, DOI 10.1073/pnas.0813203106; Turner TT, 2004, J ANDROL, V25, P514; van den Brink GR, 2007, PHYSIOL REV, V87, P1343, DOI 10.1152/physrev.00054.2006; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Yang J, 2008, P NATL ACAD SCI USA, V105, P10750, DOI 10.1073/pnas.0805353105; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Yuan Z, 2007, ONCOGENE, V26, P1046, DOI 10.1038/sj.onc.1209860; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200	51	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e89899	10.1371/journal.pone.0089899	http://dx.doi.org/10.1371/journal.pone.0089899			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608521	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000332485800012
J	Slagt, IKB; IJzermans, JNM; Visser, LJ; Weimar, W; Roodnat, JI; Terkivatan, T				Slagt, Inez K. B.; IJzermans, Jan N. M.; Visser, Laurents J.; Weimar, Willem; Roodnat, Joke I.; Terkivatan, Turkan			Independent Risk Factors for Urological Complications after Deceased Donor Kidney Transplantation	PLOS ONE			English	Article							MULTIPLE RENAL-ARTERIES; HEART-BEATING DONORS; EXTRAVESICAL URETERONEOCYSTOSTOMY; URETERAL COMPLICATIONS; METAANALYSIS; NEPHRECTOMY; EXPERIENCE; SURVIVAL; IMPACT	Urological complications after kidney transplantation are mostly related to the ureteroneocystostomy, often requiring interventions with additional costs, morbidity and mortality. Our aim was to assess risk factors for urological complications in deceased donor kidney transplantation. Between January 2000 and December 2011, 566 kidney transplantations were performed with deceased donor kidneys. Recipients were divided in a group with, and a group without urological complications, defined as the need for a percutaneous nephrostomy catheter or surgical revision of the ureteroneocystostomy. Univariate and multivariate analyses were performed. Univariate analysis showed increased number of male donors (p = 0.041), male recipients (p = 0.002), pre-emptively transplanted recipients (p = 0.007), and arterial reconstructions (p = 0.004) in the group with urological complications. Less urological complications occurred in recipients on hemodialysis (p = 0.005). More overall surgical interventions (p < 0.001), surgical site infections (p = 0.042), urinary tract infections (p < 0.001) and lymphoceles (p < 0.001) occurred in the group with urological complications. Multivariate analysis showed that male recipients (p = 0.010) and arterial reconstructions (p = 0.019) were independent risk factors. No difference was found between both groups in patient or graft survival. In conclusion, recipient male gender and arterial reconstruction are independent risk factors for urological complications after deceased donor kidney transplantation. Nevertheless, graft and recipient survival is not different between both groups.	[Slagt, Inez K. B.; IJzermans, Jan N. M.; Visser, Laurents J.; Terkivatan, Turkan] Erasmus MC, Univ Med Ctr, Div Transplant Surg, Dept Surg, Rotterdam, Netherlands; [Weimar, Willem; Roodnat, Joke I.] Erasmus MC, Univ Med Ctr, Div Nephrol, Dept Internal Med, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Terkivatan, T (corresponding author), Erasmus MC, Univ Med Ctr, Div Transplant Surg, Dept Surg, Rotterdam, Netherlands.	t.terkivatan@erasmusmc.nl	Roodnat, Joke/GLN-4175-2022					Alberts VP, 2012, UROL INT, V88, P333, DOI 10.1159/000335329; Butterworth PC, 1997, BRIT J UROL, V79, P499, DOI 10.1046/j.1464-410X.1997.00117.x; Carter JT, 2005, AM J TRANSPLANT, V5, P1312, DOI 10.1111/j.1600-6143.2005.00859.x; Dinckan A, 2007, TRANSPL INT, V20, P702, DOI 10.1111/j.1432-2277.2007.00500.x; Dols LFC, 2011, TRANSPL P, V43, P1623, DOI 10.1016/j.transproceed.2011.01.186; Dunkin BJ, 2000, J AM COLL SURGEONS, V190, P96, DOI 10.1016/S1072-7515(99)00210-0; GREGOIR W, 1964, Acta Chir Belg, V63, P431; Kayler L, 2010, TRANSPL P, V42, P1413, DOI 10.1016/j.transproceed.2010.04.016; Keizer KM, 2005, TRANSPLANTATION, V79, P1195, DOI 10.1097/01.TP.0000160765.66962.0B; Khairoun M, 2009, TRANSPL INT, V22, P192, DOI 10.1111/j.1432-2277.2008.00756.x; Koffman G, 2003, J NEPHROL, V16, P334; KOOTSTRA G, 1995, TRANSPLANT P, V27, P2893; Krol R, 2006, TRANSPL P, V38, P127, DOI 10.1016/j.transproceed.2005.12.100; Kuo PC, 1998, AM J SURG, V176, P559, DOI 10.1016/S0002-9610(98)00260-8; Laging M, 2012, TRANSPL INT; Mangus RS, 2004, AM J TRANSPLANT, V4, P1889, DOI 10.1111/j.1600-6143.2004.00595.x; Neri F, 2009, TRANSPL P, V41, P1224, DOI 10.1016/j.transproceed.2009.03.044; POLITANO VA, 1958, J UROLOGY, V79, P932, DOI 10.1016/S0022-5347(17)66369-9; Praz V, 2005, UROL INT, V75, P144, DOI 10.1159/000087169; Slagt IKB, 2012, TRANSPLANTATION, V94, P1179, DOI 10.1097/TP.0b013e3182643544; Streeter EH, 2002, BJU INT, V90, P627, DOI 10.1046/j.1464-410X.2002.03004.x; van Roijen JH, 2001, J UROLOGY, V165, P1884, DOI 10.1016/S0022-5347(05)66234-9; Wilson CH, 2005, TRANSPLANTATION, V80, P877, DOI 10.1097/01.tp.0000181197.21706.fa; Zavos G, 2008, TRANSPL P, V40, P1386, DOI 10.1016/j.transproceed.2008.03.103	24	27	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91211	10.1371/journal.pone.0091211	http://dx.doi.org/10.1371/journal.pone.0091211			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608797	Green Published, gold, Green Submitted			2022-12-25	WOS:000332485800115
J	Padmanabhan, RK; Somasundar, VH; Griffith, SD; Zhu, JL; Samoyedny, D; Tan, KS; Hu, JH; Liao, XJ; Carin, L; Yoon, SS; Flaherty, KT; DiPaola, RS; Heitjan, DF; Lal, P; Feldman, MD; Roysam, B; Lee, WMF				Padmanabhan, Raghav K.; Somasundar, Vinay H.; Griffith, Sandra D.; Zhu, Jianliang; Samoyedny, Drew; Tan, Kay See; Hu, Jiahao; Liao, Xuejun; Carin, Lawrence; Yoon, Sam S.; Flaherty, Keith T.; DiPaola, Robert S.; Heitjan, Daniel F.; Lal, Priti; Feldman, Michael D.; Roysam, Badrinath; Lee, William M. F.			An Active Learning Approach for Rapid Characterization of Endothelial Cells in Human Tumors	PLOS ONE			English	Article							GENE-EXPRESSION DATA; ANGIOGENESIS; QUANTIFICATION; BEVACIZUMAB; RELEVANCE; CANCER	Currently, no available pathological or molecular measures of tumor angiogenesis predict response to antiangiogenic therapies used in clinical practice. Recognizing that tumor endothelial cells (EC) and EC activation and survival signaling are the direct targets of these therapies, we sought to develop an automated platform for quantifying activity of critical signaling pathways and other biological events in EC of patient tumors by histopathology. Computer image analysis of EC in highly heterogeneous human tumors by a statistical classifier trained using examples selected by human experts performed poorly due to subjectivity and selection bias. We hypothesized that the analysis can be optimized by a more active process to aid experts in identifying informative training examples. To test this hypothesis, we incorporated a novel active learning (AL) algorithm into FARSIGHT image analysis software that aids the expert by seeking out informative examples for the operator to label. The resulting FARSIGHT-AL system identified EC with specificity and sensitivity consistently greater than 0.9 and outperformed traditional supervised classification algorithms. The system modeled individual operator preferences and generated reproducible results. Using the results of EC classification, we also quantified proliferation (Ki67) and activity in important signal transduction pathways (MAP kinase, STAT3) in immunostained human clear cell renal cell carcinoma and other tumors. FARSIGHT-AL enables characterization of EC in conventionally preserved human tumors in a more automated process suitable for testing and validating in clinical trials. The results of our study support a unique opportunity for quantifying angiogenesis in a manner that can now be tested for its ability to identify novel predictive and response biomarkers.	[Padmanabhan, Raghav K.; Somasundar, Vinay H.; Roysam, Badrinath] Univ Houston, Dept Elect & Comp Engn, Houston, TX 77004 USA; [Griffith, Sandra D.] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Zhu, Jianliang; Samoyedny, Drew; Hu, Jiahao; Lee, William M. F.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Tan, Kay See; Heitjan, Daniel F.] Univ Penn, Dept Biostat & Epidemiol, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Liao, Xuejun; Carin, Lawrence] Duke Univ, Dept Elect & Comp Engn, Durham, NC USA; [Yoon, Sam S.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Flaherty, Keith T.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Flaherty, Keith T.] MGH, Dept Med, Boston, MA USA; [DiPaola, Robert S.] Canc Inst New Jersey, New Brunswick, NJ USA; [DiPaola, Robert S.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA; [Heitjan, Daniel F.; Feldman, Michael D.; Lee, William M. F.] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Lal, Priti; Feldman, Michael D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA	University of Houston System; University of Houston; Cleveland Clinic Foundation; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Duke University; Memorial Sloan Kettering Cancer Center; Harvard University; Harvard Medical School; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Padmanabhan, RK (corresponding author), Univ Houston, Dept Elect & Comp Engn, Houston, TX 77004 USA.	raghav.krishna@gmail.com; broysam@central.uh.edu; leemingf@mail.med.upenn.edu		Carin, Lawrence/0000-0001-6277-7948	National Institutes of Health [R01 CA135509, T32 CA093283]; NATIONAL CANCER INSTITUTE [T32CA093283, P30CA016520, R01CA135509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants R01 CA135509 (W.M.F.L., B.R., D.F.H., P.L., K.T.F) and T32 CA093283 (S.D.G.) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kofahi Y, 2011, HISTOPATHOLOGY, V59, P40, DOI 10.1111/j.1365-2559.2011.03878.x; Al-Kofahi Y, 2010, IEEE T BIO-MED ENG, V57, P841, DOI 10.1109/TBME.2009.2035102; [Anonymous], 1908, BIOMETRIKA, V6, P1; Bache K, 2013, UCI MACHINE LEARNING; Bennett K. P., 2003, NATO SCI SERIES, V190, P227; Bjornsson CS, 2008, J NEUROSCI METH, V170, P165, DOI 10.1016/j.jneumeth.2007.12.024; Boykov Y, 2001, IEEE T PATTERN ANAL, V23, P1222, DOI 10.1109/34.969114; Chia SK, 2001, J CLIN ONCOL, V19, P3660, DOI 10.1200/JCO.2001.19.16.3660; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Doyle S, 2009, OPTIMHISE WORKSH MIC; Doyle S, 2010, LECT N BIOINFORMAT, V6282, P313, DOI 10.1007/978-3-642-16001-1_27; Eberhard A, 2000, CANCER RES, V60, P1388; Fedorov V, 1972, THEORY OPTIMAL EXPT; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Guo YH, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P823; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Kachites McCallum A., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P350; Lassoued W, 2010, CANCER BIOL THER, V10, P1326, DOI 10.4161/cbt.10.12.14009; Lee S.-I., 2006, EFFICIENT L1 REGULAR, V1, P401; Li LJ, 2011, HEMATOL ONCOL CLIN N, V25, P667, DOI 10.1016/j.hoc.2011.04.004; Liao XJ, 2009, IEEE T GEOSCI REMOTE, V47, P1454, DOI 10.1109/TGRS.2008.2005268; Lin G, 2007, CYTOM PART A, V71A, P724, DOI 10.1002/cyto.a.20430; Liu Y, 2004, J CHEM INF COMP SCI, V44, P1936, DOI 10.1021/ci049810a; McAllister SS, 2010, J CLIN ONCOL, V28, P4022, DOI 10.1200/JCO.2010.28.4257; Murphy DA, 2006, AM J PATHOL, V169, P1875, DOI 10.2353/ajpath.2006.050711; Muslea I, 2000, SELECTIVE SAMPLING R; Negrier S, 2012, INVEST NEW DRUG, V30, P1791, DOI 10.1007/s10637-011-9677-6; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Sharma S, 2005, HISTOPATHOLOGY, V46, P481, DOI 10.1111/j.1365-2559.2005.02142.x; Thomas MC, 2006, ELEMENTS INFORM THEO; Tong S, 2002, J MACH LEARN RES, V2, P45, DOI 10.1162/153244302760185243; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Wu XW, 2004, EURASIP J APPL SIG P, V2004, P53, DOI 10.1155/S1110865704309145; Xu ZB, 2007, LECT NOTES COMPUT SC, V4425, P246; Yao X, 2007, CLIN CANCER RES, V13, P161, DOI 10.1158/1078-0432.CCR-06-0774; Zhu X., 2003, ICML WORKSH CONT LAB	38	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90495	10.1371/journal.pone.0090495	http://dx.doi.org/10.1371/journal.pone.0090495			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603893	Green Published, Green Submitted, gold			2022-12-25	WOS:000332483600057
J	Siegenthaler, C; Gunawan, R				Siegenthaler, Caroline; Gunawan, Rudiyanto			Assessment of Network Inference Methods: How to Cope with an Underdetermined Problem	PLOS ONE			English	Article								The inference of biological networks is an active research area in the field of systems biology. The number of network inference algorithms has grown tremendously in the last decade, underlining the importance of a fair assessment and comparison among these methods. Current assessments of the performance of an inference method typically involve the application of the algorithm to benchmark datasets and the comparison of the network predictions against the gold standard or reference networks. While the network inference problem is often deemed underdetermined, implying that the inference problem does not have a (unique) solution, the consequences of such an attribute have not been rigorously taken into consideration. Here, we propose a new procedure for assessing the performance of gene regulatory network (GRN) inference methods. The procedure takes into account the underdetermined nature of the inference problem, in which gene regulatory interactions that are inferable or non-inferable are determined based on causal inference. The assessment relies on a new definition of the confusion matrix, which excludes errors associated with non-inferable gene regulations. For demonstration purposes, the proposed assessment procedure is applied to the DREAM 4 In Silico Network Challenge. The results show a marked change in the ranking of participating methods when taking network inferability into account.	[Siegenthaler, Caroline; Gunawan, Rudiyanto] Swiss Fed Inst Technol, Inst Chem & Bioengn, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Gunawan, R (corresponding author), Swiss Fed Inst Technol, Inst Chem & Bioengn, Zurich, Switzerland.	rudi.gunawan@chem.ethz.ch	Gunawan, Rudiyanto/D-4650-2009	Gunawan, Rudiyanto/0000-0002-6480-7976	Swiss National Science Foundation [200021-137614]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was supported by the Swiss National Science Foundation (project number 200021-137614). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho A. V., 1972, SIAM Journal on Computing, V1, P131, DOI 10.1137/0201008; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Andersson SA, 1997, ANN STAT, V25, P505; Craciun G, 2008, J MATH CHEM, V44, P244, DOI 10.1007/s10910-007-9307-x; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; Emmert-Streib Frank, 2012, Frontiers in Genetics, V3, P8, DOI [10.3389/fgene.2012.00313, 10.3389/fgene.2012.00008]; Jaynes E, 1984, INVERSE PROBL, V14, P151; Marbach D., 2009, DRAFT VERSION 03; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Marbach D, 2009, ANN NY ACAD SCI, V1158, P234, DOI 10.1111/j.1749-6632.2008.03944.x; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Narendra V, 2011, GENOMICS, V97, P7, DOI 10.1016/j.ygeno.2010.10.003; Pearl J, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1203; Penfold CA, 2011, INTERFACE FOCUS, V1, P857, DOI 10.1098/rsfs.2011.0053; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Schaffter T, 2011, BIOINFORMATICS, V27, P2263, DOI 10.1093/bioinformatics/btr373; Spirtes P, 2010, J MACH LEARN RES, V11, P1643; Stolovitzky G, 2007, ANN NY ACAD SCI, V1115, P1, DOI 10.1196/annals.1407.021; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Szederkenyi G, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-177; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wagner A, 2001, BIOINFORMATICS, V17, P1183, DOI 10.1093/bioinformatics/17.12.1183	23	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90481	10.1371/journal.pone.0090481	http://dx.doi.org/10.1371/journal.pone.0090481			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603847	Green Published, gold, Green Submitted			2022-12-25	WOS:000332483600055
J	Adams, AK; Hallenbeck, GE; Casper, KA; Patil, YJ; Wilson, KM; Kimple, RJ; Lambert, PF; Witte, DP; Xiao, W; Gillison, ML; Wikenheiser-Brokamp, KA; Wise-Draper, TM; Wells, SI				Adams, A. K.; Hallenbeck, G. E.; Casper, K. A.; Patil, Y. J.; Wilson, K. M.; Kimple, R. J.; Lambert, P. F.; Witte, D. P.; Xiao, W.; Gillison, M. L.; Wikenheiser-Brokamp, K. A.; Wise-Draper, T. M.; Wells, S. I.			DEK promotes HPV-positive and -negative head and neck cancer cell proliferation	ONCOGENE			English	Article							HUMAN-PAPILLOMAVIRUS; EPIDERMAL MORPHOGENESIS; EPITHELIAL DEVELOPMENT; OROPHARYNGEAL CANCER; BREAST-CANCER; UNITED-STATES; E7 ONCOGENE; P63; EXPRESSION; CARCINOMA	Head and neck squamous cell carcinoma (HNSCC) is the sixth most common malignancy worldwide, and patient outcomes using current treatments remain poor. Tumor development is etiologically associated with tobacco or alcohol use and/or human papillomavirus (HPV) infection. HPV-positive HNSCCs, which frequently harbor wild-type p53, carry a more favorable prognosis and are a biologically distinct subgroup when compared with their HPV-negative counterparts. HPV E7 induces expression of the human DEK gene, both in vitro and in vivo. In keratinocytes, DEK overexpression is sufficient for causing oncogenic phenotypes in the absence of E7. Conversely, DEK loss results in cell death in HPV-positive cervical cancer cells at least in part through p53 activation, and Dek knockout mice are relatively resistant to the development of chemically induced skin papillomas. Despite the established oncogenic role of DEK in HPV-associated cervical cancer cell lines and keratinocytes, a functional role of DEK has not yet been explored in HNSCC. Using an established transgenic mouse model of HPV16 E7-induced HNSCC, we demonstrate that Dek is required for optimal proliferation of E7-transgenic epidermal cells and for the growth of HNSCC tumors. Importantly, these studies also demonstrate that DEK protein is universally upregulated in both HPV-positive and -negative human HNSCC tumors relative to adjacent normal tissue. Furthermore, DEK knockdown inhibited the proliferation of HPV-positive and -negative HNSCC cells, establishing a functional role for DEK in human disease. Mechanistic studies reveal that attenuated HNSCC cell growth in response to DEK loss was associated with reduced expression of the oncogenic p53 family member, Delta Np63. Exogenous Delta Np63 expression rescued the proliferative defect in the absence of DEK, thereby establishing a functional DEK-Delta Np63 oncogenic pathway that promotes HNSCC. Taken together, our data demonstrate that DEK stimulates HNSCC cellular growth and identify Delta Np63 as a novel DEK effector.	[Adams, A. K.; Hallenbeck, G. E.; Wise-Draper, T. M.; Wells, S. I.] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA; [Casper, K. A.; Patil, Y. J.; Wilson, K. M.] Univ Cincinnati, Dept Otolaryngol Head & Neck Surg, Cincinnati, OH 45267 USA; [Kimple, R. J.; Lambert, P. F.] Univ Wisconsin, Sch Med & Publ Hlth, McArdle Lab Canc Res, Madison, WI USA; [Witte, D. P.] Cincinnati Childrens Hosp Med Ctr, Div Pathol & Lab Med, Cincinnati, OH 45229 USA; [Xiao, W.; Gillison, M. L.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Wikenheiser-Brokamp, K. A.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Pathol & Lab Med & Pulm Biol, Cincinnati, OH 45267 USA; [Wise-Draper, T. M.] Univ Cincinnati, Univ Hosp, Div Hematol Oncol, Cincinnati, OH 45267 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Wisconsin System; University of Wisconsin Madison; Cincinnati Children's Hospital Medical Center; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Wise-Draper, TM (corresponding author), Univ Cincinnati, Dept Hematol Oncol, 231 Albert Sabin Way,ML 0562, Cincinnati, OH 45267 USA.	wiseth@uc.edu; Susanne.Wells@cchmc.org	Kimple, Randall/L-6460-2019	Kimple, Randall/0000-0001-8336-8000; Wise-Draper, Trisha/0000-0002-7279-4028	NIH [T32ES007250, R00 CA160639, AR-47363, DK78392, DK90971]; Clinical Scientist Training Program at the University of Cincinnati, Public Health Service from the NIH [R01 CA116316]; NATIONAL CANCER INSTITUTE [R01CA116316, R00CA160639, T32CA117846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR047363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090971, P30DK078392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007250] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Scientist Training Program at the University of Cincinnati, Public Health Service from the NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Clinical Scientist Training Program at the University of Cincinnati (TWD), Public Health Service Grant R01 CA116316 from the NIH (SIW), NIH Training Grant T32ES007250 (AKA) and R00 CA160639 from the NIH (RJK). All flow cytometric data were acquired using equipment in the Research Flow Cytometry Core in the Division of Rheumatology at Cincinnati Children's Hospital Medical Center, supported in part by NIH AR-47363, NIH DK78392 and NIH DK90971. We would like to acknowledge the CCHMC pathology core with excellent technical support by Meredith Taylor for Ventana HPV in situ hybridization, Dr Madhavi Kadakia for providing the HA-Delta Np63 construct, Marie Matrka for providing protein lysates, and expert technical support by Dr Ronald Waclaw for use of his Leica microscope.	Alexandrova EM, 2013, CELL DEATH DIFFER, V20, P1698, DOI 10.1038/cdd.2013.122; Alexiadis V, 2000, GENE DEV, V14, P1308; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Bradford CR, 2003, HEAD NECK-J SCI SPEC, V25, P654, DOI 10.1002/hed.10274; Carro MS, 2006, CELL CYCLE, V5, P1202, DOI 10.4161/cc.5.11.2801; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Gupta S, 2009, INT J CANCER, V125, P2159, DOI 10.1002/ijc.24533; Herber R, 1996, J VIROL, V70, P1873, DOI 10.1128/JVI.70.3.1873-1881.1996; Hoskins EE, 2009, ONCOGENE, V28, P674, DOI 10.1038/onc.2008.416; Jabbar S, 2010, VIROLOGY, V407, P60, DOI 10.1016/j.virol.2010.08.003; Kappes F, 2008, MOL CELL BIOL, V28, P3245, DOI 10.1128/MCB.01921-07; Khodadoust MS, 2009, CANCER RES, V69, P6405, DOI 10.1158/0008-5472.CAN-09-1063; Kimple RJ, 2013, CANCER RES, V73, P4791, DOI 10.1158/0008-5472.CAN-13-0587; Koster MI, 2007, P NATL ACAD SCI USA, V104, P3255, DOI 10.1073/pnas.0611376104; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Liu SP, 2012, PATHOL INT, V62, P176, DOI 10.1111/j.1440-1827.2011.02775.x; Lu ZL, 2005, WORLD J GASTROENTERO, V11, P3850; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Moll UM, 2004, MOL CANCER RES, V2, P371; National Comprehensive Cancer Network, 2008, J Natl Compr Canc Netw, V6, P646; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pignon JC, 2013, P NATL ACAD SCI USA, V110, P8105, DOI 10.1073/pnas.1221216110; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Romano RA, 2012, DEVELOPMENT, V139, P772, DOI 10.1242/dev.071191; Sitwala KV, 2002, ONCOGENE, V21, P8862, DOI 10.1038/sj.onc.1206041; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Strati K, 2007, CANCER RES, V67, P11585, DOI 10.1158/0008-5472.CAN-07-3007; Strati K, 2006, P NATL ACAD SCI USA, V103, P14152, DOI 10.1073/pnas.0606698103; Su XH, 2013, NAT REV CANCER, V13, P136, DOI 10.1038/nrc3446; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Vinnedge LMP, 2011, ONCOGENE, V30, P2741, DOI 10.1038/onc.2011.2; Vinnedge LMP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046985; VONLINDERN M, 1992, MOL CELL BIOL, V12, P1687, DOI 10.1128/MCB.12.4.1687; Wise-Draper TM, 2005, J VIROL, V79, P14309, DOI 10.1128/JVI.79.22.14309-14317.2005; Wise-Draper TM, 2006, MOL CELL BIOL, V26, P7506, DOI 10.1128/MCB.00430-06; Wise-Draper TM, 2012, TRANSL RES, V160, P167, DOI 10.1016/j.trsl.2012.02.002; Wise-Draper TM, 2009, CANCER RES, V69, P1792, DOI 10.1158/0008-5472.CAN-08-2304; Wise-Draper TM, 2009, AM J PATHOL, V174, P71, DOI 10.2353/ajpath.2009.080330; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539	42	34	40	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 12	2015	34	7					868	877		10.1038/onc.2014.15	http://dx.doi.org/10.1038/onc.2014.15			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CB2QF	24608431	Green Accepted			2022-12-25	WOS:000349472000007
J	Richards, J; Ko, B; All, S; Cheng, KY; Hoover, RS; Gumz, ML				Richards, Jacob; Ko, Benjamin; All, Sean; Cheng, Kit-Yan; Hoover, Robert S.; Gumz, Michelle L.			A Role for the Circadian Clock Protein Per1 in the Regulation of the NaCl Co-transporter ( NCC) and the with-no-lysine Kinase ( WNK) Cascade in Mouse Distal Convoluted Tubule Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Circadian Clock; Gene Expression; Kidney; Renal Physiology; Sodium Transport; Transcription	ALPHA-ENAC EXPRESSION; NA+/H+ EXCHANGER NHE3; GENE-EXPRESSION; BLOOD-PRESSURE; PERIOD 1; TRANSCRIPTIONAL ACTIVITY; PHOSPHORYLATION; RHYTHMICITY; INHIBITION; FEEDBACK	Background: The role of the circadian protein Per1 in the regulation of sodium reabsorption in the distal convoluted tubule (DCT) is unknown. Results: Per1 transcriptionally regulates the sodium transporter NCC and the WNK kinase cascade. Conclusion: Per1 regulates sodium reabsorption in the DCT through NCC and the WNK cascade. Significance: These data demonstrate a role for Per1 in the regulation of renal sodium transporters. It has been well established that blood pressure and renal function undergo circadian fluctuations. We have demonstrated that the circadian protein Per1 regulates multiple genes involved in sodium transport in the collecting duct of the kidney. However, the role of Per1 in other parts of the nephron has not been investigated. The distal convoluted tubule (DCT) plays a critical role in renal sodium reabsorption. Sodium is reabsorbed in this segment through the actions of the NaCl co-transporter (NCC), which is regulated by the with-no-lysine kinases (WNKs). The goal of this study was to test if Per1 regulates sodium transport in the DCT through modulation of NCC and the WNK kinases, WNK1 and WNK4. Pharmacological blockade of nuclear Per1 entry resulted in decreased mRNA expression of NCC and WNK1 but increased expression of WNK4 in the renal cortex of mice. These findings were confirmed by using Per1 siRNA and pharmacological blockade of Per1 nuclear entry in mDCT15 cells, a model of the mouse distal convoluted tubule. Transcriptional regulation was demonstrated by changes in short lived heterogeneous nuclear RNA. Chromatin immunoprecipitation experiments demonstrated interaction of Per1 and CLOCK with the promoters of NCC, WNK1, and WNK4. This interaction was modulated by blockade of Per1 nuclear entry. Importantly, NCC protein expression and NCC activity, as measured by thiazide-sensitive, chloride-dependent Na-22 uptake, were decreased upon pharmacological inhibition of Per1 nuclear entry. Taken together, these data demonstrate a role for Per1 in the transcriptional regulation of NCC, WNK1, and WNK4.	[Richards, Jacob; All, Sean; Cheng, Kit-Yan; Gumz, Michelle L.] Univ Florida, Dept Med, Gainesville, FL 32610 USA; [Richards, Jacob; Gumz, Michelle L.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Ko, Benjamin] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Hoover, Robert S.] Emory Univ, Div Nephrol, Dept Med, Atlanta, GA 30322 USA; [Hoover, Robert S.] Atlanta Vet Affairs Med Ctr, Res Serv, Atlanta, GA 30033 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Chicago; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Gumz, ML (corresponding author), Univ Florida, Dept Med, Dept Biochem & Mol Biol, 1600 SW Archer Rd,Box 100224, Gainesville, FL 32610 USA.	Michelle.Gumz@medicine.ufl.edu	Gumz, Michelle/AGX-2097-2022	Gumz, Michelle/0000-0002-1342-0878; All, Sean/0000-0002-9191-083X	National Institutes of Health [DK085193, DK098460, NIHK08 DK081728, NIHR01 DK085097]; American Society of Nephrology Foundation for Kidney Research; American Heart Association Predoctoral Fellowship [13PRE16910096]; Research Service, Atlanta Veterans Affairs Medical Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK085193, R03DK098460, K08DK081728, R01DK085097] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Nephrology Foundation for Kidney Research; American Heart Association Predoctoral Fellowship(American Heart Association); Research Service, Atlanta Veterans Affairs Medical Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK085193 and DK098460 (to M. L. G.), NIHK08 DK081728 (to B. K.), and NIHR01 DK085097 (to R. S. H.). This work was also supported by the American Society of Nephrology Foundation for Kidney Research (to M. L. G.), American Heart Association Predoctoral Fellowship 13PRE16910096 (to J. R.), and the Research Service, Atlanta Veterans Affairs Medical Center (to R. S. H.).	Albrecht U, 2003, CURR OPIN GENET DEV, V13, P271, DOI 10.1016/S0959-437X(03)00055-8; Anea CB, 2009, CIRCULATION, V119, P1510, DOI 10.1161/CIRCULATIONAHA.108.827477; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balakrishnan A, 2012, DIGEST DIS SCI, V57, P1525, DOI 10.1007/s10620-012-2166-8; Bhutta HY, 2013, DIGEST DIS SCI, V58, P1537, DOI 10.1007/s10620-013-2669-y; Bonny O, 2013, CURR OPIN NEPHROL HY, V22, P439, DOI 10.1097/MNH.0b013e32836213b8; Bose S, 2010, ENDOCRINOLOGY, V151, P2287, DOI 10.1210/en.2009-1252; Bugaj V, 2008, AM J PHYSIOL-RENAL, V295, pF1063, DOI 10.1152/ajprenal.90321.2008; Chavez-Canales M, 2013, J HYPERTENS, V31, P303, DOI 10.1097/HJH.0b013e32835bbb83; Chen H, 2006, J NUTR, V136, P2463, DOI 10.1093/jn/136.10.2463; Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012; Curtis AM, 2007, P NATL ACAD SCI USA, V104, P3450, DOI 10.1073/pnas.0611680104; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Doi M, 2010, NAT MED, V16, P67, DOI 10.1038/nm.2061; Durgan DJ, 2010, CIRC RES, V106, P647, DOI 10.1161/CIRCRESAHA.109.209957; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Gamba G, 2012, AM J PHYSIOL-RENAL, V303, pF1573, DOI 10.1152/ajprenal.00508.2012; Gumz ML, 2010, BBA-GENE REGUL MECH, V1799, P622, DOI 10.1016/j.bbagrm.2010.09.003; Gumz ML, 2009, J CLIN INVEST, V119, P2423, DOI 10.1172/JCI36908; Ko B, 2013, AM J PHYSIOL-RENAL, V305, pF645, DOI 10.1152/ajprenal.00053.2013; Ko B, 2012, AM J PHYSIOL-RENAL, V303, pF700, DOI 10.1152/ajprenal.00139.2012; Ko B, 2009, CURR OPIN NEPHROL HY, V18, P421, DOI 10.1097/MNH.0b013e32832f2fcb; Kunieda T, 2008, CIRC RES, V102, P607, DOI 10.1161/CIRCRESAHA.107.162230; Lee HM, 2011, P NATL ACAD SCI USA, V108, P16451, DOI 10.1073/pnas.1107178108; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P9774, DOI 10.1073/pnas.86.24.9774; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubarski I, 2005, J BIOL CHEM, V280, P37717, DOI 10.1074/jbc.M506397200; Marques FZ, 2011, HYPERTENSION, V58, P1093, DOI 10.1161/HYPERTENSIONAHA.111.180729; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Nikolaeva S, 2012, J AM SOC NEPHROL, V23, P1019, DOI 10.1681/ASN.2011080842; Nishinaga H, 2009, BIOMED RES-TOKYO, V30, P87, DOI 10.2220/biomedres.30.87; Oster H, 2003, GENE DEV, V17, P1366, DOI 10.1101/gad.256103; Padmanabhan K, 2012, SCIENCE, V337, P599, DOI 10.1126/science.1221592; Perreau-Lenz S, 2012, NEUROPSYCHOPHARMACOL, V37, P2121, DOI 10.1038/npp.2012.62; Richards J, 2013, AM J PHYSIOL-RENAL, V305, pF1697, DOI 10.1152/ajprenal.00472.2013; Richards J, 2013, AM J PHYSIOL-REG I, V305, pR735, DOI 10.1152/ajpregu.00195.2013; Richards J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00253; Richards J, 2013, AM J PHYSIOL-REG I, V304, pR1053, DOI 10.1152/ajpregu.00066.2013; Richards J, 2012, AM J PHYSIOL-RENAL, V303, pF918, DOI 10.1152/ajprenal.00678.2011; Richards J, 2012, FASEB J, V26, P3602, DOI 10.1096/fj.12-203554; Rohman MS, 2005, KIDNEY INT, V67, P1410, DOI 10.1111/j.1523-1755.2005.00218.x; Sheward WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009783; Stow LR, 2012, HYPERTENSION, V59, P1151, DOI 10.1161/HYPERTENSIONAHA.112.190892; Stow LR, 2011, J AM SOC NEPHROL, V22, P598, DOI 10.1681/ASN.2010080803; Subramanya AR, 2006, AM J PHYSIOL-RENAL, V290, pF619, DOI 10.1152/ajprenal.00280.2005; Susa K, 2012, BIOCHEM BIOPH RES CO, V427, P743, DOI 10.1016/j.bbrc.2012.09.130; Suzuki J, 2010, HYPERTENS RES, V33, P1060, DOI 10.1038/hr.2010.125; Vukolic A, 2010, AM J PHYSIOL-REG I, V298, pR627, DOI 10.1152/ajpregu.00404.2009; Yang CL, 2005, J CLIN INVEST, V115, P1379, DOI 10.1172/JCI200522452; Zagorska A, 2007, J CELL BIOL, V176, P89, DOI 10.1083/jcb.200605093; Zuber AM, 2009, P NATL ACAD SCI USA, V106, P16523, DOI 10.1073/pnas.0904890106	52	42	45	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11791	11806		10.1074/jbc.M113.531095	http://dx.doi.org/10.1074/jbc.M113.531095			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24610784	Green Published, hybrid			2022-12-25	WOS:000335010600020
J	Chen, J; Liang, L; Zhan, LB; Zhou, Y; Zheng, LP; Sun, XX; Gong, J; Sui, H; Jiang, RJ; Zhang, FL; Zhang, L				Chen, Jing; Liang, Lina; Zhan, Libin; Zhou, Yan; Zheng, Luping; Sun, Xiaoxin; Gong, Jin; Sui, Hua; Jiang, Rujiao; Zhang, Fuliang; Zhang, Lin			ZiBuPiYin Recipe Protects db/db Mice from Diabetes-Associated Cognitive Decline through Improving Multiple Pathological Changes	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; DENDRITIC SPINE; LEPTIN; BRAIN; NEURONS; GSK-3-BETA; DISORDERS; PROTEINS; RATS	Multiple organ systems, including the brain, which undergoes changes that may increase the risk of cognitive decline, are adversely affected by diabetes mellitus (DM). Here, we demonstrate that type 2 diabetes mellitus (T2DM) db/db mice exhibited hippocampus-dependent memory impairment, which might associate with a reduction in dendritic spine density in the pyramidal neurons of brain, A beta(1-42) deposition in the prefrontal cortex (PFC) and hippocampus, and a decreased expression of neurostructural proteins including microtubule-associated protein (MAP2), a marker of dendrites, and postsynaptic density 95 (PSD95), a marker of excitatory synapses. To investigate the effects of the ZiBuPiYin recipe (ZBPYR), a traditional Chinese medicine recipe, on diabetes-related cognitive decline (DACD), db/db mice received daily administration of ZBPYR over an experimental period of 6 weeks. We then confirmed that ZBPYR rescued learning and memory performance impairments, reversed dendritic spine loss, reduced A beta(1-42) deposition and restored the expression levels of MAP2 and PSD95. The present study also revealed that ZBPYR strengthened brain leptin and insulin signaling and inhibited GSK3 beta overactivity, which may be the potential mechanism or underlying targets of ZBPYR. These findings conclude that ZBPYR prevents DACD, most likely by improving dendritic spine density and attenuating brain leptin and insulin signaling pathway injury. Our findings provide further evidence for the effects of ZBPYR on DACD.	[Chen, Jing; Zhan, Libin; Zhou, Yan] Dalian Med Univ, Affiliated Hosp 2, Dalian, Liaoning, Peoples R China; [Liang, Lina; Zhan, Libin; Zheng, Luping; Sun, Xiaoxin; Sui, Hua; Jiang, Rujiao; Zhang, Lin] Dalian Med Univ, Coll Inst Integrat Med, Dalian, Liaoning, Peoples R China; [Gong, Jin] Dalian Med Univ, Dept Anat, Dalian, Liaoning, Peoples R China; [Zhang, Fuliang] Dalian Med Univ, Dept Publ Hlth, Dalian, Liaoning, Peoples R China	Dalian Medical University; Dalian Medical University; Dalian Medical University; Dalian Medical University	Zhan, LB (corresponding author), Dalian Med Univ, Affiliated Hosp 2, Dalian, Liaoning, Peoples R China.	libinzhan@hotmail.com		Chen, Jing/0000-0001-6751-0935	National Natural Science Foundation, China [81230084]; Specialized Research Fund for the Doctoral Program of Higher Education, China [20112105110006]; Program for Professor of Special Appointment in Liaoning Province	National Natural Science Foundation, China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education, China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Program for Professor of Special Appointment in Liaoning Province	This work was financially supported by The Key Project of National Natural Science Foundation, China (No. 81230084), The Specialized Research Fund for the Doctoral Program of Higher Education, China (No. 20112105110006) and The Program for Professor of Special Appointment in Liaoning Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahtiluoto S, 2010, NEUROLOGY, V75, P1195, DOI 10.1212/WNL.0b013e3181f4d7f8; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Bhatt DH, 2009, ANNU REV PHYSIOL, V71, P261, DOI 10.1146/annurev.physiol.010908.163140; Chiu SL, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-7; Clodfelder-Miller B, 2005, J BIOL CHEM, V280, P39723, DOI 10.1074/jbc.M508824200; Dehmelt L, 2005, GENOME BIOL, V6; Dinel AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024325; Gonzalez-Ramirez MM, 2014, NEUROBIOL LEARN MEM, V109, P94, DOI 10.1016/j.nlm.2013.11.017; Guo ZH, 2008, J BIOL CHEM, V283, P1754, DOI 10.1074/jbc.M703753200; Hains AB, 2009, P NATL ACAD SCI USA, V106, P17957, DOI 10.1073/pnas.0908563106; Hamilton GF, 2010, SYNAPSE, V64, P127, DOI 10.1002/syn.20711; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Irvine EE, 2011, LEARN MEMORY, V18, P375, DOI 10.1101/lm.2111311; Jones TS, 2012, NEURAL PLAST, V2012, P1; Keith D, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.004.2008; Kopf D, 2009, J ALZHEIMERS DIS, V16, P677, DOI 10.3233/JAD-2009-1011; Kulkarni VA, 2012, MOL CELL NEUROSCI, V50, P10, DOI 10.1016/j.mcn.2012.03.005; Lee CC, 2011, NEUROPHARMACOLOGY, V61, P867, DOI 10.1016/j.neuropharm.2011.06.003; Li XL, 2012, EXP THER MED, V4, P125, DOI 10.3892/etm.2012.562; Morrison CD, 2009, BBA-MOL BASIS DIS, V1792, P401, DOI 10.1016/j.bbadis.2008.12.004; Murphy GG, 2013, EPILEPSY CURR, V13, P26, DOI 10.5698/1535-7511-13.1.26; Oomura Yutaka, 2010, Pathophysiology, V17, P119, DOI 10.1016/j.pathophys.2009.04.004; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Perez Sylvia E, 2012, Int J Physiol Pathophysiol Pharmacol, V4, P115; Piao Y, 2012, EVID-BASED COMPL ALT, V2012, P1; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Ronn SG, 2007, DIABETES, V56, P541, DOI 10.2337/db06-1068; Sharma AN, 2010, PHYSIOL BEHAV, V101, P381, DOI 10.1016/j.physbeh.2010.07.002; Shen H, 2012, AM J PHYSIOL-ENDOC M, V302, pE932, DOI 10.1152/ajpendo.00479.2011; Shi X, 2011, DIABETOLOGIA, V54, P1888, DOI 10.1007/s00125-011-2147-z; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Stranahan AM, 2008, NAT NEUROSCI, V11, P309, DOI 10.1038/nn2055; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Tello PS, 2011, INT J ALZHEIMERS DIS, V2011, P1; Terry AV, 2009, FRONT NEUROSCI, P267; Tezapsidis N, 2009, J ALZHEIMERS DIS, V16, P731, DOI 10.3233/JAD-2009-1021; Valentinuzzi VS, 2004, J BIOL RHYTHM, V19, P312, DOI 10.1177/0748730404265688; Wen ZN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018278; Yin J, 2009, AM J PHYSIOL-ENDOC M, V296, pE1275, DOI 10.1152/ajpendo.00092.2009; Zhan LB, 2008, CHIN J INTEGR MED, V14, P117, DOI 10.1007/s11655-008-0117-1; Zhan Li-bin, 2009, Zhong Xi Yi Jie He Xue Bao, V7, P242; Zhang J, 2007, AM J PHYSIOL-REG I, V292, pR868, DOI 10.1152/ajpregu.00213.2006; Zhao Q, 2011, J PHARMACOL SCI, V117, P230, DOI 10.1254/jphs.11115FP; Zhou FQ, 2005, SCIENCE, V308, P211, DOI 10.1126/science.1110301	45	35	37	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91680	10.1371/journal.pone.0091680	http://dx.doi.org/10.1371/journal.pone.0091680			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614172	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300148
J	Chen, RX; Song, HY; Dong, YY; Hu, C; Zheng, QD; Xue, TC; Liu, XH; Zhang, Y; Chen, J; Ren, ZG; Liu, YK; Cui, JF				Chen, Rong-Xin; Song, Hai-Yan; Dong, Yin-Ying; Hu, Chao; Zheng, Qiong-Dan; Xue, Tong-Chun; Liu, Xiao-Hui; Zhang, Yang; Chen, Jie; Ren, Zheng-Gang; Liu, Yin-Kun; Cui, Jie-Feng			Dynamic Expression Patterns of Differential Proteins during Early Invasion of Hepatocellular Carcinoma	PLOS ONE			English	Article							METASTATIC POTENTIALS; CANCER METASTASIS; CELLS; MODELS; IDENTIFICATION; VIMENTIN; CULTURE; GENE	Background: Tumor cell invasion into the surrounding matrix has been well documented as an early event of metastasis occurrence. However, the dynamic expression patterns of proteins during early invasion of hepatocellular carcinoma (HCC) are largely unknown. Using a three-dimensional HCC invasion culture model established previously, we investigated the dynamic expression patterns of identified proteins during early invasion of HCC. Materials and Methods: Highly metastatic MHCC97H cells and a liver tissue fragment were long-term co-cultured in a rotating wall vessel (RWV) bioreactor to simulate different pathological states of HCC invasion. The established spherical co-cultures were collected on days 0, 5, 10, and 15 for dynamic expression pattern analysis. Significantly different proteins among spheroids at different time points were screened and identified using quantitative proteomics of iTRAQ labeling coupled with LC-MS/MS. Dynamic expression patterns of differential proteins were further categorized by K-means clustering. The expression modes of several differentially expressed proteins were confirmed by Western blot and qRT-PCR. Results: Time course analysis of invasion/metastasis gene expressions (MMP2, MMP7, MMP9, CD44, SPP1, CXCR4, CXCL12, and CDH1) showed remarkable, dynamic alterations during the invasion process of HCC. A total of 1,028 proteins were identified in spherical co-cultures collected at different time points by quantitative proteomics. Among these proteins, 529 common differential proteins related to HCC invasion were clustered into 25 types of expression patterns. Some proteins displayed significant dynamic alterations during the early invasion process of HCC, such as upregulation at the early invasion stage and downregulation at the late invasion stage (e. g., MAPRE1, PHB2, cathepsin D, etc.) or continuous upregulation during the entire invasion process (e. g., vitronectin, Met, clusterin, ICAM1, GSN, etc.). Conclusions: Dynamic expression patterns of candidate proteins during the early invasion process of HCC facilitate the discovery of new molecular targets for early intervention to prevent HCC invasion and metastasis.	[Chen, Rong-Xin; Dong, Yin-Ying; Zheng, Qiong-Dan; Xue, Tong-Chun; Chen, Jie; Ren, Zheng-Gang; Liu, Yin-Kun; Cui, Jie-Feng] Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Shanghai 200032, Peoples R China; [Chen, Rong-Xin; Dong, Yin-Ying; Zheng, Qiong-Dan; Xue, Tong-Chun; Chen, Jie; Ren, Zheng-Gang; Liu, Yin-Kun; Cui, Jie-Feng] Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai, Peoples R China; [Song, Hai-Yan] Shanghai Univ Tradit Chinese Med, Inst Digest Dis, Longhua Hosp, Shanghai, Peoples R China; [Hu, Chao] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Shanghai 200030, Peoples R China; [Liu, Xiao-Hui; Zhang, Yang] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Shanghai University of Traditional Chinese Medicine; Shanghai Jiao Tong University; Fudan University	Cui, JF (corresponding author), Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Shanghai 200032, Peoples R China.	cui.jiefeng@zs-hospital.sh.cn	Dong, Yinying/HHC-3041-2022	Hu, Chao/0000-0001-5895-6038	National Natural Science Foundation of China [81071902, 81272583, 81272723, 81000909]; Shanghai Science and Technology Program [11JC1402100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Program	This study was sponsored by grants from the National Natural Science Foundation of China (Nos. 81071902; 81272583; 81272723; and 81000909) and the Shanghai Science and Technology Program (No. 11JC1402100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chakrabarti A, 2012, ANN BIOMED ENG, V40, P2488, DOI 10.1007/s10439-012-0655-8; Chen B, 2013, CELL BIOL INT, V37, P643, DOI 10.1002/cbin.10062; Chen RX, 2012, ANN SURG ONCOL, V19, pS375, DOI 10.1245/s10434-011-1836-7; Cheng J, 2013, MOL CARCINOG; Ding SJ, 2004, PROTEOMICS, V4, P982, DOI 10.1002/pmic.200300653; Feng HX, 2010, J PROTEOMICS, V73, P1421, DOI 10.1016/j.jprot.2009.12.004; Goyal L, 2013, CLIN CANCER RES, V19, P2310, DOI 10.1158/1078-0432.CCR-12-2791; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He H, 2002, GENE EXPRESSION, V10, P231, DOI 10.3727/000000002783992406; Huang XF, 2000, WORLD J GASTROENTERO, V6, P693; Kim JB, 2005, SEMIN CANCER BIOL, V15, P365, DOI 10.1016/j.semcancer.2005.05.002; Kimlin LC, 2013, MOL CARCINOGEN, V52, P167, DOI 10.1002/mc.21844; Kitamura Y, 2011, ANTICANCER RES, V31, P1289; Lau SH, 2006, ONCOGENE, V25, P1242, DOI 10.1038/sj.onc.1209141; Lee JM, 2013, LAB INVEST, V93, P528, DOI 10.1038/labinvest.2013.41; Li Y, 2004, J CANCER RES CLIN, V130, P460, DOI 10.1007/s00432-004-0564-9; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Li Y, 2012, NAT REV GASTRO HEPAT, V9, P32, DOI 10.1038/nrgastro.2011.196; Liu SP, 2013, GASTROENTEROLOGY, V144, P1031, DOI 10.1053/j.gastro.2013.01.046; Orimo T, 2008, HEPATOLOGY, V48, P1851, DOI 10.1002/hep.22552; Pan TL, 2012, J PROTEOMICS, V75, P4676, DOI 10.1016/j.jprot.2012.02.017; Schmidt VA, 2008, MOL CELL BIOL, V28, P1489, DOI 10.1128/MCB.01090-07; Song PM, 2009, PROTEOM CLIN APPL, V3, P841, DOI 10.1002/prca.200780131; Tang JH, 2011, TUMOR BIOL, V32, P469, DOI 10.1007/s13277-010-0140-7; Tang ZY, 2004, J CANCER RES CLIN, V130, P187, DOI 10.1007/s00432-003-0511-1; Tonack S, 2009, J PROTEOMICS, V73, P352, DOI 10.1016/j.jprot.2009.07.009; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wang C, 2012, INT J BIOCHEM CELL B, V44, P2308, DOI 10.1016/j.biocel.2012.09.012; Weeks CA, 2013, BIOTECHNOL BIOENG, V110, P2548, DOI 10.1002/bit.24899; Woo HG, 2011, MOL CARCINOGEN, V50, P235, DOI 10.1002/mc.20691; Wu J, 2013, BIOMED PHARMACOTHER, V67, P313, DOI 10.1016/j.biopha.2013.01.011; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843; Yi X, 2008, MOL CELL PROTEOMICS, V7, P315, DOI 10.1074/mcp.M700116-MCP200	34	29	29	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e88543	10.1371/journal.pone.0088543	http://dx.doi.org/10.1371/journal.pone.0088543			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614035	Green Submitted, Green Published, gold			2022-12-25	WOS:000332839300007
J	Kwasiborski, A; Bajji, M; Renaut, J; Delaplace, P; Jijakli, MH				Kwasiborski, Anthony; Bajji, Mohammed; Renaut, Jenny; Delaplace, Pierre; Jijakli, M. Haissam			Identification of Metabolic Pathways Expressed by Pichia anomala Kh6 in the Presence of the Pathogen Botrytis cinerea on Apple: New Possible Targets for Biocontrol Improvement	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; METSCHNIKOWIA-PULCHERRIMA; TRICHODERMA-ATROVIRIDE; POSTHARVEST PATHOGENS; STATIONARY-PHASE; YEAST PROTEINS; STRAIN-K; GROWTH; ANTAGONIST; COMPONENTS	Yeast Pichia anomala strain Kh6 Kurtzman (Saccharomycetales: Endomycetaceae) exhibits biological control properties that provide an alternative to the chemical fungicides currently used by fruit or vegetable producers against main post-harvest pathogens, such as Botrytis cinerea (Helotiales: Sclerotiniaceae). Using an in situ model that takes into account interactions between organisms and a proteomic approach, we aimed to identify P. anomala metabolic pathways influenced by the presence of B. cinerea. A total of 105 and 60 P. anomala proteins were differentially represented in the exponential and stationary growth phases, respectively. In the exponential phase and in the presence of B. cinerea, the pentose phosphate pathway seems to be enhanced and would provide P. anomala with the needed nucleic acids and energy for the wound colonisation. In the stationary phase, P. anomala would use alcoholic fermentation both in the absence and presence of the pathogen. These results would suggest that the competitive colonisation of apple wounds could be implicated in the mode of action of P. anomala against B. cinerea.	[Kwasiborski, Anthony; Bajji, Mohammed; Jijakli, M. Haissam] Gembloux Agrobio Tech Univ Liege, Plant Pathol Unit, Gembloux, Belgium; [Renaut, Jenny] Ctr Rech Publ Gabriel Lippmann, Dept Environm & Agrobiotechnol, Belvaux, Luxembourg; [Delaplace, Pierre] Gembloux Agrobio Tech Univ Liege, Plant Biol Unit, Gembloux, Belgium	Luxembourg Institute of Science & Technology	Kwasiborski, A (corresponding author), Gembloux Agrobio Tech Univ Liege, Plant Pathol Unit, Gembloux, Belgium.	kwasiborski@hotmail.fr	Renaut, Jenny/K-3216-2012	Renaut, Jenny/0000-0002-0450-3866; Delaplace, Pierre/0000-0001-6198-7820	Belgian Fond National de la Recherche Scientifique (FNRS) [FRFC 2.4.574.08.F]	Belgian Fond National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the Belgian Fond National de la Recherche Scientifique (FNRS, FRFC 2.4.574.08.F convention) [URL: http://www.frs-fnrs.be/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abano E.E., 2012, INT J ADV BIOL RES, V2, P1; Andrew EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066242; ANDREWS JH, 1994, CAN J MICROBIOL, V40, P6, DOI 10.1139/m94-002; Bajji M., 2009, IOBC/WPRS Bulletin, V43, P327; BARRETT AJ, 1965, BIOCHEM J, V94, P617, DOI 10.1042/bj0940617; BOGONEZ E, 1985, J GEN MICROBIOL, V131, P1425; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Castoria R, 2001, POSTHARVEST BIOL TEC, V22, P7, DOI 10.1016/S0925-5214(00)00186-1; Delaplace P, 2006, PROTEOMICS, V6, P6494, DOI 10.1002/pmic.200600493; Demianova M, 1996, J BIOL CHEM, V271, P11383, DOI 10.1074/jbc.271.19.11383; Donoso I, 2005, MOL GENET GENOMICS, V274, P155, DOI 10.1007/s00438-005-0005-8; DROBY S, 1989, CAN J MICROBIOL, V35, P794, DOI 10.1139/m89-132; Droby S, 2009, POSTHARVEST BIOL TEC, V52, P137, DOI 10.1016/j.postharvbio.2008.11.009; Dumas R, 2001, ACCOUNTS CHEM RES, V34, P399, DOI 10.1021/ar000082w; Filonow AB, 1998, BIOCONTROL SCI TECHN, V8, P243, DOI 10.1080/09583159830315; Fravel DR, 2005, ANNU REV PHYTOPATHOL, V43, P337, DOI 10.1146/annurev.phyto.43.032904.092924; Fredlund E, 2004, APPL ENVIRON MICROB, V70, P5905, DOI 10.1128/AEM.70.10.5905-5911.2004; Fredlund E, 2004, FEMS MICROBIOL LETT, V238, P133, DOI 10.1016/j.femsle.2004.07.027; Friel D, 2007, MOL PLANT MICROBE IN, V20, P371, DOI 10.1094/MPMI-20-4-0371; FUGE EK, 1994, J BACTERIOL, V176, P5802, DOI 10.1128/JB.176.18.5802-5813.1994; Gorg A, 2005, PROTEOMICS, V5, P826, DOI 10.1002/pmic.200590007; Grevesse C, 2003, PHYTOPATHOLOGY, V93, P1145, DOI 10.1094/PHYTO.2003.93.9.1145; Grinyer J, 2005, CURR GENET, V47, P381, DOI 10.1007/s00294-005-0575-3; Grinyer J, 2004, CURR GENET, V45, P163, DOI 10.1007/s00294-003-0474-4; Haissam JM, 2011, ANTON LEEUW INT J G, V99, P93, DOI 10.1007/s10482-010-9541-2; Janisiewicz WJ, 2002, ANNU REV PHYTOPATHOL, V40, P411, DOI 10.1146/annurev.phyto.40.120401.130158; Jijakli M. H., 1993, Mededelingen Faculteit Landbouwkundige en Toegepaste Biologische Wetenschappen Universiteit Gent, V58, P1349; Jijakli M. H, 1999, BIOTECHNOLOGICAL APP, P31, DOI DOI 10.1007/978-1-4615-4745-7_2; Jijakli MH, 1998, PHYTOPATHOLOGY, V88, P335, DOI 10.1094/PHYTO.1998.88.4.335; Jijakli MH, 1993, IOBC WPRS B, V16, P106; Kwasiborski A, 2012, BIOCONTROL, V57, P837, DOI 10.1007/s10526-012-9460-4; Marra R, 2006, CURR GENET, V50, P307, DOI 10.1007/s00294-006-0091-0; Massart S, 2006, PHYTOPATHOLOGY, V96, P80, DOI 10.1094/PHYTO-96-0080; Matsushika A, 2012, ENZYME MICROB TECH, V51, P16, DOI 10.1016/j.enzmictec.2012.03.008; Nair N, 2007, APPL ENVIRON MICROB, V73, P2001, DOI 10.1128/AEM.02515-06; Norbeck J, 1997, YEAST, V13, P1519, DOI 10.1002/(SICI)1097-0061(199712)13:16<1519::AID-YEA211>3.0.CO;2-U; Piano S, 1997, POSTHARVEST BIOL TEC, V11, P131, DOI 10.1016/S0925-5214(97)00022-7; PRIMERANO DA, 1983, J BACTERIOL, V153, P259, DOI 10.1128/JB.153.1.259-269.1983; Spadaro D, 2004, INT J FOOD MICROBIOL, V91, P185, DOI 10.1016/S0168-1605(03)00380-5; Spadaro D, 2002, POSTHARVEST BIOL TEC, V24, P123, DOI 10.1016/S0925-5214(01)00172-7; ter Schure EG, 2000, FEMS MICROBIOL REV, V24, P67, DOI 10.1016/S0168-6445(99)00030-3; VICTOR J, 1979, J BIOL CHEM, V254, P2647; WISNIEWSKI M, 1989, CAN J BOT, V67, P2317, DOI 10.1139/b89-296; WISNIEWSKI M, 1991, PHYSIOL MOL PLANT P, V39, P245, DOI 10.1016/0885-5765(91)90033-E; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Zakrajsek T, 2011, J PROTEOMICS, V74, P2837, DOI 10.1016/j.jprot.2011.06.026; Zanelli CF, 2006, BIOCHEM BIOPH RES CO, V348, P1358, DOI 10.1016/j.bbrc.2006.07.195	47	14	16	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91434	10.1371/journal.pone.0091434	http://dx.doi.org/10.1371/journal.pone.0091434			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614090	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300125
J	Lopez, J; Hurwood, D; Dryden, B; Fuller, S				Lopez, Jobina; Hurwood, David; Dryden, Bart; Fuller, Susan			Feral Pig Populations Are Structured at Fine Spatial Scales in Tropical Queensland, Australia	PLOS ONE			English	Article							SUS-SCROFA; PHYLOGENETIC-RELATIONSHIPS; GENETIC-STRUCTURE; DNA; ERADICATION; DISEASE; ORIGIN; PREVALENCE; MANAGEMENT; SOFTWARE	Feral pigs occur throughout tropical far north Queensland, Australia and are a significant threat to biodiversity and World Heritage values, agriculture and are a vector of infectious diseases. One of the constraints on long-lasting, local eradication of feral pigs is the process of reinvasion into recently controlled areas. This study examined the population genetic structure of feral pigs in far north Queensland to identify the extent of movement and the scale at which demographically independent management units exist. Genetic analysis of 328 feral pigs from the Innisfail to Tully region of tropical Queensland was undertaken. Seven microsatellite loci were screened and Bayesian clustering methods used to infer population clusters. Sequence variation at the mitochondrial DNA control region was examined to identify pig breed. Significant population structure was identified in the study area at a scale of 25 to 35 km, corresponding to three demographically independent management units (MUs). Distinct natural or anthropogenic barriers were not found, but environmental features such as topography and land use appear to influence patterns of gene flow. Despite the strong, overall pattern of structure, some feral pigs clearly exhibited ancestry from a MU outside of that from which they were sampled indicating isolated long distance dispersal or translocation events. Furthermore, our results suggest that gene flow is restricted among pigs of domestic Asian and European origin and non-random mating influences management unit boundaries. We conclude that the three MUs identified in this study should be considered as operational units for feral pig control in far north Queensland. Within a MU, coordinated and simultaneous control is required across farms, rainforest areas and National Park Estates to prevent recolonisation from adjacent localities.	[Lopez, Jobina; Hurwood, David; Fuller, Susan] Queensland Univ Technol, Fac Sci & Engn, Brisbane, Qld 4001, Australia; [Dryden, Bart] Terrain Nat Resource Management Ltd, Innisfail, Qld, Australia	Queensland University of Technology (QUT)	Fuller, S (corresponding author), Queensland Univ Technol, Fac Sci & Engn, Brisbane, Qld 4001, Australia.	s.fuller@qut.edu.au	; Hurwood, David/I-9923-2012	Fuller, Susan/0000-0003-4399-0166; Hurwood, David/0000-0001-9143-360X	TerrainNRM	TerrainNRM	TerrainNRM funded this project and provided tissue samples. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkrim J, 2005, CONSERV BIOL, V19, P1509, DOI 10.1111/j.1523-1739.2005.00206.x; Alexander LJ, 1996, ANIM GENET, V27, P137, DOI 10.1111/j.1365-2052.1996.tb00941.x; [Anonymous], 1996, MANAGING VERTEBRATE; Caley P, 1997, WILDLIFE RES, V24, P77, DOI 10.1071/WR94075; Caley P, 1993, THESIS U CANBERRA; CAMPBELL NJH, 1995, MOL ECOL, V4, P407, DOI 10.1111/j.1365-294X.1995.tb00234.x; CHOQUENOT D, 1993, WILDLIFE RES, V20, P15, DOI 10.1071/WR9930015; Cowled BD, 2008, CONSERV GENET, V9, P211, DOI 10.1007/s10592-007-9331-1; Cowled BD, 2006, J WILDLIFE MANAGE, V70, P1690, DOI 10.2193/0022-541X(2006)70[1690:MTDAGE]2.0.CO;2; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Giuffra E, 2000, GENETICS, V154, P1785; Giuffra E, 2002, MAMM GENOME, V13, P569, DOI 10.1007/s00335-002-2184-5; Gongora J, 2004, MOL PHYLOGENET EVOL, V33, P339, DOI 10.1016/j.ympev.2004.06.004; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hampton JO, 2004, J APPL ECOL, V41, P735, DOI 10.1111/j.0021-8901.2004.00936.x; Hampton J, 2006, ECOHEALTH, V3, P103, DOI 10.1007/s10393-006-0018-8; HONE J, 1983, AUST WILDLIFE RES, V10, P269; Hone J, 2002, BIOL CONSERV, V105, P231, DOI 10.1016/S0006-3207(01)00185-9; Kim KI, 2002, ANIM GENET, V33, P19, DOI 10.1046/j.1365-2052.2002.00784.x; LETTS G. A., 1962, Australian Veterinary Journal, V38, P282, DOI 10.1111/j.1751-0813.1962.tb04032.x; Luetkemeier ES, 2010, MOL PHYLOGENET EVOL, V54, P680, DOI 10.1016/j.ympev.2009.11.004; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; McInerney J, 1995, AUST VET J, V72, P448, DOI 10.1111/j.1751-0813.1995.tb03486.x; MEYER A, 1990, NATURE, V347, P550, DOI 10.1038/347550a0; MILLER B, 1985, BIOL CONSERV, V34, P55, DOI 10.1016/0006-3207(85)90057-6; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mitchell J, 2009, WILDLIFE RES, V36, P110, DOI 10.1071/WR06066; Mitchell J, 2003, THESIS J COOK U; MITCHELL J, 1993, SYSTEMATIC ASSESSMEN; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; PAVLOV PM, 1992, WILDLIFE RES, V19, P179, DOI 10.1071/WR9920179; PAVLOV PM, 1981, AUST J EXP AGR, V21, P570, DOI 10.1071/EA9810570; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PECH RP, 1988, J APPL ECOL, V25, P63, DOI 10.2307/2403610; Pritchard JK, 2000, GENETICS, V155, P945; PULLAR E. M., 1950, AUSTRALIAN VET JOUR, V26, P99, DOI 10.1111/j.1751-0813.1950.tb04901.x; Pullar EM, 1953, MEMOIRS NATL MUSEUM; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rekwot PI, 2001, ANIM REPROD SCI, V65, P157, DOI 10.1016/S0378-4320(00)00223-2; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Robertson BC, 2004, J APPL ECOL, V41, P1042, DOI 10.1111/j.0021-8901.2004.00984.x; Spencer P. B. S., 2004, ECOLOGICAL MANAGEMEN, V5, P231, DOI [10.1111/j.1442-8903.2004.209-9.x, DOI 10.1111/J.1442-8903.2004.209-9.X]; Spencer PBS, 2005, J WILDLIFE MANAGE, V69, P377, DOI 10.2193/0022-541X(2005)069&lt;0377:ITAGSO&gt;2.0.CO;2; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON RCA, 1988, AUST VET J, V65, P188, DOI 10.1111/j.1751-0813.1988.tb14298.x; Tisdell C., 1984, Tigerpaper (Bangkok), V11, P13; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Watanabe T, 2001, J MOL EVOL, V52, P281, DOI 10.1007/s002390010156; Watanobe T, 1999, MOL ECOL, V8, P1509, DOI 10.1046/j.1365-294x.1999.00729.x; Wurster CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043538	52	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91657	10.1371/journal.pone.0091657	http://dx.doi.org/10.1371/journal.pone.0091657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614160	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300147
J	Mutinda, M; Chenge, G; Gakuya, F; Otiende, M; Omondi, P; Kasiki, S; Soriguer, RC; Alasaad, S				Mutinda, Matthew; Chenge, Geoffrey; Gakuya, Francis; Otiende, Moses; Omondi, Patrick; Kasiki, Samuel; Soriguer, Ramon C.; Alasaad, Samer			Detusking Fence-Breaker Elephants as an Approach in Human-Elephant Conflict Mitigation	PLOS ONE			English	Article							CROP-RAIDING ELEPHANTS; SELECTION; WILDLIFE; CHOICE	Background: Human-elephant conflict (HEC) is a recurring problem that appears wherever the range of elephants and humans overlap. Different methods including the use of electric fences are used worldwide to mitigate this conflict. Nonetheless, elephants learn quickly that their tusks do not conduct electricity and use them to break down fences (fence-breakers). Methodology/Principal Findings: In Lewa Wildlife Conservancy, Kenya, destructive elephants (Loxodonta africana) were monitored between 2010 and 2013. The fence-breaking rate reached four incidents (fence-breaking) per elephant per 100 days. Ten bull males and 57 females were identified as fence-breakers. The bulls were involved in 85.07% and the females in 14.93% of incidents. The Kenya Wildlife Service approved detusking (partial cutting of tusks) in four of the 10 fence-breakers as a way of preventing them from breaking down fences, thereby mitigating HEC in the Conservancy. The result of the detusking was a drastic six-fold reduction in damage to fences (range: 1.67 to 14.5 times less fence-breaking) by the four worst fence-breaker elephants, because with trimmed tusks elephants lack the tools to break down fences. Detusking could not totally eliminate fence destruction because, despite lacking their tools, elephants can still destroy fences using their heads, bodies and trunks, albeit less effectively. On the other hand, apart from inherent aesthetic considerations, the detusking of elephants may have certain negative effects on factors such as elephants' social hierarchies, breeding, mate selection and their access to essential minerals and food. Conclusions: Elephant detusking seems to be effective in drastically reducing fence-breaking incidents, nonetheless its negative effects on behaviour, access to food and its aesthetical consequences still need to be further studied and investigated.	[Mutinda, Matthew; Gakuya, Francis; Otiende, Moses; Omondi, Patrick; Kasiki, Samuel] Kenya Wildlife Serv, Nairobi, Kenya; [Chenge, Geoffrey] Lewa Wildlife Conservancy, Isiolo, Kenya; [Soriguer, Ramon C.; Alasaad, Samer] CSIC, Estn Biol Donana, E-41080 Seville, Spain; [Alasaad, Samer] Univ Zurich, Inst Evolutionary Biol & Environm Studies IEU, Zurich, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Zurich	Mutinda, M (corresponding author), Kenya Wildlife Serv, Nairobi, Kenya.	mmutinda@kws.go.ke; sameralasaad@hotmail.com	Soriguer, Ramon/J-1494-2014; Angelone, Samer/G-4727-2013	Soriguer, Ramon/0000-0002-9165-7766; Angelone, Samer/0000-0003-0868-7276				ALLEN JL, 1984, J AM VET MED ASSOC, V185, P1447; Allendorf FW, 2009, P NATL ACAD SCI USA, V106, P9987, DOI 10.1073/pnas.0901069106; [Anonymous], 2011, KWS REP; Archie EA, 2012, MOL ECOL, V21, P765, DOI 10.1111/j.1365-294X.2011.05237.x; Athreya V., 2006, CONSERV SOC, V4, P419; Balfour D., 2007, REV OPTIONS MANAGING; Beringer J, 2002, WILDLIFE SOC B, V30, P767; Bouche P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020619; Chiyo PI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031382; Corti P, 2002, CAN J ZOOL, V80, P2108, DOI [10.1139/z02-207, 10.1139/Z02-207]; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Frynta D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063110; Gakuya F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043342; Graham M., 2009, TRIALS FARM BASED DE; GRAHAM MD, 2009, 1 LAIK EL PROJ; Hedges S, 2010, ORYX, V44, P139, DOI 10.1017/S0030605309990093; Hoare, 1999, STANDARDISED DATA CO; HOARE R, 1995, PACHYDERM, V19, P54; JENKINS PR, 1982, LAIKIPIA ELEPHANT PR; Jones AG, 2009, P NATL ACAD SCI USA, V106, P10001, DOI 10.1073/pnas.0901129106; King LE, 2011, AFR J ECOL, V49, P431, DOI 10.1111/j.1365-2028.2011.01275.x; Kioko J, 2008, S AFR J WILDL RES, V38, P52, DOI 10.3957/0379-4369-38.1.52; Loarie SR, 2009, BIOL CONSERV, V142, P3086, DOI 10.1016/j.biocon.2009.08.008; Mijele D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071179; Moss C, 2013, TRUTH TUSKS; Nelson A., 2003, REV HUMAN ELEPHANT C; NEWMARK WD, 1994, CONSERV BIOL, V8, P249, DOI 10.1046/j.1523-1739.1994.08010249.x; Ngene S, 2009, PACHYDERM, V45, P77; Ngene S, 2010, THESIS U TWENTE NETH; Okech RN, 2010, AFR J CONFL RESOLUT, V10, P65; Osborn FV, 2003, ORYX, V37, P80, DOI 10.1017/S0030605303000152; Osborn FV, 2004, AFR J ECOL, V42, P322, DOI 10.1111/j.1365-2028.2004.00531.x; Parker G. E., 2007, HUMAN ELEPHANT CONFL; Pelletier F, 2004, ANIM BEHAV, V67, P1163, DOI 10.1016/j.anbehav.2003.07.009; POOLE JH, 1989, ANIM BEHAV, V37, P842, DOI 10.1016/0003-3472(89)90068-7; R Core Team, 2022, R LANG ENV STAT COMP; Rode KD, 2006, J TROP ECOL, V22, P441, DOI 10.1017/S0266467406003233; THOULESS CR, 1995, BIOL CONSERV, V72, P99, DOI 10.1016/0006-3207(94)00071-W; Vollrath F, 2002, NATURWISSENSCHAFTEN, V89, P508, DOI 10.1007/s00114-002-0375-2; Wambwa Elizabeth, 2001, Pachyderm, V31, P58; WEIR JS, 1969, J ZOOL, V158, P293	41	23	24	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91749	10.1371/journal.pone.0091749	http://dx.doi.org/10.1371/journal.pone.0091749			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614538	Green Published, gold, Green Submitted			2022-12-25	WOS:000332839300154
J	Schmitz, AMT; Oudejans, JJ; Gilhuijs, KGA				Schmitz, Alexander M. Th; Oudejans, Joost J.; Gilhuijs, Kenneth G. A.			Agreement on Indication for Systemic Therapy between Biopsied Tissue and Surgical Excision Specimens in Breast Cancer Patients	PLOS ONE			English	Article							PATHOLOGICAL PROGNOSTIC-FACTORS; CONSERVING THERAPY; CORE BIOPSIES; NODE BIOPSY; TUMOR SIZE; FOLLOW-UP; TRIAL; ULTRASOUND; ABLATION; CARCINOMA	Purpose: In breast cancer therapy, the indication for systemic therapy is typically based on prognostic markers from the surgical excision specimen. If such is unavailable, for instance prior to tumor ablation therapy, the indication for adjuvant systemic therapy may be assessed from pretreatment biopsies. The effect of differences in tumor characteristics between biopsy and excision specimen on agreement in indication for systemic therapy is, however, largely unknown. The aim of this study is to determine the agreement in eligibility for systemic therapy between preoperative and postoperative assessment. Secondly, to identify which patient-, tumor-or lymph node characteristics may influence this agreement. Materials and Methods: In this retrospective study, 300 consecutive female patients with primary invasive breast carcinoma on biopsy were included. Indication for systemic therapy was determined separately from biopsied tissue and from excision specimens using national guidelines based on adjuvant! online. Agreement was assessed, and patient-, tumor-and lymph node characteristics affecting agreement analyzed. Results: Agreement in tumor characteristics between biopsy and excision specimen varied from high (ER-status: 99%), to lower (tumor grade: 62%, tumor size: 59%, and lymph node status: 67%). Without preoperative sentinel node biopsy (SNB), agreement on systemic therapy exists in 77% of patients (kappa = 0,547). Positive pretreatment indication for systemic therapy was highly indicative of the postoperative indication (PPV = 94%). Negative indication was, however, only indicative in 67% of patients. Conversely, with preoperative SNB, agreement on negative indication was raised to 89%. Agreement was especially high for ER-negative status, tumor grade 3, tumor size > 2 cm, lymph node positivity at biopsy and a negative preoperative SNB. Conclusions: A positive indication for systemic therapy from biopsy is highly indicative for a positive indication from the excision specimen. When the indication is negative, additional stratification using preoperative SNB raises the agreement. Still, discordance occurs in 1 out of 10 patients.	[Schmitz, Alexander M. Th; Gilhuijs, Kenneth G. A.] Univ Med Ctr Utrecht, Image Sci Inst, Dept Radiol, Utrecht, Netherlands; [Oudejans, Joost J.] Diakonessen Hosp, Dept Pathol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Diakonessenhuis	Gilhuijs, KGA (corresponding author), Univ Med Ctr Utrecht, Image Sci Inst, Dept Radiol, Utrecht, Netherlands.	k.g.a.gilhuijs@umcutrecht.nl		Oudejans, Joost/0000-0003-3162-5516	Dutch Pink Ribbon Foundation [9684, 2011.WO36]	Dutch Pink Ribbon Foundation	The study was conducted with financial support of The Dutch Pink Ribbon Foundation (www.pinkribbon.nl), grant number 9684, 2011.WO36. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badoual C, 2005, BREAST, V14, P22, DOI 10.1016/j.breast.2004.07.005; Bartelink H, 2007, J CLIN ONCOL, V25, P3259, DOI 10.1200/JCO.2007.11.4991; Bosch AM, 2003, EUR J RADIOL, V48, P285, DOI 10.1016/S0720-048X(03)00081-0; Bueno-de-Mesquita JM, ANN ONCOL, V21, P40; Burge CN, 2006, BREAST, V15, P167, DOI 10.1016/j.breast.2005.06.004; Cahill RA, 2006, ANN SURG ONCOL, V13, P45, DOI 10.1245/ASO.2006.03.047; de Kanter AY, 1999, BRIT J SURG, V86, P1459, DOI 10.1046/j.1365-2168.1999.01243.x; Deurloo EE, 2003, EUR J CANCER, V39, P1068, DOI 10.1016/S0959-8049(02)00748-7; Douglas-Jones AG, 2001, J CLIN PATHOL, V54, P951, DOI 10.1136/jcp.54.12.951; Esteva FJ, 2004, BREAST CANCER RES, V6, P109, DOI 10.1186/bcr777; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Gianfelice D, 2003, RADIOLOGY, V227, P849, DOI 10.1148/radiol.2281012163; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Harris GC, 2003, AM J SURG PATHOL, V27, P11, DOI 10.1097/00000478-200301000-00002; Kuenen-Boumeester V, 2003, EUR J CANCER, V39, P170, DOI 10.1016/S0959-8049(02)00501-4; Kuhl C, 2007, RADIOLOGY, V244, P356, DOI 10.1148/radiol.2442051620; Kuhl CK, 2007, RADIOLOGY, V244, P672, DOI 10.1148/radiol.2443051661; Luparia A, 2013, RADIOL MED; Mook S, LANCET ONCOL, V10, P1070; Naik AM, 2004, ANN SURG, V240, P462, DOI 10.1097/01.sla.0000137130.23530.19; Nichols EM, 2010, INT J RADIAT ONCOL, V77, P197, DOI 10.1016/j.ijrobp.2009.04.063; O'Leary R, 2004, J CLIN PATHOL, V57, P193, DOI 10.1136/jcp.2003.12914; Olivotto IA, J CLIN ONCOL, V23, P2716; Onesti JK, 2008, AM J SURG, V196, P844, DOI 10.1016/j.amjsurg.2008.07.028; Palta M, 2012, INT J RADIAT ONCOL, V82, P37, DOI 10.1016/j.ijrobp.2010.09.041; Postma EL, 2013, EUR J PHARM; Rakha EA, J CLIN ONCOL, V26, P3153; Ravdin PM, J CLIN ONCOL, V19, P980; Sabel MS, 2004, ANN SURG ONCOL, V11, P542, DOI 10.1245/ASO.2004.08.003; Schmitz AC, 2008, EUR RADIOL, V18, P1431, DOI 10.1007/s00330-008-0906-0; Sharifi S, 1999, MODERN PATHOL, V12, P941; van den Bosch M, 2008, J MAGN RESON IMAGING, V27, P204, DOI 10.1002/jmri.21190; van Dongen JA, 2000, JNCI-J NATL CANCER I, V92, P1143, DOI 10.1093/jnci/92.14.1143; VERONESI U, 1995, EUR J CANCER, V31A, P1574, DOI 10.1016/0959-8049(95)00271-J; Wishart GC, BR J CANC, V107, P800; Zhao Z, 2010, EJSO-EUR J SURG ONC, V36, P1149, DOI 10.1016/j.ejso.2010.09.012	36	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91439	10.1371/journal.pone.0091439	http://dx.doi.org/10.1371/journal.pone.0091439			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614128	Green Published, gold, Green Submitted			2022-12-25	WOS:000332839300126
J	Franco, FP; Santiago, AC; Henrique-Silva, F; de Castro, PA; Goldman, GH; Moura, DS; Silva-Filho, MC				Franco, Flavia P.; Santiago, Adelita C.; Henrique-Silva, Flavio; de Castro, Patricia Alves; Goldman, Gustavo H.; Moura, Daniel S.; Silva-Filho, Marcio C.			The Sugarcane Defense Protein SUGARWIN2 Causes Cell Death in Colletotrichum falcatum but Not in Non-Pathogenic Fungi	PLOS ONE			English	Article							PATHOGENESIS-RELATED PROTEIN; EUROPEAN CORN-BORER; ASPERGILLUS-NIDULANS; ANTIFUNGAL ACTIVITY; NEUROSPORA-CRASSA; PR-4 PROTEINS; WHEAT; GENE; GROWTH; LEPIDOPTERA	Plants respond to pathogens and insect attacks by inducing and accumulating a large set of defense-related proteins. Two homologues of a barley wound-inducible protein (BARWIN) have been characterized in sugarcane, SUGARWIN1 and SUGARWIN2 (sugarcane wound-inducible proteins). Induction of SUGARWINs occurs in response to Diatraea saccharalis damage but not to pathogen infection. In addition, the protein itself does not show any effect on insect development; instead, it has antimicrobial activities toward Fusarium verticillioides, an opportunistic fungus that usually occurs after D. saccharalis borer attacks on sugarcane. In this study, we sought to evaluate the specificity of SUGARWIN2 to better understand its mechanism of action against phytopathogens and the associations between fungi and insects that affect plants. We used Colletotrichum falcatum, a fungus that causes red rot disease in sugarcane fields infested by D. saccharalis, and Ceratocystis paradoxa, which causes pineapple disease in sugarcane. We also tested whether SUGARWIN2 is able to cause cell death in Aspergillus nidulans, a fungus that does not infect sugarcane, and in the model yeast Saccharomyces cerevisiae, which is used for bioethanol production. Recombinant SUGARWIN2 altered C. falcatum morphology by increasing vacuolization, points of fractures and a leak of intracellular material, leading to germling apoptosis. In C. paradoxa, SUGARWIN2 showed increased vacuolization in hyphae but did not kill the fungi. Neither the non-pathogenic fungus A. nidulans nor the yeast S. cerevisiae was affected by recombinant SUGARWIN2, suggesting that the protein is specific to sugarcane opportunistic fungal pathogens.	[Franco, Flavia P.; Silva-Filho, Marcio C.] Univ Sao Paulo, Dept Genet, Escola Super Agr Luiz de Queiroz, Piracicaba, SP, Brazil; [Santiago, Adelita C.; Henrique-Silva, Flavio] Univ Fed Sao Carlos, Dept Genet & Evolucao, BR-13560 Sao Carlos, SP, Brazil; [de Castro, Patricia Alves; Goldman, Gustavo H.] Univ Sao Paulo, Fac Ciencias Farmaceut, BR-14049 Ribeirao Preto, SP, Brazil; [Goldman, Gustavo H.] Lab Nacl Ciencia & Tecnol Bioetanol CTBE, Campinas, SP, Brazil; [Moura, Daniel S.] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Dept Ciencias Biol, Piracicaba, SP, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Carlos; Universidade de Sao Paulo; Universidade de Sao Paulo	Silva-Filho, MC (corresponding author), Univ Sao Paulo, Dept Genet, Escola Super Agr Luiz de Queiroz, Piracicaba, SP, Brazil.	mdcsilva@usp.br	Henrique-Silva, Flavio/A-1937-2013; Silva-Filho, Marcio/F-2639-2012; Goldman, Gustavo Henrique/F-1848-2013; Santiago, Adelita Carolina/R-9825-2017; Franco, Flávia Pereira/C-5795-2016; Moura, Daniel S/D-6673-2012	Silva-Filho, Marcio/0000-0003-2129-0388; Goldman, Gustavo Henrique/0000-0002-2986-350X; Franco, Flávia Pereira/0000-0003-3739-8625; Moura, Daniel S/0000-0003-2042-1403	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [08/52067-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [474542/2010-6]; Instituto Nacional de Ciencia e Tecnologia do Bioetanol [574002/2008-1]; FAPESP [08/57908-6]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia do Bioetanol; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) grant 08/52067-3, the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) grant 474542/2010-6, and the Instituto Nacional de Ciencia e Tecnologia do Bioetanol grant 574002/2008-1 and FAPESP 08/57908-6. M. C. Silva-Filho, G. H. Goldman, F. Henrique-Silva and D. S. Moura are also research fellows of CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS TH, 1992, MOL CELL BIOL, V12, P3827, DOI 10.1128/MCB.12.9.3827; Bai SH, 2013, PLANT PHYSIOL BIOCH, V62, P23, DOI 10.1016/j.plaphy.2012.10.016; Banno S, 2005, GENES GENET SYST, V80, P25, DOI 10.1266/ggs.80.25; Bertini L, 2003, PLANT SCI, V164, P1067, DOI 10.1016/S0168-9452(03)00112-2; Bertini L, 2006, BIOL CHEM, V387, P1101, DOI 10.1515/BC.2006.136; Bertini L, 2009, FEBS LETT, V583, P2865, DOI 10.1016/j.febslet.2009.07.045; BOYLAN MT, 1987, MOL CELL BIOL, V7, P3113, DOI 10.1128/MCB.7.9.3113; Bravo JM, 2003, PLANT MOL BIOL, V52, P745, DOI 10.1023/A:1025016416951; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; Caporale C, 2004, FEBS LETT, V575, P71, DOI 10.1016/j.febslet.2004.07.091; Caporale C, 2003, J MOL MODEL, V9, P9, DOI 10.1007/s00894-002-0103-z; CARRUTHERS RI, 1986, ANN ENTOMOL SOC AM, V79, P385, DOI 10.1093/aesa/79.3.385; Caruso C, 2001, J PROTEIN CHEM, V20, P327, DOI 10.1023/A:1010905802749; Cui JP, 2002, PLANT PHYSIOL, V129, P551, DOI 10.1104/pp.010815; Ericsson M, 2000, J BACTERIOL, V182, P5551, DOI 10.1128/JB.182.19.5551-5555.2000; Falco MC, 2001, GENET MOL BIOL, V24, P113, DOI 10.1590/S1415-47572001000100016; Gatch EW, 2002, PLANT DIS, V86, P1156, DOI 10.1094/PDIS.2002.86.10.1156; Guest GM, 2004, FUNGAL GENET BIOL, V41, P13, DOI 10.1016/j.fgb.2003.08.006; HEJGAARD J, 1992, FEBS LETT, V307, P389, DOI 10.1016/0014-5793(92)80720-2; Jeong HY, 2003, FUNGAL GENET BIOL, V38, P228, DOI 10.1016/S1087-1845(02)00527-3; Kays AM, 2000, MOL CELL BIOL, V20, P7693, DOI 10.1128/MCB.20.20.7693-7705.2000; Kempel A, 2010, FUNCT ECOL, V24, P293, DOI 10.1111/j.1365-2435.2009.01647.x; LEE BN, 1994, MOL MICROBIOL, V14, P323, DOI 10.1111/j.1365-2958.1994.tb01293.x; Li SJ, 2006, MOL MICROBIOL, V62, P1418, DOI 10.1111/j.1365-2958.2006.05447.x; Li XD, 2010, MOL BIOL REP, V37, P995, DOI 10.1007/s11033-009-9783-0; Lu HC, 2012, PLANT PHYSIOL BIOCH, V56, P1, DOI 10.1016/j.plaphy.2012.04.004; Luchi N, 2012, FOREST PATHOL, V42, P246, DOI 10.1111/j.1439-0329.2011.00750.x; Ludovico P, 2001, MICROBIOL-SGM, V147, P3335, DOI 10.1099/00221287-147-12-3335; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Madigan MT, 2000, BROCK BIOL MICROBIOL; MARHOUL JF, 1995, GENETICS, V139, P537; McFarlane SA, 2009, ANN APPL BIOL, V155, P349, DOI 10.1111/j.1744-7348.2009.00345.x; McKaig N, 1936, J AGRIC RES, V52, P0017; Medeiros AH, 2012, MOL PLANT MICROBE IN, V25, P613, DOI 10.1094/MPMI-09-11-0254; Mello M. L. S., 2007, CELULA; MIAN AA, 1969, CAN J CHEM ENG, V47, P499, DOI 10.1002/cjce.5450470517; MONHEIT JE, 1984, ARCH PATHOL LAB MED, V108, P616; NIDERMAN T, 1995, PLANT PHYSIOL, V108, P17, DOI 10.1104/pp.108.1.17; OGUNWOLU EO, 1991, CROP PROT, V10, P57, DOI 10.1016/0261-2194(91)90027-O; PONSTEIN AS, 1994, PLANT PHYSIOL, V104, P109, DOI 10.1104/pp.104.1.109; SCHLUMBAUM A, 1986, NATURE, V324, P365, DOI 10.1038/324365a0; Shimizu K, 2001, GENETICS, V157, P591; SVENSSON B, 1992, BIOCHEMISTRY-US, V31, P8767, DOI 10.1021/bi00152a012; Talukder M. I., 2007, Journal of Agriculture & Rural Development (Gazipur), V5, P79; Van der Ent S, 2009, PHYTOCHEMISTRY, V70, P1581, DOI 10.1016/j.phytochem.2009.06.009; Van Wees SCM, 2008, CURR OPIN PLANT BIOL, V11, P443, DOI 10.1016/j.pbi.2008.05.005; von Burg S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046333; WESSELS JGH, 1993, NEW PHYTOL, V123, P397, DOI 10.1111/j.1469-8137.1993.tb03751.x; Zhu T, 2006, J PHYTOPATHOL, V154, P378, DOI 10.1111/j.1439-0434.2006.01110.x	50	14	15	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91159	10.1371/journal.pone.0091159	http://dx.doi.org/10.1371/journal.pone.0091159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608349	gold, Green Published, Green Submitted			2022-12-25	WOS:000332485800109
J	Star, B; Nederbragt, AJ; Hansen, MHS; Skage, M; Gilfillan, GD; Bradbury, IR; Pampoulie, C; Stenseth, NC; Jakobsen, KS; Jentoft, S				Star, Bastiaan; Nederbragt, Alexander J.; Hansen, Marianne H. S.; Skage, Morten; Gilfillan, Gregor D.; Bradbury, Ian R.; Pampoulie, Christophe; Stenseth, Nils Chr; Jakobsen, Kjetill S.; Jentoft, Sissel			Palindromic Sequence Artifacts Generated during Next Generation Sequencing Library Preparation from Historic and Ancient DNA	PLOS ONE			English	Article							GENOME SEQUENCE; NEANDERTHAL; DAMAGE; PATTERNS; REVEALS; SYSTEM	Degradation-specific processes and variation in laboratory protocols can bias the DNA sequence composition from samples of ancient or historic origin. Here, we identify a novel artifact in sequences from historic samples of Atlantic cod (Gadus morhua), which forms interrupted palindromes consisting of reverse complementary sequence at the 5' and 3'-ends of sequencing reads. The palindromic sequences themselves have specific properties - the bases at the 5'-end align well to the reference genome, whereas extensive misalignments exists among the bases at the terminal 3'-end. The terminal 3' bases are artificial extensions likely caused by the occurrence of hairpin loops in single stranded DNA (ssDNA), which can be ligated and amplified in particular library creation protocols. We propose that such hairpin loops allow the inclusion of erroneous nucleotides, specifically at the 3'-end of DNA strands, with the 5'-end of the same strand providing the template. We also find these palindromes in previously published ancient DNA (aDNA) datasets, albeit at varying and substantially lower frequencies. This artifact can negatively affect the yield of endogenous DNA in these types of samples and introduces sequence bias.	[Star, Bastiaan; Nederbragt, Alexander J.; Hansen, Marianne H. S.; Skage, Morten; Stenseth, Nils Chr; Jakobsen, Kjetill S.; Jentoft, Sissel] Univ Oslo, Dept Biosci, CEES, Oslo, Norway; [Gilfillan, Gregor D.] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Bradbury, Ian R.] Fisheries & Oceans Canada, St John, NF, Canada; [Pampoulie, Christophe] Marine Res Inst, IS-121 Reykjavik, Iceland	University of Oslo; University of Oslo; Fisheries & Oceans Canada; Marine & Freshwater Research Institute (MFRI)	Star, B (corresponding author), Univ Oslo, Dept Biosci, CEES, Oslo, Norway.	bastiaan.star@ibv.uio.no	Gilfillan, Gregor Duncan/N-9541-2019; Stenseth, Nils Chr./G-5212-2016	Stenseth, Nils Chr./0000-0002-1591-5399; Jentoft, Sissel/0000-0001-8707-531X; Star, Bastiaan/0000-0003-0235-9810; Nederbragt, Lex/0000-0001-5539-0999; Christophe, Pampoulie/0000-0001-6425-9060; Gilfillan, Gregor/0000-0001-8116-0134	Norwegian Research Council [203850/E40]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by the Norwegian Research Council under the project, "Fisheries induced evolution in Atlantic cod investigated by ancient and historic samples (#203850/E40)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Dabney J, 2012, BIOTECHNIQUES, V52, P87, DOI 10.2144/000113809; Gansauge MT, 2013, NAT PROTOC, V8, P737, DOI 10.1038/nprot.2013.038; Ginolhac A, 2011, BIOINFORMATICS, V27, P2153, DOI 10.1093/bioinformatics/btr347; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2009, EMBO J, V28, P2494, DOI 10.1038/emboj.2009.222; Jonsson H, 2013, BIOINFORMATICS, V29, P1682, DOI 10.1093/bioinformatics/btt193; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Meyer M., 2010, COLD SPRING HARBOR P, V2010, DOI 10.1101/pdb.prot5448; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Orlando L, 2011, GENOME RES, V21, P1705, DOI 10.1101/gr.122747.111; Overballe-Petersen S, 2012, TRENDS BIOTECHNOL, V30, P364, DOI 10.1016/j.tibtech.2012.03.007; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Schubert M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-178; Seguin-Orlando A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078575; Sinding M-HS, 2012, J ARCHAEOLOGICAL SCI; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342	25	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e89676	10.1371/journal.pone.0089676	http://dx.doi.org/10.1371/journal.pone.0089676			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608104	Green Published, Green Submitted, gold			2022-12-25	WOS:000332485800005
J	Tamam, OAS				Tamam, Omar A. S.			The Aetiology, Histopathology, and Ultrastructural Features of Perianal Erythema (Red Anus Syndrome) in the European Eel (Anguilla anguilla)	PLOS ONE			English	Article							LIFE-CYCLE; CRASSUS; PREVALENCE; INFECTION; PARASITES; NEMATODE; FISH	The European eel (Anguilla anguilla) is a critically endangered species. Red anus syndrome (RAS) is known to be associated with parasitic infections of the eel, particularly with Anguillicola crassus, but the full range of causative pathogenic organisms has not been systematically investigated. Here we examined the infective organisms and histopathological and ultrastructural features of seventy eels with RAS. In total, nine different pathogens were detected in association with RAS: Pseudomonas aeruginosa were present in twelve specimens (17%), the metacercaria of Euclinostromum heterostomum in three cases (4%), Gastrostome (Bucephalidae family) in seven cases (10%), A. crassus in forty-five cases (64%), Bothriocephalus in seventeen cases (24%), and Proteocephalus in twenty-three cases (32%). Yeast, amoeba, and myxobolus-like pathogens were seen in the anal skin in all cases when examined in combination with electron microscopy. Histopathologically, the lesions appeared as anoproctitis of varying severity from mild anusitis to severe haemorrhagic anoproctitis, with severe perianal oedema, haemorrhage, and proctoptosis. Gut inflammation ranged from mild catarrhal enteritis to severe haemorrhagic enteritis with mucosal sloughing. RAS is associated with a range of parasitic infections, not only A. crassus, some of which we describe here for the first time. Since RAS is not associated with direct invasion by parasites, it is likely that RAS is a secondary phenomenon caused by superadded infection on a background of generalised immunosuppression, or indirect local toxic effects. RAS may be used as a non-invasive indicator of underlying parasitic infection, but further investigations are required to establish the causative organisms for effective fishery management.	Univ Sadat City, Environm Studies & Res Inst, Dept Nat Resources, Sadat City, Egypt	Egyptian Knowledge Bank (EKB); University of Sadat City	Tamam, OAS (corresponding author), Univ Sadat City, Environm Studies & Res Inst, Dept Nat Resources, Sadat City Campus, Sadat City, Egypt.	Otamam2002@hotmail.com						Abdelmonem AA, 2010, PARASITOL RES, V106, P463, DOI 10.1007/s00436-009-1688-2; Banning PV, 1990, EFFECTS SWIMBLADDER, P317; Buller N. B., 2004, Bacteria from fish and other aquatic animals: a practical identification manual, DOI [10.1079/9780851997384.0137, 10.1079/9780851997384.0000]; COPLAND JW, 1982, J FISH DIS, V5, P549, DOI 10.1111/j.1365-2761.1982.tb00516.x; Crean SR, 2003, J FISH BIOL, V62, P482, DOI 10.1046/j.1095-8649.2003.00034.x; Culling CFA, 1974, HDB HISTOPATHOLOGICA, V3rd; Fernando CH, 1972, U WATERLOO SERIES; Fingold S, 1982, BAILEY SCOTTS DIAGNO, P128; Hedrick RP, 2002, AM FISH S S, V29, P45; HOGLUND J, 1992, J FISH DIS, V15, P507, DOI 10.1111/j.1365-2761.1992.tb00682.x; Jhansilakshmibai K, 1997, SYST PARASITOL, V38, P51, DOI 10.1023/A:1005829625739; Kennedy CR, 2007, J FISH DIS, V30, P319, DOI 10.1111/j.1365-2761.2007.00821.x; KENNEDY CR, 1990, J FISH BIOL, V36, P117, DOI 10.1111/j.1095-8649.1990.tb05588.x; Lucky Z., 1977, METHODS DIAGNOSIS FI; MELLERGAARD S, 1987, AQUACULTURE, V67, P139, DOI 10.1016/0044-8486(87)90019-6; MOLNAR K, 1986, Journal of Applied Ichthyology, V2, P42, DOI 10.1111/j.1439-0426.1986.tb00428.x; PILCHER MW, 1993, J FISH BIOL, V43, P339, DOI 10.1006/jfbi.1993.1135; Roberts RJ., 2012, FISH PATHOL, V4, DOI [10.1002/9781118222942, DOI 10.1002/9781118222942]; Rodjuk Galina, 2006, Wiadomosci Parazytologiczne, V52, P121; Scholz T, 1998, FOLIA PARASIT, V45, P27; Thune Ronald L., 1993, Annual Review of Fish Diseases, V3, P37, DOI 10.1016/0959-8030(93)90028-A; TRUST TJ, 1986, ANNU REV MICROBIOL, V40, P479, DOI 10.1146/annurev.mi.40.100186.002403; Wardle RA, 1952, ZOOLOGY TAPEWORMS TA; Woo PTK, 1995, FISH DIS DISORDERS, V1; Wurtz J, 2000, DIS AQUAT ORGAN, V39, P121, DOI 10.3354/dao039121; Wurtz J, 1998, DIS AQUAT ORGAN, V32, P137, DOI 10.3354/dao032137; Yamaguti S., 1971, P1; Yamaguti S, 1971, SYNOPSIS DIGENETIC T, VII	28	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90790	10.1371/journal.pone.0090790	http://dx.doi.org/10.1371/journal.pone.0090790			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608418	Green Submitted, Green Published, gold			2022-12-25	WOS:000332485800051
J	Zhao, YH; Miao, W; Li, CY; Yu, XH; Shan, ZY; Guan, HX; Teng, WP				Zhao, Yuhang; Miao, Wei; Li, Chenyang; Yu, Xiaohui; Shan, Zhongyan; Guan, Haixia; Teng, Weiping			Dynamic Changes in Serum 25-Hydroxyvitamin D during Pregnancy and Lack of Effect on Thyroid Parameters	PLOS ONE			English	Article							VITAMIN-D STATUS; MATERNAL WEIGHT-GAIN; D DEFICIENCY; CALCIUM HOMEOSTASIS; BONE METABOLISM; D INSUFFICIENCY; HIGH PREVALENCE; SEASONAL-CHANGES; SUN EXPOSURE; WOMEN	Background & Aims: To explore vitamin D status and its dynamic changes during pregnancy in women living in Northeast China. The association between 25-hydroxyvitamin D and serum calcium, phosphate and parathyroid hormone was studied. Because vitamin D deficiency or thyroid dysfunction/autoimmunity during pregnancy may lead to similar adverse events, the relationship between 25-hydroxyvitamin D and thyroid parameters was investigated. Methods: Serum samples of 50 women (aged 22 to 36 years) were selected retrospectively. The samples were collected at gestational 8 weeks +/- 3 days, 20 weeks +/- 3 days and 32 weeks +/- 3 days for measurement of 25-hydroxyvitamin D, calcium, phosphate, parathyroid hormone, and thyroid parameters. Results: The median 25-hydroxyvitamin D levels were 28.29, 39.23 and 40.03 nmol/L, respectively, from the first to the third trimester. The 25-hydroxyvitamin D concentration during the first trimester was significantly lower than the next two trimesters (p < 0.01) and was unchanged between the second and the third trimester. Of these women, 96%, 78% and 76% showed 25-hydroxyvitamin D <= 50 nmol/L during each trimester. Season was associated with 25-hydroxyvitamin D during each trimester (p < 0.05), and a significant association was found between calcium and 25-hydroxyvitamin D during the first and the second trimesters. Only triiodothyronine was associated with 25-hydroxyvitamin D in the first trimester (p = 0.024), but statistical significance was only a trend (p = 0.063) after excluding abnormal values. No association was observed between 25-hydroxyvitamin D and phosphate, parathyroid hormone, and other thyroid parameters. Conclusions: Vitamin D deficiency during pregnancy was prevalent in women from Northeast China who did not use supplementation. No significant relationships were observed between 25-hydroxyvitamin D and thyroid parameters during pregnancy.	[Zhao, Yuhang; Miao, Wei; Yu, Xiaohui; Shan, Zhongyan; Guan, Haixia; Teng, Weiping] China Med Univ, Affiliated Hosp 1, Liaoning Prov Key Lab Endocrine Dis, Dept Endocrinol & Metab,Inst Endocrinol, Shenyang, Liaoning Provin, Peoples R China; [Li, Chenyang] Shenyang Womens & Childrens Hosp, Dept Gynecol & Obstet, Shenyang, Liaoning Provin, Peoples R China	China Medical University	Shan, ZY (corresponding author), China Med Univ, Affiliated Hosp 1, Liaoning Prov Key Lab Endocrine Dis, Dept Endocrinol & Metab,Inst Endocrinol, Shenyang, Liaoning Provin, Peoples R China.	shanzhongyan@medmail.com.cn			special project of national 973 Plan [2011CB512112]	special project of national 973 Plan	The present study was supported by grants from the special project of national 973 Plan (project No. 2011CB512112). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS B, 1995, OBSTET GYNECOL, V86, P163, DOI 10.1016/0029-7844(95)00118-B; Aghajafari F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1169; Alzaim M, 2013, NUTR REV, V71, P158, DOI 10.1111/nure.12018; Andersen R, 2013, EUR J CLIN NUTR, V67, P270, DOI 10.1038/ejcn.2013.3; Andersen S, 2013, BRIT J NUTR, V110, P50, DOI 10.1017/S0007114512004709; BERG JP, 1994, J STEROID BIOCHEM, V50, P145, DOI 10.1016/0960-0760(94)90021-3; Bezerra FF, 2002, J NUTR, V132, P2183, DOI 10.1093/jn/132.8.2183; Bikle D, 2009, J CLIN ENDOCR METAB, V94, P26, DOI 10.1210/jc.2008-1454; Bodnar LM, 2007, J CLIN ENDOCR METAB, V92, P3517, DOI 10.1210/jc.2007-0718; Bodnar LM, 2007, J NUTR, V137, P447, DOI 10.1093/jn/137.2.447; Brembeck Petra, 2013, Br J Nutr, V110, P856, DOI 10.1017/S0007114512005855; Brot C, 2001, BRIT J NUTR, V86, pS97, DOI 10.1079/BJN2001345; Cantorna MT, 2004, AM J CLIN NUTR, V80, p1717S, DOI 10.1093/ajcn/80.6.1717S; Carmichael S, 1997, PAEDIATR PERINAT EP, V11, P392, DOI 10.1046/j.1365-3016.1997.d01-28.x; Chailurkit LO, 2013, THYROID, V23, P25, DOI 10.1089/thy.2012.0001; Charatcharoenwitthaya N, 2013, CLIN ENDOCRINOL, V78, P126, DOI 10.1111/j.1365-2265.2012.04470.x; CROSS NA, 1995, AM J CLIN NUTR, V61, P514, DOI 10.1093/ajcn/61.3.514; Datt S, 2002, BJOG-INT J OBSTET GY, V109, P905, DOI 10.1016/S1470-0328(02)01171-0; Deluca HF, 2001, FASEB J, V15, P2579, DOI 10.1096/fj.01-0433rev; FAO/WHO/UNU, 2004, FAO FOOD NUTR TECH R, V1, P103; GILLETTE ME, 1982, CALCIFIED TISSUE INT, V34, P9, DOI 10.1007/BF02411200; Ginde AA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.11.036; Glinoer D, 1997, ENDOCR REV, V18, P404, DOI 10.1210/er.18.3.404; Godel JC, 2007, PAED CHILD HEALT-CAN, V12, P583, DOI 10.1093/pch/12.7.583; Goswami R, 2009, BRIT J NUTR, V102, P382, DOI 10.1017/S0007114509220824; Grundmann M, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-146; HASHIZUME K, 1991, BIOCHEM BIOPH RES CO, V177, P388, DOI 10.1016/0006-291X(91)91995-O; Heaney RP, 2005, J STEROID BIOCHEM, V97, P13, DOI 10.1016/j.jsbmb.2005.06.020; Hedlund L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060864; HIRAMATSU K, 1983, J CLIN ENDOCR METAB, V56, P623, DOI 10.1210/jcem-56-3-623; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Institute of Medicine, 2009, WEIGHT GAIN PREGN RE; Institute of Medicine, 2010, DIETARY REFERENCE IN; Karakosta P, 2012, J CLIN ENDOCR METAB, V97, P4464, DOI 10.1210/jc.2012-2540; KENT GN, 1993, OSTEOPOROSIS INT, V3, pS44; Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210/er.18.6.832; Krassas GE, 2010, ENDOCR REV, V31, P702, DOI 10.1210/er.2009-0041; Lapillonne A, 2010, MED HYPOTHESES, V74, P71, DOI 10.1016/j.mehy.2009.07.054; Levenson CW, 2008, NUTR REV, V66, P726, DOI 10.1111/j.1753-4887.2008.00122.x; Li Y, 2010, ELECTRICAL CONDUCTIVE ADHESIVES WITH NANOTECHNOLOGIES, P25, DOI 10.1007/978-0-387-88783-8_2; McAree T, 2013, MATERN CHILD NUTR, V9, P23, DOI 10.1111/mcn.12014; Merlino LA, 2004, ARTHRITIS RHEUM-US, V50, P72, DOI 10.1002/art.11434; Miller AE, 1997, NEUROLOGY, V48, P312, DOI 10.1212/WNL.48.2.312; Negro R, 2011, BEST PRACT RES CL EN, V25, P927, DOI 10.1016/j.beem.2011.07.010; NIfHaC, 2009, IMPR HLTH NUTR PREG; Novakovic B, 2009, J BIOL CHEM, V284, P14838, DOI 10.1074/jbc.M809542200; Ojah RCI, 2012, NUTRIENTS, V4, P399, DOI 10.3390/nu4050399; PITKIN RM, 1977, AM J OBSTET GYNECOL, V127, P775, DOI 10.1016/0002-9378(77)90256-3; Prentice A, 2000, ANNU REV NUTR, V20, P249, DOI 10.1146/annurev.nutr.20.1.249; Ritchie LD, 1998, AM J CLIN NUTR, V67, P693, DOI 10.1093/ajcn/67.4.693; Rosen CJ, 2011, NEW ENGL J MED, V364, P248, DOI 10.1056/NEJMcp1009570; Samuel S, 2008, NUTR REV, V66, pS116, DOI 10.1111/j.1753-4887.2008.00094.x; SAR M, 1980, CELL TISSUE RES, V209, P161; SMITH MA, 1989, SURGERY, V106, P987; Smyth PPA, 2005, THYROID, V15, P474, DOI 10.1089/thy.2005.15.474; Tamer G, 2011, THYROID, V21, P891, DOI 10.1089/thy.2009.0200; Thuesen B, 2012, BONE, V50, P605, DOI 10.1016/j.bone.2011.12.016; Tsiaras WG, 2011, ACTA DERM-VENEREOL, V91, P115, DOI 10.2340/00015555-0980; Tsur A, 2011, OSTEOPOROSIS INT, V22, P2895, DOI 10.1007/s00198-010-1492-y; Urrutia RP, 2012, CURR OPIN OBSTET GYN, V24, P57, DOI 10.1097/GCO.0b013e3283505ab3; Van Belle TL, 2011, BEST PRACT RES CL EN, V25, P617, DOI 10.1016/j.beem.2011.04.009; van der Meer IM, 2006, AM J CLIN NUTR, V84, P350; Vandevijvere S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043868; WEISMAN Y, 1979, NATURE, V281, P317, DOI 10.1038/281317a0; Xiang F, 2013, J ENDOCRINOL INVEST, V36, P503, DOI 10.3275/8814; Yamashita H, 2000, SURGERY, V127, P377, DOI 10.1067/msy.2000.104123; Zipitis CS, 2008, ARCH DIS CHILD, V93, P512, DOI 10.1136/adc.2007.128579	67	8	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90161	10.1371/journal.pone.0090161	http://dx.doi.org/10.1371/journal.pone.0090161			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608866	Green Submitted, gold, Green Published			2022-12-25	WOS:000332485800018
J	Dewavrin, F; Zerimech, F; Boyer, A; Maboudou, P; Balduyck, M; Duhamel, A; Nseir, S				Dewavrin, Florent; Zerimech, Farid; Boyer, Alexandre; Maboudou, Patrice; Balduyck, Malika; Duhamel, Alain; Nseir, Saad			Accuracy of Alpha Amylase in Diagnosing Microaspiration in Intubated Critically-Ill Patients	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; INTENSIVE-CARE-UNIT; RISK-FACTORS; ASPIRATION PNEUMONIA; ACQUIRED PNEUMONIA; GASTRIC CONTENTS; TRACHEAL TUBES; CUFF PRESSURE; COLONIZATION; PREVENTION	Objectives: Amylase concentration in respiratory secretions was reported to be a potentially useful marker for aspiration and pneumonia. The aim of this study was to determine accuracy of alpha-amylase in diagnosing microaspiration in critically ill patients. Methods: Retrospective analysis of prospectively collected data collected in a medical ICU. All patients requiring mechanical ventilation for at least 48 h, and included in a previous randomized controlled trial were eligible for this study, provided that at least one tracheal aspirate was available for alpha-amylase measurement. As part of the initial trial, pepsin was quantitatively measured in all tracheal aspirates during a 48-h period. All tracheal aspirates were frozen, allowing subsequent measurement of alpha-amylase for the purpose of the current study. Microaspiration was defined as the presence of at least one positive tracheal aspirate for pepsin (>200 ng.mL(-1)). Abundant microaspiration was defined as the presence of pepsin at significant level in >74% of tracheal aspirates. Results: Amylase was measured in 1055 tracheal aspirates, collected from 109 patients. Using mean alpha-amylase level per patient, accuracy of alpha-amylase in diagnosing microaspiration was moderate (area under the receiver operator curve 0.72 +/- 0.05 [95% CI 0.61-0.83], for an alpha-amylase value of 1685 UI.L-1). However, when alpha-amylase levels, coming from all samples, were taken into account, area under the receiver operator curve was 0.56 +/- 0.05 [0.53-0.60]. Mean alpha-amylase level, and percentage of tracheal aspirates positive for alpha-amylase were significantly higher in patients with microaspiration, and in patients with abundant microaspiration compared with those with no microaspiration; and similar in patients with microaspiration compared with those with abundant microaspiration. alpha-amylase and pepsin were significantly correlated (r(2) = 0.305, p = 0.001). Conclusion: Accuracy of mean alpha-amylase in diagnosing microaspiration is moderate. Further, when all alpha-amylase levels were taken into account, alpha-amylase was inaccurate in diagnosing microaspiration, compared with pepsin.	[Dewavrin, Florent] Valenciennes Hosp, Intens Care Unit, Valenciennes, France; [Zerimech, Farid; Maboudou, Patrice; Balduyck, Malika] Univ Lille 2, Fac Pharm, Biochem & Mol Biol Lab, Lille, France; [Boyer, Alexandre] CHU Bordeaux, Med Intens Care Unit, Bordeaux, France; [Duhamel, Alain] Nord de France Univ, Lille, France; [Nseir, Saad] Univ Hosp Lille, R Salengro Hosp, Crit Care Ctr, Lille, France; [Nseir, Saad] Univ Lille Nord France, EA 2694, Med Assessment Lab, Lille, France	CH de Valenciennes; Universite de Lille - ISITE; Universite de Lille; CHU Bordeaux; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille	Nseir, S (corresponding author), Univ Hosp Lille, R Salengro Hosp, Crit Care Ctr, Lille, France.	s-nseir@chru-lille.fr	Duhamel, Alain/A-4899-2013; Zerimech, Farid/B-5745-2011	BOYER, Alexandre/0000-0003-4384-8872; Nseir, Saad/0000-0002-7618-0357; Zerimech, Farid/0000-0003-2964-1031				Abou Jaoude P, 2010, EXPERT REV MOL DIAGN, V10, P309, DOI [10.1586/ERM.10.7, 10.1586/erm.10.7]; [Anonymous], AM J RESP CRIT CARE, V188, P220; Beuret P, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-45; Bohman JK, 2013, CHEST, V143, P1407, DOI 10.1378/chest.12-1860; BONTEN MJM, 1994, CHEST, V105, P878, DOI 10.1378/chest.105.3.878; Bosch X, 2012, EUR J INTERN MED, V23, P720, DOI 10.1016/j.ejim.2012.08.006; Cvejic L, 2011, RESPIROLOGY, V16, P269, DOI 10.1111/j.1440-1843.2010.01875.x; Dudeck MA, 2013, AM J INFECT CONTROL, V41, P286, DOI 10.1016/j.ajic.2013.01.002; El-Solh AA, 2011, CURR OPIN INFECT DIS, V24, P148, DOI 10.1097/QCO.0b013e328343b6cc; European Centre for Disease Prevention and Control, 2011, REP 2009 SURV DAT 20; Filloux B, 2013, MINERVA ANESTESIOL, V79, P1003; GarrousteOrgeas M, 1997, AM J RESP CRIT CARE, V156, P1647, DOI 10.1164/ajrccm.156.5.96-04076; Gross RD, 2009, AM J RESP CRIT CARE, V179, P559, DOI 10.1164/rccm.200807-1139OC; Heyland DK, 2001, CRIT CARE MED, V29, P1495, DOI 10.1097/00003246-200108000-00001; Jaillette E, 2013, BMC ANESTHESIOL, V13, DOI 10.1186/1471-2253-13-50; Jaillette E, 2011, CRIT CARE MED, V39, P725, DOI 10.1097/CCM.0b013e318208ec61; LeGall JR, 1996, JAMA-J AM MED ASSOC, V276, P802, DOI 10.1001/jama.276.10.802; Lucangelo U, 2008, CRIT CARE MED, V36, P409, DOI 10.1097/01.CCM.0000297888.82492.31; Marik PE, 2001, NEW ENGL J MED, V344, P665, DOI 10.1056/NEJM200103013440908; Melsen WG, 2013, LANCET INFECT DIS, V13, P665, DOI 10.1016/S1473-3099(13)70081-1; Melsen WG, 2009, CRIT CARE MED, V37, P2709, DOI 10.1097/CCM.0b013e3181ab8655; Metheny NA, 2006, CRIT CARE MED, V34, P1007, DOI 10.1097/01.CCM.0000206106.65220.59; Metheny NA, JPEN J PARENTER ENTE, V28, P79; NIEDERMAN MS, 1989, CHEST, V95, P155, DOI 10.1378/chest.95.1.155; Nseir S, 2003, INFECT DIS CLIN N AM, V17, P707, DOI 10.1016/S0891-5520(03)00075-8; Nseir S, 2011, AM J RESP CRIT CARE, V184, P1041, DOI 10.1164/rccm.201104-0630OC; Nseir Saad, 2011, Infectious Disorders - Drug Targets, V11, P413; Nseir S, 2010, INTENS CARE MED, V36, P1156, DOI 10.1007/s00134-010-1892-7; Rosenthal VD, 2012, CRIT CARE MED, V40, P3121, DOI 10.1097/CCM.0b013e3182657916; Touat L, 2013, INTENS CARE MED, V39, P575, DOI 10.1007/s00134-012-2750-6; Tsai HC, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.12.008; Weiss CH, 2013, CRIT CARE MED, V41, P765, DOI 10.1097/CCM.0b013e31827417bc; Winklmaier U, 2006, DYSPHAGIA, V21, P237, DOI 10.1007/s00455-006-9047-2; Wu YC, 2009, CHEST, V136, P118, DOI 10.1378/chest.08-2668	34	34	36	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90851	10.1371/journal.pone.0090851	http://dx.doi.org/10.1371/journal.pone.0090851			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603906	Green Published, gold, Green Submitted			2022-12-25	WOS:000332483600098
J	Sakurai, T; Woolls, MJ; Jin, SW; Murakami, M; Simons, M				Sakurai, Takashi; Woolls, Melissa J.; Jin, Suk-Won; Murakami, Masahiro; Simons, Michael			Inter-Cellular Exchange of Cellular Components via VE-Cadherin-Dependent Trans-Endocytosis	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL CADHERIN; FLUORESCENT PROTEIN; INDEPENDENT ENDOCYTOSIS; LIGAND ENDOCYTOSIS; LIVING CELLS; BETA-CATENIN; MYOSIN-II; MECHANISM; JUNCTIONS; P120-CATENIN	Cell-cell communications typically involve receptor-mediated signaling initiated by soluble or cell-bound ligands. Here, we report a unique mode of endocytosis: proteins originating from cell-cell junctions and cytosolic cellular components from the neighboring cell are internalized, leading to direct exchange of cellular components between two adjacent endothelial cells. VE-cadherins form transcellular bridges between two endothelial cells that are the basis of adherence junctions. At such adherens junction sites, we observed the movement of the entire VE-cadherin molecule from one endothelial cell into the other with junctional and cytoplasmic components. This phenomenon, here termed trans-endocytosis, requires the establishment of a VE-cadherin homodimer in trans with internalization proceeding in a Rac1-, and actomyosin-dependent manner. Importantly, the trans-endocytosis is not dependent on any known endocytic pathway including clathrin-dependent endocytosis, macropinocytosis or phagocytosis. This novel form of cell-cell communications, leading to a direct exchange of cellular components, was observed in 2D and 3D-cultured endothelial cells as well as in the developing zebrafish vasculature.	[Sakurai, Takashi; Woolls, Melissa J.; Jin, Suk-Won; Murakami, Masahiro; Simons, Michael] Yale Univ, Sch Med, Dept Internal Med, Yale Cardiovasc Res Ctr, New Haven, CT 06510 USA; [Sakurai, Takashi; Woolls, Melissa J.; Jin, Suk-Won; Murakami, Masahiro; Simons, Michael] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Simons, Michael] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Sakurai, T (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Yale Cardiovasc Res Ctr, New Haven, CT 06510 USA.	takashi_sakurai@gakushikai.jp	Simons, Michael/G-8553-2014	Simons, Michael/0000-0003-0348-7734	American Heart Association [10SDG4170137]; National Institutes of Health [R01 HL084619]; American Heart Pre-Doctoral Fellowship [11PRE7760026]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084619] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Pre-Doctoral Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by an American Heart Association Scientist Development Grant 10SDG4170137 (MM) and National Institutes of Health R01 HL084619 (MS). MJW was supported by an American Heart Pre-Doctoral Fellowship, 11PRE7760026. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens T, 2003, J MOL BIOL, V325, P733, DOI 10.1016/S0022-2836(02)01286-X; Allport JR, 2002, J LEUKOCYTE BIOL, V71, P821; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Conway DE, 2013, CURR BIOL, V23, P1024, DOI 10.1016/j.cub.2013.04.049; Domhan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021283; Donaldson JG, 2009, CELL SIGNAL, V21, P1, DOI 10.1016/j.cellsig.2008.06.020; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Golachowska MR, 2010, TRENDS CELL BIOL, V20, P618, DOI 10.1016/j.tcb.2010.08.004; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Habuchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003944; Haga Y, 2009, EMBO J, V28, P1197, DOI 10.1038/emboj.2009.78; Hansson EM, 2010, J CELL SCI, V123, P2931, DOI 10.1242/jcs.073239; Hatanaka K, 2011, AM J PHYSIOL-HEART C, V300, pH162, DOI 10.1152/ajpheart.00650.2010; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Herren B, 1998, MOL BIOL CELL, V9, P1589, DOI 10.1091/mbc.9.6.1589; Hosoda T, 2011, CIRCULATION, V123, P1287, DOI 10.1161/CIRCULATIONAHA.110.982918; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; IPPENIHLER KA, 1986, ANNU REV GENET, V20, P593, DOI 10.1146/annurev.ge.20.120186.003113; Jamur MC, 2010, METHODS MOL BIOL, V588, P63, DOI 10.1007/978-1-59745-324-0_9; Jerke U, 2013, J BIOL CHEM, V288, P12910, DOI 10.1074/jbc.M112.434613; Jordan K, 2001, J CELL SCI, V114, P763; Katakowski M, 2010, CANCER RES, V70, P8259, DOI 10.1158/0008-5472.CAN-10-0604; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Kim JD, 2012, DEV CELL, V23, P441, DOI 10.1016/j.devcel.2012.07.007; Kogure T, 2011, HEPATOLOGY, V54, P1237, DOI 10.1002/hep.24504; Kowalczyk AP, 2004, CURR OPIN CELL BIOL, V16, P522, DOI 10.1016/j.ceb.2004.07.001; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; Kusakari S, 2008, J CELL SCI, V121, P1213, DOI 10.1242/jcs.025015; Lanahan AA, 2006, PHYSIOL GENOMICS, V27, P380, DOI 10.1152/physiolgenomics.00145.2006; Larrivee B, 2012, DEV CELL, V22, P489, DOI 10.1016/j.devcel.2012.02.005; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Lecuit T, 2010, NAT CELL BIOL, V12, P522, DOI 10.1038/ncb2066; Legrand P, 2001, J BIOL CHEM, V276, P3581, DOI 10.1074/jbc.M002667200; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; Matsuda M, 2004, J CELL SCI, V117, P1247, DOI 10.1242/jcs.00972; Maxfield F R, 1987, Adv Exp Med Biol, V225, P189; McKinney MC, 2011, DEV DYNAM, V240, P1391, DOI 10.1002/dvdy.22612; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Nichols JT, 2007, J CELL BIOL, V176, P445, DOI 10.1083/jcb.200609014; Nickel BM, 2008, BIOCHEM BIOPH RES CO, V374, P679, DOI 10.1016/j.bbrc.2008.07.108; Niu XL, 2009, J CELL SCI, V122, P600, DOI 10.1242/jcs.031427; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Schnatwinkel C, 2004, PLOS BIOL, V2, P1363, DOI 10.1371/journal.pbio.0020261; Schulte D, 2011, EMBO J, V30, P4157, DOI 10.1038/emboj.2011.304; Schulz B, 2008, CIRC RES, V102, P1192, DOI 10.1161/CIRCRESAHA.107.169805; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Spacek J, 2004, J NEUROSCI, V24, P4233, DOI 10.1523/JNEUROSCI.0287-04.2004; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stirling L, 2009, MOL BIOL CELL, V20, P2991, DOI 10.1091/mbc.E08-10-1074; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Valiunas V, 2005, J PHYSIOL-LONDON, V568, P459, DOI 10.1113/jphysiol.2005.090985; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Weis WI, 2006, J BIOL CHEM, V281, P35593, DOI 10.1074/jbc.R600027200; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440	70	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90736	10.1371/journal.pone.0090736	http://dx.doi.org/10.1371/journal.pone.0090736			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603875	gold, Green Published, Green Submitted			2022-12-25	WOS:000332483600077
J	Wehrkamp, CJ; Gutwein, AR; Natarajan, SK; Phillippi, MA; Mott, JL				Wehrkamp, Cody J.; Gutwein, Ashley R.; Natarajan, Sathish Kumar; Phillippi, Mary Anne; Mott, Justin L.			XIAP Antagonist Embelin Inhibited Proliferation of Cholangiocarcinoma Cells	PLOS ONE			English	Article							FLUORESCENT-PROBE SUBSTRATE; X-LINKED INHIBITOR; APOPTOSIS PROTEIN; HEPATOCELLULAR-CARCINOMA; MITOCHONDRIAL PATHWAY; STRUCTURAL BASIS; CYTOCHROME-C; G2/M PHASE; CANCER; IAP	Cholangiocarcinoma cells are dependent on antiapoptotic signaling for survival and resistance to death stimuli. Recent mechanistic studies have revealed that increased cellular expression of the E3 ubiquitin-protein ligase X-linked inhibitor of apoptosis (XIAP) impairs TRAIL-and chemotherapy-induced cytotoxicity, promoting survival of cholangiocarcinoma cells. This study was undertaken to determine if pharmacologic antagonism of XIAP protein was sufficient to sensitize cholangiocarcinoma cells to cell death. We employed malignant cholangiocarcinoma cell lines and used embelin to antagonize XIAP protein. Embelin treatment resulted in decreased XIAP protein levels by 8 hours of treatment with maximal effect at 16 hours in KMCH and Mz-ChA-1 cells. Assessment of nuclear morphology demonstrated a concentration-dependent increase in nuclear staining. Interestingly, embelin induced nuclear morphology changes as a single agent, independent of the addition of TNF-related apoptosis inducing ligand (TRAIL). However, caspase activity assays revealed that increasing embelin concentrations resulted in slight inhibition of caspase activity, not activation. In addition, the use of a pan-caspase inhibitor did not prevent nuclear morphology changes. Finally, embelin treatment of cholangiocarcinoma cells did not induce DNA fragmentation or PARP cleavage. Apoptosis does not appear to contribute to the effects of embelin on cholangiocarcinoma cells. Instead, embelin caused inhibition of cell proliferation and cell cycle analysis indicated that embelin increased the number of cells in S and G2/M phase. Our results demonstrate that embelin decreased proliferation in cholangiocarcinoma cell lines. Embelin treatment resulted in decreased XIAP protein expression, but did not induce or enhance apoptosis. Thus, in cholangiocarcinoma cells the mechanism of action of embelin may not be dependent on apoptosis.	[Wehrkamp, Cody J.; Gutwein, Ashley R.; Natarajan, Sathish Kumar; Phillippi, Mary Anne; Mott, Justin L.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Mott, JL (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA.	justin.mott@unmc.edu		Mott, Justin/0000-0002-2927-6962	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health [R03 DK092263]; Medical Student Summer Research Program; Fred and Pamela Buffett Cancer Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK092263] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Student Summer Research Program; Fred and Pamela Buffett Cancer Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grant number R03 DK092263 (J.L.M.) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of NIDDK. Additional support was from the Medical Student Summer Research Program (A.R.G.) and the Fred and Pamela Buffett Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KS, 2007, MOL PHARMACOL, V71, P209, DOI 10.1124/mol.106.028787; Aird KM, 2008, MOL CANCER THER, V7, P38, DOI 10.1158/1535-7163.MCT-07-0370; BRANDTS JF, 1990, BIOCHEMISTRY-US, V29, P6927, DOI 10.1021/bi00481a024; Che YF, 2012, AM J PATHOL, V180, P1798, DOI 10.1016/j.ajpath.2012.01.016; Clawson KA, 2010, J SURG RES, V163, P244, DOI 10.1016/j.jss.2010.03.067; Cliby WA, 2002, J BIOL CHEM, V277, P1599, DOI 10.1074/jbc.M106287200; Dai Y, 2011, AM J CANCER RES, V1, P128; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; FRANCIS R, 1995, GENETICS, V139, P579; FUKADA H, 1983, J BIOL CHEM, V258, P3193; GUPTA O P, 1977, Indian Journal of Physiology and Pharmacology, V21, P31; Heo JY, 2011, CANCER LETT, V308, P71, DOI 10.1016/j.canlet.2011.04.015; Hu R, 2011, MED ONCOL, V28, P1584, DOI 10.1007/s12032-010-9601-5; Kim SW, 2013, PROSTATE, V73, P296, DOI 10.1002/pros.22574; KNUTH A, 1985, J HEPATOL, V1, P579, DOI 10.1016/S0168-8278(85)80002-7; KUBISTA M, 1987, BIOCHEMISTRY-US, V26, P4545, DOI 10.1021/bi00388a057; Kurita S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018330; Li Y, 2013, ONCOL LETT, V5, P1005, DOI 10.3892/ol.2012.1084; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Maciejowski J, 2006, DEV BIOL, V292, P142, DOI 10.1016/j.ydbio.2005.12.046; MIYAGIWA M, 1989, IN VITRO CELL DEV B, V25, P503; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Mori T, 2007, J SURG RES, V142, P281, DOI 10.1016/j.jss.2007.03.068; MUNSHI SR, 1972, INDIAN J MED RES, V60, P1054; MURAKAMI T, 1987, HEPATOLOGY, V7, P551, DOI 10.1002/hep.1840070322; Nikolovska-Coleska Z, 2004, J MED CHEM, V47, P2430, DOI 10.1021/jm030420+; Shiraishi J, 2001, AM J PHYSIOL-HEART C, V281, pH1637, DOI 10.1152/ajpheart.2001.281.4.H1637; SHRAKE A, 1990, J BIOL CHEM, V265, P5055; SHRAKE A, 1992, BIOPOLYMERS, V32, P925, DOI 10.1002/bip.360320804; Siegelin MD, 2009, NEUROCHEM INT, V55, P423, DOI 10.1016/j.neuint.2009.04.011; Sirica AE, 2008, HEPATOLOGY, V47, P1178, DOI 10.1002/hep.22088; Taghiyev A, 2012, EXP THER MED, V4, P649, DOI 10.3892/etm.2012.637; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Yamagiwa Y, 2004, CANCER RES, V64, P1293, DOI 10.1158/0008-5472.CAN-03-2517; Yasujima T, 2011, J PHARM SCI-US, V100, P4006, DOI 10.1002/jps.22548; Yasujima T, 2010, DRUG METAB DISPOS, V38, P715, DOI 10.1124/dmd.109.030221	40	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90238	10.1371/journal.pone.0090238	http://dx.doi.org/10.1371/journal.pone.0090238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603802	gold, Green Published			2022-12-25	WOS:000332483600034
J	Aryal, RP; Ju, TZ; Cummings, RD				Aryal, Rajindra P.; Ju, Tongzhong; Cummings, Richard D.			Identification of a Novel Protein Binding Motif within the T-synthase for the Molecular Chaperone Cosmc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); Glycobiology; Glycoprotein; Glycoprotein Biosynthesis; Glycosylation; Molecular Chaperone; Protein Folding; Cosmc; T-synthase	COLLAGEN TRIPLE-HELIX; TOLL-LIKE RECEPTORS; O-GLYCOSYLATION; IN-VITRO; CORE-1 BETA-1,3-GALACTOSYLTRANSFERASE; CAENORHABDITIS-ELEGANS; LEUKOCYTE RECRUITMENT; PSGL-1 BINDING; UDP-GLCNAC; MUCIN	Background: We hypothesize that ER chaperone Cosmc binds specifically to its single client T-synthase. Results: Using molecular and biochemical approaches, we demonstrate that Cosmc recognizes a specific peptide within unfolded T-synthase. Conclusion: Cosmc-T-synthase interaction requires unique peptide recognition in the unfolded T-synthase that becomes inaccessible to Cosmc upon final folding. Significance: This study describes a novel peptide-specific chaperone recognition that regulates protein O-glycosylation. Prior studies suggested that the core 1 3-galactosyltransferase (T-synthase) is a specific client of the endoplasmic reticulum chaperone Cosmc, whose function is required for T-synthase folding, activity, and consequent synthesis of normal O-glycans in all vertebrate cells. To explore whether the T-synthase encodes a specific recognition motif for Cosmc, we used deletion mutagenesis to identify a cryptic linear and relatively hydrophobic peptide in the N-terminal stem region of the T-synthase that is essential for binding to Cosmc (Cosmc binding region within T-synthase, or CBRT). Using this sequence information, we synthesized a peptide containing CBRT and found that it directly interacts with Cosmc and also inhibits Cosmc-assisted in vitro refolding of denatured T-synthase. Moreover, engineered T-synthase carrying mutations within CBRT exhibited diminished binding to Cosmc that resulted in the formation of inactive T-synthase. To confirm the general recognition of CBRT by Cosmc, we performed a domain swap experiment in which we inserted the stem region of the T-synthase into the human 4GalT1 and found that the CBRT element can confer Cosmc binding onto the 4GalT1 chimera. Thus, CBRT is a unique recognition motif for Cosmc to promote its regulation and formation of active T-synthase and represents the first sequence-specific chaperone recognition system in the ER/Golgi required for normal protein O-glycosylation.	[Aryal, Rajindra P.; Ju, Tongzhong; Cummings, Richard D.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Ju, TZ (corresponding author), Emory Univ, Sch Med, Dept Biochem, O Wayne Rollins Res Ctr, 1510 Clifton Rd,Ste 4001, Atlanta, GA 30322 USA.	tju@emory.edu; rdcummi@emory.edu		Ju, Tongzhong/0000-0002-4429-1976; Aryal, Rajindra P/0000-0001-8718-636X	National Institutes of Health [DK0808760, GM068559]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068559] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK0808760 (to T. J.) and GM068559 (to R. D. C.).	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Aryal RP, 2012, J BIOL CHEM, V287, P15317, DOI 10.1074/jbc.M111.312587; Aryal RP, 2010, J BIOL CHEM, V285, P2456, DOI 10.1074/jbc.M109.065169; Bergstrom KSB, 2013, GLYCOBIOLOGY, V23, P1026, DOI 10.1093/glycob/cwt045; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; Boeggeman EE, 2003, PROTEIN EXPRES PURIF, V30, P219, DOI 10.1016/S1046-5928(03)00093-7; BROCKHAUSEN I, 1985, BIOCHEMISTRY-US, V24, P1866, DOI 10.1021/bi00329a010; Cho SK, 1997, J BIOL CHEM, V272, P13622, DOI 10.1074/jbc.272.21.13622; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; Dafforn TR, 2001, J BIOL CHEM, V276, P49310, DOI 10.1074/jbc.M108896200; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Frydman J, 1996, SCIENCE, V272, P1497, DOI 10.1126/science.272.5267.1497; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; Hang HC, 2005, BIOORGAN MED CHEM, V13, P5021, DOI 10.1016/j.bmc.2005.04.085; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Herzog BH, 2013, NATURE, V502, P105, DOI 10.1038/nature12501; Huang J, 2014, MOL CARCINOGEN, V53, pE62, DOI 10.1002/mc.22011; Iwai T, 2002, J BIOL CHEM, V277, P12802, DOI 10.1074/jbc.M112457200; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johswich A, 2009, J CELL BIOL, V184, P173, DOI 10.1083/jcb.200801071; Ju TZ, 2008, J CELL BIOL, V182, P531, DOI 10.1083/jcb.200711151; Ju TZ, 2008, CANCER RES, V68, P1636, DOI 10.1158/0008-5472.CAN-07-2345; Ju TZ, 2006, GLYCOBIOLOGY, V16, P947, DOI 10.1093/glycob/cwl008; Ju TZ, 2013, PROTEOM CLIN APPL, V7, P618, DOI 10.1002/prca.201300024; Ju TZ, 2011, GLYCOBIOLOGY, V21, P352, DOI 10.1093/glycob/cwq168; Ju TZ, 2011, ANGEW CHEM INT EDIT, V50, P1770, DOI 10.1002/anie.201002313; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Ju TZ, 2002, J BIOL CHEM, V277, P169, DOI 10.1074/jbc.M109056200; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Kawar ZS, 2002, J BIOL CHEM, V277, P34924, DOI 10.1074/jbc.M206112200; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kitazume-Kawaguchi S, 1999, GLYCOBIOLOGY, V9, P1397; Koide T, 2006, J BIOL CHEM, V281, P3432, DOI 10.1074/jbc.M509707200; Koide T, 2002, J BIOL CHEM, V277, P6178, DOI 10.1074/jbc.M106497200; Kraft B, 2011, CELL MOL LIFE SCI, V68, P4091, DOI 10.1007/s00018-011-0725-3; Lee HJ, 2005, J BIOL CHEM, V280, P525, DOI 10.1074/jbc.M410245200; Lee JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056211; Legaigneur P, 2001, J BIOL CHEM, V276, P21608, DOI 10.1074/jbc.M100860200; Madsen CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072413; McEver RP, 1997, J CLIN INVEST, V100, P485, DOI 10.1172/JCI119556; McEver RP, 1997, J CLIN INVEST, V100, pS97; Merulla J, 2013, TRAFFIC, V14, P767, DOI 10.1111/tra.12068; Mi RJ, 2012, J BIOL CHEM, V287, P41523, DOI 10.1074/jbc.M112.371989; Narimatsu Y, 2011, FEBS LETT, V585, P1276, DOI 10.1016/j.febslet.2011.04.010; Qasba PK, 2008, CURR DRUG TARGETS, V9, P292, DOI 10.2174/138945008783954943; Raineri E, 2010, BIOINFORMATICS, V26, P1685, DOI 10.1093/bioinformatics/btq287; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Schietinger A, 2006, SCIENCE, V314, P304, DOI 10.1126/science.1129200; Siegers K, 1999, EMBO J, V18, P75, DOI 10.1093/emboj/18.1.75; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Stevens FJ, 1999, SEMIN CELL DEV BIOL, V10, P443, DOI 10.1006/scdb.1999.0315; Sun QA, 2011, J BIOL CHEM, V286, P11529, DOI 10.1074/jbc.M110.173591; TENHAGEN KG, 2003, GLYCOBIOLOGY, V13, P1; Thulasiraman V, 1999, EMBO J, V18, P85, DOI 10.1093/emboj/18.1.85; Tian E, 2009, GLYCOCONJUGATE J, V26, P325, DOI 10.1007/s10719-008-9162-4; van Die I, 1999, FEBS LETT, V450, P52, DOI 10.1016/S0014-5793(99)00462-7; Wang YC, 2012, P NATL ACAD SCI USA, V109, P16143, DOI 10.1073/pnas.1208253109; Wang YC, 2010, P NATL ACAD SCI USA, V107, P9228, DOI 10.1073/pnas.0914004107; Widmer C, 2012, P NATL ACAD SCI USA, V109, P13243, DOI 10.1073/pnas.1208072109; Wu S, 2012, J BIOL CHEM, V287, P6735, DOI 10.1074/jbc.M111.309526; Xia LJ, 2004, J CELL BIOL, V164, P451, DOI 10.1083/jcb.200311112; Yagi-Utsumi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045930; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005	67	16	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11630	11641		10.1074/jbc.M114.555870	http://dx.doi.org/10.1074/jbc.M114.555870			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24616093	hybrid, Green Published			2022-12-25	WOS:000335010600006
J	Tar, K; Dange, T; Yang, CY; Yao, YH; Bulteau, AL; Salcedo, EF; Braigen, S; Bouillaud, F; Finley, D; Schmidt, M				Tar, Krisztina; Dange, Thomas; Yang, Ciyu; Yao, Yanhua; Bulteau, Anne-Laure; Salcedo, Elena Fernandez; Braigen, Stephen; Bouillaud, Frederic; Finley, Daniel; Schmidt, Marion			Proteasomes Associated with the Blm10 Activator Protein Antagonize Mitochondrial Fission through Degradation of the Fission Protein Dnm1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mitochondria; Oxidative Stress; Proteasome; Protein Degradation; Respiration	PROGRAMMED CELL-DEATH; REG-GAMMA-PROTEASOME; SACCHAROMYCES-CEREVISIAE; GENE DISRUPTION; REPEAT PROTEIN; CORE PARTICLE; DNA-REPAIR; YEAST; PA200; MITOFUSIN	Background: Blm10 binds to the proteasome core particle and stimulates its proteolytic activity. Results: Loss of BLM10 results in impaired respiration, elevated oxidative stress sensitivity, increased mitochondrial fission, and stabilization of the fission protein Dnm1. Conclusion: Blm10 proteasome-mediated Dnm1 degradation is a regulatory mechanism to maintain correct mitochondrial function. Significance: Blm10 is involved in mitochondrial quality control under oxidative stress. The conserved Blm10/PA200 activators bind to the proteasome core particle gate and facilitate turnover of peptides and unfolded proteins in vitro. We report here that Blm10 is required for the maintenance of functional mitochondria. BLM10 expression is induced 25-fold upon a switch from fermentation to oxidative metabolism. In the absence of BLM10, Saccharomyces cerevisiae cells exhibit a temperature-sensitive growth defect under oxidative growth conditions and produce colonies with dysfunctional mitochondria at high frequency. Loss of BLM10 leads to reduced respiratory capacity, increased mitochondrial oxidative damage, and reduced viability in the presence of oxidative stress or death stimuli. In the absence of BLM10, increased fragmentation of the mitochondrial network under oxidative stress is observed indicative of elevated activity of the mitochondrial fission machinery. The degradation of Dnm1, the main factor mediating mitochondrial fission, is impaired in the absence of BLM10 in vitro and in vivo. These data suggest that the mitochondrial functional and morphological changes observed are related to elevated Dnm1 levels. This hypothesis is supported by the finding that cells that constitutively overexpress DNM1 display the same mitochondrial defects as blm10 cells. The data are consistent with a model in which Blm10 proteasome-mediated turnover of Dnm1 is required for the maintenance of mitochondrial function and provides cytoprotection under conditions that induce increased mitochondrial damage and programmed cell death.	[Tar, Krisztina; Dange, Thomas; Yang, Ciyu; Yao, Yanhua; Salcedo, Elena Fernandez; Braigen, Stephen; Schmidt, Marion] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Bulteau, Anne-Laure; Bouillaud, Frederic] INSERM, Inst Cochin, F-75014 Paris, France; [Finley, Daniel] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Yeshiva University; Albert Einstein College of Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Harvard University; Harvard Medical School	Schmidt, M (corresponding author), Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	marion.schmidt@einstein.yu.edu	Bouillaud, Frédéric R/L-3238-2017; bulteau, anne-laure/AAN-4004-2020; YAO, Yanhua/E-6513-2016	Bouillaud, Frédéric R/0000-0002-7518-9237; YAO, Yanhua/0000-0002-7989-8604	National Institutes of Health [R01 GM084228, R37 GM43601, R01 GM65592]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065592, R01GM084228, R37GM043601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM084228 (to M. S.) and R37 GM43601 and R01 GM65592 (to D. F.).	Altmann K, 2005, MOL BIOL CELL, V16, P5410, DOI 10.1091/mbc.E05-07-0678; Anton F, 2013, MOL CELL, V49, P487, DOI 10.1016/j.molcel.2012.12.003; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Blickwedehl J, 2008, P NATL ACAD SCI USA, V105, P16165, DOI 10.1073/pnas.0803145105; Blickwedehl J, 2012, MOL CANCER RES, V10, P937, DOI 10.1158/1541-7786.MCR-11-0493-T; Brachmann CB, 1998, YEAST, V14, P115; Braun RJ, 2011, BIOCHEM SOC T, V39, P1520, DOI 10.1042/BST0391520; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022; Cohen MMJ, 2008, MOL BIOL CELL, V19, P2457, DOI 10.1091/mbc.E08-02-0227; Dange T, 2011, J BIOL CHEM, V286, P42830, DOI 10.1074/jbc.M111.300178; Dejean L, 2000, BBA-BIOENERGETICS, V1457, P45, DOI 10.1016/S0005-2728(00)00053-0; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; Elgass K, 2013, BBA-MOL CELL RES, V1833, P150, DOI 10.1016/j.bbamcr.2012.05.002; Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904; Fehlker M, 2003, EMBO REP, V4, P959, DOI 10.1038/sj.embor.embor938; FERGUSON LR, 1992, MUTAT RES, V265, P103, DOI 10.1016/0027-5107(92)90042-Z; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fisk HA, 1999, J CELL BIOL, V145, P1199, DOI 10.1083/jcb.145.6.1199; Fukushima NH, 2001, MOL BIOL CELL, V12, P2756, DOI 10.1091/mbc.12.9.2756; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; Glickman MH, 1999, MOL BIOL REP, V26, P21, DOI 10.1023/A:1006928316738; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Iwanczyk J, 2006, J MOL BIOL, V363, P648, DOI 10.1016/j.jmb.2006.08.010; Jansen G, 2005, GENE, V344, P43, DOI 10.1016/j.gene.2004.10.016; Joshi KK, 2011, J MOL BIOL, V410, P383, DOI 10.1016/j.jmb.2011.05.005; Karbowski M, 2007, J CELL BIOL, V178, P71, DOI 10.1083/jcb.200611064; Khor B, 2006, MOL CELL BIOL, V26, P2999, DOI 10.1128/MCB.26.8.2999-3007.2006; Koirala S, 2013, P NATL ACAD SCI USA, V110, pE1342, DOI 10.1073/pnas.1300855110; Kruegel U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002253; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Laporte D, 2008, J CELL BIOL, V181, P737, DOI 10.1083/jcb.200711154; Leboucher GP, 2012, MOL CELL, V47, P547, DOI 10.1016/j.molcel.2012.05.041; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Lopez AD, 2011, MOL BIOL CELL, V22, P528, DOI 10.1091/mbc.E10-04-0352; Mao K, 2013, DEV CELL, V26, P9, DOI 10.1016/j.devcel.2013.05.024; Marques AJ, 2007, J BIOL CHEM, V282, P34869, DOI 10.1074/jbc.M705836200; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002; Parone PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003257; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Qian MX, 2013, CELL, V153, P1012, DOI 10.1016/j.cell.2013.04.032; Radke S, 2008, J BIOL CHEM, V283, P12681, DOI 10.1074/jbc.C800036200; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Rinaldi T, 2008, MOL BIOL CELL, V19, P1022, DOI 10.1091/mbc.E07-07-0717; Russell SJ, 1999, J BIOL CHEM, V274, P21943, DOI 10.1074/jbc.274.31.21943; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Schmidt M, 2005, NAT STRUCT MOL BIOL, V12, P294, DOI 10.1038/nsmb914; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Stadtmueller BM, 2011, MOL CELL, V41, P8, DOI 10.1016/j.molcel.2010.12.020; Strehl B, 2005, IMMUNOL REV, V207, P19, DOI 10.1111/j.0105-2896.2005.00308.x; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Sutovsky P, 1996, BIOL REPROD, V55, P1195, DOI 10.1095/biolreprod55.6.1195; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Takeda K, 2010, AUTOPHAGY, V6, P564, DOI 10.4161/auto.6.4.11948; Teng XC, 2009, METHODS MOL BIOL, V559, P335, DOI 10.1007/978-1-60327-017-5_23; Tieu Q, 2002, J CELL BIOL, V158, P445, DOI 10.1083/jcb.200205031; Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779; Ustrell V, 2002, EMBO J, V21, P3516, DOI 10.1093/emboj/cdf333; Vabulas RM, 2005, SCIENCE, V310, P1960, DOI 10.1126/science.1121925; Wang HX, 2011, J BIOL CHEM, V286, P11649, DOI 10.1074/jbc.M110.144238; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Zunino R, 2007, J CELL SCI, V120, P1178, DOI 10.1242/jcs.03418	66	28	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					12145	12156		10.1074/jbc.M114.554105	http://dx.doi.org/10.1074/jbc.M114.554105			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24604417	hybrid, Green Published			2022-12-25	WOS:000335010600050
J	Bartels, M; Calgarotto, AK; Martens, AC; Maso, V; da Silva, SL; Bierings, MB; de Souza Queiroz, ML; Coffer, PJ				Bartels, Marije; Calgarotto, Andrana K.; Martens, Anton C.; Maso, Victor; da Silva, Saulo L.; Bierings, Marc B.; de Souza Queiroz, Mary L.; Coffer, Paul J.			Differential Effects of Nitrostyrene Derivatives on Myelopoiesis Involve Regulation of C/EBP alpha and p38MAPK Activity	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; TRANSCRIPTIONAL REGULATION; P38 MAPK; INHIBITORS; KINASE; HEMATOPOIESIS; GRANULOCYTE; APOPTOSIS; BETA; GRANULOPOIESIS	Bone marrow failure syndromes and MDS represent a heterogenous group of diseases, characterized by ineffective myelopoiesis, the risk of clonal evolution and a generally poor response to chemotherapy-based treatment regimen. Nitrostyrene derivatives have been studied as protein phosphatase inhibitors in various tumor models. Pharmacological studies have identified nitrostyrene as the structural core underlying a pro-apoptotic effect in tumor cells, yet their effects on normal cells, including those of the hematopoietic system, are largely unknown. In this study, utilizing umbilical cord blood-derived myeloid progenitor cells, patient-derived bone marrow cells, and a (BALB/c) mouse model; we investigated the effects of treatment with two nitrostyrene derivatives (NTS1 and NTS2) on myeloid development. We demonstrate that these compounds stimulate the expansion and differentiation of myeloid progenitors in vitro and improve myeloid reconstitution after chemotherapy-induced bone marrow depletion in vitro and in vivo. These effects were accompanied by increased C/EBP alpha expression and activity and inhibition of the p38MAPK signalling pathway. Together, our data suggest that nitrostyrenes improve myelopoiesis and represent potential new treatment strategies for patients suffering from bone marrow failure syndromes, hypocellular myelodysplastic syndrome and chemotherapy-induced aplasia.	[Bartels, Marije; Martens, Anton C.; Coffer, Paul J.] Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands; [Bartels, Marije; Bierings, Marc B.; Coffer, Paul J.] Univ Med Ctr Utrecht, Div Pediat, Utrecht, Netherlands; [Calgarotto, Andrana K.; Maso, Victor; de Souza Queiroz, Mary L.] Univ Estadual Campinas, Dept Farmacol, Campinas, SP, Brazil; [Martens, Anton C.] Univ Med Ctr Utrecht, Dept Immunol, Utrecht, Netherlands; [da Silva, Saulo L.] Univ Fed Sao Joao, Dept Quim, Ouro Branco, MG, Brazil	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Universidade Estadual de Campinas; Utrecht University; Utrecht University Medical Center; Universidade Federal de Sao Joao del-Rei	Bartels, M (corresponding author), Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands.	mbartel2@umcutrecht.nl	Coffer, Paul/AAF-7970-2020; Da Silva, Saulo Luís/AGX-1028-2022	Da Silva, Saulo Luis/0000-0002-7029-2016	Coordenacao de Aperfeicoamento de Pessoal de Nivel (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)	Coordenacao de Aperfeicoamento de Pessoal de Nivel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The work of AKC was supported financially by Coordenacao de Aperfeicoamento de Pessoal de Nivel (CAPES) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado-Kristensson M, 2005, J BIOL CHEM, V280, P6238, DOI 10.1074/jbc.M409718200; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Berliner N, 2008, BLOOD, V111, P5427, DOI 10.1182/blood-2007-10-077396; Cantor AB, 2001, CURR OPIN GENET DEV, V11, P513, DOI 10.1016/S0959-437X(00)00226-4; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; Enver T, 1998, BLOOD, V92, P348, DOI 10.1182/blood.V92.2.348.Con3_348_351; Fathi AR, 2000, BIOORG MED CHEM LETT, V10, P1605, DOI 10.1016/S0960-894X(00)00294-8; FECCHIO D, 1990, INFLAMMATION, V14, P125, DOI 10.1007/BF00914035; Friedman AD, 2003, BLOOD CELL MOL DIS, V31, P338, DOI 10.1016/S1079-9796(03)00135-9; Friedman AD, 2002, INT J HEMATOL, V75, P466, DOI 10.1007/BF02982108; Friedman AD, 2002, ONCOGENE, V21, P3377, DOI 10.1038/sj.onc.1205324; Geest CR, 2009, J LEUKOCYTE BIOL, V86, P237, DOI 10.1189/jlb.0209097; Kaap S, 2003, BIOCHEM PHARMACOL, V65, P603, DOI 10.1016/S0006-2952(02)01618-0; Katsoulidis E, 2005, CANCER RES, V65, P9029, DOI 10.1158/0008-5472.CAN-04-4555; Kim JH, 2003, MOL PHARMACOL, V63, P1117, DOI 10.1124/mol.63.5.1117; Lin SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049605; Metcalf D, 1998, BLOOD, V92, P345, DOI 10.1182/blood.V92.2.345b.Con2_345_347; Navas TA, 2006, BLOOD, V108, P4170, DOI 10.1182/blood-2006-05-023093; Park J, 2004, BIOCHEMISTRY-US, V43, P15014, DOI 10.1021/bi0486233; Peng A, 2010, ONCOGENE, V29, P5977, DOI 10.1038/onc.2010.371; Prickett TD, 2007, MOL CELL BIOL, V27, P4217, DOI 10.1128/MCB.00067-07; RICH IN, 1991, BLOOD, V77, P1164; Ross SE, 2004, MOL CELL BIOL, V24, P675, DOI 10.1128/MCB.24.2.675-686.2004; Schonthal AH, 2001, CANCER LETT, V170, P1, DOI 10.1016/S0304-3835(01)00561-4; Spinelli E, 2012, CLIN CANCER RES, V18, P3079, DOI 10.1158/1078-0432.CCR-11-0686; Verma A, 2002, J BIOL CHEM, V277, P7726, DOI 10.1074/jbc.M106640200; Villar JAFP, 2008, TOXICON, V51, P1467, DOI 10.1016/j.toxicon.2008.03.023; Wang D, 2006, BLOOD, V108, P1223, DOI 10.1182/blood-2005-12-008763; Wang WY, 2007, BIOCHEM PHARMACOL, V74, P601, DOI 10.1016/j.bcp.2007.06.001; Ward AC, 2000, LEUKEMIA, V14, P973, DOI 10.1038/sj.leu.2401808	30	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90586	10.1371/journal.pone.0090586	http://dx.doi.org/10.1371/journal.pone.0090586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614182	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300031
J	Batke, SP; Jocque, M; Kelly, DL				Batke, Sven P.; Jocque, Merlijn; Kelly, Daniel L.			Modelling Hurricane Exposure and Wind Speed on a Mesoclimate Scale: A Case Study from Cusuco NP, Honduras	PLOS ONE			English	Article							LUQUILLO-EXPERIMENTAL-FOREST; PUERTO-RICO; CATASTROPHIC WIND; DAMAGE; RECOVERY; HUGO; VEGETATION; MORTALITY; PROFILES; PATTERNS	High energy weather events are often expected to play a substantial role in biotic community dynamics and large scale diversity patterns but their contribution is hard to prove. Currently, observations are limited to the documentation of accidental records after the passing of such events. A more comprehensive approach is synthesising weather events in a location over a long time period, ideally at a high spatial resolution and on a large geographic scale. We provide a detailed overview on how to generate hurricane exposure data at a meso-climate level for a specific region. As a case study we modelled landscape hurricane exposure in Cusuco National Park (CNP), Honduras with a resolution of 50 mx50 m patches. We calculated actual hurricane exposure vulnerability site scores (EVVS) through the combination of a wind pressure model, an exposure model that can incorporate simple wind dynamics within a 3-dimensional landscape and the integration of historical hurricanes data. The EVSS was calculated as a weighted function of sites exposure, hurricane frequency and maximum wind velocity. Eleven hurricanes were found to have affected CNP between 1995 and 2010. The highest EVSS's were predicted to be on South and South-East facing sites of the park. Ground validation demonstrated that the South-solution (i.e. the South wind inflow direction) explained most of the observed tree damage (90% of the observed tree damage in the field). Incorporating historical data to the model to calculate actual hurricane exposure values, instead of potential exposure values, increased the model fit by 50%.	[Batke, Sven P.; Kelly, Daniel L.] Univ Dublin Trinity Coll, Dept Bot, Dublin 2, Ireland; [Batke, Sven P.; Kelly, Daniel L.] Trinity Coll Dublin, Trinity Ctr Biodivers Res, Dublin, Ireland; [Jocque, Merlijn] Koninklijk Belgisch Inst Natuurwetenschappen, Brussels, Belgium; [Batke, Sven P.; Jocque, Merlijn; Kelly, Daniel L.] Operat Wallacea, Old Bolingbroke, Lincs, England; [Jocque, Merlijn] Rutgers State Univ, Dept Biol Sci, Newark, NJ 07102 USA	Trinity College Dublin; Trinity College Dublin; Rutgers State University Newark; Rutgers State University New Brunswick	Batke, SP (corresponding author), Univ Dublin Trinity Coll, Dept Bot, Dublin 2, Ireland.	batkesp@tcd.ie		Batke, Sven/0000-0002-1938-3625	Trinity College Dublin; Rufford Foundation; Operation Wallacea; Royal Geographic Society London	Trinity College Dublin; Rufford Foundation; Operation Wallacea; Royal Geographic Society London	This project was funded by Trinity College Dublin, the Rufford Foundation, Operation Wallacea and the Royal Geographic Society London (in collaboration with Dr. Merlijn Jocque). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLINGHAM PJ, 1992, J TROP ECOL, V8, P217, DOI 10.1017/S0266467400006386; Boose ER, 2004, ECOL MONOGR, V74, P335, DOI 10.1890/02-4057; BOOSE ER, 1994, ECOL MONOGR, V64, P369, DOI 10.2307/2937142; Breloer H, 1994, BODY LANGUAGE TREES; BROKAW NVL, 1991, BIOTROPICA, V23, P442, DOI 10.2307/2388264; BW Blanchard, 2005, RADIAL VARIATION TAN, P1; Censky EJ, 1998, NATURE, V395, P556, DOI 10.1038/26886; Chapman L, 2000, METEOROL APPL, V7, P335, DOI 10.1017/S1350482700001729; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; ESRI, 2011, ARCGIS; Everham EM, 1996, BOT REV, V62, P113, DOI 10.1007/BF02857920; FOSTER DR, 1992, J ECOL, V80, P79, DOI 10.2307/2261065; FRANGI JL, 1991, BIOTROPICA, V23, P324, DOI 10.2307/2388248; Hanewinkel M, 2011, EUR J FOREST RES, V130, P329, DOI 10.1007/s10342-010-0392-1; Harper B., 2002, TROPICAL CYCLONE PAR, V83; Hartshorn G, 1983, TROPICAL RAIN FOREST; HOLLAND GJ, 1980, MON WEATHER REV, V108, P1212, DOI 10.1175/1520-0493(1980)108<1212:AAMOTW>2.0.CO;2; Holland G, 2008, MON WEATHER REV, V136, P3432, DOI 10.1175/2008MWR2395.1; Holland GJ, 2010, MON WEATHER REV, V138, P4393, DOI 10.1175/2010MWR3317.1; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Lanquaye-Opoku N, 2005, FOREST ECOL MANAG, V216, P134, DOI 10.1016/j.foreco.2005.05.032; Mark D.M., 1975, GEOGR ANN A, V57, P165, DOI [DOI 10.2307/520612, 10.2307/520612]; Microsoft Office Professional Plus, 2010, MICR EXC SPREADSH; Mikita T, 2010, J LANDSCAPE ECOL, V3, P45; NOAA, 1999, HURR BAS; NOAA, 2012, NHC DAT ARCH; Ostertag R, 2005, BIOTROPICA, V37, P16, DOI 10.1111/j.1744-7429.2005.04052.x; Perotto-Baldiviezo HL, 2004, AGR ECOSYST ENVIRON, V103, P165, DOI 10.1016/j.agee.2003.10.011; Peterson CJ, 2000, FOREST ECOL MANAG, V135, P237, DOI 10.1016/S0378-1127(00)00283-8; Philpott SM, 2008, AGR ECOSYST ENVIRON, V128, P12, DOI 10.1016/j.agee.2008.04.016; Pietri L, 2009, MEC IND, V10, P181, DOI 10.1051/meca/2009047; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; REILLY AE, 1991, BIOTROPICA, V23, P414, DOI 10.2307/2388260; Rossi E, 2013, GISCI REMOTE SENS, V50, P385, DOI 10.1080/15481603.2013.820066; Smith J, 1997, ASSESSMENT SOIL WATE; Vickery PJ, 2000, J STRUCT ENG-ASCE, V126, P1203, DOI 10.1061/(ASCE)0733-9445(2000)126:10(1203); WALKER LR, 1991, BIOTROPICA, V23, P379, DOI 10.2307/2388255; Wang Y, 2012, STRUCT SAF, V35, P40, DOI 10.1016/j.strusafe.2011.12.001; WOLF JHD, 1993, ANN MO BOT GARD, V80, P928, DOI 10.2307/2399938; Xi WM, 2008, FORESTRY, V81, P317, DOI 10.1093/forestry/cpn020; YOU CX, 1991, BIOTROPICA, V23, P400, DOI 10.2307/2388258; ZIMMERMAN JK, 1995, FOREST ECOL MANAG, V77, P65, DOI 10.1016/0378-1127(95)03575-U; ZIMMERMAN JK, 1994, J ECOL, V82, P911, DOI 10.2307/2261454	43	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91306	10.1371/journal.pone.0091306	http://dx.doi.org/10.1371/journal.pone.0091306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614168	Green Submitted, Green Published, gold			2022-12-25	WOS:000332839300109
J	Fleury, M; Rodrigues, RR; do Couto, HTZ; Galetti, M				Fleury, Marina; Rodrigues, Ricardo R.; do Couto, Hilton T. Z.; Galetti, Mauro			Seasonal Variation in the Fate of Seeds under Contrasting Logging Regimes	PLOS ONE			English	Article							LEAF-CUTTING ANTS; ATLANTIC RAIN-FOREST; RATTUS-EXULANS PEALE; HOME-RANGE USE; TROPICAL FOREST; SMALL MAMMALS; AMAZONIAN FOREST; FRAGMENT SIZE; LONG-TERM; PREDATION	Seed predators and dispersers may drive the speed and structure of forest regeneration in natural ecosystems. Rodents and ants prey upon and disperse seeds, yet empirical studies on the magnitude of these effects are lacking. Here, we examined the role of ants and rodents on seed predation in 4 plant species in a successional gradient on a tropical rainforest island. We found that (1) seeds are mostly consumed rather than dispersed; (2) rates of seed predation vary by habitat, season, and species; (3) seed size, shape, and hardness do not affect the probability of being depredated. Rodents were responsible for 70% of seed predation and were negligible (0.14%) seed dispersers, whereas ants were responsible for only 2% of seed predation and for no dispersal. We detected seasonal and habitat effects on seed loss, with higher seed predation occurring during the wet season and in old-growth forests. In the absence of predators regulating seed-consumer populations, the densities of these resilient animals explode to the detriment of natural regeneration and may reduce diversity and carrying capacity for consumers and eventually lead to ecological meltdown.	[Fleury, Marina; Galetti, Mauro] Univ Estadual Paulista, Dept Ecol, Sao Paulo, Brazil; [Fleury, Marina; Rodrigues, Ricardo R.] Univ Sao Paulo, USP ESALQ, Dept Ciencias Biol, Lab Ecol & Restauracao Florestal, Sao Paulo, Brazil; [do Couto, Hilton T. Z.] USP ESALQ, Dept Ciencias Florestais, Lab Metodos Quantitat, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade de Sao Paulo	Fleury, M (corresponding author), Univ Estadual Paulista, Dept Ecol, Sao Paulo, Brazil.	marina.fleury@mac.com	Galetti, Mauro/C-5275-2008; Galetti, Mauro/M-8751-2013; Rodrigues, Ricardo Ribeiro/D-5557-2012	Galetti, Mauro/0000-0002-8187-8696; Galetti, Mauro/0000-0002-8187-8696; Rodrigues, Ricardo Ribeiro/0000-0003-4818-0736	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2004/13230-5, 2005/55093-7]; FAPESP; Conselho Nacional de Pesquisas	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisas	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (2004/13230-5 and 2005/55093-7). MF and RSB received fellowships from FAPESP, and MG, RRR and HTZ received fellowships from Conselho Nacional de Pesquisas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aide TM, 1994, RESTOR ECOL, V2, P219, DOI [10.1111/j.1526-100X.1994.tb00054.x, DOI 10.1111/J.1526-100X.1994.TB00054.X]; Aliaga-Rossel E, 2008, J TROP ECOL, V24, P367, DOI 10.1017/S0266467408005129; Asquith NM, 1999, J TROP ECOL, V15, P229, DOI 10.1017/S0266467499000772; Asquith NM, 1997, ECOLOGY, V78, P941, DOI 10.1890/0012-9658(1997)078[0941:DMCCCR]2.0.CO;2; BENCKE CINARA S.C., 2002, Braz. J. Bot., V25, P269, DOI 10.1590/S0100-84042002000300003; Blate GM, 1998, OIKOS, V82, P522, DOI 10.2307/3546373; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bovendorp RS, 2007, BIOL INVASIONS, V9, P353, DOI 10.1007/s10530-006-9031-7; Bovendorp RS, 2013, MAMMALIA, V77, P51, DOI 10.1515/mammalia-2011-0099; BOWERS MA, 1993, OECOLOGIA, V94, P247, DOI 10.1007/BF00341324; Bowers MA, 1997, J MAMMAL, V78, P999, DOI 10.2307/1383044; Brancalion PHS, 2011, BIOTROPICA, V43, P12, DOI 10.1111/j.1744-7429.2010.00726.x; BUDOWSKI G, 1965, TURRIALBA, V15, P40; BURKEY TV, 1993, BIOL CONSERV, V66, P139, DOI 10.1016/0006-3207(93)90145-Q; Calderon-Miller L, 2008, THESIS UNESP RIO CLA; Campbell DJ, 2002, BIOL CONSERV, V107, P19, DOI 10.1016/S0006-3207(02)00039-3; Campbell DJ, 1999, J ROY SOC NEW ZEAL, V29, P265, DOI 10.1080/03014223.1999.9517597; Carson W., 2008, TROPICAL FOREST COMM, P367; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Cole RJ, 2009, BIOTROPICA, V41, P319, DOI 10.1111/j.1744-7429.2009.00490.x; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Dalling J. W., 2005, Seed fate: predation, dispersal and seedling establishment, P31, DOI 10.1079/9780851998060.0031; DAVIDSON DW, 1980, BIOSCIENCE, V30, P233, DOI 10.2307/1307877; Dirzo R, 2007, BIOTROPICA, V39, P355, DOI 10.1111/j.1744-7429.2007.00274.x; Donatti CI, 2009, ECOL RES, V24, P1187, DOI 10.1007/s11284-009-0601-x; Duncan RS, 2000, BIOTROPICA, V32, P33, DOI 10.1111/j.1744-7429.2000.tb00445.x; Ecroyd CE, 1996, NEW ZEAL J ECOL, V20, P81; Emsens WJ, 2013, BIOTROPICA, V45, P88, DOI 10.1111/j.1744-7429.2012.00888.x; Fadini RF, 2008, ACTA OECOL, DOI [10.1016/j.actao.2008.10.001, DOI 10.1016/J.ACTA0.2008.10.001]; Farwig N, 2012, BASIC APPL ECOL, V13, P109, DOI 10.1016/j.baae.2012.02.006; Fleury M, 2004, ACTA OECOL, V26, P179, DOI 10.1016/j.actao.2004.04.003; Fleury M, 2006, BIOL CONSERV, V131, P1, DOI 10.1016/j.biocon.2005.10.049; Forget Pierre-Michel, 2005, P379, DOI 10.1079/9780851998060.0000; Forget PM, 1996, J TROP ECOL, V12, P751, DOI 10.1017/S0266467400009998; FOURNIER LA, 1974, TURRIALBA, V24, P422; Galetti M, 2006, BOT J LINN SOC, V151, P141, DOI 10.1111/j.1095-8339.2006.00529.x; Galetti M, 2013, BIOL CONSERV, V163, P1, DOI 10.1016/j.biocon.2013.04.020; Galetti M, 2010, ZOOLOGIA-CURITIBA, V27, P472, DOI 10.1590/S1984-46702010000300022; Genini J, 2009, FLORA, V204, P131, DOI 10.1016/j.flora.2008.01.002; Guariguata MR, 2001, FOREST ECOL MANAG, V148, P185, DOI 10.1016/S0378-1127(00)00535-1; GUILLAUMON J.R., 1989, PLANO MANEJO PARQUE; Guimaraes Paulo R. Jr, 2008, PLoS ONE, V3, pUnpaginated, DOI 10.1371/journal.pone.0001745; Harrington Graham N., 1997, P292; Hill JK, 2004, J APPL ECOL, V41, P744, DOI 10.1111/j.0021-8901.2004.00926.x; Holl KD, 1997, BIOTROPICA, V29, P459, DOI 10.1111/j.1744-7429.1997.tb00040.x; Houghton RA, 2010, TELLUS B, V62, P337, DOI 10.1111/j.1600-0889.2010.00473.x; Howe HF, 1999, ECOLOGY, V80, P1776, DOI 10.1890/0012-9658(1999)080[1776:EOBARO]2.0.CO;2; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; HULME PE, 1994, J ECOL, V82, P645, DOI 10.2307/2261271; Hulme Philip E., 2005, P9, DOI 10.1079/9780851998060.0009; Jansen PA, 2004, ECOL MONOGR, V74, P569, DOI 10.1890/03-4042; Jansen PA, 2012, P NATL ACAD SCI USA, V109, P12610, DOI 10.1073/pnas.1205184109; Jansen PA, 2010, J TROP ECOL, V26, P473, DOI 10.1017/S0266467410000337; Jones ER, 2008, J TROP ECOL, V24, P259, DOI 10.1017/S026646740800494X; Kasangaki A, 2003, AFR J ECOL, V41, P115, DOI 10.1046/j.1365-2028.2003.00383.x; Krishna A, 2008, OIKOS, V117, P1609, DOI 10.1111/j.1600-0706.2008.16540.x; Legendre P., 1998, NUMERICAL ECOLOGY, V24; LI-COR, 1991, PLANT CAN AN OP MAN; Luize BG, 2007, 2 WORKSH FEN COM FER; MATHER AS, 1992, AREA, V24, P367; McGarigal K., 2000, MULTIVARIATE STAT WI; Meyer ST, 2011, ECOL ENTOMOL, V36, P14, DOI 10.1111/j.1365-2311.2010.01241.x; Morellato LPC, 2000, BIOTROPICA, V32, P786, DOI 10.1111/j.1744-7429.2000.tb00618.x; Morris RJ, 2010, PHILOS T R SOC B, V365, P3709, DOI 10.1098/rstb.2010.0273; Muller-Landau H. C., 2002, Seed dispersal and frugivory: ecology, evolution and conservation. Third International Symposium-Workshop on Frugivores and Seed Dispersal, Sao Pedro, Brazil, 6-11 August 2000, P35, DOI 10.1079/9780851995250.0035; Muller-Landau HC, 2007, BIOTROPICA, V39, P372, DOI 10.1111/j.1744-7429.2007.00290.x; Munro NT, 2011, RESTOR ECOL, V19, P223, DOI 10.1111/j.1526-100X.2010.00703.x; Myster RW, 2004, PLANT ECOL, V172, P199, DOI 10.1023/B:VEGE.0000026338.57498.40; Nepstad DC, 1996, OIKOS, V76, P25, DOI 10.2307/3545745; Nogales M, 2012, NEW PHYTOL, V194, P313, DOI 10.1111/j.1469-8137.2011.04051.x; Notman E, 2001, BIOTROPICA, V33, P621, DOI 10.1111/j.1744-7429.2001.tb00220.x; Notman Evan M., 2005, P55, DOI 10.1079/9780851998060.0055; OSUNKOYA OO, 1994, AUST J ECOL, V19, P52, DOI 10.1111/j.1442-9993.1994.tb01543.x; Palmer M. A., 2006, FDN RESTORATION ECOL, P1; Pardini R, 2005, BIOL CONSERV, V124, P253, DOI 10.1016/j.biocon.2005.01.033; Pardini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013666; Pena-Claros M, 2002, J TROP ECOL, V18, P261, DOI 10.1017/S0266467402002171; PICKETT STA, 1987, BOT REV, V53, P335, DOI 10.1007/BF02858321; Puttker T, 2008, STUD NEOTROP FAUNA E, V43, P11, DOI 10.1080/01650520701553651; R Core Team, 2021, R LANG ENV STAT COMP; Rees M, 2001, SCIENCE, V293, P650, DOI 10.1126/science.1062586; Rodrigues RR, 2009, BIOL CONSERV, V142, P1242, DOI 10.1016/j.biocon.2008.12.008; Silvius KM, 2003, BIOTROPICA, V35, P74, DOI 10.1111/j.1744-7429.2003.tb00264.x; Silvius KM, 2002, J TROP ECOL, V18, P707, DOI 10.1017/S0266467402002468; Suntsov VV, 2003, MAMMALIA, V67, P379, DOI 10.1515/mamm.2003.67.3.379; Svenning JC, 2008, J BIOGEOGR, V35, P394, DOI 10.1111/j.1365-2699.2007.01841.x; Terborgh J., 2002, Seed dispersal and frugivory: ecology, evolution and conservation. Third International Symposium-Workshop on Frugivores and Seed Dispersal, Sao Pedro, Brazil, 6-11 August 2000, P1, DOI 10.1079/9780851995250.0001; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; THOMPSON K, 1993, FUNCT ECOL, V7, P236, DOI 10.2307/2389893; Umetsu F, 2007, LANDSCAPE ECOL, V22, P517, DOI 10.1007/s10980-006-9041-y; Urbas P, 2007, BIOTROPICA, V39, P489, DOI 10.1111/j.1744-7429.2007.00285.x; Vander Wall SB, 2005, ECOLOGY, V86, P801, DOI 10.1890/04-0847; Vander Wall SB, 2004, TRENDS ECOL EVOL, V19, P155, DOI 10.1016/j.tree.2003.12.004; Vander Wall SB., 1990, FOOD HOARDING ANIMAL; Wijdeven SMJ, 2000, RESTOR ECOL, V8, P414, DOI 10.1046/j.1526-100x.2000.80056.x; Wilder SM, 2005, OECOLOGIA, V144, P391, DOI 10.1007/s00442-005-0086-4; Williams PA, 2000, AUSTRAL ECOL, V25, P523, DOI 10.1046/j.1442-9993.2000.01078.x; Wilson DJ, 2007, ECOGRAPHY, V30, P105, DOI [10.1111/j.2006.0906-7590.04771.x, 10.1111/j.0906-7590.2007.04771.x]; Wirth R, 2007, J TROP ECOL, V23, P501, DOI 10.1017/S0266467407004221; Wright SJ, 2010, ANN NY ACAD SCI, V1195, P1, DOI [10.1111/j.1749-6632.2009.05400.x, 10.1111/j.1749-6632.2010.05455.x]; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Wuethrich B, 2007, SCIENCE, V315, P1070, DOI 10.1126/science.315.5815.1070; Zar JH, 1998, BIOSTATITICAL ANAL	103	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90060	10.1371/journal.pone.0090060	http://dx.doi.org/10.1371/journal.pone.0090060			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614500	Green Published, gold, Green Submitted			2022-12-25	WOS:000332839300016
J	Krin, E; Cambray, G; Mazel, D				Krin, Evelyne; Cambray, Guillaume; Mazel, Didier			The Superintegron Integrase and the Cassette Promoters Are Co-Regulated in Vibrio cholerae	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE GENES; CYCLIC-AMP; ESCHERICHIA-COLI; PROTEIN COMPLEX; EXPRESSION; TRANSCRIPTION; VIRULENCE; TOXIN; COLONIZATION; ENVIRONMENT	Chromosome 2 of Vibrio cholerae carries a chromosomal superintegron, composed of an integrase, a cassette integration site (attI) and an array of mostly promoterless gene cassettes. We determined the precise location of the promoter, Pc, which drives the transcription of the first cassettes of the V. cholerae superintegron. We found that cassette mRNA starts 65 bp upstream of the attI site, so that the inversely oriented promoters Pc and Pint (integrase promoter) partly overlap, allowing for their potential co-regulation. Pint was previously shown to be induced during the SOS response and is further controlled by the catabolite repression cAMP-CRP complex. We found that cassette expression from Pc was also controlled by the cAMP-CRP complex, but is not part of the SOS regulon. Pint and Pc promoters were both found to be induced in rich medium, at high temperature, high salinity and at the end of exponential growth phase, although at very different levels and independently of sigma factor RpoS. All these results show that expression from the integrase and cassette promoters can take place at the same time, thus leading to coordinated excisions and integrations within the superintegron and potentially coupling cassette shuffling to immediate selective advantage.	[Krin, Evelyne; Cambray, Guillaume; Mazel, Didier] Inst Pasteur, Dept Genomes & Genet, Unite Plasticite Genome Bacterien, Paris, France; [Krin, Evelyne; Mazel, Didier] CNRS, UMR 3525, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Mazel, D (corresponding author), Inst Pasteur, Dept Genomes & Genet, Unite Plasticite Genome Bacterien, Paris, France.	mazel@pasteur.fr	Cambray, Guillaume/A-9476-2015; Mazel, Didier/F-9200-2013	Cambray, Guillaume/0000-0003-0087-2469; Mazel, Didier/0000-0001-6482-6002	Institut Pasteur; Centre National de la Recherche Scientifique [CNRS-UMR3525]; French National Research Agency [ANR-2012-Blanc SVSE3-DynamINT]; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]; European Union	Institut Pasteur(European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); French National Research Agency(French National Research Agency (ANR)); French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"(French National Research Agency (ANR)); European Union(European Commission)	This study was funded by the Institut Pasteur, the Centre National de la Recherche Scientifique (CNRS-UMR3525), the French National Research Agency (ANR-2012-Blanc SVSE3-DynamINT), the French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" (grant noANR-10-LABX-62-IBEID) and the European Union Seventh Framework Programme (FP7-HEALTH-2011-single-stage) "Evolution and Transfer of Antibiotic Resistance" (EvoTAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYEKYAW, 1990, BIOCHEM MED METAB B, V43, P80, DOI 10.1016/0885-4505(90)90011-O; Baharoglu Z, 2012, J BACTERIOL, V194, P1659, DOI 10.1128/JB.05982-11; Baharoglu Z, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001165; Barnard A, 2004, CURR OPIN MICROBIOL, V7, P102, DOI 10.1016/j.mib.2004.02.011; Biskri L, 2005, J BACTERIOL, V187, P1740, DOI 10.1128/JB.187.5.1740-1750.2005; Biskri L, 2003, ANTIMICROB AGENTS CH, V47, P3326, DOI 10.1128/AAC.47.10.3326-3331.2003; Boucher Y, 2011, MBIO, V2, DOI 10.1128/mBio.00335-10; Butala M, 2008, FEMS MICROBIOL LETT, V283, P104, DOI 10.1111/j.1574-6968.2008.01161.x; Cambray G, 2010, ANNU REV GENET, V44, P141, DOI 10.1146/annurev-genet-102209-163504; COLLIS CM, 1995, ANTIMICROB AGENTS CH, V39, P155, DOI 10.1128/AAC.39.1.155; Collis CM, 2002, J BACTERIOL, V184, P3017, DOI 10.1128/JB.184.11.3017-3026.2002; da Fonseca EL, 2011, J ANTIMICROB CHEMOTH, V66, P797, DOI 10.1093/jac/dkr011; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; DEPAOLA A, 1987, APPL ENVIRON MICROB, V53, P1181, DOI 10.1128/AEM.53.5.1181-1182.1987; DiRita V.J., 2001, PRINCIPLES BACTERIAL, P457; Erill I, 2003, BIOINFORMATICS, V19, P2225, DOI 10.1093/bioinformatics/btg303; Erill I, 2007, FEMS MICROBIOL REV, V31, P637, DOI 10.1111/j.1574-6976.2007.00082.x; Guerin E, 2011, J BACTERIOL, V193, P5675, DOI 10.1128/JB.05246-11; Guerin E, 2009, SCIENCE, V324, P1034, DOI 10.1126/science.1172914; Guerout AM, 2013, J BACTERIOL, V195, P2270, DOI 10.1128/JB.01389-12; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Hommais F, 2004, MICROBIOL-SGM, V150, P61, DOI 10.1099/mic.0.26659-0; Jove T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000793; Krin E, 2010, RES MICROBIOL, V161, P363, DOI 10.1016/j.resmic.2010.04.002; Le Roux F, 2009, ENVIRON MICROBIOL, V11, P1959, DOI 10.1111/j.1462-2920.2009.01918.x; Lee HJ, 2008, J BIOL CHEM, V283, P30438, DOI 10.1074/jbc.M802219200; Lee SH, 1999, CELL, V99, P625, DOI 10.1016/S0092-8674(00)81551-2; LEVESQUE C, 1994, GENE, V142, P49, DOI 10.1016/0378-1119(94)90353-0; Liang W, 2007, MICROBIOL-SGM, V153, P2964, DOI 10.1099/mic.0.2007/006668-0; Mazel D, 1998, SCIENCE, V280, P605, DOI 10.1126/science.280.5363.605; Michael CA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-82; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mishra A, 2003, J MED MICROBIOL, V52, P933, DOI 10.1099/jmm.0.05171-0; Nielsen AT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001102; OGAWA A, 1993, MICROBIOL IMMUNOL, V37, P607, DOI 10.1111/j.1348-0421.1993.tb01683.x; Partridge SR, 2009, FEMS MICROBIOL REV, V33, P757, DOI 10.1111/j.1574-6976.2009.00175.x; Quinones M, 2005, MOL CELL, V17, P291, DOI 10.1016/j.molcel.2004.11.046; Rapa RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058430; Rowe-Magnus DA, 2003, GENOME RES, V13, P428, DOI 10.1101/gr.617103; Rowe-Magnus DA, 1999, RES MICROBIOL, V150, P641, DOI 10.1016/S0923-2508(99)00127-8; Rowe-Magnus DA, 2002, MOL MICROBIOL, V43, P1657, DOI 10.1046/j.1365-2958.2002.02861.x; Rowe-Magnus DA, 2001, P NATL ACAD SCI USA, V98, P652, DOI 10.1073/pnas.98.2.652; SCHAFER DE, 1970, P NATL ACAD SCI USA, V67, P851, DOI 10.1073/pnas.67.2.851; Skorupski K, 1997, P NATL ACAD SCI USA, V94, P265, DOI 10.1073/pnas.94.1.265; Soutourina O, 1999, J BACTERIOL, V181, P7500, DOI 10.1128/JB.181.24.7500-7508.1999; Szekeres S, 2007, MOL MICROBIOL, V63, P1588, DOI 10.1111/j.1365-2958.2007.05613.x; TADDEI F, 1995, P NATL ACAD SCI USA, V92, P11736, DOI 10.1073/pnas.92.25.11736; van Dongen WMAM, 1987, MOL GEN LIFE SCI ADV, V6, P85; Vital M, 2007, MICROBIOL-SGM, V153, P1993, DOI 10.1099/mic.0.2006/005173-0; Yildiz FH, 1998, J BACTERIOL, V180, P773, DOI 10.1128/JB.180.4.773-784.1998	50	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91194	10.1371/journal.pone.0091194	http://dx.doi.org/10.1371/journal.pone.0091194			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614503	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300094
J	Tang, BZ; Chen, J; Hou, YM; Meng, E				Tang, Baozhen; Chen, Jun; Hou, Youming; Meng, E.			Transcriptome Immune Analysis of the Invasive Beetle Octodonta nipae (Maulik) (Coleoptera: Chrysomelidae) Parasitized by Tetrastichus brontispae Ferriere (Hymenoptera: Eulophidae)	PLOS ONE			English	Article							PLUTELLA-XYLOSTELLA; INTEGRIN BETA-1; INNATE IMMUNITY; MANDUCA-SEXTA; RHO-GTPASES; INSECT; RESPONSES; ENCAPSULATION; STRATEGIES; PROTEINS	The beetle Octodonta nipae (Maulik) (Coleoptera: Chrysomelidae) is a serious invasive insect pest of palm plants in southern China, and the endoparasitoid Tetrastichus brontispae Ferriere (Hymenoptera: Eulophidae) is a natural enemy of this pest that exhibits great ability in the biocontrol of O. nipae. For successful parasitism, endoparasitoids often introduce or secrete various virulence factors to suppress host immunity. To investigate the effects of parasitization by T. brontispae on the O. nipae immune system, the transcriptome of O. nipae pupae was analyzed with a focus on immune-related genes through Illumina sequencing. De novo assembly generated 49,919 unigenes with a mean length of 598 bp. Of these genes, 27,490 unigenes (55.1% of all unigenes) exhibited clear homology to known genes in the NCBI nr database. Parasitization had significant effects on the transcriptome profile of O. nipae pupae, and most of these differentially expressed genes were down-regulated. Importantly, the expression profiles of immune-related genes were significantly regulated after parasitization. Taken together, these transcriptome sequencing efforts shed valuable light on the host (O. nipae) manipulation mechanisms induced by T. brontispae, which will pave the way for the development of novel immune defense-based management strategies of O. nipae, and provide a springboard for further molecular analyses, particularly of O. nipae invasion.	[Tang, Baozhen; Chen, Jun; Hou, Youming; Meng, E.] Fujian Agr & Forestry Univ, Dept Plant Protect, Fujian Prov Key Lab Insect Ecol, Fuzhou, Fujian, Peoples R China; [Tang, Baozhen; Chen, Jun; Hou, Youming; Meng, E.] Minist Agr, Key Lab Integrated Pest Management Crops Fujian T, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Ministry of Agriculture & Rural Affairs	Hou, YM (corresponding author), Fujian Agr & Forestry Univ, Dept Plant Protect, Fujian Prov Key Lab Insect Ecol, Fuzhou, Fujian, Peoples R China.	ymhou@fafu.edu.cn		Hou, Youming/0000-0001-7984-9688	National Natural Science Foundation of China [31071749, 31272108, 31301727]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the National Natural Science Foundation of China (31071749, 31272108 and 31301727). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latief M, 2008, INSECT BIOCHEM MOLEC, V38, P136, DOI 10.1016/j.ibmb.2007.10.001; Asgari S, 2006, ARCH INSECT BIOCHEM, V61, P146, DOI 10.1002/arch.20109; Asgari S, 2012, PARASITOID VIRUSES: SYMBIONTS AND PATHOGENS, P217, DOI 10.1016/B978-0-12-384858-1.00018-7; Asgari S, 2011, ANNU REV ENTOMOL, V56, P313, DOI 10.1146/annurev-ento-120709-144849; Askew R.R., 1986, P225; Barandoc KP, 2010, J MICROBIOL, V48, P117, DOI 10.1007/s12275-009-9261-3; Beck MH, 2007, P NATL ACAD SCI USA, V104, P19267, DOI 10.1073/pnas.0708056104; Beckage NE, 2004, ANNU REV ENTOMOL, V49, P299, DOI 10.1146/annurev.ento.49.061802.123324; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Cho MY, 1999, EUR J BIOCHEM, V262, P737, DOI 10.1046/j.1432-1327.1999.00416.x; Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Colinet D, 2009, DEV COMP IMMUNOL, V33, P681, DOI 10.1016/j.dci.2008.11.013; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Etebari K, 2012, DEV COMP IMMUNOL, V38, P517, DOI 10.1016/j.dci.2012.08.006; Etebari K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-446; Fang Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026888; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gunaratna RT, 2013, DEV COMP IMMUNOL, V39, P388, DOI 10.1016/j.dci.2012.10.004; Hou YM, 2010, ENVIRON ENTOMOL, V39, P1676, DOI 10.1603/EN10015; Howard F.W., 2001, INSECTS PALMS, V131, DOI [10.1079/9780851993263.0000, DOI 10.1079/9780851993263.0000]; Hu JA, 2010, J INSECT PHYSIOL, V56, P1846, DOI 10.1016/j.jinsphys.2010.08.001; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kaeslin M, 2010, J INSECT PHYSIOL, V56, P686, DOI 10.1016/j.jinsphys.2009.12.005; Keeling CI, 2012, INSECT BIOCHEM MOLEC, V42, P525, DOI 10.1016/j.ibmb.2012.03.010; Kim T, 2005, J BIOCHEM MOL BIOL, V38, P121; Lavine MD, 2003, INSECT MOL BIOL, V12, P441, DOI 10.1046/j.1365-2583.2003.00428.x; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levin DM, 2005, INSECT BIOCHEM MOLEC, V35, P369, DOI 10.1016/j.ibmb.2005.01.003; Lu Z, 2008, J BIOL CHEM, V283, P21325, DOI 10.1074/jbc.M801593200; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NAPPI AJ, 1993, PIGM CELL RES, V6, P117, DOI 10.1111/j.1600-0749.1993.tb00590.x; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; NOBES C, 1994, CURR OPIN GENET DEV, V4, P77, DOI 10.1016/0959-437X(94)90094-9; Pennacchio F, 2006, ANNU REV ENTOMOL, V51, P233, DOI 10.1146/annurev.ento.51.110104.151029; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Schlenke TA, 2007, PLOS PATHOG, V3, P1486, DOI 10.1371/journal.ppat.0030158; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Song KH, 2008, J INSECT PHYSIOL, V54, P1271, DOI 10.1016/j.jinsphys.2008.06.010; Vassiliou VA, 2011, PHYTOPARASITICA, V39, P51, DOI 10.1007/s12600-010-0128-2; Williams MJ, 2006, J CELL SCI, V119, P2015, DOI 10.1242/jcs.02920; Williams MJ, 2005, GENES CELLS, V10, P813, DOI 10.1111/j.1365-2443.2005.00883.x; Xu Li, 2011, Chinese Journal of Applied Entomology, V48, P922; Xu QY, 2012, DEV COMP IMMUNOL, V37, P438, DOI 10.1016/j.dci.2012.02.003; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9; Zhu Jia-Ying, 2013, PLoS ONE, V8, pe54411, DOI 10.1371/journal.pone.0054411; ZHU JY, 2012, PLOS ONE, V7; Zhuang S, 2008, DEV COMP IMMUNOL, V32, P365, DOI 10.1016/j.dci.2007.07.007; Zhuang SF, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M700341200; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177	56	46	50	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91482	10.1371/journal.pone.0091482	http://dx.doi.org/10.1371/journal.pone.0091482			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614330	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300132
J	Tinetti, ME; Han, L; McAvay, GJ; Lee, DSH; Peduzzi, P; Dodson, JA; Gross, CP; Zhou, BQ; Lin, HQ				Tinetti, Mary E.; Han, Ling; McAvay, Gail J.; Lee, David S. H.; Peduzzi, Peter; Dodson, John A.; Gross, Cary P.; Zhou, Bingqing; Lin, Haiqun			Anti-Hypertensive Medications and Cardiovascular Events in Older Adults with Multiple Chronic Conditions	PLOS ONE			English	Article							BLOOD-PRESSURE; BIAS REDUCTION; AGED 85; HYPERTENSION; METAANALYSIS; PEOPLE; DISEASE; TRIAL	Importance: Randomized trials of anti-hypertensive treatment demonstrating reduced risk of cardiovascular events in older adults included participants with less comorbidity than clinical populations. Whether these results generalize to all older adults, most of whom have multiple chronic conditions, is uncertain. Objective: To determine the association between anti-hypertensive medications and CV events and mortality in a nationally representative population of older adults. Design: Competing risk analysis with propensity score adjustment and matching in the Medicare Current Beneficiary Survey cohort over three-year follow-up through 2010. Participants and Setting: 4,961 community-living participants with hypertension. Exposure: Anti-hypertensive medication intensity, based on standardized daily dose for each anti-hypertensive medication class participants used. Main Outcomes and Measures: Cardiovascular events (myocardial infarction, unstable angina, cardiac revascularization, stroke, and hospitalizations for heart failure) and mortality. Results: Of 4,961 participants, 14.1% received no anti-hypertensives; 54.6% received moderate, and 31.3% received high, anti-hypertensive intensity. During follow-up, 1,247 participants (25.1%) experienced cardiovascular events; 837 participants (16.9%) died. Of deaths, 430 (51.4%) occurred in participants who experienced cardiovascular events during follow-up. In the propensity score adjusted cohort, after adjusting for propensity score and other covariates, neither moderate (adjusted hazard ratio, 1.08 [95% CI, 0.89-1.32]) nor high (1.16 [0.94-1.43]) anti-hypertensive intensity was associated with experiencing cardiovascular events. The hazard ratio for death among all participants was 0.79 [0.65-0.97] in the moderate, and 0.72 [0.58-0.91] in the high intensity groups compared with those receiving no anti-hypertensives. Among participants who experienced cardiovascular events, the hazard ratio for death was 0.65 [0.48-0.87] and 0.58 [0.42-0.80] in the moderate and high intensity groups, respectively. Results were similar in the propensity score-matched subcohort. Conclusions and Relevance: In this nationally representative cohort of older adults, anti-hypertensive treatment was associated with reduced mortality but not cardiovascular events. Whether RCT results generalize to older adults with multiple chronic conditions remains uncertain.	[Tinetti, Mary E.; Han, Ling; McAvay, Gail J.; Gross, Cary P.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Tinetti, Mary E.; Peduzzi, Peter; Zhou, Bingqing] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Lee, David S. H.] Oregon Hlth & Sci Univ, Oregon State Univ, Coll Pharm, Portland, OR USA; [Dodson, John A.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Yale University; Yale University; Oregon Health & Science University; Oregon State University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Tinetti, ME (corresponding author), Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA.	mary.tinetti@yale.edu		Lin, Haiqun/0000-0002-3114-9671	National Institute on Aging [R01 AG038528]; Yale Pepper Center from the National Institute on Aging [P30 AG021342]; NATIONAL INSTITUTE ON AGING [R01AG038528, P30AG021342] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Yale Pepper Center from the National Institute on Aging; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was funded by R01 AG038528 from the National Institute on Aging and by the Yale Pepper Center (P30 AG021342) from the National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P. D., 1999, LOGISTIC REGRESSION; Andrade SE, 2012, PHARMACOEPIDEM DR S, V21, P100, DOI 10.1002/pds.2312; Aronow WS, 2011, J AM COLL CARDIOL, V57, P2037, DOI 10.1016/j.jacc.2011.01.008; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Beckett N, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7541; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Bejan-Angoulvant T, 2010, J HYPERTENS, V28, P1366, DOI 10.1097/HJH.0b013e328339f9c5; Biskupiak JE, 2010, J CLIN HYPERTENS, V12, P935, DOI 10.1111/j.1751-7176.2010.00362.x; Chen J, 2010, CIRCULATION, V121, P1322, DOI 10.1161/CIRCULATIONAHA.109.862094; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Danaei G, 2012, AM J EPIDEMIOL, V175, P250, DOI 10.1093/aje/kwr301; Denardo SJ, 2010, AM J MED, V123, P719, DOI 10.1016/j.amjmed.2010.02.014; Dhruva SS, 2008, ARCH INTERN MED, V168, P136, DOI 10.1001/archinternmed.2007.56; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fang Jing, 2012, Morbidity and Mortality Weekly Report, V61, P379; Faries DE, 2010, ANALYSIS OF OBSERVAT; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Gu QP, 2012, CIRCULATION, V126, P2105, DOI 10.1161/CIRCULATIONAHA.112.096156; Gueyffier F, 1999, LANCET, V353, P793, DOI 10.1016/S0140-6736(98)08127-6; Hosmer DW, 1999, WILEY PS TX; Jatos Study Grp, 2008, HYPERTENS RES, V31, P2115, DOI 10.1291/hypres.31.2115; Johnson ES, 2013, PHARMACOEPIDEM DR S, V22, P1, DOI 10.1002/pds.3334; Kohl M, 2012, TECHNICAL REPORT 08; Leon AC, 2007, STAT MED, V26, P110, DOI 10.1002/sim.2458; Messerli FH, 2006, ANN INTERN MED, V144, P884, DOI 10.7326/0003-4819-144-12-200606200-00005; Molander L, 2008, J AM GERIATR SOC, V56, P1853, DOI 10.1111/j.1532-5415.2008.01948.x; Musini VM, 2009, COCHRANE DATABASE SY, V7; National Institute for Health and Clinical Excellence, HYPERTENSION; Ogihara T, 2011, GERIATR GERONTOL INT, V11, P414, DOI 10.1111/j.1447-0594.2011.00690.x; Rastas S, 2006, J AM GERIATR SOC, V54, P912, DOI 10.1111/j.1532-5415.2006.00742.x; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Tinetti ME, 2014, JAMA INTERNAL MEDICI; Voko Z, 1999, HYPERTENSION, V34, P1181, DOI 10.1161/01.HYP.34.6.1181; WHO Collaborating Centre for Drug Statistics Methodology, 2013, GUIDELINES FOR ATC C; Woolcott JC, 2009, ARCH INTERN MED, V169, P1952, DOI 10.1001/archinternmed.2009.357; Xu R, 2000, BIOSTATISTICS, V1; Zhou BQ, 2012, BIOSTATISTICS, V13, P371, DOI 10.1093/biostatistics/kxr032	39	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90733	10.1371/journal.pone.0090733	http://dx.doi.org/10.1371/journal.pone.0090733			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614535	gold, Green Submitted, Green Published			2022-12-25	WOS:000332839300036
J	Zhang, RY; Li, X; Shi, YN; Shao, YF; Sun, KX; Wang, AP; Sun, FY; Liu, WH; Wang, D; Jin, JJ; Li, YX				Zhang, Renyu; Li, Xiang; Shi, Yanan; Shao, Yufeng; Sun, Kaoxiang; Wang, Aiping; Sun, Fengying; Liu, Wanhui; Wang, Di; Jin, Jingji; Li, Youxin			The Effects of LPM570065, a Novel Triple Reuptake Inhibitor, on Extracellular Serotonin, Dopamine and Norepinephrine Levels in Rats	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; DETECTION FOLLOWING DERIVATIZATION; TREATMENT-RESISTANT DEPRESSION; COLUMN LIQUID-CHROMATOGRAPHY; DORSAL RAPHE NUCLEUS; 5-HT1A RECEPTORS; FRONTAL-CORTEX; IN-VIVO; DESVENLAFAXINE SUCCINATE; ANTIDEPRESSANT TREATMENT	Triple reuptake inhibitors (TRIs) are currently being developed as a new class of promising antidepressants that block serotonin (5-HT), dopamine (DA) and norepinephrine (NE) transporters, thereby increasing extracellular monoamine concentrations. The purpose of this study was to investigate the effects of LPM570065, a novel TRI and a desvenlafaxine prodrug, on extracellular 5-HT, DA and NE levels in the rat striatum after acute and chronic administration relative to desvenlafaxine, using High Performance Liquid Chromatography (HPLC) and microdialysis. Acute administration was performed by providing rodents with oral solutions (0.06 mmol.kg(-1) p.o.), oral suspensions (0.06 mmol.kg(-1) p.o.) and intravenous solutions (0.04 mmol.kg(-1) i.v.) of LPM570065 and desvenlafaxine. Oral suspensions (0.06 mmol.kg(-1).day(-1)) of the two drugs were also administered for a 14-day chronic period. HPLC analysis revealed that LPM570065 rapidly penetrated the rat striatum, converted into desvenlafaxine and exhibited larger total exposure compared with the administration of desvenlafaxine. Microdialysis revealed that acute and chronic administration of oral suspension of LPM570065 increased the 5-HT, DA and NE levels more than the relative administration of desvenlafaxine. Unlike desvenlafaxine, acute administration of an intravenous LPM570065 solution did not induce the undesirable 90% decrease in extracellular 5-HT levels. In contrast to the fully dose-dependent elevation of 5-HT induced by desvenlafaxine, the acute administration of LPM570065 showed a capped increase in extracellular 5-HT levels when combined with WAY-100635. Additionally, forced swim test demonstrated that acute and chronic administration of LPM570065 reduced the immobility time more than the relative administration of desvenlafaxine. These data suggest that LPM570065 may have greater efficacy and/or a more rapid onset of antidepressant action than desvenlafaxine and also counterbalance the harmful effects of desvenlafaxine on 5-HT neurotransmission related to 5-HT1A autoreceptors. Thus, this new class of drugs, TRIs has the potential to provide a new therapeutic mechanism for treating depression.	[Zhang, Renyu; Li, Xiang; Shi, Yanan; Sun, Fengying; Wang, Di; Jin, Jingji; Li, Youxin] Jilin Univ, Sch Life Sci, Changchun 130023, Jilin Province, Peoples R China; [Zhang, Renyu; Li, Xiang; Shi, Yanan; Shao, Yufeng; Sun, Kaoxiang; Wang, Aiping; Liu, Wanhui; Li, Youxin] Luye Pharmaceut Co Ltd, State Key Lab Long Acting & Targeting Drug Delive, Yantai, Shandong, Peoples R China; [Sun, Kaoxiang; Wang, Aiping; Liu, Wanhui; Li, Youxin] Yantai Univ, Sch Pharm, Yantai, Shandong, Peoples R China	Jilin University; Yantai University	Jin, JJ (corresponding author), Jilin Univ, Sch Life Sci, Changchun 130023, Jilin Province, Peoples R China.	jjjin@jlu.edu.cn; liyouxin@jlu.edu.cn			National Major Scientific and Technological Special Project for "Significant New Drugs Development'' [2013ZX09402201-002]; National Basic Research Program of China [2012CB724003]	National Major Scientific and Technological Special Project for "Significant New Drugs Development''; National Basic Research Program of China(National Basic Research Program of China)	This research was supported by the National Major Scientific and Technological Special Project for "Significant New Drugs Development'' during the Twelfth Five-year Plan Period (2013ZX09402201-002, http://www.nmp.gov.cn/) and the National Basic Research Program of China (No 2012CB724003, http://www.cas.cn/ky/kyxm/973xm/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Alfinito PD, 2006, BRAIN RES, V1098, P71, DOI 10.1016/j.brainres.2006.04.057; Aman TK, 2007, J PHARMACOL EXP THER, V320, P376, DOI 10.1124/jpet.106.111690; Amat J, 2001, BRAIN RES, V917, P118, DOI 10.1016/S0006-8993(01)02934-1; Baldwin DS, 2006, J CLIN PSYCHIAT, V67, P9; Barr JL, 2011, NEUROSCIENCE, V182, P105, DOI 10.1016/j.neuroscience.2011.03.020; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Beyer CE, 2002, J PSYCHOPHARMACOL, V16, P297, DOI 10.1177/026988110201600403; Breuer ME, 2008, EUR NEUROPSYCHOPHARM, V18, P908, DOI 10.1016/j.euroneuro.2008.07.011; Ceglia I, 2004, BRIT J PHARMACOL, V142, P469, DOI 10.1038/sj.bjp.0705800; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; Dawson LA, 2002, J PSYCHOPHARMACOL, V16, P145, DOI 10.1177/026988110201600205; Deecher DC, 2006, J PHARMACOL EXP THER, V318, P657, DOI 10.1124/jpet.106.103382; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Fava M, 2002, J CLIN PSYCHIAT, V63, P13; Fava M, 2006, J CLIN PSYCHIAT, V67, P1754, DOI 10.4088/JCP.v67n1113; Geisler S, 2008, CNS SPECTRUMS, V13, P484, DOI 10.1017/S1092852900016710; Golembiowska K, 2012, SYNAPSE, V66, P435, DOI 10.1002/syn.21531; Gorwood Philip, 2008, Dialogues Clin Neurosci, V10, P291; Guiard BP, 2008, INT J NEUROPSYCHOPH, V11, P625, DOI 10.1017/S1461145707008383; Guiard BP, 2011, INT J NEUROPSYCHOPH, V14, P211, DOI 10.1017/S1461145710000076; Guilding C, 2007, EUR J NEUROSCI, V25, P3195, DOI 10.1111/j.1460-9568.2007.05581.x; Haj-Dahmane S, 2001, EUR J NEUROSCI, V14, P125, DOI 10.1046/j.0953-816x.2001.01616.x; Hasler G, 2004, NEUROPSYCHOPHARMACOL, V29, P1765, DOI 10.1038/sj.npp.1300506; JOLAS T, 1994, J PHARMACOL EXP THER, V268, P1432; Kehr J, 2011, BRIT J PHARMACOL, V164, P1949, DOI 10.1111/j.1476-5381.2011.01499.x; Klimek V, 2002, BIOL PSYCHIAT, V52, P740, DOI 10.1016/S0006-3223(02)01383-5; KREISS DS, 1995, J PHARMACOL EXP THER, V274, P866; Lam RW, 2004, J CLIN PSYCHIAT, V65, P337; Lavretsky H, 2003, J CLIN PSYCHIAT, V64, P1410, DOI 10.4088/JCP.v64n1202; Lavretsky H, 2001, AM J GERIAT PSYCHIAT, V9, P298, DOI 10.1176/appi.ajgp.9.3.298; Le Poul E, 2000, NEUROPHARMACOLOGY, V39, P110, DOI 10.1016/S0028-3908(99)00088-X; Lecourtier L, 2007, NEUROSCI BIOBEHAV R, V31, P658, DOI 10.1016/j.neubiorev.2007.01.004; Li K, 2013, SCIENCE, V341, P1016, DOI 10.1126/science.1240729; Liederer BM, 2006, J PHARM SCI-US, V95, P1177, DOI 10.1002/jps.20542; Mann JJ, 2005, NEW ENGL J MED, V353, P1819, DOI 10.1056/NEJMra050730; Martin-Ruiz R, 2001, J NEUROCHEM, V77, P762, DOI 10.1046/j.1471-4159.2001.00275.x; Mendlin A, 1998, EUR J PHARMACOL, V351, P291, DOI 10.1016/S0014-2999(98)00321-5; Millan MJ, 2009, NEUROTHERAPEUTICS, V6, P53, DOI 10.1016/j.nurt.2008.10.039; Millan MJ, 2000, J PSYCHOPHARMACOL, V14, P114, DOI 10.1177/026988110001400202; Morissette MC, 2008, BEHAV BRAIN RES, V187, P17, DOI 10.1016/j.bbr.2007.08.021; Parent M, 2001, J COMP NEUROL, V439, P162, DOI 10.1002/cne.1340; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Prins J, 2011, EXPERT OPIN INV DRUG, V20, P1107, DOI 10.1517/13543784.2011.594039; ROY A, 1992, ARCH GEN PSYCHIAT, V49, P447; Scorza MC, 2012, BRIT J PHARMACOL, V167, P1021, DOI 10.1111/j.1476-5381.2011.01770.x; Shelton RC, 2005, J CLIN PSYCHIAT, V66, P1289, DOI 10.4088/JCP.v66n1012; Skolnick P, 2003, EUR J PHARMACOL, V461, P99, DOI 10.1016/S0014-2999(03)01310-4; Skolnick P, 2006, CNS DRUG REV, V12, P123, DOI 10.1111/j.1527-3458.2006.00123.x; Spina E, 2012, CNS DRUGS, V26, P39, DOI 10.2165/11594710-000000000-00000; Tian JW, 2011, NEUROSCIENCE, V196, P124, DOI 10.1016/j.neuroscience.2011.08.064; Tizzano JP, 2008, J PHARMACOL EXP THER, V324, P1111, DOI 10.1124/jpet.107.133132; Tran P, 2012, J PSYCHIATR RES, V46, P64, DOI 10.1016/j.jpsychires.2011.09.003; Trivedi MH, 2006, NEW ENGL J MED, V354, P1243, DOI 10.1056/NEJMoa052964; Weikop P, 2007, J PSYCHOPHARMACOL, V21, P795, DOI 10.1177/0269881107077347; Yamada J, 2004, EUR J PHARMACOL, V504, P207, DOI 10.1016/j.ejphar.2004.09.057; Yoshitake T, 2004, J CHROMATOGR B, V807, P177, DOI 10.1016/j.jchromb.2004.03.069; Yoshitake T, 2003, ANAL BIOCHEM, V312, P125, DOI 10.1016/S0003-2697(02)00435-9; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069934	60	13	15	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91775	10.1371/journal.pone.0091775	http://dx.doi.org/10.1371/journal.pone.0091775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614602	Green Published, gold, Green Submitted			2022-12-25	WOS:000332839300156
J	Hayat, T; Ashraf, MB; Alsulami, HH; Alhuthali, MS				Hayat, Tasawar; Ashraf, Muhammad Bilal; Alsulami, Hamed H.; Alhuthali, Muhammad Shahab			Three-Dimensional Mixed Convection Flow of Viscoelastic Fluid with Thermal Radiation and Convective Conditions	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; MASS-TRANSFER; HEAT-TRANSFER; STAGNATION-POINT; CHEMICAL-REACTION; STRETCHING SHEET; MAXWELL FLUID; SLIP-FLOW; MHD FLOW; NANOFLUID	The objective of present research is to examine the thermal radiation effect in three-dimensional mixed convection flow of viscoelastic fluid. The boundary layer analysis has been discussed for flow by an exponentially stretching surface with convective conditions. The resulting partial differential equations are reduced into a system of nonlinear ordinary differential equations using appropriate transformations. The series solutions are developed through a modern technique known as the homotopy analysis method. The convergent expressions of velocity components and temperature are derived. The solutions obtained are dependent on seven sundry parameters including the viscoelastic parameter, mixed convection parameter, ratio parameter, temperature exponent, Prandtl number, Biot number and radiation parameter. A systematic study is performed to analyze the impacts of these influential parameters on the velocity and temperature, the skin friction coefficients and the local Nusselt number. It is observed that mixed convection parameter in momentum and thermal boundary layers has opposite role. Thermal boundary layer is found to decrease when ratio parameter, Prandtl number and temperature exponent are increased. Local Nusselt number is increasing function of viscoelastic parameter and Biot number. Radiation parameter on the Nusselt number has opposite effects when compared with viscoelastic parameter.	[Hayat, Tasawar; Ashraf, Muhammad Bilal] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Hayat, Tasawar; Alsulami, Hamed H.; Alhuthali, Muhammad Shahab] King Abdulaziz Univ, Fac Sci, Nonlinear Anal & Appl Math NAAM Res Grp, Jeddah 21413, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Ashraf, MB (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad, Pakistan.	bilalashraf_qau@yahoo.com	Hayat, Tasawar/Y-2524-2019; Hayat, Tasawar/E-9449-2015; Hayat, Tasawar/A-3853-2013		Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [26-130-35 Hi Ci]; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	This paper was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant number 26-130-35 Hi Ci. The authors, therefore, acknowledge with thanks DSR technical and financial support. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasbandy S, 2013, QUAEST MATH, V36, P93, DOI 10.2989/16073606.2013.780336; Abbasbandy S, 2012, UPB SCI B, V74; Al-Odat M. Q., 2006, International Journal of Applied Mechanics and Engineering, V11, P289; Aziz MAE, 2012, MATH PROBL ENG, V2012; Bhattacharyya K., 2010, J MATH MATH SCI, V25, P41; Bhattacharyya K, 2012, INT J HEAT MASS TRAN, V55, P2945, DOI 10.1016/j.ijheatmasstransfer.2012.01.051; Bhattacharyya K, 2011, CHINESE PHYS LETT, V28, DOI 10.1088/0256-307X/28/8/084702; Bhattacharyya K, 2011, INT COMMUN HEAT MASS, V38, P917, DOI 10.1016/j.icheatmasstransfer.2011.04.020; Cortell R, 2007, APPL MATH COMPUT, V184, P864, DOI 10.1016/j.amc.2006.06.077; Deger G, 2011, Z NATURFORSCH A, V66, P321, DOI 10.1515/zna-2011-0508; Elbashbeshy E. M. A., 2001, Archives of Mechanics, V53, P643; Ellahi R, 2013, APPL MATH MODEL, V37, P1451, DOI 10.1016/j.apm.2012.04.004; GUPTA PS, 1977, CAN J CHEM ENG, V55, P744, DOI 10.1002/cjce.5450550619; Hayat T, 2013, J THERMOPHYS HEAT TR, V27, P733, DOI 10.2514/1.T4039; Hayat T, 2013, APPL MATH MECH-ENGL, V34, P823, DOI 10.1007/s10483-013-1710-7; Hayat T, 2013, APPL MATH MECH-ENGL, V34, P153, DOI 10.1007/s10483-013-1660-8; Hayat T, 2011, APPL MATH MECH-ENGL, V32, P1119, DOI 10.1007/s10483-011-1486-6; Hayat T, 2010, INT J HEAT MASS TRAN, V53, P466, DOI 10.1016/j.ijheatmasstransfer.2009.09.010; Hayat T, 2009, NONLINEAR ANAL-REAL, V10, P1514, DOI 10.1016/j.nonrwa.2008.01.019; Jamil M, 2011, COMMUN NONLINEAR SCI, V16, P1378, DOI 10.1016/j.cnsns.2010.07.004; Jamil M, 2010, NONLINEAR ANAL-REAL, V11, P4302, DOI 10.1016/j.nonrwa.2010.05.016; Kandasamy R, 2011, NUCL ENG DES, V241, P2155, DOI 10.1016/j.nucengdes.2011.03.002; Keimanesh M, 2011, COMPUT MATH APPL, V62, P2871, DOI 10.1016/j.camwa.2011.07.054; Liao S., 2003, PERTURBATION INTRO H, DOI 10.1201/9780203491164; Liao S., 2012, HOMOTOPY ANAL METHOD; Liu IC, 2013, CHEM ENG COMMUN, V200, P253, DOI 10.1080/00986445.2012.703148; Liu JG, 2010, NONLINEAR ANAL-REAL, V11, P3066, DOI 10.1016/j.nonrwa.2009.10.026; Liu YP, 2013, J SYMB COMPUT, V55, P72, DOI 10.1016/j.jsc.2013.03.006; Magyari E, 1999, J PHYS D APPL PHYS, V32, P577, DOI 10.1088/0022-3727/32/5/012; Makinde OD, 2005, INT COMMUN HEAT MASS, V32, P1411, DOI 10.1016/j.icheatmasstransfer.2005.07.005; Mukhopadhyay S, 2013, CHINESE PHYS B, V22, DOI 10.1088/1674-1056/22/7/074701; Mukhopadhyay S, 2013, J APPL MECH-T ASME, V80, DOI 10.1115/1.4023618; Mustafaa M, 2013, INT J NUMER METHOD H, V23, P945, DOI 10.1108/HFF-09-2011-0179; Nadeem S, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-94; Nazar R., 2009, EUR J SCI RES, V29, P509; Pal D, 2010, APPL MATH COMPUT, V217, P2356, DOI 10.1016/j.amc.2010.07.035; Rashidi MM, 2014, INT J HEAT MASS TRAN, V70, P892, DOI 10.1016/j.ijheatmasstransfer.2013.11.058; Sajid M, 2008, INT COMMUN HEAT MASS, V35, P347, DOI 10.1016/j.icheatmasstransfer.2007.08.006; SAKIADIS BC, 1961, AICHE J, V7, P26, DOI 10.1002/aic.690070108; Sanjayanand E, 2006, INT J THERM SCI, V45, P819, DOI 10.1016/j.ijthermalsci.2005.11.002; Schlichting H, 1964, BOUNDARY LAYER THEOR; Turkyilmazoglu M, 2013, INT J HEAT MASS TRAN, V57, P82, DOI 10.1016/j.ijheatmasstransfer.2012.10.006; Turkyilmazoglu M, 2012, COMMUN NONLINEAR SCI, V17, P4097, DOI 10.1016/j.cnsns.2012.01.030; Turkyilmazoglu M, 2011, INT J THERM SCI, V50, P2264, DOI 10.1016/j.ijthermalsci.2011.05.014; Zheng LC, 2012, MATH COMPUT MODEL, V56, P133, DOI 10.1016/j.mcm.2011.11.080	45	28	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90038	10.1371/journal.pone.0090038	http://dx.doi.org/10.1371/journal.pone.0090038			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608594	Green Published, gold, Green Submitted			2022-12-25	WOS:000332485800013
J	Jossart, Q; Wattier, RA; Kastally, C; Aron, S; David, B; De Ridder, C; Rigaud, T				Jossart, Quentin; Wattier, Remi A.; Kastally, Chedly; Aron, Serge; David, Bruno; De Ridder, Chantal; Rigaud, Thierry			Genetic Evidence Confirms Polygamous Mating System in a Crustacean Parasite with Multiple Hosts	PLOS ONE			English	Article							SPERM COMPETITION; CHIONOECETES-OPILIO; LARVAL DEVELOPMENT; PATERNITY; BRACHYURA; PARENTAGE; FERTILIZATION; PINNOTHERIDAE; CONSEQUENCES; EVOLUTION	Mating systems are diverse in animals, notably in crustaceans, but can be inferred from a limited set of parameters. Baeza and Thiel (2007) proposed a model predicting mating systems of symbiotic crustaceans with three host characteristic and risk of predation. These authors proposed five mating systems, ranging from monogamy to polygynandry here pie mating occurs for both enders). Using microsatellite loci, we tested the putatively mating system ectoparasite crab Dissodactylus primitivus We determined the mating frequencies of ales and females, parentage assignment (COLONY & GERUD software) as well as the contents e ale sperrnathecae. Our results are globally consistent with the model of Baeza and Thiel and showed, together with previous aquarium experiments, that his ectoparasite evolved a polygamous mating system where males and females move between hosts for mate search. Parentage analyses vealed that polyandry is frequent and concerns more than 60% of clutches, with clutches being fertilized by up to 6 different fathers. Polygyny is supported by the detection of eight males having sired two different broods. We also detected a significant paternity skew in 92% of the multipaternal broods. Moreover, this skew probably higher than the estimation he brood because additional alleles were detected in most of spermathecae. This h skew could be explained by several factors as sperm competition or cryptic female choice. Our genetic data, combined with previous anatomic analyses provide consistent arguments to suggest sperm precedence in D. prirnitivus.	[Jossart, Quentin; Kastally, Chedly; De Ridder, Chantal] Univ Libre Bruxelles, Dept Biol Organismes, Lab Biol Marine, Brussels, Belgium; [Jossart, Quentin; Wattier, Remi A.; David, Bruno; Rigaud, Thierry] Univ Bourgogne, Biogeosci UMR CNRS 6282, Dijon, France; [Kastally, Chedly; Aron, Serge] Univ Libre Bruxelles, Dept Biol Organismes Behav & Evolutionary Ecol, Brussels, Belgium	Universite Libre de Bruxelles; Universite de Bourgogne; Universite Libre de Bruxelles	Jossart, Q (corresponding author), Univ Libre Bruxelles, Dept Biol Organismes, Lab Biol Marine, Brussels, Belgium.	qjossart@ulb.ac.be	Wattier, Remi/ABC-3410-2021; Rigaud, Thierry/T-4053-2017; Rigaud, Thierry/ABE-2552-2020	Rigaud, Thierry/0000-0002-0163-6639; Rigaud, Thierry/0000-0002-0163-6639; Jossart, Quentin/0000-0002-2280-243X	Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture - FRIA [1.E047.11F]; Conseil regional de Bourgogne [2012-9201AAO050505502]	Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture - FRIA(Fonds de la Recherche Scientifique - FNRS); Conseil regional de Bourgogne(Region Bourgogne-Franche-Comte)	This work was supported by a PhD grant (1.E047.11F) to Q. Jossart (Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture - FRIA) and a grant (2012-9201AAO050505502) from the Conseil regional de Bourgogne (programme PAK. It is a contribution of the Centre Interuniversitaire de Biologie Marine (CIBIM - Departement de Biologie des Organismes) and of the laboratory Biogeosciences (Centre National de la Recherche Scientifique, CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CM, 2010, MOL ECOL RESOUR, V10, P576, DOI 10.1111/j.1755-0998.2010.02851.x; Angeloni L, 2003, BEHAV ECOL, V14, P554, DOI 10.1093/beheco/arg033; [Anonymous], 1995, SEA STARS SEA URCHIN; Arnaud Ludovic, 1999, Biotechnologie Agronomie Societe et Environnement, V3, P86; Avise JC, 2011, P NATL ACAD SCI USA, V108, P11512, DOI 10.1073/pnas.1109216108; Baeza JA, 2013, J ZOOL, V289, P172, DOI 10.1111/j.1469-7998.2012.00974.x; Baeza JA, 2008, MAR BIOL, V153, P387, DOI 10.1007/s00227-007-0815-9; Baeza J. Antonio, 2007, P249; Baggio RA, 2011, MAR BIOL RES, V7, P520, DOI 10.1080/17451000.2010.528771; Bailie DA, 2011, MAR ECOL PROG SER, V421, P173, DOI 10.3354/meps08895; Becker C, 2011, J MORPHOL, V272, P12, DOI 10.1002/jmor.10884; BELL JL, 1983, MAR ECOL PROG SER, V13, P141, DOI 10.3354/meps013141; Bretman A, 2004, P ROY SOC B-BIOL SCI, V271, P159, DOI 10.1098/rspb.2003.2563; Caulier G, 2012, ZOOSYMPOSIA, V7, P177, DOI 10.11646/zoosymposia.7.1.17; De Bruyn C, 2010, MAR ECOL PROG SER, V398, P183, DOI 10.3354/meps08315; De Bruyn C, 2009, MAR ECOL PROG SER, V375, P173, DOI 10.3354/meps07733; EBERHARD WG, 1991, BIOL REV, V66, P1, DOI 10.1111/j.1469-185X.1991.tb01133.x; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Jensen PC, 1996, BIOL BULL, V190, P336, DOI 10.2307/1543026; Jones AG, 2005, MOL ECOL NOTES, V5, P708, DOI 10.1111/j.1471-8286.2005.01029.x; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Jossart Q, 2013, MAR ECOL PROG SER, V475, P167, DOI 10.3354/meps10131; Karaket T, 2012, AQUACULTURE, V324, P307, DOI 10.1016/j.aquaculture.2011.10.045; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; McDonald J.H., 2009, HDB BIOL STAT; McKeown NJ, 2008, MAR ECOL PROG SER, V368, P209, DOI 10.3354/meps07634; Moreau J, 2002, ANIM BEHAV, V64, P569, DOI 10.1006/anbe.2002.4000; Neff BD, 2002, J FISH BIOL, V61, P739, DOI 10.1111/j.1095-8649.2002.tb00908.x; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Ocampo EH, 2012, J EXP MAR BIOL ECOL, V429, P36, DOI 10.1016/j.jembe.2012.06.009; Pamilo P, 1996, OIKOS, V75, P533, DOI 10.2307/3545895; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Pearcy M, 2009, INSECT SOC, V56, P94, DOI 10.1007/s00040-008-1043-0; POHLE G, 1981, B MAR SCI, V31, P753; Ross DM, 1983, BIOL CRUSTACEA, V7; Sainte-Marie Bernard, 2007, P191; Sainte-Marie G, 2000, CAN J ZOOL, V78, P1902, DOI 10.1139/cjz-78-11-1902; SHUSTER SM, 2003, MG BEH ECOL, pR7; Shuster SM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0046; Streiff R, 2004, MAR BIOTECHNOL, V6, P60, DOI 10.1007/s10126-003-0015-7; Takami Y, 2007, BEHAV ECOL, V18, P628, DOI 10.1093/beheco/arm022; TELFORD M, 1982, B MAR SCI, V32, P584; Thiel M, 2001, SYMBIOSIS, V30, P163; Urbani N, 1998, CAN J FISH AQUAT SCI, V55, P1104, DOI 10.1139/cjfas-55-5-1104; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vogt G, 2013, BIOL REV, V88, P81, DOI 10.1111/j.1469-185X.2012.00241.x; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Yue GH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012721; Yue GH, 2010, INT J BIOL SCI, V6, P107	51	26	26	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90680	10.1371/journal.pone.0090680	http://dx.doi.org/10.1371/journal.pone.0090680			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609105	Green Published, gold			2022-12-25	WOS:000332485800043
J	Truong, TK; Guidon, A; Song, AW				Trong-Kha Truong; Guidon, Arnaud; Song, Allen W.			Cortical Depth Dependence of the Diffusion Anisotropy in the Human Cortical Gray Matter In Vivo	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; INDUCED PHASE ERRORS; CEREBRAL-CORTEX; K-SPACE; RADIAL ORGANIZATION; INHERENT CORRECTION; WATER DIFFUSION; BRAIN; MRI; RECONSTRUCTION	Diffusion tensor imaging (DTI) is typically used to study white matter fiber pathways, but may also be valuable to assess the microstructure of cortical gray matter. Although cortical diffusion anisotropy has previously been observed in vivo, its cortical depth dependence has mostly been examined in high-resolution ex vivo studies. This study thus aims to investigate the cortical depth dependence of the diffusion anisotropy in the human cortex in vivo on a clinical 3 T scanner. Specifically, a novel multishot constant-density spiral DTI technique with inherent correction of motion-induced phase errors was used to achieve a high spatial resolution (0.625x0.625x3 mm) and high spatial fidelity with no scan time penalty. The results show: (i) a diffusion anisotropy in the cortical gray matter, with a primarily radial diffusion orientation, as observed in previous ex vivo and in vivo studies, and (ii) a cortical depth dependence of the fractional anisotropy, with consistently higher values in the middle cortical lamina than in the deep and superficial cortical laminae, as observed in previous ex vivo studies. These results, which are consistent across subjects, demonstrate the feasibility of this technique for investigating the cortical depth dependence of the diffusion anisotropy in the human cortex in vivo.	[Trong-Kha Truong; Guidon, Arnaud; Song, Allen W.] Duke Univ, Brain Imaging & Anal Ctr, Durham, NC 27708 USA	Duke University	Truong, TK (corresponding author), Duke Univ, Brain Imaging & Anal Ctr, Durham, NC 27708 USA.	trongkha.truong@duke.edu	Truong, Trong-Kha/S-3089-2016	Truong, Trong-Kha/0000-0003-2699-1554	National Institutes of Health [R01EB012586, R01EB009483, R01NS075017]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009483, R01EB012586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (grants R01EB012586, R01EB009483, and R01NS075017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwander A., 2010, P INT SOC MAGN RESON, P109; Bock AS, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00149; Budde MD, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00003; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; deIpolyi AR, 2005, NEUROIMAGE, V27, P579, DOI 10.1016/j.neuroimage.2005.04.027; Dyrby TB, 2011, HUM BRAIN MAPP, V32, P544, DOI 10.1002/hbm.21043; Frank LR, 2010, NEUROIMAGE, V49, P1510, DOI 10.1016/j.neuroimage.2009.09.010; Gupta RK, 2005, J NEUROSCI RES, V81, P172, DOI 10.1002/jnr.20547; Heidemann RM, 2012, NEUROIMAGE, V60, P967, DOI 10.1016/j.neuroimage.2011.12.081; Heidemann RM, 2010, MAGN RESON MED, V64, P9, DOI 10.1002/mrm.22480; Jaermann T, 2008, AM J NEURORADIOL, V29, P146, DOI 10.3174/ajnr.A0742; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kleinnijenhuis M, 2011, P INT SOC MAG RESON, V19, P2085; Kleinnijenhuis M, 2013, CORTEX, V49, P2569, DOI 10.1016/j.cortex.2012.11.015; Kroenke CD, 2007, J NEUROSCI, V27, P12506, DOI 10.1523/JNEUROSCI.3063-07.2007; Leuze C. W., 2011, P INT SOC MAGNETIC R, V19, P2371; Leuze CWU, 2014, CEREB CORTEX, V24, P328, DOI 10.1093/cercor/bhs311; Leuze CW, 2012, P EUR SOC MAGN RESON, V29, P417; Leuze CWU, 2012, P INT SOC MAG RESON, V20, P3594; Liu CL, 2005, MAGN RESON MED, V54, P1412, DOI 10.1002/mrm.20706; Maas LC, 2004, NEUROIMAGE, V22, P1134, DOI 10.1016/j.neuroimage.2004.02.035; McKinstry RC, 2002, CEREB CORTEX, V12, P1237, DOI 10.1093/cercor/12.12.1237; McNab JA, 2013, NEUROIMAGE, V69, P87, DOI 10.1016/j.neuroimage.2012.11.065; Mcnab JA, 2009, NEUROIMAGE, V46, P775, DOI 10.1016/j.neuroimage.2009.01.008; Miller KL, 2011, NEUROIMAGE, V57, P167, DOI 10.1016/j.neuroimage.2011.03.070; Mukherjee P, 2006, NEUROIMAG CLIN N AM, V16, P19, DOI 10.1016/j.nic.2005.11.004; Pruessmann KP, 2001, MAGNET RESON MED, V46, P638, DOI 10.1002/mrm.1241; Ronen I, 2005, MAGN RESON MED, V54, P317, DOI 10.1002/mrm.20542; Sizonenko SPV, 2007, CEREB CORTEX, V17, P2609, DOI 10.1093/cercor/bhl168; Sotiropoulos SN, 2013, NEUROIMAGE, V80, P125, DOI 10.1016/j.neuroimage.2013.05.057; Takahashi E, 2010, NEUROIMAGE, V49, P1231, DOI 10.1016/j.neuroimage.2009.09.002; Thornton JS, 1997, MAGN RESON IMAGING, V15, P433, DOI 10.1016/S0730-725X(96)00378-5; Trivedi R, 2009, NEURORADIOLOGY, V51, P567, DOI 10.1007/s00234-009-0533-8; Truong TK, 2014, MAGN RESON MED, V71, P790, DOI 10.1002/mrm.24709; Truong TK, 2012, MAGN RESON MED, V68, P1255, DOI 10.1002/mrm.24124; Truong TK, 2011, NEUROIMAGE, V57, P1343, DOI 10.1016/j.neuroimage.2011.06.008; Van AT, 2011, IEEE T MED IMAGING, V30, P1933, DOI 10.1109/TMI.2011.2158654	37	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91424	10.1371/journal.pone.0091424	http://dx.doi.org/10.1371/journal.pone.0091424			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608869	Green Submitted, Green Published, gold			2022-12-25	WOS:000332485800134
J	Vassena, E; Silvetti, M; Boehler, CN; Achten, E; Fias, W; Verguts, T				Vassena, Eliana; Silvetti, Massimo; Boehler, Carsten N.; Achten, Eric; Fias, Wim; Verguts, Tom			Overlapping Neural Systems Represent Cognitive Effort and Reward Anticipation	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; ACUTE TRYPTOPHAN DEPLETION; MEDIAL PREFRONTAL CORTEX; RAPHE SEROTONIN NEURONS; INDIVIDUAL-DIFFERENCES; DOPAMINERGIC MIDBRAIN; BRAIN ACTIVATION; DECISION-MAKING; MENTAL FATIGUE; FUTURE REWARDS	Anticipating a potential benefit and how difficult it will be to obtain it are valuable skills in a constantly changing environment. In the human brain, the anticipation of reward is encoded by the Anterior Cingulate Cortex (ACC) and Striatum. Naturally, potential rewards have an incentive quality, resulting in a motivational effect improving performance. Recently it has been proposed that an upcoming task requiring effort induces a similar anticipation mechanism as reward, relying on the same cortico-limbic network. However, this overlapping anticipatory activity for reward and effort has only been investigated in a perceptual task. Whether this generalizes to high-level cognitive tasks remains to be investigated. To this end, an fMRI experiment was designed to investigate anticipation of reward and effort in cognitive tasks. A mental arithmetic task was implemented, manipulating effort (difficulty), reward, and delay in reward delivery to control for temporal confounds. The goal was to test for the motivational effect induced by the expectation of bigger reward and higher effort. The results showed that the activation elicited by an upcoming difficult task overlapped with higher reward prospect in the ACC and in the striatum, thus highlighting a pivotal role of this circuit in sustaining motivated behavior.	[Vassena, Eliana; Silvetti, Massimo; Boehler, Carsten N.; Fias, Wim; Verguts, Tom] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium; [Vassena, Eliana; Silvetti, Massimo; Boehler, Carsten N.; Achten, Eric; Fias, Wim; Verguts, Tom] Ghent Univ Hosp, Ghent Inst Funct & Metab Imaging, Ghent, Belgium	Ghent University; Ghent University; Ghent University Hospital	Vassena, E (corresponding author), Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium.	Eliana.Vassena@UGent.be	Boehler, Carsten/J-8619-2015; Verguts, Tom/A-4792-2008; Vassena, Eliana/R-4591-2019; Fias, Wim/D-6861-2010; Vassena, Eliana/O-9984-2019; Silvetti, Massimo/V-3106-2019	Boehler, Carsten/0000-0001-5963-2780; Verguts, Tom/0000-0002-7783-4754; Fias, Wim/0000-0002-5788-7306; Vassena, Eliana/0000-0002-5761-6813; Silvetti, Massimo/0000-0002-2925-0615	Ghent University GOA [BOF08/GOA/011]	Ghent University GOA(Ghent University)	The authors EV, MS, WF and TV were supported by Ghent University GOA grant BOF08/GOA/011. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aarts E, 2008, J NEUROSCI, V28, P4671, DOI 10.1523/JNEUROSCI.4400-07.2008; Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; Amat J, 2005, NAT NEUROSCI, V8, P365, DOI 10.1038/nn1399; Amiez C, 2006, CEREB CORTEX, V16, P1040, DOI 10.1093/cercor/bhj046; Assadi SM, 2009, NEUROSCI BIOBEHAV R, V33, P383, DOI 10.1016/j.neubiorev.2008.10.010; Aston-Jones G, 2005, J COMP NEUROL, V493, P99, DOI 10.1002/cne.20723; Bardgett ME, 2009, BEHAV NEUROSCI, V123, P242, DOI 10.1037/a0014625; Basten U, 2010, P NATL ACAD SCI USA, V107, P21767, DOI 10.1073/pnas.0908104107; Beierholm U, 2013, NEUROPSYCHOPHARMACOL, V38, P1495, DOI 10.1038/npp.2013.48; Berridge KC, 2004, PHYSIOL BEHAV, V81, P179, DOI 10.1016/j.physbeh.2004.02.004; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Boehler CN, 2011, J NEUROSCI, V31, P4955, DOI 10.1523/JNEUROSCI.4845-10.2011; Boksem MAS, 2008, BRAIN RES REV, V59, P125, DOI 10.1016/j.brainresrev.2008.07.001; Botvinick MM, 2009, COGN AFFECT BEHAV NE, V9, P16, DOI 10.3758/CABN.9.1.16; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Boureau YL, 2011, NEUROPSYCHOPHARMACOL, V36, P74, DOI 10.1038/npp.2010.151; Bromberg-Martin ES, 2010, J NEUROSCI, V30, P6262, DOI 10.1523/JNEUROSCI.0015-10.2010; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Cools R, 2005, PSYCHOPHARMACOLOGY, V180, P670, DOI 10.1007/s00213-005-2215-5; Cools R, 2008, NEUROPSYCHOPHARMACOL, V33, P2291, DOI 10.1038/sj.npp.1301598; Cools R, 2008, TRENDS COGN SCI, V12, P31, DOI 10.1016/j.tics.2007.10.011; Cools R, 2011, CURR OPIN NEUROBIOL, V21, P402, DOI 10.1016/j.conb.2011.04.002; Cools R, 2011, NEUROPSYCHOPHARMACOL, V36, P98, DOI 10.1038/npp.2010.121; Croxson PL, 2009, J NEUROSCI, V29, P4531, DOI 10.1523/JNEUROSCI.4515-08.2009; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; Engstrom M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00140; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Harmer CJ, 2006, BIOL PSYCHIAT, V59, P816, DOI 10.1016/j.biopsych.2005.10.015; Hubner R, 2010, PSYCHON B REV, V17, P821, DOI 10.3758/PBR.17.6.821; Imbo I, 2005, PSYCHOL BELG, V45, P101, DOI 10.5334/pb-45-2-101; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kennerley SW, 2009, J COGNITIVE NEUROSCI, V21, P1162, DOI 10.1162/jocn.2009.21100; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Kobayashi S, 2008, J NEUROSCI, V28, P7837, DOI 10.1523/JNEUROSCI.1600-08.2008; Kong H, 2005, COGNITIVE BRAIN RES, V22, P397, DOI 10.1016/j.cogbrainres.2004.09.011; Krebs RM, 2012, CEREB CORTEX, V22, P607, DOI 10.1093/cercor/bhr134; Kurniawan IT, 2010, J NEUROPHYSIOL, V104, P313, DOI 10.1152/jn.00027.2010; Kurniawan IT, 2013, J NEUROSCI, V33, P6160, DOI 10.1523/JNEUROSCI.4777-12.2013; Kurniawan IT, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00081; Lallement JH, 2014, SOC COGN AFFECT NEUR, V9, P342, DOI 10.1093/scan/nss147; Levy DJ, 2011, J NEUROSCI, V31, P14693, DOI 10.1523/JNEUROSCI.2218-11.2011; Liu X, 2011, NEUROSCI BIOBEHAV R, V35, P1219, DOI 10.1016/j.neubiorev.2010.12.012; Lorist MM, 2005, COGNITIVE BRAIN RES, V24, P199, DOI 10.1016/j.cogbrainres.2005.01.018; Luks TL, 2002, NEUROIMAGE, V17, P792, DOI 10.1006/nimg.2002.1210; Luo S, 2009, J NEUROSCI, V29, P14820, DOI 10.1523/JNEUROSCI.4261-09.2009; Malecek NJ, 2013, BEHAV BRAIN SCI, V36, P698, DOI 10.1017/S0140525X13001106; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; McGuire JT, 2010, P NATL ACAD SCI USA, V107, P7922, DOI 10.1073/pnas.0910662107; Miyazaki K, 2011, J NEUROSCI, V31, P469, DOI 10.1523/JNEUROSCI.3714-10.2011; Miyazaki KW, 2012, J NEUROSCI, V32, P10451, DOI 10.1523/JNEUROSCI.0915-12.2012; Moeller SJ, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.110; Naccache L, 2005, NEUROPSYCHOLOGIA, V43, P1318, DOI 10.1016/j.neuropsychologia.2004.11.024; Naidic T, 2009, DUVERNOYS ATLAS HUMA; Nakagawa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056606; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; Oikawa H, 2002, AM J NEURORADIOL, V23, P1747; Park SQ, 2011, J NEUROSCI, V31, P9307, DOI 10.1523/JNEUROSCI.4973-10.2011; Pessiglione M, 2007, SCIENCE, V316, P904, DOI 10.1126/science.1140459; Peters J, 2011, TRENDS COGN SCI, V15, P227, DOI 10.1016/j.tics.2011.03.002; Raizada RDS, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.003.2007; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Robinson OJ, 2012, PSYCHOPHARMACOLOGY, V219, P599, DOI 10.1007/s00213-011-2410-5; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; Salamone JD, 2005, CURR OPIN PHARMACOL, V5, P34, DOI 10.1016/j.coph.2004.09.004; Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P389, DOI 10.1007/s00213-006-0623-9; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Schmidt L, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001266; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schweighofer N, 2008, J NEUROSCI, V28, P4528, DOI 10.1523/JNEUROSCI.4982-07.2008; Schweighofer N, 2007, ANN NY ACAD SCI, V1104, P289, DOI 10.1196/annals.1390.011; Schweimer J, 2010, LEARN MEMORY, V13, P777; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Silvetti M, 2013, CORTEX, V49, P1627, DOI 10.1016/j.cortex.2012.05.008; Silvetti M, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00075; Sohn MH, 2007, P NATL ACAD SCI USA, V104, P10330, DOI 10.1073/pnas.0703225104; Sterling P, 2012, PHYSIOL BEHAV, V106, P5, DOI 10.1016/j.physbeh.2011.06.004; Stoppel CM, 2011, BRAIN RES, V1383, P218, DOI 10.1016/j.brainres.2011.01.095; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Treadway MT, 2012, J NEUROSCI, V32, P6170, DOI 10.1523/JNEUROSCI.6459-11.2012; van der Veen FM, 2007, NEUROPSYCHOPHARMACOL, V32, P216, DOI 10.1038/sj.npp.1301212; Verguts T, 2009, TRENDS COGN SCI, V13, P252, DOI 10.1016/j.tics.2009.02.007; Walton ME, 2006, NEURAL NETWORKS, V19, P1302, DOI 10.1016/j.neunet.2006.03.005; Walton ME, 2008, ANN NY ACAD SCI, V44, P1; Woo CW, 2013, NEUROIMAGE	86	105	106	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91008	10.1371/journal.pone.0091008	http://dx.doi.org/10.1371/journal.pone.0091008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4IY	24608867	Green Published, gold, Green Submitted			2022-12-25	WOS:000332485800078
J	Zhang, YA; Zhu, JM; Yin, J; Tang, WQ; Guo, YM; Shen, XZ; Liu, TT				Zhang, Yi-An; Zhu, Ji-Min; Yin, Jie; Tang, Wen-Qing; Guo, Yan-Mei; Shen, Xi-Zhong; Liu, Tao-Tao			High Expression of Neuro-Oncological Ventral Antigen 1 Correlates with Poor Prognosis in Hepatocellular Carcinoma	PLOS ONE			English	Article							RNA-BINDING PROTEIN; TRANSLATIONAL REGULATION; IN-VITRO; RECEPTOR; GROWTH; CANCER; ANTIBODY; PATIENT; LIVER	Neuro-oncological ventral antigen 1 (Nova1) is a neuron-specific RNA-binding protein in human paraneoplastic opsoclonus-myoclonus ataxia accompanying with malignant tumors, but its role in hepatocellular carcinoma (HCC) remains elusive. In this study, we found that overexpressed intratumoral Nova1 was associated with poor survival rate and increased recurrence rate of HCC, especially early recurrence, and was an independent prognostic factor for overall survival rate and tumor recurrence. HCC cell lines over-expressing Nova1 exhibited greater potentials in cell proliferation, invasion and migration, while knockdown of Nova1 had the opposite effects. All these findings indicate that Nova1 may act as a prognostic marker for poor outcome and high recurrence in HCC.	[Zhang, Yi-An; Zhu, Ji-Min; Yin, Jie; Tang, Wen-Qing; Shen, Xi-Zhong] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China; [Guo, Yan-Mei] Tongji Univ, Peoples Hosp 10, Dept Gastroenterol, Shanghai 200092, Peoples R China	Fudan University; Tongji University		liu.taotao@zs-hospital.sh.cn	zhu, jimin/HDN-1451-2022; liu, taotao/GSI-7460-2022	Zhu, Ji-Min/0000-0002-2150-473X	Shanghai Science and Technology Commission [10410709400, 10411950100]; National Nature Science Foundation of China [81000968, 81101540, 81101637, 81172273]; National Clinical Key Special Subject of China; China Postdoctoral Science Foundation	Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Clinical Key Special Subject of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported by the Shanghai Science and Technology Commission (10410709400, 10411950100), National Nature Science Foundation of China (81000968, 81101540, 81101637 and 81172273), the National Clinical Key Special Subject of China and China Postdoctoral Science Foundation funded project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brieva-Ruiz L, 2008, CLIN NEUROL NEUROSUR, V110, P1044, DOI 10.1016/j.clineuro.2008.06.016; Buckanovich RJ, 1996, J NEUROSCI, V16, P1114; BUCKANOVICH RJ, 1993, NEURON, V11, P657, DOI 10.1016/0896-6273(93)90077-5; CURTIS D, 1995, CELL, V81, P171, DOI 10.1016/0092-8674(95)90325-9; Darnell RB, 2003, NEW ENGL J MED, V349, P1543, DOI 10.1056/NEJMra023009; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Esteves CL, 2013, J MOL ENDOCRINOL, V51, P91, DOI 10.1530/JME-13-0029; Ganguly S, 2010, AM J PATHOL, V177, P2701, DOI 10.2353/ajpath.2010.100617; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Johnstone O, 2001, ANNU REV GENET, V35, P365, DOI 10.1146/annurev.genet.35.102401.090756; Kazarian M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-33; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; LIAW YF, 1986, GASTROENTEROLOGY, V90, P263, DOI 10.1016/0016-5085(86)90919-4; Liu Y, 2008, WORLD J GASTROENTERO, V14, P7175, DOI 10.3748/wjg.14.7175; Liu Z, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-153; Lodewyks C, 2011, CAN J PHYSIOL PHARM, V89, P393, DOI [10.1139/y11-031, 10.1139/Y11-031]; Marrero JA, 2011, HEPATOLOGY, V53, P1060, DOI 10.1002/hep.24033; Qin LX, 2004, J CANCER RES CLIN, V130, P497, DOI 10.1007/s00432-004-0572-9; Rahman J, 2013, EUR J NEUROSCI; Schwarz N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041269; Sobin L, 2009, TNM CLASSIFICATION M; Stich O, 2009, ACTA NEUROL SCAND, V119, P338, DOI 10.1111/j.1600-0404.2008.01102.x; Sun D, 2003, AM J PHYSIOL-GASTR L, V285, pG12, DOI 10.1152/ajpgi.00513.2002; Tamburino AM, 2013, G3-GENES GENOM GENET, V3, P297, DOI 10.1534/g3.112.004390; Tsao CM, 2012, HEPATOLOGY, V56, P2277, DOI 10.1002/hep.25933; Wang T, 2008, LIFE SCI, V82, P536, DOI 10.1016/j.lfs.2007.12.014; Wirtz PW, 2002, J NEUROL, V249, P1710, DOI 10.1007/s00415-002-0913-z	27	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90955	10.1371/journal.pone.0090955	http://dx.doi.org/10.1371/journal.pone.0090955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608171	Green Published, Green Submitted, gold			2022-12-25	WOS:000332485800068
J	Zhang, R; Ran, HH; Cai, LL; Zhu, L; Sun, JF; Peng, L; Liu, XJ; Zhang, LN; Fang, Z; Fan, YY; Cui, G				Zhang, Ran; Ran, Hai-Hong; Cai, Li-Li; Zhu, Li; Sun, Jun-Fang; Peng, Liang; Liu, Xiao-Juan; Zhang, Lan-Ning; Fang, Zhou; Fan, Yong-Yan; Cui, Geng			Simulated microgravity-induced mitochondrial dysfunction in rat cerebral arteries	FASEB JOURNAL			English	Article						hindlimb unweighting; oxidative stress; NADPH oxidase	MANGANESE SUPEROXIDE-DISMUTASE; MESENTERIC SMALL ARTERIES; CELL-ADHESION MOLECULE-1; OXIDATIVE STRESS; VASCULAR DYSFUNCTION; NADPH OXIDASES; ENDOTHELIAL DYSFUNCTION; CAROTID ARTERIES; HEART-FAILURE; HYPERTENSION	Exposure to microgravity results in cardiovascular deconditioning, and cerebrovascular oxidative stress injury has been suggested to occur. To elucidate the mechanism for this condition, we investigated whether simulated microgravity induces mitochondrial dysfunction in rat arteries. Four-week hindlimb unweighting (HU) was used to simulate microgravity in rats. Mitochondrial reactive oxygen species (ROS), mitochondrial membrane potential (Delta psi m), mitochondrial permeability transition pore (mPTP) opening, mitochondrial respiratory control ratio (RCR), MnSOD/GPx activity and expression, and mitochondrial malondialdehyde (MDA) were examined in rat cerebral and mesenteric VSMCs. Compared with the control rats, mitochondrial ROS levels, mPTP opening, and MDA content increased significantly (P<0.001, P<0.01, and P<0.01, respectively), Delta psi m, RCR, MnSOD/GPx activity (P<0.001 for Delta psi m and RCR; P<0.05 for MnSOD; and P<0.001 for GPx activity) and protein abundance of mitochondrial MnSOD/GPx-1 decreased (P<0.001 for MnSOD and GPx-1) in HU rat cerebral but not mesenteric arteries. Chronic treatment with NADPH oxidase inhibitor apocynin and mitochondria-targeted antioxidant mitoTempol promoted recovery of mitochondrial function in HU rat cerebral arteries, but exerted no effects on HU rat mesenteric arteries. Therefore, simulated microgravity resulted in cerebrovascular mitochondrial dysfunction, and crosstalk between NADPH oxidase and mitochondria participated in the process.	[Zhang, Ran; Sun, Jun-Fang; Peng, Liang; Liu, Xiao-Juan; Zhang, Lan-Ning; Fang, Zhou; Fan, Yong-Yan] Chinese Peoples Liberat Army, Inst Geriatr Cardiol, Gen Hosp, Beijing 100853, Peoples R China; [Ran, Hai-Hong] Chinese Peoples Liberat Army, Dept Geriatr Hematol, Gen Hosp, Beijing 100853, Peoples R China; [Cai, Li-Li] Chinese Peoples Liberat Army, Dept Clin Lab Med, Gen Hosp, Beijing 100853, Peoples R China; [Cui, Geng] Chinese Peoples Liberat Army, Dept Osteol, Gen Hosp, Beijing 100853, Peoples R China; [Zhu, Li] Second Mil Med Univ, Changhai Hosp, Shanghai, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Naval Medical University	Cui, G (corresponding author), Chinese Peoples Liberat Army, Dept Osteol, Gen Hosp, 28 Fuxing Rd, Beijing 100853, Peoples R China.	bjzhangran@126.com	Zhang, Ran/ABB-5587-2021		National Natural Science Foundation of China [81101468, 81030002/H02]; Beijing NOVO Program [XX2013105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing NOVO Program	This work was supported by the National Natural Science Foundation of China (81101468 and 81030002/H02) and the Beijing NOVO Program (XX2013105). The authors declare no conflicts of interest.	Afolayan AJ, 2012, AM J PHYSIOL-LUNG C, V303, pL870, DOI 10.1152/ajplung.00098.2012; Bao JX, 2007, AVIAT SPACE ENVIR MD, V78, P852; Brandes RP, 2010, HYPERTENSION, V56, P17, DOI 10.1161/HYPERTENSIONAHA.108.120295; Cheng Jiu-Hua, 2009, Shengli Xuebao, V61, P386; Chrissobolis S, 2008, HYPERTENSION, V51, P872, DOI 10.1161/HYPERTENSIONAHA.107.103572; Convertino Victor A, 2002, J Gravit Physiol, V9, P1; Dai DF, 2012, CIRC RES, V110, P1109, DOI 10.1161/CIRCRESAHA.111.246140; Dai DF, 2012, CARDIOVASC RES, V93, P79, DOI 10.1093/cvr/cvr274; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; Dikalov SI, 2014, ANTIOXID REDOX SIGN, V20, P281, DOI 10.1089/ars.2012.4918; Dikalov SI, 2013, AM J PHYSIOL-HEART C, V305, pH1417, DOI 10.1152/ajpheart.00089.2013; Dikalov SI, 2013, ANTIOXID REDOX SIGN, V19, P1085, DOI 10.1089/ars.2012.4604; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Ding Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020008; Doughan AK, 2008, CIRC RES, V102, P488, DOI 10.1161/CIRCRESAHA.107.162800; Faraci FM, 2004, ARTERIOSCL THROM VAS, V24, P1367, DOI 10.1161/01.ATV.0000133604.20182.cf; Freed JK, 2013, ARTERIOSCL THROM VAS, V33, P673, DOI 10.1161/ATVBAHA.13.301039; Fu ZJ, 2004, AM J PHYSIOL-HEART C, V287, pH1505, DOI 10.1152/ajpheart.00143.2004; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Gao Fang, 2007, Shengli Xuebao, V59, P821; Gao L, 2008, VET CLIN N AM-SMALL, V38, P137, DOI 10.1016/j.cvsm.2007.10.004; GOLDSTEIN MA, 1992, J APPL PHYSIOL, V73, pS94, DOI 10.1152/jappl.1992.73.2.S94; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; Handy DE, 2009, J BIOL CHEM, V284, P11913, DOI 10.1074/jbc.M900392200; Hargens AR, 1996, MED SCI SPORT EXER, V28, P977, DOI 10.1097/00005768-199608000-00007; Javadov S, 2009, J PHARMACOL EXP THER, V330, P670, DOI 10.1124/jpet.109.153213; Kang HY, 2013, CELL BIOCHEM BIOPHYS, V66, P121, DOI 10.1007/s12013-012-9460-0; Kluge MA, 2013, CIRC RES, V112, P1171, DOI 10.1161/CIRCRESAHA.111.300233; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Lin LJ, 2009, J APPL PHYSIOL, V107, P1710, DOI 10.1152/japplphysiol.00493.2009; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Miller JD, 2010, AM J PHYSIOL-HEART C, V298, pH1600, DOI 10.1152/ajpheart.01108.2009; Miller MW, 2013, AM J PHYSIOL-HEART C, V304, pH1624, DOI 10.1152/ajpheart.00987.2012; Morbidelli L, 2005, BIOCHEM BIOPH RES CO, V334, P491, DOI 10.1016/j.bbrc.2005.06.124; Oelze M, 2014, HYPERTENSION, V63, P390, DOI 10.1161/HYPERTENSIONAHA.113.01602; Panov A, 2005, J BIOL CHEM, V280, P42026, DOI 10.1074/jbc.M508628200; Ren XL, 2011, CLIN EXP PHARMACOL P, V38, P683, DOI 10.1111/j.1440-1681.2011.05565.x; Taylor CR, 2013, FASEB J, V27, P2282, DOI 10.1096/fj.12-222687; Tsutsui H, 2009, CARDIOVASC RES, V81, P449, DOI 10.1093/cvr/cvn280; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Wenzel P, 2008, CARDIOVASC RES, V80, P280, DOI 10.1093/cvr/cvn182; Xi Q, 2005, CIRC RES, V97, P354, DOI 10.1161/01.RES.0000177669.29525.78; Xue JH, 2007, AM J PHYSIOL-HEART C, V293, pH691, DOI 10.1152/ajpheart.01229.2006; Xue JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019775; Zang Q, 2007, J APPL PHYSIOL, V102, P103, DOI 10.1152/japplphysiol.00359.2006; Zhan CD, 2004, J HYPERTENS, V22, P2025, DOI 10.1097/00004872-200410000-00027; Zhang LF, 2001, J APPL PHYSIOL, V91, P2415, DOI 10.1152/jappl.2001.91.6.2415; Zhang LF, 2013, EUR J APPL PHYSIOL, V113, P2873, DOI 10.1007/s00421-013-2597-8; Zhang R, 2008, J PHYSIOL SCI, V58, P67, DOI 10.2170/physiolsci.RP010707; Zhang R, 2012, J PHYSIOL BIOCHEM, V68, P99, DOI 10.1007/s13105-011-0123-1; Zhang R, 2010, EXCLI J, V9, P195; Zhang R, 2009, J APPL PHYSIOL, V106, P251, DOI 10.1152/japplphysiol.01278.2007	52	27	32	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2014	28	6					2715	2724		10.1096/fj.13-245654	http://dx.doi.org/10.1096/fj.13-245654			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AM5GA	24604081				2022-12-25	WOS:000339883600029
J	Chiyomaru, T; Fukuhara, S; Saini, S; Majid, S; Deng, GR; Shahryari, V; Chang, I; Tanaka, Y; Enokida, H; Nakagawa, M; Dahiya, R; Yamamura, S				Chiyomaru, Takeshi; Fukuhara, Shinichiro; Saini, Sharanjot; Majid, Shahana; Deng, Guoren; Shahryari, Varahram; Chang, Inik; Tanaka, Yuichiro; Enokida, Hideki; Nakagawa, Masayuki; Dahiya, Rajvir; Yamamura, Soichiro			Long Non-coding RNA HOTAIR Is Targeted and Regulated by miR-141 in Human Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Biology; Cell Growth; Gene Regulation; Invasion; MicroRNA; Genistein; HOTAIR; Long Non-coding RNA; miR-141; Renal Carcinoma	EPITHELIAL-MESENCHYMAL TRANSITION; MAMMALIAN MESSENGER-RNAS; TRANSCRIPTIONAL ACTIVITY; MICRORNA TARGETS; MIR-200 FAMILY; CODING REGIONS; PROSTATE-CANCER; GENE-EXPRESSION; REPRESSORS ZEB1; ALPHA-AMANITIN	Background: Silencing of long non-coding RNA (lncRNA) by microRNA (miRNA) has only been recently observed. Results: miR-141 binds to HOTAIR and suppresses its oncogenic function in Ago2 (Argounaute2). Conclusion: miR-141 targets and silences HOTAIR in an Ago2-dependent manner in cancer cells. Significance: Our results suggest that regulation of lncRNA expression by miRNA plays essential roles in gene expression and cellular functions. HOTAIR is a long non-coding RNA that interacts with the polycomb repressive complex and suppresses its target genes. HOTAIR has also been demonstrated to promote malignancy. MicroRNA-141 (miR-141) has been reported to play a role in the epithelial to mesenchymal transition process, and the expression of miR-141 is inversely correlated with tumorigenicity and invasiveness in several human cancers. We found that HOTAIR expression is inversely correlated to miR-141 expression in renal carcinoma cells. HOTAIR promotes malignancy, including proliferation and invasion, whereas miR-141 suppresses malignancy in human cancer cells. miR-141 binds to HOTAIR in a sequence-specific manner and suppresses HOTAIR expression and functions, including proliferation and invasion. Both HOTAIR and miR-141 were associated with the immunoprecipitated Ago2 (Argonaute2) complex, and the Ago2 complex cleaved HOTAIR in the presence of miR-141. These results demonstrate that HOTAIR is suppressed by miR-141 in an Ago2-dependent manner.	[Chiyomaru, Takeshi; Fukuhara, Shinichiro; Saini, Sharanjot; Majid, Shahana; Deng, Guoren; Shahryari, Varahram; Tanaka, Yuichiro; Dahiya, Rajvir; Yamamura, Soichiro] San Francisco VA Med Ctr, Dept Urol, San Francisco, CA 94121 USA; [Chiyomaru, Takeshi; Fukuhara, Shinichiro; Saini, Sharanjot; Majid, Shahana; Deng, Guoren; Shahryari, Varahram; Tanaka, Yuichiro; Dahiya, Rajvir; Yamamura, Soichiro] Univ Calif San Francisco, San Francisco, CA 94121 USA; [Chang, Inik] Yonsei Univ, Coll Dent, Dept Oral Biol, Seoul 120752, South Korea; [Enokida, Hideki; Nakagawa, Masayuki] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Urol, Kagoshima 8908520, Japan	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; Yonsei University; Yonsei University Health System; Kagoshima University	Yamamura, S (corresponding author), Vet Affairs Med Ctr, Urol Res Ctr 112F, 4150 Clement St, San Francisco, CA 94121 USA.	yamamuras@urology.ucsf.edu			National Institutes of Health [RO1CA130860]; Veterans Affairs Program Project; Veterans Affairs Merit Review grants; NATIONAL CANCER INSTITUTE [R01CA130860, R01CA160079] Funding Source: NIH RePORTER; Veterans Affairs [IP1BX001604] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Program Project; Veterans Affairs Merit Review grants(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant RO1CA130860. This study was also supported by Veterans Affairs Program Project and Veterans Affairs Merit Review grants.	Banerjee S, 2008, CANCER LETT, V269, P226, DOI 10.1016/j.canlet.2008.03.052; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Bhan A, 2013, J MOL BIOL, V425, P3707, DOI 10.1016/j.jmb.2013.01.022; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Chiyomaru T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070372; Chiyomaru T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058929; Chiyomaru T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043812; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gong XQ, 2004, J BIOL CHEM, V279, P27422, DOI 10.1074/jbc.M402163200; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hu MH, 2010, DIGEST DIS SCI, V55, P2365, DOI 10.1007/s10620-009-1008-9; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Ishibashi M, 2013, ONCOL REP, V29, P946, DOI 10.3892/or.2012.2219; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim K, 2013, ONCOGENE, V32, P1616, DOI 10.1038/onc.2012.193; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin HR, 2011, P NATL ACAD SCI USA, V108, P5148, DOI 10.1073/pnas.1102033108; Liu C, 2012, THESIS U TEXAS HOUST; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lu LG, 2012, BREAST CANCER RES TR, V136, P875, DOI 10.1007/s10549-012-2314-z; Majid S, 2010, CANCER RES, V70, P2809, DOI 10.1158/0008-5472.CAN-09-4176; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Nguyen VT, 1996, NUCLEIC ACIDS RES, V24, P2924, DOI 10.1093/nar/24.15.2924; Nie Y, 2013, CANCER SCI, V104, P458, DOI 10.1111/cas.12092; Niinuma T, 2012, CANCER RES, V72, P1126, DOI 10.1158/0008-5472.CAN-11-1803; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pavese JM, 2010, CANCER METAST REV, V29, P465, DOI 10.1007/s10555-010-9238-z; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Pratt AJ, 2009, J BIOL CHEM, V284, P17897, DOI 10.1074/jbc.R900012200; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Schnall-Levin M, 2011, GENOME RES, V21, P1395, DOI 10.1101/gr.121210.111; Schnall-Levin M, 2010, P NATL ACAD SCI USA, V107, P15751, DOI 10.1073/pnas.1006172107; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Xiao J, 2012, PROSTATE, V72, P1514, DOI 10.1002/pros.22501; Xu H., 2013, CELL BIOCH IN PRESS; Zhang YK, 2011, EPIGENETICS-US, V6, P888, DOI 10.4161/epi.6.7.16315; Zhang YK, 2011, EXP BIOL MED, V236, P714, DOI 10.1258/ebm.2011.010347; Zhang Z, 2013, CELL DEATH DIFFER, V20, P1558, DOI 10.1038/cdd.2013.110	61	152	164	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12550	12565		10.1074/jbc.M113.488593	http://dx.doi.org/10.1074/jbc.M113.488593			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24616104	Green Published, hybrid			2022-12-25	WOS:000335581400029
J	Fu, SL; Pang, H; Xu, JZ; Wu, XH				Fu, Sheng-Long; Pang, Hao; Xu, Jian-Zhong; Wu, Xue-Hui			C/EBP beta Mediates Osteoclast Recruitment by Regulating Endothelial Progenitor Cell Expression of SDF-1 alpha	PLOS ONE			English	Article							BONE-MARROW; FACTOR-I; OSTEOPROTEGERIN LIGAND; TRANSCRIPTION FACTORS; CHEMOKINE SDF-1; RAW264.7 CELLS; DIFFERENTIATION; CXCR4; PRECURSORS; RECEPTOR	Integration of tissue-engineered bone grafts with the host bone is vital for the healing of critical-size bone defects. An important aspect of this process is bone resorption, which must be carried out by osteoclasts derived from the host. However, the mechanism underlying recruitment of host osteoclast precursors to graft sites remains unclear. Endothelial progenitor cells (EPCs) mobilize from the bone marrow into the circulation and home to sites of angiogenesis such as tissue remodeling. Since EPCs express SDF-1, and C/EBP beta is known to regulate SDF-1 alpha expression, we hypothesized that EPCs may recruit CXCR4-expressing host osteoclast precursors to the repair area and that this recruitment may be mediated through C/EBP beta signaling. Using an inflammatory EPC model we showed that EPCs upregulate protein levels of both SDF-1 alpha and C/EBP beta. A luciferase assay confirmed that C/EBP beta acts on the SDF-1 alpha promoter in these cells, and that binding is increased under conditions of inflammation, while silencing of C/EBP beta reduces expression of SDF-1 alpha and C/EBP beta. Using RAW264.7 cells as a model of osteoclastic monocyte precursors, we investigated their responses to migratory factors in EPC conditioned medium. We showed that RAW264.7 cells migrate towards conditioned medium from EPCs treated with IL-1 beta, an effect which could be abolished by silencing C/EBP beta in EPCs, and was almost completely blocked by silencing CXCR4 in RAW264.7 cells. These findings show that EPCs respond to inflammatory stimuli by signaling to osteoclast precursors via SDF-1, and that C/EBP beta mediates this response.	[Fu, Sheng-Long; Pang, Hao; Xu, Jian-Zhong; Wu, Xue-Hui] Third Mil Med Univ, Southwest Hosp, Dept Orthopaed, Natl & Reg Engn Lab Tissue Engn, Chongqing, Peoples R China	Army Medical University	Xu, JZ (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Orthopaed, Natl & Reg Engn Lab Tissue Engn, Chongqing, Peoples R China.	xujz3jd@163.com; rrrranx@yeah.net	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Xu, Jianzhong/0000-0003-0434-5148	National Natural Science Foundation of China [81071465]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (No. 81071465). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; ALAM T, 1992, J BIOL CHEM, V267, P5021; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Ara T, 2003, IMMUNITY, V19, P257, DOI 10.1016/S1074-7613(03)00201-2; Benameur T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012392; Cackowski FC, 2010, BLOOD, V115, P140, DOI 10.1182/blood-2009-08-237628; Calonge E, 2010, J MOL BIOL, V396, P463, DOI 10.1016/j.jmb.2009.11.064; Cardinaux JR, 2000, GLIA, V29, P91, DOI 10.1002/(SICI)1098-1136(20000101)29:1<91::AID-GLIA9>3.0.CO;2-I; Collin-Osdoby P, 2012, METHODS MOL BIOL, V816, P187, DOI 10.1007/978-1-61779-415-5_13; Dar A, 2006, EXP HEMATOL, V34, P967, DOI 10.1016/j.exphem.2006.04.002; De Falco E, 2009, J CELL MOL MED, V13, P3405, DOI 10.1111/j.1582-4934.2009.00655.x; Dong F, 2010, CHINESE MED J-PEKING, V123, P2454, DOI 10.3760/cma.j.issn.0366-6999.2010.17.030; Fan JA, 2010, CANCER BIOTHER RADIO, V25, P521, DOI 10.1089/cbr.2010.0784; Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020; Fuller K, 1998, J EXP MED, V188, P997, DOI 10.1084/jem.188.5.997; George AL, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-24; Hirata M, 2012, HUM MOL GENET, V21, P1111, DOI 10.1093/hmg/ddr540; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Hunger C, 2012, EXP CELL RES, V318, P2178, DOI 10.1016/j.yexcr.2012.06.020; Hungness ES, 2002, INT J BIOCHEM CELL B, V34, P382, DOI 10.1016/S1357-2725(01)00129-7; Jie W, 2010, INT J EXP PATHOL, V91, P436, DOI 10.1111/j.1365-2613.2010.00720.x; Kamio N, 2013, CONNECT TISSUE RES, V54, P147, DOI 10.3109/03008207.2012.761978; Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08; Kim K, 2007, J LEUKOCYTE BIOL, V82, P1332, DOI 10.1189/jlb.1106697; Kubarek L, 2009, BIOMED PHARMACOTHER, V63, P586, DOI 10.1016/j.biopha.2008.10.007; Lacey DL, 2000, AM J PATHOL, V157, P435, DOI 10.1016/S0002-9440(10)64556-7; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; Miller RJ, 2008, J NEUROIMMUNOL, V198, P31, DOI 10.1016/j.jneuroim.2008.04.008; Murdoch C, 2000, IMMUNOL REV, V177, P175, DOI 10.1034/j.1600-065X.2000.17715.x; Pang H, 2013, BIOCHEM BIOPH RES CO, V430, P729, DOI 10.1016/j.bbrc.2012.11.081; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Przybylski M, 2010, BIOMED PHARMACOTHER, V64, P254, DOI 10.1016/j.biopha.2009.06.008; Quinn JMW, 1998, ENDOCRINOLOGY, V139, P4424, DOI 10.1210/endo.139.10.6331; Ribatti D, 2004, J CELL MOL MED, V8, P294, DOI 10.1111/j.1582-4934.2004.tb00319.x; Shalhoub V, 2000, BRIT J HAEMATOL, V111, P501, DOI 10.1046/j.1365-2141.2000.02379.x; Smink JJ, 2012, GENE, V497, P10, DOI 10.1016/j.gene.2012.01.043; Song E, 2010, INT J OPHTHALMOL-CHI, V3, P49, DOI 10.3980/j.issn.2222-3959.2010.01.11; Takagi Y, 2009, AM J PHYSIOL-LUNG C, V297, pL420, DOI 10.1152/ajplung.90477.2008; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tousoulis D, 2008, ATHEROSCLEROSIS, V201, P236, DOI 10.1016/j.atherosclerosis.2008.05.034; Vincent C, 2009, J BONE MINER METAB, V27, P114, DOI 10.1007/s00774-008-0018-6; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908; Wright LM, 2005, BONE, V36, P840, DOI 10.1016/j.bone.2005.01.021; Wu SH, 2012, INT J MED SCI, V9, P801, DOI 10.7150/ijms.4838; Wu X, 2005, J IMMUNOL, V175, P61, DOI 10.4049/jimmunol.175.1.61; Yamanaka R, 1998, INT J MOL MED, V1, P213; Yu HY, 2008, J ORTHOP RES, V26, P1147, DOI 10.1002/jor.20609; Yu XF, 2003, J BONE MINER RES, V18, P1404, DOI 10.1359/jbmr.2003.18.8.1404; Zwingenberger S, 2013, TISSUE ENG A	50	9	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91217	10.1371/journal.pone.0091217	http://dx.doi.org/10.1371/journal.pone.0091217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618682	Green Submitted, Green Published, gold			2022-12-25	WOS:000332842400057
J	Galimov, ER; Chernyak, BV; Sidorenko, AS; Tereshkova, AV; Chumakov, PM				Galimov, Evgeny R.; Chernyak, Boris V.; Sidorenko, Alena S.; Tereshkova, Alesya V.; Chumakov, Peter M.			Prooxidant Properties of p66shc Are Mediated by Mitochondria in Human Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; LIFE-SPAN; HYDROGEN-PEROXIDE; SERUM DEPRIVATION; ADAPTER PROTEIN; CYTOCHROME-C; NEURODEGENERATIVE DISORDERS; ENDOTHELIAL DYSFUNCTION; FORKHEAD PROTEINS; INDUCED APOPTOSIS	p66shc is a protein product of an mRNA isoform of SHC1 gene that has a pro-oxidant and pro-apoptotic activity and is implicated in the aging process. Mitochondria were suggested as a major source of the p66shc-mediated production of reactive oxygen species (ROS), although the underlying mechanisms are poorly understood. We studied effects of p66shc on oxidative stress induced by hydrogen peroxide or by serum deprivation in human colon carcinoma cell line RKO and in diploid human dermal fibroblasts (HDFs). An shRNA-mediated knockdown of p66shc suppressed and an overexpression of a recombinant p66shc stimulated the production of ROS in the both models. This effect was not detected in the mitochondrial DNA-depleted rho 0-RKO cells that do not have the mitochondrial electron transport chain (ETC). The p66shc-dependent accumulation of mitochondrial ROS was detected with HyPer-mito, a mitochondria-targeted fluorescent protein sensor for hydrogen peroxide. The fragmentation of mitochondria induced by mitochondrial ROS was significantly reduced in the p66shc deficient RKO cells. Mitochondria-targeted antioxidants SkQ1 and SkQR1 also decreased the oxidative stress induced by hydrogen peroxide or by serum deprivation. Together the data indicate that the p66shc-dependant ROS production during oxidative stress has mitochondrial origin in human normal and cancer cells.	[Galimov, Evgeny R.; Chernyak, Boris V.] Moscow MV Lomonosov State Univ, Belozersky Inst Phys & Chem Biol, Moscow, Russia; [Galimov, Evgeny R.; Sidorenko, Alena S.; Tereshkova, Alesya V.; Chumakov, Peter M.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia; [Chumakov, Peter M.] Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA; [Chumakov, Peter M.] Novosibirsk State Univ, Novosibirsk 630090, Russia	Lomonosov Moscow State University; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Cleveland Clinic Foundation; Novosibirsk State University	Chumakov, PM (corresponding author), Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia.	peterchumakov@gmail.com	Chernyak, Boris V/D-9917-2012; Chumakov, Peter M/E-7731-2014	Chernyak, Boris V/0000-0003-1523-0864; Galimov, Evgeniy/0000-0001-8891-3362; Chumakov, Peter/0000-0002-8078-2908	Russian Fund for Basic Research [11-04-00410, 11-04-92697, 12-04-00538]; Mitotech LLC.	Russian Fund for Basic Research(Russian Foundation for Basic Research (RFBR)); Mitotech LLC.	The study was supported by grants 11-04-00410, 11-04-92697, and 12-04-00538 from the Russian Fund for Basic Research (www.rfbr.ru) and a grant from Mitotech LLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2010, FASEB J, V24, P5033, DOI 10.1096/fj.10-166934; Antonenko YN, 2008, J MEMBRANE BIOL, V222, P141, DOI 10.1007/s00232-008-9108-6; Antonenko YN, 2011, J BIOL CHEM, V286, P17831, DOI 10.1074/jbc.M110.212837; Arany I, 2008, J BIOL CHEM, V283, P6110, DOI 10.1074/jbc.M708799200; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Berniakovich I, 2008, J BIOL CHEM, V283, P34283, DOI 10.1074/jbc.M804362200; Borkowska A, 2011, FREE RADICAL BIO MED, V51, P658, DOI 10.1016/j.freeradbiomed.2011.04.045; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Camici GG, 2007, P NATL ACAD SCI USA, V104, P5217, DOI 10.1073/pnas.0609656104; Chahdi A, 2008, MOL BIOL CELL, V19, P2609, DOI 10.1091/mbc.E07-05-0424; Chernyak BV, 2006, BBA-BIOENERGETICS, V1757, P525, DOI 10.1016/j.bbabio.2006.02.019; Chumakov S P, 2008, Mol Biol (Mosk), V42, P1004; Chumakov SP, 2010, PLASMID, V63, P143, DOI 10.1016/j.plasmid.2009.12.003; Chung YM, 2006, BIOCHEM BIOPH RES CO, V347, P649, DOI 10.1016/j.bbrc.2006.06.140; Chung YM, 2008, J BIOL CHEM, V283, P33763, DOI 10.1074/jbc.M805334200; Dumont A, 1999, ONCOGENE, V18, P747, DOI 10.1038/sj.onc.1202325; Egorov E E, 2007, Ontogenez, V38, P105; FERRARI G, 1995, J NEUROSCI, V15, P2857; Finkel T, 2005, NAT REV MOL CELL BIO, V6, P971, DOI 10.1038/nrm1763; Francia P, 2004, CIRCULATION, V110, P2889, DOI 10.1161/01.CIR.0000147731.24444.4D; Fukuyama R, 2002, J BIOL CHEM, V277, P41455, DOI 10.1074/jbc.M204176200; Gertz M, 2008, P NATL ACAD SCI USA, V105, P5705, DOI 10.1073/pnas.0800691105; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Haga S, 2008, J HEPATOL, V48, P422, DOI 10.1016/j.jhep.2007.11.018; Kakhlon O, 2001, BIOCHEM J, V356, P311, DOI 10.1042/0264-6021:3560311; Kapahi P, 1999, FREE RADICAL BIO MED, V26, P495, DOI 10.1016/S0891-5849(98)00323-2; Khanday FA, 2006, J CELL BIOL, V172, P817, DOI 10.1083/jcb.200506001; Khanday FA, 2006, MOL BIOL CELL, V17, P122, DOI 10.1091/mbc.e05-06-0570; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; KITAGAWA T, 1993, BIOL REPROD, V49, P730, DOI 10.1095/biolreprod49.4.730; Koch OR, 2008, LAB INVEST, V88, P750, DOI 10.1038/labinvest.2008.44; Kowaltowski AJ, 2000, BRAZ J MED BIOL RES, V33, P241, DOI 10.1590/S0100-879X2000000200014; Kravchenko JE, 2005, NATURE, V436, P735, DOI 10.1038/nature03848; KU HH, 1993, FREE RADICAL BIO MED, V15, P621, DOI 10.1016/0891-5849(93)90165-Q; Kuznetsov AV, 2011, ANAL BIOANAL CHEM, V400, P2383, DOI 10.1007/s00216-011-4764-2; Larsen NB, 2005, MITOCHONDRION, V5, P89, DOI 10.1016/j.mito.2005.02.002; Lee SB, 2011, ONCOL REP, V25, P1337, DOI 10.3892/or.2011.1210; Lee SB, 2010, APOPTOSIS, V15, P204, DOI 10.1007/s10495-009-0411-1; Lenaz G, 2012, ADV EXP MED BIOL, V942, P93, DOI 10.1007/978-94-007-2869-1_5; Leonard JV, 2000, LANCET, V355, P389, DOI 10.1016/S0140-6736(99)05226-5; Maestre I, 2003, ENDOCRINOLOGY, V144, P335, DOI 10.1210/en.2001-211282; Mailloux RJ, 2012, TRENDS ENDOCRIN MET, V23, P451, DOI 10.1016/j.tem.2012.04.004; Markova OV, 2003, BBA-BIOENERGETICS, V1557, P109, DOI 10.1016/S0005-2728(03)00003-3; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Nemoto S, 2006, J BIOL CHEM, V281, P10555, DOI 10.1074/jbc.M511626200; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Orsini F, 2004, J BIOL CHEM, V279, P25689, DOI 10.1074/jbc.M401844200; Orsini F, 2006, BIOL CHEM, V387, P1405, DOI 10.1515/BC.2006.176; Pandey S, 2003, APOPTOSIS, V8, P497, DOI 10.1023/A:1025542424986; PETERSEN LC, 1980, BIOCHEM J, V192, P687, DOI 10.1042/bj1920687; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Pletjushkina OY, 2006, BBA-BIOENERGETICS, V1757, P518, DOI 10.1016/j.bbabio.2006.03.018; Pletjushkina OY, 2005, CELL DEATH DIFFER, V12, P1442, DOI 10.1038/sj.cdd.4401685; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; Razorenova OV, 2005, GENE, V350, P89, DOI 10.1016/j.gene.2005.02.006; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Satoh T, 1996, BRAIN RES, V733, P9, DOI 10.1016/0006-8993(96)00527-6; SCHEJTER A, 1963, Biochim Biophys Acta, V73, P641; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Skulachev VP, 2009, BBA-BIOENERGETICS, V1787, P437, DOI 10.1016/j.bbabio.2008.12.008; Skulachev VP, 2004, MOL CELL BIOCHEM, V256, P341, DOI 10.1023/B:MCBI.0000009880.94044.49; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Smith WW, 2005, J CELL BIOL, V169, P331, DOI 10.1083/jcb.200410041; SUGANUMA N, 1993, HORM RES, V39, P16, DOI 10.1159/000182752; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901; Wu ZH, 2006, J CELL PHYSIOL, V209, P996, DOI 10.1002/jcp.20819; Zhuge J, 2006, FREE RADICAL BIO MED, V40, P63, DOI 10.1016/j.freeradbiomed.2005.08.012; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	71	22	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e86521	10.1371/journal.pone.0086521	http://dx.doi.org/10.1371/journal.pone.0086521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618848	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400002
J	Herrando-Perez, S; Delean, S; Brook, BW; Cassey, P; Bradshaw, CJA				Herrando-Perez, Salvador; Delean, Steven; Brook, Barry W.; Cassey, Phillip; Bradshaw, Corey J. A.			Spatial Climate Patterns Explain Negligible Variation in Strength of Compensatory Density Feedbacks in Birds and Mammals	PLOS ONE			English	Article							POPULATION-DYNAMICS; TIME-SERIES; LARGE-SCALE; ENVIRONMENTAL-FACTORS; DEPENDENCE; FLUCTUATIONS; VARIABILITY; PREDATION; WEATHER; STOCHASTICITY	The use of long-term population data to separate the demographic role of climate from density-modified demographic processes has become a major topic of ecological investigation over the last two decades. Although the ecological and evolutionary mechanisms that determine the strength of density feedbacks are now well understood, the degree to which climate gradients shape those processes across taxa and broad spatial scales remains unclear. Intuitively, harsh or highly variable environmental conditions should weaken compensatory density feedbacks because populations are hypothetically unable to achieve or maintain densities at which social and trophic interactions (e.g., competition, parasitism, predation, disease) might systematically reduce population growth. Here we investigate variation in the strength of compensatory density feedback, from long-term time series of abundance over 146 species of birds and mammals, in response to spatial gradients of broad-scale temperature precipitation variables covering 97 localities in 28 countries. We use information-theoretic metrics to rank phylogenetic generalized least-squares regression models that control for sample size (time-series length) and phylogenetic non-independence. Climatic factors explained < 1% of the remaining variation in density-feedback strength across species, with the highest non-control, model-averaged effect sizes related to extreme precipitation variables. We could not link our results directly to other published studies, because ecologists use contrasting responses, predictors and statistical approaches to correlate density feedback and climate - at the expense of comparability in a macroecological context. Censuses of multiple populations within a given species, and a priori knowledge of the spatial scales at which density feedbacks interact with climate, seem to be necessary to determine cross-taxa variation in this phenomenon. Despite the availability of robust modelling tools, the appropriate data have not yet been gathered for most species, meaning that we cannot yet make any robust generalisations about how demographic feedbacks interact with climate.	[Herrando-Perez, Salvador; Delean, Steven; Brook, Barry W.; Cassey, Phillip; Bradshaw, Corey J. A.] Univ Adelaide, Inst Environm, Adelaide, SA 5005, Australia; [Herrando-Perez, Salvador; Delean, Steven; Brook, Barry W.; Cassey, Phillip; Bradshaw, Corey J. A.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia; [Herrando-Perez, Salvador] Spanish Res Council CSIC, Natl Museum Nat Sci, Dept Biogeog & Global Change, Madrid, Spain	University of Adelaide; University of Adelaide; Consejo Superior de Investigaciones Cientificas (CSIC)	Herrando-Perez, S (corresponding author), Univ Adelaide, Inst Environm, Adelaide, SA 5005, Australia.	salvador.herrando-perez@adelaide.edu.au	Bradshaw, Corey J.A./A-1311-2008; Brook, Barry W./G-2686-2011	Bradshaw, Corey J.A./0000-0002-5328-7741; Brook, Barry W./0000-0002-2491-1517; Cassey, Phillip/0000-0002-2626-0172; Herrando-Perez, Salvador/0000-0001-6052-6854	Endeavour International Postgraduate Scholarship (University of Adelaide); Australian Research Council Discovery Project [DP0878582]	Endeavour International Postgraduate Scholarship (University of Adelaide); Australian Research Council Discovery Project(Australian Research Council)	Funding provided by an Endeavour International Postgraduate Scholarship (University of Adelaide, www.adelaide.edu.au) to SHP, and by an Australian Research Council (http://www.arc.gov.au) Discovery Project grant (DP0878582) to CJAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanes R, 2000, ECOGRAPHY, V23, P437, DOI 10.1034/j.1600-0587.2000.230406.x; Bassar RD, 2010, ANN NY ACAD SCI, V1206, P17, DOI 10.1111/j.1749-6632.2010.05706.x; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Belovsky GE, 2004, BIOSCIENCE, V54, P345, DOI 10.1641/0006-3568(2004)054[0345:TSTSTS]2.0.CO;2; Berryman A., 1999, PRINCIPLES POPULATIO; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; BJORNSTAD ON, 1995, P ROY SOC B-BIOL SCI, V262, P127, DOI 10.1098/rspb.1995.0186; Bjornstad ON, 2001, SCIENCE, V293, P638, DOI 10.1126/science.1062226; Bonenfant C, 2009, ADV ECOL RES, V41, P313, DOI 10.1016/S0065-2504(09)00405-X; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Brook BW, 2006, ECOLOGY, V87, P1445, DOI 10.1890/0012-9658(2006)87[1445:SOEFDD]2.0.CO;2; Brouwer L, 2006, J ANIM ECOL, V75, P1321, DOI 10.1111/j.1365-2656.2006.01155.x; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Bull JC, 2008, J ANIM ECOL, V77, P1296, DOI 10.1111/j.1365-2656.2008.01449.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Chamaille-Jammes S, 2008, J ANIM ECOL, V77, P135, DOI 10.1111/j.1365-2656.2007.01307.x; Clark F, 2010, METHODS ECOL EVOL, V1, P253, DOI 10.1111/j.2041-210X.2010.00029.x; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; De Valpine P, 2008, ECOLOGY, V89, P532, DOI 10.1890/06-1996.1; Dennis B, 2006, ECOL MONOGR, V76, P323, DOI 10.1890/0012-9615(2006)76[323:EDDPNA]2.0.CO;2; Doncaster CP, 2008, THEOR POPUL BIOL, V73, P483, DOI 10.1016/j.tpb.2008.02.003; Driscoll DA, 2012, ECOL MONOGR, V82, P129, DOI 10.1890/11-0916.1; Fagan WF, 2001, ECOL LETT, V4, P132, DOI 10.1046/j.1461-0248.2001.00206.x; FOLEY P, 1994, CONSERV BIOL, V8, P124, DOI 10.1046/j.1523-1739.1994.08010124.x; FOWLER CW, 1981, ECOLOGY, V62, P602, DOI 10.2307/1937727; Fox JW, 2001, J ANIM ECOL, V70, P80; Freckleton RP, 2011, AM NAT, V178, pE10, DOI 10.1086/660272; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Fryxell JM, 2005, OIKOS, V111, P143, DOI 10.1111/j.0030-1299.2005.13840.x; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Hallett TB, 2004, NATURE, V430, P71, DOI 10.1038/nature02708; Hart EM, 2011, OIKOS, V120, P1227, DOI 10.1111/j.1600-0706.2011.18707.x; Helms SE, 2005, OECOLOGIA, V145, P197, DOI 10.1007/s00442-005-0060-1; Herrando-Perez S, 2012, RESOLVING CONCEPTUAL; Herrando-Perez S, 2012, OECOLOGIA, V170, P585, DOI 10.1007/s00442-012-2347-3; Herrando-Perez S, 2012, ECOL EVOL, V2, P1922, DOI 10.1002/ece3.298; Herrando-Perez S, 2012, ECOLOGY, V93, P1728, DOI 10.1890/11-1415.1; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Ims RA, 2008, TRENDS ECOL EVOL, V23, P79, DOI 10.1016/j.tree.2007.10.010; Inchausti P, 2001, SCIENCE, V293, P655, DOI 10.1126/science.293.5530.655; Ives AR, 2010, ECOLOGY, V91, P858, DOI 10.1890/09-0442.1; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jetz W, 2011, CURR BIOL, V21, P72, DOI 10.1016/j.cub.2010.11.075; Johnson DW, 2006, ECOLOGY, V87, P1179, DOI 10.1890/0012-9658(2006)87[1179:PHCAVI]2.0.CO;2; Knape J, 2011, P ROY SOC B-BIOL SCI, V278, P985, DOI 10.1098/rspb.2010.1333; Knape J, 2008, ECOLOGY, V89, P2994, DOI 10.1890/08-0071.1; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Krebs CJ, 2002, PHILOS T ROY SOC B, V357, P1211, DOI 10.1098/rstb.2002.1122; Kruger O, 2002, J ANIM ECOL, V71, P603, DOI 10.1046/j.1365-2656.2002.00626.x; Lima M, 2002, ECOL LETT, V5, P273, DOI 10.1046/j.1461-0248.2002.00312.x; Lima M, 2006, OIKOS, V112, P555, DOI 10.1111/j.0030-1299.2006.14439.x; Mansson L, 2007, POPUL ECOL, V49, P287, DOI 10.1007/s10144-007-0053-5; Martin LJ, 2012, FRONT ECOL ENVIRON, V10, P195, DOI 10.1890/110154; McMahon CR, 2009, OECOLOGIA, V159, P69, DOI 10.1007/s00442-008-1205-9; Medawar PB, 1940, PROC R SOC SER B-BIO, V129, P332, DOI 10.1098/rspb.1940.0042; Mutshinda CM, 2011, J ANIM ECOL, V80, P101, DOI 10.1111/j.1365-2656.2010.01743.x; NELDER JA, 1961, BIOMETRICS, V17, P89, DOI 10.2307/2527498; NICHOLSON AJ, 1950, NATURE, V165, P476, DOI 10.1038/165476a0; NICHOLSON AJ, 1954, AUST J ZOOL, V2, P9, DOI 10.1071/ZO9540009; NICHOLSON AJ, 1954, NATURE, V173, P862, DOI 10.1038/173862a0; Osenberg CW, 2002, ECOL LETT, V5, P715, DOI 10.1046/j.1461-0248.2002.00377.x; Pasinelli G, 2011, J ANIM ECOL, V80, P225, DOI 10.1111/j.1365-2656.2010.01754.x; Pfister CA, 2006, ECOLOGY, V87, P2905, DOI 10.1890/0012-9658(2006)87[2905:CBSEAL]2.0.CO;2; Polansky L, 2009, ECOLOGY, V90, P2313, DOI 10.1890/08-1461.1; Post E, 2005, ECOLOGY, V86, P2320, DOI 10.1890/04-0823; Ritchie ME, 1996, FRONTIERS OF POPULATION ECOLOGY, P79; Saether BE, 2005, NATURE, V436, P99, DOI 10.1038/nature03666; Saether BE, 2008, J ANIM ECOL, V77, P869, DOI 10.1111/j.1365-2656.2008.01424.x; Saitoh T, 1997, J ANIM ECOL, V66, P14, DOI 10.2307/5960; Saitoh T, 1999, ECOLOGY, V80, P638, DOI 10.2307/176641; Saitoh T, 2008, POPUL ECOL, V50, P159, DOI 10.1007/s10144-008-0076-6; Seavy NE, 2009, J WILDLIFE MANAGE, V73, P414, DOI 10.2193/2007-420; Sibly RM, 2007, ECOL LETT, V10, P970, DOI 10.1111/j.1461-0248.2007.01092.x; Sinclair ARE, 1996, OIKOS, V75, P164, DOI 10.2307/3546240; Spencer PD, 2008, FISH OCEANOGR, V17, P396, DOI 10.1111/j.1365-2419.2008.00486.x; Steele MA, 2005, P NATL ACAD SCI USA, V102, P13513, DOI 10.1073/pnas.0504306102; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Stige LC, 2010, P ROY SOC B-BIOL SCI, V277, P3411, DOI 10.1098/rspb.2010.0602; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; TURCHIN P, 1990, NATURE, V344, P660, DOI 10.1038/344660a0; WallisDeVries MF, 2011, OECOLOGIA, V167, P559, DOI 10.1007/s00442-011-2007-z; Wang GM, 2006, ECOLOGY, V87, P95, DOI 10.1890/05-0355; Wang GM, 2002, INT J BIOMETEOROL, V46, P197, DOI 10.1007/s00484-002-0134-2; Wang GM, 2009, POPUL ECOL, V51, P123, DOI 10.1007/s10144-008-0095-3; White PJ, 2007, ECOL APPL, V17, P1598, DOI 10.1890/06-2032.1; Wiens JA, 2009, P NATL ACAD SCI USA, V106, P19729, DOI 10.1073/pnas.0901639106; Wilkerson MS, 2010, KOEPPEN GEIGER GE KM; Wilmers CC, 2007, AM NAT, V169, P673, DOI 10.1086/513484; Zeng Z, 1998, ECOLOGY, V79, P2193, DOI 10.1890/0012-9658(1998)079[2193:CPDITR]2.0.CO;2; Ziebarth NL, 2010, ECOL LETT, V13, P21, DOI 10.1111/j.1461-0248.2009.01393.x	90	9	9	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91536	10.1371/journal.pone.0091536	http://dx.doi.org/10.1371/journal.pone.0091536			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618822	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400102
J	Hong, LB; Walz, JM; Sajda, P				Hong, Linbi; Walz, Jennifer M.; Sajda, Paul			Your Eyes Give You Away: Prestimulus Changes in Pupil Diameter Correlate with Poststimulus Task-Related EEG Dynamics	PLOS ONE			English	Article							TEMPORAL EVOLUTION; LOCUS-COERULEUS; ALPHA-BAND; ERP; DISCRIMINATION; ORIGINS	Pupillary measures have been linked to arousal and attention as well as activity in the brainstem's locus coeruleus norepinephrine (LC-NE) system. Similarly, there is evidence that evoked EEG responses, such as the P3, might have LC-NE activity as their basis. Since it is not feasible to record electrophysiological data directly from the LC in humans due to its location in the brainstem, an open question has been whether pupillary measures and EEG variability can be linked in a meaningful way to shed light on the nature of the LC-NE role in attention and arousal. We used an auditory oddball task with a data-driven approach to learn task-relevant projections of the EEG, for windows of data spanning the entire trial. We investigated linear and quadratic relationships between the evoked EEG along these projections and both prestimulus (baseline) and poststimulus (evoked dilation) pupil diameter measurements. We found that baseline pupil diameter correlates with early (175-200 ms) and late (350-400 ms) EEG component variability, suggesting a linear relationship between baseline (tonic) LC-NE activity and evoked EEG. We found no relationships between evoked EEG and evoked pupil dilation, which is often associated with evoked (phasic) LC activity. After regressing out reaction time (RT), the correlation between EEG variability and baseline pupil diameter remained, suggesting that such correlation is not explainable by RT variability. We also investigated the relationship between these pupil measures and prestimulus EEG alpha activity, which has been reported as a marker of attentional state, and found a negative linear relationship with evoked pupil dilation. In summary, our results demonstrate significant relationships between prestimulus and poststimulus neural and pupillary measures, and they provide further evidence for tight coupling between attentional state and evoked neural activity and for the role of cortical and subcortical networks underlying the process of target detection.	[Hong, Linbi; Walz, Jennifer M.; Sajda, Paul] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA	Columbia University	Sajda, P (corresponding author), Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA.	psajda@columbia.edu	Walz, Jennifer/J-7052-2015	Walz, Jennifer/0000-0003-3578-7264; Hong, Linbi/0000-0003-3630-9125	NIH [R01-MH085092]; Army Research Office [W911NF-11-1-0219]; NSF GRFP; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085092] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office; NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by NIH (R01-MH085092), Army Research Office (W911NF-11-1-0219), and a NSF GRFP awarded to JMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE ED, 1988, NEUROSCIENCE, V27, P897, DOI 10.1016/0306-4522(88)90192-3; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Babiloni C, 2006, CEREB CORTEX, V16, P1690, DOI 10.1093/cercor/bhj104; Benarroch EE, 2009, NEUROLOGY, V73, P1699, DOI 10.1212/WNL.0b013e3181c2937c; Critchley HD, 2005, NEUROIMAGE, V27, P885, DOI 10.1016/j.neuroimage.2005.05.047; de Gee JW, 2014, P NATL ACAD SCI US; Duoandikoetxea J, 2000, FOURIER ANAL; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Gajewski PD, 2008, BRAIN RES, V1189, P127, DOI 10.1016/j.brainres.2007.10.076; Gerson AD, 2005, NEUROIMAGE, V28, P342, DOI 10.1016/j.neuroimage.2005.06.026; Goldman RI, 2009, NEUROIMAGE, V47, P136, DOI 10.1016/j.neuroimage.2009.03.062; Kothe CA, 2011, ANN JOINT S NEUR COM, V1, P16; Lou B, 2012, ORG HUM BRAIN MAPP A, V18, P1080; Marrufo MV, 2001, COGNITIVE BRAIN RES, V12, P315; Murphy PR, 2011, PSYCHOPHYSIOLOGY, V48, P1531, DOI 10.1111/j.1469-8986.2011.01226.x; Nieuwenhuis S, 2010, PSYCHOPHYSIOLOGY; Parra L, 2002, NEUROIMAGE, V17, P223, DOI 10.1006/nimg.2002.1212; Parra LC, 2005, NEUROIMAGE, V28, P326, DOI 10.1016/j.neuroimage.2005.05.032; Rajkowski J., 1993, Society for Neuroscience Abstracts, V19, P974; RAY WJ, 1985, SCIENCE, V228, P750, DOI 10.1126/science.3992243; Robertson SD, 2013, NAT NEUROSCI, V16, P1016, DOI 10.1038/nn.3458; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; STEINHAUER SR, 1992, ANN NY ACAD SCI, V658, P182, DOI 10.1111/j.1749-6632.1992.tb22845.x; Usher M, 1999, SCIENCE, V283, P549, DOI 10.1126/science.283.5401.549; Van Dijk H, 2008, J NEUROSCI, V28, P1816, DOI 10.1523/JNEUROSCI.1853-07.2008; Walz JM, 2013, J NEUROSCI, V33, P19212, DOI 10.1523/JNEUROSCI.2649-13.2013; Warren CM, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00043	27	58	58	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91321	10.1371/journal.pone.0091321	http://dx.doi.org/10.1371/journal.pone.0091321			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618591	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400074
J	Mavrommatis, B; Offord, V; Patterson, R; Watson, M; Kanellos, T; Steinbach, F; Grierson, S; Werling, D				Mavrommatis, Bettina; Offord, Victoria; Patterson, Robert; Watson, Mick; Kanellos, Theo; Steinbach, Falko; Grierson, Sylvia; Werling, Dirk			Global Gene Expression Profiling of Myeloid Immune Cell Subsets in Response to In Vitro Challenge with Porcine Circovirus 2b	PLOS ONE			English	Article							MULTISYSTEMIC WASTING SYNDROME; COMPLETE GENOME SEQUENCE; SWINE ALVEOLAR MACROPHAGES; TUMOR-NECROSIS-FACTOR; DENDRITIC CELLS; TYPE-2 PCV2; GENOTYPE DEFINITION; MICROARRAY ANALYSIS; VIRAL-INFECTION; SYNDROME PMWS	Compelling evidence suggests that the early interaction between porcine circovirus 2 (PCV-2) and the innate immune system is the key event in the pathogenesis of Post-Weaning Multisystemic Wasting Syndrome (PMWS). Furthermore, PCV2 has been detected in bone-marrow samples, potentially enabling an easy spread and reservoir for the virus. To assess the gene-expression differences induced by an in-vitro PCV2b infection in different three different myeloid innate immune cell subsets generated from the same animal, we used the Agilent Porcine Gene Expression Microarray (V2). Alveolar macrophages (AMOs), monocyte-derived dendritic cells (MoDCs) and bone-marrow cells (BMCs) were generated from each animal, and challenged with a UK-isolate of a PCV2 genotype b-strain at a MOI of 0.5. Remarkably, analysis showed a highly distinct and cell-type dependent response to PCV2b challenge. Overall, MoDCs showed the most marked response to PCV2b challenge in vitro and revealed a key role for TNF in the interaction with PCV2b, whereas only few genes were affected in BMCs and AMOs. These observations were further supported by an enrichment of genes in the downstream NF-kappa B Signalling pathway as well as an up regulation of genes with pro-apoptotic functions post-challenge. PCV2b challenge increases the expression of a large number of immune-related and pro-apoptotic genes mainly in MoDC, which possibly explain the increased inflammation, granulomatous inflammation and lymphocyte depletion seen in PMWS-affected pigs.	[Mavrommatis, Bettina; Offord, Victoria; Patterson, Robert; Werling, Dirk] Univ London Royal Vet Coll, Hatfield, Herts, England; [Watson, Mick] Univ Edinburgh, Roslin Inst, ARK Genom, Edinburgh, Midlothian, Scotland; [Watson, Mick] Univ Edinburgh, R D SVS, Edinburgh, Midlothian, Scotland; [Kanellos, Theo] Zoetis Anim Hlth, Paris, France; [Steinbach, Falko; Grierson, Sylvia] Anim Hlth & Vet Labs Agcy, Dept Virol, Addlestone, Surrey, England	University of London; University of London Royal Veterinary College; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Zoetis; Veterinary Laboratories Agency	Werling, D (corresponding author), Univ London Royal Vet Coll, Hatfield, Herts, England.	Dwerling@RVC.AC.UK	Grierson, S/D-9587-2011; Werling, Dirk/F-5555-2013; Steinbach, Falko/V-1682-2019	Werling, Dirk/0000-0001-5411-4044; Steinbach, Falko/0000-0003-1236-2837; Watson, Mick/0000-0003-4211-0358	BBSRC 'Combating Endemic Diseases of Farmed Animals for Sustainability' (CEDFAS) initiative [BB/FO18394/1]; Zoetis Animal Health; BBSRC [BB/E018394/1, BBS/E/D/20231759, BBS/E/D/20211552, BBS/E/D/20310000] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E018394/1, BBS/E/D/20310000, BBS/E/D/20211552, BBS/E/D/20231759] Funding Source: researchfish	BBSRC 'Combating Endemic Diseases of Farmed Animals for Sustainability' (CEDFAS) initiative; Zoetis Animal Health; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a grant (BB/FO18394/1) from the BBSRC 'Combating Endemic Diseases of Farmed Animals for Sustainability' (CEDFAS) initiative, with contributions from BPEX, Biobest Laboratories and Zoetis Animal Health. The funder Zoetis Animal Health provided support in the form of salaries for author TK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section. All other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan GM, 2000, J VET DIAGN INVEST, V12, P3, DOI 10.1177/104063870001200102; Allan GM, 1999, VET MICROBIOL, V66, P115, DOI 10.1016/S0378-1135(99)00004-8; Balmelli C, 2011, IMMUNOLOGY, V132, P57, DOI 10.1111/j.1365-2567.2010.03339.x; Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Benedict CA, 2003, CYTOKINE GROWTH F R, V14, P349, DOI 10.1016/S1359-6101(03)00030-3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolin SR, 2001, J VET DIAGN INVEST, V13, P185, DOI 10.1177/104063870101300301; Bruckner M, 2012, CELL IMMUNOL, V276, P52, DOI 10.1016/j.cellimm.2012.03.008; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carman S, 2008, CAN J VET RES, V72, P259; Carrasco CP, 2001, IMMUNOLOGY, V104, P175, DOI 10.1046/j.1365-2567.2001.01299.x; Chae JS, 2011, RES VET SCI, V90, P321, DOI 10.1016/j.rvsc.2010.05.024; Chang HW, 2006, VET IMMUNOL IMMUNOP, V110, P207, DOI 10.1016/j.vetimm.2005.09.016; Chang HW, 2005, VET MICROBIOL, V108, P167, DOI 10.1016/j.vetmic.2005.03.010; Cheng S, 2012, J PROTEOMICS, V75, P3258, DOI 10.1016/j.jprot.2012.03.039; Cheung AK, 2007, ARCH VIROL, V152, P1035, DOI 10.1007/s00705-006-0909-6; Coussens PM, 2002, INFECT IMMUN, V70, P5494, DOI 10.1128/IAI.70.10.5494-5502.2002; de BC, 2004, J GEN VIROL, V85, P293; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Dupont K, 2008, VET MICROBIOL, V128, P56, DOI 10.1016/j.vetmic.2007.09.016; Fernandes LT, 2012, VIRUS RES, V165, P134, DOI 10.1016/j.virusres.2012.02.006; Fernandes LT, 2009, ANIM BIOTECHNOL, V20, P96, DOI 10.1080/10495390902885785; Fink J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000086; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gillespie J, 2009, J VET INTERN MED, V23, P1151, DOI 10.1111/j.1939-1676.2009.0389.x; Gilpin DF, 2003, VET IMMUNOL IMMUNOP, V94, P149, DOI 10.1016/S0165-2427(03)00087-4; Gordon SB, 2002, BRIT MED BULL, V61, P45, DOI 10.1093/bmb/61.1.45; Grau-Roma L, 2008, VET MICROBIOL, V128, P23, DOI 10.1016/j.vetmic.2007.09.007; Grierson SS, 2004, ARCH VIROL, V149, P1171, DOI 10.1007/s00705-003-0288-1; Hansen MS, 2013, VET PATHOL; Harding JCS, 2004, VET MICROBIOL, V98, P131, DOI 10.1016/j.vetmic.2003.10.013; Hasslung FC, 2003, J GEN VIROL, V84, P2937, DOI 10.1099/vir.0.19362-0; Huang YW, 2009, DEV COMP IMMUNOL, V33, P464, DOI 10.1016/j.dci.2008.09.010; Huang Z, 2012, J VIROL, V86, P10895, DOI 10.1128/JVI.01817-12; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jacobsen B, 2009, VET MICROBIOL, V138, P27, DOI 10.1016/j.vetmic.2009.02.005; Kalim KW, 2013, MOL IMMUNOL, V53, P274, DOI 10.1016/j.molimm.2012.08.014; Kim J, 2006, VET PATHOL, V43, P718, DOI 10.1354/vp.43-5-718; Krakowka S, 2002, VIRAL IMMUNOL, V15, P567, DOI 10.1089/088282402320914511; Larochelle R, 2003, CAN J VET RES, V67, P114; Lee G, 2010, J GEN VIROL, V91, P2585, DOI 10.1099/vir.0.022608-0; Li B, 2012, J VIROL, V86, P4716, DOI 10.1128/JVI.00268-12; Li WT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-353; Lin SQ, 2012, ARCH VIROL, V157, P1821, DOI 10.1007/s00705-012-1328-5; Liu J, 2007, J VIROL, V81, P9560, DOI 10.1128/JVI.00681-07; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; O'Brien V, 1998, J GEN VIROL, V79, P1833, DOI 10.1099/0022-1317-79-8-1833; Obermajer N, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-15; Perez-Martin E, 2007, J VIROL METHODS, V146, P86, DOI 10.1016/j.jviromet.2007.06.005; Rahman Masmudur M, 2006, PLoS Pathog, V2, pe4; Resendes AR, 2004, VET IMMUNOL IMMUNOP, V99, P203, DOI 10.1016/j.vetimm.2004.02.001; Rosell C, 1999, J COMP PATHOL, V120, P59, DOI 10.1053/jcpa.1998.0258; Segales J, 2008, VET REC, V162, P867, DOI 10.1136/vr.162.26.867; Segales J, 2004, VET MICROBIOL, V98, P151, DOI 10.1016/j.vetmic.2003.10.007; Segura E, 2013, IMMUNITY, V38, P336, DOI 10.1016/j.immuni.2012.10.018; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; SIBILLE Y, 1990, AM REV RESPIR DIS, V141, P471, DOI 10.1164/ajrccm/141.2.471; Sinha A, 2012, VET MICROBIOL, V158, P95, DOI 10.1016/j.vetmic.2012.02.013; Sorden SD, 1999, J VET DIAGN INVEST, V11, P528, DOI 10.1177/104063879901100607; Steer SA, 2003, VIRAL IMMUNOL, V16, P447, DOI 10.1089/088282403771926283; Steiner E, 2008, VIROLOGY, V378, P311, DOI 10.1016/j.virol.2008.06.009; Summerfield A, 1997, J LEUKOCYTE BIOL, V62, P176, DOI 10.1002/jlb.62.2.176; Tomas A, 2008, VET MICROBIOL, V132, P260, DOI 10.1016/j.vetmic.2008.05.023; Tomas A, 2010, VET RES, V41, DOI 10.1051/vetres/2009060; Vincent IE, 2005, IMMUNOLOGY, V115, P388, DOI 10.1111/j.1365-2567.2005.02165.x; Vincent IE, 2003, J VIROL, V77, P13288, DOI 10.1128/JVI.77.24.13288-13300.2003; Vincent IE, 2007, IMMUNOLOGY, V120, P47, DOI 10.1111/j.1365-2567.2006.02476.x; Wen LB, 2012, J VIROL, V86, P5963, DOI 10.1128/JVI.00494-12; Wen LB, 2012, J VIROL, V86, P639, DOI 10.1128/JVI.06469-11; Wieland B, 2012, VET REC, V170, P596, DOI 10.1136/vr.100276; Yang IV, 2002, GENOME BIOL, V3; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Yuan LH, 2005, INFECT IMMUN, V73, P4146, DOI 10.1128/IAI.73.7.4146-4154.2005	74	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91081	10.1371/journal.pone.0091081	http://dx.doi.org/10.1371/journal.pone.0091081			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618842	Green Published, gold			2022-12-25	WOS:000332842400047
J	Shero, MR; Pearson, LE; Costa, DP; Burns, JM				Shero, Michelle R.; Pearson, Linnea E.; Costa, Daniel P.; Burns, Jennifer M.			Improving the Precision of Our Ecosystem Calipers: A Modified Morphometric Technique for Estimating Marine Mammal Mass and Body Composition	PLOS ONE			English	Article							SOUTHERN ELEPHANT SEAL; ANTARCTIC FUR SEALS; ATLANTIC HARP SEAL; MIROUNGA-LEONINA; WATER FLUX; NUTRIENT DEPOSITION; FORAGING SUCCESS; DIVING BEHAVIOR; HOODED SEALS; BLUBBER	Mass and body composition are indices of overall animal health and energetic balance and are often used as indicators of resource availability in the environment. This study used morphometric models and isotopic dilution techniques, two commonly used methods in the marine mammal field, to assess body composition of Weddell seals (Leptonychotes weddellii, N = 111). Findings indicated that traditional morphometric models that use a series of circular, truncated cones to calculate marine mammal blubber volume and mass overestimated the animal's measured body mass by 26.9+/-1.5% SE. However, we developed a new morphometric model that uses elliptical truncated cones, and estimates mass with only 22.8+/-1.7% error (N = 10). Because this elliptical truncated cone model can estimate body mass without the need for additional correction factors, it has the potential to be a broadly applicable method in marine mammal species. While using elliptical truncated cones yielded significantly smaller blubber mass estimates than circular cones (10.2+/-0.8% difference; or 3.5+/-0.3% total body mass), both truncated cone models significantly underestimated total body lipid content as compared to isotopic dilution results, suggesting that animals have substantial internal lipid stores (N = 76). Multiple linear regressions were used to determine the minimum number of morphometric measurements needed to reliably estimate animal mass and body composition so that future animal handling times could be reduced. Reduced models estimated body mass and lipid mass with reasonable accuracy using fewer than five morphometric measurements (root-mean-square-error: 4.91% for body mass, 10.90% for lipid mass, and 10.43% for % lipid). This indicates that when test datasets are available to create calibration coefficients, regression models also offer a way to improve body mass and condition estimates in situations where animal handling times must be short and efficient.	[Shero, Michelle R.; Pearson, Linnea E.; Burns, Jennifer M.] Univ Alaska Anchorage, Dept Biol Sci, Anchorage, AK 99508 USA; [Shero, Michelle R.; Pearson, Linnea E.] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK USA; [Costa, Daniel P.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA	University of Alaska System; University of Alaska Anchorage; University of Alaska System; University of Alaska Fairbanks; University of California System; University of California Santa Cruz	Shero, MR (corresponding author), Univ Alaska Anchorage, Dept Biol Sci, Anchorage, AK 99508 USA.	mrshero@alaska.edu	Burns, Jennifer/AAC-8243-2019; Costa, Daniel/E-2616-2013	Burns, Jennifer/0000-0001-9652-2943; Costa, Daniel/0000-0002-0233-5782; Shero, Michelle/0000-0003-4633-5351	NSF [ANT-0838892, ANT-0838937]; National Science Foundation Graduate Research Fellowship [DGE-1242789]; Cooperative Institute for Alaska Research; Alaska Climate Science Center; UAF Center for Global Change Student Research Grant	NSF(National Science Foundation (NSF)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Cooperative Institute for Alaska Research; Alaska Climate Science Center; UAF Center for Global Change Student Research Grant	This research was conducted with support from NSF ANT-0838892 to D. P. C. and ANT-0838937 to J.M.B. This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. DGE-1242789. Any opinion, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. M. R. S. and this research were supported in part by a UAF Center for Global Change Student Research Grant with funds from the Cooperative Institute for Alaska Research and the Alaska Climate Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILAR A, 1990, J MAMMAL, V71, P544, DOI 10.2307/1381793; Aoki K, 2011, J EXP BIOL, V214, P2973, DOI 10.1242/jeb.055137; Arnould JPY, 1996, PHYSIOL ZOOL, V69, P93, DOI 10.1086/physzool.69.1.30164202; Beck CA, 2000, J EXP BIOL, V203, P2323; BECK GG, 1993, CAN J FISH AQUAT SCI, V50, P1372, DOI 10.1139/f93-157; Beck GG, 1995, CAN J ZOOL, V73, P1991, DOI 10.1139/z95-234; Bell CM, 1997, MAR MAMMAL SCI, V13, P669, DOI 10.1111/j.1748-7692.1997.tb00090.x; Bowen WD, 1998, PHYSIOL ZOOL, V71, P329, DOI 10.1086/515921; Boyd IL, 2001, J ANIM ECOL, V70, P747, DOI 10.1046/j.0021-8790.2001.00534.x; Bryden MM, 1967, THESIS U SYDNEY; Budge SM, 2006, MAR MAMMAL SCI, V22, P759, DOI 10.1111/j.1748-7692.2006.00079.x; Burek KA, 2008, ECOL APPL, V18, pS126, DOI 10.1890/06-0553.1; Burns JM, 2007, J COMP PHYSIOL B, V177, P687, DOI 10.1007/s00360-007-0167-2; CASTELLINI MA, 1990, MAR MAMMAL SCI, V6, P75, DOI 10.1111/j.1748-7692.1990.tb00227.x; Costa D. P., 1987, APPROACHES MARINE MA, P43; COSTA DP, 1986, J ZOOL, V209, P21, DOI 10.1111/j.1469-7998.1986.tb03563.x; COSTA DP, 1989, ECOLOGY, V70, P596, DOI 10.2307/1940211; Crocker DE, 2012, PHYSIOL BIOCHEM ZOOL, V85, P11, DOI 10.1086/663634; Crocker DE, 2001, ECOLOGY, V82, P3541, DOI 10.2307/2680171; de Bruyn PJN, 2009, AQUAT BIOL, V5, P31, DOI 10.3354/ab00135; Derocher AE, 2004, INTEGR COMP BIOL, V44, P163, DOI 10.1093/icb/44.2.163; Dunkin RC, 2005, J EXP BIOL, V208, P1469, DOI 10.1242/jeb.01559; FOLCH J, 1957, J BIOL CHEM, V226, P497; GALES NJ, 1987, AUST J ZOOL, V35, P207, DOI 10.1071/ZO9870207; GALES R, 1994, POLAR BIOL, V14, P381; GALES R, 1994, CAN J ZOOL, V72, P545, DOI 10.1139/z94-073; Hofman RJ., 1975, DISSERTATION; Koopman HN, 2007, MAR BIOL, V151, P277, DOI 10.1007/s00227-006-0489-8; Koopman HN, 2002, PHYSIOL BIOCHEM ZOOL, V75, P498, DOI 10.1086/342799; Liwanag HEM, 2012, BIOL J LINN SOC, V107, P774, DOI 10.1111/j.1095-8312.2012.01992.x; LOCKYER CH, 1984, CAN J ZOOL, V62, P2553, DOI 10.1139/z84-373; LYDERSEN C, 1992, J ZOOL, V228, P361, DOI 10.1111/j.1469-7998.1992.tb04441.x; McDonald BI, 2008, DEEP-SEA RES PT II, V55, P515, DOI 10.1016/j.dsr2.2007.11.002; Meyers L. S., 2006, APPL MULTIVARIATE RE; Miller PJO, 2012, J EXP BIOL, V215, P3622, DOI 10.1242/jeb.070128; Moore FD, 1963, BODY CELL MASS ITS S; NAGY KA, 1980, AM J PHYSIOL, V238, pR454, DOI 10.1152/ajpregu.1980.238.5.R454; NORDOY ES, 1985, AM J PHYSIOL, V249, pR471, DOI 10.1152/ajpregu.1985.249.4.R471; Noren SR, 2009, J MAMMAL, V90, P629, DOI 10.1644/08-MAMM-A-138R.1; Noren SR, 2008, PHYS BIOCH ZOOL, V81, P868; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Oftedal OT, 1996, PHYSIOL ZOOL, V69, P635, DOI 10.1086/physzool.69.3.30164220; OFTEDAL OT, 1993, PHYSIOL ZOOL, V66, P412, DOI 10.1086/physzool.66.3.30163701; ORTIZ CL, 1978, PHYSIOL ZOOL, V51, P166, DOI 10.1086/physzool.51.2.30157864; POND CM, 1978, ANNU REV ECOL SYST, V9, P519, DOI 10.1146/annurev.es.09.110178.002511; Reid K, 2001, P ROY SOC B-BIOL SCI, V268, P377, DOI 10.1098/rspb.2000.1371; REILLY JJ, 1990, J APPL PHYSIOL, V69, P885, DOI 10.1152/jappl.1990.69.3.885; Rice D. W. W., 1971, AM SOC MAMMAL, DOI DOI 10.5962/BHL.TITLE.39537; Robinson PW, 2010, J ANIM ECOL, V79, P1146, DOI 10.1111/j.1365-2656.2010.01735.x; SCHEFFER VB, 1967, J MAMMAL, V48, P459; Schick RS, 2013, J ANIM ECOL; SHENG HP, 1979, AM J CLIN NUTR, V32, P630, DOI 10.1093/ajcn/32.3.630; SLIP DJ, 1992, AUST J ZOOL, V40, P143, DOI 10.1071/ZO9920143; Speakman J.R., 2001, BODY COMPOSITION ANA; STIRLING I, 1969, ECOLOGY, V50, P573, DOI 10.2307/1936247; Struntz DJ, 2004, J MORPHOL, V259, P7, DOI 10.1002/jmor.10154; Tierney M, 2001, WILDLIFE RES, V28, P581, DOI 10.1071/WR00066; Waite JN, 2007, CAN J FISH AQUAT SCI, V64, P296, DOI 10.1139/F07-014; Webb PM, 1998, J EXP BIOL, V201, P2349; WORTHY GAJ, 1983, J MAMMAL, V64, P89, DOI 10.2307/1380753; WORTHY GAJ, 1992, J ZOOL, V227, P257, DOI 10.1111/j.1469-7998.1992.tb04821.x	61	20	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91233	10.1371/journal.pone.0091233	http://dx.doi.org/10.1371/journal.pone.0091233			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614685	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300100
J	Zimnicka, AM; Tang, HY; Guo, Q; Kuhr, FK; Oh, MJ; Wan, J; Chen, JW; Smith, KA; Fraidenburg, DR; Choudhury, MSR; Levitan, I; Machado, RF; Kaplan, JH; Yuan, JXJ				Zimnicka, Adriana M.; Tang, Haiyang; Guo, Qiang; Kuhr, Frank K.; Oh, Myung-Jin; Wan, Jun; Chen, Jiwang; Smith, Kimberly A.; Fraidenburg, Dustin R.; Choudhury, Moumita S. R.; Levitan, Irena; Machado, Roberto F.; Kaplan, Jack H.; Yuan, Jason X. -J.			Upregulated Copper Transporters in Hypoxia-Induced Pulmonary Hypertension	PLOS ONE			English	Article							LYSYL OXIDASE; ENDOTHELIAL DYSFUNCTION; OXIDATIVE STRESS; ATPASE ATP7A; HCTR1; MECHANISMS; STIFFNESS; OXYGEN; CHOLESTEROL; CHAPERONE	Pulmonary vascular remodeling and increased arterial wall stiffness are two major causes for the elevated pulmonary vascular resistance and pulmonary arterial pressure in patients and animals with pulmonary hypertension. Cellular copper (Cu) plays an important role in angiogenesis and extracellular matrix remodeling; increased Cu in vascular smooth muscle cells has been demonstrated to be associated with atherosclerosis and hypertension in animal experiments. In this study, we show that the Cu-uptake transporter 1, CTR1, and the Cu-efflux pump, ATP7A, were both upregulated in the lung tissues and pulmonary arteries of mice with hypoxia-induced pulmonary hypertension. Hypoxia also significantly increased expression and activity of lysyl oxidase (LOX), a Cu-dependent enzyme that causes crosslinks of collagen and elastin in the extracellular matrix. In vitro experiments show that exposure to hypoxia or treatment with cobalt (CoCl2) also increased protein expression of CTR1, ATP7A, and LOX in pulmonary arterial smooth muscle cells (PASMC). In PASMC exposed to hypoxia or treated with CoCl2, we also confirmed that the Cu transport is increased using Cu-64 uptake assays. Furthermore, hypoxia increased both cell migration and proliferation in a Cu-dependent manner. Downregulation of hypoxia-inducible factor 1 alpha (HIF-1 alpha) with siRNA significantly attenuated hypoxia-mediated upregulation of CTR1 mRNA. In summary, the data from this study indicate that increased Cu transportation due to upregulated CTR1 and ATP7A in pulmonary arteries and PASMC contributes to the development of hypoxia-induced pulmonary hypertension. The increased Cu uptake and elevated ATP7A also facilitate the increase in LOX activity and thus the increase in crosslink of extracellular matrix, and eventually leading to the increase in pulmonary arterial stiffness.	[Zimnicka, Adriana M.; Tang, Haiyang; Guo, Qiang; Kuhr, Frank K.; Oh, Myung-Jin; Wan, Jun; Chen, Jiwang; Smith, Kimberly A.; Fraidenburg, Dustin R.; Choudhury, Moumita S. R.; Levitan, Irena; Machado, Roberto F.; Yuan, Jason X. -J.] Univ Illinois, Dept Med, Sect Pulm Crit Care Sleep & Allergy Med, Chicago, IL 60612 USA; [Oh, Myung-Jin; Levitan, Irena; Yuan, Jason X. -J.] Univ Illinois, Dept Pharmacol, Chicago, IL USA; [Kaplan, Jack H.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL USA; [Yuan, Jason X. -J.] Univ Illinois, Ctr Cardiovasc Res, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Yuan, JXJ (corresponding author), Univ Illinois, Dept Med, Sect Pulm Crit Care Sleep & Allergy Med, Chicago, IL 60612 USA.	jxyuan@uic.edu	TANG, HAIYANG/J-4006-2013	Smith, Kimberly/0000-0002-2621-0052; Kaplan, Jack/0000-0002-7048-6574; Machado, Roberto/0000-0002-3722-5954	National Heart, Lung, and Blood Institute of the National Institutes of Health [HL114014, HL066012, HL098053, HL072742]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083298, T32HL072742, T32HL082547, R01HL066012, R01HL115014, R01HL073965, P01HL098053] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Heart, Lung, and Blood Institute of the National Institutes of Health [HL114014 (JXY), HL066012 (JXY), HL098053 (JXY), and HL072742 (AMZ)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcudia JF, 2008, FRONT BIOSCI-LANDMRK, V13, P2721, DOI 10.2741/2879; Ashino T, 2010, CIRC RES, V107, P787, DOI 10.1161/CIRCRESAHA.110.225334; Barnes N, 2009, TRAFFIC, V10, P767, DOI 10.1111/j.1600-0854.2009.00901.x; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Bogaard HJ, 2012, AM J RESP CELL MOL, V46, P582, DOI 10.1165/rcmb.2011-0296OC; Budhiraja R, 2004, CIRCULATION, V109, P159, DOI 10.1161/01.CIR.0000102381.57477.50; Byfield FJ, 2006, J LIPID RES, V47, P715, DOI 10.1194/jlr.M500439-JLR200; Byfield FJ, 2004, BIOPHYS J, V87, P3336, DOI 10.1529/biophysj.104.040634; Cross JB, 2003, APPL ENVIRON MICROB, V69, P2245, DOI 10.1128/AEM.69.4.2245-2252.2003; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Durand MJ, 2013, AM J HYPERTENS, V26, P739, DOI 10.1093/ajh/hpt015; Durmowicz A G, 1999, Pediatr Rev, V20, pe91; Eisses JF, 2000, BIOCHEMISTRY-US, V39, P7337, DOI 10.1021/bi000690j; Eisses JF, 2005, J BIOL CHEM, V280, P9635, DOI 10.1074/jbc.M500116200; Eisses JF, 2002, J BIOL CHEM, V277, P29162, DOI 10.1074/jbc.M203652200; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Feng WK, 2009, MOL PHARMACOL, V75, P174, DOI 10.1124/mol.108.051516; Firth AL, 2010, DIS MODEL MECH, V3, P268, DOI 10.1242/dmm.003616; Gabrielli LA, 2011, J CARD FAIL, V17, P1012, DOI 10.1016/j.cardfail.2011.08.008; Gaetke LM, 2003, TOXICOLOGY, V189, P147, DOI 10.1016/S0300-483X(03)00159-8; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; Kaplan JH, 2009, J BIOL CHEM, V284, P25461, DOI 10.1074/jbc.R109.031286; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Linz R, 2008, AM J PHYSIOL-RENAL, V294, pF53, DOI 10.1152/ajprenal.00314.2007; Malenfant S, 2013, PULM CIRC, V3, P278, DOI 10.4103/2045-8932.114752; Martin F, 2005, BLOOD, V105, P4613, DOI 10.1182/blood-2004-10-3980; Maryon EB, 2007, J BIOL CHEM, V282, P20376, DOI 10.1074/jbc.M701806200; Maryon EB, 2013, AM J PHYSIOL-CELL PH, V304, pC768, DOI 10.1152/ajpcell.00417.2012; Molloy SA, 2009, J BIOL CHEM, V284, P29704, DOI 10.1074/jbc.M109.000166; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Oh MJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3886; Pak O, 2007, EUR RESPIR J, V30, P364, DOI 10.1183/09031936.00128706; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rodriguez C, 2008, CARDIOVASC RES, V79, P7, DOI 10.1093/cvr/cvn102; Rucker RB, 1996, J NUTR, V126, P51, DOI 10.1093/jn/126.1.51; SATO M, 1990, J BIOMECH ENG-T ASME, V112, P263, DOI 10.1115/1.2891183; Schaefer M, 1999, AM J PHYSIOL-GASTR L, V276, pG311, DOI 10.1152/ajpgi.1999.276.2.G311; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Shentu TP, 2010, AM J PHYSIOL-CELL PH, V299, pC218, DOI 10.1152/ajpcell.00383.2009; Siddikuzzaman, 2011, Inflammopharmacology, V19, P117, DOI 10.1007/s10787-010-0073-1; Song M, 2008, J PHARMACOL EXP THER, V325, P409, DOI 10.1124/jpet.107.131227; Stamm Jason A, 2011, Pulm Circ, V1, P138, DOI 10.4103/2045-8932.83444; Sun M, 2007, J CELL SCI, V120, P2223, DOI 10.1242/jcs.001370; Tian Lian, 2012, Pulm Circ, V2, P505, DOI 10.4103/2045-8932.105040; Turski ML, 2009, J BIOL CHEM, V284, P717, DOI 10.1074/jbc.R800055200; van Suylen RJ, 1998, AM J RESP CRIT CARE, V157, P1423, DOI 10.1164/ajrccm.157.5.9709050; Wang Zhijie, 2011, Pulm Circ, V1, P212, DOI 10.4103/2045-8932.83453; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201; White C, 2009, J CELL SCI, V122, P1315, DOI 10.1242/jcs.043216; Xie LW, 2011, AM J PHYSIOL-CELL PH, V300, pC1298, DOI 10.1152/ajpcell.00023.2011; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Zhou B, 1997, P NATL ACAD SCI USA, V94, P7481, DOI 10.1073/pnas.94.14.7481	54	33	33	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90544	10.1371/journal.pone.0090544	http://dx.doi.org/10.1371/journal.pone.0090544			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614111	Green Published, gold, Green Submitted			2022-12-25	WOS:000332839300028
J	Proverbio, AM; Calbi, M; Manfredi, M; Zani, A				Proverbio, Alice Mado; Calbi, Marta; Manfredi, Mirella; Zani, Alberto			Comprehending Body Language and Mimics: An ERP and Neuroimaging Study on Italian Actors and Viewers	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; SEMANTIC INTEGRATION; N400 ERPS; BRAIN; MIRROR; FACE; REPRESENTATION; SELECTIVITY; PERCEPTION; MECHANISMS	In this study, the neural mechanism subserving the ability to understand people's emotional and mental states by observing their body language (facial expression, body posture and mimics) was investigated in healthy volunteers. ERPs were recorded in 30 Italian University students while they evaluated 280 pictures of highly ecological displays of emotional body language that were acted out by 8 male and female Italian actors. Pictures were briefly flashed and preceded by short verbal descriptions (e.g., "What a bore!") that were incongruent half of the time (e. g., a picture of a very attentive and concentrated person shown after the previous example verbal description). ERP data and source reconstruction indicated that the first recognition of incongruent body language occurred 300 ms post-stimulus. swLORETA performed on the N400 identified the strongest generators of this effect in the right rectal gyrus (BA11) of the ventromedial orbitofrontal cortex, the bilateral uncus (limbic system) and the cingulate cortex, the cortical areas devoted to face and body processing (STS, FFA EBA) and the premotor cortex (BA6), which is involved in action understanding. These results indicate that face and body mimics undergo a prioritized processing that is mostly represented in the affective brain and is rapidly compared with verbal information. This process is likely able to regulate social interactions by providing on-line information about the sincerity and trustfulness of others.	[Proverbio, Alice Mado; Calbi, Marta; Manfredi, Mirella] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Calbi, Marta] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Manfredi, Mirella] Univ Calif San Diego, Dept Cognit Sci, San Diego, CA 92103 USA; [Zani, Alberto] CNR, Inst Mol Bioimaging & Physiol IBFM, I-20133 Milan, Italy	University of Milano-Bicocca; University of Parma; University of California System; University of California San Diego; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR)	Proverbio, AM (corresponding author), Univ Milano Bicocca, Dept Psychol, Milan, Italy.	mado.proverbio@unimib.it	Zani, Alberto/ABI-3498-2020; Zani, Alberto/ABG-8894-2020	Zani, Alberto/0000-0002-3906-7988; manfredi, mirella/0000-0002-6549-1993; Calbi, Marta/0000-0001-7555-0611; Proverbio, Alice Mado/0000-0002-5138-1523	University of Milano-Bicocca	University of Milano-Bicocca	The authors gratefully acknowledge financial support from University of Milano-Bicocca (2011FAR funds). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Amoruso L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00057; Amoruso L, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00124; Bach P, 2009, SOC NEUROSCI-UK, V4, P212, DOI 10.1080/17470910802362546; Bekkering H, 2009, TOP COGN SCI, V1, P340, DOI 10.1111/j.1756-8765.2009.01023.x; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Chen J, 2011, LEARN MEMORY, V18, P523, DOI 10.1101/lm.2135211; de Gelder B, 2006, NAT REV NEUROSCI, V7, P242, DOI 10.1038/nrn1872; de Gelder B, 2004, P NATL ACAD SCI USA, V101, P16701, DOI 10.1073/pnas.0407042101; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Duran ND, 2013, FRONT PSYCHOL, V27, P4; Ekman P., 2003, ISHK, VReprint edition; Friedrich M, 2004, J COGNITIVE NEUROSCI, V16, P1465, DOI 10.1162/0898929042304705; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Grezes J, 2007, NEUROIMAGE, V35, P959, DOI 10.1016/j.neuroimage.2006.11.030; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Gu Y, 2013, PLOS ONE, V8; Gunter TC, 2004, NEUROSCI LETT, V372, P52, DOI 10.1016/j.neulet.2004.09.011; Hadjikhani N, 2003, CURR BIOL, V13, P2201, DOI 10.1016/j.cub.2003.11.049; Hagoort P, 2004, SCIENCE, V304, P438, DOI 10.1126/science.1095455; Hamm JP, 2002, CLIN NEUROPHYSIOL, V113, P1339, DOI 10.1016/S1388-2457(02)00161-X; Hutchison WD, 1999, NAT NEUROSCI, V2, P403, DOI 10.1038/8065; Iacoboni M, 2001, P NATL ACAD SCI USA, V98, P13995, DOI 10.1073/pnas.241474598; Kana RK, 2012, SOC COGN AFFECT NEUR, V7, P446, DOI 10.1093/scan/nsr022; Kaplan Jonas T, 2007, Cogn Process, V8, P103, DOI 10.1007/s10339-007-0165-z; Kounios J, 2002, TRENDS COGN SCI, V6, P272, DOI 10.1016/S1364-6613(02)01929-0; Kravitz DJ, 2011, J NEUROSCI, V31, P7322, DOI 10.1523/JNEUROSCI.4588-10.2011; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lim VK, 2009, BRAIN COGNITION, V71, P306, DOI 10.1016/j.bandc.2009.07.004; Liu BL, 2011, NEUROSCI LETT, V498, P84, DOI 10.1016/j.neulet.2011.04.068; Molnar-Szakacs I, 2006, NEUROIMAGE, V33, P923, DOI 10.1016/j.neuroimage.2006.07.035; Morrison I, 2004, COGN AFFECT BEHAV NE, V4, P270, DOI 10.3758/CABN.4.2.270; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; NEVILLE HJ, 1992, CEREB CORTEX, V2, P244, DOI 10.1093/cercor/2.3.244; Palmero-Soler E, 2007, PHYS MED BIOL, V52, P1783, DOI 10.1088/0031-9155/52/7/002; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Peelen MV, 2007, SOC COGN AFFECT NEUR, V2, P274, DOI 10.1093/scan/nsm023; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; Pineda JA, 2009, BIOL PSYCHOL, V80, P306, DOI 10.1016/j.biopsycho.2008.11.003; Proverbio AM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00883; Proverbio AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022026; Proverbio AM, 2010, NEUROPSYCHOLOGIA, V48, P1454, DOI 10.1016/j.neuropsychologia.2010.01.015; Proverbio AM, 2009, NEUROSCI LETT, V459, P142, DOI 10.1016/j.neulet.2009.05.012; Sartori L, 2011, COGNITION, V119, P242, DOI 10.1016/j.cognition.2011.01.014; Schulte-Ruther M, 2008, NEUROIMAGE, V42, P393, DOI 10.1016/j.neuroimage.2008.04.180; Schwarzlose RF, 2005, J NEUROSCI, V25, P11055, DOI 10.1523/JNEUROSCI.2621-05.2005; Shibata H, 2009, NEUROSCI LETT, V452, P189, DOI 10.1016/j.neulet.2009.01.042; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Sinke CBA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038118; Stanislavski C., 1936, ACTOR PREPARES; Urgesi C, 2004, CURR BIOL, V14, P2130, DOI 10.1016/j.cub.2004.11.031; van de Riet WAC, 2009, SOC NEUROSCI-UK, V4, P101, DOI 10.1080/17470910701865367; van Elk M, 2008, J PHYSIOLOGY-PARIS, V102, P95, DOI 10.1016/j.jphysparis.2008.03.011; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Walker MB, 1989, J LANG SOC PSYCHOL, V8; West WC, 2002, COGNITIVE BRAIN RES, V13, P363, DOI 10.1016/S0926-6410(01)00129-X; Wlotko EW, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00181	58	22	22	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91294	10.1371/journal.pone.0091294	http://dx.doi.org/10.1371/journal.pone.0091294			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608244	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000332485800125
J	Zhang, L; Wang, Y; Xiao, Y; Wang, Y; Dong, JK; Gao, K; Gao, Y; Wang, X; Zhang, W; Xu, YJ; Yan, JQ; Yu, JY				Zhang, Liang; Wang, Yue; Xiao, Yi; Wang, Yu; Dong, JinKai; Gao, Kun; Gao, Yan; Wang, Xi; Zhang, Wei; Xu, YuanJi; Yan, JinQi; Yu, JiYun			Enhancement of Antitumor Immunity Using a DNA-Based Replicon Vaccine Derived from Semliki Forest Virus	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; DENDRITIC CELLS; GENE-THERAPY; TUMOR-CELLS; PLASMID DNA; IN-VITRO; ANTIGEN; CANCER; VECTOR; RESPONSES	A DNA-based replicon vaccine derived from Semliki Forest virus, PSVK-shFcG-GM/B7.1 (Fig. 1a) was designed for tumor immunotherapy as previously constructed. The expression of the fusion tumor antigen (survivin and hCG beta-CTP37) and adjuvant molecular protein (Granulocyte-Macrophage Colony-Stimulating Factor/ GM-CSF/B7.1) genes was confirmed by Immunofluorescence assay in vitro, and immunohistochemistry assay in vivo. In this paper, the immunological effect of this vaccine was determined using immunological assays as well as animal models. The results showed that this DNA vaccine induced both humoral and cellular immune responses in C57BL/ 6 mice after immunization, as evaluated by the ratio of CD4(+)/CD8(+) cells and the release of IFN-gamma. Furthermore, the vaccination of C57BL/ 6 mice with PSVK-shFcG-GM/B7.1 significantly delayed the in vivo growth of tumors in animal models (survivin(+) and hCG beta(+) murine melanoma, B16) when compared to vaccination with the empty vector or the other control constructs (Fig. 1b). These data indicate that this type of replicative DNA vaccine could be developed as a promising approach for tumor immunotherapy. Meanwhile, these results provide a basis for further study in vaccine pharmacodynamics and pharmacology, and lay a solid foundation for clinical application.	[Zhang, Liang; Wang, Yue; Xiao, Yi; Wang, Yu; Dong, JinKai; Gao, Kun; Gao, Yan; Wang, Xi; Zhang, Wei; Xu, YuanJi; Yan, JinQi; Yu, JiYun] Beijing Inst Basic Med Sci, Beijing, Peoples R China; [Wang, Yue] China CDC, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Xiao, Yi] Gen Hosp PLA, Affiliated Hosp 1, Dept Urol, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese People's Liberation Army General Hospital	Yu, JY (corresponding author), Beijing Inst Basic Med Sci, Beijing, Peoples R China.	yujyun@126.com			863 High-Tech Projects of the Chinese Government [2007AA02Z451]; National Natural Science Foundation of China [30772002]	863 High-Tech Projects of the Chinese Government; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the 863 High-Tech Projects of the Chinese Government (No. 2007AA02Z451) and the National Natural Science Foundation of China (No. 30772002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RJ, 2007, VACCINE, V25, pB24, DOI 10.1016/j.vaccine.2007.05.030; Asselin-Paturel C, 1999, GENE THER, V6, P606, DOI 10.1038/sj.gt.3300841; Bergman PJ, 2007, VET CLIN N AM-SMALL, V37, P1111, DOI 10.1016/j.cvsm.2007.06.005; Bernstein DI, 2009, VACCINE, V28, P484, DOI 10.1016/j.vaccine.2009.09.135; Boussiotis VA, 1996, IMMUNOL REV, V153, P5, DOI 10.1111/j.1600-065X.1996.tb00918.x; Cirone P, 2006, CURR GENE THER, V6, P181, DOI 10.2174/156652306776359513; Cyster JG, 1999, J EXP MED, V189, P447, DOI 10.1084/jem.189.3.447; DAVIS NL, 1989, VIROLOGY, V171, P189, DOI 10.1016/0042-6822(89)90526-6; Durso RJ, 2007, CLIN CANCER RES, V13, P3999, DOI 10.1158/1078-0432.CCR-06-2202; Everson RG, 2008, EXPERT REV ANTICANC, V8, P717, DOI 10.1586/14737140.8.5.717; Ferrone CR, 2006, CLIN CANCER RES, V12, P5511, DOI 10.1158/1078-0432.CCR-06-0979; FYNAN EF, 1993, P NATL ACAD SCI USA, V90, P11478, DOI 10.1073/pnas.90.24.11478; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Gabrilovich DI, 1997, CLIN CANCER RES, V3, P483; HAEFFNERCAVAILLON N, 1979, J IMMUNOL, V123, P1905; He LZ, 2004, CLIN CANCER RES, V10, P1920, DOI 10.1158/1078-0432.CCR-03-0264; He Y, 2006, VACCINE, V24, P2575, DOI 10.1016/j.vaccine.2005.12.030; Herold KC, 1997, J IMMUNOL, V159, P4150; Hirohashi Y, 2002, CLIN CANCER RES, V8, P1731; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; Ikezawa H, 2002, BIOL PHARM BULL, V25, P409, DOI 10.1248/bpb.25.409; Jefferis R, 1998, IMMUNOL REV, V163, P59, DOI 10.1111/j.1600-065X.1998.tb01188.x; Kass E, 2000, CYTOKINE, V12, P960, DOI 10.1006/cyto.2000.0684; Leslie MC, 2007, GENE THER, V14, P316, DOI 10.1038/sj.gt.3302864; LILJESTROM P, 1991, BIO-TECHNOL, V9, P1356, DOI 10.1038/nbt1291-1356; Loisel-Meyer S, 2008, FRONT BIOSCI, V13, P3202; Lundstrom Kenneth, 2003, Methods Mol Med, V76, P503; Lundstrom Kenneth, 2003, Expert Rev Vaccines, V2, P447; Lundstrom K, 2009, VIRUSES-BASEL, V1, P13, DOI 10.3390/v1010013; Lyons JA, 2007, GENE THER, V14, P503, DOI 10.1038/sj.gt.3302889; Moran TP, 2007, VACCINE, V25, P6604, DOI 10.1016/j.vaccine.2007.06.058; Moulton HM, 2002, CLIN CANCER RES, V8, P2044; Nakazaki Y, 1998, GENE THER, V5, P1355, DOI 10.1038/sj.gt.3300726; Otto K, 2005, VACCINE, V23, P884, DOI 10.1016/j.vaccine.2004.08.007; Polo J M, 2000, Dev Biol (Basel), V104, P181; Qin ZH, 1997, J IMMUNOL, V159, P770; Reap EA, 2007, VACCINE, V25, P7441, DOI 10.1016/j.vaccine.2007.08.016; Reap EA, 2007, CLIN VACCINE IMMUNOL, V14, P748, DOI 10.1128/CVI.00037-07; Rice J, 2008, NAT REV CANCER, V8, P108, DOI 10.1038/nrc2326; Riezebos-Brilman A, 2009, VACCINE, V27, P701, DOI 10.1016/j.vaccine.2008.11.032; Sangiorgio Vanessa, 2004, Ital J Biochem, V53, P98; Schmitz M, 2000, CANCER RES, V60, P4845; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Sun XL, 2002, VACCINE, V20, P1466, DOI 10.1016/S0264-410X(01)00476-5; Terrazzini N, 2004, VACCINE, V22, P2146, DOI 10.1016/j.vaccine.2003.12.002; Xiang R, 2005, CANCER RES, V65, P553; XIONG C, 1989, SCIENCE, V243, P1188, DOI 10.1126/science.2922607; Yu JS, 1997, HUM GENE THER, V8, P1065, DOI 10.1089/hum.1997.8.9-1065; Zaffaroni N, 2005, J CELL MOL MED, V9, P360, DOI 10.1111/j.1582-4934.2005.tb00361.x; Zhang Liang, 2011, Nan Fang Yi Ke Da Xue Xue Bao, V31, P937	50	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90551	10.1371/journal.pone.0090551	http://dx.doi.org/10.1371/journal.pone.0090551			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608380	Green Published, gold, Green Submitted			2022-12-25	WOS:000332485800032
J	Cerchio, S; Strindberg, S; Collins, T; Bennett, C; Rosenbaum, H				Cerchio, Salvatore; Strindberg, Samantha; Collins, Tim; Bennett, Chanda; Rosenbaum, Howard			Seismic Surveys Negatively Affect Humpback Whale Singing Activity off Northern Angola	PLOS ONE			English	Article							MEGAPTERA-NOVAEANGLIAE; BALAENA-MYSTICETUS; SAKHALIN ISLAND; BOWHEAD WHALES; SONGS; HAWAIIAN; WATERS; EXPLORATION; RESPONSES; TRENDS	Passive acoustic monitoring was used to document the presence of singing humpback whales off the coast of Northern Angola, and opportunistically test for the effect of seismic survey activity in the vicinity on the number of singing whales. Two Marine Autonomous Recording Units (MARUs) were deployed between March and December 2008 in the offshore environment. Song was first heard in mid June and continued through the remaining duration of the study. Seismic survey activity was heard regularly during two separate periods, consistently throughout July and intermittently in mid-October/ November. Numbers of singers were counted during the first ten minutes of every hour for the period from 24 May to 1 December, and Generalized Additive Mixed Models (GAMMs) were used to assess the effect of survey day (seasonality), hour (diel variation), moon phase and received levels of seismic survey pulses (measured from a single pulse during each ten-minute sampled period) on singer number. Application of GAMMs indicated significant seasonal variation, which was the most pronounced effect when assessing the full dataset across the entire season (p<0.001); however seasonality almost entirely dropped out of top-ranked models when applied to a reduced dataset during the July period of seismic survey activity. Diel variation was significant in both the full and reduced datasets (from p<0.01 to p<0.05) and often included in the top-ranked models. The number of singers significantly decreased with increasing received level of seismic survey pulses (from p<0.01 to p<0.05); this explanatory variable was included among the top ranked models for one MARU in the full dataset and both MARUs in the reduced dataset. This suggests that the breeding display of humpback whales is disrupted by seismic survey activity, and thus merits further attention and study, and potentially conservation action in the case of sensitive breeding populations.	[Cerchio, Salvatore; Strindberg, Samantha; Collins, Tim; Bennett, Chanda; Rosenbaum, Howard] Wildlife Conservat Soc, Global Conservat Program, Bronx, NY USA; [Cerchio, Salvatore; Bennett, Chanda; Rosenbaum, Howard] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Bennett, Chanda] New York Aquarium, Brooklyn, NY USA	Wildlife Conservation Society; American Museum of Natural History (AMNH)	Cerchio, S (corresponding author), Wildlife Conservat Soc, Global Conservat Program, Bronx, NY USA.	scerchio@wcs.org		Collins, Tim/0000-0002-7124-4876; Cerchio, Salvatore/0000-0001-5880-5969	Angola Liquefied Natural Gas (ALNG)	Angola Liquefied Natural Gas (ALNG)	Funding for the cost and deployment of equipment used by WCS was provided by Angola Liquefied Natural Gas (ALNG). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The interpretation of results does not reflect the views of ALNG.	Andrew RK, 2011, J ACOUST SOC AM, V129, P642, DOI 10.1121/1.3518770; [Anonymous], 2010, R LANG ENV STAT COMP; Au WWL, 2006, J ACOUST SOC AM, V120, P1103, DOI 10.1121/1.2211547; Au WWL, 2000, MAR MAMMAL SCI, V16, P530, DOI 10.1111/j.1748-7692.2000.tb00949.x; Barkaszi M. J., 2012, SEISMIC SURVEY MITIG; Blackwell SB, 2013, MAR MAMMAL SCI, V29, pE342, DOI 10.1111/mms.12001; BUREAU OF OCEAN ENERGY MANAGEMENT (BOEM), 2012, IMPL SEISM SUR MIT M; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Castellote M, 2012, BIOL CONSERV, V147, P115, DOI 10.1016/j.biocon.2011.12.021; Cerchio S, 2005, ANIM BEHAV, V70, P267, DOI 10.1016/j.anbehav.2004.10.028; Cerchio S, 2001, ANIM BEHAV, V62, P313, DOI 10.1006/anbe.2001.1747; Cerchio S, 2010, SC62SH12 INT WHAL CO; Cerchio S, 2003, THESIS U MICHIGAN AN; Charif R, 2010, RAVEN PRO 1 4 USERS, P367; Cholewiak DM, 2013, MAR MAMMAL SCI, V29, pE312, DOI 10.1111/mms.12005; Cholewiak DM, 2008, THESIS CORNELL U; CLAPHAM PJ, 1990, MAR MAMMAL SCI, V6, P155, DOI 10.1111/j.1748-7692.1990.tb00238.x; Clark CW, 2009, MAR ECOL PROG SER, V395, P201, DOI 10.3354/meps08402; Clark CW, 2004, P ROY SOC B-BIOL SCI, V271, P1051, DOI 10.1098/rspb.2004.2699; Di Iorio L, 2010, BIOL LETTERS, V6, P51, DOI 10.1098/rsbl.2009.0651; Findlay KP., 2000, MEM QUEENSL MUSEUM, V47, P411; Gailey G, 2007, ENVIRON MONIT ASSESS, V134, P75, DOI 10.1007/s10661-007-9812-1; GAMBELL R, 1976, Mammal Review, V6, P41, DOI 10.1111/j.1365-2907.1976.tb00200.x; Gordon J, 2003, MAR TECHNOL SOC J, V37, P16, DOI 10.4031/002533203787536998; Guinee LN., 1983, COMMUNICATION BEHAV; Hildebrand JA, 2009, MAR ECOL PROG SER, V395, P5, DOI 10.3354/meps08353; International Association of Oil and Gas Producers, 2008, 206 INT ASS OIL GAS; IUCN, 2012, WORLD CONS C JEJ KOR; Johnson SR, 2007, ENVIRON MONIT ASSESS, V134, P1, DOI 10.1007/s10661-007-9813-0; LJUNGBLAD DK, 1988, ARCTIC, V41, P183; Madsen PT, 2005, J ACOUST SOC AM, V117, P3952, DOI 10.1121/1.1921508; Matthews L. H., 1937, Discovery Reports Cambridge, V17, P7; MATTILA DK, 1987, J MAMMAL, V68, P880, DOI 10.2307/1381574; McCauley R.D., 2000, APPEA J, V40, P692, DOI DOI 10.1071/AJ99048; McCauley RD, 1998, APPEA J, V38, P692; MCDONALD MA, 1995, J ACOUST SOC AM, V98, P712, DOI 10.1121/1.413565; MCSWEENEY DJ, 1989, MAR MAMMAL SCI, V5, P139, DOI 10.1111/j.1748-7692.1989.tb00328.x; Melcon ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032681; Miller PJO, 2000, NATURE, V405, P903, DOI 10.1038/35016148; Payne K., 1983, COMMUNICATION BEHAV, P9; PAYNE R, 1971, ANN NY ACAD SCI, V188, P110, DOI 10.1111/j.1749-6632.1971.tb13093.x; PAYNE RS, 1971, SCIENCE, V173, P585, DOI 10.1126/science.173.3997.585; Pinheiro J, 2001, MIXED EFFECTS MODELS; Richardson W.J., 1999, J ACOUST SOC AM, V106, P2281, DOI [10.1121/1.427801, DOI 10.1121/1.427801]; RICHARDSON WJ, 1986, J ACOUST SOC AM, V79, P1117, DOI 10.1121/1.393384; Richardson WJ, 1995, MARINE MAMMALS NOISE, V1st; Risch D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029741; Rosenbaum Howard, 2006, Bulletin of the Biological Society of Washington, V12, P425; Smith JN, 2008, ANIM BEHAV, V76, P467, DOI 10.1016/j.anbehav.2008.02.013; Sousa-lima RS, 2008, CANADIAN ACOUSTICS, V36, P175; Southall B. L., 2008, AQUAT MAMM, V17, P273, DOI [DOI 10.1578/AM.33.4.2007.411, 10.1578/AM, DOI 10.1578/AM]; TYACK P, 1981, BEHAV ECOL SOCIOBIOL, V8, P105, DOI 10.1007/BF00300822; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Weir CR, 2011, AFR J MAR SCI, V33, P1, DOI 10.2989/1814232X.2011.572333; Weir CR, 2013, MAMMAL REV, V43, P258, DOI 10.1111/j.1365-2907.2012.00222.x; Weir CR, 2010, MAMMAL REV, V40, P2, DOI 10.1111/j.1365-2907.2009.00153.x; Weir Caroline R., 2008, Aquatic Mammals, V34, P71, DOI 10.1578/AM.34.1.2008.71; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zuur Alain F., 2009, P1	59	54	55	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e86464	10.1371/journal.pone.0086464	http://dx.doi.org/10.1371/journal.pone.0086464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618836	Green Submitted, gold, Green Published			2022-12-25	WOS:000332842400001
J	Guo, MJ; Cai, CK; Zhao, GY; Qiu, XC; Zhao, HE; Ma, Q; Tian, LY; Li, XL; Hu, YS; Liao, B; Ma, BA; Fan, QY				Guo, Mingjun; Cai, Chengkui; Zhao, Guangyi; Qiu, Xiuchun; Zhao, Haien; Ma, Qiong; Tian, Liying; Li, Xuelian; Hu, Yunsheng; Liao, Bo; Ma, Baoan; Fan, Qingyu			Hypoxia Promotes Migration and Induces CXCR4 Expression via HIF-1 alpha Activation in Human Osteosarcoma	PLOS ONE			English	Article							INDUCIBLE FACTOR 1-ALPHA; CHEMOKINE RECEPTOR CXCR4; BREAST-CANCER; EWINGS-SARCOMA; CELL INVASION; IN-VIVO; METASTASIS; FACTOR-1; HIF-1; OVEREXPRESSION	Background: Cellular adaptation to a hypoxic microenvironment is essential for tumor progression and is largely mediated by HIF-1 alpha through coordinated regulation of hypoxia-responsive genes. The chemokine SDF-1 alpha and its unique receptor CXCR4 have been implicated in organ-specific metastases of many cancers. In this study, we investigated the response of osteosarcoma cells to hypoxia and the expression of CXCR4 and HIF-1 alpha in human osteosarcoma specimens and explored the roles of CXCR4 and HIF-1 alpha in the cell migration process. Methodology/Principal Findings: We performed immunohistochemistry, immunocytochemistry, quantitative real-time PCR, Western blots and fluorescent reporter assays to evaluate the correlation between CXCR4 and HIF-1 alpha expression in human osteosarcoma specimens or SOSP-9607 cells under normoxic and hypoxic conditions. Transwell assays were used to assess cell migration under different conditions. Exposure of SOSP-9607 cells to hypoxic conditions resulted in significantly increased migration. When SOSP-9607 cells were subjected to hypoxic conditions, the mRNA and protein levels of CXCR4 were significantly increased in a time-dependent manner. Moreover, siHIF-1 alpha significantly decreased the mRNA and protein levels of CXCR4 under hypoxia, whereas pcDNA-HIF-1 alpha significantly increased the mRNA and protein levels of CXCR4 under normoxia. A luciferase reporter gene study showed that siHIF-1 alpha reduced pGL3-CXCR4 luciferase activity. Furthermore, coexpression of HIF-1 alpha and CXCR4 was significantly higher in patients with distant metastasis compared with those without metastasis. Conclusions/Significance: The hypoxia-HIF-1 alpha-CXCR4 pathway plays a crucial role during the migration of human osteosarcoma cells, and targeting this pathway might represent a novel therapeutic strategy for patients suffering from osteosarcoma.	[Guo, Mingjun; Cai, Chengkui; Qiu, Xiuchun; Zhao, Haien; Ma, Qiong; Hu, Yunsheng; Liao, Bo; Ma, Baoan; Fan, Qingyu] Fourth Mil Med Univ, Tangdu Hosp, Dept Orthopaed, Xian 710032, Shaanxi, Peoples R China; [Zhao, Guangyi] Bethune Int Peace Hosp, Dept Orthopaed, Shijiazhuang, Hebei, Peoples R China; [Tian, Liying] Fourth Mil Med Univ, Tangdu Hosp, Dept Anesthesiol, Xian 710032, Shaanxi, Peoples R China; [Li, Xuelian] Xian Hosp TCM, Dept Surg, Xian, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Ma, BA (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Orthopaed, Xian 710032, Shaanxi, Peoples R China.	gukemba@fmmu.edu.cn; bonetm@fmmu.edu.cn			National Natural Science Foundation of China [81072194]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (NO. 81072194). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando Kosei, 2012, Sarcoma, V2012, P523432, DOI 10.1155/2012/523432; Arvidsson Y, 2010, ENDOCR-RELAT CANCER, V17, P303, DOI 10.1677/ERC-09-0085; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chen CW, 2009, IEEE T CIRC SYST VID, V19, P1, DOI 10.1109/TCSVT.2009.2012413; Chen XA, 2011, CANCER BIOL THER, V11, P287, DOI 10.4161/cbt.11.2.13966; Chen X, 2009, CYTOTECHNOLOGY, V61, P37, DOI 10.1007/s10616-009-9239-3; Cronin PA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-225; Damron TA, 2007, CLIN ORTHOP RELAT R, P40, DOI 10.1097/BLO.0b013e318059b8c9; Munoz-Guerra MF, 2009, ANN SURG ONCOL, V16, P2351, DOI 10.1245/s10434-009-0503-8; Gallagher R, 2012, ANN DIAGN PATHOL, V16, P323, DOI 10.1016/j.anndiagpath.2012.01.001; Gruber G, 2004, BREAST CANCER RES, V6, pR191, DOI 10.1186/bcr775; Hartmann TN, 2005, ONCOGENE, V24, P4462, DOI 10.1038/sj.onc.1208621; Huang CY, 2009, J CELL PHYSIOL, V221, P204, DOI 10.1002/jcp.21846; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ishikawa T, 2009, ONCOL REP, V21, P707, DOI 10.3892/or_00000275; Isobe T, 2013, INT J CLIN ONCOL, V18, P293, DOI 10.1007/s10147-012-0378-8; Jubb A, 2005, J CLIN PATHOL, V58, P1344; Knowles HJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-372; Krishnamachary B, 2003, CANCER RES, V63, P1138; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Lu X, 2010, CANCER RES, V70, P3905, DOI 10.1158/0008-5472.CAN-09-3739; Mirabello L, 2009, CANCER-AM CANCER SOC, V115, P1531, DOI 10.1002/cncr.24121; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Rivard A, 2000, J BIOL CHEM, V275, P29643, DOI 10.1074/jbc.M001029200; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Sowter HM, 2003, CANCER RES, V63, P6130; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; Wang Xubu, 2008, BIOCH BIOPHYSICAL RE, V371, P283; Yang QC, 2007, JPN J CLIN ONCOL, V37, P127, DOI 10.1093/jjco/hyl137; Yasui H, 2008, BRIT J CANCER, V99, P1442, DOI 10.1038/sj.bjc.6604720; Zagzag D, 2006, LAB INVEST, V86, P1221, DOI 10.1038/labinvest.3700482; Zhong H, 1999, CANCER RES, V59, P5830	36	68	69	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90518	10.1371/journal.pone.0090518	http://dx.doi.org/10.1371/journal.pone.0090518			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618817	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400021
J	Mayr, U; LaRoux, C; Rolheiser, T; Osternig, L; Chou, LS; van Donkelaar, P				Mayr, Ulrich; LaRoux, Charlene; Rolheiser, Tyler; Osternig, Louis; Chou, Li-Shan; van Donkelaar, Paul			Executive Dysfunction Assessed with a Task-Switching Task following Concussion	PLOS ONE			English	Article							INJURY SURVEILLANCE SYSTEM; DESCRIPTIVE EPIDEMIOLOGY; ATTENTION; DEFICITS	Concussion frequently results in executive function deficits that can be specifically probed using task-switching tasks. The current study examined in detail the influence of concussion on task switching performance using both spatial and numerical stimuli. Individuals with concussion (n = 16) were tested within 48 hours of injury and 7, 14, and 28 days later. Healthy sex-, age-, height-, weight- and activity-matched controls (n = 16) were also tested at the same intervals. Switch costs were significantly greater in the participants with concussion than in the controls for both types of stimuli. By contrast, the global costs on non-switching trials were unaffected by concussion. We conclude that concussion has pronounced negative effects on the ability to switch task sets that generalize across task combinations (spatial or numerical) and that persist across at least a month after injury.	[Mayr, Ulrich] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; [LaRoux, Charlene; Rolheiser, Tyler; Osternig, Louis; Chou, Li-Shan] Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA; [van Donkelaar, Paul] Univ British Columbia Okanagan, Sch Hlth & Exercise Sci, Kelowna, BC, Canada	University of Oregon; University of Oregon; University of British Columbia; University of British Columbia Okanagan	van Donkelaar, P (corresponding author), Univ British Columbia Okanagan, Sch Hlth & Exercise Sci, Kelowna, BC, Canada.	paul.vandonkelaar@ubc.ca			VA [A4842C8, A4843C]; University of Oregon; Peace Health Oregon Region; DoD-TATRC [W81XWH-11-1-0717]	VA(US Department of Veterans Affairs); University of Oregon; Peace Health Oregon Region; DoD-TATRC(United States Department of Defense)	This work was supported by VA (A4842C8, A4843C), University of Oregon, Peace Health Oregon Region, DoD-TATRC (W81XWH-11-1-0717). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agel J, 2007, J ATHL TRAINING, V42, P249; Arrington CM, 2005, J EXP PSYCHOL LEARN, V31, P683, DOI 10.1037/0278-7393.31.4.683; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Cantu R., 2009, J ATHL TRAINING, V44, P434, DOI [DOI 10.4085/1062-6050-44.4.434, 10.4085/1062-6050-44.4.434]; DeHaan A, 2007, NEUROPSYCHOLOGIA, V45, P406, DOI 10.1016/j.neuropsychologia.2006.06.008; Dick R, 2007, J ATHL TRAINING, V42, P221; Drew AS, 2007, NEUROSCI LETT, V417, P61, DOI 10.1016/j.neulet.2007.02.038; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Mayr U, 2006, PSYCHOL SCI, V17, P774, DOI 10.1111/j.1467-9280.2006.01781.x; McIntire A, 2006, EXP BRAIN RES, V174, P361, DOI 10.1007/s00221-006-0469-8; Rushworth MFS, 2002, J NEUROPHYSIOL, V87, P2577, DOI 10.1152/jn.2002.87.5.2577; Rushworth MFS, 2005, EXP PSYCHOL, V52, P83, DOI 10.1027/1618-3169.52.2.83; Rushworth MFS, 2003, J COGNITIVE NEUROSCI, V15, P338, DOI 10.1162/089892903321593072; Schmitter-Edgecombe M, 2006, NEUROPSYCHOLOGY, V20, P675, DOI 10.1037/0894-4105.20.6.675; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363	17	26	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91379	10.1371/journal.pone.0091379	http://dx.doi.org/10.1371/journal.pone.0091379			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9GM	24618717	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400082
J	Galiwango, RM; Lubyayi, L; Musoke, R; Kalibbala, S; Buwembo, M; Kasule, J; Serwadda, D; Gray, RH; Reynolds, SJ; Chang, LW				Galiwango, Ronald M.; Lubyayi, Lawrence; Musoke, Richard; Kalibbala, Sarah; Buwembo, Martin; Kasule, Jjingo; Serwadda, David; Gray, Ronald H.; Reynolds, Steven J.; Chang, Larry W.			Field Evaluation of PIMA Point-of-Care CD4 Testing in Rakai, Uganda	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; ANALYZER; SERVICE; MORTALITY; COUNTS	Objective: To assess the accuracy of PIMA Point-of-Care (POC) CD4 testing in rural Rakai, Uganda. Methods: 903 HIV positive persons attending field clinics provided a venous blood sample assessed on site using PIMA analyzers per manufacturer's specifications. The venous samples were then run on FACSCalibur flow cytometry at a central facility. The Bland-Altman method was used to estimate mean bias and 95% limits of agreement (LOA). Sensitivity, specificity, negative predictive value (NPV), and positive predictive value (PPV) were calculated for a CD4 threshold of <350 and <500 cells/uL for antiretroviral eligibility. Results: There was a high correlation between PIMA and FACSCalibur CD4 counts (r = 0.943, p<0.001). Relative to FACSCalibur, the PIMA POC CD4 had negative mean bias of -34.6 cells/uL (95% LOA: -219.8 to 150.6) overall. The dispersion at CD4<350 cells/uL was 5.1 cells/uL (95% LOA: -126.6 to 136.8). For a threshold of CD4<350 cells/uL, PIMA venous blood had a sensitivity of 88.6% (95% CI 84.8-92.4%), specificity of 87.5% (95% CI 84.9-90.1%), NPV of 94.9% (95% CI 93.1-96.7%), and PPV of 74.4% (95% CI 69.6-79.2%). PIMA sensitivity and PPV significantly increased to 96.1% and 88.3% respectively with increased threshold of 500 cells/uL. Conclusions: Overall, PIMA POC CD4 counts demonstrated negative bias compared to FACSCalibur. PIMA POC sensitivity improved significantly at a higher CD4 threshold of 500 than a 350 cells/uL threshold.	[Galiwango, Ronald M.; Lubyayi, Lawrence; Musoke, Richard; Kalibbala, Sarah; Buwembo, Martin; Kasule, Jjingo] Rakai Hlth Sci Program, Kalisizo, Uganda; [Gray, Ronald H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Reynolds, Steven J.] NIAID, Immunoregulat Lab, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Reynolds, Steven J.; Chang, Larry W.] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA; [Serwadda, David] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda	Rakai Health Sciences Program; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Makerere University	Chang, LW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA.	lchang8@jhmi.edu		Musoke, Richard/0000-0002-2566-4191; Reynolds, Steven/0000-0002-5403-2759; Lubyayi, Lawrence/0000-0001-5286-6488	CDC Uganda; PEPFAR Uganda; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000361, ZIAAI001040] Funding Source: NIH RePORTER	CDC Uganda; PEPFAR Uganda; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We acknowledge CDC Uganda for the funding support that availed the PIMAs to our institution and PEPFAR Uganda that supports the treatment program. This work was supported in part (SJR) by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	*AL WEBS, AL PIM CD4 CUST TRAI; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; DIAW PA, J ACQUIR IMMUNE DEFI, V58, pE103; Glencross DK, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-3; Herbert S, 2012, SEX TRANSM INFECT, V88, P413, DOI 10.1136/sextrans-2012-050507; Jaffar Shabbar, 2008, AIDS Res Ther, V5, P4, DOI 10.1186/1742-6405-5-4; Jani IV, 2011, AIDS, V25, P807, DOI 10.1097/QAD.0b013e328344f424; Kagaayi J, 2007, AIDS, V21, P1208, DOI 10.1097/QAD.0b013e32810c8dce; Kiwanuka N, 2004, JAIDS-J ACQ IMM DEF, V36, P721, DOI 10.1097/00126334-200406010-00009; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Manabe YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034319; Mnyani CN, 2012, JAIDS-J ACQ IMM DEF, V60, P260, DOI 10.1097/QAI.0b013e318256b651; Mtapuri-Zinyowera S, 2010, JAIDS-J ACQ IMM DEF, V55, P1, DOI 10.1097/QAI.0b013e3181e93071; Mwau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067612; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Thakar M, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-26	18	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e88928	10.1371/journal.pone.0088928	http://dx.doi.org/10.1371/journal.pone.0088928			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614083	Green Submitted, Green Published, gold			2022-12-25	WOS:000332839300008
J	Li, X; Sun, R; Chen, WP; Lu, BM; Li, XY; Wang, ZJ; Bao, JK				Li, Xin; Sun, Rong; Chen, Wanpeng; Lu, Bangmin; Li, Xiaoyu; Wang, Zijie; Bao, Jinku			A Systematic In Silico Mining of the Mechanistic Implications and Therapeutic Potentials of Estrogen Receptor (ER)-alpha in Breast Cancer	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; INTERACTION DATABASE; DRUG DISCOVERY; ER-ALPHA; PREDICTION; TOOL; IDENTIFICATION; MODULATORS; MICRORNAS; TARGETS	Estrogen receptor (ER)-alpha has long been a potential target in ER-alpha-positive breast cancer therapeutics. In this study, we integrated ER-alpha-related bioinformatic data at different levels to systematically explore the mechanistic and therapeutic implications of ER-alpha. Firstly, we identified ER-alpha-interacting proteins and target genes of ER-alpha-regulating microRNAs (miRNAs), and analyzed their functional gene ontology (GO) annotations of those ER-alpha-associated proteins. In addition, we predicted ten consensus miRNAs that could target ER-alpha, and screened candidate traditional Chinese medicine (TCM) compounds that might hit diverse conformations of ER-alpha ligand binding domain (LBD). These findings may help to uncover the mechanistic implications of ER-alpha in breast cancer at a systematic level, and provide clues of miRNAs- and small molecule modulators-based strategies for future ER-alpha-positive breast cancer therapeutics.	[Bao, Jinku] Sichuan Univ, Sch Life Sci, Chengdu 610064, Peoples R China; Sichuan Univ, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University	Bao, JK (corresponding author), Sichuan Univ, Sch Life Sci, Chengdu 610064, Peoples R China.	baojinku@scu.edu.cn			National Natural Science Foundation of China [81173093, 30970643, J1103518]; Special Program for Youth Science and the Technology Innovative Research Group of Sichuan Province, China [2011JTD0026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Program for Youth Science and the Technology Innovative Research Group of Sichuan Province, China	This study was supported in part by the National Natural Science Foundation of China (No. 81173093, No. 30970643, and No. J1103518), the Special Program for Youth Science and the Technology Innovative Research Group of Sichuan Province, China (No. 2011JTD0026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragues R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-172; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Banerjee S, 2011, J CELL COMMUN SIGNAL, V5, P317, DOI 10.1007/s12079-011-0138-y; Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Butler D, 2004, NATURE, V432, P423, DOI 10.1038/432423a; CAO X, 2013, BIOORG MED CHEMLETT, DOI DOI 10.1016/J.BMCL.2013.03.105.PUBMED:23608764; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chen JQ, 2004, AM J PHYSIOL-ENDOC M, V286, pE1011, DOI 10.1152/ajpendo.00508.2003; Chen JQ, 2004, J CELL BIOCHEM, V93, P358, DOI 10.1002/jcb.20178; Chen JQ, 2003, TOXICOL SCI, V75, P271, DOI 10.1093/toxsci/kfg183; Cheng LS, 2008, J MED CHEM, V51, P3878, DOI 10.1021/jm8001197; Cirillo F, 2013, J PROTEOME RES, V12, P421, DOI 10.1021/pr300753u; Corcoran C, 2011, CLIN CHEM, V57, P18, DOI 10.1373/clinchem.2010.150730; Cuzick J, 2013, LANCET, V381, P1827, DOI 10.1016/S0140-6736(13)60140-3; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Gadaleta E, 2011, BRIEF BIOINFORM, V12, P52, DOI 10.1093/bib/bbq010; Giacinti L, 2006, ONCOLOGIST, V11, P1, DOI 10.1634/theoncologist.11-1-1; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hendriks BS, 2008, BIOTECHNOL PROGR, V24, P96, DOI 10.1021/bp070084g; Howell A, 2013, LANCET, V381, P1795, DOI 10.1016/S0140-6736(13)60443-2; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Kahlert S, 2000, J BIOL CHEM, V275, P18447, DOI 10.1074/jbc.M910345199; Kar G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000601; Katchy A, 2012, J STEROID BIOCHEM, V128, P145, DOI 10.1016/j.jsbmb.2011.10.008; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Klinge CM, 2012, TRENDS ENDOCRIN MET, V23, P223, DOI 10.1016/j.tem.2012.03.002; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lang PT, 2009, RNA, V15, P1219, DOI 10.1261/rna.1563609; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Manavathi B, 2013, ENDOCR REV, V34, P1, DOI 10.1210/er.2011-1057; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; McDonnell DP, 2010, CURR OPIN PHARMACOL, V10, P620, DOI 10.1016/j.coph.2010.09.007; NANASINKAM S, 2012, CLIN PHARMACOL THER, DOI DOI 10.1038/CLPT.2012.192.PUBMED:23212103; Ostlund G, 2010, MOL CELL PROTEOMICS, V9, P648, DOI 10.1074/mcp.M900227-MCP200; PANG YP, 1994, J COMPUT AID MOL DES, V8, P669, DOI 10.1007/BF00124014; Park WC, 2002, TRENDS MOL MED, V8, P82, DOI 10.1016/S1471-4914(02)02282-7; Persico M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S21; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Prat A, 2008, NAT CLIN PRACT ONCOL, V5, P531, DOI 10.1038/ncponc1179; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Schmidt C, 2010, J NATL CANCER I, V102, P1690, DOI 10.1093/jnci/djq477; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; TANRIKULU Y, 2013, DRUG DISCOV TODAY, DOI DOI 10.1016/J.DRUDIS.2013.01.007.PUBMED:23340112; Tenette C, 1996, BIOCHEM SOC T, V24, P268, DOI 10.1042/bst0240268; Tian W, 2013, CLIN TRANSL ONCOL, V15, P335, DOI 10.1007/s12094-012-0929-5; Totrov M, 2008, CURR OPIN STRUC BIOL, V18, P178, DOI 10.1016/j.sbi.2008.01.004; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Witkos TM, 2011, CURR MOL MED, V11, P93; Wuchty S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014681; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yang YD, 2010, MOL INFORM, V29, P421, DOI 10.1002/minf.201000034; Yau C, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2120; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang YS, 2012, J BIOL CHEM, V287, P41514, DOI 10.1074/jbc.M112.404871	71	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91894	10.1371/journal.pone.0091894	http://dx.doi.org/10.1371/journal.pone.0091894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614816	Green Published, gold			2022-12-25	WOS:000332839300160
J	Battle, C; Hutchings, H; Bouamra, O; Evans, PA				Battle, Ceri; Hutchings, Hayley; Bouamra, Omar; Evans, Phillip A.			The Effect of Pre-Injury Anti-Platelet Therapy on the Development of Complications in Isolated Blunt Chest Wall Trauma: A Retrospective Study	PLOS ONE			English	Article							RIB FRACTURES; MORTALITY; RISK; PNEUMONIA; MORBIDITY	Introduction: The difficulties in the management of the blunt chest wall trauma patient in the Emergency Department due to the development of late complications are well recognised in the literature. Pre-injury anti-platelet therapy has been previously investigated as a risk factor for poor outcomes following traumatic head injury, but not in the blunt chest wall trauma patient cohort. The aim of this study was to investigate pre-injury anti-platelet therapy as a risk factor for the development of complications in the recovery phase following blunt chest wall trauma. Methods: A retrospective study was completed in which the medical notes were analysed of all blunt chest wall trauma patients presenting to a large trauma centre in Wales in 2012 and 2013. Using univariate and multivariable logistic regression analysis, pre-injury platelet therapy was investigated as a risk factor for the development of complications following blunt chest wall trauma. Previously identified risk factors were included in the analysis to address the influence of confounding. Results: A total of 1303 isolated blunt chest wall trauma patients presented to the ED in Morriston Hospital in 2012 and 2013 with complications recorded in 144 patients (11%). On multi-variable analysis, pre-injury anti-platelet therapy was found to be a significant risk factor for the development of complications following isolated blunt chest wall trauma (odds ratio: 16.9; 95% confidence intervals: 8.2-35.2). As in previous studies patient age, number of rib fractures, chronic lung disease and pre-injury anti-coagulant use were also found to be significant risk factors. Conclusions: Pre-injury anti-platelet therapy is being increasingly used as a first line treatment for a number of conditions and there is a concurrent increase in trauma in the elderly population. Pre-injury anti-platelet therapy should be considered as a risk factor for the development of complications by clinicians managing blunt chest wall trauma.	[Battle, Ceri; Evans, Phillip A.] Morriston Hosp, NISCHR Haemostasis Biomed Res Unit, Swansea, W Glam, Wales; [Hutchings, Hayley] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [Bouamra, Omar] Univ Manchester, Trauma Audit & Res Network, Manchester, Lancs, England	Morriston Hospital; Swansea University; University of Manchester	Battle, C (corresponding author), Morriston Hosp, NISCHR Haemostasis Biomed Res Unit, Swansea, W Glam, Wales.	ceri.battle@wales.nhs.uk	Battle, Ceri/AAK-5856-2021; Hutchings, Hayley A/C-9944-2013	Battle, Ceri/0000-0002-7503-1931; Hutchings, Hayley Anne/0000-0003-4155-1741; bouamra, omar/0000-0002-3155-4634; Evans, Phillip Adrian/0000-0002-0814-5162				Ahmad MA, 2010, INJURY, V41, P981, DOI 10.1016/j.injury.2010.08.004; Alexander JQ, 2000, AM SURGEON, V66, P855; Barnea Y, 2002, CAN J SURG, V45, P43; Battle CE, 2012, INJURY, V43, P8, DOI 10.1016/j.injury.2011.01.004; Battle CE, 2013, INJURY, V44, P1171, DOI 10.1016/j.injury.2012.05.019; Bergeron E, 2003, J TRAUMA, V54, P478, DOI 10.1097/01.TA.0000037095.83469.4C; Beynon C, 2012, CRIT CARE, V16, DOI 10.1186/cc11292; Blecher GE, 2008, INJURY, V39, P586, DOI 10.1016/j.injury.2007.10.021; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Brasel KJ, 2006, CRIT CARE MED, V34, P1642, DOI 10.1097/01.CCM.0000217926.40975.4B; Bulger EM, 2000, J TRAUMA, V48, P1040, DOI 10.1097/00005373-200006000-00007; Catella-Lawson F, 2001, NEW ENGL J MED, V345, P1809, DOI 10.1056/NEJMoa003199; Demirhan Recep, 2009, Interact Cardiovasc Thorac Surg, V9, P450, DOI 10.1510/icvts.2009.206599; Dubinsky I, 1997, AM J EMERG MED, V15, P240, DOI 10.1016/S0735-6757(97)90004-8; Erlich JM, 2011, CHEST, V139, P289, DOI 10.1378/chest.10-0891; Fabbri A, 2013, CRIT CARE, V17, DOI 10.1186/cc12575; Gilbert EH, 1996, ANN EMERG MED, V27, P305, DOI 10.1016/S0196-0644(96)70264-0; Harr JN, 2013, CRIT CARE MED, V41, P399, DOI 10.1097/CCM.0b013e31826ab38b; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Neal MD, 2014, ANN SURG, V00, P1; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Schror K, 1997, SEMIN THROMB HEMOST, V23, P349, DOI 10.1055/s-2007-996108; Simon BJ, 1998, J TRAUMA, V45, P673, DOI 10.1097/00005373-199810000-00005; Victorino GP, 2003, ARCH SURG-CHICAGO, V138, P1093, DOI 10.1001/archsurg.138.10.1093; Vignesh T, 2004, INDIAN J CRIT CARE M, V8, P73	25	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91284	10.1371/journal.pone.0091284	http://dx.doi.org/10.1371/journal.pone.0091284			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609084	Green Published, Green Submitted, gold			2022-12-25	WOS:000332485800121
J	Imhof, J; Huber, F; Reichelt, M; Gershenzon, J; Wiegreffe, C; Lachler, K; Binder, S				Imhof, Janet; Huber, Florian; Reichelt, Michael; Gershenzon, Jonathan; Wiegreffe, Christoph; Laechler, Kurt; Binder, Stefan			The Small Subunit 1 of the Arabidopsis Isopropylmalate Isomerase Is Required for Normal Growth and Development and the Early Stages of Glucosinolate Formation	PLOS ONE			English	Article							CHAIN AMINO-ACID; METHYLTHIOALKYLMALATE SYNTHASE; SEED DEVELOPMENT; DIFFERENT ORGANS; GENES; BIOSYNTHESIS; LEUCINE; METABOLISM; THALIANA; TARGET	In Arabidopsis thaliana the evolutionary and functional relationship between Leu biosynthesis and the Met chain elongation pathway, the first part of glucosinolate formation, is well documented. Nevertheless the exact functions of some pathway components are still unclear. Isopropylmalate isomerase (IPMI), an enzyme usually involved in Leu biosynthesis, is a heterodimer consisting of a large and a small subunit. While the large protein is encoded by a single gene (ISOPROPYLMALATE ISOMERASE LARGE SUBUNIT1), three genes encode small subunits (ISOPROPYLMALATE ISOMERASE SMALL SUBUNIT1 to 3). We have now analyzed small subunit 1 (ISOPROPYLMALATE ISOMERASE SMALL SUBUNIT1) employing artificial microRNA for a targeted knockdown of the encoding gene. Strong reduction of corresponding mRNA levels to less than 5% of wild-type levels resulted in a severe phenotype with stunted growth, narrow pale leaf blades with green vasculature and abnormal adaxial-abaxial patterning as well as anomalous flower morphology. Supplementation of the knockdown plants with leucine could only partially compensate for the morphological and developmental abnormalities. Detailed metabolite profiling of the knockdown plants revealed changes in the steady state levels of isopropylmalate and glucosinolates as well as their intermediates demonstrating a function of IPMI SSU1 in both leucine biosynthesis and the first cycle of Met chain elongation. Surprisingly the levels of free leucine slightly increased suggesting an imbalanced distribution of leucine within cells and/or within plant tissues.	[Imhof, Janet; Huber, Florian; Laechler, Kurt; Binder, Stefan] Univ Ulm, Inst Mol Bot, D-89069 Ulm, Germany; [Reichelt, Michael; Gershenzon, Jonathan] Max Planck Inst Chem Okol, Abt Biochem, Jena, Germany; [Wiegreffe, Christoph] Univ Ulm, Inst Mol & Zellulare Anat, D-89069 Ulm, Germany	Ulm University; Max Planck Society; Ulm University	Binder, S (corresponding author), Univ Ulm, Inst Mol Bot, D-89069 Ulm, Germany.	Stefan.binder@uni-ulm.de	Wiegreffe, Christoph/AAZ-2634-2020; Gershenzon, Jonathan/K-1331-2013	Gershenzon, Jonathan/0000-0002-1812-1551	Deutsche Forschungsgemeinschaft [Bi590/9-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grant Bi590/9-2 from the Deutsche Forschungsgemeinschaft (http://www.dfg.de) (http://www.dfg.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo WL, 2011, TRENDS PLANT SCI, V16, P489, DOI 10.1016/j.tplants.2011.05.008; Binder Stefan, 2010, Arabidopsis Book, V8, pe0137, DOI 10.1199/tab.0137; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Caldana C, 2013, PLANT J, V73, P897, DOI 10.1111/tpj.12080; Caldana C, 2011, PLANT J, V67, P869, DOI 10.1111/j.1365-313X.2011.04640.x; Chen H, 2010, PLANT J, V63, P573, DOI 10.1111/j.1365-313X.2010.04261.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Daschner K, 2001, PLANT PHYSIOL, V126, P601, DOI 10.1104/pp.126.2.601; de Kraker JW, 2007, PLANT PHYSIOL, V143, P970, DOI 10.1104/pp.106.085555; de Kraker JW, 2011, PLANT CELL, V23, P38, DOI 10.1105/tpc.110.079269; DEBLAERE R, 1985, NUCLEIC ACIDS RES, V13, P4777, DOI 10.1093/nar/13.13.4777; Deprost D, 2007, EMBO REP, V8, P864, DOI 10.1038/sj.embor.7401043; Ding G, 2012, PLANT J, V70, P562, DOI 10.1111/j.1365-313X.2011.04893.x; Dobrenel T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00093; Docimo T, 2012, PLANT MOL BIOL, V78, P599, DOI 10.1007/s11103-012-9886-1; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Fait A, 2006, PLANT PHYSIOL, V142, P839, DOI 10.1104/pp.106.086694; Forner J, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-28; Gao F, 2009, PLANTA, V230, P611, DOI 10.1007/s00425-009-0973-8; Haas FH, 2008, PLANT PHYSIOL, V148, P1055, DOI 10.1104/pp.108.125237; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hannah MA, 2010, PLANT PHYSIOL, V152, P2120, DOI 10.1104/pp.109.147306; He Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057118; He Y, 2011, J BIOL CHEM, V286, P28794, DOI 10.1074/jbc.M111.262519; He Y, 2011, NEW PHYTOL, V189, P160, DOI 10.1111/j.1469-8137.2010.03460.x; He Y, 2010, PLANT CELL PHYSIOL, V51, P1480, DOI 10.1093/pcp/pcq113; He Y, 2009, PLANT J, V60, P679, DOI 10.1111/j.1365-313X.2009.03990.x; Horiguchi G, 2011, PLANT J, V65, P724, DOI 10.1111/j.1365-313X.2010.04457.x; Hull G A, 1995, Methods Mol Biol, V49, P125; Husbands AY, 2009, GENE DEV, V23, P1986, DOI 10.1101/gad.1819909; Jonietz C, 2011, PLANT PHYSIOL, V157, P1430, DOI 10.1104/pp.111.181552; Kimball SR, 2006, AM J CLIN NUTR, V83, p500S; Kimball SR, 2006, J NUTR, V136, p227S, DOI 10.1093/jn/136.1.227S; Knill T, 2008, PLANT PHYSIOL, V146, P1028, DOI 10.1104/pp.107.111609; Knill T, 2009, PLANT MOL BIOL, V71, P227, DOI 10.1007/s11103-009-9519-5; Koroleva OA, 2010, PLANT J, V64, P456, DOI 10.1111/j.1365-313X.2010.04339.x; Mo XR, 2006, PLANT PHYSIOL, V141, P1425, DOI 10.1104/pp.106.084178; Moschopoulos A, 2012, J EXP BOT, V63, P5233, DOI 10.1093/jxb/ers184; Nour-Eldin HH, 2012, NATURE, V488, P531, DOI 10.1038/nature11285; Peterhansel C., 2010, PLANT BIOLOGY, V8, pe0130, DOI DOI 10.1199/TAB.0130; Pinon V, 2008, DEVELOPMENT, V135, P1315, DOI 10.1242/dev.016469; Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740; Redovnikovic IR, 2012, PLANT PHYSIOL BIOCH, V53, P77, DOI 10.1016/j.plaphy.2012.01.015; Ren MZ, 2012, PLANT CELL, V24, P4850, DOI 10.1105/tpc.112.107144; Robaglia C, 2012, CURR OPIN PLANT BIOL, V15, P301, DOI 10.1016/j.pbi.2012.01.012; Sambrook J, 2001, MOL CLONING LAB MANU; Sawada Y, 2009, PLANT CELL PHYSIOL, V50, P1181, DOI 10.1093/pcp/pcp079; Schuster J, 2005, PLANT MOL BIOL, V57, P241, DOI 10.1007/s11103-004-7533-1; Schuster J, 2006, PLANT CELL, V18, P2664, DOI 10.1105/tpc.105.039339; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Sureshkumar S, 2009, SCIENCE, V323, P1060, DOI 10.1126/science.1164014; Textor S, 2004, PLANTA, V218, P1026, DOI 10.1007/s00425-003-1184-3; Textor S, 2007, PLANT PHYSIOL, V144, P60, DOI 10.1104/pp.106.091579; Vadassery J, 2012, PLANT PHYSIOL, V159, P1159, DOI 10.1104/pp.112.198150; Watanabe M, 2013, PLANT PHYSIOL, V162, P1290, DOI 10.1104/pp.113.217380; Weigel D., 2002, ARABIDOPSIS LAB MANU; Xiong Y, 2013, NATURE, V496, P181, DOI 10.1038/nature12030; Yan XF, 2007, PLANTA, V226, P1343, DOI 10.1007/s00425-007-0627-7; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Yao Y, 2008, DEVELOPMENT, V135, P1325, DOI 10.1242/dev.017913; Yu HL, 2013, J EXP BOT, V64, P599, DOI 10.1093/jxb/ers352	62	15	15	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91071	10.1371/journal.pone.0091071	http://dx.doi.org/10.1371/journal.pone.0091071			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608865	Green Submitted, gold, Green Published			2022-12-25	WOS:000332485800095
J	Mah, W; Jiang, GQ; Olver, D; Cheung, G; Kim, B; Larjava, H; Hakkinen, L				Mah, Wesley; Jiang, Guoqiao; Olver, Dylan; Cheung, Godwin; Kim, Ben; Larjava, Hannu; Haekkinen, Lari			Human Gingival Fibroblasts Display a Non-Fibrotic Phenotype Distinct from Skin Fibroblasts in Three-Dimensional Cultures	PLOS ONE			English	Article							TRANSFORMING-GROWTH-FACTOR; LEUCINE-RICH PROTEOGLYCANS; TRIPLE-HELIX REPEAT; FACTOR-BETA; MATRIX METALLOPROTEINASES; MOLECULAR-MECHANISMS; ORAL MUCOSAL; EXPRESSION; ACTIVATION; FIBROSIS	Scar formation following skin injury can be a major psychosocial and physiological problem. However, the mechanisms of scar formation are still not completely understood. Previous studies have shown that wound healing in oral mucosa is faster, associates with a reduced inflammatory response and results to significantly reduced scar formation compared with skin wounds. In the present study, we hypothesized that oral mucosal fibroblasts from human gingiva are inherently distinct from fibroblasts from breast and abdominal skin, two areas prone to excessive scar formation, which may contribute to the preferential wound healing outcome in gingiva. To this end, we compared the phenotype of human gingival and skin fibroblasts cultured in in vivo-like three-dimensional (3D) cultures that mimic the cells' natural extracellular matrix (ECM) niche. To establish 3D cultures, five parallel fibroblast lines from human gingiva (GFBLs) and breast skin (SFBLs) were seeded in high density, and cultured for up to 21 days in serum and ascorbic acid containing medium to induce expression of wound-healing transcriptome and ECM deposition. Cell proliferation, morphology, phenotype and expression of wound healing and scar related genes were analyzed by real-time RT-PCR, Western blotting and immunocytochemical methods. The expression of a set of genes was also studied in three parallel lines of human abdominal SFBLs. Findings showed that GFBLs displayed morphologically distinct organization of the 3D cultures and proliferated faster than SFBLs. GFBLs expressed elevated levels of molecules involved in regulation of inflammation and ECM remodeling (MMPs) while SFBLs showed significantly higher expression of TGF-beta signaling, ECM and myofibroblast and cell contractility-related genes. Thus, GFBLs display an inherent phenotype conducive for fast resolution of inflammation and ECM remodeling, characteristic for scar-free wound healing, while SFBLs have a profibrotic, scar-prone phenotype.	[Mah, Wesley; Jiang, Guoqiao; Olver, Dylan; Cheung, Godwin; Kim, Ben; Larjava, Hannu; Haekkinen, Lari] Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Hakkinen, L (corresponding author), Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, Vancouver, BC V5Z 1M9, Canada.	lhakkine@dentistry.ubc.ca	Hakkinen, Lari/B-2228-2016; Larjava, Hannu/GRO-4325-2022		Canadian Institutes of Health Research (CIHR, MOP) [77550]; University of British Columbia CIHR Skin Research Training Centre (SRTC) Award; The Faculty of Dentistry, University of British Columbia	Canadian Institutes of Health Research (CIHR, MOP)(Canadian Institutes of Health Research (CIHR)); University of British Columbia CIHR Skin Research Training Centre (SRTC) Award; The Faculty of Dentistry, University of British Columbia	The study was supported by Canadian Institutes of Health Research (CIHR, MOP 77550), University of British Columbia CIHR Skin Research Training Centre (SRTC) Award, and by The Faculty of Dentistry, University of British Columbia, Undergraduate Student Research Awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021; Badri KR, 2013, J CLIN INVEST, V123, P4502, DOI 10.1172/JCI69884; Beacham Dorothy A, 2007, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1009s33; Bhattacharyya S, 2013, J PATHOL, V229, P286, DOI 10.1002/path.4131; Bhide VM, 2005, J BIOL CHEM, V280, P23103, DOI 10.1074/jbc.M410060200; Bond JE, 2011, LAB INVEST, V91, P499, DOI 10.1038/labinvest.2010.181; Braddock M, 2000, IDrugs, V3, P783; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Carracedo S, 2010, J BIOL CHEM, V285, P10434, DOI 10.1074/jbc.M109.078766; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Dang CM, 2003, PLAST RECONSTR SURG, V111, P2273, DOI 10.1097/01.PRS.0000060102.57809.DA; Delavary BM, 2012, J PLAST SURG HAND SU, V46, P95, DOI 10.3109/2000656X.2012.669184; Dobaczewski M, 2012, J CARDIOVASC TRANSL, V5, P837, DOI 10.1007/s12265-012-9406-3; Dufour A, 2013, TRENDS PHARMACOL SCI, V34, P233, DOI 10.1016/j.tips.2013.02.004; Durani Piyush, 2008, Int J Low Extrem Wounds, V7, P160, DOI 10.1177/1534734608322983; Eba H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052523; Ebisawa K, 2011, J BIOSCI BIOENG, V111, P255, DOI 10.1016/j.jbiosc.2010.11.014; Ehrlich HP, 2006, CELL BIOCHEM FUNCT, V24, P63, DOI 10.1002/cbf.1188; Fang F, 2013, AM J PATHOL, V183, P1197, DOI 10.1016/j.ajpath.2013.06.016; Fang F, 2011, AM J PATHOL, V178, P2077, DOI 10.1016/j.ajpath.2011.01.035; Fournier BPJ, 2013, STEM CELLS DEV, V22, P3157, DOI 10.1089/scd.2013.0015; Frey H, 2013, FEBS J, V280, P2165, DOI 10.1111/febs.12145; Gangemi EN, 2008, ARCH FACIAL PLAST S, V10, P93, DOI 10.1001/archfaci.10.2.93; Gauglitz GG, 2011, MOL MED, V17, P113, DOI 10.2119/molmed.2009.00153; Glim JE, 2013, WOUND REPAIR REGEN, V21, P648, DOI 10.1111/wrr.12072; Green JA, 2007, ADV DRUG DELIVER REV, V59, P1293, DOI 10.1016/j.addr.2007.08.005; Guo F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019756; HAKKINEN L, 1994, BBA-MOL CELL RES, V1224, P33, DOI 10.1016/0167-4889(94)90110-4; Hakkinen L., 2011, ENDOD TOPICS, V24, P94, DOI [DOI 10.1111/ETP.12008, 10.1111/etp.12008]; Honardoust D, 2008, WOUND REPAIR REGEN, V16, P814, DOI 10.1111/j.1524-475X.2008.00435.x; Honardoust D, 2011, WOUND REPAIR REGEN, V19, P368, DOI 10.1111/j.1524-475X.2011.00677.x; Horiguchi M, 2012, J BIOCHEM, V152, P321, DOI 10.1093/jb/mvs089; Iozzo RV, 2010, FEBS J, V277, P3864, DOI 10.1111/j.1742-4658.2010.07797.x; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Johnson A, 2013, FASEB J, V27, P3893, DOI 10.1096/fj.12-214189; Jun JI, 2010, AGING-US, V2, P627, DOI 10.18632/aging.100201; King SJ, 2011, METHODS MOL BIOL, V769, P53, DOI 10.1007/978-1-61779-207-6_5; Kyriakides TR, 2009, J CELL COMMUN SIGNAL, V3, P215, DOI 10.1007/s12079-009-0077-z; Lai YL, 2010, STEM CELLS DEV, V19, P1095, DOI 10.1089/scd.2009.0217; Lam AP, 2011, CURR OPIN RHEUMATOL, V23, P562, DOI 10.1097/BOR.0b013e32834b3309; Lan HY, 2012, SEMIN NEPHROL, V32, P236, DOI 10.1016/j.semnephrol.2012.04.002; LeClair R, 2007, TRENDS CARDIOVAS MED, V17, P202, DOI 10.1016/j.tcm.2007.05.004; Li J, 2011, BRIT J DERMATOL, V164, P1030, DOI 10.1111/j.1365-2133.2011.10215.x; Liakouli V, 2011, AUTOIMMUN REV, V10, P590, DOI 10.1016/j.autrev.2011.04.019; Loffek S, 2011, EUR RESPIR J, V38, P191, DOI 10.1183/09031936.00146510; Mak K, 2009, J DERMATOL SCI, V56, P168, DOI 10.1016/j.jdermsci.2009.09.005; Mann J, 2013, CURR OPIN RHEUMATOL, V25, P101, DOI 10.1097/BOR.0b013e32835b13e1; McKeown STW, 2007, J DENT RES, V86, P457, DOI 10.1177/154405910708600513; Mikesh LM, 2013, J PROTEOMICS, V84, P190, DOI 10.1016/j.jprot.2013.03.019; Mori R, 2008, J EXP MED, V205, P43, DOI 10.1084/jem.20071412; NAGASE H, 1991, BIOMED BIOCHIM ACTA, V50, P749; Nakerakanti Sashidhar, 2012, Open Rheumatol J, V6, P156, DOI 10.2174/1874312901206010156; Oliveira GV, 2009, INT WOUND J, V6, P445, DOI 10.1111/j.1742-481X.2009.00638.x; Penn JW, 2012, INT J BURNS TRAUMA, V2, P18; Pitiyage GN, 2011, J PATHOL, V223, P604, DOI 10.1002/path.2839; Pouyani T, 2012, IN VITRO CELL DEV-AN, V48, P493, DOI 10.1007/s11626-012-9541-9; Quiros RM, 2008, GYNECOL ONCOL, V110, P99, DOI 10.1016/j.ygyno.2008.03.006; Rinn JL, 2008, J INVEST DERMATOL, V128, P776, DOI 10.1038/sj.jid.5700986; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Sarrazy V, 2011, WOUND REPAIR REGEN, V19, pS10, DOI 10.1111/j.1524-475X.2011.00708.x; Schiavinato A, 2012, J BIOL CHEM, V287, P11498, DOI 10.1074/jbc.M111.303578; Schor S L, 1996, Oral Dis, V2, P155; SCIUBBA JJ, 1978, J ORAL PATHOL MED, V7, P214, DOI 10.1111/j.1600-0714.1978.tb01596.x; Soo C, 2000, AM J PATHOL, V157, P423, DOI 10.1016/S0002-9440(10)64555-5; Szpaderska AM, 2003, J DENT RES, V82, P621, DOI 10.1177/154405910308200810; Tocchi A, 2013, FEBS J, V280, P2332, DOI 10.1111/febs.12198; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang JF, 2008, LAB INVEST, V88, P1278, DOI 10.1038/labinvest.2008.101; Wipff PJ, 2008, EUR J CELL BIOL, V87, P601, DOI 10.1016/j.ejcb.2008.01.012; Wong JW, 2009, WOUND REPAIR REGEN, V17, P717, DOI 10.1111/j.1524-475X.2009.00531.x; Xu X, 2013, J DENT RES, V92, P825, DOI 10.1177/0022034513497961; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044	74	44	45	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90715	10.1371/journal.pone.0090715	http://dx.doi.org/10.1371/journal.pone.0090715			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24608113	gold, Green Published, Green Submitted			2022-12-25	WOS:000332485800046
J	Zhang, JF; Shu, ZJ; Xie, CY; Li, Q; Jin, XH; Gu, W; Jiang, FJ; Ling, CQ				Zhang, Jin-feng; Shu, Zhi-jun; Xie, Chun-yi; Li, Qi; Jin, Xi-hong; Gu, Wei; Jiang, Fang-jian; Ling, Chang-quan			Prognosis of Unresectable Hepatocellular Carcinoma: Comparison of Seven Staging Systems (TNM, Okuda, BCLC, CLIP, CUPI, JIS, CIS) in a Chinese Cohort	PLOS ONE			English	Article							PROSPECTIVE VALIDATION; CLINICAL-TRIALS; SCORE; INDEX; JAPAN	Background: Many liver staging systems that include the tumor stage and the extent of liver function have been developed. However, prognosis assessment for hepatocellular carcinoma (HCC) remains controversial. In this study, the performances of 7 staging systems were compared in a cohort of patients with HCC who underwent non-surgical treatment. Methods: A total of 196 consecutive patients with HCC who underwent non-surgical treatment seen between January 1, 2004, and December 31, 2007, were included. Performances of TNM sixth edition, Okuda, Barcelona Clinic Liver Cancer (BCLC), Cancer of the Liver Italian Program (CLIP), Chinese University Prognostic Index (CUPI), Japan Integrated Staging (JIS), and China integrated score (CIS) have been compared and ranked using concordance index (c-index). Predictors of survival were identified using univariate and multivariate Cox model analyses. Results: The median survival time for the cohort was 7.6 months (95% CI 5.6-9.7). The independent predictors of survival were performance status (P < .001), serum sodium (P < .001), alkaline phosphatase (P < .001), tumor diameter greater than 5 cm (P = .001), portal vein invasion (P < .001), lymph node metastasis (P = .025), and distant metastasis (P = .004). CUPI staging system had the best independent predictive power for survival when compared with the other six prognostic systems. Performance status and serum sodium improved the discriminatory ability of CUPI. Conclusion: In our selected patient population whose main etiology is hepatitis B, CUPI was the most suitable staging system in predicting survival in patients with unresectable HCC. BCLC was the second top-ranking staging system. CLIP, JIS, CIS, and TNM sixth edition were not helpful in predicting survival outcome, and their use is not supported by our data.	[Zhang, Jin-feng; Jiang, Fang-jian] Shanghai Hosp Chinese Integrat Med, Dept Tradit Chinese Med, Shanghai, Peoples R China; [Shu, Zhi-jun] Shanghai Hosp Chinese Integrat Med, Dept Surg, Shanghai, Peoples R China; [Xie, Chun-yi] Shanghai Hosp Chinese Integrat Med, Dept Cardiol, Shanghai, Peoples R China; [Li, Qi] Shanghai Univ Tradit Chinese Med, Dept Med Oncol, Shuguang Hosp, Shanghai, Peoples R China; [Jin, Xi-hong] Shanghai Univ Tradit Chinese Med, Yueyang Hosp Integrated Chinese & Western Med, Dept Massage, Shanghai, Peoples R China; [Gu, Wei; Ling, Chang-quan] Second Mil Med Univ, Changhai Hosp, Dept Tradit Chinese Med, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Naval Medical University	Ling, CQ (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Tradit Chinese Med, Shanghai, Peoples R China.	lingchangquan@hotmail.com	Ling, Changquan/J-2108-2016	Ling, Changquan/0000-0003-3476-6445; Ling, Changquan/0000-0002-0037-4059				Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Cabibbo G, 2012, WORLD J HEPATOL, V4, P256, DOI 10.4254/wjh.v4.i9.256; Chan SL, 2011, J GASTROEN HEPATOL, V26, P340, DOI 10.1111/j.1440-1746.2010.06329.x; Cho YK, 2008, CANCER-AM CANCER SOC, V112, P352, DOI 10.1002/cncr.23185; Cillo U, 2006, J HEPATOL, V44, P723, DOI 10.1016/j.jhep.2005.12.015; Collette S, 2008, ANN ONCOL, V19, P1117, DOI 10.1093/annonc/mdn030; Grieco A, 2005, GUT, V54, P411, DOI 10.1136/gut.2004.048124; Hsu CY, 2010, CANCER, V116, P9; Huitzil-Melendez FD, 2010, J CLIN ONCOL, V28, P2889, DOI 10.1200/JCO.2009.25.9895; Huo TI, 2008, DIGEST LIVER DIS, V40, P8; Kondo K, 2009, J GASTROINTEST SURG, V13, P1078, DOI 10.1007/s11605-009-0854-2; Kudo M, 2003, J GASTROENTEROL, V38, P207, DOI 10.1007/s005350300038; Kudo M, 2004, HEPATOLOGY, V40, P1396, DOI 10.1002/hep.20486; Lee YH, 2012, DIGEST LIVER DIS, V44, P868, DOI 10.1016/j.dld.2012.04.018; Lei HJ, 2006, J AM COLL SURGEONS, V203, P426, DOI 10.1016/j.jamcollsurg.2006.06.030; Leung TWT, 2002, CANCER, V94, P1760, DOI 10.1002/cncr.10384; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Manghisi G, 1998, HEPATOLOGY, V28, P751; Marrero JA, 2005, HEPATOLOGY, V41, P707, DOI 10.1002/hep.20636; OKUDA K, 1985, CANCER, V56, P918, DOI 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E; op den Winkel M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045066; Perrone F, 2000, HEPATOLOGY, V31, P840; Shen XH, 2010, WORLD J SURG, V34, P1028, DOI 10.1007/s00268-010-0400-0; Sun HC, 2007, J SURG ONCOL, V96, P37, DOI 10.1002/jso.20772; Toyoda H, 2005, AM J GASTROENTEROL, V100, P1764, DOI 10.1111/j.1572-0241.2005.41943.x; Uka K, 2007, WORLD J GASTROENTERO, V13, P414, DOI 10.3748/wjg.v13.i3.414; Zhang BH, 2010, J CANC RES CLIN ONCO, V136; Zhou L, 2013, HEPATOB PANCREAT DIS, V12, P6873	29	32	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e88182	10.1371/journal.pone.0088182	http://dx.doi.org/10.1371/journal.pone.0088182			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24609114	Green Published, gold, Green Submitted			2022-12-25	WOS:000332485800003
J	Bormann, J; Boenisch, MJ; Bruckner, E; Firat, D; Schafer, W				Bormann, Joerg; Boenisch, Marike Johanne; Brueckner, Elena; Firat, Demet; Schaefer, Wilhelm			The Adenylyl Cyclase Plays a Regulatory Role in the Morphogenetic Switch from Vegetative to Pathogenic Lifestyle of Fusarium graminearum on Wheat	PLOS ONE			English	Article							KINASE-A PATHWAY; APPRESSORIUM FORMATION; RHIZOCTONIA-SOLANI; NEUROSPORA-CRASSA; INFECTION PROCESS; G-ALPHA; GENE; CAMP; DEOXYNIVALENOL; GROWTH	Cyclic 3',5'-adenosine monophosphate (cAMP) is a nucleotide derived from adenosine triphosphate that acts as a second messenger throughout all kingdoms. Intracellular cAMP levels are synthesized by a membrane-bound protein, the adenylyl cyclase. In order to analyze the function of this gene and the importance of cAMP in the life cycle of the cereal pathogen Fusarium graminearum, the adenylyl cyclase gene (FGSG_01234) was deleted by gene replacement (Delta Fgac1). The Delta Fgac1 mutant displayed a drastically reduced growth on agar medium which could be rescued by a cAMP analogon. Furthermore, the Delta Fgac1 mutant was unable to produce perithecia on detached wheat nodes. However, artificial conditions like carrot agar allowed perithecia development. Pathogenicity towards wheat was drastically reduced in Delta Fgac1 compared to the wild type. Point-inoculated spikelets showed only small lesions but no typical head blight disease symptoms. Fluorescence microscopy using dsRed-expressing strains revealed that the Delta Fgac1 strain was unable to develop any complex infection structures like lobate appressoria and infection cushions. Instead, hyphal anastomosis occurs frequently. Scanning electron microscopy demonstrated the lack of fungal penetration. Hence, the formation of compound appressoria seems to be essential for infection of wheat. Hyphae on flower leaves produced huge amounts of new conidia, thereby circumventing the infection cycle. This abundant sporulation on wheat epidermis was not observed in wild type. Intriguingly, the Fgac1 deletion mutant was able to infect maize cobs as wild type, indicating that cAMP signaling is not important for maize infection. The DFgac1 mutant was unable to produce the mycotoxin deoxynivalenol both in vitro and during wheat infection. In this study, we show that cAMP signaling controls important cellular processes such as development of infection structures, pathogenicity, secondary metabolite production and sexual reproduction. For the first time, we show that cAMP regulates the switch from vegetative to pathogenic lifestyle of F. graminearum on wheat.	[Bormann, Joerg; Boenisch, Marike Johanne; Brueckner, Elena; Firat, Demet; Schaefer, Wilhelm] Univ Hamburg, Dept Mol Phytopathol & Genet, Bioctr Klein Flottbek, Hamburg, Germany	University of Hamburg	Bormann, J (corresponding author), Univ Hamburg, Dept Mol Phytopathol & Genet, Bioctr Klein Flottbek, Hamburg, Germany.	bormannj@botanik.uni-hamburg.de	Boenisch, Marike/AAM-2678-2020	Boenisch, Marike/0000-0001-8145-1820; Bormann, Jorg/0000-0002-3493-2450	University Hamburg	University Hamburg	The funding for this project comes from the University Hamburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMENTROUT VN, 1987, PHYTOPATHOLOGY, V77, P619, DOI 10.1094/Phyto-77-619; Ausubel F. M., 2002, SHORT PROTOCOLS MOL; Boenisch MJ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-110; Choi WB, 1997, PLANT CELL, V9, P1973, DOI 10.1105/tpc.9.11.1973; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; DAHLBERG KR, 1982, ANNU REV PHYTOPATHOL, V20, P281, DOI 10.1146/annurev.py.20.090182.001433; EMMETT RW, 1975, ANNU REV PHYTOPATHOL, V13, P147, DOI 10.1146/annurev.py.13.090175.001051; Gardiner DM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-289; Gardiner DM, 2009, MICROBIOL-SGM, V155, P3149, DOI 10.1099/mic.0.029546-0; Gardiner DM, 2009, FUNGAL GENET BIOL, V46, P604, DOI 10.1016/j.fgb.2009.04.004; Gilbert RD, 1996, PHYSIOL MOL PLANT P, V48, P335, DOI 10.1006/pmpp.1996.0027; Glass NL, 2003, EUKARYOT CELL, V2, P1, DOI 10.1128/EC.2.1.1-8.2003; GREEN CE, 1975, CROP SCI, V15, P417, DOI 10.2135/cropsci1975.0011183X001500030040x; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Hoffman CS, 2005, BIOCHEM SOC T, V33, P257, DOI 10.1042/BST0330257; Holland KA, 2002, TRANSMEMBRANE SIGNAL, DOI [10.1038/npg.els.0000847, DOI 10.1038/NPG.ELS.0000847]]; Huang L, 2008, J PLANT DIS PROTECT, V115, P9, DOI 10.1007/BF03356233; Ilgen P, 2009, MOL PLANT MICROBE IN, V22, P899, DOI 10.1094/MPMI-22-8-0899; Jansen C, 2005, P NATL ACAD SCI USA, V102, P16892, DOI 10.1073/pnas.0508467102; Jenczmionka NJ, 2005, CURR GENET, V47, P29, DOI 10.1007/s00294-004-0547-z; Kays AM, 2004, GENETICS, V166, P1229, DOI 10.1534/genetics.166.3.1229; Kazan K, 2012, MOL PLANT PATHOL, V13, P399, DOI 10.1111/j.1364-3703.2011.00762.x; Klimpel A, 2002, MOL PLANT PATHOL, V3, P439, DOI 10.1046/j.1364-3703.2002.00137.x; Kronstad J, 1998, ARCH MICROBIOL, V170, P395, DOI 10.1007/s002030050659; Kruger J, 1998, MOL GEN GENET, V260, P193, DOI 10.1007/s004380050885; LEACH J, 1982, J GEN MICROBIOL, V128, P1719; Lee N, 2003, ANNU REV PHYTOPATHOL, V41, P399, DOI 10.1146/annurev.phyto.41.052002.095728; Li GT, 2012, CURR OPIN MICROBIOL, V15, P678, DOI 10.1016/j.mib.2012.09.004; Li L, 2007, ANNU REV MICROBIOL, V61, P423, DOI 10.1146/annurev.micro.61.080706.093432; Maier FJ, 2006, MOL PLANT PATHOL, V7, P449, DOI 10.1111/j.1364-3703.2006.00351.x; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; MATSUURA K, 1986, PHYTOPATHOLOGY, V76, P811, DOI 10.1094/Phyto-76-811; Mendgen K, 1996, ANNU REV PHYTOPATHOL, V34, P367, DOI 10.1146/annurev.phyto.34.1.367; Oeser B, 2002, FUNGAL GENET BIOL, V36, P176, DOI 10.1016/S1087-1845(02)00020-8; Palecek SP, 2002, MICROBIOL-SGM, V148, P893, DOI 10.1099/00221287-148-4-893; Ponts N, 2006, FEMS MICROBIOL LETT, V258, P102, DOI 10.1111/j.1574-6968.2006.00200.x; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; REID LM, 1995, PLANT DIS, V79, P461, DOI 10.1094/PD-79-0461; Roca MG, 2005, FEMS MICROBIOL LETT, V249, P191, DOI 10.1016/j.femsle.2005.06.048; Ryu D, 1999, J FOOD PROTECT, V62, P1451, DOI 10.4315/0362-028X-62.12.1451; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schumacher J, 2008, MOL PLANT MICROBE IN, V21, P1443, DOI 10.1094/MPMI-21-11-1443; STOCKWELL V, 1983, PHYTOPATHOLOGY, V73, P1640, DOI 10.1094/Phyto-73-1640; Studt L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058185; Tamaki H, 2007, J BIOSCI BIOENG, V104, P245, DOI 10.1263/jbb.104.245; TERENZI HF, 1979, ARCH MICROBIOL, V123, P251, DOI 10.1007/BF00406658; Trail F, 2009, PLANT PHYSIOL, V149, P103, DOI 10.1104/pp.108.129684; Tsuyuki R, 2011, J AGR FOOD CHEM, V59, P1760, DOI 10.1021/jf103969d; Tudzynski P., 1995, PATHOGENESIS HOST SP, VII, P161; Van Nguyen T, 2013, MOL PLANT MICROBE IN, V26, P1378, DOI 10.1094/MPMI-04-13-0125-R; Voigt CA, 2007, EUR J PLANT PATHOL, V117, P1, DOI 10.1007/s10658-006-9063-y; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Yan X, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002385; Yu HY, 2008, MICROBIOL-SGM, V154, P392, DOI 10.1099/mic.0.2007/012260-0; Zhao XH, 2005, PLANT CELL, V17, P1317, DOI 10.1105/tpc.104.029116	55	34	38	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91135	10.1371/journal.pone.0091135	http://dx.doi.org/10.1371/journal.pone.0091135			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603887	Green Published, gold, Green Submitted			2022-12-25	WOS:000332483600135
J	Dong, Y; Ning, G; Ewing, AG; Heien, ML				Dong, Yan; Ning, Gang; Ewing, Andrew G.; Heien, Michael L.			Pituitary Adenylate Cyclase Activating Polypeptide Modulates Catecholamine Storage and Exocytosis in PC12 Cells	PLOS ONE			English	Article							PROTEIN-KINASE-A; SUBSTANTIA-NIGRA; QUANTAL SIZE; FUSION PORE; PERSISTENT STIMULATION; STRESS TRANSDUCTION; MICROARRAY ANALYSES; PARKINSONS-DISEASE; GENE-EXPRESSION; MESSENGER-RNA	A number of efforts have been made to understand how pituitary adenylate cyclase activating polypeptide (PACAP) functions as a neurotrophic and neuroprotective factor in Parkinson's disease (PD). Recently its effects on neurotransmission and underlying mechanisms have generated interest. In the present study, we investigate the effects of PACAP on catecholamine storage and secretion in PC12 cells with amperometry and transmission electron microscopy (TEM). PACAP increases quantal release induced by high K+ without significantly regulating the frequency of vesicle fusion events. TEM data indicate that the increased volume of the vesicle is mainly the result of enlargement of the fluidic space around the dense core. Moreover, the number of docked vesicles isn't modulated by PACAP. When cells are acutely treated with L-DOPA, the vesicular volume and quantal release both increase dramatically. It is likely that the characteristics of amperometric spikes from L-DOPA treated cells are associated with increased volume of individual vesicles rather than a direct effect on the mechanics of exocytosis. Treatment with PACAP versus L-DOPA results in different profiles of the dynamics of exocytosis. Release via the fusion pore prior to full exocytosis was observed with the same frequency following treatment with PACAP and L-DOPA. However, release events have a shorter duration and higher average current after PACAP treatment compared to L-DOPA. Furthermore, PACAP reduced the proportion of spikes having rapid decay time and shortened the decay time of both fast and slow spikes. In contrast, the distributions of the amperometric spike decay for both fast and slow spikes were shifted to longer time following L-DOPA treatment. Compared to L-DOPA, PACAP may produce multiple favorable effects on dopaminergic neurons, including protecting dopaminergic neurons against neurodegeneration and potentially regulating dopamine storage and release, making it a promising therapeutic agent for the treatment of PD.	[Dong, Yan] Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Dong, Yan; Ewing, Andrew G.; Heien, Michael L.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Ning, Gang] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Ewing, Andrew G.] Penn State Univ, Dept Neural & Behav Sci, Coll Med, Hershey, PA USA; [Ewing, Andrew G.] Univ Gothenburg, Dept Chem, Gothenburg, Sweden; [Heien, Michael L.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ USA	Naval Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Gothenburg; University of Arizona	Dong, Y (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China.	dongyan2006@yahoo.com; mheien@arizona.edu	Ewing, Andrew G/A-3650-2009; Heien, Michael/A-4731-2009	Heien, Michael/0000-0001-5164-9596	National Institutes of Health; Swedish Science Research Council (VR); Natural Science Foundation from Science and Technology Commission of Shanghai Municipality [11ZR1448700]; Research Foundation for Returned Scholars from Ministry of Education of China; European Union	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Science Research Council (VR)(Swedish Research Council); Natural Science Foundation from Science and Technology Commission of Shanghai Municipality; Research Foundation for Returned Scholars from Ministry of Education of China; European Union(European Commission)	This work was supported by the National Institutes of Health and the Swedish Science Research Council (VR) to AGE, and Natural Science Foundation from Science and Technology Commission of Shanghai Municipality (11ZR1448700), Research Foundation for Returned Scholars from Ministry of Education of China to Y.D. A.G.E. is supported by a Marie Curie Chair from the European Union's 6th Framework. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi K, 2001, BIOCHEM BIOPH RES CO, V286, P646, DOI 10.1006/bbrc.2001.5443; Atlasz T, 2010, ANN NY ACAD SCI, V1200, P128, DOI 10.1111/j.1749-6632.2010.05512.x; Barg S, 2002, NEURON, V33, P287, DOI 10.1016/S0896-6273(02)00563-9; Barzilai A, 2001, CELL MOL NEUROBIOL, V21, P215, DOI 10.1023/A:1010991020245; Benoit-Marand M, 2007, ELECTROCHEMICAL METH; Botia B, 2007, PEPTIDES, V28, P1746, DOI 10.1016/j.peptides.2007.04.013; Braas KM, 2007, PEPTIDES, V28, P1856, DOI 10.1016/j.peptides.2007.04.004; Bretou M, 2008, J NEUROSCI, V28, P8470, DOI 10.1523/JNEUROSCI.0860-08.2008; Brown D, 2013, J MOL NEUROSCI, V50, P600, DOI 10.1007/s12031-013-0015-7; Colliver TL, 2000, J NEUROSCI, V20, P5276, DOI 10.1523/JNEUROSCI.20-14-05276.2000; Corbitt J, 2002, NEUROPEPTIDES, V36, P34, DOI 10.1054/npep.2002.0885; Corbitt J, 1998, J NEUROCHEM, V71, P478; Costa L, 2009, HIPPOCAMPUS, V19, P99, DOI 10.1002/hipo.20488; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Deguil J, 2010, NEUROTOX RES, V17, P142, DOI 10.1007/s12640-009-9091-4; Eiden LE, 2008, ANN NY ACAD SCI, V1144, P6, DOI 10.1196/annals.1418.019; Fahn S, 2004, NEW ENGL J MED, V351, P2498; Fahn S, 1996, NEUROLOGY, V47, pS184, DOI 10.1212/WNL.47.6_Suppl_3.184S; Fahn S, 1997, CNS DRUGS, V8, P376, DOI 10.2165/00023210-199708050-00004; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Ghzili H, 2008, FRONT NEUROENDOCRIN, V29, P128, DOI 10.1016/j.yfrne.2007.10.001; Grumolato L, 2003, ENDOCRINOLOGY, V144, P2368, DOI 10.1210/en.2002-0106; Grumolato L, 2003, EUR J NEUROSCI, V17, P71, DOI 10.1046/j.1460-9568.2003.02426.x; Guillot TS, 2008, NEUROPEPTIDES, V42, P423, DOI 10.1016/j.npep.2008.04.003; Hashimoto H, 1996, J COMP NEUROL, V371, P567; Ishido M, 2004, REGUL PEPTIDES, V123, P15, DOI 10.1016/j.regpep.2004.05.020; Kalia LV, 2013, ANN NEUROL, V73, P155, DOI 10.1002/ana.23746; Kuri BA, 2009, J NEUROCHEM, V110, P1214, DOI 10.1111/j.1471-4159.2009.06206.x; Lynch KL, 2008, MOL BIOL CELL, V19, P5093, DOI 10.1091/mbc.E08-03-0235; Machado JD, 2001, MOL PHARMACOL, V60, P514; MASUO Y, 1992, BRAIN RES, V575, P113, DOI 10.1016/0006-8993(92)90430-H; Michel S, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-15; Mohrmann R, 2013, J NEUROSCI, V33, P14417, DOI 10.1523/JNEUROSCI.1236-13.2013; Mohrmann R, 2010, SCIENCE, V330, P502, DOI 10.1126/science.1193134; Muller T, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-10; Mustafa T, 2007, J BIOL CHEM, V282, P8079, DOI 10.1074/jbc.M609638200; Mustafa T, 2010, CELL SIGNAL, V22, P1420, DOI 10.1016/j.cellsig.2010.05.005; Nanmoku T, 2000, BIOCHEM BIOPH RES CO, V274, P310, DOI 10.1006/bbrc.2000.3137; Olanow CW, 2004, ANNU REV MED, V55, P41, DOI 10.1146/annurev.med.55.091902.104422; Omiatek DM, 2010, ACS CHEM NEUROSCI, V1, P234, DOI 10.1021/cn900040e; Plattner H, 1997, J CELL BIOL, V139, P1709, DOI 10.1083/jcb.139.7.1709; Pothos E, 1996, J NEUROCHEM, V66, P629; Pothos EN, 1998, J NEUROSCI, V18, P4106; Przywara DA, 1996, J BIOL CHEM, V271, P10545, DOI 10.1074/jbc.271.18.10545; Pugh PC, 2006, MOL CELL NEUROSCI, V31, P586, DOI 10.1016/j.mcn.2005.11.012; Rat D, 2011, FASEB J, V25, P3208, DOI 10.1096/fj.10-180133; Reglodi D, 2006, NEUROPEPTIDES, V40, P265, DOI 10.1016/j.npep.2006.06.001; Reglodi D, 2004, REGUL PEPTIDES, V123, P85, DOI 10.1016/j.regpep.2004.05.016; Reglodi D, 2011, CURR PHARM DESIGN, V17, P962, DOI 10.2174/138161211795589355; SCHROEDER TJ, 1992, ANAL CHEM, V64, P3077, DOI 10.1021/ac00048a003; Smith CB, 2012, J MOL NEUROSCI, V48, P403, DOI 10.1007/s12031-012-9749-x; Sombers LA, 2004, J NEUROSCI, V24, P303, DOI 10.1523/JNEUROSCI.1119-03.2004; Sombers LA, 2005, J NEUROCHEM, V93, P1122, DOI 10.1111/j.1471-4159.2005.03087.x; Stroth N, 2013, ENDOCRINOLOGY, V154, P330, DOI 10.1210/en.2012-1829; Sudhof TC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011353; Takei N, 1998, J NEUROSCI RES, V54, P698, DOI 10.1002/(SICI)1097-4547(19981201)54:5<698::AID-JNR15>3.0.CO;2-5; Taupenot L, 1999, HYPERTENSION, V34, P1152, DOI 10.1161/01.HYP.34.5.1152; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Wang G, 2005, FEBS LETT, V579, P4005, DOI 10.1016/j.febslet.2005.06.013; Wang G, 2008, NEUROPEPTIDES, V42, P267, DOI 10.1016/j.npep.2008.03.002; Watson MB, 2013, NEUROSCIENCE, V240, P277, DOI 10.1016/j.neuroscience.2013.03.002; Webb IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076365; Wong DL, 2002, ANN NY ACAD SCI, V971, P19, DOI 10.1111/j.1749-6632.2002.tb04428.x	63	6	6	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91132	10.1371/journal.pone.0091132	http://dx.doi.org/10.1371/journal.pone.0091132			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603879	Green Submitted, Green Published, gold			2022-12-25	WOS:000332483600134
J	Hao, JJ; Lee, R; Chang, A; Fan, J; Labib, C; Parsa, C; Orlando, R; Andresen, B; Huang, Y				Hao, Jijun; Lee, Rachel; Chang, Andy; Fan, Jeffery; Labib, Chantelle; Parsa, Cyrus; Orlando, Robert; Andresen, Bradley; Huang, Ying			DMH1, a Small Molecule Inhibitor of BMP Type I Receptors, Suppresses Growth and Invasion of Lung Cancer	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; TGF-BETA SUPERFAMILY; PROSTATE-CANCER; TUMOR-GROWTH; CELLS; METASTASIS; CARCINOMAS; EXPRESSION; PATHWAYS	The bone morphogenetic protein (BMP) signaling cascade is aberrantly activated in human non-small cell lung cancer (NSCLC) but not in normal lung epithelial cells, suggesting that blocking BMP signaling may be an effective therapeutic approach for lung cancer. Previous studies demonstrated that some BMP antagonists, which bind to extracellular BMP ligands and prevent their association with BMP receptors, dramatically reduced lung tumor growth. However, clinical application of protein-based BMP antagonists is limited by short half-lives, poor intra-tumor delivery as well as resistance caused by potential gain-of-function mutations in the downstream of the BMP pathway. Small molecule BMP inhibitors which target the intracellular BMP cascades would be ideal for anticancer drug development. In a zebrafish embryo-based structure and activity study, we previously identified a group of highly selective small molecule inhibitors specifically antagonizing the intracellular kinase domain of BMP type I receptors. In the present study, we demonstrated that DMH1, one of such inhibitors, potently reduced lung cell proliferation, promoted cell death, and decreased cell migration and invasion in NSCLC cells by blocking BMP signaling, as indicated by suppression of Smad 1/5/8 phosphorylation and gene expression of Id1, Id2 and Id3. Additionally, DMH1 treatment significantly reduced the tumor growth in human lung cancer xenograft model. In conclusion, our study indicates that small molecule inhibitors of BMP type I receptors may offer a promising novel strategy for lung cancer treatment.	[Hao, Jijun] Western Univ Hlth Sci, Coll Vet Med, Pomona, CA 91766 USA; [Lee, Rachel; Chang, Andy; Fan, Jeffery; Andresen, Bradley; Huang, Ying] Western Univ Hlth Sci, Coll Pharm, Pomona, CA USA; [Labib, Chantelle] Western Univ Hlth Sci, Coll Biomed Sci, Pomona, CA USA; [Parsa, Cyrus; Orlando, Robert] Western Univ Hlth Sci, Coll Osteopath Med, Dept Clin Sci, Pomona, CA USA	Western University of Health Sciences; Western University of Health Sciences; Western University of Health Sciences; Western University of Health Sciences	Hao, JJ (corresponding author), Western Univ Hlth Sci, Coll Vet Med, Pomona, CA 91766 USA.	jhao@westernu.edu; yhuang@westernu.edu		Andresen, Bradley/0000-0002-3948-7456	College of Veterinary Medicine at Western University of Health Sciences; Western University of Health Sciences Faculty Development Fund	College of Veterinary Medicine at Western University of Health Sciences; Western University of Health Sciences Faculty Development Fund	This work was supported by the seed fund of College of Veterinary Medicine at Western University of Health Sciences (J.H), and Western University of Health Sciences Faculty Development Fund (Y.H). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamgeer M, 2013, RESPIROLOGY, V18, P757, DOI 10.1111/resp.12094; Alarmo EL, 2010, ENDOCR-RELAT CANCER, V17, pR123, DOI 10.1677/ERC-09-0273; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Coppe JP, 2004, CLIN CANCER RES, V10, P2044, DOI 10.1158/1078-0432.CCR-03-0933; Cory G, 2011, METHODS MOL BIOL, V769, P25, DOI 10.1007/978-1-61779-207-6_2; Feeley BT, 2006, J BONE MINER RES, V21, P1571, DOI 10.1359/JBMR.060706; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Katsuno Y, 2008, ONCOGENE, V27, P6322, DOI 10.1038/onc.2008.232; Kosaka T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/165214; Langenfeld E, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-129; Langenfeld E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061256; Langenfeld EM, 2006, ONCOGENE, V25, P685, DOI 10.1038/sj.onc.1209110; Langenfeld EM, 2005, ANN THORAC SURG, V80, P1028, DOI 10.1016/j.athoracsur.2005.03.094; Langenfeld EM, 2004, MOL CANCER RES, V2, P141; Langenfeld EM, 2003, CARCINOGENESIS, V24, P1445, DOI 10.1093/carcin/bgg100; Lee KB, 2011, J ORTHOP RES, V29, P1712, DOI 10.1002/jor.21383; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Maegdefrau U, 2012, EXP MOL PATHOL, V92, P74, DOI 10.1016/j.yexmp.2011.10.004; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Thawani JP, 2010, NEUROSURGERY, V66, P233, DOI 10.1227/01.NEU.0000363722.42097.C2; Ye L, 2007, HISTOL HISTOPATHOL, V22, P1129, DOI 10.14670/HH-22.1129	24	34	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90748	10.1371/journal.pone.0090748	http://dx.doi.org/10.1371/journal.pone.0090748			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603907	Green Published, gold, Green Submitted			2022-12-25	WOS:000332483600079
J	Liang, WF; Zhao, YL; Liu, LQ; Wang, YC; Dong, ZL; Li, WJ; Lee, GB; Xiao, XB; Zhang, WJ				Liang, Wenfeng; Zhao, Yuliang; Liu, Lianqing; Wang, Yuechao; Dong, Zaili; Li, Wen Jung; Lee, Gwo-Bin; Xiao, Xiubin; Zhang, Weijing			Rapid and Label-Free Separation of Burkitt's Lymphoma Cells from Red Blood Cells by Optically-Induced Electrokinetics	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; DIELECTROPHORESIS; MANIPULATION; SYSTEM	Early stage detection of lymphoma cells is invaluable for providing reliable prognosis to patients. However, the purity of lymphoma cells in extracted samples from human patients' marrow is typically low. To address this issue, we report here our work on using optically-induced dielectrophoresis (ODEP) force to rapidly purify Raji cells' (a type of Burkitt's lymphoma cell) sample from red blood cells (RBCs) with a label-free process. This method utilizes dynamically moving virtual electrodes to induce negative ODEP force of varying magnitudes on the Raji cells and RBCs in an optically-induced electrokinetics (OEK) chip. Polarization models for the two types of cells that reflect their discriminate electrical properties were established. Then, the cells' differential velocities caused by a specific ODEP force field were obtained by a finite element simulation model, thereby established the theoretical basis that the two types of cells could be separated using an ODEP force field. To ensure that the ODEP force dominated the separation process, a comparison of the ODEP force with other significant electrokinetics forces was conducted using numerical results. Furthermore, the performance of the ODEP-based approach for separating Raji cells from RBCs was experimentally investigated. The results showed that these two types of cells, with different concentration ratios, could be separated rapidly using externally-applied electrical field at a driven frequency of 50 kHz at 20 V-pp. In addition, we have found that in order to facilitate ODEP-based cell separation, Raji cells' adhesion to the OEK chip's substrate should be minimized. This paper also presents our experimental results of finding the appropriate bovine serum albumin concentration in an isotonic solution to reduce cell adhesion, while maintaining suitable medium conductivity for electrokinetics-based cell separation. In short, we have demonstrated that OEK technology could be a promising tool for efficient and effective purification of Raji cells from RBCs.	[Liang, Wenfeng; Liu, Lianqing; Wang, Yuechao; Dong, Zaili; Li, Wen Jung] Chinese Acad Sci, Shenyang Inst Automat, State Key Lab Robot, Shenyang 110016, Peoples R China; [Liang, Wenfeng] Univ Chinese Acad Sci, Beijing, Peoples R China; [Liang, Wenfeng; Zhao, Yuliang; Li, Wen Jung] City Univ Hong Kong, Dept Mech & Biomed Engn, Kowloon, Hong Kong, Peoples R China; [Lee, Gwo-Bin] Natl Tsing Hua Univ, Dept Power Mech Engn, Hsinchu, Taiwan; [Xiao, Xiubin; Zhang, Weijing] Acad Mil Med Sci, Affiliated Hosp, Dept Lymphoma, Beijing, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Automation, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; City University of Hong Kong; National Tsing Hua University; Academy of Military Medical Sciences - China	Liu, LQ (corresponding author), Chinese Acad Sci, Shenyang Inst Automat, State Key Lab Robot, Shenyang 110016, Peoples R China.	lqliu@sia.cn; wenjli@cityu.edu.hk	Zhang, Weijing/GQA-9455-2022; Lee, Gwo-Bin Vincent/D-3032-2012; Li, Wen Jung/A-6153-2010	Lee, Gwo-Bin Vincent/0000-0001-6910-9133; Li, Wen Jung/0000-0001-9616-6213; Wenhua, Liang/0000-0002-1391-8238; Liang, Wenfeng/0000-0002-6605-2511	National Natural Science Foundation of China [61107043]; CAS-Croucher Joint Lab Scheme [9500011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS-Croucher Joint Lab Scheme	The work was supported by National Natural Science Foundation of China (Project No. 61107043) http://www.nsfc.gov.cn; CAS-Croucher Joint Lab Scheme (Project No. 9500011) http://www.croucher.org.hk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustsson P, 2012, ANAL CHEM, V84, P7954, DOI 10.1021/ac301723s; BOYUM A, 1976, SCAND J IMMUNOL, P9, DOI 10.1111/j.1365-3083.1976.tb03851.x; Castellanos A, 2003, J PHYS D APPL PHYS, V36, P2584, DOI 10.1088/0022-3727/36/20/023; Chau LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051577; Chiou PY, 2005, NATURE, V436, P370, DOI 10.1038/nature0383l; Gao J, 2012, ANALYST, V137, P5215, DOI 10.1039/c2an35707k; Hsu HY, 2010, LAB CHIP, V10, P165, DOI 10.1039/b906593h; Huang CJ, 2011, MICROFLUID NANOFLUID, V10, P37, DOI 10.1007/s10404-010-0644-x; Huang SB, 2013, LAB CHIP, V13, P1371, DOI 10.1039/c3lc41256c; Huang SB, 2012, INT J ELECTROCHEM SC, V7, P12656; Hwang H, 2009, BIOMICROFLUIDICS, V3, DOI 10.1063/1.3086600; Janeway CA, 2001, IMMUNOBIOLOGY; Jones T. B., 1995, ELECTROMECHANICS PAR; KAKUTANI T, 1993, BIOELECTROCH BIOENER, V31, P131, DOI 10.1016/0302-4598(93)80002-C; Lau ANK, 2009, LAB CHIP, V9, P2952, DOI 10.1039/b907840a; Li M, 2012, SCI CHINA LIFE SCI, V55, P968, DOI 10.1007/s11427-012-4399-3; Li M, 2011, BIOCHEM BIOPH RES CO, V404, P689, DOI 10.1016/j.bbrc.2010.12.043; Liang WF, 2012, MICROMACHINES-BASEL, V3, P492, DOI 10.3390/mi3020492; Liang WF, 2013, SENSOR ACTUAT A-PHYS, V193, P103, DOI 10.1016/j.sna.2013.01.020; Lin YH, 2010, SENSOR ACTUAT B-CHEM, V145, P854, DOI 10.1016/j.snb.2010.01.019; Lin YH, 2009, OPT EXPRESS, V17, P15318, DOI 10.1364/OE.17.015318; Mikolajczyk S. D., 2011, J ONCOL, V2011, P1, DOI [DOI 10.1186/1477-7819-4-67, 10.1186/1477-7819-4-67]; Moon HS, 2011, LAB CHIP, V11, P1118, DOI [10.1039/c0lc00345j, 10.1039/c01c00345j]; Morgan H., 2003, AC ELECTROKINETICS C, Vfirst; Ohta AT, 2007, IEEE J SEL TOP QUANT, V13, P235, DOI 10.1109/JSTQE.2007.893558; Ohta AT, 2010, LAB CHIP, V10, P3213, DOI [10.1039/c0lc00072h, 10.1039/C0LC00072H]; Polevaya Y, 1999, BBA-BIOMEMBRANES, V1419, P257, DOI 10.1016/S0005-2736(99)00072-3; Rosenberg R, 2002, CYTOMETRY, V49, P150, DOI 10.1002/cyto.10161; Ryu BY, 2005, P NATL ACAD SCI USA, V102, P14302, DOI 10.1073/pnas.0506970102; Sun JS, 2012, LAB CHIP, V12, P3952, DOI 10.1039/c2lc40679a; Talasaz AH, 2009, P NATL ACAD SCI USA, V106, P3970, DOI 10.1073/pnas.0813188106; Valley JK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010160; VETTORE L, 1980, AM J HEMATOL, V8, P291, DOI 10.1002/ajh.2830080307; Wang S, 2011, MICROMACHINES-BASEL, V2, P431, DOI 10.3390/mi2040431; Yang J, 1999, ANAL CHEM, V71, P911, DOI 10.1021/ac981250p	35	115	117	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e90827	10.1371/journal.pone.0090827	http://dx.doi.org/10.1371/journal.pone.0090827			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	25329056	gold, Green Submitted, Green Published			2022-12-25	WOS:000332485800056
J	Burns, DA; Woodruff, LG; Bradley, PM; Cannon, WF				Burns, Douglas A.; Woodruff, Laurel G.; Bradley, Paul M.; Cannon, William F.			Mercury in the Soil of Two Contrasting Watersheds in the Eastern United States	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; ATMOSPHERIC DEPOSITION; METHYL MERCURY; UPLAND FOREST; BULK-DENSITY; PATTERNS; METHYLMERCURY; DYNAMICS; CARBON; SEQUESTRATION	Soil represents the largest store of mercury (Hg) in terrestrial ecosystems, and further study of the factors associated with soil Hg storage is needed to address concerns about the magnitude and persistence of global environmental Hg bioaccumulation. To address this need, we compared total Hg and methyl Hg concentrations and stores in the soil of different landscapes in two watersheds in different geographic settings with similar and relatively high methyl Hg concentrations in surface waters and biota, Fishing Brook, Adirondack Mountains, New York, and McTier Creek, Coastal Plain, South Carolina. Median total Hg concentrations and stores in organic and mineral soil samples were three-fold greater at Fishing Brook than at McTier Creek. Similarly, median methyl Hg concentrations were about two-fold greater in Fishing Brook soil than in McTier Creek soil, but this difference was significant only for mineral soil samples, and methyl Hg stores were not significantly different among these watersheds. In contrast, the methyl Hg/total Hg ratio was significantly greater at McTier Creek suggesting greater climate-driven methylation efficiency in the Coastal Plain soil than that of the Adirondack Mountains. The Adirondack soil had eight-fold greater soil organic matter than that of the Coastal Plain, consistent with greater total Hg stores in the northern soil, but soil organic matter - total Hg relations differed among the sites. A strong linear relation was evident at McTier Creek (r(2) = 0.68; p<0.001), but a linear relation at Fishing Brook was weak (r(2) = 0.13; p<0.001) and highly variable across the soil organic matter content range, suggesting excess Hg binding capacity in the Adirondack soil. These results suggest greater total Hg turnover time in Adirondack soil than that of the Coastal Plain, and that future declines in stream water Hg concentrations driven by declines in atmospheric Hg deposition will be more gradual and prolonged in the Adirondacks.	[Burns, Douglas A.] US Geol Survey, Troy, NY 12180 USA; [Woodruff, Laurel G.] US Geol Survey, Mountain View, CA USA; [Bradley, Paul M.] US Geol Survey, Columbia, SC USA; [Cannon, William F.] US Geol Survey, Reston, VA 22092 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Burns, DA (corresponding author), US Geol Survey, Troy, NY 12180 USA.	daburns@usgs.gov	Burns, Douglas/A-7507-2009; Spencer, Thomas/AAD-6434-2020; Bradley, Paul M./AAC-2451-2020; navakanitworakul, raphatphorn/T-5948-2017	Bradley, Paul M./0000-0001-7522-8606; navakanitworakul, raphatphorn/0000-0001-6408-0079; Spencer, Thomas/0000-0003-2815-766X; Burns, Douglas/0000-0001-6516-2869; Burns, Gregory/0000-0003-0021-4319	United States Environmental Protection Agency; National Water Quality Assessment Program of the United States Geological Survey; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061580] Funding Source: NIH RePORTER	United States Environmental Protection Agency(United States Environmental Protection Agency); National Water Quality Assessment Program of the United States Geological Survey; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding for this work was provided by the United States Environmental Protection Agency and the National Water Quality Assessment Program of the United States Geological Survey. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS WA, 1973, J SOIL SCI, V24, P10, DOI 10.1111/j.1365-2389.1973.tb00737.x; Aelion CM, 2009, SCI TOTAL ENVIRON, V407, P2216, DOI 10.1016/j.scitotenv.2008.11.033; Akerblom S, 2008, WATER AIR SOIL POLL, V189, P239, DOI 10.1007/s11270-007-9571-1; [Anonymous], WATER AIR SOIL POLLU; Arfstrom C, 2000, WATER AIR SOIL POLL, V121, P133, DOI 10.1023/A:1005214908516; ASHWAL LD, 1982, AM MINERAL, V67, P14; Bradley PM, 2013, ENVIRON POLLUT, V172, P42, DOI 10.1016/j.envpol.2012.08.008; Bradley PM, 2011, ENVIRON SCI TECHNOL, V45, P2048, DOI 10.1021/es103923j; BROADBENT FE, 1953, ADV AGRON, V5, P153, DOI 10.1016/S0065-2113(08)60229-1; Brown Z.A., 2002, ANAL METHODS CHEM AN, P1; Burns DA, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001812; Burns DA, 2013, BIOGEOCHEMISTRY, V113, P451, DOI 10.1007/s10533-012-9773-5; Burt R, 2003, J ENVIRON QUAL, V32, P2109, DOI 10.2134/jeq2003.2109; Bushey JT, 2008, ATMOS ENVIRON, V42, P6905, DOI 10.1016/j.atmosenv.2008.05.043; Chen X, 2010, ENVIRON POLLUT, V158, P48, DOI 10.1016/j.envpol.2009.08.028; Dahl T.E., 2009, DATA COLLECTION REQU; De Vos B, 2005, SOIL SCI SOC AM J, V69, P500, DOI 10.2136/sssaj2005.0500; Demers JD, 2007, ECOL APPL, V17, P1341, DOI 10.1890/06-1697.1; Demers JD, 2013, J GEOPHYS RES-BIOGEO, V118, P825, DOI 10.1002/jgrg.20066; Desaules A, 2012, ENVIRON MONIT ASSESS, V184, P487, DOI 10.1007/s10661-011-1982-1; DeWild JF, 2004, 5A7 US GEOL SURV; Duffera M, 2007, GEODERMA, V137, P327, DOI 10.1016/j.geoderma.2006.08.018; Evers DC, 2007, BIOSCIENCE, V57, P29, DOI 10.1641/B570107; FEDERER CA, 1993, CAN J FOREST RES, V23, P1026, DOI 10.1139/x93-131; Fu XW, 2010, ENVIRON POLLUT, V158, P2324, DOI 10.1016/j.envpol.2010.01.032; Gabriel MC, 2004, ENVIRON GEOCHEM HLTH, V26, P421, DOI 10.1007/s10653-004-1308-0; Gerbig C., 2012, ENV CHEM TOXICOLOGY, DOI [10.1002/9781118146644.ch8, DOI 10.1002/9781118146644.CH8]; Grigal DF, 2003, J ENVIRON QUAL, V32, P393, DOI 10.2134/jeq2003.0393; Guo YY, 2006, SOIL SCI SOC AM J, V70, P601, DOI 10.2136/sssaj2005.0163; Harrison RB, 2003, SOIL SCI SOC AM J, V67, P1602, DOI 10.2136/sssaj2003.1602; Helsel D. R., 2005, NONDETECTS DATA ANAL; Homer C, 2004, PHOTOGRAMM ENG REM S, V70, P829, DOI 10.14358/PERS.70.7.829; Journey CA, 2012, 20125173 US GEOL SUR; Kiernan BD, 2003, ENVIRON POLLUT, V123, P347, DOI 10.1016/S0269-7491(03)00023-X; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; LaPoint S. D., 2004, WETLANDS EFFECTS DAT; Lindqvist O, 1994, WATER AIR SOIL POLL, V55, P1; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Markewich H. W., 1990, Geomorphology, V3, P417, DOI 10.1016/0169-555X(90)90015-I; McGee GG, 2007, J TORREY BOT SOC, V134, P253, DOI 10.3159/1095-5674(2007)134[253:RAFACA]2.0.CO;2; Mitchell CPJ, 2008, ENVIRON SCI TECHNOL, V42, P1010, DOI 10.1021/es0704986; NATER EA, 1992, NATURE, V358, P139, DOI 10.1038/358139a0; Obrist D, 2011, ENVIRON SCI TECHNOL, V45, P3974, DOI 10.1021/es104384m; Obrist D, 2012, ENVIRON SCI TECHNOL, V46, P5921, DOI 10.1021/es2045579; Park JH, 2005, ENVIRON SCI TECHNOL, V39, P6993, DOI 10.1021/es048301m; Post WM, 2000, GLOBAL CHANGE BIOL, V6, P317, DOI 10.1046/j.1365-2486.2000.00308.x; Ravichandran M, 2004, CHEMOSPHERE, V55, P319, DOI 10.1016/j.chemosphere.2003.11.011; Richardson G. Mark, 2003, Environmental Reviews, V11, P17, DOI 10.1139/a03-004; Richardson JB, 2013, ENVIRON POLLUT, V182, P127, DOI 10.1016/j.envpol.2013.07.011; Riva-Murray K, 2011, ECOTOXICOLOGY, V9, P1; Rogers VA, 1985, SOIL SURVEY AIKEN CO; Schelker J, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001330; Schwesig D, 1999, WATER AIR SOIL POLL, V113, P141, DOI 10.1023/A:1005080922234; Scudder BC, 2009, 20095109 US GEOL SUR; Scudder Eikenberry BC, 2012, 20111318 US GEOL SUR; Selin NE, 2009, ANNU REV ENV RESOUR, V34, P43, DOI 10.1146/annurev.environ.051308.084314; SHANLEY JB, 2002, EOS T, V83, P45, DOI DOI 10.1029/2002E0000031; Silverman M. H., 2006, SOIL SURVEY HAMILTON; Skyllberg U, 2003, BIOGEOCHEMISTRY, V64, P53, DOI 10.1023/A:1024904502633; Smith DB, 2009, APPL GEOCHEM, V24, P1357, DOI 10.1016/j.apgeochem.2009.04.008; Smith-Downey NV, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001124; Tipping E, 2011, ENVIRON POLLUT, V159, P3721, DOI 10.1016/j.envpol.2011.07.011; Tjerngren I, 2012, BIOGEOCHEMISTRY, V108, P335, DOI 10.1007/s10533-011-9603-1; WANG W, 1995, ENVIRON SCI TECHNOL, V29, P2261, DOI 10.1021/es00009a016; Wiener JG, 2006, ENVIRON SCI TECHNOL, V40, P6261, DOI 10.1021/es060822h; Woodruff LG, 2010, ENVIRON SCI TECHNOL, V44, P5371, DOI 10.1021/es100544d; Woodruff LG, 2009, APPL GEOCHEM, V24, P1369, DOI 10.1016/j.apgeochem.2009.04.009; Woodruff LG, 2010, 516 US GEOL SURV	68	176	184	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e86855	10.1371/journal.pone.0086855	http://dx.doi.org/10.1371/journal.pone.0086855			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24614226	Green Published, gold, Green Submitted			2022-12-25	WOS:000331271500010
J	Ji, X; Xu, H; Zhang, H; Hillery, CA; Gao, HQ; Pritchard, KA				Ji, Xiang; Xu, Hao; Zhang, Hao; Hillery, Cheryl A.; Gao, Hai-qing; Pritchard, Kirkwood A., Jr.			Anion Exchange HPLC Isolation of High-Density Lipoprotein (HDL) and On-Line Estimation of Proinflammatory HDL	PLOS ONE			English	Article							SICKLE-CELL-DISEASE; CHOLESTEROL LEVELS; ANTIINFLAMMATORY PROPERTIES; INHIBITS 3; ATHEROSCLEROSIS; INFLUENZA; TRANSPORT; VASODILATION; LOVASTATIN; PROTEINS	Proinflammatory high-density lipoprotein (p-HDL) is a biomarker of cardiovascular disease. Sickle cell disease (SCD) is characterized by chronic states of oxidative stress that many consider to play a role in forming p-HDL. To measure p-HDL, apolipoprotein (apo) B containing lipoproteins are precipitated. Supernatant HDL is incubated with an oxidant/LDL or an oxidant alone and rates of HDL oxidation monitored with dichlorofluorescein (DCFH). Although apoB precipitation is convenient for isolating HDL, the resulting supernatant matrix likely influences HDL oxidation. To determine effects of supernatants on p-HDL measurements we purified HDL from plasma from SCD subjects by anion exchange (AE) chromatography, determined its rate of oxidation relative to supernatant HDL. SCD decreased total cholesterol but not triglycerides or HDL and increased cell-free (cf) hemoglobin (Hb) and xanthine oxidase (XO). HDL isolated by AE-HPLC had lower p-HDL levels than HDL in supernatants after apoB precipitation. XO+xanthine (X) and cf Hb accelerated purified HDL oxidation. Although the plate and AE-HPLC assays both showed p-HDL directly correlated with cf-Hb in SCD plasma, the plate assay yielded p-HDL data that was influenced more by cf-Hb than AE-HPLC generated p-HDL data. The AE-HPLC p-HDL assay reduces the influence of the supernatants and shows that SCD increases p-HDL.	[Ji, Xiang; Gao, Hai-qing] Shandong Univ, Qilu Hosp, Dept Geriatr, Key Lab Cardiovasc Prote Shandong Prov, Jinan 250100, Shandong, Peoples R China; [Ji, Xiang; Xu, Hao; Zhang, Hao; Gao, Hai-qing; Pritchard, Kirkwood A., Jr.] Med Coll Wisconsin, Dept Surg, Div Pediat Surg, Milwaukee, WI 53226 USA; [Hillery, Cheryl A.] Med Coll Wisconsin, Dept Pediat, Div Hematol, Milwaukee, WI 53226 USA; [Hillery, Cheryl A.] Blood Res Inst, Milwaukee, WI USA; [Xu, Hao; Zhang, Hao; Hillery, Cheryl A.; Pritchard, Kirkwood A., Jr.] Childrens Res Inst, Milwaukee, WI USA; [Xu, Hao; Zhang, Hao; Hillery, Cheryl A.; Pritchard, Kirkwood A., Jr.] Med Coll Wisconsin, Milwaukee, WI 53226 USA	Shandong University; Medical College of Wisconsin; Medical College of Wisconsin; Versiti Blood Center of Wisconsin; Medical College of Wisconsin	Pritchard, KA (corresponding author), Med Coll Wisconsin, Dept Surg, Div Pediat Surg, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA.	kpritch@mcw.edu	He, Zhen/D-1275-2009	He, Zhen/0000-0001-6302-6556	American Heart Association [11SDG5120015]; National Institutes of Health [HL-102996, HL-102836, U54 HL-090503]; Midwest Athletes Against Childhood Cancer Fund; Chinese Government Graduate Student Overseas Study Program by China Scholarship Council [201206220063]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL090503, R01HL102836, R01HL112270, R21HL102996] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Midwest Athletes Against Childhood Cancer Fund; Chinese Government Graduate Student Overseas Study Program by China Scholarship Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association Grant 11SDG5120015 (to HZ); National Institutes of Health Grants HL-102996 (to KAP), HL-102836 (to KAP and CAH), U54 HL-090503 (to CAH) and Midwest Athletes Against Childhood Cancer Fund (to CAH). Chinese Government Graduate Student Overseas Study Program by China Scholarship Council (File No. 201206220063) to XJ and HQG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; Aslan M, 2001, P NATL ACAD SCI USA, V98, P15215, DOI 10.1073/pnas.221292098; ASSMANN G, 1993, CIRCULATION, V87, P28; CHUANG PT, 1990, ARTERIOSCLEROSIS, V10, P188, DOI 10.1161/01.ATV.10.2.188; Degoma EM, 2008, J AM COLL CARDIOL, V51, P2199, DOI 10.1016/j.jacc.2008.03.016; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Frei AC, 2008, BLOOD, V112, P398, DOI 10.1182/blood-2007-12-126714; Gharavi NM, 2007, ARTERIOSCL THROM VAS, V27, P1346, DOI 10.1161/ATVBAHA.107.141283; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Gurfinkel EP, 2002, CIRCULATION, V105, P2143, DOI 10.1161/01.CIR.0000016182.85461.F4; Hanson MS, 2012, AM J PHYSL HEART CIR; HATEFI Y, 1969, P NATL ACAD SCI USA, V62, P1129, DOI 10.1073/pnas.62.4.1129; Hillery CA, 2000, BRIT J HAEMATOL, V109, P322, DOI 10.1046/j.1365-2141.2000.02040.x; Hirowatari Y, 2003, J LIPID RES, V44, P1404, DOI 10.1194/jlr.D300003-JLR200; ITSKOVITZ HD, 1989, CLIN THER, V11, P862; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kuvin JT, 2002, AM HEART J, V144, P165, DOI 10.1067/mhj.2002.123145; Mastorikou M, 2006, DIABETES, V55, P3099, DOI 10.2337/db06-0723; Navab M, 2000, J LIPID RES, V41, P1481; Navab M, 2000, J LIPID RES, V41, P1495; NAVAB M, 1995, AM J CARDIOL, V76, pC18, DOI 10.1016/S0002-9149(99)80466-4; Navab M, 2001, J LIPID RES, V42, P1308; Ou JS, 2005, CIRC RES, V97, P1190, DOI 10.1161/01.RES.0000190634.60042.cb; Pritchard KA, 2004, AM J PHYSIOL-LUNG C, V286, pL705, DOI 10.1152/ajplung.00288.2002; REYNOLDS GD, 1985, AM J PATHOL, V121, P200; SADRZADEH SMH, 1984, J BIOL CHEM, V259, P4354; TILLETT HE, 1983, INT J EPIDEMIOL, V12, P344, DOI 10.1093/ije/12.3.344; TOLKACHEVA NV, 1989, VOP MED KHIM, V35, P89; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Van Lenten BJ, 2001, CIRCULATION, V103, P2283; VanLenten BJ, 1995, J CLIN INVEST, V96, P2758, DOI 10.1172/JCI118345; VINCENT SH, 1988, ARCH BIOCHEM BIOPHYS, V265, P539, DOI 10.1016/0003-9861(88)90159-2; Weihrauch D, 2007, AM J PHYSIOL-HEART C, V293, pH1432, DOI 10.1152/ajpheart.00038.2007; Woo JMP, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3020; Wood KC, 2008, FREE RADICAL BIO MED, V44, P1506, DOI 10.1016/j.freeradbiomed.2008.01.008; Xu H, 2006, FASEB J, V20, pA198; Yuditskaya S, 2009, BLOOD, V113, P1122, DOI 10.1182/blood-2008-03-142604; Zorn U, 2001, ELECTROPHORESIS, V22, P1143, DOI 10.1002/1522-2683()22:6<1143::AID-ELPS1143>3.0.CO;2-Q	38	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91089	10.1371/journal.pone.0091089	http://dx.doi.org/10.1371/journal.pone.0091089			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	25202990	Green Published, Green Submitted, gold			2022-12-25	WOS:000332485800098
J	Wang, AT; Fan, JQ; Van Houten, HK; Tilburt, JC; Stout, NK; Montori, VM; Shah, ND				Wang, Amy T.; Fan, Jiaquan; Van Houten, Holly K.; Tilburt, Jon C.; Stout, Natasha K.; Montori, Victor M.; Shah, Nilay D.			Impact of the 2009 US Preventive Services Task Force Guidelines on Screening Mammography Rates on Women in Their 40s	PLOS ONE			English	Article							BREAST-CANCER; RECOMMENDATIONS; OLDER	Background: The 2009 US Preventive Services Task Force breast cancer screening update recommended against routine screening mammography for women aged 40-49; confusion and release of conflicting guidelines followed. We examined the impact of the USPSTF update on population-level screening mammography rates in women ages 40-49. Methods and Findings: We conducted a retrospective, interrupted time-series analysis using a nationally representative, privately-insured population from 1/1/2006-12/31/2011. Women ages 40-64 enrolled for >= 1 month were included. The primary outcome was receipt of screening mammography, identified using administrative claims-based algorithms. Time-series regression models were estimated to determine the effect of the guideline change on screening mammography rates. 5.5 million women ages 40-64 were included. A 1.8 per 1,000 women (p = 0.003) decrease in monthly screening mammography rates for 40-49 year-old women was observed two months following the guideline change; no initial effect was seen for 50-64 year-old women. However, two years following the guideline change, a slight increase in screening mammography rates above expected was observed in both age groups. Conclusions: We detected a modest initial drop in screening mammography rates in women ages 40-49 immediately after the 2009 USPSTF guideline followed by an increase in screening rates. Unfavorable public reactions and release of conflicting statements may have tempered the initial impact. Renewal of the screening debate may have brought mammography to the forefront of women's minds, contributing to the observed increase in mammography rates two years after the guideline change. This pattern is unlikely to reflect informed choice and underscores the need for improved translation of evidence-based care and guidelines into practice.	[Wang, Amy T.; Tilburt, Jon C.] Mayo Clin, Div Gen Internal Med, Rochester, MN USA; [Wang, Amy T.; Tilburt, Jon C.; Montori, Victor M.; Shah, Nilay D.] Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN 55905 USA; [Fan, Jiaquan; Van Houten, Holly K.; Montori, Victor M.; Shah, Nilay D.] Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN USA; [Stout, Natasha K.] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA; [Stout, Natasha K.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Montori, Victor M.] Mayo Clin, Div Endocrinol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Mayo Clinic	Shah, ND (corresponding author), Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN 55905 USA.	shah.nilay@mayo.edu	amy.tu.wang, amy.tu.wang/F-8331-2014	amy.tu.wang, amy.tu.wang/0000-0002-0929-1399; Montori, Victor/0000-0003-0595-2898	Small Grants Program; Division of General Internal Medicine, Mayo Clinic, Rochester, Minnesota	Small Grants Program; Division of General Internal Medicine, Mayo Clinic, Rochester, Minnesota	This work was supported by the Small Grants Program sponsored by the Division of General Internal Medicine, Mayo Clinic, Rochester, Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM COLL OBST GYN, 2009, OBSTET GYNECOL, V114, P1409; American College of Obstetricians and Gynecologists, 2012, OBSTET GYNECOL, V120, P1222, DOI DOI 10.1097/AOG.1220B1013-318277C318292A; American College of Surgeons, 2010, B AM COLL SURG, V95, P51; Bevers TB, 2009, J NATL COMPR CANC NE, V7, P1060, DOI 10.6004/jnccn.2009.0070; Block LD, 2013, J GEN INTERNAL MED; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Dorn SD, 2012, CLIN GASTROENTEROL H, V10, P278, DOI 10.1016/j.cgh.2011.11.020; Fenton JJ, 2012, MED CARE; IMS Health, 2012, IMS RXBENCHMARK PHAR; Institute KPCM, 2010, BREAST CANC SCREEN C; Lee CH, 2010, J AM COLL RADIOL, V7, P18, DOI 10.1016/j.jacr.2009.09.022; Pace LE, 2013, CANCER-AM CANCER SOC, V119, P2518, DOI 10.1002/cncr.28105; Qaseem A, 2007, ANN INTERN MED, V146, P511, DOI 10.7326/0003-4819-146-7-200704030-00007; Randolph WM, 2002, HEALTH SERV RES, V37, P1643, DOI 10.1111/1475-6773.10912; Smith-Bindman R, 2006, MED CARE, V44, P463, DOI 10.1097/01.mlr.0000207436.07513.79; Squiers LB, 2011, AM J PREV MED, V40, P497, DOI 10.1016/j.amepre.2010.12.027; Stempel DA, 2001, RESP MED, V95, P227, DOI 10.1053/rmed.2000.1027; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x	18	127	128	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91399	10.1371/journal.pone.0091399	http://dx.doi.org/10.1371/journal.pone.0091399			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	25343354	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400087
J	Burns, G; Brooks, K; Wildung, M; Navakanitworakul, R; Christenson, LK; Spencer, TE				Burns, Gregory; Brooks, Kelsey; Wildung, Mark; Navakanitworakul, Raphatphorn; Christenson, Lane K.; Spencer, Thomas E.			Extracellular Vesicles in Luminal Fluid of the Ovine Uterus	PLOS ONE			English	Article							GASTRIN-RELEASING-PEPTIDE; ENDOGENOUS RETROVIRUSES; INTERFERON-TAU; EXOSOMES; PREGNANCY; EXPRESSION; MICRORNAS; PROTEIN; GENES; RNA	Microvesicles and exosomes are nanoparticles released from cells and can contain small RNAs, mRNA and proteins that affect cells at distant sites. In sheep, endogenous beta retroviruses (enJSRVs) are expressed in the endometrial epithelia of the uterus and can be transferred to the conceptus trophectoderm. One potential mechanism of enJSRVs transfer from the uterus to the conceptus is via exosomes/microvesicles. Therefore, studies were conducted to evaluate exosomes in the uterine luminal fluid (ULF) of sheep. Exosomes/microvesicles (hereafter referred to as extracellular vesicles) were isolated from the ULF of day 14 cyclic and pregnant ewes using ExoQuick-TC. Transmission electron microscopy and nanoparticle tracking analysis found the isolates contained vesicles that ranged from 50 to 200 nm in diameter. The isolated extracellular vesicles were positive for two common markers of exosomes (CD63 and HSP70) by Western blot analysis. Proteins in the extracellular vesicles were determined by mass spectrometry and Western blot analysis. Extracellular vesicle RNA was analyzed for small RNAs by sequencing and enJSRVs RNA by RT-PCR. The ULF extracellular vesicles contained a large number of small RNAs and miRNAs including 81 conserved mature miRNAs. Cyclic and pregnant ULF extracellular vesicles contained enJSRVs env and gag RNAs that could be delivered to heterologous cells in vitro. These studies support the hypothesis that ULF extracellular vesicles can deliver enJSRVs RNA to the conceptus, which is important as enJSRVs regulate conceptus trophectoderm development. Importantly, these studies support the idea that extracellular vesicles containing select miRNAs, RNAs and proteins are present in the ULF and likely have a biological role in conceptus-endometrial interactions important for the establishment and maintenance of pregnancy.	[Burns, Gregory; Brooks, Kelsey; Spencer, Thomas E.] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA; [Wildung, Mark] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Navakanitworakul, Raphatphorn; Christenson, Lane K.] Univ Kansas, Dept Mol & Integrat Physiol, Sch Med, Kansas City, KS USA	Washington State University; Washington State University; University of Kansas; University of Kansas Medical Center	Spencer, TE (corresponding author), Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA.	thomas.spencer@wsu.edu	Burns, Douglas/A-7507-2009; Spencer, Thomas/AAD-6434-2020; Bradley, Paul M./AAC-2451-2020; navakanitworakul, raphatphorn/T-5948-2017	Bradley, Paul M./0000-0001-7522-8606; navakanitworakul, raphatphorn/0000-0001-6408-0079; Spencer, Thomas/0000-0003-2815-766X; Burns, Douglas/0000-0001-6516-2869; Burns, Gregory/0000-0003-0021-4319	USDA National Institute of Food and Agriculture [2012-67015-30173]; National Institute of Health [HD061580]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061580] Funding Source: NIH RePORTER	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported in part by AFRI Competitive Grant 2012-67015-30173 (TES) from the USDA National Institute of Food and Agriculture and HD061580 (LKC) from the National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliotta JM, 2010, EXP HEMATOL, V38, P233, DOI 10.1016/j.exphem.2010.01.002; Arnaud F, 2007, PLOS PATHOG, V3, P1716, DOI 10.1371/journal.ppat.0030170; Bazer FW, 2010, MOL HUM REPROD, V16, P135, DOI 10.1093/molehr/gap095; BAZER FW, 1975, J ANIM SCI, V41, P1376, DOI 10.2527/jas1975.4151376x; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Black SG, 2010, J VIROL, V84, P9078, DOI 10.1128/JVI.00950-10; Dorniak P, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097063; Dorniak P, 2011, BIOL REPROD, V84, P1119, DOI 10.1095/biolreprod.110.089979; Dunlap KA, 2006, P NATL ACAD SCI USA, V103, P14390, DOI 10.1073/pnas.0603836103; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; FLECHON JE, 1986, REPROD NUTR DEV, V26, P1017, DOI 10.1051/rnd:19860609; Forbes K, 2012, PLACENTA, V33, P581, DOI 10.1016/j.placenta.2012.03.006; Forde N, 2010, PHYSIOL GENOMICS, V41, P53, DOI 10.1152/physiolgenomics.00162.2009; Frangsmyr L, 2005, MOL HUM REPROD, V11, P35, DOI 10.1093/molehr/gah129; FRASER M, 1994, ENDOCRINOLOGY, V135, P2440, DOI 10.1210/en.135.6.2440; Gifford CA, 2007, J DAIRY SCI, V90, P274, DOI 10.3168/jds.S0022-0302(07)72628-0; GIRAUD A, 1994, ENDOCRINOLOGY, V135, P2806, DOI 10.1210/en.135.6.2806; Gray CA, 2001, BIOL REPROD, V64, P1608, DOI 10.1095/biolreprod64.6.1608; Gray CA, 2001, BIOL REPROD, V65, P1311, DOI 10.1095/biolreprod65.5.1311; GUILLOMOT M, 1995, J REPROD FERTIL, P39; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Katakowski M, 2010, CANCER RES, V70, P8259, DOI 10.1158/0008-5472.CAN-10-0604; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2012, HUM MOL GENET, V21, pR125, DOI 10.1093/hmg/dds317; Lin J, 2011, CARCINOGENESIS, V32, P1641, DOI 10.1093/carcin/bgr199; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Mincheva-Nilsson L, 2010, AM J REPROD IMMUNOL, V63, P520, DOI 10.1111/j.1600-0897.2010.00822.x; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Ng YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058502; Pan Q, 2008, SEMIN REPROD MED, V26, P479, DOI 10.1055/s-0028-1096128; Racicot K, 2012, AM J REPROD IMMUNOL, V67, P498, DOI 10.1111/j.1600-0897.2012.01109.x; Rana S, 2012, INT J BIOCHEM CELL B, V44, P1574, DOI 10.1016/j.biocel.2012.06.018; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sabapatha A, 2006, AM J REPROD IMMUNOL, V56, P345, DOI 10.1111/j.1600-0897.2006.00435.x; Simmons RM, 2010, BIOL REPROD, V82, P35, DOI 10.1095/biolreprod.109.079608; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Song G, 2007, PLACENTA, V28, P1091, DOI 10.1016/j.placenta.2007.04.004; Song GH, 2005, ENDOCRINOLOGY, V146, P4825, DOI 10.1210/en.2005-0768; Song G, 2008, BIOL REPROD, V79, P376, DOI 10.1095/biolreprod.108.068403; Spencer T E, 2007, Soc Reprod Fertil Suppl, V64, P379; Spencer TE, 2008, REPRODUCTION, V135, P165, DOI 10.1530/REP-07-0327; Spencer TE, 2007, REPROD FERT DEVELOP, V19, P65, DOI 10.1071/RD06102; Spencer TE, 2012, J REPROD DEVELOP, V58, P33, DOI 10.1262/jrd.2011-026; Spencer Thomas E, 2004, Reprod Biol Endocrinol, V2, P49, DOI 10.1186/1477-7827-2-49; Taylor DD, 2006, J IMMUNOL, V176, P1534, DOI 10.4049/jimmunol.176.3.1534; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Tolosa JM, 2012, PLACENTA, V33, P933, DOI 10.1016/j.placenta.2012.08.004; Urnovitz HB, 1996, CLIN MICROBIOL REV, V9, P72, DOI 10.1128/CMR.9.1.72; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Yang M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-117; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100	61	176	184	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90913	10.1371/journal.pone.0090913	http://dx.doi.org/10.1371/journal.pone.0090913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614226	Green Submitted, Green Published, gold			2022-12-25	WOS:000332839300053
J	Hasegawa, Y; Takahashi, M; Ariki, S; Asakawa, D; Tajiri, M; Wada, Y; Yamaguchi, Y; Nishitani, C; Takamiya, R; Saito, A; Uehara, Y; Hashimoto, J; Kurimura, Y; Takahashi, H; Kuroki, Y				Hasegawa, Y.; Takahashi, M.; Ariki, S.; Asakawa, D.; Tajiri, M.; Wada, Y.; Yamaguchi, Y.; Nishitani, C.; Takamiya, R.; Saito, A.; Uehara, Y.; Hashimoto, J.; Kurimura, Y.; Takahashi, H.; Kuroki, Y.			Surfactant protein D suppresses lung cancer progression by downregulation of epidermal growth factor signalling (vol 34, pg 838, 2014)	ONCOGENE			English	Correction													Asakawa, Daiki/M-9393-2019; Yamaguchi, Yoshiki/N-5246-2015; Ariki, Shigeru/E-3861-2014; Asakawa, Daiki/L-7798-2016; Saito, Atsushi/M-7382-2018; Takahashi, Motoko/I-3154-2013	Asakawa, Daiki/0000-0002-9357-8420; Yamaguchi, Yoshiki/0000-0003-0100-5439; Ariki, Shigeru/0000-0001-5838-499X; Asakawa, Daiki/0000-0002-9357-8420; Saito, Atsushi/0000-0003-3430-884X; Takahashi, Motoko/0000-0002-2112-6142; Uehara, Yasuaki/0000-0002-6439-2715; Takamiya, Rina/0000-0002-5947-488X				Hasegawa Y, 2015, ONCOGENE, V34, P838, DOI [10.1038/onc.2014.20, 10.1038/onc.2015.266]	1	37	39	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 6	2015	34	32					4285	4286		10.1038/onc.2015.266	http://dx.doi.org/10.1038/onc.2015.266			2	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CO5LE	26250851	Bronze			2022-12-25	WOS:000359199800015
J	Liu, YQ; Luo, BW; Han, FY; Li, XM; Xiong, J; Jiang, M; Yang, XF; Wu, YZ; Zhang, ZR				Liu, Yuqi; Luo, Bangwei; Han, Fuyu; Li, Xiaoming; Xiong, Jian; Jiang, Man; Yang, Xioafeng; Wu, Yuzhang; Zhang, Zhiren			Erythropoietin-Derived Nonerythropoietic Peptide Ameliorates Experimental Autoimmune Neuritis by Inflammation Suppression and Tissue Protection	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC NEURITIS; PERIPHERAL NERVOUS-SYSTEM; TERTIARY STRUCTURE; CANCER-PATIENTS; CELLS; NEUROPATHIES; RECEPTOR; ANEMIA; ARA290; TRIAL	Experimental autoimmune neuritis (EAN) is an autoantigen-specific T-cell-mediated disease model for human demyelinating inflammatory disease of the peripheral nervous system. Erythropoietin (EPO) has been known to promote EAN recovery but its haematopoiesis stimulating effects may limit its clinic application. Here we investigated the effects and potential mechanisms of an EPO-derived nonerythropoietic peptide, ARA 290, in EAN. Exogenous ARA 290 intervention greatly improved EAN recovery, improved nerve regeneration and remyelination, and suppressed nerve inflammation. Furthermore, haematopoiesis was not induced by ARA 290 during EAN treatment. ARA 290 intervention suppressed lymphocyte proliferation and altered helper T cell differentiation by inducing increase of Foxp3(+)/CD4(+) regulatory T cells and IL-4(+)/CD4(+) Th2 cells and decrease of IFN-gamma(+)/CD4(+) Th1 cells in EAN. In addition, ARA 290 inhibited inflammatory macrophage activation and promoted its phagocytic activity. In vitro, ARA 290 was shown to promote Schwann cell proliferation and inhibit its inflammatory activation. In summary, our data demonstrated that ARA 290 could effectively suppress EAN by attenuating inflammation and exerting direct cell protection, indicating that ARA 290 could be a potent candidate for treatment of autoimmune neuropathies.	[Liu, Yuqi; Luo, Bangwei; Han, Fuyu; Li, Xiaoming; Xiong, Jian; Jiang, Man; Yang, Xioafeng; Wu, Yuzhang; Zhang, Zhiren] Third Mil Med Univ, Peoples Liberat Army, Inst Immunol, Chongqing, Peoples R China	Army Medical University	Wu, YZ (corresponding author), Third Mil Med Univ, Peoples Liberat Army, Inst Immunol, Chongqing, Peoples R China.	yuzhangwu@yahoo.com.cn; zhangzhiren@yahoo.com	Zhang, Zhiren/O-1012-2019; zhang, zhiren/I-1046-2014	Zhang, Zhiren/0000-0002-5238-2835; zhang, zhiren/0000-0002-5238-2835; Wu, Yuzhang/0000-0002-4049-0214	National Nature Science Foundation of China [31170851]; National Science and Technology Major Projects of New Drugs [2012ZX09103301-035]; SRF for ROCS, SEM	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Projects of New Drugs; SRF for ROCS, SEM(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This investigation was supported by National Nature Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default166.htm), No: 31170851, the National Science and Technology Major Projects of New Drugs (2012ZX09103301-035) and the SRF for ROCS, SEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bohlius J, 2006, NAT CLIN PRACT ONCOL, V3, P152, DOI 10.1038/ncponc0451; Bohr S, 2013, P NATL ACAD SCI USA, V110, P3513, DOI 10.1073/pnas.1214099110; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Brines M, 2008, P NATL ACAD SCI USA, V105, P10925, DOI 10.1073/pnas.0805594105; Chateauvieux S, 2011, BIOCHEM PHARMACOL, V82, P1291, DOI 10.1016/j.bcp.2011.06.045; CRAGGS RI, 1984, ACTA NEUROPATHOL, V62, P316, DOI 10.1007/BF00687614; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Enders U, 1998, BRAIN, V121, P1257, DOI 10.1093/brain/121.7.1257; Farrell F, 2004, ONCOLOGIST, V9, P18, DOI 10.1634/theoncologist.9-90005-18; Glaspy JA, 2009, ANNU REV MED, V60, P181, DOI 10.1146/annurev.med.60.050307.110718; Heij L, 2012, MOL MED, V18, P1430, DOI 10.2119/molmed.2012.00332; Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9; Horste GMZ, 2008, MUSCLE NERVE, V37, P3, DOI 10.1002/mus.20893; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Hughes RAC, 2002, J ANAT, V200, P331, DOI 10.1046/j.1469-7580.2002.00041.x; Kiefer R, 2001, PROG NEUROBIOL, V64, P109, DOI 10.1016/S0301-0082(00)00060-5; Kieseier BC, 2004, MUSCLE NERVE, V30, P131, DOI 10.1002/mus.20076; Maiese K, 2008, PROG NEUROBIOL, V85, P194, DOI 10.1016/j.pneurobio.2008.02.002; Maurer M, 2002, REV NEUROL-FRANCE, V158, pS7; Mausberg AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026280; Nairz M, 2012, MICROBES INFECT, V14, P238, DOI 10.1016/j.micinf.2011.10.005; Rosenzweig MQ, 2004, J PAIN SYMPTOM MANAG, V27, P185, DOI 10.1016/j.jpainsymman.2003.06.010; SCHABET M, 1991, J NEUROIMMUNOL, V31, P265, DOI 10.1016/0165-5728(91)90048-C; Shin T, 2012, ANAT CELL BIOL, V45, P215, DOI 10.5115/acb.2012.45.4.215; Soliven B, 2012, J PERIPHER NERV SYST, V17, P28, DOI 10.1111/j.1529-8027.2012.00392.x; Swartjes M, 2011, ANESTHESIOLOGY, V115, P1084, DOI 10.1097/ALN.0b013e31822fcefd; van Rijt WG, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-9; Winer JB, 2001, J CLIN PATHOL-MOL PA, V54, P381; Xanthos T, 2011, CURR PHARM DESIGN, V17, P1517, DOI 10.2174/138161211796197115; Zhang G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027067; Zhang Z, 2009, EXP NEUROL, V216, P75, DOI 10.1016/j.expneurol.2008.11.014; ZHANG ZY, 2009, NEUROPATHOL APPL NEU	34	45	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90942	10.1371/journal.pone.0090942	http://dx.doi.org/10.1371/journal.pone.0090942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603865	Green Published, Green Submitted, gold			2022-12-25	WOS:000332483600112
J	Hasegawa, Y; Takahashi, M; Ariki, S; Asakawa, D; Tajiri, M; Wada, Y; Yamaguchi, Y; Nishitani, C; Takamiya, R; Saito, A; Uehara, Y; Hashimoto, J; Kurimura, Y; Takahashi, H; Kuroki, Y				Hasegawa, Y.; Takahashi, M.; Ariki, S.; Asakawa, D.; Tajiri, M.; Wada, Y.; Yamaguchi, Y.; Nishitani, C.; Takamiya, R.; Saito, A.; Uehara, Y.; Hashimoto, J.; Kurimura, Y.; Takahashi, H.; Kuroki, Y.			Surfactant protein D suppresses lung cancer progression by downregulation of epidermal growth factor signaling	ONCOGENE			English	Article							CARBOHYDRATE-RECOGNITION DOMAIN; IDIOPATHIC PULMONARY FIBROSIS; FACTOR RECEPTOR; TYROSINE KINASE; D BINDS; NEGATIVE COOPERATIVITY; EXTRACELLULAR DOMAINS; ALVEOLAR MACROPHAGES; MYCOBACTERIUM-AVIUM; GM3 BINDING	Surfactant protein D (SP-D) is a member of the collectin family that has an important role in maintaining pulmonary homeostasis. In this study, we demonstrated that SP-D inhibited the proliferation, migration and invasion of A549 human lung adenocarcinoma cells. We found that SP-D suppressed epidermal growth factor (EGF) signaling in A549 cells, H441 human lung adenocarcinoma cells and human EGF receptor (EGFR) stable expression CHO-K1 cells. A binding study using I-125-EGF demonstrated that SP-D downregulated the binding of EGF to EGFR. A ligand blot indicated that SP-D bound to EGFR, and a lectin blot suggested that EGFR in A549 cells had both high-mannose type and complex type N-glycans. We purified the recombinant extracellular domain of EGFR (soluble EGFR=soluble EGFR (sEGFR)), and demonstrated that SP-D directly bound to sEGFR in a Ca2+-dependent manner. The binding of SP-D to sEGFR was suppressed by EDTA, mannose or N-glycopeptidase F treatment. Mass spectrometric analysis indicated that N-glycans in domain III of EGFR were of a high-type. These data suggest that SP-D reduces EGF binding to EGFR through the interaction between the carbohydrate recognition domain of SP-D and N-glycans of EGFR, and downregulates EGF signaling. Our finding suggests the novel type of regulation system of EGF signaling involving lectin-to-carbohydrate interaction and downregulation of ligand binding.	[Hasegawa, Y.; Takahashi, M.; Ariki, S.; Nishitani, C.; Takamiya, R.; Saito, A.; Uehara, Y.; Hashimoto, J.; Kurimura, Y.; Kuroki, Y.] Sapporo Med Univ, Sch Med, Dept Biochem, Sapporo, Hokkaido 0608556, Japan; [Hasegawa, Y.; Saito, A.; Uehara, Y.; Takahashi, H.] Sapporo Med Univ, Sch Med, Dept Resp Med & Allergol, Sapporo, Hokkaido 0608556, Japan; [Asakawa, D.; Tajiri, M.; Wada, Y.] Osaka Med Ctr, Dept Mol Med, Osaka, Japan; [Asakawa, D.; Tajiri, M.; Wada, Y.] Res Inst Maternal & Child Hlth, Osaka, Japan; [Yamaguchi, Y.] RIKEN, Max Planck Joint Res Ctr, Syst Glycobiol Res Grp, Wako, Saitama, Japan; [Hashimoto, J.; Kurimura, Y.] Sapporo Med Univ, Sch Med, Dept Urol, Sapporo, Hokkaido 0608556, Japan	Sapporo Medical University; Sapporo Medical University; Osaka Medical Center for Cancer & Cardiovascular Diseases; RIKEN; Sapporo Medical University	Takahashi, M (corresponding author), Sapporo Med Univ, Sch Med, Dept Biochem, Chuo Ku, South 1 West 17, Sapporo, Hokkaido 0608556, Japan.	takam@sapmed.ac.jp	Asakawa, Daiki/M-9393-2019; Yamaguchi, Yoshiki/N-5246-2015; Ariki, Shigeru/E-3861-2014; Asakawa, Daiki/L-7798-2016; Saito, Atsushi/M-7382-2018; Takahashi, Motoko/I-3154-2013	Asakawa, Daiki/0000-0002-9357-8420; Yamaguchi, Yoshiki/0000-0003-0100-5439; Ariki, Shigeru/0000-0001-5838-499X; Asakawa, Daiki/0000-0002-9357-8420; Saito, Atsushi/0000-0003-3430-884X; Takahashi, Motoko/0000-0002-2112-6142; Uehara, Yasuaki/0000-0002-6439-2715; Takamiya, Rina/0000-0002-5947-488X	Japan Society for the Promotion of Science; Takeda Science Foundation; Suhara Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Suhara Foundation	This work was supported in part by a Grant-in-Aid for Science Research from the Japan Society for the Promotion of Science, grants from the Takeda Science Foundation and from the Suhara Foundation.	Alvarado D, 2010, CELL, V142, P568, DOI 10.1016/j.cell.2010.07.015; Ariki S, 2011, J IMMUNOL, V187, P2586, DOI 10.4049/jimmunol.1100024; Aubry MC, 2002, MAYO CLIN PROC, V77, P763, DOI 10.4065/77.8.763; BASTACKY J, 1995, J APPL PHYSIOL, V79, P1615, DOI 10.1152/jappl.1995.79.5.1615; BETZ C, 1995, CANCER RES, V55, P4283; BREMER EG, 1986, J BIOL CHEM, V261, P2434; Dawson JP, 2007, STRUCTURE, V15, P942, DOI 10.1016/j.str.2007.06.013; HONDA Y, 1995, AM J RESP CRIT CARE, V152, P1860, DOI 10.1164/ajrccm.152.6.8520747; Hrustanovic G, 2013, CANCER BIOL THER, V14, P304, DOI 10.4161/cbt.23627; Hubbard R, 2000, AM J RESP CRIT CARE, V161, P5, DOI 10.1164/ajrccm.161.1.9906062; Ishii T, 2012, COPD, V9, P409, DOI 10.3109/15412555.2012.676110; Kawashima N, 2009, J BIOL CHEM, V284, P6147, DOI 10.1074/jbc.M808171200; Kingma PS, 2006, CURR OPIN PHARMACOL, V6, P277, DOI 10.1016/j.coph.2006.02.003; Kudo K, 2004, J IMMUNOL, V172, P7592, DOI 10.4049/jimmunol.172.12.7592; Kuroki Y, 2007, CELL MICROBIOL, V9, P1871, DOI 10.1111/j.1462-5822.2007.00953.x; Lin ZW, 2007, INT J ONCOL, V31, P181; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; Mason RJ, 2000, AM J PATHOL, V156, P175, DOI 10.1016/S0002-9440(10)64717-7; Nagae H, 1997, CLIN CHIM ACTA, V266, P157, DOI 10.1016/S0009-8981(97)00124-1; Nie XM, 2008, BIOCHEMISTRY-US, V47, P12878, DOI 10.1021/bi8010175; Ohya M, 2006, BIOCHEMISTRY-US, V45, P8657, DOI 10.1021/bi060176z; Oxnard GR, 2011, CLIN CANCER RES, V17, P5530, DOI 10.1158/1078-0432.CCR-10-2571; Park J, 2001, EUR RESPIR J, V17, P1216, DOI 10.1183/09031936.01.99055301; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Qi Zhi-li, 2002, Ai Zheng, V21, P772; RENNARD SI, 1986, J APPL PHYSIOL, V60, P532, DOI 10.1152/jappl.1986.60.2.532; Restrepo CI, 1999, AM J RESP CELL MOL, V21, P576, DOI 10.1165/ajrcmb.21.5.3334; Sahly H, 2002, J IMMUNOL, V169, P3267, DOI 10.4049/jimmunol.169.6.3267; Sato Y, 2001, J BIOL CHEM, V276, P11956, DOI 10.1074/jbc.M008551200; Sawada K, 2010, J BIOL CHEM, V285, P8434, DOI 10.1074/jbc.M109.074765; Sin DD, 2008, CHEST, V134, P582, DOI 10.1378/chest.08-0600; Smith KD, 1996, GROWTH FACTORS, V13, P121, DOI 10.3109/08977199609034572; SODERQUIST AM, 1984, J BIOL CHEM, V259, P2586; Tajiri M, 2005, GLYCOBIOLOGY, V15, P1332, DOI 10.1093/glycob/cwj019; Tajiri M, 2009, J PROTEOME RES, V8, P688, DOI 10.1021/pr800727w; Takahashi H, 1996, RESPIRATION, V63, P390; Takahashi M, 2013, J BIOL CHEM, V288, P32910, DOI 10.1074/jbc.M113.491902; Tino MJ, 1999, AM J PHYSIOL-LUNG C, V276, pL164, DOI 10.1152/ajplung.1999.276.1.L164; Tsuda T, 2000, J BIOL CHEM, V275, P21988, DOI 10.1074/jbc.M003400200; Wada Y, 2004, ANAL CHEM, V76, P6560, DOI 10.1021/ac049062o; Wang XQ, 2001, GLYCOBIOLOGY, V11, P515, DOI 10.1093/glycob/11.7.515; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Wright JR, 1997, PHYSIOL REV, V77, P931, DOI 10.1152/physrev.1997.77.4.931; Wu HX, 2003, J CLIN INVEST, V111, P1589, DOI 10.1172/JCI200316889; Yamazoe M, 2008, J BIOL CHEM, V283, P35878, DOI 10.1074/jbc.M807268200; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yoon SJ, 2006, P NATL ACAD SCI USA, V103, P18987, DOI 10.1073/pnas.0609281103; Zhang F, 2004, CHEST, V125, p109S, DOI 10.1378/chest.125.5_suppl.109S	49	37	39	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 12	2015	34	7					838	845		10.1038/onc.2014.20	http://dx.doi.org/10.1038/onc.2014.20			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CB2QF	26250851				2022-12-25	WOS:000349472000004
J	Wang, Y; Yan, HJ; Zhou, SY; Wang, YS; Qi, H; Deng, CY; Li, FR				Wang, Yun; Yan, Hong-Jie; Zhou, Shu-Yan; Wang, Yun-Shuang; Qi, Hui; Deng, Chun-Yan; Li, Fu-Rong			The Immunoregulation Effect of Alpha 1-Antitrypsin Prolong beta-Cell Survival after Transplantation	PLOS ONE			English	Article							ISLET TRANSPLANTATION; REDUCES INFLAMMATION; ALLOGRAFT-REJECTION; ALPHA(1)-ANTITRYPSIN; INHIBITOR	Islet transplantation has considerable potential as a cure for diabetes. However, the difficulties that arise from inflammation and the immunological rejection of transplants must be addressed for islet transplantation to be successful. Alpha 1-antitrypsin (AAT) inhibits the damage on beta cells caused by inflammatory reactions and promotes beta-cell survival and proliferation. This protein also induces specific immune tolerance to transplanted beta cells. However, whether the expression of AAT in beta cells themselves could eliminate or decrease immunological rejection of transplants is not clear. Therefore, we established a beta cell line (NIT-hAAT) that stably expresses human AAT. Interestingly, in a cytotoxic T lymphocyte (CTL)-killing assay, we found that hAAT reduced apoptosis and inflammatory cytokine production in NIT-1 cells and regulated the Th1/Th2 cytokine balance in vitro. In vivo transplantation of NIT-hAAT cells into mice with diabetes showed hAAT inhibited immunological rejection for a short period of time and increased the survival of transplanted beta cells. This study demonstrated that hAAT generated remarkable immunoprotective and immunoregulation effects in a model of beta cell islet transplantation for diabetes model.	[Wang, Yun] Ningxia Med Univ, Gen Hosp, Dept Cardiac Surg, Yinchuan, Peoples R China; [Wang, Yun; Yan, Hong-Jie; Zhou, Shu-Yan; Wang, Yun-Shuang; Qi, Hui; Deng, Chun-Yan; Li, Fu-Rong] Jinan Univ, Shenzhen Peoples Hosp, Clin Med Coll 2, Key Lab Stem Cell & Cellular Therapy, Shenzhen, Peoples R China; [Li, Fu-Rong] Shenzhen Inst Gerontol, Shenzhen, Peoples R China	Ningxia Medical University; Jinan University	Li, FR (corresponding author), Jinan Univ, Shenzhen Peoples Hosp, Clin Med Coll 2, Key Lab Stem Cell & Cellular Therapy, Shenzhen, Peoples R China.	frli62@163.com			National 973 Program of China [2007CB516811]; National Natural Science Foundation of China [30772042, 81270857]; Science and Technology Project of Shenzhen [JCYJ20120618153743791, GJHZ20120618153934353]	National 973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Shenzhen	This work was supported by the National 973 Program of China (No. 2007CB516811), The National Natural Science Foundation of China (No. 30772042 and No. 81270857), and The Science and Technology Project of Shenzhen (No. JCYJ20120618153743791, GJHZ20120618153934353). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi R, 2004, J IMMUNOL, V172, P767, DOI 10.4049/jimmunol.172.2.767; Bertuzzi F, 2004, J CLIN ENDOCR METAB, V89, P5724, DOI 10.1210/jc.2004-0659; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; Brantly M, 2002, AM J RESP CELL MOL, V27, P652, DOI 10.1165/rcmb.F250; BRANTLY ML, 1991, CHEST, V100, P703, DOI 10.1378/chest.100.3.703; Churg A, 2001, LAB INVEST, V81, P1119, DOI 10.1038/labinvest.3780324; HAMAGUCHI K, 1991, DIABETES, V40, P842, DOI 10.2337/diabetes.40.7.842; Jie ZJ, 2003, CHINESE MED J-PEKING, V116, P1678; Kalis M, 2010, ISLETS, V2, P185, DOI 10.4161/isl.2.3.11654; Koulmanda M, 2012, P NATL ACAD SCI USA, V109, P15443, DOI 10.1073/pnas.1018366109; Lewis EC, 2005, P NATL ACAD SCI USA, V102, P12153, DOI 10.1073/pnas.0505579102; Lewis EC, 2008, P NATL ACAD SCI USA, V105, P16236, DOI 10.1073/pnas.0807627105; Lu YQ, 2006, HUM GENE THER, V17, P625, DOI 10.1089/hum.2006.17.625; Ludvigsson J, 2010, CURR DIABETES REP, V10, P370, DOI 10.1007/s11892-010-0138-y; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Ottaviani S, 2011, TRANSL RES, V157, P332, DOI 10.1016/j.trsl.2010.12.014; Ozeri E, 2012, J IMMUNOL, V189, P146, DOI 10.4049/jimmunol.1101340; Petrache L, 2006, AM J RESP CRIT CARE, V173, P1222, DOI 10.1164/rccm.200512-1842OC; Pott GB, 2009, J LEUKOCYTE BIOL, V85, P886, DOI 10.1189/jlb.0208145; Robertson RP, 2010, DIABETES, V59, P1285, DOI 10.2337/db09-1846; Shahaf G, 2011, MOL MED, V17, P1000, DOI 10.2119/molmed.2011.00145; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Slobedman B, 2009, J VIROL, V83, P9618, DOI 10.1128/JVI.01098-09; Tawara I, 2012, P NATL ACAD SCI USA, V109, P564, DOI 10.1073/pnas.1117665109; Walters S, 2009, J IMMUNOL, V182, P793, DOI 10.4049/jimmunol.182.2.793; Wei P, 2012, BIOCHEM BIOPH RES CO, V418, P330, DOI 10.1016/j.bbrc.2012.01.021; Weir GC, 2009, CURR DIABETES REP, V9, P100, DOI 10.1007/s11892-009-0018-5; Ye J, 2013, IMMUNOL LETT, V150, P61, DOI 10.1016/j.imlet.2013.01.009; Zhang B, 2007, DIABETES, V56, P1316, DOI 10.2337/db06-1273	29	59	63	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94548	10.1371/journal.pone.0094548	http://dx.doi.org/10.1371/journal.pone.0094548			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24740145	gold, Green Published			2022-12-25	WOS:000336909100095
J	Wang, H; Sun, W; Ma, JQ; Pan, YC; Wang, L; Zhang, WB				Wang, Hua; Sun, Wen; Ma, Junqing; Pan, Yongchu; Wang, Lin; Zhang, Weibing			Polycystin-1 Mediates Mechanical Strain-Induced Osteoblastic Mechanoresponses via Potentiation of Intracellular Calcium and Akt/beta-Catenin Pathway	PLOS ONE			English	Article							FOCAL ADHESION KINASE; KIDNEY-DISEASE; PROTEIN-KINASE; OSTEOGENIC DIFFERENTIATION; FLUID-FLOW; BONE-CELLS; PKD1 GENE; SKELETAL; ACTIVATION; MECHANOTRANSDUCTION	Mechanical regulation of bone formation involves a complex biophysical process, yet the underlying mechanisms remain poorly understood. Polycystin-1 (PC1) is postulated to function as a mechanosensory molecule mediating mechanical signal transduction in renal epithelial cells. To investigate the involvement of PC1 in mechanical strain-induced signaling cascades controlling osteogenesis, PKD1 gene was stably silenced in osteoblastic cell line MC3T3-E1 by using lentivirus-mediated shRNA technology. Here, our findings showed that mechanical tensile strain sufficiently enhanced osteogenic gene expressions and osteoblastic proliferation. However, PC1 deficiency resulted in the loss of the ability to sense external mechanical stimuli thereby promoting osteoblastic osteogenesis and proliferation. The signal pathways implicated in this process were intracellular calcium and Akt/beta-catenin pathway. The basal levels of intracellular calcium, phospho-Akt, phospho-GSK-3 beta and nuclear accumulation of active beta-catenin were significantly attenuated in PC1 deficient osteoblasts. In addition, PC1 deficiency impaired mechanical strain-induced potentiation of intracellular calcium, and activation of Akt-dependent and Wnt/beta-catenin pathways, which was able to be partially reversed by calcium ionophore A23187 treatment. Furthermore, applications of LiCl or A23187 in PC1 deficient osteoblasts could promote osteoblastic differentiation and proliferation under mechanical strain conditions. Therefore, our results demonstrated that osteoblasts require mechanosensory molecule PC1 to adapt to external mechanical tensile strain thereby inducing osteoblastic mechanoresponse, partially through the potentiation of intracellular calcium and downstream Akt/b-catenin signaling pathway.	[Wang, Hua; Ma, Junqing; Pan, Yongchu; Wang, Lin; Zhang, Weibing] Nanjing Med Univ, Inst Stomatol, Nanjing, Jiangsu, Peoples R China; [Sun, Wen] Nanjing Med Univ, Res Ctr Bone & Stem Cells, Dept Anat Histol & Embryol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Wang, L (corresponding author), Nanjing Med Univ, Inst Stomatol, Nanjing, Jiangsu, Peoples R China.	nydwlktz@gmail.com; weibingzhang.njmu@gmail.com		wang, wei/0000-0002-0440-0859	National Natural Science Foundation of China [30973361, 81170981]; Natural Science Foundation for Colleges and Universities in JiangSu Province [10kJB320004]; Jiangsu Province Innovation Project for Graduate Student of China [CXZZ12_0589]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation for Colleges and Universities in JiangSu Province; Jiangsu Province Innovation Project for Graduate Student of China	This study was supported in part by the National Natural Science Foundation of China (30973361, 81170981) and Natural Science Foundation for Colleges and Universities in JiangSu Province (10kJB320004) and by the Jiangsu Province Innovation Project for Graduate Student of China (CXZZ12_0589). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Boletta Alessandra, 2009, Pathogenetics, V2, P6, DOI 10.1186/1755-8417-2-6; Boulter C, 2001, P NATL ACAD SCI USA, V98, P12174, DOI 10.1073/pnas.211191098; Boutahar N, 2004, J BIOL CHEM, V279, P30588, DOI 10.1074/jbc.M313244200; Case N, 2008, J BIOL CHEM, V283, P29196, DOI 10.1074/jbc.M801907200; Case N, 2010, J CELL BIOCHEM, V110, P545, DOI 10.1002/jcb.22574; Chauvet V, 2004, J CLIN INVEST, V114, P1433, DOI 10.1172/JCI200421753; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dalagiorgou G, 2013, CELL MOL LIFE SCI, V70, P167, DOI 10.1007/s00018-012-1164-5; Danciu TE, 2003, FEBS LETT, V536, P193, DOI 10.1016/S0014-5793(03)00055-3; Distefano G, 2009, MOL CELL BIOL, V29, P2359, DOI 10.1128/MCB.01259-08; DUNCAN RL, 1995, CALCIFIED TISSUE INT, V57, P344, DOI 10.1007/BF00302070; Faibish D, 2006, CLIN ORTHOP RELAT R, P28, DOI 10.1097/01.blo.0000200241.14684.4e; Forman JR, 2005, J MOL BIOL, V349, P861, DOI 10.1016/j.jmb.2005.04.008; Gao JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063084; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Gay IC, 2007, ORTHOD CRANIOFAC RES, V10, P149, DOI 10.1111/j.1601-6343.2007.00399.x; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Hoey DA, 2012, STEM CELLS, V30, P2561, DOI 10.1002/stem.1235; Hou B, 2009, BONE, V44, P1121, DOI 10.1016/j.bone.2009.02.018; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Huiskes R, 2000, NATURE, V405, P704, DOI 10.1038/35015116; Kanno T, 2007, J CELL BIOCHEM, V101, P1266, DOI 10.1002/jcb.21249; Khan KM, 2009, BRIT J SPORT MED, V43, P247, DOI 10.1136/bjsm.2008.054239; Koike M, 2005, J BONE MINER METAB, V23, P219, DOI 10.1007/s00774-004-0587-y; Kolpakova-Hart E, 2008, DEV BIOL, V321, P407, DOI 10.1016/j.ydbio.2008.07.005; Kreja L, 2008, BIOCHEM BIOPH RES CO, V368, P582, DOI 10.1016/j.bbrc.2008.01.106; Lei G, 2011, BIOL CELL, V103, P185, DOI 10.1042/BC20100134; Liu DW, 2008, BONE, V42, P644, DOI 10.1016/j.bone.2007.09.058; Liu F, 2008, CELL SIGNAL, V20, P999, DOI 10.1016/j.cellsig.2007.11.011; Low SH, 2006, DEV CELL, V10, P57, DOI 10.1016/j.devcel.2005.12.005; Lu WN, 2001, HUM MOL GENET, V10, P2385, DOI 10.1093/hmg/10.21.2385; Macsai CE, 2008, J CELL PHYSIOL, V215, P578, DOI 10.1002/jcp.21342; Malone AMD, 2007, P NATL ACAD SCI USA, V104, P13325, DOI 10.1073/pnas.0700636104; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Nauli SM, 2004, BIOESSAYS, V26, P844, DOI 10.1002/bies.20069; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nauli SM, 2006, J AM SOC NEPHROL, V17, P1015, DOI 10.1681/ASN.2005080830; Papachristou DJ, 2009, BIOESSAYS, V31, P794, DOI 10.1002/bies.200800223; Qiu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046038; Qiu N, 2012, J CELL BIOCHEM, V113, P967, DOI 10.1002/jcb.23426; Raisz LG, 1999, CLIN CHEM, V45, P1353; Rangaswami H, 2012, J BIOL CHEM, V287, P21509, DOI 10.1074/jbc.M112.347245; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Sharif-Naeini R, 2009, CELL, V139, P587, DOI 10.1016/j.cell.2009.08.045; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Thompson WR, 2012, GENE, V503, P179, DOI 10.1016/j.gene.2012.04.076; Walker LM, 2000, J CELL BIOCHEM, V79, P648, DOI 10.1002/1097-4644(20001215)79:4<648::AID-JCB130>3.0.CO;2-Q; Weimbs T, 2007, AM J PHYSIOL-RENAL, V293, pF1423, DOI 10.1152/ajprenal.00275.2007; Weimbs T, 2006, CELL CYCLE, V5, P2425, DOI 10.4161/cc.5.21.3408; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Xiao ZS, 2008, J BIOL CHEM, V283, P12624, DOI 10.1074/jbc.M710407200; Xiao ZS, 2006, J BIOL CHEM, V281, P30884, DOI 10.1074/jbc.M604772200; Xiao ZS, 2011, FASEB J, V25, P2418, DOI 10.1096/fj.10-180299; Xiao ZS, 2010, J BIOL CHEM, V285, P1177, DOI 10.1074/jbc.M109.050906; You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200; Yu Y, 2012, HISTOCHEM CELL BIOL, V137, P513, DOI 10.1007/s00418-011-0908-x; Zhang WB, 2009, J CELL BIOCHEM, V108, P600, DOI 10.1002/jcb.22291	58	93	98	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91730	10.1371/journal.pone.0091730	http://dx.doi.org/10.1371/journal.pone.0091730			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618832	Green Published, Green Submitted, gold			2022-12-25	WOS:000332842400123
J	Sun, XR; Sun, Z; Zhu, Z; Guan, HX; Zhang, JY; Zhang, YN; Xu, HM; Sun, MJ				Sun, Xuren; Sun, Zhe; Zhu, Zhi; Guan, Haixia; Zhang, Junyan; Zhang, Yining; Xu, Huimian; Sun, Mingjun			Clinicopathological Significance and Prognostic Value of Lactate Dehydrogenase A Expression in Gastric Cancer Patients	PLOS ONE			English	Article							AEROBIC GLYCOLYSIS; GLUCOSE-METABOLISM; LDH-A; CELLS; GROWTH	Introduction: LDH-A, the enzyme responsible for transforming pyruvate into lactate, has been demonstrated to be up-regulated in many types of cancer and to give rise to more aggressive behavior by regulating proliferation and antiapoptosis. However, its expression in gastric cancer (GC) has not been characterized thoroughly. The purpose of this study was to clarify the expression and potential impact of LDH-A in GC. Methods: We examined LDH-A expression by immunohistochemistry on GC tissue microarray (TMA) and using Western blot on fresh GC tissues and cell lines. Prognostic value and correlation with other clinicopathologic factors were evaluated. We transfected siRNA into GC cells against LDH-A. LDH-A was analyzed by Western blotting and real-time RT-PCR. Cell growth was evaluated in vitro and in vivo. Lactate and ATP production by cells were determined. Results: There was significantly higher LDH-A expression in carcinoma than in non-neoplastic mucosa (NNM). There was a positive correlation of LDH-A expression with age, histological type and Lymph node metastases. Survival analysis demonstrated that high expression of LDH-A in GC was associated with lower overall survival (OS). When stratified by Lauren grade and histological classification, significance appeared in diffuse type and undifferentiated type GC. In multivariate analysis, the LDH-A expression in GC was an independent prognostic risk factor for OS (hazard ratio = 1.829, 95% CI 1.375-2.433, P<0.0001). Specific siRNA against LDH-A in GC cell line retarded cell growth both in vitro and in mouse models. LDH-A knockdown also reduced lactate and ATP production in GC cells. Conclusions: Our study indicated the oncogenic role of LDH-A in GC. LDH-A expression is an independent prognostic risk factor in GC patients and up-regulated expression of LDH-A could be predictive of poor outcomes in diffuse type and undifferentiated type GC. Our results suggested that LDH-A might be a potential therapeutic target in gastric cancer.	[Sun, Xuren; Sun, Mingjun] China Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Shenyang, Liaoning Provin, Peoples R China; [Sun, Zhe; Zhu, Zhi; Zhang, Junyan; Xu, Huimian] China Med Univ, Affiliated Hosp 1, Dept Surg Oncol, Shenyang, Liaoning Provin, Peoples R China; [Guan, Haixia] China Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Shenyang, Liaoning Provin, Peoples R China; [Zhang, Yining; Sun, Mingjun] China Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Endoscopy, Shenyang, Liaoning Provin, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University	Sun, MJ (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Shenyang, Liaoning Provin, Peoples R China.	smjmw@sina.com		Pan, Chen-Wei/0000-0003-3362-4613	Liaoning Province Science and Technology Department [2007225017, 2009225011-2, 2011415052]; Science and Technology projects in Shenyang City [F11-264-1-19]	Liaoning Province Science and Technology Department; Science and Technology projects in Shenyang City	This study was supported by grants from the research projects in Liaoning Province Science and Technology Department (No. 2007225017, No. 2009225011-2 and No. 2011415052) and Science and Technology projects in Shenyang City (No. F11-264-1-19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brand KA, 1997, FASEB J, V11, P388, DOI 10.1096/fasebj.11.5.9141507; Cai Z, 2010, MOL CELL PROTEOMICS, V9, P2617, DOI 10.1074/mcp.M110.000661; Chen Z, 2007, J BIOENERG BIOMEMBR, V39, P267, DOI 10.1007/s10863-007-9086-x; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gillies RJ, 2008, J NUCL MED, V49, p24S, DOI 10.2967/jnumed.107.047258; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lewis BC, 1997, MOL CELL BIOL, V17, P4967, DOI 10.1128/MCB.17.9.4967; Robey IF, 2008, NEOPLASIA, V10, P745, DOI 10.1593/neo.07724; Rong YF, 2013, TUMOR BIOL, V34, P1523, DOI 10.1007/s13277-013-0679-1; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Vegran F, 2011, CANCER RES, V71, P2550, DOI 10.1158/0008-5472.CAN-10-2828; Wang ZY, 2012, BREAST CANCER RES TR, V131, P791, DOI 10.1007/s10549-011-1466-6; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yao F, 2013, TUMOR BIOL, V34, P25, DOI 10.1007/s13277-012-0506-0; Zhang YJ, 2012, CANCER LETT, V321, P45, DOI 10.1016/j.canlet.2012.03.013	18	66	69	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2014	9	3							e91068	10.1371/journal.pone.0091068	http://dx.doi.org/10.1371/journal.pone.0091068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4IY	24788769	gold, Green Published, Green Submitted			2022-12-25	WOS:000332485800094
J	Wang, H; Zhou, L; Guo, JM; Sun, L; Long, QL; Ma, Y; Zhang, L; Lin, ZM; Zhu, TY; Wang, GM				Wang, Hang; Zhou, Lin; Guo, Jianming; Sun, Li'an; Long, Qilai; Ma, Yong; Zhang, Li; Lin, Zongming; Zhu, Tongyu; Wang, Guomin			Mini-Flank Supra-12th Rib Incision for Open Partial Nephrectomy Compared with Laparoscopic Partial Nephrectomy and Traditional Open Partial Nephrectomy	PLOS ONE			English	Article							RADICAL NEPHRECTOMY; COMPLICATIONS; OUTCOMES; SURGERY; TUMORS	Purpose: The purpose of this study was to report our approach of partial nephrectomy (PN) using a supra-12th rib mini-flank incision. We compared mini-incision open partial nephrectomy (MI-OPN) with open partial nephrectomy (OPN) and laparoscopic partial nephrectomy (LPN) to verify whether MI-OPN can be an alternative to OPN and LPN. Methods: This was a retrospective single-center study including 194 patients who underwent partial nephrectomy (PN) between February 2005 and December 2010. Demographic, perioperative, and complication data were compared among the MI-OPN group, OPN group and LPN group. Results: No statistical differences were reported in either group for age, sex, BMI, tumour side (right or left kidney), RENAL nephrometry scores, PADUA score and preoperative eGFR. The operative time was longer in LPN group when compared with MI-OPN and OPN group (all P < 0.001). The warm ischemia time of LPN group was longer than MI-OPN group (P = 0.032) and OPN group (P = 0.005). The length of stay of LPN group was shorter than OPN group (P = 0.018), but was similar to MI-OPN group (P = 0.094). The incidence of renal artery clamping was lower in OPN group when compared with MI-OPN and LPN group (all P, 0.001). More estimated blood loss was found in OPN group when compared with MI-OPN group (p = 0.003) and LPN group (P = 0.014). The overall incidence of postoperative complications was similar. Conclusions: The approach of MI-OPN can couple the benefits of both minimally invasive and open partial nephrectomy techniques with less estimated blood loss, shorter operative time, shorter length of stay, less postoperative complications, and a smaller incision. MI-OPN may be an effective alternative to laparoscopic or traditional open approaches, which maybe more suitable for the tumors with high RENAL nephrometry score or PADUA score.	[Wang, Hang; Zhou, Lin; Guo, Jianming; Sun, Li'an; Long, Qilai; Ma, Yong; Zhang, Li; Lin, Zongming; Zhu, Tongyu; Wang, Guomin] Fudan Univ, Zhongshan Hosp, Dept Urol, Shanghai 200433, Peoples R China	Fudan University	Wang, H (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Urol, Shanghai 200433, Peoples R China.	wang.hang@zs-hospital.sh.cn; guo.jianming@zs-hospital.sh.cn		wang, wei/0000-0002-0440-0859				Breda A, 2007, J UROLOGY, V178, P47, DOI 10.1016/j.juro.2007.03.045; Chatterjee S, 2004, UROL ONCOL-SEMIN ORI, V22, P36, DOI 10.1016/S1078-1439(03)00099-1; DiBlasio CJ, 2006, BJU INT, V97, P149, DOI 10.1111/j.1464-410X.2006.05882.x; Ficarra V, 2009, EUR UROL, V56, P786, DOI 10.1016/j.eururo.2009.07.040; Frank I, 2006, J UROLOGY, V175, P849, DOI 10.1016/S0022-5347(05)00346-0; Gill IS, 2000, J UROLOGY, V163, P1665, DOI 10.1016/S0022-5347(05)67516-7; GILL IS, 1995, J UROLOGY, V154, P479, DOI 10.1016/S0022-5347(01)67078-2; Huang WC, 2007, NAT CLIN PRACT UROL, V4, P444, DOI 10.1038/ncpuro0855; Jain S, 2013, J UROLOGY, V189, P1643, DOI 10.1016/j.juro.2012.11.170; Kenney Chad Wotkowicz, 2012, CAMPBELL WALSH UROLO, V2, P1567; Kutikov A, 2009, J UROLOGY, V182, P844, DOI 10.1016/j.juro.2009.05.035; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Marszalek M, 2009, EUR UROL, V55, P1171, DOI 10.1016/j.eururo.2009.01.042; Mitropoulos D, 2012, EUR UROL, V61, P341, DOI 10.1016/j.eururo.2011.10.033; Nadu A, 2009, J UROLOGY, V181, P42, DOI 10.1016/j.juro.2008.09.014; Permpongkosol S, 2007, J UROLOGY, V177, P580, DOI 10.1016/j.juro.2006.09.031; Peycelon M, 2009, J UROLOGY, V181, P35, DOI 10.1016/j.juro.2008.09.025; Ramani AP, 2005, J UROLOGY, V173, P42, DOI 10.1097/01.ju.0000147177.20458.73; Russo P, 2010, BJU INT, V105, P1494, DOI 10.1111/j.1464-410X.2010.09388.x; Ward J N, 1974, Urology, V3, P163, DOI 10.1016/S0090-4295(74)80006-3	20	93	98	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89155	10.1371/journal.pone.0089155	http://dx.doi.org/10.1371/journal.pone.0089155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24618832	gold, Green Published, Green Submitted			2022-12-25	WOS:000331717900058
J	Wang, HB; Fang, G; Yu, WZ; Du, F; Fan, CX; Liu, QL; Hao, LX; Liu, Y; Zheng, JS; Qin, ZY; Xia, W; Zhang, SY; Yin, ZD; Jing, Q; Zhang, YX; Huang, RN; Yang, RP; Tong, WB; Qi, Q; Guan, XJ; Jing, YL; Ma, QL; Wang, J; Ma, XZ; Chen, N; Zheng, HR; Li, YQ; Ma, C; Su, QR; Reilly, KH; Luo, HM; Wu, XP; Wen, N; Yang, WZ				Wang, Hai-Bo; Fang, Gang; Yu, Wen-Zhou; Du, Fei; Fan, Chun-Xiang; Liu, Qing-Lian; Hao, Li-Xin; Liu, Yu; Zheng, Jing-Shan; Qin, Zhi-Ying; Xia, Wei; Zhang, Shi-Yue; Yin, Zun-Dong; Jing, Qiong; Zhang, Yan-Xia; Huang, Rong-Na; Yang, Ru-Pei; Tong, Wen-Bin; Qi, Qi; Guan, Xu-Jing; Jing, Yu-Lin; Ma, Qian-Li; Wang, Jin; Ma, Xiao-Zhen; Chen, Na; Zheng, Hong-Ru; Li, Yin-Qiao; Ma, Chao; Su, Qi-Ru; Reilly, Kathleen H.; Luo, Hui-Ming; Wu, Xian-Ping; Wen, Ning; Yang, Wei-Zhong			An Outbreak of Type Pi Vaccine- Derived Poliovirus in Sichuan Province, China: Emergence and Circulation in an Under-Immunized Population	PLOS ONE			English	Article							POLIOMYELITIS	Background: During August 2011-February 2012, an outbreak of type P circulating vaccine-derived poliovirus (cVDPVs) occurred in Sichuan Province, China. Methods: A field investigation of the outbreak was conducted to characterize outbreak isolates and to guide emergency response. Sequence analysis of poliovirus capsid protein VP1 was performed to determine the viral propagation, and a coverage survey was carried out for risk assessment. Results: One clinical compatible polio case and three VDPV cases were determined in Ngawa County, Ngawa Tibetan and Qiang Autonomous Prefecture, Sichuan Province. Case patients were unimmunized children, 0.8-1 years old. Genetic sequencing showed that the isolates diverged from the VP1 region of the type P Sabin strain by 5-12 nucleotides (nt) and shared the same 5 nt VP1 substitutions, which indicate single lineage of cVDPVs. Of the 7 acute flaccid paralysis cases (all. 6 months) reported in Ngawa Prefecture in 2011, 4 (57.1%) cases (including 2 polio cases) did not receive oral attenuated poliovirus vaccine. Supplementary immunization activities (SIAs) were conducted in February-May, 2012, and the strain has not been isolated since. Conclusion: High coverage of routine immunization should be maintained among children until WPV transmission is globally eradicated. Risk assessments should be conducted regularly to pinpoint high risk areas or subpopulations, with SIAs developed if necessary.	[Wang, Hai-Bo; Yu, Wen-Zhou; Fan, Chun-Xiang; Hao, Li-Xin; Zheng, Jing-Shan; Xia, Wei; Yin, Zun-Dong; Zhang, Yan-Xia; Ma, Chao; Su, Qi-Ru; Luo, Hui-Ming; Wen, Ning; Yang, Wei-Zhong] Chinese Ctr Dis Control & Prevent, Beijing 100050, Peoples R China; [Wang, Hai-Bo] Peking Univ, Clin Res Inst, Beijing 100191, Peoples R China; [Fang, Gang; Du, Fei; Liu, Qing-Lian; Liu, Yu; Qin, Zhi-Ying; Tong, Wen-Bin; Qi, Qi; Guan, Xu-Jing; Jing, Yu-Lin; Ma, Qian-Li; Wang, Jin; Ma, Xiao-Zhen; Chen, Na; Zheng, Hong-Ru; Li, Yin-Qiao; Wu, Xian-Ping] Sichuan Prov Ctr Dis Control & Prevent, Chengdu 610041, Sichuan Provinc, Peoples R China; [Zhang, Shi-Yue; Jing, Qiong] Ngawa Tibetan & Qiang Autonomous Prefectural Ctr, Chengdu 624000, Sichuan Provinc, Peoples R China; [Huang, Rong-Na; Yang, Ru-Pei] Chengdu City Ctr Dis Control & Prevent, Chengdu 610041, Sichuan Provinc, Peoples R China; [Reilly, Kathleen H.] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing 100050, Peoples R China	Chinese Center for Disease Control & Prevention; Peking University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Luo, HM (corresponding author), Chinese Ctr Dis Control & Prevent, Nanwei Rd 27, Beijing 100050, Peoples R China.	Hmluo@vip.sina.com; wwwuxp@163.com; ning_wen@163.com; yangwz@chinacdc.cn		wang, wei/0000-0002-0440-0859				Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P545; [Anonymous], 1999, MMWR MORB MORTAL WKL, V48, P747; Bahta L., 2005, Morbidity and Mortality Weekly Report, V54, P1053; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1002; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P967; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P145; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P113; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P357; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P736; Estivariz CF, 2008, J INFECT DIS, V197, P347, DOI 10.1086/525049; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kew OM, 2004, B WORLD HEALTH ORGAN, V82, P16; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Liang XF, 2006, J INFECT DIS, V194, P545, DOI 10.1086/506359; Lowther SA, 2013, MMWR-MORBID MORTAL W, V62, P335; Luo HM, 2013, NEW ENGL J MED, V369, P1981, DOI 10.1056/NEJMoa1303368; Mundel T, 2013, NEW ENGL J MED, V369, P2045, DOI 10.1056/NEJMe1311591; *NAT COMM CERT POL, 2000, DOC CERT POL ER; NATHANSON N, 1979, AM J EPIDEMIOL, V110, P672, DOI 10.1093/oxfordjournals.aje.a112848; Patriarca PA, 1997, J INFECT DIS, V175, pS165, DOI 10.1093/infdis/175.Supplement_1.S165; Rakoto-Andrianarivelo M, 2008, J INFECT DIS, V197, P1427, DOI 10.1086/587694; Tao WJ, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20343; Wassilak Steve, 2012, Morbidity and Mortality Weekly Report, V61, P353; Wassilak S, 2011, J INFECT DIS, V203, P898, DOI 10.1093/infdis/jiq140; World Health Organization Advisory Committee on Poliomyelitis Eradication, 2005, Wkly Epidemiol Rec, V80, P410; Yoshida H, 2002, J GEN VIROL, V83, P1107, DOI 10.1099/0022-1317-83-5-1107	26	93	98	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e113880	10.1371/journal.pone.0113880	http://dx.doi.org/10.1371/journal.pone.0113880			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	24618832	Green Submitted, Green Published, gold			2022-12-25	WOS:000347146700011
J	Wang, YW; Shi, DB; Chen, X; Gao, C; Gao, P				Wang, Ya-Wen; Shi, Duan-Bo; Chen, Xu; Gao, Chao; Gao, Peng			Clinicopathological Significance of MicroRNA-214 in Gastric Cancer and Its Effect on Cell Biological Behaviour	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; TUMOR ANGIOGENESIS; TARGETING PTEN; EXPRESSION; PROLIFERATION; GROWTH; INVASIVENESS; PROGRESSION; SURVIVAL; INVASION	Accumulating evidence indicates that numerous microRNAs are involved in the tumorigenesis and progression of gastric cancer, while the clinical significance of microRNA-214 in gastric cancer is poorly understood and the exact role of microRNA-214 in gastric cancer remains obscure. In the present study, expression levels of microRNA-214 in 80 gastric carcinoma tissues, 18 nontumourous gastric tissues, and 4 types of gastric cancer cell lines were quantified by reverse transcription followed by real-time quantitative polymerase chain reaction (RT-qPCR), and the relationship between microRNA-214 expression and cliniopathological characteristics including prognosis was explored. To investigate the potential role of microRNA-214 in gastric cancer cell biological behaviour, we performed cell proliferation, apoptosis, migration and invasion assays in four gastric cancer cell lines and an immortalized gastric cell line in vitro. Our results showed that microRNA-214 was dramatically downregulated in gastric cancer tissues and gastric cancer cell lines, compared with nontumourous gastric tissues. Stepwise downregulation of microRNA-214 expression was observed among nontumourous gastric mucosa, nonmetastasis gastric cancer tissues, and metastasis gastric cancer tissues. The expression of microRNA-214 was significantly inversely correlated with lymph node metastasis and tumour size but had no correlation with the patient's prognosis. Ectopic expression of microRNA-214 could inhibit cell migration and invasion ability in SGC7901 and MKN45 gastric cancer cells. And knockdown of microRNA-214 significantly facilitated cell proliferation, migration and invasion in a cell-specific manner in MKN28, BGC823 and GES-1 cells. Colony stimulating factor 1 (CSF1) was identified as a target gene of microRNA-214. In summary, our data demonstrated that microRNA-214 is a promising novel biomarker for lymph node metastasis in patients with gastric cancer. And we identified that downregulation of microRNA-214 may regulate the proliferation, invasion and migration of gastric cancer cells by directly targeting CSF1.	[Wang, Ya-Wen; Shi, Duan-Bo; Chen, Xu; Gao, Chao; Gao, Peng] Shandong Univ, Sch Med, Dept Pathol, Jinan 250100, Peoples R China	Shandong University	Gao, P (corresponding author), Shandong Univ, Sch Med, Dept Pathol, Jinan 250100, Peoples R China.	gaopeng@sdu.edu.cn			National Natural Science Foundation of China [81172351, 81372856]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81172351 and 81372856). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aligeti S, 2011, FERTIL STERIL, V95, P2464, DOI 10.1016/j.fertnstert.2011.03.026; BAIOCCHI G, 1991, CANCER, V67, P990, DOI 10.1002/1097-0142(19910215)67:4<990::AID-CNCR2820670422>3.0.CO;2-8; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Dai XZ, 2011, CHINESE SCI BULL, V56, P3301, DOI 10.1007/s11434-011-4717-3; Derfoul A, 2011, CARCINOGENESIS, V32, P1607, DOI 10.1093/carcin/bgr184; Espinosa I, 2011, AM J PATHOL, V179, P2100, DOI 10.1016/j.ajpath.2011.06.021; Gao P, 2013, ONCOGENE, V32, P491, DOI 10.1038/onc.2012.61; Gao P, 2011, J HEPATOL, V54, P1177, DOI 10.1016/j.jhep.2010.09.023; Gill K, 2001, FERTIL STERIL, V76, P1005, DOI 10.1016/S0015-0282(01)02735-2; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Motoyama K, 2010, INT J ONCOL, V36, P1089, DOI 10.3892/ijo_00000590; Mroczko B, 2007, CLIN CHIM ACTA, V380, P208, DOI 10.1016/j.cca.2007.02.037; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Okazaki T, 2005, J IMMUNOL, V174, P7531, DOI 10.4049/jimmunol.174.12.7531; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peng RQ, 2012, J BIOL CHEM, V287, P14301, DOI 10.1074/jbc.M111.337642; Penna E, 2011, EMBO J, V30, P1990, DOI 10.1038/emboj.2011.102; Qiang R, 2011, INT J BIOCHEM CELL B, V43, P632, DOI 10.1016/j.biocel.2011.01.002; Tsukamoto Y, 2010, CANCER RES, V70, P2339, DOI 10.1158/0008-5472.CAN-09-2777; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Wang HJ, 2009, J DIGEST DIS, V10, P258, DOI 10.1111/j.1751-2980.2009.00394.x; Wu WKK, 2010, ONCOGENE, V29, P5761, DOI 10.1038/onc.2010.352; Xing AY, 2013, EXP MOL PATHOL, V95, P91, DOI 10.1016/j.yexmp.2013.05.003; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yang ZZ, 2009, IUBMB LIFE, V61, P1075, DOI 10.1002/iub.252; Zhang BG, 2012, ONCOL REP, V27, P1019, DOI 10.3892/or.2012.1645; Zhang C, 2012, ADV ENG FORUM, V2-3, P7, DOI 10.4028/www.scientific.net/AEF.2-3.7; Zhang ZY, 2008, LAB INVEST, V88, P1358, DOI 10.1038/labinvest.2008.94	28	59	63	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91307	10.1371/journal.pone.0091307	http://dx.doi.org/10.1371/journal.pone.0091307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24740145	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300110
